# Den Europæiske Unions L 115/4. m

| | ISSN 1977-0634 |
| --- | --- |
| Den Europæiske Unions
  Tidende | L 115 |
| | |
| Dansk udgave | Retsforskrifter | 61. årgang4. maj 2018 |

ISSN 1977-0634

Den Europæiske Unions

Tidende

L 115

Dansk udgave

Retsforskrifter

61. årgang4. maj 2018

---

| Indhold | | II   Ikke-lovgivningsmæssige retsakter | Side |
| --- | --- | --- | --- |
| | | FORORDNINGER |
| | * | Kommissionens forordning (EU) 2018/669 af 16. april 2018 om ændring med henblik på tilpasning til den tekniske og videnskabelige udvikling af Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 om klassificering, mærkning og emballering af stoffer og blandinger (
  1
  ) | 1 |

Indhold

II   Ikke-lovgivningsmæssige retsakter

Side

FORORDNINGER

*

Kommissionens forordning (EU) 2018/669 af 16. april 2018 om ændring med henblik på tilpasning til den tekniske og videnskabelige udvikling af Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 om klassificering, mærkning og emballering af stoffer og blandinger (
  1
  )

1

1

| | |
| --- | --- |
| | (1)   EØS-relevant tekst. |

---

(1)   EØS-relevant tekst.

1

| DA | De akter, hvis titel er trykt med magre typer, er løbende retsakter inden for rammerne af landbrugspolitikken og har normalt en begrænset gyldighedsperiode.
  Titlen på alle øvrige akter er trykt med fede typer efter en asterisk. |
| --- | --- |

DA

De akter, hvis titel er trykt med magre typer, er løbende retsakter inden for rammerne af landbrugspolitikken og har normalt en begrænset gyldighedsperiode.

Titlen på alle øvrige akter er trykt med fede typer efter en asterisk.

---

II Ikke-lovgivningsmæssige retsakter

FORORDNINGER

| 4.5.2018 | DA | Den Europæiske Unions Tidende | L 115/1 |
| --- | --- | --- | --- |

4.5.2018

DA

Den Europæiske Unions Tidende

L 115/1

---

KOMMISSIONENS FORORDNING (EU) 2018/669

af 16. april 2018

om ændring med henblik på tilpasning til den tekniske og videnskabelige udvikling af Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 om klassificering, mærkning og emballering af stoffer og blandinger

(EØS-relevant tekst)

EUROPA-KOMMISSIONEN HAR —

under henvisning til traktaten om Den Europæiske Unions funktionsmåde,

under henvisning til Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 af 16. december 2008 om klassificering, mærkning og emballering af stoffer og blandinger og om ændring og ophævelse af direktiv 67/548/EØF og 1999/45/EF og om ændring af forordning (EF) nr. 1907/2006 (1), særlig artikel 53, stk. 1, og

ud fra følgende betragtninger:

| (1) | Tabel 3.1 og 3.2 i bilag VI til forordning (EF) nr. 1272/2008 indeholder listen over harmoniseret klassificering og mærkning af farlige stoffer, men kun på engelsk hvad angår alle forordningens sprogudgaver. |
| --- | --- |

(1)

Tabel 3.1 og 3.2 i bilag VI til forordning (EF) nr. 1272/2008 indeholder listen over harmoniseret klassificering og mærkning af farlige stoffer, men kun på engelsk hvad angår alle forordningens sprogudgaver.

| (2) | Den 2. december 2008 (2) forpligtede Kommissionen sig til at sikre, at de kemiske navne, der svarer til den internationale kemiske identifikation i tabel 3.1 og 3.2 i bilag VI til forordning (EF) nr. 1272/2008, offentliggøres på samme sprog som de sprogudgaver, på hvilke forordningen er offentliggjort. |
| --- | --- |

(2)

Den 2. december 2008 (2) forpligtede Kommissionen sig til at sikre, at de kemiske navne, der svarer til den internationale kemiske identifikation i tabel 3.1 og 3.2 i bilag VI til forordning (EF) nr. 1272/2008, offentliggøres på samme sprog som de sprogudgaver, på hvilke forordningen er offentliggjort.

| (3) | Tabel 3.1 i bilag VI til forordning (EF) nr. 1272/2008 er blevet ændret flere gange for at afspejle den tekniske og videnskabelige udvikling ved at tilføje, slette og ændre stoffer eller deres klassificering. For at tage hensyn til disse forandringer og for at sikre, at alle kemiske navne i tabel 3.1 i bilag VI til forordning (EF) nr. 1272/2008 angives på det sprog, på hvilket forordningen er offentliggjort, vil tabel 3.1 til dels blive erstattet. |
| --- | --- |

(3)

Tabel 3.1 i bilag VI til forordning (EF) nr. 1272/2008 er blevet ændret flere gange for at afspejle den tekniske og videnskabelige udvikling ved at tilføje, slette og ændre stoffer eller deres klassificering. For at tage hensyn til disse forandringer og for at sikre, at alle kemiske navne i tabel 3.1 i bilag VI til forordning (EF) nr. 1272/2008 angives på det sprog, på hvilket forordningen er offentliggjort, vil tabel 3.1 til dels blive erstattet.

| (4) | I henhold til undtagelsen (3), der gælder for oversættelsen til irsk af retsakter, der ikke er vedtaget af Europa-Parlamentet og Rådet i fællesskab, bør de kemiske navne i tabel 3.1 i bilag VI ikke oversættes til irsk. |
| --- | --- |

(4)

I henhold til undtagelsen (3), der gælder for oversættelsen til irsk af retsakter, der ikke er vedtaget af Europa-Parlamentet og Rådet i fællesskab, bør de kemiske navne i tabel 3.1 i bilag VI ikke oversættes til irsk.

| (5) | Tabel 3.2 indeholder en liste over harmoniseret klassificering og mærkning af farlige stoffer baseret på de kriterier, der er anført i bilag VI til Rådets direktiv 67/548/EØF (4), der er ophævet med virkning fra 1. juni 2015. Som følge heraf vil tabel 3.2 udgå i henhold til artikel 1, stk. 2, i Kommissionens forordning (EU) 2016/1179 (5) med virkning fra 1. juni 2017. Den tabel bør derfor ikke ændres. Som følge deraf er tabel 3.1 blevet omdøbt til tabel 3 i overensstemmelse med artikel 2, stk. 2, i Kommissionens forordning (EU) 2017/776 (6) med virkning fra 1. juni 2017. |
| --- | --- |

(5)

Tabel 3.2 indeholder en liste over harmoniseret klassificering og mærkning af farlige stoffer baseret på de kriterier, der er anført i bilag VI til Rådets direktiv 67/548/EØF (4), der er ophævet med virkning fra 1. juni 2015. Som følge heraf vil tabel 3.2 udgå i henhold til artikel 1, stk. 2, i Kommissionens forordning (EU) 2016/1179 (5) med virkning fra 1. juni 2017. Den tabel bør derfor ikke ændres. Som følge deraf er tabel 3.1 blevet omdøbt til tabel 3 i overensstemmelse med artikel 2, stk. 2, i Kommissionens forordning (EU) 2017/776 (6) med virkning fra 1. juni 2017.

| (6) | Leverandører bør gives tilstrækkelig tid til at tilpasse mærkningen og emballeringen af stoffer og blandinger til de nye bestemmelser vedrørende oversættelse og til at sælge eksisterende lagre. |
| --- | --- |

(6)

Leverandører bør gives tilstrækkelig tid til at tilpasse mærkningen og emballeringen af stoffer og blandinger til de nye bestemmelser vedrørende oversættelse og til at sælge eksisterende lagre.

| (7) | Leverandører bør have mulighed for at anvende forordningen inden dens anvendelsesdato for at sikre et højt beskyttelsesniveau for menneskers sundhed og for miljøet og for derigennem at tilvejebringe tilstrækkelig fleksibilitet for leverandører. |
| --- | --- |

(7)

Leverandører bør have mulighed for at anvende forordningen inden dens anvendelsesdato for at sikre et højt beskyttelsesniveau for menneskers sundhed og for miljøet og for derigennem at tilvejebringe tilstrækkelig fleksibilitet for leverandører.

| (8) | Foranstaltningerne i denne forordning er i overensstemmelse med udtalelsen fra det udvalg, der er nedsat ved artikel 133 i Europa-Parlamentets og Rådets forordning (EF) nr. 1907/2006 (7) — |
| --- | --- |

(8)

Foranstaltningerne i denne forordning er i overensstemmelse med udtalelsen fra det udvalg, der er nedsat ved artikel 133 i Europa-Parlamentets og Rådets forordning (EF) nr. 1907/2006 (7) —

VEDTAGET DENNE FORORDNING:

Artikel 1

De indgange, der er fastsat i bilag VI til forordning (EF) nr. 1272/2008 og svarer til de indgange, der er fastsat i bilaget til nærværende forordning, erstattes af de indgange, der er fastsat i bilaget til nærværende forordning.

Artikel 2

Denne forordning træder i kraft på tyvendedagen efter offentliggørelsen i Den Europæiske Unions Tidende.

Den anvendes fra den 1. december 2019

Uanset andet afsnit må stoffer og blandinger klassificeres, mærkes og emballeres i overensstemmelse med forordning (EF) nr. 1272/2008, som ændret ved nærværende forordning, før den 1. december 2019.

Denne forordning er bindende i alle enkeltheder og gælder umiddelbart i hver medlemsstat.

Udfærdiget i Bruxelles, den 16. april 2018.

På Kommissionens vegne

Jean-Claude JUNCKER

Formand

---

(1)  
  EUT L 353 af 31.12.2008, s. 1.

1

(2)  Berigtigelse af Europa-Parlamentets holdning, der blev fastlagt ved førstebehandlingen den 3. september 2008, med henblik på vedtagelse af Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 om klassificering, mærkning og emballering af stoffer og blandinger og om ændring og ophævelse af direktiv 67/548/EØF og 1999/45/EF og om ændring af forordning (EF) nr. 1907/2006 — P6_TA(2008)0392 (KOM(2007)0355 — C6-0197/2007 — 2007/0121 (COD)).

2

(3)  Rådets forordning (EU) nr. 1257/2010 af 20. december 2010 om forlængelse af de midlertidige undtagelsesforanstaltninger fra forordning nr. 1 af 15. april 1958 om den ordning, der skal gælde for Det Europæiske Økonomiske Fællesskab på det sproglige område, og fra forordning nr. 1 af 15. april 1958 om den ordning, der skal gælde for Det Europæiske Atomenergifællesskab på det sproglige område, der er indført ved forordning (EF) nr. 920/2005 (EUT L 343 af 29.12.2010, s. 5).

3

(4)  Rådets direktiv 67/548/EØF af 27. juni 1967 om tilnærmelse af love og administrative bestemmelser om klassificering, emballering og etikettering af farlige stoffer (EFT 196 af 16.8.1967, s. 1).

4

(5)  Kommissionens forordning (EU) 2016/1179 af 19. juli 2016 om ændring, med henblik på tilpasning til den tekniske og videnskabelige udvikling, af Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 om klassificering, mærkning og emballering af stoffer og blandinger (EUT L 195 af 20.7.2016, s. 11).

5

(6)  Kommissionens forordning (EU) 2017/776 af 4. maj 2017 om ændring, med henblik på tilpasning til den tekniske og videnskabelige udvikling, af Europa-Parlamentets og Rådets forordning (EF) nr. 1272/2008 om klassificering, mærkning og emballering af stoffer og blandinger (EUT L 116 af 5.5.2017, s. 1).

6

(7)  Europa-Parlamentets og Rådets forordning (EF) nr. 1907/2006 af 18. december 2006 om registrering, vurdering, godkendelse af samt begrænsninger for kemikalier (REACH), om oprettelse af et europæisk kemikalieagentur og om ændring af direktiv 1999/45/EF og ophævelse af Rådets forordning (EØF) nr. 793/93 og Kommissionens forordning (EF) nr. 1488/94 samt Rådets direktiv 76/769/EØF og Kommissionens direktiv 91/155/EØF, 93/67/EØF, 93/105/EF og 2000/21/EF (EUT L 396 af 30.12.2006, s. 1).

7

---

BILAG

| Indeksnr. | International kemisk identifikation | EF nr. | CAS nr. | Klassificering | Mærkning | Specifikke koncentrationsgrænser, M-faktorer | Noter |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Fareklasse og
  kategorikode(r) | Fare-sætnings-kode(r) | Piktogram-, signalordskode(r) | Faresætningskode(r) | Suppl. faresætningskode(r) |
| (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11) |
| 001-001-00-9 | hydrogen (brint) | 215-605-7 | 1333-74-0 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 001-002-00-4 | aluminiumlithiumhydrid | 240-877-9 | 16853-85-3 | Water-react. 1
  Skin Corr. 1A | H260
  H314 | GHS02
  GHS05
  Dgr | H260
  H314 | | | |
| 001-003-00-X | natriumhydrid | 231-587-3 | 7646-69-7 | Water-react. 1 | H260 | GHS02
  Dgr | H260 | | | |
| 001-004-00-5 | calciumhydrid | 232-189-2 | 7789-78-8 | Water-react. 1 | H260 | GHS02
  Dgr | H260 | | | |
| 003-001-00-4 | lithium | 231-102-5 | 7439-93-2 | Water-react. 1
  Skin Corr. 1B | H260
  H314 | GHS02
  GHS05
  Dgr | H260
  H314 | EUH014 | | |
| 003-002-00-X | n-hexyllithium | 404-950-0 | 21369-64-2 | Water-react. 1
  Pyr. Sol. 1
  Skin Corr. 1A | H260
  H250
  H314 | GHS02
  GHS05
  Dgr | H260
  H250
  H314 | EUH014 | | |
| 003-003-00-5 | (2-methylpropyl)lithium;
  isobutyllithium | 440-620-2 | 920-36-5 | Water-react. 1
  Pyr. Liq. 1
  Skin Corr. 1A
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H260
  H250
  H314
  H336
  H400
  H410 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H260
  H250
  H314
  H336
  H410 | EUH014 | | |
| 004-001-00-7 | beryllium | 231-150-7 | 7440-41-7 | Carc. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H350i
  H330
  H301
  H372 **
  H319
  H335
  H315
  H317 | GHS06
  GHS08
  Dgr | H350i
  H330
  H301
  H372 **
  H319
  H335
  H315
  H317 | | | |
| 004-002-00-2 | berylliumforbindelser med undtagelse af aluminiumberylliumsillicater samt sådanne nævnt andetsteds i dette bilag | — | — | Carc. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H350i
  H330
  H301
  H372 **
  H319
  H335
  H315
  H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350i
  H330
  H301
  H372 **
  H319
  H335
  H315
  H317
  H411 | | | A |
| 004-003-00-8 | berylliumoxid | 215-133-1 | 1304-56-9 | Carc. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H350i
  H330
  H301
  H372 **
  H319
  H335
  H315
  H317 | GHS06
  GHS08
  Dgr | H350i
  H330
  H301
  H372 **
  H319
  H335
  H315
  H317 | | | |
| 005-001-00-X | bortrifluorid | 231-569-5 | 7637-07-2 | Press. Gas
  Acute Tox. 2 *
  Skin Corr. 1A | H330
  H314 | GHS04
  GHS06
  GHS05
  Dgr | H330
  H314 | EUH014 | | U |
| 005-002-00-5 | bortriclorid | 233-658-4 | 10294-34-5 | Press. Gas
  Acute Tox. 2 *
  Acute Tox. 2 *
  Skin Corr. 1B | H330
  H300
  H314 | GHS04
  GHS06
  GHS05
  Dgr | H330
  H300
  H314 | EUH014 | | U |
| 005-003-00-0 | bortribromid | 233-657-9 | 10294-33-4 | Acute Tox. 2 *
  Acute Tox. 2 *
  Skin Corr. 1A | H330
  H300
  H314 | GHS06
  GHS05
  Dgr | H330
  H300
  H314 | EUH014 | | |
| 005-004-00-6 | trialkylboraner, fast | — | — | Pyr. Sol. 1
  Skin Corr. 1B | H250
  H314 | GHS02
  GHS05
  Dgr | H250
  H314 | | | A |
| 005-004-01-3 | trialkylboraner, flydende | — | — | Pyr. Liq. 1
  Skin Corr. 1B | H250
  H314 | GHS02
  GHS05
  Dgr | H250
  H314 | | | A |
| 005-005-00-1 | trimethylborat | 204-468-9 | 121-43-7 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H312 | GHS02
  GHS07
  Wng | H226
  H312 | | | |
| 005-006-00-7 | dibutyltinhydrogenborat | 401-040-5 | 75113-37-0 | Repr. 1B
  Muta. 2
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H360FD
  H341
  H372
  H312
  H302
  H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H360FD
  H341
  H372 **
  H312
  H302
  H318
  H317
  H410 | | | |
| 005-007-00-2 | borsyre; [1]
  borsyre; [2] | 233-139-2 [1]
  234-343-4 [2] | 10043-35-3 [1]
  11113-50-1 [2] | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | Repr.1B;
  H360FD: C ≥ 5,5  % | |
| 005-008-00-8 | dibortrioxid;
  boroxid | 215-125-8 | 1303-86-2 | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | Repr.1B;
  H360FD:C ≥ 3,1  % | |
| 005-009-00-3 | tetrabutylammonium butyltriphenylborat | 418-080-4 | 120307-06-4 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 005-010-00-9 | N, N-dimethylanilinium-tetrakis(pentafluorphenyl)borat | 422-050-6 | 118612-00-3 | Carc. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1 | H351
  H302
  H315
  H318 | GHS08
  GHS05
  GHS07
  Dgr | H351
  H302
  H315
  H318 | | | |
| 005-011-00-4 | dinatriumtetraborat, vandfrit; borsyredinatriumsalt; [1]
  tetrabordinatriumheptaoxid, hydrat; [2] orthoborsyre, natriumsalt [3] | 215-540-4 [1]
  235-541-3 [2]
  237-560-2 [3] | 1330-43-4 [1]
  12267-73-1 [2]
  13840-56-7 [3] | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | Repr. 1B; H360FD: C ≥ 4,5  % | |
| 005-011-01-1 | dinatriumtetraborat decahydrat;
  borax decahydrat | 215-540-4 | 1303-96-4 | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | Repr.1B; H360FD: C ≥ 8,5  % | |
| 005-011-02-9 | dinatriumtetraborat pentahydrat;
  borax pentahydrat | 215-540-4 | 12179-04-3 | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | Repr.1B; H360FD: C ≥ 6,5  % | |
| 005-012-00-X | diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienyliden]cyclohexa-2,5-dienyliden}ammonium butyltriphenylborat(1-) | 418-070-1 | 141714-54-7 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 005-013-00-5 | diethylmethoxyboran | 425-380-9 | 7397-46-8 | Pyr. Liq. 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 4 | H250
  H332
  H312
  H302
  H373 **
  H314
  H317
  H413 | GHS02
  GHS05
  GHS08
  GHS07
  Dgr | H250
  H332
  H312
  H302
  H373 **
  H314
  H317
  H413 | | | |
| 005-014-00-0 | 4-formylphenylboronsyre | 438-670-5 | 87199-17-5 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 005-015-00-6 | 1-chlormethyl-4-fluor-1,4-diazoniabicyclo[2.2.2]octanbis(tetrafluorborat) | 414-380-4 | 140681-55-6 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H317
  H412 | | | |
| 005-016-00-1 | tetrabutylammonium-butyl-tris-(4-tert-butylphenyl)borat | 431-370-5 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 005-017-00-7 | natriumperborat; [1]
  natriumperoxometaborat; [2]
  natriumperoxoborat;
  [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | 239-172-9 [1]
  231-556-4 [2] | 15120-21-5 [1]
  7632-04-4 [2] | Ox. Sol. 2
  Repr. 1B
  Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1 | H272
  H360Df
  H302
  H335
  H318 | GHS03
  GHS05
  GHS08
  GHS07
  Dgr | H272
  H360Df
  H302
  H335
  H318 | | Repr.1B; H360Df: C ≥ 9 % Repr.1B; H360 D: 6,5  % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % | |
| 005-017-01-4 | natriumperborat; [1]
  natriumperoxometaborat; [2] natriumperoxoborat;
  [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | 239-172-9 [1] 231-556-4 [2] | 15120-21-5 [1]
  7632-04-4 [2] | Ox. Sol. 2
  Repr. 1B
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1 | H272
  H360Df
  H331
  H302
  H335
  H318 | GHS03
  GHS06
  GHS05
  GHS08
  Dgr | H272
  H360Df
  H331
  H302
  H335
  H318 | | Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5  % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % | |
| 005-018-00-2 | perborsyre, (H3BO2(O2)), mononatriumsalt trihydrat; [1]
  perborsyre, natriumsalt, tetrahydrat; [2] perborsyre (HBO(O2)), natriumsalt, tetrahydrat [3]
  natriumperoxoborat hexahydrat;
  [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | 239-172-9 [1]
  234-390-0 [2]
  231-556-4 [3] | 13517-20-9 [1]
  37244-98-7 [2]
  10486-00-7 [3] | Repr. 1B
  STOT SE 3
  Eye Dam. 1 | H360Df
  H335
  H318 | GHS05
  GHS08
  GHS07
  Dgr | H360Df
  H335
  H318 | | Repr. 1B;
  H360Df: C ≥ 14 % Repr. 1B;
  H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2;
  H319: 22 % ≤ C < 36 % | |
| 005-018-01-X | perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1]
  perborsyre, natriumsalt, tetrahydrat; [2]
  perborsyre (HBO(O2)), natriumsalt, tetrahydrat; [3]
  natriumperoxoborat hexahydrat;
  [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | 239-172-9 [1]
  234-390-0 [2]
  231-556-4 [3] | 13517-20-9 [1]
  37244-98-7 [2]
  10486-00-7 [3] | Repr. 1B
  Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1 | H360Df
  H332
  H335
  H318 | GHS05
  GHS08
  GHS07
  Dgr | H360Df
  H332
  H335
  H318 | | Repr. 1B; H360
  Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % | |
| 005-019-00-8 | perborsyre, natriumsalt; [1]
  perborsyre, natriumsalt, monohydrat; [2] perborsyre (HBO(O2)), natriumsalt, monohydrat; [3]
  natriumperoxoborat;
  [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | 234-390-0 [1]
  234-390-0 [2]
  231-556-4 [3] | 11138-47-9 [1]
  12040-72-1 [2]
  10332-33-9 [3] | Ox. Sol. 3
  Repr. 1B
  Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1 | H272
  H360Df
  H302
  H335
  H318 | GHS03
  GHS05
  GHS08
  GHS07
  Dgr | H272
  H360Df
  H302
  H335
  H318 | | Repr. 1B; H360Df: C ≥ 9 %
  Repr. 1B; H360D: 6,5  % ≤ C < 9 %
  Eye Dam. 1; H318: C ≥ 22 %
  Eye Irrit. 2; H319: 14 % ≤ C < 22 % | |
| 005-019-01-5 | perborsyre, natriumsalt; [1]
  perborsyre, natriumsalt, monohydrat; [2]
  perborsyre (HBO(O2)), natriumsalt, monohydrat; [3]
  natriumperoxoborat;
  [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | 234-390-0 [1]
  234-390-0 [2]
  231-556-4 [3] | 11138-47-9 [1]
  12040-72-1 [2]
  10332-33-9 [3] | Ox. Sol. 3
  Repr. 1B
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1 | H272
  H360Df
  H331
  H302
  H335
  H318 | GHS03
  GHS06
  GHS05
  GHS08
  Dgr | H272
  H360Df
  H331
  H302
  H335
  H318 | | Repr. 1B; H360Df: C ≥
  9 %
  Repr. 1B; H360D: 6,5  %
  ≤ C < 9 %
  Eye Dam. 1; H318: C ≥ 22 %
  Eye Irrit. 2; H319: 14 % ≤ C < 22 % | |
| 006-001-00-2 | carbonmonoxid | 211-128-3 | 630-08-0 | Flam. Gas 1
  Press. Gas
  Repr. 1A
  Acute Tox. 3 *
  STOT RE 1 | H220
  H360D ***
  H331
  H372 ** | GHS02
  GHS04
  GHS06
  GHS08
  Dgr | H220
  H360D *** H331
  H372 ** | | | U |
| 006-002-00-8 | phosgen; carbonylchlorid | 200-870-3 | 75-44-5 | Press. Gas
  Acute Tox. 2 *
  Skin Corr. 1B | H330
  H314 | GHS04
  GHS06
  GHS05
  Dgr | H330
  H314 | | | U |
| 006-003-00-3 | carbondisulfid | 200-843-6 | 75-15-0 | Flam. Liq. 2
  Repr. 2
  STOT RE 1
  Eye Irrit. 2
  Skin Irrit. 2 | H225
  H361fd
  H372 **
  H319
  H315 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H361fd
  H372 **
  H319
  H315 | | Repr. 2; H361fd: C ≥ 1 %
  STOT RE 1; H372: C ≥ 1 %
  STOT RE 2; H373: 0,2  %
  ≤ C < 1 % | |
| 006-004-00-9 | calciumcarbid | 200-848-3 | 75-20-7 | Water-react. 1 | H260 | GHS02
  Dgr | H260 | | | T |
| 006-005-00-4 | thiram (ISO);
  tetramethylthiuramdisulfid | 205-286-2 | 137-26-8 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H373 **
  H319
  H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H332
  H302
  H373 **
  H319
  H315
  H317
  H410 | | M = 10 | |
| 006-006-00-X | hydrogencyanid;
  blåsyre | 200-821-6 | 74-90-8 | Flam. Liq. 1
  Acute Tox. 2 * Aquatic Acute 1
  Aquatic Chronic 1 | H224
  H330
  H400
  H410 | GHS02
  GHS06
  GHS09
  Dgr | H224
  H330
  H410 | | | |
| 006-006-01-7 | hydrogencyanid ... %;
  blåsyre ... % | 200-821-6 | 74-90-8 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H410 | | | B |
| 006-007-00-5 | salte af hydrogencyanid med undtagelse af komplekse salte som cyanoferrat (II) og-(III) og kviksølv(II)oxidcyanid samt sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H410 | EUH032 | | A |
| 006-008-00-0 | antu (ISO);
  1-(1-naphthyl)-2-thiourinstof | 201-706-3 | 86-88-4 | Acute Tox. 2 *
  Carc. 2 | H300
  H351 | GHS06
  GHS08
  Dgr | H300
  H351 | | | |
| 006-009-00-6 | 1-isopropyl-3-methylpyrazol-5-yldimethylcarbamat;
  isolan | 204-318-2 | 119-38-0 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 006-010-00-1 | 5,5-dimethyl-3-oxocyclohex-1-enyldimethylcarbamat; 5,5-dimethyldihydroresorcinoldimethylcarbamat; dimetan | 204-525-8 | 122-15-6 | Acute Tox. 3 * | H301 | GHS06
  Dgr | H301 | | | |
| 006-011-00-7 | carbaryl (ISO);
  1-naphthylmethylcarbamat | 200-555-0 | 63-25-2 | Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1 | H351
  H332
  H302
  H400 | GHS08
  GHS07
  GHS09
  Wng | H351
  H332
  H302
  H400 | | M = 100 | |
| 006-012-00-2 | ziram (ISO);
  zink-bis(N, N-dimethyldithiocarbamat) | 205-288-3 | 137-30-4 | Acute Tox. 2 *
  Acute Tox. 4 *
  STOT RE 2 *
  STOT SE 3
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H302
  H373 **
  H335
  H318
  H317
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H330
  H302
  H373 **
  H335
  H318
  H317
  H410 | | M = 100 | |
| 006-013-00-8 | metam-natrium (ISO);
  natrium-N-methyldithiocarbamat | 205-293-0 | 137-42-8 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H317
  H410 | EUH031 | | |
| 006-014-00-3 | nabam (ISO);
  dinatriumethylenbisdithiocarbamat | 205-547-0 | 142-59-6 | Acute Tox. 4 *
  STOT SE 3
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H335
  H317
  H410 | GHS07
  GHS09
  Wng | H302
  H335
  H317
  H410 | | | |
| 006-015-00-9 | diuron (ISO);
  3-(3,4-dichlorphenyl)-1,1-dimethylurinstof | 206-354-4 | 330-54-1 | Carc. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H373 ** H410 | | M = 10 | |
| 006-016-00-4 | propoxur (ISO);
  2-isopropyloxyphenylmethylcarbamat;
  2-isopropoxyphenylmethylcarbamat | 204-043-8 | 114-26-1 | Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | | |
| 006-017-00-X | aldicarb (ISO);
  2-methyl-2-(methylthio)propionaldehyd-O-(methylcarbamoyl)oxim | 204-123-2 | 116-06-3 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H311
  H410 | | | |
| 006-018-00-5 | aminocarb (ISO);
  4-dimethylamino-3-tolylmethylcarbamat | 217-990-7 | 2032-59-9 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | | |
| 006-019-00-0 | di-allat (ISO);

  S-2,3-dichlorallyldiisopropylthiocarbamat | 218-961-1 | 2303-16-4 | Carc. 2
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H410 | | | |
| 006-020-00-6 | barban (ISO);
  4-chlorbut-2-ynyl-3-chlorphenylcarbamat | 202-930-4 | 101-27-9 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 006-021-00-1 | linuron (ISO);
  3-(3,4-dichlorphenyl)-1-methoxy-1-methylurinstof | 206-356-5 | 330-55-2 | Repr. 1B Carc. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H351
  H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H360Df
  H351
  H302
  H373 **
  H410 | | | |
| 006-022-00-7 | decarbofuran (ISO);
  2,3-dihydro-2-methyl-7-benzofuranyl-methylcarbamat | — | 1563-67-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | |
| 006-023-00-2 | mercaptodimethur (ISO);
  methiocarb (ISO);
  4-methylthio-3,5-xylylmethylcarbamat methiocarb | 217-991-2 | 2032-65-7 | Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | | |
| 006-024-00-8 | proxan-Na (ISO);
  natrium-isopropyl-xanthogenat | 205-443-5 | 140-93-2 | Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Chronic 2 | H302
  H315
  H411 | GHS07
  GHS09
  Wng | H302
  H315
  H411 | | | |
| 006-025-00-3 | allethrin;
  (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3RS)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat; bioallethrin;
  (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat; [1]

  S-bioallethrin; [2]
  (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat; [3]
  esbiothrin;
  (RS)-3-allyl-2-methyl-4- oxocyclopent-2-enyl(1R,3R)- 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat | 209-542-4 [1]
  249-013-5 [2]-[3] | 584-79-2 [1]
  28434-00-6 [2]
  84030-86-4 [3] | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H302
  H410 | | | C |
| 006-026-00-9 | carbofuran (ISO);
  2,3-dihydro-2,2-dimethylbenzofuran-7-ylmethylcarbamat | 216-353-0 | 1563-66-2 | Acute Tox. 2 *
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H410 | | | |
| 006-028-00-X | dinobuton (ISO);
  2-sec-butyl-4,6-dinitrophenylisopropylcarbonat | 213-546-1 | 973-21-7 | Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | | |
| 006-029-00-5 | dioxacarb (ISO);
  2-(1,3-dioxolan-2-yl)phenylmethylcarbamat | 230-253-4 | 6988-21-2 | Acute Tox. 3 * Aquatic Chronic 2 | H301
  H411 | GHS06
  GHS09
  Dgr | H301
  H411 | | | |
| 006-030-00-0 | EPTC (ISO);

  S-ethyldipropylthiocarbamat | 212-073-8 | 759-94-4 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 006-031-00-6 | formetanat (ISO);
  3-[(EZ)-dimethylaminomethylenamino]phenylmethylcarbamat | 244-879-0 | 22259-30-9 | Acute Tox. 2 *
  Acute Tox. 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H317
  H410 | | | |
| 006-032-00-1 | monolinuron (ISO);
  3-(4-dichlorphenyl)-1-methoxy-1-methylurinstof | 217-129-5 | 1746-81-2 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H410 | | | |
| 006-033-00-7 | metoxuron (ISO);

  N'-(3-chlor-4-methoxyphenyl)-N, N-dimethylurinstof | 243-433-2 | 19937-59-8 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 006-034-00-2 | pebulat (ISO);

  S-propylbutyl (ethyl) thiocarbamat | 214-215-4 | 1114-71-2 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 006-036-00-3 | benzthiazuron (ISO);
  1-benzothiazol-2-yl-3-methylurinstof | 217-685-9 | 1929-88-0 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 006-037-00-9 | promecarb (ISO);
  5-isopropyl-3-tolylmethylcarbamat | 220-113-0 | 2631-37-0 | Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | | |
| 006-038-00-4 | sulfallat (ISO);
  2-chlorallyldiethyldithiocarbamat | 202-388-9 | 95-06-7 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H410 | | | |
| 006-039-00-X | tri-allat (ISO);

  S-2,3,3-trichlorallyldiisopropylthiocarbamat | 218-962-7 | 2303-17-5 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H317
  H410 | | | |
| 006-040-00-5 | (3-methyl-1H-pyrazol-5-yl)-N, N-dimethylcarbamat; | — | 2532-43-6 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | |
| 006-041-00-0 | dimethylcarbamoylchlorid | 201-208-6 | 79-44-7 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H350
  H331
  H302
  H319
  H335
  H315 | GHS06
  GHS08
  Dgr | H350
  H331
  H302
  H319
  H335
  H315 | | Carc. 1B;
  H350: C ≥ 0.001 % | |
| 006-042-00-6 | monuron (ISO);
  3-(4-dichlorphenyl)-1,1-dimethylurinstof | 205-766-1 | 150-68-5 | Carc. 2
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H410 | | | |
| 006-043-00-1 | 3-(4-chlorphenyl)-1,1-dimethyluroniumtrichloracetat;
  monuron-TCA | — | 140-41-0 | Carc. 2
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H319
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H319
  H315
  H410 | | | |
| 006-044-00-7 | isoproturon (ISO);
  3-(4-isopropylphenyl)-1,1-dimethylurinstof | 251-835-4 | 34123-59-6 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | M = 10 | |
| 006-045-00-2 | methomyl (ISO);
  1-(methylthio)ethylidenamino-N-methylcarbamat | 240-815-0 | 16752-77-5 | Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H410 | | M = 100 | |
| 006-047-00-3 | bufencarb (ISO);
  blanding af 3-(1-methylbutyl) phenylmethylcarbamat og 3-(1-ethylpropyl) phenylmethylcarbamat (3:1) | — | 8065-36-9 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | | |
| 006-048-00-9 | ethiofencarb (ISO);
  2-ethylthiomethylphenylmethylcarbamat | 249-981-9 | 29973-13-5 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 006-049-00-4 | dixanthogen;

  O,O-diethyldithiobis(thioformiat) | 207-944-4 | 502-55-6 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 006-050-00-X | 1,1-dimethylphenyluroniumtrichloracetat;
  fenuron-TCA | — | 4482-55-7 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 006-051-00-5 | ferbam (ISO);
  jerntris(dimethyldithiocarbamat) | 238-484-2 | 14484-64-1 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H410 | | | |
| 006-052-00-0 | formetanathydrochlorid;
  3-(N, N-dimethylaminomethylenamino)phenyl-N-methylcarbamat | 245-656-0 | 23422-53-9 | Acute Tox. 2 *
  Acute Tox. 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H317
  H410 | | | |
| 006-053-00-6 | isoprocarb (ISO);

  O-cumenylmethylcarbamat | 220-114-6 | 2631-40-5 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 006-054-00-1 | mexacarbat (ISO);
  4-dimethylamino-3,5-xylylmethylcarbamat | 206-249-3 | 315-18-4 | Acute Tox. 2 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H312
  H410 | | | |
| 006-055-00-7 | xylylcarb (ISO);
  3,4-dimethylphenyl N-methylcarbamat;
  3,4-xylylmethylcarbamat;
  MPMC | 219-364-9 | 2425-10-7 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 006-056-00-2 | metolcarb (ISO);

  m-tolylmethylcarbamat;
  MTMC | 214-446-0 | 1129-41-5 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 006-057-00-8 | nitrapyrin (ISO);
  2-chlor-6-trichlormethylpyridin | 217-682-2 | 1929-82-4 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 006-058-00-3 | noruron (ISO);
  1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urinstof | — | 2163-79-3 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 006-059-00-9 | oxamyl (ISO);

  N',N'-dimethylcarbamoyl(methylthio)methylenamin-N-methylcarbamat | 245-445-3 | 23135-22-0 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H330
  H300
  H312
  H411 | GHS06
  GHS09
  Dgr | H330
  H300
  H312
  H411 | | | |
| 006-060-00-4 | oxycarboxin (ISO);
  5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxanilid-4,4-dioxid | 226-066-2 | 5259-88-1 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 006-061-00-X | S-ethyl-N-(dimethylaminopropyl)thiocarbamathydrochlorid;
  prothiocarb hydrochlorid | 243-193-9 | 19622-19-6 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 006-062-00-5 | methyl-3,4-dichlorphenylcarbanilat
  SWEP | — | 1918-18-9 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 006-063-00-0 | thiobencarb (ISO);
  S-4-chlorbenzyldiethylthiocarbamat | 248-924-5 | 28249-77-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 006-064-00-6 | thiofanox (ISO);
  3,3-dimethyl-1-(methylthio)butanon-O-(N-methylcarbamoyl)oxim | 254-346-4 | 39196-18-4 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | | |
| 006-065-00-1 | 3-chlor-6-cyanobicyclo(2,2,1)heptan-2-on-O-(N-methylcarbamoyl)oxim;
  triamid | — | 15271-41-7 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H300
  H311
  H411 | GHS06
  GHS09
  Dgr | H300
  H311
  H411 | | | |
| 006-066-00-7 | vernolat (ISO);

  S-propyldipropylthiocarbamat | 217-681-7 | 1929-77-7 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 006-067-00-2 | 3,5-xylylmethylcarbamat; XMC | — | 2655-14-3 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 006-068-00-8 | diazomethan | 206-382-7 | 334-88-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 006-069-00-3 | thiophanatmethyl (ISO);
  1,2-di-(3-methoxycarbonyl-2-thioureido)benzen | 245-740-7 | 23564-05-8 | Muta. 2
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H332
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H341
  H332
  H317
  H410 | | | |
| 006-070-00-9 | furmecyclox (ISO);

  N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamid | 262-302-0 | 60568-05-0 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 006-071-00-4 | cyclooct-4-en-1-ylmethylcarbonat | 401-620-8 | 87731-18-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 006-072-00-X | prosulfocarb (ISO);
  S-benzyl-N, N-dipropylthiocarbamat | 401-730-6 | 52888-80-9 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 006-073-00-5 | 3-(dimethylamino)propylurinstof | 401-950-2 | 31506-43-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 006-074-00-0 | 2-(3-(prop-1-en-2-yl)phenyl)prop-2-ylisocyanat | 402-440-2 | 2094-99-7 | Acute Tox. 2 *
  Skin Corr. 1B
  STOT RE 2 *
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H314
  H373 **
  H334
  H317
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H330
  H314
  H373 **
  H334
  H317
  H410 | | | |
| 006-076-00-1 | mancozeb (ISO);
  manganethylenbis(dithiocarbamat) (polymer), kompleks med zinksalt | — | 8018-01-7 | Repr. 2
  Skin Sens. 1
  Aquatic Acute 1 | H361d ***
  H317
  H400 | GHS08
  GHS07
  GHS09
  Wng | H361d ***
  H317
  H400 | | M = 10 | |
| 006-077-00-7 | maneb (ISO);
  manganethylenbis(dithiocarbamat) (polymer) | 235-654-8 | 12427-38-2 | Repr. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d ***
  H332
  H319
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361d ***
  H332
  H319
  H317
  H410 | | M = 10 | |
| 006-078-00-2 | zineb (ISO);
  zinkethylenbis(dithiocarbamat) (polymer) | 235-180-1 | 12122-67-7 | STOT SE 3
  Skin Sens. 1 | H335
  H317 | GHS07
  Wng | H335
  H317 | | | |
| 006-079-00-8 | disulfiram;
  tetraethylthiuramdisulfid | 202-607-8 | 97-77-8 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H317
  H410 | | | |
| 006-080-00-3 | tetramethylthiurammonosulfid | 202-605-7 | 97-74-5 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 006-081-00-9 | zinkbis(dibutyldithiocarbamat) | 205-232-8 | 136-23-2 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H335
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H317
  H410 | | | |
| 006-082-00-4 | zinkbis(diethyldithiocarbamat) | 238-270-9 | 14324-55-1 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H335
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H335
  H315
  H317
  H410 | | | |
| 006-083-00-X | butocarboxim (ISO;
  3-(methylthio)-2-butanon O-[(methylamino)carbonyl]oxim | 252-139-3 | 34681-10-2 | Flam. Liq. 3
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H331
  H311
  H301
  H319
  H400
  H410 | GHS02
  GHS06
  GHS09
  Dgr | H226
  H331
  H311
  H301
  H319
  H410 | | | |
| 006-084-00-5 | carbosulfan (ISO);
  2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamat | 259-565-9 | 55285-14-8 | Acute Tox. 2 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H301
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H301
  H317
  H410 | | | |
| 006-085-00-0 | fenobucarb (ISO);
  2-butylphenylmethylcarbamat | 223-188-8 | 3766-81-2 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 006-086-00-6 | fenoxycarb (ISO);
  ethyl [2-(4-phenoxyphenoxy)ethyl]carbamat | 276-696-7 | 72490-01-8 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | M = 1
  M = 10 000 | |
| 006-087-00-1 | furathiocarb (ISO);
  2,3-dihydro-2,2-dimethyl-7-benzofuryl-2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoat | 265-974-3 | 65907-30-4 | Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H301
  H373 **
  H319
  H315
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H301
  H373 **
  H319
  H315
  H317
  H410 | | M = 100 | |
| 006-088-00-7 | benfuracarb (ISO);
  ethyl-N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninat | — | 82560-54-1 | Repr. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f ***
  H331
  H302
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361f ***
  H331
  H302
  H410 | | | |
| 006-090-00-8 | 2-(3-iodprop-2-yn-1-yloxy)ethylphenylcarbamat | 408-010-0 | 88558-41-2 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H332
  H318
  H412 | GHS05
  GHS07
  Dgr | H332
  H318
  H412 | | | |
| 006-091-00-3 | propineb (ISO)
  polymert zink-propylenbis(dithiocarbamat) | — | 9016-72-2 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1 | H332
  H373 **
  H317
  H400 | GHS08
  GHS07
  GHS09
  Wng | H332
  H373 **
  H317
  H400 | | | |
| 006-092-00-9 | tert-butyl-(1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamat | 425-420-5 | 98737-29-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 006-093-00-4 | 2,2'-dithio-di(ethylammonium)bis(dibenzyldithiocarbamat) | 427-180-7 | — | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 006-094-00-X | O-isobutyl-N-ethoxycarbonylthiocarbamat | 434-350-4 | 103122-66-3 | Flam. Liq. 3
  Carc. 1B
  Muta. 1B
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H226
  H350
  H340
  H302
  H373 **
  H317
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H226
  H350
  H340
  H302
  H373 **
  H317
  H411 | | | |
| 006-095-00-5 | fosetyl-aluminium (ISO);
  aluminiumtriethyltriphosphonat | 254-320-2 | 39148-24-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 006-096-00-0 | chlorpropham (ISO);
  isopropyl-3-chlorcarbanilat | 202-925-7 | 101-21-3 | Carc. 2
  STOT RE 2 *
  Aquatic Chronic 2 | H351
  H373 **
  H411 | GHS08
  GHS09
  Wng | H351
  H373 **
  H411 | | | |
| 006-097-00-6 | 1-phenyl-3-(p-toluensulfonyl)urinstof | 424-620-1 | 13909-63-2 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 3 | H302
  H373 **
  H412 | GHS08
  GHS07
  Wng | H302
  H373 **
  H412 | | | |
| 006-098-00-1 | tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamat | 429-170-8 | 134575-17-0 | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H373 **
  H318
  H317 | GHS05
  GHS08
  GHS07
  Dgr | H302
  H373 **
  H318
  H317 | | | |
| 006-099-00-7 | N-(p-toluensulfonyl)-N'-(3-(p-toluensulfonyloxy)phenyl)urinstof;
  3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzensulfonat | 520-2 | 232938-43-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 006-101-00-6 | blanding af N, N''-(methylendi-4,1-phenylen)bis[N'-phenylurinstof];

  N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurinstof;

  N, N''-(methylendi-4,1-phenylen)bis[N'-cyclohexylurinstof] | 423-070-8 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 006-102-00-1 | O-hexyl-N-ethoxycarbonylthiocarbamat | 432-750-3 | — | Carc. 1B
  Muta. 1B
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H350
  H340
  H302
  H373 **
  H317
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H340
  H302
  H373 **
  H317
  H411 | | | |
| 006-103-00-7 | N,N′′-(methylendi-4,1-phenylen)bis[N′-octyl]urinstof | 445-760-8 | — | Eye Dam. 1
  Resp. Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H334
  H400
  H410 | GHS05
  GHS08
  GHS09
  Dgr | H318
  H334
  H410 | | M = 100 | |
| 007-001-00-5 | ammoniak, vandfri | 231-635-3 | 7664-41-7 | Flam. Gas 2
  Press. Gas
  Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Acute 1 | H221
  H331
  H314
  H400 | GHS04
  GHS06
  GHS05
  GHS09
  Dgr | H221
  H331
  H314
  H400 | | | U |
| 007-001-01-2 | ammoniak ....% | 215-647-6 | 1336-21-6 | Skin Corr. 1B
  Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | | STOT SE 3; H335: C ≥ 5 % | B |
| 007-002-00-0 | nitrogendioxid; [1]
  dinitrogentetraoxid [2] | 233-272-6 [1]
  234-126-4 [2] | 10102-44-0 [1]
  10544-72-6 [2] | Press. Gas
  Ox. Gas 1
  Acute Tox. 2 *
  Skin Corr. 1B | H270
  H330
  H314 | GHS04
  GHS03
  GHS06
  GHS05
  Dgr | H270
  H330
  H314 | | *
  STOT SE 3; H335: C ≥ 0,5  % | 5 |
| 007-003-00-6 | chlormequatchlorid (ISO);
  2-chlorethyltrimethylammoniumchlorid | 213-666-4 | 999-81-5 | Acute Tox. 4 *
  Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 007-006-00-2 | ethylnitrit | 203-722-6 | 109-95-5 | Flam. Gas 1
  Press. Gas
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H220
  H332
  H312
  H302 | GHS02
  GHS04
  GHS07
  Dgr | H220
  H332
  H312
  H302 | | | U |
| 007-007-00-8 | ethylnitrat | 210-903-3 | 625-58-1 | Unst. Expl. | H200 | GHS01
  Dgr | H200 | | | |
| 007-008-00-3 | hydrazin | 206-114-9 | 302-01-2 | Flam. Liq. 3
  Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H350
  H331
  H311
  H301
  H314
  H317
  H400
  H410 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H226
  H350
  H331
  H311
  H301
  H314
  H317
  H410 | | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 %
  Eye Irrit. 2; H319: 3 % ≤ C < 10 % | |
| 007-009-00-9 | dicyclohexylammoniumnitrit | 221-515-9 | 3129-91-7 | Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H302 | GHS07
  Wng | H332
  H302 | | * | |
| 007-010-00-4 | natriumnitrit | 231-555-9 | 7632-00-0 | Ox. Sol. 3
  Acute Tox. 3 *
  Aquatic Acute 1 | H272
  H301
  H400 | GHS03
  GHS06
  GHS09
  Dgr | H272
  H301
  H400 | | * | |
| 007-011-00-X | kaliumnitrit | 231-832-4 | 7758-09-0 | Ox. Sol. 2
  Acute Tox. 3 *
  Aquatic Acute 1 | H272
  H301
  H400 | GHS03
  GHS06
  GHS09
  Dgr | H272
  H301
  H400 | | * | |
| 007-012-00-5 | N, N-dimethylhydrazin | 200-316-0 | 57-14-7 | Flam. Liq. 2
  Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H225
  H350
  H331
  H301
  H314
  H411 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H225
  H350
  H331
  H301
  H314
  H411 | | | |
| 007-013-00-0 | 1,2-dimethylhydrazin | — | 540-73-8 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H350
  H331
  H311
  H301
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H311
  H301
  H411 | | Carc. 1B; H350: C ≥ 0,01  % | |
| 007-014-00-6 | salte af hydrazin | — | — | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H331
  H311
  H301
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H311
  H301
  H317
  H410 | | | A |
| 007-015-00-1 | O-ethylhydroxylamin | 402-030-3 | 624-86-2 | Flam. Liq. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H225
  H331
  H311
  H301
  H372 **
  H319
  H317
  H400 | GHS02
  GHS06
  GHS08
  GHS09
  Dgr | H225
  H331
  H311
  H301
  H372 **
  H319
  H317
  H400 | | | |
| 007-016-00-7 | butylnitrit | 208-862-1 | 544-16-1 | Flam. Liq. 2
  Acute Tox. 3 *
  Acute Tox. 3 * | H225
  H331
  H301 | GHS02
  GHS06
  Dgr | H225
  H331
  H301 | | | |
| 007-017-00-2 | isobutylnitrit | 208-819-7 | 542-56-3 | Flam. Liq. 2
  Carc. 1B
  Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H350
  H341
  H332
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H350
  H341
  H332
  H302 | | | |
| 007-018-00-8 | sec-butylnitrit | 213-104-8 | 924-43-6 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H332
  H302 | GHS02
  GHS07
  Dgr | H225
  H332
  H302 | | | |
| 007-019-00-3 | tert-butylnitrit | 208-757-0 | 540-80-7 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H332
  H302 | GHS02
  GHS07
  Dgr | H225
  H332
  H302 | | | |
| 007-020-00-9 | pentylnitrit; [1]
  amylnitrit, blanding af isomerer [2] | 207-332-7 [1]
  203-770-8 [2] | 463-04-7 [1]
  110-46-3 [2] | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H332
  H302 | GHS02
  GHS07
  Dgr | H225
  H332
  H302 | | | |
| 007-021-00-4 | hydrazobenzen;
  1,2-diphenylhydrazin | 204-563-5 | 122-66-7 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H410 | | | |
| 007-022-00-X | hydrazinbis(3-carboxy-4-hydroxybenzensulfonat) | 405-030-1 | — | Carc. 1B
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H350
  H302
  H314
  H317
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H350
  H302
  H314
  H317
  H412 | | | |
| 007-023-00-5 | natrium-3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzensulfonat | 405-510-0 | — | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 007-024-00-0 | 2-(decylthio)ethylammoniumchlorid | 405-640-8 | 36362-09-1 | STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H315
  H318
  H400
  H410 | GHS08
  GHS05
  GHS09
  Dgr | H373 **
  H315
  H318
  H410 | | | |
| 007-025-00-6 | (4-hydrazinophenyl)-N-methylmethansulfonamidhydrochlorid | 406-090-1 | 81880-96-8 | Muta. 2
  Acute Tox. 3 *
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H301
  H372 **
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H341
  H301
  H372 **
  H317
  H410 | | | |
| 007-026-00-1 | oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazid | 413-230-5 | 122035-71-6 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 007-027-00-7 | 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexan | 420-190-2 | 771478-66-1 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H373 **
  H314
  H317
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H373 **
  H314
  H317
  H410 | | | |
| 007-028-00-2 | hydroxylammoniumnitrat | 236-691-2 | 13465-08-2 | Expl. 1,1 ****
  Carc. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H201
  H351
  H311
  H302
  H373 **
  H319
  H315
  H317
  H400 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H351
  H311
  H302
  H373 **
  H319
  H315
  H317
  H400 | | | |
| 007-029-00-8 | diethyldimethylammoniumhydroxid | 419-400-5 | 95500-19-9 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | | |
| 008-001-00-8 | ilt | 231-956-9 | 7782-44-7 | Ox. Gas 1
  Press. Gas | H270 | GHS03
  GHS04
  Dgr | H270 | | | U |
| 008-003-00-9 | hydrogenperoxidopløsning ... % | 231-765-0 | 7722-84-1 | Ox. Liq. 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H271
  H332
  H302
  H314 | GHS03
  GHS05
  GHS07
  Dgr | H271
  H332
  H302
  H314 | | Ox. Liq. 1; H271: C ≥ 70 % ****
  Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****
  *
  Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 %
  Skin Irrit. 2; H315: 35 % ≤ C < 50 %
  Eye Dam. 1; H318: 8 % ≤ C < 50 %
  Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 % | B |
| 009-001-00-0 | fluor | 231-954-8 | 7782-41-4 | Press. Gas
  Ox. Gas 1
  Acute Tox. 2 *
  Skin Corr. 1A | H270
  H330
  H314 | GHS04
  GHS03
  GHS06
  GHS05
  Dgr | H270
  H330
  H314 | | | |
| 009-002-00-6 | hydrogenfluorid | 231-634-8 | 7664-39-3 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Skin Corr. 1A | H330
  H310
  H300
  H314 | GHS06
  GHS05
  Dgr | H330
  H310
  H300
  H314 | | | |
| 009-003-00-1 | hydrogenfluorid, opløsning ... % | 231-634-8 | 7664-39-3 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Skin Corr. 1A | H330
  H310
  H300
  H314 | GHS06
  GHS05
  Dgr | H330
  H310
  H300
  H314 | | Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C < 7 % Eye Irrit. 2; H319: 0,1  % ≤ C < 1 % | B |
| 009-004-00-7 | natriumfluorid | 231-667-8 | 7681-49-4 | Acute Tox. 3 *
  Eye Irrit. 2
  Skin Irrit. 2 | H301
  H319
  H315 | GHS06
  Dgr | H301
  H319
  H315 | EUH032 | | |
| 009-005-00-2 | kaliumfluorid | 232-151-5 | 7789-23-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | |
| 009-006-00-8 | ammoniumfluorid | 235-185-9 | 12125-01-8 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | |
| 009-007-00-3 | natriumbifluorid;
  natriumhydrogenfluorid | 215-608-3 | 1333-83-1 | Acute Tox. 3 *
  Skin Corr. 1B | H301
  H314 | GHS06
  GHS05
  Dgr | H301
  H314 * | | Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1  % ≤ C < 7 % Eye Irrit. 2;
  H319: 0,1  % ≤
  C < 1 % | |
| 009-008-00-9 | kaliumbiflourid;
  kaliumhydrogenfluorid | 232-156-2 | 7789-29-9 | Acute Tox. 3 *
  Skin Corr. 1B | H301
  H314 | GHS06
  GHS05
  Dgr | H301
  H314 | | *
  Skin Corr. 1B; H314: C ≥ 1 %
  Skin Irrit. 2; H315: 0,1  % ≤ C < 1 %
  Eye Irrit. 2; H319: 0,1  % ≤ C < 1 % | |
| 009-009-00-4 | ammoniumbiflourid;
  ammoniumhydrogenfluorid | 215-676-4 | 1341-49-7 | Acute Tox. 3 *
  Skin Corr. 1B | H301
  H314 | GHS06
  GHS05
  Dgr | H301
  H314 | | *
  Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1  % ≤ C < 1 %
  Eye Irrit. 2; H319: 0,1  % ≤ C < 1 % | |
| 009-010-00-X | flourborsyre ... % | 240-898-3 | 16872-11-0 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
  Eye Irrit. 2; H319: 10 % ≤
  C < 25 % | B |
| 009-011-00-5 | hydrogensilicimhexafluorid ... %, fluskiselsyre ... % % | 241-034-8 | 16961-83-4 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | B |
| 009-012-00-0 | ammonium- og alkalihexafluorosilicater(Na); [1]
  ammonium- og alkalihexafluorosilicater(K); [2] ammonium- og alkalihexafluorosilicater(NH4) [3] | 240-934-8 [1]
  240-896-2 [2]
  240-968-3 [3] | 16893-85-9 [1]
  16871-90-2 [2]
  16919-19-0 [3] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | * | A |
| 009-013-00-6 | hexafluorosilicater, undtagen de andetsteds i dette bilag nævnte | — | — | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | * | A |
| 009-014-00-1 | blyhexafluorosilicat | 247-278-1 | 25808-74-6 | Repr. 1A
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H332
  H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H360Df
  H332
  H302
  H373 **
  H410 | | | 1 |
| 009-015-00-7 | sulfuryldifluorid | 220-281-5 | 2699-79-8 | Press. Gas
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1 | H331
  H373 **
  H400 | GHS04
  GHS06
  GHS08
  GHS09
  Dgr | H331
  H373 **
  H400 | | | U |
| 009-016-00-2 | trinatriumhexafluoraluminat [1]
  trinatriumhexafluoraluminat(cryolite) [2] | 237-410-6 [1]
  239-148-8 [2] | 13775-53-6 [1]
  15096-52-3 [2] | STOT RE 1
  Acute Tox. 4
  Aquatic Chronic 2 | H372
  H332
  H411 | GHS07
  GHS08
  GHS09
  Dgr | H372
  H332
  H411 | | | |
| 009-017-00-8 | kalium-mu-fluor-bis(triethylaluminium) | 400-040-2 | 12091-08-6 | Flam. Sol. 1
  Water-react. 1
  Skin Corr. 1A
  Acute Tox. 4 * | H228
  H270
  H314
  H332 | GHS02
  GHS05
  GHS07
  Dgr | H228
  H270
  H314
  H332 | EUH014 | | T |
| 009-018-00-3 | magnesiumhexafluorosilicat | 241-022-2 | 16949-65-8 | Acute Tox. 3 * | H301 | GHS06
  Dgr | H301 | | * | |
| 011-001-00-0 | natrium | 231-132-9 | 7440-23-5 | Water-react. 1
  Skin Corr. 1B | H260
  H314 | GHS02
  GHS05
  Dgr | H260
  H314 | EUH014 | | |
| 011-002-00-6 | natriumhydroxid; kaustisk soda | 215-185-5 | 1310-73-2 | Skin Corr. 1A | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5  % ≤ C < 2 % Eye Irrit.2; H319: 0,5  % ≤ C < 2 % | |
| 011-003-00-1 | natriumperoxid | 215-209-4 | 1313-60-6 | Ox. Sol. 1
  Skin Corr. 1A | H271
  H314 | GHS03
  GHS05
  Dgr | H271
  H314 | | | |
| 011-004-00-7 | natriumazid | 247-852-1 | 26628-22-8 | Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H400
  H410 | EUH032 | | |
| 011-005-00-2 | natriumcarbonat | 207-838-8 | 497-19-8 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 011-006-00-8 | natriumcyanat | 213-030-6 | 917-61-3 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 011-007-00-3 | natriumpropoxycarbazon | — | 181274-15-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 10 | |
| 012-001-00-3 | magnesiumpulver (ustabiliseret) | 231-104-6 | 7439-95-4 | Water-react. 1
  Pyr. Sol. 1 | H260
  H250 | GHS02
  Dgr | H260
  H250 | | | T |
| 012-002-00-9 | magnesiumpulver (stabiliseret) og -spåner | 231-104-6 | — | Flam. Sol. 1
  Water-react. 2
  Self-heat. 1 | H228
  H261
  H252 | GHS02
  Dgr | H228
  H261
  H252 | | | T |
| 012-003-00-4 | magnesiumalkyler | — | — | Pyr. Liq. 1
  Water-react. 1
  Skin Corr. 1B | H250
  H260
  H314 | GHS02
  GHS05
  Dgr | H250
  H260
  H314 | EUH014 | | A |
| 012-004-00-X | aluminium-magnesium-carbonat-hydroxid-perchlorat-hydrat | 422-150-1 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 013-001-00-6 | aluminiumpulver (ustabiliseret) | 231-072-3 | 7429-90-5 | Water-react. 2
  Pyr. Sol. 1 | H261
  H250 | GHS02
  Dgr | H261
  H250 | | | T |
| 013-002-00-1 | aluminiumpulver (stabiliseret) | 231-072-3 | 7429-90-5 | Water-react. 2
  Flam. Sol. 1 | H261
  H228 | GHS02
  Dgr | H261
  H228 | | | T |
| 013-003-00-7 | aluminiumchlorid, vandfrit | 231-208-1 | 7446-70-0 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 013-004-00-2 | aluminiumalkyler | — | — | Pyr. Liq. 1
  Water-react. 1
  Skin Corr. 1B | H250
  H260
  H314 | GHS02
  GHS05
  Dgr | H250
  H260
  H314 | EUH014 | | A |
| 013-005-00-8 | diethyl(ethyldimethylsilanolato)aluminium | 401-160-8 | 55426-95-4 | Water-react. 1
  Pyr. Liq. 1
  Skin Corr. 1A | H260
  H250
  H314 | GHS02
  GHS05
  Dgr | H260
  H250
  H314 | EUH014 | | |
| 013-006-00-3 | (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxy-2-propanolato)aluminium(III), dimeriseret | 402-370-2 | — | Flam. Liq. 3
  Eye Dam. 1 | H226
  H318 | GHS02
  GHS05
  Dgr | H226
  H318 | | | |
| 013-007-00-9 | poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) | 403-430-0 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 013-008-00-4 | di-n-octylaluminiumiodid | 408-190-0 | 7585-14-0 | Pyr. Liq. 1
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H250
  H314
  H400
  H410 | GHS02
  GHS05
  GHS09
  Dgr | H250
  H314
  H410 | EUH014 | | |
| 013-009-00-X | natrium((n-butyl)x(ethyl)y-1,5-dihydro)aluminat) x = 0,5 y = 1,5 | 418-720-2 | — | Flam. Sol. 1
  Water-react. 1
  Pyr. Sol. 1
  Acute Tox. 4 *
  Skin Corr. 1A | H228
  H260
  H250
  H332
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H228
  H260
  H250
  H332
  H314 | EUH014 | | T |
| 013-010-00-5 | hydroxy-aluminium-bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxid) | 430-650-4 | 151841-65-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 014-001-00-9 | trichlorsilan | 233-042-5 | 10025-78-2 | Flam. Liq. 1
  Pyr. Liq. 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H224
  H250
  H332
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H224
  H250
  H332
  H302
  H314 | EUH014
  EUH029 | *
  STOT SE 3; H335: C ≥ 1 % | T |
| 014-002-00-4 | Siliciumtetrafluorid | 233-054-0 | 10026-04-7 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | EUH014 | | |
| 014-003-00-X | dichlordimethylsilan | 200-901-0 | 75-78-5 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H225
  H319
  H335
  H315 | GHS02
  GHS07
  Dgr | H225
  H319
  H335
  H315 | | | |
| 014-004-00-5 | trichlor(methyl)silan; methyltrichlorsilan | 200-902-6 | 75-79-6 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H225
  H319
  H335
  H315 | GHS02
  GHS07
  Dgr | H225
  H319
  H335
  H315 | EUH014 | Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | |
| 014-005-00-0 | tetraethylsilicat;
  ethylsilicat | 201-083-8 | 78-10-4 | Flam. Liq. 3
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H226
  H332
  H319
  H335 | GHS02
  GHS07
  Wng | H226
  H332
  H319
  H335 | | | |
| 014-006-00-6 | bis(4-fluorphenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silanhydrochlorid | 401-380-4 | — | Eye Irrit. 2
  Aquatic Chronic 2 | H319
  H411 | GHS07
  GHS09
  Wng | H319
  H411 | | | |
| 014-007-00-1 | triethoxyisobutylsilan | 402-810-3 | 17980-47-1 | Skin Irrit. 2 | H315 | GHS07
  Wng | H315 | | | |
| 014-008-00-7 | (chlormethyl)bis(4-fluorphenyl)methylsilan | 401-200-4 | 85491-26-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 014-009-00-2 | isobutylisopropyldimethoxysilan | 402-580-4 | 111439-76-0 | Flam. Liq. 3
  Acute Tox. 4 *
  Skin Irrit. 2 | H226
  H332
  H315 | GHS02
  GHS07
  Wng | H226
  H332
  H315 | | | |
| 014-010-00-8 | dinatriummetasilicat | 229-912-9 | 6834-92-0 | Skin Corr. 1B
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | | | |
| 014-011-00-3 | cyclohexyldimethoxymethylsilan | 402-140-1 | 17865-32-6 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 014-012-00-9 | bis(3-(trimethoxysilyl)propyl)amin | 403-480-3 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 014-013-00-4 | α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxan) | 404-920-7 | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H312
  H302
  H314
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H314
  H411 | | | |
| 014-014-00-X | etacelasil (ISO);
  6-(2-chlorethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecan | 253-704-7 | 37894-46-5 | Repr. 1B
  Acute Tox. 4 *
  STOT RE 2 * | H360D *** H302
  H373 ** | GHS08
  GHS07
  Dgr | H360D *** H302
  H373 ** | | | |
| 014-015-00-5 | α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilandiyl]-co-oxy (dimethylsilan)) | 406-420-4 | 69430-40-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 014-016-00-0 | blanding af 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxan;
  1,3-dihexen-1-yl-1,1,3,3-tetramethyldisiloxan | 406-490-6 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 014-017-00-6 | flusilazol (ISO);
  bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silan | — | 85509-19-9 | Carc. 2
  Repr. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H351
  H360D *** H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H351
  H360D *** H302
  H411 | | | |
| 014-018-00-1 | octamethylcyclotetrasiloxan | 209-136-7 | 556-67-2 | Repr. 2
  Aquatic Chronic 4 | H361f *** H413 | GHS08
  Wng | H361f *** H413 | | | |
| 014-019-00-7 | blanding af 4-[[bis-(4-fluorphenyl)methylsilyl]methyl]-4H-1,2,4-triazol;
  1-[[bis-(4-fluorphenyl)methylsilyl]methyl]-1H-1,2,4-triazol | 403-250-2 | — | Carc. 2
  Repr. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H351
  H360D *** H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H351
  H360D *** H302
  H411 | | | |
| 014-020-00-2 | bis(1,1-dimetil-2-propinilossi)dimetilsilano | 414-960-7 | 53863-99-3 | Acute Tox. 4 * | H332 | GHS07
  Wng | H332 | | | |
| 014-021-00-8 | tris(isopropenyloxy)phenylsilan | 411-340-8 | 52301-18-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H400
  H410 | | | |
| 014-022-00-3 | reaktionsproduktet af (2-hydroxy-4-(3-propenoxy)benzophenon og triethoxysilan med (hydrolyseproduktet af silica og methyltrimethoxy-silan) | 401-530-9 | — | Flam. Sol. 1
  STOT SE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H228
  H370 **
  H332
  H312
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H228
  H370 **
  H332
  H312
  H302 | | | T |
| 014-023-00-9 | α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxan) | 408-160-7 | 125613-45-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 014-024-00-4 | 1-((3-(3-chlor-4-fluorphenyl)propyl)dimethylsilanyl)-4-ethoxybenzen | 412-620-2 | 121626-74-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 014-025-00-X | 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidin | 411-400-3 | 102089-33-8 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H373 **
  H315
  H318
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H373 **
  H315
  H318
  H412 | | | |
| 014-026-00-5 | dichlor-(3-(3-chlor-4-fluorphenyl)propyl)methylsilan | 407-180-3 | 770722-36-6 | Skin Corr. 1A | H314 | GHS05
  Dgr | H314 | | | |
| 014-027-00-0 | chlor(3-(3-chlor-4-fluorphenyl)propyl)dimethylsilan | 410-270-5 | 770722-46-8 | Skin Corr. 1A | H314 | GHS05
  Dgr | H314 | | | |
| 014-028-00-6 | α-[3-(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyloxy-ω-[3-(1-oxoprop-2-enyl-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxan) | 415-290-8 | 193159-06-7 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 014-029-00-1 | O, O'-(ethenylmethylsilylen)di[(4-methylpentan-2-on)oxim] | 421-870-1 | 156145-66-3 | Repr. 2
  Acute Tox. 4 *
  STOT RE 2 * | H361f *** H302
  H373 ** | GHS08
  GHS07
  Wng | H361f *** H302
  H373 ** | | | |
| 014-030-00-7 | [(dimethylsilylen)bis((1,2,3,3a,7a-η)-1H-inden-1-yliden)dimethyl]hafnium | 422-060-0 | 137390-08-0 | Acute Tox. 2 * | H300 | GHS06
  Dgr | H300 | | | |
| 014-031-00-2 | bis(1-methylethyl)-dimethoxysilan | 421-540-7 | 18230-61-0 | Flam. Liq. 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H226
  H315
  H317
  H412 | GHS02
  GHS07
  Wng | H226
  H315
  H317
  H412 | | | |
| 014-032-00-8 | dicyclopentyldimethoxysilan | 404-370-8 | 126990-35-0 | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | | |
| 014-033-00-3 | 2-methyl-3-(trimethoxysilyl)propyl-2-propenoat, hydrolyseprodukt med silica | 419-030-4 | 125804-20-8 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H336 | | | |
| 014-034-00-9 | 3-hexylheptamethyltrisiloxan | 428-700-5 | 1873-90-1 | Acute Tox. 4 *
  Aquatic Chronic 4 | H332
  H413 | GHS07
  Wng | H332
  H413 | | | |
| 014-035-00-4 | 2-(3,4-epoxycyclohexyl)ethyltriethoxy silan | 425-050-4 | 10217-34-2 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 014-036-00-X | (4-ethoxyphenyl)(3-(4-fluor-3-phenoxyphenyl)propyl)dimethylsilan | 405-020-7 | 105024-66-6 | Repr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H360F *** H400
  H410 | GHS08
  GHS09
  Dgr | H360F *** H410 | | M = 1 000 | |
| 014-037-00-5 | 2-butanon-O, O',O''-(phenylsilylidyn)trioxim | 433-360-6 | 34036-80-1 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 3 | H373 **
  H317
  H412 | GHS08
  GHS07
  Wng | H373 **
  H317
  H412 | | | |
| 014-038-00-0 | S-(3-(triethoxysilyl)propyl)octanthioat | 436-690-9 | 220727-26-4 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilan | 439-360-2 | 142877-45-0 | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H315
  H318
  H412 | GHS05
  Dgr | H315
  H318
  H412 | | | |
| 014-041-00-7 | N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilan | 445-890-5 | 201290-01-9 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 014-042-00-2 | blanding af O, O',O'',O'''-silantetrayl-tetrakis(4-methyl-2-pentanonoxim) (3 stereoisomerer) | 423-010-0 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 014-043-00-8 | reaktionsprodukt mellem amorf silica (50-85 %), butyl(1-methylpropyl)magnesium (3-15 %), tetraethylorthosilicat (5-15 %) og titantetrachlorid (5-20 %) | 432-200-2 | — | STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H335
  H315
  H318
  H412 | GHS05
  GHS07
  Dgr | H335
  H315
  H318
  H412 | | | |
| 014-044-00-3 | 3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilan | 433-050-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 014-045-00-9 | magnesiumnatriumfluoridsilicat | 442-650-1 | — | STOT RE 2 * | H373 ** | GHS08
  Wng | H373 ** | | | |
| 015-001-00-1 | phosphor, hvid og gul | 231-768-7 | 12185-10-3 | Pyr. Sol. 1
  Acute Tox. 2 *
  Acute Tox. 2 *
  Skin Corr. 1A
  Aquatic Acute 1 | H250
  H330
  H300
  H314
  H400 | GHS02
  GHS06
  GHS05
  GHS09
  Dgr | H250
  H330
  H300
  H314
  H400 | | | |
| 015-002-00-7 | phosphor, rød | 231-768-7 | 7723-14-0 | Flam. Sol. 1
  Aquatic Chronic 3 | H228
  H412 | GHS02
  Dgr | H228
  H412 | | | |
| 015-004-00-8 | aluminiumphosphid | 244-088-0 | 20859-73-8 | Water-react. 1
  Acute Tox. 2
  Acute Tox. 3
  Acute Tox. 1
  Aquatic Acute 1 | H260
  H300
  H311
  H330
  H400 | GHS02
  GHS06
  GHS09
  Dgr | H260
  H300
  H311
  H330
  H400 | EUH029
  EUH032 | M = 100 | |
| 015-005-00-3 | magnesiumphosphid;
  trimagnesiumdiphosphid | 235-023-7 | 12057-74-8 | Water-react. 1
  Acute Tox. 2
  Acute Tox. 3
  Acute Tox. 1
  Aquatic Acute 1 | H260
  H300
  H311
  H330
  H400 | GHS02
  GHS06
  GHS09
  Dgr | H260
  H300
  H311
  H330
  H400 | EUH029
  EUH032 | M = 100 | |
| 015-006-00-9 | trizinkdiphosphid;
  zincphosphid | 215-244-5 | 1314-84-7 | Water-react. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H260
  H300
  H400
  H410 | GHS02
  GHS06
  GHS09
  Dgr | H260
  H300
  H410 | EUH029
  EUH032 | M = 100 | T |
| 015-007-00-4 | phosphortrichlorid | 231-749-3 | 7719-12-2 | Acute Tox. 2 *
  Acute Tox. 2 *
  STOT RE 2 *
  Skin Corr. 1A | H330
  H300
  H373 **
  H314 | GHS06
  GHS08
  GHS05
  Dgr | H330
  H300
  H373 **
  H314 | EUH014
  EUH029 | | |
| 015-008-00-X | phosphorpentachlorid | 233-060-3 | 10026-13-8 | Acute Tox. 2 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B | H330
  H302
  H373 **
  H314 | GHS06
  GHS08
  GHS05
  Dgr | H330
  H302
  H373 **
  H314 | EUH014
  EUH029 | | |
| 015-009-00-5 | phosphoryltrichlorid | 233-046-7 | 10025-87-3 | Acute Tox. 2 *
  STOT RE 1
  Acute Tox. 4 *
  Skin Corr. 1A | H330
  H372 **
  H302
  H314 | GHS06
  GHS08
  GHS05
  Dgr | H330
  H372 **
  H302
  H314 | EUH014
  EUH029 | | |
| 015-010-00-0 | phosphorpentaoxid | 215-236-1 | 1314-56-3 | Skin Corr. 1A | H314 | GHS05
  Dgr | H314 | | | |
| 015-011-00-6 | phosphorsyre ...% orthophosphorsyre ... % | 231-633-2 | 7664-38-2 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B |
| 015-012-00-1 | tetraphosphortrisulfid;
  phosphorsesquisulfid | 215-245-0 | 1314-85-8 | Flam. Sol. 2
  Water-react. 1
  Acute Tox. 4 *
  Aquatic Acute 1 | H228
  H260
  H302
  H400 | GHS02
  GHS07
  GHS09
  Dgr | H228
  H260
  H302
  H400 | | | T |
| 015-013-00-7 | triethylphosphat | 201-114-5 | 78-40-0 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 015-014-00-2 | tributylphosphat | 204-800-2 | 126-73-8 | Carc. 2
  Acute Tox. 4 *
  Skin Irrit. 2 | H351
  H302
  H315 | GHS08
  GHS07
  Wng | H351
  H302
  H315 | | | |
| 015-015-00-8 | tricresylphosphater (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolylphosphater (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-) | 201-103-5 | 78-30-8 | STOT SE 1
  Aquatic Chronic 2 | H370 **
  H411 | GHS08
  GHS09
  Dgr | H370 **
  H411 | | STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2  % ≤ C < 1 % | C |
| 015-016-00-3 | tricresylphosphater (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolylphosphater (m-m-m-, m-m-p-, m-p-p-, p-p-p-) | 201-105-6 | 78-32-0 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H312
  H302
  H411 | GHS07
  GHS09
  Wng | H312
  H302
  H411 | | * | C |
| 015-019-00-X | dichlorvos (ISO);
  2,2-dichlorvinyldimethylphosphat | 200-547-7 | 62-73-7 | Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1 | H330
  H311
  H301
  H317
  H400 | GHS06
  GHS09
  Dgr | H330
  H311
  H301
  H317
  H400 | | M = 1 000 | |
| 015-020-00-5 | mevinphos (ISO);
  2-methoxycarbonyl-1-methylvinyldimethylphosphat | 232-095-1 | 7786-34-7 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | M = 10 000 | |
| 015-021-00-0 | trichlorfon (ISO);
  dimethyl-2,2,2-trichlor-1-hydroxyethylphosphonat | 200-149-3 | 52-68-6 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H400
  H410 | | M = 1 000 | |
| 015-022-00-6 | phosphamidon (ISO);
  (2-chlor-3-diethylamino-1-methyl-3-oxo-prop-1-en-yl)-dimethylphosphat | 236-116-5 | 13171-21-6 | Muta. 2
  Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H300
  H311
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H341
  H300
  H311
  H410 | | | |
| 015-023-00-1 | pyrazoxon;

  O, O-diethyl-O-(3-methyl-1H-pyrazol-5-yl)-phosphat | — | 108-34-9 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 * | H330
  H310
  H300 | GHS06
  Dgr | H330
  H310
  H300 | | | |
| 015-024-00-7 | triamiphos (ISO);
  5-amino-3-phenyl-1,2,4-triazol-1-yl-N, N,N',N'-tetramethylphosphondiamid | — | 1031-47-6 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-025-00-2 | TEPP (ISO);
  tetraethylpyrophosphat | 203-495-3 | 107-49-3 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1 | H310
  H300
  H400 | GHS06
  GHS09
  Dgr | H310
  H300
  H400 | | | |
| 015-026-00-8 | schradan (ISO);
  octamethylpyrophosphoramid | 205-801-0 | 152-16-9 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-027-00-3 | sulfotep (ISO);

  O, O,O, O-tetraethyldithiopyrophosphat | 222-995-2 | 3689-24-5 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | M = 1 000 | |
| 015-028-00-9 | demeton-O (ISO);

  O, O-diethyl-O-2-ethylthioethylthiophosphat | 206-053-8 | 298-03-3 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1 | H310
  H300
  H400 | GHS06
  GHS09
  Dgr | H310
  H300
  H400 | | | |
| 015-029-00-4 | demeton-S (ISO);
  diethyl-S-2-ethylthioethylthiophosphat | 204-801-8 | 126-75-0 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-030-00-X | demeton-O-methyl (ISO);

  O-2-ethylthioethyl-O, O-dimethylthiophosphat | 212-758-1 | 867-27-6 | Acute Tox. 3 * | H301 | GHS06
  Dgr | H301 | | | |
| 015-031-00-5 | demeton-S-methyl (ISO);

  S-2-ethylthioethyldimethylthiophosphat | 213-052-6 | 919-86-8 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H311
  H301
  H411 | GHS06
  GHS09
  Dgr | H311
  H301
  H411 | | | |
| 015-032-00-0 | prothoat (ISO);

  O, O-diethylisopropylcarbamoylmethyldithiophosphat | 218-893-2 | 2275-18-5 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Chronic 3 | H310
  H300
  H412 | GHS06
  Dgr | H310
  H300
  H412 | | | |
| 015-033-00-6 | phorat (ISO);

  O, O-diethylethylthiomethyldithiophosphat | 206-052-2 | 298-02-2 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | M = 1 000 | |
| 015-034-00-1 | parathion (ISO);

  O, O-diethyl-O-4-nitrophenylthiophosphat | 200-271-7 | 56-38-2 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H311
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H300
  H311
  H372 **
  H410 | | M = 100 | |
| 015-035-00-7 | parathion — methyl (ISO);

  O, O-dimethyl-O-4-nitrophenylthiophosphat | 206-050-1 | 298-00-0 | Flam. Liq. 3
  Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H330
  H300
  H311
  H373 **
  H400
  H410 | GHS02
  GHS06
  GHS08
  GHS09
  Dgr | H226
  H330
  H300
  H311
  H373 **
  H410 | | M = 100 | |
| 015-036-00-2 | O-ethyl-O-4-nitrophenylphenylthiophosphonat;
  EPN | 218-276-8 | 2104-64-5 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | | |
| 015-037-00-8 | phencapton (ISO);

  O, O-diethyl-S-(2,5-dichlorphenylthiomethyl)-dithiophosphat | 218-892-7 | 2275-14-1 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | | |
| 015-038-00-3 | coumaphos (ISO);

  O-3-chlor-4-methylcumarin-7-yl-O, O-diethylthiophosphat | 200-285-3 | 56-72-4 | Acute Tox. 2 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H312
  H410 | | | |
| 015-039-00-9 | azinphos-methyl (ISO);

  O, O-dimethyl-4-oxobenzotriazin-3-ylmethyldithiophosphat | 201-676-1 | 86-50-0 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H311
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H311
  H317
  H410 | | | |
| 015-040-00-4 | diazinon (ISO);

  O, O-diethyl-O-2-isopropyl-6-methylpyrimidin-4-ylthiophosphat | 206-373-8 | 333-41-5 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H400
  H410 | | | |
| 015-041-00-X | malathion (ISO);
  1,2-bis(ethoxycarbonyl)ethyl-O, O-dimethylphosphordithioat [indeholdende ≤ 0,03 % isomalathion] | 204-497-7 | 121-75-5 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | M = 1 000 | |
| 015-042-00-5 | chlorthion; O-(3-chlor-4-nitrophenyl)-O, O-dimethylthiophosphat | 207-902-5 | 500-28-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | M = 100 | |
| 015-043-00-0 | phosnichlor (ISO);

  O-(4-chlor-3-nitrophenyl)-O, O-dimethylthiophosphat | — | 5826-76-6 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H312
  H302 | GHS07
  Wng | H332
  H312
  H302 | | | |
| 015-044-00-6 | carbophenothion (ISO);
  4-chlorphenylthiomethyl-O, O-diethyldithiophosphat | 212-324-1 | 786-19-6 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | | |
| 015-045-00-1 | mecarbam (ISO);

  N-ethoxycarbonyl-N-methylcarbamoylmethyl-O, O-diethyldithiophosphat | 219-993-9 | 2595-54-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H400
  H410 | | | |
| 015-046-00-7 | oxydemeton-methyl;

  O, O-dimethyl-S-2-(ethylsulfinyl)-ethyl)-thiophosphat | 206-110-7 | 301-12-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1 | H311
  H301
  H400 | GHS06
  GHS09
  Dgr | H311
  H301
  H400 | | | |
| 015-047-00-2 | ethion (ISO);

  O, O,O',O'-tetraethyl-S, S'-methylendi (dithiophosphat);
  diethion | 209-242-3 | 563-12-2 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H312
  H410 | | M = 10 000 | |
| 015-048-00-8 | fenthion (ISO);

  O, O-dimethyl-O-(4-methylthion-m-tolyl) phosphorthioat | 200-231-9 | 55-38-9 | Muta. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H331
  H312
  H302
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H341
  H331
  H312
  H302
  H372 ** H410 | | M = 100 | |
| 015-049-00-3 | endothion (ISO);

  S-5-methoxy-4-oxopyran-2-ylmethyldimethylthiophosphat | 220-472-3 | 2778-04-3 | Acute Tox. 3 *
  Acute Tox. 3 * | H311
  H301 | GHS06
  Dgr | H311
  H301 | | | |
| 015-050-00-9 | thiometon (ISO);

  S-2-ethylthioethyl-O, O-dimethyldithiophosphat | 211-362-6 | 640-15-3 | Acute Tox. 3 *
  Acute Tox. 4 * | H301
  H312 | GHS06
  Dgr | H301
  H312 | | | |
| 015-051-00-4 | dimethoat (ISO);

  O, O-dimethylmethylcarbamoylmethyldithiophosphat | 200-480-3 | 60-51-5 | Acute Tox. 4 *
  Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 015-052-00-X | fenchlorphos (ISO);

  O, O-dimethyl-O-2,4,5-trichlorphenylthiophosphat | 206-082-6 | 299-84-3 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 015-053-00-5 | menazon (ISO);
  S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyldithiophosphat | 201-123-4 | 78-57-9 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 015-054-00-0 | fenitrothion (ISO);

  O, O-dimethyl-O-4-nitro-m-tolylthiophosphat | 204-524-2 | 122-14-5 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 015-055-00-6 | naled (ISO);
  1,2-dibrom-2,2-dichlorethyldimethylphosphat | 206-098-3 | 300-76-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1 | H312
  H302
  H319
  H315
  H400 | GHS07
  GHS09
  Wng | H312
  H302
  H319
  H315
  H400 | | M = 1 000 | |
| 015-056-00-1 | azinphos-ethyl (ISO);

  O, O-diethyl-4-oxobenzotriazin-3-ylmethyldithiophosphat | 220-147-6 | 2642-71-9 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H410 | | M = 100 | |
| 015-057-00-7 | formothion (ISO);

  N-formyl-N-methylcarbamoylmethyl-O, O-dimethyldithiophosphat | 219-818-6 | 2540-82-1 | Acute Tox. 4 *
  Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 015-058-00-2 | morphothion (ISO);

  O, O-dimethyl-S-(morpholinocarbonylmethyl)-dithiophosphat | 205-628-0 | 144-41-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | | |
| 015-059-00-8 | vamidothion (ISO);
  dimethyl-S-2-(1-methylcarbamoylethylthio) ethylthiophospat | 218-894-8 | 2275-23-2 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1 | H301
  H312
  H400 | GHS06
  GHS09
  Dgr | H301
  H312
  H400 | | | |
| 015-060-00-3 | disulfoton (ISO);

  O, O-diethyl-2-ethylthioethyldithiophosphat | 206-054-3 | 298-04-4 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | | |
| 015-061-00-9 | dimefox (ISO);
  tetramethylphosphorsyrediamidfluorid | 204-076-8 | 115-26-4 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-062-00-4 | mipafox (ISO);

  N, N'-diisopropylphosphorsyrediamidfluorid | 206-742-3 | 371-86-8 | STOT SE 1 | H370 ** | GHS08
  Dgr | H370 ** | | | |
| 015-063-00-X | dioxathion (ISO);
  1,4-dioxan-2,3-diyl-O, O,O',O'-tetraethyldi (dithiophosphat) | 201-107-7 | 78-34-2 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H311
  H410 | | M = 1 000 | |
| 015-064-00-5 | bromophos-ethyl (ISO);

  O-4-brom-2,5-dichlorphenyl-O, O-diethylthiophosphat | 225-399-0 | 4824-78-6 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H312
  H410 | | | |
| 015-065-00-0 | S-2-ethylsulfinyl-ethyl-O, O-dimethyl-dithiophosphat | — | 2703-37-9 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Chronic 2 | H330
  H310
  H300
  H411 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H411 | | | |
| 015-066-00-6 | omethoat (ISO);

  O, O-dimethyl-S-methylcarbamoylmethylthiophosphat | 214-197-8 | 1113-02-6 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1 | H301
  H312
  H400 | GHS06
  GHS09
  Dgr | H301
  H312
  H400 | | | |
| 015-067-00-1 | phosalon (ISO);

  S-(6-chlor-2-oxo-benzoxazolin-3-ylmethyl)-O, O-diethyl-phosphordithioat | 218-996-2 | 2310-17-0 | Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H332
  H312
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H332
  H312
  H317
  H410 | | M = 1 000 | |
| 015-068-00-7 | dichlofenthion (ISO);

  O-2,4-dichlorphenyl-O, O-diethylthiophosphat | 202-564-5 | 97-17-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H400
  H410 | | | |
| 015-069-00-2 | methidathion (ISO);
  2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O, O-dimethyldithiophosphat | 213-449-4 | 950-37-8 | Acute Tox. 2 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H312
  H410 | | | |
| 015-070-00-8 | cyanthoat (ISO);

  S-(N-(1-cyano-1-methylethyl) carbamoylmethyl)-O, O-diethylthiophosphat | 223-099-4 | 3734-95-0 | Acute Tox. 2 *
  Acute Tox. 3 * | H300
  H311 | GHS06
  Dgr | H300
  H311 | | | |
| 015-071-00-3 | chlorfenvinphos (ISO);
  2-chlor-1-(2,4-dichlorphenyl) vinyldiethylphosphat | 207-432-0 | 470-90-6 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H410 | | | |
| 015-072-00-9 | monocrotophos (ISO);
  dimethyl-1-methyl-2-(methylcarbamoyl)vinylphosphat | 230-042-7 | 6923-22-4 | Muta. 2
  Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H330
  H300
  H311
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H341
  H330
  H300
  H311
  H410 | | | |
| 015-073-00-4 | dicrotophos (ISO);
  (Z)-2-dimethylcarbamoyl-1-methylvinyldimethylphosphat | 205-494-3 | 141-66-2 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H410 | | | |
| 015-074-00-X | crufomat (ISO);
  4-tert-butyl-2-chlorphenylmethylmethylphosphoramidat | 206-083-1 | 299-86-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 015-075-00-5 | S-2-ethylsulfinyl-isopropyl-O, O-dimethyl-thiophosphat | — | 2635-50-9 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | |
| 015-076-00-0 | potasan;

  O, O-diethyl-O-(4-methyl-7-coumarinyl)-thiophosphat | — | 299-45-6 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H410 | | M = 1 000 | |
| 015-077-00-6 | O-(2,2-dichlorovinyl)-O-methyl-O-(2-ethylsulfinyl-ethyl)-phosphat | — | 7076-53-1 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | |
| 015-078-00-1 | demeton-S-methylsulfon (ISO);

  S-2-ethylsulfonylethyldimethylthiophosphat | 241-109-5 | 17040-19-6 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H301
  H312
  H411 | GHS06
  GHS09
  Dgr | H301
  H312
  H411 | | | |
| 015-079-00-7 | acephat (ISO);

  O, S-dimethylacetylthiophosphoramidat | 250-241-2 | 30560-19-1 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 015-080-00-2 | amidithion (ISO);
  2-methoxyethylcarbamoylmethyl-O, O-dimethyldithiophosphat | — | 919-76-6 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 015-081-00-8 | O, O,O',O'-tetrapropyldithiopyrophosphat | 221-817-0 | 3244-90-4 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 015-082-00-3 | azothoat (ISO);

  O-4-(4-chlor-phenylazo)-phenyl-O, O-dimethyl-thiophosphat | 227-419-3 | 5834-96-8 | Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H302 | GHS07
  Wng | H332
  H302 | | | |
| 015-083-00-9 | bensulid (ISO);

  O, O-diisopropyl-2-phenylsulfonylaminoethyldithiophosphat | 212-010-4 | 741-58-2 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 015-084-00-4 | chlorpyrifos (ISO);

  O, O-diethyl-O-3,5,6-trichlor-2-pyridylthiophosphat | 220-864-4 | 2921-88-2 | Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H400
  H410 | | M = 10 000 | |
| 015-085-00-X | chlorphoniumchlorid (ISO);
  tributyl (2,4-dichlorbenzyl) phosphoniumchlorid | 204-105-4 | 115-78-6 | Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H301
  H312
  H319
  H315 | GHS06
  Dgr | H301
  H312
  H319
  H315 | | | |
| 015-086-00-5 | coumithoat (ISO);

  O, O-diethyl-O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-ylthiophosphat | — | 572-48-5 | Acute Tox. 3 * | H301 | GHS06
  Dgr | H301 | | | |
| 015-087-00-0 | cyanophos (ISO);

  O-4-cyanophenyl-O, O-dimethylthiophosphat | 220-130-3 | 2636-26-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 015-088-00-6 | dialisfos (ISO);
  2-chlor-1-phthalimidoethyl-O, O-diethyldithiophosphat | 233-689-3 | 10311-84-9 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H400
  H410 | | | |
| 015-089-00-1 | ethoat-methyl (ISO);
  ethylcarbamoylmethyl-O, O-dimethyldithiophosphat | 204-121-1 | 116-01-8 | Acute Tox. 4 *
  Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 015-090-00-7 | fensulfothion (ISO);

  O, O-diethyl-O-4-methylsulfinylphenylthiophosphat | 204-114-3 | 115-90-2 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | | |
| 015-091-00-2 | fonofos (ISO);

  O-ethylphenylethyldithiophosphonat | 213-408-0 | 944-22-9 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | | |
| 015-092-00-8 | phosacetim (ISO);

  O, O-bis(4-chlorphenyl)-N-acetimidoylthiophosphoramidat | 223-874-7 | 4104-14-7 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | | |
| 015-093-00-3 | leptophos (ISO);

  O-4-brom-2,5-dichlorphenyl-O-methylphenylthiophosphonat | 244-472-8 | 21609-90-5 | Acute Tox. 3 *
  STOT SE 1
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H370 **
  H312
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H370 **
  H312
  H410 | | | |
| 015-094-00-9 | mephosfolan (ISO);
  diethyl-4-methyl-1,3-dithiolan-2-ylidenphosphoramidat | 213-447-3 | 950-10-7 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Chronic 2 | H310
  H300
  H411 | GHS06
  GHS09
  Dgr | H310
  H300
  H411 | | | |
| 015-095-00-4 | methamidophos (ISO);

  O, S-dimethylthiophosphoramidat | 233-606-0 | 10265-92-6 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1 | H330
  H300
  H311
  H400 | GHS06
  GHS09
  Dgr | H330
  H300
  H311
  H400 | | | |
| 015-096-00-X | oxydisulfoton (ISO);

  O, O-diethyl-S-2-ethylsulfinyl-ethyl-dithiophosphat | 219-679-1 | 2497-07-6 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H410 | | M = 10 | |
| 015-097-00-5 | phenthoat (ISO);
  ethyl-2-(dimethoxythiophosphinoylthio)-2-phenylacetat | 219-997-0 | 2597-03-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | M = 100 | |
| 015-098-00-0 | trichloronat (ISO);

  O-ethyl-O-2,4,5-trichlorphenylethylthiophosphonat | 206-326-1 | 327-98-0 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H410 | | | |
| 015-099-00-6 | pirimiphos-ethyl (ISO);

  O, O-diethyl-O-2-diethylamino-6-methylpyrimidin-4-ylthiophosphat | 245-704-0 | 23505-41-1 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H312
  H410 | | | |
| 015-100-00-X | phoxim (ISO);
  α-(diethoxyphosphinothioylimino)phenylacetonitril | 238-887-3 | 14816-18-3 | Repr. 2
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f *** H302
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361f *** H302
  H317
  H410 | | M = 1 000 | |
| 015-101-00-5 | phosmet (ISO);

  O, O-dimethylphthalimidomethyldithiophosphat | 211-987-4 | 732-11-6 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | M = 100 | |
| 015-102-00-0 | tris(2-chlorethyl)phosphat | 204-118-5 | 115-96-8 | Carc. 2
  Repr. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H351
  H360F *** H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H351
  H360F *** H302
  H411 | | | |
| 015-103-00-6 | phosphortribromid | 232-178-2 | 7789-60-8 | Skin Corr. 1B
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | EUH014 | | |
| 015-104-00-1 | diphosphorpentasulfid; phosphorpentasulfid | 215-242-4 | 1314-80-3 | Flam. Sol. 1
  Water-react. 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1 | H228
  H260
  H332
  H302
  H400 | GHS02
  GHS07
  GHS09
  Dgr | H228
  H260
  H332
  H302
  H400 | EUH029 | | T |
| 015-105-00-7 | triphenylphosphit | 202-908-4 | 101-02-0 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H410 | | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % | |
| 015-106-00-2 | hexamethylphosphortriamid; hexamethylphosphoramid | 211-653-8 | 680-31-9 | Carc. 1B
  Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | Carc. 1B;
  H350: C ≥ 0,01  % | |
| 015-107-00-8 | ethoprophos (ISO);
  ethyl-S, S-dipropyldithiophosphat | 236-152-1 | 13194-48-4 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H301
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H301
  H317
  H410 | | | |
| 015-108-00-3 | bromophos (ISO);

  O-4-brom-2,5-dichlorphenyl-O, O-dimethylthiophosphat | 218-277-3 | 2104-96-3 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 100 | |
| 015-109-00-9 | crotoxyphos (ISO);
  1-phenylethyl-3-(dimethoxyphosphinyloxy) isocrotonat | 231-720-5 | 7700-17-6 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | M = 10 | |
| 015-110-00-4 | cyanofenphos (ISO);

  O-4-cyanophenyl-O-ethylphenylthiophosphonat | — | 13067-93-1 | Acute Tox. 3 *
  STOT SE 1
  Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 2 | H301
  H370 **
  H312
  H319
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H370 **
  H312
  H319
  H411 | | | |
| 015-111-00-X | phosfolan (ISO);
  diethyl-1,3-dithiolan-2-ylidenphosphoramidat | 213-423-2 | 947-02-4 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-112-00-5 | thionazin (ISO);

  O, O-diethyl-O-pyrazin-2-ylthiophosphat | 206-049-6 | 297-97-2 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-113-00-0 | tolclofos-methyl (ISO);

  O-(2,6-dichlor-p-tolyl)-O, O-dimethylthiophosphat | 260-515-3 | 57018-04-9 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 015-114-00-6 | chlormephos (ISO);

  S-chlormethyl-O, O-diethylphosphordithioat | 246-538-1 | 24934-91-6 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | M = 10 | |
| 015-115-00-1 | chlorthiophos (ISO);
  [isomer blanding, hvori O-2,5-dichlorphenyl-4-methylthiophenyl-O, O-diethylthiophosphat er fremherskende] | 244-663-6 | 21923-23-9 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H410 | | M = 1 000 | |
| 015-116-00-7 | demephion-O (ISO):

  O, O-dimethyl-O-2-methylthioethylthiophosphat | 211-666-9 | 682-80-4 | Acute Tox. 2 *
  Acute Tox. 3 * | H300
  H311 | GHS06
  Dgr | H300
  H311 | | | |
| 015-117-00-2 | demephion-S (ISO);
  dimethyl-S-2-methylthioethylthiophosphat | 219-971-9 | 2587-90-8 | Acute Tox. 2 *
  Acute Tox. 3 * | H300
  H311 | GHS06
  Dgr | H300
  H311 | | | |
| 015-118-00-8 | demeton | — | 8065-48-3 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1 | H310
  H300
  H400 | GHS06
  GHS09
  Dgr | H310
  H300
  H400 | | | |
| 015-119-00-3 | dimethyl-4-(methylthio)phenylphosphat | — | 3254-63-5 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-120-00-9 | ditalimfos (ISO);

  O, O-diethylphthalimidophosphonothionat | 225-875-8 | 5131-24-8 | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 015-121-00-4 | edifenphos (ISO);
  ethyl-S, S-diphenyldithiophosphat | 241-178-1 | 17109-49-8 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H312
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H312
  H317
  H410 | | | |
| 015-122-00-X | etrimfos (ISO);

  O-6-ethoxy-2-ethylpyrimidin-4-yl-O, O-dimethylthiophosphat | 253-855-9 | 38260-54-7 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 10 | |
| 015-123-00-5 | fenamiphos (ISO);
  ethyl-4-methylthio-m-tolyl-N-isopropylphosphoramidat | 244-848-1 | 22224-92-6 | Acute Tox. 2
  Acute Tox. 2
  Acute Tox. 2
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H310
  H330
  H319
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H310
  H330
  H319
  H410 | | M = 100
  M = 100 | |
| 015-124-00-0 | fosthietan (ISO);
  diethyl-1,3-dithietan-2-ylidenphosphoramidat | 244-437-7 | 21548-32-3 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 015-125-00-6 | glyphosin (ISO);

  N, N-bis(phosphonomethyl)glycin | 219-468-4 | 2439-99-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 015-126-00-1 | heptenophos (ISO);
  7-chlorbicyclo(3.2.0)hepta-2,6-dien-6-yldimethylphosphat | 245-737-0 | 23560-59-0 | Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | M = 100 | |
| 015-127-00-7 | iprobenfos (ISO);

  S-benzyldiisopropylthiophosphat | 247-449-0 | 26087-47-8 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 015-128-00-2 | IPSP;

  S-ethylsulfinylmethyl-O, O-diisopropyldithiophosphat | — | 5827-05-4 | Acute Tox. 1
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H301
  H410 | | M = 100 | |
| 015-129-00-8 | isofenphos (ISO);

  O-ethyl-O-2-isopropoxycarbonylphenyl-N-isopropylthiophosphoramidat | 246-814-1 | 25311-71-1 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | M = 100 | |
| 015-130-00-3 | isothioat (ISO);

  S-2-isopropylthioethyl-O, O-dimethyldithiophosphat | — | 36614-38-7 | Acute Tox. 3 *
  Acute Tox. 3 * | H311
  H301 | GHS06
  Dgr | H311
  H301 | | | |
| 015-131-00-9 | isoxathion (ISO);

  O, O-diethyl-O-5-phenylisoxazol-3-ylthiophosphat | 242-624-8 | 18854-01-8 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | | |
| 015-132-00-4 | S-(chlorphenylthiomethyl)-O, O-dimethyldithiophosphat; methylcarbophenothion | — | 953-17-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | M = 1 000 | |
| 015-133-00-X | piperophos (ISO);

  S-2-methylpiperidinocarbonylmethyl-O, O-dipropyldithiophosphat | — | 24151-93-7 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 10 | |
| 015-134-00-5 | pirimiphos-methyl (ISO);

  O-(2-diethylamino-6-methylpyrimidin-4-yl)-O, O-dimethylthiophosphat | 249-528-5 | 29232-93-7 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 015-135-00-0 | profenofos (ISO);

  O-(4-brom-2-chlorphenyl)-O-ethyl-S-propylthiophosphat | 255-255-2 | 41198-08-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | M = 1 000 | |
| 015-136-00-6 | trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonat;
  isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonat; propetamphos (ISO) | 250-517-2 | 31218-83-4 | Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | M = 100 | |
| 015-137-00-1 | pyrazophos (ISO);

  O, O-diethyl-O-(6-ethoxycarbonyl-5-methylpyrazolo(2,3-a)pyrimidin-2-yl) thiophosphat | 236-656-1 | 13457-18-6 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H302
  H410 | | | |
| 015-138-00-7 | quinalphos (ISO);

  O, O-diethyl-O-quinoxalin-2-ylthiophosphat | 237-031-6 | 13593-03-8 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H312
  H410 | | M = 1 000 | |
| 015-139-00-2 | terbufos (ISO);

  S-tert-butylthiomethyl-O, O-diethyldithiophosphat | 235-963-8 | 13071-79-9 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | M = 1 000 | |
| 015-140-00-8 | triazophos (ISO);

  O, O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-ylthiophosphat | 245-986-5 | 24017-47-8 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H312
  H410 | | M = 100 | |
| 015-141-00-3 | ethylendiammonium-O, O-bis(octyl)dithiophosphat, blanding af isomerer | 400-520-1 | — | Skin Corr. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H302
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H302
  H410 | | | |
| 015-142-00-9 | butyl(dialkyloxy(dibutoxyphosphoryloxy)titan)phosphat | 401-100-0 | — | Flam. Liq. 2
  Eye Irrit. 2
  Aquatic Chronic 2 | H225
  H319
  H411 | GHS02
  GHS07
  GHS09
  Dgr | H225
  H319
  H411 | | | T |
| 015-143-00-4 | blanding af 2-chlorethyl-chlorpropyl-2-chlorethylphosphonat, blanding af isomerer og 2-chlorethyl-chlorpropyl-2-chlorpropylphosphonat, blanding af isomerer | 401-740-0 | — | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 015-144-00-X | blanding af pentylmethylphosphinat og 2-methylbutylmethylphosphinat | 402-090-0 | 87025-52-3 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 015-145-00-5 | blanding af kobber(I)-O, O-diisopropyldithiophosphat og kobber(I)-O-isopropyl-O-(4-methylpent-2-yl)dithiophosphat og kobber(I)-O, O-bis(4-methylpent-2-yl)dithiophosphat | 401-520-4 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 015-146-00-0 | S-(tricyclo(5.2.1.02,6)deca-3-en-8(eller 9)-yl-O-(isopropyl eller isobutyl eller 2-ethylhexyl)-O-(isopropyl eller isobutyl eller 2-ethylhexyl)dithiophosphat | 401-850-9 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 015-147-00-6 | blanding af C12-14-tert-alkylammoniumdiphenylthiophosphat og dinonylsulfid (eller -disulfid) | 400-930-0 | — | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H411 | | | |
| 015-148-00-1 | 2-(diphosphonomethyl)ravsyre | 403-070-4 | 51395-42-7 | Skin Corr. 1B
  Skin Sens. 1 | H314
  H317 | GHS05
  GHS07
  Dgr | H314
  H317 | | | |
| 015-149-00-7 | blanding af hexyldioctylphosphinoxid; dihexyloctylphosphinoxid; trioctylphosphinoxid | 403-470-9 | — | Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | | |
| 015-150-00-2 | (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphoniumbromid | 404-940-6 | 86608-70-0 | Acute Tox. 4 *
  Eye Dam. 1
  STOT RE 2 *
  Aquatic Chronic 3 | H302
  H318
  H373 **
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H318
  H373 **
  H412 | | | |
| 015-151-00-8 | tris(isopropyl/tert-butylphenyl)phosphat | 405-010-2 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 015-152-00-3 | dioxabenzofos (ISO);
  2-methoxy-4H-1,3,2-benzodioxaphosphorin-2-sulfid | 223-292-3 | 3811-49-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT SE 1
  Aquatic Chronic 2 | H311
  H301
  H370 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H311
  H301
  H370 **
  H411 | | | |
| 015-153-00-9 | isazofos (ISO);

  O-(5-chlor-1-isopropyl-1,2,4-triazol-3-yl)-O, O-diethylthiophosphat | 255-863-8 | 42509-80-8 | Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H311
  H301
  H373 **
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H311
  H301
  H373 **
  H317
  H410 | | | |
| 015-154-00-4 | ethephon; 2-chlorethylphosphonsyre | 240-718-3 | 16672-87-0 | Acute Tox. 3
  Acute Tox. 4
  Acute Tox. 4
  Skin Corr. 1C
  Aquatic Chronic 2 | H311
  H332
  H302
  H314
  H411 | GHS06
  GHS05
  GHS09
  Dgr | H311
  H332
  H302
  H314
  H411 | EUH071 | | |
| 015-155-00-X | glufosinat ammonium (ISO);
  ammonium-2-amino-4-(hydroxymethylphosphinyl)butyrat | 278-636-5 | 77182-82-2 | Repr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 * | H360Fd
  H332
  H312
  H302
  H373 ** | GHS08
  GHS07
  Dgr | H360Fd
  H332
  H312
  H302
  H373 ** | | | |
| 015-156-00-5 | methyl-3-[(dimethoxyphosphinothioyl)oxy]methacrylat; [1]
  methacrifos (ISO);
  methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylat [2] | 250-366-9 [1]-[2] | 30864-28-9 [1]
  62610-77-9 [2] | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 015-157-00-0 | trihydroxophosphor; [1]
  phosponsyre [2] | 237-066-7 [1]
  233-663-1 [2] | 13598-36-2 [1]
  10294-56-1 [2] | Acute Tox. 4 *
  Skin Corr. 1A | H302
  H314 | GHS05
  GHS07
  Dgr | H302
  H314 | | | |
| 015-158-00-6 | (η-ciclopentadienyl)(η-cumenyl)jern(1+)hexafluorphosphat(1-) | 402-340-9 | 32760-80-8 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 015-159-00-1 | hydroxyphosphonoeddikesyre | 405-710-8 | 23783-26-8 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1 | H302
  H373 **
  H314
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H373 **
  H314
  H317 | | | |
| 015-160-00-7 | vanadylpyrophosphat | 406-260-5 | 58834-75-6 | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H319
  H317
  H412 | GHS07
  Wng | H319
  H317
  H412 | | | |
| 015-161-00-2 | divanadylpyrophosphat | 407-130-0 | 65232-89-5 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 015-162-00-8 | vanadium(IV)oxidhydrogenphosphathemihydrat, lithium, zink, molybden, jern og chlor dopet | 407-350-7 | — | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Aquatic Chronic 2 | H332
  H373 **
  H318
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H332
  H373 **
  H318
  H411 | | | |
| 015-163-00-3 | bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxid | 412-010-6 | 145052-34-2 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 015-164-00-9 | calcium-P, P'-(1-hydroxyethyliden)bis(hydrogenphosphonat)dihydrat | 400-480-5 | 36669-85-9 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 015-165-00-4 | blanding af thiobis(4,1-phenylen)-S, S,S',S'-tetraphenyldisulfoniumbishexafluorphosphat; diphenyl(4-phenylthiophenyl)sulfoniumhexafluorphosphat | 404-986-7 | — | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 015-166-00-X | 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecan | 410-290-4 | 80693-00-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 015-167-00-5 | 3-(hydroxyphenylphosphinoyl)propansyre | 411-200-6 | 14657-64-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 015-168-00-0 | fosthiazat (ISO);
  (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylthiophosphonat | — | 98886-44-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H312
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H312
  H317
  H410 | EUH070 | | |
| 015-169-00-6 | tributyltetradecylphosphonium tetrafluorborat | 413-520-1 | — | Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H314
  H317
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H302
  H373 ** H314
  H317
  H410 | | | |
| 015-170-00-1 | blanding af di-(1-octan-N, N,N-trimethylammonium)-octylphosphat: 1-octan-N, N,N-trimethylammonium di-octylphosphat; 1-octan-N, N,N-trimethylammonium-octylphosphat | 407-490-9 | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | | |
| 015-171-00-7 | O, O,O-tris(2(eller 4)-C9-10-isoalkylphenyl) thiophosphat | 406-940-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 015-172-00-2 | blanding af bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphat;
  isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphat | 406-240-6 | — | Flam. Liq. 3
  Skin Corr. 1B
  Aquatic Chronic 2 | H226
  H314
  H411 | GHS02
  GHS05
  GHS09
  Dgr | H226
  H314
  H411 | | | |
| 015-173-00-8 | methyl-[2-(1,1-dimethylethyl)-6-methoxypirimidin-4-yl]ethylthiophosphat | 414-080-3 | 117291-73-3 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 015-174-00-3 | 1-chlor-N, N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramin | 411-370-1 | 82857-68-9 | Acute Tox. 3 *
  Eye Dam. 1
  Aquatic Chronic 2 | H301
  H318
  H411 | GHS06
  GHS05
  GHS09
  Dgr | H301
  H318
  H411 | | | |
| 015-175-00-9 | tert-butyl-(triphenylphosphoranyliden)acetat | 412-880-7 | 35000-38-5 | Acute Tox. 3 *
  STOT RE 2 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H301
  H373 **
  H319
  H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H373 ** H319
  H317
  H411 | | | |
| 015-176-00-4 | P, P,P',P'-tetrakis-(o-methoxyphenyl)propan-1,3-diphosphin | 413-430-2 | 116163-96-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 015-177-00-X | ((4-phenylbutyl)hydroxyphosphoryl)eddikesyre | 412-170-7 | 83623-61-4 | STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H373 **
  H318
  H317 | GHS08
  GHS05
  Dgr | H373 ** H318
  H317 | | | |
| 015-178-00-5 | (R)-α-phenylethylammonium-(-)-(1R, 2S)-(1,2-epoxypropyl)phosphonatmonohydrat | 418-570-8 | 25383-07-7 | Repr. 2
  Aquatic Chronic 2 | H361f *** H411 | GHS08
  GHS09
  Wng | H361f *** H411 | | | |
| 015-179-00-0 | UVCB kondensationsprodukt af tetrakis-hydroxymethylphosphoniumchlorid, urinstof og destilleret hydrogeneret C16-18-talg-alkylamin | 422-720-8 | 166242-53-1 | Carc. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H373 **
  H314
  H317
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H351
  H302
  H373 ** H314
  H317
  H410 | | | |
| 015-180-00-6 | [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] eddikesyre, (-)-cinchonidin (1:1) salt | 415-820-8 | 137590-32-0 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 015-181-00-1 | phosphin | 232-260-8 | 7803-51-2 | Flam. Gas 1
  Press. Gas
  Acute Tox. 2 *
  Skin Corr. 1B
  Aquatic Acute 1 | H220
  H330
  H314
  H400 | GHS02
  GHS04
  GHS06
  GHS05
  GHS09
  Dgr | H220
  H330
  H314
  H400 | | | U |
| 015-182-00-7 | tetraisopropyldichlormethylenbisphosphonat | 430-630-5 | 10596-22-2 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1 | H302
  H319
  H317 | GHS07
  Wng | H302
  H319
  H317 | | | |
| 015-183-00-2 | (1-hydroxydodecyliden)diphosphonsyre | 425-230-2 | 16610-63-2 | Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | | |
| 015-184-00-8 | glyphosat, salte heraf, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | A |
| 015-186-00-9 | chlorpyrifos-methyl (ISO);

  O, O-dimethyl O-3,5,6-trichlor-2-pyridylthiophosphat | 227-011-5 | 5598-13-0 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | M = 10 000 | |
| 015-187-00-4 | blanding af tetranatrium(((2-hydroxyethyl)imino)bis(methylen))bisphosphonat, N-oxid;
  trinatrium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonat, N-oxid, P-oxid | 417-540-1 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 015-189-00-5 | phenyl bis(2,4,6-trimethylbenzoyl)-phosphinoxid | 423-340-5 | 162881-26-7 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 015-190-00-0 | bis(2,4-dicumylphenyl)neopentyldiphosphit;
  3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecan | 421-920-2 | 154862-43-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 015-191-00-6 | dodecyldiphenylphosphat | 431-760-5 | 27460-02-2 | Skin Irrit. 2
  Aquatic Chronic 3 | H315
  H412 | GHS07
  Wng | H315
  H412 | | | |
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylenbiphosphat | 432-770-2 | 139189-30-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butansulfonamid (1:1) | 442-960-7 | 332350-93-3 | Acute Tox. 3 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H318
  H400
  H410 | GHS05
  GHS06
  GHS09
  Dgr | H301
  H318
  H410 | | | |
| 015-194-00-2 | tetrabutylphosphonium-nonafluorbutan-1-sulfonat | 444-440-5 | 220689-12-3 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 015-195-00-8 | blanding af kalium-o-toluenphosphonat;
  kalium-m-toluenphosphonat;
  kalium-p-toluenphosphonat | 433-860-4 | — | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H319
  H317
  H412 | GHS07
  Wng | H319
  H317
  H412 | | | |
| 015-196-00-3 | blanding af dimethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;
  diethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;
  methylethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat | 435-960-3 | — | Carc. 1B
  Muta. 1B
  Skin Sens. 1 | H350
  H340
  H317 | GHS08
  GHS07
  Dgr | H350
  H340
  H317 | | | |
| 015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonsyre | 420-160-9 | 107667-02-7 | Flam. Liq. 3
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H226
  H331
  H302
  H314
  H411 | GHS02
  GHS06
  GHS05
  GHS09
  Dgr | H226
  H331
  H302
  H314
  H411 | | | |
| 015-198-00-4 | (4-phenylbutyl)phosphinsyre | 420-450-5 | 86552-32-1 | Carc. 2
  Eye Dam. 1 | H351
  H318 | GHS05
  GHS08
  Dgr | H351
  H318 | | | |
| 015-199-00-X | tris[2-chlor-1-chlormethyl)ethyl] phosphat | 237-159-2 | 13674-87-8 | Carc. 2 | H351 | GSH08
  Wng | H351 | | | |
| 015-200-00-3 | indiumphosphid | 244-959-5 | 22398-80-7 | Carc. Repr. 2
  STOT RE 1 | H350
  H361f
  H372 (lunger) | GHS08
  Dgr | H350
  H361f
  H372 (lunger) | | STOT RE 1; H372: C ≥ 0,1  % Carc 1B;
  H350: C
  ≥ 0,01  % STOT RE 2;
  H373: 0,01  % ≤
  C < 0,1  % | |
| 015-201-00-9 | trixylylphosphat | 246-677-8 | 25155-23-1 | Repr. 1B | H360F | GHS08
  Dgr | H360F | | | |
| 015-202-00-4 | tris(nonylphenyl)phosphit | 247-759-6 | 26523-78-4 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 015-203-00-X | diphenyl(2,4,6-trimethylbenzoyl)phosphinoxid | 278-355-8 | 75980-60-8 | Repr. 2 | H361f (forårsager svækkelse af testiklerne) | GHS08
  Wng | H361f (forårsager svækkelse af testiklerne) | | | |
| 016-001-00-4 | hydrogensulfid | 231-977-3 | 7783-06-4 | Flam. Gas 1
  Press. Gas
  Acute Tox. 2 *
  Aquatic Acute 1 | H220
  H330
  H400 | GHS02
  GHS04
  GHS06
  GHS09
  Dgr | H220
  H330
  H400 | | | U |
| 016-002-00-X | bariumsulfid | 244-214-4 | 21109-95-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1 | H332
  H302
  H400 | GHS07
  GHS09
  Wng | H332
  H302
  H400 | EUH031 | | |
| 016-003-00-5 | bariumpolysulfider | 256-814-3 | 50864-67-0 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H319
  H335
  H315
  H400 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H400 | EUH031 | | |
| 016-004-00-0 | calciumsulfid | 243-873-5 | 20548-54-3 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H319
  H335
  H315
  H400 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H400 | EUH031 | | |
| 016-005-00-6 | calciumpolysulfider | 215-709-2 | 1344-81-6 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H319
  H335
  H315
  H400 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H400 | EUH031 | | |
| 016-006-00-1 | dikaliumsulfid;
  kaliumsulfid | 215-197-0 | 1312-73-8 | Skin Corr. 1B
  Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | EUH031 | | |
| 016-007-00-7 | kaliumpolysulfider | 253-390-1 | 37199-66-9 | Skin Corr. 1B
  Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | EUH031 | | |
| 016-008-00-2 | ammoniumpolysulfider | 232-989-1 | 9080-17-5 | Skin Corr. 1B
  Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | EUH031 | EUH031: C ≥ 1 % | |
| 016-009-00-8 | dinatriumsulfid;
  natriumsulfid | 215-211-5 | 1313-82-2 | Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1 | H311
  H302
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H311
  H302
  H314
  H400 | | | |
| 016-010-00-3 | natriumpolysulfider | 215-686-9 | 1344-08-7 | Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Acute 1 | H301
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H301
  H314
  H400 | EUH031 | | |
| 016-011-00-9 | svovldioxid | 231-195-2 | 7446-09-5 | Press. Gas
  Acute Tox. 3 *
  Skin Corr. 1B | H331
  H314 | GHS04
  GHS06
  GHS05
  Dgr | H331
  H314 | | * | U5 |
| 016-012-00-4 | disvovldichlorid;
  svovlmonochlorid | 233-036-2 | 10025-67-9 | Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1A
  Aquatic Acute 1 | H301
  H332
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H301
  H332
  H314
  H400 | EUH014
  EUH029 | STOT SE 3; H335: C ≥ 1 % | |
| 016-013-00-X | svovldichlorid | 234-129-0 | 10545-99-0 | Skin Corr. 1B
  STOT SE 3
  Aquatic Acute 1 | H314
  H335
  H400 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H335
  H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 016-014-00-5 | svovltetrachlorid | — | 13451-08-6 | Skin Corr. 1B
  Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 016-015-00-0 | thionyldichlorid;
  thionylchlorid | 231-748-8 | 7719-09-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H332
  H302
  H314 | GHS05
  GHS07
  Dgr | H332
  H302
  H314 | EUH014
  EUH029 | STOT SE 3; H335: C ≥ 1 % | |
| 016-016-00-6 | sulfurylchlorid | 232-245-6 | 7791-25-5 | Skin Corr. 1B
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | EUH014 | | |
| 016-017-00-1 | chlorsulfonsyre | 232-234-6 | 7790-94-5 | Skin Corr. 1A
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | EUH014 | | |
| 016-018-00-7 | fluorsulfonsyre | 232-149-4 | 7789-21-1 | Acute Tox. 4 *
  Skin Corr. 1A | H332
  H314 | GHS05
  GHS07
  Dgr | H332
  H314 | | | |
| 016-019-00-2 | oleum ... % SO3 | — | — | Skin Corr. 1A
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | EUH014 | | B |
| 016-020-00-8 | svovlsyre ... % | 231-639-5 | 7664-93-9 | Skin Corr. 1A | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C
  < 15 %
  Eye Irrit. 2; H319: 5 % ≤ C
  < 15 % | B |
| 016-021-00-3 | methanthiol;
  methylmercaptan | 200-822-1 | 74-93-1 | Flam. Gas. 1
  Press. Gas
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H220
  H331
  H400
  H410 | GHS02
  GHS04
  GHS06
  GHS09
  Dgr | H220
  H331
  H410 | | | U |
| 016-022-00-9 | ethanethiol;
  ethylmercaptan | 200-837-3 | 75-08-1 | Flam. Liq. 2
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H332
  H400
  H410 | GHS02
  GHS07
  GHS09
  Dgr | H225
  H332
  H410 | | | |
| 016-023-00-4 | dimethylsulfat | 201-058-1 | 77-78-1 | Carc. 1B
  Muta. 2
  Acute Tox. 2 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1 | H350
  H341
  H330
  H301
  H314
  H317 | GHS06
  GHS08
  GHS05
  Dgr | H350
  H341
  H330
  H301
  H314
  H317 | | Carc. 1B; H350: C ≥ 0,01  % Muta. 2; H341: C ≥ 0,01  % STOT SE 3; H335: C ≥ 5 % | |
| 016-024-00-X | dimexano (ISO);
  bis(methoxy-thiocarbonyl)-disulfid | 215-993-8 | 1468-37-7 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 016-025-00-5 | disul (ISO);
  2-(2,4-dichlorphenoxy)-ethylhydrogensulfat;
  2,4-DES | 205-259-5 | 149-26-8 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1 | H302
  H315
  H318 | GHS05
  GHS07
  Dgr | H302
  H315
  H318 | | | |
| 016-026-00-0 | sulfamidsyre;
  sulfaminsyre | 226-218-8 | 5329-14-6 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 3 | H319
  H315
  H412 | GHS07
  Wng | H319
  H315
  H412 | | | |
| 016-027-00-6 | diethylsulfat | 200-589-6 | 64-67-5 | Carc. 1B
  Muta. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H350
  H340
  H332
  H312
  H302
  H314 | GHS05
  GHS08
  GHS07
  Dgr | H350
  H340
  H332
  H312
  H302
  H314 | | | |
| 016-028-00-1 | natriumdithionit;
  natriumhydrosulfit | 231-890-0 | 7775-14-6 | Self-heat. 1
  Acute Tox. 4 * | H251
  H302 | GHS02
  GHS07
  Dgr | H251
  H302 | EUH031 | | |
| 016-029-00-7 | p-toluensulfonsyre, indeholdende mere end 5 % H2SO4 | — | — | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
  Eye Irrit. 2; H319: 10 % ≤ C < 25 % | |
| 016-030-00-2 | p-toluensulfonsyre (indeholdende højst 5 % H2SO4) | 203-180-0 | 104-15-4 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | STOT SE 3; H335: C ≥ 20 % | |
| 016-031-00-8 | tetrahydrothiophen-1,1-dioxid;
  sulfolan | 204-783-1 | 126-33-0 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 016-032-00-3 | 1,3-propansulton;
  1,2-oxathiolan 2,2-dioxid | 214-317-9 | 1120-71-4 | Carc. 1B
  Acute Tox. 4 *
  Acute Tox. 4 * | H350
  H312
  H302 | GHS08
  GHS07
  Dgr | H350
  H312
  H302 | | Carc. 1B; H350: C ≥ 0,01  % | |
| 016-033-00-9 | dimethylsulfamoylchlorid | 236-412-4 | 13360-57-1 | Carc. 1B
  Acute Tox. 2 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H350
  H330
  H312
  H302
  H314 | GHS06
  GHS05
  GHS08
  Dgr | H350
  H330
  H312
  H302
  H314 | | | |
| 016-034-00-4 | tetranatrium-3,3'-(piperazin-1,4-diylbis((6-chlor-1,3,5-triazin-4,2-diyl)imino(2-acetamido)-4,1-phenylenazo))bis(naphthalen-1,5-disulfonat) | 400-010-9 | 81898-60-4 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-035-00-X | pentanatrium-5-anilino-3-(4-(4-(6-chlor-4-(3-sulfonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat | 400-120-7 | — | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 016-036-00-5 | tetranatrium-5-(4,6-dichlor-5-cyanpyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalen-1,2,5,7-disulfonat | 400-130-1 | — | Resp. Sens. 1
  Aquatic Chronic 2 | H334
  H411 | GHS08
  GHS09
  Dgr | H334
  H411 | | | |
| 016-037-00-0 | dinatrium-1-amino-4-(4-benzensulfonamido-3-sulfonatoanilino)anthraquinon-2-sulfonat | 400-350-8 | 85153-93-1 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 016-038-00-6 | dinatrium-6-((4-chlor-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulfonatophenylazo)naphthalen-3-sulfonat | 400-380-1 | 86393-35-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-039-00-1 | tetranatrium-2-(6-chlor-4-(4-(2,5-dimethyl-4-(2,5-disulfonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzen-1,4-disulfonat | 400-430-2 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-040-00-7 | blanding af dinatrium-6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulfonatophenylazo)-4-hydroxynaphthalen-2-sulfonat og dinatrium-6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulfonatophenylazo)-4-hydroxynaphthalen-2-sulfonat og trinatrium-6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulfonato-2-naphthylazo)anilino)-3-sulfonatophenylazo)-4-hydroxynaphthalen-2-sulfonat | 400-570-4 | — | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 016-041-00-2 | calcium-2,5-dichlor-4-(4-((5-chlor-4-methyl-2-sulfonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzensulfonat | 400-710-4 | — | Acute Tox. 4 * | H332 | GHS07
  Wng | H332 | | | |
| 016-042-00-8 | tetranatrium-5-benzamido-3-(5-(4-fluor-6-(1-sulfonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat | 400-790-0 | 85665-97-0 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | |
| 016-043-00-3 | dilithium-6-acetamido-4-hydroxy-3-(4-((2-sulfonatooxy)ethylsulfonyl)phenylazo)naphthalen-2-sulfonat | 401-010-1 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-044-00-9 | dinatrium-S, S-hexan-1,6-diyldi(thiosulfat)dihydrat | 401-320-7 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 016-045-00-4 | lithiumnatriumhydrogen-4-amino-6-(5-(5-chlor-2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat | 401-560-2 | 108624-00-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-046-00-X | natriumhydrogensulfat | 231-665-7 | 7681-38-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 016-047-00-5 | hexanatrium-7-(4-(4-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulfonatonaphthylazo)naphthalen-1,3,5- trisulfonat | 401-650-1 | 85665-96-9 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-048-00-0 | natrium-3,5-dichlor-2-(5-cyan-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzensulfonat | 401-870-8 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 016-049-00-6 | calciumoctadecylxylensulfonat | 402-040-8 | — | Skin Corr. 1B
  Aquatic Chronic 2 | H314
  H411 | GHS05
  GHS09
  Dgr | H314
  H411 | | | |
| 016-050-00-1 | kaliumnatrium-5-(4-chlor-6-(N-(4-(4-chlor-6-(5-hydroxy-2,7-disulfonato-6-(2-sulfonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino)phenyl- N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulfonatophenylazo)naphthalen-2,7-disulfonat | 402-150-6 | — | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 016-051-00-7 | trinatrium-7-(4-(6-fluor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6- trisulfonat | 402-170-5 | 106359-91-5 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-052-00-2 | benzyltributylammonium-4-hydroxynaphthalen-1-sulfonat | 402-240-5 | 102561-46-6 | Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H411 | GHS07
  GHS09
  Wng | H332
  H411 | | | |
| 016-053-00-8 | (C16 eller C18-n-alkyl)(C16 eller C18-n-alkyl)ammonium-2-((C16 eller C18-n-alkyl)(C16 eller C18-n-alkyl)carbamoyl)benzensulfonat | 402-460-1 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H315
  H317
  H413 | GHS07
  Wng | H315
  H317
  H413 | | | |
| 016-054-00-3 | natrium-4-(2,4,4-trimethylpentylcarbonyloxy)benzensulfonat | 400-030-8 | — | Acute Tox. 3 *
  STOT RE 1
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Sens. 1 | H331
  H372 **
  H302
  H319
  H335
  H317 | GHS06
  GHS08
  Dgr | H331
  H372 ** H302
  H319
  H335
  H317 | | | |
| 016-055-00-9 | tetranatrium-4-amino-3,6-bis(5-(6-chlor-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalen-2,7-sulfonat (der indeholder > 35 % natriumchlorid og natriumacetat) | 400-510-7 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 016-056-00-4 | kaliumhydrogensulfat | 231-594-1 | 7646-93-7 | Skin Corr. 1B
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | | | |
| 016-057-00-X | styren-4-sulfonylchlorid | 404-770-2 | 2633-67-2 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H315
  H318
  H317 | | | |
| 016-058-00-5 | thionylchlorid, reaktionsprodukter med 1,3,4-thiadiazol-2,5-dithiol, tert-nonanthiol og C12-14-tert-alkylamin | 404-820-3 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H315
  H317
  H412 | GHS07
  Wng | H315
  H317
  H412 | | | |
| 016-059-00-0 | N, N,N',N'-tetramethyldithiobis(ethylen)diamindihydrochlorid | 405-300-9 | 17339-60-5 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H317
  H410 | | | |
| 016-060-00-6 | diammoniumperoxodisulfat; ammoniumpersulfat | 231-786-5 | 7727-54-0 | Ox. Sol. 3
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1 | H272
  H302
  H319
  H335
  H315
  H334
  H317 | GHS03
  GHS08
  GHS07
  Dgr | H272
  H302
  H319
  H335
  H315
  H334
  H317 | | | |
| 016-061-00-1 | dikaliumperoxodisulfat; kaliumpersulfat | 231-781-8 | 7727-21-1 | Ox. Sol. 3
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1 | H272
  H302
  H319
  H335
  H315
  H334
  H317 | GHS03
  GHS08
  GHS07
  Dgr | H272
  H302
  H319
  H335
  H315
  H334
  H317 | | | |
| 016-062-00-7 | bensultap (ISO);
  di-S-benzensulfonyl-2-(dimethylamino)propan-1,3-dithiol | — | 17606-31-4 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 016-063-00-2 | natriummetabisulfit | 231-673-0 | 7681-57-4 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | EUH031 | | |
| 016-064-00-8 | natriumhydrogensulfit ... %;
  natriumdisulfit . . . % | 231-548-0 | 7631-90-5 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | EUH031 | | B |
| 016-065-00-3 | natrium-1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthrachinon-2-sulfonat | 400-100-8 | 84057-97-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 016-066-00-9 | tetranatrium-[5-((4-amino-6-chlor-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2-sulfonatobenzylidenhydrazino)benzoat]kobber(II) | 404-070-7 | 116912-62-0 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 016-067-00-4 | (4-methylphenyl)mesitylen-sulfonat | 407-530-5 | 67811-06-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 016-068-00-X | natrium-3,5-bis(tetradecyloxycarbonyl)benzensulfinat | 407-720-8 | 155160-86-4 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 016-069-00-5 | 3,5-bis(tetradecyloxycarbonyl)benzensulfinsyre | 407-990-7 | 141915-64-2 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 016-070-00-0 | 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfon | 408-220-2 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 016-071-00-6 | trinatrium-3-amino-6,13-dichlor-10-((3-((4-chlor-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazindisulfonat | 410-130-3 | 136248-03-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 016-072-00-1 | 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzensulfonamid | 411-520-6 | 112195-27-4 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 016-073-00-7 | tetrakis(phenylmethyl)thioperoxydi(carbothioamid) | 404-310-0 | 10591-85-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 016-074-00-2 | 6-fluor-2-methyl-3-(4-methylthiobenzyl)inden | 405-410-7 | — | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H411 | | | |
| 016-075-00-8 | 2,2'-diallyl-4,4'-sulfonyldiphenol | 411-570-9 | 41481-66-7 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 016-076-00-3 | 2,3-bis((2-mercapto-ethyl)thio)-1-propanthiol | 411-290-7 | 131538-00-6 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H410 | | | |
| 016-077-00-9 | 2-chlor-p-toluensulfochlorid | 412-890-1 | 42413-03-6 | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H314
  H317
  H412 | GHS05
  GHS07
  Dgr | H314
  H317
  H412 | | | |
| 016-078-00-4 | 4-methyl-N, N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)-benzensulfonamid | 413-300-5 | 56187-04-3 | Aquatic Chronic 4 | H413 | — | | | | |
| 016-079-00-X | N, N-bis(2-(p-toluensulfonyloxy)ethyl)-p-toluensulfonamid | 412-920-3 | 16695-22-0 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 016-080-00-5 | natrium-2-anilin-5-(2-nitro-4-(N-phenylsulfamoyl))anilinbenzensulfonat | 412-320-1 | 31361-99-6 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 016-081-00-0 | hexahydrocyclopenta[c]pyrrol-1-(1H)-ammonium-N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanid | 418-350-1 | — | Muta. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H341
  H302
  H319
  H317
  H411 | GHS08
  GHS07
  GHS09
  Wng | H341
  H302
  H319
  H317
  H411 | | | |
| 016-082-00-6 | ethoxysulfuron (ISO);
  1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urinstof | — | 126801-58-9 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 016-083-00-1 | acibenzolar-S-methyl;
  benzo[1,2,3]thiadiazol-7-carbothiosyre S-methylester | 420-050-0 | 135158-54-2 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H335
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H317
  H410 | | | |
| 016-084-00-7 | prosulfuron (ISO);
  1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluorpropyl)phenylsulfonyl]urinstof | — | 94125-34-5 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 100 | |
| 016-085-00-2 | flazasulfuron (ISO);
  1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urinstof | — | 104040-78-0 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 016-086-00-8 | tetranatrium-10-amino-6,13-dichlor-3-(3-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacen-4,11-disulfonat | 402-590-9 | 109125-56-6 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 016-087-00-3 | blanding af thiobis(4,1-phenylen)-S, S,S',S'-tetraphenyldisulfoniumbishexafluorphosphat;
  diphenyl(4-phenylthiophenyl)sulfoniumhexafluorphosphat;
  propylencarbonat | 403-490-8 | 104558-95-4 | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H317
  H410 | | | |
| 016-088-00-9 | 4-(bis(4-(diethylamino)phenyl)methyl)benzen-1,2-dimethansulfonsyre | 407-280-7 | 71297-11-5 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 016-089-00-4 | blanding af estere af 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan og 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalen | 413-840-1 | — | Self-react. C ****
  Aquatic Chronic 4 | H242
  H413 | GHS02
  Dgr | H242
  H413 | | | |
| 016-090-00-X | 4-methyl-N-(methylsulfonyl)benzensulfonamid | 415-040-8 | 14653-91-9 | Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1 | H302
  H335
  H318 | GHS05
  GHS07
  Dgr | H302
  H335
  H318 | | | |
| 016-091-00-5 | C12-14-tert-alkylammonium-1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonat | 414-110-5 | — | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 016-092-00-0 | blanding af 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecandithiol;
  4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecandithiol og 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecandithiol | 427-050-1 | — | Repr. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f
  H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361f
  H315
  H317
  H410 | | | |
| 016-093-00-6 | blanding af (2:1)(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonat) og 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonat) | 414-770-4 | 140698-96-0 | Self-react. C ****
  Carc. 2 | H242
  H351 | GHS02
  GHS08
  Dgr | H242
  H351 | | | |
| 016-094-00-1 | svovl | 231-722-6 | 7704-34-9 | Skin Irrit. 2 | H315 | GHS07
  Wng | H315 | | | |
| 016-095-00-7 | blanding af reaktionsprodukt af 4,4'-methylenbis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxo-naphthalensulfonat (1:2) og reaktionsprodukt af 4,4'-methylenbis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxo-naphthalensulfonat (1:3) | 417-980-4 | — | Self-react. C ****
  Carc. 2 | H242
  H351 | GHS02
  GHS08
  Dgr | H242
  H351 | | | |
| 016-096-00-2 | thifensulfuron-methyl (ISO);
  methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophen-2-carboxylat | — | 79277-27-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 016-097-00-8 | 1-amino-2-methyl-2-propanthiolhydrochlorid | 434-480-1 | 32047-53-3 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H314
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H314
  H317
  H412 | | | |
| 017-001-00-7 | chlor | 231-959-5 | 7782-50-5 | Ox. Gas 1
  Press. Gas
  Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H270
  H331
  H319
  H335
  H315
  H400 | GHS03
  GHS04
  GHS06
  GHS09
  Dgr | H270
  H331
  H319
  H335
  H315
  H400 | | M = 100 | U |
| 017-002-00-2 | hydrogenchlorid | 231-595-7 | 7647-01-0 | Press. Gas
  Acute Tox. 3 *
  Skin Corr. 1A | H331
  H314 | GHS04
  GHS06
  GHS05
  Dgr | H331
  H314 | | | U5 |
| 017-002-01-X | saltsyre ... % | 231-595-7 | — | Skin Corr. 1B
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
  Eye Irrit. 2; H319: 10 % ≤ C < 25 %
  STOT SE 3; H335: C ≥ 10 % | B |
| 017-003-00-8 | bariumchlorat | 236-760-7 | 13477-00-4 | Ox. Sol. 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H271
  H332
  H302
  H411 | GHS03
  GHS07
  GHS09
  Dgr | H271
  H332
  H302
  H411 | | | |
| 017-004-00-3 | kaliumchlorat | 223-289-7 | 3811-04-9 | Ox. Sol. 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H271
  H332
  H302
  H411 | GHS03
  GHS07
  GHS09
  Dgr | H271
  H332
  H302
  H411 | | | |
| 017-005-00-9 | natriumchlorat | 231-887-4 | 7775-09-9 | Ox. Sol. 1
  Acute Tox. 4 *
  Aquatic Chronic 2 | H271
  H302
  H411 | GHS03
  GHS07
  GHS09
  Dgr | H271
  H302
  H411 | | | |
| 017-006-00-4 | perchlorsyre ... % | 231-512-4 | 7601-90-3 | Ox. Liq. 1
  Skin Corr. 1A | H271
  H314 | GHS03
  GHS05
  Dgr | H271
  H314 | | Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 %
  Skin Irrit. 2; H315: 1 % ≤ C
  < 10 %
  Eye Irrit. 2; H319: 1 % ≤ C
  < 10 %
  Ox. Liq. 1; H271: C > 50 %:
  Ox. Liq. 2; H272: C ≤ 50 %: | B |
| 017-007-00-X | bariumperchlorat | 236-710-4 | 13465-95-7 | Ox. Sol. 1
  Acute Tox. 4 *
  Acute Tox. 4 * | H271
  H332
  H302 | GHS03
  GHS07
  Dgr | H271
  H332
  H302 | | | |
| 017-008-00-5 | kaliumperchlorat | 231-912-9 | 7778-74-7 | Ox. Sol. 1
  Acute Tox. 4 * | H271
  H302 | GHS03
  GHS07
  Dgr | H271
  H302 | | | |
| 017-009-00-0 | ammoniumperchlorat | 232-235-1 | 7790-98-9 | Expl. 1,1
  Ox. Sol. 1 | H201
  H271 | GHS01
  Dgr | H201
  H271 | | | T |
| 017-010-00-6 | natriumperchlorat | 231-511-9 | 7601-89-0 | Ox. Sol. 1
  Acute Tox. 4 * | H271
  H302 | GHS03
  GHS07
  Dgr | H271
  H302 | | | |
| 017-011-00-1 | natriumhypochloritopløsning ... % aktiv chlor | 231-668-3 | 7681-52-9 | Skin Corr. 1B
  Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | EUH031 | EUH031: C ≥ 5 % | B |
| 017-012-00-7 | calciumhypochlorit | 231-908-7 | 7778-54-3 | Ox. Sol. 2
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1 | H272
  H302
  H314
  H400 | GHS03
  GHS05
  GHS07
  GHS09
  Dgr | H272
  H302
  H314
  H400 | EUH031 | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C
  < 5 %
  Eye Dam.1; H318: 3 % ≤ C
  < 5 %
  Eye Irrit. 2; H319: 0,5  % ≤ C < 3 %
  M = 10 | T |
| 017-013-00-2 | calciumchlorid | 233-140-8 | 10043-52-4 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 017-014-00-8 | ammoniumchlorid | 235-186-4 | 12125-02-9 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 017-015-00-3 | (2-(aminomethyl)phenyl)acetylchlorid hydrochlorid | 417-410-4 | 61807-67-8 | Acute Tox. 4 *
  Skin Corr. 1A
  Skin Sens. 1 | H302
  H314
  H317 | GHS05
  GHS07
  Dgr | H302
  H314
  H317 | | | |
| 017-016-00-9 | methyltriphenylphosphoniumchlorid | 418-400-2 | 1031-15-8 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H312
  H302
  H315
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H315
  H318
  H411 | | | |
| 017-017-00-4 | (Z)-13-docosenyl-N, N-bis(2-hydroxyethyl)-N-methylammoniumchlorid | 426-210-6 | 120086-58-0 | Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | | |
| 017-018-00-X | N, N,N-trimethyl-2,3-bis(stearoyloxy)propylammoniumchlorid | 405-660-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 017-019-00-5 | (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisochinolinhydrochlorid | 415-110-8 | 54417-53-7 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 017-020-00-0 | ethylpropoxyaluminiumchlorid | 421-790-7 | 13014-29-4 | Water-react. 1
  Skin Corr. 1A | H260
  H314 | GHS02
  GHS05
  Dgr | H260
  H314 | EUH014 | | |
| 017-021-00-6 | behenamidopropyl-dimethyl-(dihydroxypropyl) ammoniumchlorid | 423-420-1 | 136920-10-0 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H410 | | | |
| 017-023-00-7 | [phosphinyldyntris(oxy)]-tris[3-aminopropyl-2-hydroxy-N, N-dimethyl-N-(C6-18)-alkyl]-trichlorider | 425-520-9 | 197179-61-6 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 017-026-00-3 | chlordioxid | 233-162-8 | 10049-04-4 | Press. Gas
  Ox. Gas 1
  Acute Tox. 2 *
  Skin Corr. 1B
  Aquatic Acute 1 | H270
  H330
  H314
  H400 | GHS04
  GHS03
  GHS06
  GHS05
  GHS09
  Dgr | H270
  H330
  H314
  H400 | | M = 10 | 5 |
| 017-026-01-0 | chlordioxid ... % | 233-162-8 | 10049-04-4 | Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Acute 1 | H301
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H301
  H314
  H400 | | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C
  < 5 %
  Eye Dam.1; H318: 3 % ≤ C
  < 5 %
  Eye Irrit. 2; H319: 0,3  % ≤ C < 3 %
  STOT SE 3; H335: C ≥ 3 % M = 10 | B |
| 019-001-00-2 | kalium | 231-119-8 | 7440-09-7 | Water-react. 1
  Skin Corr. 1B | H260
  H314 | GHS02
  GHS05
  Dgr | H260
  H314 | EUH014 | | |
| 019-002-00-8 | kaliumhydroxid;
  kaustisk potaske | 215-181-3 | 1310-58-3 | Acute Tox. 4 *
  Skin Corr. 1A | H302
  H314 | GHS05
  GHS07
  Dgr | H302
  H314 | | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C
  < 5 %
  Skin Irrit. 2; H315: 0,5  % ≤ C < 2 %
  Eye Irrit. 2; H319: 0,5  % ≤ C < 2 % | |
| 020-001-00-X | calcium | 231-179-5 | 7440-70-2 | Water-react. 2 | H261 | GHS02
  Dgr | H261 | | | |
| 020-002-00-5 | calciumcyanid | 209-740-0 | 592-01-8 | Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H410 | EUH032 | | |
| 020-003-00-0 | blanding af dicalcium (bis(2-hydroxy-5-tetrapropenylphenylmethyl)methylamin)dihydroxid;
  tricalcium (tris(2-hydroxy-5-tetrapropenylphenylmethyl)methylamin)trihydroxid;
  poly[calcium ((2-hydroxy-5-tetrapropenyl-phenylmethyl)methylamin)hydroxid] | 420-470-4 | — | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | |
| 022-001-00-5 | titantetrachlorid | 231-441-9 | 7550-45-0 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | EUH014 | | |
| 022-002-00-0 | titan(4+)oxalat | 403-260-7 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 022-003-00-6 | bis(η5-cyclopentadienyl)-bis[2,6-difluor-3-(pyrrol-1-yl)-phenyl]titan | 412-000-1 | 125051-32-3 | Flam. Sol. 1
  Repr. 2
  STOT RE 2 *
  Aquatic Chronic 2 | H228
  H361f *** H373 **
  H411 | GHS02
  GHS08
  GHS09
  Dgr | H228
  H361f *** H373 ** H411 | | | T |
| 022-004-00-1 | kaliumtitanoxid (K2Ti6O13) | 432-240-0 | 12056-51-8 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 022-005-00-7 | [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][1,2,3,4-η)-1,3-pentadien]-titan | 419-840-8 | 169104-71-6 | Flam. Sol. 1****
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 4 | H228
  H314
  H317
  H413 | GHS02
  GHS05
  GHS07
  Dgr | H228
  H314
  H317
  H413 | | | |
| 023-001-00-8 | divanadiumpentaoxid;
  vanadiumpentaoxid | 215-239-8 | 1314-62-1 | Muta. 2
  Repr. 2
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Aquatic Chronic 2 | H341
  H361d *** H372 **
  H332
  H302
  H335
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H341
  H361d *** H372 **
  H332
  H302
  H335
  H411 | | | |
| 024-001-00-0 | chromtrioxid | 215-607-8 | 1333-82-0 | Ox. Sol. 1
  Carc. 1A
  Muta. 1B Repr. 2
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Skin Corr. 1A
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H271
  H350
  H340
  H361f *** H330
  H311
  H301
  H372 **
  H314
  H334
  H317
  H400
  H410 | GHS03
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H271
  H350
  H340
  H361f *** H330
  H311
  H301
  H372 **
  H314
  H334
  H317
  H410 | | STOT SE 3; H335: C ≥ 1 % | |
| 024-002-00-6 | kaliumdichromat | 231-906-6 | 7778-50-9 | Ox. Sol. 2
  Carc. 1B
  Muta. 1B
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Acute Tox. 4 *
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H350
  H340
  H360FD
  H330
  H301
  H372 **
  H312
  H314
  H334
  H317
  H400
  H410 | GHS03
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H272
  H350
  H340
  H360FD
  H330
  H301
  H372 **
  H312
  H314
  H334
  H317
  H410 | | STOT SE 3; H335: C ≥ 5 % | 3 |
| 024-003-00-1 | ammoniumdichromat | 232-143-1 | 7789-09-5 | Ox. Sol. 2 ****
  Carc. 1B
  Muta. 1B
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Acute Tox. 4 *
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H350
  H340
  H360FD
  H330
  H301
  H372 **
  H312
  H314
  H334
  H317
  H400
  H410 | GHS03
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H272
  H350
  H340
  H360FD
  H330
  H301
  H372 **
  H312
  H314
  H334
  H317
  H410 | | STOT SE 3; H335: C ≥ 5 %
  Resp. Sens.; H334: C ≥ 0,2  %
  Skin Sens.; H317:C ≥ 0,2  % | G3 |
| 024-004-00-7 | natriumdichromat | 234-190-3 | 10588-01-9 | Ox. Sol. 2
  Carc. 1B
  Muta. 1B
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 1
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H350
  H340
  H360FD
  H330
  H301
  H312
  H372 **
  H314
  H334
  H317
  H400
  H410 | GHS03
  GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H272
  H350
  H340
  H360FD
  H330
  H301
  H312
  H372 **
  H314
  H334
  H317
  H410 | | Resp. Sens. 1; H334: C ≥ 0,2  %
  Skin Sens. 1; H317:C ≥ 0,2  %
  STOT SE 3; H335: C ≥ 5 % | 3 |
| 024-005-00-2 | chromyldichlorid | 239-056-8 | 14977-61-8 | Ox. Liq. 1
  Carc. 1B
  Muta. 1B
  Skin Corr. 1A
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H271
  H350i
  H340
  H314
  H317
  H400
  H410 | GHS03
  GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H271
  H350i
  H340
  H314
  H317
  H410 | | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C
  < 10 %
  Skin Irrit. 2; H315: 0,5  % ≤
  C < 5 %
  Eye Irrit. 2; H319: 0,5  % ≤
  C < 5 %
  STOT SE 3; H335: 0,5  % ≤ C < 5 %
  Skin Sens. 1; H317: C ≥ 0,5  % | T3 |
| 024-006-00-8 | kaliumchromat | 232-140-5 | 7789-00-6 | Carc. 1B
  Muta. 1B
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H340
  H319
  H335
  H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H340
  H319
  H335
  H315
  H317
  H410 | | Skin Sens. 1; H317:C ≥ 0,5  % | 3 |
| 024-007-00-3 | zinkchromater, herunder zinkkaliumchromat | — | — | Carc. 1A
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H317
  H410 | | | A |
| 024-008-00-9 | calciumchromat | 237-366-8 | 13765-19-0 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H410 | | | |
| 024-009-00-4 | strontiumchromat | 232-142-6 | 7789-06-2 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H400
  H410 | | | |
| 024-010-00-X | dichromtris(chromat);
  chrom III chromat;
  chromchromat | 246-356-2 | 24613-89-6 | Ox. Sol. 1
  Carc. 1B
  Skin Corr. 1A
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H271
  H350
  H314
  H317
  H400
  H410 | GHS03
  GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H271
  H350
  H314
  H317
  H410 | | | T |
| 024-011-00-5 | ammoniumbis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromat(1-) | 400-110-2 | 109125-51-1 | Self-react. C ****
  Aquatic Acute 1
  Aquatic Chronic 1 | H242
  H400
  H410 | GHS02
  GHS09
  Dgr | H242
  H410 | | | |
| 024-012-00-0 | trinatriumbis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulfonato-1-naphtholato)chromat(1-) | 400-810-8 | — | Muta. 2 | H341 | GHS08
  Wng | H341 | | | |
| 024-013-00-6 | trinatrium-(6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulfonato-1-naphtholato)(4-sulfonato-1,1'-azodi-2,2'naphtholato)chromat(1-) | 402-500-8 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 024-014-00-1 | trinatriumbis(2-(5-chlor-4-nitro-2-oxidophenylazo)-5-sulfonato-1-naphtholato)chromat(1-) | 402-870-0 | 93952-24-0 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 024-015-00-7 | dinatrium(3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromat(1-) | 404-930-1 | — | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H332
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H332
  H318
  H411 | | | |
| 024-016-00-2 | tetradecylammoniumbis(1-(5-chlor-2-oxidophenylazo)-2-naphtholato)chromat(1-) | 405-110-6 | 88377-66-6 | STOT RE 2 *
  Aquatic Chronic 4 | H373 **
  H413 | GHS08
  Wng | H373 **
  H413 | | | |
| 024-017-00-8 | chrom(VI)forbindelser, med undtagelse af bariumchromat samt sådanne nævnt andetsteds i dette bilag | — | — | Carc. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H317
  H410 | | | A |
| 024-018-00-3 | natriumchromat | 231-889-5 | 7775-11-3 | Carc. 1B
  Muta. 1B
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Acute Tox. 4 *
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H340
  H360FD
  H330
  H301
  H372 **
  H312
  H314
  H334
  H317
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H350
  H340
  H360FD
  H330
  H301
  H372 **
  H312
  H314
  H334
  H317
  H410 | | Resp. Sens.;
  H334: C ≥ 0,2  %
  Skin Sens.; H317:C ≥ 0,2  % | 3 |
| 024-019-00-9 | hovedkomponent: acetoeddikesyre/3-amino-1-hydroxybenzen (ATAN-MAP): trinatrium {6-[(2 eller 3 eller 4)-amino-(4 eller 5 eller 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalen-2''-azobenzen-1'',2'''-diolato}chromat (III);
  biprodukt 1: acetoeddikesyreanilid / acetoeddikesyreanilid (ATAN-ATAN): trinatrium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato}chromat (III);
  biprodukt 2: 3-amino-1-hydroxybenzen/3-amino-1-hydroxybenzen (MAP-MAP): trinatrium bis{6-[(2 eller 3 eller 4)-amino-(4 eller 5 eller 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato} chromat (III) | 419-230-1 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 024-020-00-4 | trinatrium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzen-2',4-diolato)]chromat(III) | 418-220-4 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 024-021-00-X | kaliumtetranatrium-bis[(N, N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzenazo-1'-prop-1'-en-2,2'-diolato]chromat(III) | 425-830-4 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 025-001-00-3 | mangandioxid | 215-202-6 | 1313-13-9 | Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H302 | GHS07
  Wng | H332
  H302 | | | |
| 025-002-00-9 | kaliumpermanganat | 231-760-3 | 7722-64-7 | Ox. Sol. 2
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H302
  H400
  H410 | GHS03
  GHS07
  GHS09
  Dgr | H272
  H302
  H410 | | | |
| 025-003-00-4 | mangansulfat | 232-089-9 | 7785-87-7 | STOT RE 2 *
  Aquatic Chronic 2 | H373 **
  H411 | GHS08
  GHS09
  Wng | H373 ** H411 | | | |
| 025-004-00-X | bis(N, N',N''-trimethyl-1,4,7-triazacyclononan)-trioxo-dimangan (IV) di(hexafluorphosphat)monohydrat | 411-760-1 | 116633-53-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 025-005-00-5 | blanding af tri-natrium [29H, 31H-phthalocyanin-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganat (3-);
  tetranatrium [29H,31H-phthalocyanin-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganat (3-);
  pentanatrium [29H,31H-phthalocyanin-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganat (3-) | 417-660-4 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 026-001-00-6 | (η-cumen)-(η-cyclopentadienyl)jern(II)-hexafluorantimonat | 407-840-0 | 100011-37-8 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 026-002-00-1 | (η-cumen)-(η-cyclopentadienyl)jern(II)-trifluormethan-sulfonat | 407-880-9 | 117549-13-0 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 026-003-00-7 | jern(II)sulfat | 231-753-5 | 7720-78-7 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H302
  H319
  H315 | GHS07
  Wng | H302
  H319
  H315 | | | |
| 026-003-01-4 | jern(II)sulfat (1:1) heptahydrat; svovlsyre, jern(II)-salt (1:1), heptahydrat;
  ferrosulfat heptahydrat | 231-753-5 | 7782-63-0 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H302
  H319
  H315 | GHS07
  Wng | H302
  H319
  H315 | | Skin Irrit.2; H315: C ≥ 25 % | |
| 026-004-00-2 | kaliumferrit | 430-010-4 | 12160-44-0 | Skin Corr. 1B
  Skin Sens. 1 | H314
  H317 | GHS05
  GHS07
  Dgr | H314
  H317 | | | |
| 027-001-00-9 | cobalt | 231-158-0 | 7440-48-4 | Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 4 | H334
  H317
  H413 | GHS08
  Dgr | H334
  H317
  H413 | | | |
| 027-002-00-4 | cobaltoxid | 215-154-6 | 1307-96-6 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | M = 10 | |
| 027-003-00-X | cobaltsulfid | 215-273-3 | 1317-42-6 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | M = 10 | |
| 027-004-00-5 | cobaltdichlorid | 231-589-4 | 7646-79-9 | Carc. 1B
  Muta. 2
  Repr. 1B
  Acute Tox. 4 *
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360f *** H302
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H360f *** H302
  H334
  H317
  H410 | | Carc. 1B; H350i: C ≥ 0,01  % M = 10 | 1 |
| 027-005-00-0 | cobaltsulfat | 233-334-2 | 10124-43-3 | Carc. 1B
  Muta. 2
  Repr. 1B
  Acute Tox. 4 *
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360f *** H302
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H360f *** H302
  H334
  H317
  H410 | | Carc. 1B; H350i: C ≥ 0,01  % M = 10 | 1 |
| 027-006-00-6 | cobaltdi(acetat) | 200-755-8 | 71-48-7 | Carc. 1B
  Muta. 2
  Repr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360f *** H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360f *** H334
  H317
  H410 | | Carc. 1B; H350i: C ≥ 0,01  %
  M = 10 | 1 |
| 027-007-00-1 | zinkhexacyanocobaltat(III), tert-butylalkohol/polypropylenglycolkompleks | 425-240-7 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 027-008-00-7 | kompleks af cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamid), hydrat (n H2O, 2<n<3) | 427-390-9 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 027-009-00-2 | cobaltdinitrat | 233-402-1 | 10141-05-6 | Carc. 1B
  Muta. 2
  Repr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360f *** H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360f *** H334
  H317
  H410 | | Carc. 1B; H350i: C ≥ 0,01  %
  M = 10 | 1 |
| 027-010-00-8 | cobaltcarbonat | 208-169-4 | 513-79-1 | Carc. 1B
  Muta. 2
  Repr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360f *** H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360f *** H334
  H317
  H410 | | Carc. 1B; H350i: C ≥ 0,01  % M = 10 | 1 |
| 028-001-00-1 | tetracarbonylnikkel;
  nikkeltetracarbonyl | 236-669-2 | 13463-39-3 | Flam. Liq. 2
  Carc. 2
  Repr. 1B
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H351
  H360D *** H330
  H400
  H410 | GHS02
  GHS06
  GHS08
  GHS09
  Dgr | H225
  H351
  H360D *** H330
  H410 | | | |
| 028-002-00-7 | nikkel | 231-111-4 | 7440-02-0 | Carc. 2
  STOT RE 1
  Skin Sens. 1 | H351
  H372 **
  H317 | GHS08
  GHS07
  Dgr | H351
  H372 **
  H317 | | | S7 |
| 028-002-01-4 | nikkelpulver; [partikeldiameter < 1 mm] | 231-111-4 | 7440-02-0 | Carc. 2
  STOT RE 1
  Skin Sens. 1
  Aquatic Chronic 3 | H351
  H372 **
  H317
  H412 | GHS08
  GHS07
  Dgr | H351
  H372 **
  H317
  H412 | | | |
| 028-003-00-2 | nikkelmonoxid; [1]
  nikkeloxid; [2]
  bunsenit [3] | 215-215-7 [1]
  234-323-5 [2]-[3] | 1313-99-1 [1]
  11099-02-8 [2]
  34492-97-2 [3] | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Chronic 4 | H350i
  H372 **
  H317
  H413 | GHS08
  GHS07
  Dgr | H350i
  H372 **
  H317
  H413 | | | |
| 028-004-00-8 | nikkeldioxid | 234-823-3 | 12035-36-8 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Chronic 4 | H350i
  H372 **
  H317
  H413 | GHS08
  GHS07
  Dgr | H350i
  H372 **
  H317
  H413 | | | |
| 028-005-00-3 | dinikkeltrioxid | 215-217-8 | 1314-06-3 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Chronic 4 | H350i
  H372 **
  H317
  H413 | GHS08
  GHS07
  Dgr | H350i
  H372 **
  H317
  H413 | | | |
| 028-006-00-9 | nikkel(II)sulfid; [1]
  nikkelsulfid; [2]
  millerit [3] | 240-841-2 [1]
  234-349-7 [2]-[3] | 16812-54-7 [1]
  11113-75-0 [2]
  1314-04-1 [3] | Carc. 1A
  Muta. 2
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H372 **
  H317
  H410 | | | |
| 028-007-00-4 | trinikkeldisulfid;
  nikkelsubsulfid; [1]
  heazlewoodit [2] | 234-829-6 [1]
  - [2] | 12035-72-2 [1]
  12035-71-1 [2] | Carc. 1A
  Muta. 2
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H372 ** H317
  H410 | | | |
| 028-008-00-X | nikkeldihydroxid; [1]
  nikkelhydroxid [2] | 235-008-5 [1]
  234-348-1 [2] | 12054-48-7 [1]
  11113-74-9 [2] | Carc. 1A
  Repr. 1B
  Muta. 2
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i H360D *** H341
  H372 **
  H332
  H302
  H315
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H360D *** H341
  H372 **
  H332
  H302
  H315
  H334
  H317
  H410 | | | |
| 028-009-00-5 | nikkelsulfat | 232-104-9 | 7786-81-4 | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H315
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 ** H332
  H302
  H315
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 %
  STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Irrit. 2; H315: C ≥ 20 %
  Skin Sens. 1; H317: C ≥
  0,01  %
  M = 1 | |
| 028-010-00-0 | nikkelcarbonat;
  basisk nikkelcarbonat;
  kulsyre, nikkel(2+)-salt; [1];
  kulsyre, nikkelsalt; [2]
  [μ-[carbonato(2-)-O:O']]-dihydroxytrinikkel; [3]
  [carbonato(2-)]tetrahydroxytrinikkel [4] | 222-068-2 [1]
  240-408-8 [2]
  265-748-4 [3]
  235-715-9 [4] | 3333-67-3 [1]
  16337-84-1 [2]
  65405-96-1 [3]
  12607-70-4 [4] | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H315
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H315
  H334
  H317
  H410 | | | |
| 028-011-00-6 | nikkeldichlorid | 231-743-0 | 7718-54-9 | Carc. 1A Muta. 2
  Repr. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H331
  H301
  H372 **
  H315
  H334
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H331
  H301
  H372 **
  H315
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 %
  STOT RE 2; H373: 0,1  % < C < 1 %
  Skin Irrit. 2; H315: C ≥ 20 %
  Skin Sens. 1; H317: C ≥ 0,01  %
  M = 1 | |
| 028-012-00-1 | nikkeldinitrat; [1]
  salpetersyre, nikkelsalt [2] | 236-068-5 [1]
  238-076-4 [2] | 13138-45-9 [1]
  14216-75-2 [2] | Ox. Sol. 2
  Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H350i
  H341
  H360D *** H372 **
  H332
  H302
  H315
  H318
  H334
  H317
  H400
  H410 | GHS03
  GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H272
  H350i
  H341
  H360D *** H372 **
  H332
  H302
  H315
  H318
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 %
  STOT RE 2; H373: 0,1  % < C < 1 %
  Skin Irrit. 2; H315: C ≥ 20 %
  Skin Sens. 1; H317 C ≥ 0,01  %
  M = 1 | |
| 028-013-00-7 | nikkelsten | 273-749-6 | 69012-50-6 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i *** H372 **
  H317
  H410 | | | |
| 028-014-00-2 | mudder og slam, kobberraffineringselektrolyse-, renset for kobber, nikkelsulfat | 295-859-3 | 92129-57-2 | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H315
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H315
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-015-00-8 | mudder og slam, kobberraffineringselektrolyse-, renset for kobber | 305-433-1 | 94551-87-8 | Carc. 1A Muta. 2
  Repr. 1A
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | | |
| 028-016-00-3 | nikkeldiperchlorat;
  perchlorsyre, nikkel(II)salt | 237-124-1 | 13637-71-3 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H314
  H334
  H317
  H400
  H410 | GHS05
  GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H314
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317: C ≥ 0,01  %
  M = 1 | |
| 028-017-00-9 | nikkeldikaliumbis(sulfat); [1]
  diammoniumnikkelbis(sulfat) [2] | 237-563-9 [1]
  239-793-2 [2] | 13842-46-1 [1]
  15699-18-0 [2] | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-018-00-4 | nikkelbis(sulfamidat);
  nikkelsulfamat | 237-396-1 | 13770-89-3 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-019-00-X | nikkelbis(tetrafluorborat) | 238-753-4 | 14708-14-6 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 ** H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317: C ≥ 0,01  %
  M = 1 | |
| 028-021-00-0 | nikkeldiformat; [1]
  myresyre, nikkelsalt; [2]
  myresyre, kobbernikkkelsalt [3] | 222-101-0 [1]
  239-946-6 [2]
  268-755-0 [3] | 3349-06-2 [1]
  15843-02-4 [2]
  68134-59-8 [3] | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 ** H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-022-00-6 | nikkeldi(acetat); [1]
  nikkelacetat [2] | 206-761-7 [1]
  239-086-1 [2] | 373-02-4 [1]
  14998-37-9 [2] | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H334
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H332
  H302
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-024-00-7 | nikkeldibenzoat | 209-046-8 | 553-71-9 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-025-00-2 | nikkelbis(4-cyclohexylbutyrat) | 223-463-2 | 3906-55-6 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-026-00-8 | nikkel(II)stearat;
  nikkel(II) octadecanoat | 218-744-1 | 2223-95-2 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-027-00-3 | nikkeldilactat | — | 16039-61-5 | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %
  Skin Sens. 1; H317: C ≥ 0,01  %
  M = 1 | |
| 028-028-00-9 | nikkel(II)octanoat | 225-656-7 | 4995-91-9 | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Skin Corr. 1A
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H314
  H334
  H317
  H400
  H410 | GHS05
  GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H314
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317: C ≥ 0,01  %
  M = 1 | |
| 028-029-00-4 | nikkeldifluorid; [1]
  nikkeldibromid; [2]
  nikkeldiiodid; [3]
  nikkelkaliumfluorid [4] | 233-071-3 [1]
  236-665-0 [2]
  236-666-6 [3]
  - [4] | 10028-18-9 [1]
  13462-88-9 [2]
  13462-90-3 [3]
  11132-10-8 [4] | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 ** H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317: C ≥ 0,01  %
  M = 1 | |
| 028-030-00-X | nikkelhexafluorsilicat | 247-430-7 | 26043-11-8 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-031-00-5 | nikkelselenat | 239-125-2 | 15060-62-5 | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-032-00-0 | nikkelhydrogenphosphat; [1]
  nikkelbis(dihydrogenphosphat); [2]
  trinikkelbis(orthophosphat); [3]
  dinikkeldiphosphat; [4]
  nikkelbis(phosphinat); [5]
  nikkelphosphinat; [6]
  phosphorsyre, calciumnikkelsalt; [7]
  diphosphorsyyre, nikkel(II)salt [8] | 238-278-2 [1]
  242-522-3 [2]
  233-844-5 [3]
  238-426-6 [4]
  238-511-8 [5]
  252-840-4 [6]
  - [7]
  - [8] | 14332-34-4 [1]
  18718-11-1 [2]
  10381-36-9 [3]
  14448-18-1 [4]
  14507-36-9 [5]
  36026-88-7 [6]
  17169-61-8 [7]
  19372-20-4 [8] | Carc. 1A
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H372 **
  H334
  H317
  H410 | | | |
| 028-033-00-6 | diammoniumnikkelhexacyanoferrat | — | 74195-78-1 | Carc. 1A
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i H372 ** H334
  H317
  H410 | | | |
| 028-034-00-1 | nikkeldicyanid | 209-160-8 | 557-19-7 | Carc. 1A
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H372 **
  H334
  H317
  H410 | EUH032 | | |
| 028-035-00-7 | nikkelchromat | 238-766-5 | 14721-18-7 | Carc. 1A
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H372 **
  H334
  H317
  H410 | | | |
| 028-036-00-2 | nikkel(II)silicat; [1]
  dinikkelorthosilicat; [2]
  nikkelsilicat (3:4); [3]
  kiselsyre, nikkelsalt; [4] trihydrogenhydroxybis[orthosilicato(4-)]trinikkelat(3-) [5] | 244-578-4 [1]
  237-411-1 [2]
  250-788-7 [3]
  253-461-7 [4]
  235-688-3 [5] | 21784-78-1 [1]
  13775-54-7 [2]
  31748-25-1 [3]
  37321-15-6 [4]
  12519-85-6 [5] | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i
  H372 ** H317
  H410 | | | |
| 028-037-00-8 | dinikkelhexacyanoferrat | 238-946-3 | 14874-78-3 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H372 ** H317
  H410 | | | |
| 028-038-00-3 | trinikkel bis(arsenat);
  nikkel(II)arsenat | 236-771-7 | 13477-70-8 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H372 ** H317
  H410 | | | |
| 028-039-00-9 | nikkeloxalat; [1]
  oxalsyre, nikkelsalt [2] | 208-933-7 [1]
  243-867-2 [2] | 547-67-1 [1]
  20543-06-0 [2] | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H372 ** H317
  H410 | | | |
| 028-040-00-4 | nikkeltellurid | 235-260-6 | 12142-88-0 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H372 ** H317
  H410 | | | |
| 028-041-00-X | trinikkeltetrasulfid | — | 12137-12-1 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H372 ** H317
  H410 | | | |
| 028-042-00-5 | trinikkelbis(arsenit) | — | 74646-29-0 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H372 ** H317
  H410 | | | |
| 028-043-00-0 | cobaltnikkelgrå periclas;
  C.I. Pigment Black 25; C.I. 77332; [1]
  cobaltnikkeldioxid; [2]
  cobaltnikkeloxid [3] | 269-051-6 [1]
  261-346-8 [2]
  - [3] | 68186-89-0 [1]
  58591-45-0 [2]
  12737-30-3 [3] | Carc. 1A
  STOT RE 1
  Skin Sens. 1 | H350i
  H372 **
  H317 | GHS08
  GHS07
  Dgr | H350i H372 ** H317 | | | |
| 028-044-00-6 | nikkeltintrioxid;
  nikkelstannat | 234-824-9 | 12035-38-0 | Carc. 1A
  STOT RE 1
  Skin Sens. 1 | H350i
  H372 **
  H317 | GHS08
  GHS07
  Dgr | H350i *** H372 **
  H317 | | | |
| 028-045-00-1 | nikkeltriurandecaoxid | 239-876-6 | 15780-33-3 | Carc. 1A
  STOT RE 1
  Skin Sens. 1 | H350i
  H372 **
  H317 | GHS08
  GHS07
  Dgr | H350i *** H372 **
  H317 | | | |
| 028-046-00-7 | nikkeldithiocyanat | 237-205-1 | 13689-92-4 | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | EUH032 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-047-00-2 | nikkeldichromat | 239-646-5 | 15586-38-6 | Carc. 1A
  Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317:C ≥ 0,01  %
  M = 1 | |
| 028-048-00-8 | nikkel(II)selenit | 233-263-7 | 10101-96-9 | Carc. 1A
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i *** H372 **
  H334
  H317
  H410 | | | |
| 028-049-00-3 | nikkelselenid | 215-216-2 | 1314-05-2 | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i *** H372 **
  H317
  H410 | | | |
| 028-050-00-9 | kiselsyre, blynikkelsalt | — | 68130-19-8 | Carc. 1A
  Repr. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H360Df H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H360Df H372 **
  H317
  H410 | | | |
| 028-051-00-4 | nikkeldiarsenid; [1]
  nikkelarsenid [2] | 235-103-1 [1]
  248-169-1 [2] | 12068-61-0 [1]
  27016-75-7 [2] | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i *** H372 **
  H317
  H410 | | | |
| 028-052-00-X | nikkelbariumtitanprimulagul priderit;
  C.I. Pigment Yellow 157; C.I. 77900 | 271-853-6 | 68610-24-2 | Carc. 1A
  STOT RE 1
  Skin Sens. 1 | H350i
  H372 **
  H317 | GHS08
  GHS07
  Dgr | H350i *** H372 **
  H317 | | | |
| 028-053-00-5 | nikkeldichlorat; [1]
  nikkeldibromat; [2]
  ethylhydrogensulfat, nikkel(II)salt [3] | 267-897-0 [1]
  238-596-1 [2]
  275-897-7 [3] | 67952-43-6 [1]
  14550-87-9 [2]
  71720-48-4 [3] | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < %
  Skin Sens. 1; H317:C ≥ 0,01  % 1
  M = 1 | |
| 028-054-00-0 | nikkel(II)trifluoracetat; [1]
  nikkel(II)propionat; [2]
  nikkelbis(benzensulfonat); [3]
  nikkel(II)hydrogencitrat; [4]
  citronsyre, ammoniumnikkelsalt; [5]
  citronsyre, nikkelsalt; [6]
  nikkelbis(2-ethylhexanoat); [7]
  2-ethylhexansyre, nikkelsalt; [8]
  dimethylhexansyre, nikkelsalt; [9]
  nikkel(II)isooctanoat; [10]
  nikkelisooctanoat; [11]
  nikkelbis(isononanoat); [12]
  nikkel(II)neononanoat; [13]
  nikkel(II)isodecanoat; [14]
  nikkel(II)neodecanoat; [15]
  neodecansyre, nikkelsalt;[16]
  nikkel(II)neoundecanoat; [17]
  bis(D-gluconato-O1,O2)nikkel; [18]
  nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoat (1:2); [19]
  nikkel(II)palmitat; [20]
  (2-ethylhexanoato-O)(isononanoato-O)nikkel; [21]
  (isononanoato-O)(isooctanoato-O)nikkel; [22]
  (isooctanoato-O)(neodecanoato-O)nikkel; [23]
  (2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24]
  (2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25]
  (isodecanoato-O)(isooctanoato-O)nikkel; [26]
  (isodecanoato-O)(isononanoato-O)nikkel; [27]
  (isononanoato-O)(neodecanoato-O)nikkel; [28]
  fedtsyrer, C6-19-forgrenede, nikkelsalte; [29]
  fedtsyrer, C8-18 og C18-umættede, nikkelsalte; [30]
  2,7-naphthalendisulfonsyre, nikkel(II)salt; [31] | 240-235-8 [1]
  222-102-6 [2]
  254-642-3 [3]
  242-533-3 [4]
  242-161-1 [5]
  245-119-0 [6]
  224-699-9 [7]
  231-480-1 [8]
  301-323-2 [9]
  249-555-2 [10]
  248-585-3 [11]
  284-349-6 [12]
  300-094-6 [13]
  287-468-1 [14]
  287-469-7 [15]
  257-447-1 [16]
  300-093-0 [17]
  276-205-6 [18]
  258-051-1 [19]
  294-302-1 [29]
  283-972-0 [30]
  - [31]
  237-138-8 [20]
  287-470-2 [21]
  287-471-8 [22]
  284-347-5 [23]
  284-351-7 [24]
  285-698-7 [25]
  285-909-2 [26]
  284-348-0 [27]
  287-592-6 [28] | 16083-14-0 [1]
  3349-08-4 [2]
  39819-65-3 [3]
  18721-51-2 [4]
  18283-82-4 [5]
  22605-92-1 [6]
  4454-16-4 [7]
  7580-31-6 [8]
  93983-68-7 [9]
  29317-63-3 [10]
  27637-46-3 [11]
  84852-37-9 [12]
  93920-10-6 [13]
  85508-43-6 [14]
  85508-44-7 [15]
  51818-56-5 [16]
  93920-09-3 [17]
  71957-07-8 [18]
  52625-25-9 [19]
  13654-40-5 [20]
  85508-45-8 [21]
  85508-46-9 [22]
  84852-35-7 [23]
  84852-39-1 [24]
  85135-77-9
  [25]
  85166-19-4 [26]
  84852-36-8 [27]
  85551-28-6 [28]
  91697-41-5 [29]
  84776-45-4 [30]
  72319-19-8 [31] | Carc. 1A Muta. 2
  Repr. 1B
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i
  H341
  H360D *** H372 **
  H334
  H317
  H410 | | STOT RE 1;
  H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %
  Skin Sens. 1; H317: C ≥
  0,01  % M = 1 | |
| 028-055-00-6 | nikkel(II)sulfit; [1]
  nikkeltellurtrioxid; [2]
  nikkeltellurtetraoxid; [3]
  molybdennikkelhydroxidoxidphosphat [4] | 231-827-7 [1]
  239-967-0 [2]
  239-974-9 [3]
  268-585-7 [4] | 7757-95-1 [1]
  15851-52-2 [2]
  15852-21-8 [3]
  68130-36-9 [4] | Carc. 1A
  STOT RE 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H334
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350i H372 **
  H334
  H317
  H410 | | | |
| 028-056-00-1 | nikkelborid (NiB); [1]
  dinikkelborid; [2]
  trinikkelborid; [3]
  nikkelborid; [4]
  dinikkelsilicid; [5]
  nikkeldisilicid; [6]
  dinikkelphosphid; [7]
  nikkelborphosphid [8] | 234-493-0 [1]
  234-494-6 [2]
  234-495-1 [3]
  235-723-2 [4]
  235-033-1 [5]
  235-379-3 [6]
  234-828-0 [7]
  - [8] | 12007-00-0 [1]
  12007-01-1 [2]
  12007-02-2 [3]
  12619-90-8 [4]
  12059-14-2 [5]
  12201-89-7 [6]
  12035-64-2 [7]
  65229-23-4 [8] | Carc. 1A
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H372 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350i H372 **
  H317
  H410 | | | |
| 028-057-00-7 | dialuminiumnikkeltetraoxid; [1]
  nikkeltitantrioxid;[2]
  nikkeltitanoxid; [3]
  nikkeldivanadiumhexaoxid; [4]
  cobaltdimolybdennikkeloctaoxid; [5]
  nikkelzirkoniumtrioxid; [6]
  molybdennikkeltetraoxid; [7]
  nikkelwolframtetraoxid; [8]
  olivin, nikkelgrøn; [9]
  lithiumnikkeldioxid; [10]
  molybdennikkeloxid; [11] | 234-454-8 [1]
  234-825-4 [2]
  235-752-0 [3]
  257-970-5 [4]
  268-169-5 [5]
  274-755-1 [6]
  238-034-5 [7]
  238-032-4 [8]
  271-112-7 [9]
  - [10]
  - [11] | 12004-35-2 [1]
  12035-39-1 [2]
  12653-76-8 [3]
  52502-12-2 [4]
  68016-03-5 [5]
  70692-93-2 [6]
  14177-55-0 [7]
  14177-51-6 [8]
  68515-84-4 [9]
  12031-65-1 [10]
  12673-58-4 [11] | Carc. 1A
  STOT RE 1
  Skin Sens. 1 | H350i
  H372 **
  H317 | GHS08
  GHS07
  Dgr | H350i H372 **
  H317 | | | |
| 028-058-00-2 | cobaltlithiumnikkeloxid | 442-750-5 | — | Carc. 1A
  Acute Tox. 2 *
  STOT RE 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350i
  H330
  H372 **
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350i
  H330
  H372 **
  H317
  H410 | | | |
| 029-001-00-4 | kobberchlorid; kobber(I)chlorid | 231-842-9 | 7758-89-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H400
  H410 | | | |
| 029-003-00-5 | naphthensyrer, kobbersalte;
  kobber napthenat | 215-657-0 | 1338-02-9 | Flam. Liq. 3
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H302
  H400
  H410 | GHS02
  GHS07
  GHS09
  Wng | H226
  H302
  H410 | | | |
| 029-004-00-0 | kobbersulfat | 231-847-6 | 7758-98-7 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H315
  H410 | | | |
| 029-005-00-6 | (tris(chlormethyl)phthalocyaninato)kobber(II), reaktionsprodukter med N-methylpiperazin og methoxyeddikesyre | 401-260-1 | — | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 029-006-00-1 | tris(octadec-9-enylammonium)-(trisulfonatophthalocyaninato)kobber(II) | 403-210-4 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 029-007-00-7 | (trinatrium-(2-((3-(6-(2-chlor-5-sulfonato)anilino-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)kobber(3-))hydroxid | 404-670-9 | 89797-01-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | G |
| 029-008-00-2 | kobber(II)methansulfonat | 405-400-2 | 54253-62-2 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H410 | | | |
| 029-009-00-8 | phthalocyanin-N-[3-(diethylamino)propyl]sulfonamid kobberkomplex | 413-650-9 | 93971-95-0 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 029-010-00-3 | blanding af forbindelser fra (dodecakis(p-tolylthio)phthalocyaninato)kobber(II) til (hexadecakis(p-tolylthio)phthalocyaninato)kobber(II) | 407-700-9 | 101408-30-4 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 029-011-00-9 | natrium-[29H,31H-phtalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonat, kobberkomplex | 412-730-0 | 150522-10-4 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 029-012-00-4 | natrium-((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)kobber(II) | 407-340-2 | 124719-24-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 029-013-00-X | trinatrium-(2-(α-(3-(4-chlor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenhydrazino)-4-sulfonatobenzoato)kobber(II) | 407-580-8 | 130201-51-3 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 029-014-00-5 | en blanding af 2,2'-[[cis-1,2-cyclohexandiylbis(nitrilomethyliden)]bis[phenolat]](2-)-N, N',O, O'-kobberkompleks og 2,2'-[[trans-1,2-cyclohexandiylbis(nitrilomethylidyn)]bis[phenolat]](2-)-N, N',O, O'-kobberkompleks | 419-610-7 | 171866-24-3 | STOT RE 2 *
  Aquatic Chronic 2 | H373 **
  H411 | GHS08
  GHS09
  Wng | H373 **
  H411 | | | |
| 030-001-00-1 | zinkpulver — zinkstøv (ustabiliseret) | 231-175-3 | 7440-66-6 | Water-react. 1
  Pyr. Sol. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H260
  H250
  H400
  H410 | GHS02
  GHS09
  Dgr | H260
  H250
  H410 | | | T |
| 030-001-01-9 | zinkpulver — zinkstøv (stabiliseret) | 231-175-3 | 7440-66-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 030-003-00-2 | zinkchlorid | 231-592-0 | 7646-85-7 | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H410 | | STOT SE 3; H335: C ≥ 5 % | |
| 030-004-00-8 | dimethylzink; [1]
  diethylzink [2] | 208-884-1 [1]
  209-161-3 [2] | 544-97-8 [1]
  557-20-0 [2] | Pyr. Liq. 1
  Water-react. 1
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H250
  H260
  H314
  H400
  H410 | GHS02
  GHS05
  GHS09
  Dgr | H250
  H260
  H314
  H410 | EUH014 | | |
| 030-005-00-3 | diamindiisocyanoatozink | 401-610-3 | — | Acute Tox. 4 *
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1 | H302
  H318
  H334
  H317
  H400 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H302
  H318
  H334
  H317
  H400 | | | |
| 030-006-00-9 | zinksulfat (vandholdig) (mono-, hexa- og heptahydrat); [1]
  zinksulfat (vandfri) [2] | 231-793-3 [1]
  231-793-3 [2] | 7446-19-7 [1]
  7733-02-0 [2] | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H410 | | | |
| 030-007-00-4 | bis(3,5-di-tert-butylsalicylato-O1,O2)zink | 403-360-0 | 42405-40-3 | Flam. Sol. 1
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H228
  H302
  H400
  H410 | GHS02
  GHS07
  GHS09
  Dgr | H228
  H302
  H410 | | | T |
| 030-008-00-X | hydroxo(2-(benzensulfonamido)benzoato)zink(II) | 403-750-0 | 113036-91-2 | Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H411 | GHS07
  GHS09
  Wng | H332
  H411 | | | |
| 030-009-00-5 | zink-bis(4-(n-octyloxycarbonylamino)salicylat) dihydrat | 417-130-2 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 030-010-00-0 | 2-dodec-1-enylbutandisyre, 4-methylester, zinksalt | 430-740-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 030-011-00-6 | trizinkbis(orthophosphat) | 231-944-3 | 7779-90-0 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 030-012-00-1 | aluminium-magnesium-zink-carbonat-hydroxid | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 | | H413 | | | |
| 030-013-00-7 | zinkoxid | 215-222-5 | 1314-13-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 030-015-00-8 | tetrazink(2+)-bis(hexacyanocobalt(3+))diacetat | 440-060-9 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 033-001-00-X | arsen | 231-148-6 | 7440-38-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H410 | | | |
| 033-002-00-5 | arsenforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H410 | | * | A1 |
| 033-003-00-0 | diarsentrioxid;
  arsentrioxid | 215-481-4 | 1327-53-3 | Carc. 1A
  Acute Tox. 2 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H300
  H314
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H350
  H300
  H314
  H410 | | | |
| 033-004-00-6 | diarsenpentaoxid;
  arsenpentaoxid;
  arsenoxid | 215-116-9 | 1303-28-2 | Carc. 1A
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H331
  H301
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H301
  H410 | | | |
| 033-005-00-1 | arsensyre og dets salte undtagen sådanne nævnt andetsteds i dette bilag | — | — | Carc. 1A
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H331
  H301
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H301
  H410 | | | A |
| 033-006-00-7 | arsin | 232-066-3 | 7784-42-1 | Flam. Gas 1
  Press. Gas
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H220
  H330
  H373 **
  H400
  H410 | GHS02
  GHS04
  GHS06
  GHS08
  GHS09
  Dgr | H220
  H330
  H373 ** H410 | | | U |
| 033-007-00-2 | tert-butylarsin | 423-320-6 | 4262-43-5 | Pyr. Liq. 1
  Acute Tox. 2 * | H250
  H330 | GHS02
  GHS06
  Dgr | H250
  H330 | | | |
| 034-001-00-2 | selen | 231-957-4 | 7782-49-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 4 | H331
  H301
  H373 **
  H413 | GHS06
  GHS08
  Dgr | H331
  H301
  H373 ** H413 | | | |
| 034-002-00-8 | selenforbindelser med undtagelse af cadmiumsulfoselenid undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H301
  H373 **
  H410 | | | A |
| 034-003-00-3 | natriumselenit | 233-267-9 | 10102-18-8 | Acute Tox. 2 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Chronic 2 | H300
  H331
  H317
  H411 | GHS06
  GHS09
  Dgr | H300
  H331
  H317
  H411 | EUH031 | | |
| 035-001-00-5 | brom | 231-778-1 | 7726-95-6 | Acute Tox. 2 *
  Skin Corr. 1A
  Aquatic Acute 1 | H330
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H330
  H314
  H400 | | | |
| 035-002-00-0 | hydrogenbromid | 233-113-0 | 10035-10-6 | Press. Gas
  Skin Corr. 1A
  STOT SE 3 | H314
  H335 | GHS04
  GHS05
  GHS07
  Dgr | H314
  H335 | | | U |
| 035-002-01-8 | hydrogenbromid ... % | — | — | Skin Corr. 1B
  STOT SE 3 | H314
  H335 | GHS05
  GHS07
  Dgr | H314
  H335 | | Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 %
  Eye Irrit. 2; H319: 10 % ≤ C < 40 %
  STOT RE 3; H335: C ≥ 10 % | B |
| 035-003-00-6 | kaliumbromat | 231-829-8 | 7758-01-2 | Ox. Sol. 1
  Carc. 1B
  Acute Tox. 3 * | H271
  H350
  H301 | GHS03
  GHS06
  GHS08
  Dgr | H271
  H350
  H301 | | | |
| 035-004-00-1 | 2-hydroxyethylammoniumperbromid | 407-440-6 | — | Ox. Sol. 2 ****
  Acute Tox. 4 *
  Skin Corr. 1A
  Skin Sens. 1
  Aquatic Acute 1 | H272
  H302
  H314
  H317
  H400 | GHS03
  GHS05
  GHS07
  GHS09
  Dgr | H272
  H302
  H314
  H317
  H400 | | | |
| 040-001-00-3 | zirconiumpulver (ustabiliseret) | 231-176-9 | 7440-67-7 | Water-react. 1
  Pyr. Sol. 1 | H260
  H250 | GHS02
  Dgr | H260
  H250 | | | T |
| 040-002-00-9 | zirkoniumpulver, tør (stabiliseret) | — | — | Self-heat. 1 | H251 | GHS02
  Dgr | H251 | | | T |
| 040-003-00-4 | reaktionsprodukt af 3,5-di-tert-butylsalicylsyre og zirconiumoxychlorid, dehydreret, basisk Zr: DTBS = 1,0:1,0 til 1,0: 1,5 | 430-610-6 | 226996-19-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 042-001-00-9 | molybdentrioxid | 215-204-7 | 1313-27-5 | Carc. 2
  Eye Irrit. 2
  STOT SE 3 | H351
  H319
  H335 | GHS08
  GHS07
  Wng | H351
  H319
  H335 | | | |
| 042-002-00-4 | tetrakis(dimethylditetradecylammonium)hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdat(4-) | 404-760-8 | 117342-25-3 | Acute Tox. 3 *
  Eye Dam. 1 | H331
  H318 | GHS06
  GHS05
  Dgr | H331
  H318 | | | |
| 042-003-00-X | tetrakis(trimethylhexadecylammonium)hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdat(4-) | 404-860-1 | 116810-46-9 | Flam. Sol. 1
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H228
  H318
  H400
  H410 | GHS02
  GHS05
  GHS09
  Dgr | H228
  H318
  H410 | | | T |
| 042-004-00-5 | reaktionsprodukt af ammoniummolybdat og C12-C24-diethoxyleret alkylamin (1:5-1:3) | 412-780-3 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H317
  H411 | GHS07
  GHS09
  Wng | H315
  H317
  H411 | | | |
| 042-005-00-0 | blanding af mono- og di-glyceroler af rapsolie;
  rapsoliefedtsyreamid af forgrenet 1,3-propandiamin, N-[3-(tridecyloxy)-propyl];

  N, N-diorgano-dithiocarbamat molybdenkompleks | 434-240-6 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 046-001-00-X | tetramminpalladium (II) hydrogencarbonat | 425-270-0 | 134620-00-1 | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H302
  H373 ** H318
  H317
  H410 | | | |
| 047-001-00-2 | sølvnitrat | 231-853-9 | 7761-88-8 | Ox. Sol. 2
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H314
  H400
  H410 | GHS03
  GHS05
  GHS09
  Dgr | H272
  H314
  H410 | | | |
| 047-002-00-8 | polyphosphorsyre, kobber-, natrium-, magnesium-, calcium-, sølv- og zinksalt | 416-850-4 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 048-001-00-5 | cadmiumforbindelser, med undtagelse af cadmiumsulfoselenid (xCdS.yCdSe) og blandinger af cadmiumsulfid med zinksulfid (xCdS.yZnS), blandinger af cadmiumsulfid med kviksølvsulfid (xCdS.yHgS) samt sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | * | A1 |
| 048-002-00-0 | cadmium (stabiliseret); [1]
  cadmiumoxid (stabiliseret) [2] | 231-152-8 [1]
  215-146-2 [2] | 7440-43-9 [1]
  1306-19-0 [2] | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 2 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H341
  H361fd
  H330
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H361fd
  H330
  H372 ** H410 | | | |
| 048-003-00-6 | cadmiumdiformat;
  cadmiumformat | 224-729-0 | 4464-23-7 | Acute Tox. 3 *
  Acute Tox. 3 *
  Carc. 2
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H351
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H301
  H351
  H373 ** H410 | | *
  STOT RE 2; H373: C ≥ 0,25  % | |
| 048-004-00-1 | cadmiumcyanid | 208-829-1 | 542-83-6 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Carc. 2
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H351
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H351
  H373 ** H410 | EUH032 | STOT RE 2; H373: C ≥ 0,1  %
  EUH032:C ≥ 1 % | |
| 048-005-00-7 | cadmiumhexafluorsilicat(2-);
  cadmiumfluorsilicat | 241-084-0 | 17010-21-8 | Acute Tox. 3 *
  Acute Tox. 3 *
  Carc. 2
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H351
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H301
  H351
  H373 ** H410 | | *
  STOT RE 2; H373: C ≥ 0,1  % | |
| 048-006-00-2 | cadmiumfluorid | 232-222-0 | 7790-79-6 | Carc. 1B
  Muta. 1B
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H340
  H360FD
  H330
  H301
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H340
  H360FD H330
  H301
  H372 ** H410 | | Carc. 1B; H350: C ≥ 0,01  %
  - oral
  STOT RE 1; H372: C ≥ 7 % STOT RE 2;
  0,1  % ≤ C < 7 % | |
| 048-007-00-8 | cadmiumiodid | 232-223-6 | 7790-80-9 | Acute Tox. 3 *
  Acute Tox. 3 *
  Carc. 2
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H351
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H301
  H351
  H373 ** H410 | | *
  STOT RE 2; H373: C ≥ 0,1  % | |
| 048-008-00-3 | cadmiumchlorid | 233-296-7 | 10108-64-2 | Carc. 1B
  Muta. 1B
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H340
  H360FD
  H330
  H301
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H340
  H360FD H330
  H301
  H372 ** H410 | | Carc. 1B; H350: C ≥ 0,01  %
  - oral
  STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1  % ≤ C < 7 % | |
| 048-009-00-9 | cadmiumsulfat | 233-331-6 | 10124-36-4 | Carc. 1B
  Muta. 1B
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H340
  H360FD
  H330
  H301
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H340
  H360FD H330
  H301
  H372 ** H410 | | Carc. 1B; H350: C ≥ 0,01  %
  - oral
  STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373:0,1  % ≤ C < 7 % | |
| 048-010-00-4 | cadmiumsulfid | 215-147-8 | 1306-23-6 | Carc. 1B
  Muta. 2
  Repr. 2
  STOT RE 1
  Acute Tox. 4 *
  Aquatic Chronic 4 | H350
  H341
  H361fd
  H372 **
  H302
  H413 | GHS08
  GHS07
  Dgr | H350
  H341
  H361fd
  H372 ** H302
  H413 | | *
  STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1  % ≤ C < 10 % | 1 |
| 048-011-00-X | cadmium (ustabiliseret) | 231-152-8 | 7440-43-9 | Pyr. Sol. 1
  Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 2 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H250
  H350
  H341
  H361fd
  H330
  H372 **
  H400
  H410 | GHS02
  GHS06
  GHS08
  GHS09
  Dgr | H250
  H350
  H341
  H361fd
  H330
  H372 ** H410 | | | |
| 050-001-00-5 | tintetrachlorid;
  tinchlorid | 231-588-9 | 7646-78-8 | Skin Corr. 1B
  Aquatic Chronic 3 | H314
  H412 | GHS05
  Dgr | H314
  H412 | | STOT SE 3; H335:C ≥ 5 % | |
| 050-002-00-0 | cyhexatin (ISO);
  hydroxytricyclohexylstannan;
  tri(cyclohexyl)tinhydroxid | 236-049-1 | 13121-70-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | M = 1 000 | |
| 050-003-00-6 | fentinacetat (ISO);
  triphenyltinacetat | 212-984-0 | 900-95-8 | Carc. 2
  Repr. 2
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H361d *** H330
  H311
  H301
  H372 **
  H335
  H315
  H318
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H351
  H361d *** H330
  H311
  H301
  H372 **
  H335
  H315
  H318
  H410 | | M = 10 | |
| 050-004-00-1 | fentinhydroxid (ISO);
  triphenyltinhydroxid | 200-990-6 | 76-87-9 | Carc. 2
  Repr. 2
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H361d *** H330
  H311
  H301
  H372 **
  H335
  H315
  H318
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H351
  H361d *** H330
  H311
  H301
  H372 **
  H335
  H315
  H318
  H410 | | M = 10 | |
| 050-005-00-7 | trimethyltin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H410 | | * | A1 |
| 050-006-00-2 | triethyltin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H410 | | * | A1 |
| 050-007-00-8 | tripropyltin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | * | A1 |
| 050-009-00-9 | fluortripentylstannan; [1]
  hexapentyldistannoxan [2] | 243-546-7 [1]
  247-143-7 [2] | 20153-49-5 [1]
  25637-27-8 [2] | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | * | 1 |
| 050-010-00-4 | fluortrihexylstannan | 243-547-2 | 20153-50-8 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | * | 1 |
| 050-011-00-X | triphenyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | * M = 100 | A1 |
| 050-012-00-5 | tetracyclohexylstannan; [1]
  chlortricyclohexylstannan; [2]
  butyltricyclohexylstannan [3] | 215-910-5 [1]
  221-437-5 [2]
  230-358-5 [3] | 1449-55-4 [1]
  3091-32-5 [2]
  7067-44-9 [3] | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | * | A1 |
| 050-013-00-0 | trioctylin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 4 | H319
  H335
  H315
  H413 | GHS07
  Wng | H319
  H335
  H315
  H413 | | Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | A1 |
| 050-017-00-2 | fenbutatin-oxid (ISO);
  bis(tris(2-methyl-2-phenylpropyl)tin)-oxid | 236-407-7 | 13356-08-6 | Acute Tox. 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H319
  H315
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H319
  H315
  H410 | | | |
| 050-018-00-8 | tin(II)methansulfonat | 401-640-7 | 53408-94-9 | Skin Corr. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H314
  H302
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H302
  H317
  H411 | | | |
| 050-019-00-3 | azocyclotin (ISO);
  1-(tricyclohexylstannyl)-1H-1,2,4-triazol | 255-209-1 | 41083-11-8 | Acute Tox. 2 *
  Acute Tox. 3 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H301
  H335
  H315
  H318
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H330
  H301
  H335
  H315
  H318
  H410 | | | |
| 050-020-00-9 | trioctylstannan | 413-320-4 | 869-59-0 | STOT RE 1
  Skin Irrit. 2
  Aquatic Chronic 4 | H372 **
  H315
  H413 | GHS08
  GHS07
  Dgr | H372 ** H315
  H413 | | | |
| 050-021-00-4 | dichlordioctylstannan | 222-583-2 | 3542-36-7 | Acute Tox. 3 *
  STOT RE 1
  Aquatic Chronic 3 | H331
  H372 **
  H412 | GHS06
  GHS08
  Dgr | H331
  H372 **
  H412 | | | |
| 050-022-00-X | dibutyltindichlorid;
  (DBTC) | 211-670-0 | 683-18-1 | Muta. 2
  Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 1
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H360FD
  H330
  H301
  H312
  H372 **
  H314
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H341
  H360FD H330
  H301
  H312
  H372 **
  H314
  H410 | | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01  % ≤ C < 5 %
  Eye Dam.1; H318: 3 % ≤ C
  < 5 %
  Eye Irrit. 2; H319: 0,01  % ≤ C < 3 %
  M = 10 | |
| 050-023-00-5 | blanding af: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannan;
  bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxid; bis(1-phenyl-1,3-decandionyl)dioctylstannan;
  ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decandionyl)dioctylstannan | 422-920-5 | — | STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H373 **
  H410 | | M = 10 | |
| 050-024-00-0 | blanding af: tri-p-tolyltinhydroxid;
  hexa-p-tolyl-distannoxan | 432-230-6 | — | STOT RE 1
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H372 **
  H302
  H315
  H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H372 **
  H302
  H315
  H318
  H317
  H410 | | | |
| 050-025-00-6 | trichlormethylstannan | 213-608-8 | 993-16-8 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 050-026-00-1 | 2-ethylhexyl-10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]-thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat | 260-828-5 | 57583-34-3 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 050-027-00-7 | 2-ethylhexyl-10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat | 239-622-4 | 15571-58-1 | Repr. 1B | H360D | GHS08
  Dgr | H360D | | | |
| 050-028-00-2 | 2-ethylhexyl-10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat | 260-829-0 | 57583-35-4 | Repr. 2
  Acute Tox. 4
  STOT RE 1
  Skin Sens. 1A | H361d
  H302
  H372
  (nervesystem, immunsystem)
  H317 | GHS08
  GHS07
  Dgr | H361d
  H302
  H372 (nervesystem, immunsystem)
  H317 | | | |
| 050-029-00-8 | dimethyltindichlorid | 212-039-2 | 753-73-1 | Repr. 2
  Acute Tox. 2
  Acute Tox. 3
  Acute Tox. 3
  STOT RE 1
  Skin Corr. 1B | H361d
  H330
  H301
  H311
  H372
  (nervesystem, immunsystem)
  H314 | GHS08
  GHS06
  GHS05
  Dgr | H361d
  H330
  H301
  H311
  H372 (nervesystem, immunsystem)
  H314 | EUH071 | | |
| 051-001-00-8 | antimontrichlorid | 233-047-2 | 10025-91-9 | Skin Corr. 1B
  Aquatic Chronic 2 | H314
  H411 | GHS05
  GHS09
  Dgr | H314
  H411 | | STOT SE 3; H335: C ≥ 5 % | |
| 051-002-00-3 | antimonpentachlorid | 231-601-8 | 7647-18-9 | Skin Corr. 1B
  Aquatic Chronic 2 | H314
  H411 | GHS05
  GHS09
  Dgr | H314
  H411 | | STOT SE 3; H335: C ≥ 5 % | |
| 051-003-00-9 | antimonforbindelser, med undtagelse af antimontetraoxid (Sb2O4), antimonpentoxid (Sb2O5), antimontrisulfid (Sb2S3), antimonpentasulfid (Sb2S5) samt sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H302
  H411 | GHS07
  GHS09
  Wng | H332
  H302
  H411 | | * | A1 |
| 051-004-00-4 | antimontrifluorid | 232-009-2 | 7783-56-4 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H411 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H411 | | | |
| 051-005-00-X | antimontrioxid | 215-175-0 | 1309-64-4 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 051-006-00-5 | diphenyl(4-phenylthiophenyl)sulfoniumhexafluorantimonat | 403-500-0 | — | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 051-007-00-0 | bis(4-dodecylphenyl)iodonium hexafluorantimonat | 404-420-9 | 71786-70-4 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 053-001-00-3 | iod | 231-442-4 | 7553-56-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1 | H332
  H312
  H400 | GHS07
  GHS09
  Wng | H332
  H312
  H400 | | | |
| 053-002-00-9 | hydrogeniodid | 233-109-9 | 10034-85-2 | Press. Gas
  Skin Corr. 1A | H314 | GHS04
  GHS05
  Dgr | H314 | | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2  % ≤ C < 10 %
  Skin Irrit. 2; H315: 0,02  % ≤ C < 0,2  %
  Eye Irrit. 2; H319: 0,02  % ≤ C < 0,2  %
  STOT RE 3; H335: C ≥ 0,02  % | U5 |
| 053-002-01-6 | hydrogeniodidsyre ... % | — | — | Skin Corr. 1B | H314 | GHS05
  Dgr | | | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %
  Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B |
| 053-003-00-4 | iodoxybenzen | — | 696-33-3 | Expl. **** | **** | **** | **** | | | |
| 053-004-00-X | calciumiodoxybenzoat | — | — | Expl. **** | **** | **** | **** | | | C |
| 053-005-00-5 | (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorphenyl)borat(1-) | 422-960-3 | 178233-72-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H312
  H302
  H373 ** H410 | | | |
| 056-001-00-1 | bariumperoxid | 215-128-4 | 1304-29-6 | Ox. Sol. 2
  Acute Tox. 4 *
  Acute Tox. 4 * | H272
  H332
  H302 | GHS03
  GHS07
  Dgr | H272
  H332
  H302 | | | |
| 056-002-00-7 | bariumsalte, undtagen bariumsulfat, salte af 1-azo-2-hydroxynaphthalenylarylsulfonsyre, og salte nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H302 | GHS07
  Wng | H332
  H302 | | * | A1 |
| 056-003-00-2 | bariumcarbonat | 208-167-3 | 513-77-9 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 056-004-00-8 | bariumchlorid | 233-788-1 | 10361-37-2 | Acute Tox. 3 *
  Acute Tox. 4 * | H301
  H332 | GHS06
  Dgr | H301
  H332 | | | |
| 064-001-00-8 | gadolinium(III)sulfittrihydrat | 456-900-2 | 51285-81-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 072-001-00-4 | hafnium-tetra-n-butoxid | 411-740-2 | 22411-22-9 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 074-001-00-X | hexanatrium-dihydrogen-dodecawolframat | 412-770-9 | 12141-67-2 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 074-002-00-5 | reaktionsprodukter af wolframhexachlorid med 2-methylpropan-2-ol, nonylphenol og pentan-2,4-dion | 408-250-6 | — | Flam. Liq. 2
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H332
  H314
  H317
  H400
  H410 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H225
  H332
  H314
  H317
  H410 | | | |
| 076-001-00-5 | osmiumtetraoxid;
  osmiumsyre | 244-058-7 | 20816-12-0 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Skin Corr. 1B | H330
  H310
  H300
  H314 | GHS06
  GHS05
  Dgr | H330
  H310
  H300
  H314 | | | |
| 078-001-00-0 | tetrachlorplatinater, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H318
  H334
  H317 | | | A |
| 078-002-00-6 | diammoniumtetrachlorplatinat | 237-499-1 | 13820-41-2 | Acute Tox. 3 *
  Skin Irrit. 2
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H315
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H315
  H318
  H334
  H317 | | | |
| 078-003-00-1 | dinatriumtetrachlorplatinat | 233-051-4 | 10026-00-3 | Acute Tox. 3 *
  Skin Irrit. 2
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H315
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H315
  H318
  H334
  H317 | | | |
| 078-004-00-7 | dikaliumtetrachlorplatinat | 233-050-9 | 10025-99-7 | Acute Tox. 3 *
  Skin Irrit. 2
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H315
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H315
  H318
  H334
  H317 | | | |
| 078-005-00-2 | hexachlorplatinater, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H318
  H334
  H317 | | | A |
| 078-006-00-8 | dinatriumhexachlorplatinat | 240-983-5 | 16923-58-3 | Acute Tox. 3 *
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H318
  H334
  H317 | | | |
| 078-007-00-3 | dikaliumhexachlorplatinat | 240-979-3 | 16921-30-5 | Acute Tox. 3 *
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H318
  H334
  H317 | | | |
| 078-008-00-9 | diammoniumhexachlorplatinat | 240-973-0 | 16919-58-7 | Acute Tox. 3 *
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H318
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H318
  H334
  H317 | | | |
| 078-009-00-4 | hexachloroplatinsyre | 241-010-7 | 16941-12-1 | Acute Tox. 3 *
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1 | H301
  H314
  H334
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H301
  H314
  H334
  H317 | | | |
| 078-010-00-X | tetramminplatin(II)hydrogencarbonat | 426-730-3 | 123439-82-7 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 078-011-00-5 | hydroxydisulfitoplatin(II)syre | 423-310-1 | 61420-92-6 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1A
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H373
  H314
  H334
  H317
  H412 | GHS05
  GHS08
  GHS07
  Dgr | H302
  H373
  H314
  H334
  H317
  H412 | | | |
| 078-012-00-0 | platin(IV)nitrat/salpetersyreopløsning | 432-400-1 | — | Skin Corr. 1A
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | | |
| 080-001-00-0 | kviksølv | 231-106-7 | 7439-97-6 | Repr. 1B
  Acute Tox. 2 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D *** H330
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H360D *** H330
  H372 **
  H410 | | | |
| 080-002-00-6 | uorganiske kviksølvforbindelser, undtagen kviksølv (II) sulfid (cinnober) samt sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 ** H410 | | *
  STOT RE 2; H373: C ≥ 0,1  % | A1 |
| 080-003-00-1 | dikviksølvdichlorid | 233-307-5 | 10112-91-1 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H335
  H315
  H410 | | | |
| 080-004-00-7 | organiske kviksølvforbindelser undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 ** H410 | | *
  STOT RE 2; H373: C ≥ 0,1  % | A1 |
| 080-005-00-2 | kviksølvdifulminat;
  kviksølvfulminat;
  fulminat af kviksølv | 211-057-8 | 628-86-4 | Unst. Expl.
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H200
  H331
  H311
  H301
  H373 **
  H400
  H410 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H200
  H331
  H311
  H301
  H373 ** H400
  H410 | | | |
| 080-005-01-X | kviksølvdifulmat;
  kviksølvfulmat;
  fulmat af kviksølv [≥ 20 % flegmatiseringsmiddel] | 211-057-8 | 628-86-4 | Expl. 1,1
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H331
  H311
  H301
  H373 **
  H400
  H410 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H331
  H311
  H301
  H373 ** H400
  H410 | | | |
| 080-006-00-8 | dikviksølvdicyanidoxid;
  kviksølvoxycyanid | 215-629-8 | 1335-31-5 | Expl. 1,1
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H331
  H311
  H301
  H373 **
  H400
  H410 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H331
  H311
  H301
  H373 **
  H410 | | | |
| 080-007-00-3 | dimethylkviksølv; [1]
  diethylkviksølv [2] | 209-805-3 [1]
  211-000-7 [2] | 593-74-8 [1]
  627-44-1 [2] | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 ** H410 | | *
  STOT RE 2; H373: C ≥ 0,05  % | 1 |
| 080-008-00-9 | phenylkviksølvnitrat; [1]
  phenylkviksølvhydroxid; [2]
  blanding af (1) og (2) [3] | 200-242-9 [1]
  202-866-7 [2]
  -[3] | 55-68-5 [1]
  100-57-2 [2]
  8003-05-2 [3] | Acute Tox. 3 *
  STOT RE 1
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H372 **
  H314
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H301
  H372 ** H314
  H410 | | | |
| 080-009-00-4 | 2-methoxyethylkviksølvchlorid | 204-659-7 | 123-88-6 | Acute Tox. 3 *
  STOT RE 1
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H372 **
  H314
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H301
  H372 ** H314
  H410 | | | |
| 080-010-00-X | kviksølvdichlorid; kviksølvchlorid | 231-299-8 | 7487-94-7 | Muta. 2
  Repr. 2
  Acute Tox. 2 *
  STOT RE 1
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H361f *** H300
  H372 **
  H314
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H341
  H361f *** H300
  H372 **
  H314
  H410 | | | |
| 080-011-00-5 | phenylkviksølvacetat | 200-532-5 | 62-38-4 | Acute Tox. 3 *
  STOT RE 1
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H372 **
  H314
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H301
  H372 ** H314
  H410 | | | |
| 081-001-00-3 | thallium | 231-138-1 | 7440-28-0 | Acute Tox. 2 *
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 4 | H330
  H300
  H373 **
  H413 | GHS06
  GHS08
  Dgr | H330
  H300
  H373 ** H413 | | | |
| 081-002-00-9 | thalliumforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 2 | H330
  H300
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H300
  H373 ** H411 | | | A |
| 081-003-00-4 | dithalliumsulfat;
  thallium(I)sulfat | 231-201-3 | 7446-18-6 | Acute Tox. 2 *
  STOT RE 1
  Skin Irrit. 2
  Aquatic Chronic 2 | H300
  H372 **
  H315
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H300
  H372 ** H315
  H411 | | | |
| 082-001-00-6 | blyforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Repr. 1A
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H332
  H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H360Df
  H332
  H302
  H373 ** H410 | | Repr.2 H361f C ≥ 2,5  %
  *
  STOT RE 2; H373: C ≥ 0,5  % | A1 |
| 082-002-00-1 | blyalkyler | — | — | Repr. 1A
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H330
  H310
  H300
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H360Df
  H330
  H310
  H300
  H373 ** H410 | | Repr.1A; H360D: C ≥ 0,1  %
  *
  STOT RE 2; H373: C ≥ 0,05  % | A1 |
| 082-003-00-7 | blydiazid;
  blyazid | 236-542-1 | 13424-46-9 | Unst. Expl. Repr. 1A
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H200
  H360Df
  H332
  H302
  H373 **
  H400
  H410 | GHS01
  GHS08
  GHS07
  GHS09
  Dgr | H200
  H360Df
  H332
  H302
  H373 ** H410 | | | 1 |
| 082-003-01-4 | blydiazid;
  blyazid [≥ 20 % flegmatiseringsmiddel] | 236-542-1 | 13424-46-9 | Expl. 1,1
  Repr. 1A
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H360Df
  H332
  H302
  H373 **
  H400
  H410 | GHS01
  GHS08
  GHS07
  GHS09
  Dgr | H201
  H360Df
  H332
  H302
  H373 ** H410 | | | 1 |
| 082-004-00-2 | blychromat | 231-846-0 | 7758-97-6 | Carc. 1B
  Repr. 1A
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H360Df H373 **
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H360Df H373 **
  H410 | | | 1 |
| 082-005-00-8 | blydi(acetat) | 206-104-4 | 301-04-2 | Repr. 1A
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H373 **
  H400
  H410 | GHS08
  GHS09
  Dgr | H360Df
  H373 ** H410 | | | 1 |
| 082-006-00-3 | triblybis(orthophosphat) | 231-205-5 | 7446-27-7 | Repr. 1A
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H373 **
  H400
  H410 | GHS08
  GHS09
  Dgr | H360Df
  H373 ** H410 | | | 1 |
| 082-007-00-9 | blyacetat, basisk | 215-630-3 | 1335-32-6 | Carc. 2
  Repr. 1A
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H360Df
  H373 **
  H400
  H410 | GHS08
  GHS09
  Dgr | H351
  H360Df
  H373 ** H410 | | | 1 |
| 082-008-00-4 | bly(II)methansulfonat | 401-750-5 | 17570-76-2 | Repr. 1A
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1 | H360Df
  H332
  H302
  H373 **
  H315
  H318 | GHS08
  GHS05
  GHS07
  Dgr | H360Df
  H332
  H302
  H373 ** H315
  H318 | | | 1 |
| 082-009-00-X | blysulfochromatgul; C.I. Pigment Yellow 34;
  [Denne forbindelse identificeres i Colour Index ved Colour Indeks Constitution Number C.I. 77603.] | 215-693-7 | 1344-37-2 | Carc. 1B
  Repr. 1A
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H360Df H373 **
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H360Df H373 **
  H410 | | | 1 |
| 082-010-00-5 | blychromatmolybdatsulfatrød (C.I. Pigment Red 104;
  [Denne forbindelse identificeres i Colour Index ved Colour Indeks Constitution-nummer, C.I. 77605.] | 235-759-9 | 12656-85-8 | Carc. 1B
  Repr. 1A
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H360Df H373 **
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H360Df H373 **
  H410 | | | 1 |
| 082-011-00-0 | blyhydrogenarsenat | 232-064-2 | 7784-40-9 | Carc. 1A
  Repr. 1A
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H360Df
  H331
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H360Df
  H331
  H301
  H373 ** H410 | | | 1 |
| 082-012-00-6 | barium-bly-calcium-caesium-samarium-strontium-bromid-chlorid-fluorid-iodid, europium-doteret | 431-780-4 | 199876-46-5 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 2 | H302
  H373 **
  H411 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H411 | | | |
| 092-001-00-8 | uran | 231-170-6 | 7440-61-1 | Acute Tox. 2 *
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 4 | H330
  H300
  H373 **
  H413 | GHS06
  GHS08
  Dgr | H330
  H300
  H373 ** H413 | | | |
| 092-002-00-3 | uranforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 2 *
  STOT RE 2
  Aquatic Chronic 2 | H330
  H300
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H300
  H373 **
  H411 | | | A |
| 601-001-00-4 | methan | 200-812-7 | 74-82-8 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 601-002-00-X | ethan | 200-814-8 | 74-84-0 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 601-003-00-5 | propan | 200-827-9 | 74-98-6 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 601-004-00-0 | butan; [1]
  og isobutan [2] | 203-448-7 [1]
  200-857-2 [2] | 106-97-8 [1]
  75-28-5 [2] | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | C U |
| 601-004-01-8 | butan (indhold ≥ 0.1 % butadin (203-450-8)); [1]
  isobutan (indhold ≥ 0.1 % butadin (203-450-8)) [2] | 203-448-7 [1]
  200-857-2 [2] | 106-97-8 [1]
  75-28-5 [2] | Flam. Gas 1
  Press. Gas
  Carc. 1A
  Muta. 1B | H220
  H350
  H340 | GHS02
  GHS04
  GHS08
  Dgr | H220
  H350
  H340 | | | C S U |
| 601-005-00-6 | 2,2-dimethylpropan;
  neopentan | 207-343-7 | 463-82-1 | Flam. Gas 1
  Press. Gas
  Aquatic Chronic 2 | H220
  H411 | GHS02
  GHS04
  GHS09
  Dgr | H220
  H411 | | | U |
| 601-006-00-1 | pentan | 203-692-4 | 109-66-0 | Flam. Liq. 2
  Asp. Tox. 1
  STOT SE 3
  Aquatic Chronic 2 | H225
  H304
  H336
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H304
  H336
  H411 | EUH066 | | C |
| 601-007-00-7 | hexan (indeholdende < 5 % n-hexan (203-777-6)); 2-methylpentan; [1]
  3-methylpentan; [2]
  2,2-dimethylbutan; [3]
  2,3-dimethylbutan [4] | 203-523-4 [1]
  202-481-4 [2]
  200-906-8 [3]
  201-193-6 [4] | 107-83-5 [1]
  96-14-0 [2]
  75-83-2 [3]
  79-29-8 [4] | Flam. Liq. 2
  Asp. Tox. 1
  Skin Irrit. 2
  STOT SE 3
  Aquatic Chronic 2 | H225
  H304
  H315
  H336
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H304
  H315
  H336
  H411 | | | C |
| 601-008-00-2 | heptan; n-heptan; [1]
  2,4-dimethylpentan; [2]
  2,2,3-trimethylbutan; [3]
  3,3-dimethylpentan; [4]
  2,3-dimethylpentan; [5]
  3-methylhexan; [6]
  2,2-dimethylpentan; [7]
  2-methylhexan; [8]
  3-ethylpentan; [9]
  isoheptan; [10] | 205-563-8 [1]
  203-548-0 [2]
  207-346-3 [3]
  209-230-8 [4]
  209-280-0 [5]
  209-643-3 [6]
  209-680-5 [7]
  209-730-6 [8]
  210-529-0 [9]
  250-610-8 [10] | 142-82-5 [1]
  108-08-7 [2]
  464-06-2 [3]
  562-49-2 [4]
  565-59-3 [5]
  589-34-4 [6]
  590-35-2 [7]
  591-76-4 [8]
  617-78-7 [9]
  31394-54-4 [10] | Flam. Liq. 2
  Asp. Tox. 1
  Skin Irrit. 2
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H304
  H315
  H336
  H400
  H410 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H304
  H315
  H336
  H410 | | | C |
| 601-009-00-8 | octan; n-octan; [1]
  2,2,4-trimethylpentan; [2]
  2,3,3-trimethylpentan; [3]
  3,3-dimethylhexan; [4]
  2,2,3-trimethylpentan; [5]
  2,3,4-trimethylpentan; [6]
  3,4-dimethylhexan; [7]
  2,3-dimethylhexan; [8]
  2,4-dimethylhexan; [9]
  4-methylheptan; [10]
  3-methylheptan; [11]
  2,2-dimethylhexan; [12]
  2,5-dimethylhexan; [13]
  2-methylheptan; [14]
  2,2,3,3-tetramethylbutan; [15]
  3-ethyl-2-methylpentan; [16]
  3-ethylhexan; [17]
  3-ethyl-3-methylpentan; [18]
  isooctan; [19] | 203-892-1 [1]
  208-759-1 [2]
  209-207-2 [3]
  209-243-9 [4]
  209-266-4 [5]
  209-292-6 [6]
  209-504-7 [7]
  209-547-1 [8]
  209-649-6 [9]
  209-650-1 [10]
  209-660-6 [11]
  209-689-4 [12]
  209-745-8 [13]
  209-747-9 [14]
  209-855-6 [15]
  210-187-2 [16]
  210-621-0 [17]
  213-923-0 [18]
  247-861-0 [19] | 111-65-9 [1]
  540-84-1 [2]
  560-21-4 [3]
  563-16-6 [4]
  564-02-3 [5]
  565-75-3 [6]
  583-48-2 [7]
  584-94-1 [8]
  589-43-5 [9]
  589-53-7 [10]
  589-81-1 [11]
  590-73-8 [12]
  592-13-2 [13]
  592-27-8 [14]
  594-82-1 [15]
  609-26-7 [16]
  619-99-8 [17]
  1067-08-9 [18]
  26635-64-3 [19] | Flam. Liq. 2
  Asp. Tox. 1
  Skin Irrit. 2
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H304
  H315
  H336
  H400
  H410 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H304
  H315
  H336
  H410 | | | C |
| 601-010-00-3 | ethylen | 200-815-3 | 74-85-1 | Flam. Gas 1
  Press. Gas
  STOT SE 3 | H220
  H336 | GHS02
  GHS04
  GHS07
  Dgr | H220
  H336 | | | U |
| 601-011-00-9 | propen; propylen | 204-062-1 | 115-07-1 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 601-012-00-4 | but-1-en; [1]
  buten, blanding af-1-og-2-isomerer; [2]
  2-methylpropen; [3]
  (Z)-but-2-en; [4]
  (E)-but-2-en [5] | 203-449-2 [1]
  203-452-9 [2]
  204-066-3 [3]
  209-673-7 [4]
  210-855-3 [5] | 106-98-9 [1]
  107-01-7 [2]
  115-11-7 [3]
  590-18-1 [4]
  624-64-6 [5] | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | C U |
| 601-013-00-X | 1,3-butadien;
  buta-1,3-dien | 203-450-8 | 106-99-0 | Flam. Gas 1
  Press. Gas
  Carc. 1A
  Muta. 1B | H220
  H350
  H340 | GHS02
  GHS04
  GHS08
  Dgr | H220
  H350
  H340 | | | D U |
| 601-014-00-5 | isopren (stabiliseret) 2-methyl-1,3-butadien | 201-143-3 | 78-79-5 | Flam. Liq. 1
  Carc. 1B Muta. 2
  Aquatic Chronic 3 | H224
  H350
  H341
  H412 | GHS02
  GHS08
  Dgr | H224
  H350
  H341
  H412 | | | D |
| 601-016-00-6 | cyclopropan | 200-847-8 | 75-19-4 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 601-017-00-1 | cyclohexan | 203-806-2 | 110-82-7 | Flam. Liq. 2
  Asp. Tox. 1
  Skin Irrit. 2
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H304
  H315
  H336
  H400
  H410 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H304
  H315
  H336
  H410 | | | |
| 601-018-00-7 | methylcyclohexan | 203-624-3 | 108-87-2 | Flam. Liq. 2
  Asp. Tox. 1
  Skin Irrit. 2
  STOT SE 3
  Aquatic Chronic 2 | H225
  H304
  H315
  H336
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H304
  H315
  H336
  H411 | | | |
| 601-019-00-2 | 1,4-dimethylcyclohexan | 209-663-2 | 589-90-2 | Flam. Liq. 2
  Asp. Tox. 1
  Skin Irrit. 2
  STOT SE 3
  Aquatic Chronic 2 | H225
  H304
  H315
  H336
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H304
  H315
  H336
  H411 | | | |
| 601-020-00-8 | benzen | 200-753-7 | 71-43-2 | Flam. Liq. 2
  Carc. 1a

  Muta. 1B
  STOT RE 1
  Asp. Tox. 1
  Eye Irrit. 2
  Skin Irrit. 2 | H225
  H350
  H340
  H372 **
  H304
  H319
  H315 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H350
  H340
  H372 ** H304
  H319
  H315 | | | E |
| 601-021-00-3 | toluen | 203-625-9 | 108-88-3 | Flam. Liq. 2
  Repr. 2
  Asp. Tox. 1
  STOT RE 2 *
  Skin Irrit. 2
  STOT SE 3 | H225
  H361d *** H304
  H373 **
  H315
  H336 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H361d *** H304
  H373 ** H315
  H336 | | | |
| 601-022-00-9 | o-xylen; [1]

  p-xylen; [2]

  m-xylen; [3]
  xylen [4] | 202-422-2 [1]
  203-396-5 [2]
  203-576-3 [3]
  215-535-7 [4] | 95-47-6 [1]
  106-42-3 [2]
  108-38-3 [3]
  1330-20-7 [4] | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2 | H226
  H332
  H312
  H315 | GHS02
  GHS07
  Wng | H226
  H332
  H312
  H315 | | * | C |
| 601-023-00-4 | ethylbenzen | 202-849-4 | 100-41-4 | Flam. Liq. 2
  Acute Tox. 4 *
  STOT RE 2
  Asp. Tox. 1 | H225
  H332
  H373
  (høreorganer)
  H304 | GHS02
  GHS07
  GHS08
  Dgr | H225
  H332
  H373
  (høreorganer)
  H304 | | | |
| 601-024-00-X | cumen; [1]
  propylbenzen [2] | 202-704-5 [1]
  203-132-9 [2] | 98-82-8 [1]
  103-65-1 [2] | Flam. Liq. 3
  Asp. Tox. 1
  STOT SE 3
  Aquatic Chronic 2 | H226
  H304
  H335
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H226
  H304
  H335
  H411 | | | C |
| 601-025-00-5 | mesitylen;
  1,3,5-trimethylbenzen | 203-604-4 | 108-67-8 | Flam. Liq. 3
  STOT SE 3
  Aquatic Chronic 2 | H226
  H335
  H411 | GHS02
  GHS07
  GHS09
  Wng | H226
  H335
  H411 | | STOT SE 3; H335: C ≥ 25 % | |
| 601-026-00-0 | styren | 202-851-5 | 100-42-5 | Flam. Liq. 3
  Repr. 2
  Acute Tox. 4 *
  STOT RE 1
  Skin Irrit. 2
  Eye Irrit. 2 | H226
  H361d
  H332
  H372
  (høreorganer)
  H315
  H319 | GHS02
  GHS08
  GHS07
  Dgr | H226
  H361d
  H332
  H372
  (høreorganer)
  H315
  H319 | | * | D |
| 601-027-00-6 | 2-phenylpropen;
  α-methylstyren | 202-705-0 | 98-83-9 | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3
  Aquatic Chronic 2 | H226
  H319
  H335
  H411 | GHS02
  GHS07
  GHS09
  Wng | H226
  H319
  H335
  H411 | | STOT SE 3; H335: C ≥ 25 % | |
| 601-028-00-1 | 2-methylstyren;
  2-vinyltoluen | 210-256-7 | 611-15-4 | Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H411 | GHS07
  GHS09
  Wng | H332
  H411 | | | |
| 601-029-00-7 | dipenten; limonen; [1]
  (R)-p-mentha-1,8-dien; d-limonen: [2]
  (S)-p-mentha-1,8-dien; l-limonen; [3]
  trans-1-methyl-4-(1-methylvinyl)cyclohexen; [4]
  (±)-1-methyl-4-(1-methylvinyl)cyclohexen [5] | 205-341-0 [1]
  227-813-5 [2]
  227-815-6 [3]
  229-977-3 [4]
  231-732-0 [5] | 138-86-3 [1]
  5989-27-5 [2]
  5989-54-8 [3]
  6876-12-6 [4]
  7705-14-8 [5] | Flam. Liq. 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H315
  H317
  H400
  H410 | GHS02
  GHS07
  GHS09
  Wng | H226
  H315
  H317
  H410 | | | C |
| 601-030-00-2 | cyclopentan | 206-016-6 | 287-92-3 | Flam. Liq. 2
  Aquatic Chronic 3 | H225
  H412 | GHS02
  Dgr | H225
  H412 | | | |
| 601-031-00-8 | 2,4,4-trimethylpent-1-en | 203-486-4 | 107-39-1 | Flam. Liq. 2
  Aquatic Chronic 2 | H225
  H411 | GHS02
  GHS09
  Dgr | H225
  H411 | | | |
| 601-032-00-3 | benzo[a]pyren;
  benzo[def]chrysen | 200-028-5 | 50-32-8 | Carc. 1B
  Muta. 1B
  Repr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H340
  H360FD
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H340
  H360FD H317
  H410 | | Carc. 1B; H350: C ≥ 0,01  % | |
| 601-033-00-9 | benzo[a]anthracen | 200-280-6 | 56-55-3 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | M = 100 | |
| 601-034-00-4 | benzo[e]acephenanthryleno | 205-911-9 | 205-99-2 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | | |
| 601-035-00-X | benzo[j]fluoranthen | 205-910-3 | 205-82-3 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | | |
| 601-036-00-5 | benzo[k]fluoranthen | 205-916-6 | 207-08-9 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | | |
| 601-037-00-0 | n-hexan | 203-777-6 | 110-54-3 | Flam. Liq. 2
  Repr. 2
  Asp. Tox. 1
  STOT RE 2 *
  Skin Irrit. 2
  STOT SE 3
  Aquatic Chronic 2 | H225
  H361f *** H304
  H373 **
  H315
  H336
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H361f *** H304
  H373 ** H315
  H336
  H411 | | STOT RE 2; H373: C ≥ 5 % | |
| 601-041-00-2 | dibenzo[a, h]anthracen | 200-181-8 | 53-70-3 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | Carc. 1B; H350: C ≥ 0,01  % M = 100 | |
| 601-042-00-8 | biphenyl;
  diphenyl | 202-163-5 | 92-52-4 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H410 | | | |
| 601-043-00-3 | 1,2,4-trimethylbenzen | 202-436-9 | 95-63-6 | Flam. Liq. 3
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H226
  H332
  H319
  H335
  H315
  H411 | GHS02
  GHS07
  GHS09
  Wng | H226
  H332
  H319
  H335
  H315
  H411 | | | |
| 601-044-00-9 | 3a,4,7,7a-tetrahydro-4,7-methanoinden | 201-052-9 | 77-73-6 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H225
  H332
  H302
  H319
  H335
  H315
  H411 | GHS02
  GHS07
  GHS09
  Dgr | H225
  H332
  H302
  H319
  H335
  H315
  H411 | | | |
| 601-045-00-4 | 1,2,3,4-tetrahydronaphtalen | 204-340-2 | 119-64-2 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H319
  H315
  H411 | GHS07
  GHS09
  Wng | H319
  H315
  H411 | EUH019 | | |
| 601-046-00-X | 7-methylocta-1,6-dien | 404-210-7 | 42152-47-6 | Flam. Liq. 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H400
  H410 | GHS02
  GHS09
  Wng | H226
  H410 | | | |
| 601-047-00-5 | m-mentha-1,3(8)-dien | 404-150-1 | 17092-80-7 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 601-048-00-0 | chrysen | 205-923-4 | 218-01-9 | Carc. 1B Muta. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H341
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H341
  H410 | | | |
| 601-049-00-6 | benzo[e]pyren | 205-892-7 | 192-97-2 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | | |
| 601-051-00-7 | 4-phenylbut-1-en | 405-980-7 | 768-56-9 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 601-052-00-2 | naphthalen | 202-049-5 | 91-20-3 | Carc. 2
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H400
  H410 | GHS07
  GHS08
  GHS09
  Wng | H351
  H302
  H410 | | | |
| 601-053-00-8 | nonylphenol; [1]
  4-nonylphenol, forgrenet [2] | 246-672-0 [1]
  284-325-5 [2] | 25154-52-3 [1]
  84852-15-3 [2] | Repr. 2
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H361fd
  H302
  H314
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H361fd
  H302
  H314
  H410 | | | |
| 601-054-00-3 | blanding af isomerer af: dibenzylbenzen; dibenzyl(methyl)benzen; dibenzyl(dimethyl)benzen; dibenzyl(trimethyl)benzen | 405-570-8 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 601-055-00-9 | blanding af isomerer af: mono-(2-tetradecyl)naphthalener og di-(2-tetradecyl)naphthalener og tri-(2-tetradecyl)naphthalener | 410-190-0 | 132983-41-6 | Eye Irrit. 2
  Aquatic Chronic 4 | H319
  H413 | GHS07
  Wng | H319
  H413 | | | |
| 601-056-00-4 | blanding af isomerer af: methyldiphenylmethan og dimethyldiphenylmethan | 405-470-4 | 73807-39-3 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 601-057-00-X | N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammoniumtosylat | 421-130-8 | 156679-41-3 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H410 | | | |
| 601-058-00-5 | di-L-para-menthen | 417-870-6 | 83648-84-4 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 601-059-00-0 | methyl 2-benzyliden-3-oxobutyrat | 420-940-9 | 15768-07-7 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H319
  H315
  H411 | GHS07
  GHS09
  Wng | H319
  H315
  H411 | | | |
| 601-060-00-6 | 1,2-bis[4-fluor-6-{4-sulfo-5-(2-(4-sulfonaphthalen-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalen-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethan;
  x-natrium, y-kaliumsalte x = 7,755 y = 0,245 | 417-610-1 | 155522-09-1 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 601-061-00-1 | (ethyl-1,2-ethandiyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethandiyl) | 418-960-8 | — | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H411 | | | |
| 601-062-00-7 | blanding af: forgrenet triacontan og forgrenet dotriacontan og forgrenet tetratriacontan og forgrenet hexatriacontan | 417-030-9 | 151006-59-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 601-063-00-2 | blanding af isomerer af forgrenet tetracosan | 417-060-2 | 151006-61-0 | Acute Tox. 4 *
  Aquatic Chronic 4 | H332
  H413 | GHS07
  Wng | H332
  H413 | | | |
| 601-064-00-8 | forgrenet hexatriacontan | 417-070-7 | 151006-62-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 601-065-00-3 | en blanding af: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxan-5,2'-norcaran) og (1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxan-5,2'-norcaran) | 416-930-9 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 601-066-00-9 | 1-(4-(trans-4-heptylcyclohexyl)phenyl)ethan | 426-820-2 | 78531-60-9 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 601-067-00-4 | triethylarsenat | 427-700-2 | 15606-95-8 | Carc. 1A
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H331
  H301
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H301
  H410 | | | |
| 601-068-00-X | 1,2-diacetoxybut-3-en | 421-720-5 | 18085-02-4 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 601-069-00-5 | 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridiniumbromid | 422-680-1 | 287933-44-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 601-070-00-0 | en blanding af: forgrenet icosan og forgrenet docosan og forgrenet tetracosan | 417-050-8 | 151006-58-5 | Acute Tox. 4 *
  Aquatic Chronic 4 | H332
  H413 | GHS07
  Wng | H332
  H413 | | | |
| 601-071-00-6 | 1-dimethoxymethyl-2-nitro-benzen | 423-830-9 | 20627-73-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 601-072-00-1 | en blanding af: 1-(4-isopropylphenyl)-1-phenylethan og 1-(3-isopropylphenyl)-1-phenylethan og 1-(2-isopropylphenyl)-1-phenylethan | 430-690-2 | 52783-21-8 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 601-073-00-7 | 1-brom-3,5-difluorbenzen | 416-710-2 | 461-96-1 | Flam. Liq. 3
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H302
  H373 ** H315
  H317
  H400
  H410 | GHS02
  GHS08
  GHS07
  GHS09
  Wng | H226
  H302
  H373 ** H315
  H317
  H410 | | | |
| 601-074-00-2 | en blanding af: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octan og 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octan og spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan] og spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] | 422-040-1 | — | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H319
  H315
  H411 | GHS07
  GHS09
  Wng | H319
  H315
  H411 | | | |
| 601-075-00-8 | 4,4'-bis(N-carbamoyl-4-methylbenzensulfonamid)diphenylmethan | 418-770-5 | 151882-81-4 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 601-076-00-3 | ethynylcyclopropan | 425-430-1 | 6746-94-7 | Flam. Liq. 2
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H225
  H315
  H318
  H412 | GHS02
  GHS05
  Dgr | H225
  H315
  H318
  H412 | | | |
| 601-077-00-9 | en blanding af: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octan og 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octan | 426-510-7 | 196965-91-0 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 601-078-00-4 | en blanding af: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptan og 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptan | 427-040-5 | — | Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | | |
| 601-079-00-X | en blanding af: trans-trans-cyclohexadeca-1,9-dien og cis-trans-cyclohexadeca-1,9-dien | 429-620-3 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H315
  H317
  H413 | GHS07
  Wng | H315
  H317
  H413 | | | |
| 601-080-00-5 | blanding af: sec-butylphenyl(phenyl)methan, blandede isomerer og 1-(sec-butylphenyl(phenyl)-2-phenylethan, blandede isomerer og 1-(sec-butylphenyl-1-phenylethan, blandede isomerer | 431-100-6 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 601-081-00-0 | cyclohexadeca-1,9-dien | 431-730-1 | 4277-06-9 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H315
  H317
  H413 | GHS07
  Wng | H315
  H317
  H413 | | | |
| 601-082-00-6 | blanding af: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan og exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan | 434-420-4 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | | |
| 601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-en | 435-000-3 | 22094-83-3 | Asp. Tox. 1
  Skin Irrit. 2
  Aquatic Chronic 4 | H304
  H315
  H413 | GHS08
  GHS07
  Dgr | H304
  H315
  H413 | | | |
| 601-084-00-7 | blanding af: 5-endo-butyl-bicyclo[2.2.1]hept-2-en og 5-exo-butyl-bicyclo[2.2.1]hept-2-en (80:20) | 435-180-3 | — | Asp. Tox. 1
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H304
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H304
  H315
  H410 | | | |
| 601-085-00-2 | isopentan;
  2-methylbutan | 201-142-8 | 78-78-4 | Flam. Liq. 1
  Asp. Tox. 1
  STOT SE 3
  Aquatic Chronic 2 | H224
  H304
  H336
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H224
  H304
  H336
  H411 | EUH066 | | |
| 601-087-00-3 | 2,4,4-trimethylpenten | 246-690-9 | 25167-70-8 | Flam. Liq. 2
  Asp. Tox. 1
  STOT SE 3 | H225
  H304
  H336 | GHS02
  GHS07
  GHS08
  Dgr | H225
  H304
  H336 | | | D |
| 601-088-00-9 | 4-vinylcyclohexen | 202-848-9 | 100-40-3 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 601-089-00-4 | muscalure; cis-tricos-9-en | 248-505-7 | 27519-02-4 | Skin Sens. 1B | H317 | GHS07
  Wng | H317 | | | |
| 602-001-00-7 | chlormethan;
  methylchlorid | 200-817-4 | 74-87-3 | Flam. Gas 1
  Press. Gas
  Carc. 2
  STOT RE 2 * | H220
  H351
  H373 ** | GHS02
  GHS04
  GHS08
  Dgr | H220
  H351
  H373 ** | | | U |
| 602-002-00-2 | brommethan;
  methylbromid | 200-813-2 | 74-83-9 | Press. Gas
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Ozone 1 | H341
  H331
  H301
  H373 **
  H319
  H335
  H315
  H400
  H420 | GHS04
  GHS06
  GHS08
  GHS09
  Dgr | H341
  H331
  H301
  H373 ** H319
  H335
  H315
  H400
  H420 | | | U |
| 602-003-00-8 | dibrommethan | 200-824-2 | 74-95-3 | Acute Tox. 4 *
  Aquatic Chronic 3 | H332
  H412 | GHS07
  Wng | H332
  H412 | | * | |
| 602-004-00-3 | dichlormethan;
  methylenchlorid | 200-838-9 | 75-09-2 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 602-005-00-9 | methyliodid;
  iodmethan | 200-819-5 | 74-88-4 | Carc. 2
  Acute Tox. 4 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT SE 3
  Skin Irrit. 2 | H351
  H312
  H331
  H301
  H335
  H315 | GHS06
  GHS08
  Dgr | H351
  H312
  H331
  H301
  H335
  H315 | | | |
| 602-006-00-4 | chloroform;
  trichlormethan | 200-663-8 | 67-66-3 | Carc. 2
  Repr. 2
  Acute Tox. 3
  Acute Tox. 4
  STOT RE 1
  Eye Irrit. 2
  Skin Irrit. 2 | H351
  H361d
  H331
  H302
  H372
  H319
  H315 | GHS06
  GHS08
  Dgr | H351
  H361d
  H331
  H302
  H372
  H319
  H315 | | | |
| 602-007-00-X | bromoform;
  tribrommethan | 200-854-6 | 75-25-2 | Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H331
  H302
  H319
  H315
  H411 | GHS06
  GHS09
  Dgr | H331
  H302
  H319
  H315
  H411 | | | |
| 602-008-00-5 | carbontetrachlorid;
  tetrachlormethan | 200-262-8 | 56-23-5 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Aquatic
  Chronic 3
  Ozone 1 | H351
  H331
  H311
  H301
  H372 **
  H412
  H420 | GHS06
  GHS08
  Dgr | H351
  H331
  H311
  H301
  H372 ** H412
  H420 | | *
  STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,2  % ≤ C
  < 1 % | |
| 602-009-00-0 | chlorethan | 200-830-5 | 75-00-3 | Flam. Gas 1
  Press. Gas
  Carc. 2
  Aquatic Chronic 3 | H220
  H351
  H412 | GHS02
  GHS04
  GHS08
  Dgr | H220
  H351
  H412 | | | U |
| 602-010-00-6 | 1,2-dibromethan | 203-444-5 | 106-93-4 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H350
  H331
  H311
  H301
  H319
  H335
  H315
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H311
  H301
  H319
  H335
  H315
  H411 | | * | |
| 602-011-00-1 | 1,1-dichlorethan | 200-863-5 | 75-34-3 | Flam. Liq. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Aquatic Chronic 3 | H225
  H302
  H319
  H335
  H412 | GHS02
  GHS07
  Dgr | H225
  H302
  H319
  H335
  H412 | | * | |
| 602-012-00-7 | 1,2-dichlorethan;
  ethylendichlorid | 203-458-1 | 107-06-2 | Flam. Liq. 2
  Carc. 1B
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H225
  H350
  H302
  H319
  H335
  H315 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H350
  H302
  H319
  H335
  H315 | | | |
| 602-013-00-2 | 1,1,1-trichlorethan;
  methylchloroform | 200-756-3 | 71-55-6 | Acute Tox. 4 *
  Ozone 1 | H332
  H420 | GHS07
  Wng | H332
  H420 | | | F |
| 602-014-00-8 | 1,1,2-trichlorethan | 201-166-9 | 79-00-5 | Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H351
  H332
  H312
  H302 | GHS08
  GHS07
  Wng | H351
  H332
  H312
  H302 | EUH066 | * | |
| 602-015-00-3 | 1,1,2,2-tetrachlorethan | 201-197-8 | 79-34-5 | Acute Tox. 2 *
  Acute Tox. 1
  Aquatic Chronic 2 | H330
  H310
  H411 | GHS06
  GHS09
  Dgr | H330
  H310
  H411 | | | |
| 602-016-00-9 | 1,1,2,2-tetrabromethan | 201-191-5 | 79-27-6 | Acute Tox. 2 *
  Eye Irrit. 2
  Aquatic Chronic 3 | H330
  H319
  H412 | GHS06
  Dgr | H330
  H319
  H412 | | | |
| 602-017-00-4 | pentachlorethan | 200-925-1 | 76-01-7 | Carc. 2
  STOT RE 1
  Aquatic Chronic 2 | H351
  H372 **
  H411 | GHS08
  GHS09
  Dgr | H351
  H372 ** H411 | | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2  % ≤ C < 1 % | |
| 602-018-00-X | 1-chlorpropan; [1]
  2-chlorpropan [2] | 208-749-7 [1]
  200-858-8 [2] | 540-54-5 [1]
  75-29-6 [2] | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H332
  H312
  H302 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302 | | | C |
| 602-019-00-5 | 1-brompropan:
  n-propylbromid | 203-445-0 | 106-94-5 | Flam. Liq. 2
  Repr. 1B
  STOT RE 2 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  STOT SE 3 | H225
  H360FD
  H373 **
  H319
  H335
  H315
  H336 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H360FD H373 **
  H319
  H335
  H315
  H336 | | | |
| 602-021-00-6 | 1,2-dibrom-3-chlorpropan | 202-479-3 | 96-12-8 | Carc. 1B
  Muta. 1B
  Repr. 1A
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 3 | H350
  H340
  H360f *** H301
  H373 **
  H412 | GHS06
  GHS08
  Dgr | H350
  H340
  H360f *** H301
  H373 ** H412 | | | |
| 602-022-00-1 | 1-chlorpentan; [1]
  2-chlorpentan; [2]
  3-chlorpentan [3] | 208-846-4 [1]
  210-885-7 [2]
  210-467-4 [3] | 543-59-9 [1]
  625-29-6 [2]
  616-20-6 [3] | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H332
  H312
  H302 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302 | | | C |
| 602-023-00-7 | vinylchlorid;
  chlorethylen | 200-831-0 | 75-01-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A | H220
  H350 | GHS02
  GHS08
  Dgr | H220
  H350 | | | D U |
| 602-024-00-2 | bromethylen | 209-800-6 | 593-60-2 | Press. Gas
  Flam. Gas 1
  Carc. 1B | H220
  H350 | GHS02
  GHS08
  Dgr | H220
  H350 | | | U |
| 602-025-00-8 | 1,1-dichlorethylen;
  vinylidenchlorid | 200-864-0 | 75-35-4 | Flam. Liq. 1
  Carc. 2
  Acute Tox. 4 * | H224
  H351
  H332 | GHS02
  GHS08
  GHS07
  Dgr | H224
  H351
  H332 | | * | D |
| 602-026-00-3 | 1,2-dichlorethylen; [1]

  cis-dichlorethylen; [2]

  trans-dichlorethylen [3] | 208-750-2 [1]
  205-859-7 [2]
  205-860-2 [3] | 540-59-0 [1]
  156-59-2 [2]
  156-60-5 [3] | Flam. Liq. 2
  Acute Tox. 4 *
  Aquatic Chronic 3 | H225
  H332
  H412 | GHS02
  GHS07
  Dgr | H225
  H332
  H412 | | * | C |
| 602-027-00-9 | trichlorethylen;
  trichlorethen | 201-167-4 | 79-01-6 | Carc. 1B
  Muta. 2
  Eye Irrit. 2
  Skin Irrit. 2
  STOT SE 3
  Aquatic Chronic 3 | H350
  H341
  H319
  H315
  H336
  H412 | GHS08
  GHS07
  Dgr | H350
  H341
  H319
  H315
  H336
  H412 | | | |
| 602-028-00-4 | tetrachlorethylen | 204-825-9 | 127-18-4 | Carc. 2
  Aquatic Chronic 2 | H351
  H411 | GHS08
  GHS09
  Wng | H351
  H411 | | | |
| 602-029-00-X | 3-chlorpropen;
  allylchlorid | 203-457-6 | 107-05-1 | Flam. Liq. 2
  Carc. 2
  Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H225
  H351
  H341
  H332
  H312
  H302
  H373 ** H319
  H335
  H315
  H400 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H351
  H341
  H332
  H312
  H302
  H373 ** H319
  H335
  H315
  H400 | | | D |
| 602-030-00-5 | 1,3-dichlorpropen; [1]
  (Z)-1,3-dichlorpropen [2] | 208-826-5 [1]
  233-195-8 [2] | 542-75-6 [1]
  10061-01-5 [2] | Flam. Liq. 3
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Asp. Tox. 1
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H311
  H301
  H332
  H304
  H319
  H335
  H315
  H317
  H400
  H410 | GHS02
  GHS06
  GHS08
  GHS09
  Dgr | H226
  H311
  H301
  H332
  H304
  H319
  H335
  H315
  H317
  H410 | | | C D |
| 602-031-00-0 | 1,1-dichlorpropen | 209-253-3 | 563-58-6 | Flam. Liq. 2
  Acute Tox. 3 *
  Aquatic Chronic 3 | H225
  H301
  H412 | GHS02
  GHS06
  Dgr | H225
  H301
  H412 | | | |
| 602-032-00-6 | 3-chlor-2-methylpropen | 209-251-2 | 563-47-3 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H225
  H332
  H302
  H314
  H317
  H411 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H225
  H332
  H302
  H314
  H317
  H411 | | | |
| 602-034-00-7 | 1,2-dichlorbenzen;
  ortho-dichlorbenzen | 202-425-9 | 95-50-1 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H335
  H315
  H410 | | * | |
| 602-035-00-2 | 1,4-dichlorbenzen;
  para-dichlorbenzen | 203-400-5 | 106-46-7 | Carc. 2
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H319
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H319
  H410 | | | |
| 602-036-00-8 | chloropren (stabiliseret);
  2-chlor-1,3-butadien (stabiliseret) | 204-818-0 | 126-99-8 | Flam. Liq. 2
  Carc. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H225
  H350
  H332
  H302
  H373 **
  H319
  H335
  H315 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H350
  H332
  H302
  H373 ** H319
  H335
  H315 | | | D |
| 602-037-00-3 | α-chlortoluen;
  benzylchlorid | 202-853-6 | 100-44-7 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H350
  H331
  H302
  H373 **
  H335
  H315
  H318 | GHS06
  GHS08
  GHS05
  Dgr | H350
  H331
  H302
  H373 ** H335
  H315
  H318 | | | |
| 602-038-00-9 | α, α,α-trichlortoluen;
  trichlormethylbenzen | 202-634-5 | 98-07-7 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H350
  H331
  H302
  H335
  H315
  H318 | GHS06
  GHS08
  GHS05
  Dgr | H350
  H331
  H302
  H335
  H315
  H318 | | | |
| 602-039-00-4 | polychlorerede biphenyler;
  PCB | 215-648-1 | 1336-36-3 | STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H373 ** H410 | | STOT RE 2; H373: C ≥ 0.005 % | C |
| 602-040-00-X | 2-chlortoluen; [1]
  3-chlortoluen; [2]
  4-chlortoluen; [3]
  chlortoluen [4] | 202-424-3 [1]
  203-580-5 [2]
  203-397-0 [3]
  246-698-2 [4] | 95-49-8 [1]
  108-41-8 [2]
  106-43-4 [3]
  25168-05-2 [4] | Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H411 | GHS07
  GHS09
  Wng | H332
  H411 | | | C |
| 602-041-00-5 | pentachlornaphthalen | 215-320-8 | 1321-64-8 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H319
  H315
  H410 | | | C |
| 602-042-00-0 | 1,2,3,4,5,6-hexachlorcyclohexaner med undtagelse af sådanne angivet andetsteds i dette bilag | — | — | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H301
  H312
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H301
  H312
  H410 | | | A C |
| 602-043-00-6 | lindan (ISO);
  γ-HCH eller γ-BHC;
  γ-1,2,3,4,5,6-hexachlorcyclohexan | 200-401-2 | 58-89-9 | Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Lact.
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H332
  H312
  H373 **
  H362
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H332
  H312
  H373 ** H362
  H410 | | M = 10 | |
| 602-044-00-1 | camphechlor (ISO);
  toxaphen | 232-283-3 | 8001-35-2 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H301
  H312
  H335
  H315
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H301
  H312
  H335
  H315
  H410 | | | |
| 602-045-00-7 | DDT (ikke anerkendt af ISO);
  clofenotan (INN);
  dicophan; 1,1,1-trichlor-2,2-bis(4-chlorphenyl)ethan;
  dichlordiphenyltrichlorethan | 200-024-3 | 50-29-3 | Carc. 2
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H301
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H301
  H372 ** H410 | | | |
| 602-046-00-2 | heptachlor (ISO);
  1,4,5,6,7,8,8-heptachlor-3a,4,7,7a-tetrahydro-4,7-methanoinden | 200-962-3 | 76-44-8 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H311
  H301
  H373 ** H410 | | | |
| 602-047-00-8 | chlordan (ISO);
  1,2,4,5,6,7,8,8-octachlor-3a,4,7,7a-tetrahydro-4,7-methanoindan | 200-349-0 | 57-74-9 | Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H312
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H312
  H302
  H410 | | | |
| 602-048-00-3 | aldrin (ISO) | 206-215-8 | 309-00-2 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H311
  H301
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H311
  H301
  H372 ** H410 | | | |
| 602-049-00-9 | dieldrin (ISO) | 200-484-5 | 60-57-1 | Carc. 2
  Acute Tox. 1
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H310
  H301
  H372 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H310
  H301
  H372 ** H410 | | | |
| 602-050-00-4 | isodrin;
  (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachlor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalen | 207-366-2 | 465-73-6 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H410 | | M = 100 | |
| 602-051-00-X | endrin (ISO);
  1,2,3,4,10,10-hexachlor-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalen | 200-775-7 | 72-20-8 | Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H311
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H311
  H410 | | | |
| 602-052-00-5 | endosulfan (ISO);
  1,2,3,4,7,7-hexachlor-8,9,10-trinorborn-2-en-5,6-ylendimethylsulfit;
  1,2,3,4,7,7-hexachlor-8,9,10-trinorborn-5-en-2,3-ylendimethylsulfit | 204-079-4 | 115-29-7 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H312
  H410 | | | |
| 602-053-00-0 | isobenzan (ISO);
  1,3,4,5,6,7,8,8-octachlor- 1,3,3a,4,7,7a-hexahydro-4,7- methanoisobenzofuran | 206-045-4 | 297-78-9 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1 | H310
  H300
  H400 | GHS06
  GHS09
  Dgr | H310
  H300
  H400 | | | |
| 602-054-00-6 | 3-iodpropen;
  allyliodid | 209-130-4 | 556-56-9 | Flam. Liq. 2
  Skin Corr. 1B | H225
  H314 | GHS02
  GHS05
  Dgr | H225
  H314 | | | |
| 602-055-00-1 | bromethan; | 200-825-8 | 74-96-4 | Flam. Liq. 2
  Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H351
  H332
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H351
  H332
  H302 | | | |
| 602-056-00-7 | α, α,α-trifluortoluen;
  trifluormethylbenzen | 202-635-0 | 98-08-8 | Flam. Liq. 2
  Aquatic Chronic 2 | H225
  H411 | GHS02
  GHS09
  Dgr | H225
  H411 | | | |
| 602-057-00-2 | α-bromtoluen;
  benzylbromid | 202-847-3 | 100-39-0 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | | |
| 602-058-00-8 | α, α-dichlortoluen;
  benzylidendichlorid;
  benzalchlorid | 202-709-2 | 98-87-3 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H351
  H331
  H302
  H335
  H315
  H318 | GHS06
  GHS08
  GHS05
  Dgr | H351
  H331
  H302
  H335
  H315
  H318 | | | |
| 602-059-00-3 | 1-chlorbutan;
  butylchlorid | 203-696-6 | 109-69-3 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 602-060-00-9 | brombenzen | 203-623-8 | 108-86-1 | Flam. Liq. 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H226
  H315
  H411 | GHS02
  GHS07
  GHS09
  Wng | H226
  H315
  H411 | | | |
| 602-061-00-4 | hexafluorpropen;
  hexaflourpropylen | 204-127-4 | 116-15-4 | Press. Gas
  Acute Tox. 4 *
  STOT SE 3 | H332
  H335 | GHS07
  Wng | H332
  H335 | | | U |
| 602-062-00-X | 1,2,3-trichlorpropan | 202-486-1 | 96-18-4 | Carc. 1B
  Repr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H350
  H360f *** H332
  H312
  H302 | GHS08
  GHS07
  Dgr | H350
  H360f *** H332
  H312
  H302 | | | D |
| 602-063-00-5 | heptachlorepoxid;
  2,3-epoxy-1,4,5,6,7,8,8-heptachlor-3a,4,7,7a-tetrahydro-4,7-methanoindan | 213-831-0 | 1024-57-3 | Carc. 2
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H301
  H373 ** H410 | | | |
| 602-064-00-0 | 1,3-dichlor-2-propanol | 202-491-9 | 96-23-1 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 4 * | H350
  H301
  H312 | GHS06
  GHS08
  Dgr | H350
  H301
  H312 | | | |
| 602-065-00-6 | hexachlorbenzen | 204-273-9 | 118-74-1 | Carc. 1B
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H372 **
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H372 ** H410 | | | |
| 602-066-00-1 | tetrachlor-p-benzoquinon | 204-274-4 | 118-75-2 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H410 | | | |
| 602-067-00-7 | 1,3-dichlorbenzen | 208-792-1 | 541-73-1 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 602-068-00-2 | ethylenbis(trichloracetat) | 219-732-9 | 2514-53-6 | Skin Irrit. 2 | H315 | GHS07
  Wng | H315 | | | |
| 602-069-00-8 | dichloracetylen | — | 7572-29-4 | Unst. Expl. Carc. 2
  STOT RE 2 * | H200
  H351
  H373 ** | GHS01
  GHS08
  Wng | H200
  H351
  H373 ** | | | |
| 602-070-00-3 | 3-chlor-4,5,α, α,α-pentafluortoluen | 401-930-3 | 77227-99-7 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1 | H226
  H332
  H302
  H400 | GHS02
  GHS07
  GHS09
  Wng | H226
  H332
  H302
  H400 | | | |
| 602-071-00-9 | brombenzylbromtoluen, blanding af isomerer | 402-210-1 | 99688-47-8 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H373 ** H317
  H410 | | | |
| 602-072-00-4 | dichlor[(dichlorphenyl)methyl]methylbenzen, blanding af isomerer; (dichlorphenyl)(dichlortolyl)methan, blanding af isomerer (IUPAC) | 278-404-3 | 76253-60-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 602-073-00-X | 1,4-dichlorbut-2-en | 212-121-8 | 764-41-0 | Carc. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H330
  H311
  H301
  H314
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H350
  H330
  H311
  H301
  H314
  H410 | | Carc. 1B; H350: C ≥ 0,01  % STOT SE 3; H335:C ≥ 5 % | |
| 602-074-00-5 | pentachlorbenzen | 210-172-0 | 608-93-5 | Flam. Sol. 1
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H228
  H302
  H400
  H410 | GHS02
  GHS07
  GHS09
  Dgr | H228
  H302
  H410 | | | T |
| 602-075-00-0 | 4,4,5,5-tetrachlor-1,3-dioxolan-2-on | 404-060-2 | 22432-68-4 | Acute Tox. 2 *
  Acute Tox. 4 *
  Skin Corr. 1B | H330
  H302
  H314 | GHS06
  GHS05
  Dgr | H330
  H302
  H314 | | | |
| 602-076-00-6 | 2,3,4-trichlorbut-1-en | 219-397-9 | 2431-50-7 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H331
  H302
  H319
  H335
  H315
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H331
  H302
  H319
  H335
  H315
  H410 | | Carc. 2; H351: C
  ≥ 0,1  % | |
| 602-077-00-1 | dodecachlorpentacyclo[5.2.1.02,6.03,9.05,8]decan;
  mirex | 219-196-6 | 2385-85-5 | Carc. 2
  Repr. 2
  Lact.
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H361fd
  H362
  H312
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H361fd
  H362
  H312
  H302
  H410 | | | |
| 602-078-00-7 | hexachlorcyclopentadien | 201-029-3 | 77-47-4 | Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H311
  H302
  H314
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H330
  H311
  H302
  H314
  H410 | | | |
| 602-079-00-2 | 2,3-dichlorpropen;
  2,3-dichlorpropylen | 201-153-8 | 78-88-6 | Flam. Liq. 2
  Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H225
  H341
  H332
  H312
  H302
  H335
  H315
  H318
  H412 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H225
  H341
  H332
  H312
  H302
  H335
  H315
  H318
  H412 | | | |
| 602-080-00-8 | alkaner, C10-13-, chlor-; chlorerede paraffiner, C10-13 | 287-476-5 | 85535-84-8 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | EUH066 | | |
| 602-081-00-3 | 2-chlor-4,5-difluorbenzoesyre | 405-380-5 | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H312
  H302
  H318
  H317 | GHS05
  GHS07
  Dgr | H312
  H302
  H318
  H317 | | | |
| 602-082-00-9 | 2,2,6,6-tetrakis(brommethyl)-4-oxaheptan-1,7-diol | 408-020-5 | 109678-33-3 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 602-083-00-4 | diphenylether, pentabromderivat;
  pentabromdiphenylether | 251-084-2 | 32534-81-9 | STOT RE 2 *
  Lact.
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H362
  H400
  H410 | GHS08
  GHS09
  Wng | H373 ** H362
  H410 | | | |
| 602-084-00-X | 1,1-dichlor-1-fluorethan | 404-080-1 | 1717-00-6 | Aquatic
  Chronic 3
  Ozone 1 | H412
  H420 | GHS07
  Wng | H412
  H420 | | | |
| 602-085-00-5 | 2-brompropan | 200-855-1 | 75-26-3 | Flam. Liq. 2
  Repr. 1a

  STOT RE 2 * | H225
  H360f *** H373 ** | GHS02
  GHS08
  Dgr | H225
  H360f *** H373 ** | EUH066 | | |
| 602-086-00-0 | trifluoriodmethan;
  triflourmethyliodid | 219-014-5 | 2314-97-8 | Muta. 2 | H341 | GHS08
  Wng | H341 | | | |
| 602-087-00-6 | 1,2,4-trichlorbenzen | 204-428-0 | 120-82-1 | Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H315
  H410 | | | |
| 602-088-00-1 | 2,3-dibrompropan-1-ol;
  2,3-dibrom-1-propanol | 202-480-9 | 96-13-9 | Carc. 1B Repr. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H350
  H361f *** H311
  H332
  H302
  H412 | GHS08
  GHS07
  Dgr | H350
  H361f *** H311
  H332
  H302
  H412 | | | |
| 602-089-00-7 | 4-brom-2-chlorfluorbenzen | 405-580-2 | 60811-21-4 | Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H315
  H410 | | | |
| 602-090-00-2 | 1-allyl-3-chlor-4-fluorbenzen | 406-630-6 | 121626-73-1 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 602-091-00-8 | 1,3-dichlor-4-fluorbenzen | 406-160-1 | 1435-48-9 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2 | H302
  H373 **
  H315
  H411 | GHS08
  GHS07
  Wng | H302
  H373 ** H315
  H411 | | | |
| 602-092-00-3 | 1-brom-3,4,5-trifluorbenzen | 418-480-9 | 138526-69-9 | Flam. Liq. 3
  Carc. 2
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H226
  H351
  H315
  H318
  H411 | GHS02
  GHS08
  GHS05
  GHS09
  Dgr | H226
  H351
  H315
  H318
  H411 | | | |
| 602-093-00-9 | α, α,α,4-tetrachlortoluen;

  p-chlorbenzotrichlorid | 226-009-1 | 5216-25-1 | Carc. 1B Repr. 2
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2 | H350
  H361f *** H372 **
  H312
  H302
  H335
  H315 | GHS08
  GHS07
  Dgr | H350
  H361f *** H372 ** H312
  H302
  H335
  H315 | | | |
| 602-094-00-4 | diphenylether, octabromderivat | 251-087-9 | 32536-52-0 | Repr. 1B | H360Df | GHS08
  Dgr | H360Df | | | |
| 602-095-00-X | alkaner, C14-17-, chlor-;
  chlorerede paraffiner, C14-17 | 287-477-0 | 85535-85-9 | Lact.
  Aquatic Acute 1
  Aquatic Chronic 1 | H362
  H400
  H410 | GHS09
  Wng | H362
  H410 | EUH066 | | |
| 602-096-00-5 | malachite green hydrochlorid; [1]
  malachite green oxalat [2] | 209-322-8 [1]
  219-441-7 [2] | 569-64-2 [1]
  2437-29-8 [2] | Repr. 2
  Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d *** H302
  H318
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H361d *** H302
  H318
  H410 | | | |
| 602-097-00-0 | 1-brom-9-(4,4,5,5,5-pentafluorpentylthio)nonan | 422-850-5 | 148757-89-5 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 602-098-00-6 | 2-(3-bromphenoxy)tetrahydro-2H-pyran | 429-030-6 | 57999-49-2 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 602-099-00-1 | 3-(4-fluorphenyl)-2-methylpropionylchlorid | 426-370-7 | — | Skin Corr. 1A
  Acute Tox. 4 *
  Aquatic Chronic 3 | H314
  H302
  H412 | GHS05
  GHS07
  Dgr | H314
  H302
  H412 | EUH014
  EUH029 | | |
| 602-100-00-5 | en blanding af: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluorpentan;
  (S,S)-1,1,1,2,2,3,4,5,5,5-decafluorpentan | 420-640-8 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 602-101-00-0 | 2-chlor-4-fluor-5-nitrophenyl (isobutyl)carbonat | 427-020-6 | 141772-37-4 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H373 **
  H317
  H410 | | | |
| 602-102-00-6 | 1,1,1,3,3-pentafluorbutan | 430-250-1 | 406-58-6 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 602-103-00-1 | 1-(chlorphenylmethyl)-2-methylbenzen | 431-450-1 | 41870-52-4 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 602-104-00-7 | 1,1,2,2,3,3,4-heptafluorcyclopentan | 430-710-1 | 15290-77-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 602-105-00-2 | natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butansulfinat | 422-100-7 | 102061-82-5 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 602-106-00-8 | 2-brom-4,6-difluoranilin | 429-430-0 | 444-14-4 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 602-107-00-3 | 3,3,4,4-tetrafluor-4-iod-1-buten | 439-500-2 | 33831-83-3 | Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Chronic 2 | H302
  H315
  H411 | GHS07
  GHS09
  Wng | H302
  H315
  H411 | | | |
| 602-108-00-9 | (2,3,5,6-tetrafluorphenyl)methanol | 443-840-7 | 4084-38-2 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1 | H302
  H319
  H317 | GHS07
  Wng | H302
  H319
  H317 | | | |
| 602-109-00-4 | hexabromcyclododecan [1]
  1,2,5,6,9,10-hexabromcyclododecan [2] | 247-148-4 [1]
  221-695-9 [2] | 25637-99-4 [1]
  3194-55-6 [2] | Repr. 2
  Lact. | H361
  H362 | GHS08
  Wng | H361
  H362 | | | |
| 603-001-00-X | methanol | 200-659-6 | 67-56-1 | Flam. Liq. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT SE 1 | H225
  H331
  H311
  H301
  H370** | GHS02
  GHS06
  GHS08
  Dgr | H225
  H331
  H311
  H301
  H370** | | *
  STOT SE 1; H370: C ≥ 10 %
  STOT SE 2; H371: 3 % ≤ C < 10 % | |
| 603-002-00-5 | ethanol;
  ethylalkohol | 200-578-6 | 64-17-5 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 603-003-00-0 | propan-1-ol;
  n-propanol | 200-746-9 | 71-23-8 | Flam. Liq. 2
  Eye Dam. 1
  STOT SE 3 | H225
  H318
  H336 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H318
  H336 | | | |
| 603-004-00-6 | butan-1-ol;

  n-butanol | 200-751-6 | 71-36-3 | Flam. Liq. 3
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  STOT SE 3 | H226
  H302
  H335
  H315
  H318
  H336 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H302
  H335
  H315
  H318
  H336 | | | |
| 603-005-00-1 | 2-methylpropan-2-ol;

  tert-butylalkohol | 200-889-7 | 75-65-0 | Flam. Liq. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H225
  H332
  H319
  H335 | GHS02
  GHS07
  Dgr | H225
  H332
  H319
  H335 | | | |
| 603-006-00-7 | pentanol-isomerer, undtagen sådanne nævnt andetsteds i dette bilag | 250-378-8 | | Flam. Liq. 3
  Acute Tox. 4 * STOT SE 3 | H226
  H332
  H335 | GHS02
  GHS07
  Wng | H226
  H332
  H335 | EUH066 | | C |
| 603-007-00-2 | 2-methyl-2-butanol;

  tert-pentanolalkohol | 200-908-9 | 75-85-4 | Flam. Liq. 2
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2 | H225
  H332
  H335
  H315 | GHS02
  GHS07
  Dgr | H225
  H332
  H335
  H315 | | | |
| 603-008-00-8 | 4-methyl-2-pentanol;
  methylamylalkohol | 203-551-7 | 108-11-2 | Flam. Liq. 3
  STOT SE 3 | H226
  H335 | GHS02
  GHS07
  Wng | H226
  H335 | | STOT SE 3; H335: C ≥ 25 % | |
| 603-009-00-3 | cyclohexanol | 203-630-6 | 108-93-0 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2 | H332
  H302
  H335
  H315 | GHS07
  Wng | H332
  H302
  H335
  H315 | | | |
| 603-010-00-9 | 2-methylcyclohexanol, blanding af isomerer; [1]

  cis-2-methylcyclohexanol; [2]

  trans-2-methylcyclohexanol [3] | 209-512-0 [1]
  231-187-9 [2]
  231-186-3 [3] | 583-59-5 [1]
  7443-70-1 [2]
  7443-52-9 [3] | Acute Tox. 4 * | H332 | GHS07
  Wng | H332 | | | C |
| 603-011-00-4 | 2-methoxyethanol;
  methylglycol | 203-713-7 | 109-86-4 | Flam. Liq. 3
  Repr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H226
  H360FD
  H332
  H312
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H226
  H360FD H332
  H312
  H302 | | | |
| 603-012-00-X | 2-ethoxyethanol;
  ethylglycol | 203-804-1 | 110-80-5 | Flam. Liq. 3
  Repr. 1B
  Acute Tox. 3
  Acute Tox. 4 | H226
  H360FD
  H331
  H302 | GHS02
  GHS08
  GHS06
  Dgr | H226
  H360FD H331
  H302 | | | |
| 603-013-00-5 | 2-isopropoxyethanol;
  isopropylglycol | 203-685-6 | 109-59-1 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2 | H332
  H312
  H319 | GHS07
  Wng | H332
  H312
  H319 | | | |
| 603-014-00-0 | 2-butoxyethanol;
  butylglycol | 203-905-0 | 111-76-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H332
  H312
  H302
  H319
  H315 | GHS07
  Wng | H332
  H312
  H302
  H319
  H315 | | | |
| 603-015-00-6 | allylalkohol | 203-470-7 | 107-18-6 | Flam. Liq. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H225
  H331
  H311
  H301
  H319
  H335
  H315
  H400 | GHS02
  GHS06
  GHS09
  Dgr | H225
  H331
  H311
  H301
  H319
  H335
  H315
  H400 | | | |
| 603-016-00-1 | 4-hydroxy-4-methyl-2-pentanon; diacetonalkohol | 204-626-7 | 123-42-2 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | Eye Irrit. 2; H319: C ≥ 10 % | |
| 603-018-00-2 | furfurylalkohol | 202-626-1 | 98-00-0 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  STOT SE 3 | H351
  H331
  H312
  H302
  H373 **
  H319
  H335 | GHS06
  GHS08
  Dgr | H351
  H331
  H312
  H302
  H373 **
  H319
  H335 | | | |
| 603-019-00-8 | dimethylether | 204-065-8 | 115-10-6 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 603-020-00-3 | methylethylether | — | 540-67-0 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | U |
| 603-021-00-9 | methylvinylether | 203-475-4 | 107-25-5 | Flam. Gas 1
  Press. Gas | H220 | GHS02
  GHS04
  Dgr | H220 | | | D U |
| 603-022-00-4 | diethylether;
  ether | 200-467-2 | 60-29-7 | Flam. Liq. 1
  Acute Tox. 4 *
  STOT SE 3 | H224
  H302
  H336 | GHS02
  GHS07
  Dgr | H224
  H302
  H336 | EUH019
  EUH066 | | |
| 603-023-00-X | ethylenoxid;
  oxiran | 200-849-9 | 75-21-8 | Press. Gas
  Flam. Gas 1
  Carc. 1B
  Muta. 1B
  Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H220
  H350
  H340
  H331
  H319
  H335
  H315 | GHS02
  GHS04
  GHS06
  GHS08
  Dgr | H220
  H350
  H340
  H331
  H319
  H335
  H315 | | | U |
| 603-024-00-5 | 1,4-dioxan | 204-661-8 | 123-91-1 | Flam. Liq. 2
  Carc. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H351
  H319
  H335 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H351
  H319
  H335 | EUH019
  EUH066 | | D |
| 603-025-00-0 | tetrahydrofuran | 203-726-8 | 109-99-9 | Flam. Liq. 2
  Carc. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H351
  H319
  H335 | GHS02
  GHS07
  GHS08
  Dgr | H225
  H351
  H319
  H335 | EUH019 | STOT SE 3; H335: C ≥ 25 % Eye Irrit.2;
  H319: C ≥ 25 % | |
| 603-026-00-6 | 1-chlor-2,3-epoxypropan; epichlorhydrin | 203-439-8 | 106-89-8 | Flam. Liq. 3
  Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1 | H226
  H350
  H331
  H311
  H301
  H314
  H317 | GHS02
  GHS06
  GHS08
  GHS05
  Dgr | H226
  H350
  H331
  H311
  H301
  H314
  H317 | | * | |
| 603-027-00-1 | ethandiol;
  ethylenglycol | 203-473-3 | 107-21-1 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 603-028-00-7 | 2-chlorethanol;
  ethylenchlorhydrin | 203-459-7 | 107-07-3 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 * | H330
  H310
  H300 | GHS06
  Dgr | H330
  H310
  H300 | | | |
| 603-029-00-2 | bis(2-chlorethyl)ether | 203-870-1 | 111-44-4 | Carc. 2
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 * | H351
  H330
  H310
  H300 | GHS06
  GHS08
  Dgr | H351
  H330
  H310
  H300 | | | |
| 603-030-00-8 | 2-aminoethanol;
  ethanolamin | 205-483-3 | 141-43-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H332
  H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H332
  H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | |
| 603-031-00-3 | 1,2-dimethoxyethan;
  ethylenglycoldimethylether;
  EDGME | 203-794-9 | 110-71-4 | Flam. Liq. 2
  Repr. 1B
  Acute Tox. 4 * | H225
  H360FD
  H332 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H360FD H332 | EUH019 | | |
| 603-032-00-9 | ethylendinitrat;
  ethylenglycoldinitrat | 211-063-0 | 628-96-6 | Unst. Expl.
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 | H200
  H330
  H310
  H300
  H373 ** | GHS01
  GHS06
  GHS08
  Dgr | H200
  H330
  H310
  H300
  H373 ** | | | |
| 603-033-00-4 | oxydiethylendinitrat;
  diethylenglycoldinitrat;
  digoldinitrat | 211-745-8 | 693-21-0 | Unst. Expl
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 3 | H200
  H330
  H310
  H300
  H373 **
  H412 | GHS01
  GHS06
  GHS08
  Dgr | H200
  H330
  H310
  H300
  H373 **
  H412 | | | |
| 603-033-01-1 | oxydiethylendinitrat;
  diethylenglycoldinitrat;
  digoldinitrat;
  [>25 % flegmatiseringsmiddel] | 211-745-8 | 693-21-0 | Expl. 1,1
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 3 | H201
  H330
  H310
  H300
  H373 **
  H412 | GHS01
  GHS06
  GHS08
  Dgr | H201
  H330
  H310
  H300
  H373 ** H412 | | | |
| 603-034-00-X | glyceroltrinitrat; nitroglycerin | 200-240-8 | 55-63-0 | Unst. Expl.
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 2 | H200
  H330
  H310
  H300
  H373 ** H411 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H200
  H330
  H310
  H300
  H373 ** H411 | | | |
| 603-034-01-7 | glyceroltrinitrat; nitroglycerin; [>40 % flegmatiseringsmiddel] | 200-240-8 | 55-63-0 | Expl. 1,1
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 2 | H201
  H330
  H310
  H300
  H373 ** H411 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H330
  H310
  H300
  H373 ** H411 | | | |
| 603-035-00-5 | pentaerythritoltetranitrat; pentaerythrittetranitrat; PETN | 201-084-3 | 78-11-5 | Unst. Expl. | H200 | GHS01
  Dgr | H200 | | | |
| 603-035-01-2 | pentaerythritoltetranitrat; pentaerythrittetranitrat; PETN; [>20 % flegmatiseringsmiddel] | 201-084-3 | 78-11-5 | Expl. 1,1 | H201 | GHS01
  Dgr | H201 | | | T |
| 603-036-00-0 | mannitolhexanitrat; nitromannit | 239-924-6 | 15825-70-4 | Unst. Expl. | H200 | GHS01
  Dgr | H200 | | | |
| 603-036-01-8 | mannitolhexanitrat; nitromannit; [>40 % flegmatiseringsmiddel] | 239-924-6 | 15825-70-4 | Expl. 1,1 | H201 | GHS01
  Dgr | H201 | | | |
| 603-037-00-6 | cellulosenitrat; nitrocellulose | — | — | Expl. 1,1 | H201 | GHS01
  Dgr | H201 | | | T |
| 603-038-00-1 | allylglycidylether; allyl 2,3-epoxypropylether; prop-2-en-1-yl 2,3-epoxypropylether | 203-442-4 | 106-92-3 | Flam. Liq. 3
  Carc. 2
  Muta. 2
  Repr. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H226
  H351
  H341
  H361f *** H332
  H302
  H335
  H315
  H318
  H317
  H412 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H226
  H351
  H341
  H361f *** H332
  H302
  H335
  H315
  H318
  H317
  H412 | | | |
| 603-039-00-7 | 1-butoxy-2,3-epoxypropan; butylglycidylether | 219-376-4 | 2426-08-6 | Flam. Liq. 3
  Carc. 2
  Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Sens. 1
  Aquatic Chronic 3 | H226
  H351
  H341
  H332
  H302
  H335
  H317
  H412 | GHS02
  GHS08
  GHS07
  Wng | H226
  H351
  H341
  H332
  H302
  H335
  H317
  H412 | | | |
| 603-040-00-2 | natriummethanolat; natriummethoxid; [1] kaliummethanolat; kaliummethoxid; [2] lithiummethanolat; lithiummethoxid [3] | 204-699-5 [1]
  212-736-1 [2]
  212-737-7 [3] | 124-41-4 [1]
  865-33-8 [2]
  865-34-9 [3] | Self-heat 1
  Skin Corr. 1B | H251
  H314 | GHS02
  GHS05
  Dgr | H251
  H314 | EUH014 | | T |
| 603-041-00-8 | kaliumethanolat; kaliumethoxid; [1] natriummethanolat; natriumethoxid [2] | 213-029-0 [1]
  205-487-5 [2] | 917-58-8 [1]
  141-52-6 [2] | Self-heat 1
  Skin Corr. 1B | H251
  H314 | GHS02
  GHS05
  Dgr | H251
  H314 | EUH014 | | T |
| 603-042-00-3 | aluminiumtriisopropylat; aluminiumtriisopropoxid | 209-090-8 | 555-31-7 | Flam. Sol. 1 | H228 | GHS02
  Dgr | H228 | | | T |
| 603-043-00-9 | triarimol (ISO); 2,4-dichlorphenyl-α-phenyl-pyrimidin-5-yl-methanol | — | 26766-27-8 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 603-044-00-4 | dicofol (ISO); 2,2,2-trichlor-1,1-bis(4-chlorphenyl)ethanol | 204-082-0 | 115-32-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H315
  H317
  H410 | | | |
| 603-045-00-X | diisopropylether; [1] dipropylether [2] | 203-560-6 [1]
  203-869-6 [2] | 108-20-3 [1]
  111-43-3 [2] | Flam. Liq. 2
  STOT SE 3 | H225
  H336 | GHS02
  GHS07
  Dgr | H225
  H336 | EUH019
  EUH066 | | C |
| 603-046-00-5 | bis(chlormethyl)ether; oxybis(chlormethan) | 208-832-8 | 542-88-1 | Flam. Liq. 2
  Carc. 1A
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 4 * | H225
  H350
  H330
  H311
  H302 | GHS02
  GHS06
  GHS08
  Dgr | H225
  H350
  H330
  H311
  H302 | | Carc. 1A; H350: C ≥ 0,001  % | |
| 603-047-00-0 | 2-dimethylaminoethanol; N, N-dimethylethanolamin | 203-542-8 | 108-01-0 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1B | H226
  H332
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H332
  H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | |
| 603-048-00-6 | 2-diethylaminoethanol; N, N-diethylethanolamin | 202-845-2 | 100-37-8 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1B | H226
  H332
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H226
  H332
  H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | |
| 603-049-00-1 | chlorfenethol (ISO); 1,1-bis (4-chlorphenyl) ethanol | 201-246-3 | 80-06-8 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 603-050-00-7 | 1-(2-butoxypropoxy)-2-propanol | 246-011-6 | 24083-03-2 | Acute Tox. 4 * Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 603-051-00-2 | 2-ethylbutanol | 202-621-4 | 97-95-0 | Acute Tox. 4 * Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 603-052-00-8 | 3-butoxy-2-propanol; propylenglycolmonobutylether | 225-878-4 | 5131-66-8 | Eye Irrit. 2
  Skin Irrit. 2 | H319
  H315 | GHS07
  Wng | H319
  H315 | | | |
| 603-053-00-3 | 2-methyl-2,4-pentandiol | 203-489-0 | 107-41-5 | Eye Irrit. 2
  Skin Irrit. 2 | H319
  H315 | GHS07
  Wng | H319
  H315 | | | |
| 603-054-00-9 | di-n-butylether; dibutylether | 205-575-3 | 142-96-1 | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 3 | H226
  H319
  H335
  H315
  H412 | GHS02
  GHS07
  Wng | H226
  H319
  H335
  H315
  H412 | | STOT SE 3; H335: C ≥ 10 % | |
| 603-056-00-X | [(p-tolyloxy)methyl]oxiran; [1] [[(m-tolyloxy)methyl]oxiran; [2] 2,3-epoxypropyl-o-tolylether; [3][(tolyloxy)methyl]oxiran; cresylglycidylether [4] | 218-574-8 [1]
  218-575-3 [2]
  218-645-3 [3]
  247-711-4 [4] | 2186-24-5 [1]
  2186-25-6 [2]
  2210-79-9 [3]
  26447-14-3 [4] | Muta. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H341
  H315
  H317
  H411 | GHS08
  GHS07
  GHS09
  Wng | H341
  H315
  H317
  H411 | | | C |
| 603-057-00-5 | benzylalkohol | 202-859-9 | 100-51-6 | Acute Tox. 4 * Acute Tox. 4 * | H332
  H302 | GHS07
  Wng | H332
  H302 | | | |
| 603-058-00-0 | oxetan | 207-964-3 | 503-30-0 | Flam. Liq. 2
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225
  H332
  H312
  H302 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302 | | | |
| 603-059-00-6 | 1-hexanol | 203-852-3 | 111-27-3 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 603-060-00-1 | 2,2'-bioxiran;1,2:3,4-diepoxybutan | 215-979-1 | 1464-53-5 | Carc. 1B Muta. 1B
  Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B | H350
  H340
  H330
  H311
  H301
  H314 | GHS06
  GHS08
  GHS05
  Dgr | H350
  H340
  H330
  H311
  H301
  H314 | | | |
| 603-061-00-7 | tetrahydro-2-furylmethanol; tetrahydrofurfurylalkohol | 202-625-6 | 97-99-4 | Repr. 1B Eye Irrit. 2 | H360Df
  H319 | GHS08
  GHS07
  Dgr | H360Df
  H319 | | | |
| 603-062-00-2 | 2,5-bis(hydroxymethyl)oxolan | 203-239-0 | 104-80-3 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | STOT SE 3; H335: C ≥ 10 % | |
| 603-063-00-8 | 2,3-epoxypropan-1-ol; glycidol: oxiranmethanol | 209-128-3 | 556-52-5 | Carc. 1B Muta. 2
  Repr. 1B
  Acute Tox. 3 * Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H350
  H341
  H360f *** H331
  H312
  H302
  H319
  H335
  H315 | GHS06
  GHS08
  Dgr | H350
  H341
  H360f *** H331
  H312
  H302
  H319
  H335
  H315 | | | |
| 603-064-00-3 | 1-methoxy-2-propanol; monopropylenglycolmethylether | 203-539-1 | 107-98-2 | Flam. Liq. 3
  STOT SE 3 | H226
  H336 | GHS02
  GHS07
  Wng | H226
  H336 | | | |
| 603-065-00-9 | resorcinoldiglycidylether; 1,3-bis(2,3-epoxypropoxy)benzen | 202-987-5 | 101-90-6 | Carc. 2
  Muta. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H351
  H341
  H312
  H302
  H319
  H315
  H317
  H412 | GHS08
  GHS07
  Wng | H351
  H341
  H312
  H302
  H319
  H315
  H317
  H412 | | | |
| 603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexan; 4-vinylcyclohexendiepoxid | 203-437-7 | 106-87-6 | Carc. 2
  Acute Tox. 3 * Acute Tox. 3 *
  Acute Tox. 3 * | H351
  H331
  H311
  H301 | GHS06
  GHS08
  Dgr | H351
  H331
  H311
  H301 | | * | |
| 603-067-00-X | phenylglycidylether; 2,3-epoxypropyl phenyl ether; 1,2-epoxy-3-phenoxypropan | 204-557-2 | 122-60-1 | Carc. 1B Muta. 2
  Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H350
  H341
  H332
  H335
  H315
  H317
  H412 | GHS08
  GHS07
  Dgr | H350
  H341
  H332
  H335
  H315
  H317
  H412 | | | |
| 603-068-00-5 | 1-(2-ethylcyclohexanoxy)-2,3-epoxypropan; ethylcyclohexylglycidylether | — | 130014-35-6 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | |
| 603-069-00-0 | 2,4,6-tris(dimethylamino-methyl)-phenol | 202-013-9 | 90-72-2 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H302
  H319
  H315 | GHS07
  Wng | H302
  H319
  H315 | | | |
| 603-070-00-6 | 2-amino-2-methylpropanol | 204-709-8 | 124-68-5 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 3 | H319
  H315
  H412 | GHS07
  Wng | H319
  H315
  H412 | | | |
| 603-071-00-1 | 2,2'-iminodiethanol; diethanolamin | 203-868-0 | 111-42-2 | Acute Tox. 4 * STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1 | H302
  H373 ** H315
  H318 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H373 ** H315
  H318 | | | |
| 603-072-00-7 | 1,4-bis(2,3 epoxypropoxy)butan; butandioldiglycidylether | 219-371-7 | 2425-79-8 | Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H332
  H312
  H319
  H315
  H317 | GHS07
  Wng | H332
  H312
  H319
  H315
  H317 | | | |
| 603-073-00-2 | bisphenol-A-diglycidylether; 2,2-bis(p-(2,3-epoxipropoxi)phenyl]propan | 216-823-5 | 1675-54-3 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % | |
| 603-074-00-8 | reaktionsprodukt: bisphenol-A-epichlorhydrin; epoxy harpiks (gennemsnitlig molekylevægt ≤ 700) | 500-033-5 | 25068-38-6 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H319
  H315
  H317
  H411 | GHS07
  GHS09
  Wng | H319
  H315
  H317
  H411 | | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C ≥ 5 % | |
| 603-075-00-3 | chlormethylmethylether; chlordimethylether | 203-480-1 | 107-30-2 | Flam. Liq. 2
  Carc. 1A
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225
  H350
  H332
  H312
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H350
  H332
  H312
  H302 | | | |
| 603-076-00-9 | but-2-yn-1,4-diol; 2-butyn-1,4-diol | 203-788-6 | 110-65-6 | Skin Corr. 1B
  Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 *
  Skin Sens. 1 | H314
  H331
  H301
  H312
  H373 ** H317 | GHS06
  GHS05
  GHS08
  Dgr | H314
  H331
  H301
  H312
  H373 ** H317 | | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 25 % ≤ C < 50 %
  Eye Irrit. 2; H319: 25 % ≤
  C < 50 % | D |
| 603-077-00-4 | 1-dimethylaminopropan-2-ol; dimepranol (INN) | 203-556-4 | 108-16-7 | Flam. Liq. 3
  Acute Tox. 4 *
  Skin Corr. 1B | H226
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H302
  H314 | | | |
| 603-078-00-X | prop-2-yn-1-ol; propargylalkohol | 203-471-2 | 107-19-7 | Flam. Liq. 3
  Acute Tox. 3 * Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H226
  H331
  H311
  H301
  H314
  H411 | GHS02
  GHS06
  GHS05
  GHS09
  Dgr | H226
  H331
  H311
  H301
  H314
  H411 | | | |
| 603-079-00-5 | 2,2'-methyliminodiethanol; N-methyldiethanolamin | 203-312-7 | 105-59-9 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 603-080-00-0 | 2-methylaminoethanol; N-methylethanolamin; N-methyl-2-ethanolamin; N-methyl-2-aminoethanol; 2-(methylamino)ethanol | 203-710-0 | 109-83-1 | Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1B | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | |
| 603-081-00-6 | 2,2'-thiodiethanol; thiodiglycol | 203-874-3 | 111-48-8 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 603-082-00-1 | 1-aminopropan-2-ol; isopropanolamin | 201-162-7 | 78-96-6 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 603-083-00-7 | 1,1'-iminodipropan-2-ol; diisopropanolamin | 203-820-9 | 110-97-4 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 603-084-00-2 | styrenoxid; (epoxyethyl)benzen; phenyloxiran | 202-476-7 | 96-09-3 | Carc. 1B
  Acute Tox. 4 *
  Eye Irrit. 2 | H350
  H312
  H319 | GHS08
  GHS07
  Dgr | H350
  H312
  H319 | | | |
| 603-085-00-8 | bronopol (INN); 2-brom-2-nitropropan-1,3-diol | 200-143-0 | 52-51-7 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1 | H312
  H302
  H335
  H315
  H318
  H400 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H335
  H315
  H318
  H400 | | M = 10 | |
| 603-086-00-3 | ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol | 245-949-3 | 23947-60-6 | Acute Tox. 4 * | H312 | GHS07
  Wng | H312 | | | |
| 603-087-00-9 | 2-ethylhexan-1,3-diol; octylenglycol; ethoexadiol | 202-377-9 | 94-96-2 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 603-088-00-4 | 2-(octylthio)ethanol; 2-hydroxyethyloctylsulfid | 222-598-4 | 3547-33-9 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 603-089-00-X | 7,7-dimethyl-3-oxa-6-azaoctan-1-ol | 400-390-6 | — | Skin Corr. 1A
  Acute Tox. 4 * | H314
  H302 | GHS05
  GHS07
  Dgr | H314
  H302 | | | |
| 603-090-00-5 | 2-(2-bromethoxy)anisol | 402-010-4 | 4463-59-6 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 603-091-00-0 | exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol | 402-470-6 | 87172-89-2 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 603-092-00-6 | 2-methyl-4-phenylpentanol | 402-770-7 | 92585-24-5 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 603-093-00-1 | cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptan | 402-410-9 | 87818-31-3 | Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H411 | GHS07
  GHS09
  Dgr | H332
  H411 | | | |
| 603-094-00-7 | 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropan | 241-536-7 | 17557-23-2 | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 603-095-00-2 | 2-(propyloxy)ethanol; EGPE | 220-548-6 | 2807-30-9 | Acute Tox. 4 *
  Eye Irrit. 2 | H312
  H319 | GHS07
  Wng | H312
  H319 | | | |
| 603-096-00-8 | 2-(2-butoxyethoxy)ethanol; diethylenglycolmonobutylether | 203-961-6 | 112-34-5 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 603-097-00-3 | 1,1',1''-nitrilotripropan-2-ol; triisopropanolamin | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 603-098-00-9 | 2-phenoxyethanol | 204-589-7 | 122-99-6 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 603-099-00-4 | 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propan-1,2-diolhydrochlorid | 403-440-5 | 93633-79-5 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 603-100-00-8 | 1,2-dimethoxypropan | 404-630-0 | 7778-85-0 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | EUH019 | | |
| 603-101-00-3 | tetrahydro-2-isobutyl-4-methylpyran-4-ol, blanding af isomerer (cis og trans) | 405-040-6 | — | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 603-103-00-4 | oxiran, mono[(C12-14-alkyloxy)methyl]derivater | 271-846-8 | 68609-97-2 | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 603-104-00-X | fenarimol (ISO); 2,4'-dichlor-α-(pyrimidin-5-yl)benzhydrylalkohol | 262-095-7 | 60168-88-9 | Repr. 2
  Lact.
  Aquatic Chronic 2 | H361fd
  H362
  H411 | GHS08
  GHS09
  Wng | H361fd
  H362
  H411 | | | |
| 603-105-00-5 | furan | 203-727-3 | 110-00-9 | Flam. Liq. 1
  Carc. 1B Muta. 2
  Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
  Skin Irrit. 2
  Aquatic Chronic 3 | H224
  H350
  H341
  H332
  H302
  H373 ** H315
  H412 | GHS02
  GHS08
  GHS07
  Dgr | H224
  H350
  H341
  H332
  H302
  H373 ** H315
  H412 | EUH019 | | |
| 603-106-00-0 | 2-methoxypropanol | 216-455-5 | 1589-47-5 | Flam. Liq. 3
  Repr. 1B
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H226
  H360D *** H335
  H315
  H318 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H226
  H360D *** H335
  H315
  H318 | | | |
| 603-107-00-6 | 2-(2-methoxyethoxy)ethanol; diethylenglycolmonomethylether | 203-906-6 | 111-77-3 | Repr. 2 | H361d *** | GHS08
  Wng | H361d *** | | | |
| 603-108-00-1 | 2-methylpropan-1-ol; isobutanol | 201-148-0 | 78-83-1 | Flam. Liq. 3
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  STOT SE 3 | H226
  H335
  H315
  H318
  H336 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H335
  H315
  H318
  H336 | | | |
| 603-109-00-7 | en blanding af 1-ethoxy-1,1,2,3,3,3-hexafluor-2-(trifluormethyl)propan og 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorbutan | 425-340-0 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-110-00-2 | en blanding af cis-2-isobutyl-5-methyl-1,3-dioxan og trans-2-isobutyl-5-methyl-1,3-dioxan | 426-130-1 | 166301-21-9 | Skin Irrit. 2
  Aquatic Chronic 3 | H315
  H412 | GHS07
  Wng | H315
  H412 | | | |
| 603-111-00-8 | en blanding af 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexan og 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexan | 426-530-6 | — | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 603-112-00-3 | cyclopentyl-2-phenylethyl-ether | 428-340-9 | — | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 603-113-00-9 | 6-glycidyloxynapht-1-yloxymethyloxiran | 429-960-2 | 27610-48-6 | Muta. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H341
  H312
  H315
  H317
  H412 | GHS08
  GHS07
  Wng | H341
  H312
  H315
  H317
  H412 | | | |
| 603-114-00-4 | 9-(2-propenyloxy)tricyclo[5.2.1.02,6]dec-3(eller-4-)-en | 430-830-2 | 26912-64-1 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 603-115-00-X | en blanding af O, O',O''-(methylsilantriyl)tris(4-methyl-2-pentanonoxim) (3 stereoisomerer) | 423-580-0 | — | STOT RE 2 *
  Aquatic Chronic 4 | H373 ** H413 | GHS08
  Wng | H373 ** H413 | | | |
| 603-116-00-5 | (Z)-(2,4-difluorphenyl)piperidin-4-ylmethanonoxim monohydrochlorid | 424-740-2 | 138271-16-6 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 603-117-00-0 | propan-2-ol; isopropylalkohol; isopropanol | 200-661-7 | 67-63-0 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H336 | | | |
| 603-118-00-6 | 6-dimethylaminohexan-1-ol | 404-680-3 | 1862-07-3 | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 3 | H302
  H314
  H412 | GHS05
  GHS07
  Dgr | H302
  H314
  H412 | | | |
| 603-119-00-1 | 1,1'-(1,3-phenylendioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) | 405-840-5 | — | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 603-120-00-7 | 2-methyl-5-phenylpentanol | 405-890-8 | 25634-93-9 | Eye Irrit. 2
  Skin Irrit. 2 | H319
  H315 | GHS07
  Wng | H319
  H315 | | | |
| 603-121-00-2 | 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinon | 406-057-1 | 114565-66-1 | Carc. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H351
  H317
  H413 | GHS08
  GHS07
  Wng | H351
  H317
  H413 | | | |
| 603-122-00-8 | natrium-2-ethylhexanolat | 406-150-7 | 38411-13-1 | Flam. Sol. 1
  Skin Corr. 1B
  Aquatic Chronic 3 | H228
  H314
  H412 | GHS02
  GHS05
  Dgr | H228
  H314
  H412 | | | T |
| 603-123-00-3 | 4-methyl-8-methylentricyclo[3.3.1.13,7]decan-2-ol | 406-330-5 | 122760-84-3 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H317
  H411 | GHS07
  GHS09
  Wng | H315
  H317
  H411 | | | |
| 603-124-00-9 | 1,4-bis[2-(vinyloxy)ethoxy]benzen | 406-900-3 | 84563-49-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 603-125-00-4 | 2-(2,4-dichlorphenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol | 407-850-5 | 89544-40-1 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 603-126-00-X | 2-((4-methyl-2-nitrophenyl)amino)ethanol | 408-090-7 | 100418-33-5 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H317
  H412 | GHS07
  Wng | H302
  H317
  H412 | | | |
| 603-127-00-5 | butan-2-ol; [1](S)-butan-2-ol; [2] (R)-butan-2-ol; [3] (±)-butan-2-ol [4] | 201-158-5 [1]
  224-168-1 [2]
  238-967-8 [3]
  240-029-8 [4] | 78-92-2 [1]
  4221-99-2 [2]
  14898-79-4 [3]
  15892-23-6 [4] | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3
  STOT SE 3 | H226
  H319
  H335
  H336 | GHS02
  GHS07
  Wng | H226
  H319
  H335
  H336 | | | C |
| 603-128-00-0 | 2-(phenylmethoxy)naphthalen | 405-490-3 | 613-62-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-129-00-6 | 1-tert-butoxypropan-2-ol | 406-180-0 | 57018-52-7 | Flam. Liq. 3
  Eye Dam. 1 | H226
  H318 | GHS02
  GHS05
  Dgr | H226
  H318 | | | |
| 603-130-00-1 | blanding af isomerer af α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylen) | 406-325-8 | — | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 603-131-00-7 | en blanding af 1-deoxy-1-[methyl-(1-oxododecyl)amino]-.sc.D.sc.-glucitol og 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-.sc.D.sc.-glucitol | 407-290-1 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 603-132-00-2 | 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decan | 408-200-3 | 63187-91-7 | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H315
  H318
  H412 | GHS05
  Dgr | H315
  H318
  H412 | | | |
| 603-133-00-8 | en blanding af 3-[(4-amino-2-chlor-5-nitrophenyl)amino]propan-1,2-diol og 3,3'-(2-chlor-5-nitro-1,4-phenylendiimino)bis(propan-1,2-diol) | 408-240-1 | — | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 603-134-00-3 | blanding af substitueret dodecyl og/eller tetradecyl diphenylethere. Stoffet er fremstillet ved Friedel-Craft-reaktion. Katalysatoren bliver fjernet fra reaktionsprodukter. Diphenylether bliver substitueret med C1-C10 alkylgrupper. Alkylgrupperne bliver bundet tilfældigt til kulstofatomer mellem position 1 og 6. Lineær C12 og C14, 50/50 benyttes. | 410-450-3 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-135-00-9 | bis[[2,2',2''-nitrilotris-[ethanolato]]-(1-)N,O]-bis[2-(2-methoxyethoxy)ethoxy]titan | 410-500-4 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 603-136-00-4 | 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol | 410-910-3 | 104226-19-9 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 603-137-00-X | blanding af 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-.sc.D.sc.-glucitol og 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-.sc.D.sc.-glucitol | 411-130-6 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 603-138-00-5 | 3-(2,2-dimethyl-3-hydroxypropyl)toluen; (alt.): 2,2-dimethyl-3-(3-methylphenyl)propan-1-ol | 403-140-4 | 103694-68-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 603-139-00-0 | bis(2-methoxyethyl)ether | 203-924-4 | 111-96-6 | Flam. Liq. 3
  Repr. 1B | H226
  H360FD | GHS02
  GHS08
  Dgr | H226
  H360FD | EUH019 | | |
| 603-140-00-6 | 2,2'-oxydiethanol; diethylenglycol | 203-872-2 | 111-46-6 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 603-141-00-1 | blanding af dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]pentadecan og dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]heptadecan | 413-780-6 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 603-142-00-7 | 2-(2-(2-hydroxyethoxy)-ethyl)-2-aza-bicyclo[2.2.1]heptan | 407-360-1 | 116230-20-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1 | H312
  H302
  H373 ** H315
  H318 | GHS06
  GHS08
  GHS05
  Dgr | H312
  H302
  H373 ** H315
  H318 | | | |
| 603-143-00-2 | R-2,3-epoxypropan-1-ol | 404-660-4 | 57044-25-4 | Self-react. C **** Carc. 1B
  Muta. 2
  Repr. 1B
  Acute Tox. 3 * Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H242
  H350
  H341
  H360f *** H331
  H312
  H302
  H314 | GHS02
  GHS06
  GHS08
  GHS05
  Dgr | H242
  H350
  H341
  H360f *** H331
  H312
  H302
  H314 | | | |
| 603-144-00-8 | en blanding af 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol og 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol | 413-530-6 | 111850-00-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 603-145-00-3 | 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxy-propan | 406-970-5 | 129228-11-1 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 603-146-00-9 | 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol | 406-080-7 | 83016-70-0 | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 3 | H302
  H314
  H412 | GHS05
  GHS07
  Dgr | H302
  H314
  H412 | | | |
| 603-147-00-4 | (-)-trans-4-(4'-fluorphenyl)-3-hydroxymethyl-N-methylpiperidin | 406-030-4 | 105812-81-5 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 603-148-00-X | 1,4-bis[(vinyloxy)methyl]cyclohexan | 413-370-7 | 17351-75-6 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 603-149-00-5 | blanding af diastereoisomerer af 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexan | 407-640-3 | 63767-86-2 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H319
  H315
  H411 | GHS07
  GHS09
  Wng | H319
  H315
  H411 | | | |
| 603-150-00-0 | (±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol | 411-580-3 | 107898-54-4 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 603-151-00-6 | (±)-2-(2,4-dichlorphenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol | 413-570-4 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 603-152-00-1 | 2-(4-tert-butylphenyl)ethanol | 410-020-5 | 5406-86-0 | Repr. 2
  STOT RE 2 *
  Eye Dam. 1
  Aquatic Chronic 2 | H361f *** H373 ** H318
  H411 | GHS08
  GHS05
  GHS09
  Dgr | H361f *** H373 ** H318
  H411 | | | |
| 603-153-00-7 | 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propan-1,2-diol | 410-010-0 | 104333-00-8 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 603-154-00-2 | 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol | 412-300-2 | 139504-68-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 603-156-00-3 | 2-(2,4-dichlorphenyl)-2-(2-propenyl)oxiran | 411-210-0 | 89544-48-9 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 603-157-00-9 | 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonan-1,2,9-triol | 411-450-6 | 143747-72-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-158-00-4 | blanding af 4 diastereoisomerer af 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-dien | 412-460-3 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 603-159-00-X | 2-cyclododecylpropan-1-ol | 411-410-8 | 118562-73-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 603-160-00-5 | 1,2-diethoxypropan | 412-180-1 | 10221-57-5 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | EUH019 | | |
| 603-161-00-0 | 1,3-diethoxypropan | 413-140-6 | 3459-83-4 | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | |
| 603-162-00-6 | α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-γ-(nonylphenoxy)poly[oxo(methyl-1,2-ethandiyl)] | 413-420-8 | 144736-29-8 | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H411 | | | |
| 603-163-00-1 | 2-phenyl-1,3-propandiol | 411-810-2 | 1570-95-2 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 603-164-00-7 | 2-butyl-4-chlor-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazol | 412-420-5 | 133909-99-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-165-00-2 | en blanding af 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol | 417-470-1 | — | Muta. 2
  Skin Sens. 1 | H341
  H317 | GHS08
  GHS07
  Wng | H341
  H317 | | | |
| 603-166-00-8 | (R)-1-chlor-2,3-epoxypropan | 424-280-2 | 51594-55-9 | Flam. Liq. 3
  Carc. 1B
  Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1 | H226
  H350
  H331
  H311
  H301
  H314
  H317 | GHS02
  GHS06
  GHS08
  GHS05
  Dgr | H226
  H350
  H331
  H311
  H301
  H314
  H317 | | | |
| 603-167-00-3 | 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol | 407-920-5 | 6390-69-8 | Aquatic Chronic 4 | H413 | GHS05
  Dgr | H413 | | | |
| 603-168-00-9 | 3-(2-ethylhexyloxy)propan-1,2-diol | 408-080-2 | 70445-33-9 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 603-169-00-4 | (±)-trans-4-(4-fluorphenyl)-3-hydroxymethyl-N-methylpiperidin | 415-550-0 | 109887-53-8 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 603-170-00-X | en blanding af 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol og 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol og 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol | 415-990-3 | 67739-11-1 | Eye Irrit. 2
  Aquatic Chronic 2 | H319
  H411 | GHS07
  GHS09
  Wng | H319
  H411 | | | |
| 603-171-00-5 | 5-tiazolilmetanol | 414-780-9 | 38585-74-9 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 603-172-00-0 | mono-2-[2-(4-dibenzo[b, f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol-trans-butendioat | 415-180-1 | 773058-82-5 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 603-173-00-6 | 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octan | 421-750-9 | 57280-22-5 | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 603-174-00-1 | 4-cyclohexyl-2-methyl-2-butanol | 420-630-3 | 83926-73-2 | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 603-175-00-7 | 2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylenglycolmonohexylether; 3,6-dioxa-1-dodecanol; hexylcarbitol; 3,6-dioxadodecan-1-ol | 203-988-3 | 112-59-4 | Acute Tox. 4 *
  Eye Dam. 1 | H312
  H318 | GHS05
  GHS07
  Dgr | H312
  H318 | | | |
| 603-176-00-2 | 1,2-bis(2-methoxyethoxy)ethan; TEGDME; triethylenglycoldimethylether; triglym | 203-977-3 | 112-49-2 | Repr. 1B | H360Df | GHS08
  Dgr | H360Df | EUH019 | | |
| 603-177-00-8 | 1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylenglycolmonoethylether; [1] propylenglycolmonoethylether; 2PG1EEA [2] | 216-374-5 [1]
  259-370-9 [2] | 1569-02-4 [1]
  54839-24-6 [2] | Flam. Liq. 3
  STOT SE 3 | H226
  H336 | GHS02
  GHS07
  Wng | H226
  H336 | | | |
| 603-178-00-3 | 2-hexyloxyethanol; ethylenglycolmonohexylether; n-hexylglycol | 203-951-1 | 112-25-4 | Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1B | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | | |
| 603-179-00-9 | ergocalciferol (ISO); Vitamin D2 | 200-014-9 | 50-14-6 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | H330
  H311
  H301
  H372 ** | GHS06
  GHS08
  Dgr | H330
  H311
  H301
  H372 ** | | | |
| 603-180-00-4 | colecalciferol; Vitamin D3 | 200-673-2 | 67-97-0 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | H330
  H311
  H301
  H372 ** | GHS06
  GHS08
  Dgr | H330
  H311
  H301
  H372 ** | | | |
| 603-181-00-X | (tert-butyl)methylether; MTBE; 2-methoxy-2-methylpropan | 216-653-1 | 04-04-1634 | Flam. Liq. 2
  Skin Irrit. 2 | H225
  H315 | GHS02
  GHS07
  Dgr | H225
  H315 | | | |
| 603-182-00-5 | en blanding af mættede, enkeltumættede og flerumættede langkædede, delvis forestrede alkoholer af vegetabilsk oprindelse (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) med O, O-diisobutyldithiophosphat og 2-ethylhexylamin og hydrogenperoxid | 428-630-5 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 603-183-00-0 | 2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylenglycolmonobutylether; butoxytriethylenglycol | 205-592-6 | 143-22-6 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | Eye Dam.1; H318: C ≥ 30 % Eye Irrit. 2; H319: 20 % ≤ C < 30 % | |
| 603-184-00-6 | 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propandiol | 416-380-1 | 146925-83-9 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 603-185-00-1 | 2,4-dichlor-3-ethyl-6-nitrophenol | 420-740-1 | 99817-36-4 | Acute Tox. 3 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H318
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H301
  H318
  H317
  H410 | | | |
| 603-186-00-7 | trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol | 419-050-3 | 79944-37-9 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 603-187-00-2 | 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanoldichlorid | 419-360-9 | 163661-77-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 603-188-00-8 | en blanding af 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalen og 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalen | 426-970-9 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 603-189-00-3 | blanding af komplekser af titanium, 2,2'-oxydiethanol, ammoniumlactat, nitrilotris(2-propanol) og ethylenglycol | 405-250-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 603-190-00-9 | 8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decan | 424-030-2 | 62406-73-9 | Skin Irrit. 2
  Aquatic Chronic 3 | H315
  H412 | GHS07
  Wng | H315
  H412 | | | |
| 603-191-00-4 | 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol | 419-740-4 | 137658-79-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-192-00-X | (E, E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol | 423-240-1 | 125474-34-2 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | | |
| 603-193-00-5 | dinatrium-9,10-anthracendioxid | 426-030-8 | 46492-07-3 | Skin Corr. 1A | H314 | GHS05
  Dgr | H314 | | | |
| 603-194-00-0 | 2-(2-aminoethylamino)ethanol; (AEEA) | 203-867-5 | 111-41-1 | Repr. 1B
  Skin Corr. 1B
  Skin Sens. 1 | H360Df
  H314
  H317 | GHS05
  GHS08
  GHS07
  Dgr | H360Df
  H314
  H317 | | STOT SE 3; H335: C ≥ 5 % | |
| 603-195-00-6 | 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol | 430-810-3 | 154825-62-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 603-196-00-1 | 2-(7-ethyl-1H-indol-3-yl)ethanol | 431-020-1 | 41340-36-7 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 2 | H302
  H373 ** H411 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H411 | | | |
| 603-199-00-8 | etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorphenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetol | — | 153233-91-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 100 | |
| 603-200-00-1 | 1-pentanol; [1] 3-pentanol [2] | 200-752-1 [1]
  209-526-7 [2] | 71-41-0 [1]
  584-02-1 [2] | Flam. Liq. 3
  Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2 | H226
  H332
  H335
  H315 | GHS02
  GHS07
  Wng | H226
  H332
  H335
  H315 | | | |
| 603-201-00-7 | (E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol | 416-120-5 | — | Skin Irrit. 2
  Aquatic Chronic 4 | H315
  H413 | GHS07
  Wng | H315
  H413 | | | |
| 603-202-00-2 | 4,4,5,5,5-pentafluorpentan-1-ol | 421-360-9 | 148043-73-6 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 603-203-00-8 | (1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecan | 427-580-1 | — | Skin Irrit. 2 | H315 | GHS07
  Wng | H315 | | | |
| 603-204-00-3 | en blanding af 2,2'-(heptan-1,7-diyl)bis-1,3-dioxolan og 2,2'-(heptan-1,6-diyl)bis-1,3-dioxolan | 428-110-8 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 603-205-00-9 | (1S-cis)-4-(2-amino-6-chlor-9H-purin-9-yl)-2-cyclopenten-1-methanol hydrochlorid | 426-200-1 | 172015-79-1 | STOT RE 1
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H372 ** H302
  H318
  H317
  H412 | GHS05
  GHS08
  GHS07
  Dgr | H372 ** H302
  H318
  H317
  H412 | | | |
| 603-206-00-4 | 2,2-dichlor-1,3-benzodioxol | 426-850-6 | 2032-75-9 | Flam. Liq. 3
  Skin Corr. 1A
  Acute Tox. 4 *
  Skin Sens. 1 | H226
  H314
  H302
  H317 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H314
  H302
  H317 | EUH014 | | |
| 603-207-00-X | 2-isobutyl-2-isopropyl-1,3-dimethoxypropan | 430-800-9 | 129228-21-3 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 603-208-00-5 | 1,2-diethoxyethan | 211-076-1 | 629-14-1 | Flam. Liq. 2
  Repr. 1A Eye Irrit. 2 | H225
  H360Df
  H319 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H360Df
  H319 | EUH019 | | |
| 603-209-00-0 | spinosad (blanding af spinosyn A og spinosyn D i forholdet 95:5 til 50:50); blanding af 50-95 % (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacen-7,15-dion og 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacen-7,15-dion; [1]spinosyn A; [2]spinosyn D [3] | - [1]
  - [2]
  - [3] | - [1]
  131929-60-7 [2]
  131929-63-0 [3] | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 10 | |
| 603-210-00-6 | 2,4-diethyl-1,5-pentandiol | 429-310-8 | 57987-55-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 603-211-00-1 | 2,3-epoxypropyltrimethylammoniumchlorid ...%; glycidyltrimethylammoniumchlorid ...% | 221-221-0 | 3033-77-0 | Carc. 1B Muta. 2
  Repr. 2
  Acute Tox. 4 * Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H350
  H341
  H361f *** H312
  H302
  H373 ** H318
  H317
  H412 | GHS05
  GHS08
  GHS07
  Dgr | H350
  H341
  H361f *** H312
  H302
  H373 ** H318
  H317
  H412 | | | B |
| 603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolid; (HHCB) | 214-946-9 | 1222-05-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 603-213-00-2 | 2-methoxy-2-methylbutan; tert-amylmethylether | 213-611-4 | 994-05-8 | Flam. Liq. 2
  Acute Tox. 4 * STOT SE 3 | H225
  H302
  H336 | GHS02
  GHS07
  Dgr | H225
  H302
  H336 | | | |
| 603-214-00-8 | 1,1-diisopropoxycyclohexan | 413-740-8 | 1132-95-2 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 603-215-00-3 | 1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octan-bis(tetrafluorborat) | 418-330-2 | 162241-33-0 | Expl. 1,1 ****
  Acute Tox. 4 * STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H302
  H373 ** H318
  H317
  H400
  H410 | GHS01
  GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H201
  H302
  H373 ** H318
  H317
  H410 | | | |
| 603-216-00-9 | cis-1-amino-2,3-dihydro-1H-inden-2-ol | 422-660-2 | 7480-35-5 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 603-217-00-4 | 2,4,6-tri-tert-butylphenyl-2-butyl-2-ethyl-1,3-propandiolphosphit | 423-560-1 | 161717-32-4 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 603-220-00-0 | 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol | 432-890-5 | 72955-94-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-221-00-6 | 1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid; [indeholdende < 0,1 % 4-chloranilin (EF-nr. 203-401-0)] | 433-580-2 | 214353-17-0 | Acute Tox. 4 *
  Skin Corr. 1B Aquatic Chronic 2 | H302
  H314
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H411 | | | |
| 603-221-01-3 | 1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid; [indeholdende ≥ 0,1 % 4-chloranilin (EF-nr. 203-401-0)] | 433-580-2 | 214353-17-0 | Carc. 1B
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H350
  H302
  H314
  H411 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H314
  H411 | | | |
| 603-222-00-1 | (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-oxo-1-oxacyclotetradecan | 433-820-6 | 118058-74-5 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 603-223-00-7 | 2-cyclopentylidencyclopentanol; 1,1'-bi(cyclopentyliden)-2-ol | 434-270-1 | 6261-30-9 | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H315
  H318
  H412 | GHS05
  Dgr | H315
  H318
  H412 | | | |
| 603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)-hexan | 435-790-1 | 297730-93-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-225-00-8 | erythromycin A9-oxim (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6,-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-dimethylamino-β-D-xylohexapyranosyl)oxy)oxacyclotetradecan-2-on-10-oxim (E) | 437-070-0 | 13127-18-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 603-226-00-3 | 4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzen-1,3-diol | 444-500-0 | 1440-00-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)]ether med 2,2-bis(hydroxymethyl)-1,3-propandiol (4:1); reaktionsprodukt af α-hydro-ω-((chlorcarbonyl)oxy)-poly(oxy(methyl-1,2-ethandiyl))ether med 2,2-bis(hydroxymethyl)-1,3-propandiol og kalium-1,1-dimethylethylperoxalat | 445-060-2 | 203574-04-3 | ****
  Aquatic Acute 1
  Aquatic Chronic 1 | **** H400
  H410 | **** GHS09
  Wng | **** H410 | | | |
| 603-228-00-4 | (+/-)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluor-2-(2-oxiranyl)chroman | 419-620-1 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 603-229-00-X | nnatrium-(Z)-3-chlor-3-(4-chlorphenyl)-1-hydroxy-2-propen-1-sulfonat | 420-800-7 | — | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | | |
| 603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan | 440-030-5 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 4 | H315
  H318
  H413 | GHS05
  Dgr | H315
  H318
  H413 | | | |
| 603-231-00-0 | (S)-1,1-diphenyl-1,2-propandiol | 443-220-6 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecan | 444-420-6 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 603-233-00-1 | en blanding af 4-(1,3A,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol og 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol og 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol og 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol og (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol og (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol | 444-430-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 603-234-00-7 | (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-en | 444-480-3 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 604-001-00-2 | phenol; carbolsyre; monohydroxybenzen; phenylalkohol | 203-632-7 | 108-95-2 | Muta. 2
  Acute Tox. 3 * Acute Tox. 3 *
  Acute Tox. 3 * STOT RE 2 *
  Skin Corr. 1B | H341
  H331
  H311
  H301
  H373 ** H314 | GHS06
  GHS08
  GHS05
  Dgr | H341
  H331
  H311
  H301
  H373 ** H314 | | *
  Skin Corr. 1B; H314: C ≥ 3 %
  Skin Irrit. 2; H315 1 % ≤ C < 3 %
  Eye Irrit. 2; H319 1 % ≤ C < 3 % | |
| 604-002-00-8 | pentachlorphenol | 201-778-6 | 87-86-5 | Carc. 2
  Acute Tox. 2 * Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H330
  H311
  H301
  H319
  H335
  H315
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H330
  H311
  H301
  H319
  H335
  H315
  H410 | | | |
| 604-003-00-3 | natriumpentachlorphenolat; [1] kaliumpentachlorphenolat [2] | 205-025-2 [1]
  231-911-3 [2] | 131-52-2 [1]
  7778-73-6 [2] | Carc. 2
  Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H330
  H311
  H301
  H319
  H335
  H315
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H330
  H311
  H301
  H319
  H335
  H315
  H410 | | | |
| 604-004-00-9 | m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] | 203-577-9 [1]
  202-423-8 [2]
  203-398-6 [3]
  215-293-2 [4] | 108-39-4 [1]
  95-48-7 [2]
  106-44-5 [3]
  1319-77-3 [4] | Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B | H311
  H301
  H314 | GHS06
  GHS05
  Dgr | H311
  H301
  H314 | | * | C |
| 604-005-00-4 | 1,4-dihydroxybenzen; hydroquinon; quinol | 204-617-8 | 123-31-9 | Carc. 2
  Muta. 2
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H351
  H341
  H302
  H318
  H317
  H400 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H351
  H341
  H302
  H318
  H317
  H400 | | M = 10 | |
| 604-006-00-X | 3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(og 2,5)-xylenol [7] | 202-439-5 [1]
  202-461-5 [2]
  203-321-6 [3]
  208-395-3 [4]
  209-400-1 [5]
  215-089-3 [6]
  276-245-4 [7] | 95-65-8 [1]
  95-87-4 [2]
  105-67-9 [3]
  526-75-0 [4]
  576-26-1 [5]
  1300-71-6 [6]
  71975-58-1 [7] | Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H311
  H301
  H314
  H411 | GHS06
  GHS05
  GHS09
  Dgr | H311
  H301
  H314
  H411 | | | C |
| 604-007-00-5 | 2-naphthol | 205-182-7 | 135-19-3 | Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1 | H332
  H302
  H400 | GHS07
  GHS09
  Wng | H332
  H302
  H400 | | | |
| 604-008-00-0 | 2-chlorphenol; [1] 4-chlorphenol; [2] 3-chlorphenol; [3] chlorphenol [4] | 202-433-2 [1]
  203-402-6 [2]
  203-582-6 [3]
  246-691-4 [4] | 95-57-8 [1]
  106-48-9 [2]
  108-43-0 [3]
  25167-80-0 [4] | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H312
  H302
  H411 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H411 | | | C |
| 604-009-00-6 | pyrogallol; 1,2,3-trihydroxybenzen | 201-762-9 | 87-66-1 | Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H341
  H332
  H312
  H302
  H412 | GHS08
  GHS07
  Wng | H341
  H332
  H312
  H302
  H412 | | * | |
| 604-010-00-1 | resorcinol; 1,3-benzendiol | 203-585-2 | 108-46-3 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1 | H302
  H319
  H315
  H400 | GHS07
  GHS09
  Wng | H302
  H319
  H315
  H400 | | * | |
| 604-011-00-7 | 2,4-dichlorphenol | 204-429-6 | 120-83-2 | Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H311
  H302
  H314
  H411 | GHS06
  GHS05
  GHS09
  Dgr | H311
  H302
  H314
  H411 | | | |
| 604-012-00-2 | 4-chlor-o-cresol; 4-chlor-2-methylphenol | 216-381-3 | 1570-64-5 | Acute Tox. 3 *
  Skin Corr. 1A Aquatic Acute 1 | H331
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H314
  H400 | | STOT SE 3; H335: C ≥ 1 % | |
| 604-013-00-8 | 2,3,4,6-tetrachlorphenol | 200-402-8 | 58-90-2 | Acute Tox. 3 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H319
  H315
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H319
  H315
  H410 | | *
  Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2;
  H315: C ≥ 5 % | |
| 604-014-00-3 | chlorocresol; 4-chlor-m-cresol; 4-chlor-3-methylphenol | 200-431-6 | 59-50-7 | Acute Tox. 4 * Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H312
  H302
  H318
  H317
  H400 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H318
  H317
  H400 | | * | |
| 604-015-00-9 | 2,2'-methylen-bis-(3,4,6-trichlorphenol); hexachlorophen | 200-733-8 | 70-30-4 | Acute Tox. 3 *
  Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H301
  H410 | | * | |
| 604-016-00-4 | dihydroxybenzen; pyrocatechol | 204-427-5 | 120-80-9 | Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H312
  H302
  H319
  H315 | GHS07
  Wng | H312
  H302
  H319
  H315 | | | |
| 604-017-00-X | 2,4,5-trichlorphenol | 202-467-8 | 95-95-4 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H315
  H410 | | *
  Eye Irrit. 2; H319: C ≥ 5 %
  Skin Irrit.2; H315: C ≥ 5 % | |
| 604-018-00-5 | 2,4,6-trichlorphenol | 201-795-9 | 88-06-2 | Carc. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H319
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H319
  H315
  H410 | | | |
| 604-019-00-0 | dichlorophen (ISO) | 202-567-1 | 97-23-4 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H410 | | | |
| 604-020-00-6 | 2-phenylphenol (ISO); biphenyl-2-ol; 2-hydroxybiphenyl | 201-993-5 | 90-43-7 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H319
  H335
  H315
  H400 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H400 | | | |
| 604-021-00-1 | natrium-2-biphenylat; natriumbiphenyl-2-yloxid | 205-055-6 | 132-27-4 | Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1 | H302
  H335
  H315
  H318
  H400 | GHS05
  GHS07
  GHS09
  Wng | H302
  H335
  H315
  H318
  H400 | | | |
| 604-022-00-7 | 2,2-dimethyl-1,3-benzodioxol-4-ol | 400-900-7 | 22961-82-6 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 604-023-00-2 | 2,4-dichlor-3-ethylphenol | 401-060-4 | — | Skin Corr. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | | |
| 604-024-00-8 | 4,4-isobutylethylidendiphenol | 401-720-1 | 6807-17-6 | Repr. 1B
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H360f *** H319
  H400
  H410 | GHS08
  GHS09
  Dgr | H360f *** H319
  H410 | | | |
| 604-025-00-3 | 2,5-bis(1,1-dimethylbutyl)hydroquinon | 400-220-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 604-026-00-9 | 2,2-spirobi(6-hydroxy-4,4,7-trimethylchroman) | 400-270-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 604-027-00-4 | 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinon | 400-530-6 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 604-028-00-X | 4-amino-3-fluorphenol | 402-230-0 | 399-95-1 | Carc. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H350
  H302
  H317
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H317
  H411 | | | |
| 604-029-00-5 | 1-naphtol | 201-969-4 | 90-15-3 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H312
  H302
  H335
  H315
  H318 | GHS05
  GHS07
  Dgr | H312
  H302
  H335
  H315
  H318 | | | |
| 604-031-00-6 | guaiacol | 201-964-7 | 90-05-1 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H302
  H319
  H315 | GHS07
  Wng | H302
  H319
  H315 | | | |
| 604-032-00-1 | thymol | 201-944-8 | 89-83-8 | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H302
  H314
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H411 | | | |
| 604-033-00-7 | isobutylbut-3-enoat | 401-170-2 | 24342-03-8 | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | |
| 604-034-00-2 | 4,4'-thiodi-o-cresol | 403-330-7 | 24197-34-0 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 604-035-00-8 | 4-nonylphenol, reaktionsprodukter med formaldehyd og dodecan-1-thiol | 404-160-6 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 604-036-00-3 | 4,4'-oxybis(ethylenthio)diphenol | 404-590-4 | 90884-29-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 604-037-00-9 | 3,5-xylenol, 3,5-dimethylphenol | 203-606-5 | 108-68-9 | Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B | H311
  H301
  H314 | GHS06
  GHS05
  Dgr | H311
  H301
  H314 | | | |
| 604-038-00-4 | 4-chlor-3,5-dimethylphenol; [1] chlorxylenol [2] | 201-793-8 [1]
  215-316-6 [2] | 88-04-0 [1]
  1321-23-9 [2] | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H302
  H319
  H315
  H317 | GHS07
  Wng | H302
  H319
  H315
  H317 | | | |
| 604-039-00-X | ethyl-2-[4-[(6-chlorbenzoxazol-2-yl)oxy]phenoxy]propionat; fenoxaprop-ethyl | 266-362-9 | 66441-23-4 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 604-040-00-5 | fomesafen (ISO); 5-[2-chlor-4-(trifluormethyl)phenoxy]-N-(methylsulfonyl)-2-nitrobenzamid | 276-439-9 | 72178-02-0 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 604-041-00-0 | acifluorfen (ISO); 5-[2-chlor-4-(trifluormethyl)phenoxy]-2-nitrobenzoesyre [1] natrium-5-[2-chlor-4-(trifluormethyl)phenoxy]-2- nitrobenzoat; acifluorfen-natrium [2] | 256-634-5 [1]
  263-560-7 [2] | 50594-66-6 [1]
  62476-59-9 [2] | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H315
  H318
  H410 | | | |
| 604-042-00-6 | 4-nitrosophenol | 203-251-6 | 104-91-6 | Muta. 2
  Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H341
  H302
  H318
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H341
  H302
  H318
  H411 | | | |
| 604-043-00-1 | monobenzon; 4-hydroxyphenyl benzylether; hydroquinon monobenzylether | 203-083-3 | 103-16-2 | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 604-044-00-7 | mequinol; 4-methoxyphenol; hydroquinon monomethylether | 205-769-8 | 150-76-5 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1 | H302
  H319
  H317 | GHS07
  Wng | H302
  H319
  H317 | | | |
| 604-045-00-2 | 2,3,5-trimethylhydroquinon | 211-838-3 | 700-13-0 | Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H335
  H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H332
  H335
  H315
  H318
  H317
  H410 | | | |
| 604-046-00-8 | 4-(4-isopropoxyphenylsulfonyl)phenol | 405-520-5 | 95235-30-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 604-047-00-3 | 4-(4-tolyloxy)biphenyl | 405-730-7 | 51601-57-1 | STOT RE 2 *
  Aquatic Chronic 4 | H373 ** H413 | GHS08
  Wng | H373 ** H413 | | | |
| 604-048-00-9 | 4,4',4''-(ethan-1,1,1-triyl)triphenol | 405-800-7 | 27955-94-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 604-049-00-4 | 4-4'-methylenbis(oxyethylenthio)diphenol | 407-480-4 | 93589-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 604-051-00-5 | 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol | 401-110-5 | 87113-78-8 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 604-052-00-0 | 2,2'-methylenbis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) | 403-800-1 | 103597-45-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 604-053-00-6 | 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol | 410-760-9 | 157661-93-3 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 604-054-00-1 | en blanding af 2-methoxy-4-(tetrahydro-4-methylen-2H-pyran-2-yl)phenol og 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol | 412-020-0 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 604-055-00-7 | 2,2'-((3,3',5,5'-tetramethyl(1,1'-biphenyl)-4,4'-diyl)bis(oxymethylen))bisoxiran | 413-900-7 | 85954-11-6 | Carc. 2
  Skin Sens. 1 | H351
  H317 | GHS08
  GHS07
  Wng | H351
  H317 | | | |
| 604-056-00-2 | 2-(2-hydroxy-3,5-dinitroanilin)ethanol | 412-520-9 | 99610-72-7 | Flam. Sol. 2
  Repr. 2
  Acute Tox. 4 * | H228
  H361f *** H302 | GHS02
  GHS07
  GHS08
  Dgr | H228
  H361f *** H302 | | | |
| 604-058-00-3 | 1,2-bis(3-methylphenoxy)ethan | 402-730-9 | 54914-85-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 604-059-00-9 | 2-n-hexadecylhydroquinon | 406-400-5 | — | STOT RE 2 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H373 ** H315
  H317
  H413 | GHS08
  GHS07
  Wng | H373 ** H315
  H317
  H413 | | | |
| 604-060-00-4 | 9,9-bis(4-hydroxyphenyl)fluoren | 406-950-6 | 3236-71-3 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H410 | | | |
| 604-061-00-X | en blanding af 2-chlor-5-sec-tetradecylhydroquinoner hvor sec-tetradecyl= 1-methyltridecyl; 1-ethyldodecyl;
  1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl | 407-740-7 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H315
  H317
  H412 | GHS07
  Wng | H315
  H317
  H412 | | | |
| 604-062-00-5 | 2,4-dimethyl-6-(1-methyl-pentadecyl)-phenol | 411-220-5 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 604-063-00-0 | 5,6-dihydroxy-indol | 412-130-9 | 3131-52-0 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 604-064-00-6 | 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol | 411-380-6 | 147315-50-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 604-065-00-1 | 4,4',4''-(1-methylpropan-1-yl-3-yliden)tris(2-cyclohexyl-5-methylphenol) | 407-460-5 | 111850-25-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 604-066-00-7 | blanding af phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-forbindelse) og methan, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-forbindelse); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol og 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol og 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol | 414-550-8 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 604-067-00-2 | en blanding af 2,2'-[[(2-hydroxyethyl)imino]bis(methylen)bis[4-dodecylphenol]; formaldehyd, oligomer med 4-dodecylphenol og 2-aminoethanol(n = 2); formaldehyd, oligomer med 4-dodecylphenol og 2-aminoethanol(n = 3, 4 og derover) | 414-520-4 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | | |
| 604-068-00-8 | (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenolhydrochlorid | 415-170-5 | 90274-24-1 | Acute Tox. 4 * Acute Tox. 4 *
  Skin Sens. 1 | H332
  H302
  H317 | GHS07
  Wng | H332
  H302
  H317 | | | |
| 604-069-00-3 | 2-(1-methylpropyl)-4-tert-butylphenol | 421-740-4 | 51390-14-8 | Skin Corr. 1B
  Aquatic Chronic 2 | H314
  H411 | GHS05
  GHS09
  Dgr | H314
  H411 | | | |
| 604-070-00-9 | triclosan; 2,4,4'-trichlor-2'-hydroxydiphenylether; 5-chlor-2-(2,4-dichlorphenoxy)phenol | 222-182-2 | 3380-34-5 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H410 | | M = 100 | |
| 604-071-00-4 | 4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethyliden)diphenol | 425-600-3 | 110726-28-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 604-072-00-X | 1,2-bis(phenoxymethyl)benzen | 428-620-0 | 10403-74-4 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 604-073-00-5 | (E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | 428-010-4 | 82413-20-5 | Carc. 2
  Repr. 1B Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H360f *** H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H351
  H360f *** H317
  H410 | | | |
| 604-074-00-0 | tetrabrombisphenol-A; 2,2',6,6'-tetrabrom-4,4'-isopropylidendiphenol | 201-236-9 | 79-94-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol | 205-426-2 | 140-66-9 | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | M = 10 | |
| 604-076-00-1 | phenolphthalein | 201-004-7 | 77-09-8 | Carc. 1B Muta. 2
  Repr. 2 | H350
  H341
  H361f *** | GHS08
  Dgr | H350
  H341
  H361f *** | | Carc. 1B; H350: C ≥ 1 % | |
| 604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | 419-750-9 | 98809-58-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 604-079-00-8 | 4,4'-(1,3-phenylen-bis(1-methylethyliden))bis-phenol | 428-970-4 | 13595-25-0 | Repr. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H361f *** H317
  H411 | GHS08
  GHS07
  GHS09
  Wng | H361f *** H317
  H411 | | | |
| 604-080-00-3 | 4-fluor-3-trifluormethylphenol | 432-560-0 | 61721-07-1 | Acute Tox. 4 *
  Skin Corr. 1A
  Skin Sens. 1
  Aquatic Chronic 2 | H332
  H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H332
  H314
  H317
  H411 | | | |
| 604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethan | 433-130-5 | 1571-75-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 604-082-00-4 | 2-chlor-6-fluorphenol | 433-890-8 | 2040-90-6 | Muta. 1B Repr. 2
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H340
  H361f *** H302
  H314
  H317
  H411 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H340
  H361f *** H302
  H314
  H317
  H411 | | | |
| 604-083-00-X | 4,4'-sulfonylbisphenol, polymer med ammoniumchlorid (NH4Cl), pentachlorphosphoran og phenol | 439-270-3 | 260408-02-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 604-084-00-5 | 1-ethoxy-2,3-difluorbenzen | 441-000-4 | 121219-07-6 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 604-087-00-1 | en blanding af 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)monoester og 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol; 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)diester og 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol; ,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)triester og 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol | 433-640-8 | — | Pyr. Sol. 1
  Aquatic Chronic 4 | H250
  H413 | GHS02
  Dgr | H250
  H413 | EUH044 | | |
| 604-089-00-2 | 2-methyl-5-tert-butylthiophenol | 444-970-7 | — | Flam. Liq. 3
  Repr. 2
  STOT RE 2 *
  Asp. Tox. 1
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H361d *** H373 ** H304
  H319
  H315
  H317
  H336
  H400
  H410 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H226
  H361d *** H373 ** H304
  H319
  H315
  H317
  H336
  H410 | | | |
| 604-090-00-8 | 4-tert-butylphenol | 202-679-0 | 98-54-4 | Repr. 2
  Skin Irrit. 2
  Eye Dam. 1 | H361f
  H315
  H318 | GHS08
  GHS05
  Dgr | H361f
  H315
  H318 | | | |
| 604-091-00-3 | etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzylether | 407-980-2 | 80844-07-1 | Lact.
  Aquatic Acute 1
  Aquatic Chronic 1 | H362
  H400
  H410 | GHS09
  Wng | H362
  H410 | | M = 100
  M = 1 000 | |
| 605-001-00-5 | formaldehyd ...% | 200-001-8 | 50-00-0 | Carc. 1B Muta. 2
  Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1 | H350
  H341
  H301
  H311
  H331
  H314
  H317 | GHS08
  GHS06
  GHS05
  Dgr | H350
  H341
  H301
  H311
  H331
  H314
  H317 | | *
  Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C
  < 25 %
  Eye Irrit. 2; H319: 5 % ≤ C
  < 25 %
  STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2  % | B, D |
| 605-002-00-0 | 1,3,5-trioxan; trioxymethylen | 203-812-5 | 110-88-3 | Flam. Sol. 1
  Repr. 2
  STOT SE 3 | H228
  H361d *** H335 | GHS02
  GHS08
  GHS07
  Dgr | H228
  H361d *** H335 | | | T |
| 605-003-00-6 | acetaldehyd; ethanal | 200-836-8 | 75-07-0 | Flam. Liq. 1
  Carc. 2
  Eye Irrit. 2
  STOT SE 3 | H224
  H351
  H319
  H335 | GHS02
  GHS08
  GHS07
  Dgr | H224
  H351
  H319
  H335 | | | |
| 605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxan; paraldehyd | 204-639-8 | 123-63-7 | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | |
| 605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctan; metaldehyd | 203-600-2 | 108-62-3 | Flam. Sol. 2
  Acute Tox. 4 * | H228
  H302 | GHS02
  GHS07
  Wng | H228
  H302 | | | |
| 605-006-00-2 | butyraldehyd | 204-646-6 | 123-72-8 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 605-007-00-8 | 1,1-dimethoxyethan; dimethylacetal | 208-589-8 | 534-15-6 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 605-008-00-3 | acrolein; prop-2-enal; acrylaldehyd | 203-453-4 | 107-02-8 | Flam. Liq. 2
  Acute Tox. 1
  Acute Tox. 2
  Acute Tox. 3
  Skin Corr. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H330
  H300
  H311
  H314
  H400
  H410 | GHS02
  GHS06
  GHS05
  GHS09
  Dgr | H225
  H330
  H300
  H311
  H314
  H410 | EUH071 | Skin Corr. 1B; H314:C ≥ 0,1  %
  M = 100
  M = 1 | D |
| 605-009-00-9 | crotonaldehyd; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyd [2] | 224-030-0 [1]
  204-647-1 [2] | 4170-30-3 [1]
  123-73-9 [2] | Flam. Liq. 2
  Muta. 2
  Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1 | H225
  H341
  H330
  H311
  H301
  H373 ** H335
  H315
  H318
  H400 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H225
  H341
  H330
  H311
  H301
  H373 ** H335
  H315
  H318
  H400 | | | |
| 605-010-00-4 | 2-furaldehyd | 202-627-7 | 98-01-1 | Carc. 2
  Acute Tox. 3 * Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H351
  H331
  H301
  H312
  H319
  H335
  H315 | GHS06
  GHS08
  Dgr | H351
  H331
  H301
  H312
  H319
  H335
  H315 | | | |
| 605-011-00-X | 2-chlorbenzaldehyd; o-chlorbenzaldehyd | 201-956-3 | 89-98-5 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 605-012-00-5 | benzaldehyd | 202-860-4 | 100-52-7 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 605-014-00-6 | chloralhydrat: 2,2,2-trichlorethan-1,1-diol | 206-117-5 | 302-17-0 | Acute Tox. Eye Irrit. 2
  Skin Irrit. 2 | H301
  H319
  H315 | GHS06
  Dgr | H301
  H319
  H315 | | | |
| 605-015-00-1 | 1,1-diethoxyethan; acetal | 203-310-6 | 105-57-7 | Flam. Liq. 2
  Eye Irrit. 2
  Skin Irrit. 2 | H225
  H319
  H315 | GHS02
  GHS07
  Dgr | H225
  H319
  H315 | | | |
| 605-016-00-7 | glyoxal ... %; ethandial ... % | 203-474-9 | 107-22-2 | Muta. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H341
  H332
  H319
  H315
  H317 | GHS07
  GHS08
  Wng | H341
  H332
  H319
  H315
  H317 | | * | B |
| 605-017-00-2 | 1,3-dioxolan | 211-463-5 | 646-06-0 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 605-018-00-8 | propanal; propionaldehyd | 204-623-0 | 123-38-6 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H225
  H319
  H335
  H315 | GHS02
  GHS07
  Dgr | H225
  H319
  H335
  H315 | | | |
| 605-019-00-3 | citral | 226-394-6 | 5392-40-5 | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 605-020-00-9 | safrole; 5-allyl-1,3-benzodioxol | 202-345-4 | 94-59-7 | Carc. 1B Muta. 2
  Acute Tox. 4 * | H350
  H341
  H302 | GHS08
  GHS07
  Dgr | H350
  H341
  H302 | | | |
| 605-021-00-4 | formaldehyd, reaktionsprodukter med butylphenol | 294-145-9 | 91673-30-2 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 605-024-00-0 | 2-brom-5-hydroxy-4-methoxybenzaldehyd | 426-540-0 | 2973-59-3 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 605-025-00-6 | chloracetaldehyd | 203-472-8 | 107-20-0 | Carc. 2
  Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B
  Aquatic Acute 1 | H351
  H330
  H311
  H301
  H314
  H400 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H351
  H330
  H311
  H301
  H314
  H400 | | STOT SE 3; H335: C ≥ 5 % | |
| 605-026-00-1 | 2,5,7,7-tetramethyloctanal | 405-690-0 | 114119-97-0 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H317
  H411 | GHS07
  GHS09
  Wng | H315
  H317
  H411 | | | |
| 605-027-00-7 | en blanding af 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-carboxaldehyd; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-carboxaldehyd | 410-480-7 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 605-028-00-2 | β-methyl-3-(1-methylethyl)-benzenpropanal | 412-050-4 | 125109-85-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 605-029-00-8 | 2-cyclohexyl propanal | 412-270-0 | 2109-22-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 605-030-00-3 | 1-(p-methoxyphenyl)-acetaldehydoxim | 411-510-1 | 3353-51-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 605-031-00-9 | en blanding af 2,2-dimethoxyethanal (denne komponent anses for at være anhydrid, hvad angår identitet, struktur og sammensætning. 2,2-dimethoxyethanal eksisterer dog i hydratform. 60 % anhydrid svarer til 70,4 % hydrat); vand (herunder frit vand og vand i 2,2-dimethoxyethanal-hydrat) | 421-890-0 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 605-032-00-4 | 3-[3-(4-fluorphenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal | 425-370-4 | 93957-50-7 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 605-033-00-X | en blanding af 3,7,11-trimethyl-cis-6,10-dodecadienal og 3,7,11-trimethyl-trans-6,10-dodecadienal | 425-910-9 | 32480-08-3 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 605-034-00-5 | en blanding af (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.02,6]decan-3-carbaldehyd; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decan-3-carbaldehyd og
  (1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decan-4-carbaldehyd | 429-860-9 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 605-035-00-0 | (E)-3-(4-(4-fluorphenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal | 426-330-9 | 177964-68-0 | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H319
  H317
  H413 | GHS07
  Wng | H319
  H317
  H413 | | | |
| 605-036-00-6 | 2-brommalonaldehyd | 430-470-6 | 2065-75-0 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 605-037-00-1 | trans-3-[2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd; 3-[(E)-2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd | 421-800-1 | 120578-03-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 605-038-00-7 | 3-methyl-5-phenylpentan-1-al | 433-900-0 | 55066-49-4 | Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H315
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H315
  H317
  H411 | | | |
| 605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyd | 441-810-8 | 116313-85-0 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H318
  H317 | | | |
| 606-001-00-8 | acetone; propan-2-on; propanon | 200-662-2 | 67-64-1 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H336 | EUH066 | | |
| 606-002-00-3 | butanon; ethylmethylketon | 201-159-0 | 78-93-3 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H336 | EUH066 | | |
| 606-003-00-9 | 3-heptanon; ethylbutylketon | 203-388-1 | 106-35-4 | Flam. Liq. 3
  Acute Tox. 4 *
  Eye Irrit. 2 | H226
  H332
  H319 | GHS02
  GHS07
  Wng | H226
  H332
  H319 | | | |
| 606-004-00-4 | 4-methylpentan-2-on; methylisobutylketon | 203-550-1 | 108-10-1 | Flam. Liq. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H225
  H332
  H319
  H335 | GHS02
  GHS07
  Dgr | H225
  H332
  H319
  H335 | EUH066 | | |
| 606-005-00-X | 2,6-dimethyl-4-heptanon; diisobutylketon | 203-620-1 | 108-83-8 | Flam. Liq. 3
  STOT SE 3 | H226
  H335 | GHS02
  GHS07
  Wng | H226
  H335 | | STOT SE 3; H335: C ≥ 10 % | |
| 606-006-00-5 | pentan-3-on; diethylketon | 202-490-3 | 96-22-0 | Flam. Liq. 2
  STOT SE 3
  STOT SE 3 | H225
  H335
  H336 | GHS02
  GHS07
  Dgr | H225
  H335
  H336 | EUH066 | | |
| 606-007-00-0 | 3-methyl-2-butanon; ethylisopropylketon | 209-264-3 | 563-80-4 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 606-009-00-1 | 4-methyl-3-penten-2-on; mesityloxid | 205-502-5 | 141-79-7 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 *
  Acute Tox. 4 * | H226
  H332
  H312
  H302 | GHS02
  GHS07
  Wng | H226
  H332
  H312
  H302 | | * | |
| 606-010-00-7 | cyclohexanon | 203-631-1 | 108-94-1 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H332 | GHS02
  GHS07
  Wng | H226
  H332 | | | |
| 606-011-00-2 | 2-methylcyclohexanon | 209-513-6 | 583-60-8 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H332 | GHS02
  GHS07
  Wng | H226
  H332 | | | |
| 606-012-00-8 | 3,5,5-trimethylcyclohex-2-enon; isophoron | 201-126-0 | 78-59-1 | Carc. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H351
  H312
  H302
  H319
  H335 | GHS08
  GHS07
  Wng | H351
  H312
  H302
  H319
  H335 | | STOT SE 3; H335: C ≥ 10 % | |
| 606-013-00-3 | p-benzoquinon; quinon | 203-405-2 | 106-51-4 | Acute Tox. 3 * Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1 | H331
  H301
  H319
  H335
  H315
  H400 | GHS06
  GHS09
  Dgr | H331
  H301
  H319
  H335
  H315
  H400 | | M = 10 | |
| 606-016-00-X | pindon (ISO), 2-pivaloylindan-1,3-dion | 201-462-8 | 83-26-1 | Acute Tox. 3 * STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H372 ** H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H372 ** H410 | | | |
| 606-017-00-5 | acetylketen; diketen | 211-617-1 | 674-82-8 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H332 | GHS02
  GHS07
  Wng | H226
  H332 | | | D |
| 606-018-00-0 | dichlon (ISO); 2,3-dichlor-1,4-naphthoquinon | 204-210-5 | 117-80-6 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H315
  H410 | | | |
| 606-019-00-6 | chlordecon (ISO); perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one; decachlorpentacyclo[5,2,1,02,6,03,9,05,8]decan-4-on | 205-601-3 | 143-50-0 | Carc. 2
  Acute Tox. 3 * Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H311
  H301
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H311
  H301
  H410 | | | |
| 606-020-00-1 | 5-methyl-3-heptanon | 208-793-7 | 541-85-5 | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3 | H226
  H319
  H335 | GHS02
  GHS07
  Wng | H226
  H319
  H335 | | STOT SE 3; H335: C ≥ 10 % | |
| 606-022-00-2 | 1-phenyl-3-pyrazolidon | 202-155-1 | 92-43-3 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 606-023-00-8 | 4-methoxy-4-methylpentan-2-on | 203-512-4 | 107-70-0 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H332 | GHS02
  GHS07
  Wng | H226
  H332 | | | |
| 606-024-00-3 | heptan-2-on; methylpentylketon | 203-767-1 | 110-43-0 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 * | H226
  H332
  H302 | GHS02
  GHS07
  Wng | H226
  H332
  H302 | | | |
| 606-025-00-9 | cyclopentanon | 204-435-9 | 120-92-3 | Flam. Liq. 3
  Eye Irrit. 2
  Skin Irrit. 2 | H226
  H319
  H315 | GHS02
  GHS07
  Wng | H226
  H319
  H315 | | | |
| 606-026-00-4 | 5-methylhexan-2-on; isoamylmethylketon | 203-737-8 | 110-12-3 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H332 | GHS02
  GHS07
  Wng | H226
  H332 | | | |
| 606-027-00-X | heptan-4-on; dipropylketon | 204-608-9 | 123-19-3 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H332 | GHS02
  GHS07
  Wng | H226
  H332 | | | |
| 606-028-00-5 | 2,4-dimethylpentan-3-on; diisopropylketon | 209-294-7 | 565-80-0 | Flam. Liq. 2
  Acute Tox. 4 * | H225
  H332 | GHS02
  GHS07
  Dgr | H225
  H332 | | | |
| 606-029-00-0 | 2,4-pentandion; acetylacetone | 204-634-0 | 123-54-6 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H302 | GHS02
  GHS07
  Wng | H226
  H302 | | | |
| 606-030-00-6 | hexan-2-on; methylbutylketon; butylmethylketon; methyl-n-butylketon | 209-731-1 | 591-78-6 | Flam. Liq. 3
  Repr. 2
  STOT RE 1
  STOT SE 3 | H226
  H361f *** H372 ** H336 | GHS02
  GHS08
  GHS07
  Dgr | H226
  H361f *** H372 ** H336 | | | |
| 606-031-00-1 | 3-propanolid; 1,3-propiolacton | 200-340-1 | 57-57-8 | Carc. 1B
  Acute Tox. 2 *
  Eye Irrit. 2
  Skin Irrit. 2 | H350
  H330
  H319
  H315 | GHS06
  GHS08
  Dgr | H350
  H330
  H319
  H315 | | | |
| 606-032-00-7 | hexachloracetone | 204-129-5 | 116-16-5 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 606-033-00-2 | 2-(3,4-dichlorphenyl)-4-methyl-1,2,4-oxadiazolidindion; methazol | 243-761-6 | 20354-26-1 | Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H312
  H302
  H319
  H315
  H411 | GHS07
  GHS09
  Wng | H312
  H302
  H319
  H315
  H411 | | | |
| 606-034-00-8 | metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5-(4H)-on; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-on | 244-209-7 | 21087-64-9 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 10 | |
| 606-035-00-3 | cloridazon (ISO); 5-amino-4-chlor-2-phenylpyridazin-3-on; pyrazon | 216-920-2 | 1698-60-8 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 606-036-00-9 | quinomethionat; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-on | 219-455-3 | 2439-01-2 | Repr. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Acute Tox. 4 * STOT RE 2 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f *** H332
  H312
  H302
  H373 ** H319
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361f *** H332
  H312
  H302
  H373 ** H319
  H317
  H410 | | | |
| 606-037-00-4 | triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanon | 256-103-8 | 43121-43-3 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 606-038-00-X | diphacinon (ISO); 2-diphenylacetylindan-1,3-dion | 201-434-5 | 82-66-6 | Acute Tox. 2 * STOT RE 1 | H300
  H372 ** | GHS06
  GHS08
  Dgr | H300
  H372 ** | | | |
| 606-039-00-5 | 5(eller 6)-tert-butyl-2'-chlor-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthen)-3-on | 400-680-2 | — | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H410 | | | |
| 606-040-00-0 | (N-benzyl-N-ethyl)amino-3-hydroxyacetophenonhydrochlorid | 401-840-4 | 55845-90-4 | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 606-042-00-1 | acetophenon | 202-708-7 | 98-86-2 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 606-043-00-7 | 2,4-di-tert-butylcyclohexanon | 405-340-7 | 13019-04-0 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 606-044-00-2 | 2,4,6-trimethylbenzophenon | 403-150-9 | 954-16-5 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H410 | | | |
| 606-045-00-8 | oxadiazon (ISO); 3-[2,4-dichlor-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxdiazol-2(3H)-on | 243-215-7 | 19666-30-9 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-046-00-3 | blanding af cis- og trans-cyclohexadec-8-en-1-on | 401-700-2 | 3100-36-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-047-00-9 | 2-benzyl-2-dimethylamino-4-morpholinobutyrophenon | 404-360-3 | 119313-12-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-048-00-4 | 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-on | 406-480-1 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-049-00-X | 4-(trans-4-propylcyclohexyl)acetophenon | 406-700-6 | 78531-61-0 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 606-050-00-5 | 6-anilin-1-benzoyl-4-(4-tert-pentylphenoxy)naphtho[1,2,3-de]chinolin-2,7-(3H)-dion | 412-480-2 | 72453-58-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-051-00-0 | 4-pentylcyclohexanon | 406-670-4 | 61203-83-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-052-00-6 | 4-(N, N-dibutylamino)-2-hydroxy-2'-carboxy-2-(4-dibutylamino-2-hydroxybenzoyl)benzoesyre | 410-410-5 | 54574-82-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 606-053-00-1 | flurtamon (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-on | — | 96525-23-4 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-055-00-2 | 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)-ethanon | 411-180-9 | 92836-10-7 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 2 | H302
  H373 ** H411 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H411 | | | |
| 606-056-00-8 | 4-chlor-3',4'-dimethoxybenzophenon | 404-610-1 | 116412-83-0 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-057-00-3 | 4-propylcyclohexanon | 406-810-4 | 40649-36-3 | Skin Irrit. 2
  Aquatic Chronic 3 | H315
  H412 | GHS07
  Wng | H315
  H412 | | | |
| 606-058-00-9 | 4'-fluor-2,2-dimethoxyacetophenon | 407-500-1 | 21983-80-2 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 606-059-00-4 | 2,4-difluor-α-(1H-1,2,4-triazol-1-yl)acetophenonhydrochlorid | 412-390-3 | 86386-75-6 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H318
  H317 | | | |
| 606-060-00-X | en blanding af trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalen-2-yl)-1,3-dioxolan; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalen-2-yl)-1,3-dioxolan | 412-950-7 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-061-00-5 | (3-chlorphenyl)-(4-methoxy-3-nitrophenyl)methanon | 423-290-4 | 66938-41-8 | Muta. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H400
  H410 | GHS08
  GHS09
  Wng | H341
  H410 | | | |
| 606-062-00-0 | tetrahydrothiopyran-3-carboxaldehyd | 407-330-8 | 61571-06-0 | Repr. 1B
  Eye Dam. 1
  Aquatic Chronic 3 | H360D *** H318
  H412 | GHS08
  GHS05
  Dgr | H360D *** H318
  H412 | | | |
| 606-063-00-6 | (E)-3-(2-chlorphenyl)-2-(4-fluorphenyl)propenal | 410-980-5 | 112704-51-5 | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 606-064-00-1 | pregn-5-en-3,20-dionbis(ethylenketal) | 407-450-0 | 7093-55-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-065-00-7 | 1-(4-morpholinphenyl)butan-1-on | 413-790-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-066-00-2 | (E)-5[(4-chlorphenyl)methylen]-2,2-dimethylcyclopentanon | 410-440-9 | 164058-20-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-067-00-8 | en blanding af 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanon; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanon | 414-870-8 | 96792-67-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-068-00-3 | 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al | 415-770-7 | 07-05-1638 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 3 | H373 ** H317
  H412 | GHS08
  GHS07
  Wng | H373 ** H317
  H412 | | | |
| 606-069-00-9 | spiro[1,3-dioxolan-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methannaphthalen)] | 415-460-1 | 154171-76-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-070-00-4 | butrozydim (ISO);5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-on | 414-790-3 | 138164-12-2 | Repr. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H361fd
  H302
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361fd
  H302
  H315
  H410 | | | |
| 606-071-00-X | 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-dien-3-on | 421-050-3 | 13258-43-0 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-072-00-5 | 3-acetyl-1-phenyl-pyrrolidin-2,4-dion | 421-600-2 | 719-86-8 | STOT RE 2 *
  Aquatic Chronic 2 | H373 ** H411 | GHS08
  GHS09
  Wng | H373 ** H411 | | | |
| 606-073-00-0 | 4,4'-bis(dimethylamino)benzophenon; Michlers keton | 202-027-5 | 90-94-8 | Carc. 1B Muta. 2
  Eye Dam. 1 | H350
  H341
  H318 | GHS08
  GHS05
  Dgr | H350
  H341
  H318 | | | |
| 606-074-00-6 | en blanding af (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalen og (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalen | 425-570-1 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-075-00-1 | 1-benzyl-5-ethoxyimidazolidin-2,4-dion | 417-340-4 | 65855-02-9 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 606-076-00-7 | 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidindion | 418-630-3 | 136465-99-1 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 606-077-00-2 | (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanon | 418-650-2 | 104872-06-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-078-00-8 | 1-octylazepin-2-on | 420-040-6 | 59227-88-2 | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H411 | | | |
| 606-079-00-3 | 2-n-butyl-benzo[d]isothiazol-3-on | 420-590-7 | 4299-07-4 | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H410 | | | |
| 606-081-00-4 | (3β, 5α, 6β)-3-(acetyloxy)-5-brom-6-hydroxy-androstan-17-on | 419-790-7 | 4229-69-0 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 606-082-00-X | blanding af butan-2-on-oxim; syn-O, O'-di(butan-2-on-oxim)diethoxysilan | 406-930-7 | | STOT RE 1
  Skin Sens. 1
  Aquatic Chronic 3 | H372 ** H317
  H412 | GHS08
  GHS07
  Dgr | H372 ** H317
  H412 | | | |
| 606-083-00-5 | 2-chlor-5-sec-hexadexylhydroquinon | 407-750-1 | 137193-60-3 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H319
  H315
  H317
  H412 | GHS07
  Wng | H319
  H315
  H317
  H412 | | | |
| 606-084-00-0 | 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propandion | 414-540-3 | 484-33-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-085-00-6 | (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-on | 418-530-1 | 79200-56-9 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H318
  H317 | | | |
| 606-086-00-1 | 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one | 422-330-8 | 56973-87-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-087-00-7 | 6-ethyl-5-fluor-4(3H)-pyrimidon | 422-460-5 | 137234-87-8 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 606-088-00-2 | 2,4,4,7-tetramethyl-6-octen-3-on | 422-520-0 | 74338-72-0 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 606-089-00-8 | en blanding af 1,4-diamino-2-chlor-3-phenoxyanthraquinon; 1,4-diamino-2,3-bis-phenoxyanthraquinon | 423-220-2 | 12223-77-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-090-00-3 | 1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanon | 430-920-1 | 73096-98-7 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 606-091-00-9 | 6-chlor-5-(2-chlorethyl)-1,3-dihydroindol-2-on | 421-320-0 | 118289-55-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-092-00-4 | en blanding af (E)-oxacyclohexadec-12-en-2-on; (E)-oxacyclohexadec-13-en-2-on; a) (Z)-oxacyclohexadec-(12)-en-2-on og b) (Z)-oxacyclohexadec-(13)-en-2-on | 422-320-3 | | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-093-00-X | 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-on | 414-470-3 | 95885-13-5 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 606-094-00-5 | N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazol-4(1H),1'(3'H)-isobenzofuran]-3'-on | 417-460-7 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-095-00-0 | (R,S)-2-azabicyclo[2.2.1]hept-5-en-3-on | 421-830-3 | 49805-30-3 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 606-096-00-6 | 3-(6-O-(6-deoxy-α-L-mannopyranosyl-O-(α-D-glucopyranosyl)-(β-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-on | 424-170-4 | 130603-71-3 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 606-097-00-1 | 2,2''-dihydroxy-4,4''-(2-hydroxy-propan-1,3-diyldioxy)dibenzophenon | 424-210-0 | 23911-85-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-098-00-7 | 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidindion | 431-220-9 | 158574-65-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-099-00-2 | 5-methoxy-4'-(trifluormethyl)valerophenon | 425-000-1 | 61718-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-100-00-6 | 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-on | 425-150-8 | 94723-86-1 | Repr. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H360f *** H302
  H317
  H412 | GHS08
  GHS07
  Dgr | H360f *** H302
  H317
  H412 | | | |
| 606-101-00-1 | en blanding af 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracendion; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracendion; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracendion; 1-[(2-ethylhexyl)amino]-5-[3-methoxypropyl)amino]-9,10-anthracendion: 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracendion og 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracendion | 426-050-7 | 165038-51-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 606-102-00-7 | 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenon | 431-490-8 | 79876-59-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-103-00-2 | 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanon | 426-460-6 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 606-104-00-8 | 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanon | 426-830-7 | 78531-59-6 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 606-105-00-3 | 3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dion | 431-500-0 | 226065-73-2 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 606-106-00-9 | 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanon | 427-320-7 | 83626-30-6 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 606-107-00-4 | 8-azaspiro[4.5]decan-7,9-dion | 427-770-4 | 1075-89-4 | Acute Tox. 3 *
  Aquatic Chronic 2 | H301
  H411 | GHS06
  GHS09
  Dgr | H301
  H411 | | | |
| 606-108-00-X | 1,1,1,2,2,4,5,5,5-nonafluor-4-(trifluormethyl)-3-pentanon | 436-710-6 | 756-13-8 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 606-109-00-5 | 2-(4-methyl-3-pentenyl)anthraquinon | 428-320-1 | 71308-16-2 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 4 | H302
  H317
  H413 | GHS07
  Wng | H302
  H317
  H413 | | | |
| 606-110-00-0 | 5-ethoxy-5H-furan-2-on | 428-330-4 | 2833-30-9 | Skin Corr. 1B
  Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
  Skin Sens. 1 | H314
  H312
  H302
  H373 ** H317 | GHS05
  GHS08
  GHS07
  Dgr | H314
  H312
  H302
  H373 ** H317 | | | |
| 606-111-00-6 | 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-on | 428-410-9 | 67014-36-2 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 606-112-00-1 | (4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-e, f][2]benzazepin-6-on | 428-690-2 | 1668-86-6 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 3 | H302
  H319
  H412 | GHS07
  Wng | H302
  H319
  H412 | | | |
| 606-113-00-7 | 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-on | 429-040-0 | 272460-97-6 | Eye Dam. 1
  Aquatic Chronic 4 | H318
  H413 | GHS05
  Dgr | H318
  H413 | | | |
| 606-114-00-2 | 4,4',5,5',6,6',7,7'-octachlor-(2,2')biisoindolyl-1,1',3,3'-tetraon | 429-150-9 | 67887-47-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-115-00-8 | profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorphenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-on | — | 139001-49-3 | Carc. 2
  Repr. 2
  Skin Sens. 1 | H351
  H361d
  H317 | GHS08
  GHS07
  Wng | H351
  H361d
  H317 | | | |
| 606-116-00-3 | tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chlorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-on | — | 149979-41-9 | Carc. 2
  Repr. 2 | H351
  H361fd | GHS08
  Wng | H351
  H361fd | | | |
| 606-117-00-9 | 2,6-bis(1,1-dimethylethyl)-4-(phenylenmethylen)cyclohexa-2,5-dien-1-on | 429-460-4 | 7078-98-0 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 606-118-00-4 | N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinondiimin | 429-640-2 | 52870-46-9 | Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H410 | | | |
| 606-119-00-X | (E)-3-methyl-5-cyclopentadecen-1-on | 429-900-5 | — | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 606-120-00-5 | 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-on | 430-170-5 | 114625-74-0 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 606-121-00-0 | (+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-spiro-1'-(cyclohex-2'-en-4'-on) | 430-460-1 | 133636-82-5 | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H410 | | | |
| 606-122-00-6 | 3-(2-brompropionoyl)-4,4-dimethyl-1,3-oxazolan-2-on | 430-820-8 | 114341-88-7 | Acute Tox. 4 * STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H315
  H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H302
  H373 ** H315
  H318
  H317
  H410 | | | |
| 606-123-00-1 | 4-hexadecyl-1-phenylpyrazolidin-3-on | 430-840-7 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluormethylphenyl)-1,3-propandion | 421-080-7 | 161462-35-7 | STOT RE 2 * Aquatic Acute 1
  Aquatic Chronic 1 | H373 ** H400
  H410 | GHS08
  GHS09
  Wng | H373 ** H410 | | | |
| 606-125-00-2 | 1-benzylimidazolidin-2,4-dion | 421-340-1 | 05-05-6777 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinon | 421-470-7 | 99788-75-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 606-128-00-9 | 2,2'-(1,3-phenylen)bis[5-chlor-1H-isoindol]-1,3(2H)-dion | 422-650-8 | 148935-94-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-129-00-4 | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-on; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-on | 423-090-7 | 156732-13-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanon | 423-860-2 | 56309-94-5 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 606-131-00-5 | cyclisk 3-(1,2-ethandiylacetal)-estra-5(10),9(11)-dien-3,17-dion | 427-230-8 | 5571-36-8 | Repr. 1B
  STOT RE 2 *
  Aquatic Chronic 2 | H360f *** H373 ** H411 | GHS08
  GHS09
  Dgr | H360f *** H373 ** H411 | | | |
| 606-132-00-0 | (6β)-6,19-epoxyandrost-4-en-3,17-dion | 433-490-3 | 6563-83-3 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 606-134-00-1 | androsta-1,4,9(11)-trien-3,17-dion | 433-560-3 | 15375-21-0 | Repr. 2 | H361f *** | GHS08
  Wng | H361f *** | | | |
| 606-135-00-7 | cyclohexadecanon | 438-930-8 | 2550-52-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-136-00-2 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosan-2,5,8,11,14,17,20,23-octaon | 444-350-6 | 133413-70-4 | Eye Irrit. 2
  Aquatic Chronic 4 | H319
  H413 | GHS07
  Wng | H319
  H413 | | | |
| 606-137-00-8 | trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinyliden]-3,3'-dion | 444-750-0 | 211387-26-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanon | 444-800-1 | 141645-23-0 | Flam. Liq. 3
  Acute Tox. 4 * STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H302
  H373 ** H315
  H318
  H317
  H400
  H410 | GHS02
  GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H226
  H302
  H373 ** H315
  H318
  H317
  H410 | | M = 10 | |
| 606-139-00-9 | (S)-4-(3,4-dichlorphenyl)-3,4-dihydro-2H-naphthalen-1-on | 444-830-5 | 124379-29-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-on | 444-860-9 | 474510-57-1 | STOT RE 2 * Aquatic Acute 1
  Aquatic Chronic 1 | H373 ** H400
  H410 | GHS08
  GHS09
  Wn | H373 ** H410 | | | |
| 606-141-00-X | natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolat | 418-410-7 | — | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 606-142-00-5 | en blanding af (1RS,2SR,7SR,8SR,E)-9- og 10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on; (1RS,2SR,7SR,8SR,Z)-10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on; (1RS,2SR,7SR,8SR,Z)-9-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on | 434-290-9 | — | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 606-143-00-0 | abamectin (kombination af avermectin B1a og avermectin B1b) (ISO); [1] avermectin B1a (renhed ≥ 80 %); [2] | _ [1]
  265-610-3 [2] | 71751-41-2 [1]
  65195-55-3 [2] | Repr. 2
  Acute Tox. 2
  Acute Tox. 1
  STOT RE 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d
  H300
  H330
  H372 (nervesystem) H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361d
  H300
  H330
  H372 (nervesystem) H410 | | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5  %
  ≤ C < 5 %
  M = 10 000 | |
| 606-144-00-6 | acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylacetat | — | 57960-19-7 | Skin Sens. 1
  STOT SE 1
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H370 (lunge) (inhalation) H373 (blodsystem)
  H400
  H410 | GHS07
  GHS08
  GHS09
  Dgr | H317
  H370 (lunge) (inhalation) H373 (blodsystem)
  H410 | | M = 1 000 | |
| 606-145-00-1 | sulcotrion (ISO); 2-[2-chlor-4-(methylsulfonyl)benzoyl]cyclohexan-1,3-dion | | 99105-77-8 | Repr. 2
  STOT RE 2
  Skin Sens. 1A Aquatic Acute 1
  Aquatic Chronic 1 | H373 (nyrer) H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361d H373 (nyrer) H317
  H410 | | M = 1
  M = 10 | |
| 606-146-00-7 | tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5- mesitylcyclohex-2-en-1-on | — | 87820-88-0 | Carc. 2
  Acute Tox. 4
  Aquatic Chronic 2 | H351
  H302
  H411 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H411 | | | |
| 606-147-00-2 | cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3- yl)cyclohex-2-en-1-on | 405-230-9 | 101205-02-1 | Repr. 2 | H361d | GHS08
  Wng | H361d | | | |
| 607-001-00-0 | myresyre ... % | 200-579-1 | 64-18-6 | Skin Corr. 1A | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 %
  Skin Irrit. 2; H315: 2 % ≤ C
  < 10 %
  Eye Irrit. 2; H319: 2 % ≤
  < 10 % | B |
| 607-002-00-6 | eddikesyre ... % | 200-580-7 | 64-19-7 | Flam. Liq. 3
  Skin Corr. 1A | H226
  H314 | GHS02
  GHS05
  Dgr | H226
  H314 | | Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 25 % ≤ C < 90 %
  Skin Irrit. 2; H315: 10 % ≤ C < 25 %
  Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B |
| 607-003-00-1 | chloreddikesyre | 201-178-4 | 79-11-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B Aquatic Acute 1 | H331
  H311
  H301
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H311
  H301
  H314
  H400 | | STOT SE 3; H335: C ≥ 5 % | |
| 607-004-00-7 | TCA (ISO); trichloreddikesyre | 200-927-2 | 76-03-9 | Skin Corr. 1A Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | STOT SE 3; H335: C ≥ 1 % | |
| 607-005-00-2 | TCA-Na (ISO); natriumtrichloracetat | 211-479-2 | 650-51-1 | STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H335
  H400
  H410 | GHS07
  GHS09
  Wng | H335
  H410 | | | |
| 607-006-00-8 | oxalsyre | 205-634-3 | 144-62-7 | Acute Tox. 4 * Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | * | |
| 607-007-00-3 | oxalsyrens salte undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 * Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | * | A |
| 607-008-00-9 | eddikesyreanhydrid | 203-564-8 | 108-24-7 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1B | H226
  H332
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H332
  H302
  H314 | | Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤ C
  < 25 %
  Eye Dam. 1; H318: 5 % ≤ C
  < 25 %
  Eye Irrit. 2; H319: 1 % ≤ C
  < 5 %
  STOT SE 3; H335: C ≥ 5 % | |
| 607-009-00-4 | phthalsyreanhydrid | 201-607-5 | 85-44-9 | Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H302
  H335
  H315
  H318
  H334
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H335
  H315
  H318
  H334
  H317 | | | |
| 607-010-00-X | propionsyreanhydrid | 204-638-2 | 123-62-6 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C <25 %
  Eye Irrit. 2; H319: 10 % ≤ C <25 % | |
| 607-011-00-5 | acetylchlorid | 200-865-6 | 75-36-5 | Flam. Liq. 2
  Skin Corr. 1B | H225
  H314 | GHS02
  GHS05
  Dgr | H225
  H314 | EUH014 | | |
| 607-012-00-0 | benzoylchlorid | 202-710-8 | 98-88-4 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H332
  H312
  H302
  H314
  H317 | GHS05
  GHS07
  Dgr | H332
  H312
  H302
  H314
  H317 | | | |
| 607-013-00-6 | dimethylcarbonat | 210-478-4 | 616-38-6 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 607-014-00-1 | methylformiat | 203-481-7 | 107-31-3 | Flam. Liq. 1
  Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H224
  H332
  H302
  H319
  H335 | GHS02
  GHS07
  Dgr | H224
  H332
  H302
  H319
  H335 | | | |
| 607-015-00-7 | ethylformiat | 203-721-0 | 109-94-4 | Flam. Liq. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H225
  H332
  H302
  H319
  H335 | GHS02
  GHS07
  Dgr | H225
  H332
  H302
  H319
  H335 | | | |
| 607-016-00-2 | propylformiat; [1] isopropylformiat [2] | 203-798-0 [1]
  210-901-2 [2] | 110-74-7 [1]
  625-55-8 [2] | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3
  STOT SE 3 | H225
  H319
  H335
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H335
  H336 | | | C |
| 607-017-00-8 | butylformiat; [1] tert-butylformiat; [2] isobutylformiat [3] | 209-772-5 [1]
  212-105-0 [2]
  208-818-1 [3] | 592-84-7 [1]
  762-75-4 [2]
  542-55-2 [3] | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H335 | GHS02
  GHS07
  Dgr | H225
  H319
  H335 | | | C |
| 607-018-00-3 | isopentylformiat; [1] 2-methylbutylformiat [2] | 203-769-2 [1]
  252-343-2 [2] | 110-45-2 [1]
  35073-27-9 [2] | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H335 | GHS02
  GHS07
  Dgr | H225
  H319
  H335 | | | C |
| 607-019-00-9 | methylchlorformiat | 201-187-3 | 79-22-1 | Flam. Liq. 2
  Acute Tox. 2 * Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H225
  H330
  H312
  H302
  H314 | GHS02
  GHS06
  GHS05
  Dgr | H225
  H330
  H312
  H302
  H314 | | | |
| 607-020-00-4 | ethylchlorformiat | 208-778-5 | 541-41-3 | Flam. Liq. 2
  Acute Tox. 2 * Acute Tox. 4 *
  Skin Corr. 1B | H225
  H330
  H302
  H314 | GHS02
  GHS06
  GHS05
  Dgr | H225
  H330
  H302
  H314 | | | |
| 607-021-00-X | methylacetat | 201-185-2 | 79-20-9 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H336 | EUH066 | | |
| 607-022-00-5 | ethylacetat | 205-500-4 | 141-78-6 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H336 | EUH066 | | |
| 607-023-00-0 | vinylacetat | 203-545-4 | 108-05-4 | Flam. Liq. 2
  Carc. 2
  Acute Tox. 4
  STOT SE 3 | H225
  H351
  H332
  H335 | GHS02
  GHS08
  GHS07
  Dgr | H225
  H351
  H332
  H335 | | | D |
| 607-024-00-6 | propylacetat; [1] isopropylacetat [2] | 203-686-1 [1]
  203-561-1 [2] | 109-60-4 [1]
  108-21-4 [2] | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3 | H225
  H319
  H336 | GHS02
  GHS07
  Dgr | H225
  H319
  H336 | EUH066 | | C |
| 607-025-00-1 | n-butylacetat | 204-658-1 | 123-86-4 | Flam. Liq. 3
  STOT SE 3 | H226
  H336 | GHS02
  GHS07
  Wng | H226
  H336 | EUH066 | | |
| 607-026-00-7 | sec-butylacetat; [1] isobutylacetat; [2] tert-butylacetat [3] | 203-300-1 [1]
  203-745-1 [2]
  208-760-7 [3] | 105-46-4 [1]
  110-19-0 [2]
  540-88-5 [3] | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | EUH066 | | C |
| 607-027-00-2 | methylpropionat | 209-060-4 | 554-12-1 | Flam. Liq. 2
  Acute Tox. 4 * | H225
  H332 | GHS02
  GHS07
  Dgr | H225
  H332 | | | |
| 607-028-00-8 | ethylpropionat | 203-291-4 | 105-37-3 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 607-029-00-3 | n-butylpropionat; [1] sec-butylpropionat; [2] iso-butylpropionat [3] | 209-669-5 [1]
  - [2]
  208-746-0 [3] | 590-01-2 [1]
  591-34-4 [2]
  540-42-1 [3] | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | C |
| 607-030-00-9 | propylpropionat | 203-389-7 | 106-36-5 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H332 | GHS02
  GHS07
  Wng | H226
  H332 | | | |
| 607-031-00-4 | butylbutyrat | 203-656-8 | 109-21-7 | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | C |
| 607-032-00-X | ethylacrylat | 205-438-8 | 140-88-5 | Flam. Liq. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H225
  H332
  H312
  H302
  H319
  H335
  H315
  H317 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H319
  H335
  H315
  H317 | | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % | D |
| 607-033-00-5 | n-butylmethacrylat | 202-615-1 | 97-88-1 | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H226
  H319
  H335
  H315
  H317 | GHS02
  GHS07
  Wng | H226
  H319
  H335
  H315
  H317 | | | D |
| 607-034-00-0 | methylacrylat; methylpropenoat | 202-500-6 | 96-33-3 | Flam. Liq. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H225
  H332
  H312
  H302
  H319
  H335
  H315
  H317 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H319
  H335
  H315
  H317 | | | D |
| 607-035-00-6 | methylmethacrylat; methyl 2-methylprop2enoat; methyl 2-methylpropenoat | 201-297-1 | 80-62-6 | Flam. Liq. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H225
  H335
  H315
  H317 | GHS02
  GHS07
  Dgr | H225
  H335
  H315
  H317 | | | D |
| 607-036-00-1 | 2-methoxyethylacetat; methylglycolacetat | 203-772-9 | 110-49-6 | Repr. 1B
  Acute Tox. 4 * Acute Tox. 4 *
  Acute Tox. 4 * | H360FD H332
  H312
  H302 | GHS08
  GHS07
  Dgr | H360FD H332
  H312
  H302 | | | |
| 607-037-00-7 | 2-ethoxyethylacetat; ethylglycolacetat | 203-839-2 | 111-15-9 | Flam. Liq. 3
  Repr. 1B
  Acute Tox. 4 * Acute Tox. 4 *
  Acute Tox. 4 * | H226
  H360FD H332
  H312
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H226
  H360FD H332
  H312
  H302 | | | |
| 607-038-00-2 | 2-butoxyethylacetat; butylglycolacetat | 203-933-3 | 112-07-2 | Acute Tox. 4 * Acute Tox. 4 * | H332
  H312 | GHS07
  Wng | H332
  H312 | | | |
| 607-039-00-8 | 2,4-D (ISO); 2,4-dichlorphenoxyeddikesyre | 202-361-1 | 94-75-7 | Acute Tox. 4 * STOT SE 3
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H335
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H335
  H318
  H317
  H412 | | | |
| 607-040-00-3 | salte af 2,4-D | — | — | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | A |
| 607-041-00-9 | 2,4,5-T; 2,4,5-trichlorphenoxyeddikesyre | 202-273-3 | 93-76-5 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H335
  H315
  H410 | | | |
| 607-042-00-4 | salte og estere af 2,4,5-T; salte og estere af 2,4,5-trichlorphenoxyeddikesyre | — | — | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H335
  H315
  H410 | | | A |
| 607-043-00-X | dicamba (ISO); 2,5-dichlor-6-methoxybenzoesyre; 3,6-dichlor-2-methoxybenzoesyre | 217-635-6 | 1918-00-9 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 607-044-00-5 | 3,6-dichlor-o-anissyre, forbindelse med dimethylamin (1:1); [1] kalium-3,6-dichlor-o-anisat [2] | 218-951-7 [1]
  233-002-7 [2] | 2300-66-5 [1]
  10007-85-9 [2] | Eye Irrit. 2
  Aquatic Chronic 3 | H319
  H412 | GHS07
  Wng | H319
  H412 | | | |
| 607-045-00-0 | dichlorprop (ISO); 2-(2,4-dichlorphenoxy) propionsyre | 204-390-5 | 120-36-5 | Acute Tox. 4 * Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1 | H312
  H302
  H315
  H318 | GHS05
  GHS07
  Dgr | H312
  H302
  H315
  H318 | | | |
| 607-046-00-6 | salte af dichlorprop | — | — | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H332
  H312
  H302 | GHS07
  Wng | H332
  H312
  H302 | | | A |
| 607-047-00-1 | fenoprop (ISO); 2-(2,4,5-trichlorphenoxy)propionsyre | 202-271-2 | 93-72-1 | Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H315
  H410 | | | |
| 607-048-00-7 | salte af fenoprop; salte af 2-(2,4,5-trichlorphenoxy)propionsyre | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | | A |
| 607-049-00-2 | mecoprop (ISO); 2-(4-chlor-o-tolyloxy) propionsyre; (RS)-2-(4-chlor-o-tolyloxy) propionsyre; [1] 2-2-(4-chlor-2-methylphenoxy)propionsyre [2] | 230-386-8 [1]
  202-264-4 [2] | 7085-19-0 [1]
  708519-0 [2] | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H315
  H318
  H410 | | M = 100 | |
| 607-050-00-8 | salte af mechlorprop | — | — | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H315
  H318
  H410 | | | A |
| 607-051-00-3 | MCPA (ISO); 4-chlor-o-tolyloxyeddikesyre | 202-360-6 | 94-74-6 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H315
  H318
  H410 | | | |
| 607-052-00-9 | salte og estere af MCPA | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | | A |
| 607-053-00-4 | MCPB (ISO); 4-(4-chlor-o-tolyloxy) smørsyre | 202-365-3 | 94-81-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-054-00-X | salte og estere af MCPB | — | — | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | A |
| 607-055-00-5 | endothalnatrium (ISO); dinatrium-7-oxabicyclo(2,2,1)heptan-2,3-dicarboxylat | 204-959-8 | 129-67-9 | Acute Tox. 3 * Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H301
  H312
  H319
  H335
  H315 | GHS06
  Dgr | H301
  H312
  H319
  H335
  H315 | | | |
| 607-057-00-6 | coumachlor (ISO); 3-(1-(4-chlorphenyl)-3-oxobutyl)-4-hydroxycumarin | 201-378-1 | 81-82-3 | STOT RE 2 *
  Aquatic Chronic 3 | H373 ** H412 | GHS08
  Wng | H373 ** H412 | | | |
| 607-058-00-1 | coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)-butyl]-coumarin | 204-195-5 | 117-52-2 | Acute Tox. 3 * STOT RE 1
  Aquatic Chronic 3 | H301
  H372 ** H412 | GHS06
  GHS08
  Dgr | H301
  H372 ** H412 | | | |
| 607-060-00-2 | dicumarol; 4,4'-dihydroxy-3,3' methylenbis(2H-chromen-2-on) | 200-632-9 | 66-76-2 | STOT RE 1
  Acute Tox. 4 *
  Aquatic Chronic 2 | H372 ** H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H372 ** H302
  H411 | | | |
| 607-061-00-8 | acrylsyre; 2-propensyre | 201-177-9 | 79-10-7 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1A Aquatic Acute 1 | H226
  H332
  H312
  H302
  H314
  H400 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H226
  H332
  H312
  H302
  H314
  H400 | | STOT SE 3; H335: C ≥ 1 % | D |
| 607-062-00-3 | butylacrylat | 205-480-7 | 141-32-2 | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H226
  H319
  H335
  H315
  H317 | GHS02
  GHS07
  Wng | H226
  H319
  H335
  H315
  H317 | | | D |
| 607-063-00-9 | isosmørsyre | 201-195-7 | 79-31-2 | Acute Tox. 4 * Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 607-064-00-4 | benzylchlorformiat | 207-925-0 | 501-53-1 | Skin Corr. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H400
  H410 | GHS05
  GHS09
  Dgr | H314
  H410 | | STOT SE 3; H335: C ≥ 5 % | |
| 607-065-00-X | bromeddikesyre | 201-175-8 | 79-08-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1A
  Skin Sens. 1
  Aquatic Acute 1 | H331
  H311
  H301
  H314
  H317
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H311
  H301
  H314
  H317
  H400 | | | |
| 607-066-00-5 | dichloreddikesyre | 201-207-0 | 79-43-6 | Skin Corr. 1A Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | | | |
| 607-067-00-0 | dichloracetylchlorid | 201-199-9 | 79-36-7 | Skin Corr. 1A Aquatic Acute 1 | H314
  H400 | GHS05
  GHS09
  Dgr | H314
  H400 | | | |
| 607-068-00-6 | iodeddikesyre | 200-590-1 | 64-69-7 | Acute Tox. 3 *
  Skin Corr. 1A | H301
  H314 | GHS06
  GHS05
  Dgr | H301
  H314 | | | |
| 607-069-00-1 | ethylbromacetat | 203-290-9 | 105-36-2 | Acute Tox. 2 * Acute Tox. 1
  Acute Tox. 2 * | H330
  H310
  H300 | GHS06
  Dgr | H330
  H310
  H300 | | | |
| 607-070-00-7 | ethylchloracetat | 203-294-0 | 105-39-5 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * Aquatic Acute 1 | H331
  H311
  H301
  H400 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H400 | | | |
| 607-071-00-2 | ethylmethacrylat | 202-597-5 | 97-63-2 | Flam. Liq. 2
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H225
  H319
  H335
  H315
  H317 | GHS02
  GHS07
  Dgr | H225
  H319
  H335
  H315
  H317 | | | D |
| 607-072-00-8 | 2-hydroxyethylacrylat | 212-454-9 | 818-61-1 | Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1 | H311
  H314
  H317
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H311
  H314
  H317
  H400 | | *
  Skin Sens. 1; H317: C ≥ 0,2  % | D |
| 607-073-00-3 | 4-CPA (ISO); 4-chlorphenoxyeddikesyre | 204-581-3 | 122-88-3 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-074-00-9 | chlorfenac; 2,3,6-trichlorphenyleddikesyre | 201-599-3 | 85-34-7 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-075-00-4 | chlorfenprop-methyl; methyl-2-chlor-3-(4-chlorphenyl)propionat | 238-413-5 | 14437-17-3 | Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 607-076-00-X | dodin; dodecylguanidinacetat | 219-459-5 | 2439-10-3 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H315
  H410 | | | |
| 607-077-00-5 | erbon; 2-(2,4,5-trichlorphenoxy)ethyl-2,2-dichlorpropionat | — | 136-25-4 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-078-00-0 | fluenetil (ISO); 2-fluorethylbiphenyl-4-ylacetat | — | 4301-50-2 | Acute Tox. 1
  Acute Tox. 2 * | H310
  H300 | GHS06
  Dgr | H310
  H300 | | | |
| 607-079-00-6 | kelevan (ISO);ethyl 5-(perchlor-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoat; ethyl 5-(1,2,3,5,6,7,8,9,10,10- decachlor-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4- yl)-4-oxovalerat | — | 4234-79-1 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H311
  H302
  H411 | GHS06
  GHS09
  Dgr | H311
  H302
  H411 | | | |
| 607-080-00-1 | chloracetylchlorid | 201-171-6 | 79-04-9 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1
  Skin Corr. 1A Aquatic Acute 1 | H331
  H311
  H301
  H372 ** H314
  H400 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H331
  H311
  H301
  H372 ** H314
  H400 | EUH014
  EUH029 | | |
| 607-081-00-7 | fluoreddikesyre | 205-631-7 | 144-49-0 | Acute Tox. 2 * Aquatic Acute 1 | H300
  H400 | GHS06
  GHS09
  Dgr | H300
  H400 | | | |
| 607-082-00-2 | monofluoracetater, opløselige | — | — | Acute Tox. 2 * Aquatic Acute 1 | H300
  H400 | GHS06
  GHS09
  Dgr | H300
  H400 | | | A |
| 607-083-00-8 | 2,4-DB (ISO); 4-(2,4-dichlorphenoxy)smørsyre | 202-366-9 | 94-82-6 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-084-00-3 | salte af 2,4-DB | — | — | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | A |
| 607-085-00-9 | benzylbenzoat | 204-402-9 | 120-51-4 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-086-00-4 | diallylphthalat | 205-016-3 | 131-17-9 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 607-088-00-5 | methacrylsyre; 2-methylpropensyre | 201-204-4 | 79-41-4 | Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1A | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 1 % | D |
| 607-089-00-0 | propionsyre ... % | 201-176-3 | 79-09-4 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 %
  Eye Irrit. 2; H319: 10 % ≤
  C < 25 %
  STOT SE 3; H335: C ≥ 10 % | B |
| 607-090-00-6 | thioglycolsyre | 200-677-4 | 68-11-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B | H331
  H311
  H301
  H314 | GHS06
  GHS05
  Dgr | H331
  H311
  H301
  H314 | | * | |
| 607-091-00-1 | trifluoreddikesyre . . . % | 200-929-3 | 76-05-1 | Acute Tox. 4 *
  Skin Corr. 1A
  Aquatic Chronic 3 | H332
  H314
  H412 | GHS05
  GHS07
  Dgr | H332
  H314
  H412 | | * | B |
| 607-092-00-7 | methyllactat; [1] methyl-(±)-lactat; [2] methyl-(R)-lactat; [3] methyl-(S)-(-)-lactat [4] | 208-930-0 [1]
  218-449-8 [2]
  241-420-6 [3]
  248-704-9 [4] | 547-64-8 [1]
  2155-30-8 [2]
  17392-83-5 [3]
  27871-49-4 [4] | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3 | H226
  H319
  H335 | GHS02
  GHS07
  Wng | H226
  H319
  H335 | | | C |
| 607-093-00-2 | propionylchlorid | 201-170-0 | 79-03-8 | Flam. Liq. 2
  Skin Corr. 1B | H225
  H314 | GHS02
  GHS05
  Dgr | H225
  H314 | EUH014 | | B D |
| 607-094-00-8 | pereddikesyre . . . % | 201-186-8 | 79-21-0 | Flam. Liq. 3
  Org. Perox. D **** Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A Aquatic Acute 1 | H226
  H242
  H332
  H312
  H302
  H314
  H400 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H226
  H242
  H332
  H312
  H302
  H314
  H400 | | *
  STOT SE 3; H335: C ≥ 1 % | B D |
| 607-095-00-3 | maleinsyre | 203-742-5 | 110-16-7 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H302
  H319
  H335
  H315
  H317 | GHS07
  Wng | H302
  H319
  H335
  H315
  H317 | | Skin Sens. 1; H317: C ≥ 0,1  % | |
| 607-096-00-9 | maleinsyreanhydrid | 203-571-6 | 108-31-6 | Acute Tox. 4 *
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1 | H302
  H314
  H334
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H314
  H334
  H317 | | | |
| 607-097-00-4 | benzen-1,2,4-tricarboxylsyre-1,2-anhydrid; trimellitsyreanhydrid | 209-008-0 | 552-30-7 | STOT SE 3
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H335
  H318
  H334
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H335
  H318
  H334
  H317 | | | |
| 607-098-00-X | benzen-1,2:4,5-tetracarboxylsyredianhydrid; 1,2,4,5-benzentetracarboxylsyredianhydrid | 201-898-9 | 89-32-7 | Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H318
  H334
  H317 | GHS08
  GHS05
  Dgr | H318
  H334
  H317 | | | |
| 607-099-00-5 | 1,2,3,6-tetrahydrophtalsyreanhydrid; [1] cis-1,2,3,6-tetrahydrophthalsyreanhydrid; [2] 3,4,5,6-tetrahydrophtalsyreanhydrid; [3] tetrahydrophthalsyreanhydrid [4] | 201-605-4 [1]
  213-308-7 [2]
  219-374-3 [3]
  247-570-9 [4] | 85-43-8 [1]
  935-79-5 [2]
  2426-02-0 [3]
  26266-63-7 [4] | Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H334
  H317
  H412 | GHS08
  GHS05
  Dgr | H318
  H334
  H317
  H412 | | | C |
| 607-100-00-9 | 3,3',4,4'-benzophenontetracarboxylsyredianhydrid; 4,4'-carbonyldi(phtalsyreanhydrid) | 219-348-1 | 2421-28-5 | Eye Irrit. 2
  STOT SE 3 | H319
  H335 | GHS07
  Wng | H319
  H335 | | Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | |
| 607-101-00-4 | 1,4,5,6,7,7-hexachlorbicyclo-[2,2,1]-hept-5-en-2,3-dicarboxylsyreanhydrid; chlorendinsyreanhydrid | 204-077-3 | 115-27-5 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | |
| 607-102-00-X | cyclohexan-1,2-dicarboxylsyreanhydrid; [1] cis-cyclohexan-1,2-dicarboxylsyreanhydrid; [2] trans-cyclohexan-1,2-dicarboxylsyreanhydrid [3] | 201-604-9 [1]
  236-086-3 [2]
  238-009-9 [3] | 85-42-7 [1]
  13149-00-3 [2]
  14166-21-3 [3] | Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H318
  H334
  H317 | GHS08
  GHS05
  Dgr | H318
  H334
  H317 | | | C |
| 607-103-00-5 | ravsyreanhydrid | 203-570-0 | 108-30-5 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H302
  H319
  H335 | GHS07
  Wng | H302
  H319
  H335 | | *
  Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | |
| 607-104-00-0 | 1,2,3,4-cyclopentantetracarboxylsyredianhydrid | 227-964-7 | 6053-68-5 | Eye Irrit. 2
  STOT SE 3 | H319
  H335 | GHS07
  Wng | H319
  H335 | | Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | |
| 607-105-00-6 | 8,9,10-trinorborn-5-en-2,3-dicarboxylsyreanhydrid; [1] 1,2,3,6-tetrahydro-3,6-methanophthalsyreanhydrid; [2](1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalsyreanhydrid [3] | 204-957-7 [1]
  212-557-9 [2]
  220-384-5 [3] | 129-64-6 [1]
  826-62-0 [2]
  2746-19-2 [3] | Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H318
  H334
  H317 | GHS08
  GHS05
  Dgr | H318
  H334
  H317 | | | C |
| 607-106-00-1 | 1-methyl-5-norbornen-2,3-dicarboxylsyreanhydrid; 8,9-dinorborn-5-en-2,3-dicarboxylsyreanhydrid | — | 123748-85-6 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H302
  H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H302
  H319
  H335
  H315
  H334 | | STOT SE 3; H335: C ≥ 10 % | C |
| 607-107-00-7 | 2-ethylhexylacrylat | 203-080-7 | 103-11-7 | STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H335
  H315
  H317 | GHS07
  Wng | H335
  H315
  H317 | | | D |
| 607-108-00-2 | 2-hydroxy-1-methylethylacrylat; [1] 2-hydroxypropylacrylat; [2] acrylsyre, monoester med propan-1,2-diol [3] | 220-852-9 [1]
  213-663-8 [2]
  247-118-0 [3] | 2918-23-2 [1]
  999-61-1 [2]
  25584-83-2 [3] | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1 | H331
  H311
  H301
  H314
  H317 | GHS06
  GHS05
  Dgr | H331
  H311
  H301
  H314
  H317 | | *
  Skin Sens. 1; H317:C ≥ 0,2  % | C D |
| 607-109-00-8 | hexamethylendiacrylat; 1,6-hexandioldiacrylat | 235-921-9 | 13048-33-4 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | D |
| 607-110-00-3 | pentaerythritoltriacrylat | 222-540-8 | 3524-68-3 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | D |
| 607-111-00-9 | 2,2-bis(acryloyloxymethyl)butylacrylat; trimethylolpropantriacrylat | 239-701-3 | 15625-89-5 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | D |
| 607-112-00-4 | 2,2-dimethylpropandiol-1,3-diacrylat; neopentylglycoldiacrylat | 218-741-5 | 2223-82-7 | Acute Tox. 3 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H311
  H319
  H315
  H317 | GHS06
  Dgr | H311
  H319
  H315
  H317 | | * | D |
| 607-113-00-X | isobutylmethacrylat | 202-613-0 | 97-86-9 | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H226
  H319
  H335
  H315
  H317
  H400 | GHS02
  GHS07
  GHS09
  Wng | H226
  H319
  H335
  H315
  H317
  H400 | | | D |
| 607-114-00-5 | ethylendimethacrylat | 202-617-2 | 97-90-5 | STOT SE 3
  Skin Sens. 1 | H335
  H317 | GHS07
  Wng | H335
  H317 | | STOT SE 3; H335: C ≥ 10 % | D |
| 607-115-00-0 | isobutylacrylat | 203-417-8 | 106-63-8 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1 | H226
  H332
  H312
  H315
  H317 | GHS02
  GHS07
  Wng | H226
  H332
  H312
  H315
  H317 | | | D |
| 607-116-00-6 | cyclohexylacrylat | 221-319-3 | 3066-71-5 | STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H335
  H315
  H411 | GHS07
  GHS09
  Wng | H335
  H315
  H411 | | STOT SE 3; H335: C ≥ 10 % | D |
| 607-117-00-1 | 2,3-epoxypropylacrylat, glycidylacrylat | 203-440-3 | 106-90-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1 | H331
  H311
  H301
  H314
  H317 | GHS06
  GHS05
  Dgr | H331
  H311
  H301
  H314
  H317 | | *
  Skin Sens. 1; H317:C ≥ 0,2  % | D |
| 607-118-00-7 | 1-methyltrimethylendiacrylat; 1,3-butylenglycoldiacrylat | 243-105-9 | 19485-03-1 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H312
  H314
  H317 | GHS05
  GHS07
  Dgr | H312
  H314
  H317 | | | D |
| 607-119-00-2 | tetramethylendiacrylat; 1,4-butylenglycoldiacrylat | 213-979-6 | 1070-70-8 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H312
  H314
  H317 | GHS05
  GHS07
  Dgr | H312
  H314
  H317 | | | D |
| 607-120-00-8 | 2,2'-oxydiethyldiacrylat; diethylenglycoldiacrylat | 223-791-6 | 4074-88-8 | Acute Tox. 3 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H311
  H319
  H315
  H317 | GHS06
  Dgr | H311
  H319
  H315
  H317 | | *
  Skin Sens. 1; H317:C ≥ 0,2  % | D |
| 607-121-00-3 | 8,9,10-trinorborn-2-ylacrylat | — | 10027-06-2 | Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1 | H312
  H315
  H317 | GHS07
  Wng | H312
  H315
  H317 | | | D |
| 607-122-00-9 | pentaerythritoltetraacrylat | 225-644-1 | 4986-89-4 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | D |
| 607-124-00-X | 2-hydroxyethylmethacrylat | 212-782-2 | 868-77-9 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | D |
| 607-125-00-5 | 2-hydroxypropylmethacrylat; [1] 3-hydroxypropylmethacrylat [2] | 213-090-3 [1]
  220-426-2 [2] | 923-26-2 [1]
  2761-09-3 [2] | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | C D |
| 607-126-00-0 | 2,2'-(ethylendioxy)diethyldiacrylat; triethylenglycoldiacrylat | 216-853-9 | 1680-21-3 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | D |
| 607-127-00-6 | 2-diethylaminoethylmethacrylat | 203-275-7 | 105-16-8 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H332
  H319
  H315
  H317 | GHS07
  Wng | H332
  H319
  H315
  H317 | | | D |
| 607-128-00-1 | 2-tert-butylaminoethylmethacrylat | 223-228-4 | 3775-90-4 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | D |
| 607-129-00-7 | ethyllactat; ethyl DL-lactat; [1] ethyl (S)-2-hydroxypropionat; ethyl L-lactat; ethyl-(S)-lactat [2] | 202-598-0 [1]
  211-694-1 [2] | 97-64-3 [1]
  687-47-8 [2] | Flam. Liq. 3
  STOT SE 3
  Eye Dam. 1 | H226
  H335
  H318 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H335
  H318 | | | C |
| 607-130-00-2 | pentylacetat; [1] isopentylacetat; [2] 1-methylbutylacetat; [3] 2-methylbutylacetat; [4] 2(eller 3)-methylbutyl acetat [5] | 211-047-3 [1]
  204-662-3 [2]
  210-946-8 [3]
  210-843-8 [4]
  282-263-3 [5] | 628-63-7 [1]
  123-92-2 [2]
  626-38-0 [3]
  624-41-9 [4]
  84145-37-9 [5] | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | EUH066 | | C |
| 607-131-00-8 | isopentylpropionat; [1] pentylpropionat; [2] 2-methylbutylpropionat [3] | 203-322-1 [1]
  210-852-7 [2]
  219-449-0 [3] | 105-68-0 [1]
  624-54-4 [2]
  2438-20-2 [3] | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | C |
| 607-132-00-3 | 2-dimethylaminoethylmethacrylat | 220-688-8 | 2867-47-2 | Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H312
  H302
  H319
  H315
  H317 | GHS07
  Wng | H312
  H302
  H319
  H315
  H317 | | | D |
| 607-133-00-9 | monoalkyl eller monoaryl eller monoalkylaryl esters af acrylsyre undtagen sådanne nævnt andetsteds i dette bilag | — | — | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H319
  H335
  H315
  H411 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H411 | | STOT SE 3; H335: C ≥ 10 % | A |
| 607-134-00-4 | monoalkyl eller monoaryl eller monoalkylaryl esters af methacrylater undtagen sådanne nævnt andetsteds i dette bilag | — | — | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | STOT SE 3; H335: C ≥ 10 % | A |
| 607-135-00-X | smørsyre | 203-532-3 | 107-92-6 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 607-136-00-5 | butyroylchlorid | 205-498-5 | 141-75-3 | Flam. Liq. 2
  Skin Corr. 1B | H225
  H314 | GHS02
  GHS05
  Dgr | H225
  H314 | | | |
| 607-137-00-0 | methylacetoacetat | 203-299-8 | 105-45-3 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-138-00-6 | butylchlorformiat; chlormyresyrebutylester | 209-750-5 | 592-34-7 | Flam. Liq. 3
  Acute Tox. 3 *
  Skin Corr. 1B | H226
  H331
  H314 | GHS02
  GHS06
  GHS05
  Dgr | H226
  H331
  H314 | | | |
| 607-139-00-1 | 2-chlorpropionsyre | 209-952-3 | 598-78-7 | Acute Tox. 4 *
  Skin Corr. 1A | H302
  H314 | GHS05
  GHS07
  Dgr | H302
  H314 | | | |
| 607-140-00-7 | isobutyroylchlorid | 201-194-1 | 79-30-1 | Flam. Liq. 2
  Skin Corr. 1A | H225
  H314 | GHS02
  GHS05
  Dgr | H225
  H314 | | | |
| 607-141-00-2 | oxydiethylenbis(chloroformiat) | 203-430-9 | 106-75-2 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H315
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H315
  H318
  H411 | | | |
| 607-142-00-8 | propylchlorformiat; chlormyresyrepropylester; n-propylchlorformiat | 203-687-7 | 109-61-5 | Flam. Liq. 2
  Acute Tox. 3 *
  Skin Corr. 1B | H225
  H331
  H314 | GHS02
  GHS06
  GHS05
  Dgr | H225
  H331
  H314 | | | |
| 607-143-00-3 | valerianesyre | 203-677-2 | 109-52-4 | Skin Corr. 1B
  Aquatic Chronic 3 | H314
  H412 | GHS05
  Dgr | H314
  H412 | | | |
| 607-144-00-9 | adipinsyre | 204-673-3 | 124-04-9 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-145-00-4 | methansulfonsyre | 200-898-6 | 75-75-2 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 607-146-00-X | fumarsyre | 203-743-0 | 110-17-8 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-147-00-5 | diethyloxalat; ethyloxalat | 202-464-1 | 95-92-1 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 607-148-00-0 | guanidinhydrochlorid; guanidiniumchlorid | 200-002-3 | 50-01-1 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2 | H302
  H319
  H315 | GHS07
  Wng | H302
  H319
  H315 | | | |
| 607-149-00-6 | urethan (INN); ethylcarbamat | 200-123-1 | 51-79-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 607-150-00-1 | endothal; 7-oxabicyclo(2,2,1)heptan-2,3-dicarboxylsyre | 205-660-5 | 145-73-3 | Acute Tox. 3 * Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H301
  H312
  H319
  H335
  H315 | GHS06
  Dgr | H301
  H312
  H319
  H335
  H315 | | | |
| 607-151-00-7 | propargit (ISO); 2-(4-tert-butylphenoxy) cyclohexylprop-2-ynylsulfit | 219-006-1 | 2312-35-8 | Carc. 2
  Acute Tox. 3 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H331
  H315
  H318
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H351
  H331
  H315
  H318
  H410 | | M = 10 | |
| 607-152-00-2 | 2,3,6-TBA (ISO), 2,3,6-trichlorbenzoesyre | 200-026-4 | 50-31-7 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-153-00-8 | benazolin (ISO), 4-chlor-2-oxobenzothiazolin-3-yleddikesyre | 223-297-0 | 3813-05-6 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 3 | H319
  H315
  H412 | GHS07
  Wng | H319
  H315
  H412 | | | |
| 607-154-00-3 | ethyl-N-benzoyl-N-(3,4-dichlorphenyl)-.sc.DL.sc.-alaninat; benzoylprop-ethyl (ISO) | 244-845-5 | 22212-55-1 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 607-155-00-9 | 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylsyre;
  blasticidin-s | — | 2079-00-7 | Acute Tox. 2 * | H300 | GHS06
  Dgr | H300 | | | |
| 607-156-00-4 | chlorfenson (ISO); 4-chlorphenyl-4-chlorbenzensulfonat | 201-270-4 | 80-33-1 | Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H315
  H410 | | | |
| 607-158-00-5 | natrium-salt af chloreddikesyre; natriumchloracetat | 223-498-3 | 3926-62-3 | Acute Tox. 3 *
  Skin Irrit. 2
  Aquatic Acute 1 | H301
  H315
  H400 | GHS06
  GHS09
  Dgr | H301
  H315
  H400 | | | |
| 607-159-00-0 | chlorobenzilat (ISO); ethyl 2,2-di(4-chlorphenyl)-2-hydroxyacetat; ethyl-4,4'-dichlorbenzilat | 208-110-2 | 510-15-6 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 607-160-00-6 | isobutyl-2-(4-(4-chlorphenoxy)phenoxy)propionat; clofop-isobutyl (ISO) | — | 51337-71-4 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-161-00-1 | salt af diethanolamin af 4-CPA | — | — | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-162-00-7 | dalapon; 2,2-dichlorpropionsyre; [1] dalapon-natrium; natrium-2,2-dichlorpropionat [2] | 200-923-0 [1]
  204-828-5 [2] | 75-99-0 [1]
  127-20-8 [2] | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H315
  H318
  H412 | GHS05
  Dgr | H315
  H318
  H412 | | | |
| 607-163-00-2 | 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dion; dehydracetsyre | 208-293-9 | 520-45-6 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-164-00-8 | natrium-1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-yliden)ethanolat; natrium dehydracetat | 224-580-1 | 4418-26-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-165-00-3 | diclofop-methyl (ISO); methyl-2-(4-(2,4-dichlorphenoxy)phenoxy)propionat; methyl (RS)-2-[4-(2,4-dichlorphenoxy)phenoxy]propionat | 257-141-8 | 51338-27-3 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 607-166-00-9 | medinoterbacetat (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenylacetat | 219-634-6 | 06-01-2487 | Acute Tox. 3 * Acute Tox. 4 * | H301
  H312 | GHS06
  Dgr | H301
  H312 | | | |
| 607-167-00-4 | natrium-3-chloracrylat | — | 4312-97-4 | Acute Tox. 4 * Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 607-168-00-X | dipropyl-6,7-methylendioxy-1,2,3,4-tetrahydro-3-methylnaphthalen-1,2-dicarboxylat; propylisom | — | 83-59-0 | Acute Tox. 3 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H302
  H400
  H410 | GHS06
  GHS09
  Dgr | H311
  H302
  H410 | | | |
| 607-169-00-5 | natriumfluoracetat | 200-548-2 | 62-74-8 | Acute Tox. 2 * Acute Tox. 1
  Acute Tox. 2 * Aquatic Acute 1 | H330
  H310
  H300
  H400 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H400 | | | |
| 607-170-00-0 | bis(1,2,3-trithiacyclohexyldimethylammonium)oxalat; thiocyclamhydrogenoxalat | 250-859-2 | 31895-22-4 | Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 607-173-00-7 | dimethyl-(3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionat | 400-460-6 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-174-00-2 | blanding af tetradecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionat og dodecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionat | 400-580-9 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 607-175-00-8 | methyl-2-(2-nitrobenzyliden)acetoacetat | 400-650-9 | 39562-27-1 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-176-00-3 | blanding af α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylen) og α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylen) | 400-830-7 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-177-00-9 | tribenuron-methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoesyre-methylester; methyl-2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulfonyl)benzoat | 401-190-1 | 101200-48-0 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | M = 100 | |
| 607-178-00-4 | methyl-α-((4,6-dimethoxypyrimidin-2-yl)ureidosulfonyl)-o-toluat | 401-340-6 | 83055-99-6 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-179-00-X | (benzothiazol-2-ylthio)ravsyre | 401-450-4 | 95154-01-1 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-180-00-5 | kalium-2-hydroxycarbazol-1-carboxylat | 401-630-2 | 96566-70-0 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Aquatic Chronic 3 | H302
  H319
  H335
  H412 | GHS07
  Wng | H302
  H319
  H335
  H412 | | | |
| 607-181-00-0 | 3,5-dichlor-2,4-difluorbenzoylfluorid | 401-800-6 | 101513-70-6 | Acute Tox. 3 *
  Skin Corr. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H331
  H314
  H302
  H317
  H412 | GHS06
  GHS05
  Dgr | H331
  H314
  H302
  H317
  H412 | EUH029 | | |
| 607-182-00-6 | methyl-3-sulfamoyl-2-thenoat | 402-050-2 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-183-00-1 | zink-2-hydroxy-5-C13-18-alkylbenzoat | 402-280-3 | — | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H319
  H315
  H411 | GHS07
  GHS09
  Wng | H319
  H315
  H411 | | | |
| 607-184-00-7 | S-(3-trimethoxysilyl)propyl-19-isocyanoato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanthioat | 402-290-8 | 85702-90-5 | Flam. Liq. 3
  Resp. Sens. 1
  Skin Sens. 1 | H226
  H334
  H317 | GHS02
  GHS08
  Dgr | H226
  H334
  H317 | | | |
| 607-185-00-2 | ethyl-trans-3-dimethylaminoacrylat | 402-650-4 | 1117-37-9 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-186-00-8 | quinclorac (ISO); 3,7-dichlorquinolin-8-carboxylsyre | 402-780-1 | 84087-01-4 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-187-00-3 | bis(2,2,6,6-tetramethyl-4-piperidyl)succinat | 402-940-0 | 62782-03-0 | Eye Irrit. 2
  Aquatic Chronic 3 | H319
  H412 | GHS07
  Wng | H319
  H412 | | | |
| 607-188-00-9 | hydrogennatrium-N-carboxylatoethyl-N-octadec-9-enylmaleamat | 402-970-4 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-189-00-4 | trimethylendiamintetraeddikesyre | 400-400-9 | 1939-36-2 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 607-190-00-X | methylacrylamidomethoxyacetat (der indeholder ≥ 0,1 % acrylamid) | 401-890-7 | 77402-03-0 | Carc. 1B Muta. 1B
  Acute Tox. 4 *
  Eye Irrit. 2 | H350
  H340
  H302
  H319 | GHS08
  GHS07
  Dgr | H350
  H340
  H302
  H319 | | | |
| 607-191-00-5 | isobutyl-3,4-epoxybutyrat | 401-920-9 | 100181-71-3 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 607-192-00-0 | dinatrium-N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinat | 402-360-8 | 92511-22-3 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-194-00-1 | propylencarbonat | 203-572-1 | 108-32-7 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-195-00-7 | 2-methoxy-1-methylethylacetat | 203-603-9 | 108-65-6 | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | |
| 607-196-00-2 | heptansyre | 203-838-7 | 111-14-8 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 607-198-00-3 | propyl-3,4,5-trihydroxybenzoat | 204-498-2 | 121-79-9 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 607-199-00-9 | octyl-3,4,5-trihydroxybenzoat | 213-853-0 | 1034-01-1 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 607-200-00-2 | dodecyl-3,4,5-trihydroxybenzoat | 214-620-6 | 1166-52-5 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-201-00-8 | tiocarbonylchlorid | 207-341-6 | 463-71-8 | Acute Tox. 3 * Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H331
  H302
  H319
  H335
  H315 | GHS06
  Dgr | H331
  H302
  H319
  H335
  H315 | | | |
| 607-203-00-9 | 2-ethylhexyl-[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetat | 279-452-8 | 80387-97-9 | Repr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H360D *** H317
  H412 | GHS08
  GHS07
  Dgr | H360D *** H317
  H412 | | | |
| 607-204-00-4 | (chlorphenyl)(chlortolyl)methan, blanding af isomerer | 400-140-6 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-205-00-X | methylchloracetat | 202-501-1 | 96-34-4 | Flam. Liq. 3
  Acute Tox. 3 * Acute Tox. 3 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H226
  H331
  H301
  H335
  H315
  H318 | GHS02
  GHS06
  GHS05
  Dgr | H226
  H331
  H301
  H335
  H315
  H318 | | | |
| 607-206-00-5 | isopropylchloracetat | 203-301-7 | 105-48-6 | Flam. Liq. 3
  Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H226
  H301
  H319
  H335
  H315 | GHS02
  GHS06
  Dgr | H226
  H301
  H319
  H335
  H315 | | | |
| 607-207-00-0 | haloxyfop-etotyl (ISO); 2-ethoxyethyl-2-(4-(3-chlor-5-trifluormethyl-2-pyridyloxy)phenoxy)propionat; haloxyfop-(2-etoxyethyl) | 402-560-5 | 87237-48-7 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 607-208-00-6 | 4,8,12-trimethyltrideca-3,7,11-triensyre, blanding af isomerer | 403-000-2 | 91853-67-7 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 607-209-00-1 | blanding af O, O'-diisopropyl-(trithio)dithioformiat og O, O'-diisopropyl-(tetrathio)dithioformiat og O, O'-diisopropyl-(pentathio)dithioformiat | 403-030-6 | — | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 607-210-00-7 | methylacrylamidoglycolat (der indeholder ≥ 0,1 % acrylamid) | 403-230-3 | 77402-05-2 | Carc. 1B Muta. 1B
  Skin Corr. 1B
  Skin Sens. 1 | H350
  H340
  H314
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H350
  H340
  H314
  H317 | | | |
| 607-211-00-2 | methyl-3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionat | 403-270-1 | 6386-39-6 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-212-00-8 | poly(oxypropylencarbonyl-co-oxy(ethylethylen)carbonyl), indholdende 27 % hydroxyvalerat | 403-300-3 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-213-00-3 | ethyl-3,3-bis(tert-pentylperoxy)butyrat | 403-320-2 | 67567-23-1 | Org. Perox. D **** Flam. Liq. 3
  Aquatic Chronic 2 | H242
  H226
  H411 | GHS02
  GHS09
  Dgr | H242
  H226
  H411 | | | |
| 607-214-00-9 | N, N-hydrazinodieddikesyre | 403-510-5 | 19247-05-3 | Acute Tox. 3 * STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 3 | H301
  H373 ** H317
  H412 | GHS06
  GHS08
  Dgr | H301
  H373 ** H317
  H412 | | | |
| 607-215-00-4 | 3-(3-tert-butyl-4-hydroxyphenyl)propionsyre | 403-920-4 | 107551-67-7 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 607-216-00-X | glutaminsyre, reaktionsprodukter med N-(C12-14-alkyl)propylendiamin | 403-950-8 | — | Acute Tox. 2 * Acute Tox. 4 *
  Skin Corr. 1B Aquatic Acute 1 | H330
  H302
  H314
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H330
  H302
  H314
  H400 | | | |
| 607-217-00-5 | 2-ethoxyethyl-2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetat | 403-960-2 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 607-218-00-0 | dichlorprop-P ISO; (+)-R-2-(2,4-dichlorphenoxy)propionsyre | 403-980-1 | 15165-67-0 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H302
  H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H315
  H318
  H317 | | | |
| 607-219-00-6 | bis(2-ethylhexyl)dithiodiacetat | 404-510-8 | 62268-47-7 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 607-221-00-7 | 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalen-2-carboxylsyre | 404-550-6 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 607-222-00-2 | 6-(2,3-dimethylmaleimido)hexylmethacrylat | 404-870-6 | 63740-41-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-223-00-8 | transfluthrin (ISO); 2,3,5,6-tetrafluorbenzyl-trans-2-(2,2-dichlorvinyl)-3,3-dimethylcyclopropancarboxylat | 405-060-5 | 118712-89-3 | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 607-224-00-3 | methyl-2-(3-nitrobenzyliden)acetoacetat | 405-270-7 | 39562-17-9 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-225-00-9 | 3-azidosulfonylbenzoesyre | 405-310-3 | 15980-11-7 | Self-React. C **** STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H241
  H373 ** H318
  H317 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H241
  H373 ** H318
  H317 | | | |
| 607-226-00-4 | blanding af 2-methacryloyloxyethylhydrogencyclohexan-1,2-dicarboxylat og 2-acryloyloxyethylhydrogencyclohexan-1,2-dicarboxylat | 405-360-6 | — | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H315
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H315
  H318
  H317
  H412 | | | |
| 607-227-00-X | kalium-2-amino-2-methylpropionatoctahydrat | 405-560-3 | 120447-91-8 | Acute Tox. 4 *
  Skin Corr. 1A | H302
  H314 | GHS05
  GHS07
  Dgr | H302
  H314 | | | |
| 607-228-00-5 | bis(2-methoxyethyl)phthalat | 204-212-6 | 117-82-8 | Repr. 1B | H360Df | GHS08
  Dgr | H360Df | | | |
| 607-229-00-0 | diethylcarbamoylchlorid | 201-798-5 | 88-10-8 | Carc. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H351
  H332
  H302
  H319
  H335
  H315 | GHS08
  GHS07
  Wng | H351
  H332
  H302
  H319
  H335
  H315 | | | |
| 607-230-00-6 | 2-ethylhexansyre | 205-743-6 | 149-57-5 | Repr. 2 | H361d *** | GHS08
  Wng | H361d *** | | | |
| 607-231-00-1 | clopyralid (ISO); 3,6-dichlorpyridin-2-carboxylsyre | 216-935-4 | 1702-17-6 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-232-00-7 | pyridat (ISO); O-(6-chlor-3-phenylpyridazin-4-yl)-S-octylthiocarbonat | 259-686-7 | 55512-33-9 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 607-233-00-2 | hexylacrylat | 219-698-5 | 2499-95-8 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H319
  H335
  H315
  H317
  H411 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H317
  H411 | | | |
| 607-234-00-8 | flurenol (ISO); 9-hydroxy-9H-fluoren-9-carboxylsyre | 207-397-1 | 467-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-235-00-3 | mecrilat; methyl-2-cyanacrylat | 205-275-2 | 137-05-3 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | STOT SE 3; H335: C ≥ 10 % | |
| 607-236-00-9 | ethyl-2-cyanacrylat | 230-391-5 | 7085-85-0 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | STOT SE 3; H335: C ≥ 10 % | |
| 607-237-00-4 | benzyl-2-chlor-4-(trifluormethyl)thiazol-5-carboxylat; flurazol | 276-942-3 | 72850-64-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-238-00-X | tau-fluvalinat; cyan(3-phenoxyphenyl)methyl-N-[2-chlor-4-(trifluoromethyl)phenyl-.sc.D.sc.-valinat | — | 102851-06-9 | Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H315
  H410 | | | |
| 607-239-00-5 | fenpropathrin (ISO); α-cyan-3-phenoxybenzyl-2,2,3,3-tetramethylcyclopropancarboxylat | 254-485-0 | 39515-41-8 | Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H301
  H312
  H410 | | | |
| 607-240-00-0 | cis-1,2,3,6-tetrahydro-4-methylphthalsyreanhydrid; [1]1,2,3,6-tetrahydro-4-methylphthalsyreanhydrid; [2]1,2,3,6-tetrahydro-3-methylphthalsyreanhydrid; [3] tetrahydromethylphthalsyreanhydrid; [4] 1,2,3,6-tetrahydromethylphthalsyreanhydrid; [5] tetrahydro-4-methylphthalsyreanhydrid; [6]2,3,5,6-tetrahydro-2-methylphthalsyreanhydrid [7] | 216-906-6 [1]
  222-323-8 [2]
  226-247-6 [3]
  234-290-7 [4]
  247-830-1 [5]
  251-823-9 [6]
  255-853-3 [7] | 1694-82-2 [1]
  3425-89-6 [2]
  5333-84-6 [3]
  11070-44-3 [4]
  26590-20-5 [5]
  34090-76-1 [6]
  42498-58-8 [7] | Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H318
  H334
  H317 | GHS08
  GHS05
  Dgr | H318
  H334
  H317 | | | C |
| 607-241-00-6 | hexahydro-4-methylphthalsyreanhydrid; [1] hexahydromethylphthalsyreanhydrid; [2] hexahydro-1-methylphthalsyreanhydrid; [3] hexahydro-3-methylphthalsyreanhydrid [4] | 243-072-0 [1]
  247-094-1 [2]
  256-356-4 [3]
  260-566-1 [4] | 19438-60-9 [1]
  25550-51-0 [2]
  48122-14-1 [3]
  57110-29-9 [4] | Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H318
  H334
  H317 | GHS08
  GHS05
  Dgr | H318
  H334
  H317 | | | C |
| 607-242-00-1 | tetrachlorphthalsyreanhydrid | 204-171-4 | 117-08-8 | Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H334
  H317
  H400
  H410 | GHS08
  GHS05
  GHS09
  Dgr | H318
  H334
  H317
  H410 | | | |
| 607-243-00-7 | natrium-3,6-dichlor-o-anisat; [1] 3,6-dichlor-o-anissyre, forbindelse med 2,2'-iminodiethanol (1:1); [2] 3,6-dichlor-o-anissyre, forbindelse med 2-aminoethanol (1:1) [3] | 217-846-3 [1]
  246-590-5 [2]
  258-527-9 [3] | 1982-69-0 [1]
  25059-78-3 [2]
  53404-28-7 [3] | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-244-00-2 | isooctylacrylat | 249-707-8 | 29590-42-9 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H410 | | STOT SE 3; H335: C ≥ 10 % | |
| 607-245-00-8 | tert-butylacrylat | 216-768-7 | 1663-39-4 | Flam. Liq. 2
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H225
  H332
  H312
  H302
  H335
  H315
  H317
  H411 | GHS02
  GHS07
  GHS09
  Dgr | H225
  H332
  H312
  H302
  H335
  H315
  H317
  H411 | | | D |
| 607-246-00-3 | allylmethacrylat; 2-methylpropensyreprop-2-en-1-ylester | 202-473-0 | 96-05-9 | Flam. Liq. 3
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1 | H226
  H331
  H312
  H302
  H400 | GHS02
  GHS06
  GHS09
  Dgr | H226
  H331
  H312
  H302
  H400 | | | |
| 607-247-00-9 | dodecylmethacrylat | 205-570-6 | 142-90-5 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H335
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H410 | | STOT SE 3; H335: C ≥ 10 % | |
| 607-248-00-4 | naptalam-natrium (ISO); natrium N-naphth-1-ylphthalamat | 205-073-4 | 132-67-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-249-00-X | (1-methyl-1,2-ethandiyl)bis[oxy(methyl-2,1-ethandiyl)]diacrylat | 256-032-2 | 42978-66-5 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H319
  H335
  H315
  H317
  H411 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H317
  H411 | | STOT SE 3; H335: C ≥ 10 % | |
| 607-250-00-5 | 4H-3,1-benzoxazin-2,4(1H)-dion | 204-255-0 | 118-48-9 | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 607-251-00-0 | 2-methoxypropylacetat | 274-724-2 | 70657-70-4 | Flam. Liq. 3
  Repr. 1B
  STOT SE 3 | H226
  H360D *** H335 | GHS02
  GHS08
  GHS07
  Dgr | H226
  H360D *** H335 | | | |
| 607-252-00-6 | lambda-cyhalothrin (ISO); en 1:1 blanding af (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chlor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropancarboxylat og
  (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chlor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropancarboxylat | 415-130-7 | 91465-08-6 | Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H301
  H312
  H410 | | M = 10 000 | |
| 607-253-00-1 | cyfluthrin (ISO); α-cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat | 269-855-7 | 68359-37-5 | Acute Tox. 2 *
  Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H300
  H331
  H400
  H410 | GHS06
  GHS09
  Dgr | H300
  H331
  H410 | | M = 1 000 | |
| 607-254-00-7 | a-cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat;
  beta-cyfluthrin | 269-855-7 | 68359-37-5 | Acute Tox. 2 *
  Acute Tox. 2 * Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H410 | | | |
| 607-255-00-2 | fluroxypyr (ISO); 4-amino-3,5-dichlor-6-fluor-2-pyridyloxyeddikesyre | — | 69377-81-7 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-256-00-8 | azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4- yloxy]phenyl}-3-methoxyacrylat | — | 131860-33-8 | Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H410 | | | |
| 607-257-00-3 | isopropylpropionat | 211-300-8 | 637-78-5 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | |
| 607-258-00-9 | dodecyl-3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorbenzoat | 403-990-6 | 70950-45-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-259-00-4 | methyl-2R,3S-(-)-3-(4-methoxyphenyl)oxirancarboxylat | 404-130-2 | 105560-93-8 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 607-260-00-X | ethyl-2-(3-nitrobenzyliden)acetoacetat | 404-490-0 | 39562-16-8 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 607-261-00-5 | iso(C10-C14)alkyl-(3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetat | 404-800-4 | 118832-72-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-262-00-0 | 7-chlor-1-cyclopropyl-6-fluor-1,4-dihydro-4-oxochinolin-3-carboxylsyre | 405-050-0 | 86393-33-1 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 607-263-00-6 | kalium/jern(III)-1,3-propandiamin-N, N,N',N'-tetraacetathemihydrat | 405-680-6 | — | Self-heat. 2 **** Aquatic Chronic 2 | H252
  H411 | GHS02
  GHS09
  Wng | H252
  H411 | | | |
| 607-264-00-1 | 2-chlor-4-(methylsulfonyl)benzoesyre | 406-520-8 | 53250-83-2 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-265-00-7 | ethyl-2-chlor-2,2-diphenylacetat | 406-580-5 | 52460-86-3 | Skin Irrit. 2
  Aquatic Chronic 3 | H315
  H412 | GHS07
  Wng | H315
  H412 | | | |
| 607-266-00-2 | blanding af hydroxyaluminium-bis[2-hydroxy-3,5-di-tert-butylbenzoat]; 3,5-di-tert-butyl-salicylsyre | 406-890-0 | 130296-87-6 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 607-267-00-8 | tert-butyl-(5S,6R,7R)-3-brommethyl-5,8-dioxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-en-2-carboxylat | 407-620-4 | 33610-13-8 | Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H334
  H317
  H412 | GHS08
  Dgr | H334
  H317
  H412 | | | |
| 607-268-00-3 | 2-methylpropyl-(R)-2-hydroxypropanoat | 407-770-0 | 61597-96-4 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-269-00-9 | (R)-2-(4-hydroxyphenoxy)propansyre | 407-960-3 | 94050-90-5 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-270-00-4 | 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecan | 410-730-5 | 90498-90-1 | Acute Tox. 4 * | H312 | GHS07
  Wng | H312 | | | |
| 607-271-00-X | 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropan | 417-420-9 | 156324-82-2 | Eye Irrit. 2
  Aquatic Chronic 2 | H319
  H411 | GHS07
  GHS09
  Wng | H319
  H411 | | | |
| 607-272-00-5 | fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichlor-6-fluor-2-pyridyloxy) acetat; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichlor-6-fluor-2-pyridyloxy) acetat [2] | 279-752-9 [1]
  - [2] | 81406-37-3 [1]
  154486-27-8 [2] | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-273-00-0 | ammonium-7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoat | 404-520-2 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-274-00-6 | 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoat | 405-350-1 | 54527-73-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-275-00-1 | natrium-4-(benzoyloxy)benzensulfonat | 405-450-5 | 66531-87-1 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-276-00-7 | bis[(1-methylimidazol)-(2-ethyl-hexanoat)], zinkcomplex | 405-635-0 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | | |
| 607-277-00-2 | en blanding af 2-(hexylthio)ethylaminhydrochlorid; natriumpropionat | 405-720-2 | — | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 607-278-00-8 | blanding af isomerer af natriumphenethylnaphthalensulfonat og natrium(2-naphthylethyl)benzensulfonat | 405-760-0 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 607-279-00-3 | blanding af N-octadecylaminodiethylbis(hydrogenmaleat) og N-octadecylaminodiethylhydrogenmaleathydrogenphthalat | 405-960-8 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-280-00-9 | natrium-4-chlor-1-hydroxybutan-1-sulfonat | 406-190-5 | 54322-20-2 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1 | H302
  H319
  H317 | GHS07
  Wng | H302
  H319
  H317 | | | |
| 607-281-00-4 | blanding af forgrenet og lineær C7-C9 alkyl-3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionater | 407-000-3 | 127519-17-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-282-00-X | 2-acetoxymethyl-4-benzyloxybut-1-ylacetat | 407-140-5 | 131266-10-9 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-283-00-5 | (E)-ethyl-4-oxo-4-phenylcrotonat | 408-040-4 | 15121-89-8 | Acute Tox. 4 * Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H315
  H318
  H317
  H410 | | | |
| 607-284-00-0 | en blanding af natrium-3,3’ (1,4-phenylenbis(carbonylimino-3,1-propandiylimino))bis(10-amino-6,13-dichlor)-4,11-triphenodioxazindisulfonat); lithium-3,3'-(1,4-phenylenbis(carbonylimino-3,1-propandiylimino))bis(10-amino-6,13-dichlor)-4,11-triphenodioxazindisulfonat) | 410-040-4 | 136213-76-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-285-00-6 | en blanding af 7-(((3-aminophenyl)sulfonyl)amino)naphthalen-1,3-disulfonsyre; natrium-7-(((3-aminophenyl)sulfonyl)amino)naphthalen-1,3-disulfonat; kalium-7-(((3-aminophenyl)sulfonyl)amino)naphthalen-1,3-disulfonat | 410-065-0 | — | Skin Sens. 1 | H317 | GHS07
  Wng | | | | |
| 607-286-00-1 | blanding af natrium/kalium-7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]naphthalen-1,3-disulfonat | 410-070-8 | 141880-36-6 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-287-00-7 | O'-methyl-O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalat | 410-140-8 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-288-00-2 | tetranatrium-(c-(3-(1-(3-(e-6-dichlor-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phtalocyanin-a, b,d-trisulfonat(6-))nikkel (II), hvor a er 1 eller 2 eller 3 eller 4, b er 8 eller 9 eller 10 eller 11, c er 15 eller 16 eller 17 eller 18, d er 22 eller 23 eller 24 eller 25, og hvor e og f er enten 2 og 4 eller 4 og 2 | 410-160-7 | 148732-74-5 | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H319
  H317
  H412 | GHS07
  Wng | H319
  H317
  H412 | | | |
| 607-289-00-8 | 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propansyre | 410-370-9 | 105488-33-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-290-00-3 | blanding (forhold ukendt) af ammonium-1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethan-1-sulfonat og ammonium-2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethan-1-sulfonat | 410-540-2 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 607-291-00-9 | dodecyl-ω-(C5/C6-cycloalkyl)alkylcarboxylat | 410-630-1 | 104051-92-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-292-00-4 | en blanding af [1-(methoxymethyl)-2-(C12-alkoxy)ethoxy]eddikesyre og [1-(methoxymethyl)-2-(C14-alkoxy)ethoxy]eddikesyre | 410-640-6 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | | |
| 607-293-00-X | en blanding af N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenylether di-sulfonat;

  N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenylether di-sulfonat | 410-650-0 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 607-294-00-5 | natrium-2-benzoyloxy-1-hydroxyethan-sulfonat | 410-680-4 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-295-00-0 | blanding af tetranatrium-phosphonethan-1,2-dicarboxylat; hexanatrium-phosphonbutan-1,2,3,4-tetracarboxylat | 410-800-5 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-296-00-6 | blanding af tetraestere af pentaerythriol med heptansyre og 2-ethylhexansyre | 410-830-9 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-297-00-1 | (E,E)-3,3'-(1,4-phenylendimethyliden)bis(2-oxobornan-10-sulfonsyre) | 410-960-6 | 92761-26-7 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-298-00-7 | 2-(trimethylammonium)-ethoxycarboxybenzen-4-sulfonat | 411-010-3 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-299-00-2 | methyl-3-(acetylthio)-2-methylpropanat | 411-040-7 | 97101-46-7 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 607-300-00-6 | trinatrium-[2-(5-chlor-2,6-difluorpyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprat(II) hvor a =1,2,3 eller 4, b =8,9,10 eller 11, c=15,16,17 eller 18 og d =22,23,24 eller 25 | 411-430-7 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-301-00-1 | blanding af dodecansyre; poly(1-7)lactatestere af dodecansyre | 411-860-5 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-302-00-7 | blanding af tetradecansyre og poly(1-7)lactatestere af tetradecansyre | 411-910-6 | — | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H411 | | | |
| 607-303-00-2 | 1-cyclopropyl-6,7-difluor-1,4-dihydro-4-oxoquinolin-3-carboxylsyre | 413-760-7 | 93107-30-3 | Repr. 2
  Aquatic Chronic 3 | H361f *** H412 | GHS08
  Wng | H361f *** H412 | | | |
| 607-304-00-8 | fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluormethyl-2-pyridyloxy)phenoxy]propianat | 274-125-6 | 69806-50-4 | Repr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D *** H400
  H410 | GHS08
  GHS09
  Dgr | H360D *** H410 | | | |
| 607-305-00-3 | fluazifop-butyl (ISO); butyl-2-[4-[[5-(trifluormethyl)-2-pyridyl]oxy]phenoxy]propionat | — | 79241-46-6 | Repr. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d *** H400
  H410 | GHS08
  GHS09
  Wng | H361d *** H410 | | | |
| 607-306-00-9 | chlozolinate (ISO); ethyl-(RS)-3-(3,5-dichlorphenyl)-5-methyl-2,4-dioxo-oxazolidin-5-carboxylat | 282-714-4 | 84332-86-5 | Carc. 2
  Aquatic Chronic 2 | H351
  H411 | GHS08
  GHS09
  Wng | H351
  H411 | | | |
| 607-307-00-4 | vinclozolin (ISO); N-3,5-dichlorphenyl-5-methyl-5-vinyl-1,3-oxazolidin-2,4-dion | 256-599-6 | 50471-44-8 | Carc. 2
  Repr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H351
  H360FD H317
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H351
  H360FD H317
  H411 | | | |
| 607-308-00-X | estere af 2,4-D | — | — | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | A |
| 607-309-00-5 | carfentrazon-ethyl (ISO); ethyl (RS)-2-chlor-3-[2-chlor-4-fluor-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionat | — | 128639-02-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-310-00-0 | kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetat | — | 143390-89-0 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 607-311-00-6 | benazolin-ethyl; ethyl-4-chlor-2-oxo-2H-benzothiazol-3-acetat | 246-591-0 | 25059-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-312-00-1 | methoxyeddikesyre | 210-894-6 | 625-45-6 | Repr. 1B
  Acute Tox. 4 *
  Skin Corr. 1B | H360FD H302
  H314 | GHS08
  GHS05
  GHS07
  Dgr | H360FD H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | |
| 607-313-00-7 | neodecanoylchlorid | 254-875-0 | 40292-82-8 | Acute Tox. 2 * Acute Tox. 4 *
  Skin Corr. 1B | H330
  H302
  H314 | GHS06
  GHS06
  Dgr | H330
  H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | |
| 607-314-00-2 | ethofumesat (ISO); (±)-(2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl)methansulfonat | 247-525-3 | 26225-79-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-315-00-8 | glyphosat (ISO); N-(phosphonomethyl)glycin | 213-997-4 | 1071-83-6 | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 607-316-00-3 | gliphosal-trimesium; glyphosat-trimethylsulfonium | — | 81591-81-3 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-317-00-9 | bis(2-ethylhexyl)phthalat; di-(2-ethylhexyl)phthalat; DEHP | 204-211-0 | 117-81-7 | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | | |
| 607-318-00-4 | dibutylphthalat; DBP | 201-557-4 | 84-74-2 | Repr. 1B
  Aquatic Acute 1 | H360Df
  H400 | GHS08
  GHS09
  Dgr | H360Df
  H400 | | | |
| 607-319-00-X | deltamethrin (ISO); (S)-α-cyan-3-phenoxybenzyl-(1R, 3R)-3-(2,2-dibromvinyl)-2,2-dimethylcyclopropancarboxylat | 258-256-6 | 52918-63-5 | Acute Tox. 3 *
  Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H410 | | M=1 000 000 | |
| 607-320-00-5 | bis[4-(ethenyloxy)butyl]-1,3-benzendicarboxylat | 413-930-0 | 130066-57-8 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-321-00-0 | (S)-methyl-2-chlorpropionat | 412-470-8 | 73246-45-4 | Flam. Liq. 3
  STOT RE 2 *
  Eye Irrit. 2 | H226
  H373 ** H319 | GHS02
  GHS08
  Wng | H226
  H373 ** H319 | | | |
| 607-322-00-6 | 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoesyre | 413-120-7 | 107144-30-9 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-323-00-1 | 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl-acrylat | 413-850-6 | 123968-25-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-324-00-7 | en blanding af N, N-di(hydrogeneret alkyl C14-C18) phthalamidsyre; dihydrogeneret alkyl (C14-C18)amin | 413-800-3 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-325-00-2 | (S)-2-chlorpropionsyre | 411-150-5 | 29617-66-1 | Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1A | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | | |
| 607-326-00-8 | blanding af isobutylhydrogen-2-(α-2,4,6-trimethylnon-2-enyl)succinat og
  isobutylhydrogen-2-(ß-2,4,6-trimethylnon-2-enyl)succinat | 410-720-0 | 141847-13-4 | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 607-327-00-3 | 2-(2-iodethyl)-1,3-propandioldiacetat | 411-780-0 | 127047-77-2 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-328-00-9 | methyl-4-brommethyl-3-methoxybenzoat | 410-310-1 | 70264-94-7 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | | |
| 607-329-00-4 | blanding af natrium-2-(C12-18-n-alkyl)amino-1,4-butandioat og natrium-2-octadecenyl-amino-1,4-butandioat | 411-250-9 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-330-00-X | (S)-2,3-dihydro-1H-indol-2-carboxylsyre | 410-860-2 | 79815-20-6 | Repr. 2
  STOT RE 2 *
  Skin Sens. 1 | H361f *** H373 ** H317 | GHS08
  GHS07
  Wng | H361f *** H373 ** H317 | | | |
| 607-331-00-5 | blanding af bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decandioat og 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octan | 406-750-9 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-332-00-0 | cyclopentylchlorformiat | 411-460-0 | 50715-28-1 | Flam. Liq. 3
  Acute Tox. 3 * Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H226
  H331
  H302
  H373 ** H318
  H317 | GHS02
  GHS06
  GHS08
  GHS05
  Dgr | H226
  H331
  H302
  H373 ** H318
  H317 | | | |
| 607-333-00-6 | blanding af dodecyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninat og
  tetradecyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninat | 405-670-1 | — | Acute Tox. 4 * STOT RE 2 *
  Skin Corr. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H314
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H302
  H373 ** H314
  H410 | | | |
| 607-334-00-1 | ethyl-1-ethyl-6,7,8-trifluor-1,4-dihydro-4-oxoquinolin-3-carboxylat | 405-880-3 | 100501-62-0 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-335-00-7 | methyl-(R)-2-(4-(3-chlor-5-trifluormethyl-2-pyridyloxy)phenoxy)propionat | 406-250-0 | 72619-32-0 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 607-336-00-2 | 4-methyl-8-methylentricyclo[3.3.1.13,7]dec-2-ylacetat | 406-560-6 | 122760-85-4 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H317
  H411 | GHS07
  GHS09
  Wng | H315
  H317
  H411 | | | |
| 607-337-00-8 | di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinat | 406-052-4 | 125078-60-6 | Flam. Liq. 3
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H226
  H302
  H315
  H318
  H411 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H226
  H302
  H315
  H318
  H411 | | | |
| 607-338-00-3 | 2-methylpropyl-2-hydroxy-2-methylbut-3-enoat | 406-235-9 | 72531-53-4 | Eye Irrit. 2
  Skin Irrit. 2 | H319
  H315 | GHS07
  Wng | H319
  H315 | | | |
| 607-339-00-9 | 2,3,4,5-tetrachlorbenzoylchlorid | 406-760-3 | 42221-52-3 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H302
  H314
  H317 | GHS05
  GHS07
  Dgr | H302
  H314
  H317 | | | |
| 607-340-00-4 | 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-ylacetat | 406-990-4 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-341-00-X | (9S)-9-amino-9-deoxyerythromycin | 406-790-7 | 26116-56-3 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 607-342-00-5 | 4-chlorbutylveratrat | 410-950-1 | 69788-75-6 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-343-00-0 | 4,7-methanooctahydro-1H-inden-diyldimethylbis(2-carboxybenzoat) | 407-410-2 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-344-00-6 | en blanding af 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoralkylsulfonamido)propionsyre og

  N-[dimethyl-3-(C4-8-perfluoralkylsulfonamido)propylammonium-propionat og
  3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoralkylsulfonamido)propionsyre-propionat | 407-810-7 | — | STOT RE 2 * | H373 ** | GHS08
  Wng | H373 ** | | | |
| 607-345-00-1 | kalium-2-(2,4-dichlorphenoxy)-(R)-propanat | 413-580-9 | 113963-87-4 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H302
  H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H315
  H318
  H317 | | | |
| 607-346-00-7 | 3-icosyl-4-henicosyliden-2-oxetanon | 401-210-9 | 83708-14-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-347-00-2 | natrium-(R)-2-(2,4-dichlorphenoxy)propionat | 413-340-3 | 119299-10-4 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H302
  H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H315
  H318
  H317 | | | |
| 607-348-00-8 | magnesium-bis((R)-2-(2,4-dichlorphenoxy)propionat) | 413-360-2 | — | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H302
  H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H315
  H318
  H317 | | | |
| 607-349-00-3 | mono-(tetrapropylammonium)hydrogen-2,2'-dithiobisbenzoat | 411-270-8 | — | Aquatic Chronic 3 | H412 | | H412 | | | |
| 607-350-00-9 | bis(4-(1,2-bis(ethoxycarbonyl)-ethylamino)-3-methyl-cyclohexyl)-methan | 412-060-9 | 136210-32-7 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-351-00-4 | methyl-O-(4-amino-3,5-dichlor-6-fluorpyridin-2-yloxy)acetat | 407-550-4 | 69184-17-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-352-00-X | 4,4'-oxydiphtalsyreanhydrid | 412-830-4 | 1823-59-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-353-00-5 | blanding af ethyl-exo-tricyclo[5.2.1.02,6]decan-endo-2-carboxylat; ethyl-endo-tricyclo[5.2.1.02,6]decan-exo-2-carboxylat | 407-520-0 | 80657-64-3 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 607-354-00-0 | ethyl-2-cyclohexylpropionat | 412-280-5 | 2511-00-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-355-00-6 | p-tolyl-4-chlorbenzoat | 411-530-0 | 15024-10-9 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-356-00-1 | ethyl-trans-2,2,6-trimethylcyclohexancarboxylat | 412-540-8 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 607-357-00-7 | en blanding af trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran og cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran | 412-450-9 | 131766-73-9 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-358-00-2 | (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylat | 412-670-5 | 54275-93-3 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 607-359-00-8 | (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylen-1-oxo-7-phenylacetamido-cepham-4-carboxylat | 412-800-0 | 76109-32-5 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 607-360-00-3 | natrium-3-acetoacetylamino-4-methoxytolyl-6-sulfonat | 411-680-7 | 133167-77-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-361-00-9 | methyl-(R)-2-(4-hydroxyphenoxy)-propionat | 411-950-4 | 96562-58-2 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-362-00-4 | en blanding af (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoat;
  (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoat;
  (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoat;
  (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoat | 413-500-2 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H315
  H318
  H411 | GHS05
  GHS09
  Dgr | H315
  H318
  H411 | | | |
| 607-363-00-X | methyl-3-methoxyacrylat | 412-900-4 | 5788-17-0 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-364-00-5 | 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dion | 413-330-9 | 134724-55-3 | Aquatic Chronic 4 | H413 | | H413 | | | |
| 607-365-00-0 | 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetylchloridhydrochlorid | 410-620-7 | 119154-86-8 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H302
  H314
  H317 | GHS05
  GHS07
  Dgr | H302
  H314
  H317 | | | |
| 607-366-00-6 | 3,5-dimethylbenzoylchlorid | 413-010-9 | 6613-44-1 | Skin Corr. 1B
  Skin Sens. 1 | H314
  H317 | GHS05
  GHS07
  Dgr | H314
  H317 | | | |
| 607-367-00-1 | kalium-bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N, O,O, N)-ferrat-(1-) monohydrat | 411-640-9 | 153352-59-1 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-368-00-7 | 1-(N, N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazol | 411-650-3 | 110895-43-7 | Acute Tox. 3 *
  Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H410 | | | |
| 607-369-00-2 | en blanding af trans-(2R)-5-acetoxy-1,3-oxathiolan-2-carboxylsyre og cis-(2R)-5-acetoxy-1,3-oxathiolan-2-carboxylsyre | 411-660-8 | 147027-04-1 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H302
  H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H315
  H318
  H317 | | | |
| 607-370-00-8 | 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol | 412-210-3 | 41620-33-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-371-00-3 | 3-ethyl-5-methyl-4-(2-chlorphenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridindicarboxylat | 413-410-3 | 88150-62-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-372-00-9 | ethoxyleret-bisphenol A di-(norbornencarboxylat) | 412-410-0 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-373-00-4 | (±) tetrahydrofurfuryl-(R)-2-[4-(6-chlorchinoxalin-2-yloxy)-phenyloxy]propanoat | 414-200-4 | 119738-06-6 | Muta. 2
  Repr. 1B
  Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H360Df
  H302
  H373 ** H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H341
  H360Df
  H302
  H373 ** H410 | | | |
| 607-374-00-X | 5-amino-2,4,6-triiodo-1,3-benzendicarbonyldichlorid | 417-220-1 | 37441-29-5 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-376-00-0 | benzyl-2,4-dibrombutanoat | 420-710-8 | 23085-60-1 | Repr. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f *** H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361f *** H315
  H317
  H410 | | | |
| 607-377-00-6 | trans-4-cyclohexyl-sc.L.sc.-prolinmonohydrochlorid | 419-160-1 | 90657-55-9 | Repr. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H361f *** H302
  H315
  H318
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H361f *** H302
  H315
  H318
  H317 | | | |
| 607-378-00-1 | ammonium-(Z)-α-methoxyimino-2-furylacetat | 405-990-1 | 97148-39-5 | Flam. Sol. 2 | H228 | GHS02
  Dgr | H228 | | | T |
| 607-379-00-7 | en blanding af 2-[N-(2-hydroxyethyl)stearamido]ethyl-stearat og
  natrium-[bis[2-(stearoyloxy)ethyl]amino]methylsulfonat og natrium-[bis(2-hydroxyethyl)amino]methylsulfonat og N, N-bis(2-hydroxyethyl)stearamid | 401-230-8 | | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-380-00-2 | blanding af ammonium-1,2-bis(hexyloxycarbonyl)ethansulfonat;
  ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethansulfonat;
  ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethansulfonat | 407-320-3 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H315
  H318
  H412 | GHS05
  Dgr | H315
  H318
  H412 | | | |
| 607-381-00-8 | blanding af triestere af 2,2-bis(hydroxymethyl)butanol med C7-alkansyre og 2-ethylhexansyre | 413-710-4 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-382-00-3 | 2-((4-amino-2-nitrophenyl)amino)benzoesyre | 411-260-3 | 117907-43-4 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 607-383-00-9 | en blanding af 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoat og 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoat | 415-430-8 | 86403-32-9 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H410 | | | |
| 607-384-00-4 | blanding af estere af C14-C15-forgrenede alkoholer med 3,5-di-t-butyl-4-hydroxyphenyl-propionsyre og
  C15-forgrenet og ligekædet alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenpropanoat og
  C13-forgrenet og ligekædet alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenpropanoat | 413-750-2 | 171090-93-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-385-00-X | copolymer af vinyl-alkohol og vinyl-acetat delvis acetileret med 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium-methylsulfat | 414-590-6 | 125229-74-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-386-00-5 | blanding af tetradecansyre (42.5-47,5 %) og poly(1-7)lactatestere af tetradecansyre (52,5-57,5 %) | 412-580-6 | 174591-51-6 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | | |
| 607-387-00-0 | blanding af dodecansyre (35-40 %) og poly(1-7)lactatestere af dodecansyre (60-65 %) | 412-590-0 | 58856-63-6 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | | |
| 607-388-00-6 | 4-ethylamino-3-nitrobenzoesyre | 412-090-2 | 2788-74-1 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H317
  H412 | GHS07
  Wng | H302
  H317
  H412 | | | |
| 607-389-00-1 | trinatrium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionat | 414-130-4 | 119710-96-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-390-00-7 | 1,2,3,4-tetrahydro-6-nitro-quinoxalin | 414-270-6 | 41959-35-7 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-391-00-2 | dimethylcyclopropan-1,1-dicarboxylat | 414-240-2 | 6914-71-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-392-00-8 | 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoat | 414-260-1 | 88938-37-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-393-00-3 | 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsyre | 415-750-8 | 106447-44-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-394-00-9 | 5-methylpyrazin-2-carboxylsyre | 413-260-9 | 5521-55-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-395-00-4 | blanding af natrium-1-tridecyl-4-allyl-(2 eller 3)-sulfobutandioat og natrium-1-dodecyl-4allyl-(2 eller 3)-sulfobutandioat | 410-230-7 | — | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H411 | | | |
| 607-396-00-X | bis(1,2,2,6,6-pentamethyl-4-piperidinyl)-2-(4-methoxybenzyliden)malonat | 414-840-4 | 147783-69-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-397-00-5 | en blanding af Ca-salicylater (forgrenet C10-14- og C18-30-alkyleret) og Ca-phenater (forgrenet C10-14- og C18-30-alkyleret) og Ca-phenater, svovlbehandlede (forgrenet C10-14- og C18-30-alkyleret) | 415-930-6 | — | Repr. 2
  Skin Sens. 1 | H361f *** H317 | GHS08
  GHS07
  Wng | H361f *** H317 | | | |
| 607-398-00-0 | ethyl-N-(5-chlor-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamat | 414-820-5 | 125630-94-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-399-00-6 | 2,2-dimethyl-3-methyl-3-butenylpropanoat | 415-610-6 | 104468-21-5 | Skin Irrit. 2
  Aquatic Chronic 3 | H315
  H412 | GHS07
  Wng | H315
  H412 | | | |
| 607-400-00-X | methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoat | 414-400-1 | 32750-89-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-401-00-5 | ethyl-3-hydroxy-5-oxo-3-cyclohexen-1-carboxylat | 414-450-4 | 88805-65-6 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H315
  H318
  H317 | | | |
| 607-402-00-0 | methyl N-(phenyloxycarbonyl)-.sc.L.sc.-valinat | 414-500-5 | 153441-77-1 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-403-00-6 | blanding af bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammoniumsuccinat og
  isopropylalkohol | 414-810-0 | — | STOT RE 2 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 ** H318
  H400
  H410 | GHS08
  GHS05
  GHS09
  Dgr | H373 ** H318
  H410 | | | |
| 607-404-00-1 | en blanding af ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropansyre; di-((E)-3,7-dimethyl-2,6-octadienyl)butandioat; di-((Z)-3,7-dimethyl-2,6-octadienyl)butandioat;
  (Z)-3,7-dimethyl-2,6-octadienylbutandioat; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropansyre | 415-190-4 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-405-00-7 | 2-hexyldecyl-p-hydroxybenzoat | 415-380-7 | 148348-12-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-406-00-2 | kalium-2,5-dichlorbenzoat | 415-700-5 | 184637-62-5 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 607-407-00-8 | ethyl-2-carboxy-3-(2-thienyl)propionat | 415-680-8 | 143468-96-6 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H315
  H318
  H317 | | | |
| 607-408-00-3 | kalium-N-(4-fluorophenyl)glycinat | 415-710-1 | 184637-63-6 | STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H373 ** H318
  H317
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H373 ** H318
  H317
  H412 | | | |
| 607-409-00-9 | en blanding af (3R)-[1S-(1α, 2α, 6β ((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalen]-3,5-dihydroxyheptansyre og inert biomasse fra Aspergillus terreus | 415-840-7 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-410-00-4 | mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butandioat og/eller mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butandioat | 415-880-5 | 779343-34-9 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | | |
| 607-411-00-X | oxiranmethanol, 4-methylbenzen-sulfonat, (S)- | 417-210-7 | 70987-78-9 | Carc. 1B Muta. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H350
  H341
  H318
  H317
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H350
  H341
  H318
  H317
  H411 | | | |
| 607-412-00-5 | ethyl-2-(1-cyanocyclohexyl)acetat | 415-970-4 | 133481-10-4 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 3 | H302
  H373 ** H412 | GHS08
  GHS07
  Wng | H302
  H373 ** H412 | | | |
| 607-413-00-0 | trans-4-phenyl-.sc.L.sc.-prolin | 416-020-1 | 96314-26-0 | Repr. 2
  Skin Sens. 1 | H361f *** H317 | GHS08
  GHS07
  Wng | H361f *** H317 | | | |
| 607-414-00-6 | tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazin-2,4,6-triyltriimino)tribenzoat | 402-070-1 | 88122-99-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-415-00-1 | poly-(methylmethacrylat)-co-(butylmethacrylat)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzylcarbamat)-co-(maleinsyreanhydrid) | 419-590-1 | — | Flam. Sol. 1
  Skin Sens. 1 | H228
  H317 | GHS02
  GHS07
  Dgr | H228
  H317 | | | T |
| 607-416-00-7 | 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamid | 420-730-7 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-417-00-2 | 3-chlorpropylchlorformiat | 425-770-9 | 628-11-5 | Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H331
  H302
  H373 ** H315
  H318
  H317 | GHS06
  GHS05
  GHS08
  Dgr | H331
  H302
  H373 ** H315
  H318
  H317 | | | |
| 607-418-00-8 | 2-ethylhexyl-4-aminobenzoat | 420-170-3 | 26218-04-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-419-00-3 | (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-yliden)-1-methyl-ethyliden)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-eddikesyre | 422-240-9 | 166596-68-5 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-420-00-9 | 2,2-bis(hydroxymethyl)butansyre | 424-090-1 | 10097-02-6 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-421-00-4 | cypermethrin cis/trans +/- 40/60; α-cyan-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat | 257-842-9 | 52315-07-8 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H335
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H302
  H335
  H410 | | | |
| 607-422-00-X | α-cypermethrin (ISO); racemat bestående af (R)-α-cyan-3-phenoxybenzyl-(1S,3S)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat og (S)-α-cyan-3-phenoxybenzyl-(1R,3R)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat | 257-842-9 | 67375-30-8 | Acute Tox. 3 * STOT RE 2 * STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H373 ** H335
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H373 ** H335
  H410 | | M = 1 000 | |
| 607-423-00-5 | mechlorprop og mechlorprop-P, estere heraf | — | — | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | A |
| 607-424-00-0 | trifloxystrobin (ISO); (E,E)-α-(methoxyimino)-2-[[[[1-[3-(trifluormethyl)phenyl]ethyliden]amino]oxy]methyl]phenyleddikesyremethylester | — | 141517-21-7 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-425-00-6 | metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-.sc.DL.sc.-alaninat | 260-979-7 | 57837-19-1 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H317
  H412 | GHS07
  Wng | H302
  H317
  H412 | | | |
| 607-426-00-1 | 1,2-benzendicarboxylsyredipentylester, forgrenet og ligekædet; [1] isopentyl-n-pentylphthalat; [2] dipentylphthalat; [3] diisopentylphthalat [4] | 284-032-2 [1]
  - [2]
  205-017-9 [3]
  210-088-4 [4] | 84777-06-0 [1]
  - [2]
  131-18-0 [3]
  605-50-5 [4] | Repr. 1B
  Aquatic Acute 1 | H360FD H400 | GHS08
  GHS09
  Dgr | H360FD H400 | | | |
| 607-427-00-7 | bromoxynil-heptanoat (ISO); 2,6-dibrom-4-cyanphenylheptanoat | 260-300-4 | 56634-95-8 | Repr. 2
  Acute Tox. 4 * Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d *** H332
  H302
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361d *** H332
  H302
  H317
  H410 | | | |
| 607-428-00-2 | tetranatrium-ethylendiamintetraacetat | 200-573-9 | 64-02-8 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 607-429-00-8 | edetinsyre; (EDTA) | 200-449-4 | 60-00-4 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-430-00-3 | BBP; benzylbutylphthalat | 201-622-7 | 85-68-7 | Repr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H400
  H410 | GHS08
  GHS09
  Dgr | H360Df
  H410 | | | |
| 607-431-00-9 | prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat | 245-387-9 | 23031-36-9 | Acute Tox. 3 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H302
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H302
  H410 | | | |
| 607-432-00-4 | S-metolachlor; blanding af (S)-2-chlor-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamid (80-100 %); [1](R)-2-chlor-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamid (0-20 %) [2] | - [1]
  - [2] | 87392-12-9 [1]
  178961-20-1 [2] | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-433-00-X | cypermethrin cis/trans +/- 80/20; (RS)-α-cyan-3-phenoxybenzyl(1RS;3RS; 1RS,3SR)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat | 257-842-9 | 52315-07-8 | Acute Tox. 4 * STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H335
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H335
  H315
  H317
  H410 | | | |
| 607-434-00-5 | mecoprop-P [1] og salte heraf; (R)-2-(4-chlor-2-methylphenoxy)propionsyre | 240-539-0 | 16484-77-8 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 607-435-00-0 | 2S-isopropyl-5R-methyl-1R-cyclohexyl-2,2-dihydroxyacetat | 416-810-6 | 111969-64-3 | STOT RE 2 *
  Eye Dam. 1
  Aquatic Chronic 2 | H373 ** H318
  H411 | GHS08
  GHS05
  GHS09
  Dgr | H373 ** H318
  H411 | | | |
| 607-436-00-6 | 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoat | 417-350-9 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | | |
| 607-437-00-1 | 3-(4-aminophenyl)-2-cyano-2-propensyre | 417-480-6 | 252977-62-1 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-438-00-7 | methyl-2-[(aminosulfonyl)methyl]benzoat | 419-010-5 | 112941-26-1 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 607-439-00-2 | methyl tetrahydro-2-furancarboxylat | 420-670-1 | 37443-42-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-440-00-8 | methyl 2-aminosulfonyl-6-(trifluormethyl)pyridin-3-carboxylat | 421-220-7 | 144740-59-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-441-00-3 | 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionsyre | 421-490-6 | 167684-63-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-442-00-9 | benzyl-[hydroxy-(4-phenylbutyl)phosphinyl]acetat | 416-050-5 | 87460-09-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-444-00-X | blanding af cis-1,4-dimethylcyclohexyldibenzoat og trans-1,4-dimethylcyclohexyldibenzoat | 416-230-3 | 35541-81-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-445-00-5 | jern (III) tris(4-methylbenzensulfonat) | 420-960-8 | 77214-82-5 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-446-00-0 | methyl-2-[4-(2-chlor-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionat | 416-240-8 | 155522-12-6 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 607-447-00-6 | natrium-4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzensulfonat | 416-370-5 | 156738-27-1 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-448-00-1 | 2,3,5,6-tetrafluorbenzoesyre | 416-800-1 | 652-18-6 | Skin Irrit. 2
  Eye Dam. 1 | H315
  H318 | GHS05
  Dgr | H315
  H318 | | | |
| 607-449-00-7 | en blanding af 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazin-1,3,5-triyl)tris[methylen(3,5,5-trimethyl-3,1-cyclohexandiyl)iminocarbonyloxy-2,1-ethandiyl(ethyl)amino]]trisbenzendiazoniumtri[bis(2-methylpropyl)naphthalensulfonat] og 4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexandiyl)methylen]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazin-1,1',3,3'-tetrayl]tetrakis[methylen(3,5,5-trimethyl-3,1-cyclohexandiyl)iminocarbonyloxy-2,1-ethandiyl(ethyl)amino]]tetrakisbenzendiazoniumtetra[bis(2-methylpropyl)naphthalensulfonat] | 417-080-1 | — | Self-react. D
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H242
  H317
  H400
  H410 | GHS02
  GHS07
  GHS09
  Dgr | H242
  H317
  H410 | | | |
| 607-450-00-2 | 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetat | 419-040-9 | 89604-92-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-451-00-8 | 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzensulfonsyre, natriumsalt | 417-640-5 | 161935-19-9 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-453-00-9 | 4-benzyl-2,6-dihydroxy-4-azaheptylen bis(2,2-dimethyloctanoat) | 418-100-1 | 172964-15-7 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 607-454-00-4 | blanding af trans-2-(1-methylethyl)-1,3-dioxan-5-carboxylsyre og cis-2-(1-methylethyl)-1,3-dioxan-5-carboxylsyre | 418-170-3 | 116193-72-7 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-455-00-X | 1-amino-4-(3-[4-chlor-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinon-2-sulfonsyre, na/li-salt | 419-520-8 | 172890-93-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-456-00-5 | 3-amino-4-chlorbenzoesyre, hexadecylester | 419-700-6 | 143269-74-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-457-00-0 | tetranatriumdihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazin-4,2-diyl-imino)]bis(2,2'-azonaphthalen-1',3,6-trisulfonat) | 420-350-1 | 172277-97-3 | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 607-458-00-6 | en blanding af 2-ethyl-[2,6-dibrom-4-[1-[3,5-dibrom-4(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoat og 2,2'-diethyl-[4,4'-bis(2,6-dibromphenoxy)-1-methylethyliden] dipropenoat og 2,2'-[(1-methylethyliden)bis[[2,6-dibrom-4,1-phenylen)oxy]ethanol]] | 420-850-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-459-00-1 | isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridyliden]hydrazino}benzoat | 418-930-4 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-460-00-7 | 3-tridecyloxy-propyl-ammonium 9-octadecenoat | 418-990-1 | 778577-53-0 | STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 ** H319
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H373 ** H319
  H315
  H410 | | | |
| 607-461-00-2 | blanding af pentanatrium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethansulfonyl)-phenylamino]-1.3.5-triazin-2-ylamino}-benzen-1,4-disulfonat og
  pentanatrium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethansulfonyl)-phenylamino]-1.3.5-triazin-2-ylamino}-benzen-1,4-disulfonat | 421-160-1 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-462-00-8 | en blanding af 1-hexylacetat og 2-methyl-1-pentylacetat og 3-methyl-1-pentylacetat og 4-methyl-1-pentylacetat og andre blandede ligekædede og forgrenede C6-alkylacetater | 421-230-1 | 88230-35-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-463-00-3 | 3-(phenothiazin-10-yl)propionsyre | 421-260-5 | 362-03-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-464-00-9 | en blanding af blanding af 7-chlor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyre og
  5-chlor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyre | 421-280-4 | | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-465-00-4 | tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalen-1,3-disulfonat | 421-440-3 | 778583-04-3 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-466-00-X | blanding af phenyl 1-(1-[2-chlor-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazol-5-carboxylat og phenyl 2-(1-(2-chlor-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazol-5-carboxylat og phenyl 3-(1-(2-chlor-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazol-5-carboxylat | 421-480-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-467-00-5 | 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate | 419-430-9 | 56533-00-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
  Skin Corr. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H373 ** H314
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H373 ** H314
  H410 | | | |
| 607-468-00-0 | en blanding af mononatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat og
  dinatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat og
  trinatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat og
  tetranatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat | 419-450-8 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-469-00-6 | dinatrium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalensulfonat | 419-460-2 | 120029-06-3 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-470-00-1 | kalium natrium 6,13-dichlor-3,10-bis{2-[4-[3-(2-idrossisulfonylossiethansulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino-[2,3-b]phenoxazin-4,11-disulfonat | 414-100-0 | 154336-20-6 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-471-00-7 | 1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexan | 429-280-6 | 151900-44-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-473-00-8 | pentaerythritol, dipentaerythritol, fedtsyrer, C6-10, blandede estere med adipinsyre, heptansyre og isostearinsyre | 426-590-3 | 187412-41-5 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-474-00-3 | (4-(-4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo2-pyrazolin-1-yl)benzoesyre | 410-430-4 | 117573-89-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-475-00-9 | blanding (50/50) af tetranatrium-7-(4-[4-chlor-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat og tetranatrium-7-(4-[4-chlor-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat | 412-940-2 | 148878-18-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-476-00-4 | N, N-bis(carbossimetil)-β-alanina di trisodio | 414-070-9 | 129050-62-0 | Skin Corr. 1B
  Aquatic Chronic 3 | H314
  H412 | GHS05
  Dgr | H314
  H412 | | | |
| 607-477-00-X | (1α,5α,6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexan-methansulfonatsalt | 426-740-8 | — | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 607-478-00-5 | tetramethylammoniumhydrogenphthalat | 416-900-5 | 79723-02-7 | Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 | H301
  H373 ** H400 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H373 ** H400 | | | |
| 607-479-00-0 | hexadecyl 4-chlor-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoat | 418-550-9 | 168689-49-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-480-00-6 | 1,2-benzendicarboxylsyre, di-C7-11-forgrenede og ligekædede alkylestere | 271-084-6 | 68515-42-4 | Repr. 1B | H360Df | GHS08
  Dgr | H360Df | | | |
| 607-481-00-1 | blanding af trihexylcitrat; dihexyloctylcitrat, dioctylhexylcitrat og dihexyldecylcitrat | 430-290-8 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-482-00-7 | N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydrid | 430-360-8 | 84793-24-8 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-483-00-2 | 1,2-benzendicarboxylsyre; di-C6-8-forgrenede og lineære alkylestere, C7-rige | 276-158-1 | 71888-89-6 | Repr. 1B | H360D *** | GHS08
  Dgr | H360D *** | | | |
| 607-484-00-8 | ethyl-2-{[3-acetylamino-4-(6-brom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionat | 430-480-0 | 221452-67-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-485-00-3 | (3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorphenyl)-1-piperidincarboxylat | 430-510-2 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-486-00-9 | kaliumnatrium-5'-(6-chlor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalen-1,2',5,7'-disulfonat | 402-110-8 | 110081-40-8 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-487-00-4 | blanding af dinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienyliden)-4,5-dihydro-5-oxopyrazol-1-yl)benzensulfonatog trinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienyliden)-4,5-dihydro-5-oxopyrazol-1-yl)benzensulfonat | 402-660-9 | — | Repr. 1B
  Aquatic Chronic 3 | H360D *** H412 | GHS08
  Dgr | H360D *** H412 | | | |
| 607-488-00-X | ethyl (2-acetylamino-5-fluor-4-isothiocyanatphenoxy)acetat | 414-210-9 | 147379-38-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-489-00-5 | en blanding af 2-ethylhexyllinolenat, linolat og olat og 2-ethylhexylepoxyolat og 2-ethylhexyldiepoxylinolat og
  2-ethylhexyltriepoxylinolenat | 414-890-7 | 71302-79-9 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-490-00-0 | N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methylglycinat | 415-060-7 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-491-00-6 | blanding af diester af 4,4'-methylenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonsyre (1:2) og
  triester af 4,4'-methylenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonsyre (1:3) | 427-140-9 | — | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 607-492-00-1 | 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methylpropylpropanoat | 415-490-5 | 141773-73-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-493-00-7 | methyl-(3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazol-6-carboxylat | 415-670-3 | 78850-37-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-494-00-2 | bis(2-ethylhexyl)octylphosphonat | 417-170-0 | 52894-02-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-495-00-8 | natrium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoat | 417-550-6 | 168151-92-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-496-00-3 | 2,2'-methylenbis(4,6-di-tert-butyl-phenyl)-2-ethylhexylphosphit | 418-310-3 | 126050-54-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-497-00-9 | ceriumoxidisostearat | 419-760-3 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-498-00-4 | (E)-3,7-dimethyl-2,6-octadienylhexadecanoat | 421-370-3 | 3681-73-0 | Skin Irrit. 2
  Aquatic Chronic 4 | H315
  H413 | GHS07
  Wng | H315
  H413 | | | |
| 607-499-00-X | bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethandiyl-bis(2-hexadecenylsuccinat) | 421-660-1 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 607-500-00-3 | calcium 2,2,bis[(5-tetrapropylen-2-hydroxy)phenyl]ethanoat | 421-670-4 | — | Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H410 | | | |
| 607-501-00-9 | blanding af triphenylthiophosphat og tertiære butylerede phenylderivater | 421-820-9 | 192268-65-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-502-00-4 | (N-benzyl-N, N,N-tributyl)ammonium 4-dodecylbenzensulfonat | 422-200-0 | 178277-55-9 | Skin Corr. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H314
  H302
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H302
  H411 | | | |
| 607-503-00-X | 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinan | 422-210-5 | 68957-94-8 | Skin Corr. 1B | H314 | GHS05
  Dgr | H314 | | | |
| 607-504-00-5 | diammonium-1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxy-phenylazo)-7-amino-3-naphthalensulfonat | 422-670-7 | — | Repr. 2
  Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1
  Aquatic Chronic 1 | H361f
  H301
  H373 ** H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361f
  H301
  H373 ** H410 | | | |
| 607-505-00-0 | pentanatrium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chlor-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat | 422-930-1 | | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-506-00-6 | blanding af strontium-(4-chlor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzensulfonat og
  dinatrium-(4-chlor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzensulfonat | 422-970-8 | | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-507-00-1 | kalium, natrium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzensulfonat | 422-980-2 | 187026-95-5 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-508-00-7 | dinatrium 3,3'-[iminobis[sulfonyl-4,1-phenylen-(5-hydroxy-3-methylpyrazol-1,4-diyl)azo-4,1-phenylensulfonylimino-(4-amino-6-hydroxypyrimidin-2,5-diyl)azo-4,1-phenylensulfonylimino(4-amino-6-hydroxypyrimidin-2,5-diyl)azo]bis(benzensulfonat)] | 423-110-4 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-509-00-2 | 2-phenoxyethyl-4-aminobenzoat | 430-880-5 | 88938-23-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-510-00-8 | (2S,5R)-6,6-dibrom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylsyre-4,4-dioxid | 427-200-4 | 76646-91-8 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H302
  H315
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H315
  H318
  H317 | | | |
| 607-511-00-3 | en blanding af 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxosmørsyre og
  4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxosmørsyre | 423-750-4 | — | Eye Irrit. 2
  Aquatic Chronic 2 | H319
  H411 | GHS07
  GHS09
  Wng | H319
  H411 | | | |
| 607-512-00-9 | trinatrium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzensulfonat | 423-970-0 | 182926-43-8 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-513-00-4 | en blanding af trinatrium 4-benzoylamiino-6-(6-ethensulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hyroxynaphthalen-2,7-disulfonat og
  5-(benzoylamino)-4-hyroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphtyl)azo)naphthalen-2,7-disulfonsyre natriumsalt og
  5-(benzoylamino)-4-hyroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphtyl)azo)naphthalen-2,7-disulfonsyre | 423-200-3 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 607-514-00-X | kalium-N-(1-methoxy-1-oxobut-2-en-3-yl)valinat | 427-240-2 | 134841-35-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-515-00-5 | en blanding af dinatrium hexyldiphenyletherdisulfonat og dinatrium dihexyldiphenyletherdisulfonat | 429-650-7 | 147732-60-3 | Eye Irrit. 2
  Aquatic Chronic 2 | H319
  H411 | GHS07
  GHS09
  Wng | H319
  H411 | | | |
| 607-516-00-0 | N, N'-bis(trifluoracetyl)-S,S'-bis-.sc.L.sc.-homocystein | 429-670-6 | 105996-54-1 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-517-00-6 | (S)-α-(acetylthio)benzenpropansyre | 430-300-0 | 76932-17-7 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H318
  H317 | | | |
| 607-518-00-1 | 3-oxoandrost-4-en-17β-carboxylsyre | 414-990-0 | 302-97-6 | Repr. 2
  Aquatic Chronic 4 | H361f
  H413 | GHS08
  Wng | H361f
  H413 | | | |
| 607-519-00-7 | poly-[((4-((4-ethyl-ethylen)amino)phenyl)-(4-(ethyl-(2-oxyethylen)amino)phenyl)methinyl)cyclohexa-2,5-dienyliden)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetat] | 427-280-0 | 176429-27-9 | STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H335
  H315
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H335
  H315
  H318
  H410 | | | |
| 607-520-00-2 | blanding af natrium-4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphat og
  dinatrium-4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphat | 427-740-0 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-521-00-8 | tetraethyl-N, N'-(methylendicyclohexan-4,1-diyl)bis-DL-aspartat | 429-270-1 | 136210-30-5 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-522-00-3 | natriumsalt af polymer af natrium-2-methyl-buta-1,3-dien-1-sulfonat med acrylsyre og 2-hydroxyethyl-2-methylacrylat | 429-720-7 | 184246-86-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-523-00-9 | blanding af mono- til tetra(lithium og/eller natrium)-3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6,13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og
  mono- til tetra(lithium og/eller natrium)-3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6,13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og
  mono- til penta(lithium og/eller natrium)-10,10'-diamino-6,6',13,13'-tetrachlor-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og
  mono- til hepta(lithium og/eller natrium)-10-amino-6,6',13,13'-tetrachlor-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og
  mono- til hepta(lithium og/eller natrium)-10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylendiiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat | 430-200-7 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-524-00-4 | tallolie-2-[(tetrahydro-2H-pyran-2-yl)thio]ethylestere | 430-310-5 | — | Aquatic Chronic 4 | H413 | | H413 | | | |
| 607-525-00-X | (Z)-2-methoxyimino-2-[2-(tritylamino)thiazol-4-yl]eddikesyre | 431-520-1 | 64485-90-1 | Flam. Sol. 1 **** Carc. 2
  Aquatic Chronic 3 | H228
  H351
  H412 | GHS02
  GHS08
  Dgr | H228
  H351
  H412 | | | |
| 607-526-00-5 | cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propan | — | 15263-53-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-527-00-0 | en blanding af 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl) 12-(1''H,1''H,2''H,2''H-tridecafluoroctyl)dodecandioat og
  1-(1'H,1'H,2'H,2'H-tridecafluoroctyl) 12-(1''H,1''H,2''H,2''H-heptdecafluordecyl)dodecandioat og
  1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)12-(1''H,1''H,2''H,2''H-heneicosafluordodecyl)dodecandioat og
  1-(1'H,1'H,2'H,2'H-tridecafluoroctyl) 12-(1''H,1''H,2''H,2''H-pentacosafluortetradecyl)dodecandioat og 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl) 12 (1''H,1''H,2''H,2''H-heptadecafluordecyl)dodecandioat og 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl) 12-(1''H,1''H,2''H,2''H-heneicosafluordodecyl)dodecandioat | 423-180-6 | — | STOT RE 2 * | H373 ** | GHS08
  Wng | H373 ** | | | |
| 607-528-00-6 | (S)-3-methyl-2-(2-oxotetrahydropyrimidin-1-yl)smørsyre | 430-900-2 | 192725-50-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-529-00-1 | benzyl-cis-4-ammonium-4'-toluensulfonato-1-cyclohexancarboxylat | 426-070-6 | 67299-45-0 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-530-00-7 | blanding af isomerer af C7-9-alkyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionat | 406-040-9 | 125643-61-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-531-00-2 | methyl-3-amino-4,6-dibrom-2-methyl-benzoat | 425-190-6 | 119916-05-1 | STOT RE 2 *
  Aquatic Chronic 2 | H373 ** H411 | GHS08
  GHS09
  Wng | H373 ** H411 | | | |
| 607-532-00-8 | (S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentancarboxylsyre, cyclohexylaminsalt | 425-510-4 | 167944-94-7 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-533-00-3 | pentanatrium-monohydrogen-6-chlor-3,10-bis[2-[4-chlor-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5,6][1,4]oxazino[2,3-b]phenoxazin-4,11-disulfonat | 414-910-4 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-534-00-9 | ethyl-2-(3-benzoylphenyl)propanoat | 414-920-9 | 60658-04-0 | Acute Tox. 3 * STOT RE 1
  Skin Sens. 1
  Aquatic Chronic 2 | H301
  H372 ** H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H372 ** H317
  H411 | | | |
| 607-535-00-4 | kalium-4-iod-2-sulfonato-benzoesyre | 426-620-5 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-536-00-X | (2,6-xylyloxy)eddikesyre | 430-910-7 | 13335-71-2 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 607-537-00-5 | isopropylammonium-2-(3-benzoylphenyl)propionat | 417-970-1 | — | Acute Tox. 3 * Acute Tox. 4 * STOT RE 1
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H312
  H372 ** H318
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H301
  H312
  H372 ** H318
  H410 | | | |
| 607-539-00-6 | propyl-((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethylenamino)acetat | 431-000-2 | 198705-81-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-540-00-1 | 1-(mercaptomethyl)cyclopropyleddikesyre | 420-240-3 | 162515-68-6 | Skin Corr. 1B
  Acute Tox. 4 * Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H314
  H312
  H302
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H312
  H302
  H317
  H411 | | | |
| 607-541-00-7 | [(1-methyl-1,2-ethandiyl)bis[nitrilobis(methylen)]]tetrakis(phosphonsyre) | 421-940-1 | 28698-31-9 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 607-542-00-2 | methyl-2-(4-butansulfonamido-phenoxy)tetradecanoat | 422-110-1 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-543-00-8 | poly-[((4-((4-(ethyl-ethylen)amino)phenyl)-(4-(ethyl-(2-oxyethylen)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienyliden)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetat] | 427-480-8 | 176429-22-4 | STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H335
  H315
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H335
  H315
  H318
  H410 | | | |
| 607-544-00-3 | ethyl-6,8-difluor-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinolin-3-carboxylat | 427-490-2 | 158585-86-5 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-545-00-9 | 1,2-dimethyl-3-(1-methylethenyl)cyclopentylacetat | 424-070-0 | 94346-09-5 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 607-546-00-4 | blanding af methyl-{[5-acetylamino-4-(2-chlor-4-nitro-phenylazo)phenyl]methoxy-carbonylmethylamino}acetat og
  methyl-{[5-acetylamino-4-(2-chlor-4-nitro-phenylazo)phenyl]ethoxy-carbonylmethylamino}acetat | 424-290-7 | 188070-47-5 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-547-00-X | 18-methylnonadecyl-2,2-dimethylpropanoat | 424-370-1 | 125496-22-2 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H315
  H317
  H413 | GHS07
  Wng | H315
  H317
  H413 | | | |
| 607-548-00-5 | 1-(2,4-dichlorphenyl)-2-(1H-imidazol-1-yl)ethanonmethansulfonat | 431-010-7 | 154486-26-7 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 607-549-00-0 | methyl-(E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoat | 424-430-7 | 125778-19-0 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-550-00-6 | 2-amino-4-brom-5-chlorbenzoesyre | 424-700-4 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-551-00-1 | tetrabutylammonium-2-amino-6-iodpurinat | 424-710-9 | 156126-48-6 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H312
  H302
  H373 ** H315
  H318
  H317
  H411 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H312
  H302
  H373 ** H315
  H318
  H317
  H411 | | | |
| 607-552-00-7 | hexadecyl-3-amino-4-isopropoxybenzoat | 424-830-1 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-553-00-2 | 7-amino-4-hydroxy-2-naphthalensulfonsyre, koblet med 5 (eller 8) -amino-8 (eller 5)-[[4-[[4-[[4-amino-6 (eller 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalensulfonsyre og 4-hydroxy-7-(phenylamino)-2-naphthalensulfonsyre, natriumsalt | 424-850-0 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-554-00-8 | 2,4-diamino-5-[4-[(2-sulfoxylethyl)sulfonyl]phenylazo]benzensulfonsyre | 424-870-1 | 27624-67-5 | Expl. 1,1
  Eye Dam. 1
  Aquatic Chronic 3 | H201
  H318
  H412 | GHS01
  GHS05
  Dgr | H201
  H318
  H412 | | | |
| 607-555-00-3 | 1,1,3,3-tetramethylbutylperoxypivalat | 424-980-8 | 22288-41-1 | Flam. Liq. 2
  Org. Perox. D
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H225
  H242
  H315
  H317
  H411 | GHS02
  GHS07
  GHS09
  Dgr | H225
  H242
  H315
  H317
  H411 | | | |
| 607-556-00-9 | 2-acetoxymethylen-4-acetylphenylacetat | 425-160-2 | 24085-06-1 | Acute Tox. 4 * STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09 Dgr | H302
  H373 ** H318
  H317
  H410 | | | |
| 607-557-00-4 | salt af (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol og [R-[R*R*]]-2,3-dihydroxybutandisyre | 425-210-3 | 169939-84-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-558-00-X | 2S-isopropyl-5R-methyl-1R-cyclohexyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]-oxathiolan-2-carboxylat | 425-250-1 | 147027-10-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-559-00-5 | kokosolie, reaktionsprodukter med glycerolestere af 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenpropansyre | 425-400-6 | 179986-09-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-560-00-0 | (R,S)-2-butyloctandisyre | 431-210-4 | 50905-10-7 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-561-00-6 | natrium-4-hydroxy-3-(N'-(2-(2-hydroxyethylensulfonyl)ethylen)ureido)-5-nitro-benzensulfonat | 425-460-3 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-562-00-1 | en blanding af (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium-methansulfonat og
  (2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium-methansulfonat | 425-530-3 | 98769-75-6 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 607-563-00-7 | 5,7-dichlor-4-hydroxyquinolin-3-carboxylsyre | 431-250-2 | 171850-30-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-564-00-2 | 1,6-hexandiammonium-natrium-5-sulfato-1,3-benzendicarboxylat | 425-730-0 | 51178-75-7 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-565-00-8 | 3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat | 425-820-1 | 88150-42-9 | Acute Tox. 3 * STOT RE 2 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H373 ** H318
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H301
  H373 ** H318
  H410 | | | |
| 607-566-00-3 | blanding af dodecylphenyl-dodecylhydroxybenzencarboxylat og
  bis(dodecylphenyl)dodecyl-hydroxybenzendicarboxylat | 426-140-6 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-567-00-9 | kalium-3-iod-6-methylbenzensulfonat | 426-300-5 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-568-00-4 | kalium-2-chlor-3-(benzyloxy)propionat | 426-350-8 | 138666-92-9 | Acute Tox. 4 * STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H373 ** H318
  H317 | GHS05
  GHS08
  GHS07
  Dgr | H302
  H373 ** H318
  H317 | | | |
| 607-569-00-X | blanding af natrium-2-amino-4-(2,6-difluorpyrimidin-4-ylamino)benzensulfonat og
  natrium-2-amino-4-(4,6-difluorpyrimidin-4-ylamino)benzensulfonat | 426-470-0 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-570-00-5 | natrium-(6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylat monohydrat | 426-520-1 | 71420-85-4 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-571-00-0 | 2-cyclopenten-1-eddikesyre, 3-hydroxy-2-pentyl-, methylesteracetat | 431-400-7 | 57374-49-9 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-572-00-6 | diethyl-thiophosphoryl-(Z)-(2-aminothiazol-4-yl)methoxyimino acetat | 426-790-0 | 162208-27-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H373 ** H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H312
  H302
  H373 ** H317
  H410 | | | |
| 607-573-00-1 | blanding af dinatrium-7-(2,4-difluorpyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalen-2-sulfonat og dinatrium-7-(4,6-difluorpyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalen-2-sulfonat | 426-840-1 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-574-00-7 | [1R-(1α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butandioat | 426-890-4 | 77341-67-4 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-575-00-2 | 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-yliden]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoesyre triethylaminsalt | 426-900-7 | — | STOT SE 3
  Aquatic Chronic 3 | H335
  H412 | GHS07
  Wng | H335
  H412 | | | |
| 607-576-00-8 | forgrenet octyl-3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoat | 427-030-0 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-577-00-3 | (2R*,3S*)-2-(2,4-difluorphenyl)-3-(5-fluor-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonat | 427-100-0 | — | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H317
  H412 | | | |
| 607-578-00-9 | ethyl-4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazol-3-carboxylat | 427-110-5 | — | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 4 | H302
  H373 ** H413 | GHS08
  GHS07
  Wng | H302
  H373 ** H413 | | | |
| 607-579-00-4 | diethyl[(p-ethoxyanilino)methylen]malonat | 431-430-0 | 103976-28-9 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 607-580-00-X | ethyl-7-chlor-1-(2,4-difluorphenyl)-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylat | 422-360-1 | 100491-29-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-581-00-5 | ethyl-2-ethoxy-4-carboxymethylbenzoat | 427-630-2 | 99469-99-5 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-582-00-0 | blanding af tetranatrium-7-(4-(4-fluor-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat og tetranatrium-7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat | 427-650-1 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-583-00-6 | 4-amino-3-[[4-[[2-(sulfoxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalensulfonsyre | 427-680-5 | 188907-52-0 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 607-584-00-1 | trinatrium-3-[2-acetylamino-4-[4-chlor-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalen-1,5-disulfonat | 427-710-7 | 215612-56-9 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 607-585-00-7 | strontium-2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalen-1-sulfonat | 427-930-3 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-586-00-2 | dodecyl-3-amino-4-chlorbenzoat | 428-020-9 | 6195-20-6 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 607-587-00-8 | ethyl-cis-4-[4-[[2-(2,4-dichlorphenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-carboxylat | 428-030-3 | 67914-69-6 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H410 | | | |
| 607-588-00-3 | en blanding af 2-ethylhexyl-2,3,4,5-tetrabrombenzoat og bis(2-ethylhexyl)-3,4,5,6-tetrabromphthalat | 428-050-2 | — | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-589-00-9 | tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butantetracarboxylat | 428-070-1 | 91788-83-9 | STOT RE 1
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H372 ** H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H372 ** H302
  H410 | | | |
| 607-590-00-4 | hexadecyl-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoat | 428-140-1 | 210706-50-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-591-00-X | blanding af trinatrium-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfoxyethansulfonyl)phenylazo)naphthalen-2,7-disulfonat og dinatrium-3-(4-ethensulfonylphenylazo)-5 (4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalen-2,7-disulfonat | 428-400-4 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-592-00-5 | di(C9-11-alkyl)cyclohexan-1,4-dicarboxylat | 428-870-0 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-593-00-0 | 4-(2-methylacryloyloxy)phenyl-4-allyloxybenzoat | 429-000-2 | 159235-16-2 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-594-00-6 | ethyl-(1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-en-3-carboxylat | 429-020-1 | 204254-96-6 | STOT RE 2 *
  Skin Sens. 1 | H373 ** H317 | GHS08
  GHS07
  Wng | H373 ** H317 | | | |
| 607-595-00-1 | N-amidino-N-methylglycin-2-oxopropionat | 429-120-5 | 208535-04-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-596-00-7 | ethyl-2-(4-phenoxyphenyl)lactat | 429-220-9 | 132584-17-9 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-597-00-2 | tetranatrium-4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilben-2,2'-disulfonat | 429-230-3 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-598-00-8 | trinatrium-3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluor-1,3,5-triazin-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalen-2,7-disulfonat | 429-240-8 | 212652-59-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-599-00-3 | 1,1-dimethylpropyl-3,5,5-trimethylperoxyhexanoat | 431-610-9 | 68860-54-8 | Org. Perox. D
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H242
  H317
  H400
  H410 | GHS02
  GHS07
  GHS09
  Dgr | H242
  H317
  H410 | | | |
| 607-600-00-7 | (1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl-propanoat | 431-700-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-601-00-2 | 1,4-dihydroxy-2,2,6,6-tetramethylpiperidinium-2-hydroxy-1,2,3-propantricarboxylat | 429-370-5 | 220410-74-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-602-00-8 | ethyl-(3-cyanmethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetat | 429-680-0 | 122665-86-5 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-603-00-3 | lithium-natrium-4,4',4''-(nitrilotris(ethan-2,1-diylimino(6-chlor-1,3,5-triazin-4,2-diyl)imino))-tris(5-hydroxy-6-(1-sulfonaphthalen-2-ylazo)-2,7-naphthalen)disulfonat | 429-730-1 | 193562-37-7 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-604-00-9 | guanidiniumbenzoat | 429-820-0 | 26739-54-8 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-605-00-4 | methyl-4-iod-2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl)benzoat | 429-890-2 | 144550-06-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-606-00-X | (Z)-2-(2-tert-butoxycarbonylamino-4-thiazolyl)pent-2-ensyre | 430-100-3 | 86978-24-7 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-607-00-5 | en blanding af calcium-bis(C10-14 forgrenet alkyl-salicylat) og calcium-bis(C18-30-alkylsalicylat) og calcium-C10-14 forgrenet alkyl-salicylato-C18-30-alkylsalicylat og calcium-bis(C10-14 forgrenet alkyl-phenolat) og calcium-bis(C18-30-alkylphenolat) og calcium-C10-14 forgrenet alkyl-phenolato-C18-30-alkylphenolat og C10-14 forgrenet alkyl-phenol og C18-30-alkylphenol | 430-180-1 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 607-608-00-0 | pentakalium-2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-yliden]-3-(2-pyrrolidinon-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzen-1,4-disulfonat | 430-210-1 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-609-00-6 | ethyl-(3R)-4-cyan-3-hydroxybutanoat | 430-220-6 | 141942-85-0 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-610-00-1 | trinatrium-4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalen-2-sulfonat | 430-280-3 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-611-00-7 | methyl-3-amino-2,2,3-trimethylbutyrat | 431-720-7 | 90886-53-6 | Skin Corr. 1B
  Acute Tox. 4 *
  Aquatic Chronic 3 | H314
  H302
  H412 | GHS05
  GHS07
  Dgr | H314
  H302
  H412 | | | |
| 607-612-00-2 | blanding af 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluor-1-octansulfonsyre og ammonium-3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluor-1-octansulfonat | 432-190-1 | 182176-52-9 | Acute Tox. 4 * STOT RE 2 *
  Eye Dam. 1 | H302
  H373 ** H318 | GHS05
  GHS08
  GHS07
  Dgr | H302
  H373 ** H318 | | | |
| 607-613-00-8 | blanding af ravsyre; monoperoxyravsyre; diperoxyravsyre; monomethylester af ravsyre; monomethylester af peroxyravsyre; dimethylsuccinat; glutarsyre; monoperoxyglutarsyre; diperoxyglutarsyre; monomethylester af glutarsyre; monomethylester af peroxyglutarsyre; dimethylglutarat; adipinsyre; monoperoxyadipinsyre; diperoxyadipinsyre; monomethylester af adipinsyre; monomethylester af peroxyadipinsyre; dimethyladipat; hydrogenperoxid; methanol og vand | 432-790-1 | | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  Skin Corr. 1B STOT SE 2 | H332
  H312
  H302
  H314
  H371 (øjne) | GHS07
  GHS05
  GHS08
  Dgr | H332
  H312
  H302
  H314
  H371 (øjne) | | | |
| 607-614-00-3 | 2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)ravsyre | 426-480-5 | 63562-33-4 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 607-615-00-9 | reaktionsprodukt af thioglycerol og mercaptoeddikesyre, som hovedsagelig består af 3-mercapto-1,2-bismercaptoacetoxypropan og oligomerer heraf | 431-120-5 | — | Acute Tox. 3 * Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1 | H331
  H302
  H319
  H317 | GHS06
  Dgr | H331
  H302
  H319
  H317 | | | |
| 607-616-00-4 | 2,4-dichlor-5-fluorbenzoylchlorid | 428-390-1 | 86393-34-2 | STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H335
  H315
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H335
  H315
  H318
  H317
  H412 | | | |
| 607-617-00-X | bis(2-ethylhexyl)-4,5-epoxycyclohexan-1,2-dicarboxylat | 430-700-5 | 10138-36-0 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-618-00-5 | menadionnatriumbisulfit; 2-naphthalensulfonsyre, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, natriumsalt | 204-987-0 | 130-37-0 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H410 | | | |
| 607-619-00-0 | menadionnicotinamidbisulfit; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalen-2-sulfonsyre, forbindelse med nicotin-3-amid (1:1) | 277-543-7 | 73581-79-0 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H410 | | | |
| 607-620-00-6 | trinatriumnitrilotriacetat | 225-768-6 | 5064-31-3 | Carc. 2
  Acute Tox. 4 *
  Eye Irrit. 2 | H351
  H302
  H319 | GHS08
  GHS07
  Wng | H351
  H302
  H319 | | Carc. 2; H351: C
  ≥ 5 % | |
| 607-621-00-1 | milbemectin (ISO); [blanding af milbemycin A3 (CAS-nr. 51596-10-2) og milbemycin A4 (CAS-nr. 51596-11-3) (30:70)] | — | — | Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H302
  H410 | | M = 100 | |
| 607-622-00-7 | 2-ethylhexyl-2-ethylhexanoat | 231-057-1 | 7425-14-1 | Repr. 2 | H361d *** | GHS08
  Wng | H361d *** | | | |
| 607-624-00-8 | perfluoroctansulfonsyre; heptadecafluoroctan-1-sulfonsyre; [1] kaliumperfluoroctansulfonat;
  kaliumheptadecafluoroctan-1-sulfonat; [2] diethanolaminperfluoroctansulfonat; [3] ammoniumperfluoroctansulfonat; ammoniumheptadecafluoroctansulfonat; [4] lithiumperfluoroctansulfonat; lithiumheptadecafluoroctansulfonat [5] | 217-179-8 [1]
  220-527-1 [2]
  274-460-8 [3]
  249-415-0 [4]
  249-644-6 [5] | 1763-23-1 [1]
  2795-39-3 [2]
  70225-14-8 [3]
  29081-56-9 [4]
  29457-72-5 [5] | Carc. 2
  Repr. 1B
  STOT RE 1
  Acute Tox. 4 * Acute Tox. 4 *
  Lact.
  Aquatic Chronic 2 | H351
  H360D *** H372 **
  H332
  H302
  H362
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H351
  H360D *** H372 **
  H332
  H302
  H362
  H411 | | | |
| 607-625-00-3 | clodinafop-propargyl (ISO) | — | 105512-06-9 | Acute Tox. 4 * STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H317
  H410 | | Skin Sens. 1; H317: C ≥ 0,001  %
  M = 1 | |
| 607-626-00-9 | ethyl-1-(2,4-dichlorphenyl)-5-(trichlormethyl)-1H-1,2,4-triazol-3-carboxylat | 401-290-5 | 103112-35-2 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | | |
| 607-627-00-4 | [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzensulfonat | 416-360-0 | 162221-28-5 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-628-00-X | 4-oxo-4-(p-tolyl)smørsyre, addukt med 4-ethylmorpholin | 419-240-6 | 171054-89-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]eddikesyre | 419-270-1 | 123599-82-6 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-630-00-0 | acrylsyre, 3-(trimethoxysilyl)propylester | 419-560-6 | 4369-14-6 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H332
  H314
  H317
  H412 | GHS05
  GHS07
  Dgr | H332
  H314
  H317
  H412 | | | |
| 607-631-00-6 | en blanding af 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl-oxo(phenyl)acetat og (2-(2-hydroxyethoxy)ethyl)-oxo(phenyl)acetat | 442-300-8 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-632-00-1 | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamid | 420-210-1 | 111244-14-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-633-00-7 | trinatrium-5-{[4-chlor-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalendisulfonat | 440-480-2 | 341026-59-3 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-634-00-2 | (S)-(-)-2-acetoxypropionylchlorid; (1S)-2-chlor-1-methyl-2-oxoethylacetat | 420-610-4 | 36394-75-9 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H302
  H314
  H317 | GHS05
  GHS07
  Dgr | H302
  H314
  H317 | | | |
| 607-635-00-8 | trinatrium-N-(3-propionato)-L-aspartat | 422-090-4 | 172737-80-3 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-636-00-3 | 1-brom-2-methylpropylpropionat | 422-900-6 | 158894-67-8 | Flam. Liq. 3
  Carc. 2
  Skin Corr. 1B
  Skin Sens. 1 | H226
  H351
  H314
  H317 | GHS02
  GHS05
  GHS08
  GHS07
  Dgr | H226
  H351
  H314
  H317 | | | |
| 607-637-00-9 | dinatrium-8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalen-2-sulfonat | 423-730-5 | 250688-43-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-638-00-4 | 2-hydroxybenzoesyre-2-butyloctylester | 431-090-3 | 190085-41-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenylacetat | 431-770-1 | 216698-07-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-641-00-0 | 2-(formylamino)-3-thiophencarboxylsyre; 2-formamido-3-thiophencarboxylsyre | 431-930-9 | 43028-69-9 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 607-642-00-6 | 3,6,9-trithiaundecamethylen-1,11-dimethacrylat | 432-210-7 | 141631-22-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 607-643-00-1 | dimethyl (2S)-2-hydroxysuccinat | 432-310-0 | 617-55-0 | Flam. Liq. 3
  Eye Dam. 1
  Skin Sens. 1 | H226
  H318
  H317 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H318
  H317 | | | |
| 607-644-00-7 | methyl-2,2-dimethyl-6-methylencyclohexancarboxylat | 432-350-9 | 81752-87-6 | Skin Irrit. 2 | H315 | GHS07
  Wng | H315 | | | |
| 607-645-00-2 | tetranatrium-2-(4-fluor-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalen-1,7-disulfonat | 432-550-6 | 243858-01-7 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-646-00-8 | D-erythro-hexansyre-2,4-dideoxy-3,5-O-(1-methylethyliden)-1,1-dimethylethylester; tert-butyl-2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetat | 432-960-5 | 124655-09-0 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-647-00-3 | 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolan | 433-530-1 | 143446-73-5 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1 | H302
  H317
  H400 | GHS07
  GHS09
  Wng | H302
  H317
  H400 | | | |
| 607-649-00-4 | [3-(chlorcarbonyl)-2-methylphenyl]acetat | 433-690-0 | 167678-46-8 | Skin Corr. 1A
  Skin Sens. 1 | H314
  H317 | GHS05
  GHS07
  Dgr | H314
  H317 | | | |
| 607-650-00-X | 2-methyl-1,5-pentandiamin-1,3-benzendicarboxylat | 433-910-5 | 145153-52-2 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-651-00-5 | natrium-2-(nonanoyloxy)benzensulfonat | 434-360-9 | 91125-43-8 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-652-00-0 | ethyl-N2-dodecanoyl-L-argininathydrochlorid | 434-630-6 | 60372-77-2 | Eye Dam. 1
  Aquatic Acute 1 | H318
  H400 | GHS05
  GHS09
  Dgr | H318
  H400 | | | |
| 607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium)-3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalen-2-sulfonat | 434-840-8 | 225786-91-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-654-00-1 | (S)-3-hydroxy-γ-butyrolacton | 434-990-4 | 7331-52-4 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-655-00-7 | ethyl-6,8-dichloroctanoat | 435-080-1 | 1070-64-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-656-00-2 | natriumsalt af 4-amino-3,6-bis[[5-[[4-chlor-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalendisulfonsyre | 435-350-7 | 141250-43-3 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-657-00-8 | pentanatrium-7-(4-(4-(3-(2-sulfatoethansulfonyl)phenylamino)-6-(4-(2-sulfatoethansulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat | 436-920-8 | 172399-10-9 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-658-00-3 | 3,10-diamino-6,13-dichlor-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazindisulfonsyre, lithiumkaliumnatriumsalt | 440-770-9 | 371921-63-0 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-659-00-9 | pentanatrium-N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chlor-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropansyre | 442-030-0 | 321912-47-4 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-660-00-4 | 2-{4-[4-[4-fluor-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalen-4,6,8-trisulfonat, trinatriumsalt | 442-230-8 | 321679-52-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 607-661-00-X | 1,1-dimethylethyl-4'-(brommethyl)biphenyl-2-carboxylat | 442-850-9 | 114772-40-6 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 607-662-00-5 | methyl-2-(acetylamino)-3-chlorpropionat | 442-860-3 | 87333-22-0 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 607-663-00-0 | bis(2-ethylhexyl)-naphthalen-2,6-dicarboxylat | 442-980-6 | 127474-91-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-664-00-6 | methyl-2-chlorsulfonyl-4-(methansulfonylaminomethyl)benzoat | 443-120-2 | 393509-79-0 | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 607-665-00-1 | trans-methyl-2-ethyl-but-2-enoat | 443-150-6 | 101226-85-1 | Flam. Liq. 3 | H226 | GHS02
  Wng | H226 | | | |
| 607-666-00-7 | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentansyre | 443-560-5 | 88784-33-2 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 607-667-00-2 | chlor-1-ethylcyclohexylcarbonat | 444-950-8 | 99464-83-2 | Muta. 2
  Skin Sens. 1 | H341
  H317 | GHS08
  GHS07
  Wng | H341
  H317 | | | |
| 607-668-00-8 | trans-2-isopropyl-5-carboxy-1,3-dioxan | 445-770-2 | 42031-28-7 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 607-669-00-3 | methyl-(9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoat | 445-990-9 | 376588-17-9 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propylammoniumoxalat;
  (5-amino-2-butylbenzofuran-3-yl)-[4-(3-dibutylaminopropoxy)phenyl]methanon, dioxalat | 448-700-9 | 500791-70-8 | STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 ** H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H373 ** H318
  H317
  H410 | | M = 10 | |
| 607-671-00-4 | diethyl-1,4-cyclohexandicarboxylat | 417-310-0 | 72903-27-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 607-672-00-X | en blanding af 2-hydroxy-3-(methacryloyloxy)propyl-(2-benzoyl)benzoat; 1-hydroxymethyl-2-(methacryloyloxy)ethyl-(2-benzoyl)benzoat; x-hydroxy-y-(methacryloyloxy)propyl(eller -ethyl)-(2-benzoyl)benzoat | 419-000-0 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinoliniumtosylat | 419-570-0 | — | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 607-675-00-6 | blanding af cis-9-octadecendisyre; cis-9-cis-12-octadecadiendisyre; hexadecandisyre;
  octadecandisyre | 422-260-8 | — | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 607-676-00-1 | en blanding af 2-methylnonandisyre; 2,4-dimethyl-4-methoxycarbonylundecandisyre; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecandisyre; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecandisyre | 423-670-1 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 607-677-00-7 | 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinat | 424-660-8 | — | STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H373 ** H318
  H317 | GHS05
  GHS08
  GHS07
  Dgr | H373 ** H318
  H317 | | | |
| 607-678-00-2 | blanding af ethyl-(2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat og ethyl-(2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat | 427-090-8 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-679-00-8 | en blanding af 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3 (methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammoniumdi(acetat); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat) | 431-440-5 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 607-680-00-3 | tert-butyl(6-{2-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetat | 432-810-9 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-681-00-9 | en blanding af 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecansyre; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecansyre;
  dihexadecyl-9-nonyl-10-octylnonadecandioat; 1-octadecyl-19-hexadecyl-9-nonyl-10-octylnonadecandioat; dioctadecyl-9-nonyl-10-octylnonadecandioat | 432-910-2 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-682-00-4 | kompleks blanding af kinesisk gummiharpiks, efterfølgende behandlet med acrylsyre | 434-230-1 | 144413-22-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-683-00-X | blanding af methyl-3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat; methyl-3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat (20:80) | 435-450-0 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 607-684-00-5 | alkener, C12-14, hydroformyleringsprodukter, destillationsrester, C-(hydrogensulfobutandioater), dinatriumsalte | 435-660-2 | 243662-67-1 | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 607-685-00-0 | ammonium-2-cocoyloxyethansulfonat | 441-050-7 | — | Skin Irrit. 2
  Eye Dam. 1 | H315
  H318 | GHS05
  Dgr | H315
  H318 | | | |
| 607-686-00-6 | 6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylen-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonyloxy)-6-methyl-2-phenylen]di(naphthalen-1-sulfonat) | 441-550-5 | — | Self-react. C **** Carc. 2 | H242
  H351 | GHS02
  GHS08
  Dgr | H242
  H351 | | | |
| 607-687-00-1 | en blanding af 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);
  2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %) | 442-800-6 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 607-688-00-7 | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchlorid | 444-320-2 | — | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 607-689-00-2 | blanding af methyl-1,4-dimethylcyclohexancarboxylat (»para-isomer« inkl. cis- og trans-isomerer); methyl-1,3-dimethylcyclohexancarboxylat (»meta-isomer« inkl. cis- og trans-isomerer) | 444-920-4 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 607-690-00-8 | dimethyl-[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N, N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoat | 432-860-1 | 255387-46-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 607-691-00-3 | magnesiumsalte, fedtsyrer, C16-18- og C18-umættede, forgrenede og lineære | 448-690-6 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-692-00-9 | zinksalte, fedtsyrer, C16-18- og C18-umættede, forgrenede og lineære | 446-470-4 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-693-00-4 | hexyl-2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoat | 443-860-6 | 302776-68-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 607-694-00-X | ethyl-5,5-diphenyl-2-isoxazolin-3-carboxylat | 443-870-0 | 163520-33-0 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 607-696-00-0 | pentylformat | 211-340-6 | 638-49-3 | Flam. Liq. 3
  Eye Irrit. 2
  STOT SE 3 | H226
  H319
  H335 | GHS02
  GHS07
  Dgr | H226
  H319
  H335 | | | C |
| 607-697-00-6 | tert-butylpropionat | — | 20487-40-5 | Flam. Liq. 2 | H225 | GHS02
  Dgr | H225 | | | C |
| 607-698-00-1 | 4-tert-butylbenzoesyre | 202-696-3 | 98-73-7 | Repr. 1B
  STOT RE 1
  Acute Tox. 4 | H360F H372
  H302 | GHS07
  GHS08
  Dgr | H360F H372
  H302 | | | |
| 607-699-00-7 | bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chlor-3,3,3-trifluorprop-1-en-1-yl]-2,2-dimethylcyclopropancarboxylat | | 82657-04-3 | Carc. 2
  Acute Tox. 3
  Acute Tox. 2
  STOT RE 1
  Skin Sens. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H331
  H300
  H372 (nervesystem)
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H331
  H300
  H372 (nervesystem)
  H317
  H410 | | M = 10 000
  M = 100 000 | |
| 607-700-00-0 | indoxacarb (ISO); methyl (4aS)-7-chlor-2-{(methoxycarbonyl)[4-(trifluorme thoxy)phenyl]carbamoyl}-2,5- dihydroindeno[1,2-e][1,3,4]oxadiazin-4a(3H)-carboxylat [1]
  blanding af (S)-indoxacarb og (R)-indoxacarb 75:25; methyl 7-chlor-2-{(methoxy-carbonyl)[4-(triflourmethoxy)phenyl]-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazin-4a(3H)-carboxylat | | 173584-44-6 [1]
  144171-61-9 [2] | Acute Tox. 3
  Acute Tox. 4
  STOT RE 1
  Skin Sens. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H332
  H372 (blod, nervesystem, hjerte)
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H332
  H372 (blod, nervesystem, hjerte)
  H317
  H410 | | M = 1
  M = 1 | |
| 607-702-00-1 | dihexylphthalat | 201-559-5 | 84-75-3 | Repr. 1B | H360FD | GHS08
  Dgr | H360FD | | | |
| 607-703-00-7 | ammoniumpentadecafluoroctansyre | 223-320-4 | 3825-26-1 | Carc. 2
  Repr. 1B Lact.
  Acute Tox. 4
  Acute Tox. 4
  STOT RE 1
  Eye Dam.1 | H351
  H360D H362
  H332
  H302
  H372 (lever) H318 | GHS08
  GHS07
  GHS05
  Dgr | H351
  H360D H362
  H332
  H302
  H372 (lever) H318 | | | |
| 607-704-00-2 | perfluoroctansyre | 206-397-9 | 335-67-1 | Carc. 2
  Repr. 1B Lact.
  Acute Tox. 4
  Acute Tox. 4
  STOT RE 1
  Eye Dam. 1 | H351
  H360D H362
  H332
  H302
  H372 (lever) H318 | GHS08
  GHS07
  GHS05
  Dgr | H351
  H360D H362
  H332
  H302
  H372 (lever) H318 | | | |
| 607-705-00-8 | benzoesyre | 200-618-2 | 65-85-0 | STOT RE 1
  Skin Irrit. 2
  Eye Dam. 1 | H372 (lunger) (indånding) H315
  H318 | GHS08
  GHS05
  Dgr | H372 (lunger) (indånding) H315
  H318 | | | |
| 607-706-00-3 | methyl 2,5-dichlorbenzoat | 220-815-7 | 2905-69-3 | Acute Tox. 4
  STOT SE 3
  Aquatic Chronic 2 | H302
  H336
  H411 | GHS07
  GHS09
  Wng | H302
  H336
  H411 | | | |
| 608-001-00-3 | acetonitril; cyanmethan | 200-835-2 | 75-05-8 | Flam. Liq. 2
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2 | H225
  H332
  H312
  H302
  H319 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H319 | | | |
| 608-002-00-9 | trichloracetonitril | 208-885-7 | 545-06-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H411 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H411 | | | |
| 608-003-00-4 | acrylonitril | 203-466-5 | 107-13-1 | Flam. Liq. 2
  Carc. 1B
  Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H225
  H350
  H331
  H311
  H301
  H335
  H315
  H318
  H317
  H411 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H225
  H350
  H331
  H311
  H301
  H335
  H315
  H318
  H317
  H411 | | * | D |
| 608-004-00-X | 2-hydroxy-2-methylpropionitril; 2-cyan-2-propanol; acetonecyanhydrin | 200-909-4 | 75-86-5 | Acute Tox. 2 * Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H410 | | | |
| 608-005-00-5 | n-butyronitril | 203-700-6 | 109-74-0 | Flam. Liq. 2
  Acute Tox. 3 * Acute Tox. 3 *
  Acute Tox. 3 * | H225
  H331
  H311
  H301 | GHS02
  GHS06
  Dgr | H225
  H331
  H311
  H301 | | | |
| 608-006-00-0 | bromoxynil (ISO), 3,5-dibrom-4-hydroxybenzonitril; bromoxynil-phenol | 216-882-7 | 1689-84-5 | Repr. 2
  Acute Tox. 2 * Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d *** H330
  H301
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361d *** H330
  H301
  H317
  H410 | | M = 10 | |
| 608-007-00-6 | ioxynil (ISO); 4-hydroxy-3,5-diiodbenzonitril | 216-881-1 | 1689-83-4 | Repr. 2
  Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d *** H331
  H301
  H312
  H373 ** H319
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361d *** H331
  H301
  H312
  H373 ** H319
  H410 | | M = 10 | |
| 608-008-00-1 | chloracetonitril | 203-467-0 | 107-14-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H411 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H411 | | | |
| 608-009-00-7 | malononitril | 203-703-2 | 109-77-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | | |
| 608-010-00-2 | methacrylnitril; 2-methyl-2-propennitril | 204-817-5 | 126-98-7 | Flam. Liq. 2
  Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *
  Skin Sens. 1 | H225
  H331
  H311
  H301
  H317 | GHS02
  GHS06
  Dgr | H225
  H331
  H311
  H301
  H317 | | *
  Skin Sens. 1; H317: C ≥ 0,2  % | D |
| 608-011-00-8 | oxalonitril; cyanogen | 207-306-5 | 460-19-5 | Press. Gas
  Flam. Gas 1
  Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H220
  H331
  H400
  H410 | GHS02
  GHS04
  GHS06
  GHS09
  Dgr | H220
  H331
  H410 | | | U |
| 608-012-00-3 | benzonitril | 202-855-7 | 100-47-0 | Acute Tox. 4 * Acute Tox. 4 * | H312
  H302 | GHS07
  Wng | H312
  H302 | | | |
| 608-013-00-9 | 2-chlorbenzonitril | 212-836-5 | 873-32-5 | Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2 | H312
  H302
  H319 | GHS07
  Wng | H312
  H302
  H319 | | | |
| 608-014-00-4 | chlorothalonil (ISO); tetrachlorisophthalonitril | 217-588-1 | 1897-45-6 | Carc. 2
  Acute Tox. 2 * STOT SE 3
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H330
  H335
  H318
  H317
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H351
  H330
  H335
  H318
  H317
  H410 | | M = 10 | |
| 608-015-00-X | dichlobenil (ISO); 2,6-dichlorbenzonitril | 214-787-5 | 1194-65-6 | Acute Tox. 4 *
  Aquatic Chronic 2 | H312
  H411 | GHS07
  GHS09
  Wng | H312
  H411 | | | |
| 608-016-00-5 | 1,4-dicyano-2,3,5,6-tetra-chlor-benzen | 401-550-8 | 1897-41-2 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 608-017-00-0 | bromoxynil-octanoat (ISO); 2,6-dibrom-4-cyanophenyloctanoat | 216-885-3 | 1689-99-2 | Repr. 2
  Acute Tox. 3 * Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d *** H331
  H302
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361d *** H331
  H302
  H317
  H410 | | M = 10 | |
| 608-018-00-6 | ioxynil-octanoat (ISO); 4-cyan-2,6-diiodophenyloctanoat | 223-375-4 | 3861-47-0 | Repr. 2
  Acute Tox. 3 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d *** H301
  H319
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361d *** H301
  H319
  H317
  H410 | | M = 10 | |
| 608-019-00-1 | 2,2'-dimethyl-2,2'-azodipropiononitril; ADZN | 201-132-3 | 78-67-1 | Self-react. C
  Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Chronic 3 | H242
  H332
  H302
  H412 | GHS02
  GHS07
  Dgr | H242
  H332
  H302
  H412 | | | T |
| 608-020-00-7 | diphenoxymethylencyanamid | 427-300-8 | 79463-77-7 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 608-021-00-2 | 3-(2-(diaminomethylenamino)thiazol-4-ylmethylthio)propiononitril | 403-710-2 | 76823-93-3 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 608-022-00-8 | 3,7-dimethyloctannitril | 403-620-3 | 40188-41-8 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H315
  H317
  H411 | GHS07
  GHS09
  Wng | H315
  H317
  H411 | | | |
| 608-023-00-3 | fenbuconazol (ISO); 4-(4-chlorphenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butannitril | 406-140-2 | 114369-43-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 608-024-00-9 | 2-(4-(N-butyl-N-phenethylamino)phenyl)ethen-1,1,2-tricarbonitril | 407-650-8 | 97460-76-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 608-025-00-4 | 2-nitro-4,5-bis(benzyloxy)phenylacetonitril | 410-970-0 | 117568-27-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 608-026-00-X | 3-cyano-3,5,5-trimethylcyclohexanon | 411-490-4 | 04-11-7027 | Acute Tox. 4 * STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H373 ** H317
  H412 | GHS08
  GHS07
  Wng | H302
  H373 ** H317
  H412 | | | |
| 608-027-00-5 | en blanding af 3-(4-ethylphenyl)-2,2-dimethylpropannitril; 3-(2-ethylphenyl)-2,2-dimethylpropannitril;
  3-(3-ethylphenyl)-2,2-dimethylpropannitril | 412-660-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 608-028-00-0 | 4-(2-cyano-3-phenylamino)-acryloyloxy-methyl-cyclohexyl-methyl-2-cyano-3-phenylamino)-acrylat | 413-510-7 | 147374-67-2 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H373 ** H317
  H411 | GHS08
  GHS09
  Wng | H373 ** H317
  H411 | | | |
| 608-029-00-6 | 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridincarbonitril | 411-990-2 | 68612-94-2 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 608-030-00-1 | N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthiazol-5-yl-methylen)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamid | 412-340-0 | 147741-93-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 608-031-00-7 | 2-benzyl-2-methyl-3-butenitril | 407-870-4 | 97384-48-0 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 608-032-00-2 | acetamiprid (ISO);
  (E)-N1-[(6-chlor-3-pyridyl)methyl]-N2-cyan-N1-methylacetamidin | — | 135410-20-7 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 608-033-00-8 | N-butyl-3-(2-chlor-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-en-1,3-dicarboximid | 407-970-8 | 75511-91-0 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 608-034-00-3 | chlorfenapyr (ISO); 4-brom-2-(4-chlorphenyl)-1-ethoxymethyl-5-trifluormethylpyrrol-3-carbonitril | — | 122453-73-0 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H302
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H302
  H410 | | M = 100 | |
| 608-035-00-9 | (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorbenzen-aceto-nitril | 419-290-9 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 608-036-00-4 | 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitril | 419-060-8 | 79026-02-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 608-037-00-X | en blanding af (E)-2,12-tridecadiennitril; (E)-3,12-tridecadiennitril; (Z)-3,12-tridecadiennitril | 422-190-8 | | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 608-038-00-5 | 2,2,4-trimethyl-4-phenyl-butannitril | 422-580-8 | 75490-39-0 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 608-039-00-0 | 2-phenylhexannitril | 423-460-8 | 3508-98-3 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 608-040-00-6 | 4,4'-dithiobis(5-amino-1-(2,6-dichlor-4-(trifluormethyl)phenyl)-1H-pyrazol-3-carbonitril) | 423-490-1 | 130755-46-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 608-041-00-1 | 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)(1,1'-biphenyl)-2-carbonitril | 423-500-4 | 138401-24-8 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 608-042-00-7 | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrilhydrobromid | 421-810-4 | 194602-27-2 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 608-043-00-2 | 3-(cis-3-hexenyloxy)propannitril | 415-220-6 | 142653-61-0 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H302
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H302
  H410 | | | |
| 608-044-00-8 | 2-cyclohexyliden-2-phenylacetonitril | 423-740-1 | 10461-98-0 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 608-046-00-9 | 5-(4-chlor-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridin-3-carbonitril | 425-310-7 | 77889-90-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 608-047-00-4 | 2-piperidin-1-yl-benzonitril | 427-330-1 | 72752-52-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 608-048-00-X | 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexancarbonitril | 427-450-4 | 152630-47-2 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H373 **
  H317
  H411 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H317
  H411 | | | |
| 608-049-00-5 | 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyan-5-oxo-1,5-dihydropyrrol-2-yliden)propandinitril | 429-180-2 | 157362-53-3 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 608-050-00-0 | en blanding af 5-(2-cyan-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylamino-nicotinonitril og
  5-(2-cyan-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylamino-nicotinonitril | 429-760-5 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 608-051-00-6 | (R)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril | 430-760-2 | 219861-18-4 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 608-052-00-1 | (S)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril | 430-770-7 | 128173-52-4 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 608-053-00-7 | (R,S)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril | 430-780-1 | 103146-25-4 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 608-054-00-2 | (R,S)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril hemisulfat | 430-790-6 | — | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 608-056-00-3 | N-methyl-N-cyanmethylmorpholinium-methylsulfat | 429-340-1 | — | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 608-057-00-9 | 4-cyanmethyl-4-methylmorpholin-4-ium-hydrogensulfat | 431-200-1 | 208538-34-5 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H318
  H317 | GHS05
  GHS07
  Dgr | H302
  H318
  H317 | | | |
| 608-058-00-4 | esfenvalerat (ISO);
  (S)-α-cyan-3-phenoxybenzyl-(S)-2-(4-chlorphenyl)-3-methylbutyrat | — | 66230-04-4 | Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H301
  H317
  H410 | | M = 10 000 | |
| 608-059-00-X | 5-amino-1-(2,6-dichlor-4-(trifluormethyl)phenyl)-1H-pyrazol-3-carbonitril | 421-240-6 | 120068-79-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophencarbonitril | 421-300-1 | 138564-59-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 608-062-00-6 | 2-fluor-4-hydroxybenzonitril | 422-810-7 | 82380-18-5 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 608-063-00-1 | (S)-α-hydroxy-3-phenoxy-benzenacetonitril | 441-070-6 | 61826-76-4 | Acute Tox. 3 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H318
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H301
  H318
  H317
  H410 | | | |
| 608-064-00-7 | cyanmethyltrimethylammoniummethylsulfat | 433-720-2 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 608-065-00-2 | salte af bromoxynil undtagen sådanne nævnt andetsteds i dette bilag | — | — | Repr. 2
  Acute Tox. 2 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361D *** H330
  H301
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361D *** H330
  H301
  H317
  H410 | | M = 10 | A |
| 608-066-00-8 | salte af ioxynil undtagen sådanne nævnt andetsteds i dette bilag | — | — | Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H361D *** H331
  H301
  H312
  H373 **
  H319
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H361D *** H331
  H301
  H312
  H373 **
  H319
  H410 | | M = 10 | A |
| 609-001-00-6 | 1-nitropropan | 203-544-9 | 108-03-2 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H226
  H332
  H312
  H302 | GHS02
  GHS07
  Wng | H
  226
  H332
  H312
  H302 | | * | |
| 609-002-00-1 | 2-nitropropan | 201-209-1 | 79-46-9 | Flam. Liq. 3
  Carc. 1B
  Acute Tox. 4 *
  Acute Tox. 4 * | H226
  H350
  H332
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H226
  H350
  H332
  H302 | | | |
| 609-003-00-7 | nitrobenzen | 202-716-0 | 98-95-3 | Carc. 2. Repr. 1B
  Acute Tox. 3
  Acute Tox. 3
  Acute Tox. 3
  STOT RE 1
  Aquatic Chronic 3 | H351
  H360F
  H301
  H331
  H311
  H372 (blod) H412 | GHS06
  GHS08
  Dgr | H351
  H360F
  H301
  H331
  H311
  H372 (blod) H412 | | | |
| 609-004-00-2 | dinitrobenzen; [1]
  1,4-dinitrobenzen; [2]
  1,3-dinitrobenzen; [3]
  1,2-dinitrobenzen; [4] | 246-673-6 [1]
  202-833-7 [2]
  202-776-8 [3]
  208-431-8 [4] | 25154-54-5 [1]
  100-25-4 [2]
  99-65-0 [3]
  528-29-0 [4] | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 **
  H410 | | | |
| 609-005-00-8 | 1,3,5-trinitrobenzen | 202-752-7 | 99-35-4 | Expl. 1,1
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H330
  H310
  H300
  H373 **
  H400
  H410 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H330
  H310
  H300
  H373 **
  H410 | | | |
| 609-006-00-3 | 4-nitrotoluen | 202-808-0 | 99-99-0 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H411 | | | |
| 609-007-00-9 | 2,4-dinitrotoluen; [1]
  dinitrotoluen [2] | 204-450-0 [1]
  246-836-1 [2] | 121-14-2 [1]
  25321-14-6 [2] | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H410 | | | |
| 609-008-00-4 | 2,4,6-trinitrotoluen; TNT | 204-289-6 | 118-96-7 | Expl. 1,1
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H201
  H331
  H311
  H301
  H373 **
  H411 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H331
  H311
  H301
  H373 **
  H411 | | | |
| 609-009-00-X | 2,4,6-trinitrophenol;
  picrinsyre | 201-865-9 | 88-89-1 | Expl. 1,1
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H201
  H331
  H311
  H301 | GHS01
  GHS06
  Dgr | H201
  H331
  H311
  H301 | | | |
| 609-010-00-5 | picrinsyrens salte | — | — | Unst. Expl
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H201
  H331
  H311
  H301 | GHS01
  GHS06
  Dgr | H201
  H331
  H311
  H301 | | | T |
| 609-011-00-0 | 2,4,6-trinitroanisol | — | 606-35-9 | Expl. 1,1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H201
  H332
  H312
  H302
  H411 | GHS01
  GHS07
  GHS09
  Wng | H201
  H332
  H312
  H302
  H411 | | | |
| 609-012-00-6 | 2,4,6-trinitro-m-cresol | 210-027-1 | 602-99-3 | Expl. 1,1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H201
  H332
  H312
  H302 | GHS01
  GHS07
  Wng | H201
  H332
  H312
  H302 | | | |
| 609-013-00-1 | 2,4,6-trinitro-m-xylen | 211-187-5 | 632-92-8 | Expl. 1,1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 * | H201
  H332
  H312
  H302
  H373 ** | GHS01
  GHS08
  GHS07
  Wng | H201
  H332
  H312
  H302
  H373 ** | | | |
| 609-015-00-2 | 4-nitrophenol;

  p-nitrophenol | 202-811-7 | 100-02-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 * | H332
  H312
  H302
  H373 ** | GHS08
  GHS07
  Wng | H332
  H312
  H302
  H373 ** | | | |
| 609-016-00-8 | dinitrophenol, (blanding af isomerer); [1]
  2,4(eller 2,6)-dinitrophenol [2] | 247-096-2 [1]
  275-732-9 [2] | 25550-58-7 [1]
  71629-74-8 [2] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H410 | | | |
| 609-018-00-9 | 2,4,6-trinitroresorcinol
  styphninsyre | 201-436-6 | 82-71-3 | Expl. 1,1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H201
  H332
  H312
  H302 | GHS01
  GHS07
  Dgr | H201
  H332
  H312
  H302 | | | |
| 609-019-00-4 | bly-2,4,6-trinitro-m-phenylendioxid;
  bly-2,4,6-trinitroresorcinoxid;
  blystyphnat | 239-290-0 | 15245-44-0 | Unst. Expl
  Repr. 1A
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H200
  H360Df
  H332
  H302
  H373 **
  H400
  H410 | GHS01
  GHS08
  GHS07
  GHS09
  Dgr | H200
  H360Df
  H332
  H302
  H373 **
  H410 | | | 1 |
| 609-019-01-1 | bly-2,4,6-trinitro-m-phenylendioxid;
  bly-2,4,6-trinitroresorcinoxid;
  blystyphnat (≥ 20 % flegmatiseret) | 239-290-0 | 15245-44-0 | Expl. 1,1
  Repr. 1A
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H360Df
  H332
  H302
  H373 **
  H400
  H410 | GHS01
  GHS08
  GHS07
  GHS09
  Dgr | H201
  H360Df
  H332
  H302
  H373 **
  H410 | | | 1 |
| 609-020-00-X | DNOC (ISO);
  4,6-dinitro-o-cresol | 208-601-1 | 534-52-1 | Muta. 2
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H330
  H310
  H300
  H315
  H318
  H317
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H341
  H330
  H310
  H300
  H315
  H318
  H317
  H410 | EUH044 | | |
| 609-021-00-5 | DNOC-Na;
  natrium 4,6-dinitro-o-cresolat; [1]
  DNOC-K; kalium 4,6-dinitro-o-cresolat [2] | 219-007-7 [1]
  - [2] | 2312-76-7 [1]
  5787-96-2 [2] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H410 | | | |
| 609-022-00-0 | DNOC-ammonium; ammonium 4,6-dinitro-o-tolyloxid | 221-037-0 | 2980-64-5 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H310
  H300
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 **
  H410 | | | |
| 609-023-00-6 | dinocap (ISO);
  (RS)-2,6-dinitro-4-octylphenylcrotonater og (RS)-2,4-dinitro-6-octylphenylcrotonater, hvori »octyl« er en blanding
  af 1-methylheptyl-, 1-ethylhexyl- og 1-propylpentylgrupper | 254-408-0 | 39300-45-3 | Repr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D ***
  H332
  H302
  H373 **
  H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H360D ***
  H332
  H302
  H373 **
  H315
  H317
  H410 | | M = 100 | |
| 609-024-00-1 | binapacryl (ISO);
  2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonat | 207-612-9 | 485-31-4 | Repr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D *** H312
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H360D *** H312
  H302
  H410 | | | |
| 609-025-00-7 | dinoseb(ISO);
  6-sec-butyl-2,4-dinitrophenol | 201-861-7 | 88-85-7 | Repr. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H311
  H301
  H319
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H360Df
  H311
  H301
  H319
  H410 | EUH044 | | |
| 609-026-00-2 | salte og estere af dinoseb, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Repr. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H311
  H301
  H319
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H360Df
  H311
  H301
  H319
  H410 | EUH044 | | A |
| 609-027-00-8 | dinocton
  blanding af isomerer:
  methyl 2-octyl-4,6-dinitrophenylcarbonat og methyl 4-octyl-2,6- dinitrophenylcarbonat | — | 63919-26-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 609-028-00-3 | dinex (ISO);
  2-cyclohexyl-4,6-dinitrophenol | 205-042-5 | 131-89-5 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | | |
| 609-029-00-9 | salte og estere af dinex | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | | A |
| 609-030-00-4 | dinoterb (ISO);
  2-tert-butyl-4,6-dinitrophenol | 215-813-8 | 1420-07-1 | Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D *** H300
  H311
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H360D *** H300
  H311
  H410 | EUH044 | | |
| 609-031-00-X | salte og estere af dinoterb | — | — | Repr. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D *** H300
  H311
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H360D *** H300
  H311
  H410 | | | A |
| 609-032-00-5 | bromophenoxim (ISO);
  3,5-dibrom-4-hydroxybenzaldehyd-O-(2,4-dinitrophenyl)-oxim | 236-129-6 | 13181-17-4 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 609-033-00-0 | dinosam (ISO);
  2-(1-methyl-n-butyl)-4,6-dinitrophenol | — | 4097-36-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | | |
| 609-034-00-6 | salte og estere af dinosam | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H410 | | | A |
| 609-035-00-1 | nitroethan | 201-188-9 | 79-24-3 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 * | H226
  H332
  H302 | GHS02
  GHS07
  Wng | H226
  H332
  H302 | | * | |
| 609-036-00-7 | nitromethan | 200-876-6 | 75-52-5 | Flam. Liq. 3
  Acute Tox. 4 * | H226
  H302 | GHS02
  GHS07
  Wng | H226
  H302 | | * | |
| 609-037-00-2 | 5-nitroacenaphthen | 210-025-0 | 602-87-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 609-038-00-8 | 2-nitronaphthalen | 209-474-5 | 581-89-5 | Carc. 1B
  Aquatic Chronic 2 | H350
  H411 | GHS08
  GHS09
  Dgr | H350
  H411 | | | |
| 609-039-00-3 | 4-nitrobiphenyl | 202-204-7 | 92-93-3 | Carc. 1B
  Aquatic Chronic 2 | H350
  H411 | GHS08
  GHS09
  Dgr | H350
  H411 | | | |
| 609-040-00-9 | nitrofen (ISO);
  2,4-dichlorphenyl-4-nitrophenylether | 217-406-0 | 1836-75-5 | Carc. 1B
  Repr. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H360D *** H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H360D *** H302
  H410 | | | |
| 609-041-00-4 | 2,4-dinitrophenol | 200-087-7 | 51-28-5 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1 | H331
  H311
  H301
  H373 **
  H400 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H400 | | | |
| 609-042-00-X | pendimethalin (ISO);

  N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidin | 254-938-2 | 40487-42-1 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 609-043-00-5 | quintozen (ISO);
  pentachlornitrobenzen | 201-435-0 | 82-68-8 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 609-044-00-0 | tecnazen (ISO)
  1,2,4,5-tetrachlor-3-nitrobenzen | 204-178-2 | 117-18-0 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 609-045-00-6 | en blanding af 4,6-dinitro-2-(3-octyl)phenylmethylcarbonat og 4,6-dinitro-2-(4-octyl)phenylmethylcarbonat og dinocton-6 | — | 8069-76-9 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 609-046-00-1 | trifluralin (ISO) (indeholdende < 0,5 ppm NPDA);
  α, α,α-trifluor-2,6-dinitro-N, N-dipropyl-p-toluidin (indeholdende < 0,5 ppm NPDA);
  2,6-dinitro-N, N-dipropyl-4-trifluormethylanilin (indeholdende < 0,5 ppm NPDA);

  N, N-dipropyl-2,6-dinitro-4-trifluormethylanilin (indeholdende < 0,5 ppm NPDA) | 216-428-8 | 1582-09-8 | Carc. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H317
  H410 | | M = 10 | |
| 609-047-00-7 | 2-nitroanisol | 202-052-1 | 91-23-6 | Carc. 1B
  Acute Tox. 4 * | H350
  H302 | GHS08
  GHS07
  Dgr | H350
  H302 | | | |
| 609-048-00-2 | natrium-3-nitrobenzensulfonat | 204-857-3 | 127-68-4 | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 609-049-00-8 | 2,6-dinitrotoluen | 210-106-0 | 606-20-2 | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 3 | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H412 | GHS06
  GHS08
  Dgr | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H412 | | | |
| 609-050-00-3 | 2,3-dinitrotoluen | 210-013-5 | 602-01-7 | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H410 | | | |
| 609-051-00-9 | 3,4-dinitrotoluen | 210-222-1 | 610-39-9 | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H411 | | | |
| 609-052-00-4 | 3,5-dinitrotoluen | 210-566-2 | 618-85-9 | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 3 | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H412 | GHS06
  GHS08
  Dgr | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H412 | | | |
| 609-053-00-X | hydrazin (trinitromethan) | 414-850-9 | — | Expl. 1,1 ****
  Self-react. A
  Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Sens. 1 | H201
  H240
  H350
  H331
  H301
  H317 | GHS01
  GHS06
  GHS08
  Dgr | H201
  H240
  H350
  H331
  H301
  H317 | | | |
| 609-054-00-5 | 2,3-dinitrophenol; [1]
  2,5-dinitrophenol; [2]
  2,6-dinitrophenol; [3]
  3,4-dinitrophenol; [4]
  salte af dinitrophenol [5] | 200-628-7 [1]
  206-348-1 [2]
  209-357-9 [3]
  209-415-3 [4]-[5] | 66-56-8 [1]
  329-71-5 [2]
  573-56-8 [3]
  577-71-9 [4]-[5] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H411 | | | |
| 609-055-00-0 | 2,5-dinitrotoluen | 210-581-4 | 619-15-8 | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H361f ***
  H331
  H311
  H301
  H373 **
  H411 | | | |
| 609-056-00-6 | 2,2-dibrom-2-nitroethanol | 412-380-9 | 69094-18-4 | Expl. 1,1
  Carc. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1A
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H351
  H302
  H373 **
  H314
  H317
  H400
  H410 | GHS01
  GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H201
  H351
  H302
  H373 **
  H314
  H317
  H410 | | *
  STOT SE 3; H335: C ≥ 1 % | T |
| 609-057-00-1 | 3-chlor-2,4-difluornitrobenzen | 411-980-8 | 3847-58-3 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H317
  H410 | | | |
| 609-058-00-7 | 2-nitro-2-phenylpropan-1,3-diol | 410-360-4 | 5428-02-4 | STOT RE 1;
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H372 ** H312
  H302
  H317
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H372 **
  H312
  H302
  H317
  H411 | EUH070 | | |
| 609-059-00-2 | 2-chlor-6-(ethylamino)-4-nitrophenol | 411-440-1 | 131657-78-8 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 609-060-00-8 | 4-[(3-hydroxypropyl)amino]-3-nitrophenol | 406-305-9 | 92952-81-3 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 609-061-00-3 | (E,Z)-4-chlorphenyl(cyclopropyl)keton-O-(4-nitrophenylmethyl)oxim | 406-100-4 | 94097-88-8 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 609-062-00-9 | 2-brom-2-nitropropanol | 407-030-7 | 24403-04-1 | Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H311
  H302
  H373 **
  H314
  H317
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H311
  H302
  H373 **
  H314
  H317
  H410 | | | |
| 609-063-00-4 | 2-[(4-chlor-2-nitrophenyl)amino]ethanol | 413-280-8 | 59320-13-7 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 609-064-00-X | mesotrion (ISO);
  2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexandion | — | 104206-82-8 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 609-065-00-5 | 2-nitrotoluen | 201-853-3 | 88-72-2 | Carc. 1B
  Muta. 1B
  Repr. 2
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H340
  H361f *** H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H340
  H361f *** H302
  H411 | | | |
| 609-066-00-0 | lithium natrium 3-amino-10-{4-(10-amino-6,13-dichlor-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazin-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorbenzo[5,6][1,4]oxazino[2,3-b]phenoxazin-4,11-disulfonat | 418-870-9 | 154212-58-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 2 ** | H332
  H312
  H302
  H371 ** | GHS08
  GHS07
  Dgr | H332
  H312
  H302
  H371 ** | | | |
| 609-067-00-6 | natrium- og kalium-4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazin | 416-280-6 | 156769-97-0 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 609-068-00-1 | moskusxylen;
  5-tert-butyl-2,4,6-trinitro-m-xyleno | 201-329-4 | 81-15-2 | Expl. 1,1
  Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H351
  H400
  H410 | GHS01
  GHS08
  GHS09
  Wng | H201
  H351
  H410 | | | T |
| 609-069-00-7 | moskusketon;
  3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenon;
  4'-tert-butyl-2',6'-dimethyl-3',
  5'-dinitroacetophenon | 201-328-9 | 81-14-1 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 609-070-00-2 | 1,4-dichlor-2-(1,1,2,3,3,3-hexafluorpropoxy)-5-nitrobenzen | 415-580-4 | 130841-23-5 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 609-071-00-8 | en blanding af 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazin og
  2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol | 423-520-3 | 156137-33-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 609-072-00-3 | 4-mesyl-2-nitrotoluen | 430-550-0 | 1671-49-4 | Repr. 2
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H361f ***
  H302
  H317
  H412 | GHS08
  GHS07
  Wng | H361f ***
  H302
  H317
  H412 | | | |
| 609-073-00-9 | lithium-kalium-natrium-N, N''-bis(6-(7-(4-(4-chlor-1,3,5-triazin-2-yl)amino)-4-(2-ureidophenylazo))naphthalen-1,3,6-trisulfonato)-N'-(2-aminoethyl)piperazin | 427-850-9 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 610-001-00-3 | trichlornitromethan;
  chlorpicrin | 200-930-9 | 76-06-2 | Acute Tox. 2 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H330
  H302
  H319
  H335
  H315 | GHS06
  Dgr | H330
  H302
  H319
  H335
  H315 | | | |
| 610-002-00-9 | 1,1-dichlor-1-nitroethan | 209-854-0 | 594-72-9 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | |
| 610-003-00-4 | chlordinitrobenzen | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H410 | | | C |
| 610-004-00-X | 2-chlor-1,3,5-trinitrobenzen | 201-864-3 | 88-88-0 | Expl. 1,1
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H330
  H310
  H300
  H400
  H410 | GHS01
  GHS06
  GHS09
  Dgr | H201
  H330
  H310
  H300
  H410 | | | |
| 610-005-00-5 | 1-chlor-4-nitrobenzen | 202-809-6 | 100-00-5 | Carc. 2
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H351
  H341
  H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H341
  H331
  H311
  H301
  H373 **
  H411 | | | |
| 610-006-00-0 | chlornitroaniliner undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 2 | H330
  H310
  H300
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 **
  H411 | | | A C |
| 610-007-00-6 | 1-chlor-1-nitropropan | 209-990-0 | 600-25-9 | Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H302 | GHS07
  Wng | H332
  H302 | | * | |
| 610-008-00-1 | 2,6-dichlor-4-nitroanisol | 403-350-6 | 17742-69-7 | Acute Tox. 3 *
  Aquatic Chronic 2 | H301
  H411 | GHS06
  GHS09
  Dgr | H301
  H411 | | | |
| 610-009-00-7 | 2-chlor-4-nitroanilin | 204-502-2 | 121-87-9 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 610-010-00-2 | 2-(2-brom-2-nitroethenyl)furan | 406-110-9 | 35950-52-8 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H314
  H317
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H302
  H373 **
  H314
  H317
  H410 | | | |
| 611-001-00-6 | azobenzen | 203-102-5 | 103-33-3 | Carc. 1B Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H341
  H332
  H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H341
  H332
  H302
  H373 **
  H410 | | | |
| 611-002-00-1 | azoxybenzen | 207-802-1 | 495-48-7 | Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H302 | GHS07
  Wng | H332
  H302 | | | |
| 611-003-00-7 | fenaminosulf (ISO);
  natrium-4-dimethylaminobenzendiazosulfonat | 205-419-4 | 140-56-7 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H301
  H312
  H412 | GHS06
  Dgr | H301
  H312
  H412 | | | |
| 611-004-00-2 | (methyl-ONN-azoxy)methylacetat;
  (methylazoxymethyl)acetat | 209-765-7 | 592-62-1 | Carc. 1B
  Repr. 1B | H350
  H360D *** | GHS08
  Dgr | H350
  H360D *** | | | |
| 611-005-00-8 | dinatrium-{5-[(4'-((2,6-dihydroxy-3-((2-hydroxy-5-sulfophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprat(2-);
  CI Direct Brown 95 | 240-221-1 | 16071-86-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 611-006-00-3 | 4-o-tolylazo-o-toluidin;
  4-amino-2',3-dimethylazobenzen;
  fast garnet GBC base; AAT;

  o-aminoazotoluen | 202-591-2 | 97-56-3 | Carc. 1B
  Skin Sens. 1 | H350
  H317 | GHS08
  Dgr | H350
  H317 | | | |
| 611-007-00-9 | tricyclazol (ISO);
  5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazol | 255-559-5 | 41814-78-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 611-008-00-4 | 4-aminoazobenzen;
  4-phenylazoanilin | 200-453-6 | 60-09-3 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | | |
| 611-009-00-X | natrium-(1-(5-(4-(4-anilino-3-sulfophenylazo)-2-methyl-5-methylsulfonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulfonato-2-naphtholato)jern(II) | 401-220-3 | — | Acute Tox. 4 *
  Aquatic Chronic 3 | H332
  H412 | GHS07
  Wng | H332
  H412 | | | |
| 611-010-00-5 | 2'-(2-cyan-4,6-dinitrophenylazo)-5'-(N, N-dipropylamino)propionanilid | 403-010-7 | 106359-94-8 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 611-011-00-0 | N, N,N',N'-tetramethyl-3,3'-(propylenbis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridin-3,1-diyl)))di(propylammonium)dilactat | 403-340-1 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 611-012-00-6 | blanding af 2-methylaminoethanol-6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazol-7-sulfonat og N, N-diethylpropan-1,3-diamin-6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazol-7-sulfonat og 2,2-iminodiethanol-6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazol-7-sulfonat | 403-410-1 | 114565-65-0 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-013-00-1 | trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalen-3-sulfonat | 403-650-7 | 117409-78-6 | Expl. 1,3 ****
  Aquatic Chronic 2 | H203
  H411 | GHS01
  GHS09
  Dgr | H203
  H411 | | | |
| 611-014-00-7 | (tetranatrium-1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium)hydroxid | 404-250-5 | 115099-55-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-015-00-2 | tetranatrium-4-amino-5-hydroxy-6-(3-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat | 404-320-5 | 116889-78-2 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-016-00-8 | blanding af; 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(eller2,6 eller3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridiniumdichlo og 1,1'-((dihydroxyphenylen)bis(azo-3,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridin-5,3-diyl)))dipyridiniumdichlorid, dihydrochlorid, blanding af isomerer | 404-540-1 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-017-00-3 | 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramid | 404-910-2 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-018-00-9 | tetraammonium-5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalat | 405-130-5 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-019-00-4 | tetralithium-6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalen-2,7-disulfonat | 405-150-4 | 106028-58-4 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-020-00-X | tetrakis(tetramethylammonium)-
  6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalen-2,7-disulfonat | 405-170-3 | 116340-05-7 | Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Chronic 3 | H301
  H317
  H412 | GHS06
  Dgr | H301
  H317
  H412 | | | |
| 611-021-00-5 | 2-(4-(4-cyan-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethylacetat | 405-480-9 | — | Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2
  Aquatic Chronic 4 | H302
  H373 ** H315
  H413 | GHS08
  GHS07
  Wng | H302
  H373 **
  H315
  H413 | | | |
| 611-022-00-0 | 4-dimethylaminobenzendiazonium-3-carboxy-4-hydroxybenzensulfonat | 404-980-4 | — | Self-react. C
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H242
  H331
  H301
  H312
  H373 **
  H318
  H317
  H400
  H410 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H242
  H331
  H301
  H312
  H373 **
  H318
  H317
  H410 | | | T |
| 611-023-00-6 | dinatrium-7-(4,6-dichlor-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalen-2-sulfonat | 404-600-7 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-024-00-1 | benzidinbaserede azofarvestoffer;
  4,4'-diarylazobiphenyl farvestoffer, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | A |
| 611-025-00-7 | dinatrium-4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphthalen-2,7-disulfonat;
  C.I. Direct Black 38 | 217-710-3 | 1937-37-7 | Carc. 1B Repr. 2 | H350
  H361D *** | GHS08
  Dgr | H350
  H361D *** | | | |
| 611-026-00-2 | tetranatrium-3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalen-2,7-disulfonat];
  C.I. Direct Blue 6 | 220-012-1 | 2602-46-2 | Carc. 1B Repr. 2 | H350
  H361D *** | GHS08
  Dgr | H350
  H361D *** | | | |
| 611-027-00-8 | dinatrium-3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalen-1-sulfonat); C.I. Direct Red 28 | 209-358-4 | 573-58-0 | Carc. 1B Repr. 2 | H350
  H361D *** | GHS08
  Dgr | H350
  H361D *** | | | |
| 611-028-00-3 | C, C'-azodi(formamid) | 204-650-8 | 123-77-3 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | G |
| 611-029-00-9 | o-dianisidin azobaserede farvestoffer;
  4,4-diarylazo-3,3'dimethoxybiphenyl farvestoffer, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | A |
| 611-030-00-4 | 4,4'-bi-o-toluidin baserede azofarvestoffer, undtagen sådanne nævnt andetsteds i dette bilag;
  4,4'-diarylazo-3,3'dimethylbiphenyl farvestoffer, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | A |
| 611-031-00-X | 4,4'-(4-iminocyclohexa-2,5-dienylidenmethylen)dianilinhydrochlorid;
  C.I. Basic Red 9 | 209-321-2 | 569-61-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 611-032-00-5 | 1,4,5,8-tetraaminoanthra-
  quinon;
  C.I. Disperse Blue 1 | 219-603-7 | 2475-45-8 | Carc. 1B
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1 | H350
  H315
  H318
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H350
  H315
  H318
  H317 | | | |
| 611-033-00-0 | hexanatrium-[4,4''-azoxybis(2,2'-disulfonatostilben-4,4'-diylazo)]-bis[5'-sulfonatobenzen-2,2'-diolato-O(2),O(2),N(1)]-kobber(II) | 400-020-3 | 82027-60-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-034-00-6 | N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamid | 402-430-8 | 105076-77-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-035-00-1 | tetralithium-6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalen-2,7-disulfonat | 403-660-1 | 107246-80-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-036-00-7 | 2-(4-(5,6(eller 6,7)-dichlor-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethylacetat | 405-440-0 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-037-00-2 | 3(eller 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazoliummethylsulfat | 406-055-0 | 124584-00-5 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 611-038-00-8 | trinatrium-1-hydroxynaphthalen-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzen)-2',2'',4-trisulfonat | 406-820-9 | — | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 611-039-00-3 | 7-[((4,6-dichlor-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalen-2-sulfonsyre | 407-050-6 | 117715-57-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-040-00-9 | 3-(5-acetamido-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalensulfonsyre | 407-670-7 | 115099-58-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 611-041-00-4 | 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamid | 407-680-1 | 98809-11-1 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 611-042-00-X | trinatrium-5-amino-3-[5-(2-bromacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalen-2,7-disulfonat | 411-770-6 | 136213-71-3 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-043-00-5 | blanding (2:1:1) af trinatrium-N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4(eller 6)-hydroxy-(eller 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalen-2,1'-azobenzen-1,2'-diolato-O(1),O(2'))-chromat;
  trinatrium-N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonato
  bis(naphthalen-2,1'-azobenzen-1,2'-diolato-O(1),O(2'))-chromat;
  trinatrium-N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(eller 6)-hydroxy-(eller 4-amino-2-hydroxy)phenylazo]-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalen-2,1'-azobenzen-1,2'-diolato-O(1),O(2'))-chromat | 402-850-1 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-044-00-0 | en blanding af tert-alkyl(C12-C14)ammoniumbis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]chromat(1-); tert-alkyl(C12-C14)ammonium-bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]chromat(1-);

  tert-alkyl(C12-C14)ammoniumbis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]chromat(1-);

  tert-alkyl(C12-C14)ammonium-[[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]chromat(1-);

  tert-alkyl(C12-C14)ammonium-[[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]chromat(1-);
  C12-14-tert-alkylammonium
  ((1-(4(eller 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromat(1-) | 403-720-7 | 117527-94-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-045-00-6 | 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophen | 404-830-8 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-046-00-1 | 4,4'-diamino-2-methylazobenzen | 407-590-2 | 43151-99-1 | Acute Tox. 3 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H373 **
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H373 **
  H317
  H410 | | | |
| 611-047-00-7 | en blanding af 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorbenzothiazol og 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorbenzothiazol | 407-890-3 | 111381-11-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-048-00-2 | en blanding (1:1) af 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorbenzothiazol og 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorbenzothiazol | 407-900-6 | 111381-12-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-049-00-8 | en blanding af 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)naphthalen-2-sulfonat, eddikesyre, malkesyre (2:1:1) | 408-000-6 | 118658-98-3 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 3 | H373 **
  H317
  H412 | GHS08
  Wng | H373 **
  H317
  H412 | | | |
| 611-050-00-3 | en blanding af pentanatrium
  -3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalen-2-sulfonat;
  pentanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalen-2-sulfonat;
  pentanatrium-6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat og
  hexanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat | 415-350-3 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-051-00-9 | 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methylbenzothiazoliumchlorid | 411-110-7 | 136213-74-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 611-052-00-4 | mononatrium-aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonat], jernkomplex | 400-720-9 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-053-00-X | 2,2'-azobis[2-methylpropionamidin]dihydrochlorid | 221-070-0 | 2997-92-4 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 611-055-00-0 | C.I. Disperse Yellow 3;

  N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamid | 220-600-8 | 2832-40-8 | Carc. 2
  Skin Sens. 1 | H351
  H317 | GHS08
  GHS07
  Wng | H351
  H317 | | | |
| 611-056-00-6 | C.I. Solvent Yellow 14;
  1-phenylazo-2-naphthol | 212-668-2 | 842-07-9 | Carc. 2
  Muta. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H351
  H341
  H317
  H413 | GHS08
  GHS07
  Wng | H351
  H341
  H317
  H413 | | | |
| 611-057-00-1 | 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridincarbonitril | 400-340-3 | 85136-74-9 | Carc. 1B
  Aquatic Chronic 4 | H350
  H413 | GHS08
  Wng | H350
  H413 | | | |
| 611-058-00-7 | (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium]-format | 402-060-7 | 108225-03-2 | Carc. 1B
  Eye Dam. 1
  Aquatic Chronic 2 | H350
  H318
  H411 | GHS08
  GHS05
  GHS09
  Dgr | H350
  H318
  H411 | | | |
| 611-059-00-2 | octanatrium 2-(6-(4-chlor-6-(3-(N-methyl-N-(4-chlor-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalen-1,5-disulfonat | 412-960-1 | 148878-21-1 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 611-060-00-8 | blanding af natrium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophtalat;
  ammonium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophtalat;
  5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatnaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatnaphthalen-2-ylazo]-isophthalsyre | 413-180-4 | 187285-15-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-061-00-3 | dinatrium-5-[5-[4-(5-chlor-2,6-difluorpyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonat | 412-530-3 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-062-00-9 | octanatrium-2-(8-(4-chlor-6-(3-((4-chlor-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalen-1,5-disulfonat | 413-550-5 | — | Skin Irrit. 2
  Eye Dam. 1 | H315
  H318 | GHS05
  Dgr | H315
  H318 | | | |
| 611-063-00-4 | trinatrium-[4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O, O',O'',O''']kobber(II) | 413-590-3 | 164058-22-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 611-064-00-X | 4-(3,4-dichlorphenylazo)-2,6-di-sec-butyl-phenol | 410-600-8 | 124719-26-2 | STOT RE 2 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H373 **
  H315
  H410 | | | |
| 611-065-00-5 | 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol | 410-610-2 | 111850-24-9 | STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H319
  H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H373 **
  H319
  H315
  H317
  H410 | | | |
| 611-066-00-0 | tetranatrium-5-[4-chlor-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat | 411-540-5 | 130201-57-9 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 611-067-00-6 | en blanding af bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium)-7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalen-2-sulfonat og
  bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium)-7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalen-2-sulfonat | 406-910-8 | — | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 611-068-00-1 | tetranatrium-4-amino-3,6-bis(5-[4-chlor-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalen-2,7-disulfonat | 400-690-7 | 85665-98-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-069-00-7 | N, N-di-[poly(oxyethylen)-co-poly(oxypropylen)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylanilin | 413-380-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-070-00-2 | en blanding (1:1) af dinatrium-(6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chlor-2-oxidophenylazo)-2-naphtholato)chromat(1-) og
  trinatriumbis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromat(1-) | 405-665-4 | — | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 611-071-00-8 | tris(tetramethylammonium)-5-hydroxy-1-(4-sulfonatophenyl)-4-(4-sulfonatophenylazo)pyrazol-3-carboxylat | 406-073-9 | 131013-81-5 | Acute Tox. 3 *
  Aquatic Chronic 3 | H301
  H412 | GHS06
  Dgr | H301
  H412 | | | |
| 611-072-00-3 | 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzendihydrochlorid | 407-010-8 | 118208-02-9 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 611-073-00-9 | dimethyl-3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionat | 407-310-9 | 122630-55-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-074-00-4 | blanding af natrium/kalium-(3-(4-(5-(5-chlor-2,6-difluorpyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)kobber(II) og
  natrium/kalium-(3-(4-(5-(5-chlor-4,6-difluorpyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)kobber(II) | 407-100-7 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-075-00-X | blanding (2:1) af tris(3,5,5-trimethylhexylammonium)-4-amino-3-(4-(4-(2-amino-4-hydroxyphenyl
  azo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalen-2,7-disulfonat og
  tris(3,5,5-trimethylhexylammonium)-2-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalen-2,7-disulfonat | 406-000-0 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 611-076-00-5 | 3-(2,6-dichlor-4-nitrophenylazo)-1-methyl-2-phenylindol | 406-280-4 | 117584-16-4 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 611-077-00-0 | dilithiumdinatrium-(5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenbisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalen-2,7-disulfonato(8)))dicuprat(2-) | 407-230-4 | 126637-70-5 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 611-078-00-6 | (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dikobber(II)acetatlactat | 407-240-9 | 159604-94-1 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-079-00-1 | dinatrium-7-[4-chlor-6-(N-ethyl-o-toluidin)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalensulfonat | 410-390-8 | 147703-64-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-080-00-7 | natrium-3-(2-acetamid-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzensulfonat | 410-150-2 | 147703-65-9 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-081-00-2 | tetranatrium-[7-(2,5-dihydroxy-КO2-7-sulfonato-6-[4-(2,5,6-trichlor-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-КO8-naphthalen-1,3,5-trisulfonato(6-)]cuprat(II) | 411-470-5 | 141048-13-7 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 611-082-00-8 | blanding af pentanatriumbis(1-(3(eller 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrat(1-) og pentanatrium-[(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrat(1-) | 407-570-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-083-00-3 | en blanding (1:1) af 2-[N-ethyl-4-[(5,6-dichlorbenzothiazol-2-yl)azo]-m-toludin]ethyl-acetat og
  2-[N-ethyl-4-[(6,7-dichlorbenzothiazol-2-yl)azo]-m-toludin]ethyl-acetat | 411-560-4 | — | STOT RE 1
  Skin Sens. 1
  Aquatic Chronic 2 | H372 ** H317
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H372 ** H317
  H411 | | | |
| 611-085-00-4 | en blanding af 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)-propylamino]-pyridin;
  3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)-propylamino]-pyridin;
  3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]-pyridin og
  3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]-pyridin | 411-880-4 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-086-00-X | monolithium-5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonat], jernkomplex,
  monohydrat | 411-360-7 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-087-00-5 | en blanding af 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethylphenol og
  3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) | 411-710-9 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-088-00-0 | blanding af trilithium-4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)-naphthalen-2,7-disulfonat og
  trilithium-4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)-naphthalen-2,7-disulfonat | 411-890-9 | — | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 611-089-00-6 | 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium-methylsulfat | 411-100-2 | 136213-73-5 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 ** H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H373 ** H317
  H410 | | | |
| 611-090-00-1 | 2,5-dibutoxy-4-(morpholin-4-yl)-benzendiazonium 4-methylbenzensulfonat | 413-290-2 | 93672-52-7 | Self-react. C
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H242
  H302
  H318
  H317
  H412 | GHS02
  GHS05
  GHS07
  Dgr | H242
  H302
  H318
  H317
  H412 | | | T |
| 611-091-00-7 | natrium (1.0-1.95)/lithium (0.05-1)-5-((5-((5-chlor-6-fluor-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinmethylsulfonat | 413-470-0 | 134595-59-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-092-00-2 | tert-(dodecyl/tetradecyl)-ammonium-bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzensulfonamidat)chromat | 413-210-6 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-093-00-8 | natrium-2-(4-(4-fluor-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzen-1-sulfonat | 410-770-3 | 146177-84-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-094-00-3 | en blanding (50:50) af 2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichlor-1,3-benzothiazol og
  2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichlor-1,3-benzotriazol | 411-600-0 | 143145-93-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-095-00-9 | hexanatrium-1,1'-[(1-amino-8-hydroxy-3,6-disulfonato-2,7-naphthalendiyl)bis(azo(4-sulfonato-1,3-phenyl)imino[6-[(4-chlor-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxid | 412-240-7 | 89797-03-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-096-00-4 | methyl-N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinat | 413-040-2 | 149850-30-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-097-00-X | blanding af jernkomplekser af 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)-benzen
  og 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]-benzen (n=2,5,6) | 414-150-3 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-098-00-5 | tetrakis(tetramethylammonium)-3,3'-(6-(2-hydroxyethylamino)1,3,5-triazin-2,4-diyldiiminobis(2-methyl-4,1-phenylenazo))dinaphthalen-1,5-disulfonat | 405-950-3 | 131013-83-7 | Acute Tox. 3 * Aquatic Chronic 3 | H301
  H412 | GHS06
  Dgr | H301
  H412 | | | |
| 611-099-00-0 | (methylenbis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridin-5,3-diyl)))-1,1'-dipyridiniumdichloriddihydrochlorid | 401-500-5 | 118658-99-4 | Carc. 1B
  Aquatic Chronic 2 | H350
  H411 | GHS08
  GHS09
  Dgr | H350
  H411 | | | |
| 611-100-00-4 | kaliumnatrium-3,3'-(3(eller4)-methyl-1,2-phenylenbis(imino(6-chlor)-1,3,5-triazin-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalen-1,5-disulfonat | 403-810-6 | 140876-13-7 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-101-00-X | 2'-(4-chlor-3-cyan-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilid | 405-200-5 | 104366-25-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-102-00-5 | reaktionsprodukt af C.I. Leuco Sulfur Black 1 og en blanding af dinatrium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid og dinatrium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzendiazoniumchlorid | 424-500-7 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-103-00-0 | trinatrium-(1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nikkel(II) | 407-110-1 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 611-104-00-6 | en blanding (1:1) af trinatrium-(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(eller 4 eller 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(eller 2 eller 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrat(1-);
  trinatrium-bis(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrat(1-);
  trinatrium-(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(eller 4 eller 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(eller 2 eller 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrat(1-); trinatrium-(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(eller
  4 eller 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(eller 2 eller 6)-(3-sulfonatophenylazo)phenolato)ferrat(1-) og
  dinatrium-3,3'-(2,4-dihydroxy-1,3(eller 1,5 eller 3,5)-phenylendiazo)dibenzensulfonat | 406-870-1 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-105-00-1 | natrium-4-(4-chlor-6-(N-ethylanilino)-,1,3,5-triazin-2-ylamino)-2-(1-(2-chlorphenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzensulfonat | 407-800-2 | 136213-75-7 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-106-00-7 | hexanatrium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenbis[imino(6-chlor-1,3,5-triazin-4,2-diyl)imino]]dinaphthalen-2-sulfonat | 410-180-6 | 157627-99-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-107-00-2 | kalium natrium 4-(4-chlor-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethansulfonyl)-phenylazo)-naphthalen-1,7-disulfonat | 412-490-7 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-108-00-8 | dinatrium-5-((4-((4-chlor-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalensulfonat | 413-600-6 | 6527-62-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-109-00-3 | reaktionsprodukter af kobber(II)sulfat og tetranatrium-2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazin (2:1) | 407-710-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-110-00-9 | tetra-natrium/lithium-4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzen | 408-210-8 | 124605-82-9 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-111-00-4 | dinatrium 2-[[4-(2-chlor ethylsulfonyl)phenyl]-[(2- hydroxy-5-sulfo-3-[3-[2-(2-(sul fooxy)ethylsulfonyl)ethylazo]-4- sulfobenzoato(3-)cuprat(1-) | 414-230-8 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-112-00-X | tetranatrium-4-hydroxy-5-[4-[3-(2-sulfatethansulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalen-2,7-disulfonat | 413-070-6 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-113-00-5 | lithiumnatrium (2-(((5-((2,5-dichlorphenyl)azo)-2-hydroxyphenyl)methylen)amino)benzoato(2-))-(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-))-chromat(2-) | 414-280-0 | 149626-00-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-114-00-0 | lithiumnatrium (4-((5-chlor-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))-(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzensulfonato(3-))-chromat(2-) | 414-250-7 | 149564-66-9 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 611-115-00-6 | trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalensulfonato(3-))chromat(3-) | 414-290-5 | 149564-65-8 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 611-116-00-1 | blanding af trinatrium 5-{4-chlor-6-[2-(2,6-dichlor-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat;
  trinatrium 5-{4-chlor-6-[2-(2,6-dichlor-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat;
  trinatrium 5-{4-chlor-6-[2-(4,6-dichlor-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat og
  trinatrium 5-{4-chlor-6-[2-(4,6-dichlor-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat | 414-620-8 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-117-00-7 | 1,3-bis{6-fluor-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propan lithium-, natriumsalt | 415-100-3 | 149850-29-3 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-118-00-2 | natrium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluor-1,3,5-triazin-2-ylamino]-propan, natriumsalt | 413-990-8 | | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 611-119-00-8 | tetranatrium-4-[4-chlor-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalen-2,7-disulfonat | 415-400-4 | 148878-22-2 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-120-00-3 | 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chlor-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphtalen-2-ylazo)-naphthalen-2,7-disulfonsyre natriumsalt | 418-340-7 | 157707-94-3 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-121-00-9 | hovedkomponent 6 (isomer): asym. 1:2 Cr(III)-kompleks af A: 3-hydroxy-4-(2-hydroxy-naphthalen-1-ylazo)-naphthalen-1-sulfonsyre, natriumsalt og B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalen-2-ol;
  hovedkomponent 8 (isomer):
  asym. 1:2 Cr-kompleks af A:
  3-hydroxy-4-(2-hydroxy-naphthalen-1-ylazo)-naphthalen-1-sulfonsyre, natriumsalt og B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalen-2-ol | 417-280-9 | 30785-74-1 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 611-122-00-4 | hexanatrium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfonatoanilino]-6-chlor-1,3,5-triazin-2-ylamino}phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nikkel | 417-250-5 | 151436-99-6 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-123-00-X | 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammoniumlactat | 424-310-4 | 178452-66-9 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-124-00-5 | en blanding af pentanatrium
  5-amino-3-(5-{4-chlor-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibrompropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalen-2,7-disulfonat;
  pentanatrium 5-amino-6-[5-(2-bromacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chlor-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat
  tetranatrium 5-amino-3-[5-{4-chlor-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibrompropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalen-2,7-disulfonat | 424-320-9 | | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 611-125-00-0 | en blanding af dinatrium 4-((8-oxido-7-(2-oxido-4-ethenylsulfonyl-5-(methoxyphenyl)azo)-6-sulfonato)naphthalen-2-ylazo)-5-oxo-1-(4-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-3-carboxylsyre kobber (II) kompleks og
  dinatrium 4-((8-oxido-7-(2-oxido-4-(2-hydroxyethylsulfonyl)-5-(methoxyphenyl)azo)-6-sulfonato)naphthalen-2-ylazo)-5-oxo-1-(4-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-3-carboxylsyre kobber (II) kompleks | 423-940-7 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 611-126-00-6 | 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazin, dichlorid | 424-120-1 | 174514-06-8 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 611-127-00-1 | pentanatrium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethansulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethansulfonyl)phenylazo)naphthalen-2,7-disulfonat | 423-790-2 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | G |
| 611-128-00-7 | N, N'-bis{6-chlor-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonsyre-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethan-1,2-diamin, natriumsalt | 419-500-9 | 171599-85-2 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-129-00-2 | en blanding af 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoesyre og
  5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoesyre | 418-230-9 | 163879-69-4 | Expl. 1,3 ****
  Repr. 2
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H203
  H361f ***
  H373 **
  H317
  H411 | GHS01
  GHS08
  GHS07
  GHS09
  Dgr | H203
  H361f ***
  H373 **
  H317
  H411 | | | |
| 611-130-00-8 | tetraammonium-2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoat | 418-520-5 | 183130-96-3 | Eye Irrit. 2
  Aquatic Chronic 3 | H319
  H412 | GHS07
  Wng | H319
  H412 | | | |
| 611-131-00-3 | 2-[2-hydroxy-3-(2-chlorphenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-on | 420-580-2 | 151798-26-4 | Repr. 1B
  Aquatic Chronic 4 | H360D *** H413 | GHS08
  Dgr | H360D *** H413 | | | |
| 611-132-00-9 | pentanatrium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalen-2-azobenzen-1,2'-diolato} chromat (III) | 419-210-2 | 178452-71-6 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-133-00-4 | procesprodukt-jernkompleks af azo-farvestoffer opnået ved kobling af en blanding af diazoteret 2-amino-1-hydroxybenzen-4-sulfanilid og 2-amino-1-hydroxybenzen-4-sulfonamid med resorcin, hvor den herved opnåede blanding efterfølgende underkastes en yderligere koblingsreaktion med en blanding af diazoteret 3-aminobenzen-1-sulfonsyre (metanilsyre) og 4'-amino-4-nitro-1,1'-diphenylamin-2-sulfonsyre og en metallisering med ferrichlorid, natriumsalt | 419-260-5 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 611-134-00-X | trinatrium 2-{α[2-hydroxy-3-[4-chlor-6-[4-(2,3-dibrompropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenhydrazino}-4-sulfonatobenzoat, kobberkompleks | 423-770-3 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 611-135-00-5 | reaktionsprodukt af 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzensulfonsyre med 2,4,6-trifluorpyrimidin og delvis hydrolyse til det tilsvarende vinylsulfonylderivat, blandet kalium/natriumsalt | 424-250-9 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-136-00-0 | 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropylformat | 424-260-3 | — | Repr. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H361f ***
  H318
  H411 | GHS05
  GHS08
  GHS09
  Dgr | H361f ***
  H318
  H411 | | | |
| 611-137-00-6 | 6-tert-butyl-7-chlor-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazol | 419-870-1 | 159038-16-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 611-138-00-1 | 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazol | 415-910-7 | 152828-25-6 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 611-139-00-7 | reaktionsprodukt af C.I. Leuco Sulfur Black 1 med (3-chlor-2-hydroxypropyl)trimethylammoniumchlorid | 424-510-1 | — | Eye Dam. 1
  Aquatic Chronic 2 | H318
  H411 | GHS05
  GHS09
  Dgr | H318
  H411 | | | |
| 611-140-00-2 | azafenidin (ISO);
  2-(2,4-dichlor-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro1,2,4-triazolo[4,3-a]pyridin3(2H)-on | — | 68049-83-2 | Repr. 1B
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360Df
  H373 ** H400
  H410 | GHS08
  GHS09
  Dgr | H360Df
  H373 **
  H410 | | M = 1 000 | |
| 611-141-00-8 | 5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenyl-azo)isophthalsyre, blandet mononatrium- og diammoniumsalt | 414-410-6 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-142-00-3 | procesprodukt-defineret polyazo-farvestof fremkommet ved kobling af 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzendiazonium med en blanding af 4-carboxybenzendiazonium og diphenylamin-3-sulfo-4,4'-bisdiazonium, og yderligere kobling af de herved opnåede forbindelser med en blanding af naphth-2-ol og 3-aminophenol, natriumsalte og
  natriumchlorid | 425-740-5 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-143-00-9 | en blanding af trinatrium-2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzyliden]hydrazino-κ-N')-6-(2,6-difluorpyrimidin-4-ylamino)-4-sulfonatophenolatocuprat(II) og
  trinatrium-2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzyliden]hydrazino-κ-N')-6-(4,6-difluorpyrimidin-2-ylamino)-4-sulfonatophenolatocuprat(II) | 428-260-4 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-144-00-4 | en blanding af 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2-sulfonsyre, Na/K-salt;
  7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalen-2-sulfonsyre, Na/K-salt;
  7-amino-8-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalen-2-sulfonsyre, Na/K-salt og
  7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalen-2-sulfonsyre, Na/K-salt | 429-070-4 | 214362-06-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-145-00-X | en blanding af tetranatrium-3-(1,5-disulfonatonaphthalen-2-ylazo)-4-hydroxy-7-{4-chlor-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}naphthalen-2-sulfonat og
  3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chlor-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}naphthalen-2-sulfonsyre, natriumsalt | 429-440-5 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-146-00-5 | en blanding af
  pentanatrium-3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalen-2-sulfonat;
  pentanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalen-2-sulfonat;
  pentanatrium-6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat og
  hexanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat | 430-070-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-147-00-0 | natrium-, kalium-, lithium-5-amino-3,6-bis(5-(4-chlor-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat | 430-090-0 | 205764-96-1 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-148-00-6 | en blanding af 2-(3-(2,6-dichlor-4-nitrophenylazo)carbazol-9-yl)ethanol;
  2-(2-(3-(2,6-dichlor-4-nitro-phenylazo)carbazol-9-yl)ethoxy)ethanol og
  3-(2,6-dichlor-4-nitrophenylazo)carbazol | 429-590-1 | — | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 611-149-00-1 | 2-(2-chloracetoxy)ethyl-3-((4-(2,5-dichlor-4-fluorsulfonylphenylazo)-3-methylphenyl)ethylamino)propionat | 427-570-7 | 193486-83-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 611-150-00-7 | tetralithium-2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoat | 440-460-3 | — | Eye Irrit. 2
  Aquatic Chronic 3 | H319
  H412 | GHS07
  Wng | H319
  H412 | | | |
| 611-151-00-2 | chrysoidin;
  4-(phenylazo)benzen-1,3-diamin | 207-803-7 | 495-54-5 | Muta. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H302
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H341
  H302
  H315
  H410 | | | |
| 611-152-00-8 | chrysoidin monohydrochlorid;
  4-phenylazophenylen-1,3-diamin monohydrochlorid; [1] chrysoidinmonoacetat;
  4-(phenylazo)benzen-1,3-diaminmonoacetat; [2]
  chrysoidinacetat
  4-(phenylazo)benzen-1,3-diaminacetat; [3]
  chrysoidin-p-dodecylbenzensulfonat; dodecylbenzensulfonsyre, forbindelse med 4-(phenylazo)benzen-1,3-diamin (1:1); [4]
  chrysoidin dihydrochlorid;
  4-(phenylazo)benzen-1,3-diamin dihydrochlorid; [5]
  chrysoidinsulfat;
  bis[4-(phenylazo)benzen-1,3-diamin]sulfat; [6] | 208-545-8 [1]
  278-290-5 [2]
  279-116-0 [3]
  264-409-8 [4]
  281-549-5 [5]
  282-432-1 [6] | 532-82-1 [1]
  75660-25-2 [2]
  79234-33-6 [3]
  63681-54-9 [4]
  83968-67-6 [5]
  84196-22-5 [6] | Muta. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H302
  H315
  H318
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H341
  H302
  H315
  H318
  H410 | | | |
| 611-153-00-3 | chrysoidin C10-14-alkylderivater;
  benzensulfonsyre, mono-C10-14-alkylderivater, forbindelser
  med 4-(phenylazo)-1,3-benzendiamin; [1]
  chrysoidin, forbindelse med dibutylnaphtalensulfon
  syre;
  dibutylnaphthalensulfonsyre, forbindelse med 4-(phenylazo)benzen-1,3-diamin (1:1) [2] | 286-946-7 [1]
  304-236-8 [2] | 85407-90-5 [1]
  94247-67-3 [2] | Muta. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1 | H341
  H302
  H315
  H318 | GHS05
  GHS08
  GHS07
  Dgr | H341
  H302
  H315
  H318 | | | |
| 611-154-00-9 | trinatrium-5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalen-2,7-disulfonat | 403-670-6 | 92408-46-3 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-155-00-4 | 4,4'-oxybis(benzensulfonylazid) | 431-850-4 | 7456-68-0 | Expl. 1.1 ****
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H201
  H373 **
  H400
  H410 | GHS01
  GHS08
  GHS09
  Dgr | H201
  H373 **
  H410 | | | |
| 611-156-00-X | triammonium-4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoat | 432-270-4 | 221354-37-6 | Repr. 2
  STOT RE 2 *
  Aquatic Chronic 2 | H361f *** H373 **
  H411 | GHS08
  GHS09
  Wng | H361f *** H373 **
  H411 | | | |
| 611-157-00-5 | benzensulfonsyre, 3,3'-(methylenbis((dihydroxyphenylen)azo))bis-, kaliumnatriumsalt
  kaliumnatrium-3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzensulfonat | 432-590-4 | 243869-48-9 | Eye Irrit. 2
  Aquatic Chronic 3 | H319
  H412 | GHS07
  Wng | H319
  H412 | | | |
| 611-158-00-0 | reaktionsprodukt af 2,3,4,2',3',
  4'-hexahydroxy-5,5'-diacetyl-diphenylmethan og 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonylchlorid og 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalensulfonylchlorid | 421-520-8 | — | ****
  Aquatic Chronic 4 | **** H413 | **** | **** H413 | | | |
| 611-159-00-6 | dinatrium-4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalen-2,7-disulfonat | 421-880-6 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-160-00-1 | en blanding af 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalen-1''-sulfonato)ethan; 1,1,1-tris(phenyl-4'-(6''-diazo-5'',
  6''-dihydro-5''-oxo-naphthalen-1''-sulfonato)ethan;
  reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (2:1)
  reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (1:2) | 422-760-6 | — | ****
  Aquatic Chronic 4 | **** H413 | **** | **** H413 | | | |
| 611-161-00-7 | trinatrium-[1,2'-(2-(8-amino-3,5-disulfonatonaphthalen)azo)-(4'-nitrobenzen)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzen)diolato-O, O,N]chromat(III) | 423-100-1 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-162-00-2 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolbis(methansulfonat) | 429-600-4 | — | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 611-163-00-8 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolsulfat | 429-610-9 | — | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 2 | H302
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H411 | | | |
| 611-164-00-3 | en blanding af 2,2'-dimethyl-2,2'-azobutannitril;
  2-methylpentannitril-2-azo-2'-(2'-methylpropannitril);
  2,2'-dimethyl-2,2'-azoheptannitril;
  2-methylheptannitril-2-azo-2'-(2'-methylpropannitril) og
  2-methylheptannitril-2-azo-2'-(2'-methylbutannitril) | 429-710-2 | — | Self-react. D
  Acute Tox. 4 *
  Aquatic Chronic 2 | H242
  H302
  H411 | GHS02
  GHS07
  GHS09
  Dgr | H242
  H302
  H411 | | | |
| 611-165-00-9 | blanding af tetranatrium-4-amino-6-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat og
  tetranatrium-4-amino-6-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat | 431-830-5 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-166-00-4 | en blanding af pentanatrium
  4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat og
  tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat og tetranatrium-4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat | 432-100-9 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-167-00-X | natrium-bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato]cuprat(II) | 435-240-9 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-168-00-5 | en blanding af 3-[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chlor-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre og
  3,5-bis[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre | 435-440-6 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-169-00-0 | natrium-5-(2-carboxyphenylazo)-6-hydroxynaphthalen-2-sulfonat | 435-800-2 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-170-00-6 | blanding af trinatrium-2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoat(5-)-κ-O)cuprat(II)
  dinatrium-2-((1-(5-ethensulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoat-κ-O-(5-))cuprat(II) | 435-880-9 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 611-171-00-1 | blanding af trinatrium-3-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat og
  trinatrium-3-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat | 436-890-6 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-172-00-7 | en blanding af triammonium-
  6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalensulfonat og
  diammonium-3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoat | 438-310-7 | — | Self-react. C ****
  Repr. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 3 | H242
  H361f ***
  H302
  H373 **
  H412 | GHS02
  GHS08
  GHS07
  Dgr | H242
  H361f ***
  H302
  H373 **
  H412 | | | |
| 611-173-00-2 | en blanding af 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, trinatriumsalt og 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, dinatriumsalt | 440-510-4 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-174-00-8 | en blanding af 3-[5-(4-ethensulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt og
  3-[5-(4-(2-chlorethansulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt | 442-290-5 | 457624-86-1 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 611-175-00-3 | blanding af trinatrium-5-{4-chlor-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat
  trinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  dinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat og
  tetranatrium-5-{4-chlor-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2,7-disulfonat | 444-050-5 | — | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 611-176-00-9 | 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol, ester med 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonat | 444-250-2 | — | Self-react. C **** Aquatic Chronic 2 | H242
  H411 | GHS02
  GHS09
  Dgr | H242
  H411 | | | |
| 611-177-00-4 | blanding af pentanatrium-bis[6-anilino-3,5'-disulfonatonaphthalen-2-azobenzen-1,2'-diolato]cobaltat(III);
  tetranatrium-[6-anilino-3,5'-disulfonatonaphthalen-2-azobenzen-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato]cobaltat(III) og trinatrium-bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato]cobaltat(III) | 444-290-0 | 508202-43-5 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 611-178-00-X | en blanding af pentanatrium
  -4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat;
  tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; tetranatrium-4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  trinatrium-4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[2-sulfonato-4-(2-hydro
  xyethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat | 445-280-9 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 611-179-00-5 | en blanding af pentanatrium
  -2-[[8-[[4-chlor-6-[[4-(2-sulfonatoethylsulfonyl)]phe
  nyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat og
  2-[[8-[[4-chlor-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat | 450-010-8 | — | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 611-180-00-0 | jern, komplekser med diazoteret
  4-aminobenzensulfonamid, diazoteret 3-aminobenzensulfonsyre, diazoteret 3-amino-4-hydroxybenzensulfonamid, diazoteret 3-amino-4-hydroxy-N-phenylbenzensulfonamid, diazoteret 5-amino-2-(phenylamino)benzensulfonsyre og resorcinol, natriumsalte | 417-850-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 612-001-00-9 | mono-methylamin; [1]
  di-methylamin; [2]
  tri-methylamin [3] | 200-820-0 [1]
  204-697-4 [2]
  200-875-0 [3] | 74-89-5 [1]
  124-40-3 [2]
  75-50-3 [3] | Flam. Gas 1
  Press. Gas
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H220
  H332
  H335
  H315
  H318 | GHS02
  GHS04
  GHS05
  GHS07
  Dgr | H220
  H332
  H335
  H315
  H318 | | *
  Skin Irrit. 2;
  H315: C ≥ 5 %
  Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2;
  H319: 0,5  % ≤
  C < 5 %
  STOT SE 3; H335: C ≥ 5 % | U5 |
| 612-001-01-6 | mono-methylamin ... %; [1]
  di-methylamin ... %; [2]
  tri-methylamin ... % [3] | 200-820-0 [1]
  204-697-4 [2]
  200-875-0 [3] | 74-89-5 [1]
  124-40-3 [2]
  75-50-3 [3] | Flam. Liq. 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H224
  H332
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H224
  H332
  H302
  H314 | | *
  STOT SE 3; H335: C ≥ 5 % | B |
| 612-002-00-4 | ethylamin | 200-834-7 | 75-04-7 | Flam. Gas 1
  Press. Gas
  Eye Irrit. 2
  STOT SE 3 | H220
  H319
  H335 | GHS02
  GHS04
  GHS07
  Dgr | H220
  H319
  H335 | | | U |
| 612-003-00-X | diethylamin | 203-716-3 | 109-89-7 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H225
  H332
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 1 % | |
| 612-004-00-5 | triethylamin | 204-469-4 | 121-44-8 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H225
  H332
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 1 % | |
| 612-005-00-0 | butylamin | 203-699-2 | 109-73-9 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H225
  H332
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 1 % | |
| 612-006-00-6 | ethylendiamin;
  1,2-diaminoethan | 203-468-6 | 107-15-3 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1 | H226
  H312
  H302
  H314
  H334
  H317 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H226
  H312
  H302
  H314
  H334
  H317 | | | |
| 612-007-00-1 | 2-propanamin;
  isopropylamin | 200-860-9 | 75-31-0 | Flam. Liq. 1
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H224
  H319
  H335
  H315 | GHS02
  GHS07
  Dgr | H224
  H319
  H335
  H315 | | | |
| 612-008-00-7 | anilin | 200-539-3 | 62-53-3 | Carc. 2
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H351
  H341
  H331
  H311
  H301
  H372 **
  H318
  H317
  H400 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H351
  H341
  H331
  H311
  H301
  H372 **
  H318
  H317
  H400 | | *
  STOT RE 1; H372: C ≥ 1 %
  STOT RE 2; H373: 0,2  % ≤ C < 1 % | |
| 612-009-00-2 | salte af anilin | — | — | Carc. 2
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H351
  H341
  H331
  H311
  H301
  H372 **
  H318
  H317
  H400 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H351
  H341
  H331
  H311
  H301
  H372 **
  H318
  H317
  H400 | | *
  STOT RE 1; H372: C ≥ 1 % STOT RE 2;
  H373: 0,2  % ≤
  C < 1 % | A |
| 612-010-00-8 | chloraniliner, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H410 | | | C |
| 612-011-00-3 | 4-nitrosoanilin | 211-535-6 | 659-49-4 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H312
  H302 | GHS07
  Wng | H332
  H312
  H302 | | | |
| 612-012-00-9 | o-nitroanilin; [1] m-nitroanilin; [2] p-nitroanilin [3] | 201-855-4 [1]
  202-729-1 [2]
  202-810-1 [3] | 88-74-4 [1]
  99-09-2 [2]
  100-01-6 [3] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 3 | H331
  H311
  H301
  H373 **
  H412 | GHS06
  GHS08
  Dgr | H331
  H311
  H301
  H373 **
  H412 | | | C |
| 612-013-00-4 | 3-aminobenzensulfonsyre;
  metanilsyre | 204-473-6 | 121-47-1 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H312
  H302 | GHS07
  Wng | H332
  H312
  H302 | | | |
| 612-014-00-X | sulfanilsyre;
  4-aminobenzensulfonsyre | 204-482-5 | 121-57-3 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H315
  H317 | GHS07
  Wng | H319
  H315
  H317 | | | |
| 612-015-00-5 | N-methylanilin | 202-870-9 | 100-61-8 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H410 | | | |
| 612-016-00-0 | N, N-dimethylanilin | 204-493-5 | 121-69-7 | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H351
  H331
  H311
  H301
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H331
  H311
  H301
  H411 | | | |
| 612-017-00-6 | N-methyl-N-2,4,6-tetranitroanilin; tetryl | 207-531-9 | 479-45-8 | Expl. 1,1
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 | H201
  H331
  H311
  H301
  H373 ** | GHS01
  GHS06
  GHS08
  Dgr | H201
  H331
  H311
  H301
  H373 ** | | | |
| 612-018-00-1 | bis(2,4,6-trinitrophenyl)amin;
  hexyl | 205-037-8 | 131-73-7 | Expl. 1,1
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2
  Aquatic Chronic 2 | H201
  H330
  H310
  H300
  H373 **
  H411 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H330
  H310
  H300
  H373 **
  H411 | | | |
| 612-019-00-7 | dipicrylamin, ammoniumsalt | 220-639-0 | 2844-92-0 | Expl. 1,1
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2
  Aquatic Chronic 2 | H201
  H330
  H310
  H300
  H373 **
  H411 | GHS01
  GHS06
  GHS08
  GHS09
  Dgr | H201
  H330
  H310
  H300
  H373 **
  H411 | | | |
| 612-020-00-2 | 1-naphthylamin | 205-138-7 | 134-32-7 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 612-022-00-3 | 2-naphthylamin | 202-080-4 | 91-59-8 | Carc. 1A
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H411 | | Carc. 1A; H350: C ≥ 0,01  % | |
| 612-023-00-9 | phenylhydrazin; [1]
  phenylhydraziniumchlorid; [2]
  phenylhydrazin-hydrochlorid; [3]
  phenylhydraziniumsulfat (2:1) [4] | 202-873-5 [1]
  200-444-7 [2]
  248-259-0 [3]
  257-622-2 [4] | 100-63-0 [1]
  59-88-1 [2]
  27140-08-5 [3]
  52033-74-6 [4] | Carc. 1B
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H350
  H341
  H331
  H311
  H301
  H372 **
  H319
  H315
  H317
  H400 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H331
  H311
  H301
  H372 **
  H319
  H315
  H317
  H400 | | | |
| 612-024-00-4 | m-toluidin;
  3-aminotoluen | 203-583-1 | 108-44-1 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1 | H331
  H311
  H301
  H373 **
  H400 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H400 | | | |
| 612-025-00-X | nitrotoluidiner, med undtagelse af sådanne specificeret andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H411 | | | C |
| 612-026-00-5 | diphenylamin | 204-539-4 | 122-39-4 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H410 | | | |
| 612-027-00-0 | xylidiner, med undtagelse af sådanne specificeret andetsteds i dette bilag
  dimethylaniliner, med undtagelse af sådanne specificeret andetsteds i dette bilag | — | — | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H411 | | | C |
| 612-028-00-6 | p-phenylendiamin | 203-404-7 | 106-50-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H319
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H319
  H317
  H410 | | | |
| 612-029-00-1 | benzen-1,4-diamindihydrochlorid;
  p-phenylendiamindihydrochlorid | 210-834-9 | 624-18-0 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H319
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H311
  H301
  H319
  H317
  H410 | | | |
| 612-030-00-7 | 2-methyl-p-phenylendiaminsulfat [1] | 210-431-8 [1]
  228-871-4 [2] | 615-50-9 [1]
  6369-59-1 [2] | Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H301
  H332
  H312
  H317
  H411 | GHS06
  GHS09
  Dgr | H301
  H332
  H312
  H317
  H411 | | | |
| 612-031-00-2 | N, N-dimethylbenzen-1,3-diamin; [1]
  4-amino-N, N-dimethylanilin;
  3-amino-N, N'-dimethylanilin
  [2] | 220-623-3 [1]
  202-807-5 [2] | 2836-04-6 [1]
  99-98-9 [2] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H331
  H311
  H301 | GHS06
  Dgr | H331
  H311
  H301 | | | C |
| 612-032-00-8 | N, N,N'-N'-tetramethyl-p-pheny
  lendiamin | 202-831-6 | 100-22-1 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H312
  H302 | GHS07
  Wng | H332
  H312
  H302 | | | |
| 612-033-00-3 | 2-aminofenol | 202-431-1 | 95-55-6 | Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 * | H341
  H332
  H302 | GHS08
  GHS07
  Wng | H341
  H332
  H302 | | | |
| 612-034-00-9 | 2-amino-4,6-dinitrophenol;
  picraminsyre | 202-544-6 | 96-91-3 | Expl. 1,1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H201
  H332
  H312
  H302
  H412 | GHS01
  GHS07
  Dgr | H201
  H332
  H312
  H302
  H412 | | | |
| 612-034-01-6 | 2-amino-4,6-dinitrophenol;
  picraminsyre; [≥ 20 % vand] | 202-544-6 | 96-91-3 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H332
  H312
  H302
  H412 | GHS07
  Wng | H332
  H312
  H302
  H412 | | | G |
| 612-035-00-4 | 2-methoxyanilin;
  ortho-anisidin | 201-963-1 | 90-04-0 | Carc. 1B Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 * | H350
  H341
  H331
  H311
  H301 | GHS06
  GHS08
  Dgr | H350
  H341
  H331
  H311
  H301 | | | |
| 612-036-00-X | 3,3'-dimethoxybenzidin;

  o-dianisidin | 204-355-4 | 119-90-4 | Carc. 1B
  Acute Tox. 4 * | H350
  H302 | GHS08
  GHS07
  Dgr | H350
  H302 | | | |
| 612-037-00-5 | salte af 3,3'-dimethoxyben
  zidin; salte af o-dianisidin | — | — | Carc. 1B
  Acute Tox. 4 * | H350
  H302 | GHS08
  GHS07
  Dgr | H350
  H302 | | | A |
| 612-038-00-0 | 2-nitro-p-anisidin
  4-methoxy-2-nitroanilin | 202-547-2 | 96-96-8 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 3 | H330
  H310
  H300
  H373 **
  H412 | GHS06
  GHS08
  Dgr | H330
  H310
  H300
  H373 **
  H412 | | | |
| 612-039-00-6 | 2-ethoxyanilin;
  ortho-phenetidin | 202-356-4 | 94-70-2 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 * | H331
  H311
  H301
  H373 ** | GHS06
  GHS08
  Dgr | H331
  H311
  H301
  H373 ** | | | |
| 612-040-00-1 | 2,4-dinitroanilin | 202-553-5 | 97-02-9 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Chronic 2 | H330
  H310
  H300
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 **
  H411 | | | |
| 612-041-00-7 | 4,4'-bis-o-toluidin | 204-358-0 | 119-93-7 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H411 | | | |
| 612-042-00-2 | benzidin
  1,1'-biphenyl-4,4'-diamin;
  4,4'-diaminobiphenyl;
  biphenyl-4,4'-ylendiamin | 202-199-1 | 92-87-5 | Carc. 1A
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H410 | | Carc. 1A; H350: C ≥ 0,01  % | |
| 612-043-00-8 | N, N'-dimethylbenzidin | — | 2810-74-4 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H332
  H312
  H302 | GHS07
  Wng | H332
  H312
  H302 | | | |
| 612-044-00-3 | N, N'-diacetylbenzidin | 210-338-2 | 613-35-4 | Carc. 1B Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H350
  H341
  H332
  H312
  H302 | GHS08
  GHS07
  Dgr | H350
  H341
  H332
  H312
  H302 | | | |
| 612-046-00-4 | allylamin | 203-463-9 | 107-11-9 | Flam. Liq. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H225
  H331
  H311
  H301
  H411 | GHS02
  GHS06
  GHS09
  Dgr | H225
  H331
  H311
  H301
  H411 | | | |
| 612-047-00-X | benzylamin | 202-854-1 | 100-46-9 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | | |
| 612-048-00-5 | dipropylamin | 205-565-9 | 142-84-7 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H225
  H332
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H314 | | STOT SE 3; H335: C ≥ 1 % | |
| 612-049-00-0 | dibutylamin; [1]
  di-sec-butylamin [2] | 203-921-8 [1]
  210-937-9 [2] | 111-92-2 [1]
  626-23-3 [2] | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H226
  H332
  H312
  H302 | GHS02
  GHS07
  Wng | H226
  H332
  H312
  H302 | | | |
| 612-050-00-6 | cyclohexylamin | 203-629-0 | 108-91-8 | Flam. Liq. 3
  Repr. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H226
  H361f ***
  H312
  H302
  H314 | GHS02
  GHS05
  GHS08
  GHS07
  Dgr | H226
  H361f ***
  H312
  H302
  H314 | | | |
| 612-051-00-1 | 4,4'-diaminodiphenylmethan;
  4,4'-methylendianilin | 202-974-4 | 101-77-9 | Carc. 1B
  Muta. 2
  STOT SE 1
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H350
  H341
  H370 **
  H373 **
  H317
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H341
  H370 **
  H373 **
  H317
  H411 | | | |
| 612-052-00-7 | (S)-sec-butylamin
  (S)-2-aminobutan; [1] (R)-sec-butylamin;
  (R)-2-aminobutan; [2]

  sec-butylamin;
  2-aminobutan [3] | 208-164-7 [1]
  236-232-6 [2]
  237-732-7 [3] | 513-49-5 [1]
  13250-12-9 [2]
  13952-84-6 [3] | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A
  Aquatic Acute 1 | H225
  H332
  H302
  H314
  H400 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H225
  H332
  H302
  H314
  H400 | | | C |
| 612-053-00-2 | N-ethylanilin | 203-135-5 | 103-69-5 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 * | H331
  H311
  H301
  H373 ** | GHS06
  GHS08
  Dgr | H331
  H311
  H301
  H373 ** | | | |
| 612-054-00-8 | N, N-diethylanilin | 202-088-8 | 91-66-7 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H411 | | * | |
| 612-055-00-3 | N-methyl-o-toluidin; [1] N-methyl-m-toluidin; [2] N-methyl-p-toluidin [3] | 210-260-9 [1]
  211-795-0 [2]
  210-769-6 [3] | 611-21-2 [1]
  696-44-6 [2]
  623-08-5 [3] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 3 | H331
  H311
  H301
  H373 **
  H412 | GHS06
  GHS08
  Dgr | H331
  H311
  H301
  H373 **
  H412 | | | C |
| 612-056-00-9 | N, N-dimethyl-p-toluidin; [1] N, N-dimethyl-m-toluidin; [2] N, N-dimethyl-o-toluidin [3] | 202-805-4 [1]
  204-495-6 [2]
  210-199-8 [3] | 99-97-8 [1]
  121-72-2 [2]
  609-72-3 [3] | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 3 | H331
  H311
  H301
  H373 **
  H412 | GHS06
  GHS08
  Dgr | H331
  H311
  H301
  H373 **
  H412 | | * | C |
| 612-057-00-4 | piperazin; [fast] | 203-808-3 | 110-85-0 | Repr. 2
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1 | H361fd
  H314
  H334
  H317 | GHS05
  GHS08
  Dgr | H361fd
  H314
  H334
  H317 | | | |
| 612-057-01-1 | piperazin; [væske] | 203-808-3 | 110-85-0 | Repr. 2
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1 | H361fd
  H314
  H334
  H317 | GHS05
  GHS08
  Dgr | H361fd
  H314
  H334
  H317 | | | |
| 612-058-00-X | 2,2'-iminodiethylamin;
  diethylentriamin | 203-865-4 | 111-40-0 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H312
  H302
  H314
  H317 | GHS05
  GHS07
  Dgr | H312
  H302
  H314
  H317 | | | |
| 612-059-00-5 | 3,6-diazaoctanethylendiamin;
  triethylentetramin | 203-950-6 | 112-24-3 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H312
  H314
  H317
  H412 | GHS05
  GHS07
  Dgr | H312
  H314
  H317
  H412 | | | |
| 612-060-00-0 | 3,6,9-triazaundecamethylendiamin; tetraethylen-pentamin | 203-986-2 | 112-57-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H312
  H302
  H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H314
  H317
  H411 | | | |
| 612-061-00-6 | 3-(dimethylamino)propylamin; N, N-dimethyl-1,3-diaminopropan | 203-680-9 | 109-55-7 | Flam. Liq. 3
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H226
  H302
  H314
  H317 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H302
  H314
  H317 | | | |
| 612-062-00-1 | 3-(diethylamino)propylamin);

  N, N-diethyl-1,3-diaminopropan | 203-236-4 | 104-78-9 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H226
  H312
  H302
  H314
  H317 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H312
  H302
  H314
  H317 | | | |
| 612-063-00-7 | 3,3'-iminodi(propylamin)
  dipropylentriamin | 200-261-2 | 56-18-8 | Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1A
  Skin Sens. 1 | H330
  H311
  H302
  H314
  H317 | GHS06
  GHS05
  Dgr | H330
  H311
  H302
  H314
  H317 | | | |
| 612-064-00-2 | 3,6,9,12-tetraazatetradecan-k,4-diamin; pentaethylenhexamin | 223-775-9 | 4067-16-7 | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H410 | | | |
| 612-065-00-8 | polyethylenpolyaminer undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H314
  H317
  H410 | | | |
| 612-066-00-3 | dicyclohexylamin | 202-980-7 | 101-83-7 | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H410 | | | |
| 612-067-00-9 | 3-aminomethyl-3,5,5-trimethylcyclohexylamin | 220-666-8 | 2855-13-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H312
  H302
  H314
  H317
  H412 | GHS05
  GHS07
  Dgr | H312
  H302
  H314
  H317
  H412 | | | |
| 612-068-00-4 | 3,3'-dichlorbenzidin
  3,3'-dichlorbiphenyl-4,4'-ylendiamin | 202-109-0 | 91-94-1 | Carc. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H312
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H312
  H317
  H410 | | | |
| 612-069-00-X | salte af 3,3'-dichlorbenzidin;
  salte af 3,3'-dichlorbiphenyl4,4'-ylendiamin | — | — | Carc. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H312
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H312
  H317
  H410 | | | A |
| 612-070-00-5 | salte af benzidin | 208-519-6
  208-520-1
  244-236-4
  252-984-8 | 531-85-1
  531-86-2
  21136-70-9
  36341-27-2 | Carc. 1A
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H410 | | | A |
| 612-071-00-0 | salte af 2-nafthylamin | 209-030-0
  210-313-6 | 553-00-4
  612-52-2 | Carc. 1A
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H411 | | | A |
| 612-072-00-6 | biphenyl-4-ylamin;
  xenylamin;
  4-aminobiphenyl | 202-177-1 | 92-67-1 | Carc. 1A
  Acute Tox. 4 * | H350
  H302 | GHS08
  GHS07
  Dgr | H350
  H302 | | | |
| 612-073-00-1 | salte af biphenyl-4-ylamin;
  salte af xenylamin;
  salte af 4-aminobiphenyl | — | — | Carc. 1A
  Acute Tox. 4 * | H350
  H302 | GHS08
  GHS07
  Dgr | H350
  H302 | | | A |
| 612-074-00-7 | benzyldimethylamin | 203-149-1 | 103-83-3 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 3 | H226
  H332
  H312
  H302
  H314
  H412 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H332
  H312
  H302
  H314
  H412 | | | |
| 612-075-00-2 | 2-aminoethyldimethylamin
  2-dimethylaminoethylamin | 203-541-2 | 108-00-9 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H225
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H312
  H302
  H314 | | | |
| 612-076-00-8 | ethyldimethylamin | 209-940-8 | 598-56-1 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H225
  H332
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H332
  H302
  H314 | | | |
| 612-077-00-3 | dimethylnitrosoamin;

  N-nitrosodimethylamin | 200-549-8 | 62-75-9 | Carc. 1B
  Acute Tox. 2 *
  Acute Tox. 3 *
  STOT RE 1
  Aquatic Chronic 2 | H350
  H330
  H301
  H372 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H330
  H301
  H372 **
  H411 | | Carc. 1B; H350: C ≥ 0,001  % | |
| 612-078-00-9 | 2,2'-dichlor-4,4'-methylendianilin
  4,4'-methylenbis(2-chloranilin) | 202-918-9 | 101-14-4 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H410 | | | |
| 612-079-00-4 | salte af 2,2'-dichlor-4,4'-methylendianilin;
  salte af 4,4'-methylenbis(2-chloranilin) | — | — | Carc. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H410 | | | A |
| 612-080-00-X | 4-amino-N, N-diethylanilin;

  N, N-diethyl-4-aminoanilin | 202-214-1 | 93-05-0 | Acute Tox. 3 *
  Skin Corr. 1B | H301
  H314 | GHS06
  GHS05
  Dgr | H301
  H314 | | | |
| 612-081-00-5 | salte af 4,4'-bi-o-toluidin;
  salte af 3,3′-dimethoxybenzidin;
  salte af o-tolidin | 210-322-5
  265-294-7
  277-985-0 | 612-82-8
  64969-36-4
  74753-18-7 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H411 | | | A |
| 612-082-00-0 | thiourea;
  thiourinstof | 200-543-5 | 62-56-6 | Carc. 2
  Repr. 2
  Acute Tox. 4 *
  Aquatic Chronic 2 | H351
  H361D *** H302
  H411 | GHS08
  GHS07
  GHS09
  Wng | H351
  H361D *** H302
  H411 | | | |
| 612-083-00-6 | 1-methyl-3-nitro-1-nitrosoguanidin | 200-730-1 | 70-25-7 | Carc. 1B
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H350
  H332
  H319
  H315
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H332
  H319
  H315
  H411 | | Carc. 1B; H350: C ≥ 0,01  % | |
| 612-084-00-1 | dapson;
  4,4'-diaminodiphenylsulfon | 201-248-4 | 80-08-0 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 612-085-00-7 | 4,4'-methylendi-o-toluidin | 212-658-8 | 838-88-0 | Carc. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H317
  H410 | | | |
| 612-086-00-2 | amitraz (ISO)

  N, N-bis(2,4-xylyliminomethyl)
  methylamin | 251-375-4 | 33089-61-1 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H317
  H410 | | M = 10 | |
| 612-087-00-8 | guazatin (ISO) | | 108173-90-6 | Acute Tox. 2 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H312
  H302
  H335
  H315
  H318
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H330
  H312
  H302
  H335
  H315
  H318
  H410 | | | |
| 612-088-00-3 | simazin (ISO)
  6-chlor-N, N'-diethyl-1,3,5- triazin-2,4-diamin | 204-535-2 | 122-34-9 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 612-089-00-9 | 1,5-naphthylendiamin | 218-817-8 | 2243-62-1 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 612-090-00-4 | 2,2'-(nitrosoimino)bisethanol | 214-237-4 | 1116-54-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 612-091-00-X | o-toluidin;
  2-aminotoluen | 202-429-0 | 95-53-4 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Aquatic Acute 1 | H350
  H331
  H301
  H319
  H400 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H301
  H319
  H400 | | | |
| 612-092-00-5 | N, N'-(2,2-dimethylpropyli
  den)hexamethylendiamin | 401-660-6 | 1000-78-8 | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 612-093-00-0 | 3,5-dichlor-4-(1,1,2,2-tetrafluorethoxy)anilin | 401-790-3 | 104147-32-2 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 612-094-00-6 | 4-(2-chlor-4-trifluormethyl)phenoxy-2-fluoranilin hydrochlorid | 402-190-4 | 113674-95-6 | STOT RE 1
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H372 **
  H302
  H373 **
  H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H372 **
  H302
  H373 **
  H318
  H317
  H410 | | | |
| 612-095-00-1 | benzyl-2-hydroxydodecyldi-
  methylammoniumbenzoat | 402-610-6 | 113694-52-3 | Skin Corr. 1B
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H302
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H302
  H410 | | | |
| 612-096-00-7 | 4,4'-carbonimidoylbis[N, N-dimethylanilin] | 207-762-5 | 492-80-8 | Carc. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 2 | H351
  H302
  H319
  H411 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H319
  H411 | | | |
| 612-097-00-2 | salte af 4,4'-carbonimid-
  oylbis[N, N-dimethylanilin] | — | — | Carc. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 2 | H351
  H302
  H319
  H411 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H319
  H411 | | | A |
| 612-098-00-8 | nitrosodipropylamin | 210-698-0 | 621-64-7 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H411 | | Carc. 1B; H350: C ≥ 0,001  % | |
| 612-099-00-3 | 4-methyl-m-phenylendiamin;
  2,4-toluendiamin | 202-453-1 | 95-80-7 | Carc. 1B
  Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H350
  H341
  H361f ***
  H301
  H312
  H373 **
  H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H361f ***
  H301
  H312
  H373 **
  H317
  H411 | | | |
| 612-100-00-7 | propylendiamin | 201-155-9 | 78-90-0 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A | H226
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H226
  H312
  H302
  H314 | | | |
| 612-101-00-2 | methenamin;
  hexamethylentetramin | 202-905-8 | 100-97-0 | Flam. Sol. 2
  Skin Sens. 1 | H228
  H317 | GHS02
  GHS07
  Wng | H228
  H317 | | | |
| 612-102-00-8 | N, N-bis(3-aminopro-
  pyl)methylamin | 203-336-8 | 105-83-9 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1B | H331
  H311
  H302
  H314 | GHS06
  GHS05
  Dgr | H331
  H311
  H302
  H314 | | | |
| 612-103-00-3 | N, N,N',N'-tetramethylethylendiamin | 203-744-6 | 110-18-9 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H225
  H332
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H332
  H302
  H314 | | | |
| 612-104-00-9 | hexamethylendiamin | 204-679-6 | 124-09-4 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Corr. 1B | H312
  H302
  H335
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H335
  H314 | | | |
| 612-105-00-4 | 2-piperazin-1-ylethylamin | 205-411-0 | 140-31-8 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H312
  H302
  H314
  H317
  H412 | GHS05
  GHS07
  Dgr | H312
  H302
  H314
  H317
  H412 | | | |
| 612-106-00-X | 2,6-diethylanilin | 209-445-7 | 579-66-8 | Acute Tox. 4 * | H302 | — | H302 | | | |
| 612-107-00-5 | 1-phenylethylamin; [1]
  .sc.DL.sc.-α-methylbenzylamin [2] | 202-706-6 [1]
  210-545-8 [2] | 98-84-0 [1]
  618-36-0 [2] | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | | |
| 612-108-00-0 | 3-aminopropyltriethoxysilan | 213-048-4 | 919-30-2 | Acute Tox. 4 *
  Skin Corr. 1B | H302
  H314 | GHS05
  GHS07
  Dgr | H302
  H314 | | | |
| 612-109-00-6 | bis(2-dimethylaminoe-
  thyl)(methyl)amin | 221-201-1 | 3030-47-5 | Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1B | H311
  H302
  H314 | GHS06
  GHS05
  Dgr | H311
  H302
  H314 | | | |
| 612-110-00-1 | 2,2'-dimethyl-4,4'-methylenbis(cyclohexylamin) | 229-962-1 | 6864-37-5 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1A
  Aquatic Chronic 2 | H331
  H311
  H302
  H314
  H411 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H311
  H302
  H314
  H411 | | | |
| 612-111-00-7 | 2-methyl-m-phenylendiamin;
  2,6-toluendiamin | 212-513-9 | 823-40-5 | Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H341
  H312
  H302
  H317
  H411 | GHS08
  GHS07
  GHS09
  Wng | H341
  H312
  H302
  H317
  H411 | | | |
| 612-112-00-2 | p-anisidin;
  4-methoxyanilin | 203-254-2 | 104-94-9 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  STOT RE 2 *
  Aquatic Acute 1 | H330
  H310
  H300
  H373 **
  H400 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H310
  H300
  H373 **
  H400 | | | |
| 612-113-00-8 | 6-methyl-2,4-bis(methylthio)phenylen-1,3-diamin | 403-240-8 | 106264-79-3 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 612-114-00-3 | R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamidhydrogen-2,3-bis(benzoyloxy)succinat | 404-390-7 | — | Flam. Sol. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H228
  H317
  H412 | GHS02
  GHS07
  Wng | H228
  H317
  H412 | | | |
| 612-115-00-9 | dimethyldioctadecylammoniumhydrogensulfat | 404-050-8 | 123312-54-9 | Eye Irrit. 2
  Aquatic Chronic 4 | H319
  H413 | GHS07
  Wng | H319
  H413 | | | |
| 612-116-00-4 | C8-18salkylbis(2-hydroxyethyl)ammoniumbis(2-ethylhexyl)phosphat | 404-690-8 | 68132-19-4 | Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H314
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H314
  H317
  H410 | | | |
| 612-117-00-X | C12-14-tert-alkylamin, methylphosphonsyresalt | 404-750-3 | 119415-07-5 | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H302
  H314
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H411 | | | |
| 612-118-00-5 | en blanding af (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium-4-toluensulfonat og
  (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromid | 405-080-4 | — | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 612-119-00-0 | benzyldimethyloctadecylammonium-3-nitrobenzensulfonat | 405-330-2 | — | Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H315
  H318
  H410 | | | |
| 612-120-00-6 | aclonifen (ISO);
  2-chlor-6-nitro-3-phenoxyanilin | 277-704-1 | 74070-46-5 | Carc. 2
  Skin Sens. 1A
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H317
  H400
  H410 | GHS08
  GHS07
  GH09
  Wng | H351
  H317
  H410 | | M = 100
  M = 10 | |
| 612-121-00-1 | aminer, polyethylenpoly-; HEPA | 268-626-9 | 68131-73-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H314
  H317
  H410 | | | |
| 612-122-00-7 | hydroxylamin ....%,
  [> 55 % i vandig opløsning] | 232-259-2 | 7803-49-8 | Unst. Expl. Met. Corr. 1
  Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H200
  H290
  H351
  H312
  H302
  H373 **
  H335
  H315
  H318
  H317
  H400 | GHS01
  GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H200
  H290
  H351
  H312
  H302
  H373 **
  H335
  H315
  H318
  H317
  H400 | | | B |
| 612-122-01-4 | hydroxylamin ...% [≤ 55 % i vandig opløsning] | 232-259-2 | 7803-49-8 | Met. Corr. 1
  Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H290
  H351
  H312
  H302
  H373 **
  H335
  H315
  H318
  H317
  H400 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H290
  H351
  H312
  H302
  H373 **
  H335
  H315
  H318
  H317
  H400 | | | B |
| 612-123-00-2 | hydroxylammoniumchlorid; hydroxylamin hydrochlorid;
  [1] bis(hydroxylammonium)sulfat;
  hydroxylamin sulfat (2:1) [2] | 226-798-2 [1]
  233-118-8 [2] | 5470-11-1 [1]
  10039-54-0 [2] | Met. Corr. 1
  Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H290
  H351
  H312
  H302
  H373 **
  H319
  H315
  H317
  H400 | GHS05
  GHS08
  GHS07
  GHS09
  Wng | H290
  H351
  H312
  H302
  H373 **
  H319
  H315
  H317
  H400 | | | |
| 612-124-00-8 | N, N,N-trimethylaniliniumchlorid | 205-319-0 | 138-24-9 | Acute Tox. 3 *
  Acute Tox. 3 * | H311
  H301 | GHS06
  Dgr | H311
  H301 | | | |
| 612-125-00-3 | 2-methyl-p-phenylendiamin
  2,5-toluendiamin | 202-442-1 | 95-70-5 | Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H301
  H332
  H312
  H317
  H411 | GHS06
  GHS09
  Dgr | H301
  H332
  H312
  H317
  H411 | | | |
| 612-126-00-9 | toluen-2,4-diammoniumsulfat;
  4-methyl-m-phenylendiamin
  sulfat | 265-697-8 | 65321-67-7 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H350
  H301
  H312
  H319
  H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H301
  H312
  H319
  H317
  H411 | | | |
| 612-127-00-4 | 3-aminophenol | 209-711-2 | 591-27-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H302
  H411 | GHS07
  GHS09
  Wng | H332
  H302
  H411 | | | |
| 612-128-00-X | 4-aminophenol | 204-616-2 | 123-30-8 | Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H332
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H341
  H332
  H302
  H410 | | | |
| 612-129-00-5 | diisopropylamin | 203-558-5 | 108-18-9 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H225
  H332
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H332
  H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | |
| 612-130-00-0 | 2,6-diamino-3,5-diethyltoluen;
  4,6-diethyl-2-methylbenzen-1,3-diamin; [1]
  2,4-diamino-3,5-diethyltoluen;
  2,4-diethyl-6-methylbenzen-1,3-diamin; [2] diethylmethylbenzendiamin
  [3] | 218-255-3 [1]
  218-256-9 [2]
  270-877-4 [3] | 04-01-2095 [1]
  05-02-2095 [2]
  68479-98-1 [3] | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H373 **
  H319
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H312
  H302
  H373 **
  H319
  H410 | | | C |
| 612-131-00-6 | didecyldimethylammoniumchlorid | 230-525-2 | 7173-51-5 | Acute Tox. 4 *
  Skin Corr. 1B | H302
  H314 | GHS05
  GHS07
  Dgr | H302
  H314 | | | |
| 612-132-00-1 | N, N'-diphenyl-p-phenylendiamin

  N, N'-diphenyl-1,4-benzendiamin | 200-806-4 | 74-31-7 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 612-133-00-7 | (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammoniumsulfat;
  4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenyldiamin
  sulfat | 247-162-0 | 25646-77-9 | Acute Tox. 3 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H373 **
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H373 **
  H317
  H410 | | | |
| 612-134-00-2 | N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methansulfonamidsesquisulfat
  4-(N-ethyl-N-2-metansulfonylaminoethyl)-2-methylphenylendiamin sesquisulfat monohydrat | 247-161-5 | 25646-71-3 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 612-135-00-8 | N-2-naphthylanilin;

  N-phenyl-2-napthylamin | 205-223-9 | 135-88-6 | Carc. 2
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H351
  H319
  H315
  H317
  H411 | GHS08
  GHS07
  GHS09
  Wng | H351
  H319
  H315
  H317
  H411 | | | |
| 612-136-00-3 | N-isopropyl-N'-phenyl-p-phenylendiamin | 202-969-7 | 101-72-4 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | Skin Sens. 1; H317:C ≥ 0,1  % | |
| 612-137-00-9 | 4-chloranilin | 203-401-0 | 106-47-8 | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H331
  H311
  H301
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H311
  H301
  H317
  H410 | | | |
| 612-138-00-4 | furalaxyl (ISO);
  methyl-N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-.sc.DL.sc.-alaninat | 260-875-1 | 57646-30-7 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 612-139-00-X | mefenacet (ISO);
  2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamid | 277-328-8 | 73250-68-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 612-140-00-5 | kvaternære ammoniumforbindelser, benzyl-C8-18-alkyldimethyl-, chlorider | 264-151-6 | 63449-41-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1 | H312
  H302
  H314
  H400 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H314
  H400 | | | |
| 612-141-00-0 | 4,4'-methylenbis(2-ethylanilin);
  4,4'-methylenbis(2-ethylbenzenamin) | 243-420-1 | 19900-65-3 | Carc. 2
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H410 | | | |
| 612-142-00-6 | biphenyl-2-ylamin | 201-990-9 | 90-41-5 | Carc. 2
  Acute Tox. 4 * Aquatic Chronic 3 | H351
  H302
  H412 | GHS08
  GHS07
  Wng | H351
  H302
  H412 | | | |
| 612-143-00-1 | N5,N5-diethyltoluen-2,5-diaminmonohydrochlorid
  4-diethylamino-2-methylanilinmonohydrochlorid | 218-130-3 | 2051-79-8 | Acute Tox. 3 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H319
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H319
  H317
  H410 | | | |
| 612-144-00-7 | flumethralin (ISO)

  N-(2-chlor-6-fluorbenzyl)-N-ethyl-α, α,α-trifluor-2,6-dinitro-p-toluidin | — | 62924-70-3 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H317
  H410 | | | |
| 612-145-00-2 | o-phenylendiamin | 202-430-6 | 95-54-5 | Carc. 2
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H341
  H301
  H332
  H312
  H319
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H341
  H301
  H332
  H312
  H319
  H317
  H410 | | | |
| 612-146-00-8 | o-phenylendiamindihydrochlorid | 210-418-7 | 615-28-1 | Carc. 2
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H341
  H301
  H332
  H312
  H319
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H341
  H301
  H332
  H312
  H319
  H317
  H410 | | | |
| 612-147-00-3 | m-phenylendiamin | 203-584-7 | 108-45-2 | Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H331
  H311
  H301
  H319
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H341
  H331
  H311
  H301
  H319
  H317
  H410 | | | |
| 612-148-00-9 | m-phenylendiamindihydrochlorid | 208-790-0 | 541-69-5 | Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H331
  H311
  H301
  H319
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H341
  H331
  H311
  H301
  H319
  H317
  H410 | | | |
| 612-149-00-4 | 1,3-diphenylguanidin | 203-002-1 | 102-06-7 | Repr. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H361f ***
  H302
  H319
  H335
  H315
  H411 | GHS08
  GHS07
  GHS09
  Wng | H361f ***
  H302
  H319
  H335
  H315
  H411 | | | |
| 612-151-00-5 | methyl-phenylendiamin;
  diaminotoluen;
  [teknisk produkt — blanding af 4-methyl-m-phenylendiamin (EF-nr. 202-453-1) og 2-methyl-m-phenylendiamin (EF-nr. 212-513-9)] | — | — | Carc. 1B Muta. 2
  Repr. 2
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H350
  H341
  H361f ***
  H301
  H312
  H373 **
  H319
  H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H361f ***
  H301
  H312
  H373 **
  H319
  H317
  H411 | | | |
| 612-152-00-0 | N, N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamin | 406-610-7 | 62478-82-4 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1A
  Aquatic Chronic 3 | H226
  H332
  H302
  H373 **
  H314
  H412 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H226
  H332
  H302
  H373 **
  H314
  H412 | | | |
| 612-153-00-6 | 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzenmonohydrochlorid | 407-020-2 | 132885-85-9 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H317
  H412 | GHS07
  Wng | H302
  H317
  H412 | | | |
| 612-154-00-1 | 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthen] | 410-890-6 | 95235-29-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 612-155-00-7 | 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthen | 411-730-8 | 93071-94-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 612-156-00-2 | blanding af trihexadecylmethylammoniumchlorid og dihexadecyldimethylammoniumchlorid | 405-620-9 | — | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 612-157-00-8 | (Z)-1-benzo[b]thien-2-ylethanonoximhydrochlorid | 410-780-8 | — | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H373 **
  H318
  H317
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H302
  H373 **
  H318
  H317
  H411 | | | |
| 612-158-00-3 | blanding af bis(5-dodecyl-2-hydroxybenzald-oximat)-kobber (II) C12-alkyl gruppen er forgrenet og
  4-dodecylsalicylaldoxim | 410-820-4 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 612-159-00-9 | reaktionsprodukter af trimethylhexamethylendiamine (en blanding af 2,2,4-trimethyl-1,6-hexandiamin og 2,4,4-trimethyl-1,6-hexandiamin, EINECS listet), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxiran-derivater)
  og p-toluen-sulfonsyre | 410-880-1 | — | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H410 | | | |
| 612-160-00-4 | p-toluidin;
  4-aminotoluen; [1]

  p-toluidiniumchlorid [2]

  p-toluidinsulfat (1:1) [3] | 203-403-1 [1]
  208-740-8 [2]
  208-741-3 [3] | 106-49-0 [1]
  540-23-8 [2]
  540-25-0 [3] | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H351
  H331
  H311
  H301
  H319
  H317
  H400 | GHS06
  GHS08
  GHS09
  Dgr | H351
  H331
  H311
  H301
  H319
  H317
  H400 | | | |
| 612-161-00-X | 2,6-xylidin;
  2,6-dimethylanilin | 201-758-7 | 87-62-7 | Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 2 | H351
  H332
  H312
  H302
  H335
  H315
  H411 | GHS08
  GHS07
  GHS09
  Wng | H351
  H332
  H312
  H302
  H335
  H315
  H411 | | | |
| 612-162-00-5 | dimethyldioctadecylammoniumchlorid
  DODMAC | 203-508-2 | 107-64-2 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 612-163-00-0 | metalaxyl-M (ISO)
  mefenoxam
  (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propion
  syremethylester | — | 70630-17-0 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 612-164-00-6 | 2-butyl-2-ethyl-1,5-diaminopentan | 412-700-7 | 137605-95-9 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H312
  H302
  H373 **
  H314
  H317
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H312
  H302
  H373 **
  H314
  H317
  H412 | | | |
| 612-165-00-1 | N, N'-diphenyl-N, N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamin | 413-810-8 | 65181-78-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 612-166-00-7 | blanding af cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanmethylammonium-phosphat (1:1) og
  trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanmethylammonium-phosphat (1:1) | 411-830-1 | 114765-88-7 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 612-167-00-2 | 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b, f]azepin hydrochlorid | 410-490-1 | — | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H373 **
  H318
  H317
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H302
  H373 **
  H318
  H317
  H411 | | | |
| 612-168-00-8 | 3,5-dichlor-2,6-difluorpyridin-4-amin | 220-630-1 | 2840-00-8 | Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Chronic 2 | H312
  H302
  H411 | GHS07
  GHS09
  Wng | H312
  H302
  H411 | | | |
| 612-169-00-3 | bis(N-methyl-N-phenylhydrazin)sulfat | 423-170-1 | 618-26-8 | Flam. Liq. 2
  STOT RE 1
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H225
  H372 **
  H302
  H318
  H317
  H400
  H410 | GHS02
  GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H225
  H372 **
  H302
  H318
  H317
  H410 | | | |
| 612-170-00-9 | 4-chlorphenylcyclopropylketon-O-(4-aminobenzyl)oxim | 405-260-2 | — | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 612-171-00-4 | N, N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethan | 410-060-3 | 130728-76-6 | Muta. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H341
  H317
  H411 | GHS08
  GHS09
  Wng | H341
  H317
  H411 | | | |
| 612-172-00-X | 4,4'-methylenbis(N, N'-dimethyl-cyclohexanamin) | 412-840-9 | 13474-64-1 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1A
  Aquatic Chronic 3 | H302
  H373 **
  H314
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H373 **
  H314
  H412 | | | |
| 612-173-00-5 | lithium-1-amino-4-(4-tert-butylanilino)-anthraquinon-2-sulfonat | 411-140-0 | 125328-86-1 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 612-174-00-0 | 4,4-dimethoxybutylamin | 407-690-6 | 19060-15-2 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H314
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H314
  H317
  H412 | | | |
| 612-175-00-6 | 2-(O-aminooxy)ethylamindihydrochlorid | 412-310-7 | 37866-45-8 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 612-176-00-1 | polymer af 1,3-dibrompropan og N, N-dietyl-N',N'-dimetyl-1,3-propandiamin | 410-570-6 | 143747-73-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 612-177-00-7 | 2-naphthylamino-6-sulfo
  methylamid | 412-120-4 | 104295-55-8 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H373 **
  H317
  H411 | GHS08
  GHS09
  Wng | H373 **
  H317
  H411 | | | |
| 612-178-00-2 | 1,4,7,10-tetraazacyclododecan disulfat | 412-080-8 | 112193-77-8 | Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H335
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H335
  H318
  H412 | | | |
| 612-179-00-8 | 1-(2-propenyl)pyridiniumchlorid | 412-740-5 | 25965-81-5 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 612-180-00-3 | 3-aminobenzylamin | 412-230-2 | 4403-70-7 | Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H302
  H314
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H411 | | | |
| 612-181-00-9 | 2-phenylthioanilin | 413-030-8 | 1134-94-7 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 612-182-00-4 | 1-ethyl-1-methylmorpholiniumbromid | 418-210-1 | 65756-41-4 | Muta. 2 | H341 | GHS08
  Wng | H341 | | | |
| 612-183-00-X | 1-ethyl-1-methylpyrrolidiniumbromid | 418-200-5 | 69227-51-6 | Muta. 2 | H341 | GHS08
  Wng | H341 | | | |
| 612-184-00-5 | 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-on | 403-830-5 | 89331-94-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 612-185-00-0 | 1-[3-[4-((heptadecafluornonyl)oxy)-benzamido]propyl]-N, N,N-trimethylammoniumiodid | 407-400-8 | 59493-72-0 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 612-186-00-6 | bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-yliden)dimethylammonium)sulfat | 406-770-8 | 149057-64-7 | STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H318
  H317
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H373 **
  H318
  H317
  H410 | | | |
| 612-187-00-1 | 2,3,4-trifluoranilin | 407-170-9 | 3862-73-5 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H312
  H302
  H373 **
  H315
  H318
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H373 **
  H315
  H318
  H411 | | | |
| 612-188-00-7 | 4,4'-(9H-fluoren-9-yliden)bis(2-chloranilin) | 407-560-9 | 107934-68-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 612-189-00-2 | 4-amino-2-(aminomethyl)phenoldihydrochlorid | 412-510-4 | 135043-64-0 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 612-190-00-8 | 4,4'-methylenbis(2-isopropyl-6-methylanilin) | 415-150-6 | 16298-38-7 | STOT RE 2 *
  Aquatic Chronic 2 | H373 **
  H411 | GHS08
  GHS09
  Wng | H373 **
  H411 | | | |
| 612-191-00-3 | polymer af allylaminhydrochlorid | 415-050-2 | 71550-12-4 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 612-192-00-9 | 2-isopropyl-4-(N-methyl)aminomethylthiazol | 414-800-6 | 154212-60-9 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H312
  H302
  H315
  H318
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H315
  H318
  H411 | | | |
| 612-193-00-4 | 3-methylaminomethylphenylamin | 414-570-7 | 18759-96-1 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H314
  H317
  H410 | | | |
| 612-194-00-X | 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N, N,N-trimethyl-1-propanammoniumchlorid | 414-670-0 | 141890-30-4 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H410 | | | |
| 612-195-00-5 | bis[tributyl(4-methylbenzyl)ammonium]-1,5-naphthalendisulfonat | 415-210-1 | 160236-81-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H332
  H302
  H318
  H410 | | | |
| 612-196-00-0 | 4-chlor-o-toluidin; [1]
  4-chlor-o-toluidiniumchlorid [2] | 202-441-6 [1]
  221-627-8 [2] | 95-69-2 [1]
  3165-93-3 [2] | Carc. 1B
  Muta. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H341
  H331
  H311
  H301
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H341
  H331
  H311
  H301
  H410 | | | |
| 612-197-00-6 | 2,4,5-trimethylanilin [1]
  2,4,5-trimethylaniliniumchlorid [2] | 205-282-0 [1]-[2] | 137-17-7 [1]
  21436-97-5 [2] | Carc. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H350
  H331
  H311
  H301
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H331
  H311
  H301
  H411 | | | |
| 612-198-00-1 | 4,4'-thiodianilin salte heraf | 205-370-9 | 139-65-1 | Carc. 1B
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H302
  H411 | | | |
| 612-199-00-7 | 4,4'-oxydianilin, salte heraf

  p-aminophenylether | 202-977-0 | 101-80-4 | Carc. 1B Muta.
  1B Repr. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 2 | H350
  H340
  H361f ***
  H331
  H311
  H301
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H350
  H340
  H361f ***
  H331
  H311
  H301
  H411 | | | |
| 612-200-00-0 | 2,4-diaminoanisol
  4-methoxy-m-phenylendiamin [1]
  2,4-diaminoanisolsulfat [2] | 210-406-1 [1]
  254-323-9 [2] | 615-05-4 [1]
  39156-41-7 [2] | Carc. 1B Muta. 2
  Acute Tox. 4 *
  Aquatic Chronic 2 | H350
  H341
  H302
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H341
  H302
  H411 | | | |
| 612-201-00-6 | N, N,N',N'-tetramethyl-4,4'-methylendianilin | 202-959-2 | 101-61-1 | Carc. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H410 | | | |
| 612-202-00-1 | 3,4-dichloranilin | 202-448-4 | 95-76-1 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H318
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H311
  H301
  H318
  H317
  H410 | | | |
| 612-203-00-7 | dimethyl (hydroxyethyl) (C8-10-alkyl) ammoniumchlorid, kæde < C8: < 3 %; kæde = C8: 40-70 %; kæde = C10: 30-60 %; kæde > C10: < 3 % | 417-360-3 | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2 | H312
  H302
  H315 | GHS07
  Wng | H312
  H302
  H315 | | | |
| 612-204-00-2 | C.I. Basic Violet 3;
  4-[4,4'-bis(dimethylamino) benzhydryliden]cyclohexa-2,5-dien-1-yliden]dimethylammoniumchlorid | 208-953-6 | 548-62-9 | Carc. 2
  Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H318
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H351
  H302
  H318
  H410 | | | |
| 612-205-00-8 | C.I. Basic Violet 3 med ≥ 0,1 %
  af Michlers keton (EF-nr.
  202-027-5) | 208-953-6 | 548-62-9 | Carc. 1B
  Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H302
  H318
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H350
  H302
  H318
  H410 | | | |
| 612-206-00-3 | famoxadon (ISO)
  3-anilin-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidin-2,4-dion | — | 131807-57-3 | STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H373 **
  H410 | | | |
| 612-207-00-9 | 4-ethoxyanilin;

  p-phenetidin | 205-855-5 | 156-43-4 | Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1 | H341
  H332
  H312
  H302
  H319
  H317 | GHS08
  GHS07
  Wng | H341
  H332
  H312
  H302
  H319
  H317 | | | |
| 612-208-00-4 | N-methylbenzen-1,2-diammoniumhydrogenphosphat | 424-460-0 | — | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 612-209-00-X | 6-methoxy-m-toluidin;

  p-cresidin | 204-419-1 | 120-71-8 | Carc. 1B
  Acute Tox. 4 * | H350
  H302 | GHS08
  GHS07
  Dgr | H350
  H302 | | | |
| 612-210-00-5 | 5-nitro-o-toluidin; [1]
  5-nitro-o-toluidinhydrochlorid [2] | 202-765-8 [1]
  256-960-8 [2] | 99-55-8 [1]
  51085-52-0 [2] | Carc. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Aquatic Chronic 3 | H351
  H331
  H311
  H301
  H412 | GHS06
  GHS08
  Dgr | H351
  H331
  H311
  H301
  H412 | | | |
| 612-211-00-0 | N-[(benzotriazol-1-yl)methyl)]-4-carboxybenzensulfonamid | 416-470-9 | 170292-97-4 | Eye Irrit. 2
  Aquatic Chronic 2 | H319
  H411 | GHS07
  GHS09
  Wng | H319
  H411 | | | |
| 612-212-00-6 | 2,6-dichlor-4-trifluormethylanilin | 416-430-0 | 24279-39-8 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H302
  H315
  H317
  H410 | | | |
| 612-213-00-1 | isobutyliden-(2-(2-isopropyl-4,4-dimethyloxazolidin-3-yl)-1,1-dimethylethyl)amin | 419-850-2 | 148348-13-4 | Skin Corr. 1B
  Aquatic Chronic 3 | H314
  H412 | GHS05
  Dgr | H314
  H412 | | | |
| 612-214-00-7 | 4-(2,2-diphenylethenyl)-N, N-di-phenylbenzenamin | 421-390-2 | 89114-90-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 612-215-00-2 | 3-chlor-2-(isopropylthio)anilin | 421-700-6 | 179104-32-6 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 612-216-00-8 | 1-amino-1-cyanamino-2,2-dicya-
  nethylen, natriumsalt | 425-870-2 | 19450-38-5 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 612-217-00-3 | 1-methoxy-2-propylamin | 422-550-4 | 37143-54-7 | Flam. Liq. 2
  Skin Corr. 1B
  Acute Tox. 4 *
  Aquatic Chronic 3 | H225
  H314
  H302
  H412 | GHS02
  GHS05
  GHS07
  Dgr | H225
  H314
  H302
  H412 | | | |
| 612-219-00-4 | (2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammoniumchlorid | 402-200-7 | — | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 612-220-00-X | N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amin | 431-060-1 | 153719-38-1 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H317
  H412 | GHS07
  Wng | H302
  H317
  H412 | | | |
| 612-221-00-5 | 2-amino-4-(trifluormethyl)benzenthiol hydrochlorid | 429-560-8 | 4274-38-8 | Skin Corr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1 | H314
  H332
  H312
  H302
  H373 **
  H317
  H400 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H314
  H332
  H312
  H302
  H373 **
  H317
  H400 | | | |
| 612-222-00-0 | cis-1-(3-(4-fluorphenoxy)propyl)-3-methoxy-4-piperidinamin | 425-080-8 | 104860-26-6 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H373 **
  H318
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H312
  H302
  H373 **
  H318
  H410 | | | |
| 612-223-00-6 | N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amin | 425-300-2 | 186450-73-7 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 612-224-00-1 | N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazin-2,4,6-triamin | 426-150-0 | 121246-28-4 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 612-225-00-7 | 1,4,7,10-tetraazacyclododecan | 425-450-9 | 294-90-6 | Skin Corr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H312
  H302
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H312
  H302
  H410 | | | |
| 612-226-00-2 | 3-(2'-phenoxyethoxy)propylamin | 427-870-8 | 6903-18-0 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H315
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H315
  H318
  H412 | | | |
| 612-227-00-8 | benzyl-N-(2-(2-methoxyphenoxy)ethyl)amin hydrochlorid | 428-290-8 | 120606-08-8 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H410 | | | |
| 612-228-00-3 | en blanding af N-(3-(trimethoxysilyl)propyl)ethylendiamin;

  N-benzyl-N-(3-trimethoxysilyl)propyl)ethylendiamin; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylendiamin;

  N, N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylendiamin; N, N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylendiamin og

  N, N-bis-benzyl-N'-[3-(trimetho-
  xysilyl)propyl]ethylendiamin | 414-340-6 | — | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT SE 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H226
  H332
  H312
  H302
  H371
  H318
  H317
  H412 | GHS02
  GHS05
  GHS08
  GHS07
  Dgr | H226
  H332
  H312
  H302
  H371
  H318
  H317
  H412 | | | |
| 612-229-00-9 | mepanipyrim
  4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamin | — | 110235-47-7 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 612-230-00-4 | N, N-bis(cocoyl-2-oxypropyl)-N, N-dibutylammoniumbromid | 431-530-4 | — | Skin Corr. 1A
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H410 | | | |
| 612-231-00-X | 3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N, N-dimethyl-1-propanaminiumchlorid | 427-370-1 | 164288-56-6 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 612-232-00-5 | en blanding af triisopropanolaminsalt af 1-amino-4-(3-propionamidoanilino)anthraquinon-2-sulfonsyre og
  triisopropanolaminsalt af 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinon-2-sulfonsyre | 430-410-9 | 186148-38-9 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 612-237-00-2 | hydroxylammoniumhydrogensulfat;
  hydroxylaminsulfat (1:1); [1]
  hydroxylaminphosphat; [2]
  hydroxylamindihydrogenphosphat; [3]
  hydroxylamin-4-methylben
  zensulfonat [4] | 233-154-4 [1]
  244-077-0 [2]
  242-818-2 [3]
  258-872-5 [4] | 10046-00-1 [1]
  20845-01-6 [2]
  19098-16-9 [3]
  53933-48-5 [4] | Expl. 1,1
  Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H201
  H351
  H312
  H302
  H373 **
  H319
  H315
  H317
  H400 | GHS01
  GHS08
  GHS07
  GHS09
  Dgr | H201
  H351
  H312
  H302
  H373 **
  H319
  H315
  H317
  H400 | | | T |
| 612-238-00-8 | (3-chlor-2-hydroxypropyl)
  trimethylammoniumchlorid ...% | 222-048-3 | 3327-22-8 | Carc. 2
  Aquatic Chronic 3 | H351
  H412 | GHS08
  Wng | H351
  H412 | | | B |
| 612-239-00-3 | biphenyl-3,3',4,4'-tetrayltetraamin;
  diaminobenzidin | 202-110-6 | 91-95-2 | Carc. 1B Muta. 2 | H350
  H341 | GHS08
  Dgr | H350
  H341 | | | |
| 612-240-00-9 | pyrimethanil (ISO);

  N-(4,6-dimethylpyrimidin-2-yl)anilin | — | 53112-28-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 612-241-00-4 | piperazinhydrochlorid; [1] piperazindihydrochlorid; [2] piperazinphosphat [3] | 228-042-7 [1]
  205-551-2 [2]
  217-775-8 [3] | 6094-40-2 [1]
  142-64-3 [2]
  1951-97-9 [3] | Repr. 2
  Eye Irrit. 2
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H361fd
  H319
  H315
  H334
  H317
  H412 | GHS08
  Dgr | H361fd
  H319
  H315
  H334
  H317
  H412 | | | |
| 612-242-00-X | cyprodinil (ISO);
  4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amin | — | 121552-61-2 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | M = 10 | |
| 612-243-00-5 | (1S-cis)-4-(3,4-dichlorphenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamin-2-hydroxy-2-phenylacetat | 420-560-3 | 79617-97-3 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | M = 10 | |
| 612-244-00-0 | 3-(piperazin-1-yl)-benzo[d]isothiazolhydrochlorid | 421-310-6 | 87691-88-1 | Repr. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f ***
  H302
  H319
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361f ***
  H302
  H319
  H317
  H410 | | | |
| 612-245-00-6 | 2-ethylphenylhydrazinhydrochlorid | 421-460-2 | 19398-06-2 | Carc. 2
  STOT RE 1
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H372 **
  H302
  H318
  H317
  H400
  H410 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H351
  H372 **
  H302
  H318
  H317
  H410 | | M = 10 | |
| 612-246-00-1 | (2-chlorethyl)(3-hydroxypropyl)ammoniumchlorid | 429-740-6 | 40722-80-3 | Carc. 1B
  Muta. 1B
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 3 | H350
  H340
  H373 **
  H317
  H412 | GHS08
  GHS07
  Dgr | H350
  H340
  H373 **
  H317
  H412 | | | |
| 612-247-00-7 | N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzencarboximidamid | 423-530-8 | 152828-23-4 | STOT RE 1
  Acute Tox. 4 *
  Aquatic Chronic 3 | H372 ** H302
  H412 | GHS08
  GHS07
  Dgr | H372 **
  H302
  H412 | | | |
| 612-248-00-2 | reaktionsprodukt af diphenylamin, phenothiazin og alkener, forgrenede (C8-10, C9-rige) | 439-540-0 | — | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H315
  H317
  H413 | GHS07
  Wng | H315
  H317
  H413 | | | |
| 612-249-00-8 | 4-[(3-chlorphenyl)(1H-imidazol-1-yl)methyl]-1,2-benzendiamindihydrochlorid | 425-030-5 | 159939-85-2 | Repr. 2
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H361f ***
  H302
  H314
  H317
  H411 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H361f ***
  H302
  H314
  H317
  H411 | | | |
| 612-250-00-3 | chlor-N, N-dimethylformiminiumchlorid | 425-970-6 | 3724-43-4 | Repr. 1B
  Acute Tox. 4 *
  Skin Corr. 1A | H360D ***
  H302
  H314 | GHS05
  GHS08
  GHS07
  Dgr | H360D ***
  H302
  H314 | EUH014 | | |
| 612-251-00-9 | cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantanchlorid | 426-020-3 | 51229-78-8 | Flam. Sol. 2
  Repr. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H228
  H361D ***
  H302
  H315
  H317
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Wng | H228
  H361D ***
  H302
  H315
  H317
  H411 | | | |
| 612-252-00-4 | imidacloprid (ISO);
  1-(6-chlorpyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamin | 428-040-8 | 138261-41-3 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 612-253-00-X | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on; [indeholdende < 0,5 % formamid (EF-nr. 200-842-0)] | 429-400-7 | 199327-61-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 612-253-01-7 | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on; [indeholdende ≥ 0,5 % formamid (EF-nr. 200-842-0)] | 429-400-7 | 199327-61-2 | Repr. 1B
  Aquatic Chronic 3 | H360D ***
  H412 | GHS08
  Dgr | H360D ***
  H412 | | | |
| 612-254-00-5 | reaktionsprodukter af diisopropanolamin med formaldehyd (1:4) | 432-440-8 | 220444-73-5 | Carc. 2
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H351
  H302
  H314
  H317
  H411 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H351
  H302
  H314
  H317
  H411 | | | |
| 612-255-00-0 | 1-(3-methoxypropyl)-4-piperidinamin | 431-950-8 | 179474-79-4 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Chronic 3 | H312
  H302
  H314
  H412 | GHS05
  GHS07
  Dgr | H312
  H302
  H314
  H412 | | | |
| 612-256-00-6 | benzyl(S)-2-[(2'-cyanbiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrat | 427-470-3 | 137864-22-3 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 612-257-00-1 | tripropylammoniumdihydrogenphosphat | 433-700-3 | 35687-90-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 612-259-00-2 | N-ethyl-3-trimethoxysilyl-2-methyl-propanamin | 437-720-3 | 227085-51-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 612-261-00-3 | 3,5-dichlor-2-fluor-4-(1,1,2,3,3,3-hexafluorpropoxy)anilin | 441-190-9 | 121451-05-6 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | M = 10 | |
| 612-265-00-5 | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammoniumacetat | 444-360-0 | 191617-13-7 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 612-266-00-0 | 3-chlor-4-(3-fluorbenzyloxy)anilin | 445-590-4 | 202197-26-0 | Muta. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H341
  H302
  H373 **
  H410 | | | |
| 612-267-00-6 | bis(hydrogeneret C16-18-talgalkyl)hydroxylamin | 418-370-0 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 612-269-00-7 | en blanding af 1-[di(4-octylp-
  henyl)aminomethyl]-5-methyl-1H-benzotriazol og
  1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazol
  en blanding af N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin og

  N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin | 420-720-2 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 612-270-00-2 | (S)-azetidin-2-carboxylsyre
  -4-cyanbenzylamidhydrochlorid | 433-010-2 | — | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H317
  H412 | GHS07
  Wng | H302
  H317
  H412 | | | |
| 612-271-00-8 | blanding af ethyl-2-((4-(5,6-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat og
  ethyl-2-((4-(6,7-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat | 434-970-5 | 160987-57-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 612-272-00-3 | ammonium-(η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butan-1,4-dioato(4-))jern(3+)monohydrat | 435-210-5 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 612-273-00-9 | alkyl(rapsolie), bis(2-hydroxyethyl)ammoniumfluorid | 435-650-8 | — | Acute Tox. 4 *
  Skin Corr. 1A
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H410 | | | |
| 612-274-00-4 | (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanolacetat | 445-750-3 | — | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H317
  H412 | | | |
| 612-275-00-X | fedtsyrer, C18-umættede, dimerer, reaktionsprodukter med 1-piperazinethanamin og tallolie | 447-880-6 | 206565-89-1 | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | M = 10 | |
| 612-276-00-5 | 1-amino-4-[(4-amino-2-sulfophenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracensulfonsyre, dinatriumsalt, reaktionsprodukter med 2-[[3-[(4,6-dichlor-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethylhydrogensulfat, natriumsalte | 451-430-4 | 500717-36-2 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 612-277-00-0 | en blanding af 4-amino-3-(4-ethensulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalen-2,7-disulfonat kalium/natrium og
  4-amino-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethansulfonyl)phenylazo)naphthalen-2,7-disulfonat kalium/natrium | 451-440-9 | 586372-44-3 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 612-278-00-6 | ethidiumbromid;
  3,8-diamino-1-ethyl-6-phenylphenantridiniumbromid | 214-984-6 | 1239-45-8 | Muta. 2
  Acute Tox. 2 *
  Acute Tox. 4 * | H341
  H330
  H302 | GHS06
  GHS08
  Dgr | H341
  H330
  H302 | | | |
| 612-279-00-1 | (R,S)-2-amino-3,3-dimethylbutanamid | 447-860-7 | 144177-62-8 | Repr. 2
  STOT RE 2 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H361f *** H373 ** H319
  H315
  H317 | GHS08
  GHS07
  Wng | H361f *** H373 **
  H319
  H315
  H317 | | | |
| 612-280-00-7 | 3-amino-9-ethylcarbazol;
  9-ethylcarbazol-3-ylamin | 205-057-7 | 132-32-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 612-281-00-2 | leucomalakit grønt; N, N,N',N'-tetramethyl-4,4'- benzylidendianilin | 204-961-9 | 129-73-7 | Carc. 2
  Muta. 2 | H351
  H341 | GHS08
  Wng | H351
  H341 | | | |
| 612-282-00-8 | octadecylamin | 204-695-3 | 124-30-1 | Asp. Tox. 1
  STOT RE 2
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H304
  H373 (mavetarmkanal, lever, immun
  system)
  H315
  H318
  H400
  H410 | GHS05
  GHS08
  GHS09
  Dgr | H304
  H373 (mavetarmkanal, lever, immun
  system)
  H315
  H318
  H410 | | M = 10
  M = 10 | |
| 612-283-00-3 | (Z)-octadec-9-enylamin | 204-015-5 | 112-90-3 | Acute Tox. 4
  Asp Tox. 1
  STOT SE 3
  STOT RE 2
  Skin Corr. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H304
  H335
  H373 (mavetarmkanal, lever, immunsystem)
  H314
  H400
  H410 | GHS05
  GHS07
  GHS08
  GHS09
  Dgr | H302
  H304
  H335
  H373 (mavetarmkanal, lever, immunsystem)
  H314
  H410 | | M = 10
  M = 10 | |
| 612-284-00-9 | aminer, hydrogeneret talg-alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1
  STOT RE 2
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H304
  H373 (mavetarmkanal, lever, immunsystem)
  H315
  H318
  H400
  H410 | GHS08
  GHS05
  GHS09
  Dgr | H304
  H373 (mavetarmkanal, lever, immunsystem)
  H315
  H318
  H410 | | M = 10
  M = 10 | |
| 612-285-00-4 | aminer, kokosalkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4
  Asp. Tox. 1
  STOT SE 3
  STOT RE 2
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H304
  H335
  H373 (mavetarmkanal, lever, immunsystem)
  H314
  H400
  H410 | GHS05
  GHS07
  GHS08
  GHS09
  Dgr | H302
  H304
  H335
  H373 (mavetarmkanal, lever, immunsystem)
  H314
  H410 | | M = 10
  M = 10 | |
| 612-286-00-X | aminer, talg-alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4
  Asp. Tox. 1
  STOT RE 2
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H304
  H373 (mavetarmkanal, lever, immunsystem)
  H314
  H400
  H410 | GHS05
  GHS07
  GHS08
  GHS09
  Dgr | H302
  H304
  H373 (mavetarmkanal, lever, immunsystem)
  H314
  H410 | | M = 10
  M = 10 | |
| 612-287-00-5 | fluazinam (ISO); 3-chlor-N-[3-chlor-2,6-dinitro-4-(trifluormethyl)phenyl]-5-(trifluormethyl)pyridin-2-amin | — | 79622-59-6 | Repr. 2
  Acute Tox. 4
  Eye Dam. 1
  Skin Sens. 1A
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d
  H332
  H318
  H317
  H400
  H410 | GHS08
  GHS07
  GHS05
  GHS09
  Dgr | H361d
  H332
  H318
  H317
  H410 | | M = 10
  M = 10 | |
| 613-001-00-1 | ethyleneimin;
  aziridin | 205-793-9 | 151-56-4 | Flam. Liq. 2
  Carc. 1B
  Muta. 1B
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H225
  H350
  H340
  H330
  H310
  H300
  H314
  H411 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H225
  H350
  H340
  H330
  H310
  H300
  H314
  H411 | | | D |
| 613-002-00-7 | pyridin | 203-809-9 | 110-86-1 | Flam. Liq. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H225
  H332
  H312
  H302 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302 | | * | |
| 613-003-00-2 | 1,2,3,4-tetranitrocarbazol | — | 6202-15-9 | Expl. 1.1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * | H201
  H332
  H312
  H302 | GHS01
  GHS07
  Dgr | H201
  H332
  H312
  H302 | | | |
| 613-004-00-8 | crimidin (ISO);
  2-chlor-6-methylpyrimidin-4- yldimethylamin | 208-622-6 | 535-89-7 | Acute Tox. 2 * | H300 | GHS06
  Dgr | H300 | | | |
| 613-007-00-4 | desmetryne (ISO);
  6-isopropylamino-2-methylamino-4-methylthio-1,3,5- triazine | 213-800-1 | 1014-69-3 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 613-008-00-X | dazomet (ISO);
  tetrahydro-3,5-dimethyl-1,3,5- thiadiazine-2-thion | 208-576-7 | 533-74-4 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H410 | | | |
| 613-009-00-5 | 2,4,6-trichlor-1,3,5-triazin;
  cyanurchlorid | 203-614-9 | 108-77-0 | Acute Tox. 2 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1 | H330
  H302
  H314
  H317 | GHS06
  GHS05
  Dgr | H330
  H302
  H314
  H317 | EUH014 | STOT SE 3; H335: C ≥ 5 % | |
| 613-010-00-0 | ametryn (ISO);
  2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazin | 212-634-7 | 834-12-8 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 100 | |
| 613-011-00-6 | amitrol (ISO);
  1,2,4-triazol-3-ylamin | 200-521-5 | 61-82-5 | Repr. 2
  STOT RE 2 *
  Aquatic Chronic 2 | H361d *** H373 **
  H411 | GHS08
  GHS09
  Wng | H361d *** H373 **
  H411 | | | |
| 613-012-00-1 | bentazon (ISO);
  3-isopropyl-2,1,3-benzothiadiazin-4-on-2,2-dioxid | 246-585-8 | 25057-89-0 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H319
  H317
  H412 | GHS07
  Wng | H302
  H319
  H317
  H412 | | | |
| 613-013-00-7 | cyanazin (ISO);
  2-(4-chlor-6-ethylamino-1,3,5-triazin-2-ylamino)-2-methylpropionitril | 244-544-9 | 21725-46-2 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-014-00-2 | ethoxyquin (ISO);
  6-ethoxy-1,2-dihydro-2,2,4-trimethylquinolin | 202-075-7 | 91-53-2 | Acute Tox. 4* | H302 | GHS07
  Wng | H302 | | | |
| 613-015-00-8 | fenazaflor (ISO);
  phenyl 5,6-dichlor-2-trifluormethylbenzimidazol-1-carboxylat | 238-134-9 | 14255-88-0 | Acute Tox. 4*
  Acute Tox. 4*
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 613-016-00-3 | fuberidazol (ISO);
  2-(2-furyl-)-1H-benzimidazol | 223-404-0 | 3878-19-1 | Carc. 2
  Acute Tox. 4
  STOT RE 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H373 (heart)
  H317
  H400
  H410 | GHS07
  GHS08
  GHS09
  Wng | H351
  H302
  H373 (heart)
  H317
  H410 | | M = 1 | |
| 613-017-00-9 | bis(8-hydroxyquinolinium)sulfat | 205-137-1 | 134-31-6 | Acute Tox. 4* | H302 | GHS07
  Wng | H302 | | | |
| 613-018-00-4 | morfamquat (ISO);
  1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridyl | | 7411-47-4 | Acute Tox. 4*
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 3 | H302
  H319
  H335
  H315
  H412 | GHS07
  Wng | H302
  H319
  H335
  H315
  H412 | | | |
| 613-019-00-X | thioquinox (ISO);
  2-thio-1,3-dithiolo(4,5,b)quinoxalin | 202-272-8 | 93-75-4 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 613-020-00-5 | tridemorph (ISO);
  2,6-dimethyl-4-tridecylmorpholin | 246-347-3 | 24602-86-6 | Repr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D *** H332
  H302
  H315
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H360D *** H332
  H302
  H315
  H410 | | | |
| 613-021-00-0 | dithianon (ISO);
  5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazin-2,3-dicarbonitril | 222-098-6 | 3347-22-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-022-00-6 | pyrethriner indeholdende cineriner, med undtagelse af sådanne specificeret andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | | A |
| 613-023-00-1 | 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemat;
  pyrethrin I | 204-455-8 | 121-21-1 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | | |
| 613-024-00-7 | 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropancarboxylat;
  pyrethrin II | 204-462-6 | 121-29-9 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | | |
| 613-025-00-2 | cinerin I;
  3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-
  dimethyl-3-(2-methylprop-1- enyl)cyclopropanecarboxylate | 246-948-0 | 25402-06-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-026-00-8 | cinerin II;
  3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropancarboxylat | 204-454-2 | 121-20-0 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-027-00-3 | piperidin | 203-813-0 | 110-89-4 | Flam. Liq. 2
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B | H225
  H331
  H311
  H314 | GHS02
  GHS06
  GHS05
  Dgr | H225
  H331
  H311
  H314 | | * | |
| 613-028-00-9 | morpholin | 203-815-1 | 110-91-8 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H226
  H332
  H312
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dg | H226
  H332
  H312
  H302
  H314 | | | |
| 613-029-00-4 | dichlor-1,3,5-triazintrion;
  dichlorisocyanursyre | 220-487-5 | 2782-57-2 | Ox. Sol. 2
  Acute Tox. 4 * Eye Irrit. 2
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H302
  H319
  H335
  H400
  H410 | GHS03
  GHS07
  GHS09
  Dgr | H272
  H302
  H319
  H335
  H410 | EUH031 | | T |
| 613-030-00-X | troclosen-kalium; [1]
  troclosen-natrium [2] | 218-828-8 [1]
  220-767-7 [2] | 2244-21-5 [1]
  2893-78-9 [2] | Ox. Sol. 2
  Acute Tox. 4 * Eye Irrit. 2
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H302
  H319
  H335
  H400
  H410 | GHS03
  GHS07
  GHS09
  Dgr | H272
  H302
  H319
  H335
  H410 | EUH031 | *
  STOT SE 3;
  H335: C ≥ 10 % EUH031: C ≥10 % | G |
| 613-030-01-7 | troclosennatrium, dihydrat | 220-767-7 | 51580-86-0 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H335
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H335
  H410 | EUH031 | | |
| 613-031-00-5 | symclosen; trichlorisocyanursyre; trichlor-1,3,5-triazinetrion | 201-782-8 | 87-90-1 | Ox. Sol. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Aquatic Acute 1
  Aquatic Chronic 1 | H272
  H302
  H319
  H335
  H400
  H410 | GHS03
  GHS07
  GHS09
  Dgr | H272
  H302
  H319
  H335
  H410 | EUH031 | | |
| 613-032-00-0 | methyl-2,3,5,6-tetrachlor-4-pyridylsulfon;
  2,3,5,6-tetrachlor-4-(methylsulfonyl)pyridin | 236-035-5 | 13108-52-6 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1 | H312
  H302
  H319
  H317 | GHS07
  Wng | H312
  H302
  H319
  H317 | | | |
| 613-033-00-6 | 2-methylaziridin;
  propyleneimin | 200-878-7 | 75-55-8 | Flam. Liq. 2
  Carc. 1B
  Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Eye Dam. 1
  Aquatic Chronic 2 | H225
  H350
  H330
  H310
  H300
  H318
  H411 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H225
  H350
  H330
  H310
  H300
  H318
  H411 | | Carc. 1B;
  H350: C ≥ 0,01  % | |
| 613-034-00-1 | 1,2-dimethylimidazol | 217-101-2 | 1739-84-0 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1 | H302
  H315
  H318 | GHS05
  GHS07
  Dgr | H302
  H315
  H318 | | | |
| 613-035-00-7 | 1-methylimidazol | 210-484-7 | 616-47-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1B | H312
  H302
  H314 | GHS05
  GHS07
  Dgr | H312
  H302
  H314 | | | |
| 613-036-00-2 | 2-methylpyridin;
  2-picolin | 203-643-7 | 109-06-8 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3 | H226
  H332
  H312
  H302
  H319
  H335 | GHS02
  GHS07
  Wng | H226
  H332
  H312
  H302
  H319
  H335 | | | |
| 613-037-00-8 | 4-methylpyridin;
  4-picolin | 203-626-4 | 108-89-4 | Flam. Liq. 3
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H226
  H311
  H332
  H302
  H319
  H335
  H315 | GHS02
  GHS06
  Dgr | H226
  H311
  H332
  H302
  H319
  H335
  H315 | | | |
| 613-038-00-3 | 6-phenyl-1,3,5-triazin-2,4- diyldiamin;
  6-phenyl-1,3,5-triazin-2,4-diamin;
  benzoguanamin | 202-095-6 | 91-76-9 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 613-039-00-9 | ethylenthiourinstof;
  imidazolidin-2-thion;
  2-imidazolin-2-thiol | 202-506-9 | 96-45-7 | Repr. 1B
  Acute Tox. 4 * | H360D *** H302 | GHS08
  GHS07
  Dgr | H360D *** H302 | | | |
| 613-040-00-4 | azaconazol (ISO);
  1-{[2-(2,4-dichlorphenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazol | 262-102-3 | 60207-31-0 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 613-041-00-X | morpholin-4-carbonylchlorid | 239-213-0 | 15159-40-7 | Carc. 2
  Eye Irrit. 2
  Skin Irrit. 2 | H351
  H319
  H315 | GHS08
  Wng | H351
  H319
  H315 | EUH014 | | |
| 613-043-00-0 | imazalilsulfat (ISO) pulver;
  1-[2-(allyloxy)ethyl-2-(2,4-dichlorphenyl)]-1H-imidazoliumhydrogensulfat; [1]
  (±)-1-[2-(allyloxy)ethyl-2-(2,4-dichlorphenyl)]-1H-imidazoliumhydrogensulfat [2] | 261-351-5 [1]
  281-291-3 [2] | 58594-72-2 [1]
  83918-57-4 [2] | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 613-043-01-8 | imazalilsulfat (ISO), vandig opløsning;
  1-[2-(allyloxy)ethyl-2-(2,4- dichlorphenyl)]-1H-imidazoliumhydrogensulfat; [1]
  (±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorphenyl)]-1H-imidazoliumhydrogensulfat [2] | 261-351-5 [1]
  281-291-3 [2] | 58594-72-2 [1]
  83918-57-4 [2] | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Wng | H302
  H314
  H317
  H410 | | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 %
  Eye Dam. 1; H318: 15 % ≤ C < 50 %
  Eye Irrit. 2; H319: 5 % ≤ C < 15 % | |
| 613-044-00-6 | captan (ISO);
  1,2,3,6-tetrahydro-N-(trichlormethylthio)phthalimid | 205-087-0 | 133-06-2 | Carc. 2
  Acute Tox. 3 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H351
  H331
  H318
  H317
  H400 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H351
  H331
  H318
  H317
  H400 | | M=10 | |
| 613-045-00-1 | folpet (ISO);

  N-(trichlormethylthio)phthalimid | 205-088-6 | 133-07-3 | Carc. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H351
  H332
  H319
  H317
  H400 | GHS08
  GHS07
  GHS09
  Wng | H351
  H332
  H319
  H317
  H400 | | M=10 | |
| 613-046-00-7 | captafol (ISO);
  1,2,3,6-tetrahydro-N-(1,1,2,2- tetrachlorethylthio)phthalimid | 219-363-3 | 2425-06-1 | Carc. 1B Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H350
  H317
  H400
  H410 | GHS08
  GHS09
  Dgr | H350
  H317
  H410 | | | |
| 613-047-00-2 | 1-dimethylcarbamoyl-5-methylpyrazol-3-yldimethylcarbamat; dimetilan (ISO) | 211-420-0 | 644-64-4 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H312
  H410 | | | |
| 613-048-00-8 | carbendazim (ISO);
  methylbenzimidazol-2-ylcarbamat | 234-232-0 | 10605-21-7 | Muta. 1B Repr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H340
  H360FD H400
  H410 | GHS08
  GHS09
  Dgr | H340
  H360FD H410 | | | |
| 613-049-00-3 | benomyl (ISO);
  methyl-1-(butylcarbamoyl)benzimidazol-2-ylcarbamat | 241-775-7 | 17804-35-2 | Muta. 1B Repr. 1B STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H340
  H360FD H335
  H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H340
  H360FD H335
  H315
  H317
  H410 | | M = 10 | |
| 613-050-00-9 | carbadox (INN);
  methyl 3-(quinoxalin-2-ylmethylen)carbazat-1,4-dioxid;
  2-(methoxycarbonylhydrazonomethyl)quinoxalin-1,4-dioxid | 229-879-0 | 6804-07-5 | Flam. Sol. 1
  Carc. 1B
  Acute Tox. 4 * | H228
  H350
  H302 | GHS02
  GHS08
  GHS07
  Dgr | H228
  H350
  H302 | | | T |
| 613-051-00-4 | molinat (ISO);
  S-ethyl-1-perhydroazepincarbothioat;
  S-ethyl-perhydroazepin-1-carbothioat | 218-661-0 | 2212-67-1 | Carc. 2
  Repr. 2
  Acute Tox. 4 * Acute Tox. 4 *
  STOT RE 2 * Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H361f *** H332
  H302
  H373 ** H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H361f *** H332
  H302
  H373 ** H317
  H410 | | M = 100 | |
| 613-052-00-X | trifenmorph (ISO);
  4-tritylmorpholin | 215-812-2 | 1420-06-0 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-053-00-5 | anilazin (ISO);
  2-chlor-N-(4,6-dichlor-1,3,5- triazin-2-yl)anilin | 202-910-5 | 101-05-3 | Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H315
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H315
  H410 | | | |
| 613-054-00-0 | thiabendazol (ISO);
  2-(thiazol-4-yl)benzimidazol | 205-725-8 | 148-79-8 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-056-00-1 | 1,2-dimethyl-3,5-diphenylpyrazoliummethylsulfat; difenzoquatmethylsulfat | 256-152-5 | 43222-48-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS09
  Wng | H302
  H410 | | | |
| 613-058-00-2 | permethrin (ISO);

  m-phenoxybenzyl 3-(2,2-dichorovinyl)-2,2-dimethylcyclopropancarboxylat | 258-067-9 | 52645-53-1 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H302
  H317
  H410 | | M = 1 000 | |
| 613-059-00-8 | profluralin (ISO);

  N-(cyclopropylmethyl)-α, α,α-trifluor-2,6-dinitro-N-propyl-p-toluidin | 247-656-6 | 26399-36-0 | Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H410 | | | |
| 613-060-00-3 | resmethrin (ISO);
  5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemat | 233-940-7 | 10453-86-8 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M=1000 | |
| 613-061-00-9 | 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl)pyrrol-2-carboxylat;
  ryania | 239-732-2 | 15662-33-6 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 613-062-00-4 | sabadilla (ISO);
  veratrin | — | 8051-02-3 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H319
  H335
  H315 | GHS07
  Wng | H319
  H335
  H315 | | | |
| 613-063-00-X | secbumeton (ISO);
  2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazin | 247-554-1 | 26259-45-0 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H410 | | | |
| 613-064-00-5 | 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolan; sesamex | — | 51-14-9 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 613-065-00-0 | simetryn (ISO);
  2,4-bis(ethylamino)-6-methylthio-1,3,5-triazin | 213-801-7 | 1014-70-6 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-066-00-6 | terbumeton (ISO);
  2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazin | 251-637-8 | 33693-04-8 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-067-00-1 | propazin (ISO);
  2-chlor-4,6-bis(isopropylamino)-1,3,5-triazin | 205-359-9 | 139-40-2 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 613-068-00-7 | atrazin (ISO);
  2-chlor-4-ethylamin-6-isopropylamin-1,3,5-triazin | 217-617-8 | 1912-24-9 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 ** H317
  H400
  H410 | GHS08
  GHS09
  Wng | H373 ** H317
  H410 | | | |
| 613-069-00-2 | ε-caprolactam | 203-313-2 | 105-60-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2 | H332
  H302
  H319
  H335
  H315 | GHS07
  Wng | H332
  H302
  H319
  H335
  H315 | | | |
| 613-070-00-8 | propylenthiourinstof | — | 2122-19-2 | Repr. 2
  Acute Tox. 4 *
  Aquatic Chronic 3 | H361d *** H302
  H412 | GHS08
  GHS07
  Wng | H361d *** H302
  H412 | | | |
| 613-071-00-3 | 2-fluor-5-trifluormethylpyridin | 400-290-2 | 69045-82-5 | Flam. Liq. 3
  Skin Sens. 1
  Aquatic Chronic 3 | H226
  H317
  H412 | GHS02
  GHS07
  Wng | H226
  H317
  H412 | | | |
| 613-072-00-9 | N, N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amin | 401-280-0 | 91273-04-0 | Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H411 | | | |
| 613-073-00-4 | N, N-dimethyl-2-(3-(4-chlorphenyl)-4,5-dihydropyrazol-1-ylphenylsulfonyl)ethylamin | 401-410-6 | 10357-99-0 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H373 ** H317
  H411 | GHS08
  GHS09
  Wng | H373 ** H317
  H411 | | | |
| 613-074-00-X | 3-(3-methylpent-3-yl)isoxazol-5-ylamin | 401-460-9 | 82560-06-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  Eye Dam. 1
  Aquatic Chronic 3 | H331
  H301
  H318
  H412 | GHS06
  GHS05
  Dgr | H331
  H301
  H318
  H412 | | | |
| 613-075-00-5 | 1,3-dichlor-5-ethyl-5-methylimidazolidin-2,4-dion | 401-570-7 | 89415-87-2 | Ox. Sol. 1 ****
  Acute Tox. 3 *
  Skin Corr. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1 | H271
  H331
  H314
  H302
  H317
  H400 | GHS03
  GHS06
  GHS05
  GHS09
  Dgr | H271
  H331
  H314
  H302
  H317
  H400 | | | |
| 613-076-00-0 | 3-chlor-5-trifluormethyl-2-pyridylamin | 401-670-0 | 79456-26-1 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 613-077-00-6 | blanding af 5-heptyl-1,2,4-triazol-3-ylamin og 5-nonyl-1,2,4-triazol-3-ylamin | 401-940-8 | — | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 2 | H302
  H319
  H411 | GHS07
  GHS09
  Wng | H302
  H319
  H411 | | | |
| 613-078-00-1 | N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecan-1,10- diamin | 401-990-0 | 106990-43-6 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 613-079-00-7 | 4-(1(eller 4 eller 5 eller 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridin, blanding af isomerer | 402-520-7 | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H315
  H317
  H410 | | | |
| 613-080-00-2 | 3-(bis(2-ethylhexyl)aminomethyl)benzothiazol-2(3H)-thion | 402-540-6 | 105254-85-1 | Skin Corr. 1B Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H410 | | | |
| 613-081-00-8 | 1-butyl-2-methylpyridiniumbromid | 402-680-8 | 26576-84-1 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 613-082-00-3 | 2-methyl-1-pentylpyridiniumbromid | 402-690-2 | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H312
  H302
  H412 | GHS07
  Wng | H312
  H302
  H412 | | | |
| 613-083-00-9 | 2-(4-(3-(4-chlorphenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammoniumformiat | 402-120-2 | — | Skin Corr. 1B STOT RE 2 * Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H373 ** H317
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H314
  H373 ** H317
  H410 | | | |
| 613-084-00-4 | 2-(4-(3-(4-chlorphenyl)-4,5-dihydropyrazolyl)phenylsulfonyl)ethyldimethylammoniumhydrogenphosphonat | 402-490-5 | 106359-93-7 | Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H410 | | | |
| 613-085-00-X | blanding af 1,1'-(methylenbis(4,1-phenylen))dipyrrol-2,5-dion og N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamid og 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrol-2,5-dion | 401-970-1 | — | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 613-086-00-5 | coffein | 200-362-1 | 58-08-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 613-087-00-0 | tetrahydrothiophen | 203-728-9 | 110-01-0 | Flam. Liq. 2
  Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 3 | H225
  H332
  H312
  H302
  H319
  H315
  H412 | GHS02
  GHS07
  Dgr | H225
  H332
  H312
  H302
  H319
  H315
  H412 | | | |
| 613-088-00-6 | 1,2-benzisothiazol-3(2H)-on;
  1,2-benzisothiazolin-3-on | 220-120-9 | 2634-33-5 | Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H302
  H315
  H318
  H317
  H400 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H315
  H318
  H317
  H400 | | Skin Sens. 1; H317: C ≥ 0,05  % | |
| 613-089-00-1 | diquatdibromid; [1]
  diquatdichlorid; [2]
  6,7-dihydrodipyrido[1,2-α:2',1'- c]pyrazindiyliumdihydroxid [3] | 201-579-4 [1]
  223-714-6 [2]
  301-467-6 [3] | 85-00-7 [1]
  4032-26-2 [2]
  94021-76-8 [3] | Acute Tox. 2 * STOT RE 1
  Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H372 ** H302
  H319
  H335
  H315
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H372 ** H302
  H319
  H335
  H315
  H317
  H410 | | | |
| 613-090-00-7 | paraquat-dichlorid;
  1,1-dimethyl-4,4'-bipyridiniumdichlorid; [1]
  paraquat-dimethylsulfat;
  1,1-dimethyl-4,4'-bipyridiniumdimethylsulfat [2] | 217-615-7 [1]
  218-196-3 [2] | 1910-42-5 [1]
  2074-50-2 [2] | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H311
  H301
  H372 ** H319
  H335
  H315
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H311
  H301
  H372 ** H319
  H335
  H315
  H410 | | | |
| 613-091-00-2 | morfamquatdichlorid; [1]
  morfamquatsulfat [2] | 225-062-8 [1] [2] | 4636-83-3 [1]
  29873-36-7 [2] | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Chronic 3 | H302
  H319
  H335
  H315
  H412 | GHS07
  Wng | H302
  H319
  H335
  H315
  H412 | | | |
| 613-092-00-8 | 1,10-phenanthrolin | 200-629-2 | 66-71-7 | Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | | |
| 613-093-00-3 | hexanatrium-6,13-dichlor-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacen-4,11-disulfonat | 400-050-7 | 85153-92-0 | Resp. Sens. 1
  Skin Sens. 1 | H334
  H317 | GHS08
  Dgr | H334
  H317 | | | |
| 613-094-00-9 | 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamin | 401-360-5 | 5248-39-5 | Acute Tox. 4 * STOT RE 2 * | H302
  H373 ** | GHS08
  GHS07
  Wng | H302
  H373 ** | | | |
| 613-095-00-4 | natrium-3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzensulfonat | 403-080-9 | 92484-48-5 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-096-00-X | 2-amino-6-ethoxy-4-methylamino-1,3,5-triazin | 403-580-7 | 62096-63-3 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 613-097-00-5 | 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylsyre | 403-690-5 | 111298-82-9 | Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H334
  H317
  H412 | GHS08
  Dgr | H334
  H317
  H412 | | | |
| 613-098-00-0 | N-(n-octyl)-2-pyrrolidon | 403-700-8 | 2687-94-7 | Skin Corr. 1B Aquatic Chronic 2 | H314
  H411 | GHS05
  GHS09
  Dgr | H314
  H411 | | | |
| 613-099-00-6 | 1-dodecyl-2-pyrrolidon | 403-730-1 | 2687-96-9 | Skin Corr. 1B Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H317
  H410 | | | |
| 613-100-00-X | 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridin-7,14-dion | 404-230-6 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 613-101-00-5 | N-tert-pentyl-2-benzothiazolsulfenamid | 404-380-2 | 110799-28-5 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 613-102-00-0 | dimethomorph (ISO);
  4-(3-(4-chlorphenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholin | 404-200-2 | 110488-70-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-103-00-6 | natrium-5-n-butylbenzotriazol | 404-450-2 | 118685-34-0 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1
  Aquatic Chronic 2 | H302
  H314
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H317
  H411 | | | |
| 613-104-00-1 | 5-tert-butyl-3-isoxazolylaminhydrochlorid | 404-840-2 | — | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1
  Aquatic Chronic 3 | H302
  H373 ** H318
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H373 ** H318
  H412 | | | |
| 613-105-00-7 | hexakis(tetramethylammonium)-4,4'-vinylenbis((3-sulfonato-4,1-phenylen)imino(6-morpholino-1,3,5-triazin-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalen-2,7-disulfonat) | 405-160-9 | 124537-30-0 | Acute Tox. 3 * Skin Sens. 1
  Aquatic Chronic 3 | H301
  H317
  H412 | GHS06
  Dgr | H301
  H317
  H412 | | | |
| 613-106-00-2 | tetrakalium-2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienyliden)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzen-1,4-disulfonat | 405-240-3 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 613-107-00-8 | hexanatrium-2,2'-vinylenbis((3-sulfonato-4,1-phenylen)imino(6-(N-cyanethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazin-4,2-diyl)imino)dibenzen-1,4-disulfonat | 405-280-1 | 76508-02-6 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 613-108-00-3 | benzothiazol-2-thiol | 205-736-8 | 149-30-4 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 613-109-00-9 | bis(piperidinothiocarbonyl)disulfid | 202-328-1 | 94-37-1 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1 | H319
  H335
  H315
  H317 | GHS07
  Wng | H319
  H335
  H315
  H317 | | | |
| 613-110-00-4 | dimepiperat (ISO);

  S-(1-methyl-1-phenylethyl)piperidin-1-carbothioat | 262-784-2 | 61432-55-1 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 613-111-00-X | 1,2,4-triazol | 206-022-9 | 288-88-0 | Repr. 2
  Acute Tox. 4 *
  Eye Irrit. 2 | H361d *** H302
  H319 | GHS08
  GHS07
  Wng | H361d *** H302
  H319 | | | |
| 613-112-00-5 | octhilinon (ISO);
  2-octyl-2H-isothiazol-3-on | 247-761-7 | 26530-20-1 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H302
  H314
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H311
  H302
  H314
  H317
  H410 | | Skin Sens. 1; H317: C ≥ 0,05  % | |
| 613-113-00-0 | 2-(morpholinothio)benzothiazol | 203-052-4 | 102-77-2 | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H319
  H315
  H317
  H411 | GHS07
  GHS09
  Wng | H319
  H315
  H317
  H411 | | | |
| 613-114-00-6 | 2,2',2''-(hexahydro-1,3,5-triazin-1,3,5-triyl)triethanol;
  1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazin | 225-208-0 | 4719-04-4 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | Skin Sens. 1; H317: C ≥ 0,1  % | |
| 613-115-00-1 | hymexazol (ISO);
  3-hydroxy-5-methylisoxazol | 233-000-6 | 10004-44-1 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 613-116-00-7 | tolylfluanid (ISO);
  dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid
  indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm | 211-986-9 | 731-27-1 | Acute Tox. 2 * STOT RE 1
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H330
  H372** H319
  H335
  H315
  H317
  H400 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H372** H319
  H335
  H315
  H317
  H400 | | M=10 | |
| 613-116-01-4 | tolylfluanid (ISO);
  dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid
  indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm | 211-986-9 | 731-27-1 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1 | H319
  H335
  H315
  H317
  H400 | GHS07
  GHS09
  Wng | H319
  H335
  H315
  H317
  H400 | | M=10 | |
| 613-117-00-2 | diniconazol (ISO);
  (E)-β-[(2,4-dichlorphenyl)methylen]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;
  (E)-(RS)-1-(2,4-dichlorphenyl)-4,4-dimethyl-2-(1H-1,2,4- triazol-1-yl)pent-1-en-3-ol | — | 76714-88-0 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-118-00-8 | flubenzimin (ISO);

  N-[3-phenyl-4,5-bis[(trifluormethyl)imino]thiazolidin-2-yliden]anilin | 253-703-1 | 37893-02-0 | Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H319
  H400
  H410 | GHS07
  GHS09
  Wng | H319
  H410 | | | |
| 613-119-00-3 | (benzothiazol-2-ylthio)methylthiocyanat;
  TCMTB | 244-445-0 | 21564-17-0 | Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H302
  H319
  H315
  H317
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H302
  H319
  H315
  H317
  H410 | | | |
| 613-120-00-9 | bioresmethrin (ISO);
  (5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropancarboxylat | 249-014-0 | 28434-01-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 1000 | |
| 613-122-00-X | diclobutrazol (ISO);
  (R*, R*)-(±)-β-[(2,4-dichlorphenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorphenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol | — | 75736-33-3 | Eye Irrit. 2
  Aquatic Chronic 2 | H319
  H411 | GHS07
  GHS09
  Wng | H319
  H411 | | | |
| 613-123-00-5 | 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazol-3-thion;
  etem | 251-684-4 | 33813-20-6 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-124-00-0 | fenpropimorph (ISO);

  cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholin | 266-719-9 | 67564-91-4 | Repr. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Chronic 2 | H361d *** H302
  H315
  H411 | GHS08
  GHS07
  GHS09
  Wng | H361d *** H302
  H315
  H411 | | | |
| 613-125-00-6 | hexythiazox (ISO);

  trans-5-(4-chlorphenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidincarboxamid | — | 78587-05-0 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-126-00-1 | imazapyr (ISO);
  2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridincarboxylat | — | 81334-34-1 | Eye Irrit. 2
  Aquatic Chronic 3 | H319
  H412 | GHS07
  Wng | H319
  H412 | | | |
| 613-127-00-7 | 1,1-dimethylpiperidiniumchlorid;
  mepiquat-chlorid | 246-147-6 | 24307-26-4 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 613-128-00-2 | prochloraz (ISO);

  N-propyl-N-[2-(2,4,6-trichlorphenoxy)ethyl]-1H-imidazol-1-carboxamid | 266-994-5 | 67747-09-5 | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-129-00-8 | metamitron (ISO);
  4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-on | 255-349-3 | 41394-05-2 | Acute Tox. 4 *
  Aquatic Acute 1 | H302
  H400 | GHS07
  GHS09
  Wng | H302
  H400 | | | |
| 613-131-00-9 | pyroquilon (ISO);
  1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-on | — | 57369-32-1 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 613-132-00-4 | hexazinon (ISO);
  3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazin-2,4-dion | 257-074-4 | 51235-04-2 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H410 | | | |
| 613-134-00-5 | myclobutanil (ISO);
  2-(4-chlorphenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexannitril | — | 88671-89-0 | Repr. 2
  Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 2 | H361d *** H302
  H319
  H411 | GHS08
  GHS07
  GHS09
  Wng | H361d *** H302
  H319
  H411 | | | |
| 613-135-00-0 | di(benzothiazol-2-yl)disulfid | 204-424-9 | 120-78-5 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | EUH031 | | |
| 613-136-00-6 | N-cyclohexylbenzothiazol-2-sulfenamid | 202-411-2 | 95-33-0 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 613-137-00-1 | methabenzthiazuron (ISO);
  1-(1,3-benzothiazol-2-yl)1,3-dimethylurinstof | 242-505-0 | 18691-97-9 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-138-00-7 | quinoxyfen (ISO);
  5,7-dichlor-4-(4-fluorphenoxy)quinolin | — | 124495-18-7 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 613-139-00-2 | metsulfuron-methyl (ISO);
  2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)benzoesyre | — | 74223-64-6 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 1000 | |
| 613-140-00-8 | cycloheximid (ISO);
  4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidin-2,6-dion | 200-636-0 | 66-81-9 | Muta. 2
  Repr. 1B
  Acute Tox. 2 *
  Aquatic Chronic 2 | H341
  H360D *** H300
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H341
  H360D *** H300
  H411 | | | |
| 613-141-00-3 | 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinon | 401-470-3 | 93686-63-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-142-00-9 | trans-N-methyl-2-styryl-[4'-aminomethin-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridiniumacetat | 405-860-4 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 613-143-00-4 | 1-(3-phenylpropyl)-2-methylpyridiniumbromid | 405-930-4 | 10551-42-5 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 3 | H302
  H319
  H412 | GHS07
  Wng | H302
  H319
  H412 | | | |
| 613-144-00-X | reaktionsprodukter af: poly(vinylacetat), delvist hydrolyseret, med (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethylsulfat | 406-460-2 | 125139-08-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 613-145-00-5 | (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium-4-methylbenzensulfonat | 406-960-0 | 77497-97-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-146-00-0 | N-ethyl-N-methylpiperidiniumiodid | 407-780-5 | 4186-71-4 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 613-147-00-6 | 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholin | 407-940-4 | 111681-72-2 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-148-00-1 | tetranatrium-1,2-bis(4-fluor-6-[5-(1-amino-2-sulfonatoanthraquinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethan | 411-240-4 | 143683-23-2 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 613-150-00-2 | 2,2'-[3,3'-(piperazin-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l, m,n][3,8]phenanthrolin-1,3,6-trion | 406-295-6 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-151-00-8 | 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymin | 406-360-9 | 104218-44-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-152-00-3 | phenyl-N-(4,6-dimethoxypyrimidin-2-yl)carbamat | 406-600-2 | 89392-03-0 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 613-153-00-9 | 2,3,5-trichlorpyridin | 407-270-2 | 16063-70-0 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 613-154-00-4 | 2-amino-4-chlor-6-methoxypyrimidin | 410-050-9 | 5734-64-5 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 613-155-00-X | 5-chlor-2,3-difluorpyridin | 410-090-7 | 89402-43-7 | Flam. Liq. 3
  Acute Tox. 4 *
  Aquatic Chronic 3 | H226
  H302
  H412 | GHS02
  GHS07
  Wng | H226
  H302
  H412 | | | |
| 613-156-00-5 | 2-butyl-4-chlor-5-formylimidazol | 410-260-0 | 83857-96-9 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 613-157-00-0 | 2,4-diamino-5-methoxymethylpyrimidin | 410-330-0 | 54236-98-5 | Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2 | H302
  H373 ** H319 | GHS08
  GHS07
  Wng | H302
  H373 ** H319 | | | |
| 613-158-00-6 | 2,3-dichlor-5-trifluormethylpyridin | 410-340-5 | 69045-84-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H332
  H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H332
  H302
  H318
  H317
  H411 | | | |
| 613-159-00-1 | fenazaquin (ISO);
  4-[2-[4-(1,1-dimethylethyl)phenyl]ethoxy]quinazolin | 410-580-0 | 120928-09-8 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H332
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H332
  H410 | | | |
| 613-160-00-7 | (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptandihydrobromid | 411-000-9 | 125224-62-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 613-161-00-2 | 2,4-diamino-6-hydroxymethylpteridin hydrobromid | 430-620-0 | 76145-91-0 | STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 3 | H373** H317
  H412 | GHS08
  GHS07
  Wng | H373** H317
  H412 | | | |
| 613-162-00-8 | (6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-en-3-yl)methyl)pyridiniumiodid | 423-260-0 | 100988-63-4 | Muta. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H341
  H317
  H411 | GHS08
  GHS07
  GHS09
  Wng | H341
  H317
  H411 | | | |
| 613-163-00-3 | azimsulfuron (ISO);
  1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urinstof | — | 120162-55-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M=1000 | |
| 613-164-00-9 | flufenacet (ISO);

  N-(4-fluorphenyl)-N-isopropyl-2-(5-trifluormethyl-[1,3,4]thiadiazol-2-yloxy)acetamid | — | 142459-58-3 | Acute Tox. 4 * STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373** H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373** H317
  H410 | | M=100 | |
| 613-165-00-4 | flupyrsulfuron-methyl-natrium (ISO);
  methyl-2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluormethyl]nicotinat, mononatriumsalt | — | 144740-54-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M=100 | |
| 613-167-00-5 | en blanding af: 5-chlor-2-methyl-4-isothiazolin-3-on [EF nr. 247-500-7] og 2-methyl-2H-isothiazol-3-on [EF nr. 220-239-6] (3:1) | — | 55965-84-9 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H311
  H301
  H314
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H311
  H301
  H314
  H317
  H410 | | Skin Corr. 1B; H314: C ≥0,6  %
  Skin Irrit. 2; H315: 0,06  % ≤ C < 0,6  %
  Eye Irrit. 2; H319: 0,06  % ≤ C < 0,6  %
  Skin Sens. 1; H317: C ≥ 0,0015  % | |
| 613-168-00-0 | 1-vinyl-2-pyrrolidon | 201-800-4 | 88-12-0 | Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 * STOT RE 2 *
  STOT SE 3
  Eye Dam. 1 | H351
  H332
  H312
  H302
  H373 ** H335
  H318 | GHS06
  GHS05
  GHS09
  Dgr | H351
  H332
  H312
  H302
  H373 ** H335
  H318 | | | D |
| 613-169-00-6 | 9-vinylcarbazol | 216-055-0 | 1484-13-5 | Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H341
  H312
  H302
  H315
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H341
  H312
  H302
  H315
  H317
  H410 | | M=100 | |
| 613-170-00-1 | 2,2-ethylmethylthiazolidin | 404-500-3 | 694-64-4 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 613-171-00-7 | hexaconazol (ISO);
  (RS)-2-(2,4-dichlorphenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol | 413-050-7 | 79983-71-4 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 613-172-00-2 | 5-chlor-1,3-dihydro-2H-indol-2-on | 412-200-9 | 17630-75-0 | Repr. 2
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 3 | H361f *** H302
  H317
  H412 | GHS08
  GHS07
  Wng | H361f *** H302
  H317
  H412 | | | |
| 613-173-00-8 | fluquinconazol (ISO);
  3-(2,4-dichlorphenyl)-6-fluor-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-on | 411-960-9 | 136426-54-5 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H372 ** H312
  H315
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H301
  H372 ** H312
  H315
  H410 | | | |
| 613-174-00-3 | tetraconazol (ISO);
  (+/-) 2-(2,4-dichlorphenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluorethylether | 407-760-6 | 112281-77-3 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 2 | H332
  H302
  H411 | GHS07
  GHS09
  Wng | H332
  H302
  H411 | | | |
| 613-175-00-9 | epoxiconazol (ISO); (2RS,3SR)-3-(2-chlorphenyl)-2-(4-fluorphenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxiran | 406-850-2 | 133855-98-8 | Carc. 2
  Repr. 1B
  Aquatic Chronic 2 | H351
  H360Df
  H411 | GHS08
  GHS09
  Dgr | H351
  H360Df
  H411 | | | |
| 613-176-00-4 | 2-methyl-2-azabicyclo[2.2.1]heptan | 404-810-9 | 4524-95-2 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B | H226
  H312
  H302
  H373 **
  H314 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H226
  H312
  H302
  H373 **
  H314 | | | |
| 613-177-00-X | 8-amino-7-methylquinolin | 412-760-4 | 5470-82-6 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H312
  H302
  H317
  H411 | GHS07
  GHS09
  Wng | H312
  H302
  H317
  H411 | | | |
| 613-178-00-5 | 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidin | 410-470-2 | 137796-06-6 | Skin Corr. 1B
  Skin Sens. 1 | H314
  H317 | GHS05
  GHS07
  Dgr | H314
  H317 | | STOT SE 3; H335: C ≥ 5 % | |
| 613-179-00-0 | lithium-3-oxo-1,2-(2H)-benzisothiazol-2-id | 411-690-1 | 111337-53-2 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H314
  H317
  H411 | GHS05
  GHS07
  Dgr | H302
  H314
  H317
  H411 | | | |
| 613-180-00-6 | N-(1,1-dimethylethyl)bis(2-benzothiazolsulfen)amid | 407-430-1 | 3741-80-8 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-181-00-1 | 5,5-dimethyl-perhydro-pyrimidin-2-on-α-(4-trifluormethyltyryl)-α-(4-trifluormethyl)cinnamylidenhydrazon | 405-090-9 | 67485-29-4 | STOT RE 1
  Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H372 **
  H302
  H319
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H372 **
  H302
  H319
  H410 | | | |
| 613-182-00-7 | 1-(1-naphthylmethyl)quinoliniumchlorid | 406-220-7 | 65322-65-8 | Carc. 2
  Muta. 2
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H351
  H341
  H302
  H315
  H318
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H351
  H341
  H302
  H315
  H318
  H412 | | | |
| 613-183-00-2 | en blanding af 5-(N-methylperfluoroctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-on og
  5-(N-methylperfluorheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-on | 413-640-4 | — | STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H373 **
  H410 | | | |
| 613-184-00-8 | nitrilotriethylenammoniopropan-2-ol-2-ethylhexanat | 413-670-8 | — | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 613-185-00-3 | 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-on | 407-630-9 | 82633-79-2 | Acute Tox. 3 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H318
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H301
  H318
  H317
  H410 | | | |
| 613-186-00-9 | (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-ylacetat | 408-050-9 | 76855-69-1 | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H319
  H317
  H411 | GHS07
  GHS09
  Wng | H319
  H317
  H411 | | | |
| 613-187-00-4 | 5-(2-amino-5-cyan-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilthiophen | 410-530-8 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 613-188-00-X | 1-(3-(4-fluorphenoxy)propyl)-3-methoxy-4-piperidinon | 411-500-7 | 116256-11-2 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 613-189-00-5 | 1,4,7,10-tetrachis(p-toluensolfonil)-1,4,7,10-tetraazaciclododecano | 414-030-0 | 52667-88-6 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 613-190-00-0 | dinatrium 1-amino-4-(2-(5-chlor-6-fluor-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracen-2-sulfonat | 414-040-5 | 149530-93-8 | Acute Tox. 4 *
  Skin Sens. 1 | H302
  H317 | GHS07
  Wng | H302
  H317 | | | |
| 613-191-00-6 | 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidin | 421-150-7 | 143860-04-2 | Repr. 1B
  Skin Corr. 1B Aquatic Acute 1
  Aquatic Chronic 1 | H360f *** H314
  H400
  H410 | GHS08
  GHS05
  GHS09
  Dgr | H360f *** H314
  H410 | | | |
| 613-192-00-1 | 3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexan | 426-750-2 | 151860-15-0 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 613-193-00-7 | pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecan-1,11-diyldisulfamoyl)di[phthalocyaninkobber(II)]heptalactat | 414-930-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-194-00-2 | 6,13-dichlor-3,10-bis{2-[4-fluor-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazin-4,11-disulfonsyre, lithium-, natriumsalt | 418-000-8 | 163062-28-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-195-00-8 | 2,2-(1,4-phenylen)bis((4H-3,1-benzoxazin-4-on) | 418-280-1 | 18600-59-4 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 613-196-00-3 | 5-[[4-chlor-6-[[2-[[4-fluor-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphthalen-2,7-disulfonsyre, natriumsalt | 418-380-5 | 168113-78-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-197-00-9 | en blanding af 2,4,6-tri(butylcarbamoyl)-1,3,5-triazin;
  2,4,6-tri(methylcarbamoyl)-1,3,5-triazin;
  [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazin og
  [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazin | 420-390-1 | 187547-46-2 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 613-198-00-4 | 2-amino-4-dimethylamino-6-trifluorethoxy-1,3,5-triazin | 415-500-8 | 145963-84-4 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 3 | H302
  H373 **
  H412 | GHS08
  GHS07
  Wng | H302
  H373 **
  H412 | | | |
| 613-199-00-X | en blanding af 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazin-2,4,6-trion;
  blanding af oligomerer af
  3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazin-2,4,6-trion | 421-550-1 | — | Carc. 1B
  Repr. 1B
  Skin Sens. 1
  Aquatic Chronic 3 | H350
  H360D *** H317
  H412 | GHS08
  Dgr | H350
  H360D *** H317
  H412 | | | |
| 613-200-00-3 | reaktionsprodukt af kobber, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorsvovlsyre og 3-(2-sulfooxyethylsulfonyl)anilin, natriumsalte | 420-980-7 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-201-00-9 | (R)-5-brom-3-(1-methyl-2-pyrrolidinylmethyl)-1H-indol | 422-390-5 | 143322-57-0 | Repr. 2
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f *** H372 **
  H332
  H302
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Dgr | H361f *** H372 **
  H332
  H302
  H317
  H410 | EUH070 | | |
| 613-202-00-4 | pymetrozin (ISO);
  (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethylenamino)-1,2,4-triazin-3(2H)-on | — | 123312-89-0 | Carc. 2
  Aquatic Chronic 3 | H351
  H412 | GHS08
  Wng | H351
  H412 | | | |
| 613-203-00-X | pyraflufen-ethyl (ISO);
  2-chlor-5-(4-chlor-5-difluormethoxy-1-methylpyrazol-3-yl)-4-fluorphenoxyeddikesyreethylester; [1] pyraflufen (ISO);
  2-chlor-5-(4-chlor-5-difluormethoxy-1-methylpyrazol-3-yl)-4-fluorphenoxyeddikesyre [2] | - [1]
  - [2] | 129630-19-9 [1]
  129630-17-7 [2] | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 1 000 | |
| 613-204-00-5 | oxadiargyl (ISO);
  3-[2,4-dichlor-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-on | 254-637-6 | 39807-15-3 | Repr. 2
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H361D *** H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H361D *** H373 **
  H410 | | M = 1 000 | |
| 613-205-00-0 | propiconazol (ISO);
  (+)-1-[2-(2,4-dichlorphenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol | 262-104-4 | 60207-90-1 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 613-206-00-6 | fenamidon (ISO);
  (S)-5-methyl-2-methylthio-5-phenyl-3-phenyl-3,5-dihydroimidazol-4-on | — | 161326-34-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-208-00-7 | imazamox (ISO);
  (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-(methoxymethyl)nicotinsyre | — | 114311-32-9 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-209-00-2 | cis-1-(3-chlorpropyl)-2,6-dimethyl-piperidinhydrochlorid | 417-430-3 | 63645-17-0 | Acute Tox. 3 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Chronic 2 | H301
  H373 **
  H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H373 **
  H317
  H411 | | | |
| 613-210-00-8 | 2-(3-chlorpropyl)-2,5,5-trimethyl-1,3-dioxan | 417-650-1 | 88128-57-8 | STOT RE 2 *
  Aquatic Chronic 3 | H373 **
  H412 | GHS08
  Wng | H373 **
  H412 | | | |
| 613-211-00-3 | N-methyl-4-(p-formylstyryl)-pyridiniummethylsulfat | 418-240-3 | 74401-04-0 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 613-212-00-9 | 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinan-1,1-dioxid) | 418-320-8 | 133467-41-1 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-213-00-4 | cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-.sc.L.sc.-prolin | 416-040-0 | 120807-02-5 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 613-214-00-X | N, N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-chinolyliden)-1,3-dioxoindan-5-carboxamid | 416-260-7 | 147613-95-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-215-00-5 | 2-chlormethyl-3,4-dimethoxypyridiniumchlorid | 416-440-5 | 72830-09-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H312
  H302
  H373 **
  H315
  H318
  H317
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H312
  H302
  H373 **
  H315
  H318
  H317
  H411 | | | |
| 613-216-00-0 | 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazol | 416-490-8 | 162208-01-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-217-00-6 | 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidin | 416-770-1 | 73754-27-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-218-00-1 | 6-hydroxyindol | 417-020-4 | 2380-86-1 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H317
  H411 | | | |
| 613-219-00-7 | 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazol | 417-140-7 | 79185-77-6 | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 613-220-00-2 | trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol-, 7,7-dioxid | 417-290-3 | 147086-81-5 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 613-221-00-8 | 2-chlor-5-methyl-pyridin | 418-050-0 | 18368-64-4 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Aquatic Chronic 3 | H312
  H302
  H315
  H412 | GHS07
  Wng | H312
  H302
  H315
  H412 | | | |
| 613-222-00-3 | 4-(1-oxo-2-propenyl)-morpholin | 418-140-1 | 04-12-5117 | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H373 **
  H318
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H373 **
  H318
  H317 | | | |
| 613-223-00-9 | N-isopropyl-3-(4-fluorphenyl)-1H-indol | 418-790-4 | 93957-49-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-224-00-4 | 2,5-dimercaptomethyl-1,4-dithian | 419-770-8 | 136122-15-1 | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H317
  H410 | | | |
| 613-225-00-X | blanding af [2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl]-1,3,5-triazin og
  2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazin | 421-290-9 | — | STOT RE 2 *
  Aquatic Chronic 4 | H373 **
  H413 | GHS08
  Wng | H373 **
  H413 | | | |
| 613-226-00-5 | 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl-pyridiniumdichlorid | 420-950-3 | 163831-67-2 | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 613-227-00-0 | (±)-[(R*,R*) og (R*,S*)]-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 419-600-2 | 99199-90-3 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 613-228-00-6 | (±)-(R*,S*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 419-630-6 | 793669-26-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-229-00-1 | 1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidin | 411-930-5 | 106917-31-1 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 613-230-00-7 | florasulam;
  2',6',8-trifluor-5-methoxy-5-triazolo[1,5-c];
  pyrimidin-2-sulfonanilid | — | 145701-23-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-231-00-2 | 2,6-diamino-3-((pyridin-3-yl)azo)pyridin | 421-430-9 | 28365-08-4 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 2 | H302
  H373 **
  H411 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H411 | | | |
| 613-232-00-8 | 3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazin-4-oxid | 431-030-6 | 163269-30-5 | Acute Tox. 3 *
  STOT RE 2 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H373 **
  H318
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H331
  H373 **
  H318
  H410 | | | |
| 613-233-00-3 | 4,4'-(oxy-(bismethylen))-bis-1,3-dioxolan | 423-230-7 | 56552-15-9 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-234-00-9 | imidazo[1,2-b]pyridazin hydrochlorid | 431-510-5 | 18087-70-2 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 613-235-00-4 | 2,3-dihydro-2,2-dimethyl-1H-perimidin | 424-060-6 | 6364-17-6 | Acute Tox. 4 *
  STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H317
  H410 | | | |
| 613-236-00-X | 2-chlor-3-trifluormethylpyridin | 424-520-6 | 65753-47-1 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 1
  Skin Corr. 1B
  Aquatic Chronic 3 | H311
  H301
  H372 **
  H314
  H412 | GHS06
  GHS05
  GHS08
  Dgr | H311
  H301
  H372 **
  H314
  H412 | | | |
| 613-237-00-5 | 6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazin | 424-950-4 | 133949-92-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-238-00-0 | natrium-2-[[4-[(4,6-dichlor-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethylsulfat | 430-890-1 | 81992-66-7 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 613-239-00-6 | 2-[3-(methylamino)propyl]-1H-benzimidazol | 425-760-4 | 64137-52-6 | Eye Dam. 1
  Aquatic Chronic 3 | H318
  H412 | GHS05
  Dgr | H318
  H412 | | | |
| 613-241-00-7 | 3-(2H-tetrazol-5-yl)pyridin | 426-810-8 | 3250-74-6 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-242-00-2 | reaktionsprodukter af 3,10-bis((2-aminopropyl)amino)-6,13-dichlor-4,11-triphenodioxazindisulfonsyre med 2-amino-1,4-benzendisulfonsyre, 2-((4-aminophenyl)sulfonyl)ethylhydrogensulfat og 2,4,6-trifluor-1,3,5-triazin, natriumsalte | 426-860-0 | 191877-09-5 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-243-00-8 | 4,4'-(1,6-hexamethylenbis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidin) | 427-350-0 | 182235-14-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-244-00-3 | 5,7-dichlor-4-hydroxyquinolin | 427-420-0 | 21873-52-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-245-00-9 | 2-fluor-6-trifluormethylpyridin | 428-100-3 | 94239-04-0 | Flam. Liq. 3
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H226
  H332
  H302
  H412 | GHS02
  GHS07
  Wng | H226
  H332
  H302
  H412 | | | |
| 613-246-00-4 | 2-hydroxymethyl-3-methyl-4-(2,2,2-trifluorethoxy)pyridin | 428-200-7 | 103577-66-8 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 613-247-00-X | 3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindol | 428-910-7 | 107786-36-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-248-00-5 | 3,4-dimethyl-1H-pyrazol | 429-130-1 | 2820-37-3 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 613-249-00-0 | 1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfat | 429-300-3 | 155601-30-2 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 613-250-00-6 | blanding af carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidin;
  methyl-carbonato-N-ethyl-2-isopropyl-1,3-oxazolidin og
  2-isopropyl-N-hydroxyethyl-1,3-oxazolidin | 429-990-6 | — | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H318
  H317
  H412 | | | |
| 613-251-00-1 | (R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indol | 430-560-5 | 180637-89-2 | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H302
  H373 **
  H318
  H317 | GHS05
  GHS08
  GHS07
  Dgr | H302
  H373 **
  H318
  H317 | | | |
| 613-253-00-2 | 2,2-dialkyl-4-hydroxymethyl-1,3-dioxolan;
  reaktionsprodukter med ethylenoxid, alkyl er C1-12 og tilsammen på C13, med en gennemsnitlig ethoxyleringsgrad på 3,5 | 430-580-4 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | EUH019 | | |
| 613-254-00-8 | forchlorfenuron (ISO);
  1-(2-chlor-4-pyridyl)-3-phenylurinstof | — | 68157-60-8 | Carc. 2
  Aquatic Chronic 2 | H351
  H411 | GHS08
  GHS09
  Wng | H351
  H411 | | | |
| 613-255-00-3 | blanding af isomerer af natrium-[(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazin-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfophthalocyaninato)]kobber(II) | 424-270-8 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-256-00-9 | 3'5'-anhydrothymidin | 425-810-5 | 38313-48-3 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 613-257-00-4 | 2-phthalimidoethyl-N-[4-(2-cyan-4-nitrophenylazo)phenyl]-N-methyl-β-alaninat | 426-400-9 | 170222-39-6 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 613-258-00-X | en blanding af 4-chlor-7-methylbenzotriazol natriumsalt;
  4-chlor-5-methylbenzotriazol natriumsalt og
  5-chlor-4-methylbenzotriazol natriumsalt | 427-730-6 | 202420-04-0 | Skin Corr. 1B
  Aquatic Chronic 3 | H314
  H412 | GHS05
  Dgr | H314
  H412 | | | |
| 613-259-00-5 | en blanding af [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemat og
  [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemat | 428-790-6 | 72963-72-5 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 613-260-00-0 | (±)-4-(3-chlorphenyl)-6-[(4-chlorphenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin | 430-730-9 | — | Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H400
  H410 | GHS05
  GHS09
  Dgr | H318
  H410 | | | |
| 613-261-00-6 | pyrazol-1-carboxamidin monohydrochlorid | 429-520-1 | 4023-02-3 | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H373 ** H318
  H317
  H412 | GHS05
  GHS08
  GHS07
  Dgr | H302
  H373 **
  H318
  H317
  H412 | | | |
| 613-262-00-1 | dinatrium-(E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethen | 427-310-2 | 180850-95-7 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-263-00-7 | mononatrium-3-cyan-5-fluor-6-hydroxy-pyridin-2-olat | 429-570-2 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 613-266-00-3 | 2-chlor-5-chlormethylthiazol | 429-830-5 | 105827-91-6 | Acute Tox. 3 *
  Skin Corr. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H311
  H314
  H302
  H317
  H411 | GHS06
  GHS05
  GHS09
  Dgr | H311
  H314
  H302
  H317
  H411 | | | |
| 613-267-00-9 | thiamethoxam (ISO)
  3-(2-chlorthiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-yliden-N-nitroamin | 428-650-4 | 153719-23-4 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 10 | |
| 613-268-00-4 | (4aS-cis-)-6-benzyl-octahydropyrrolo[3,4-b]pyridin | 425-930-8 | 151213-39-7 | Skin Corr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 2 | H314
  H332
  H302
  H373 **
  H411 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H314
  H332
  H302
  H373 **
  H411 | | | |
| 613-269-00-X | 2-thiazolidinylidencyanamid | 427-720-1 | 26364-65-8 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 3 | H302
  H373 ** H412 | GHS08
  GHS07
  Wng | H302
  H373 **
  H412 | | | |
| 613-270-00-5 | 5-amino-N-(2,6-dichlor-3-methylphenyl)-1H-1,2,4-triazol-3-sulfonamid | 428-150-6 | 113171-13-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 613-271-00-0 | tritosulfuron (indeholdende ≤ 0,02 % AMTT);
  1-[4-methoxy-6-(trifluormethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluormethyl)benzensul-fonyl]urinstof (indeholdende ≤ 0,02 % AMTT) | — | 142469-14-5 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | M = 10 | |
| 613-272-00-6 | pyraclostrobin; (ISO)
  methyl-N-{2-[1-(4-chlorphenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamat | — | — | Acute Tox. 3 *
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H315
  H400
  H410 | GHS06
  GHS09
  Dgr | H331
  H315
  H410 | | M = 100 | |
| 613-273-00-1 | tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-yliden-N-nitroamin | 427-600-9 | 192439-46-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-274-00-7 | 2,6-dichlor-1-fluorpyridiniumtetrafluorborat | 427-400-1 | 140623-89-8 | Skin Corr. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H314
  H302
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H314
  H302
  H317
  H410 | | | |
| 613-275-00-2 | 3-(2-chlorethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-on monohydrochlorid | 424-530-0 | 93076-03-0 | Acute Tox. 3 *
  STOT SE 2
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H301
  H371 **
  H373 **
  H318
  H317
  H411 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H301
  H371 **
  H373 **
  H318
  H317
  H411 | | | |
| 613-276-00-8 | 1-(2-chlorphenyl)-1,2-dihydro-5H-tetrazol-5-on | 426-110-2 | 98377-35-6 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 613-277-00-3 | (4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-on | 427-070-9 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-278-00-9 | (3-aminophenyl)pyridin-3-ylmethanon | 428-230-0 | 79568-06-2 | STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H373 **
  H410 | | | |
| 613-279-00-4 | 2-ethyl-2,3-dihydro-2-methyl-1H-perimidin | 424-380-6 | 43057-68-7 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H410 | | | |
| 613-280-00-X | tetrahydro-1,3-dimethyl-1H-pyrimidin-2-on;
  dimethylpropylenurinstof | 230-625-6 | 7226-23-5 | Repr. 2
  Acute Tox. 4 *
  Eye Dam. 1 | H361f ***
  H302
  H318 | GHS05
  GHS08
  GHS07
  Dgr | H361f ***
  H302
  H318 | | | |
| 613-281-00-5 | quinolin | 202-051-6 | 91-22-5 | Carc. 1B Muta. 2
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H350
  H341
  H312
  H302
  H319
  H315
  H411 | GHS08
  GHS07
  GHS09
  Dgr | H350
  H341
  H312
  H302
  H319
  H315
  H411 | | | |
| 613-282-00-0 | triticonazol (ISO);
  (RS)-(E)-5-(4-chlorbenzyliden)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | — | 131983-72-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 613-283-00-6 | ketoconazol;
  1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorphenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanon | 265-667-4 | 65277-42-1 | Repr. 1B
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H360F ***
  H301
  H373 **
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H360f ***
  H301
  H373 **
  H410 | | | |
| 613-284-00-1 | metconazol (ISO);
  (1RS,5RS;1RS,5SR)-5-(4-chlorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | — | 125116-23-6 | Repr. 2
  Acute Tox. 4 *
  Aquatic Chronic 2 | H361D ***
  H302
  H411 | GHS08
  GHS07
  GHS09
  Wng | H361D ***
  H302
  H411 | | | |
| 613-285-00-7 | 1-hydroxybenzotriazol, vandfri; [1]
  1-hydroxybenzotriazol, monohydrat [2] | 219-989-7 [1]
  219-989-7 [2] | 2592-95-2 [1]
  123333-53-9 [2] | Expl. 1,3 | H203 | GHS01
  Dgr | H203 | | | |
| 613-286-00-2 | kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat;
  [indeholdende < 0,5 % N, N-dimethylformamid (EF-nr.
  200-679-5)] | 418-260-2 | 183196-57-8 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 613-286-01-X | kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat
  [indeholdende ≥ 0,5 % N, N-dimethylformamid (EF-nr. 200-679-5)] | 418-260-2 | 183196-57-8 | Repr. 1B
  Skin Sens. 1 | H360D *** H317 | GHS08
  GHS07
  Dgr | H360D *** H317 | | | |
| 613-287-00-8 | 1-(3-iod-4-aminobenzyl)-1H-1,2,4-triazol | 419-540-7 | 160194-26-3 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 613-288-00-3 | 1,3-bis(dimethylcarbamoyl)-imidazoliumchlorid | 420-930-4 | 135756-61-5 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 613-289-00-9 | 3-(4-chlor-2-fluor-5-methylphenyl)-1-methyl-5-(trifluormethyl)-1H-pyrazol | 432-020-4 | 142623-48-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-290-00-4 | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-onhydrochlorid | 432-470-1 | 189012-93-9 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H410 | | | |
| 613-291-00-X | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-on | 434-820-9 | 106461-41-0 | STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H373 **
  H410 | | | |
| 613-292-00-5 | N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazin | 435-010-8 | 26157-73-3 | Muta. 2
  Aquatic Chronic 3 | H341
  H412 | GHS08
  Wng | H341
  H412 | | | |
| 613-293-00-0 | 2-(4-tert-butylphenyl)-6-cyan-5-[bis(ethoxycarbonyl-
  methyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazol-7-carboxylsyre-2,6-di-tert-butyl-4-methylcyclohexylester | 448-050-6 | 444065-11-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-294-00-6 | 2-hexyldecansyre-[4-(6-tert-butyl-7-chlor-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester | 448-260-8 | 379268-96-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-295-00-1 | 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepinhydrochlorid | 448-720-8 | 363138-44-7 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 613-296-00-7 | pentakalium-2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-yliden]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzen-1,4-disulfonat | 418-270-7 | — | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 613-297-00-2 | 5-(2-bromphenyl)-2-tert-butyl-2H-tetrazol | 420-820-6 | — | Flam. Liq. 3
  Acute Tox. 4 *
  Aquatic Chronic 2 | H226
  H302
  H411 | GHS02
  GHS07
  GHS09
  Wng | H226
  H302
  H411 | | | |
| 613-298-00-8 | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-on)ethylendilactat | 421-560-6 | — | STOT RE 2 *
  Eye Dam. 1
  Aquatic Chronic 2 | H373 **
  H318
  H411 | GHS05
  GHS08
  GHS09
  Dgr | H373 **
  H318
  H411 | | | |
| 613-299-00-3 | hovedkomponent 1 (isomer 1):
  2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;
  hovedkomponent 1 (isomer 2):
  2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;
  hovedkomponent 2: 2,3-bis-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;
  hovedkomponent 3: 2,3-bis-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt; | 422-610-1 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-300-00-7 | 1-imidazol-1-yl-octadecan-2-ol | 434-120-3 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 613-301-00-2 | dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl}imidazol-4,5-dicarboxylat | 443-910-7 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-302-00-8 | dinatrium-2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridin-3-ylazo)-4-(4-fluor-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazin-2-ylamino)benzensulfonat | 432-980-4 | 243858-60-8 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 613-303-00-3 | 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridin | 429-800-1 | 95737-68-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-304-00-9 | 5,6-dihydroxy-2,3-dihydro-1H-indoliumbromid | 421-170-6 | 138937-28-7 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 613-305-00-4 | 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazol | 448-630-9 | 3147-77-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 613-306-00-X | (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethylcarbonat | 433-520-5 | 82911-69-1 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H317
  H411 | | | |
| 613-307-00-5 | clothianidin (ISO);
  3-[(2-chlor-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidin | — | 210880-92-5 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | M = 10 | |
| 613-308-00-0 | 2-amino-5-methylthiazol | 423-800-5 | 7305-71-7 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 **
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 **
  H410 | | | |
| 613-309-00-6 | 1-methyl-3-phenyl-1-piperazin | 431-180-2 | 5271-27-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 3 | H312
  H302
  H315
  H318
  H412 | GHS05
  GHS07
  Dgr | H312
  H302
  H315
  H318
  H412 | | | |
| 613-310-00-1 | (-)(3S,4R)-4-(4-fluorphenyl)-3-(3,4-methylendioxy-phenoxymethyl)-N-benzylpiperidinhydrochlorid | 432-360-3 | 105813-13-6 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 613-311-00-7 | methyl-5-nitrophenyl-guanidin | 435-500-1 | 152460-07-6 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H319
  H317
  H412 | GHS07
  Wng | H302
  H319
  H317
  H412 | | | |
| 613-312-00-2 | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenmethanolmonohydrochlorid | 420-200-5 | — | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H317
  H412 | | | |
| 613-313-00-8 | 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindol-1,3(2H)-dion | 442-780-9 | 173838-67-0 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 613-314-00-3 | 4-decyloxazolidin-2-on;
  4-decyl-1,3-oxazolidin-2-on | 443-770-7 | 7693-82-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 613-315-00-9 | tetrakalium-4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-yliden]-3-(piperidinocarbonyl)penta-1,3-dienyliden]-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-3-carboxylat | 430-390-1 | — | Acute Tox. 4 *
  Aquatic Chronic 3 | H332
  H412 | GHS07
  Wng | H332
  H412 | | | |
| 613-316-00-4 | trimethylopropan-tri(3-aziridinylpropanoat);
  (TAZ) | 257-765-0 | 52234-82-9 | Muta. 2
  Eye Dam. 1
  Skin Sens. 1 | H341
  H318
  H317 | GHS05
  GHS08
  GHS07
  Dgr | H341
  H318
  H317 | | | |
| 613-317-00-X | penconazol (ISO); 1-[2-(2,4- dichlorphenyl)pentyl]-1H1,2,4-triazol | 266-275-6 | 66246-88-6 | Repr. 2
  Acute Tox. 4
  Aquatic Acute 1
  Aquatic Chronic 1 | H361d
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361d
  H302
  H410 | | M = 1
  M = 1 | |
| 614-002-00-X | salte af nicotin | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Chronic 2 | H330
  H310
  H300
  H411 | GHS06
  GHS09
  Dgr | H330
  H310
  H300
  H411 | | | A |
| 614-003-00-5 | strychnin | 200-319-7 | 57-24-9 | Acute Tox. 1
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H310
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H310
  H300
  H410 | | | |
| 614-004-00-0 | salte af strychnin | — | — | Acute Tox. 2 *
  Acute Tox. 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H300
  H400
  H410 | GHS06
  GHS09
  Dgr | H330
  H300
  H410 | | | A |
| 614-005-00-6 | colchicin | 200-598-5 | 64-86-8 | Muta. 1B
  Acute Tox. 2 * | H340
  H300 | GHS06
  GHS08
  Dgr | H340
  H300 | | | |
| 614-006-00-1 | brucin;
  2,3-dimethoxystrychnin | 206-614-7 | 357-57-3 | Acute Tox. 2 *
  Acute Tox. 2 *
  Aquatic Chronic 3 | H330
  H300
  H412 | GHS06
  Dgr | H330
  H300
  H412 | | | |
| 614-007-00-7 | brucinsulfat; [1]
  brucinnitrat; [2]
  strychnidin-10-on, 2,3-dimethoxy-, mono[(R)-1-methylheptyl-1,2-benzendicarboxylat]; [3]
  strychnidin-10-on, 2,3-dimethoxy-, forbindelse med (S)-mono(1-methylheptyl)-1,2-benzendicarboxylat (1:1) [4] | 225-432-9 [1]
  227-317-9 [2]
  269-439-5 [3]
  269-710-8 [4] | 4845-99-2 [1]
  5786-97-0 [2]
  68239-26-9 [3]
  68310-42-9 [4] | Acute Tox. 2 *
  Acute Tox. 2 *
  Aquatic Chronic 3 | H330
  H300
  H412 | GHS06
  Dgr | H330
  H300
  H412 | | | A |
| 614-008-00-2 | aconitin | 206-121-7 | 302-27-2 | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | |
| 614-009-00-8 | salte af aconitin | — | — | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | A |
| 614-010-00-3 | atropin | 200-104-8 | 51-55-8 | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | |
| 614-011-00-9 | salte af atropin | — | — | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | A |
| 614-012-00-4 | hyoscyamin | 202-933-0 | 101-31-5 | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | |
| 614-013-00-X | salte af hyoscyamin | — | — | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | A |
| 614-014-00-5 | scopolamin | 200-090-3 | 51-34-3 | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 * | H330
  H310
  H300 | GHS06
  Dgr | H330
  H310
  H300 | | | |
| 614-015-00-0 | salte af scopolamin | — | — | Acute Tox. 2 *
  Acute Tox. 1
  Acute Tox. 2 * | H330
  H310
  H300 | GHS06
  Dgr | H330
  H310
  H300 | | | A |
| 614-016-00-6 | pilocarpin | 202-128-4 | 92-13-7 | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | |
| 614-017-00-1 | salte af pilocarpin | — | — | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | A |
| 614-018-00-7 | papaverin | 200-397-2 | 58-74-2 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 614-019-00-2 | salte af papaverin | — | — | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | A |
| 614-020-00-8 | physostigmin | 200-332-8 | 57-47-6 | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | |
| 614-021-00-3 | salte af physostigmin | — | — | Acute Tox. 2 *
  Acute Tox. 2 * | H330
  H300 | GHS06
  Dgr | H330
  H300 | | | A |
| 614-022-00-9 | digitoxin | 200-760-5 | 71-63-6 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 * | H331
  H301
  H373 ** | GHS06
  GHS08
  Dgr | H331
  H301
  H373 ** | | | |
| 614-023-00-4 | ephedrin | 206-080-5 | 299-42-3 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 614-024-00-X | salte af ephedrin | — | — | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | A |
| 614-025-00-5 | G-strophantin | 211-139-3 | 630-60-4 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 * | H331
  H301
  H373 ** | GHS06
  GHS08
  Dgr | H331
  H301
  H373 ** | | | |
| 614-026-00-0 | K-strophantin | 234-239-9 | 11005-63-3 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 * | H331
  H301
  H373 ** | GHS06
  GHS08
  Dgr | H331
  H301
  H373 ** | | | |
| 614-027-00-6 | 6β-acetoxy-3y(β-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolid | 208-077-4 | 507-60-8 | Acute Tox. 2 * | H300 | GHS06
  Dgr | H300 | | | |
| 614-028-00-1 | en blanding af 2-ethylhexyl-mono-D-glucopyranosid og
  2-ethylhexyl-di-D-glucopyranosid | 414-420-0 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 614-029-00-7 | strukturisomerer af penta-O-allyl-β-.sc.D.sc.-fructofuranosyl-α-.sc.D.sc.-glucopyranosid;
  strukturisomerer af hexa-O-allyl-β-.sc.D.sc.-fructofuranosyl-α-.sc.D.sc.-glucopyranosid og
  strukturisomerer af hepta-O-allyl-β-.sc.D.sc.-fructofuranosyl-α-.sc.D.sc.-glucopyranosid | 419-640-0 | 68784-14-5 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 615-001-00-7 | methylisocyanat | 210-866-3 | 624-83-9 | Flam. Liq. 2
  Repr. 2
  Acute Tox. 2 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  Resp. Sens. 1
  Skin Sens. 1
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1 | H225
  H361D *** H330
  H311
  H301
  H334
  H317
  H335
  H315
  H318 | GHS02
  GHS06
  GHS05
  GHS08
  Dgr | H225
  H361D *** H330
  H311
  H301
  H334
  H317
  H335
  H315
  H318 | | | |
| 615-002-00-2 | methylisothiocyanat | 209-132-5 | 556-61-6 | Acute Tox. 3 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H301
  H314
  H317
  H400
  H410 | GHS06
  GHS05
  GHS09
  Dgr | H331
  H301
  H314
  H317
  H410 | | | |
| 615-003-00-8 | thiocyansyre | 207-337-4 | 463-56-9 | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H332
  H312
  H302
  H412 | GHS07
  Wng | H332
  H312
  H302
  H412 | EUH032 | | |
| 615-004-00-3 | salte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H332
  H312
  H302
  H412 | GHS07
  Wng | H332
  H312
  H302
  H412 | EUH032 | | A |
| 615-005-00-9 | 4,4'-methylendiphenyldiisocyanat; diphenylmethan-4,4'-diisocyanat; [1]
  2,2'-methylendiphenyldiisocyanat; diphenylmethan-2,2'-diisocyanat; [2]

  o-(p-isocyanatobenzyl)phenylisocyanat;
  diphenylmethan-2,4'-diisocyanat; [3]
  methylendiphenyldiisocyanat
  [4] | 202-966-0 [1]
  219-799-4 [2]
  227-534-9 [3]
  247-714-0 [4] | 101-68-8 [1]
  2536-05-2 [2]
  5873-54-1 [3]
  26447-40-5 [4] | Carc. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1 | H351
  H332
  H373 **
  H319
  H335
  H315
  H334
  H317 | GHS08
  GHS07
  Dgr | H351
  H332
  H373 **
  H319
  H335
  H315
  H334
  H317 | | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1  %
  STOT SE 3; H335: C ≥ 5 % | C2 |
| 615-006-00-4 | 2-methyl-m-phenylendiisocyanat;
  2,4-diisocyanatotoluen; [1]
  4-methyl-m-phenylendiisocyanat;
  2,6-diisocyanatotoluen; [2]

  m-tolylidendiisocyanat;
  diisocyanatoluen [3] | 202-039-0 [1]
  209-544-5 [2]
  247-722-4 [3] | 91-08-7 [1]
  584-84-9 [2]
  26471-62-5 [3] | Carc. 2
  Acute Tox. 2 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H351
  H330
  H319
  H335
  H315
  H334
  H317
  H412 | GHS06
  GHS08
  Dgr | H351
  H330
  H319
  H335
  H315
  H334
  H317
  H412 | | Resp. Sens. 1; H334: C ≥
  0,1  % | C |
| 615-007-00-X | 1,5-naphthylendiisocyanat | 221-641-4 | 3173-72-6 | Acute Tox. 4 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Aquatic Chronic 3 | H332
  H319
  H335
  H315
  H334
  H412 | GHS08
  GHS07
  Dgr | H332
  H319
  H335
  H315
  H334
  H412 | | | |
| 615-008-00-5 | 3-isocyanatomethyl-3,5,5-trimethylcyclohexylisocyanat; isophorondiisocyanat | 223-861-6 | 4098-71-9 | Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H331
  H319
  H335
  H315
  H334
  H317
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H319
  H335
  H315
  H334
  H317
  H411 | | *
  Resp. Sens. 1; H334: C ≥ 0,5  %
  Skin Sens.1; H317: C ≥ 0,5  % | 2 |
| 615-009-00-0 | 4,4'-methylendi(cyclohexylisocyanat); dicyclohexylmethan-4,4'-diisocyanat | 225-863-2 | 5124-30-1 | Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1 | H331
  H319
  H335
  H315
  H334
  H317 | GHS06
  GHS08
  Dgr | H331
  H319
  H335
  H315
  H334
  H317 | | *
  Resp. Sens. 1; H334: C ≥ 0,5  %
  Skin Sens. 1; H317: C ≥ 0,5  % | 2 |
| 615-010-00-6 | 2,2,4-trimethylhexamethylen-1,6-diisocyanat; [1]
  2,4,4-trimethylhexamethylen-1,6-diisocyanat [2] | 241-001-8 [1]
  239-714-4 [2] | 16938-22-0 [1]
  15646-96-5 [2] | Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H331
  H319
  H335
  H315
  H334 | GHS06
  GHS08
  Dgr | H331
  H319
  H335
  H315
  H334 | | *
  Resp. Sens. 1; H334: C ≥ 0,5  %
  Skin Sens. 1; H317: C ≥ 0,5  % | C2 |
| 615-011-00-1 | hexamethylen-1,6-diisocyanat | 212-485-8 | 822-06-0 | Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1
  Skin Sens. 1 | H331
  H319
  H335
  H315
  H334
  H317 | GHS06
  GHS08
  Dgr | H331
  H319
  H335
  H315
  H334
  H317 | | *
  Resp. Sens. 1; H334: C ≥
  0,5  %
  Skin Sens. 1; H317: C ≥ 0,5  % | 2 |
| 615-012-00-7 | 4-toluensulfonylisocyanat;
  tosylisocyanat | 223-810-8 | 4083-64-1 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | EUH014 | Eye Irrit.
  H319: C ≥ 5 %
  STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % | |
| 615-014-00-8 | tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrat | — | 7276-58-6 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 615-015-00-3 | 1,7,7-trimethylbicyclo(2,2,1)hept-2-ylthiocyanatoacetat;
  isobornyl thiocyanoacetat | 204-081-5 | 115-31-1 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 615-016-00-9 | kaliumcyanat | 209-676-3 | 590-28-3 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 615-017-00-4 | calciumcyanamid | 205-861-8 | 156-62-7 | Acute Tox. 4 *
  STOT SE 3
  Eye Dam. 1 | H302
  H335
  H318 | GHS05
  GHS07
  Dgr | H302
  H335
  H318 | | | |
| 615-018-00-X | 2-(2-butoxythoxy)ethylthio
  cyanat | 203-985-7 | 112-56-1 | Flam. Liq. 3
  Acute Tox. 3 *
  Acute Tox. 3 * | H226
  H311
  H301 | GHS02
  GHS06
  Dgr | H226
  H311
  H301 | | | |
| 615-019-00-5 | dicyclohexylcarbodiimid | 208-704-1 | 538-75-0 | Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H311
  H302
  H318
  H317 | GHS06
  GHS05
  Dgr | H311
  H302
  H38
  H317 | | | |
| 615-020-00-0 | methylendithiocyanat | 228-652-3 | 6317-18-6 | Acute Tox. 2 *
  Acute Tox. 3 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1 | H330
  H301
  H314
  H317
  H400 | GHS06
  GHS05
  GHS09
  Dgr | H330
  H301
  H314
  H317
  H400 | | | |
| 615-021-00-6 | 1,3,5-tris(oxiranylmethyl)-1,3,5-triazin-2,4,6(1H,3H,5H)-trion;
  TGIC | 219-514-3 | 2451-62-9 | Muta. 1B
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H340
  H331
  H301
  H373 **
  H318
  H317
  H412 | GHS06
  GHS08
  GHS05
  Dgr | H340
  H331
  H301
  H373 **
  H318
  H317
  H412 | | | |
| 615-022-00-1 | methyl-3-isocyanatosulfonyl-2-thiophencarboxylat | 410-550-7 | 79277-18-2 | STOT RE 2 *
  Resp. Sens. 1
  Skin Sens. 1 | H373 **
  H334
  H317 | GHS08
  Dgr | H373 **
  H334
  H317 | EUH014 | | |
| 615-023-00-7 | 2-(isocyanatosulfonylmethyl)benzoesyre-methylester; (alt.):methyl 2-(isocyanatosulfo nylmethyl)benzoat | 410-900-9 | 83056-32-0 | Flam. Liq. 3
  Muta. 2
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Resp. Sens. 1 | H226
  H341
  H332
  H373 **
  H318
  H334 | GHS02
  GHS08
  GHS05
  GHS07
  Dgr | H226
  H341
  H332
  H373 **
  H318
  H334 | EUH014 | | |
| 615-024-00-2 | 2-phenylethylisocyanat | 413-080-0 | 1943-82-4 | Acute Tox. 3 *
  Acute Tox. 4 *
  Skin Corr. 1A
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H331
  H302
  H314
  H334
  H317
  H411 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H331
  H302
  H314
  H334
  H317
  H411 | | | |
| 615-025-00-8 | 4,4'-ethylidendiphenyldicyanat | 405-740-1 | 47073-92-7 | Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H302
  H373 **
  H318
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H332
  H302
  H373 **
  H318
  H410 | | | |
| 615-026-00-3 | 4,4'-methylenbis(2,6-dimethylphenylcyanat) | 405-790-4 | 101657-77-6 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 615-028-00-4 | ethyl-2-(isocyanatosulfonyl)benzoat | 410-220-2 | 77375-79-2 | Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Resp. Sens. 1
  Skin Sens. 1 | H302
  H373 **
  H318
  H334
  H317 | GHS05
  GHS08
  GHS07
  Dgr | H302
  H373 **
  H318
  H334
  H317 | EUH014 | | |
| 615-029-00-X | 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptan | 411-280-2 | — | Acute Tox. 2 *
  Acute Tox. 4 *
  Skin Corr. 1B
  Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H330
  H302
  H314
  H334
  H317
  H412 | GHS06
  GHS08
  GHS05
  Dgr | H330
  H302
  H314
  H334
  H317
  H412 | | | |
| 615-030-00-5 | alkalisalte og jordalkalisalte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Chronic 3 | H332
  H312
  H302
  H412 | GHS07
  Wng | H332
  H312
  H302
  H412 | | | A |
| 615-031-00-0 | thalliumthiocyanat | 222-571-7 | 3535-84-0 | Acute Tox. 2 *
  Acute Tox. 2 *
  Acute Tox. 4 *
  STOT RE 2
  Aquatic Chronic 2 | H330
  H300
  H312
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H330
  H300
  H312
  H373 **
  H411 | | | |
| 615-032-00-6 | metalsalt af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag | — | — | Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H332
  H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H332
  H312
  H302
  H410 | | | A |
| 615-033-00-1 | reaktionsprodukt af diphenylmethandiisocyanat, octylamin, oleylamin og cyclohexylamin (1:1.58:0.32:0.097) | 430-980-9 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 615-034-00-7 | reaktionsprodukt af diphenylmethandiisocyanat, octylamin,
  4-ethoxyanilin og ethylendiamin (1:0.37:1.53:0.05) | 430-750-8 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 615-035-00-2 | reaktionsprodukt af diphenylmethandiisocyanat, octylamin og oleylamin (molforholdet
  1:1.86:0.14) | 430-930-6 | 122886-55-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 615-036-00-8 | reaktionsprodukt af diphenylmethandiisocyanat, toluendiisocyanat (isomerblanding med:
  65 % 2,4- og 35 % 2,6-diisocyanat), octylamin, oleylamin og 4-ethoxyanilin (molforholdet 4:1:7:1:2) | 430-940-0 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 615-037-00-3 | reaktionsprodukt af diphenylmethandiisocyanat, toluendiisocyanat (isomerblanding med: 65 % 2,4- og 35 % 2,6-diisocyanat), octylamin og oleylamin (molforholdet 4:1:9:1) | 430-950-5 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 615-038-00-9 | reaktionsprodukt af toluendiisocyanat (isomerblanding med: 65 % 2,4- og 35 % 2,6-diisocyanat) og anilin
  (molforholdet 1:2) | 430-960-1 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 615-039-00-4 | reaktionsprodukt af diphenylmethandiisocyanat, toluendiisocyanat (isomerblanding med: 65 % 2,4- og 35 % 2,6-diisocyanat), octylamin, oleylamin og 4-ethoxyanilin (molforholdet 3.88:1:6.38:0.47:2.91) | 430-970-4 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 615-044-00-1 | 4-chlorphenylisocyanat | 203-176-9 | 104-12-1 | Acute Tox. 2 *
  Acute Tox. 4 *
  STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Resp. Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H330
  H302
  H335
  H315
  H318
  H334
  H400
  H410 | GHS06
  GHS05
  GHS08
  GHS09
  Dgr | H330
  H302
  H335
  H315
  H318
  H334
  H410 | | | |
| 615-045-00-7 | 4,4'-methylen-bis(3-chlor-2,6-di-ethylphenylisocyanat) | 420-530-1 | — | Resp. Sens. 1
  Skin Sens. 1
  Aquatic Chronic 4 | H334
  H317
  H413 | GHS08
  Dgr | H334
  H317
  H413 | | | |
| 616-001-00-X | N, N-dimethylformamid;
  dimethylformamid | 200-679-5 | 68-12-2 | Repr. 1B
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2 | H360D *** H332
  H312
  H319 | GHS08
  GHS07
  Dgr | H360D *** H332
  H312
  H319 | | | |
| 616-002-00-5 | 2-fluoracetamid | 211-363-1 | 640-19-7 | Acute Tox. 2 *
  Acute Tox. 3 * | H300
  H311 | GHS06
  Dgr | H300
  H311 | | | |
| 616-003-00-0 | acrylamid;
  prop-2-enamid | 201-173-7 | 79-06-1 | Carc. 1B
  Muta. 1B Repr. 2
  Acute Tox. 3 *
  STOT RE 1
  Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1 | H350
  H340
  H361f *** H301
  H372 **
  H332
  H312
  H319
  H315
  H317 | GHS06
  GHS08
  Dgr | H350
  H340
  H361f *** H301
  H372 **
  H332
  H312
  H319
  H315
  H317 | | | D |
| 616-004-00-6 | allidochlor (ISO);

  N, N-diallylchloracetamid | 202-270-7 | 93-71-0 | Acute Tox. 4 *
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H312
  H302
  H319
  H315
  H411 | GHS07
  GHS09
  Wng | H312
  H302
  H319
  H315
  H411 | | | |
| 616-005-00-1 | chlorthiamid (ISO);
  2,6-dichlor (thiobenzamid) | 217-637-7 | 1918-13-4 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 616-007-00-2 | diphenamid (ISO);

  N, N-dimethyl-2,2-diphenylacetamid | 213-482-4 | 957-51-7 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 616-008-00-8 | propachlor (ISO);
  2-chlor-N-isopropylacetanilid
  α-chlor-N-isopropylacetanilid | 217-638-2 | 1918-16-7 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H319
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H319
  H317
  H410 | | | |
| 616-009-00-3 | propanil (ISO);
  3',4'-dichlorpropionanilid | 211-914-6 | 709-98-8 | Acute Tox. 4 *
  Aquatic Acute 1 | H302
  H400 | GHS07
  GHS09
  Wng | H302
  H400 | | M = 10 | |
| 616-010-00-9 | tosylchloramidnatrium | 204-854-7 | 127-65-1 | Acute Tox. 4 *
  Skin Corr. 1B
  Resp. Sens. 1 | H302
  H314
  H334 | GHS08
  GHS05
  GHS07
  Dgr | H302
  H314
  H334 | EUH031 | | |
| 616-012-00-X | N-(dichlorfluormethylthio)phthalimid;

  N-(fluorodichloromethylthio)-phtalimid | 211-952-3 | 719-96-0 | Skin Irrit. 2 | H315 | GHS07
  Wng | H315 | | | |
| 616-013-00-5 | butyraldehydoxim | 203-792-8 | 110-69-0 | Acute Tox. 3 *
  Acute Tox. 4 *
  Eye Irrit. 2 | H311
  H302
  H319 | GHS06
  Dgr | H311
  H302
  H319 | | | |
| 616-014-00-0 | 2-butanonoxim;
  ethylmethylketoxim;
  ethylmethylketonoxim | 202-496-6 | 96-29-7 | Carc. 2
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1 | H351
  H312
  H318
  H317 | GHS08
  GHS05
  GHS07
  Dgr | H351
  H312
  H318
  H317 | | | |
| 616-015-00-6 | alachlor (ISO);
  2-chlor-2',6'-diethyl-N-(methoxymethyl)acetanilid | 240-110-8 | 15972-60-8 | Carc. 2
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H317
  H410 | | M = 10 | |
| 616-016-00-1 | 1-(3,4-dichlorphenylimino)
  thiosemicarbazid | — | 5836-73-7 | Acute Tox. 2 * | H300 | GHS06
  Dgr | H300 | | | |
| 616-017-00-7 | cartaphydrochlorid | 239-309-2 | 15263-52-2 | Acute Tox. 4 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H312
  H302
  H400
  H410 | GHS07
  GHS09
  Wng | H312
  H302
  H410 | | | |
| 616-018-00-2 | N, N-diethyl-m-toluamid;
  deet | 205-149-7 | 134-62-3 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 3 | H302
  H319
  H315
  H412 | GHS07
  Wng | H302
  H319
  H315
  H412 | | | |
| 616-019-00-8 | perfluidon (ISO);
  1,1,1-trifluor-N-(4-phenylsulfonyl-o-tolyl)methansulfonamid | 253-718-3 | 37924-13-3 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 616-020-00-3 | tebuthiuron (ISO);
  1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurinstof | 251-793-7 | 34014-18-1 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 616-021-00-9 | thiazfluron (ISO);
  1,3-dimethyl-1-(5-trifluormethyl-1,3,4-thiadiazol-2-yl)urinstof | 246-901-4 | 25366-23-8 | Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 616-022-00-4 | acetamid | 200-473-5 | 60-35-5 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 616-023-00-X | N-hexadecyl(eller octadecyl)-N-hexadecyl(eller octadecyl)benzamid | 401-980-6 | — | Skin Irrit. 2
  Skin Sens. 1 | H315
  H317 | GHS07
  Wng | H315
  H317 | | | |
| 616-024-00-5 | 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chlor-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilid | 402-260-4 | 54942-74-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-025-00-0 | valinamid | 402-840-7 | 20108-78-5 | Repr. 2
  Eye Irrit. 2
  Skin Sens. 1 | H361f *** H319
  H317 | GHS08
  Wng | H361f *** H319
  H317 | | | |
| 616-026-00-6 | thioacetamid | 200-541-4 | 62-55-5 | Carc. 1B
  Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 3 | H350
  H302
  H319
  H315
  H412 | GHS08
  GHS07
  Dgr | H350
  H302
  H319
  H315
  H412 | | | |
| 616-027-00-1 | tris(-(2-hydroxyethoxy)ethyl)ammonium-3-acetoacetamido-4-methoxybenzensulfonat | 403-760-5 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 616-028-00-7 | N-(4-(3-(4-cyanphenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamid | 403-790-9 | 108673-51-4 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-029-00-2 | N, N'-ethylenbis(vinylsulfonylacetamid) | 404-790-1 | 66710-66-5 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 616-030-00-8 | ethidimuron (ISO);
  1-(5-ethylsulfonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurinstof | 250-010-6 | 30043-49-3 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 616-031-00-3 | dimethachlor (ISO):
  2-chlor-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamid | 256-625-6 | 50563-36-5 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 616-032-00-9 | diflufenican (ISO);

  N-(2,4-difluorphenyl)-2-[3-(trifluormethyl)phenoxy]-3-pyridincarboxamid | — | 83164-33-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 616-033-00-4 | cyprofuram (ISO);

  N-(3-chlorphenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropancarboxamid | 274-050-9 | 69581-33-5 | Acute Tox. 3 *
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H312
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H312
  H410 | | | |
| 616-034-00-X | pyracarbolid (ISO);
  3,4-dihydro-6-methyl-2H-pyran5-carboxanilid | 246-419-4 | 24691-76-7 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 616-035-00-5 | cymoxanil (ISO);
  2-cyan-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamid | 261-043-0 | 57966-95-7 | Repr. 2
  Acute Tox. 4
  STOT RE 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361fd
  H302
  H373 (blod, brissel)
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H361fd
  H302
  H373 (blod, brissel)
  H317
  H410 | | M = 1
  M = 1 | |
| 616-036-00-0 | 2-chloracetamid | 201-174-2 | 79-07-2 | Repr. 2
  Acute Tox. 3 *
  Skin Sens. 1 | H361f *** H301
  H317 | GHS06
  GHS08
  Dgr | H361f *** H301
  H317 | | Skin Sens. 1; H317: C ≥ 0,1  % | |
| 616-038-00-1 | (4-aminophenyl)-N-methylmethylensulfonamidhydrochlorid | 406-010-5 | 88918-84-7 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H318
  H317
  H411 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H411 | | | |
| 616-039-00-7 | 3',5'-dichlor-4'-ethyl-2'-hydro
  xypalmitanilid | 406-200-8 | 117827-06-2 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 616-040-00-2 | kalium-N-(4-toluensulfonyl)-4-toluensulfonamid | 406-650-5 | 97888-41-0 | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 616-041-00-8 | 3',5'-dichlor-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxy-hexananilid | 406-840-8 | 101664-25-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-042-00-3 | N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazol[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamid | 407-070-5 | 142859-67-4 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-043-00-9 | isoxaben (ISO);

  N-(3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl)-2,6-dimethoxybenzamid | 407-190-8 | 82558-50-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-044-00-4 | N-(3,5-dichlor-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)butanamid | 402-510-2 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 616-045-00-X | 2'-(4-chlor-3-cyan-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilid | 405-190-2 | 122371-93-1 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-046-00-5 | N-(2-(6-chlor-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamid | 406-390-2 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-047-00-0 | en blanding af 2,2',2'',2'''-(ethylendinitrilotetrakis-N, N-di(C16)alkylacetamid og
  2,2',2'',2'''-(ethylendinitrilotetrakis-N, N-di(C18)alkylacetamid | 406-640-0 | — | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 616-048-00-6 | 3'-trifluormethylisobutyranilid | 406-740-4 | 1939-27-1 | STOT RE 2 *
  Aquatic Chronic 2 | H373 **
  H411 | GHS08
  GHS09
  Wng | H373 **
  H411 | | | |
| 616-049-00-1 | 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichlor-4-ethyl-2-hydroxyphenyl)hexanamid | 408-150-2 | 99141-89-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-050-00-7 | lufenuron (ISO);

  N-[2,5-dichlor-4-(1,1,2,3,3,3-hexafluorpropoxy)-phenyl-aminocarbonyl]-2,6-difluorbenzamid | 410-690-9 | 103055-07-8 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 616-051-00-2 | en blanding af 2,4 -bis(N'-(4-methylphenyl)ureido)toluen og
  2,6 -bis(N'-(4-methylphenyl)ureido)toluen | 411-070-0 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-052-00-8 | formamid | 200-842-0 | 75-12-7 | Repr. 1B | H360D *** | GHS08
  Dgr | H360D *** | | | |
| 616-053-00-3 | N-methylacetamid | 201-182-6 | 79-16-3 | Repr. 1B | H360D *** | GHS08
  Dgr | H360D *** | | | |
| 616-054-00-9 | iprodion (ISO);
  3-(3,5-dichlorphenyl)-2,4-dioxo-N-isopropylimidazolidin-1-carboxamid | 253-178-9 | 36734-19-7 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 616-055-00-4 | propyzamid (ISO);
  3,5-dichlor-N-(1,1-dimethylprop-2-ynyl)benzamid | 245-951-4 | 23950-58-5 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | | |
| 616-056-00-X | N-methylformamid | 204-624-6 | 123-39-7 | Repr. 1B
  Acute Tox. 4 * | H360D *** H312 | GHS08
  GHS07
  Dgr | H360D *** H312 | | | |
| 616-057-00-5 | en blanding af N-[3-hydroxy-2-(2-methyl-acryloylamino-methoxy)-propoxymethyl]-2-methyl-acrylamid;

  N-[2,3-bis-(2-methyl-acryloylamino-methoxy)propoxymethyl]-2-methylacrylamid; methacrylamid;
  2-methyl-N-(2-methyl-acryloylamino-methoxy-methyl)-acrylamid og

  N-(2,3-dihydroxy-propoxymethyl)-2-methyl-acrylamid | 412-790-8 | — | Carc. 1B
  Muta. 2
  STOT RE 2 * | H350
  H341
  H373 ** | GHS08
  Dgr | H350
  H341
  H373 ** | | | |
| 616-058-00-0 | 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzen | 412-570-1 | 119462-56-5 | STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H318
  H317
  H400
  H410 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H373 **
  H318
  H317
  H410 | | | |
| 616-059-00-6 | 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalencarboxamid | 412-650-6 | 121487-83-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-060-00-1 | kondensationsprodukt af 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexen-1,2-dicarboxylsyre med polyaminer (fortrinsvis amino-ethyl-piperazin og triethylentetramin) | 413-770-1 | — | Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H314
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H314
  H317
  H410 | | | |
| 616-061-00-7 | N, N'-1,6-hexandiylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamid | 413-610-0 | 124172-53-8 | Eye Irrit. 2
  Aquatic Chronic 3 | H319
  H412 | GHS07
  Wng | H319
  H412 | | | |
| 616-062-00-2 | N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenyl-acetamid | 411-590-8 | 70693-57-1 | Skin Corr. 1B
  Aquatic Chronic 3 | H314
  H412 | GHS05
  Dgr | H314
  H412 | | | |
| 616-063-00-8 | 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)yl) pyrrolidin-2,5-dion | 411-920-0 | 106917-30-0 | Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1A
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H302
  H373 **
  H314
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H331
  H302
  H373 **
  H314
  H410 | | | |
| 616-064-00-3 | N-tert-butyl-3-methylpicolinamid | 406-720-5 | 32998-95-1 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 616-065-00-9 | 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurinstof | 411-970-3 | 79881-89-3 | Acute Tox. 4 *
  STOT RE 2 * | H302
  H373 ** | GHS08
  GHS07
  Wng | H302
  H373 ** | | | |
| 616-066-00-4 | 5,6,12,13-tetrachloranthra(2,1,9-def:6,5,10-d'e'f)diisoquinolin-1,3,8,10(2H,9H)-tetron | 405-100-1 | 115662-06-1 | Repr. 2 | H361f *** | GHS08
  Wng | H361f *** | | | |
| 616-067-00-X | dodecyl-3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorbenzoat | 407-300-4 | 92683-20-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-068-00-5 | kalium-4-(11-methacrylamidoundecanamido)benzensulfonat | 406-500-9 | 174393-75-0 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 616-069-00-0 | 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamidchlorbenzoat | 406-210-2 | 110560-22-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-070-00-6 | en blanding af 3,3'-dicyclohexyl-1,1'-methylenbis(4,1-phenylen)diurinstof
  3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urinstof
  3,3'-dioctadecyl-1,1'-methylenbis(4,1-phenylen)diurinstof | 406-530-2 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-071-00-1 | blanding (1:2:1) af bis(N-cyclohexyl-N'-phenylenureido)methylen;
  bis(N-octadecyl-N'-phenylenureido)methylen
  bis(N-dicyclohexyl-N'-phenylenureido)methylen | 406-550-1 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-072-00-7 | 1-(2-deoxy-5-O-trityl-β-.sc.D.sc.-threopentofuranosyl)thymin | 407-120-6 | 55612-11-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-073-00-2 | 4'-ethoxy-2-benzimidazol-anilid | 407-600-5 | 120187-29-3 | Muta. 2
  Aquatic Chronic 4 | H341
  H413 | GHS08
  Wng | H341
  H413 | | | |
| 616-074-00-8 | N-butyl-2-(4-morpholinylcarbonyl)benzamid | 407-730-2 | 104958-67-0 | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H319
  H317
  H412 | GHS07
  Wng | H319
  H317
  H412 | | | |
| 616-075-00-3 | .sc.D.sc.,.sc.L.sc.-(N, N-diethyl-2-hydroxy-2-phenylacetamid) | 408-120-9 | 65197-96-8 | Acute Tox. 4 *
  Eye Dam. 1 | H302
  H318 | GHS05
  GHS07
  Dgr | H302
  H318 | | | |
| 616-076-00-9 | tebufenozid (ISO);

  N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazid | 412-850-3 | 112410-23-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 616-077-00-4 | en blanding af 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-yl-ethansulfonsyre;
  kalium-2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def:
  6,5,10-d'e'f']diisoquinolin-2-yl-ethansulfat | 411-310-4 | — | Eye Dam. 1 | H318 | GHS05
  Dgr | H318 | | | |
| 616-078-00-X | 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)-hexanamid | 411-330-3 | 104541-33-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-079-00-5 | 1,6-hexandiyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamat | 411-700-4 | 140921-24-0 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 616-080-00-0 | 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzensulfonamid) | 411-850-0 | 119018-29-0 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 616-081-00-6 | 5-brom-8-naphtholactam | 413-480-5 | 24856-00-6 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | | |
| 616-082-00-1 | N-(5-chlor-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)-benzamid | 413-200-1 | 129604-78-0 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 616-083-00-7 | [2-[(4-nitrophenyl)amino]ethyl]urinstof | 410-700-1 | 27080-42-8 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 616-084-00-2 | 2,4-bis[N'-(4-methylphenyl)ureido]-toluen | 411-790-5 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-085-00-8 | 3-(2,4-dichlorphenyl)-6-fluorquinazolin-2,4(1H,3H)-dion | 412-190-6 | 168900-02-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-086-00-3 | 2-acetylamino-6-chlor-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadien | 412-250-1 | 102387-48-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-087-00-9 | en blanding af 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoat og
  7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoat | 412-260-6 | 52658-19-2 | Eye Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H319
  H317
  H411 | GHS07
  GHS09
  Wng | H319
  H317
  H411 | | | |
| 616-088-00-4 | 2-aminosulfonyl-N, N-dimethylnicotinamid | 413-440-7 | 112006-75-4 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 616-089-00-X | 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin)-3- fluor-2-hydroxymethyltetrahydrofuran | 415-360-8 | 41107-56-6 | Muta. 2 | H341 | GHS08
  Wng | H341 | | | |
| 616-090-00-5 | 1-(1,4-benzodioxan-2-ylcarbonyl)piperazinhydrochlorid | 415-660-9 | 70918-74-0 | Acute Tox. 3 *
  Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Aquatic Chronic 2 | H331
  H311
  H301
  H373 **
  H411 | GHS06
  GHS08
  GHS09
  Dgr | H331
  H311
  H301
  H373 **
  H411 | | | |
| 616-091-00-0 | 1,3,5-tris-[(2S og 2R)-2,3-epoxypropyl]-1,3,5-triazin-2,4,6-(1H,3H,5H)-trion | 423-400-0 | 59653-74-6 | Muta. 1B
  Acute Tox. 3 *
  Acute Tox. 4 *
  STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1 | H340
  H331
  H302
  H373 **
  H318
  H317 | GHS06
  GHS08
  GHS05
  Dgr | H340
  H331
  H302
  H373 **
  H318
  H317 | | | |
| 616-092-00-6 | polymerreaktionsprodukt af bicyclo[2.2.1]hepta-2,5-dien, ethen, 1,4-hexadien, 1-propen med N, N-di-2-propenylformamid | 404-035-6 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-093-00-1 | reaktionsprodukter af anilin-terephthalaldehyd-o-toluidinkondensat med maleinsyreanhydrid | 406-620-1 | 129217-90-9 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-095-00-2 | 3,3'-dioctadecyl-1,1'-methylen
  -bis(4,1-phenylen)diurinstof | 406-690-3 | 43136-14-7 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-096-00-8 | N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamid | 408-110-4 | 110483-07-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-097-00-3 | N, N'-1,4-phenylenbis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamid | 411-840-6 | 83372-55-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-098-00-9 | 1-[4-chlor-3-((2,2,3,3,3-pentafluorpropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazol-3-carboxamid | 411-750-7 | 119126-15-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 616-099-00-4 | 2-[4-[(4-idrossifenil)solfonil]fenossi]-4,4-dimetil-N-[5-[(metilsolfonil)ammino]-2-[4-(1,1,3,3-tetrametilbutil)fenossi]fenil]-3-ossopentanammide | 414-170-2 | 135937-20-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-100-00-8 | 1,3-dimetil-1,3-bis(trimetilsilil)urea | 414-180-7 | 10218-17-4 | Acute Tox. 4 *
  Skin Irrit. 2 | H302
  H315 | GHS07
  Wng | H302
  H315 | | | |
| 616-101-00-3 | (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isochinolincarboxamid | 414-600-9 | 149182-72-9 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 616-102-00-9 | blanding af α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylen-co-oxypropylen);
  1,2-(eller 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylen-co-oxypropylen)]-3-(eller 2-)propanol og
  1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylen-co-oxypropylen)]propan] | 415-870-0 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-103-00-4 | (S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamid | 415-030-3 | 120298-38-6 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | | |
| 616-104-00-X | benalaxyl (ISO);
  methyl-N-(2,6-dimethylphenyl)-N-(phenylacetyl)-.sc.DL.sc.-alaninat | 275-728-7 | 71626-11-4 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-105-00-5 | chlortoluron (ISO);
  3-(3-chlor-p-tolyl)-1,1-dimethylurinstof | 239-592-2 | 15545-48-9 | Carc. 2
  Repr. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H361D *** H400
  H410 | GHS08
  GHS09
  Wng | H351
  H361D *** H410 | | | |
| 616-106-00-0 | phenmedipham (ISO);
  methyl-3-(3-methylcarbaniloyloxy)carbanilat | 237-199-0 | 13684-63-4 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-107-00-6 | cinidon ethyl (ISO);
  ethyl-(Z)-2-chlor-3-[2-chlor-5-(cyclohex-1-en-1,2-dicarboximido)phenyl]acrylat | — | 142891-20-1 | Carc. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H317
  H410 | | | |
| 616-108-00-1 | iodsulfuron-methyl-natrium; natrium ({[5-iod-2-(methoxycarbonyl)phenyl]sulfonyl}}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanid | — | 144550-36-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-109-00-7 | sulfosulfuron (ISO);
  1-(4,6-dimethoxypyrimidin-2- yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea | — | 141776-32-1 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-110-00-2 | cyclanilid (ISO);
  1-(2,4-dichloranilinocarbonyl)cyclopropancarboxylsyre | 419-150-7 | 113136-77-9 | Acute Tox. 4 *
  Aquatic Chronic 2 | H302
  H411 | GHS07
  GHS09
  Wng | H302
  H411 | | | |
| 616-111-00-8 | fenhexamid (ISO);

  N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid | 422-530-5 | 126833-17-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 616-112-00-3 | oxasulfuron (ISO);
  oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl]-carbamoylsulfamoyl]benzoat | — | 144651-06-9 | STOT RE 2 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H373 **
  H400
  H410 | GHS08
  GHS09
  Wng | H373 **
  H410 | | | |
| 616-113-00-9 | desmedipham (ISO);
  ethyl 3-phenylcarbamoyloxyphenylcarbamat | 237-198-5 | 13684-56-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 10 | |
| 616-114-00-4 | dodecanamid, N, N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracen)-4,4'-diyl)bis- | 418-010-2 | 136897-58-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-115-00-X | N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamid | 416-150-9 | 136450-06-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-116-00-5 | N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidat | 416-790-9 | 143052-96-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-117-00-0 | N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamid | 416-860-9 | 777891-21-1 | Repr. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H361f *** H317
  H400
  H410 | GHS08
  GHS09
  Wng | H361f *** H317
  H410 | | | |
| 616-118-00-6 | N-(2',6'-dimethylphenyl)-2-piperidincarboxamid hydrochlorid | 417-950-0 | 65797-42-4 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 616-119-00-1 | 2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamid | 418-060-5 | 118020-93-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-120-00-7 | en blanding af N-(3-dimethylamino-4-methyl-phenyl)-benzamid;

  N-(3-dimethylamino-2-methyl-phenyl)-benzamid og

  N-(3-dimethylamino-3-methyl-phenyl)-benzamid | 420-600-1 | — | STOT RE 2 *
  Aquatic Chronic 2 | H373 **
  H411 | GHS08
  GHS09
  Wng | H373 **
  H411 | | | |
| 616-121-00-2 | 2,4-dihydroxy-N-(2-methoxyphenyl)benzamid | 419-090-1 | 129205-19-2 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-122-00-8 | methylneodecanamid | 414-460-9 | 105726-67-8 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 616-123-00-3 | N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamid | 414-740-0 | 96141-86-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-124-00-9 | lithium-bis(trifluormethylsulfonyl)imid | 415-300-0 | 90076-65-6 | Acute Tox. 3 *
  Acute Tox. 3 *
  STOT RE 2 *
  Skin Corr. 1B
  Aquatic Chronic 3 | H311
  H301
  H373 **
  H314
  H412 | GHS06
  GHS05
  GHS08
  Dgr | H311
  H301
  H373 **
  H314
  H412 | | | |
| 616-125-00-4 | 3-cyano-N-(1,1-dimethylethyl)androsta-3,5-dien-17-β-carboxamid | 415-730-9 | 151338-11-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | 410 | | | |
| 616-126-00-X | 1-methyl-4-nitro-3-propyl-1H-pyrazol-5-carboxamid | 423-960-6 | 139756-01-7 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 3 | H302
  H373 **
  H412 | GHS08
  GHS07
  Wng | H302
  H373 **
  H412 | | | |
| 616-127-00-5 | en blanding af N, N'-ethan-1,2-diylbis(decanamid);
  12-hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamid og

  N, N'-ethan-1,2-diylbis(12-hydroxyoctadecanamid) | 430-050-2 | — | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-128-00-0 | N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)acetamid | 417-530-7 | 123590-00-1 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-129-00-6 | N, N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamid | 419-710-0 | 42774-15-2 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 616-130-00-1 | N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamid | 421-780-2 | 150919-56-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-131-00-7 | 1-aminocyclopentancarboxamid | 422-950-9 | 17193-28-1 | STOT RE 1
  Acute Tox. 4 *
  Eye Dam. 1 | H372 **
  H302
  H318 | GHS05
  GHS08
  GHS07
  Dgr | H372 **
  H302
  H318 | | | |
| 616-132-00-2 | N-[4-(4-cyano-2-furfuryliden-2,5-dihydro-5-oxo-3-furyl)phenyl]butan-1-sulfonamid | 423-250-6 | 130016-98-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-133-00-8 | N-cyclohexyl-S,S-dioxo
  -benzo[b]tiophen-2-carboxamid | 423-990-1 | 149118-66-1 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H410 | | | |
| 616-134-00-3 | 3,3'-bis(dioctyloxythiophosphinoylthio)-N, N'-oxybis(methylen)dipropionamid | 401-820-5 | 793710-14-2 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 616-135-00-9 | (3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinolin-3-carboxamid | 430-230-0 | 136522-17-3 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 616-136-00-4 | reaktionsprodukt af kokosalkyldiethanolamider og kokosalkylmonoglycerider og molybdentrioxid (1,75-2,2: 0,75-1,0:0,1-1,1) | 430-380-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 616-137-00-X | 4-dichloracetyl-1-oxa-4-azaspiro[4.5]decan | 401-130-4 | 71526-07-3 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-138-00-5 | benzoesyre, N-tert-butyl-N'-(4-chlorbenzoyl)hydrazid | 431-600-4 | 112226-61-6 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-139-00-0 | (3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolincarboxamid | 420-380-5 | 136465-81-1 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Chronic 3 | H302
  H318
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H412 | | | |
| 616-140-00-6 | N, N''-(methylendi-4,1-phenylen)bis[N'-(4-methylphenyl)urinstof] | 429-380-1 | 133336-92-2 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-141-00-1 | zoxamid (ISO)
  (RS)-3,5-dichlor-N-(3-chlor-1-ethyl-1-methyl-2-oxopropyl)-p-toluamid | — | 156052-68-5 | Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H400
  H410 | GHS07
  GHS09
  Wng | H317
  H410 | | M = 10 | |
| 616-142-00-7 | 1,3-bis(vinylsulfonylacetamido)propan | 428-350-3 | 93629-90-4 | Muta. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H341
  H318
  H317
  H412 | GHS08
  GHS05
  GHS07
  Dgr | H341
  H318
  H317
  H412 | | | |
| 616-143-00-2 | N, N'-dihexadecyl-N, N'-bis(2-hydroxyethyl)propandiamid | 422-560-9 | 149591-38-8 | Repr. 2
  Eye Irrit. 2
  Aquatic Chronic 4 | H361f *** H319
  H413 | GHS08
  Wng | H361f *** H319
  H413 | | | |
| 616-144-00-8 | 3,4-dichlor-N-[5-chlor-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamid | 431-130-1 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-145-00-3 | pethoxamid (ISO);
  2-chlor-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamid | — | 106700-29-2 | Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H317
  H410 | | M = 100 | |
| 616-146-00-9 | N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentansyreamid | 431-330-7 | 142776-95-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-147-00-4 | 1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazol-5-sulfonamid | 424-160-1 | 139481-22-4 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 616-148-00-X | N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamid | 424-550-1 | 84245-12-5 | Carc. 1B
  Muta. 1B
  Repr. 1B | H350
  H340
  H360FD | GHS08
  Dgr | H350
  H340
  H360FD | | | |
| 616-150-00-0 | (2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzensulfonamid hydrochlorid | 425-260-6 | — | STOT RE 2 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H373 **
  H318
  H317
  H411 | GHS05
  GHS08
  GHS07
  GHS09
  Dgr | H373 **
  H318
  H317
  H411 | | | |
| 616-151-00-6 | N-(2-amino-4,6-dichlorpyrimidin-5-yl)formamid | 425-650-6 | 171887-03-9 | Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 3 | H302
  H318
  H317
  H412 | GHS05
  GHS07
  Dgr | H302
  H318
  H317
  H412 | | | |
| 616-152-00-1 | 4-(4-fluorphenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamid | 425-850-3 | 125971-96-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-153-00-7 | 4-methyl-3-oxo-N-phenyl-2-(phenylmethylen)pentanamid | 425-860-8 | 125971-57-5 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-154-00-2 | 3,4-dichlor-N-[5-chlor-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamid | 431-110-0 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-155-00-8 | N, N,N',N'-tetracyclohexyl-1,3-benzendicarboxamid | 431-040-0 | 104560-40-9 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-156-00-3 | 6-(2-chlor-6-cyan-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilid | 430-500-8 | 204277-61-2 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-157-00-9 | 3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzensulfonamid hydrochlorid | 427-780-9 | 114565-70-7 | Acute Tox. 4 *
  Eye Dam. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H318
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H302
  H318
  H410 | | | |
| 616-158-00-4 | N-[4-cyan-3-trifluormethylphenyl]methacrylamid | 427-880-2 | 90357-53-2 | STOT RE 2 *
  Aquatic Chronic 2 | H373 **
  H411 | GHS08
  GHS09
  Wng | H373 **
  H411 | | | |
| 616-160-00-5 | 2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamid] | 429-090-3 | 61551-69-7 | Skin Sens. 1
  Aquatic Chronic 3 | H317
  H412 | GHS07
  Wng | H317
  H412 | | | |
| 616-161-00-0 | 2,4-dichlor-5-hydroxyacetanilid | 429-110-0 | 67669-19-6 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 616-162-00-6 | isostearinsyre monoisopropanolamid | 431-540-9 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 616-163-00-1 | 4,4'-methylenbis[N-(4-chlorphenyl)-3-hydroxynaphthalen-2-carboxamid] | 430-350-3 | 192463-88-0 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-164-00-7 | dimoxystrobin (ISO);
  (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid | — | 149961-52-4 | Carc. 2
  Repr. 2
  Acute Tox. 4 *
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H361D ***
  H332
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H361D ***
  H332
  H410 | | M = 10 | |
| 616-165-00-2 | beflubutamid (ISO);
  (RS)-N-benzyl-2-(α, α,α,4-tetrafluor-m-tolyoxy)butyramid | — | 113614-08-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 100 | |
| 616-166-00-8 | cyazofamid (ISO);
  4-chlor-2-cyan-N, N-dimethyl-5-p-tolylimidazol-1-sulfonamid | — | 120116-88-3 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 10 | |
| 616-167-00-3 | N, N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamid | 418-290-6 | 168612-06-4 | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 616-168-00-9 | 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium | 418-440-0 | 136997-71-2 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 616-169-00-4 | 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chlor-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorphenyl)-2-pyrazolin-5-on | 420-220-4 | 92771-56-7 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-170-00-X | (2R)-2-amino-2-phenylacetamid | 420-370-0 | 6485-67-2 | Eye Irrit. 2
  Skin Sens. 1 | H319
  H317 | GHS07
  Wng | H319
  H317 | | | |
| 616-171-00-5 | 2-(p-chlorphenyl)glycinamid | 420-830-0 | 102333-75-5 | Eye Dam. 1
  Skin Sens. 1 | H318
  H317 | GHS05
  GHS07
  Dgr | H318
  H317 | | | |
| 616-172-00-0 | N-(2,2,6,6,-tetramethyl-1-oxylpiperidin-4-yl)acetamid;
  (4-acetamido-2,2,6,6-tetra
  -methyl-1-piperidinyl)oxidanyl | 423-840-3 | 14691-89-5 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 616-174-00-1 | 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-onhydrochlorid | 424-560-4 | 151257-01-1 | Acute Tox. 4 *
  Eye Irrit. 2 | H302
  H319 | GHS07
  Wng | H302
  H319 | | | |
| 616-175-00-7 | 2-(2-hexyldecyloxy)benzamid | 431-230-3 | 202483-62-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-176-00-2 | 3-N, N-bis(methoxyethyl)aminoacetanilid | 432-530-7 | 24294-01-7 | Acute Tox. 4 *
  Aquatic Chronic 3 | H302
  H412 | GHS07
  Wng | H302
  H412 | | | |
| 616-177-00-8 | (3-(4-(2-(butyl-(4-methylphenylsulfonyl)-amino)-phenylthio)-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-ylamino)-4-chlorphenyl)tetradecanamid;

  N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorphenyl]tetradecanamid | 432-970-1 | 217324-98-6 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-178-00-3 | N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyan-4,6-dinitrophenyl)azo)phenyl)acetamid | 434-500-9 | 52583-35-4 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-179-00-9 | 2-chlor-N-(4-methylphenyl)acetamid | 435-170-9 | 16634-82-5 | Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H318
  H317
  H410 | | | |
| 616-180-00-4 | N, N-(dimethylamino)thioacetamidhydrochlorid | 435-470-1 | 27366-72-9 | Repr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H360D *** H400
  H410 | GHS08
  GHS09
  Dgr | H360D *** H410 | | | |
| 616-181-00-X | 4'-methyldodecan-1-sulfonanilid | 435-490-9 | 17417-32-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-182-00-5 | N'-(1,3-dimethylbutyliden)-3-hydroxy-2-naphthohydrazid | 435-860-1 | 214417-91-1 | Skin Sens. 1
  Aquatic Chronic 2 | H317
  H411 | GHS07
  GHS09
  Wng | H317
  H411 | | | |
| 616-183-00-0 | N-dodecyl-4-methoxybenzamid | 442-340-6 | 1854-15-5 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-184-00-6 | 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamid | 442-560-2 | 105043-55-8 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-186-00-7 | N, N'-(2-chlor-1,4-phenylen)bis(3-oxobutanamid) | 443-010-4 | 53641-10-4 | Aquatic Chronic 3 | H412 | — | H412 | | | |
| 616-188-00-8 | 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentansyreamid | 443-980-9 | 221215-20-9 | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-189-00-3 | N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-brom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamid | 444-780-4 | 452962-97-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-190-00-9 | N-decyl-4-nitrobenzamid | 445-880-0 | 64026-19-3 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-191-00-4 | 2-ethyl-N-methyl-N-(3-methylphenyl)butanamid | 446-190-2 | 406488-30-0 | Acute Tox. 4 *
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H302
  H319
  H315
  H317
  H411 | GHS07
  GHS09
  Wng | H302
  H319
  H315
  H317
  H411 | | | |
| 616-192-00-X | 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilid | 448-060-0 | 727678-39-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-193-00-5 | N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamid | 449-940-7 | 368450-39-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-194-00-0 | 2,2-diethoxy-N, N-dimethylacetamid | 449-950-1 | 34640-92-1 | Eye Irrit. 2 | H319 | GHS07
  Wng | H319 | | | |
| 616-196-00-1 | dinatriumsalt af 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamid | 419-990-4 | — | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 616-197-00-7 | blanding af kalium-N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamidat og

  N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctan
  sulfonamid | 422-500-1 | — | STOT RE 2 * | H373 ** | GHS08
  Wng | H373 ** | | | |
| 616-198-00-2 | 1,3-bis[12-hydroxy-octadecamid-N-methylen]benzen | 423-300-7 | — | Skin Sens. 1
  Aquatic Chronic 4 | H317
  H413 | GHS07
  Wng | H317
  H413 | | | |
| 616-200-00-1 | blanding af N, N'-ethan-1,2-diylbis(hexanamid) og
  12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamid og N, N'-ethan-1,2-diylbis(12-hydroxyoctadecanamid) | 432-430-3 | | Aquatic Chronic 4 | H413 | | H413 | | | |
| 616-201-00-7 | 12-hydroxyoctadecansyre, reaktionsprodukter med 1,3-benzendimethanamin og hexamethylendiamin | 432-840-2 | 220926-97-6 | Acute Tox. 4 *
  Aquatic Chronic 4 | H332
  H413 | GHS07
  Wng | H332
  H413 | | | |
| 616-202-00-2 | en blanding af 2,2'-[(3,3'-dichlor[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamid;
  2-[[3,3'-dichlor-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamid og
  2-[[3,3'-dichlor-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamid | 434-330-5 | — | Carc. 2
  Skin Sens. 1
  Aquatic Chronic 4 | H351
  H317
  H413 | GHS08
  GHS07
  Wng | H351
  H317
  H413 | | | |
| 616-203-00-8 | en blanding af N-[5-[bis-(2-methoxy-ethyl)-amino]-2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)-phenyl]-acetamid og

  N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]-acetamid | 442-280-0 | — | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-204-00-3 | N, N''-(methylendi-4,1-phenylen)bis[N'-octylurinstof] | 451-060-3 | 122886-55-9 | Aquatic Chronic 4 | H413 | — | H413 | | | |
| 616-205-00-9 | metazachlor (ISO);
  2-chlor-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamid | 266-583-0 | 67129-08-2 | Skin Sens. 1B
  Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H317
  H351
  H400
  H410 | GHS07
  GHS08
  GHS09
  Wng | H317
  H351
  H410 | | M = 100
  M = 100 | |
| 616-206-00-4 | flufenoxuron (ISO);
  1-(4-(2-chlor-α, α,α-p-trifluortolyloxy)-2-fluorphenyl)-3- (2,6-difluorbenzolyl)urinstof | 417-680-3 | 101463-69-8 | Lact.
  Aquatic Acute 1
  Aquatic Chronic 1 | H362
  H400
  H410 | GHS09
  Wng | H362
  H410 | | M = 10 000
  M = 10 000 | |
| 616-208-00-5 | N-ethyl-2-pyrrolidon;

  N-ethyl-2-pyrrolidon; | 220-250-6 | 2687-91-4 | Repr. 1B | H360D | GHS08
  Dgr | H360D | | | |
| 616-209-00-0 | amidosulfuron (ISO);
  3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urinstof | 407-380-0 | 120923-37-7 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | M = 100
  M = 100 | |
| 616-210-00-6 | tebufenpyrad (ISO);

  N-(4-tertbutylbenzyl)-4-chlor-3-ethyl-1-methyl-1H-pyrazol-5-carboxamid | | 119168-77-3 | Acute Tox. 3
  Acute Tox. 4
  STOT RE 2
  Skin Sens. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H332
  H373 (mavetarmkanal) (oral)
  H317
  H400
  H410 | GHS06
  GHS08
  GHS09
  Dgr | H301
  H332
  H373 (mavetarmkanal) (oral)
  H317
  H410 | | M = 10
  M = 10 | |
| 616-211-00-1 | proquinazid (ISO);
  6-iod-2-propoxy-3-propylquinazolin-4(3H)-on | | 189278-12-4 | Carc. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H400
  H410 | GHS08
  GHS09
  Wng | H351
  H410 | | M = 1
  M = 10 | |
| 616-212-00-7 | 3-iod-2-propynyl-butylcarbamat;
  3-iodprop-2-yn-1-yl-butylcarbamat | 259-627-5 | 55406-53-6 | Acute Tox. 3
  Acute Tox. 4
  STOT RE 1
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H331
  H302
  H372 (strubehoved) H318
  H317
  H400
  H410 | GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H331
  H302
  H372 (strubehoved) H318
  H317
  H410 | | M = 10
  M = 1 | |
| 617-001-00-2 | di-tert-butylperoxid | 203-733-6 | 110-05-4 | Org. Perox. E
  Flam. Liq. 2
  Muta. 2 | H242
  H225
  H341 | GHS02
  GHS08
  Dgr | H242
  H225
  H341 | | | |
| 617-002-00-8 | α, α-dimethylbenzylhydroperoxid
  cumenhydroperoxid | 201-254-7 | 80-15-9 | Org. Perox. E
  Acute Tox. 3 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  STOT RE 2 *
  Skin Corr. 1B
  Aquatic Chronic 2 | H242
  H331
  H312
  H302
  H373 **
  H314
  H411 | GHS02
  GHS06
  GHS08
  GHS05
  GHS09
  Dgr | H242
  H331
  H312
  H302
  H373 **
  H314
  H411 | | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C
  < 10 %
  Eye Dam. 1; H318: 3 % ≤ C
  < 10 %
  Eye Irrit. 2; H319: 1 % ≤ C
  < 3 %
  STOT SE 3; H335: C < 10 % | |
| 617-003-00-3 | dilauroylperoxid | 203-326-3 | 105-74-8 | Org. Perox. D | H242 | GHS02
  Dgr | H242 | | | |
| 617-004-00-9 | 1,2,3,4-tetrahydro-1-naphthylhydroperoxid | 212-230-0 | 771-29-9 | Org. Perox. D
  Acute Tox. 4 *
  Skin Corr. 1B
  Aquatic Acute 1
  Aquatic Chronic 1 | H242
  H302
  H314
  H400
  H410 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H242
  H302
  H314
  H410 | | STOT SE 3; H335: C ≥ 5 % | |
| 617-006-00-X | bis (α, α-dimethylbenzyl)
  peroxid | 201-279-3 | 80-43-3 | Org. Perox. F
  Eye Irrit. 2
  Skin Irrit. 2
  Aquatic Chronic 2 | H242
  H319
  H315
  H411 | GHS02
  GHS07
  GHS09
  Wng | H242
  H319
  H315
  H411 | | | |
| 617-007-00-5 | tert-butyl-α, α-dimethylbenzylperoxid | 222-389-8 | 3457-61-2 | Org. Perox. E
  Skin Irrit. 2
  Aquatic Chronic 2 | H242
  H315
  H411 | GHS02
  GHS07
  GHS09
  Wng | H242
  H315
  H411 | | | |
| 617-008-00-0 | dibenzoylperoxid;
  benzoylperoxid | 202-327-6 | 94-36-0 | Org. Perox. B
  Eye Irrit. 2
  Skin Sens. 1 | H241
  H319
  H317 | GHS01
  GHS02
  GHS07
  Dgr | H241
  H319
  H317 | | | |
| 617-010-00-1 | 1-hydroperoxycyclohexyl-1-hydroxycyclohexylperoxid; [1]
  1,1'-dioxybiscyclohexan-1-ol; [2]
  cyclohexylidenhydroperoxid; [3]
  cyclohexanonperoxid [4] | 201-091-1 [1]
  219-306-2 [2]
  220-279-4 [3]
  235-527-7 [4] | 78-18-2 [1]
  2407-94-5 [2]
  2699-11-8 [3]
  12262-58-7 [4] | Org. Perox. A
  Skin Corr. 1B
  Acute Tox. 4 * | H240
  H314
  H302 | GHS01
  GHS05
  GHS07
  Dgr | H240
  H314
  H302 | | STOT SE 3; H335: C ≥ 5 % | C |
| 617-010-01-9 | 1-hydroperoxycyclohexyl-1-hydroxycyclohexylperoxid; [1]
  1,1'-dioxybiscyclohexan-1-ol; [2]
  cyclohexylidenhydroperoxid;
  [3] cyclohexanon, peroxid [4] [≤ 91 % opløsning] | 201-091-1 [1]
  219-306-2 [2]
  220-279-4 [3]
  235-527-7 [4] | 78-18-2 [1]
  2407-94-5 [2]
  2699-11-8 [3]
  12262-58-7 [4] | Org. Perox. C
  Acute Tox. 4 *
  Skin Corr. 1B | H242
  H302
  H314 | GHS02
  GHS05
  GHS07
  Dgr | H242
  H302
  H314 | | STOT SE 3; H335: C ≥ 5 % | C T |
| 617-012-00-2 | 8-p-menthanylhydroperoxid;

  p-menthanhydroperoxid | 201-281-4 | 80-47-7 | Org. Perox. D
  Skin Corr. 1B
  Acute Tox. 4 * | H242
  H314
  H332 | GHS02
  GHS05
  GHS07
  Dgr | H242
  H314
  H332 | | STOT SE 3; H335: C ≥ 5 % | |
| 617-013-00-8 | O, O-tert-butyl-O-docosylmonoperoxyoxalat | 404-300-6 | 116753-76-5 | Org. Perox. C **** Aquatic Acute 1
  Aquatic Chronic 1 | H242
  H400
  H410 | GHS02
  GHS09
  Dgr | H242
  H410 | | | |
| 617-014-00-3 | 6-(nonylamino)-6-oxo-peroxyhexansyre | 406-680-9 | 104788-63-8 | Org. Perox. C **** Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1 | H242
  H318
  H317
  H400 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H242
  H318
  H317
  H400 | | | |
| 617-015-00-9 | bis(4-methylbenzoyl)peroxid | 407-950-9 | 895-85-2 | Org. Perox. B**** Aquatic Acute 1
  Aquatic Chronic 1 | H241
  H400
  H410 | GHS01
  GHS02
  GHS09
  Dgr | H241
  H410 | | | |
| 617-016-00-4 | 3-hydroxy-1,1-dimethylbutyl-2-ethyl-2-methylheptanperoxoat | 413-910-1 | — | Org. Perox. C **** Flam. Liq. 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H242
  H226
  H315
  H400
  H410 | GHS02
  GHS07
  GHS09
  Dgr | H242
  H226
  H315
  H410 | | | |
| 617-017-00-X | en blanding af 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzen og
  2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzen | 412-140-3 | 32144-25-5 | Org. Perox. D
  Aquatic Chronic 4 | H242
  H413 | GHS02
  Dgr | H242
  H413 | | | T |
| 617-018-00-5 | en blanding af 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxid,
  63 vægtprocent og
  1-methyl-1-(4-(1-methyl-
  ethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxid, 31 vægtprocent | 410-840-3 | 71566-50-2 | Org. Perox. C ****
  Aquatic Chronic 2 | H242
  H411 | GHS02
  GHS09
  Dgr | H242
  H411 | | | T |
| 617-019-00-0 | 6-(phthalimido)peroxyhexansyre | 410-850-8 | 128275-31-0 | Org. Perox. D
  Eye Dam. 1
  Aquatic Acute 1 | H242
  H318
  H400 | GHS02
  GHS05
  GHS09
  Dgr | H242
  H318
  H400 | | | T |
| 617-020-00-6 | 1,3-di(prop-2,2-diyl)benzen bis(neodecanoylperoxid) | 420-060-5 | 117663-11-3 | Flam. Liq. 3
  Org. Perox. D **** Aquatic Chronic 2 | H226
  H242
  H411 | GHS02
  GHS09
  Dgr | H226
  H242
  H411 | | | |
| 617-021-00-1 | methylethylketonperoxid trimer | 429-320-2 | — | Org. Perox. B****
  Asp. Tox. 1
  Skin Irrit. 2
  Skin Sens. 1 | H241
  H304
  H315
  H317 | GHS01
  GHS02
  GHS08
  GHS07
  Dgr | H241
  H304
  H315
  H317 | | | |
| 617-022-00-7 | en blanding af 1,2-dimethylpropylidendihydroperoxid og dimethyl-1,2-benzendicarboxylat | 442-480-8 | — | Org. Perox. C
  Acute Tox. 4 *
  Skin Corr. 1B
  Skin Sens. 1
  Aquatic Chronic 2 | H242
  H302
  H314
  H317
  H411 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H242
  H302
  H314
  H317
  H411 | | | |
| 647-001-00-8 | glucosidase, β- | 232-589-7 | 9001-22-3 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 647-002-00-3 | cellulase | 232-734-4 | 9012-54-8 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 647-003-00-9 | cellobiohydrolase, exo- | 253-465-9 | 37329-65-0 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 647-004-00-4 | cellulaser undtagen sådanne nævnt andetsteds i dette bilag | — | — | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | A |
| 647-005-00-X | bromelain, saft | 232-572-4 | 9001-00-7 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-006-00-5 | ficin | 232-599-1 | 9001-33-6 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-007-00-0 | papain | 232-627-2 | 9001-73-4 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-008-00-6 | pepsin A | 232-629-3 | 9001-75-6 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-009-00-1 | rennin | 232-645-0 | 9001-98-3 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-010-00-7 | trypsin | 232-650-8 | 9002-07-7 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-011-00-2 | chymotrypsin | 232-671-2 | 9004-07-3 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-012-00-8 | subtilisin | 232-752-2 | 9014-01-1 | STOT SE 3
  Skin Irrit. 2
  Eye Dam. 1
  Resp. Sens. 1 | H335
  H315
  H318
  H334 | GHS08
  GHS05
  GHS07
  Dgr | H335
  H315
  H318
  H334 | | | |
| 647-013-00-3 | proteinase, mikrobiel neutral | 232-966-6 | 9068-59-1 | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-014-00-9 | proteaser undtagen sådanne nævnt andetsteds i dette bilag | — | — | Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Resp. Sens. 1 | H319
  H335
  H315
  H334 | GHS08
  GHS07
  Dgr | H319
  H335
  H315
  H334 | | | |
| 647-015-00-4 | amylase, α- | 232-565-6 | 9000-90-2 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 647-016-00-X | amylaser undtagen sådanne nævnt andetsteds i dette bilag | — | — | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 647-017-00-5 | laccase | 420-150-4 | 80498-15-3 | Resp. Sens. 1 | H334 | GHS08
  Dgr | H334 | | | |
| 648-001-00-0 | destillat (stenkulstjære), benzenfraktion;
  letolie; [en sammensat blanding af carbonhydrider opnået ved destillationen af stenkulstjære. Den består af carbonhydrider, primært C4 til C10, med kogeinterval
  omtrent fra 80 oC til
  160 oC.] | 283-482-7 | 84650-02-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 648-002-00-6 | tjæreolier, brunkul; letolie;
  [destillatet fra brunkulstjære, med kogeinterval omtrent fra 80 oC til 250 oC. Sammensat primært af aliphatiske og aromatiske carbonhydrider og monobasiske phenoler.] | 302-674-4 | 94114-40-6 | Carc. 1B
  Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-003-00-1 | benzenforløb (kul); redestilleret letolie, lavtkogende;
  [destillat fra koksovns
  letolie med et omtrentligt destillationsinterval under 100 oC. Sammensat primært af aliphatiske C4- til C6-carbonhydrider.] | 266-023-5 | 65996-88-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-004-00-7 | destillater (stenkulstjære), benzenfraktion, benzen-, toluen- og xylenrige;
  redestilleret letolie, lavtkogende;
  [en rest fra destillationen af rå benzen til fjernelse
  af de første benzendestillationsprodukter.] Sammensat primært af benzen, toluen og xylen, med kogeinterval omtrent fra 75 oC til 200 oC. | 309-984-9 | 101896-26-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-005-00-2 | aromatiske carbonhydrider, C6-10-, C8-rige; redestilleret letolie,
  lavtkogende | 292-697-5 | 90989-41-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-006-00-8 | solventnaphtha (kul), let; redestilleret letolie, lavtkogende | 287-498-5 | 85536-17-0 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-007-00-3 | solventnaphtha (kul), xylen-styrenfraktion; redestilleret letolie, mellemdestillat | 287-502-5 | 85536-20-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-008-00-9 | solventnaphtha (kul), coumaron-styrenholdig; redestilleret letolie,
  mellemdestillat | 287-500-4 | 85536-19-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-009-00-4 | naphtha (kul), destillationsrester;
  redestilleret letolie, højtkogende;
  [resten tilbageblevet ved
  destillation af genvundet naphta. Sammensat primært af naphthalen og kondensationsprodukter af inden og styren.] | 292-636-2 | 90641-12-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-010-00-X | aromatiske carbonhydrider, C8; redestilleret letolie, højtkogende | 292-694-9 | 90989-38-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-012-00-0 | aromatiske carbonhydrider, C8-9, biprodukter fra carbonhydridharpikspolymerisation;
  redestilleret letolie, højtkogende;
  [en sammensat blanding af carbonhydrider opnået ved afdampning af solvent, under
  vakuum, fra polymeriseret carbonhydridharpiks. Den består overvejende af aromatiske carbonhydrider,
  overvejende C8 til og med C9, med kogeinterval omtrent fra 120 oC til
  215 oC.] | 295-281-1 | 91995-20-9 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-013-00-6 | aromatiske carbonhydrider, C9-12-, benzendestillation;
  redestilleret letolie, højtkogende
  lavtkogende | 295-551-9 | 92062-36-7 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-014-00-1 | ekstraktionsrester (kul), alkalisk benzenfraktion, syreekstrakt;
  syrefri letolie, lavtkogende;
  [redestillatet fra destillatet,
  befriet for tjæresyrer og tjærebaser, fra højtemperaturstjære fra bituminøse kul, med kogeinterval omtrent fra 90 oC til 160 oC. Det består overvejende af benzen, toluen og xylener.] | 295-323-9 | 91995-61-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-015-00-7 | ekstraktionsrester (stenkulstjære), benzolfraktion alkaliske, syreekstrakt;
  syrefri letolie, lavtkogende
  [en sammensat blanding af carbonhydrider opnået ved
  redestillationen af destillatet af højtemperatursstenkulstjære (tjæresyre- og tjærebasefri). Den består overvejende af usubstituerede og substituerede monocycliske, aromatiske carbonhydrider med kogeinterval fra 85 oC til 195 oC.] | 309-868-8 | 101316-63-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-016-00-2 | ekstraktionsrester (kul), benzenfraktion, syre;
  syrefri letolie, lavtkogende;
  [et syreslamsbiprodukt fra svovlsyreraffineringen af rå højtemperaturskul. Sammensat primært af svovlsyre og organiske forbindelser.] | 298-725-2 | 93821-38-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-017-00-8 | ekstraktionsrester (kul), letolie alkaliske, destillationstopfraktioner;
  syrefri letolie,
  lavtkogende;
  [den første fraktion fra destillation af aromatiske carbonhydrider, coumaron-, naphthalen- og indenrige præfraktioneringskolonnebundfraktioner eller vasket carbololie, kogt væsentligt under 145 oC.
  Sammensat primært af C7 og C8 aliphatiske og aromatiske carbonhydrider.] | 292-625-2 | 90641-02-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-018-00-3 | ekstraktionsrester (kul), letolie-alkaliske, syreekstrakt, indenfraktion;
  syrefri letolie, mellemdestillat | 309-867-2 | 101316-62-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-019-00-9 | ekstraktionsrester (kul), letolie alkaliske, indennaphthafraktion; syrefri letolie, højkogende;
  [destillatet fra aromatiske carbonhydrider, coumaron-, naphthalen- og indenrige præfraktioneringskolonnebundfraktioner eller vasket
  carbololie, med kogeinterval omtrent fra
  155 oC til
  180 oC. Sammensat primært af inden, indan og trimethylbenzener.] | 292-626-8 | 90641-03-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-020-00-4 | solventnaphtha (kul);
  syrefri letolie, højtkogende;
  destillatet fra enten højtemperatursstenkulstjære, koksovnsletolie eller alkalisk
  ekstraktionsrest af stenkulstjæreolie, med et omtrentligt destillationsinterval fra 130 oC til 210 oC. Sammensat primært af inden og andre polycycliske ringsystemer indeholdende en enkelt aromatisk ring. Kan indeholde phenolforbindelser og aromatiske nitrogenbaser.] | 266-013-0 | 65996-79-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-021-00-X | destillater (stenkulstjære), letolier, neutral fraktion; syrefri letolie, højtkogende
  [et destillat fra den fraktionerede destillation af højtemperatursstenkulstjære. Sammensat primært af alkylsubstituerede, monocycliske, aromatiske carbonhydrider, med kogeinterval omtrent fra
  135 oC til
  210 oC. Kan også indeholde umættede carbonhydrider såsom inden og coumaron.] | 309-971-8 | 101794-90-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-022-00-5 | destillater (stenkulstjære), lette olier, syreekstrakter; syrefri letolie, højtkogende;
  [denne olie er en sammensat blanding af aromatiske carbonhydrider, primært inden, naphthalen, coumaron, phenol og o-, m- og p-cresol, med kogeinterval fra 140 oC til 215 oC.] | 292-609-5 | 90640-87-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-023-00-0 | destillater (stenkulstjære), lette olier; karbololie;
  [en sammensat blanding af carbonhydrider opnået ved destillation af stenkulstjære. Den består af aromater og andre carbonhydrider, phenolforbindelser og aromatiske nitrogenforbindelser og med destillationsinterval omtrent fra 150 oC
  til 210 oC.] | 283-483-2 | 84650-03-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-024-00-6 | tjæreolier, stenkuls; letolie;
  [destillat fra
  højtemperatursstenkulstjære med et omtrentligt destillationsinterval fra 130 oC til 250 oC. Sammensat primært af naphthalen, alkylnaphthalener, phenolforbindelser og aromatiske nitrogenbaser.] | 266-016-7 | 65996-82-9 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-026-00-7 | ekstraktionsrester (kul), letolie alkaliske, syreekstrakt;
  syrefri karbololie; [olien fremkommet ved syrevask
  af alkalivasket carbololie for at fjerne mindre mængder af basiske forbindelser (tjærebaser).
  Sammensat primært af inden,
  indan og alkylbenzener.] | 292-624-7 | 90641-01-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-027-00-2 | ekstraktionsrester (kul), tjæreolie alkaliske;
  syrefri karbololie [rest opnået fra stenkulstjæreolie ved en alkalisk vask, såsom
  vandig natriumhydroxid, efter fjernelsen af råstenkulstjæresyrer. Sammensat primært af naphthalener og aromatiske
  nitrogenbaser.] | 266-021-4 | 65996-87-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-028-00-8 | ekstraktionsolier (stenkul), letolier; syreekstrakt;
  [det vandige ekstrakt fremstillet ved sur vask af alkalivasket carbololie. Sammensat
  primært af syresalte af forskellige aromatiske nitrogenbaser, inklusive pyridin, quinolin og deres alkylderivater.] | 292-622-6 | 90640-99-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-029-00-3 | pyridin, alkylderivater; råtjærebaser;
  [den sammensatte blanding af polyalkylerede pyridiner opnået
  ved stenkulstjæredestillation eller som højtkogende destillater, omtrent højere end 150 oC, fra reaktion mellem ammoniak
  og acetaldehyd, formaldehyd
  eller paraformaldehyd.] | 269-929-9 | 68391-11-7 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-030-00-9 | tjærebaser, stenkuls-, picolinfraktion;
  basedestillater;
  [pyridinbaser, med kogeinterval omtrent fra 125 oC til 160 oC, opnået ved destillation af et neutraliseret syreekstrakt fra den baseholdige tjærefraktion, opnået ved destillationen af bituminøs stenkulstjære. Sammensat hovedsagelig af lutidiner og picoliner.] | 295-548-2 | 92062-33-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-031-00-4 | tjærebaser, stenkuls-, lutidinfraktion;
  basedestillater | 293-766-2 | 91082-52-9 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-032-00-X | ekstraktionsolier (kul), tjærebase, collidinfraktion;
  basedestillater;
  [ekstraktet fremstillet ved den sure ekstraktion af baser fra aromatiske olier fra rå kultjære, neutralisation og destillation af baserne. Sammensat primært af collidiner, anilin, toluidiner, lutidiner og xylidiner.] | 273-077-3 | 68937-63-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-033-00-5 | tjærebaser, stenkuls-, collidinfraktion;
  basedestillater;
  [destillationsfraktionen, med kogeinterval omtrent fra
  181 oC til 186 oC,
  fra råbaser, opnået fra den neutraliserede,
  syreekstraherede, baseholdige tjærefraktion, opnået ved destillationen af bituminøs stenkulstjære. Den indeholder hovedsagelig anilin og collidiner.] | 295-543-5 | 92062-28-7 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-034-00-0 | tjærebaser, stenkuls-, anilinfraktion; basedestillater;
  [destillationsfraktionen med kogeinterval omtrent fra
  180 oC til 200 oC,
  fra råbaser opnået ved at fjerne phenoler og
  baser fra den carbolerede olie fra destillationen af stenkulstjære.
  Den indeholder hovedsagelig anilin, collidiner, lutidiner og toluidiner.] | 295-541-4 | 92062-27-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-035-00-6 | tjærebaser, stenkuls-, toluidinfraktion;
  basedestillater | 293-767-8 | 91082-53-0 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-036-00-1 | destillater (råolie), alken-alkyn-fabrikations-pyrolyseolie, blandet med højtemperatursstenkulstjære, indenfraktion;
  redestillater;
  [en sammensat blanding af carbonhydrider opnået som et redestillat fra den fraktionerede destillation af højtemperaturstjære fra bituminøse kul, og restolier, der er opnået fra den pyrolytiske fremstilling af alkener og alkyner ud fra råolieprodukter eller naturgas. Den består overvejende af inden og har kogeinterval omtrent fra 160 oC til 190 oC.] | 295-292-1 | 91995-31-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-037-00-7 | destillater (kul), stenkulstjære-restpyrolyseolier, naphthalenolier;
  redestillater;
  [redestillatet, opnået fra den fraktionerede destillation af højtemperaturstjære fra bituminøse kul og pyrolyserestolier, med kogeinterval omtrent fra 190 oC til 270 oC. Sammensat primært af substituerede, bicycliske aromater.] | 295-295-8 | 91995-35-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-038-00-2 | ekstraktionsrester (kul), stenkulstjære restpyrolyseolier, naphthalenolie, restdestillat; redestillater;
  [redestillatet fra den fraktionerede destillation af phenol og basefri methylnaphthalenolie opnået fra højtemperaturstjære fra bituminøse kul og restpyrolyseolier, med kogeinterval omtrent fra 220 oC til 230 oC. Det består overvejende af usubstituerede og substituerede, bicycliske, aromatiske carbonhydrider.] | 295-329-1 | 91995-66-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-039-00-8 | ekstraktionsolier (stenkul), stenkulstjære rest-pyrolyseolier, naphthalenolier;
  redestillater;
  [en neutral olie opnået ved fjernelse af base og phenol fra olien opnået ved destillation af højtemperaturstjære og pyrolyserestolier, med kogeinterval omtrent fra 225 oC til 255 oC. Sammensat primært af substituerede bicykliske aromatiske carbonhydrider.] | 310-170-0 | 122070-79-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-040-00-3 | ekstraktionsolier (stenkul), stenkulstjære rest-pyrolyseolier, naphthalenolie, destillationsrester;
  redestillater;
  [rest fra destillationen af
  methylnaphthalenolie (fra tjære fra bituminøse kul og pyrolyserestolier), der er befriet for phenol og baser, med et
  kogeinterval fra 240 oC til
  260 oC. Sammensat primært af substituerede bicykliske aromatiske og heterocycliske carbonhydrider.] | 310-171-6 | 122070-80-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-041-00-9 | absorptionsolier, bicycliske aromater og heterocyclisk carbonhydridfraktion;
  redestilleret vaskeolie;
  [en sammensat blanding af carbonhydrider opnået som et redestillat fra destillationen
  af vaskeolie. Den består overvejende af 2-ringede aromatiske og heterocycliske carbonhydrider, med kogeinterval omtrent fra 260 oC til 290 oC.] | 309-851-5 | 101316-45-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-042-00-4 | destillater (stenkulstjære), øvre, fluorenrige;
  redestilleret vaskeolie;
  [en sammensat blanding af carbonhydrider opnået ved
  krystallisationen af tjæreolie. Den består af aromatiske og polycycliske carbonhydrider, primært fluoren og noget acenaphthen.] | 284-900-0 | 84989-11-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-043-00-X | creosotolie, acenaphthenfraktion, acenaphthenfri; redestilleret vaskeolie;
  [den tiloversblevne olie efter fjernelse,
  ved en krystallisationsproces, af acenaphthen fra acenaphthenolie fra stenkulstjære. Sammensat primært af naphthalen og alkylnaphthalener.] | 292-606-9 | 90640-85-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-044-00-5 | destillater (stenkulstjære), tunge olier; tung antracenolie; [destillater, fra fraktioneret destillation af stenkulstjære fra bituminøse kul, med kogeinterval omtrent fra 240 oC til 400 oC. Sammensat primært af tri- og polycycliske, carbonhydrider og heterocycliske forbindelser.] | 292-607-4 | 90640-86-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 648-045-00-0 | destillater (stenkulstjære), øvre; tung antracenolie;
  [destillatet fra stenkulstjære
  med et omtrentligt destillationsinterval fra 220 oC til 450 oC. Sammensat primært af aromatiske carbonhydrider,
  bestående af tre- til firleddede kondenserede ringe og andre carbonhydrider.] | 266-026-1 | 65996-91-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-046-00-6 | anthracenolie, syreekstrakt; basefri antracenolie; [en sammensat blanding af carbonhydrider, fra den basebefriede fraktion opnået fra destillationen af stenkulstjære, med kogeinterval omtrent fra 325 oC til 365 oC. Den indeholder overvejende anthracen og phenanthren og deres alkylderivater] | 295-274-3 | 91995-14-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-047-00-1 | destillater (stenkulstjære); tung antracenolie;
  [destillatet fra stenkulstjære med et omtrentligt destillationsinterval fra 100 oC til 450 oC. Sammensat primært af aromatiske carbonhydrider, bestående af to- til firleddede kondenserede ringe, phenolforbindelser og aromatiske nitrogenbaser.] | 266-027-7 | 65996-92-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-048-00-7 | destillater (stenkulstjære), beg-, tunge olier;
  tung antracenolie;
  [destillatet fra destillationen
  af begen opnået fra bituminøs
  højtemperaturstjære. Sammensat primært af tri- og polycycliske aromatiske carbonhydrider,
  med kogeinterval omtrent fra 300 oC til 470 oC. Produktet kan også indeholde heteroatomer.] | 295-312-9 | 91995-51-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-049-00-2 | destillater (kultjære) beg; tung antracenolie;
  [olien opnået ved kondensering af dampene fra varmebehandlingen af beg.
  Sammensat primært af to- til firringede aromatiske forbindelser, med kogeinterval omtrent fra 200 oC til mere end 400 oC.] | 309-855-7 | 101316-49-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-050-00-8 | destillater (stenkulstjære), tunge olier, pyrenfraktion;
  redestilleret tung antracenolie;
  [redestillatet, opnået fra fraktioneret destillation af
  begdestillat, med kogeinterval omtrent fra 350 oC til 400 oC. Består overvejende af tri- og polycycliske aromater og heterocycliske carbonhydrider.] | 295-304-5 | 91995-42-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-051-00-3 | destillater (stenkulstjære), beg-, pyrenfraktion;
  redestilleret tung antracenolie;
  [redestillatet, opnået fra fraktioneret destillation af
  begdestillat, med kogeinterval omtrent fra 380 oC til 410 oC. Sammensat primært af tri- og polycycliske aromatiske carbonhydrider og heteocycliske forbindelser.] | 295-313-4 | 91995-52-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-052-00-9 | paraffinvokser (kul), brunkulhøjtemperaturstjære, carbonbehandlet;
  syre- og basefri kultjære; [en sammensat blanding af carbonhydrider opnået ved behandlingen af brunkul-forkulningstjære med aktivt kul for at fjerne sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] | 308-296-6 | 97926-76-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-053-00-4 | paraffinvokser (kul), brunkulhøjtemperaturstjære, lerbehandlet; syre- og basefri kultjære;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af brunkul-forkulningstjære med bentonit for at fjerne sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] | 308-297-1 | 97926-77-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-054-00-X | beg; tjærebeg | 263-072-4 | 61789-60-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-055-00-5 | beg, kultjære-, højtemperaturs-; tjærebeg; [resten fra destillationen af højtemperatursstenkulstjære. Et sort, fast stof med et blødgøringspunkt omtrent fra 30 oC til 180 oC. Består primært af en sammensat blanding af aromatiske carbonhydrider, bestående af tre- eller flerleddede kondenserede ringe.] | 266-028-2 | 65996-93-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 648-056-00-0 | beg, kultjære, højtemperatur, varmebehandlet; tjærebeg; [den varmebehandlede rest fra destillationen af
  højtemperaturstenkulstjære. Et sort, fast stof med et blødgøringspunkt omtrent fra 80 oC til 180 oC. Sammensat primært af en kompleks blanding af tre- eller flerleddede, kondenserede, aromatiske carbonhydrider.] | 310-162-7 | 121575-60-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-057-00-6 | beg, kultjære-, højtemperaturs, sekundær;
  redestilleret tjærebeg; [resten opnået under destillationen af højtkogende fraktioner fra højtemperaturstjære fra bituminøse kul og/eller begkoksolie, med et blødgøringspunkt fra 140 oC til 170 oC ifølge DIN 52025. Sammensat primært af tri-og polycycliske, aromatiske forbindelser, som også indeholder heteroatomer.] | 302-650-3 | 94114-13-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-058-00-1 | rester (stenkulstjære), begdestillations-; redestilleret tjærebeg;
  [rest, fra den fraktionerede destillation af begdestillat,
  med kogeinterval omtrent fra 400 oC til 470 oC. Sammensat primært af polycycliske, aromatiske carbonhydrider og heterocycliske forbindelser.] | 295-507-9 | 92061-94-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-059-00-7 | tjære, stenkuls-, højtemperatur, destillations- og oplageringsrester;
  kultjæresediment;
  [koks- og askeholdige, faste rester, der adskilles ved destillation og termisk behandling af højtemperaturstjære fra bituminøse kul i destillationsinstallationer og oplageringsbeholdere. Består overvejende af carbon, og indeholder små mængder af heteroforbindelser, så vel som askekomponenter.] | 295-535-1 | 92062-20-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-060-00-2 | tjære, stenkuls-, lagerrester; kultjæresediment;
  [aflejringer, fjernet fra lagre af rå stenkulstjære. Består primært af stenkulstjære og kulholdigt, findelt stof.] | 293-764-1 | 91082-50-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-061-00-8 | tjære, stenkuls-, højtemperaturs-, rester, kultjæresediment;
  [faste stoffer dannet under
  forkoksningen af bituminøse kul for at fremstille rå højtemperaturstjære. Sammensat primært af koks- og kulpartikler, højt aromatiserede forbindelser og mineralske stoffer.] | 309-726-5 | 100684-51-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-062-00-3 | tjære, stenkuls-, højtemperatur, højt indhold af faste stoffer;
  kultjæresediment;
  [kondensationsproduktet opnået ved køling, omtrent til omgivende temperatur, af gassen udviklet ved højtemperaturstørdestillationen (højere end 700 oC) af kul. Består primært af en sammensat blanding af kondenserede aromatiske carbonhydrider med et højt faststof indhold af kul-og koks-lignende materialer.] | 273-615-7 | 68990-61-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-063-00-9 | affaldsstoffer, faste, kultjærebegsforkoksnings-;
  kultjæresediment;
  [det samlede affald dannet ved forkoksningen af bituminøs kultjærebeg. Der består overvejende af carbon.] | 295-549-8 | 92062-34-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-064-00-4 | ekstraktrester (kul), brunkul; syre- og basefri kultjære;
  [resten fra toluenekstraktion af tørret brunkul.] | 294-285-0 | 91697-23-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-065-00-X | paraffinvokser (kul), brunkulshøjtemperaturstjære;
  syre -og basefri kultjære; [en sammensat blanding af carbonhydrider, opnået fra brunkulsforkulningstjære ved solventkrystallisation (solventafoliering), ved svedning eller en adduktionsproces. Den består overvejende af ligekædede og
  forgrenede, mættede carbonhydrider, overvejende større end C12.] | 295-454-1 | 92045-71-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-066-00-5 | paraffinvokser (kul), brunkulshøjtemperaturstjære, hydrogenbehandlede;
  syre -og basefri kultjære; [en sammensat blanding af carbonhydrider, opnået fra brunkulsforkulningstjære ved solventkrystallisation (solventafoliering), ved svedning eller en adduktionsproces, behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af ligekædede og forgrenede, mættede carbonhydrider, overvejende større end C12.] | 295-455-7 | 92045-72-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-067-00-0 | paraffinvokser (kul), brunkulhøjtemperaturstjære, kiselsyrebehandlet;
  syre- og basefri kultjære;
  [en sammensat blanding af carbonhydrider opnået ved
  behandlingen af brunkul-forkulningstjære med kiselsyre for af fjerne sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større
  end C12.] | 308-298-7 | 97926-78-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-068-00-6 | tjære, stenkuls-, lavtemperatur, destillationsrester;
  kultjæreolie, mellemdestillat; [rester fra fraktioneret destillation af lavtemperatursstenkulstjære for at fjerne olier, der koger i området op til omtrent 300 oC. Sammensat primært af aromatiske forbindelser.] | 309-887-1 | 101316-85-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-069-00-1 | beg, kultjære-, lavtemperatur, tjærebeg;
  [et sammensat sort, fast, eller halvfast stof opnået ved destillation af en lavtemperaturstenkulstjære. Det har et blødgøringspunkt mellem omtrent 40 oC og 180 oC. Sammensat primært af en kompleks blanding af carbonhydrider.] | 292-651-4 | 90669-57-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-070-00-7 | beg, kultjære, lavtemperatur, oxideret;
  tjærebeg, oxideret;
  [produktet opnået ved at luftgennemblæse lavtemperaturkultjærebeg ved forhøjet temperatur. Det har et blødgøringspunkt mellem omtrent 70 oC og
  180 oC. Sammensat primært af en kompleks blanding af carbonhydrider.] | 292-654-0 | 90669-59-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-071-00-2 | beg, kultjære-, lavtemperatur, varmebehandlet;
  tjærebeg, oxideret; tjærebeg, varmebehandlet;
  [et sammensat sort, fast, stof opnået
  ved varmebehandling af lavtemperaturkultjærebeg. Det har et blødgøringspunkt mellem omtrent 50 oC og 140 oC. Sammensat primært af en kompleks blanding af aromatiske forbindelser.] | 292-653-5 | 90669-58-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-072-00-8 | destillater (kul og råolie), kondenserede aromat-;
  destillater;
  [destillatet fra en blandning af stenkulstjære og aromatiske råoliestrømme med destillationsområde omtrent fra 220 oC til 450 oC. Sammensat primært af aromatiske carbonhydrider, bestående af 3- til 4-ledede kondenserede ringe.] | 269-159-3 | 68188-48-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-073-00-3 | aromatiske carbonhydrider, C20-28-, polycycliske, blandet kultjærebeg, polyethylen og polypropylen, pyrolyse-afledte; pyrolyseprodukter;
  [en sammensat blanding af carbonhydrider opnået ved pyrolyse af blandet kultjærebeg, polyethylen og polypropylen. Sammensat primært af polycycliske, aromatiske carbonhydrider, overvejende C20 til og med C28, med et blødgøringspunkt fra 100 oC til 220 oC ifølge DIN 52025.] | 309-956-6 | 101794-74-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-074-00-9 | aromatiske carbonhydrider, C20-28-, polycycliske, blandet kultjærebeg og polyethylen, pyrolyseafledte;
  pyrolyseprodukter;
  [en sammensat blanding af carbonhydrider opnået ved
  pyrolyse af blandet kultjærebeg og polyethylen. Sammensat primært af polycycliske, aromatiske carbonhydrider, overvejende C20 til og med C28, med et blødgøringspunkt fra 100 oC til 220 oC ifølge DIN 52025.] | 309-957-1 | 101794-75-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-075-00-4 | aromatiske carbonhydrider, C20-28-, polycycliske, blandet kultjærebeg og polystyren, pyrolyseafledte;
  pyrolyseprodukter;
  [en sammensat blanding af carbonhydrider opnået ved
  pyrolyse af blandet kultjærebeg og polystyren. Sammensat primært af polycycliske, aromatiske carbonhydrider, overvejende C20 til og med C28, med et blødgøringspunkt fra 100 oC til
  220 oC
  ifølge DIN 52025.] | 309-958-7 | 101794-76-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-076-00-X | beg, kultjære- og råolie-; tjærebeg;
  [resten fra destillationen af en blanding af stenkulstjære og aromatiske råoliestrømme. Et fast stof med et blødgøringspunkt fra 40 oC til
  180 oC. Sammensat primært af en kompleks blanding af aromatiske carbonhydrider, bestående af tre- eller flerleddede kondenserede ringe.] | 269-109-0 | 68187-57-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-077-00-5 | phenanthren, destillationsrester; redestilleret tung antracenolie;
  [rest, fra destillationen af rå phenanthren, kogende i
  området omtrent fra 340 oC til 420 oC. Den består overvejende af phenanthren, anthracen og carbazol.] | 310-169-5 | 122070-78-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-078-00-0 | destillater (stenkulstjære), øvre, fluorenfri; redestilleret vaskeolie;
  [en sammensat blanding af carbonhydrider opnået ved
  krystallisationen af tjæreolie. Den består af aromatiske, polycykliske carbonhydrider, primært diphenyl, dibenzofuran og acenaphthen.] | 284-899-7 | 84989-10-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-079-00-6 | anthracenolie; antracenolie;
  [en sammensat blanding af polycycliske aromatiske carbonhydrider opnået fra stenkulstjære, med destillationsinterval omtrent fra 300 oC til 400 oC. Sammensat primært af phenanthren, anthracen og carbazol.] | 292-602-7 | 90640-80-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-080-00-1 | rester (stenkulstjære), creosotolie detillations-; redestilleret vaskeolie;
  [resten, fra fraktioneret destillation af vaskeolie, med kogeinterval omtrent fra 270 oC til 330 oC. Den består overvejende af bicycliske aromatiske og heterocycliske carbonhydrider.] | 295-506-3 | 92061-93-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-081-00-7 | tjære, stenkuls-; stenkulstjære;
  [biproduktet fra tørdestillation af kul. Næsten sort halvfast stof. En sammensat blanding af
  aromatiske carbonhydrider, phenolforbindelser, nitrogenbaser og thiophen.] | 232-361-7 | 8007-45-2 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 648-082-00-2 | tjære, stenkuls-, højtemperaturs-; stenkulstjære; [kondensationsproduktet opnået ved at nedkøle, til omtrent omgivelsestemperatur, den gas, der udvikles ved tørdestillation af kul ved høj temperatur (højere end 700 oC). En sort, viskøs væske tungere end vand. Består primært af en sammensat blanding af kondenserede aromatiske carbonyhdrider. Kan indeholde mindre mængder phenolforbindelser og aromatiske nitrogenbaser.] | 266-024-0 | 65996-89-6 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 648-083-00-8 | tjære, stenkuls-, lavtemperatur; stenkulsolie;
  [kondensationsproduktet opnået ved at nedkøle, til omtrent omgivelsestemperatur, den gas, der udvikles ved tørdestillation af kul ved lav temperatur (lavere end 700 oC). En sort, viskøs væske tungere end vand. Sammensat primært af kondenserede aromatiske carbonhydrider, phenolforbindelser, aromatiske nitrogenbaser og deres alkylderivater.] | 266-025-6 | 65996-90-9 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 648-084-00-3 | destillater (kul), koksovns-letolie, naphthalenfraktion; naftalinolie;
  [den sammensatte blanding af carbonhydrider opnået ved præfraktionering (kontinuerlig
  destillation) af koksovnsletolie. Den består overvejende af naphtalen, coumaron og inden og koger højere end
  148 oC.] | 285-076-5 | 85029-51-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-085-00-9 | destillater (stenkulstjære), naph
  thalenolier; naftalinolie;
  [en sammensat blanding af carbonhydrider opnået ved
  destillationen af stenskulstjære. Den består primært af aromater og andre carbonhydrider, phenolforbindelser og aromatiske nitrogenforbindelser med destillationsinterval omtrent fra 200 oC til 250 oC.] | 283-484-8 | 84650-04-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-086-00-4 | destillater (stenkulstjære), naphthalenolier, med lavt indhold af naphthalen; redestilleret naftalinolie; [en sammensat blanding af carbonhydrider opnået ved krystallisation af naphthalenolie. Sammensat primært af naphthalen, alkylnaphthalen og phenolforbindelser.] | 284-898-1 | 84989-09-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-087-00-X | destillater (stenkulstjære), naphthalenolie-krystallisationsmoderlud; redestilleret naftalinolie;
  [en sammensat blanding af organiske forbindelser, opnået som
  et filtrat fra krystallisationen af naphthalenfraktionen fra stenkulstjære, med kogeinterval
  omtrent fra 200 oC til
  230 oC. Indeholder hovedsagelig naphthalen, thionaphthalen og alkylnaphthalener.] | 295-310-8 | 91995-49-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-088-00-5 | ekstraktionsrester (stenkul), naphtahalenolie, alkaliske; syrefri naftalinolie
  ;
  [en sammensat blanding af carbonhydrider opnået fra den
  alkaliske vask af naphthalenolie for at fjerne phenolforbindelser (tjæresyrer). Den består af naphthalen og alkylnaphthalener.] | 310-166-9 | 121620-47-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-089-00-0 | ekstraktionsrester (stenkul), naphthalenolie, alkaliske, med lavt indhold af naphthalen;
  syrefri naftalinolie
  ;
  [en sammensat blanding af carbonhydrider, der er blevet tilbage efter
  fjernelsen af naphthalen fra alkalivasket naphthalenolie ved en krystalliseringsproces. Den er sammensat primært af
  naphthalen og alkylnaphthalener.] | 310-167-4 | 121620-48-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-090-00-6 | destillater (stenkulstjære), naphthalenolier, naphthalenfrie, alkaliske ekstrakter;
  syrefri naftalinolie
  ;
  [Den tilbageblevne olie efter fjernelse af phenolforbindelser (tjæresyrer) fra drænet naphthalenolie ved en alkalisk vask. Sammensat primært af naphthalen og alkylnaphthalener.] | 292-612-1 | 90640-90-7 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-091-00-1 | ekstrationsrester (kul), naphthalenolie alkaliske, destillationstopfraktioner;
  syrefri naftalinolie
  ;
  [destillatet fra alkalivasket naphthalenolie med destillationsinterval omtrent fra 180 oC til 220 oC. Sammensat primært af naphthalen,
  alkylbenzener, inden og indan.] | 292-627-3 | 90641-04-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-092-00-7 | destillater (stenkulstjære), naphthalenolier, methylnaphthalenfraktion;
  methylnaftalin;
  [et destillat fra den fraktionerede destillation af højtemperaturs-
  stenkulstjære. Sammensat primært af substituerede, bicycliske, aromatiske carbonhydrider og aromatiske nitrogenbaser med kogeinterval omtrent fra 225 oC til 255 oC.] | 309-985-4 | 101896-27-9 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-093-00-2 | destillater (stenkulstjære), naphthalenolier, indol-methylnaphthalenfraktion; methylnaftalin;
  [et destillat fra den fraktionerede destillation af højtemperaturs-
  stenkulstjære. Sammensat primært af indol og methylnaphthalen, med kogeinterval omtrent fra 235 oC til 255 oC.] | 309-972-3 | 101794-91-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-094-00-8 | destillater (stenkulstjære), naphtalenolier, syreekstrakter; methylnaftalinolie;
  [en sammensat blanding af carbonhydrider, opnået ved
  at fjerne baser fra methylnaphthalenfraktionen opnået ved destillation af stenkulstjære, med kogeinterval omtrent fra 230 oC til 255 oC. Indeholder hovedsagelig 1(2)-methylnaphthalen, naphthalen, dimethylnaphthalen og biphenyl.] | 295-309-2 | 91995-48-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-095-00-3 | ekstraktionsrester (kul), naphthalenolie alkaliske, destillationsrester; methylnaftalinolie; [resten fra destillationen af alkalivasket naphthalenolie, med destillationsinterval omtrent fra 220 oC til 300 oC. Sammensat primært af naphthalen, alkylnaphthalener og aromatiske nitrogenbaser.] | 292-628-9 | 90641-05-7 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-096-00-9 | ekstraktionsolier (kul), sure, tjærebase-frie;
  methylnaftalinolie;
  [ekstraktionsolien, med kogeinterval omtrent fra 220 oC til 265 oC, fra alkaliske stenkultjære-ekstraktionsrester fremstillet ved en sur vask, såsom vandig svovlsyre, efter destillation for at fjerne tjærebaser. Sammensat primært af alkylnaphthalener.] | 284-901-6 | 84989-12-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-097-00-4 | destillater (stenkulstjære), benzolfraktion, destillationsrester;
  vaskeolie;
  [en sammensat blanding af carbonhydrider opnået ved
  destillation af rå benzol (højtemperaturstenkulstjære). Den kan være en væske med et destillationsinterval omtrent fra 150 oC til 300 oC eller et halvfast eller fast stof med et smeltepunkt på op til 70 oC. Den er sammensat primært af naphthalen og alkylnaphthalener.] | 310-165-3 | 121620-46-0 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-098-00-X | creosotolie, acenaphthenfraktion;
  vaskeolie; [en sammensat blanding af carbonhydrider, fremstillet ved destillation af stenkulstjære, med kogeinterval omtrent fra 240 oC til 280 oC. Sammensat primært af acenaphthen, naphthalen og alkylnaphthalen.] | 292-605-3 | 90640-84-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-099-00-5 | creosotolie;
  [En sammensat blanding af carbonhydrider opnået ved destillationen af stenkulstjære. Den
  består primært af aromatiske carbonhydrider og kan indeholde betydelige mængder tjæresyrer og tjærebaser. Den destillerer i området omtrent fra 200 oC til 325 oC.] | 263-047-8 | 61789-28-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-100-00-9 | creosotolie, højtkogende destillat;
  vaskeolie;
  [Den højtkogende destillationsfraktion opnået fra højtemperaturforkulningen af bituminøse kul, som yderligere raffineres for at fjerne overskud af krystallinske salte. Den består primært af creosotolie, hvorfra nogle af de normale polycykliske aromatiske salte, som er komponenter af stenkulstjæredestillater, er fjernet. Den er krystalfri ved omtrent 5 oC.] | 274-565-9 | 70321-79-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-101-00-4 | creosot;
  [destillatet af stenkulstjære fremstillet ved højtemperatursforkulning af bituminøs kul. Det består primært af aromatiske carbonhydrider, tjæresyrer og tjærebaser.] | 232-287-5 | 8001-58-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 648-102-00-X | ekstraktionsrester (stenkul), creosotolie sure;
  vaskeolieekstraktionsrest;
  [en sammensat blanding af carbonhydrider fra den basebefriede fraktion fra destillationen af stenkulstjære, med kogeinterval omtrent fra 250 oC til 280 oC. Den består overvejende af biphenyl og isomere diphenylnaphthener.] | 310-189-4 | 122384-77-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-103-00-5 | Anthracenolie, anthracenpasta;
  Antracenoliefraktion;
  det anthracenrige faste stof, der fremkommer ved krystallisation og centrifugering af anthracenolie. Det er sammensat primært af anthracen, carbazol og phenanthren.] | 292-603-2 | 90640-81-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-104-00-0 | anthracenolie, med lavt indhold af anthracen; antracenoliefraktion;
  [den tiloversblevne olie efter fjernelse, ved en krystallisationsproces, af et anthracenrigt fast stof (anthracenpasta) fra anthracenolie. Den er sammensat primært af bi, tri og tetracykliske aromatiske forbindelser.] | 292-604-8 | 90640-82-7 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-105-00-6 | rester (stenkulstjære), anthracenolie destillations-; antracenoliefraktion;
  [resten fra fraktioneret destillation af rå anthracen, med kogeinterval omtrent fra 340 oC til 400 oC. Den består overvejende af tri- og polycycliske, aromatiske og heterocycliske carbonhydrider.] | 295-505-8 | 92061-92-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-106-00-1 | anthracenolie, anthracenpasta, anthracenfraktion; antracenoliefraktion;
  [en sammensat blanding af
  carbonhydrider fra destillationen af anthracen, opnået ved krystallisation af anthracenolie fra bituminøs højtemperaturstjære, med kogeinterval omtrent fra 330 oC til 350 oC. Den indeholder hovedsagelig anthracen,
  carbazol og phenanthren.] | 295-275-9 | 91995-15-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-107-00-7 | anthracenolie, anthracenpasta, carbazolfraktion; antracenoliefraktion;
  [en sammensat blanding af carbonhydrider fra destillationen af anthracen, opnået ved krystallisation af anthracenolie fra højtemperaturstjære fra bituminøse kul, med kogeinterval omtrent fra 350 oC til 360 oC. Den indeholder hovedsagelig anthracen, carbazol og phenanthren.] | 295-276-4 | 91995-16-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-108-00-2 | anthracenolie, anthracenpasta, lette destillationsfraktioner;
  antracenoliefraktion;
  [en sammensat blanding af carbonhydrider fra destillationen af anthracen, opnået ved krystallisation af anthracenolie fra bituminøs højtemperaturstjære, med kogeinterval omtrent fra 290 oC til 340 oC. Den indeholder hovedsagelig tricycliske aromater og deres dihydroderivater.] | 295-278-5 | 91995-17-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-109-00-8 | tjæreolier, stenkuls-, lavtemperaturs; kultjæreolie, højtkogende;
  [et destillat fra lavtemperatursstenkulstjære. Sammensat primært af carbonhydrider, phenolforbindelser og aromatiske nitrogenbaser, med kogeinterval omtrent fra 160 oC til 340 oC.] | 309-889-2 | 101316-87-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-110-00-3 | ekstraktionsrester (stenkul), lavtemperaturstenkulstjære alkaliske;
  [resten fra lavtemperaturstenkulstjæreolier efter en alkalisk vask, såsom vandig natriumhydroxid, for at fjerne råstenkulstjæresyrer. Sammensat primært af carbonhydrider og aromatiske nitrogenbaser.] | 310-191-5 | 122384-78-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-111-00-9 | phenoler, ammoniakludsekstrakt; alkaliske ekstrakter;
  [blandingen af phenoler, ekstraheret ved brug af isobutylacetat, fra ammoniakluden, der er kondenseret fra gassen fra lavtemperaturstørdestillation (mindre end 700 oC) af kul. Den består overvejende af en blanding af mono og dihydroxyphenoler.] | 284-881-9 | 84988-93-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-112-00-4 | destillater (stenkulstjære), letolier, alkaliske ekstrakter;
  alkaliske ekstrakter;
  [det vandige ekstrakt fra carbololie fremstillet ved en alkalisk vask med f. eks. vandig natriumhydroxid. Sammensat primært af alkalimetalsalte af forskellige phenolforbindelser.] | 292-610-0 | 90640-88-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-113-00-X | ekstrakter, stenkulstjæreolie, alkaliske; alkaliske ekstrakter;
  [ekstrakt fra stenkulstjæreolie fremstillet ved en alkalisk vask med f.eks. vandig natriumhydroxid. Sammensat primært af alkalimetalsalte af forskellige phenolforbindelser.] | 266-017-2 | 65996-83-0 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-114-00-5 | destillater (stenkulstjære), naph
  thalenolier, alkaliske ekstrakter; alkaliske ekstrakter;
  [det vandige ekstrakt fra naph
  thalenolie fremstillet ved en alkalisk vask med f. eks vandig natriumhydroxid. Sammensat primært af alkalimetalsalte af forskellige phenolforbindelser.] | 292-611-6 | 90640-89-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-115-00-0 | ekstraktionsrester (kul), tjæreolie, alkaliske, carbonaterede, kalkede;
  råfenol; [produktet fra behandling af et alkalisk stenkulstjæreolieekstrakt med CO2 og CaO. Sammensat primært af CaCO3, Ca(OH)2, Na2CO3 og andre organiske og uorganiske urenheder.] | 292-629-4 | 90641-06-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-116-00-6 | tjæresyrer, stenkuls-, rå; råfenol;
  [reaktionsprodukt opnået ved at neutralisere alkalisk ekstrakt fra stenkulstjæreolie med en sur opløsning, såsom vandig svovlsyre, eller gasformig carbondioxid, for at udvinde de frie syrer. Sammensat primært af tjæresyrer såsom phenol, cresoler og xylenoler.] | 266-019-3 | 65996-85-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-117-00-1 | tjæresyrer, brunkuls-, rå; råfenol;
  [et forsuret alkalisk ekstrakt af brunkulstjæredestillat.
  Sammensat primært af phenol og phenolhomologer.] | 309-888-7 | 101316-86-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-118-00-7 | tjæresyrer, brunkulsforgas
  nings-;
  råfenol;
  [en sammensat blanding af organiske forbindelser fra brunkulsforgasning. Sammensat primært af C6-10-hydroxyaromatiske phenoler og deres homologer.] | 295-536-7 | 92062-22-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-119-00-2 | tjæresyrer, destillationsrester; fenoldestillater;
  [en rest fra destillationen af råphenol fra kul. Den består overvejende af phenoler, C8 til og med C10, med blødgøringspunkt fra 60 oC til 80 oC.] | 306-251-5 | 96690-55-0 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-120-00-8 | tjæresyrer, methylphenolfraktion;
  fenoldestillater;
  [fraktionen af tjæresyre, rig på
  3- og 4-methylphenol, genvundet ved destillation af rå tjæresyre fra lavtemperatursstenkuls
  tjære.] | 284-892-9 | 84989-04-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-121-00-3 | tjæresyrer, polyalkylphenolfraktion;
  fenoldestillater;
  [fraktionen af tjæresyrer, genvundet ved destillation af rå tjæresyrer fra lavtemperatursstenkulstjære,
  med kogeinterval omtrent fra 225 oC til
  320 oC.] Sammensat primært af polyalkylphenoler.] | 284-893-4 | 84989-05-9 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-122-00-9 | tjæresyrer, xylenolfraktion; fenoldestillater;
  [fraktionen af tjæresyrer, rig på
  2,4- og 2,5-dimethylphenol, genvundet ved destillation af rå tjæresyrer fra lavtemperatursstenkuls
  tjære.] | 284-895-5 | 84989-06-0 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-123-00-4 | tjæresyrer, ethylphenolfraktion; fenoldestillater;
  [fraktionen af tjæresyrer, rig på
  3- og 4-ethylphenol, genvundet ved destillation af rå tjæresyrer fra lavtemperatursstenkulstjære.] | 284-891-3 | 84989-03-7 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-124-00-X | tjæresyrer, 3,5-xylenolfraktion; fenoldestillater;
  [fraktionen af tjæresyrer, rig på
  3,5-dimethylphenol, genvundet ved destillation af lavtemperatursstenkultjæresyrer.] | 284-896-0 | 84989-07-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-125-00-5 | tjæresyrer, rester, destillater, første fraktion;
  fenoldestillater;
  [resten fra destillationen i området fra 235 oC til 355 oC af let karbololie.] | 270-713-1 | 68477-23-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-126-00-0 | tjæresyrer, cresyliske, rester; fenoldestillater;
  [resten fra rå stenkulstjæresyrer efter fjernelse af phenol, cresoler, xylenoler og alle højerekogende phenoler. Et sort fast stof med et smeltepunkt på omtrent 80 oC. Sammensat primært af polyalkylphenoler, harpiksgummier og uorganiske salte.] | 271-418-0 | 68555-24-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-127-00-6 | phenoler, C9-11; fenoldestillater | 293-435-2 | 91079-47-9 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-128-00-1 | tjæresyrer, cresyliske; fenoldestillater;
  [en sammensat blanding af organiske forbindelser, opnået fra brunkul, med kogeinterval omtrent fra 200 oC til 230 oC. Den består hovedsagelig af phenoler og pyridinbaser.] | 295-540-9 | 92062-26-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-129-00-7 | tjæresyrer, brunkuls-, C2-alkylphenolfraktion
  fenoldestillater;
  [destillatet fra syrebehandlingen af alkalisk vasket brunkulstjæredestillat, med kogeinterval
  omtrent fra 200 oC til
  230 oC. Sammensat primært af m- og p-ethylphenol såvel som cresoler og xylenoler.] | 302-662-9 | 94114-29-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-130-00-2 | ekstraktionsolier (stenkul), naphtalenolier;
  syreekstrakt;
  [det vandige ekstrakt fremstillet ved en sur vask af alkali
  vasket naphthalenolie. Sammensat primært af syresalte af forskellige aromatiske nitrogenbaser, inklusive
  pyridin, quinolin og deres alkylderivater.] | 292-623-1 | 90641-00-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-131-00-8 | tjære, quinolinderivater; basedestillater | 271-020-7 | 68513-87-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-132-00-3 | tjærebaser, stenkuls-, quinolinderivatfraktion;
  basedestillater | 274-560-1 | 70321-67-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-133-00-9 | tjærebaser, stenkuls-, destillationsrester; basedestillater;
  [destillationsresten efter destillationen
  af den neutraliserede, syreekstraherede, baseholdige tjærefraktion, opnået ved destillationen af stenkulstjærer. Den indeholder hovedsagelig anilin, collidiner, quinolinderivater og toluidiner.] | 295-544-0 | 92062-29-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-134-00-4 | carbonhydridolier, aromatiske, blandet med polyethylen og polypropylen, pyrolyserede, let oliefraktion;
  varmebehandlede produkter [Olie opnået ved varmebehandling af en polyethylen/polypropylenblanding med kultjærebeg eller aromatiske olier. Den består overvejende af benzen og dens homologer, med kogeinterval omtrent fra 70 oC til 120 oC.] | 309-745-9 | 100801-63-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-135-00-X | carbonhydridolier, aromatiske, blandet med polyethylen, pyrolyserede, let oliefraktion;
  varmebehandlede produkter;
  [olie opnået ved varmebehandling af polyethylen med kultjærebeg eller aromatiske olier. Den består overvejende af benzen og dens homologer, med kogeinterval omtrent fra 70 oC til 120 oC.] | 309-748-5 | 100801-65-8 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-136-00-5 | carbonhydridolier, aromatiske, blandet med polystyren, pyrolyserede, let oliefraktion;
  varmebehandlede produkter;
  [olie opnået ved varmebehandling af polystyren med kultjærebeg eller aromatiske olier. Den består overvejende af benzen og dens homologer, med kogeinterval omtrent fra 70 oC til 210 oC
  .] | 309-749-0 | 100801-66-9 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-137-00-0 | ekstraktionsrester (kul), alkalisk tjæreolie, naphthalendestillationsrester; syrefri naftalinolie;
  [resten opnået fra kemisk olie ekstraheret efter fjernelsen af naphthalen ved destillation, består primært af bi til tetracykliske kondenserede aromatiske carbonhydrider og aromatiske nitrogenbaser.] | 277-567-8 | 73665-18-6 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-138-00-6 | creosotolie, lavtkogende destillat;
  vaskeolie;
  [den lavtkogende destillationsfraktion opnået fra højtemperaturforkulningen af bituminøse kul, som yderligere raffineres for at fjerne overskud af krystallinske salte. Den består primært af creosotolie, hvorfra nogle af de normale polycykliske aromatiske salte, som er komponenter af stenkulstjæredestillat, er fjernet. Den er krystalfri ved omtrent 38 oC.] | 274-566-4 | 70321-80-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-139-00-1 | tjæresyrer, cresyliske, natriumsalte, kaustiske opløsninger; alkaliske ekstrakter | 272-361-4 | 68815-21-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-140-00-7 | ekstraktionsolier (kul), tjærebase-; syreekstrakt;
  [ekstrakt fra alkalisk ekstraktionrest af stenkulstjæreolie fremstillet ved en sur vask med f.eks. vandig svovlsyre efter destillation for at fjerne naphthalen. Sammensat primært af syresalte af forskellige aromatiske nitrogenbaser, herunder pyridin, quinolin og deres alkylderivater.] | 266-020-9 | 65996-86-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-141-00-2 | tjærebaser, stenkuls-, rå; råtjærebaser
  [reaktionsprodukt opnået
  ved at neutralisere ekstraktionsolie fra stenkulstjærebase med en alkalisk opløsning, såsom vandig natriumhydroxid, for at udvinde de frie baser. Sammensat primært af organiske baser, såsom acridin, phenanthridin, pyridin, quinolin og deres alkylderivater.] | 266-018-8 | 65996-84-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | JM |
| 648-142-00-8 | rester (kul), flydende solventekstraktions-;
  [et kohæsivt pulver sammensat af kulmineralsk stof og
  uopløst kul tilbageblevet efter ekstraktion af kul med et flydende solvent.] | 302-681-2 | 94114-46-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-143-00-3 | kulvæsker, flydende solventekstraktionsopløsning;
  (produkt opnået ved filtrering af kulmineralsk stof og uopløst kul fra kulekstraktionsopløsning fremstillet ved at omsætte kul i et flydende solvent. En sort, viskøs og højkompleks væskeblanding sammensat primært af aromatiske og delvist hydrogenerede, aromatiske carbonhydrider, aromatiske nitrogenforbindelser, aromatiske svovlforbindelser, phenolske og andre aromatiske oxygenforbindelser og deres alkylderivater.] | 302-682-8 | 94114-47-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-144-00-9 | kulvæsker, flydende solventekstraktion;
  [det substantielle solventfrie produkt opnået ved destillation af solventet fra filtreret kulekstraktionsopløsning fremstillet ved at omsætte kul i et flydende solvent. Et sort, halvfast stof, bestående primært af en sammensat blanding af ringkondenserede, aromatiske carbonhydrider, aromatiske nitrogenforbindelser, aromatiske svovlforbindelser, phenolforbindelser og andre aromatiske oxygenforbindelser og deres alkylderivater.] | 302-683-3 | 94114-48-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | M |
| 648-145-00-4 | tjære, brunkuls-;
  [en olie destilleret fra brunkulstjære. Sammensat primært af aliphatiske, naphthenske og bi- til tricycliske aromatiske carbonhybrider, deres alkylderivater, heteroaromater og en- og toringede phenoler, med kogeinterval omtrent fra 150 oC til 360 oC.] | 309-885-0 | 101316-83-0 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 648-146-00-X | tjære, brunkuls-, lavtemperaturs-;
  [en tjære, opnået ved lavtemperatursforkulning og lavtemperatursforgasning af brunkul. Sammensat primært af aliphatiske, naphtenske og cycliske aromatiske carbonhydrider, heteroaromatiske carbonhydrider og cycliske phenoler.] | 309-886-6 | 101316-84-1 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 648-147-00-5 | letolie (kul), koksovns-; rå benzol;
  [den flygtige, organiske væske ekstraheret fra gassen fra tørdestillation af kul ved høj temperatur (højere end 700 oC). Sammensat primært af benzen, toluen og xylener. Kan indeholde andre mindre carbonhydridkomponenter.] Kan indeholde andre mindre carbonhydridkomponenter.] | 266-012-5 | 65996-78-3 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-148-00-0 | destillater (kul), flydende solventekstraktion, primære;
  [det flydende produkt fra kondensation af dampe afgivet under omsætningen af kul i et flydende solvent, med kogeinterval omtrent fra 30 oC til 300 oC. Sammensat primært af delvist hydrogenerede polycykliske annelerede aromatiske carbonhydrider, aromatiske forbindelser indeholdende nitrogen, oxygen og svovl og deres alkylderivater, med carbonantal overvejende i området fra C4 til og med C14.] | 302-688-0 | 94114-52-0 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-149-00-6 | destillater (kul), solvent-ekstraktion, hydrokrakket;
  [destillat fra hydrokrakning af kulekstrakt eller opløsning fremstillet ved flydende
  solventekstraktions- eller superkritiske gasekstraktionsprocesser, med kogeinterval omtrent fra 30 oC til 300 oC. Sammensat primært af aromatiske, hydrogenerede aromatiske og naphthenske forbindelser, deres alkylderivater og alkaner med carbonantal overvejende C4 til og med C14. Nitrogen-, svovl- og oxygenholdige aromatiske og hydrogenerede aromatiske forbindelser er også til stede.] | 302-689-6 | 94114-53-1 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-150-00-1 | naphta (kul), solventekstraktion, hydrokrakket;
  [fraktion af destillatet opnået ved hydrokrakning af kulekstrakt eller opløsning fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 30 oC til 180 oC. Sammensat primært af aromatiske, hydrogenerede aromatiske og naphtheniske forbindelser, deres alkylderivater og alkaner med carbonantal overvejende C4 til C9. Nitrogen-, svovl- og oxygenholdige aromatiske og hydrogenerede aromatiske forbindelser er også til stede.] | 302-690-1 | 94114-54-2 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-151-00-7 | benzin, kul solventekstraktion, hydrokrakket naphtha
  [motorbrændstof fremstillet ved reformering af den raffinerede naphthafraktion fra produkterne fra hydrokrakning af kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 30 oC til 180 oC. Sammensat primært af aromatiske og naphthenske carbonhydrider, deres alkylderivater og alkylcarbonhydrider, C4 til og med C9.] | 302-691-7 | 94114-55-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 648-152-00-2 | destillater (kul), solventekstraktion, hydrokrakkede middeltunge;
  [destillat opnået ved
  hydrokrakning af kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 180 oC til 300 oC. Sammesat primært af bicycliske aromatiske, hydrogenerede aromatiske og naphtheniske forbindelser, deres alkylderivater og alkaner med carbonantal overvejende C9 til og med C14. Nitrogen-, svovl- og oxygenholdige forbindelser er også til stede.] | 302-692-2 | 94114-56-4 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-153-00-8 | destillater (kul), solventekstraktion hydrokrakkede hydrogenerede middeltunge;
  [destillat fra hydrogeneringen af et hydrokrakket middeltungt destillat fra kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 180 oC til 280 oC. Sammensat primært af hydrogenerede, bicycliske carbonforbindelser og deres alkylderivater med carbonantal overvejende C9 til og med C14.] | 302-693-8 | 94114-57-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 648-154-00-3 | brændstoffer, jetfly-, kulsolventekstraktion, hydrokrakkede-hydrogenerede;
  [jetmotorbrændstof fremstillet ved hydrogenering af den middeltunge destillationsfraktion fra produkterne fra hydrokrakning af kul-ekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med koge-interval omtrent fra 180 oC til 225 oC. Sammensat primært af hydrogenerede, bicycliske carbonhydrider og deres alkylderivater, overvejende C10 til og med C12.] | 302-694-3 | 94114-58-6 | Carc. 2 | H351 | GHS08
  Wng | H350 | | | |
| 648-155-00-9 | brændstoffer, diesel- kul solventekstraktion, hydrokrakkede hydrogenerede; [dieselmotorbrændstof fremstillet ved hydrogenering af den middeltunge destillationsfraktion fra produkterne fra hydrokrakning af kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 200 oC til 280 oC. Sammensat primært af hydrogenerede, bicycliske carbonhydrider og deres alkylderivater, overvejende C11 til og med C14.] | 302-695-9 | 94114-59-7 | Carc. 2 | H351 | GHS08
  Wng | H350 | | | |
| 648-156-00-4 | letolie (kul), halvforkoksningsproces-; frisk olie; [den flygtige organiske væske kondenseret fra gassen udviklet ved lavtemperaturstørdestillation (lavere end 700 oC) af kul. Sammensat primært af C6-10-carbonhydrider.] | 292-635-7 | 90641-11-5 | Carc. 1B Muta. 1B | H350
  H340 | GHS08
  Dgr | H350
  H340 | | | J |
| 649-001-00-3 | ekstrakter (råolie), let naphthendestillat solvent | 265-102-1 | 64742-03-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-002-00-9 | ekstrakter (råolie), tungt paraffindestillat solvent | 265-103-7 | 64742-04-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-003-00-4 | ekstrakter (råolie), let paraffindestillat solvent | 265-104-2 | 64742-05-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-004-00-X | ekstrakter (råolie), tungt naphthendestillat solvent | 265-111-0 | 64742-11-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-005-00-5 | ekstrakter (råolie), let vakuumgasolie solvent | 295-341-7 | 91995-78-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-006-00-0 | carbonhydrider, C26-55, aromatrige | 307-753-7 | 97722-04-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-007-00-6 | fedtsyrer, tallolie, reaktionsprodukter med iminodiethanol og borsyre | 400-160-5 | — | Skin Irrit. 2
  Aquatic Chronic 2 | H315
  H411 | GHS07
  GHS09
  Wng | H315
  H411 | | | |
| 649-008-00-1 | rester (råolie), atmosfærisk tårn;
  fuelolie;
  (en sammensat remanens fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-045-2 | 64741-45-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-009-00-7 | gasolier (råolie), tunge vakuum;
  fuelolie;
  (en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C20 til og med C50, med kogeinterval omtrent fra 350 oC til 600 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-058-3 | 64741-57-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-010-00-2 | destillater (råolie), tunge katalytisk krakkede;
  fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C15 til og med C35, med kogeinterval omtrent fra 260 oC til 500 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-063-0 | 64741-61-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-011-00-8 | klarede olier (råolie), katalytisk krakkede;
  fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-064-6 | 64741-62-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-012-00-3 | rester (råolie), hydro-
  krakkede; fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet som
  restfraktionen fra destillation af produkterne fra en hydrokrakningsproces. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC.] | 265-076-1 | 64741-75-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-013-00-9 | rester (råolie), termisk krakkede; fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-081-9 | 64741-80-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-014-00-4 | destillater (råolie), tunge termisk krakkede;
  fuelolie;
  [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C15 til og med C36, med kogeinterval omtrent fra 260 oC til 480 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-082-4 | 64741-81-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-015-00-X | gasolier (råolie), hydrogenbehandlede vakuum-; fuelolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C13 til og med C50, med kogeinterval omtrent fra 230 oC til 600 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-162-9 | 64742-59-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-016-00-5 | rester (råolie), hydroafsvovlede atmosfærisk tårn; fuelolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en remanens fra et atmosfærisk tårn med hydrogen i tilstedeværelse af en katalysator, under betingelser primært for at fjerne organiske svovlforbindelser. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-181-2 | 64742-78-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-017-00-0 | gasolier (råolie), hydroafsvovlede
  tunge vakuum-; fuelolie; [en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlningsproces. Den består af carbonhydrider, overvejende C20 til og med C50 med kogeinterval omtrent fra 350 oC til 600 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent eller mere aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-189-6 | 64742-86-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-018-00-6 | rester (råolie), dampkrakkede;
  fuelolie;
  [en sammensat blanding af carbonhydrider opnået som restfraktionen fra destillation af produkterne fra en dampkrakningsproces (herunder dampkrakning for at fremstille ethylen). Den består overvejende af umættede carbonhydrider, overvejende større end C14, og koger omtrent over 260 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-193-8 | 64742-90-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-019-00-1 | rester (råolie), atmosfæriske;
  fuelolie;
  [en sammensat remanens fra atmosfærisk destillation af råolie.
  Den består af carbonhydrider, overvejende større end C11, og koger omtrent over 200 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 269-777-3 | 68333-22-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-020-00-7 | klarede olier (råolie), hydroafsvovlede katalytisk krakkede;
  fuelolie;
  [En sammensat blanding af carbonhydrider opnået ved at behandle katalytisk krakkede, klarede olier med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 269-782-0 | 68333-26-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-021-00-2 | destillater (råolie), hydroafsvovlede intermediære katalytisk krakkede;
  fuelolie;
  [en sammensat blanding af carbonhydrider opnået ved
  at behandle intermediære katalytisk krakkede destillater med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består af carbonhydrider, overvejende C11 til og med C30, med kogeinterval omtrent fra 205 oC til 450 oC. Den indeholder en forholdsvis stor del tricycliske, aromatiske carbonhydrider.] | 269-783-6 | 68333-27-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-022-00-8 | destillater (råolie), hydroafsvovlede tunge katalytisk krakkede;
  fuelolie;
  [en sammensat blanding af carbonhydrider opnået ved behandling af tunge katalytisk krakkede destillater med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består af carbonhydrider, overvejende C15 til og med C35, med kogeinterval omtrent fra 260 oC til 500 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 269-784-1 | 68333-28-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-023-00-3 | brændselsolie, rester af straight-run gasolier, med højt indhold af svovl;
  fuelolie; | 270-674-0 | 68476-32-4 | Carc. 1B | H350 | HS08
  Dgr | H350 | | | |
| 649-024-00-9 | brændselsolie, rest-; fuelolie;
  [væskeproduktet fra forskellige raffinaderistrømme, sædvanligvis rester. Sammensætningen er kompleks og varierer med råoliekilden.] | 270-675-6 | 68476-33-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-025-00-4 | rester (råolie), katalytisk reformerfraktioneringskolonnerest, destillations-;
  fuelolie;
  (En sammensat remanens fra destillationen af katalytisk reformer- fraktioneringskolonnerest. Den koger omtrent over 399 oC.] | 270-792-2 | 68478-13-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-026-00-X | rester (råolie), tung cokergasolie og vakuumgasolie;
  fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillationen af tung coker-gasolie og vakuumgasolie. Den består overvejende af carbonhydrider, overvejende større end C13, og koger omtrent over 230 oC.] | 270-796-4 | 68478-17-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-027-00-5 | rester (råolie), tunge coker- og lette vakuum-;
  fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillationen af tung coker-gasolie og let vakuumgasolie. Den består overvejende af carbonhydrider, overvejende større end C13, og koger omtrent over 230 oC.] | 270-983-0 | 68512-61-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-028-00-0 | rester (råolie), lette vakuum-;
  fuelolie; [en sammensat remanens fra vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende større end C13, og koger omtrent over 230 oC.] | 270-984-6 | 68512-62-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-029-00-6 | rester (råolie), dampkrakkede, lette;
  fuelolie;
  [en sammensat remanens fra destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af aromatiske og umættede carbonhydrider, større end C7, med kogeinterval omtrent fra 101 oC til 555 oC.] | 271-013-9 | 68513-69-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-030-00-1 | brændselsolie, nr. 6; fuelolie;
  [en brændselsolie med en minimumsviskositet på 900cSt og en maximumsviskositet på 9000cSt ved 37,7 oC.] | 271-384-7 | 68553-00-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-031-00-7 | rester (råolie, topanlægs-, svovlfattige;
  fuelolie;
  [en sammensat, svovlfattig blanding af carbonhybrider fremstillet som restfraktionen fra topanlægsdestillation af råolie. Den udgør resten, efter at straight-run benzinfraktionen, petroleumfraktionen og gasoliefraktionen er blevet fjernet.] | 271-763-7 | 68607-30-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-032-00-2 | gasolier (råolie), tunge, atmosfæriske;
  fuelolie;
  (en sammensat, blanding af carbonhydrider opnået ved destillationen af råolie. Den består af carbonhydrider, overvejende C7 en C35, med kogeinterval omtrent fra 121 oC til 510 oC.] | 272-184-2 | 68783-08-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-033-00-8 | rester (råolie), coker skrubber, indeholder kondenserede aromater; fuelolie;
  [en meget sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillationen af vakuumremanensen og produkterne fra en termisk krakningsproces. Den består overvejende af carbonhydrider, overvejende større end C20 og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 272-187-9 | 68783-13-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-034-00-3 | destillater (råolie), råolierester vakuum-; fuelolie
  [en sammensat blanding af carbonhydrider ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie.] | 273-263-4 | 68955-27-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-035-00-9 | rester (råolie), dampkrakket, harpiksholdige;
  fuelolie;
  [en sammensat remanens fra destillationen af dampkrakkede råolierester.] | 273-272-3 | 68955-36-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-036-00-4 | destillater (råolie), intermediær
  vakuum;
  fuelolie;
  [en sammensat blanding af carbonhybrider fremstillet ved destillationen af remanensen af den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C14 og til og med C42 og koger omtrent i intervallet fra 250 oC til 545 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent eller mere af 4- til 6-leddede kondenserede aromatiske carbonhydrider.] | 274-683-0 | 70592-76-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-037-00-X | destillater (råolie), lette vakuum-;
  fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C11 til og med C35, med kogeinterval omtrent fra 250 oC til 545 oC.] | 274-684-6 | 70592-77-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-038-00-5 | destillater (råolie), vakuum-; fuelolie
  [en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C15 til og med C50, med kogeinterval omtrent fra 270 oC til 600 oC. Denne strøm kan indeholde 5 vægtprocent, eller mere, aromatisk carbonhydrider bestående af 4- til 6-leddede kondenserede ringe.] | 274-685-1 | 70592-78-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-039-00-0 | gasolier (råolie), hydroafsvovlede tunge coker vakuum-; fuelolie;
  [en sammensat blanding af carbonhydrider opnået ved hydroafsvovling af tunge coker-destillat råstoffer. Den består overvejende af carbonhydrider, overvejende C18 til C44, med kogeinterval omtrent fra 304 oC til 548 oC. Indeholder sandsynligvis 5 %, eller mere, aromatiske carbonhydrider bestående, af 4- til 6-leddede kondenserede ringe.] | 285-555-9 | 85117-03-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-040-00-6 | rester (råolie), dampkrakkede, destillater;
  fuelolie;
  [en sammensat blanding af carbonhydrider opnået under fremstillingen af raffineret råolietjære ved destillation af dampkrakket tjære. Den består overvejende af aromatiske og andre carbonhydrider organiske svovlforbindelser.] | 292-657-7 | 90669-75-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-041-00-1 | rester (råolie), vakuum-, lette;
  fuelolie;
  [en sammensat remanens fra vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består overvejende af carbonhydrider, overvejende større end C24, og koger omtrent over 390 oC.] | 292-658-2 | 90669-76-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-042-00-7 | brændselsolie, tung, højt svovlindhold; fuelolie;
  [en sammensat blanding af
  carbonhydrider opnået ved destillation af rå råolie. Den består overvejende af aliphatiske, aromatiske og cycloaliphatiske carbonhydrider, overvejende større end C25, der koger højere end omtrent over 400 oC.] | 295-396-7 | 92045-14-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-043-00-2 | rester (råolie), katalytisk kraknings-;
  fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet som
  restfraktionen fra destillationen af produkterne fra en katalytisk krakningsproces. Den består overvejende af carbonhydrider, overvejende større end C11, der koger
  omtrent over 200 oC.] | 295-511-0 | 92061-97-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-044-00-8 | destillater (råolie), intermediære, katalytisk krakkede, termisk nedbrudte;
  fuelolie;
  [en sammensat blanding af carbonhydrider, fremstillet ved destillationen af produkter fra en katalytisk krakningsproces, som har været brugt som en varmeoverførselsvæske. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 220 oC til 450 oC. Denne strøm indeholder sandsynligvis organiske svovlforbindelser.] | 295-990-6 | 92201-59-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-045-00-3 | restolier (råolie); fuelolie;
  [en sammensat blanding af carbonhydrider, svovlforbindelser og metalholdige organiske forbindelser opnået som resten fra raffinaderifraktionerings-krakningsprocesser. Den danner en færdig olie med viskositet over 2cSt. ved 100 oC.] | 298-754-0 | 93821-66-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-046-00-9 | rester, dampkrakkede, termisk behandlede;
  fuelolie;
  [en sammensat blanding af carbonhydrider opnået ved behandling og destillation af rå, dampkrakket naphtha. Den består overvejende af umættede carbonhydrider, der koger omtrent over 180 oC.] | 308-733-0 | 98219-64-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-047-00-4 | destillater (råolie), hydroafsvovlede full-range middeltunge; fuelolie;
  [en sammensat blanding af carbonhydrider opnået ved
  at behandle en rå råolie med hydrogen. Den består overvejende af carbonhydrider, overvejende C9 til og med C25, med kogeinterval omtrent fra 150 oC til 400 oC.] | 309-863-0 | 101316-57-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-048-00-X | rester (råolie), katalytiske reformer-fraktionator-;
  fuelolie;
  [en sammensat blanding af carbonhydrider fremstillet som
  restfraktionen fra destillation af produkterne fra en katalytisk reformeringsproces. Den består af overvejende aromatiske carbonhydrider, overvejende C10 til og med C25, med kogeinterval omtrent fra 160 oC til 400 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 265-069-3 | 64741-67-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-049-00-5 | råolie;
  [en sammensat blanding af carbonhybrider. Den består overvejende af aliphatiske,
  alicycliske og aromatiske carbonhybrider. Den kan også indeholde små mængder af nitrogen, oxygen- og svovlforbindelser. Denne kategori omfatter lette, middeltunge og tunge råolier, såvel som olier ekstraherede fra tjæresand. Carbonhydridholdige materialer, der kræver større kemiske forandringer for deres udvinding eller omdannelse til råolieraffinaderiføde såsom rå skiferolier, oprensede skiferolier og flydende kulbrændsel er ikke medtaget i denne beskrivelse.] | 232-298-5 | 8002-05-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-050-00-0 | destillater (råolie), lette paraffin-;
  uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede, aliphatiske carbonhydrider normalt til stede i dette råoliedestillationsinterval.] | 265-051-5 | 64741-50-0 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-051-00-6 | destillater (råolie), tunge paraffin-;
  uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede, aliphatiske carbonhydrider.] | 265-052-0 | 64741-51-1 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-052-00-1 | destillater (råolie), lette naphthen-;
  uraffineret eller let raffineret
  baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atomsfærisk destillation af råolie. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cST ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-053-6 | 64741-52-2 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-053-00-7 | destillater (råolie), tunge naphthen-;
  uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-054-1 | 64741-53-3 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-054-00-2 | destillater (råolie), syrebehandlede tunge naphthen-; uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cST ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-117-3 | 64742-18-3 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-055-00-8 | destillater (råolie), syrebehandlede tunge naphthen-; uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-118-9 | 64742-19-4 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-056-00-3 | destillater (råolie), syrebehandlede tunge naphthen-; uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består overvejende af mættede carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC.] | 265-119-4 | 64742-20-7 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-057-00-9 | destillater (råolie), syrebehandlede lette paraffin-; uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består overvejende af mættede carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.] | 265-121-5 | 64742-21-8 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-058-00-4 | Destillater (råolie), kemisk neutraliserede tunge paraffin-;
  uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved en behandlingsproces til fjernelse af sure materialer. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del aliphatiske carbonhydrider.] | 265-127-8 | 64742-27-4 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-059-00-X | destillater (råolie), kemisk neutraliserede lette paraffin-;
  uraffineret eller let raffineret
  baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet mindre end 19cSt ved 40 oC.] | 265-128-3 | 64742-28-5 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-060-00-5 | destillater (råolie) kemisk neutraliserede tunge naphthen-;
  uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-135-1 | 64742-34-3 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-061-00-0 | destillater (råolie), kemisk neutraliserede lette naphthen-;
  uraffineret eller let raffineret baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C15 til og med C30 og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-136-7 | 64742-35-4 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 649-062-00-6 | gasser (råolie), katalytisk krakket naphtha depropanizer-topfraktion, C3-rige syrefrie; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af katalytisk krakkede carbonhydrider og behandlet for at fjerne sure urenheder. Den består af carbonhydrider, C2 til og med C4, overvejende C3.] | 270-755-0 | 68477-73-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-063-00-1 | gasser (råolie), katalytiske krakker;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en katalytisk krakningsproces.] Den består overvejende af aliphatiske carbonhydrider, overvejende C1 til og med C6. | 270-756-6 | 68477-74-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-064-00-7 | gasser (råolie), katalytisk krakker, C1-5-rige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillationen af produkter fra en katalytisk krakningsproces. Den består af aliphatiske carbonhydrider, C1 til og med C6, overvejende C1 til og med C5.] | 270-757-1 | 68477-75-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-065-00-2 | gasser (råolie), katalytisk polymeriseret; naphtha stabilizer-topfraktion, C2-4-rige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af katalytisk polymeriseret naphtha. Den består af aliphatiske carbonhydrider, C2 til og med C6, overvejende C2 til og med C4.] | 270-758-7 | 68477-76-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-066-00-8 | gasser (råolie), katalytisk krakker, C1-4-rige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk reformeringsproces. Den består af carbonhydrider, C1 til og med C6, overvejende C1 til og med C4.] | 270-760-8 | 68477-79-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-067-00-3 | gasser (råolie), C3-5 -olefin- og paraffin-alkyleringsføde-; kulbrintegasser;
  [en sammensat blanding af olefin- og paraffin-carbonhydrider, C3 til og med C5, der anvendes som alkyleringsføde. De omgivende temperaturer er normalt højere end disse blandingers kritiske temperatur.] | 270-765-5 | 68477-83-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-068-00-9 | gasser (råolie), C4-rige; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en
  katalytisk fraktioneringsproces. Den består af aliphatiske carbonhydrider, C3 til og med C5, overvejende C4.] | 270-767-6 | 68477-85-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-069-00-4 | gasser (råolie), deethanizer-topfraktioner;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af gas- og benzinfraktionerne fra den katalytiske krakningsproces. Den indeholder overvejende ethan og ethylen.] | 270-768-1 | 68477-86-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-070-00-X | gasser (råolie), deisobutanizertårn-topfraktioner; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved den atmosfæriske destillation af en butan-butylenstrøm. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C4.] | 270-769-7 | 68477-87-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-071-00-5 | gasser (råolie), tørre depropanizer-, propenrige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra
  gas- og benzinfranktionerne fra en katalytisk krakningsproces. Den består overvejende af propylen med noget ethan og propan.] | 270-772-3 | 68477-90-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-072-00-0 | gasser (råolie), depropanizer-topfraktioner;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillation af produkterne fra gas- og benzinfraktionerne fra en katalytisk krakningsproces. Den består af aliphatiske carbonhydrider, overvejende C2 til og med C4.] | 270-773-9 | 68477-91-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-073-00-6 | gasser (råolie), gas-genvindingsanlæg depropanizer-topfraktioner; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af diverse carbonhydridstrømme. Den består overvejende af carbonhydrider, C1 til og med C4, overvejende propan.] | 270-777-0 | 68477-94-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-074-00-1 | gasser (råolie), Girbatol-enhed føde-;
  kulbrintegasser;
  (en sammensat blanding af carbonhydrider, der anvendes som føde i Girbatol-enheden for at fjerne hydrogensulfid. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C4.] | 270-778-6 | 68477-95-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-075-00-7 | gasser (råolie), isomeriseret naphtha-fraktioneringskolonne-, C4-rige, hydrogensulfidfri;
  kulbrintegasser | 270-782-8 | 68477-99-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-076-00-2 | slutgas (råolie), katalytisk krakket klaret olie og termisk krakket vakuumrest fraktioneringsrefluxkammer;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af katalytisk krakket, klaret olie og termisk krakket vakuumrest. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.] | 270-802-5 | 68478-21-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-077-00-8 | slutgas (råolie), katalytisk krakket naphtha stabiliseringsabsorber-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved stabiliseringen af katalytisk krakket naphtha. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.] | 270-803-0 | 68478-22-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-078-00-3 | slutgas (råolie), katalytisk krakker, katalytisk reformer og hydroafsvovler, kombineret fraktioneringskolonne-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af produkterne fra katalytiske kraknings-, katalytiske reformerings- og hydroafsvovlingsprocesser, behandlet for at fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.] | 270-804-6 | 68478-24-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-079-00-9 | slutgas (råolie), katalytisk reformeret naphtha fraktioneringsstabilizer-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af katalytisk reformeret naphtha. Den består overvejende af carbonhydrider, overvejende
  C1 til og med C4.] | 270-806-7 | 68478-26-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-080-00-4 | slutgas (råolie), blandet saturatgasanlægsstrøm, C4-rig; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af straight-run naphtha, destillationsslutgas og katalytisk reformeret naphthastabilizerslutgas. Den består af carbonhydrider, C3 til og med C6, overvejende butan og isobutan.] | 270-813-5 | 68478-32-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-081-00-X | slutgas (råolie), saturatgasanlæg genvindings-, C1-2-rig; kulbrintegasser
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af destillatslutgas, straight-run naphtha, katalytisk reformeret naphthastabilizerslutgas. Den består overvejende af carbonhydrider, C1 til og med C5, overvejende methan og ethan.] | 270-814-0 | 68478-33-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-082-00-5 | slutgas (råolie), vakuumrester, termisk krakker-; kulbrintegasser
  [en sammensat blanding af carbonhydrider opnået ved termisk krakning af vakuumrester. Den består af carbonhydrider, overvejende C1 til og med C5.] | 270-815-6 | 68478-34-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-083-00-0 | carbonhydrider, C3-4-rige, råoliedestillat;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation og kondensation af råolie. Den består af carbonhydrider, C3 til og med C5, overvejende C3 til og med C4.] | 270-990-9 | 68512-91-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-084-00-6 | gasser (råolie), full-range straight-run naphtha dehexanizer-aftræks-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af full-range, straight-run naphtha. Den består af carbonhydrider, overvejende C2 til og med C6.] | 271-000-8 | 68513-15-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-085-00-1 | gasser (råolie), hydrokrakningsdepropanizer-aftræks-, carbonhydridrige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillationen af produkterne fra en hydrokrakningsproces. Den består overvejende af carbonhydrider, overvejende C1 til og med C4. Den kan også indeholde små mængder hydrogen og hydrogensulfid.] | 271-001-3 | 68513-16-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-086-00-7 | gasser (råolie), let straight-run naphtha stabilizer-aftræks-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved stabiliseringen af let, straight-run naphtha. Den består af mættede, aliphatiske carbonhydrider, overvejende C2 til og med C6.] | 271-002-9 | 68513-17-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-087-00-2 | rester (råolie), alkyleringssplitter-, C4-rige
  kulbrintegasser;
  [en sammensat remanens fra destillationen af strømme fra forskellige
  raffinaderiprocesser. Den består af carbonhydrider C4 til og med C5, overvejende butan, med kogeinterval omtrent fra -11,7 oC til 27,8 oC.] | 271-010-2 | 68513-66-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-088-00-8 | carbonhydrider, C1-4-; kulbrintegasser;
  [en sammensat blanding af
  carbonhydrider fremstillet ved termiske kraknings- og absorberprocesser samt ved destillation af råolie. Den består af carbonhydrider, overvejende C1 til og med C4, med kogeinterval omtrent fra - 164 oC til -0,5 oC.] | 271-032-2 | 68514-31-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-089-00-3 | carbonhydrider, C1-4-, sweetened; kulbrintegasser;
  [ensammensat blanding af carbonhydrider opnået ved
  at underkaste carbonhydrider en sweetening-proces for at omdanne mercaptaner eller for at fjerne sure urenheder. Den består af carbonhydrider, overvejende C1 til og med C4 med kogeinterval omtrent fra - 164 oC til -0,5 oC
  .] | 271-038-5 | 68514-36-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-090-00-9 | carbonhydrider, C1-3-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider, overvejende C1 til og med C3, med kogeinterval omtrent fra - 164 oC til - 42 oC.] | 271-259-7 | 68527-16-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-091-00-4 | carbonhydrider, C1-4-, debutanizer-fraktion;
  kulbrintegasser | 271-261-8 | 68527-19-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-092-00-X | gasser (råolie), C1-5-, våde; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af råolie og/eller krakningen af tårn-gasolie. Den består af carbonhydrider, overvejende C1 til og med C5.] | 271-624-0 | 68602-83-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-093-00-5 | carbonhydrider, C2-4-; kulbrintegasser | 271-734-9 | 68606-25-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-094-00-0 | carbonhydrider, C3-; kulbrintegasser | 271-735-4 | 68606-26-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-095-00-6 | gasser (råolie), alkyleringsføde;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved
  den katalytiske krakning af gasolie. Den består af carbonhydrider, overvejende C3 til og med C4.] | 271-737-5 | 68606-27-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-096-00-1 | gasser (råolie), depropanizer-bundfraktioner, fraktioneringsaftræks-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af depropanizer-bundfraktioner. Den består overvejende af butan, isobutan og butadien.] | 271-742-2 | 68606-34-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-097-00-7 | gasser (råolie), raffinaderiblandings-;
  kulbrintegasser;
  [en sammensat blanding opnået fra forskellige raffinaderiprocesser.
  Den består af hydrogen, hydrogensulfid og carbonhydrider, overvejende C1 til og med C5.] | 272-183-7 | 68783-07-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-098-00-2 | gasser (råolie), katalytisk krakkede;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en katalytisk krakningsproces.] Den består overvejende af carbonhydrider, overvejende C3 til og med C5.] | 272-203-4 | 68783-64-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-099-00-8 | gasser (råolie), C2-4-, sweetenede;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider, opnået ved
  at underkaste et råoliedestillat en sweeteningsproces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af mættede og umættede carbonhydrider, overvejende C2 til og med C4, med kogeinterval omtrent fra - 51 oC til - 34 oC.] | 272-205-5 | 68783-65-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-100-00-1 | gasser (råolie), råoliefraktioneringsaftræks-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved fraktioneringen af råolie. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 272-871-7 | 68918-99-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-101-00-7 | gasser (råolie), dehexanizer-aftræks-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved
  fraktioneringen af kombinerede naphthastrømme. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 272-872-2 | 68919-00-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-102-00-2 | gasser (råolie), let straight-run benzinfraktioneringsstabilizer-aftræks-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af let straight-run benzin. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 272-878-5 | 68919-05-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-103-00-8 | gasser (råolie), naphthaunifiner-afsvovling, stripperaftræks-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved en naphtha unifiner-afsvovlingsproces og strippet fra naphthaproduktet. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C4.] | 272-879-0 | 68919-06-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-104-00-3 | gasser (råolie), straight-run naphtha katalytisk reformeringsaftræks-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha og fraktionering af det totale udløb. Den består af methan, ethan og propan.] | 272-882-7 | 68919-09-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-105-00-9 | gasser (råolie), fluidiseret katalytisk krakker splitter-topfraktioner; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved fraktioneringen af chargen til
  C3 -C4-splitteren. Den består overvejende af C3-carbonhydrider.] | 272-893-7 | 68919-20-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-106-00-4 | gasser (råolie), straight-run stabilizeraftræks-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af væsken fra det første tårn brugt ved destillationen af råolie. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C4.] | 272-883-2 | 68919-10-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-107-00-X | gasser (råolie), katalytisk krakker naphtha debutanizer-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af katalytisk krakket naphtha. Den består af carbonhydrider, overvejende C1 til og med C4.] | 273-169-3 | 68952-76-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-108-00-5 | slutgas (råolie), katalytisk krakket destillat- og naphthastabilizer-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af katalytisk krakket naphta og destillat. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.] | 273-170-9 | 68952-77-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-109-00-0 | slutgas (råolie), termisk krakket destillat, gasolie og naphtha absorber-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved separationen af termisk krakkede destillater, naphtha og gasolie. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.] | 273-175-6 | 68952-81-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-110-00-6 | slutgas (råolie), termisk krakket carbonhydrid fraktioneringsstabilizer, råolieforkoksnings-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af termisk krakkede carbonhydrider fra en råolieforkoksningsproces. Den består af carbonhydrider, overvejende C1 til og med C6.] | 273-176-1 | 68952-82-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-111-00-1 | gasser (råolie), lette, dampkrakkede, butadienkoncentrat; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en termisk krakningsproces. Den består af carbonhydrider, overvejende C4.] | 273-265-5 | 68955-28-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-112-00-7 | gasser (råolie), straight-run naphtha katalytisk reformer stabilizer topfraktions-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved naphtha og fraktioneringen af det totale udløb. Den består af mættede aliphatiske carbonhydrider, overvejende C2 til og med C4.] | 273-270-2 | 68955-34-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-113-00-2 | carbonhydrider, C4-; kulbrintegasser | 289-339-5 | 87741-01-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-114-00-8 | alkaner, C1-4-, C3-rige; kulbrintegasser | 292-456-4 | 90622-55-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-115-00-3 | gasser (råolie), dampkrakker, C3-rige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en dampkrakningsproces. Den består overvejende af propylen, sammen med noget propan, med kogeinterval omtrent fra - 70 oC til 0 oC.] | 295-404-9 | 92045-22-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-116-00-9 | carbonhydrider, C4-, dampkrakker-destillat;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af C4-carbonhydrider, overvejende 1-buten og 2-buten, og indeholder også butan og isobuten, med kogeinterval omtrent fra - 12 oC til 5 oC.] | 295-405-4 | 92045-23-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-117-00-4 | råoliegasser, fortættede, sweetenede, C4-fraktion; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved at underkaste en fortættet råoliegasblanding en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af mættede og umættede C4-carbonhydrider.] | 295-463-0 | 92045-80-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K S U |
| 649-118-00-X | carbonhydrider, C4-, 1,3-butadien- og isobutenfrie; kulbrintegasser | 306-004-1 | 95465-89-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-119-00-5 | raffinater (råolie), dampkrakket C4-fraktion, kobberammoniumacetatekstraktion, C3-5- og C3-5-umættede, butadienfrie; kulbrintegasser | 307-769-4 | 97722-19-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-120-00-0 | gasser (råolie), aminsystemføde-;
  raffinaderigas;
  [fødegassen til aminsystemet for fjernelse af hydrogensulfid. Den består af hydrogen. Carbonmonoxid, carbondioxid, hydrogensulfid og aliphatiske carbonhydrider, C1 til og med C5, kan også være til stede.] | 270-746-1 | 68477-65-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-121-00-6 | gasser (råolie), benzenenheds-hydroafsvovleraftræks-;
  raffinaderigas;
  [aftræksgasser fra benzenenheden. De består primært af hydrogen. Carbonmonoxid og carbonhydrider, overvejende C1 til og med C6, herunder benzen, kan også være til stede.] | 270-747-7 | 68477-66-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-122-00-1 | gasser (råolie), benzenenhed recirkulations-, hydrogenrige;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved at recirkulere gasserne fra benzenenheden. Den består primært af hydrogen med forskellige små mængder carbonmonoxid og carbonhydrider, C1 til og med C6.] | 270-748-2 | 68477-67-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-123-00-7 | gasser (råolie), blandingsolie-, hydrogen- og nitrogenrige;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved destillation af en blandingsolie. Den består primært af hydrogen og nitrogen med forskellige små mængder carbonmonoxid, carbondioxid og aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 270-749-8 | 68477-68-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-124-00-2 | gasser (råolie), katalytisk reformeret naphtha-stripper-topfraktioner;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved stabiliseringen af katalytisk reformeret naphtha. Den består af hydrogen og mættede aliphatiske carbonhydrider, overvejende
  C1 til og med C4.] | 270-759-2 | 68477-77-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-125-00-8 | gasser (råolie), C6-8-katalytisk reformer recirkulations-;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillation af produkter fra katalytisk reformering af C6-C8-føde, og recirkuleret for at bevare hydrogen. De består primært af hydrogen. Den kan også indeholde varierende små mængder carbonmonoxid, carbondioxid, nitrogen og carbonhydrider, overvejende C1 til og med C6.] | 270-761-3 | 68477-80-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-126-00-3 | gasser (råolie), C6-8-katalytisk reformer-;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra katalytisk reformering af C6-C8-føde. Den består af C1 til og med C5-carbonhydrider og hydrogen.] | 270-762-9 | 68477-81-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-127-00-9 | gasser (råolie), C6-8-katalytisk reformer recirkulations-, hydrogenrige; raffinaderigas | 270-763-4 | 68477-82-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-128-00-4 | gasser (råolie), C2-returstrøms-;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved
  ekstraktionen af hydrogen fra en gasstrøm, som primært består af hydrogen med små mængder nitrogen, carbonmonoxid, methan, ethan og ethylen. Den består overvejende af carbonhydrider, såsom methan, ethan og ethylen, med små mængder hydrogen, nitrogen og carbonmonoxid.] | 270-766-0 | 68477-84-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-129-00-X | gasser (råolie), tørre sure, gaskoncentreringsenhed aftræks-;
  raffinaderigas;
  [den sammensatte blanding af tørre gasser fra en gaskoncentreringsenhed. Den består af hydrogen, hydrogensulfid og carbonhydrider, overvejende C1 til og med C3.] | 270-774-4 | 68477-92-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-130-00-5 | gasser (råolie), gaskoncentrering reabsorberdestillations-;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra blandede gasstrømme i en gaskoncentreringsreabsorber. Den består overvejende af hydrogen, carbonmonoxid, carbondioxid, nitrogen, hydrogensulfid og carbonhydrider, C1 til og med C3.] | 270-776-5 | 68477-93-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-131-00-0 | gasser (råolie), hydrogenabsorber- aftræks-;
  raffinaderigas;
  [en sammensat blanding opnået ved at absorbere
  hydrogen fra en hydrogenrig strøm. Den består af hydrogen, carbonmonoxid, nitrogen og
  methan med små mængder
  C2-carbonhydrider.] | 270-779-1 | 68477-96-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-132-00-6 | gasser (råolie), hydrogenrige;
  raffinaderigas;
  [en sammensat blanding separeret som en gas fra carbonhydridgasser ved afkøling. Den består primært af hydrogen med forskellige små mængder carbonmonoxid, nitrogen, methan og C2-carbonhydrider.] | 270-780-7 | 68477-97-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-133-00-1 | gasser (råolie), hydrogenbehandler blandingsolierecirkulations-, hydrogen- og nitrogenrige;
  raffinaderigas;
  [en sammensat blanding opnået fra recirkuleret hydrogenbehandlet blandingsolie. Den består primært af hydrogen og nitrogen med forskellige små mængder carbonmonoxid, carbondioxid og carbonhydrider, overvejende C1 til og med C5.] | 270-781-2 | 68477-98-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-134-00-7 | gasser (råolie), recirkulations-, hydrogenrige;
  raffinaderigas;
  [en sammensat blanding opnået fra recirkulerede reaktorgasser. Den består primært af hydrogen med forskellige små mængder carbonmonoxid, carbondioxid, nitrogen, hydrogensulfid og mættede, aliphatiske carbonhydrider, C1 til og med C5.] | 270-783-3 | 68478-00-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-135-00-2 | gasser (råolie), reformer-make-up, hydrogenrige; raffinaderigas;
  [en sammensat blanding
  opnået fra reformerne. Den består primært af hydrogen med forskellige små mængder carbonmonoxid og aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 270-784-9 | 68478-01-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-136-00-8 | gasser (råolie), reformeringshydrogenbehandler-;
  raffinaderigas;
  [en sammensat blanding opnået fra reformeringshydrogenbehandlingsprocessen. Den består primært af hydrogen, methan og ethan med forskellige små mængder hydrogensulfid og aliphatiske carbonhydrider, overvejende C3 til og med C5.] | 270-785-4 | 68478-02-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-137-00-3 | gasser (råolie), reformeringshydrogenbehandler-, hydrogen- og methanrige;
  raffinaderigas;
  [en sammensat blanding opnået fra reformerings
  hydrogenbehandlingsprocessen. Den består primært af hydrogen og methan med forskellige små mængder carbonmonoxid, carbondioxid, nitrogen og mættede, aliphatiske carbonhydrider, overvejende
  C2 til og med C5.] | 270-787-5 | 68478-03-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-138-00-9 | gasser (råolie), reformeringshydrogenbehandler make-up-, hydrogenrige;
  raffinaderigas;
  [en sammensat blanding opnået fra reformerings
  hydrogenbehandlingsprocessen. Den består primært af hydrogen med forskellige små mængder carbonmonoxid og aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 270-788-0 | 68478-04-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-139-00-4 | gasser (råolie), termisk krakning destillations-;
  raffinaderigas;
  [en sammensat blanding fremstillet ved destillation af produkterne fra en termisk krakningsproces. Den består af hydrogen, hydrogensulfid, carbonmonoxid, carbondioxid og carbonhydrider, overvejende C1 til og med C6.] | 270-789-6 | 68478-05-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-140-00-X | slutgas (råolie), katalytisk krakker-refraktioneringsabsorber-; raffinaderigas;
  [en sammensat blanding af
  carbonhydrider opnået ved fraktionering af produkter fra en katalytisk krakningsproces. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C3.] | 270-805-1 | 68478-25-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-141-00-5 | slutgas (råolie), katalytisk reformeret naphtha-separator-; raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C6.] | 270-807-2 | 68478-27-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-142-00-0 | slutgas (råolie), katalytisk reformeret naphtha-stabilizer-; raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved stabiliseringen af katalytisk reformeret naphta. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C6.] | 270-808-8 | 68478-28-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-143-00-6 | slutgas (råolie), krakket destillat hydrogenbehandlerseparator-; raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved at behandle krakkede destillater med hydrogen i tilstedeværelse af en katalysator. Den består af hydrogen og mættede, aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 270-809-3 | 68478-29-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-144-00-1 | slutgas (råolie), hydroafsvovlet straight-run-naphtha-separator-;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved
  hydroafsvovling af straight-run naphtha. Den består af hydrogen og mættede, aliphatiske carbonhydrider, overvejende C1 til og med C6.] | 270-810-9 | 68478-30-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-145-00-7 | gasser (råolie), katalytisk reformeret straight-run naphtha stabilizer-topfraktioner;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha, efterfulgt af fraktionering af det totale udløb. Den består af hydrogen, methan, ethan og propan.] | 270-999-8 | 68513-14-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-146-00-2 | gasser (råolie), reformer-udløbs højtryksflashkammer aftræks-;
  raffinaderigas;
  [en sammensat blanding fremstillet ved højtryks-flashing af udløbet fra reformeringsreaktoren. Den består primært af hydrogen med forskellige små mængder methan, ethan og propan.] | 271-003-4 | 68513-18-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-147-00-8 | gasser (råolie), reformer-udløbs lavtryks-flashkammer aftræks-;
  raffinaderigas;
  [en sammensat blanding fremstillet ved lavtryks-flashing af udløbet fra reformeringsreaktoren. Den består primært af hydrogen med forskellige små mængder methan, ethan og propan.] | 271-005-5 | 68513-19-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-148-00-3 | gasser (råolie), olieraffinaderigas destillationsaftræks-;
  raffinaderigas;
  [en sammensat blanding separeret ved destillation af en gasstrøm indeholdende hydrogen, carbonmonoxid, carbondioxid og carbonhydrider, C1 til og med C6, eller opnået ved krakning af ethan og propan. Den består af carbonhydrider, overvejende C1 til og med C2, hydrogen, nitrogen og carbonmonoxid.] | 271-258-1 | 68527-15-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-149-00-9 | gasser (råolie), benzenenhed hydrogenbehandler depentanizer-topfraktioner; raffinaderigas;
  [en sammensat blanding fremstillet ved at behandle føden fra benzenenheden med hydrogen i tilstedeværelse af en katalysator, efterfulgt af depentanisering. Den består primært af hydrogen, ethan og propan med forskellige små mængder nitrogen, carbonmonoxid, carbondioxid og carbonhydrider, overvejende C1 til og med C6. Den kan indeholde spormængder af benzen.] | 271-623-5 | 68602-82-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-150-00-4 | gasser (råolie), sekundære absorberaftræks-, fluidiseret katalytisk krakker-topfraktioner fraktionerings-; raffinaderigas;
  [en sammensat blanding fremstillet ved fraktioneringen
  af topfraktionsprodukterne fra den katalytiske krakningsproces i den fluidiserede katalytiske krakker. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C3.] | 271-625-6 | 68602-84-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-151-00-X | råolieprodukter, raffinaderigasser;
  rafinaderigas; [en sammensat blanding, som primært består af hydrogen
  med forskellige små mængder methan, ethan og propan.] | 271-750-6 | 68607-11-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-152-00-5 | gasser (råolie), hydrokrakning lavtryks-separator-; raffinaderigas;
  [en sammensat blanding opnået ved væske-damp-separationen af udløbet fra hydrokrakningsprocesreaktoren. Den består overvejende af hydrogen og mættede carbonhydrider, overvejende C1 til og med C3.] | 272-182-1 | 68783-06-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-153-00-0 | gasser (råolie), raffinaderi; raffinaderigas;
  [en sammensat blanding opnået fra forskellige
  råolieraffineringsoperationer. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C3.] | 272-338-9 | 68814-67-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-154-00-6 | gasser (råolie), platformer-produkter separatoraftræks-;
  raffinaderigas;
  [en sammensat blanding opnået fra den kemiske reformering af naphthener til aromater. Den består af hydrogen og mættede aliphatiske carbonhydrider, overvejende C2 til og med C4.] | 272-343-6 | 68814-90-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-155-00-1 | gasser (råolie), hydrogenbehandlet sur petroleum depentanizer stabilisatoraftræks-;
  raffinaderigas;
  [den sammensatte blanding opnået fra depentanizer-stabiliseringen af hydrogenbehandlet petroleum. Den består primært af hydrogen, methan, ethan og propan med forskellige små mængder af nitrogen, hydrogensulfid, carbonmonoxid og carbonhydrider, overvejende C4 til og med C5.] | 272-775-5 | 68911-58-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-156-00-7 | gasser (råolie), hydrogenbehandlet, sur petroleum-flashkammer-; raffinaderigas;
  [en sammensat blanding opnået fra flashkammeret fra enheden, der behandler sur petroleum med hydrogen i tilstedeværelse af en katalysator. Den består primært af hydrogen og methan med forskellige små mængder af nitrogen, carbonmonoxid, og carbonhydrider, overvejende C2 til og med C5.] | 272-776-0 | 68911-59-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-157-00-2 | gasser (råolie), destillat unifiner afsvovlingsstripper aftræks-;
  raffinaderigas;
  [en sammensat blanding strippet fra væskeproduktet fra unifiner afsvovlingsprocessen. Den består af hydrogensulfid, methan, ethan og propan.] | 272-873-8 | 68919-01-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-158-00-8 | gasser (råolie), fluidiseret katalytisk krakker fraktioneringsaftræks-;
  raffinaderigas;
  [en sammensat blanding fremstillet ved fraktioneringen
  af topfraktionsproduktet fra den fluidiserede katalytiske krakningsproces. Den består af hydrogen, hydrogensulfid, nitrogen og carbonhydrider, overvejende
  C1 til og med C5.] | 272-874-3 | 68919-02-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-159-00-3 | gasser (råolie), fluidiseret katalytisk krakker skrubning, sekundære absorberaftræks-;
  raffinaderigas;
  [en sammensat blanding fremstillet ved at skrubbe topfraktionsgassen fra den fluidiserede, katalytiske krakker. Den består af hydrogen, nitrogen, methan, ethan og propan.] | 272-875-9 | 68919-03-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-160-00-9 | gasser (råolie), tungt destillat, hydrogenbehandlerafsvovler stripper aftræks-;
  raffinaderigas;
  [en sammensat blanding strippet fra væskeproduktet fra hydrogenbehandling-afsvovling af tungt destillat. Den består af hydrogen, hydrogensulfid og mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 272-876-4 | 68919-04-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-161-00-4 | gasser (råolie), platformerstabilizer aftræks-, fraktionering af lette produkter;
  raffinaderigas;
  [en sammensat blanding opnået ved fraktioneringen af de lette produkter fra platinreaktorerne fra platformerenheden. Den består af hydrogen, methan, ethan og propan.] | 272-880-6 | 68919-07-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-162-00-X | gasser (råolie), preflash-tårn aftræks-, rådestillation;
  raffinaderigas;
  [en sammensat blanding fremstillet fra det første tårn brugt ved destillationen af råolie. Den består af nitrogen og mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 272-881-1 | 68919-08-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-163-00-5 | gasser (råolie), tjærestripperaftræks-;
  raffinaderigas;
  [en sammensat blanding opnået ved fraktioneringen af reduceret råolie. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C4.] | 272-884-8 | 68919-11-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-164-00-0 | gasser (råolie), unifiner stripperaftræks-;
  raffinaderigas;
  [en blanding af hydrogen og methan opnået ved fraktioneringen af produkterne fra unifiner-enheden.] | 272-885-3 | 68919-12-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-165-00-6 | slutgas (råolie), katalytisk hydroafsvovlet naphthaseparator-;
  raffinaderigas;
  [en sammensat blanding af carbonhydrider opnået ved hydroafsvovlingen af naphtha. Den består af hydrogen, methan, ethan og propan.] | 273-173-5 | 68952-79-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-166-00-1 | slutgas (råolie), straight-run naphtha hydroafsvovler-; raffinaderigas;
  [en sammensat blanding
  opnået ved hydroafsvovlingen af straight-run naphtha. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C5.] | 273-174-0 | 68952-80-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-167-00-7 | gasser (råolie), sponge absorber aftræks-, fluidiseret katalytisk krakker og gasolieafsvovler topfraktionsfraktionering;
  raffinaderigas;
  [en sammensat blanding opnået ved fraktionering af produkterne fra den fluidiserede katalytiske krakker og gasolieafsvovler. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C4.] | 273-269-7 | 68955-33-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-168-00-2 | gasser (råolie), rådestillation og katalytisk krakning;
  raffinaderigas;
  [en sammensat blanding fremstillet ved rådestillations
  og katalytiske krakningsprocesser. Den består af hydrogen, hydrogensulfid, nitrogen, carbonmonoxid og paraffin- og olefincarbonhydrider, overvejende C1 til og med C6.] | 273-563-5 | 68989-88-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-169-00-8 | gasser (råolie), gasolie diethanolaminskrubber- aftræks-; raffinaderigas;
  [en sammensat blanding fremstillet ved afsvovling af gasolier med diethanolamin. Den består overvejende af hydrogensulfid, hydrogen og aliphatiske carbonhydrider, overvejende C1 til og med C5.] | 295-397-2 | 92045-15-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-170-00-3 | gasser (råolie), gasolie, hydroafsvovlingsudløbs-; raffinaderigas;
  [en sammensat blanding opnået ved separation af væskefasen fra udløbet fra hydrogeneringsreaktionen. Den består overvejende af hydrogen, hydrogensulfid og aliphatiske carbonhydrider, overvejende C1 til og med C3.] | 295-398-8 | 92045-16-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-171-00-9 | gasser (råolie), gasoliehydroafsvovling-udblæsnings-; raffinaderigas;
  [en sammensat blanding af gasser opnået fra reformeren og fra udblæsningerne fra hydrogeneringsreaktoren. Den består overvejende af hydrogen og aliphatiske carbonhydrider, overvejende C1 til og med C4.] | 295-399-3 | 92045-17-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-172-00-4 | gasser (råolie), hydrogenatorudløb-flashkammer- aftræks-;
  raffinaderigas;
  [en sammensat blanding af gasser opnået fra flashing af udløbene efter hydrogeneringsreaktionen. Den består overvejende af hydrogen og aliphatiske carbonhydrider, overvejende C1 til og med C6.] | 295-400-7 | 92045-18-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-173-00-X | gasser (råolie), naphthadampkrakning højtryksrest-;
  raffinaderigas;
  [en sammensat blanding opnået som en blanding af
  de ikke-kondenserbare dele af produktet fra en naphthadampkrakningsproces samt
  restgasser opnået under bearbejdningen af efterfølgende produkter. Den består overvejende af hydrogen og paraffin og olefincarbonhydrider, overvejende C1 til og med C5, og kan også være iblandet naturgas.] | 295-401-2 | 92045-19-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-174-00-5 | gasser (råolie), restvisbreaking-aftræks-;
  raffinaderigas;
  [en sammensat blanding opnået fra viskositetsreduktion af rester i en ovn. Den består overvejende af hydrogensulfid og paraffin og olefincarbonhydrider, overvejende C1 til og med C5.] | 295-402-8 | 92045-20-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-175-00-0 | Foot's olie (råolie), syrebehandlet;
  Foot's olie;
  [en sammensat blanding af carbonhydrider opnået ved behandling af Foot's oil med svovlsyre. Den består overvejende af forgrenede carbonhydrider, overvejende C20 til og med C50.] | 300-225-7 | 93924-31-3 | Flam. Gas 1
  Press. Gas
  Carc. 1B | H220
  H350
  H340 | GHS02
  GHS04
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-176-00-6 | Foot's oil (råolie), lerbehandlet;
  solventekstraherede eller afvoksede tunge restolier;
  [en sammensat blanding af carbonhydrider opnået ved behandling af Foot's oil med naturligt eller modificeret ler, enten i en kontakt- eller perkolationsproces for at fjerne spor af polære forbindelser og urenheder, som er til stede. Den består overvejende af forgrenede carbonhydrider, overvejende C20 til og med C50.] | 300-226-2 | 93924-32-4 | Flam. Gas 1
  Press. Gas
  Carc. 1B | H220
  H350
  H340 | GHS02
  GHS04
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-177-00-1 | gasser (råolie), C3-4-; kulbrintegasser; [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra krakningen af råolie. Den består af carbonhydrider, C3

  til og med C4, overvejende propan og propylen, med kogeinterval omtrent fra - 51 oC til - 1 oC.] | 268-629-5 | 68131-75-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-178-00-7 | slutgas (råolie), katalytisk krakket destillat- og katalytisk krakket naphtha fraktioneringsabsorber-; kulbrintegasser
  [den sammensatte blanding af carbonhydrider fra destillationen af produkterne fra katalytisk krakkede destillater og katalytisk krakket naphtha. Den består overvejende af carbonhydrider, C1

  til og med C4.] | 269-617-2 | 68307-98-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-179-00-2 | slutgas (råolie), katalytisk polymeriseret naphtha fraktionerings-stabilizer-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fra fraktionerings-stabiliseringsprodukterne
  fra polymerisering af naphtha. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.] | 269-618-8 | 68307-99-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-180-00-8 | slutgas (råolie), katalytisk reformeret naphtha fraktionerings-stabilizer-, hydrogensulfid-fri;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider, opnået ved fraktioneringsstabilisering af katalytisk reformeret naphtha, og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.] | 269-619-3 | 68308-00-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-181-00-3 | slutgas (råolie), krakket destillat hydrogenbehandler-stripper-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved at behandle termisk krakkede destillater med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede carbonhydrider, overvejende C1 til og med C6.] | 269-620-9 | 68308-01-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-182-00-9 | slutgas (råolie), straight-run destillat hydroafsvovler-, hydrogensulfidfri; kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved katalytisk hydroafsvovling af straight-run destillater og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.] | 269-630-3 | 68308-10-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-183-00-4 | slutgas (råolie), katalytisk gasoliekrakningsabsorber-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkter fra den katalytiske krakning af gasolie. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.] | 269-623-5 | 68308-03-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-184-00-X | slutgas (råolie), gas-genudvindingsanlægs-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fra destillationen af produkter fra diverse carbonhydridstrømme. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.] | 269-624-0 | 68308-04-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-185-00-5 | slutgas (råolie), gas-genvindingsanlæg deethanizer-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fra destillationen af produkter fra diverse carbonhydridstrømme. Den består af carbonhydrider, overvejende C1 til og med C4.] | 269-625-6 | 68308-05-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-186-00-0 | slutgas (råolie), hydroafsvovlet destillat- og hydroafsvovlet naphtha fraktioneringskolonne-, syrefri;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af hydroafsvovlet naphtha og destillat carbonhydridstrømme og behandlet for at fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.] | 269-626-1 | 68308-06-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-187-00-6 | slutgas (råolie), hydroafsvovlet vakuumgasolie stripper-, hydrogensulfidfri;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved stripningsstabilisering af katalytisk hydroafsvovlet vakuumgasolie og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.] | 269-627-7 | 68308-07-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-188-00-1 | slutgas (råolie), let straight-run naphtha stabilizer-, hydrogensulfidfri;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabilisering af straight-run naphtha og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.] | 269-629-8 | 68308-09-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-189-00-7 | slutgas (råolie), propan- og propylenalkyleringsføde forarbejdningsdeethanizer-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra reaktionen mellem propan og propylen. Den består af carbonhydrider, overvejende C1 til og med C4.] | 269-631-9 | 68308-11-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-190-00-2 | slutgas (råolie), vakuumgasolie hydroafsvovler-, hydrogensulfidfri;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved katalytisk hydroafsvovling af vakuumgasolie og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.] | 269-632-4 | 68308-12-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-191-00-8 | gasser (råolie), katalytisk krakker naphtha debutanizer-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkter fra den katalytiske krakningsproces. Den består af carbonhydrider, overvejende C3 til og med C5, med kogeinterval omtrent fra - 48 oC til 32 oC.] | 270-071-2 | 68409-99-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-193-00-9 | alkaner, C1-2-; kulbrintegasser | 270-651-5 | 68475-57-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-194-00-4 | alkaner, C2-3-; kulbrintegasser | 270-652-0 | 68475-58-1 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-195-00-X | alkaner, C3-4-;
  kulbrintegasser | 270-653-6 | 68475-59-2 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-196-00-5 | alkaner, C4-5-; kulbrintegasser | 270-654-1 | 68475-60-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-197-00-0 | brændselsgasser; kulbrintegasser;
  [en blanding af lette gasser. Den består overvejende af hydrogen og/eller lavmolekylære carbonhydrider.] | 270-667-2 | 68476-26-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-198-00-6 | brændselsgasser, råoliedestillater;
  kulbrintegasser;
  [en sammensat blanding af lette gasser fremstillet ved destillation af råolie og ved katalytisk reformering af naphtha. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C4, med kogeinterval omtrent fra - 217 oC til - 12 oC.] | 270-670-9 | 68476-29-9 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-199-00-1 | carbonhydrider, C3-4-; kulbrintegasser | 270-681-9 | 68476-40-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-200-00-5 | carbonhydrider, C4-5-; kulbrintegasser | 270-682-4 | 68476-42-6 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-201-00-0 | carbonhydrider, C2-4-, C3-rige; kulbrintegasser | 270-689-2 | 68476-49-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-202-00-6 | råoliegasser, fortættede; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af råolie. Den består af carbonhydrider, overvejende C3 til og med C7, med kogeinterval omtrent fra 40 oC til 80 oC.] | 270-704-2 | 68476-85-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K S U |
| 649-203-00-1 | råoliegasser, fortættede sweetenede;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved at underkaste en fortættet råoliegasblanding en sweetening-process for at omdanne mercaptaner eller for at fjerne sure urenheder. Den består af carbonhydrider, overvejende C3 til og med C7, med kogeinterval omtrent fra - 40 oC til 80 oC.] | 270-705-8 | 68476-86-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K S U |
| 649-204-00-7 | gasser (råolie), C3-4-, isobutanrige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fra destillationen af mættede og umættede carbonhydrider, sædvanligvis C3 til og med C6, overvejende butan og
  isobutan. Den består af mættede og umættede carbonhydrider, C3 til og med C4, overvejende isobutan.] | 270-724-1 | 68477-33-8 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-205-00-2 | gasser (råolie), C3-6-, piperylenrige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider fra destillationen af mættede og umættede, aliphatiske carbonhydrider, sædvanligvis C3 til og med C6. Den består af mættede og umættede carbonhydrider, C3 til og med C6, overvejende piperylener.] | 270-726-2 | 68477-35-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-206-00-8 | gasser (råolie), butansplitter- opfraktioner;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved destillationen af butanstrømmen. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C4.] | 270-750-3 | 68477-69-0 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-207-00-3 | gasser (råolie), C2-3-; kulbrintegasser;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkter fra en katalytisk fraktioneringsproces. Den indeholder overvejende ethan, ethylen, propan og propylen.] | 270-751-9 | 68477-70-3 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-208-00-9 | gasser (råolie), katalytisk krakket gasolie depropanizer-bundfraktioner, C4-rige syrefri;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af katalytisk krakket gasoliecarbonhydridstrøm
  og behandlet for at fjerne hydrogensulfid og andre sure komponenter. Den består af C3 til og med C5-carbonhydrider, overvejende C4.] | 270-752-4 | 68477-71-4 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-209-00-4 | gasser (råolie), katalytisk krakket naphtha debutanizer-bundfraktioner, C3-5-rige;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået ved stabilisering af katalytisk krakket naphtha. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C5.] | 270-754-5 | 68477-72-5 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-210-00-X | slutgas (råolie), isomeriseret naphtha fraktioneringsstabilizer-;
  kulbrintegasser;
  [en sammensat blanding af carbonhydrider opnået fra produkter fra fraktioneringsstabiliseringen af isomeriseret naphtha Den består overvejende af carbonhydrider, overvejende C1 til og med C4.] | 269-628-2 | 68308-08-7 | Press. Gas
  Flam. Gas 1
  Carc. 1A Muta. 1B | H220
  H350
  H340 | GHS04
  GHS02
  GHS08
  Dgr | H220
  H350
  H340 | | | K U |
| 649-211-00-5 | Foot's oil (råolie), carbonbehandlet;
  solventekstraherede eller afvoksede tunge restolier
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af Foots oil med aktivt kul for at fjerne sporbestandele og urenheder. Den består overvejende af mættede ligekædede carbonhydrider, overvejende større end C12.] | 308-126-0 | 97862-76-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-212-00-0 | destillater (råolie), sweetenede, middeltunge;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået ved at underkaste et råoliedestillat en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består af carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 150 oC til 345 oC.] | 265-088-7 | 64741-86-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-213-00-6 | gasolier (råolie), solventraffinerede;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C11 til og med C25, med kogeinterval omtrent fra 205 oC til 400 oC.] | 265-092-9 | 64741-90-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-214-00-1 | destillater (råolie), solventraffinerede middeltunge;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 150 oC til 345 oC.] | 265-093-4 | 64741-91-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-215-00-7 | gasolier (råolie), syrebehandlede;
  upecificeret gasolie;
  [en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhybrider, overvejende C13 til og med C25, med kogeinterval omtrent fra 230 oC til 400 oC.] | 265-112-6 | 64742-12-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-216-00-2 | destillater (råolie), syrebehandlede, middeltunge;
  upecificeret gasolie;
  [en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C11 til og med C20, med kogeinterval omtrent fra 205 oC til 345 oC.] | 265-113-1 | 64742-13-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-217-00-8 | destillater (råolie), syrebehandlede, lette;
  upecificeret gasolie;
  [en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.] | 265-114-7 | 64742-14-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-218-00-3 | gasolier (råolie), kemisk neutraliserede;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C13 til og med C25, med kogeinterval omtrent fra 230 oC til 400 oC.] | 265-129-9 | 64742-29-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-219-00-9 | destillater (råolie), kemisk neutraliserede, middeltunge;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C11 til og med C20, med kogeinterval omtrent fra 205 oC til 345 oC.] | 265-130-4 | 64742-30-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-220-00-4 | destillater (råolie), lerbehandlede, middeltunge;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 150 oC til 345 oC.] | 265-139-3 | 64742-38-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-221-00-X | destillater (råolie), hydrogen
  behandlede middeltunge;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C11 til og med C25, med kogeinterval omtrent fra 205 oC til 400 oC.] | 265-148-2 | 64742-46-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-222-00-5 | gasolier (råolie), hydro
  afsvovlede
  upecificeret gasolie;
  [en sammensat blandning af carbonhydrider opnået fra en rå råolie ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består overvejende af carbonhydrider, overvejende C13 til og med C25, med kogeinterval omtrent fra 230 oC til 400 oC] | 265-182-8 | 64742-79-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-223-00-0 | destillater (råolie), hydroafsvovlede, middeltunge;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået fra en rå råolie ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består af carbonhydrider, overvejende C11 til og med C25, med kogeinterval
  omtrent fra 205 oC til 400 oC.] | 265-183-3 | 64742-80-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-224-00-6 | brændstoffer, diesel-;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af råolie. Den består af carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 163 oC til 357 oC.] | 269-822-7 | 68334-30-5 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | N |
| 649-225-00-1 | brændselsolie, nr. 2;
  upecificeret gasolie;
  [en destillatolie med en minimumsviskositet på 2 cSt ved 37,7 oC til et maximum på 3.7 cSt ved 37,7 oC.] | 270-671-4 | 68476-30-2 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 649-226-00-7 | brændselsolie, nr. 4;
  upecificeret gasolie;
  [en destillatolie med en minimumsviskositet på 5.8 cSt ved 37,7 oC til et maximum på 26.4 cSt ved 37,7 oC.] | 270-673-5 | 68476-31-3 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 649-227-00-2 | brændstoffer, diesel-, nr. 2; uspecificeret gasolie;
  [destillatolien med en minimumsviskositet på 2 cSt ved 37,7 oC til et maximum på 4.3 cSt ved 37,7 oC.] | 270-676-1 | 68476-34-6 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 649-228-00-8 | destillater (råolie), katalytisk reformer-fraktioneringskolonnerest, højtkogende;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider fra destillationen af en rest fra en katalytisk reformer fraktioneringskolonne. Den koger omtrent fra 343 oC til 399 oC.] | 270-719-4 | 68477-29-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-229-00-3 | destillater (råolie), katalytisk reformer-fraktioneringskolonnerest, intermediært kogende;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider fra destillationen af en rest fra en katalytisk reformer fraktioneringskolonne. Den koger omtrent fra 288 oC til 371 oC.] | 270-721-5 | 68477-30-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-230-00-9 | destillater (råolie), katalytisk reformer-fraktioneringskolonnerest, lavtkogende;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider fra destillationen af en rest fra en katalytisk reformer fraktioneringskolonne. Den koger omtrent under 288 oC.] | 270-722-0 | 68477-31-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-231-00-4 | destillater (råolie), højt raffinerede, middeltunge;
  upecificeret gasolie;
  (en sammensat blanding af carbonhydrider opnået ved at underkaste en råoliefraktion flere af følgende trin: filtrering, centrifugering, atmosfærisk destillation, vakuumdestillation, syrebehandling, neutralisering og lerbehandling. Den består overvejende af carbonhydrider, overvejende C10 til og med C20) | 292-615-8 | 90640-93-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-232-00-X | destillater (råolie), katalytisk reformer-, tungt aromatisk koncentrat; uspecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået fra destillation af en katalytisk reformeret råoliefraktion. Den består overvejende af aromatiske carbonhydrider, overvejende C10 til og med C16, med kogeinterval omtrent fra 200 oC til
  300 oC.] | 295-294-2 | 91995-34-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-233-00-5 | gasolier, paraffin-; uspecificeret gasolie;
  [et destillat opnået ved redestillationen af en sammensat blanding af carbonhydrider, opnået ved destillationen af spildevandet fra kraftig, katalytisk hydrogenbehandling af paraffiner. Det har kogeinterval omtrent fra 190 oC til 330 oC.] | 300-227-8 | 93924-33-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-234-00-0 | naphtha (råolie), solvent-raffineret hydroafsvovlet tung;
  uspecificeret gasolie | 307-035-3 | 97488-96-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-235-00-6 | carbonhydrider, C16-20-hydrogenbehandlet middeltungt destillat, lette destillater;
  uspecificeret gasolie; [en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra behandlingen af et middeltungt destillat med hydrogen. Den består overvejende af carbonhydrider C16 til og med C20, med kogeinterval omtrent fra 290 oC til 350 oC. Den danner en færdig olie med en viskositet på 2 cSt ved 100 oC.] | 307-659-6 | 97675-85-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-236-00-1 | carbonhydrider, C12-20-, hydrogenbehandlet
  paraffin, lette destillater;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra behandlingen af tunge paraffiner med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende fra C12 til og med C20,
  med kogeinterval omtrent fra 230 oC til 350 oC. Den danner en færdig olie med en viskositet
  på 2 cSt ved 100 oC.] | 307-660-1 | 97675-86-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-237-00-7 | carbonhydrider, C11-17-solvent-ekstraherede, lette, naphthenske;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået ved ekstraktionen af aromaterne fra et let naphthen destillat med en viskositet på 2,2 cSt.]
  ved 40 oC. Den består overvejende af carbonhydrider, overvejende fra C11 til og med C17, med kogeinterval omtrent fra 200 oC til 300 o.] | 307-757-9 | 97722-08-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-238-00-2 | gasolier, hydrogenbehandlede; uspecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået ved redestillation af udløbene fra behandlingen af paraffiner med hydrogen, i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende fra C17 til og med C27, med kogeinterval omtrent fra 330 oC til 340 oC.] | 308-128-1 | 97862-78-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-239-00-8 | destillater (råolie), carbonbehandlet lette paraffin-;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået ved behandling af en råoliefraktion med aktivt kul, til fjernelse af spor af polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende C12 til og med C28.] | 309-667-5 | 100683-97-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-240-00-3 | destillater (råolie), intermediære paraffin-, carbonbehandlede;
  upecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af råolie med aktivt kul, til fjernelse af spor af polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende C16 til og med C36.] | 309-668-0 | 100683-98-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-241-00-9 | destillater (råolie), intermediære paraffin-, lerbehandlede; uspecificeret gasolie;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af råolie med blegejord, til fjernelse af spor polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende C16 til og med C36.] | 309-669-6 | 100683-99-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-242-00-4 | alkaner, C12-26-forgrenede og ligekædede | 292-454-3 | 90622-53-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-243-00-X | smørefedtstoffer; fedt;
  [en sammensat blanding af carbonhydrider, overvejende C12 til og med C50, som kan indeholde organiske salte af alkalimetaller, jordalkalimetaller, og/eller aluminiumforbindelser.] | 278-011-7 | 74869-21-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-244-00-5 | slack wax (råolie), råparaffin;
  [en sammensat blanding af carbonhydrider opnået fra en råoliefraktion ved solventkrystallisation (solventafvoksning), eller som en destillationsfraktion fra en meget voksagtig olie. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.] | 265-165-5 | 64742-61-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-245-00-0 | slack wax (råolie), syrebehandlet;
  råparaffin;
  [en sammensat blandning ekstraktcarbonhydrider opnået som et raffinat ved behandling af en råolie-slack wax i en svovlsyrebehandlingsproces. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.] | 292-659-8 | 90669-77-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-246-00-6 | slack wax (råolie), lerbehandlet;
  råparaffin;
  [en sammensat blanding af carbonhydrider opnået ved behandling af en råolie-slack wax-fraktion med neutralt eller modificeret ler i enten en kontakt- eller en perkoleringsproces. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.] | 292-660-3 | 90669-78-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-247-00-1 | slack wax (råolie), hydrogen
  behandlet;
  råparaffin;
  [en sammensat blanding af carbonhydrider opnået ved at behandle slack wax med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.] | 295-523-6 | 92062-09-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-248-00-7 | slack wax (råolie), lavtsmeltende;
  råparaffin;
  [en sammensat blanding af carbonhydrider opnået fra en råoliefraktion ved solventafparaffinering. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] | 295-524-1 | 92062-10-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-249-00-2 | slack wax (råolie), lavtsmeltende, hydrogenbehandlet;
  råparaffin;
  [en sammensat blanding af carbonhydrider opnået ved behandling af lavtsmeltende råolie-slack wax med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C12.] | 295-525-7 | 92062-11-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-250-00-8 | slack wax (råolie), lavtsmeltende, carbonbehandlet;
  råparaffin;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af lavtsmeltende slack wax med aktivt kul for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] | 308-155-9 | 97863-04-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-251-00-3 | slack wax (råolie), lavtsmeltende, lerbehandlet;
  råparaffin;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af lavtsmeltende råolie-slack wax med bentonit for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] | 308-156-4 | 97863-05-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-252-00-9 | slack wax (råolie), lavtsmeltende, kiselsyrebehandlet; råparaffin; [en sammensat blanding af carbonhydrider opnået ved behandlingen af lavtsmeltende råolie-slack wax med kiselsyre for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] | 308-158-5 | 97863-06-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-253-00-4 | slack wax (råolie), carbonbehandlet;
  råparaffin;
  [en sammensat blanding af carbonhydrider opnået ved behandling af råolie-slack wax med aktivt kul, for at fjerne spor af polære bestanddele og urenheder.] | 309-723-9 | 100684-49-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-254-00-X | vaselin;
  [en sammensat blanding af carbonhydrider udvundet som et halvfast stof fra afvoksning af paraffinrestolie. Den består overvejende af mættede krystallinske og flydende carbonhydrider, overvejende større end C25.] | 232-373-2 | 08-03-8009 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-255-00-5 | vaselin (råolie), oxideret;
  vaselin;
  [en sammensat blanding af organiske forbindelser, overvejende højmolekylære carboxylsyrer, opnået ved luftoxidation af vaselin.] | 265-206-7 | 64743-01-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-256-00-0 | vaselin (råolie), aluminiumoxidbehandlet;
  vaselin;
  [en sammensat blanding af carbonhydrider opnået når vaselin er behandlet med AL2O3 for at fjerne polære komponenter og urenheder. Den består overvejende af mættede, krystallinske og flydende carbonhydrider, overvejende større end C25.] | 285-098-5 | 85029-74-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-257-00-6 | vaselin (råolie), hydrogen
  behandlet;
  vaselin;
  [en sammensat blanding af carbonhydrider opnået som et halvfast stof fra afvokset paraffinrestolie behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede mikrokrystallinske og flydende carbonhydrider, overvejende større end C20.] | 295-459-9 | 92045-77-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-258-00-1 | vaselin (råolie) carbonbehandlet;
  vaselin;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af råolievaselin med aktivt kul for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede carbonhydrider, overvejende større end C20.] | 308-149-6 | 97862-97-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-259-00-7 | vaselin (råolie), kiselsyrebehandlede;
  vaselin;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af råolievaselin med kiselsyre for at fjerne polære sporbestandele og urenheder. Den består overvejende af mættede carbonhydrider, overvejende større end C20.] | 308-150-1 | 97862-98-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-260-00-2 | vaselin (råolie), lerbehandlet;
  vaselin; [en sammensat blanding af carbonhydrider opnået ved behandling af vaselin med blegejord, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende større end C25.] | 309-706-6 | 100684-33-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | N |
| 649-261-00-8 | kondensat, naturgas-;
  lavtkogende nafta;
  [en sammensat blanding af carbonhydrider adskilt fra naturgas ved processer, såsom køling eller absorption. Den består overvejende af mættede aliphatiske carbonhydrider, overvejende C4 til og med C8, med kogeinterval omtrent fra - 20 oC til 120 oC.] | 232-349-1 | 8006-61-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-262-00-3 | naphtha;
  lavtkogende nafta; [raffinerede, delvist raffinerede, eller uraffinerede råolieprodukter fremstillet ved destillation af naturgas. De består af carbonhydrider, overvejende C5 til og med C6, med kogeinterval omtrent fra 100 oC til 200 oC.] | 232-443-2 | 8030-30-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-263-00-9 | ligroin;
  lavtkogende nafta;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneret destillation af råolie. Denne fraktion har kogeinterval omtrent fra 20 oC til 135 oC.] | 232-453-7 | 8032-32-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-264-00-4 | naphtha (råolie), tung straight-run; lavtkogende nafta; [en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC.] | 265-041-0 | 64741-41-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-265-00-X | naphtha (råolie), full-range straight-run-;
  lavtkogende nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 220 oC.] | 265-042-6 | 64741-42-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-266-00-5 | naphtha (råolie), let straight-run-;
  lavtkogende nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består overvejende af aliphatiske carbonhydrider, overvejende C4 til og med C10, med kogeinterval omtrent fra - 20 oC til 180 oC.] | 265-046-8 | 64741-46-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-267-00-0 | solventnaphtha (råolie), let aliphatisk;
  lavtkogende nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillation af råolie eller naturgaskondensat. Den består overvejende af mættede carbonhydrider, overvejende C5 til og med C10, med kogeinterval omtrent fra 35 oC til 160 oC.] | 265-192-2 | 64742-89-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-268-00-6 | destillater (råolie), straight-run, lette;
  lavtkogende nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C2 til og med C7, med kogeinterval omtrent fra - 88 oC til 99 oC.] | 270-077-5 | 68410-05-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-269-00-1 | benzin, damp-genudvindings-; lavtkogende nafta;
  [en sammensat blanding af carbonhydrider separeret fra gasserne fra dampgenvindingssystemer ved afkøling. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 196 oC.] | 271-025-4 | 68514-15-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-270-00-7 | benzin, straight-run topanlægs; lavtkogende nafta;
  [en sammensat blanding af carbonhydrider fremstillet fra topanlægget ved destillation af råolie. Den har et kogeinterval omtrent fra 36,1 oC til 193,3 oC.] | 271-727-0 | 68606-11-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-271-00-2 | naphtha (råolie), ikke-sweetenet; [en sammensat blanding af carbonhydrider fremstillet ved destillation af naphthastrømme fra forskellige raffinaderiprocesser. Den består af carbonhydrider, overvejende C5 til og med C12, med kogeinterval omtrent fra 0 oC til 230 oC.] | 272-186-3 | 68783-12-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-272-00-8 | destillater (råolie), fraktionering af let straight-run benzin stabilizertopfraktioner; lavtkogende nafta;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af let straight-run benzin. Den består af mættede aliphatiske carbonhydrider, overvejende C3 til og med C6.] | 272-931-2 | 68921-08-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-273-00-3 | naphtha (råolie), tung straight-run-, aromatholdig;
  lavtkogende nafta;
  [en sammensat blanding af carbonhydrider opnået ved en destillationsproces af rå råolie. Den består overvejende af carbonhydrider,
  overvejende C8 til og med C12, med kogeinterval omtrent fra 130 oC til 210 oC.] | 309-945-6 | 101631-20-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-274-00-9 | naphtha (råolie), full-range alkylat-;
  lavtkogende modificeret
  nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillation af produkterne fra reaktionen mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 220 oC.] | 265-066-7 | 64741-64-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-275-00-4 | naphtha (råolie), tung alkylat-;
  lavtkogende modificeret nafta; [en sammensat blanding af carbonhydrider fremstillet ved
  destillation af produkterne fra reaktionen mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C9 til og med C12, med kogeinterval omtrent fra 150 oC til 220 oC.] | 265-067-2 | 64741-65-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-276-00-X | naphtha (råolie), let alkylat-;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra reaktionen mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C7 til og med C10, med kogeinterval omtrent fra 90 oC til 160 oC.] | 265-068-8 | 64741-66-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-277-00-5 | naphtha (råolie), isomeriserings-;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk isomerisering af ligekædede paraffincarbonhydrider, C4 til og med C6. Den består overvejende af mættede carbonhydrider, såsom isobutan, isopentan, 2,2-dimethylbutan, 2-methylpentan og 3-methylpentan.] | 265-073-5 | 64741-70-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-278-00-0 | naphtha (råolie), solventraffineret let;
  lavtkogende modificeret
  nafta;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra en
  solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 190 oC.] | 265-086-6 | 64741-84-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-279-00-6 | naphtha (råolie), solventraffineret, tung;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider opnået som
  raffinatet fra en solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 230 oC.] | 265-095-5 | 64741-92-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-280-00-1 | raffinater (råolie), katalytisk reformer ethylenglycol-vand modstrømsekstrakter;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra UDEX-ekstraktionsprocessen af den katalytiske reformerstrøm. Den består af mættede carbonhydrider, overvejende C6 til og med C9.] | 270-088-5 | 68410-71-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-281-00-7 | raffinater (råolie), reformer-, Lurgi-enhedsseparerede;
  lavtkogende modificeret nafta;
  [den sammensatte blanding af carbonhydrider opnået som et raffinat fra en Lurgi-separationsenhed. Den består overvejende af ikke-aromatiske carbonhydrider med varierende små mængder aromatiske carbonhydrider, overvejende C6 til og med C8.] | 270-349-3 | 68425-35-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-282-00-2 | naphtha (råolie), full-range-alkylat-, butanholdig;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra reaktion mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C7 til og med C12, med nogle butaner, med kogeinterval omtrent fra 35 oC til 200 oC.] | 271-267-0 | 68527-27-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-283-00-8 | destillater (råolie), naphthadampkrakningsudvundne, solventraffinerede lette hydrogenbehandlede;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider opnået som raffinaterne fra en solventekstraktionsproces af et hydrogenbehandlet let destillat fra dampkrakket naphtha.] | 295-315-5 | 91995-53-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-284-00-3 | naphtha (råolie), C4-12 butanalkylat, isooctan-rig; lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider opnået ved alkylering af butaner. Den består overvejende af carbonhydrider, overvejende C4 til og med C12, rig på isooctan, med kogeinterval omtrent fra 35 oC til 210 oC.] | 295-430-0 | 92045-49-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-285-00-9 | carbonhydrider, hydrogenbehandlede, lette naphthadestillater, solventraffinerede;
  lavtkogende modificeret nafta; [en sammensat blanding af carbonhydrider opnået fra destillationen af hydrogenbehandlet naphtha, efterfulgt af en solventekstraktions- og destillationsproces. Den består overvejende af mættede carbonhydrider, med kogeinterval omtrent fra 94 oC til 99 oC.] | 295-436-3 | 92045-55-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-286-00-4 | naphtha (råolie), isomerisation, C6-fraktion;
  lavtkogende modificeret
  nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillation af en benzin, der er blevet katalytisk isomeriseret. Den består overvejende af hexanisomerer med kogeinterval omtrent fra 60 oC til 66 oC.] | 295-440-5 | 92045-58-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-287-00-X | carbonhydrider, C6-7 naphthakraknings-, solventraffinerede;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider opnået ved sorptionen af benzen fra en katalytisk, fuldt hydrogeneret,
  benzen-rig carbonhydridfraktion, opnået ved destillation af præhydrogeneret, krakket naphtha. Den består overvejende af paraffin- og naphthencarbonhydrider, overvejende C6 til og med C7, med kogeinterval omtrent fra 70 oC til 100 oC.] | 295-446-8 | 92045-64-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-288-00-5 | carbonhydrider, C6-rige, hydrogenbehandlede lette naphthadistillater, solvent-raffinerede;
  lavtkogende modificeret nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillation af hydrogenbehandlet naphtha
  efterfulgt af solventekstraktion. Den består overvejende af mættede carbonhydrider, med kogeinterval omtrent fra 65 oC til 70 oC.] | 309-871-4 | 101316-67-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-289-00-0 | naphtha (råolie), tung, katalytisk krakket;
  lavtkogende katalytisk krakket nafta:
  [en sammensat blanding af
  carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC. Den indeholder en forholdsvis stor del umættede carbonhydrider.] | 265-055-7 | 64741-54-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-290-00-6 | naphtha (råolie), let katalytisk krakket;
  lavtkogende katalytisk krakket nafta:
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC. Den indeholder en forholdsvis stor del umættede carbonhydrider.] | 265-056-2 | 64741-55-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-291-00-1 | carbonhydrider, C3-11-, katalytisk krakkerdestillater;
  lavtkogende katalytisk krakket nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C3 til og med C11, og koger omtrent op til 204 oC.] | 270-686-6 | 68476-46-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-292-00-7 | naphtha (råolie), katalytisk krakket let destilleret;
  lavtkogende katalytisk krakket
  nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C1 til og med C5.] | 272-185-8 | 68783-09-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-293-00-2 | destillater (råolie), naphthadampkrakningsudvundne, hydrogenbehandlede, lette, aromatiske;
  lavtkogende katalytisk krakket nafta;
  [en sammensat blanding af carbonhydrider opnået ved at behandle et let destillat fra dampkrakket naphtha. Den består overvejende af aromatiske carbonhydrider.] | 295-311-3 | 91995-50-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-294-00-8 | naphtha (råolie), tung katalytisk krakket sweetened; lavtkogende katalytisk krakket nafta;
  [en sammensat blanding af carbonhydrider opnået ved at underkaste et katalytisk krakket råoliedestillat en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 60 oC til 200 oC.] | 295-431-6 | 92045-50-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-295-00-3 | naphtha (råolie), let katalytisk krakket sweetenet; lavtkogende katalytisk krakket nafta;
  [en sammensat blanding af carbonhydrider, opnået ved at underkaste naphtha fra en katalytisk krakningsproces en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 35 oC til 210 oC.] | 295-441-0 | 92045-59-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-296-00-9 | carbonhydrider, C8-12 katalytisk kraknings-, kemisk neutraliserede;
  lavtkogende katalytisk krakket nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af en fraktion fra den katalytiske krakningsproces, der er undergået en alkalisk vask. Den består overvejende af carbonhydrider, overvejende C8 til og med C12, med kogeinterval omtrent fra 130 oC til 210 oC.] | 295-794-0 | 92128-94-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-297-00-4 | carbonhydrider, C8-12- katalytisk krakkerdestillater;
  lavtkogende katalytisk krakket
  nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkter fra en katalytisk krakningsproces. Den består overvejende af carbonhydrider, overvejende C8 til og med C12, med kogeinterval omtrent fra 140 oC til 210 oC.] | 309-974-4 | 101794-97-2 | Carc. 1B
  Muta. 1B A
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-298-00-X | carbonhydrider, C8-12 katalytisk kraknings-, kemisk neutraliserede, sweetenede;
  lavtkogende katalytisk krakket nafta | 309-987-5 | 101896-28-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-299-00-5 | naphtha (råolie), let katalytisk reformeret;
  lavtkogende katalytisk reformeret
  nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk reformeringsproces. Den består af carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 190 oC. Den indeholder en forholdsvis stor del aromatiske og forgrenede carbonhydrider. Denne strøm kan indeholde 10 volumenprocent eller mere benzen.] | 265-065-1 | 64741-63-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-300-00-9 | naphtha (råolie), tung katalytisk reformeret;
  lavtkogende katalytisk reformeret nafta; [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk reformeringsproces. Den består af overvejende aromatiske carbonhydrider, overvejende C7 til og med C12,
  med kogeinterval omtrent fra 90 oC til 230 oC.] | 265-070-9 | 64741-68-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-301-00-4 | destillater (råolie), katalytisk reformerede depentanizer-;
  lavtkogende katalytisk reformeret nafta;
  [en sammensat blanding af carbonhydrider fra destillationen af produkterne fra en katalytisk reformeringsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C3 til og med C6, med kogeinterval omtrent fra - 49 oC til 63 oC.] | 270-660-4 | 68475-79-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-302-00-X | carbonhydrider, C2-6-, C6-8-
  katalytisk reformer;
  lavtkogende katalytisk reformeret nafta | 270-687-1 | 68476-47-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-303-00-5 | rester (råolie), C6-8-,
  katalytisk reformer;
  lavtkogende katalytisk reformeret nafta;
  [en sammensat remanens fra den katalytiske reformering af C6-8-føde. Den består af carbonhydrider, overvejende C2 til og med C6.] | 270-794-3 | 68478-15-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-304-00-0 | naphtha (råolie), let katalytisk reformeret, aromatfri; lavtkogende katalytisk reformeret nafta;
  [en sammensat blanding af carbonhydrider opnået ved
  destillation af produkterne fra en katalytisk reformeringsproces. Den består overvejende af carbonhydrider,
  overvejende C5 til og med C8, med kogeinterval omtrent fra 35 oC til 120 oC. Den indeholder en forholdsvis stor del forgrenede carbonhydrider, hvorfra de aromatiske komponenter er fjernet.] | 270-993-5 | 68513-03-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-305-00-6 | destillater (råolie), katalytisk reformeret straight-run naphtha topfraktioner;
  lavtkogende katalytisk reformeret nafta;
  [en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha, efterfulgt af fraktionering af det totale udløb. Den består af mættede, aliphatiske carbonhydrider, overvejende C2 til og med C6.] | 271-008-1 | 68513-63-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-306-00-1 | råolieprodukter, hydrofiner-powerformer reformater;
  lavtkogende katalytisk reformeret nafta;
  [den sammensatte blanding af carbonhydrider, opnået ved en hydrofiner-powerformer-proces, med kogeinterval omtrent fra 27 oC til 210 oC.] | 271-058-4 | 68514-79-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-307-00-7 | naphtha (råolie), full-range reformeret;
  lavtkogende katalytisk reformeret nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en katalytisk reformeringsproces. Den består af carbonhydrider, overvejende C5 til og med C12, med kogeinterval omtrent fra 35 oC til 230 oC.] | 272-895-8 | 68919-37-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-308-00-2 | naphtha (råolie), katalytisk reformeret;
  lavtkogende katalytisk reformeret nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved
  destillationen af produkter fra en katalytisk reformeringsproces. Den består af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra 30 oC til 220 oC. Den indeholder en forholdsvis stor del aromatiske og forgrenede carbonhydrider. Denne strøm kan indeholde 10 volumenprocent, eller mere, benzen.] | 273-271-8 | 68955-35-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-309-00-8 | destillater (råolie), katalytiske reformerede hydrogenbehandlede lette, C8-12-aromatfraktion; lavtkogende katalytisk reformeret nafta;
  [en sammensat blanding af alkylbenzener opnået ved katalytisk reformering af råolienaphta. Den består overvejende af alkylbenzener, overvejende C8 til og med C10, med kogeinterval omtrent fra 160 oC til 180 oC.] | 285-509-8 | 85116-58-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-310-00-3 | aromatiske carbonhydrider, C8-, katalytisk reformeringsudvundne;
  lavtkogende katalytisk reformeret nafta | 295-279-0 | 91995-18-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-311-00-9 | aromatiske carbonhydrider, C7-12, C8-rige;
  lavtkogende katalytisk reformeret
  nafta;
  [en sammensat blanding af carbonhydrider opnået ved separation fra den platformatholdige fraktion. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C12 (primært C8) og kan indeholde ikke-aromatiske carbonhydrider, begge med kogeinterval omtrent fra 130 oC til 200 oC.] | 297-401-8 | 93571-75-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-312-00-4 | benzin, C5-11-, højoktan stabiliseret reformeret;
  lavtkogende katalytisk reformeret nafta;
  [en sammensat højoktanblanding af carbonhydrider opnået ved katalytisk dehydrogenering af en overvejende naphthenisk naphtha. Den består overvejende af aromater og ikke-aromater, overvejende C5 til og med C11, med kogeinterval omtrent fra 45 oC til 185 oC.] | 297-458-9 | 93572-29-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-313-00-X | carbonhydrider, C7-12-, C>9-aromatrige, reformering, tung fraktion; lavtkogende katalytisk reformeret nafta
  [en sammensat blanding af carbonhydrider opnået ved separation fra den platformatholdige fraktion. Den består overvejende af ikke-aromatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval 120 oC til 210 oC, samt C9 og højere aromatiske carbonhydrider.] | 297-465-7 | 93572-35-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-314-00-5 | carbonhydrider, C5-11-, ikke-aromatrige, reformering, let fraktion;
  lavtkogende katalytisk reformeret
  nafta;
  [en sammensat blanding af carbonhydrider opnået ved separation fra den platformatholdige fraktion. Den består overvejende af ikke-aromatiske carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 125 oC, samt benzen og toluen.] | 297-466-2 | 93572-36-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-315-00-0 | Foot's oil (råolie), kiselsyrebehandlet;
  solventekstraherede eller afvoksede tunge restolier;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af Foots oil med kiselsyre for at fjerne sporbestandele og urenheder. Den består overvejende af mættede ligekædede carbonhydrider, overvejende større end C12.] | 308-127-6 | 97862-77-6 | Carc. 1B | H350
  H304 | GHS08
  Dgr | H350
  H304 | | | L |
| 649-316-00-6 | naphtha (råolie), let termisk krakket;
  lavtkogende termisk krakket nafta;
  [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C4 til og med C8, med kogeinterval omtrent fra - 10 oC til 130 oC.] | 265-075-6 | 64741-74-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-317-00-1 | naphtha (råolie), tung termisk krakket;
  lavtkogende termisk krakket nafta;
  [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 220 oC.] | 265-085-0 | 64741-83-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-318-00-7 | destillater (råolie), tunge aromatiske;
  lavtkogende termisk krakket nafta;
  [den sammensatte blanding af carbonhydrider opnået ved destillationen af produkterne fra den termiske krakning af ethan og propan. Denne højerekogende fraktion består overvejende af aromatiske C5-7-carbonhydrider med nogle umættede aliphatiske carbonhydrider, overvejende C5. Denne strøm kan indeholde benzen.] | 267-563-4 | 67891-79-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-319-00-2 | destillater (råolie), lette aromatiske;
  lavtkogende termisk krakket nafta; [den sammensatte blanding af carbonhydrider opnået ved destillationen af produkterne fra den termiske krakning af ethan og propan. Denne laverekogende fraktion består overvejende af aromatiske C5-7-carbonhydrider med nogle umættede aliphatiske
  carbonhydrider, overvejende C5. Denne strøm kan indeholde benzen.] | 267-565-5 | 67891-80-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | HS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-320-00-8 | destillater (råolie), naphtha- og raffinatpyrolysatafledte, benzinblanding;
  lavtkogende termisk krakket nafta; [den sammensatte blanding af carbonhydrider opnået ved pyrolysefraktionering ved 816 oC af naphtha og raffinat. Den består overvejende af C9-carbonhydrider og koger omtrent ved 204 oC.] | 270-344-6 | 68425-29-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-321-00-3 | aromatiske carbonhydrider, C6-8-, naphtha- og raffinatpyrolysatafledte; lavtkogende termisk krakket nafta; [en sammensat blanding af carbonhydrider opnået ved fraktioneringspyrolyse ved
  816 oC af naphtha og raffinat. Den består overvejende af aromatiske carbonhydrider, overvejende C6 til og med C8, herunder benzen.] | 270-658-3 | 68475-70-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-322-00-9 | destillater (råolie), termisk krakket naphtha og gasolie; lavtkogende termisk krakket nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af termisk krakket naphtha og/eller gasolie. Den består overvejende af olefincarbonhydrider, C5, med kogeinterval omtrent fra 33 oC til 60 oC.] | 271-631-9 | 68603-00-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-323-00-4 | destillater (råolie), termisk krakket naphtha og gasolie, C5-dimer-holdige;
  lavtkogende termisk
  krakket nafta; [en sammensat blanding af carbonhydrider fremstillet ved den ekstraktive destillation af termisk krakket naphtha og/eller gasolie. Den består overvejende af C5-carbonhydrider med nogle dimeriserede C5-olefiner, og har kogeinterval omtrent fra 33 oC til 184 oC.] | 271-632-4 | 68603-01-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-324-00-X | destillater (råolie), termisk krakket naphtha og gasolie, ekstraktive;
  lavtkogende termisk
  krakket nafta;
  [en sammensat blanding af carbonhydrider fremstillet ved den ekstraktive destillation af termisk krakket naphtha og/eller gasolie. Den består af paraffin og olefincarbonhydrider, overvejende isoamylener, såsom 2-methyl-1-buten og 2-methyl-2-buten, med kogeinterval omtrent fra 31 oC til 40 oC.] | 271-634-5 | 68603-03-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-325-00-5 | destillater (råolie), lette termisk krakkede, debutaniserede aromatiske;
  lavtkogende termisk krakket nafta; [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en termisk krakningsproces. Den består overvejende af aromatiske carbonhydrider, primært benzen.] | 273-266-0 | 68955-29-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-326-00-0 | naphtha (råolie), let termisk krakket sweetenet;
  lavtkogende termisk
  krakket nafta;
  [en sammensat blanding af carbonhydrider opnået ved at underkaste et råoliedestillat fra højtemperaturtermisk krakning af tunge oliefraktioner en sweetening-proces for at omdanne mercaptaner. Den består overvejende af aromater, olefiner og mættede carbonhydrider med kogeinterval omtrent fra 20 oC til 100 oC.] | 295-447-3 | 92045-65-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-327-00-6 | naphtha (råolie), hydro-
  genbehandlet tung;
  lavtkogende hydrogeneret nafta; [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C6 til og med C13, med kogeinterval omtrent fra 65 oC til 230 oC.] | 265-150-3 | 64742-48-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-328-00-1 | naphtha (råolie), hydro-
  genbehandlet let;
  lavtkogende hydrogeneret nafta; [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC.] | 265-151-9 | 64742-49-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-329-00-7 | naphtha (råolie), hydro-
  afsvovlet let;
  lavtkogende hydrogeneret nafta;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlingsproces. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC.] | 265-178-6 | 64742-73-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-330-00-2 | naphtha (råolie), hydro-
  afsvovlet tung;
  lavtkogende hydrogeneret nafta;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlningsproces. Den består af carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 230 oC.] | 265-185-4 | 64742-82-1 | Carc. 1B
  Muta. 1B
  STOT RE 1
  Asp. Tox. 1 | H350
  H340
  H372 (centralnervesystem)
  H304 | GHS08
  Dgr | H350
  H340
  H372 (centralnervesystem)
  H304 | | | P |
| 649-331-00-8 | destillater (råolie), hydrogenbehandlede middeltunge, intermediært kogende;
  lavtkogende hydrogeneret nafta; [en sammensat blanding af carbonhydrider opnået ved destillationen af produkter fra en hydrogenbehandlingsproces af middeltunge destillater. Den består af carbonhydrider, overvejende C5 til og med C10, med kogeinterval omtrent fra 127 oC til 188 oC.] | 270-092-7 | 68410-96-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-332-00-3 | destillater (råolie), let destillat hydrogenbehandlingsproces-, lavtkogende;
  lavtkogende hydrogeneret nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillationen af produkter fra hydrogenbehandlingsprocessen af et let destillat. Den består af carbonhydrider, overvejende C6 til og med C9, med kogeinterval omtrent fra 3 oC til 194 oC.] | 270-093-2 | 68410-97-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-333-00-9 | destillater (råolie), hydrogenbehandlet tung naphtha, deisohexanizer-topfraktioner;
  lavtkogende hydrogeneret
  nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en hydrogenbehandlingsproces af tung naphtha. Den består af carbonhydrider, overvejende C3 til og med C6, med kogeinterval omtrent fra - 49 oC til 68 oC.] | 270-094-8 | 68410-98-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-334-00-4 | solventnaphtha (råolie), let aromatisk, hydrogenbehandlet;
  lavtkogende hydrogeneret
  nafta;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende C8 til og med C10, med kogeinterval omtrent fra 135 oC til 210 oC.] | 270-988-8 | 68512-78-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-335-00-X | naphtha (råolie), hydroafsvovlet termisk krakket let; lavtkogende hydrogeneret nafta;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af et hydroafsvovlet termisk krakket destillat. Den består overvejende af
  carbonhydrider, overvejende C5 til C11, med kogeinterval omtrent fra 23 oC til 195 oC.] | 285-511-9 | 85116-60-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-336-00-5 | naphtha (råolie), hydrogenbehandlet let, cycloalkanholdig; lavtkogende hydrogeneret nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillationen af en
  råoliefraktion. Den består overvejende af alkaner og cycloalkaner med kogeinterval omtrent fra - 20 oC til 190 oC.] | 285-512-4 | 85116-61-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-337-00-0 | naphtha (råolie), tung dampkrakket, hydrogeneret; lavtkogende hydrogeneret nafta | 295-432-1 | 92045-51-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-338-00-6 | naphtha (råolie), hydroafsvovlet
  full-range;
  lavtkogende hydrogeneret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlingsproces. Den består overvejende af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra 30 oC til 250 oC.] | 295-433-7 | 92045-52-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-339-00-1 | naphtha (råolie), hydrogenbehandlet
  let dampkrakket;
  lavtkogende hydrogeneret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion, fremkommet ved en pyrolyseproces, med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af umættede carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 190 oC.] | 295-438-4 | 92045-57-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-340-00-7 | carbonhydrider, C4-12 naphtha-krakning, hydrogenbehandelede;
  lavtkogende hydrogeneret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation
  af produktet fra en naphtha-dampkrakningsproces og efterfølgende selektiv katalytisk hydrogenering af gummidannere. Den består af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra 30 oC til 230 oC.] | 295-443-1 | 92045-61-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-341-00-2 | solventnaphtha (råolie), hydrogenbehandlet let naphthen-; lavtkogende hydrogeneret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af cycloparaffincarbonhydrider, overvejende C6 til og med C7, med kogeinterval omtrent fra 73 oC til 85 oC.] | 295-529-9 | 92062-15-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-342-00-8 | naphtha (råolie), let dampkrakket, hydrogeneret; lavtkogende hydrogeneret naphtha;
  [en sammensat blanding af carbonhydrider fremstillet ved separation og efterfølgende hydrogenering af produkterne fra en dampkrakningsproces til fremstilling af ethylen. Den består overvejende af mættede og umættede paraffiner, cycliske paraffiner og cycliske aromatiske carbonhydrider, overvejende C4 til og med C10, med kogeinterval omtrent fra 50 oC til 200 oC. Andelen af benzencarbonhydrider kan være på til 30 vægtprocent, og strømmen kan også indeholde mindre mængder svovlforbindelser og oxygenerede forbindelser.] | 296-942-7 | 93165-55-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-343-00-3 | carbonhydrider, C6-11-, hydrogenbehandlede,
  dearomatiserede;
  lavtkogende hydrogeneret naphtha;
  [en sammensat blanding af carbonhydrider opnået som solventer, der har været underkastet hydrogenbehandling for at omdanne aromater til naphthener ved katalytisk hydrogenering.] | 297-852-0 | 93763-33-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-344-00-9 | carbonhydrider, C9-12-, hydrogenbehandlede,
  dearomatiserede;
  lavtkogende hydrogeneret naphtha; [en sammensat blanding af carbonhydrider opnået som solventer, der har været underkastet hydrogenbehandling for at omdanne aromater til naphthener ved katalytisk hydrogenering.] | 297-853-6 | 93763-34-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-345-00-4 | mineralsk terpentin;
  lavtkogende uspecificeret
  naphtha;
  [et farveløst, raffineret råoliedestillat, der er fri for harske eller frastødende lugte, med kogeinterval omtrent fra 148,8 oC til 204,2 oC.] | 232-489-3 | 8052-41-3 | Carc. 1B
  Muta. 1B
  STOT RE 1
  Asp. Tox. 1 | H350
  H340
  H372 (centralnervesystem)
  H304 | GHS08
  Dgr | H350
  H340
  H372 (centralnervesystem)
  H304 | | | P |
| 649-346-00-X | naturgaskondensater
  (råolie);
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider adskilt som en væske fra naturgas i en overfladeseparator ved retrograd kondensation. Den består hovedsagelig af carbonhydrider, overvejende C2 til C20. Den er en væske ved atmosfærisk temperatur og tryk.] | 265-047-3 | 64741-47-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-347-00-5 | naturgas (råolie), rå væskeblanding; lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider adskilt som en væske fra naturgas i et gasgenanvendelsesanlæg ved sådanne processer som køling eller absorption. Den består hovedsagelig af mættede, aliphatiske carbonhydrider, C2 til og med C8.] | 265-048-9 | 64741-48-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-348-00-0 | naphtha (råolie), let hydrokrakket;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, overvejende C4 til og med C10, med kogeinterval omtrent fra - 20 oC til 180 oC.] | 265-071-4 | 64741-69-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-349-00-6 | naphtha (råolie), tung hydrokrakket;
  lavtkogende uspecificeret nafta; [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC.] | 265-079-8 | 64741-78-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-350-00-1 | naphtha (råolie), sweetenet;
  lavtkogende uspecificeret naphtha; [en sammensat blanding af carbonhydrider opnået ved at underkaste en råolienaphta en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra - 10 oC til 230 oC.] | 265-089-2 | 64741-87-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-351-00-7 | naphtha (råolie), syrebehandlet;
  lavtkogende uspecificeret nafta; [en sammensat blanding af carbonhydrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 230 oC.] | 265-115-2 | 64742-15-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-352-00-2 | naphtha (råolie), kemisk neutraliseret tung;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC.] | 265-122-0 | 64742-22-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-353-00-8 | nphtha (råolie), kemisk neutraliseret let;
  lavtkogende uspecificeret naphtha; (en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC.] | 265-123-6 | 64742-23-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-354-00-3 | naphtha (råolie), katalytisk afvokset;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved
  katalytisk afvoksning af en råoliefraktion. Den består overvejende af carbonhydrider, overvejende C5 til og med C12, med kogeinterval omtrent fra 35 oC til 230 oC.] | 265-170-2 | 64742-66-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-355-00-9 | naphtha (råolie), let dampkrakket;
  lavtkogende uspecificeret naphtha; [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en dampkrakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC. Denne strøm indeholder sædvanligvis 10 volumenprocent, eller mere, benzen.] | 265-187-5 | 64742-83-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-356-00-4 | solventnaphtha (råolie), let aromatisk;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af aromatiske strømme. Den består overvejende af aromatiske carbonhydrider, overvejende C8 til og med C10, med kogeinterval omtrent fra 135 oC til 210 oC.] | 265-199-0 | 64742-95-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-357-00-X | aomatiske carbonhydrider, C6-10-, syrebehandlede, neutraliserede;
  lavtkogende uspecificeret naphtha | 268-618-5 | 68131-49-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-358-00-5 | destillater (råolie), C3-5, 2-methyl-2-butenrige;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider fra destillationen af carbonhydrider, sædvanligvis C3 til og med C5, overvejende isopentan og 3-methyl-1-buten. Den består af mættede og umættede carbonhydrider, C3 til og med C5, overvejende 2-methyl-2-buten.] | 270-725-7 | 68477-34-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-359-00-0 | destillater (råolie), polymeriserede dampkrakkede råoliedestillater, C5-12-fraktion;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillationen af polymeriseret dampkrakket råoliedestillat. Den består overvejende af carbonhydrider, overvejende
  C5 til og med C12.] | 270-735-1 | 68477-50-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-360-00-6 | destillater (råolie), dampkrakkede, C5-12-fraktion;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af organiske forbindelser opnået ved destillationen af produkter fra en dampkrakningsproces. Den
  består af umættede carbonhydrider, overvejende C5 til og med C12.] | 270-736-7 | 68477-53-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-361-00-1 | destillater (råolie), dampkrakkede, C5-10-fraktion, blandet med let dampkrakket råolienaphtha-C5-fraktion; lavtkogende uspecificeret naphtha | 270-738-8 | 68477-55-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-362-00-7 | ekstrakter (råolie), koldsyre-, C4-6; lavtkogende uspecificeret
  naphtha; [en sammensat blanding af organiske forbindelser, fremstillet ved koldsyre-enhedsekstraktion af mættede og umættede, aliphatiske carbonhydrider, sædvanligvis C3 til og med C6, overvejende pentaner og amylener. Den består overvejende af mættede og umættede carbonhydrider, C4 til og med C6, overvejende C5.] | 270-741-4 | 68477-61-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-363-00-2 | destillater (råolie), depentanizer-
  topfraktioner;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk krakket gasstrøm. Den består af aliphatiske carbonhydrider, overvejende C4 til og med C6.] | 270-771-8 | 68477-89-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-364-00-8 | rester (råolie), butansplitter-bundfraktioner;
  lavtkogende uspecificeret naphtha;
  [en sammensat remanens fra destillationen af butanstrøm. Den består af aliphatiske carbonhydrider, overvejende C4 til og med C6.] | 270-791-7 | 68478-12-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-365-00-3 | restolier (råolie), deisobutanizertårn-;
  lavtkogende uspecificeret naphtha;
  [en sammensat remanens fra den atmosfæriske destillation af butan-butylenstrømmen. Den består af aliphatiske carbonhydrider, overvejende C4 til og med C6.] | 270-795-9 | 68478-16-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-366-00-9 | naphtha (råolie), full-range coker-;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en væske-coker. Den består overvejende af umættede carbonhydrider, overvejende C4 til og med C15, med kogeinterval omtrent fra 43 oC til 250 oC.] | 270-991-4 | 68513-02-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-367-00-4 | naphtha (råolie), dampkrakket middeltung aromatisk;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra - 130 oC til 220 oC.] | 271-138-9 | 68516-20-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-368-00-X | naphtha (råolie), lerbehandlet full-range straight-run; lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider fremkomet ved behandling af full-range straight-run
  naphtha med naturligt eller modificeret ler, sædvanligvis i en perkoleringsproces til fjernelse af spormængderne af polære forbindelser og urenheder. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 220 oC.] | 271-262-3 | 68527-21-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-369-00-5 | naphtha (råolie), lerbehandlet let straight-run;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider fremkommet ved behandling af let straight-run naphtha med naturligt eller modificeret ler, sædvanligvis i en perkoleringsproces til fjernelse af spormængderne af polære forbindelser og urenheder. Den består af carbonhydrider, overvejende C7 til og med C10, med kogeinterval omtrent fra 93 oC til 180 oC.] | 271-263-9 | 68527-22-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-370-00-0 | naphtha (råolie), let dampkrakket aromatisk;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af
  carbonhydrider fremstillet ved destillation af produkterne fra en dampkrakningsproces. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C9, med kogeinterval omtrent fra 110 oC til 165 oC.] | 271-264-4 | 68527-23-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-371-00-6 | naphtha (råolie), let dampkrakket, afbenzeneret; lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra 80 oC til 218 oC.] | 271-266-5 | 68527-26-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-372-00-1 | naphtha (råolie), aromatholdig;
  lavtkogende uspecificeret
  naphtha | 271-635-0 | 68603-08-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-373-00-7 | benzin, pyrolyse-, debutanizer-bundfraktioner;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af depropanizer-bundfraktioner. Den består af carbonhydrider, overvejende større end C5.] | 271-726-5 | 68606-10-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-374-00-2 | naphtha (råolie), let sweetenet;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider, opnået ved at underkaste et råoliedestillat en sweeteningsproces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af mættede og umættede carbonhydrider, overvejende C3 til og med C6, med kogeinterval omtrent fra - 20 oC til 100 oC.] | 272-206-0 | 68783-66-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-375-00-8 | naturgaskondensater;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider, som er separeret og/eller
  kondenseret fra naturgas under transport, og som opsamles ved borehullet og/eller fra produktions, opsamlings-,
  transmissions- og distributionspipelines i undergrunden, skrubbere etc. Den består overvejende af carbonhydrider, overvejende C2 til og med C8.] | 272-896-3 | 68919-39-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-376-00-3 | destillater (råolie), naphtaunifiner stripper-;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider fremstillet ved
  stripning af produkterne fra naphthaunifineren. Den består af mættede, aliphatiske carbonhydrider, overvejende C2 til og med C6.] | 272-932-8 | 68921-09-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-377-00-9 | naphtha (råolie), katalytisk reformeret let, aromatfri fraktion;
  lavtkogende uspecificeret naphtha; | 285-510-3
  [en sammensat blanding af carbonhydrider tilbageblevet efter fjernelse af aromatiske forbindelser fra katalytisk reformeret let naphta i en selektiv absorptionsproces. Den består overvejende af paraffiniske og cycliske forbindelser, overvejende C5 til C8, med kogeinterval omtrent fra 66 oC til 121 oC.] | 85116-59-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-378-00-4 | benzin;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider bestående primært af paraffiner,
  cycloparaffiner, aromatiske og olefiniske carbonhydrider, overvejende større end C3, og med kogeinterval fra 30 oC til 260 oC.] | 289-220-8 | 86290-81-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-379-00-X | aromatiske carbonhydrider, C7-8-, dealkyleringsprodukter, destillationsrester;
  lavtkogende uspecificeret naphtha | 292-698-0 | 90989-42-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-380-00-5 | carbonhydrider, C4-6-, depentanizer lette, aromatisk hydrogenbehandling; lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået som det første gennemløb fra depentanizerkolonnen før hydrogenbehandling af de aromatiske charger. Den består overvejende af carbonhydrider, overvejende C4 til og med C6, overvejende pentaner og pentener, med kogeinterval omtrent fra 25 oC
  til 40 oC.] | 295-298-4 | 91995-38-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-381-00-0 | destillater (råolie), varmeudblødt dampkrakket naphtha, C5-rige;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af varmeudblødt dampkrakket naphtha. Den består overvejende af carbonhydrider, C4 til og med C6, overvejende C5.] | 295-302-4 | 91995-41-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-382-00-6 | ekstrakter (råolie), katalytisk reformeret let naphtha solvent-; lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået som ekstraktet fra solventekstraktionen af en katalytisk reformeret råoliefraktion. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C8, med kogeinterval omtrent fra 100 oC til 200 oC.] | 295-331-2 | 91995-68-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-383-00-1 | naphtha (råolie), hydroafsvovlet let, dearomatiseret; lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af hydroafsvovlede og dearomatiserede lette råoliefraktioner. Den består overvejende af C7-paraffiner og cycloparaffiner med kogeinterval omtrent fra 90 oC
  til 100 oC.] | 295-434-2 | 92045-53-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-384-00-7 | naphtha (råolie), let, C5-rig, sweetenet;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved at underkaste en råolienaphtha en sweetening-proces for
  at omdanne mercaptaner eller fjerne sure urenheder. Den består af carbonhydrider, overvejende C4 til og med C5, overvejende C5, med kogeinterval omtrent fra - 10 oC til 35 oC.] | 295-442-6 | 92045-60-8 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-385-00-2 | carbonhydrider, C8-11-, naphtha-krakning, toluenfraktion;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation fra præhydrogeneret, krakket naphtha. Den består overvejende af carbonhydrider, overvejende C8 til og med C11, med kogeinterval omtrent fra 130 oC til 205 oC.] | 295-444-7 | 92045-62-0 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-386-00-8 | carbonhydrider, C4-11-, naphtha-krakning, aromatfrie;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af
  carbonhydrider opnået fra præhydrogeneret, krakket naphtha efter destillativ separation af benzen- og toluenholdige carbonhydridfraktioner og en højerekogende fraktion. Den består overvejende af carbonhydrider, overvejende C4 til og med C11 med kogeinterval omtrent fra 30 oC til 205 oC.] | 295-445-2 | 92045-63-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-387-00-3 | naphtha (råolie), let varmeudblødt, dampkrakket;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider opnået ved fraktioneringen af dampkrakket]
  naphtha efter genindvinding fra en varmeudblødningsproces. Den består overvejende af carbonhydrider, overvejende C4 til og med C6, med kogeinterval omtrent fra 0 oC til 80 oC.] | 296-028-8 | 92201-97-3 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-388-00-9 | destillater (råolie), C6-rige; Lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af råolieføde. Den består
  af carbonhydrider, overvejende C5 til og med C7, rig på C6, med kogeinterval omtrent fra 60 oC til 70 oC.] | 296-903-4 | 93165-19-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-389-00-4 | benzin, pyrolyse-,
  hydrogeneret;
  lavtkogende uspecificeret naphtha;
  [en destillationsfraktion fra hydrogeneringen af pyrolysebenzin med kogeinterval omtrent fra 20 oC til 200 oC.] | 302-639-3 | 94114-03-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-390-00-X | destillater (råolie), dampkrakkede, C8-12-fraktion, polymeriserede, lette destillationsfraktioner;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af den polymeriserede C8 til og med C12-fraktion fra dampkrakkede råoliedestillater. Den består overvejende af aromatiske carbonhydrider, overvejende C8 til og med C12.] | 305-750-5 | 95009-23-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-391-00-5 | ekstrakter (råolie), tunge naphthasolvent-, lerbehandlede; lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved
  behandlingen af tung naphthasolventråolieekstrakt med blegejord. Består overvejende af carbonhydrider, overvejende C6 til og med C10, med kogeinterval omtrent fra 80 oC til 180 oC.] | 308-261-5 | 97926-43-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-392-00-0 | naphtha (råolie), let dampkrakket, debenzeneret, termisk behandlet;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved behandling og destillation af debenzeneret, let dampkrakket råolienaphtha. Den består overvejende af carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 95 oC til 200 oC.] | 308-713-1 | 98219-46-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-393-00-6 | naphtha (råolie), let dampkrakket, termisk behandlet;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af
  [en sammensat blanding af carbonhydrider opnået ved behandling og destillation af let dampkrakket råolienaphtha. Den består overvejende af carbonhydrider, overvejende C5 til og med C6,
  med kogeinterval omtrent fra 35 oC til 80 oC.] | 308-714-7 | 98219-47-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-394-00-1 | destillater (råolie), C7-9 , C8-rige, hydroafsvovlede dearomatiserede;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af en let råoliefraktion, hydroafsvovlet og dearomatiseret. Den består overvejende af carbonhydrider,
  C7 til og med C9, overvejende C8 paraffiner og cycloparaffiner, med kogeinterval omtrent fra 120 oC til 130 oC.] | 309-862-5 | 101316-56-7 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-395-00-7 | carbonhydrider, C6-8-, hydrogenerede sorption-dearomatiserede, toluenraffinering;
  lavtkogende uspecificeret
  naphtha;
  [en sammensat blanding af carbonhydrider opnået under sorptionen af toluen fra en
  carbonhydridfraktion fra krakket benzin, der er behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C6 til og med C8, med kogeinterval omtrent fra 80 oC til 135 oC.] | 309-870-9 | 101316-66-9 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-396-00-2 | naphtha (råolie), hydroafsvovlet full-range coker-;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af
  carbonhydrider opnået ved fraktionering af hydroafsvovlet cokerdestillat. Den består overvejende af carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 23 oC til 196 oC.] | 309-879-8 | 101316-76-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-397-00-8 | naphtha (råolie), sweetenet let;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af
  carbonhydrider opnået ved at underkaste en råolienaphtha en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C5 til og med C8, med kogeinterval omtrent fra 20 oC til 130 oC.] | 309-976-5 | 101795-01-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-398-00-3 | carbonhydrider, C3-6-, C5-rige, dampkrakket naphtha;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af dampkrakket naphtha. Den består overvejende af carbonhydrider, C3 til og med C6, overvejende C5.] | 310-012-0 | 102110-14-5 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-399-00-9 | carbonhydrider, C5-rige,
  dicyclopentadienholdige;
  lavtkogende uspecificeret nafta;
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en dampkrakningsproces. Den består overvejende af, C5 carbonhydrider og dicyclopentadien, med kogeinterval omtrent fra 30 oC til 170 oC.] | 310-013-6 | 102110-15-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-400-00-2 | rester (råolie), dampkrakkede lette, aromatiske;
  lavtkogende uspecificeret naphtha;
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra dampkrakning eller lignende processer, efter fjernelse af de meget lette produkter, resulterende i en rest begyndende med C>5-carbonhydrider. Den består overvejende af aromatiske carbonhydrider,
  større end C5, med kogepunkt over omtrent 40 oC.]. | 310-057-6 | 102110-55-4 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-401-00-8 | carbonhydrider, C5-, C5-6-rige; lavtkogende uspecificeret naphtha | 270-690-8 | 68476-50-6 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-402-00-3 | carbonhydrider, C5-rige;
  lavtkogende uspecificeret
  naphtha | 270-695-5 | 68476-55-1 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-403-00-9 | aromatiske carbonhydrider, C8-10; lavtkogende uspecificeret naphtha | 292-695-4 | 90989-39-2 | Carc. 1B
  Muta. 1B
  Asp. Tox. 1 | H350
  H340
  H304 | GHS08
  Dgr | H350
  H340
  H304 | | | P |
| 649-404-00-4 | petroleum (råolie); straight-run, petroleum;
  [en sammensat blanding af
  carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.] | 232-366-4 | 8008-20-6 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-405-00-X | solventnaphtha (råolie), middeltung aliphatisk;
  straight run petroleum;
  [en sammensat blanding af carbonhydrider opnået ved destillation af råolie eller naturgaskondensat. Den består overvejende af mættede carbonhydrider, overvejende C9 til og med C12, med kogeinterval omtrent fra 140 oC til 220 oC.] | 265-191-7 | 64742-88-7 | STOT RE 1
  Asp. Tox. 1 | H372 (centralnervesystem)
  H304 | GHS08
  Dgr | H372 (centralnervesystem)
  H304 | | | |
| 649-406-00-5 | solventnaphtha (råolie),
  tung aliphatisk;
  straight run petroleum;
  [en sammensat blanding af carbonhydrider opnået ved
  destillation af råolie eller naturgaskondensat. Den består overvejende af mættede carbonhydrider, overvejende C11 til og med C16, med kogeinterval omtrent fra 190 oC til 290 oC.] | 265-200-4 | 64742-96-7 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-407-00-0 | petroleum (råolie); straight-run bred fraktion;
  straight run petroleum;
  [en sammensat blandning af carbonhydrider, opnået som en bred fraktion fra atmosfærisk destillation fra en carbonhydridbrændselsfraktion, med kogeinterval omtrent fra 70 oC til 220 oC.] | 295-418-5 | 92045-37-9 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-408-00-6 | destillater (råolie), dampkrakkede;
  krakket petroleum;
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en dampkrakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C7 til og med C16, med kogeinterval omtrent fra 90 oC til 290 oC.] | 265-194-3 | 64742-91-2 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-409-00-1 | destillater (råolie), krakkede strippede dampkrakkede råoliedestillater, C8-10-fraktion;
  krakket petroleum;
  [en sammensat blanding af carbonhydrider, opnået ved
  at destillere krakkede, strippede, dampkrakkede destillater. Den består af carbonhydrider, C8 til og med C10, med kogeinterval omtrent fra 129 oC til 194 oC.] | 270-728-3 | 68477-39-4 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-410-00-7 | destillater (råolie), krakkede strippede dampkrakkede råoliedestillater, C10-12-fraktion;
  krakket petroleum;
  [en sammensat blanding af carbonhydrider opnået ved at destillere krakkede, strippede, dampkrakkede destillater. Den består overvejende af aromatiske carbonhydrider, C10 til og med C12.] | 270-729-9 | 68477-40-7 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-411-00-2 | destillater (råolie), dampkrakkede, C8-12-fraktion;
  krakket petroleum;
  [en sammensat blanding af organiske forbindelser opnået ved destillationen af produkter fra en dampkrakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C8 til og med C12.] | 270-737-2 | 68477-54-3 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-412-00-8 | petroleum (råolie), hydroafsvovlet termisk krakket; krakket petroleum;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af hydroafsvovlet termisk krakket destillat. Den består overvejende af carbonhydrider, overvejende C8 til C16, med kogeinterval omtrent fra 120 oC til 283 oC.] | 285-507-7 | 85116-55-8 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-413-00-3 | aromatiske carbonhydrider, C≥10, dampkrakning, hydrogenbehandlede; krakket petroleum;
  [en sammensat blanding af
  carbonhydrider fremstillet ved destillation af produkterne fra en dampkrakningsproces og behandling med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende større end C10, med kogeinterval omtrent fra 150 oC til 320 oC.] | 292-621-0 | 90640-98-5 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-414-00-9 | naphtha (råolie), dampkrakket, hydrogenbehandlet, C9-10-aromatrig; krakket petroleum
  [en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en dampkrakningsproces, efterfulgt af behandling med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, C9 til og med C10, med kogeinterval omtrent fra 140 oC til 200 oC.] | 292-637-8 | 90641-13-7 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-415-00-4 | destillater (råolie), termisk krakkede, alkylaromat carbonhydrid-rige;
  krakket petroleum;
  [en sammensat blanding af carbonhydrider opnået ved destillation af termisk krakkede tunge tjærer. Den består overvejende af polyalkylerede aromatiske carbonhydrider, med kogeinterval omtrent fra 100 oC til 250 oC.] | 309-866-7 | 101316-61-4 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-416-00-X | destillater (råolie), katalytisk krakket tung tjære, lette;
  krakket petroleum;
  [en sammensat blanding af carbonhydrider opnået ved destillation af katalytisk krakkede tunge tjærer. Den består overvejende af polyalkylerede aromatiske carbonhydrider, med kogeinterval omtrent fra 100 oC til 250 oC.] | 309-938-8 | 101631-13-4 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-417-00-5 | solventnaphtha (råolie), hydrokrakket tung aromatisk; krakket petroleum;
  [en sammensat blanding af carbonhydrider opnået ved destillationen af hydrokrakket råoliedestillat. Den består overvejende af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 235 oC til 290 oC.] | 309-881-9 | 101316-80-7 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-418-00-0 | destillater (råolie), dampkrakket tung tjære, lette;
  krakket petroleum;
  [en sammensat blanding af carbonhydrider opnået ved destillation af dampkrakkede tunge tjærer. Den består overvejende af polyalkylerede aromatiske carbonhydrider, med kogeinterval omtrent fra 100 oC til 250 oC.] | 309-940-9 | 101631-15-6 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-419-00-6 | destillater (råolie), alkylat-; uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra reaktionen
  mellem isobutan og monoolefinske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C11 til og med C17, med kogeinterval omtrent fra 205 oC til 320 oC.] | 265-074-0 | 64741-73-7 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-420-00-1 | ekstrakter (råolie), tung naphtha solvent-;
  uspecifeceret petroleum
  [en sammensat blanding af carbonhydrider opnået som ekstraktet fra en solventekstraktionsproces. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 220 oC.] | 265-099-7 | 64741-98-6 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-421-00-7 | destillater (råolie), kemisk neutraliserede lette; uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider fremstillet ved en
  behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.] | 265-132-5 | 64742-31-0 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-422-00-2 | destillater (råolie), hydrogenbehandlede
  lette;
  uspecifeceret petroleum
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.] | 265-149-8 | 64742-47-8 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-423-00-8 | petroleum (råolie), hydroafsvovlet;
  uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider opnået fra en rå råolie ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.] | 265-184-9 | 64742-81-0 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-424-00-3 | solventnaphtha (råolie), let aromatisk;
  uspecifeceret petroleum
  [en sammensat blanding af carbonhydrider opnået ved destillation af aromatiske strømme. Den består overvejende af aromatiske carbonhydrider, overvejende C9 til og med C16,
  med kogeinterval omtrent fra 165 oC til 290 oC
  .] | 265-198-5 | 64742-94-5 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-425-00-9 | naphtha (råolie), tung coker-;
  uspecificeret petroleum
  [en sammensat blanding af carbonhydrider fra destillationen af produkterne fra en væske-coker. Den består overvejende af umættede carbonhydrider,
  overvejende C6 til og med C15, med kongeinterval omtrent fra 157 oC til 288 oC.] | 269-778-9 | 68333-23-3 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-426-00-4 | naphtha (råolie), katalytisk reformeret hydroafsvovlet tung, aromatfraktion;
  uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider fremstillet ved fraktionering af katalytisk reformeret, hydroafsvovlet naphtha. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til C13, med kogeinterval omtrent fra 98 oC til 218 oC.] | 285-508-2 | 85116-57-0 | Asp. Tox. 1 | H304 | GHS08 Dgr | H304 | | | |
| 649-427-00-X | petroleum (råolie), sweetenet;
  uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider opnået ved at underkaste et råoliedestillat
  en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C9 til og med C16, med koge-interval omtrent fra 130 oC
  til 290 oC.] | 294-799-5 | 91770-15-9 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-428-00-5 | petroleum (råolie), solventraffineret sweetenet;
  uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider, opnået fra en rå råolie ved solventraffinering
  og sweetening, med kogeinterval omtrent fra 150 oC til 260 oC.] | 295-416-4 | 92045-36-8 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-429-00-0 | carbonhydrider, C9-16-, hydrogenbehandlede,
  afaromatiserede;
  uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider opnået som solventer, der har været underkastet hydrogenbehandling for at omdanne aromater til naphthener ved katalytisk hydrogenering.] | 297-854-1 | 93763-35-0 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-430-00-6 | petroleum (råolie), solvent-raffineret hydroafsvovlet; uspecificeret petroleum | 307-033-2 | 97488-94-3 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-431-00-1 | destillater (råolie), hydroafsvovlede full-range middeltunge coker-;
  uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering fra hydroafsvovlet coker-destillat. Den består overvejende af carbonhydrider,
  overvejende C8 til og med C16, med kogeinterval omtrent fra 120 oC til 283 oC.] | 309-864-6 | 101316-58-9 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-432-00-7 | solventnaphtha (råolie), hydroafsvovlet tung aromatisk; uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider opnået ved den katalytiske hydroafsvovling af en råoliefraktion. Den består overvejende af carbonhydrider, overvejende C10 til og med C13, med kogeinterval omtrent fra 180 oC til 240 oC.] | 309-882-4 | 101316-81-8 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-433-00-2 | solventnaphtha (råolie), hydroafsvovlet middeltung; uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider opnået ved den katalytiske hydroafsvovling af en råoliefraktion. Den består overvejende af carbonhydrider,
  overvejende C10 til og med C13, med kogeinterval omtrent fra 175 oC til 220 oC.] | 309-884-5 | 101316-82-9 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-434-00-8 | petroleum (råolie),
  hydrogenbehandlet;
  uspecificeret petroleum;
  [en sammensat blanding af carbonhydrider opnået ved destillationen af råolie og efterfølgende hydrogenbehandling. Den består overvejende af alkaner, cycloalkaner og alkylbenzener, overvejende C12 til og med C16, med kogeinterval omtrent fra 230 oC til 270 oC.] | 309-944-0 | 101631-19-0 | Asp. Tox. 1 | H304 | GHS08
  Dgr | H304 | | | |
| 649-435-00-3 | destillater (råolie), lette katalytisk krakkede;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider,
  overvejende C9 til og med C25, med kogeinterval omtrent fra 150 oC til 400 oC. Den indeholder en forholdsvis stor del bicycliske, aromatiske carbonhydrider.] | 265-060-4 | 64741-59-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-436-00-9 | destillater (råolie), intermediære katalytisk krakkede; krakket gasolie;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C11 til og med C30, med kogeinterval omtrent fra 205 oC til 450 oC. Den indeholder en forholdsvis stor del tricycliske, aromatiske carbonhydrider.] | 265-062-5 | 64741-60-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-437-00-4 | destillater (råolie), lette hydrokrakkede;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, overvejende C10 til og med C18, med kogeinterval omtrent fra 160 oC til 320 oC.] | 265-078-2 | 64741-77-1 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 649-438-00-X | destillater (råolie), lette termisk krakkede;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en temisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C10 til og med C22, med kogeinterval omtrent fra 160 oC til 370 oC.] | 265-084-5 | 64741-82-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-439-00-5 | destillater (råolie), hydroafsvovlede lette katalytisk krakkede;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle lette, katalytisk krakkede destillater med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består overvejende af carbonhydrider, overvejende C9 til og med C25, med kogeinterval omtrent fra 150 oC
  til 400 oC. Den indeholder en forholdsvis stor del bicycliske, aromatiske carbonhydrider.] | 269-781-5 | 68333-25-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-440-00-0 | destillater (råolie), let dampkrakket naphtha;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider fra den multiple destillation af produkter fra en dampkrakningsproces. Den består af carbonhydrider, overvejende C10 til og med C18.] | 270-662-5 | 68475-80-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-441-00-6 | destillater (råolie), krakkede dampkrakkede råoliedestillater;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået ved at destillere et krakket dampkrakket destillat og/eller dets fraktioneringsprodukter. Den består af carbonhydrider, overvejende C10 til lavmolekylære polymerer.] | 270-727-8 | 68477-38-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-442-00-1 | gasolier (råolie), dampkrakkede;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en dampkrakningsproces. Den består af carbonhydrider, overvejende større end C9, med kogeinterval omtrent fra 205 oC til 400 oC.] | 271-260-2 | 68527-18-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-443-00-7 | destillater (råolie), hydroafsvovlede termisk krakkede middeltunge;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering fra hydroafsvovlet, termiske krakkede destillatråstoffer. Den består overvejende af carbonhydrider, overvejende C11 til C25, med kogeinterval omtrent fra 205 oC til 400 oC.] | 285-505-6 | 85116-53-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-444-00-2 | gasolier (råolie), termisk krakkende, hydrogenafsvovlede; krakket gasolie | 295-411-7 | 92045-29-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-445-00-8 | rester (råolie), hydrogeneret dampkrakket naphtha; krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået som en restfraktion fra destillation en af hydrogenbehandlet dampkrakket naphtha. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 200 oC til 350 oC.] | 295-514-7 | 92062-00-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-446-00-3 | rester (råolie), dampkrakkede naphthadestillations-
  krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået som en kolonnebundfraktion fra separationen af udløb fra dampkrakning af naphtha ved høj temperatur. Den har kogeinterval omtrent fra 147 oC til 300 oC, og danner en færdig olie med en viskositet på 18cSt ved 50 oC.] | 295-517-3 | 92062-04-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-447-00-9 | destillater (råolie), lette katalytisk krakkede, termisk nedbrudte;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk krakningsproces, der har været brugt som en varmeoverførselsvæske. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 190 oC til 340 oC. Denne strøm indeholder sandsynligvis organiske svovlforbindelser.] | 295-991-1 | 92201-60-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-448-00-4 | rester (råolie), dampkrakket varmeudblødt naphtha; krakket gasolie;
  [en sammensat blanding af carbonhydrider, opnået som rest fra destillationen af dampkrakket varmeudblødt naphtha, med koge-interval omtrent fra 150 oC til 350 oC.] | 297-905-8 | 93763-85-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-449-00-X | carbonhydrider, C16-20, solvent-afvokset hydrokrakket paraffindestillationsrest
  krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået ved solventafvoksning af en destillationsrest fra et hydrokrakket paraffindestillat. Den består overvejende af carbonhydrider, overvejende fra C16 til og med C20, med kogeinterval omtrent fra 360 oC til 500 oC. Den danner en færdig olie med en viskositet på 4,5 cSt ved omtrent 100 oC.] | 307-662-2 | 97675-88-2 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 649-450-00-5 | gasolier (råolie), lette vakuum-, termisk-krakkede hydroafsvovlede;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået ved katalytisk hydroafsvovling af termisk-krakket let vakuumråolie. Den består overvejende af carbonhydrider, overvejende C14 til og med C20, med kogeinterval omtrent fra 270 oC til 370 oC.] | 308-278-8 | 97926-59-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-451-00-0 | destillater (råolie), hydroafsvovlede
  middeltunge coker-; krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået ved fraktionering af hydroafsvovlede coker-destillat råstoffer. Den består overvejende af carbonhydrider, overvejende C12 til og med C21 med kogeinterval omtrent fra 200 oC til 360 oC.] | 309-865-1 | 101316-59-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-452-00-6 | destillater (råolie), tunge dampkrakkede;
  krakket gasolie;
  [en sammensat blanding af carbonhydrider opnået ved dampkrakkede tunge rester. Den består overvejende af polyalkylerede tunge aromatiske carbonhydrider, med kogeinterval omtrent fra 250 oC til 400 oC.] | 309-939-3 | 101631-14-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | |
| 649-453-00-1 | destillater (råolie), tunge hydrokrakkede;
  uspecificeret baseolie
  [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, C15-C39, med kogeinterval omtrent fra 260 oC til 600 oC
  .] | 265-077-7 | 64741-76-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-454-00-7 | destillater (råolie), solventraffinerede tunge paraffin-;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består overvejende af mættede carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC.] | 265-090-8 | 64741-88-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-455-00-2 | destillater (råolie), solventraffinerede lette paraffin-;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstaktionsproces. Den består overvejende af mættede carbonhydrider, overvejende C15 til og med C30 og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.] | 265-091-3 | 64741-89-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-456-00-8 | restolier (råolie), solventafasfalterede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som
  den solventopløselige fraktion fra C3-C4-solventafasfaltering af en remanens. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.] | 265-096-0 | 64741-95-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-457-00-3 | destillater (råolie), solventraffinerede tunge naphthen-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cST ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-097-6 | 64741-96-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-458-00-9 | destillater (råolie), solventraffinerede lette naphthen-;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-098-1 | 64741-97-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-459-00-4 | restolier (råolie),
  solventraffinerede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som den solventuopløselige fraktion fra solventraffinering af en remanens, ved at anvende et polært organisk solvent, såsom phenol eller furfural. Den består af carbonhydrider, overvejende C25, og koger omtrent over 400 oC.] | 265-101-6 | 64742-01-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-460-00-X | destillater (råolie), lerbehandlede tunge paraffin-;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.] | 265-137-2 | 64742-36-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-461-00-5 | destillater (råolie), lerbehandlede lette paraffin-;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.] | 265-138-8 | 64742-37-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-462-00-0 | restolier (råolie), lerbehandlede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved
  behandling af en restolie med naturligt eller modificeret ler, i enten en kontakt- eller prekoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.] | 265-143-5 | 64742-41-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-463-00-6 | destillater (råolie), lerbehandlede tunge naphthen-; uspecificeret baseolie; [en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-146-1 | 64742-44-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-464-00-1 | destillater (råolie), lerbehandlede lette naphthen-;
  uspecificeret baseolie;
  [en sammensat blanding a carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-147-7 | 64742-45-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-465-00-7 | destillater (råolie),
  hydrogenbehandlede tunge naphthen-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider, opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-155-0 | 64742-52-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-466-00-2 | destillater (råolie),
  hydrogenbehandlede lette naphten-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-156-6 | 64742-53-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-467-00-8 | destillater (råolie),
  hydrogenbehandlede tunge paraffin-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.] | 265-157-1 | 64742-54-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-468-00-3 | destillater (råolie),
  hydrogenbehandlede lette paraffin-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af
  carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.] | 265-158-7 | 64742-55-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-469-00-9 | destillater (råolie), solventafvoksede lette paraffin-;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved
  fjernelse af normalparaffiner fra en råoliefraktion ved solvenkrystallisation. Den består overvejende af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.] | 265-159-2 | 64742-56-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-470-00-4 | restolier (råolie), hydrogenbehandlede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.] | 265-160-8 | 64742-57-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-471-00-X | restolier (råolie), solventafvoksede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved fjernelse af lange, forgrenede carbonhydrider fra en restolie ved solventkrystallisation. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.] | 265-166-0 | 64742-62-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-472-00-5 | destillater (råolie), solventafvoksede tunge naphthen-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved fjernelse af normalparaffiner fra en råoliefraktion ved solventkrystallisation. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet ikke mindre end
  19cSt ved
  40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-167-6 | 64742-63-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-473-00-0 | destillater (råolie), solventafvoksede tunge naphthen-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved fjernelse af normalparaffiner fra en råoliefraktion ved solventkrystallisation. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-168-1 | 64742-64-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-474-00-6 | destillater (råolie), solventafvoksede tunge naphthen-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved fjernelse af normalparaffiner fra en råoliefraktion ved solventkrystallisation. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet ikke mindre end 19cSt ved 40 oC.] | 265-169-7 | 64742-65-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-475-00-1 | naphthenolier (råolie), katalytisk afvoksede tunge;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en
  viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-172-3 | 64742-68-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-476-00-7 | naphthenolier (råolie), katalytisk afvoksede lette;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-173-9 | 64742-69-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-477-00-2 | paraffinolier (råolie), katalytisk afvoksede tunge;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og
  danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC.] | 265-174-4 | 64742-70-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-478-00-8 | paraffinolier (råolie), katalytisk afvoksede lette;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består overvejende af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.] | 265-176-5 | 64742-71-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-479-00-3 | naphthenolier (råolie), sammensatte afvoksede tunge;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at fjerne ligekædede
  paraffincarbonhydrider som et fast stof ved behandling med et reagens, såsom urinstof. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 265-179-1 | 64742-75-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-480-00-9 | naphthenolier (råolie), komplekse afvoksede lette;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved en
  katalytisk afvoksningsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder relativt få normalparaffiner.] | 265-180-7 | 64742-76-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-481-00-4 | smøreolier (råolie), C20-50, hydrogenbehandlede olie baseret, høj viskositet;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle let vakuumgasolie, tung vakuumgasolie og
  solvent afasfalteret restolie med hydrogen, i tilstedeværelse af en katalysator, i en to trinsproces med afvoksning udført mellem de to trin. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på omtrent 112cSt ved 40 oC. Den indeholder en relativ stor mængde af mættede carbonhydrider.] | 276-736-3 | 72623-85-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-482-00-X | smøreolier (råolie), C15-30, hydrogenbehandlede neutral olie baserede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider, opnået ved at behandle let vakuumgasolie, tung vakuumgasolie og solvent afasfalteret restolie med hydrogen, i tilstedeværelse af en katalysator, i en to trinsproces med afvoksning udført mellem de to trin. Den består overvejende af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på omtrent 15cSt ved 40 oC. Den indeholder en relativ stor mængde mættede carbonhydrider.] | 276-737-9 | 72623-86-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-483-00-5 | smøreolier (råolie), C20-50, hydrogenbehandlede neutral olie baserede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandle let vakuumgasolie, tung vakuumgasolie og solvent afasfalteret restolie med hydrogen, i tilstedeværelse af en katalysator, i en to trinsproces med afvoksning udført mellem de to trin. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på omtrent 32cSt ved 40 oC. Den indeholder en forholdsvis stor mængde mættede carbonhydrider.] | 276-738-4 | 72623-87-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-484-00-0 | smøreolier;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion og afvoksningsprocesser. Den består overvejende af mættede carbonhydrider, C15 til og med C50.] | 278-012-2 | 74869-22-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-485-00-6 | destillater (råolie), sammensatte afvoksede tunge paraffin-; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved afvoksning af et tungt paraffindestillat. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på 19cSt eller mere ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 292-613-7 | 90640-91-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-486-00-1 | destillater (råolie), sammensatte afvoksede lette patraffin-;
  uspecificeret baseolie;
  (en sammensat blanding af carbonhydrider opnået ved afvoksning af et let paraffindestillat. Det består overvejende af carbonhydrider, overvejende C12 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.] | 292-614-2 | 90640-92-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-487-00-7 | destillater (råolie), solventafvoksede tunge paraffin-, lerbehandlede; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved en afvoksning af et tungt paraffindestillat med neutral eller modificeret ler i enten en kontakt- eller perkoleringsproces. Den består overvejende af cartonhydrider, overvejende C20 til og med C50.] | 292-616-3 | 90640-94-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-488-00-2 | carbonhydrider, C20-50, solventafvoksede tunge paraffin-, hydrogenbehandlede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved at behandle et afvokset tungt paraffindestillat med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C20 til og med C50.] | 292-617-9 | 90640-95-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-489-00-8 | destillater (råolie), solventafvoksede lette paraffin-, lerbehandlede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider fremkommet ved behandling af et afvokset let paraffindestillat med naturligt eller modificeret ler i enten en kontakt- eller perkoleringsproces. Den består overvejende af carbonhydrider, overvejende C15 til og med C30.] | 292-618-4 | 90640-96-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-490-00-3 | destillater (råolie), solventafvoksede lette paraffin-, hydrogenbehandlede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider fremstillet ved
  at behandle et afvokset let paraffindestillat med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C15 til og med C30.] | 292-620-5 | 90640-97-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-491-00-9 | restolier (olie), hydrogenbehandlede, solventafvoksede; uspecificeret baseolie; | 292-656-1 | 90669-74-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-492-00-4 | restolier (råolie) katalytisk afvoksede;
  uspecificeret baseolie | 294-843-3 | 91770-57-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-493-00-X | destillater (råolie), afvoksede tunge paraffin-, hydrogenbehandlede; uspecificeret baseolie;
  [en sammensat blanding af
  carbonhydrider opnået fra en intensiv hydrogenbehandling af afvokset destillat i tilstedeværelse af en katalysator. Den består overvejende af mættede carbonhydrider, overvejende C25 til og med C39, og danner en færdig olie med en viskositet på omtrent 44 cSt ved 50 oC.] | 295-300-3 | 91995-39-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-494-00-5 | destillater (råolie), afvoksede lette paraffin-, hydrogenbehandlede; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået fra en
  intensiv hydrogenbehandling af afvoksede destillater i tilstedeværelse af en katalysator. Den
  består overvejende af mættede carbonhydrider, overvejende C21 til og med C29, og danner en færdig olie med en viskositet på omtrent 13cSt ved 50 oC.] | 295-301-9 | 91995-40-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-495-00-0 | destillater (råolie), hydrokrakkede solventraffinerede, afvoksede;
  uspecificeret baseolie; [en sammensat blanding af flydende carbonhydrider opnået ved rekrystallisation af afvoksede, hydrokrakkede, solventraffinerede råoliedestillater.] | 295-306-6 | 91995-45-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-496-00-6 | destillater (råolie), solventafvoksede lette naphthen-, hydrogenbehandlede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved at behandlede en råoliefraktion med hydrogen i tilstedeværelse af en katalysator og fjerne de aromatiske carbonhydrider ved solventekstraktion. Den består
  overvejende af naphthencarbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mellem 13cSt og 15cSt ved 40 oC.] | 295-316-0 | 91995-54-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-497-00-1 | smøreolier (råolie), C17-35-, solvent-ekstraherede, afvoksede, hydrogenbehandlede;
  uspecificeret baseolie | 295-423-2 | 92045-42-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-498-00-7 | smøreolier (råolie), hydrokrakkede ikke-aromatiske solvent-afparaffinerede;
  uspecificeret baseolie | 295-424-8 | 92045-43-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-499-00-2 | restolier (råolie), hydrokrakkede syrebehandlede solventafvoksede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider, fremstillet ved
  solventfjernelse af praffiner fra resten fra destillationen af syrebehandlede, hydrokrakkede tunge praffiner, og koger omtrent over 380 oC.] | 295-499-7 | 92061-86-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-500-00-6 | paraffinolier (råolier), solventraffinerede afvoksede tunge; uspecificeret baseolie;
  [en sammensat blanding af
  carbonhydrider opnået fra svovlholdig paraffinråolie. Den består overvejende af en solventraffineret, afparaffineret smøreolie med en viskositet på 65cSt ved 50 oC.] | 295-810-6 | 92129-09-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-501-00-1 | smøreolier (råolie), basisolier, paraffinske;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved raffinering af råolie. Den består
  overvejende of aromater, naphthener og paraffiner, og danner en færdig olie med en viskositet på 23cSt ved 40 oC).] | 297-474-6 | 93572-43-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-502-00-7 | carbonhydrider, hydrokrakkede paraffiniske destillationsrester, solventafvoksede;
  uspecificeret baseolie | 297-857-8 | 93763-38-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-503-00-2 | carbonhydrider, C20-50, restolie-hydrogenerings-vakuumdestillat-;
  uspecificeret baseolie | 300-257-1 | 93924-61-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-504-00-8 | destillater (råolie), solvent-raffinerede hydrogenbehandlede tunge, hydrogenerede;
  uspecificeret baseolie | 305-588-5 | 94733-08-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-505-00-3 | destillater (råolie), solventraffinerede hydrokrakkede lette; uspecificeret baseolie;
  [en sammensat blanding af
  carbonhydrider opnået ved solvent afaromatisering af resten fra hydrokrakket råolie. Den består overvejende af carbonhydrider, overvejende C18 til og med C27, med kogeinterval omtrent fra 370 oC til 450 oC.] | 305-589-0 | 94733-09-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-506-00-9 | smøreolier (råolie), C18-40, solventafvoksede hydrokrakkede destillatbaserede;
  uspecificeret baseolie; [en sammensat blanding af carbonhydrider opnået ved solventafparaffinering af destillationsresten fra hydrorakket råolie. Den består overvejende af carbonhydrider, overvejende C18 til og med C40, med kogeinterval omtrent fra 370 oC til 550 oC.] | 305-594-8 | 94733-15-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-507-00-4 | smøreolier (råolie), C18-40, solventafvoksede hydrokrakkede raffinatbaserede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved solventafparaffinering af det hydrogenerede raffinat, opnået ved solventekstraktion af et hydrogenbehandlet råoliedestillat. Den består overvejende af carbonhydrider, overvejende C18 til og med C40, med kogeinterval omtrent fra 370 oC til 550 oC.] | 305-595-3 | 94733-16-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-508-00-X | carbonhydrider, C13-30-, aromatrige, solvent-ekstraherede naphthenske destillater;
  uspecificeret baseolie | 305-971-7 | 95371-04-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-509-00-5 | carbonhydrider, C16-32-, aromatrige, solvent-ekstraherede naphthenske destillater;
  uspecificeret baseolie | 305-972-2 | 95371-05-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-510-00-0 | carbonhydrider, C37-68, afvoksede afasfalterede hydrogenbehandlede vakuumdestillationsrester;
  uspecificeret baseolie | 305-974-3 | 95371-07-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-511-00-6 | carbonhydrider, C37-65-, hydrogenbehandlede afasfalterede vakuumdestillationsrester;
  uspecificeret baseolie | 305-975-9 | 95371-08-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-512-00-1 | destillater (råolie), hydrokrakkede solventraffinerede, lette; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved solventbehandlingen af et destillat fra hydrokrakkede råoliedestillater. Den består overvejende af carbonhydrider, overvejende C18 til og med C27, med kogeinterval omtrent fra 370 oC til
  450 oC.] | 307-010-7 | 97488-73-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-513-00-7 | destillater (råolie), solventraffinerede hydrogenerede tunge; uspecificeret baseolie; [en sammensat blanding af carbonhydrider opnået ved behandlingen af et hydrogeneret råoliedestillat med et solvent. Den består overvejende af carbonhydrider, overvejende C19 til og med C40, med kogeinterval omtrent fra 390 oC til 550 oC.] | 307-011-2 | 97488-74-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-514-00-2 | smøreolier (råolie), C18-27-, hydrokrakkede solvent-afvoksede;
  uspecificeret baseolie | 307-034-8 | 97488-95-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-515-00-8 | carbonhydrider, C17-30-, hydrogenbehandlet solvent-afasfalteret atmosfærisk destillationsrest, lette destillater; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra behandlingen af en solvent-afasfalteret kort rest med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende fra C17 til og med C30, med kogeinterval omtrent fra 300 oC til 400 oC. Den danner en færdig olie med en viskositet på 4cSt ved omtrent 100 oC.] | 307-661-7 | 97675-87-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-516-00-3 | carbonhydrider, C17-40-, hydrogenbehandlet solvent-afasfalteret destillationsrest, lette vakuumdestillater; uspecificeret baseolie;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra den katalytiske hydrogenbehandling af en solvent-afasfalteret kort rest, med en viskositet på 8cSt ved omtrent 100 oC. Den består overvejende af carbonhydrider, overvejende fra C17 til og med C40, med kogeinterval omtrent fra 300 oC til 500 oC.] | 307-755-8 | 97722-06-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-517-00-9 | carbonhydrider, C13-27-, solvent-ekstraherede, lette, naphthenske;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved ekstraktion af aromaterne fra et let naphthendestillat med en viskositet på 9,5cSt ved 40 oC. Den består overvejende af carbonhydrider, overvejende fra C13 til og med C27, med kogeinterval omtrent fra 240 oC til 400 oC] | 307-758-4 | 97722-09-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-518-00-4 | carbonhydrider, C14-29-, solvent-ekstraherede, lette, naphthenske;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider, opnået ved ekstraktion af aromaterne fra et let naphthendestillat, med en viskositet på 16cSt ved 40 oC. Den består overvejende af carbonhydrider, overvejende C14 til og med C29, med kogeinterval omtrent fra 250 oC til 425 oC.] | 307-760-5 | 97722-10-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-519-00-X | carbonhydrider, C27-42-,
  dearomatiserede;
  uspecificeret baseolie | 308-131-8 | 97862-81-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-520-00-5 | carbonhydrider, C17-30-, hydrogenbehandlede destillater, lette destillationsfraktioner; uspecificeret baseolie | 308-132-3 | 97862-82-3 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-521-00-0 | carbonhydrider, C27-45-, naphthenske vakuumdistillations-;
  uspecificeret baseolie | 308-133-9 | 97862-83-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-522-00-6 | carbonhydrider, C27-45-,
  dearomatiserede;
  uspecificeret baseolie | 308-287-7 | 97926-68-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-523-00-1 | carbonhydrider, C20-58-,
  hydrogenbehandlede;
  uspecificeret baseolie | 308-289-8 | 97926-70-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-524-00-7 | carbonhydrider, C27-42-,
  naphthenske;
  uspecificeret baseolie | 308-290-3 | 97926-71-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-525-00-2 | restolier (råolie), carbonbehandlede, solventafvoksede; uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved behandlingen af solventafvoksede råolierestolier med aktivt kul, for at fjerne spor af polære bestanddele og urenheder.] | 309-710-8 | 100684-37-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-526-00-8 | restolier (råolie), lerbehandlede solventafvoksede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider, opnået ved behandling af solventafvoksede råolierestolier med blegejord, for at fjerne spor af polære bestanddele og
  urenheder.] | 309-711-3 | 100684-38-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-527-00-3 | smøreolier (råolie), C >25-, solventekstraherede, afasfalterede, afvoksede, hydrogenerede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion og hydrogenering af vakuumdestillationsrester. Den består overvejende af carbonhydrider,
  overvejende større end C25, og danner en færdig olie med en viskositet i området 32cSt til 37cSt ved 100 oC.] | 309-874-0 | 101316-69-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-528-00-9 | smøreolier (råolie), C17-32-, solventekstraherede, afvoksede, hydrogenerede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion og hydrogenering af atmosfærisk destillationsrester. Den består overvejende af carbonhydrider, overvejende C17 til og med C32, og danner en færdig olie med en viskositet i området fra 17cSt til 23cSt ved 40 oC.] | 309-875-6 | 101316-70-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-529-00-4 | smøreolier (råolie), C20-35-, solventekstraherede, afvoksede, hydrogenerede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion of hydrogenering af atmosfærisk destillationsrester. Den består overvejende af carbonhydrider, overvejende C20 til og med C35, og danner en færdig olie med en viskositet i området fra 37cSt til 44cSt ved 40 oC.] | 309-876-1 | 101316-71-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-530-00-X | smøreolier (råolie), C24-50-, solventekstraherede, afvoksede, hydrogenerede;
  uspecificeret baseolie;
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion of hydrogenering af atmosfærisk destillationsrester. Den består overvejende af carbonhydrider, overvejende C24 til og med C, og danner en færdig olie med en viskositet i området fra 16cSt til 75cSt ved 40 oC.] | 309-877-7 | 101316-72-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-531-00-5 | ekstrakter (råolie), tungt naphthendestillat solvent-, aromatkoncentrat;
  aromatisk ekstrakt af destillat (behandlet);
  [et aromatkoncentrat fremstillet ved at sætte vand til solventekstrakter og ekstraktionssolvent af tungt naphthadestillat.] | 272-175-3 | 68783-00-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-532-00-0 | ekstrakter (råolie), solventraffineret tungt paraffindestillat solvent-;
  aromatisk ekstrakt af destillat
  (behandlet); [en sammensat blanding af carbonhydrider opnået som ekstraktet fra re-ekstraktionen af solventraffineret, tungt paraffindestillat. Den består af mættede og aromatiske carbonhydrider, overvejende C20 til og med C50.] | 272-180-0 | 68783-04-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-533-00-6 | ekstrakter (råolie), tunge paraffindestillater, solvent-afasfalterede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået som ekstraktet fra en solventekstraktion af tungt paraffindestillat.] | 272-342-0 | 68814-89-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-534-00-1 | ekstrakter (råolie), tungt naphthendestillat solvent-, hydrogenbehandlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået ved behandling af et tungt naphthendestillatsolventekstrakt med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende C20 til og med C50, og danner
  en færdig olie på mindst 19cSt
  ved 40 oC.] | 292-631-5 | 90641-07-9 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-535-00-7 | ekstrakter (råolie), tungt paraffindestillat solvent-, hydrogenbehandlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider fremstillet ved at behandle et tungt paraffindestillat-solventekstrakt med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C21 til og med C33, med kogeinterval omtrent fra 350 oC til 480 oC.] | 292-632-0 | 90641-08-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-536-00-2 | ekstrakter (råolie), let paraffindestillat solvent-, hydrogenbehandlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider fremstillet ved at behandle et let paraffindestillat-solventekstrakt med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C17 til og med C26, med kogeinterval omtrent fra 280 oC til og med 400 oC.] | 292-633-6 | 90641-09-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-537-00-8 | ekstrakter (råolie), hydrogenbehandlet let paraffindestillat solvent-;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået som
  ekstraktet fra solventekstraktion af et intermediært paraffintopsolventdestillat, der er behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider,
  overvejende C16 til og med C36.] | 295-335-4 | 91995-73-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-538-00-3 | ekstrakter (råolie), let naphthendestillat solvent-, hydroafsvovlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået ved at behandle ekstraktet, opnået fra en solventekstraktionsproces, med hydrogen i tilstedeværelse af en katalysator under betingelser primært til fjernelse af svovlforbindelser. Den består overvejende af aromatiske carbonhydrider, overvejende C15 til og med C30. Denne strøm indeholder
  sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.] | 295-338-0 | 91995-75-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-539-00-9 | ekstrakter (råolie), let paraffindestillat solvent-, syrebehandlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået som en fraktion fra destillationen af et ekstrakt fra solventekstraktionen af lette paraffintopfraktion-råoliedestillater, der er underkastet en svovlsyreraffinering. Den består overvejende af aromatiske carbonhydrider,
  overvejende C16 til og med C32.] | 295-339-6 | 91995-76-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-540-00-4 | ekstrakter (råolie), let paraffindestillat solvent-, hydroafsvovlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion af et let paraffindestillat og behandlet med hydrogen for at omdanne
  organisk svovl til hydrogensulfid, det fjernes. Den består overvejende af carbonhydrider, overvejende C15 til og med C40, og danner en færdig olie med viskositet på mere end 10cSt ved 40 oC.] | 295-340-1 | 91995-77-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-541-00-X | ekstrakter (råolie), let vakuumgasolie solvent-, hydrogenbehandlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider, opnået ved solventekstraktion af let vakuumråoliegasolier og behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende C13 til og med C30.] | 295-342-2 | 91995-79-8 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-542-00-5 | ekstrakter (råolie), tungt paraffindestillat solvent-, lerbehandlede;
  aromatisk ekstrakt af destillat (behandlet);
  [en sammensat blanding af carbonhydrider opnået fra behandling af en råoliefraktion med naturligt eller modificeret ler i enten en kontakt- eller perkolationsproces for at fjerne spormængderne af polære forbindelser eller tilstedeværende urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C20 til og med C50. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider bestående af 4- til 6-leddede kondenserede ringe) | 296-437-1 | 92704-08-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-543-00-0 | ekstrakter (råolie), tungt naphthendestillat solvent-, hydroafsvovlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået ved et råolieråstof ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der
  fjernes. Den består overvejende af carbonhydrider, overvejende C15 til og med C50, og danner en færdig olie med en viskositet større end 19cSt ved 40 oC.] | 297-827-4 | 93763-10-1 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-544-00-6 | ekstrakter (råolie), solventafvoksende tunge paraffindestillatsolvent-, hydroafsvovlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået fra et solventafvokset råolieråstof ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består overvejende af carbonhydrider, overvejende C15 til og med C50, og danner en færdig olie med en viskositet større end 19cSt ved 40 oC.] | 297-829-5 | 93763-11-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-545-00-1 | ekstrakter (råolie), let paraffindestillat solvent-, carbonbehandlede;
  aromatisk ekstrakt af destillat (behandlet);
  [en sammensat blanding af carbonhydrider opnået som en fraktion fra destillation af et ekstrakt, genvundet ved solventekstraktion af let paraffin topråoliedestillat behandlet med aktivt kul, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C16 til og med C32.] | 309-672-2 | 100684-02-4 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-546-00-7 | ekstrakter (råolie), let paraffindestillat solvent-, lerbehandlede;
  aromatisk ekstrakt af destillat (behandlet);
  [en sammensat blanding af carbonhydrider opnået som en fraktion fra destillation af et ekstrakt genvundet ved solventekstraktion af let paraffin-topråoliedestillat, behandlet
  med blegejord, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C16 til og med C32.] | 309-673-8 | 100684-03-5 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-547-00-2 | ekstrakter (råolie), let vakuum, gasoliesolvent, carbonbehandlede;
  aromatisk ekstrakt af destillat
  (behandlet);
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion af let vakuumråoliegasolie behandlet med aktivt kul, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C13 til
  C30.] | 309-674-3 | 100684-04-6 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-548-00-8 | ekstrakter (råolie), let vakuumgasolie solvent-, lerbehandlede;
  aromatisk ekstrakt af destillat (behandlet);
  [en sammensat blanding af carbonhydrider opnået ved solventekstraktion af lette vakuumgasolier behandlede med blegejord, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C13 til og med C30.] | 309-675-9 | 100684-05-7 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-549-00-3 | foots olie (råolie), solventekstraherede eller afvoksede tunge restolier
  [en sammensat blanding af carbonhydrider opnået som oliefraktionen fra en solventafolierings-eller vokssvedningsproces. Den består overvejende af forgrenede carbonhydrider, overvejende C20 til og med C50.] | 265-171-8 | 64742-67-2 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 649-550-00-9 | foot's oil (råolie), hydrogenbehandlet; solventekstraherede eller afvoksede tunge restolier | 295-394-6 | 92045-12-0 | Carc. 1B | H350 | GHS08
  Dgr | H350 | | | L |
| 650-002-00-6 | terpentinolie | 232-350-7 | 8006-64-2 | Flam. Liq. 3
  Acute Tox. 4 * Acute Tox. 4 *
  Acute Tox. 4 *
  Asp. Tox. 1
  Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 2 | H226
  H332
  H312
  H302
  H304
  H319
  H315
  H317
  H411 | GHS02
  GHS08
  GHS07
  GHS09
  Dgr | H226
  H332
  H312
  H302
  H304
  H319
  H315
  H317
  H411 | | | |
| 650-003-00-1 | fenson (ISO);
  4-chlorphenyl-benzensulfonat | 201-274-6 | 80-38-6 | Acute Tox. 4 *
  Eye Irrit. 2
  Aquatic Chronic 2 | H302
  H319
  H411 | GHS07
  GHS09
  Wng | H302
  H319
  H411 | | | |
| 650-004-00-7 | norbormid (ISO);
  5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzyliden)bicyclo[2.2.1] hept-5-en-2,3-dicarboximid | 213-589-6 | 991-42-4 | Acute Tox. 4 * | H302 | GHS07
  Wng | H302 | | | |
| 650-005-00-2 | (2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]cromen-6-on, rotenon | 201-501-9 | 83-79-4 | Acute Tox. 3 *
  Eye Irrit. 2
  STOT SE 3
  Skin Irrit. 2
  Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H319
  H335
  H315
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H319
  H335
  H315
  H410 | | | |
| 650-006-00-8 | benquinox (ISO);

  p-benzoquinon-1-benzoylhy
  drazon-4-oxim | 207-807-9 | 495-73-8 | Acute Tox. 3 * Acute Tox. 4 * | H301
  H312 | GHS06
  Dgr | H301
  H312 | | | |
| 650-007-00-3 | chlordimeform (ISO);

  N2-(4-chlor-o-tolyl)-N1,N1-dimethylformamidin | 228-200-5 | 6164-98-3 | Carc. 2
  Acute Tox. 4 *
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H312
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H312
  H302
  H410 | | | |
| 650-008-00-9 | drazoxolon (ISO);
  4-(2-chlorphenylhydrazono)-3-methyl-5-isoxazolon | 227-197-8 | 5707-69-7 | Acute Tox. 3 * Aquatic Acute 1
  Aquatic Chronic 1 | H301
  H400
  H410 | GHS06
  GHS09
  Dgr | H301
  H410 | | | |
| 650-009-00-4 | chlordimeformhydrochlorid; N'-(4-chlor-o-tolyl)-N,N-dimethylformamidinmonohydrochlorid;

  N2-(4-chlor-o-tolyl)-N1,N1-dimethylformamidin hydorchlorid | 243-269-1 | 19750-95-9 | Carc. 2
  Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H351
  H302
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H351
  H302
  H410 | | | |
| 650-010-00-X | benzyl violet 4B;
  α-[4-(4-dimethylamino-α-{4-[ethyl(3-natriosulfonatobenzyl)amino] phenyl}benzyliden)cyclohexa-2,5-dienyliden(ethyl)ammonio]toluen-3-sulfonat | 216-901-9 | 1694-09-3 | Carc. 2 | H351 | GHS08
  Wng | H351 | | | |
| 650-012-00-0 | erionit | — | 12510-42-8 | Carc. 1A | H350 | GHS08
  Dgr | H350 | | | |
| 650-013-00-6 | asbest | —
  —
  —
  —
  —
  —
  — | 12001-28-4
  132207-32-0
  12172-73-5
  77536-66-4
  77536-68-6
  77536-67-5
  12001-29-5 | Carc. 1A
  STOT RE 1 | H350
  H372 ** | GHS08
  Dgr | H350
  H372 ** | | | |
| 650-014-00-1 | diethyl-2,4-dihydroxycyclodisiloxan-2,4-diylbis(trimethylen)diphosphonat, tetranatriumsalt, reaktionsprodukter med dinatriummetasilicat | 401-770-4 | — | Skin Corr. 1B
  Acute Tox. 4 * | H314
  H302 | GHS05
  GHS07
  Dgr | H314
  H302 | | | |
| 650-015-00-7 | terpentinfri harpiks
  kolophonium | 232-475-7
  232-484-6
  277-299-1 | 8050-09-7
  8052-10-6
  73138-82-6 | Skin Sens. 1 | H317 | GHS07
  Wng | H317 | | | |
| 650-016-00-2 | mineraluld, undtagen sådan nævnt andetsteds i dette bilag;
  [syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+MgO+BaO) over 18 % (w/w)] | — | — | Carc. 2 | H351 | GHS08
  Wng | H351 | | | AQR |
| 650-017-00-8 | ildfaste keramiske fibre, specialfibre, undtagen sådanne nævnt andetsteds i dette bilag;
  [syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+MgO+BaO) over 18 % (w/w)] | — | — | Carc. 1B | H350i | GHS08
  Dgr | H350i | | | AR |
| 650-018-00-3 | reaktionsprodukt af acetophenon, formaldehyd, cyclohexylamin, methanol og eddikesyre | 406-230-1 | — | Flam. Liq. 3
  Carc. 2
  Skin Corr. 1B
  Acute Tox. 4 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H226
  H351
  H314
  H332
  H317
  H400
  H410 | GHS02
  GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H226
  H351
  H314
  H332
  H317
  H410 | | | |
| 650-031-00-4 | bis(4-hydroxy-N-methylanilinium)sulfat | 200-237-1 | 55-55-0 | Acute Tox. 4 * STOT RE 2 *
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H373 ** H317
  H400
  H410 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H317
  H410 | | | |
| 650-041-00-9 | triasulfuron (ISO);
  1-[2-(2-chlorethoxy)phenylsulfonyl]
  -3-(4-methoxy-6-methyl-
  1,3,5-triazin-2-yl)urinstof | — | 82097-50-5 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |
| 650-042-00-4 | reaktionsprodukt af polyethylen-polyamin-(C16-C18)-alkylamider og monothio-(C2)-alkyl phosphonater | 417-450-2 | — | Eye Irrit. 2
  Skin Irrit. 2
  Skin Sens. 1
  Aquatic Chronic 3 | H319
  H315
  H317
  H412 | GHS07
  Wng | H319
  H315
  H317
  H412 | | | |
| 650-043-00-X | reaktionsprodukt af 3,5-bis-tert-butylsalicylsyre og aluminiumsulfat | 420-310-3 | — | Acute Tox. 4 * Aquatic Acute 1
  Aquatic Chronic 1 | H302
  H400
  H410 | GHS07
  GHS09
  Wng | H302
  H410 | | | |
| 650-044-00-5 | blanding af ligekædede og forgrenede C14-


  15 alkoholer ethoxylerede, reaktionsprodukt med epichlorhydrin | 420-480-9 | 158570-99-1 | Skin Irrit. 2
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H317
  H400
  H410 | GHS07
  GHS09
  Wng | H315
  H317
  H410 | | | |
| 650-045-00-0 | reaktionsprodukt af 1,2,3-propantricarboxylsyre, 2-hydroxy, diethylester, 1-propanol og zirconium tetra-n-propanolat | 417-110-3 | — | Flam. Liq. 2
  Skin Irrit. 2
  Eye Dam. 1
  Aquatic Chronic 2 | H225
  H315
  H318
  H411 | GHS02
  GHS05
  GHS09
  Dgr | H225
  H315
  H318
  H411 | | | |
| 650-046-00-6 | di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamiddisulfonat, kobber(II)kompleks, derivater | 416-180-2 | 12222-04-7 | Acute Tox. 4 *
  STOT RE 2 *
  Aquatic Chronic 2 | H302
  H373 ** H411 | GHS08
  GHS07
  GHS09
  Wng | H302
  H373 ** H411 | | | |
| 650-047-00-1 | dibenzylphenylsulfonium hexafluorantimonat | 417-760-8 | 134164-24-2 | STOT RE 1
  Acute Tox. 4 *
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Chronic 2 | H372 ** H302
  H318
  H317
  H411 | GHS08
  GHS05
  GHS07
  GHS09
  Dgr | H372 **
  H302
  H318
  H317
  H411 | | | |
| 650-048-00-7 | reaktionsprodukt af borax, hydrogenperoxid, eddikesyreanhydrid og eddikesyre | 420-070-1 | — | Org. Perox. D **** Acute Tox. 4 *
  Acute Tox. 4 *
  Acute Tox. 4 *
  Skin Corr. 1A Aquatic Acute 1 | H242
  H332
  H312
  H302
  H314
  H400 | GHS02
  GHS05
  GHS07
  GHS09
  Dgr | H242
  H332
  H312
  H302
  H314
  H400 | | | |
| 650-049-00-2 | 2-alkoyloxyethyl hydrogenmaleat, hvor alkoyl (vægtmæssigt) udgør 70 til 85 % umættet octadecoyl, 0.5 til 10 % mættet octadecoyl, og 2 til 18 % mættet hexadecoyl | 417-960-5 | — | Skin Irrit. 2
  Eye Dam. 1
  Skin Sens. 1
  Aquatic Acute 1
  Aquatic Chronic 1 | H315
  H318
  H317
  H400
  H410 | GHS05
  GHS07
  GHS09
  Dgr | H315
  H318
  H317
  H410 | | | |
| 650-050-00-8 | en blanding af 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamat og/eller 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamat;
  1,3-butandiol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionat] isomerer;
  1,3-butandiol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionat] isomerer | 423-600-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 | | | |
| 650-055-00-5 | sølvnatriumzirconiumhydrogenphosphat | 422-570-3 | 155925-27-2 | Aquatic Acute 1
  Aquatic Chronic 1 | H400
  H410 | GHS09
  Wng | H410 | | | |

Indeksnr.

International kemisk identifikation

EF nr.

CAS nr.

Klassificering

Mærkning

Specifikke koncentrationsgrænser, M-faktorer

Noter

Fareklasse og

kategorikode(r)

Fare-sætnings-kode(r)

Piktogram-, signalordskode(r)

Faresætningskode(r)

Suppl. faresætningskode(r)

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(10)

(11)

001-001-00-9

hydrogen (brint)

215-605-7

1333-74-0

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

001-002-00-4

aluminiumlithiumhydrid

240-877-9

16853-85-3

Water-react. 1

Skin Corr. 1A

H260

H314

GHS02

GHS05

Dgr

H260

H314

001-003-00-X

natriumhydrid

231-587-3

7646-69-7

Water-react. 1

H260

GHS02

Dgr

H260

001-004-00-5

calciumhydrid

232-189-2

7789-78-8

Water-react. 1

H260

GHS02

Dgr

H260

003-001-00-4

lithium

231-102-5

7439-93-2

Water-react. 1

Skin Corr. 1B

H260

H314

GHS02

GHS05

Dgr

H260

H314

EUH014

003-002-00-X

n-hexyllithium

404-950-0

21369-64-2

Water-react. 1

Pyr. Sol. 1

Skin Corr. 1A

H260

H250

H314

GHS02

GHS05

Dgr

H260

H250

H314

EUH014

003-003-00-5

(2-methylpropyl)lithium;

isobutyllithium

440-620-2

920-36-5

Water-react. 1

Pyr. Liq. 1

Skin Corr. 1A

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H260

H250

H314

H336

H400

H410

GHS02

GHS05

GHS07

GHS09

Dgr

H260

H250

H314

H336

H410

EUH014

004-001-00-7

beryllium

231-150-7

7440-41-7

Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H350i

H330

H301

H372 **

H319

H335

H315

H317

GHS06

GHS08

Dgr

H350i

H330

H301

H372 **

H319

H335

H315

H317

004-002-00-2

berylliumforbindelser med undtagelse af aluminiumberylliumsillicater samt sådanne nævnt andetsteds i dette bilag

—

—

Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H350i

H330

H301

H372 **

H319

H335

H315

H317

H411

GHS06

GHS08

GHS09

Dgr

H350i

H330

H301

H372 **

H319

H335

H315

H317

H411

A

004-003-00-8

berylliumoxid

215-133-1

1304-56-9

Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H350i

H330

H301

H372 **

H319

H335

H315

H317

GHS06

GHS08

Dgr

H350i

H330

H301

H372 **

H319

H335

H315

H317

005-001-00-X

bortrifluorid

231-569-5

7637-07-2

Press. Gas

Acute Tox. 2 *

Skin Corr. 1A

H330

H314

GHS04

GHS06

GHS05

Dgr

H330

H314

EUH014

U

005-002-00-5

bortriclorid

233-658-4

10294-34-5

Press. Gas

Acute Tox. 2 *

Acute Tox. 2 *

Skin Corr. 1B

H330

H300

H314

GHS04

GHS06

GHS05

Dgr

H330

H300

H314

EUH014

U

005-003-00-0

bortribromid

233-657-9

10294-33-4

Acute Tox. 2 *

Acute Tox. 2 *

Skin Corr. 1A

H330

H300

H314

GHS06

GHS05

Dgr

H330

H300

H314

EUH014

005-004-00-6

trialkylboraner, fast

—

—

Pyr. Sol. 1

Skin Corr. 1B

H250

H314

GHS02

GHS05

Dgr

H250

H314

A

005-004-01-3

trialkylboraner, flydende

—

—

Pyr. Liq. 1

Skin Corr. 1B

H250

H314

GHS02

GHS05

Dgr

H250

H314

A

005-005-00-1

trimethylborat

204-468-9

121-43-7

Flam. Liq. 3

Acute Tox. 4 *

H226

H312

GHS02

GHS07

Wng

H226

H312

005-006-00-7

dibutyltinhydrogenborat

401-040-5

75113-37-0

Repr. 1B

Muta. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360FD

H341

H372

H312

H302

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H360FD

H341

H372 **

H312

H302

H318

H317

H410

005-007-00-2

borsyre; [1]

borsyre; [2]

233-139-2 [1]

234-343-4 [2]

10043-35-3 [1]

11113-50-1 [2]

Repr. 1B

H360FD

GHS08

Dgr

H360FD

Repr.1B;

H360FD: C ≥ 5,5  %

005-008-00-8

dibortrioxid;

boroxid

215-125-8

1303-86-2

Repr. 1B

H360FD

GHS08

Dgr

H360FD

Repr.1B;

H360FD:C ≥ 3,1  %

005-009-00-3

tetrabutylammonium butyltriphenylborat

418-080-4

120307-06-4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

005-010-00-9

N, N-dimethylanilinium-tetrakis(pentafluorphenyl)borat

422-050-6

118612-00-3

Carc. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

H351

H302

H315

H318

GHS08

GHS05

GHS07

Dgr

H351

H302

H315

H318

005-011-00-4

dinatriumtetraborat, vandfrit; borsyredinatriumsalt; [1]

tetrabordinatriumheptaoxid, hydrat; [2] orthoborsyre, natriumsalt [3]

215-540-4 [1]

235-541-3 [2]

237-560-2 [3]

1330-43-4 [1]

12267-73-1 [2]

13840-56-7 [3]

Repr. 1B

H360FD

GHS08

Dgr

H360FD

Repr. 1B; H360FD: C ≥ 4,5  %

005-011-01-1

dinatriumtetraborat decahydrat;

borax decahydrat

215-540-4

1303-96-4

Repr. 1B

H360FD

GHS08

Dgr

H360FD

Repr.1B; H360FD: C ≥ 8,5  %

005-011-02-9

dinatriumtetraborat pentahydrat;

borax pentahydrat

215-540-4

12179-04-3

Repr. 1B

H360FD

GHS08

Dgr

H360FD

Repr.1B; H360FD: C ≥ 6,5  %

005-012-00-X

diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienyliden]cyclohexa-2,5-dienyliden}ammonium butyltriphenylborat(1-)

418-070-1

141714-54-7

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

005-013-00-5

diethylmethoxyboran

425-380-9

7397-46-8

Pyr. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 4

H250

H332

H312

H302

H373 **

H314

H317

H413

GHS02

GHS05

GHS08

GHS07

Dgr

H250

H332

H312

H302

H373 **

H314

H317

H413

005-014-00-0

4-formylphenylboronsyre

438-670-5

87199-17-5

Skin Sens. 1

H317

GHS07

Wng

H317

005-015-00-6

1-chlormethyl-4-fluor-1,4-diazoniabicyclo[2.2.2]octanbis(tetrafluorborat)

414-380-4

140681-55-6

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

005-016-00-1

tetrabutylammonium-butyl-tris-(4-tert-butylphenyl)borat

431-370-5

—

Aquatic Chronic 4

H413

—

H413

005-017-00-7

natriumperborat; [1]

natriumperoxometaborat; [2]

natriumperoxoborat;

[indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

239-172-9 [1]

231-556-4 [2]

15120-21-5 [1]

7632-04-4 [2]

Ox. Sol. 2

Repr. 1B

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H302

H335

H318

GHS03

GHS05

GHS08

GHS07

Dgr

H272

H360Df

H302

H335

H318

Repr.1B; H360Df: C ≥ 9 % Repr.1B; H360 D: 6,5  % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-017-01-4

natriumperborat; [1]

natriumperoxometaborat; [2] natriumperoxoborat;

[indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

239-172-9 [1] 231-556-4 [2]

15120-21-5 [1]

7632-04-4 [2]

Ox. Sol. 2

Repr. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H331

H302

H335

H318

GHS03

GHS06

GHS05

GHS08

Dgr

H272

H360Df

H331

H302

H335

H318

Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5  % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-018-00-2

perborsyre, (H3BO2(O2)), mononatriumsalt trihydrat; [1]

perborsyre, natriumsalt, tetrahydrat; [2] perborsyre (HBO(O2)), natriumsalt, tetrahydrat [3]

natriumperoxoborat hexahydrat;

[indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

239-172-9 [1]

234-390-0 [2]

231-556-4 [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. 1B

STOT SE 3

Eye Dam. 1

H360Df

H335

H318

GHS05

GHS08

GHS07

Dgr

H360Df

H335

H318

Repr. 1B;

H360Df: C ≥ 14 % Repr. 1B;

H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2;

H319: 22 % ≤ C < 36 %

005-018-01-X

perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1]

perborsyre, natriumsalt, tetrahydrat; [2]

perborsyre (HBO(O2)), natriumsalt, tetrahydrat; [3]

natriumperoxoborat hexahydrat;

[indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

239-172-9 [1]

234-390-0 [2]

231-556-4 [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. 1B

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H360Df

H332

H335

H318

GHS05

GHS08

GHS07

Dgr

H360Df

H332

H335

H318

Repr. 1B; H360

Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 %

005-019-00-8

perborsyre, natriumsalt; [1]

perborsyre, natriumsalt, monohydrat; [2] perborsyre (HBO(O2)), natriumsalt, monohydrat; [3]

natriumperoxoborat;

[indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

234-390-0 [1]

234-390-0 [2]

231-556-4 [3]

11138-47-9 [1]

12040-72-1 [2]

10332-33-9 [3]

Ox. Sol. 3

Repr. 1B

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H302

H335

H318

GHS03

GHS05

GHS08

GHS07

Dgr

H272

H360Df

H302

H335

H318

Repr. 1B; H360Df: C ≥ 9 %

Repr. 1B; H360D: 6,5  % ≤ C < 9 %

Eye Dam. 1; H318: C ≥ 22 %

Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-019-01-5

perborsyre, natriumsalt; [1]

perborsyre, natriumsalt, monohydrat; [2]

perborsyre (HBO(O2)), natriumsalt, monohydrat; [3]

natriumperoxoborat;

[indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

234-390-0 [1]

234-390-0 [2]

231-556-4 [3]

11138-47-9 [1]

12040-72-1 [2]

10332-33-9 [3]

Ox. Sol. 3

Repr. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H331

H302

H335

H318

GHS03

GHS06

GHS05

GHS08

Dgr

H272

H360Df

H331

H302

H335

H318

Repr. 1B; H360Df: C ≥

9 %

Repr. 1B; H360D: 6,5  %

≤ C < 9 %

Eye Dam. 1; H318: C ≥ 22 %

Eye Irrit. 2; H319: 14 % ≤ C < 22 %

006-001-00-2

carbonmonoxid

211-128-3

630-08-0

Flam. Gas 1

Press. Gas

Repr. 1A

Acute Tox. 3 *

STOT RE 1

H220

H360D ***

H331

H372 **

GHS02

GHS04

GHS06

GHS08

Dgr

H220

H360D *** H331

H372 **

U

006-002-00-8

phosgen; carbonylchlorid

200-870-3

75-44-5

Press. Gas

Acute Tox. 2 *

Skin Corr. 1B

H330

H314

GHS04

GHS06

GHS05

Dgr

H330

H314

U

006-003-00-3

carbondisulfid

200-843-6

75-15-0

Flam. Liq. 2

Repr. 2

STOT RE 1

Eye Irrit. 2

Skin Irrit. 2

H225

H361fd

H372 **

H319

H315

GHS02

GHS08

GHS07

Dgr

H225

H361fd

H372 **

H319

H315

Repr. 2; H361fd: C ≥ 1 %

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,2  %

≤ C < 1 %

006-004-00-9

calciumcarbid

200-848-3

75-20-7

Water-react. 1

H260

GHS02

Dgr

H260

T

006-005-00-4

thiram (ISO);

tetramethylthiuramdisulfid

205-286-2

137-26-8

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H373 **

H319

H315

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H332

H302

H373 **

H319

H315

H317

H410

M = 10

006-006-00-X

hydrogencyanid;

blåsyre

200-821-6

74-90-8

Flam. Liq. 1

Acute Tox. 2 * Aquatic Acute 1

Aquatic Chronic 1

H224

H330

H400

H410

GHS02

GHS06

GHS09

Dgr

H224

H330

H410

006-006-01-7

hydrogencyanid ... %;

blåsyre ... %

200-821-6

74-90-8

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

B

006-007-00-5

salte af hydrogencyanid med undtagelse af komplekse salte som cyanoferrat (II) og-(III) og kviksølv(II)oxidcyanid samt sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

EUH032

A

006-008-00-0

antu (ISO);

1-(1-naphthyl)-2-thiourinstof

201-706-3

86-88-4

Acute Tox. 2 *

Carc. 2

H300

H351

GHS06

GHS08

Dgr

H300

H351

006-009-00-6

1-isopropyl-3-methylpyrazol-5-yldimethylcarbamat;

isolan

204-318-2

119-38-0

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

006-010-00-1

5,5-dimethyl-3-oxocyclohex-1-enyldimethylcarbamat; 5,5-dimethyldihydroresorcinoldimethylcarbamat; dimetan

204-525-8

122-15-6

Acute Tox. 3 *

H301

GHS06

Dgr

H301

006-011-00-7

carbaryl (ISO);

1-naphthylmethylcarbamat

200-555-0

63-25-2

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

H351

H332

H302

H400

GHS08

GHS07

GHS09

Wng

H351

H332

H302

H400

M = 100

006-012-00-2

ziram (ISO);

zink-bis(N, N-dimethyldithiocarbamat)

205-288-3

137-30-4

Acute Tox. 2 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H373 **

H335

H318

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H330

H302

H373 **

H335

H318

H317

H410

M = 100

006-013-00-8

metam-natrium (ISO);

natrium-N-methyldithiocarbamat

205-293-0

137-42-8

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H317

H410

EUH031

006-014-00-3

nabam (ISO);

dinatriumethylenbisdithiocarbamat

205-547-0

142-59-6

Acute Tox. 4 *

STOT SE 3

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H335

H317

H410

GHS07

GHS09

Wng

H302

H335

H317

H410

006-015-00-9

diuron (ISO);

3-(3,4-dichlorphenyl)-1,1-dimethylurinstof

206-354-4

330-54-1

Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H373 ** H410

M = 10

006-016-00-4

propoxur (ISO);

2-isopropyloxyphenylmethylcarbamat;

2-isopropoxyphenylmethylcarbamat

204-043-8

114-26-1

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

006-017-00-X

aldicarb (ISO);

2-methyl-2-(methylthio)propionaldehyd-O-(methylcarbamoyl)oxim

204-123-2

116-06-3

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H311

H400

H410

GHS06

GHS09

Dgr

H330

H300

H311

H410

006-018-00-5

aminocarb (ISO);

4-dimethylamino-3-tolylmethylcarbamat

217-990-7

2032-59-9

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

006-019-00-0

di-allat (ISO);

S-2,3-dichlorallyldiisopropylthiocarbamat

218-961-1

2303-16-4

Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H410

006-020-00-6

barban (ISO);

4-chlorbut-2-ynyl-3-chlorphenylcarbamat

202-930-4

101-27-9

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

006-021-00-1

linuron (ISO);

3-(3,4-dichlorphenyl)-1-methoxy-1-methylurinstof

206-356-5

330-55-2

Repr. 1B Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H351

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Dgr

H360Df

H351

H302

H373 **

H410

006-022-00-7

decarbofuran (ISO);

2,3-dihydro-2-methyl-7-benzofuranyl-methylcarbamat

—

1563-67-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

006-023-00-2

mercaptodimethur (ISO);

methiocarb (ISO);

4-methylthio-3,5-xylylmethylcarbamat methiocarb

217-991-2

2032-65-7

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

006-024-00-8

proxan-Na (ISO);

natrium-isopropyl-xanthogenat

205-443-5

140-93-2

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 2

H302

H315

H411

GHS07

GHS09

Wng

H302

H315

H411

006-025-00-3

allethrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3RS)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat; bioallethrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat; [1]

S-bioallethrin; [2]

(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat; [3]

esbiothrin;

(RS)-3-allyl-2-methyl-4- oxocyclopent-2-enyl(1R,3R)- 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat

209-542-4 [1]

249-013-5 [2]-[3]

584-79-2 [1]

28434-00-6 [2]

84030-86-4 [3]

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H400

H410

GHS07

GHS09

Wng

H332

H302

H410

C

006-026-00-9

carbofuran (ISO);

2,3-dihydro-2,2-dimethylbenzofuran-7-ylmethylcarbamat

216-353-0

1563-66-2

Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H400

H410

GHS06

GHS09

Dgr

H330

H300

H410

006-028-00-X

dinobuton (ISO);

2-sec-butyl-4,6-dinitrophenylisopropylcarbonat

213-546-1

973-21-7

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

006-029-00-5

dioxacarb (ISO);

2-(1,3-dioxolan-2-yl)phenylmethylcarbamat

230-253-4

6988-21-2

Acute Tox. 3 * Aquatic Chronic 2

H301

H411

GHS06

GHS09

Dgr

H301

H411

006-030-00-0

EPTC (ISO);

S-ethyldipropylthiocarbamat

212-073-8

759-94-4

Acute Tox. 4 *

H302

GHS07

Wng

H302

006-031-00-6

formetanat (ISO);

3-[(EZ)-dimethylaminomethylenamino]phenylmethylcarbamat

244-879-0

22259-30-9

Acute Tox. 2 *

Acute Tox. 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H317

H400

H410

GHS06

GHS09

Dgr

H330

H300

H317

H410

006-032-00-1

monolinuron (ISO);

3-(4-dichlorphenyl)-1-methoxy-1-methylurinstof

217-129-5

1746-81-2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 **

H410

006-033-00-7

metoxuron (ISO);

N'-(3-chlor-4-methoxyphenyl)-N, N-dimethylurinstof

243-433-2

19937-59-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

006-034-00-2

pebulat (ISO);

S-propylbutyl (ethyl) thiocarbamat

214-215-4

1114-71-2

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

006-036-00-3

benzthiazuron (ISO);

1-benzothiazol-2-yl-3-methylurinstof

217-685-9

1929-88-0

Acute Tox. 4 *

H302

GHS07

Wng

H302

006-037-00-9

promecarb (ISO);

5-isopropyl-3-tolylmethylcarbamat

220-113-0

2631-37-0

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

006-038-00-4

sulfallat (ISO);

2-chlorallyldiethyldithiocarbamat

202-388-9

95-06-7

Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H410

006-039-00-X

tri-allat (ISO);

S-2,3,3-trichlorallyldiisopropylthiocarbamat

218-962-7

2303-17-5

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 **

H317

H410

006-040-00-5

(3-methyl-1H-pyrazol-5-yl)-N, N-dimethylcarbamat;

—

2532-43-6

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

006-041-00-0

dimethylcarbamoylchlorid

201-208-6

79-44-7

Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H350

H331

H302

H319

H335

H315

GHS06

GHS08

Dgr

H350

H331

H302

H319

H335

H315

Carc. 1B;

H350: C ≥ 0.001 %

006-042-00-6

monuron (ISO);

3-(4-dichlorphenyl)-1,1-dimethylurinstof

205-766-1

150-68-5

Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H410

006-043-00-1

3-(4-chlorphenyl)-1,1-dimethyluroniumtrichloracetat;

monuron-TCA

—

140-41-0

Carc. 2

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H319

H315

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H319

H315

H410

006-044-00-7

isoproturon (ISO);

3-(4-isopropylphenyl)-1,1-dimethylurinstof

251-835-4

34123-59-6

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 10

006-045-00-2

methomyl (ISO);

1-(methylthio)ethylidenamino-N-methylcarbamat

240-815-0

16752-77-5

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H400

H410

GHS06

GHS09

Dgr

H300

H410

M = 100

006-047-00-3

bufencarb (ISO);

blanding af 3-(1-methylbutyl) phenylmethylcarbamat og 3-(1-ethylpropyl) phenylmethylcarbamat (3:1)

—

8065-36-9

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

006-048-00-9

ethiofencarb (ISO);

2-ethylthiomethylphenylmethylcarbamat

249-981-9

29973-13-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

006-049-00-4

dixanthogen;

O,O-diethyldithiobis(thioformiat)

207-944-4

502-55-6

Acute Tox. 4 *

H302

GHS07

Wng

H302

006-050-00-X

1,1-dimethylphenyluroniumtrichloracetat;

fenuron-TCA

—

4482-55-7

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

006-051-00-5

ferbam (ISO);

jerntris(dimethyldithiocarbamat)

238-484-2

14484-64-1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H319

H335

H315

H410

006-052-00-0

formetanathydrochlorid;

3-(N, N-dimethylaminomethylenamino)phenyl-N-methylcarbamat

245-656-0

23422-53-9

Acute Tox. 2 *

Acute Tox. 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H317

H400

H410

GHS06

GHS09

Dgr

H330

H300

H317

H410

006-053-00-6

isoprocarb (ISO);

O-cumenylmethylcarbamat

220-114-6

2631-40-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

006-054-00-1

mexacarbat (ISO);

4-dimethylamino-3,5-xylylmethylcarbamat

206-249-3

315-18-4

Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H312

H400

H410

GHS06

GHS09

Dgr

H300

H312

H410

006-055-00-7

xylylcarb (ISO);

3,4-dimethylphenyl N-methylcarbamat;

3,4-xylylmethylcarbamat;

MPMC

219-364-9

2425-10-7

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

006-056-00-2

metolcarb (ISO);

m-tolylmethylcarbamat;

MTMC

214-446-0

1129-41-5

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

006-057-00-8

nitrapyrin (ISO);

2-chlor-6-trichlormethylpyridin

217-682-2

1929-82-4

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

006-058-00-3

noruron (ISO);

1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urinstof

—

2163-79-3

Acute Tox. 4 *

H302

GHS07

Wng

H302

006-059-00-9

oxamyl (ISO);

N',N'-dimethylcarbamoyl(methylthio)methylenamin-N-methylcarbamat

245-445-3

23135-22-0

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Chronic 2

H330

H300

H312

H411

GHS06

GHS09

Dgr

H330

H300

H312

H411

006-060-00-4

oxycarboxin (ISO);

5,6-dihydro-2-methyl-1,4-oxathiin-3-carboxanilid-4,4-dioxid

226-066-2

5259-88-1

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

006-061-00-X

S-ethyl-N-(dimethylaminopropyl)thiocarbamathydrochlorid;

prothiocarb hydrochlorid

243-193-9

19622-19-6

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

006-062-00-5

methyl-3,4-dichlorphenylcarbanilat

SWEP

—

1918-18-9

Acute Tox. 4 *

H302

GHS07

Wng

H302

006-063-00-0

thiobencarb (ISO);

S-4-chlorbenzyldiethylthiocarbamat

248-924-5

28249-77-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

006-064-00-6

thiofanox (ISO);

3,3-dimethyl-1-(methylthio)butanon-O-(N-methylcarbamoyl)oxim

254-346-4

39196-18-4

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

006-065-00-1

3-chlor-6-cyanobicyclo(2,2,1)heptan-2-on-O-(N-methylcarbamoyl)oxim;

triamid

—

15271-41-7

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Chronic 2

H300

H311

H411

GHS06

GHS09

Dgr

H300

H311

H411

006-066-00-7

vernolat (ISO);

S-propyldipropylthiocarbamat

217-681-7

1929-77-7

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

006-067-00-2

3,5-xylylmethylcarbamat; XMC

—

2655-14-3

Acute Tox. 4 *

H302

GHS07

Wng

H302

006-068-00-8

diazomethan

206-382-7

334-88-3

Carc. 1B

H350

GHS08

Dgr

H350

006-069-00-3

thiophanatmethyl (ISO);

1,2-di-(3-methoxycarbonyl-2-thioureido)benzen

245-740-7

23564-05-8

Muta. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H332

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H341

H332

H317

H410

006-070-00-9

furmecyclox (ISO);

N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamid

262-302-0

60568-05-0

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

006-071-00-4

cyclooct-4-en-1-ylmethylcarbonat

401-620-8

87731-18-8

Skin Sens. 1

H317

GHS07

Wng

H317

006-072-00-X

prosulfocarb (ISO);

S-benzyl-N, N-dipropylthiocarbamat

401-730-6

52888-80-9

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

006-073-00-5

3-(dimethylamino)propylurinstof

401-950-2

31506-43-1

Eye Dam. 1

H318

GHS05

Dgr

H318

006-074-00-0

2-(3-(prop-1-en-2-yl)phenyl)prop-2-ylisocyanat

402-440-2

2094-99-7

Acute Tox. 2 *

Skin Corr. 1B

STOT RE 2 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H314

H373 **

H334

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H330

H314

H373 **

H334

H317

H410

006-076-00-1

mancozeb (ISO);

manganethylenbis(dithiocarbamat) (polymer), kompleks med zinksalt

—

8018-01-7

Repr. 2

Skin Sens. 1

Aquatic Acute 1

H361d ***

H317

H400

GHS08

GHS07

GHS09

Wng

H361d ***

H317

H400

M = 10

006-077-00-7

maneb (ISO);

manganethylenbis(dithiocarbamat) (polymer)

235-654-8

12427-38-2

Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d ***

H332

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361d ***

H332

H319

H317

H410

M = 10

006-078-00-2

zineb (ISO);

zinkethylenbis(dithiocarbamat) (polymer)

235-180-1

12122-67-7

STOT SE 3

Skin Sens. 1

H335

H317

GHS07

Wng

H335

H317

006-079-00-8

disulfiram;

tetraethylthiuramdisulfid

202-607-8

97-77-8

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 **

H317

H410

006-080-00-3

tetramethylthiurammonosulfid

202-605-7

97-74-5

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

006-081-00-9

zinkbis(dibutyldithiocarbamat)

205-232-8

136-23-2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H319

H335

H315

H317

H400

H410

GHS07

GHS09

Wng

H319

H335

H315

H317

H410

006-082-00-4

zinkbis(diethyldithiocarbamat)

238-270-9

14324-55-1

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H335

H315

H317

H400

H410

GHS07

GHS09

Wng

H302

H319

H335

H315

H317

H410

006-083-00-X

butocarboxim (ISO;

3-(methylthio)-2-butanon O-[(methylamino)carbonyl]oxim

252-139-3

34681-10-2

Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H226

H331

H311

H301

H319

H400

H410

GHS02

GHS06

GHS09

Dgr

H226

H331

H311

H301

H319

H410

006-084-00-5

carbosulfan (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamat

259-565-9

55285-14-8

Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H301

H317

H400

H410

GHS06

GHS09

Dgr

H330

H301

H317

H410

006-085-00-0

fenobucarb (ISO);

2-butylphenylmethylcarbamat

223-188-8

3766-81-2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

006-086-00-6

fenoxycarb (ISO);

ethyl [2-(4-phenoxyphenoxy)ethyl]carbamat

276-696-7

72490-01-8

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 1

M = 10 000

006-087-00-1

furathiocarb (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl-2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoat

265-974-3

65907-30-4

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H301

H373 **

H319

H315

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H301

H373 **

H319

H315

H317

H410

M = 100

006-088-00-7

benfuracarb (ISO);

ethyl-N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninat

—

82560-54-1

Repr. 2

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H361f ***

H331

H302

H400

H410

GHS06

GHS08

GHS09

Dgr

H361f ***

H331

H302

H410

006-090-00-8

2-(3-iodprop-2-yn-1-yloxy)ethylphenylcarbamat

408-010-0

88558-41-2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H332

H318

H412

GHS05

GHS07

Dgr

H332

H318

H412

006-091-00-3

propineb (ISO)

polymert zink-propylenbis(dithiocarbamat)

—

9016-72-2

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

H332

H373 **

H317

H400

GHS08

GHS07

GHS09

Wng

H332

H373 **

H317

H400

006-092-00-9

tert-butyl-(1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamat

425-420-5

98737-29-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

006-093-00-4

2,2'-dithio-di(ethylammonium)bis(dibenzyldithiocarbamat)

427-180-7

—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

006-094-00-X

O-isobutyl-N-ethoxycarbonylthiocarbamat

434-350-4

103122-66-3

Flam. Liq. 3

Carc. 1B

Muta. 1B

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H226

H350

H340

H302

H373 **

H317

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H350

H340

H302

H373 **

H317

H411

006-095-00-5

fosetyl-aluminium (ISO);

aluminiumtriethyltriphosphonat

254-320-2

39148-24-8

Eye Dam. 1

H318

GHS05

Dgr

H318

006-096-00-0

chlorpropham (ISO);

isopropyl-3-chlorcarbanilat

202-925-7

101-21-3

Carc. 2

STOT RE 2 *

Aquatic Chronic 2

H351

H373 **

H411

GHS08

GHS09

Wng

H351

H373 **

H411

006-097-00-6

1-phenyl-3-(p-toluensulfonyl)urinstof

424-620-1

13909-63-2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373 **

H412

GHS08

GHS07

Wng

H302

H373 **

H412

006-098-00-1

tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamat

429-170-8

134575-17-0

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H302

H373 **

H318

H317

GHS05

GHS08

GHS07

Dgr

H302

H373 **

H318

H317

006-099-00-7

N-(p-toluensulfonyl)-N'-(3-(p-toluensulfonyloxy)phenyl)urinstof;

3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzensulfonat

520-2

232938-43-1

Aquatic Chronic 2

H411

GHS09

H411

006-101-00-6

blanding af N, N''-(methylendi-4,1-phenylen)bis[N'-phenylurinstof];

N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurinstof;

N, N''-(methylendi-4,1-phenylen)bis[N'-cyclohexylurinstof]

423-070-8

—

Aquatic Chronic 4

H413

—

H413

006-102-00-1

O-hexyl-N-ethoxycarbonylthiocarbamat

432-750-3

—

Carc. 1B

Muta. 1B

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H350

H340

H302

H373 **

H317

H411

GHS08

GHS07

GHS09

Dgr

H350

H340

H302

H373 **

H317

H411

006-103-00-7

N,N′′-(methylendi-4,1-phenylen)bis[N′-octyl]urinstof

445-760-8

—

Eye Dam. 1

Resp. Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H334

H400

H410

GHS05

GHS08

GHS09

Dgr

H318

H334

H410

M = 100

007-001-00-5

ammoniak, vandfri

231-635-3

7664-41-7

Flam. Gas 2

Press. Gas

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1

H221

H331

H314

H400

GHS04

GHS06

GHS05

GHS09

Dgr

H221

H331

H314

H400

U

007-001-01-2

ammoniak ....%

215-647-6

1336-21-6

Skin Corr. 1B

Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

STOT SE 3; H335: C ≥ 5 %

B

007-002-00-0

nitrogendioxid; [1]

dinitrogentetraoxid [2]

233-272-6 [1]

234-126-4 [2]

10102-44-0 [1]

10544-72-6 [2]

Press. Gas

Ox. Gas 1

Acute Tox. 2 *

Skin Corr. 1B

H270

H330

H314

GHS04

GHS03

GHS06

GHS05

Dgr

H270

H330

H314

*

STOT SE 3; H335: C ≥ 0,5  %

5

007-003-00-6

chlormequatchlorid (ISO);

2-chlorethyltrimethylammoniumchlorid

213-666-4

999-81-5

Acute Tox. 4 *

Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

007-006-00-2

ethylnitrit

203-722-6

109-95-5

Flam. Gas 1

Press. Gas

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H220

H332

H312

H302

GHS02

GHS04

GHS07

Dgr

H220

H332

H312

H302

U

007-007-00-8

ethylnitrat

210-903-3

625-58-1

Unst. Expl.

H200

GHS01

Dgr

H200

007-008-00-3

hydrazin

206-114-9

302-01-2

Flam. Liq. 3

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H350

H331

H311

H301

H314

H317

H400

H410

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H226

H350

H331

H311

H301

H314

H317

H410

Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 %

Eye Irrit. 2; H319: 3 % ≤ C < 10 %

007-009-00-9

dicyclohexylammoniumnitrit

221-515-9

3129-91-7

Acute Tox. 4 *

Acute Tox. 4 *

H332

H302

GHS07

Wng

H332

H302

*

007-010-00-4

natriumnitrit

231-555-9

7632-00-0

Ox. Sol. 3

Acute Tox. 3 *

Aquatic Acute 1

H272

H301

H400

GHS03

GHS06

GHS09

Dgr

H272

H301

H400

*

007-011-00-X

kaliumnitrit

231-832-4

7758-09-0

Ox. Sol. 2

Acute Tox. 3 *

Aquatic Acute 1

H272

H301

H400

GHS03

GHS06

GHS09

Dgr

H272

H301

H400

*

007-012-00-5

N, N-dimethylhydrazin

200-316-0

57-14-7

Flam. Liq. 2

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Chronic 2

H225

H350

H331

H301

H314

H411

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H225

H350

H331

H301

H314

H411

007-013-00-0

1,2-dimethylhydrazin

—

540-73-8

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H350

H331

H311

H301

H411

GHS06

GHS08

GHS09

Dgr

H350

H331

H311

H301

H411

Carc. 1B; H350: C ≥ 0,01  %

007-014-00-6

salte af hydrazin

—

—

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H331

H311

H301

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H331

H311

H301

H317

H410

A

007-015-00-1

O-ethylhydroxylamin

402-030-3

624-86-2

Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H225

H331

H311

H301

H372 **

H319

H317

H400

GHS02

GHS06

GHS08

GHS09

Dgr

H225

H331

H311

H301

H372 **

H319

H317

H400

007-016-00-7

butylnitrit

208-862-1

544-16-1

Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

H225

H331

H301

GHS02

GHS06

Dgr

H225

H331

H301

007-017-00-2

isobutylnitrit

208-819-7

542-56-3

Flam. Liq. 2

Carc. 1B

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

H225

H350

H341

H332

H302

GHS02

GHS08

GHS07

Dgr

H225

H350

H341

H332

H302

007-018-00-8

sec-butylnitrit

213-104-8

924-43-6

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

H225

H332

H302

GHS02

GHS07

Dgr

H225

H332

H302

007-019-00-3

tert-butylnitrit

208-757-0

540-80-7

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

H225

H332

H302

GHS02

GHS07

Dgr

H225

H332

H302

007-020-00-9

pentylnitrit; [1]

amylnitrit, blanding af isomerer [2]

207-332-7 [1]

203-770-8 [2]

463-04-7 [1]

110-46-3 [2]

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

H225

H332

H302

GHS02

GHS07

Dgr

H225

H332

H302

007-021-00-4

hydrazobenzen;

1,2-diphenylhydrazin

204-563-5

122-66-7

Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H410

007-022-00-X

hydrazinbis(3-carboxy-4-hydroxybenzensulfonat)

405-030-1

—

Carc. 1B

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H350

H302

H314

H317

H412

GHS08

GHS05

GHS07

Dgr

H350

H302

H314

H317

H412

007-023-00-5

natrium-3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzensulfonat

405-510-0

—

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

007-024-00-0

2-(decylthio)ethylammoniumchlorid

405-640-8

36362-09-1

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H315

H318

H400

H410

GHS08

GHS05

GHS09

Dgr

H373 **

H315

H318

H410

007-025-00-6

(4-hydrazinophenyl)-N-methylmethansulfonamidhydrochlorid

406-090-1

81880-96-8

Muta. 2

Acute Tox. 3 *

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H301

H372 **

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H341

H301

H372 **

H317

H410

007-026-00-1

oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazid

413-230-5

122035-71-6

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

007-027-00-7

1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexan

420-190-2

771478-66-1

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373 **

H314

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H312

H302

H373 **

H314

H317

H410

007-028-00-2

hydroxylammoniumnitrat

236-691-2

13465-08-2

Expl. 1,1 ****

Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H201

H351

H311

H302

H373 **

H319

H315

H317

H400

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H351

H311

H302

H373 **

H319

H315

H317

H400

007-029-00-8

diethyldimethylammoniumhydroxid

419-400-5

95500-19-9

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

008-001-00-8

ilt

231-956-9

7782-44-7

Ox. Gas 1

Press. Gas

H270

GHS03

GHS04

Dgr

H270

U

008-003-00-9

hydrogenperoxidopløsning ... %

231-765-0

7722-84-1

Ox. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H271

H332

H302

H314

GHS03

GHS05

GHS07

Dgr

H271

H332

H302

H314

Ox. Liq. 1; H271: C ≥ 70 % ****

Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****

*

Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 %

Skin Irrit. 2; H315: 35 % ≤ C < 50 %

Eye Dam. 1; H318: 8 % ≤ C < 50 %

Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 %

B

009-001-00-0

fluor

231-954-8

7782-41-4

Press. Gas

Ox. Gas 1

Acute Tox. 2 *

Skin Corr. 1A

H270

H330

H314

GHS04

GHS03

GHS06

GHS05

Dgr

H270

H330

H314

009-002-00-6

hydrogenfluorid

231-634-8

7664-39-3

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1A

H330

H310

H300

H314

GHS06

GHS05

Dgr

H330

H310

H300

H314

009-003-00-1

hydrogenfluorid, opløsning ... %

231-634-8

7664-39-3

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1A

H330

H310

H300

H314

GHS06

GHS05

Dgr

H330

H310

H300

H314

Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C < 7 % Eye Irrit. 2; H319: 0,1  % ≤ C < 1 %

B

009-004-00-7

natriumfluorid

231-667-8

7681-49-4

Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

H301

H319

H315

GHS06

Dgr

H301

H319

H315

EUH032

009-005-00-2

kaliumfluorid

232-151-5

7789-23-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

009-006-00-8

ammoniumfluorid

235-185-9

12125-01-8

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

009-007-00-3

natriumbifluorid;

natriumhydrogenfluorid

215-608-3

1333-83-1

Acute Tox. 3 *

Skin Corr. 1B

H301

H314

GHS06

GHS05

Dgr

H301

H314 *

Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1  % ≤ C < 7 % Eye Irrit. 2;

H319: 0,1  % ≤

C < 1 %

009-008-00-9

kaliumbiflourid;

kaliumhydrogenfluorid

232-156-2

7789-29-9

Acute Tox. 3 *

Skin Corr. 1B

H301

H314

GHS06

GHS05

Dgr

H301

H314

*

Skin Corr. 1B; H314: C ≥ 1 %

Skin Irrit. 2; H315: 0,1  % ≤ C < 1 %

Eye Irrit. 2; H319: 0,1  % ≤ C < 1 %

009-009-00-4

ammoniumbiflourid;

ammoniumhydrogenfluorid

215-676-4

1341-49-7

Acute Tox. 3 *

Skin Corr. 1B

H301

H314

GHS06

GHS05

Dgr

H301

H314

*

Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1  % ≤ C < 1 %

Eye Irrit. 2; H319: 0,1  % ≤ C < 1 %

009-010-00-X

flourborsyre ... %

240-898-3

16872-11-0

Skin Corr. 1B

H314

GHS05

Dgr

H314

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤

C < 25 %

B

009-011-00-5

hydrogensilicimhexafluorid ... %, fluskiselsyre ... % %

241-034-8

16961-83-4

Skin Corr. 1B

H314

GHS05

Dgr

H314

B

009-012-00-0

ammonium- og alkalihexafluorosilicater(Na); [1]

ammonium- og alkalihexafluorosilicater(K); [2] ammonium- og alkalihexafluorosilicater(NH4) [3]

240-934-8 [1]

240-896-2 [2]

240-968-3 [3]

16893-85-9 [1]

16871-90-2 [2]

16919-19-0 [3]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

*

A

009-013-00-6

hexafluorosilicater, undtagen de andetsteds i dette bilag nævnte

—

—

Acute Tox. 4 *

H302

GHS07

Wng

H302

*

A

009-014-00-1

blyhexafluorosilicat

247-278-1

25808-74-6

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H332

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Dgr

H360Df

H332

H302

H373 **

H410

1

009-015-00-7

sulfuryldifluorid

220-281-5

2699-79-8

Press. Gas

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

H331

H373 **

H400

GHS04

GHS06

GHS08

GHS09

Dgr

H331

H373 **

H400

U

009-016-00-2

trinatriumhexafluoraluminat [1]

trinatriumhexafluoraluminat(cryolite) [2]

237-410-6 [1]

239-148-8 [2]

13775-53-6 [1]

15096-52-3 [2]

STOT RE 1

Acute Tox. 4

Aquatic Chronic 2

H372

H332

H411

GHS07

GHS08

GHS09

Dgr

H372

H332

H411

009-017-00-8

kalium-mu-fluor-bis(triethylaluminium)

400-040-2

12091-08-6

Flam. Sol. 1

Water-react. 1

Skin Corr. 1A

Acute Tox. 4 *

H228

H270

H314

H332

GHS02

GHS05

GHS07

Dgr

H228

H270

H314

H332

EUH014

T

009-018-00-3

magnesiumhexafluorosilicat

241-022-2

16949-65-8

Acute Tox. 3 *

H301

GHS06

Dgr

H301

*

011-001-00-0

natrium

231-132-9

7440-23-5

Water-react. 1

Skin Corr. 1B

H260

H314

GHS02

GHS05

Dgr

H260

H314

EUH014

011-002-00-6

natriumhydroxid; kaustisk soda

215-185-5

1310-73-2

Skin Corr. 1A

H314

GHS05

Dgr

H314

Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5  % ≤ C < 2 % Eye Irrit.2; H319: 0,5  % ≤ C < 2 %

011-003-00-1

natriumperoxid

215-209-4

1313-60-6

Ox. Sol. 1

Skin Corr. 1A

H271

H314

GHS03

GHS05

Dgr

H271

H314

011-004-00-7

natriumazid

247-852-1

26628-22-8

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H400

H410

GHS06

GHS09

Dgr

H300

H400

H410

EUH032

011-005-00-2

natriumcarbonat

207-838-8

497-19-8

Eye Irrit. 2

H319

GHS07

Wng

H319

011-006-00-8

natriumcyanat

213-030-6

917-61-3

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

011-007-00-3

natriumpropoxycarbazon

—

181274-15-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

012-001-00-3

magnesiumpulver (ustabiliseret)

231-104-6

7439-95-4

Water-react. 1

Pyr. Sol. 1

H260

H250

GHS02

Dgr

H260

H250

T

012-002-00-9

magnesiumpulver (stabiliseret) og -spåner

231-104-6

—

Flam. Sol. 1

Water-react. 2

Self-heat. 1

H228

H261

H252

GHS02

Dgr

H228

H261

H252

T

012-003-00-4

magnesiumalkyler

—

—

Pyr. Liq. 1

Water-react. 1

Skin Corr. 1B

H250

H260

H314

GHS02

GHS05

Dgr

H250

H260

H314

EUH014

A

012-004-00-X

aluminium-magnesium-carbonat-hydroxid-perchlorat-hydrat

422-150-1

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

013-001-00-6

aluminiumpulver (ustabiliseret)

231-072-3

7429-90-5

Water-react. 2

Pyr. Sol. 1

H261

H250

GHS02

Dgr

H261

H250

T

013-002-00-1

aluminiumpulver (stabiliseret)

231-072-3

7429-90-5

Water-react. 2

Flam. Sol. 1

H261

H228

GHS02

Dgr

H261

H228

T

013-003-00-7

aluminiumchlorid, vandfrit

231-208-1

7446-70-0

Skin Corr. 1B

H314

GHS05

Dgr

H314

013-004-00-2

aluminiumalkyler

—

—

Pyr. Liq. 1

Water-react. 1

Skin Corr. 1B

H250

H260

H314

GHS02

GHS05

Dgr

H250

H260

H314

EUH014

A

013-005-00-8

diethyl(ethyldimethylsilanolato)aluminium

401-160-8

55426-95-4

Water-react. 1

Pyr. Liq. 1

Skin Corr. 1A

H260

H250

H314

GHS02

GHS05

Dgr

H260

H250

H314

EUH014

013-006-00-3

(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxy-2-propanolato)aluminium(III), dimeriseret

402-370-2

—

Flam. Liq. 3

Eye Dam. 1

H226

H318

GHS02

GHS05

Dgr

H226

H318

013-007-00-9

poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)

403-430-0

—

Eye Dam. 1

H318

GHS05

Dgr

H318

013-008-00-4

di-n-octylaluminiumiodid

408-190-0

7585-14-0

Pyr. Liq. 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H250

H314

H400

H410

GHS02

GHS05

GHS09

Dgr

H250

H314

H410

EUH014

013-009-00-X

natrium((n-butyl)x(ethyl)y-1,5-dihydro)aluminat) x = 0,5 y = 1,5

418-720-2

—

Flam. Sol. 1

Water-react. 1

Pyr. Sol. 1

Acute Tox. 4 *

Skin Corr. 1A

H228

H260

H250

H332

H314

GHS02

GHS05

GHS07

Dgr

H228

H260

H250

H332

H314

EUH014

T

013-010-00-5

hydroxy-aluminium-bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxid)

430-650-4

151841-65-5

Aquatic Chronic 2

H411

GHS09

H411

014-001-00-9

trichlorsilan

233-042-5

10025-78-2

Flam. Liq. 1

Pyr. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H224

H250

H332

H302

H314

GHS02

GHS05

GHS07

Dgr

H224

H250

H332

H302

H314

EUH014

EUH029

*

STOT SE 3; H335: C ≥ 1 %

T

014-002-00-4

Siliciumtetrafluorid

233-054-0

10026-04-7

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

EUH014

014-003-00-X

dichlordimethylsilan

200-901-0

75-78-5

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H225

H319

H335

H315

GHS02

GHS07

Dgr

H225

H319

H335

H315

014-004-00-5

trichlor(methyl)silan; methyltrichlorsilan

200-902-6

75-79-6

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H225

H319

H335

H315

GHS02

GHS07

Dgr

H225

H319

H335

H315

EUH014

Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %

014-005-00-0

tetraethylsilicat;

ethylsilicat

201-083-8

78-10-4

Flam. Liq. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H226

H332

H319

H335

GHS02

GHS07

Wng

H226

H332

H319

H335

014-006-00-6

bis(4-fluorphenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silanhydrochlorid

401-380-4

—

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

014-007-00-1

triethoxyisobutylsilan

402-810-3

17980-47-1

Skin Irrit. 2

H315

GHS07

Wng

H315

014-008-00-7

(chlormethyl)bis(4-fluorphenyl)methylsilan

401-200-4

85491-26-5

Aquatic Chronic 2

H411

GHS09

H411

014-009-00-2

isobutylisopropyldimethoxysilan

402-580-4

111439-76-0

Flam. Liq. 3

Acute Tox. 4 *

Skin Irrit. 2

H226

H332

H315

GHS02

GHS07

Wng

H226

H332

H315

014-010-00-8

dinatriummetasilicat

229-912-9

6834-92-0

Skin Corr. 1B

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

014-011-00-3

cyclohexyldimethoxymethylsilan

402-140-1

17865-32-6

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

014-012-00-9

bis(3-(trimethoxysilyl)propyl)amin

403-480-3

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

014-013-00-4

α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxan)

404-920-7

—

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H312

H302

H314

H411

GHS05

GHS07

GHS09

Dgr

H312

H302

H314

H411

014-014-00-X

etacelasil (ISO);

6-(2-chlorethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecan

253-704-7

37894-46-5

Repr. 1B

Acute Tox. 4 *

STOT RE 2 *

H360D *** H302

H373 **

GHS08

GHS07

Dgr

H360D *** H302

H373 **

014-015-00-5

α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilandiyl]-co-oxy (dimethylsilan))

406-420-4

69430-40-6

Aquatic Chronic 4

H413

—

H413

014-016-00-0

blanding af 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxan;

1,3-dihexen-1-yl-1,1,3,3-tetramethyldisiloxan

406-490-6

—

Aquatic Chronic 2

H411

GHS09

H411

014-017-00-6

flusilazol (ISO);

bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silan

—

85509-19-9

Carc. 2

Repr. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H351

H360D *** H302

H411

GHS08

GHS07

GHS09

Dgr

H351

H360D *** H302

H411

014-018-00-1

octamethylcyclotetrasiloxan

209-136-7

556-67-2

Repr. 2

Aquatic Chronic 4

H361f *** H413

GHS08

Wng

H361f *** H413

014-019-00-7

blanding af 4-[[bis-(4-fluorphenyl)methylsilyl]methyl]-4H-1,2,4-triazol;

1-[[bis-(4-fluorphenyl)methylsilyl]methyl]-1H-1,2,4-triazol

403-250-2

—

Carc. 2

Repr. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H351

H360D *** H302

H411

GHS08

GHS07

GHS09

Dgr

H351

H360D *** H302

H411

014-020-00-2

bis(1,1-dimetil-2-propinilossi)dimetilsilano

414-960-7

53863-99-3

Acute Tox. 4 *

H332

GHS07

Wng

H332

014-021-00-8

tris(isopropenyloxy)phenylsilan

411-340-8

52301-18-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H400

H410

014-022-00-3

reaktionsproduktet af (2-hydroxy-4-(3-propenoxy)benzophenon og triethoxysilan med (hydrolyseproduktet af silica og methyltrimethoxy-silan)

401-530-9

—

Flam. Sol. 1

STOT SE 1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H228

H370 **

H332

H312

H302

GHS02

GHS08

GHS07

Dgr

H228

H370 **

H332

H312

H302

T

014-023-00-9

α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxan)

408-160-7

125613-45-8

Aquatic Chronic 2

H411

GHS09

H411

014-024-00-4

1-((3-(3-chlor-4-fluorphenyl)propyl)dimethylsilanyl)-4-ethoxybenzen

412-620-2

121626-74-2

Aquatic Chronic 2

H411

GHS09

H411

014-025-00-X

4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidin

411-400-3

102089-33-8

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H302

H373 **

H315

H318

H412

GHS08

GHS05

GHS07

Dgr

H302

H373 **

H315

H318

H412

014-026-00-5

dichlor-(3-(3-chlor-4-fluorphenyl)propyl)methylsilan

407-180-3

770722-36-6

Skin Corr. 1A

H314

GHS05

Dgr

H314

014-027-00-0

chlor(3-(3-chlor-4-fluorphenyl)propyl)dimethylsilan

410-270-5

770722-46-8

Skin Corr. 1A

H314

GHS05

Dgr

H314

014-028-00-6

α-[3-(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyloxy-ω-[3-(1-oxoprop-2-enyl-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxan)

415-290-8

193159-06-7

Skin Sens. 1

H317

GHS07

Wng

H317

014-029-00-1

O, O'-(ethenylmethylsilylen)di[(4-methylpentan-2-on)oxim]

421-870-1

156145-66-3

Repr. 2

Acute Tox. 4 *

STOT RE 2 *

H361f *** H302

H373 **

GHS08

GHS07

Wng

H361f *** H302

H373 **

014-030-00-7

[(dimethylsilylen)bis((1,2,3,3a,7a-η)-1H-inden-1-yliden)dimethyl]hafnium

422-060-0

137390-08-0

Acute Tox. 2 *

H300

GHS06

Dgr

H300

014-031-00-2

bis(1-methylethyl)-dimethoxysilan

421-540-7

18230-61-0

Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H226

H315

H317

H412

GHS02

GHS07

Wng

H226

H315

H317

H412

014-032-00-8

dicyclopentyldimethoxysilan

404-370-8

126990-35-0

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

014-033-00-3

2-methyl-3-(trimethoxysilyl)propyl-2-propenoat, hydrolyseprodukt med silica

419-030-4

125804-20-8

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

014-034-00-9

3-hexylheptamethyltrisiloxan

428-700-5

1873-90-1

Acute Tox. 4 *

Aquatic Chronic 4

H332

H413

GHS07

Wng

H332

H413

014-035-00-4

2-(3,4-epoxycyclohexyl)ethyltriethoxy silan

425-050-4

10217-34-2

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

014-036-00-X

(4-ethoxyphenyl)(3-(4-fluor-3-phenoxyphenyl)propyl)dimethylsilan

405-020-7

105024-66-6

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360F *** H400

H410

GHS08

GHS09

Dgr

H360F *** H410

M = 1 000

014-037-00-5

2-butanon-O, O',O''-(phenylsilylidyn)trioxim

433-360-6

34036-80-1

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H373 **

H317

H412

GHS08

GHS07

Wng

H373 **

H317

H412

014-038-00-0

S-(3-(triethoxysilyl)propyl)octanthioat

436-690-9

220727-26-4

Skin Sens. 1

H317

GHS07

Wng

H317

014-039-00-6

(2,3-dimethylbut-2-yl)-trimethoxysilan

439-360-2

142877-45-0

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H315

H318

H412

GHS05

Dgr

H315

H318

H412

014-041-00-7

N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilan

445-890-5

201290-01-9

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

014-042-00-2

blanding af O, O',O'',O'''-silantetrayl-tetrakis(4-methyl-2-pentanonoxim) (3 stereoisomerer)

423-010-0

—

Eye Dam. 1

H318

GHS05

Dgr

H318

014-043-00-8

reaktionsprodukt mellem amorf silica (50-85 %), butyl(1-methylpropyl)magnesium (3-15 %), tetraethylorthosilicat (5-15 %) og titantetrachlorid (5-20 %)

432-200-2

—

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H335

H315

H318

H412

GHS05

GHS07

Dgr

H335

H315

H318

H412

014-044-00-3

3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilan

433-050-0

—

Aquatic Chronic 2

H411

GHS09

H411

014-045-00-9

magnesiumnatriumfluoridsilicat

442-650-1

—

STOT RE 2 *

H373 **

GHS08

Wng

H373 **

015-001-00-1

phosphor, hvid og gul

231-768-7

12185-10-3

Pyr. Sol. 1

Acute Tox. 2 *

Acute Tox. 2 *

Skin Corr. 1A

Aquatic Acute 1

H250

H330

H300

H314

H400

GHS02

GHS06

GHS05

GHS09

Dgr

H250

H330

H300

H314

H400

015-002-00-7

phosphor, rød

231-768-7

7723-14-0

Flam. Sol. 1

Aquatic Chronic 3

H228

H412

GHS02

Dgr

H228

H412

015-004-00-8

aluminiumphosphid

244-088-0

20859-73-8

Water-react. 1

Acute Tox. 2

Acute Tox. 3

Acute Tox. 1

Aquatic Acute 1

H260

H300

H311

H330

H400

GHS02

GHS06

GHS09

Dgr

H260

H300

H311

H330

H400

EUH029

EUH032

M = 100

015-005-00-3

magnesiumphosphid;

trimagnesiumdiphosphid

235-023-7

12057-74-8

Water-react. 1

Acute Tox. 2

Acute Tox. 3

Acute Tox. 1

Aquatic Acute 1

H260

H300

H311

H330

H400

GHS02

GHS06

GHS09

Dgr

H260

H300

H311

H330

H400

EUH029

EUH032

M = 100

015-006-00-9

trizinkdiphosphid;

zincphosphid

215-244-5

1314-84-7

Water-react. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H260

H300

H400

H410

GHS02

GHS06

GHS09

Dgr

H260

H300

H410

EUH029

EUH032

M = 100

T

015-007-00-4

phosphortrichlorid

231-749-3

7719-12-2

Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Skin Corr. 1A

H330

H300

H373 **

H314

GHS06

GHS08

GHS05

Dgr

H330

H300

H373 **

H314

EUH014

EUH029

015-008-00-X

phosphorpentachlorid

233-060-3

10026-13-8

Acute Tox. 2 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

H330

H302

H373 **

H314

GHS06

GHS08

GHS05

Dgr

H330

H302

H373 **

H314

EUH014

EUH029

015-009-00-5

phosphoryltrichlorid

233-046-7

10025-87-3

Acute Tox. 2 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1A

H330

H372 **

H302

H314

GHS06

GHS08

GHS05

Dgr

H330

H372 **

H302

H314

EUH014

EUH029

015-010-00-0

phosphorpentaoxid

215-236-1

1314-56-3

Skin Corr. 1A

H314

GHS05

Dgr

H314

015-011-00-6

phosphorsyre ...% orthophosphorsyre ... %

231-633-2

7664-38-2

Skin Corr. 1B

H314

GHS05

Dgr

H314

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 %

B

015-012-00-1

tetraphosphortrisulfid;

phosphorsesquisulfid

215-245-0

1314-85-8

Flam. Sol. 2

Water-react. 1

Acute Tox. 4 *

Aquatic Acute 1

H228

H260

H302

H400

GHS02

GHS07

GHS09

Dgr

H228

H260

H302

H400

T

015-013-00-7

triethylphosphat

201-114-5

78-40-0

Acute Tox. 4 *

H302

GHS07

Wng

H302

015-014-00-2

tributylphosphat

204-800-2

126-73-8

Carc. 2

Acute Tox. 4 *

Skin Irrit. 2

H351

H302

H315

GHS08

GHS07

Wng

H351

H302

H315

015-015-00-8

tricresylphosphater (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolylphosphater (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-)

201-103-5

78-30-8

STOT SE 1

Aquatic Chronic 2

H370 **

H411

GHS08

GHS09

Dgr

H370 **

H411

STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2  % ≤ C < 1 %

C

015-016-00-3

tricresylphosphater (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolylphosphater (m-m-m-, m-m-p-, m-p-p-, p-p-p-)

201-105-6

78-32-0

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H312

H302

H411

GHS07

GHS09

Wng

H312

H302

H411

*

C

015-019-00-X

dichlorvos (ISO);

2,2-dichlorvinyldimethylphosphat

200-547-7

62-73-7

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

H330

H311

H301

H317

H400

GHS06

GHS09

Dgr

H330

H311

H301

H317

H400

M = 1 000

015-020-00-5

mevinphos (ISO);

2-methoxycarbonyl-1-methylvinyldimethylphosphat

232-095-1

7786-34-7

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

M = 10 000

015-021-00-0

trichlorfon (ISO);

dimethyl-2,2,2-trichlor-1-hydroxyethylphosphonat

200-149-3

52-68-6

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H400

H410

M = 1 000

015-022-00-6

phosphamidon (ISO);

(2-chlor-3-diethylamino-1-methyl-3-oxo-prop-1-en-yl)-dimethylphosphat

236-116-5

13171-21-6

Muta. 2

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H341

H300

H311

H400

H410

GHS06

GHS08

GHS09

Dgr

H341

H300

H311

H410

015-023-00-1

pyrazoxon;

O, O-diethyl-O-(3-methyl-1H-pyrazol-5-yl)-phosphat

—

108-34-9

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

H330

H310

H300

GHS06

Dgr

H330

H310

H300

015-024-00-7

triamiphos (ISO);

5-amino-3-phenyl-1,2,4-triazol-1-yl-N, N,N',N'-tetramethylphosphondiamid

—

1031-47-6

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-025-00-2

TEPP (ISO);

tetraethylpyrophosphat

203-495-3

107-49-3

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

H310

H300

H400

GHS06

GHS09

Dgr

H310

H300

H400

015-026-00-8

schradan (ISO);

octamethylpyrophosphoramid

205-801-0

152-16-9

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-027-00-3

sulfotep (ISO);

O, O,O, O-tetraethyldithiopyrophosphat

222-995-2

3689-24-5

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

M = 1 000

015-028-00-9

demeton-O (ISO);

O, O-diethyl-O-2-ethylthioethylthiophosphat

206-053-8

298-03-3

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

H310

H300

H400

GHS06

GHS09

Dgr

H310

H300

H400

015-029-00-4

demeton-S (ISO);

diethyl-S-2-ethylthioethylthiophosphat

204-801-8

126-75-0

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-030-00-X

demeton-O-methyl (ISO);

O-2-ethylthioethyl-O, O-dimethylthiophosphat

212-758-1

867-27-6

Acute Tox. 3 *

H301

GHS06

Dgr

H301

015-031-00-5

demeton-S-methyl (ISO);

S-2-ethylthioethyldimethylthiophosphat

213-052-6

919-86-8

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H311

H301

H411

GHS06

GHS09

Dgr

H311

H301

H411

015-032-00-0

prothoat (ISO);

O, O-diethylisopropylcarbamoylmethyldithiophosphat

218-893-2

2275-18-5

Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 3

H310

H300

H412

GHS06

Dgr

H310

H300

H412

015-033-00-6

phorat (ISO);

O, O-diethylethylthiomethyldithiophosphat

206-052-2

298-02-2

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

M = 1 000

015-034-00-1

parathion (ISO);

O, O-diethyl-O-4-nitrophenylthiophosphat

200-271-7

56-38-2

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H311

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H300

H311

H372 **

H410

M = 100

015-035-00-7

parathion — methyl (ISO);

O, O-dimethyl-O-4-nitrophenylthiophosphat

206-050-1

298-00-0

Flam. Liq. 3

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H226

H330

H300

H311

H373 **

H400

H410

GHS02

GHS06

GHS08

GHS09

Dgr

H226

H330

H300

H311

H373 **

H410

M = 100

015-036-00-2

O-ethyl-O-4-nitrophenylphenylthiophosphonat;

EPN

218-276-8

2104-64-5

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

015-037-00-8

phencapton (ISO);

O, O-diethyl-S-(2,5-dichlorphenylthiomethyl)-dithiophosphat

218-892-7

2275-14-1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

015-038-00-3

coumaphos (ISO);

O-3-chlor-4-methylcumarin-7-yl-O, O-diethylthiophosphat

200-285-3

56-72-4

Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H312

H400

H410

GHS06

GHS09

Dgr

H300

H312

H410

015-039-00-9

azinphos-methyl (ISO);

O, O-dimethyl-4-oxobenzotriazin-3-ylmethyldithiophosphat

201-676-1

86-50-0

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H311

H317

H400

H410

GHS06

GHS09

Dgr

H330

H300

H311

H317

H410

015-040-00-4

diazinon (ISO);

O, O-diethyl-O-2-isopropyl-6-methylpyrimidin-4-ylthiophosphat

206-373-8

333-41-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H400

H410

015-041-00-X

malathion (ISO);

1,2-bis(ethoxycarbonyl)ethyl-O, O-dimethylphosphordithioat [indeholdende ≤ 0,03 % isomalathion]

204-497-7

121-75-5

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M = 1 000

015-042-00-5

chlorthion; O-(3-chlor-4-nitrophenyl)-O, O-dimethylthiophosphat

207-902-5

500-28-7

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

M = 100

015-043-00-0

phosnichlor (ISO);

O-(4-chlor-3-nitrophenyl)-O, O-dimethylthiophosphat

—

5826-76-6

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H332

H312

H302

GHS07

Wng

H332

H312

H302

015-044-00-6

carbophenothion (ISO);

4-chlorphenylthiomethyl-O, O-diethyldithiophosphat

212-324-1

786-19-6

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

015-045-00-1

mecarbam (ISO);

N-ethoxycarbonyl-N-methylcarbamoylmethyl-O, O-diethyldithiophosphat

219-993-9

2595-54-2

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H400

H410

015-046-00-7

oxydemeton-methyl;

O, O-dimethyl-S-2-(ethylsulfinyl)-ethyl)-thiophosphat

206-110-7

301-12-2

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

H311

H301

H400

GHS06

GHS09

Dgr

H311

H301

H400

015-047-00-2

ethion (ISO);

O, O,O',O'-tetraethyl-S, S'-methylendi (dithiophosphat);

diethion

209-242-3

563-12-2

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H400

H410

GHS06

GHS09

Dgr

H301

H312

H410

M = 10 000

015-048-00-8

fenthion (ISO);

O, O-dimethyl-O-(4-methylthion-m-tolyl) phosphorthioat

200-231-9

55-38-9

Muta. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H331

H312

H302

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H341

H331

H312

H302

H372 ** H410

M = 100

015-049-00-3

endothion (ISO);

S-5-methoxy-4-oxopyran-2-ylmethyldimethylthiophosphat

220-472-3

2778-04-3

Acute Tox. 3 *

Acute Tox. 3 *

H311

H301

GHS06

Dgr

H311

H301

015-050-00-9

thiometon (ISO);

S-2-ethylthioethyl-O, O-dimethyldithiophosphat

211-362-6

640-15-3

Acute Tox. 3 *

Acute Tox. 4 *

H301

H312

GHS06

Dgr

H301

H312

015-051-00-4

dimethoat (ISO);

O, O-dimethylmethylcarbamoylmethyldithiophosphat

200-480-3

60-51-5

Acute Tox. 4 *

Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

015-052-00-X

fenchlorphos (ISO);

O, O-dimethyl-O-2,4,5-trichlorphenylthiophosphat

206-082-6

299-84-3

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

015-053-00-5

menazon (ISO);

S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyldithiophosphat

201-123-4

78-57-9

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

015-054-00-0

fenitrothion (ISO);

O, O-dimethyl-O-4-nitro-m-tolylthiophosphat

204-524-2

122-14-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

015-055-00-6

naled (ISO);

1,2-dibrom-2,2-dichlorethyldimethylphosphat

206-098-3

300-76-5

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

H312

H302

H319

H315

H400

GHS07

GHS09

Wng

H312

H302

H319

H315

H400

M = 1 000

015-056-00-1

azinphos-ethyl (ISO);

O, O-diethyl-4-oxobenzotriazin-3-ylmethyldithiophosphat

220-147-6

2642-71-9

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H410

M = 100

015-057-00-7

formothion (ISO);

N-formyl-N-methylcarbamoylmethyl-O, O-dimethyldithiophosphat

219-818-6

2540-82-1

Acute Tox. 4 *

Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

015-058-00-2

morphothion (ISO);

O, O-dimethyl-S-(morpholinocarbonylmethyl)-dithiophosphat

205-628-0

144-41-2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

015-059-00-8

vamidothion (ISO);

dimethyl-S-2-(1-methylcarbamoylethylthio) ethylthiophospat

218-894-8

2275-23-2

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

H301

H312

H400

GHS06

GHS09

Dgr

H301

H312

H400

015-060-00-3

disulfoton (ISO);

O, O-diethyl-2-ethylthioethyldithiophosphat

206-054-3

298-04-4

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

015-061-00-9

dimefox (ISO);

tetramethylphosphorsyrediamidfluorid

204-076-8

115-26-4

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-062-00-4

mipafox (ISO);

N, N'-diisopropylphosphorsyrediamidfluorid

206-742-3

371-86-8

STOT SE 1

H370 **

GHS08

Dgr

H370 **

015-063-00-X

dioxathion (ISO);

1,4-dioxan-2,3-diyl-O, O,O',O'-tetraethyldi (dithiophosphat)

201-107-7

78-34-2

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H311

H400

H410

GHS06

GHS09

Dgr

H330

H300

H311

H410

M = 1 000

015-064-00-5

bromophos-ethyl (ISO);

O-4-brom-2,5-dichlorphenyl-O, O-diethylthiophosphat

225-399-0

4824-78-6

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H400

H410

GHS06

GHS09

Dgr

H301

H312

H410

015-065-00-0

S-2-ethylsulfinyl-ethyl-O, O-dimethyl-dithiophosphat

—

2703-37-9

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 2

H330

H310

H300

H411

GHS06

GHS09

Dgr

H330

H310

H300

H411

015-066-00-6

omethoat (ISO);

O, O-dimethyl-S-methylcarbamoylmethylthiophosphat

214-197-8

1113-02-6

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

H301

H312

H400

GHS06

GHS09

Dgr

H301

H312

H400

015-067-00-1

phosalon (ISO);

S-(6-chlor-2-oxo-benzoxazolin-3-ylmethyl)-O, O-diethyl-phosphordithioat

218-996-2

2310-17-0

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H332

H312

H317

H400

H410

GHS06

GHS09

Dgr

H301

H332

H312

H317

H410

M = 1 000

015-068-00-7

dichlofenthion (ISO);

O-2,4-dichlorphenyl-O, O-diethylthiophosphat

202-564-5

97-17-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H400

H410

015-069-00-2

methidathion (ISO);

2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O, O-dimethyldithiophosphat

213-449-4

950-37-8

Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H312

H400

H410

GHS06

GHS09

Dgr

H300

H312

H410

015-070-00-8

cyanthoat (ISO);

S-(N-(1-cyano-1-methylethyl) carbamoylmethyl)-O, O-diethylthiophosphat

223-099-4

3734-95-0

Acute Tox. 2 *

Acute Tox. 3 *

H300

H311

GHS06

Dgr

H300

H311

015-071-00-3

chlorfenvinphos (ISO);

2-chlor-1-(2,4-dichlorphenyl) vinyldiethylphosphat

207-432-0

470-90-6

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H410

015-072-00-9

monocrotophos (ISO);

dimethyl-1-methyl-2-(methylcarbamoyl)vinylphosphat

230-042-7

6923-22-4

Muta. 2

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H341

H330

H300

H311

H400

H410

GHS06

GHS08

GHS09

Dgr

H341

H330

H300

H311

H410

015-073-00-4

dicrotophos (ISO);

(Z)-2-dimethylcarbamoyl-1-methylvinyldimethylphosphat

205-494-3

141-66-2

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H410

015-074-00-X

crufomat (ISO);

4-tert-butyl-2-chlorphenylmethylmethylphosphoramidat

206-083-1

299-86-5

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

015-075-00-5

S-2-ethylsulfinyl-isopropyl-O, O-dimethyl-thiophosphat

—

2635-50-9

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

015-076-00-0

potasan;

O, O-diethyl-O-(4-methyl-7-coumarinyl)-thiophosphat

—

299-45-6

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

M = 1 000

015-077-00-6

O-(2,2-dichlorovinyl)-O-methyl-O-(2-ethylsulfinyl-ethyl)-phosphat

—

7076-53-1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

015-078-00-1

demeton-S-methylsulfon (ISO);

S-2-ethylsulfonylethyldimethylthiophosphat

241-109-5

17040-19-6

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Chronic 2

H301

H312

H411

GHS06

GHS09

Dgr

H301

H312

H411

015-079-00-7

acephat (ISO);

O, S-dimethylacetylthiophosphoramidat

250-241-2

30560-19-1

Acute Tox. 4 *

H302

GHS07

Wng

H302

015-080-00-2

amidithion (ISO);

2-methoxyethylcarbamoylmethyl-O, O-dimethyldithiophosphat

—

919-76-6

Acute Tox. 4 *

H302

GHS07

Wng

H302

015-081-00-8

O, O,O',O'-tetrapropyldithiopyrophosphat

221-817-0

3244-90-4

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

015-082-00-3

azothoat (ISO);

O-4-(4-chlor-phenylazo)-phenyl-O, O-dimethyl-thiophosphat

227-419-3

5834-96-8

Acute Tox. 4 *

Acute Tox. 4 *

H332

H302

GHS07

Wng

H332

H302

015-083-00-9

bensulid (ISO);

O, O-diisopropyl-2-phenylsulfonylaminoethyldithiophosphat

212-010-4

741-58-2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

015-084-00-4

chlorpyrifos (ISO);

O, O-diethyl-O-3,5,6-trichlor-2-pyridylthiophosphat

220-864-4

2921-88-2

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H400

H410

M = 10 000

015-085-00-X

chlorphoniumchlorid (ISO);

tributyl (2,4-dichlorbenzyl) phosphoniumchlorid

204-105-4

115-78-6

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H301

H312

H319

H315

GHS06

Dgr

H301

H312

H319

H315

015-086-00-5

coumithoat (ISO);

O, O-diethyl-O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-ylthiophosphat

—

572-48-5

Acute Tox. 3 *

H301

GHS06

Dgr

H301

015-087-00-0

cyanophos (ISO);

O-4-cyanophenyl-O, O-dimethylthiophosphat

220-130-3

2636-26-2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

015-088-00-6

dialisfos (ISO);

2-chlor-1-phthalimidoethyl-O, O-diethyldithiophosphat

233-689-3

10311-84-9

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H400

H410

015-089-00-1

ethoat-methyl (ISO);

ethylcarbamoylmethyl-O, O-dimethyldithiophosphat

204-121-1

116-01-8

Acute Tox. 4 *

Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

015-090-00-7

fensulfothion (ISO);

O, O-diethyl-O-4-methylsulfinylphenylthiophosphat

204-114-3

115-90-2

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

015-091-00-2

fonofos (ISO);

O-ethylphenylethyldithiophosphonat

213-408-0

944-22-9

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

015-092-00-8

phosacetim (ISO);

O, O-bis(4-chlorphenyl)-N-acetimidoylthiophosphoramidat

223-874-7

4104-14-7

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

015-093-00-3

leptophos (ISO);

O-4-brom-2,5-dichlorphenyl-O-methylphenylthiophosphonat

244-472-8

21609-90-5

Acute Tox. 3 *

STOT SE 1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H370 **

H312

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H370 **

H312

H410

015-094-00-9

mephosfolan (ISO);

diethyl-4-methyl-1,3-dithiolan-2-ylidenphosphoramidat

213-447-3

950-10-7

Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 2

H310

H300

H411

GHS06

GHS09

Dgr

H310

H300

H411

015-095-00-4

methamidophos (ISO);

O, S-dimethylthiophosphoramidat

233-606-0

10265-92-6

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

H330

H300

H311

H400

GHS06

GHS09

Dgr

H330

H300

H311

H400

015-096-00-X

oxydisulfoton (ISO);

O, O-diethyl-S-2-ethylsulfinyl-ethyl-dithiophosphat

219-679-1

2497-07-6

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H410

M = 10

015-097-00-5

phenthoat (ISO);

ethyl-2-(dimethoxythiophosphinoylthio)-2-phenylacetat

219-997-0

2597-03-7

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

M = 100

015-098-00-0

trichloronat (ISO);

O-ethyl-O-2,4,5-trichlorphenylethylthiophosphonat

206-326-1

327-98-0

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H410

015-099-00-6

pirimiphos-ethyl (ISO);

O, O-diethyl-O-2-diethylamino-6-methylpyrimidin-4-ylthiophosphat

245-704-0

23505-41-1

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H400

H410

GHS06

GHS09

Dgr

H301

H312

H410

015-100-00-X

phoxim (ISO);

α-(diethoxyphosphinothioylimino)phenylacetonitril

238-887-3

14816-18-3

Repr. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f *** H302

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f *** H302

H317

H410

M = 1 000

015-101-00-5

phosmet (ISO);

O, O-dimethylphthalimidomethyldithiophosphat

211-987-4

732-11-6

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

M = 100

015-102-00-0

tris(2-chlorethyl)phosphat

204-118-5

115-96-8

Carc. 2

Repr. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H351

H360F *** H302

H411

GHS08

GHS07

GHS09

Dgr

H351

H360F *** H302

H411

015-103-00-6

phosphortribromid

232-178-2

7789-60-8

Skin Corr. 1B

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

EUH014

015-104-00-1

diphosphorpentasulfid; phosphorpentasulfid

215-242-4

1314-80-3

Flam. Sol. 1

Water-react. 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

H228

H260

H332

H302

H400

GHS02

GHS07

GHS09

Dgr

H228

H260

H332

H302

H400

EUH029

T

015-105-00-7

triphenylphosphit

202-908-4

101-02-0

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 %

015-106-00-2

hexamethylphosphortriamid; hexamethylphosphoramid

211-653-8

680-31-9

Carc. 1B

Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

Carc. 1B;

H350: C ≥ 0,01  %

015-107-00-8

ethoprophos (ISO);

ethyl-S, S-dipropyldithiophosphat

236-152-1

13194-48-4

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H301

H317

H400

H410

GHS06

GHS09

Dgr

H330

H310

H301

H317

H410

015-108-00-3

bromophos (ISO);

O-4-brom-2,5-dichlorphenyl-O, O-dimethylthiophosphat

218-277-3

2104-96-3

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 100

015-109-00-9

crotoxyphos (ISO);

1-phenylethyl-3-(dimethoxyphosphinyloxy) isocrotonat

231-720-5

7700-17-6

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

M = 10

015-110-00-4

cyanofenphos (ISO);

O-4-cyanophenyl-O-ethylphenylthiophosphonat

—

13067-93-1

Acute Tox. 3 *

STOT SE 1

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2

H301

H370 **

H312

H319

H411

GHS06

GHS08

GHS09

Dgr

H301

H370 **

H312

H319

H411

015-111-00-X

phosfolan (ISO);

diethyl-1,3-dithiolan-2-ylidenphosphoramidat

213-423-2

947-02-4

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-112-00-5

thionazin (ISO);

O, O-diethyl-O-pyrazin-2-ylthiophosphat

206-049-6

297-97-2

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-113-00-0

tolclofos-methyl (ISO);

O-(2,6-dichlor-p-tolyl)-O, O-dimethylthiophosphat

260-515-3

57018-04-9

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

015-114-00-6

chlormephos (ISO);

S-chlormethyl-O, O-diethylphosphordithioat

246-538-1

24934-91-6

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

M = 10

015-115-00-1

chlorthiophos (ISO);

[isomer blanding, hvori O-2,5-dichlorphenyl-4-methylthiophenyl-O, O-diethylthiophosphat er fremherskende]

244-663-6

21923-23-9

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H410

M = 1 000

015-116-00-7

demephion-O (ISO):

O, O-dimethyl-O-2-methylthioethylthiophosphat

211-666-9

682-80-4

Acute Tox. 2 *

Acute Tox. 3 *

H300

H311

GHS06

Dgr

H300

H311

015-117-00-2

demephion-S (ISO);

dimethyl-S-2-methylthioethylthiophosphat

219-971-9

2587-90-8

Acute Tox. 2 *

Acute Tox. 3 *

H300

H311

GHS06

Dgr

H300

H311

015-118-00-8

demeton

—

8065-48-3

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

H310

H300

H400

GHS06

GHS09

Dgr

H310

H300

H400

015-119-00-3

dimethyl-4-(methylthio)phenylphosphat

—

3254-63-5

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-120-00-9

ditalimfos (ISO);

O, O-diethylphthalimidophosphonothionat

225-875-8

5131-24-8

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

015-121-00-4

edifenphos (ISO);

ethyl-S, S-diphenyldithiophosphat

241-178-1

17109-49-8

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H312

H317

H400

H410

GHS06

GHS09

Dgr

H331

H301

H312

H317

H410

015-122-00-X

etrimfos (ISO);

O-6-ethoxy-2-ethylpyrimidin-4-yl-O, O-dimethylthiophosphat

253-855-9

38260-54-7

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 10

015-123-00-5

fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl-N-isopropylphosphoramidat

244-848-1

22224-92-6

Acute Tox. 2

Acute Tox. 2

Acute Tox. 2

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H300

H310

H330

H319

H400

H410

GHS06

GHS09

Dgr

H300

H310

H330

H319

H410

M = 100

M = 100

015-124-00-0

fosthietan (ISO);

diethyl-1,3-dithietan-2-ylidenphosphoramidat

244-437-7

21548-32-3

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

015-125-00-6

glyphosin (ISO);

N, N-bis(phosphonomethyl)glycin

219-468-4

2439-99-8

Eye Dam. 1

H318

GHS05

Dgr

H318

015-126-00-1

heptenophos (ISO);

7-chlorbicyclo(3.2.0)hepta-2,6-dien-6-yldimethylphosphat

245-737-0

23560-59-0

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

M = 100

015-127-00-7

iprobenfos (ISO);

S-benzyldiisopropylthiophosphat

247-449-0

26087-47-8

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

015-128-00-2

IPSP;

S-ethylsulfinylmethyl-O, O-diisopropyldithiophosphat

—

5827-05-4

Acute Tox. 1

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H301

H400

H410

GHS06

GHS09

Dgr

H310

H301

H410

M = 100

015-129-00-8

isofenphos (ISO);

O-ethyl-O-2-isopropoxycarbonylphenyl-N-isopropylthiophosphoramidat

246-814-1

25311-71-1

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

M = 100

015-130-00-3

isothioat (ISO);

S-2-isopropylthioethyl-O, O-dimethyldithiophosphat

—

36614-38-7

Acute Tox. 3 *

Acute Tox. 3 *

H311

H301

GHS06

Dgr

H311

H301

015-131-00-9

isoxathion (ISO);

O, O-diethyl-O-5-phenylisoxazol-3-ylthiophosphat

242-624-8

18854-01-8

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

015-132-00-4

S-(chlorphenylthiomethyl)-O, O-dimethyldithiophosphat; methylcarbophenothion

—

953-17-3

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

M = 1 000

015-133-00-X

piperophos (ISO);

S-2-methylpiperidinocarbonylmethyl-O, O-dipropyldithiophosphat

—

24151-93-7

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 10

015-134-00-5

pirimiphos-methyl (ISO);

O-(2-diethylamino-6-methylpyrimidin-4-yl)-O, O-dimethylthiophosphat

249-528-5

29232-93-7

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

015-135-00-0

profenofos (ISO);

O-(4-brom-2-chlorphenyl)-O-ethyl-S-propylthiophosphat

255-255-2

41198-08-7

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

M = 1 000

015-136-00-6

trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonat;

isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonat; propetamphos (ISO)

250-517-2

31218-83-4

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

M = 100

015-137-00-1

pyrazophos (ISO);

O, O-diethyl-O-(6-ethoxycarbonyl-5-methylpyrazolo(2,3-a)pyrimidin-2-yl) thiophosphat

236-656-1

13457-18-6

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H400

H410

GHS07

GHS09

Wng

H332

H302

H410

015-138-00-7

quinalphos (ISO);

O, O-diethyl-O-quinoxalin-2-ylthiophosphat

237-031-6

13593-03-8

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H400

H410

GHS06

GHS09

Dgr

H301

H312

H410

M = 1 000

015-139-00-2

terbufos (ISO);

S-tert-butylthiomethyl-O, O-diethyldithiophosphat

235-963-8

13071-79-9

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

M = 1 000

015-140-00-8

triazophos (ISO);

O, O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-ylthiophosphat

245-986-5

24017-47-8

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H312

H400

H410

GHS06

GHS09

Dgr

H331

H301

H312

H410

M = 100

015-141-00-3

ethylendiammonium-O, O-bis(octyl)dithiophosphat, blanding af isomerer

400-520-1

—

Skin Corr. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H314

H302

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H302

H410

015-142-00-9

butyl(dialkyloxy(dibutoxyphosphoryloxy)titan)phosphat

401-100-0

—

Flam. Liq. 2

Eye Irrit. 2

Aquatic Chronic 2

H225

H319

H411

GHS02

GHS07

GHS09

Dgr

H225

H319

H411

T

015-143-00-4

blanding af 2-chlorethyl-chlorpropyl-2-chlorethylphosphonat, blanding af isomerer og 2-chlorethyl-chlorpropyl-2-chlorpropylphosphonat, blanding af isomerer

401-740-0

—

Acute Tox. 4 *

H302

GHS07

Wng

H302

015-144-00-X

blanding af pentylmethylphosphinat og 2-methylbutylmethylphosphinat

402-090-0

87025-52-3

Skin Corr. 1B

H314

GHS05

Dgr

H314

015-145-00-5

blanding af kobber(I)-O, O-diisopropyldithiophosphat og kobber(I)-O-isopropyl-O-(4-methylpent-2-yl)dithiophosphat og kobber(I)-O, O-bis(4-methylpent-2-yl)dithiophosphat

401-520-4

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

015-146-00-0

S-(tricyclo(5.2.1.02,6)deca-3-en-8(eller 9)-yl-O-(isopropyl eller isobutyl eller 2-ethylhexyl)-O-(isopropyl eller isobutyl eller 2-ethylhexyl)dithiophosphat

401-850-9

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

015-147-00-6

blanding af C12-14-tert-alkylammoniumdiphenylthiophosphat og dinonylsulfid (eller -disulfid)

400-930-0

—

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H315

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H411

015-148-00-1

2-(diphosphonomethyl)ravsyre

403-070-4

51395-42-7

Skin Corr. 1B

Skin Sens. 1

H314

H317

GHS05

GHS07

Dgr

H314

H317

015-149-00-7

blanding af hexyldioctylphosphinoxid; dihexyloctylphosphinoxid; trioctylphosphinoxid

403-470-9

—

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

015-150-00-2

(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphoniumbromid

404-940-6

86608-70-0

Acute Tox. 4 *

Eye Dam. 1

STOT RE 2 *

Aquatic Chronic 3

H302

H318

H373 **

H412

GHS08

GHS05

GHS07

Dgr

H302

H318

H373 **

H412

015-151-00-8

tris(isopropyl/tert-butylphenyl)phosphat

405-010-2

—

Aquatic Chronic 2

H411

GHS09

H411

015-152-00-3

dioxabenzofos (ISO);

2-methoxy-4H-1,3,2-benzodioxaphosphorin-2-sulfid

223-292-3

3811-49-2

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 1

Aquatic Chronic 2

H311

H301

H370 **

H411

GHS06

GHS08

GHS09

Dgr

H311

H301

H370 **

H411

015-153-00-9

isazofos (ISO);

O-(5-chlor-1-isopropyl-1,2,4-triazol-3-yl)-O, O-diethylthiophosphat

255-863-8

42509-80-8

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H311

H301

H373 **

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H311

H301

H373 **

H317

H410

015-154-00-4

ethephon; 2-chlorethylphosphonsyre

240-718-3

16672-87-0

Acute Tox. 3

Acute Tox. 4

Acute Tox. 4

Skin Corr. 1C

Aquatic Chronic 2

H311

H332

H302

H314

H411

GHS06

GHS05

GHS09

Dgr

H311

H332

H302

H314

H411

EUH071

015-155-00-X

glufosinat ammonium (ISO);

ammonium-2-amino-4-(hydroxymethylphosphinyl)butyrat

278-636-5

77182-82-2

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

H360Fd

H332

H312

H302

H373 **

GHS08

GHS07

Dgr

H360Fd

H332

H312

H302

H373 **

015-156-00-5

methyl-3-[(dimethoxyphosphinothioyl)oxy]methacrylat; [1]

methacrifos (ISO);

methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylat [2]

250-366-9 [1]-[2]

30864-28-9 [1]

62610-77-9 [2]

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

015-157-00-0

trihydroxophosphor; [1]

phosponsyre [2]

237-066-7 [1]

233-663-1 [2]

13598-36-2 [1]

10294-56-1 [2]

Acute Tox. 4 *

Skin Corr. 1A

H302

H314

GHS05

GHS07

Dgr

H302

H314

015-158-00-6

(η-ciclopentadienyl)(η-cumenyl)jern(1+)hexafluorphosphat(1-)

402-340-9

32760-80-8

Aquatic Chronic 3

H412

—

H412

015-159-00-1

hydroxyphosphonoeddikesyre

405-710-8

23783-26-8

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

H302

H373 **

H314

H317

GHS08

GHS05

GHS07

Dgr

H302

H373 **

H314

H317

015-160-00-7

vanadylpyrophosphat

406-260-5

58834-75-6

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H319

H317

H412

GHS07

Wng

H319

H317

H412

015-161-00-2

divanadylpyrophosphat

407-130-0

65232-89-5

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

015-162-00-8

vanadium(IV)oxidhydrogenphosphathemihydrat, lithium, zink, molybden, jern og chlor dopet

407-350-7

—

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2

H332

H373 **

H318

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H332

H373 **

H318

H411

015-163-00-3

bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxid

412-010-6

145052-34-2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

015-164-00-9

calcium-P, P'-(1-hydroxyethyliden)bis(hydrogenphosphonat)dihydrat

400-480-5

36669-85-9

Aquatic Chronic 3

H412

—

H412

015-165-00-4

blanding af thiobis(4,1-phenylen)-S, S,S',S'-tetraphenyldisulfoniumbishexafluorphosphat; diphenyl(4-phenylthiophenyl)sulfoniumhexafluorphosphat

404-986-7

—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

015-166-00-X

3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecan

410-290-4

80693-00-1

Aquatic Chronic 4

H413

—

H413

015-167-00-5

3-(hydroxyphenylphosphinoyl)propansyre

411-200-6

14657-64-8

Eye Dam. 1

H318

GHS05

Dgr

H318

015-168-00-0

fosthiazat (ISO);

(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylthiophosphonat

—

98886-44-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H312

H317

H400

H410

GHS06

GHS09

Dgr

H331

H301

H312

H317

H410

EUH070

015-169-00-6

tributyltetradecylphosphonium tetrafluorborat

413-520-1

—

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H314

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H302

H373 ** H314

H317

H410

015-170-00-1

blanding af di-(1-octan-N, N,N-trimethylammonium)-octylphosphat: 1-octan-N, N,N-trimethylammonium di-octylphosphat; 1-octan-N, N,N-trimethylammonium-octylphosphat

407-490-9

—

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

015-171-00-7

O, O,O-tris(2(eller 4)-C9-10-isoalkylphenyl) thiophosphat

406-940-1

—

Aquatic Chronic 2

H411

GHS09

H411

015-172-00-2

blanding af bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphat;

isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphat

406-240-6

—

Flam. Liq. 3

Skin Corr. 1B

Aquatic Chronic 2

H226

H314

H411

GHS02

GHS05

GHS09

Dgr

H226

H314

H411

015-173-00-8

methyl-[2-(1,1-dimethylethyl)-6-methoxypirimidin-4-yl]ethylthiophosphat

414-080-3

117291-73-3

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

015-174-00-3

1-chlor-N, N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramin

411-370-1

82857-68-9

Acute Tox. 3 *

Eye Dam. 1

Aquatic Chronic 2

H301

H318

H411

GHS06

GHS05

GHS09

Dgr

H301

H318

H411

015-175-00-9

tert-butyl-(triphenylphosphoranyliden)acetat

412-880-7

35000-38-5

Acute Tox. 3 *

STOT RE 2 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H301

H373 **

H319

H317

H411

GHS06

GHS08

GHS09

Dgr

H301

H373 ** H319

H317

H411

015-176-00-4

P, P,P',P'-tetrakis-(o-methoxyphenyl)propan-1,3-diphosphin

413-430-2

116163-96-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

015-177-00-X

((4-phenylbutyl)hydroxyphosphoryl)eddikesyre

412-170-7

83623-61-4

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H373 **

H318

H317

GHS08

GHS05

Dgr

H373 ** H318

H317

015-178-00-5

(R)-α-phenylethylammonium-(-)-(1R, 2S)-(1,2-epoxypropyl)phosphonatmonohydrat

418-570-8

25383-07-7

Repr. 2

Aquatic Chronic 2

H361f *** H411

GHS08

GHS09

Wng

H361f *** H411

015-179-00-0

UVCB kondensationsprodukt af tetrakis-hydroxymethylphosphoniumchlorid, urinstof og destilleret hydrogeneret C16-18-talg-alkylamin

422-720-8

166242-53-1

Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H373 **

H314

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H351

H302

H373 ** H314

H317

H410

015-180-00-6

[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] eddikesyre, (-)-cinchonidin (1:1) salt

415-820-8

137590-32-0

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

015-181-00-1

phosphin

232-260-8

7803-51-2

Flam. Gas 1

Press. Gas

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Acute 1

H220

H330

H314

H400

GHS02

GHS04

GHS06

GHS05

GHS09

Dgr

H220

H330

H314

H400

U

015-182-00-7

tetraisopropyldichlormethylenbisphosphonat

430-630-5

10596-22-2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H302

H319

H317

GHS07

Wng

H302

H319

H317

015-183-00-2

(1-hydroxydodecyliden)diphosphonsyre

425-230-2

16610-63-2

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

015-184-00-8

glyphosat, salte heraf, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Aquatic Chronic 2

H411

GHS09

H411

A

015-186-00-9

chlorpyrifos-methyl (ISO);

O, O-dimethyl O-3,5,6-trichlor-2-pyridylthiophosphat

227-011-5

5598-13-0

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 10 000

015-187-00-4

blanding af tetranatrium(((2-hydroxyethyl)imino)bis(methylen))bisphosphonat, N-oxid;

trinatrium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonat, N-oxid, P-oxid

417-540-1

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

015-189-00-5

phenyl bis(2,4,6-trimethylbenzoyl)-phosphinoxid

423-340-5

162881-26-7

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

015-190-00-0

bis(2,4-dicumylphenyl)neopentyldiphosphit;

3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecan

421-920-2

154862-43-8

Aquatic Chronic 4

H413

—

H413

015-191-00-6

dodecyldiphenylphosphat

431-760-5

27460-02-2

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

015-192-00-1

tetrakis(2,6-dimethylphenyl)-m-phenylenbiphosphat

432-770-2

139189-30-3

Skin Sens. 1

H317

GHS07

Wng

H317

015-193-00-7

triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butansulfonamid (1:1)

442-960-7

332350-93-3

Acute Tox. 3 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H318

H400

H410

GHS05

GHS06

GHS09

Dgr

H301

H318

H410

015-194-00-2

tetrabutylphosphonium-nonafluorbutan-1-sulfonat

444-440-5

220689-12-3

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

015-195-00-8

blanding af kalium-o-toluenphosphonat;

kalium-m-toluenphosphonat;

kalium-p-toluenphosphonat

433-860-4

—

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H319

H317

H412

GHS07

Wng

H319

H317

H412

015-196-00-3

blanding af dimethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;

diethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;

methylethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat

435-960-3

—

Carc. 1B

Muta. 1B

Skin Sens. 1

H350

H340

H317

GHS08

GHS07

Dgr

H350

H340

H317

015-197-00-9

bis(2,4,4-trimethylpentyl)dithiophosphonsyre

420-160-9

107667-02-7

Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H226

H331

H302

H314

H411

GHS02

GHS06

GHS05

GHS09

Dgr

H226

H331

H302

H314

H411

015-198-00-4

(4-phenylbutyl)phosphinsyre

420-450-5

86552-32-1

Carc. 2

Eye Dam. 1

H351

H318

GHS05

GHS08

Dgr

H351

H318

015-199-00-X

tris[2-chlor-1-chlormethyl)ethyl] phosphat

237-159-2

13674-87-8

Carc. 2

H351

GSH08

Wng

H351

015-200-00-3

indiumphosphid

244-959-5

22398-80-7

Carc. Repr. 2

STOT RE 1

H350

H361f

H372 (lunger)

GHS08

Dgr

H350

H361f

H372 (lunger)

STOT RE 1; H372: C ≥ 0,1  % Carc 1B;

H350: C

≥ 0,01  % STOT RE 2;

H373: 0,01  % ≤

C < 0,1  %

015-201-00-9

trixylylphosphat

246-677-8

25155-23-1

Repr. 1B

H360F

GHS08

Dgr

H360F

015-202-00-4

tris(nonylphenyl)phosphit

247-759-6

26523-78-4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

015-203-00-X

diphenyl(2,4,6-trimethylbenzoyl)phosphinoxid

278-355-8

75980-60-8

Repr. 2

H361f (forårsager svækkelse af testiklerne)

GHS08

Wng

H361f (forårsager svækkelse af testiklerne)

016-001-00-4

hydrogensulfid

231-977-3

7783-06-4

Flam. Gas 1

Press. Gas

Acute Tox. 2 *

Aquatic Acute 1

H220

H330

H400

GHS02

GHS04

GHS06

GHS09

Dgr

H220

H330

H400

U

016-002-00-X

bariumsulfid

244-214-4

21109-95-5

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

H332

H302

H400

GHS07

GHS09

Wng

H332

H302

H400

EUH031

016-003-00-5

bariumpolysulfider

256-814-3

50864-67-0

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H319

H335

H315

H400

GHS07

GHS09

Wng

H319

H335

H315

H400

EUH031

016-004-00-0

calciumsulfid

243-873-5

20548-54-3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H319

H335

H315

H400

GHS07

GHS09

Wng

H319

H335

H315

H400

EUH031

016-005-00-6

calciumpolysulfider

215-709-2

1344-81-6

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H319

H335

H315

H400

GHS07

GHS09

Wng

H319

H335

H315

H400

EUH031

016-006-00-1

dikaliumsulfid;

kaliumsulfid

215-197-0

1312-73-8

Skin Corr. 1B

Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

EUH031

016-007-00-7

kaliumpolysulfider

253-390-1

37199-66-9

Skin Corr. 1B

Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

EUH031

016-008-00-2

ammoniumpolysulfider

232-989-1

9080-17-5

Skin Corr. 1B

Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

EUH031

EUH031: C ≥ 1 %

016-009-00-8

dinatriumsulfid;

natriumsulfid

215-211-5

1313-82-2

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

H311

H302

H314

H400

GHS06

GHS05

GHS09

Dgr

H311

H302

H314

H400

016-010-00-3

natriumpolysulfider

215-686-9

1344-08-7

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1

H301

H314

H400

GHS06

GHS05

GHS09

Dgr

H301

H314

H400

EUH031

016-011-00-9

svovldioxid

231-195-2

7446-09-5

Press. Gas

Acute Tox. 3 *

Skin Corr. 1B

H331

H314

GHS04

GHS06

GHS05

Dgr

H331

H314

*

U5

016-012-00-4

disvovldichlorid;

svovlmonochlorid

233-036-2

10025-67-9

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1

H301

H332

H314

H400

GHS06

GHS05

GHS09

Dgr

H301

H332

H314

H400

EUH014

EUH029

STOT SE 3; H335: C ≥ 1 %

016-013-00-X

svovldichlorid

234-129-0

10545-99-0

Skin Corr. 1B

STOT SE 3

Aquatic Acute 1

H314

H335

H400

GHS05

GHS07

GHS09

Dgr

H314

H335

H400

EUH014

STOT SE 3; H335: C ≥ 5 %

016-014-00-5

svovltetrachlorid

—

13451-08-6

Skin Corr. 1B

Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

EUH014

STOT SE 3; H335: C ≥ 5 %

016-015-00-0

thionyldichlorid;

thionylchlorid

231-748-8

7719-09-7

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H332

H302

H314

GHS05

GHS07

Dgr

H332

H302

H314

EUH014

EUH029

STOT SE 3; H335: C ≥ 1 %

016-016-00-6

sulfurylchlorid

232-245-6

7791-25-5

Skin Corr. 1B

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

EUH014

016-017-00-1

chlorsulfonsyre

232-234-6

7790-94-5

Skin Corr. 1A

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

EUH014

016-018-00-7

fluorsulfonsyre

232-149-4

7789-21-1

Acute Tox. 4 *

Skin Corr. 1A

H332

H314

GHS05

GHS07

Dgr

H332

H314

016-019-00-2

oleum ... % SO3

—

—

Skin Corr. 1A

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

EUH014

B

016-020-00-8

svovlsyre ... %

231-639-5

7664-93-9

Skin Corr. 1A

H314

GHS05

Dgr

H314

Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C

< 15 %

Eye Irrit. 2; H319: 5 % ≤ C

< 15 %

B

016-021-00-3

methanthiol;

methylmercaptan

200-822-1

74-93-1

Flam. Gas. 1

Press. Gas

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H220

H331

H400

H410

GHS02

GHS04

GHS06

GHS09

Dgr

H220

H331

H410

U

016-022-00-9

ethanethiol;

ethylmercaptan

200-837-3

75-08-1

Flam. Liq. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H225

H332

H400

H410

GHS02

GHS07

GHS09

Dgr

H225

H332

H410

016-023-00-4

dimethylsulfat

201-058-1

77-78-1

Carc. 1B

Muta. 2

Acute Tox. 2 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

H350

H341

H330

H301

H314

H317

GHS06

GHS08

GHS05

Dgr

H350

H341

H330

H301

H314

H317

Carc. 1B; H350: C ≥ 0,01  % Muta. 2; H341: C ≥ 0,01  % STOT SE 3; H335: C ≥ 5 %

016-024-00-X

dimexano (ISO);

bis(methoxy-thiocarbonyl)-disulfid

215-993-8

1468-37-7

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

016-025-00-5

disul (ISO);

2-(2,4-dichlorphenoxy)-ethylhydrogensulfat;

2,4-DES

205-259-5

149-26-8

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

H302

H315

H318

GHS05

GHS07

Dgr

H302

H315

H318

016-026-00-0

sulfamidsyre;

sulfaminsyre

226-218-8

5329-14-6

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3

H319

H315

H412

GHS07

Wng

H319

H315

H412

016-027-00-6

diethylsulfat

200-589-6

64-67-5

Carc. 1B

Muta. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H350

H340

H332

H312

H302

H314

GHS05

GHS08

GHS07

Dgr

H350

H340

H332

H312

H302

H314

016-028-00-1

natriumdithionit;

natriumhydrosulfit

231-890-0

7775-14-6

Self-heat. 1

Acute Tox. 4 *

H251

H302

GHS02

GHS07

Dgr

H251

H302

EUH031

016-029-00-7

p-toluensulfonsyre, indeholdende mere end 5 % H2SO4

—

—

Skin Corr. 1B

H314

GHS05

Dgr

H314

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %

016-030-00-2

p-toluensulfonsyre (indeholdende højst 5 % H2SO4)

203-180-0

104-15-4

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

STOT SE 3; H335: C ≥ 20 %

016-031-00-8

tetrahydrothiophen-1,1-dioxid;

sulfolan

204-783-1

126-33-0

Acute Tox. 4 *

H302

GHS07

Wng

H302

016-032-00-3

1,3-propansulton;

1,2-oxathiolan 2,2-dioxid

214-317-9

1120-71-4

Carc. 1B

Acute Tox. 4 *

Acute Tox. 4 *

H350

H312

H302

GHS08

GHS07

Dgr

H350

H312

H302

Carc. 1B; H350: C ≥ 0,01  %

016-033-00-9

dimethylsulfamoylchlorid

236-412-4

13360-57-1

Carc. 1B

Acute Tox. 2 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H350

H330

H312

H302

H314

GHS06

GHS05

GHS08

Dgr

H350

H330

H312

H302

H314

016-034-00-4

tetranatrium-3,3'-(piperazin-1,4-diylbis((6-chlor-1,3,5-triazin-4,2-diyl)imino(2-acetamido)-4,1-phenylenazo))bis(naphthalen-1,5-disulfonat)

400-010-9

81898-60-4

Skin Sens. 1

H317

GHS07

Wng

H317

016-035-00-X

pentanatrium-5-anilino-3-(4-(4-(6-chlor-4-(3-sulfonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat

400-120-7

—

Eye Irrit. 2

H319

GHS07

Wng

H319

016-036-00-5

tetranatrium-5-(4,6-dichlor-5-cyanpyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalen-1,2,5,7-disulfonat

400-130-1

—

Resp. Sens. 1

Aquatic Chronic 2

H334

H411

GHS08

GHS09

Dgr

H334

H411

016-037-00-0

dinatrium-1-amino-4-(4-benzensulfonamido-3-sulfonatoanilino)anthraquinon-2-sulfonat

400-350-8

85153-93-1

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

016-038-00-6

dinatrium-6-((4-chlor-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulfonatophenylazo)naphthalen-3-sulfonat

400-380-1

86393-35-3

Skin Sens. 1

H317

GHS07

Wng

H317

016-039-00-1

tetranatrium-2-(6-chlor-4-(4-(2,5-dimethyl-4-(2,5-disulfonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzen-1,4-disulfonat

400-430-2

—

Skin Sens. 1

H317

GHS07

Wng

H317

016-040-00-7

blanding af dinatrium-6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulfonatophenylazo)-4-hydroxynaphthalen-2-sulfonat og dinatrium-6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulfonatophenylazo)-4-hydroxynaphthalen-2-sulfonat og trinatrium-6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulfonato-2-naphthylazo)anilino)-3-sulfonatophenylazo)-4-hydroxynaphthalen-2-sulfonat

400-570-4

—

Eye Irrit. 2

H319

GHS07

Wng

H319

016-041-00-2

calcium-2,5-dichlor-4-(4-((5-chlor-4-methyl-2-sulfonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzensulfonat

400-710-4

—

Acute Tox. 4 *

H332

GHS07

Wng

H332

016-042-00-8

tetranatrium-5-benzamido-3-(5-(4-fluor-6-(1-sulfonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat

400-790-0

85665-97-0

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

016-043-00-3

dilithium-6-acetamido-4-hydroxy-3-(4-((2-sulfonatooxy)ethylsulfonyl)phenylazo)naphthalen-2-sulfonat

401-010-1

—

Skin Sens. 1

H317

GHS07

Wng

H317

016-044-00-9

dinatrium-S, S-hexan-1,6-diyldi(thiosulfat)dihydrat

401-320-7

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

016-045-00-4

lithiumnatriumhydrogen-4-amino-6-(5-(5-chlor-2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat

401-560-2

108624-00-6

Skin Sens. 1

H317

GHS07

Wng

H317

016-046-00-X

natriumhydrogensulfat

231-665-7

7681-38-1

Eye Dam. 1

H318

GHS05

Dgr

H318

016-047-00-5

hexanatrium-7-(4-(4-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulfonatonaphthylazo)naphthalen-1,3,5- trisulfonat

401-650-1

85665-96-9

Skin Sens. 1

H317

GHS07

Wng

H317

016-048-00-0

natrium-3,5-dichlor-2-(5-cyan-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzensulfonat

401-870-8

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

016-049-00-6

calciumoctadecylxylensulfonat

402-040-8

—

Skin Corr. 1B

Aquatic Chronic 2

H314

H411

GHS05

GHS09

Dgr

H314

H411

016-050-00-1

kaliumnatrium-5-(4-chlor-6-(N-(4-(4-chlor-6-(5-hydroxy-2,7-disulfonato-6-(2-sulfonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino)phenyl- N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulfonatophenylazo)naphthalen-2,7-disulfonat

402-150-6

—

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

016-051-00-7

trinatrium-7-(4-(6-fluor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6- trisulfonat

402-170-5

106359-91-5

Skin Sens. 1

H317

GHS07

Wng

H317

016-052-00-2

benzyltributylammonium-4-hydroxynaphthalen-1-sulfonat

402-240-5

102561-46-6

Acute Tox. 4 *

Aquatic Chronic 2

H332

H411

GHS07

GHS09

Wng

H332

H411

016-053-00-8

(C16 eller C18-n-alkyl)(C16 eller C18-n-alkyl)ammonium-2-((C16 eller C18-n-alkyl)(C16 eller C18-n-alkyl)carbamoyl)benzensulfonat

402-460-1

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

016-054-00-3

natrium-4-(2,4,4-trimethylpentylcarbonyloxy)benzensulfonat

400-030-8

—

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Sens. 1

H331

H372 **

H302

H319

H335

H317

GHS06

GHS08

Dgr

H331

H372 ** H302

H319

H335

H317

016-055-00-9

tetranatrium-4-amino-3,6-bis(5-(6-chlor-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalen-2,7-sulfonat (der indeholder > 35 % natriumchlorid og natriumacetat)

400-510-7

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

016-056-00-4

kaliumhydrogensulfat

231-594-1

7646-93-7

Skin Corr. 1B

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

016-057-00-X

styren-4-sulfonylchlorid

404-770-2

2633-67-2

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H315

H318

H317

GHS05

GHS07

Dgr

H315

H318

H317

016-058-00-5

thionylchlorid, reaktionsprodukter med 1,3,4-thiadiazol-2,5-dithiol, tert-nonanthiol og C12-14-tert-alkylamin

404-820-3

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H315

H317

H412

GHS07

Wng

H315

H317

H412

016-059-00-0

N, N,N',N'-tetramethyldithiobis(ethylen)diamindihydrochlorid

405-300-9

17339-60-5

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H317

H400

H410

GHS07

GHS09

Wng

H302

H319

H317

H410

016-060-00-6

diammoniumperoxodisulfat; ammoniumpersulfat

231-786-5

7727-54-0

Ox. Sol. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

H272

H302

H319

H335

H315

H334

H317

GHS03

GHS08

GHS07

Dgr

H272

H302

H319

H335

H315

H334

H317

016-061-00-1

dikaliumperoxodisulfat; kaliumpersulfat

231-781-8

7727-21-1

Ox. Sol. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

H272

H302

H319

H335

H315

H334

H317

GHS03

GHS08

GHS07

Dgr

H272

H302

H319

H335

H315

H334

H317

016-062-00-7

bensultap (ISO);

di-S-benzensulfonyl-2-(dimethylamino)propan-1,3-dithiol

—

17606-31-4

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

016-063-00-2

natriummetabisulfit

231-673-0

7681-57-4

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

EUH031

016-064-00-8

natriumhydrogensulfit ... %;

natriumdisulfit . . . %

231-548-0

7631-90-5

Acute Tox. 4 *

H302

GHS07

Wng

H302

EUH031

B

016-065-00-3

natrium-1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthrachinon-2-sulfonat

400-100-8

84057-97-6

Aquatic Chronic 2

H411

GHS09

H411

016-066-00-9

tetranatrium-[5-((4-amino-6-chlor-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2-sulfonatobenzylidenhydrazino)benzoat]kobber(II)

404-070-7

116912-62-0

Aquatic Chronic 3

H412

—

H412

016-067-00-4

(4-methylphenyl)mesitylen-sulfonat

407-530-5

67811-06-7

Aquatic Chronic 4

H413

—

H413

016-068-00-X

natrium-3,5-bis(tetradecyloxycarbonyl)benzensulfinat

407-720-8

155160-86-4

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

016-069-00-5

3,5-bis(tetradecyloxycarbonyl)benzensulfinsyre

407-990-7

141915-64-2

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

016-070-00-0

4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfon

408-220-2

—

Aquatic Chronic 4

H413

—

H413

016-071-00-6

trinatrium-3-amino-6,13-dichlor-10-((3-((4-chlor-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazindisulfonat

410-130-3

136248-03-8

Skin Sens. 1

H317

GHS07

Wng

H317

016-072-00-1

3-amino-4-hydroxy-N-(2-methoxyethyl)-benzensulfonamid

411-520-6

112195-27-4

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

016-073-00-7

tetrakis(phenylmethyl)thioperoxydi(carbothioamid)

404-310-0

10591-85-2

Aquatic Chronic 4

H413

—

H413

016-074-00-2

6-fluor-2-methyl-3-(4-methylthiobenzyl)inden

405-410-7

—

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H315

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H411

016-075-00-8

2,2'-diallyl-4,4'-sulfonyldiphenol

411-570-9

41481-66-7

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

016-076-00-3

2,3-bis((2-mercapto-ethyl)thio)-1-propanthiol

411-290-7

131538-00-6

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 ** H410

016-077-00-9

2-chlor-p-toluensulfochlorid

412-890-1

42413-03-6

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H314

H317

H412

GHS05

GHS07

Dgr

H314

H317

H412

016-078-00-4

4-methyl-N, N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)-benzensulfonamid

413-300-5

56187-04-3

Aquatic Chronic 4

H413

—

016-079-00-X

N, N-bis(2-(p-toluensulfonyloxy)ethyl)-p-toluensulfonamid

412-920-3

16695-22-0

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

016-080-00-5

natrium-2-anilin-5-(2-nitro-4-(N-phenylsulfamoyl))anilinbenzensulfonat

412-320-1

31361-99-6

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

016-081-00-0

hexahydrocyclopenta[c]pyrrol-1-(1H)-ammonium-N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanid

418-350-1

—

Muta. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H341

H302

H319

H317

H411

GHS08

GHS07

GHS09

Wng

H341

H302

H319

H317

H411

016-082-00-6

ethoxysulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urinstof

—

126801-58-9

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

016-083-00-1

acibenzolar-S-methyl;

benzo[1,2,3]thiadiazol-7-carbothiosyre S-methylester

420-050-0

135158-54-2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H319

H335

H315

H317

H400

H410

GHS07

GHS09

Wng

H319

H335

H315

H317

H410

016-084-00-7

prosulfuron (ISO);

1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluorpropyl)phenylsulfonyl]urinstof

—

94125-34-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 100

016-085-00-2

flazasulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urinstof

—

104040-78-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

016-086-00-8

tetranatrium-10-amino-6,13-dichlor-3-(3-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacen-4,11-disulfonat

402-590-9

109125-56-6

Eye Dam. 1

H318

GHS05

Dgr

H318

016-087-00-3

blanding af thiobis(4,1-phenylen)-S, S,S',S'-tetraphenyldisulfoniumbishexafluorphosphat;

diphenyl(4-phenylthiophenyl)sulfoniumhexafluorphosphat;

propylencarbonat

403-490-8

104558-95-4

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H319

H317

H400

H410

GHS07

GHS09

Wng

H319

H317

H410

016-088-00-9

4-(bis(4-(diethylamino)phenyl)methyl)benzen-1,2-dimethansulfonsyre

407-280-7

71297-11-5

Aquatic Chronic 3

H412

—

H412

016-089-00-4

blanding af estere af 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan og 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalen

413-840-1

—

Self-react. C ****

Aquatic Chronic 4

H242

H413

GHS02

Dgr

H242

H413

016-090-00-X

4-methyl-N-(methylsulfonyl)benzensulfonamid

415-040-8

14653-91-9

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H302

H335

H318

GHS05

GHS07

Dgr

H302

H335

H318

016-091-00-5

C12-14-tert-alkylammonium-1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonat

414-110-5

—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

016-092-00-0

blanding af 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecandithiol;

4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecandithiol og 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecandithiol

427-050-1

—

Repr. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f

H315

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f

H315

H317

H410

016-093-00-6

blanding af (2:1)(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonat) og 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonat)

414-770-4

140698-96-0

Self-react. C ****

Carc. 2

H242

H351

GHS02

GHS08

Dgr

H242

H351

016-094-00-1

svovl

231-722-6

7704-34-9

Skin Irrit. 2

H315

GHS07

Wng

H315

016-095-00-7

blanding af reaktionsprodukt af 4,4'-methylenbis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxo-naphthalensulfonat (1:2) og reaktionsprodukt af 4,4'-methylenbis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxo-naphthalensulfonat (1:3)

417-980-4

—

Self-react. C ****

Carc. 2

H242

H351

GHS02

GHS08

Dgr

H242

H351

016-096-00-2

thifensulfuron-methyl (ISO);

methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophen-2-carboxylat

—

79277-27-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

016-097-00-8

1-amino-2-methyl-2-propanthiolhydrochlorid

434-480-1

32047-53-3

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H302

H314

H317

H412

GHS05

GHS07

Dgr

H302

H314

H317

H412

017-001-00-7

chlor

231-959-5

7782-50-5

Ox. Gas 1

Press. Gas

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H270

H331

H319

H335

H315

H400

GHS03

GHS04

GHS06

GHS09

Dgr

H270

H331

H319

H335

H315

H400

M = 100

U

017-002-00-2

hydrogenchlorid

231-595-7

7647-01-0

Press. Gas

Acute Tox. 3 *

Skin Corr. 1A

H331

H314

GHS04

GHS06

GHS05

Dgr

H331

H314

U5

017-002-01-X

saltsyre ... %

231-595-7

—

Skin Corr. 1B

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %

STOT SE 3; H335: C ≥ 10 %

B

017-003-00-8

bariumchlorat

236-760-7

13477-00-4

Ox. Sol. 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H271

H332

H302

H411

GHS03

GHS07

GHS09

Dgr

H271

H332

H302

H411

017-004-00-3

kaliumchlorat

223-289-7

3811-04-9

Ox. Sol. 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H271

H332

H302

H411

GHS03

GHS07

GHS09

Dgr

H271

H332

H302

H411

017-005-00-9

natriumchlorat

231-887-4

7775-09-9

Ox. Sol. 1

Acute Tox. 4 *

Aquatic Chronic 2

H271

H302

H411

GHS03

GHS07

GHS09

Dgr

H271

H302

H411

017-006-00-4

perchlorsyre ... %

231-512-4

7601-90-3

Ox. Liq. 1

Skin Corr. 1A

H271

H314

GHS03

GHS05

Dgr

H271

H314

Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 %

Skin Irrit. 2; H315: 1 % ≤ C

< 10 %

Eye Irrit. 2; H319: 1 % ≤ C

< 10 %

Ox. Liq. 1; H271: C > 50 %:

Ox. Liq. 2; H272: C ≤ 50 %:

B

017-007-00-X

bariumperchlorat

236-710-4

13465-95-7

Ox. Sol. 1

Acute Tox. 4 *

Acute Tox. 4 *

H271

H332

H302

GHS03

GHS07

Dgr

H271

H332

H302

017-008-00-5

kaliumperchlorat

231-912-9

7778-74-7

Ox. Sol. 1

Acute Tox. 4 *

H271

H302

GHS03

GHS07

Dgr

H271

H302

017-009-00-0

ammoniumperchlorat

232-235-1

7790-98-9

Expl. 1,1

Ox. Sol. 1

H201

H271

GHS01

Dgr

H201

H271

T

017-010-00-6

natriumperchlorat

231-511-9

7601-89-0

Ox. Sol. 1

Acute Tox. 4 *

H271

H302

GHS03

GHS07

Dgr

H271

H302

017-011-00-1

natriumhypochloritopløsning ... % aktiv chlor

231-668-3

7681-52-9

Skin Corr. 1B

Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

EUH031

EUH031: C ≥ 5 %

B

017-012-00-7

calciumhypochlorit

231-908-7

7778-54-3

Ox. Sol. 2

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

H272

H302

H314

H400

GHS03

GHS05

GHS07

GHS09

Dgr

H272

H302

H314

H400

EUH031

Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C

< 5 %

Eye Dam.1; H318: 3 % ≤ C

< 5 %

Eye Irrit. 2; H319: 0,5  % ≤ C < 3 %

M = 10

T

017-013-00-2

calciumchlorid

233-140-8

10043-52-4

Eye Irrit. 2

H319

GHS07

Wng

H319

017-014-00-8

ammoniumchlorid

235-186-4

12125-02-9

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

017-015-00-3

(2-(aminomethyl)phenyl)acetylchlorid hydrochlorid

417-410-4

61807-67-8

Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1

H302

H314

H317

GHS05

GHS07

Dgr

H302

H314

H317

017-016-00-9

methyltriphenylphosphoniumchlorid

418-400-2

1031-15-8

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H312

H302

H315

H318

H411

GHS05

GHS07

GHS09

Dgr

H312

H302

H315

H318

H411

017-017-00-4

(Z)-13-docosenyl-N, N-bis(2-hydroxyethyl)-N-methylammoniumchlorid

426-210-6

120086-58-0

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

017-018-00-X

N, N,N-trimethyl-2,3-bis(stearoyloxy)propylammoniumchlorid

405-660-7

—

Aquatic Chronic 2

H411

GHS09

H411

017-019-00-5

(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisochinolinhydrochlorid

415-110-8

54417-53-7

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

017-020-00-0

ethylpropoxyaluminiumchlorid

421-790-7

13014-29-4

Water-react. 1

Skin Corr. 1A

H260

H314

GHS02

GHS05

Dgr

H260

H314

EUH014

017-021-00-6

behenamidopropyl-dimethyl-(dihydroxypropyl) ammoniumchlorid

423-420-1

136920-10-0

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H318

H317

H410

017-023-00-7

[phosphinyldyntris(oxy)]-tris[3-aminopropyl-2-hydroxy-N, N-dimethyl-N-(C6-18)-alkyl]-trichlorider

425-520-9

197179-61-6

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

017-026-00-3

chlordioxid

233-162-8

10049-04-4

Press. Gas

Ox. Gas 1

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Acute 1

H270

H330

H314

H400

GHS04

GHS03

GHS06

GHS05

GHS09

Dgr

H270

H330

H314

H400

M = 10

5

017-026-01-0

chlordioxid ... %

233-162-8

10049-04-4

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1

H301

H314

H400

GHS06

GHS05

GHS09

Dgr

H301

H314

H400

Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C

< 5 %

Eye Dam.1; H318: 3 % ≤ C

< 5 %

Eye Irrit. 2; H319: 0,3  % ≤ C < 3 %

STOT SE 3; H335: C ≥ 3 % M = 10

B

019-001-00-2

kalium

231-119-8

7440-09-7

Water-react. 1

Skin Corr. 1B

H260

H314

GHS02

GHS05

Dgr

H260

H314

EUH014

019-002-00-8

kaliumhydroxid;

kaustisk potaske

215-181-3

1310-58-3

Acute Tox. 4 *

Skin Corr. 1A

H302

H314

GHS05

GHS07

Dgr

H302

H314

Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C

< 5 %

Skin Irrit. 2; H315: 0,5  % ≤ C < 2 %

Eye Irrit. 2; H319: 0,5  % ≤ C < 2 %

020-001-00-X

calcium

231-179-5

7440-70-2

Water-react. 2

H261

GHS02

Dgr

H261

020-002-00-5

calciumcyanid

209-740-0

592-01-8

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H400

H410

GHS06

GHS09

Dgr

H300

H410

EUH032

020-003-00-0

blanding af dicalcium (bis(2-hydroxy-5-tetrapropenylphenylmethyl)methylamin)dihydroxid;

tricalcium (tris(2-hydroxy-5-tetrapropenylphenylmethyl)methylamin)trihydroxid;

poly[calcium ((2-hydroxy-5-tetrapropenyl-phenylmethyl)methylamin)hydroxid]

420-470-4

—

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

022-001-00-5

titantetrachlorid

231-441-9

7550-45-0

Skin Corr. 1B

H314

GHS05

Dgr

H314

EUH014

022-002-00-0

titan(4+)oxalat

403-260-7

—

Eye Dam. 1

H318

GHS05

Dgr

H318

022-003-00-6

bis(η5-cyclopentadienyl)-bis[2,6-difluor-3-(pyrrol-1-yl)-phenyl]titan

412-000-1

125051-32-3

Flam. Sol. 1

Repr. 2

STOT RE 2 *

Aquatic Chronic 2

H228

H361f *** H373 **

H411

GHS02

GHS08

GHS09

Dgr

H228

H361f *** H373 ** H411

T

022-004-00-1

kaliumtitanoxid (K2Ti6O13)

432-240-0

12056-51-8

Carc. 2

H351

GHS08

Wng

H351

022-005-00-7

[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][1,2,3,4-η)-1,3-pentadien]-titan

419-840-8

169104-71-6

Flam. Sol. 1****

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 4

H228

H314

H317

H413

GHS02

GHS05

GHS07

Dgr

H228

H314

H317

H413

023-001-00-8

divanadiumpentaoxid;

vanadiumpentaoxid

215-239-8

1314-62-1

Muta. 2

Repr. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Aquatic Chronic 2

H341

H361d *** H372 **

H332

H302

H335

H411

GHS08

GHS07

GHS09

Dgr

H341

H361d *** H372 **

H332

H302

H335

H411

024-001-00-0

chromtrioxid

215-607-8

1333-82-0

Ox. Sol. 1

Carc. 1A

Muta. 1B Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H271

H350

H340

H361f *** H330

H311

H301

H372 **

H314

H334

H317

H400

H410

GHS03

GHS06

GHS08

GHS05

GHS09

Dgr

H271

H350

H340

H361f *** H330

H311

H301

H372 **

H314

H334

H317

H410

STOT SE 3; H335: C ≥ 1 %

024-002-00-6

kaliumdichromat

231-906-6

7778-50-9

Ox. Sol. 2

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410

GHS03

GHS06

GHS08

GHS05

GHS09

Dgr

H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410

STOT SE 3; H335: C ≥ 5 %

3

024-003-00-1

ammoniumdichromat

232-143-1

7789-09-5

Ox. Sol. 2 ****

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410

GHS03

GHS06

GHS08

GHS05

GHS09

Dgr

H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410

STOT SE 3; H335: C ≥ 5 %

Resp. Sens.; H334: C ≥ 0,2  %

Skin Sens.; H317:C ≥ 0,2  %

G3

024-004-00-7

natriumdichromat

234-190-3

10588-01-9

Ox. Sol. 2

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 1

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H272

H350

H340

H360FD

H330

H301

H312

H372 **

H314

H334

H317

H400

H410

GHS03

GHS06

GHS05

GHS08

GHS09

Dgr

H272

H350

H340

H360FD

H330

H301

H312

H372 **

H314

H334

H317

H410

Resp. Sens. 1; H334: C ≥ 0,2  %

Skin Sens. 1; H317:C ≥ 0,2  %

STOT SE 3; H335: C ≥ 5 %

3

024-005-00-2

chromyldichlorid

239-056-8

14977-61-8

Ox. Liq. 1

Carc. 1B

Muta. 1B

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H271

H350i

H340

H314

H317

H400

H410

GHS03

GHS08

GHS05

GHS07

GHS09

Dgr

H271

H350i

H340

H314

H317

H410

Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C

< 10 %

Skin Irrit. 2; H315: 0,5  % ≤

C < 5 %

Eye Irrit. 2; H319: 0,5  % ≤

C < 5 %

STOT SE 3; H335: 0,5  % ≤ C < 5 %

Skin Sens. 1; H317: C ≥ 0,5  %

T3

024-006-00-8

kaliumchromat

232-140-5

7789-00-6

Carc. 1B

Muta. 1B

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H340

H319

H335

H315

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H340

H319

H335

H315

H317

H410

Skin Sens. 1; H317:C ≥ 0,5  %

3

024-007-00-3

zinkchromater, herunder zinkkaliumchromat

—

—

Carc. 1A

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H317

H410

A

024-008-00-9

calciumchromat

237-366-8

13765-19-0

Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H410

024-009-00-4

strontiumchromat

232-142-6

7789-06-2

Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H400

H410

024-010-00-X

dichromtris(chromat);

chrom III chromat;

chromchromat

246-356-2

24613-89-6

Ox. Sol. 1

Carc. 1B

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H271

H350

H314

H317

H400

H410

GHS03

GHS08

GHS05

GHS07

GHS09

Dgr

H271

H350

H314

H317

H410

T

024-011-00-5

ammoniumbis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromat(1-)

400-110-2

109125-51-1

Self-react. C ****

Aquatic Acute 1

Aquatic Chronic 1

H242

H400

H410

GHS02

GHS09

Dgr

H242

H410

024-012-00-0

trinatriumbis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulfonato-1-naphtholato)chromat(1-)

400-810-8

—

Muta. 2

H341

GHS08

Wng

H341

024-013-00-6

trinatrium-(6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulfonato-1-naphtholato)(4-sulfonato-1,1'-azodi-2,2'naphtholato)chromat(1-)

402-500-8

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

024-014-00-1

trinatriumbis(2-(5-chlor-4-nitro-2-oxidophenylazo)-5-sulfonato-1-naphtholato)chromat(1-)

402-870-0

93952-24-0

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

024-015-00-7

dinatrium(3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromat(1-)

404-930-1

—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H332

H318

H411

GHS05

GHS07

GHS09

Dgr

H332

H318

H411

024-016-00-2

tetradecylammoniumbis(1-(5-chlor-2-oxidophenylazo)-2-naphtholato)chromat(1-)

405-110-6

88377-66-6

STOT RE 2 *

Aquatic Chronic 4

H373 **

H413

GHS08

Wng

H373 **

H413

024-017-00-8

chrom(VI)forbindelser, med undtagelse af bariumchromat samt sådanne nævnt andetsteds i dette bilag

—

—

Carc. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H317

H410

A

024-018-00-3

natriumchromat

231-889-5

7775-11-3

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410

Resp. Sens.;

H334: C ≥ 0,2  %

Skin Sens.; H317:C ≥ 0,2  %

3

024-019-00-9

hovedkomponent: acetoeddikesyre/3-amino-1-hydroxybenzen (ATAN-MAP): trinatrium {6-[(2 eller 3 eller 4)-amino-(4 eller 5 eller 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalen-2''-azobenzen-1'',2'''-diolato}chromat (III);

biprodukt 1: acetoeddikesyreanilid / acetoeddikesyreanilid (ATAN-ATAN): trinatrium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato}chromat (III);

biprodukt 2: 3-amino-1-hydroxybenzen/3-amino-1-hydroxybenzen (MAP-MAP): trinatrium bis{6-[(2 eller 3 eller 4)-amino-(4 eller 5 eller 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato} chromat (III)

419-230-1

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

024-020-00-4

trinatrium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzen-2',4-diolato)]chromat(III)

418-220-4

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

024-021-00-X

kaliumtetranatrium-bis[(N, N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzenazo-1'-prop-1'-en-2,2'-diolato]chromat(III)

425-830-4

—

Eye Dam. 1

H318

GHS05

Dgr

H318

025-001-00-3

mangandioxid

215-202-6

1313-13-9

Acute Tox. 4 *

Acute Tox. 4 *

H332

H302

GHS07

Wng

H332

H302

025-002-00-9

kaliumpermanganat

231-760-3

7722-64-7

Ox. Sol. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H272

H302

H400

H410

GHS03

GHS07

GHS09

Dgr

H272

H302

H410

025-003-00-4

mangansulfat

232-089-9

7785-87-7

STOT RE 2 *

Aquatic Chronic 2

H373 **

H411

GHS08

GHS09

Wng

H373 ** H411

025-004-00-X

bis(N, N',N''-trimethyl-1,4,7-triazacyclononan)-trioxo-dimangan (IV) di(hexafluorphosphat)monohydrat

411-760-1

116633-53-5

Aquatic Chronic 2

H411

GHS09

H411

025-005-00-5

blanding af tri-natrium [29H, 31H-phthalocyanin-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganat (3-);

tetranatrium [29H,31H-phthalocyanin-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganat (3-);

pentanatrium [29H,31H-phthalocyanin-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganat (3-)

417-660-4

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

026-001-00-6

(η-cumen)-(η-cyclopentadienyl)jern(II)-hexafluorantimonat

407-840-0

100011-37-8

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

026-002-00-1

(η-cumen)-(η-cyclopentadienyl)jern(II)-trifluormethan-sulfonat

407-880-9

117549-13-0

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

026-003-00-7

jern(II)sulfat

231-753-5

7720-78-7

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H302

H319

H315

GHS07

Wng

H302

H319

H315

026-003-01-4

jern(II)sulfat (1:1) heptahydrat; svovlsyre, jern(II)-salt (1:1), heptahydrat;

ferrosulfat heptahydrat

231-753-5

7782-63-0

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H302

H319

H315

GHS07

Wng

H302

H319

H315

Skin Irrit.2; H315: C ≥ 25 %

026-004-00-2

kaliumferrit

430-010-4

12160-44-0

Skin Corr. 1B

Skin Sens. 1

H314

H317

GHS05

GHS07

Dgr

H314

H317

027-001-00-9

cobalt

231-158-0

7440-48-4

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 4

H334

H317

H413

GHS08

Dgr

H334

H317

H413

027-002-00-4

cobaltoxid

215-154-6

1307-96-6

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M = 10

027-003-00-X

cobaltsulfid

215-273-3

1317-42-6

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 10

027-004-00-5

cobaltdichlorid

231-589-4

7646-79-9

Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360f *** H302

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360f *** H302

H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01  % M = 10

1

027-005-00-0

cobaltsulfat

233-334-2

10124-43-3

Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360f *** H302

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360f *** H302

H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01  % M = 10

1

027-006-00-6

cobaltdi(acetat)

200-755-8

71-48-7

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360f *** H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360f *** H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01  %

M = 10

1

027-007-00-1

zinkhexacyanocobaltat(III), tert-butylalkohol/polypropylenglycolkompleks

425-240-7

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

027-008-00-7

kompleks af cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamid), hydrat (n H2O, 2<n<3)

427-390-9

—

Skin Sens. 1

H317

GHS07

Wng

H317

027-009-00-2

cobaltdinitrat

233-402-1

10141-05-6

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360f *** H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360f *** H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01  %

M = 10

1

027-010-00-8

cobaltcarbonat

208-169-4

513-79-1

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360f *** H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360f *** H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01  % M = 10

1

028-001-00-1

tetracarbonylnikkel;

nikkeltetracarbonyl

236-669-2

13463-39-3

Flam. Liq. 2

Carc. 2

Repr. 1B

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H225

H351

H360D *** H330

H400

H410

GHS02

GHS06

GHS08

GHS09

Dgr

H225

H351

H360D *** H330

H410

028-002-00-7

nikkel

231-111-4

7440-02-0

Carc. 2

STOT RE 1

Skin Sens. 1

H351

H372 **

H317

GHS08

GHS07

Dgr

H351

H372 **

H317

S7

028-002-01-4

nikkelpulver; [partikeldiameter < 1 mm]

231-111-4

7440-02-0

Carc. 2

STOT RE 1

Skin Sens. 1

Aquatic Chronic 3

H351

H372 **

H317

H412

GHS08

GHS07

Dgr

H351

H372 **

H317

H412

028-003-00-2

nikkelmonoxid; [1]

nikkeloxid; [2]

bunsenit [3]

215-215-7 [1]

234-323-5 [2]-[3]

1313-99-1 [1]

11099-02-8 [2]

34492-97-2 [3]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Chronic 4

H350i

H372 **

H317

H413

GHS08

GHS07

Dgr

H350i

H372 **

H317

H413

028-004-00-8

nikkeldioxid

234-823-3

12035-36-8

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Chronic 4

H350i

H372 **

H317

H413

GHS08

GHS07

Dgr

H350i

H372 **

H317

H413

028-005-00-3

dinikkeltrioxid

215-217-8

1314-06-3

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Chronic 4

H350i

H372 **

H317

H413

GHS08

GHS07

Dgr

H350i

H372 **

H317

H413

028-006-00-9

nikkel(II)sulfid; [1]

nikkelsulfid; [2]

millerit [3]

240-841-2 [1]

234-349-7 [2]-[3]

16812-54-7 [1]

11113-75-0 [2]

1314-04-1 [3]

Carc. 1A

Muta. 2

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H372 **

H317

H410

028-007-00-4

trinikkeldisulfid;

nikkelsubsulfid; [1]

heazlewoodit [2]

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Carc. 1A

Muta. 2

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H372 ** H317

H410

028-008-00-X

nikkeldihydroxid; [1]

nikkelhydroxid [2]

235-008-5 [1]

234-348-1 [2]

12054-48-7 [1]

11113-74-9 [2]

Carc. 1A

Repr. 1B

Muta. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i H360D *** H341

H372 **

H332

H302

H315

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H360D *** H341

H372 **

H332

H302

H315

H334

H317

H410

028-009-00-5

nikkelsulfat

232-104-9

7786-81-4

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H332

H302

H315

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D *** H372 ** H332

H302

H315

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Irrit. 2; H315: C ≥ 20 %

Skin Sens. 1; H317: C ≥

0,01  %

M = 1

028-010-00-0

nikkelcarbonat;

basisk nikkelcarbonat;

kulsyre, nikkel(2+)-salt; [1];

kulsyre, nikkelsalt; [2]

[μ-[carbonato(2-)-O:O']]-dihydroxytrinikkel; [3]

[carbonato(2-)]tetrahydroxytrinikkel [4]

222-068-2 [1]

240-408-8 [2]

265-748-4 [3]

235-715-9 [4]

3333-67-3 [1]

16337-84-1 [2]

65405-96-1 [3]

12607-70-4 [4]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H332

H302

H315

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D *** H372 **

H332

H302

H315

H334

H317

H410

028-011-00-6

nikkeldichlorid

231-743-0

7718-54-9

Carc. 1A Muta. 2

Repr. 1B

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H331

H301

H372 **

H315

H334

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H350i

H341

H360D *** H331

H301

H372 **

H315

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1  % < C < 1 %

Skin Irrit. 2; H315: C ≥ 20 %

Skin Sens. 1; H317: C ≥ 0,01  %

M = 1

028-012-00-1

nikkeldinitrat; [1]

salpetersyre, nikkelsalt [2]

236-068-5 [1]

238-076-4 [2]

13138-45-9 [1]

14216-75-2 [2]

Ox. Sol. 2

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H272

H350i

H341

H360D *** H372 **

H332

H302

H315

H318

H334

H317

H400

H410

GHS03

GHS05

GHS08

GHS07

GHS09

Dgr

H272

H350i

H341

H360D *** H372 **

H332

H302

H315

H318

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1  % < C < 1 %

Skin Irrit. 2; H315: C ≥ 20 %

Skin Sens. 1; H317 C ≥ 0,01  %

M = 1

028-013-00-7

nikkelsten

273-749-6

69012-50-6

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i *** H372 **

H317

H410

028-014-00-2

mudder og slam, kobberraffineringselektrolyse-, renset for kobber, nikkelsulfat

295-859-3

92129-57-2

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H332

H302

H315

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D *** H372 **

H332

H302

H315

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-015-00-8

mudder og slam, kobberraffineringselektrolyse-, renset for kobber

305-433-1

94551-87-8

Carc. 1A Muta. 2

Repr. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

028-016-00-3

nikkeldiperchlorat;

perchlorsyre, nikkel(II)salt

237-124-1

13637-71-3

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H314

H334

H317

H400

H410

GHS05

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H314

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01  %

M = 1

028-017-00-9

nikkeldikaliumbis(sulfat); [1]

diammoniumnikkelbis(sulfat) [2]

237-563-9 [1]

239-793-2 [2]

13842-46-1 [1]

15699-18-0 [2]

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H332

H302

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D *** H372 **

H332

H302

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-018-00-4

nikkelbis(sulfamidat);

nikkelsulfamat

237-396-1

13770-89-3

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-019-00-X

nikkelbis(tetrafluorborat)

238-753-4

14708-14-6

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 ** H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01  %

M = 1

028-021-00-0

nikkeldiformat; [1]

myresyre, nikkelsalt; [2]

myresyre, kobbernikkkelsalt [3]

222-101-0 [1]

239-946-6 [2]

268-755-0 [3]

3349-06-2 [1]

15843-02-4 [2]

68134-59-8 [3]

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 ** H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-022-00-6

nikkeldi(acetat); [1]

nikkelacetat [2]

206-761-7 [1]

239-086-1 [2]

373-02-4 [1]

14998-37-9 [2]

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H332

H302

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D *** H372 **

H332

H302

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-024-00-7

nikkeldibenzoat

209-046-8

553-71-9

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-025-00-2

nikkelbis(4-cyclohexylbutyrat)

223-463-2

3906-55-6

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-026-00-8

nikkel(II)stearat;

nikkel(II) octadecanoat

218-744-1

2223-95-2

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-027-00-3

nikkeldilactat

—

16039-61-5

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01  %

M = 1

028-028-00-9

nikkel(II)octanoat

225-656-7

4995-91-9

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H314

H334

H317

H400

H410

GHS05

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H314

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01  %

M = 1

028-029-00-4

nikkeldifluorid; [1]

nikkeldibromid; [2]

nikkeldiiodid; [3]

nikkelkaliumfluorid [4]

233-071-3 [1]

236-665-0 [2]

236-666-6 [3]

- [4]

10028-18-9 [1]

13462-88-9 [2]

13462-90-3 [3]

11132-10-8 [4]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 ** H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01  %

M = 1

028-030-00-X

nikkelhexafluorsilicat

247-430-7

26043-11-8

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-031-00-5

nikkelselenat

239-125-2

15060-62-5

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-032-00-0

nikkelhydrogenphosphat; [1]

nikkelbis(dihydrogenphosphat); [2]

trinikkelbis(orthophosphat); [3]

dinikkeldiphosphat; [4]

nikkelbis(phosphinat); [5]

nikkelphosphinat; [6]

phosphorsyre, calciumnikkelsalt; [7]

diphosphorsyyre, nikkel(II)salt [8]

238-278-2 [1]

242-522-3 [2]

233-844-5 [3]

238-426-6 [4]

238-511-8 [5]

252-840-4 [6]

- [7]

- [8]

14332-34-4 [1]

18718-11-1 [2]

10381-36-9 [3]

14448-18-1 [4]

14507-36-9 [5]

36026-88-7 [6]

17169-61-8 [7]

19372-20-4 [8]

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372 **

H334

H317

H410

028-033-00-6

diammoniumnikkelhexacyanoferrat

—

74195-78-1

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i H372 ** H334

H317

H410

028-034-00-1

nikkeldicyanid

209-160-8

557-19-7

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372 **

H334

H317

H410

EUH032

028-035-00-7

nikkelchromat

238-766-5

14721-18-7

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372 **

H334

H317

H410

028-036-00-2

nikkel(II)silicat; [1]

dinikkelorthosilicat; [2]

nikkelsilicat (3:4); [3]

kiselsyre, nikkelsalt; [4] trihydrogenhydroxybis[orthosilicato(4-)]trinikkelat(3-) [5]

244-578-4 [1]

237-411-1 [2]

250-788-7 [3]

253-461-7 [4]

235-688-3 [5]

21784-78-1 [1]

13775-54-7 [2]

31748-25-1 [3]

37321-15-6 [4]

12519-85-6 [5]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372 ** H317

H410

028-037-00-8

dinikkelhexacyanoferrat

238-946-3

14874-78-3

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H372 ** H317

H410

028-038-00-3

trinikkel bis(arsenat);

nikkel(II)arsenat

236-771-7

13477-70-8

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H372 ** H317

H410

028-039-00-9

nikkeloxalat; [1]

oxalsyre, nikkelsalt [2]

208-933-7 [1]

243-867-2 [2]

547-67-1 [1]

20543-06-0 [2]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H372 ** H317

H410

028-040-00-4

nikkeltellurid

235-260-6

12142-88-0

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H372 ** H317

H410

028-041-00-X

trinikkeltetrasulfid

—

12137-12-1

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H372 ** H317

H410

028-042-00-5

trinikkelbis(arsenit)

—

74646-29-0

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H372 ** H317

H410

028-043-00-0

cobaltnikkelgrå periclas;

C.I. Pigment Black 25; C.I. 77332; [1]

cobaltnikkeldioxid; [2]

cobaltnikkeloxid [3]

269-051-6 [1]

261-346-8 [2]

- [3]

68186-89-0 [1]

58591-45-0 [2]

12737-30-3 [3]

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372 **

H317

GHS08

GHS07

Dgr

H350i H372 ** H317

028-044-00-6

nikkeltintrioxid;

nikkelstannat

234-824-9

12035-38-0

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372 **

H317

GHS08

GHS07

Dgr

H350i *** H372 **

H317

028-045-00-1

nikkeltriurandecaoxid

239-876-6

15780-33-3

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372 **

H317

GHS08

GHS07

Dgr

H350i *** H372 **

H317

028-046-00-7

nikkeldithiocyanat

237-205-1

13689-92-4

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

EUH032

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-047-00-2

nikkeldichromat

239-646-5

15586-38-6

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317:C ≥ 0,01  %

M = 1

028-048-00-8

nikkel(II)selenit

233-263-7

10101-96-9

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i *** H372 **

H334

H317

H410

028-049-00-3

nikkelselenid

215-216-2

1314-05-2

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i *** H372 **

H317

H410

028-050-00-9

kiselsyre, blynikkelsalt

—

68130-19-8

Carc. 1A

Repr. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H360Df H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H360Df H372 **

H317

H410

028-051-00-4

nikkeldiarsenid; [1]

nikkelarsenid [2]

235-103-1 [1]

248-169-1 [2]

12068-61-0 [1]

27016-75-7 [2]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i *** H372 **

H317

H410

028-052-00-X

nikkelbariumtitanprimulagul priderit;

C.I. Pigment Yellow 157; C.I. 77900

271-853-6

68610-24-2

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372 **

H317

GHS08

GHS07

Dgr

H350i *** H372 **

H317

028-053-00-5

nikkeldichlorat; [1]

nikkeldibromat; [2]

ethylhydrogensulfat, nikkel(II)salt [3]

267-897-0 [1]

238-596-1 [2]

275-897-7 [3]

67952-43-6 [1]

14550-87-9 [2]

71720-48-4 [3]

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < %

Skin Sens. 1; H317:C ≥ 0,01  % 1

M = 1

028-054-00-0

nikkel(II)trifluoracetat; [1]

nikkel(II)propionat; [2]

nikkelbis(benzensulfonat); [3]

nikkel(II)hydrogencitrat; [4]

citronsyre, ammoniumnikkelsalt; [5]

citronsyre, nikkelsalt; [6]

nikkelbis(2-ethylhexanoat); [7]

2-ethylhexansyre, nikkelsalt; [8]

dimethylhexansyre, nikkelsalt; [9]

nikkel(II)isooctanoat; [10]

nikkelisooctanoat; [11]

nikkelbis(isononanoat); [12]

nikkel(II)neononanoat; [13]

nikkel(II)isodecanoat; [14]

nikkel(II)neodecanoat; [15]

neodecansyre, nikkelsalt;[16]

nikkel(II)neoundecanoat; [17]

bis(D-gluconato-O1,O2)nikkel; [18]

nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoat (1:2); [19]

nikkel(II)palmitat; [20]

(2-ethylhexanoato-O)(isononanoato-O)nikkel; [21]

(isononanoato-O)(isooctanoato-O)nikkel; [22]

(isooctanoato-O)(neodecanoato-O)nikkel; [23]

(2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24]

(2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25]

(isodecanoato-O)(isooctanoato-O)nikkel; [26]

(isodecanoato-O)(isononanoato-O)nikkel; [27]

(isononanoato-O)(neodecanoato-O)nikkel; [28]

fedtsyrer, C6-19-forgrenede, nikkelsalte; [29]

fedtsyrer, C8-18 og C18-umættede, nikkelsalte; [30]

2,7-naphthalendisulfonsyre, nikkel(II)salt; [31]

240-235-8 [1]

222-102-6 [2]

254-642-3 [3]

242-533-3 [4]

242-161-1 [5]

245-119-0 [6]

224-699-9 [7]

231-480-1 [8]

301-323-2 [9]

249-555-2 [10]

248-585-3 [11]

284-349-6 [12]

300-094-6 [13]

287-468-1 [14]

287-469-7 [15]

257-447-1 [16]

300-093-0 [17]

276-205-6 [18]

258-051-1 [19]

294-302-1 [29]

283-972-0 [30]

- [31]

237-138-8 [20]

287-470-2 [21]

287-471-8 [22]

284-347-5 [23]

284-351-7 [24]

285-698-7 [25]

285-909-2 [26]

284-348-0 [27]

287-592-6 [28]

16083-14-0 [1]

3349-08-4 [2]

39819-65-3 [3]

18721-51-2 [4]

18283-82-4 [5]

22605-92-1 [6]

4454-16-4 [7]

7580-31-6 [8]

93983-68-7 [9]

29317-63-3 [10]

27637-46-3 [11]

84852-37-9 [12]

93920-10-6 [13]

85508-43-6 [14]

85508-44-7 [15]

51818-56-5 [16]

93920-09-3 [17]

71957-07-8 [18]

52625-25-9 [19]

13654-40-5 [20]

85508-45-8 [21]

85508-46-9 [22]

84852-35-7 [23]

84852-39-1 [24]

85135-77-9

[25]

85166-19-4 [26]

84852-36-8 [27]

85551-28-6 [28]

91697-41-5 [29]

84776-45-4 [30]

72319-19-8 [31]

Carc. 1A Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D *** H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D *** H372 **

H334

H317

H410

STOT RE 1;

H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 %

Skin Sens. 1; H317: C ≥

0,01  % M = 1

028-055-00-6

nikkel(II)sulfit; [1]

nikkeltellurtrioxid; [2]

nikkeltellurtetraoxid; [3]

molybdennikkelhydroxidoxidphosphat [4]

231-827-7 [1]

239-967-0 [2]

239-974-9 [3]

268-585-7 [4]

7757-95-1 [1]

15851-52-2 [2]

15852-21-8 [3]

68130-36-9 [4]

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i H372 **

H334

H317

H410

028-056-00-1

nikkelborid (NiB); [1]

dinikkelborid; [2]

trinikkelborid; [3]

nikkelborid; [4]

dinikkelsilicid; [5]

nikkeldisilicid; [6]

dinikkelphosphid; [7]

nikkelborphosphid [8]

234-493-0 [1]

234-494-6 [2]

234-495-1 [3]

235-723-2 [4]

235-033-1 [5]

235-379-3 [6]

234-828-0 [7]

- [8]

12007-00-0 [1]

12007-01-1 [2]

12007-02-2 [3]

12619-90-8 [4]

12059-14-2 [5]

12201-89-7 [6]

12035-64-2 [7]

65229-23-4 [8]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372 **

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i H372 **

H317

H410

028-057-00-7

dialuminiumnikkeltetraoxid; [1]

nikkeltitantrioxid;[2]

nikkeltitanoxid; [3]

nikkeldivanadiumhexaoxid; [4]

cobaltdimolybdennikkeloctaoxid; [5]

nikkelzirkoniumtrioxid; [6]

molybdennikkeltetraoxid; [7]

nikkelwolframtetraoxid; [8]

olivin, nikkelgrøn; [9]

lithiumnikkeldioxid; [10]

molybdennikkeloxid; [11]

234-454-8 [1]

234-825-4 [2]

235-752-0 [3]

257-970-5 [4]

268-169-5 [5]

274-755-1 [6]

238-034-5 [7]

238-032-4 [8]

271-112-7 [9]

- [10]

- [11]

12004-35-2 [1]

12035-39-1 [2]

12653-76-8 [3]

52502-12-2 [4]

68016-03-5 [5]

70692-93-2 [6]

14177-55-0 [7]

14177-51-6 [8]

68515-84-4 [9]

12031-65-1 [10]

12673-58-4 [11]

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372 **

H317

GHS08

GHS07

Dgr

H350i H372 **

H317

028-058-00-2

cobaltlithiumnikkeloxid

442-750-5

—

Carc. 1A

Acute Tox. 2 *

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H330

H372 **

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H350i

H330

H372 **

H317

H410

029-001-00-4

kobberchlorid; kobber(I)chlorid

231-842-9

7758-89-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H400

H410

029-003-00-5

naphthensyrer, kobbersalte;

kobber napthenat

215-657-0

1338-02-9

Flam. Liq. 3

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H226

H302

H400

H410

GHS02

GHS07

GHS09

Wng

H226

H302

H410

029-004-00-0

kobbersulfat

231-847-6

7758-98-7

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H315

H410

029-005-00-6

(tris(chlormethyl)phthalocyaninato)kobber(II), reaktionsprodukter med N-methylpiperazin og methoxyeddikesyre

401-260-1

—

Eye Irrit. 2

H319

GHS07

Wng

H319

029-006-00-1

tris(octadec-9-enylammonium)-(trisulfonatophthalocyaninato)kobber(II)

403-210-4

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

029-007-00-7

(trinatrium-(2-((3-(6-(2-chlor-5-sulfonato)anilino-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)kobber(3-))hydroxid

404-670-9

89797-01-3

Skin Sens. 1

H317

GHS07

Wng

H317

G

029-008-00-2

kobber(II)methansulfonat

405-400-2

54253-62-2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

029-009-00-8

phthalocyanin-N-[3-(diethylamino)propyl]sulfonamid kobberkomplex

413-650-9

93971-95-0

Aquatic Chronic 3

H412

—

H412

029-010-00-3

blanding af forbindelser fra (dodecakis(p-tolylthio)phthalocyaninato)kobber(II) til (hexadecakis(p-tolylthio)phthalocyaninato)kobber(II)

407-700-9

101408-30-4

Skin Sens. 1

H317

GHS07

Wng

H317

029-011-00-9

natrium-[29H,31H-phtalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonat, kobberkomplex

412-730-0

150522-10-4

Skin Corr. 1B

H314

GHS05

Dgr

H314

029-012-00-4

natrium-((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)kobber(II)

407-340-2

124719-24-0

Eye Dam. 1

H318

GHS05

Dgr

H318

029-013-00-X

trinatrium-(2-(α-(3-(4-chlor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenhydrazino)-4-sulfonatobenzoato)kobber(II)

407-580-8

130201-51-3

Eye Dam. 1

H318

GHS05

Dgr

H318

029-014-00-5

en blanding af 2,2'-[[cis-1,2-cyclohexandiylbis(nitrilomethyliden)]bis[phenolat]](2-)-N, N',O, O'-kobberkompleks og 2,2'-[[trans-1,2-cyclohexandiylbis(nitrilomethylidyn)]bis[phenolat]](2-)-N, N',O, O'-kobberkompleks

419-610-7

171866-24-3

STOT RE 2 *

Aquatic Chronic 2

H373 **

H411

GHS08

GHS09

Wng

H373 **

H411

030-001-00-1

zinkpulver — zinkstøv (ustabiliseret)

231-175-3

7440-66-6

Water-react. 1

Pyr. Sol. 1

Aquatic Acute 1

Aquatic Chronic 1

H260

H250

H400

H410

GHS02

GHS09

Dgr

H260

H250

H410

T

030-001-01-9

zinkpulver — zinkstøv (stabiliseret)

231-175-3

7440-66-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

030-003-00-2

zinkchlorid

231-592-0

7646-85-7

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H410

STOT SE 3; H335: C ≥ 5 %

030-004-00-8

dimethylzink; [1]

diethylzink [2]

208-884-1 [1]

209-161-3 [2]

544-97-8 [1]

557-20-0 [2]

Pyr. Liq. 1

Water-react. 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H250

H260

H314

H400

H410

GHS02

GHS05

GHS09

Dgr

H250

H260

H314

H410

EUH014

030-005-00-3

diamindiisocyanoatozink

401-610-3

—

Acute Tox. 4 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

H302

H318

H334

H317

H400

GHS05

GHS08

GHS07

GHS09

Dgr

H302

H318

H334

H317

H400

030-006-00-9

zinksulfat (vandholdig) (mono-, hexa- og heptahydrat); [1]

zinksulfat (vandfri) [2]

231-793-3 [1]

231-793-3 [2]

7446-19-7 [1]

7733-02-0 [2]

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

030-007-00-4

bis(3,5-di-tert-butylsalicylato-O1,O2)zink

403-360-0

42405-40-3

Flam. Sol. 1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H228

H302

H400

H410

GHS02

GHS07

GHS09

Dgr

H228

H302

H410

T

030-008-00-X

hydroxo(2-(benzensulfonamido)benzoato)zink(II)

403-750-0

113036-91-2

Acute Tox. 4 *

Aquatic Chronic 2

H332

H411

GHS07

GHS09

Wng

H332

H411

030-009-00-5

zink-bis(4-(n-octyloxycarbonylamino)salicylat) dihydrat

417-130-2

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

030-010-00-0

2-dodec-1-enylbutandisyre, 4-methylester, zinksalt

430-740-3

—

Aquatic Chronic 2

H411

GHS09

H411

030-011-00-6

trizinkbis(orthophosphat)

231-944-3

7779-90-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

030-012-00-1

aluminium-magnesium-zink-carbonat-hydroxid

423-570-6

169314-88-9

Aquatic Chronic 4

H413

H413

030-013-00-7

zinkoxid

215-222-5

1314-13-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

030-015-00-8

tetrazink(2+)-bis(hexacyanocobalt(3+))diacetat

440-060-9

—

Aquatic Chronic 2

H411

GHS09

H411

033-001-00-X

arsen

231-148-6

7440-38-2

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

033-002-00-5

arsenforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

*

A1

033-003-00-0

diarsentrioxid;

arsentrioxid

215-481-4

1327-53-3

Carc. 1A

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H300

H314

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H350

H300

H314

H410

033-004-00-6

diarsenpentaoxid;

arsenpentaoxid;

arsenoxid

215-116-9

1303-28-2

Carc. 1A

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H331

H301

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H331

H301

H410

033-005-00-1

arsensyre og dets salte undtagen sådanne nævnt andetsteds i dette bilag

—

—

Carc. 1A

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H331

H301

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H331

H301

H410

A

033-006-00-7

arsin

232-066-3

7784-42-1

Flam. Gas 1

Press. Gas

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H220

H330

H373 **

H400

H410

GHS02

GHS04

GHS06

GHS08

GHS09

Dgr

H220

H330

H373 ** H410

U

033-007-00-2

tert-butylarsin

423-320-6

4262-43-5

Pyr. Liq. 1

Acute Tox. 2 *

H250

H330

GHS02

GHS06

Dgr

H250

H330

034-001-00-2

selen

231-957-4

7782-49-2

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 4

H331

H301

H373 **

H413

GHS06

GHS08

Dgr

H331

H301

H373 ** H413

034-002-00-8

selenforbindelser med undtagelse af cadmiumsulfoselenid undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H301

H373 **

H410

A

034-003-00-3

natriumselenit

233-267-9

10102-18-8

Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Chronic 2

H300

H331

H317

H411

GHS06

GHS09

Dgr

H300

H331

H317

H411

EUH031

035-001-00-5

brom

231-778-1

7726-95-6

Acute Tox. 2 *

Skin Corr. 1A

Aquatic Acute 1

H330

H314

H400

GHS06

GHS05

GHS09

Dgr

H330

H314

H400

035-002-00-0

hydrogenbromid

233-113-0

10035-10-6

Press. Gas

Skin Corr. 1A

STOT SE 3

H314

H335

GHS04

GHS05

GHS07

Dgr

H314

H335

U

035-002-01-8

hydrogenbromid ... %

—

—

Skin Corr. 1B

STOT SE 3

H314

H335

GHS05

GHS07

Dgr

H314

H335

Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 %

Eye Irrit. 2; H319: 10 % ≤ C < 40 %

STOT RE 3; H335: C ≥ 10 %

B

035-003-00-6

kaliumbromat

231-829-8

7758-01-2

Ox. Sol. 1

Carc. 1B

Acute Tox. 3 *

H271

H350

H301

GHS03

GHS06

GHS08

Dgr

H271

H350

H301

035-004-00-1

2-hydroxyethylammoniumperbromid

407-440-6

—

Ox. Sol. 2 ****

Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

H272

H302

H314

H317

H400

GHS03

GHS05

GHS07

GHS09

Dgr

H272

H302

H314

H317

H400

040-001-00-3

zirconiumpulver (ustabiliseret)

231-176-9

7440-67-7

Water-react. 1

Pyr. Sol. 1

H260

H250

GHS02

Dgr

H260

H250

T

040-002-00-9

zirkoniumpulver, tør (stabiliseret)

—

—

Self-heat. 1

H251

GHS02

Dgr

H251

T

040-003-00-4

reaktionsprodukt af 3,5-di-tert-butylsalicylsyre og zirconiumoxychlorid, dehydreret, basisk Zr: DTBS = 1,0:1,0 til 1,0: 1,5

430-610-6

226996-19-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

042-001-00-9

molybdentrioxid

215-204-7

1313-27-5

Carc. 2

Eye Irrit. 2

STOT SE 3

H351

H319

H335

GHS08

GHS07

Wng

H351

H319

H335

042-002-00-4

tetrakis(dimethylditetradecylammonium)hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdat(4-)

404-760-8

117342-25-3

Acute Tox. 3 *

Eye Dam. 1

H331

H318

GHS06

GHS05

Dgr

H331

H318

042-003-00-X

tetrakis(trimethylhexadecylammonium)hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdat(4-)

404-860-1

116810-46-9

Flam. Sol. 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H228

H318

H400

H410

GHS02

GHS05

GHS09

Dgr

H228

H318

H410

T

042-004-00-5

reaktionsprodukt af ammoniummolybdat og C12-C24-diethoxyleret alkylamin (1:5-1:3)

412-780-3

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H315

H317

H411

GHS07

GHS09

Wng

H315

H317

H411

042-005-00-0

blanding af mono- og di-glyceroler af rapsolie;

rapsoliefedtsyreamid af forgrenet 1,3-propandiamin, N-[3-(tridecyloxy)-propyl];

N, N-diorgano-dithiocarbamat molybdenkompleks

434-240-6

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

046-001-00-X

tetramminpalladium (II) hydrogencarbonat

425-270-0

134620-00-1

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H302

H373 ** H318

H317

H410

047-001-00-2

sølvnitrat

231-853-9

7761-88-8

Ox. Sol. 2

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H272

H314

H400

H410

GHS03

GHS05

GHS09

Dgr

H272

H314

H410

047-002-00-8

polyphosphorsyre, kobber-, natrium-, magnesium-, calcium-, sølv- og zinksalt

416-850-4

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

048-001-00-5

cadmiumforbindelser, med undtagelse af cadmiumsulfoselenid (xCdS.yCdSe) og blandinger af cadmiumsulfid med zinksulfid (xCdS.yZnS), blandinger af cadmiumsulfid med kviksølvsulfid (xCdS.yHgS) samt sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

*

A1

048-002-00-0

cadmium (stabiliseret); [1]

cadmiumoxid (stabiliseret) [2]

231-152-8 [1]

215-146-2 [2]

7440-43-9 [1]

1306-19-0 [2]

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H341

H361fd

H330

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H341

H361fd

H330

H372 ** H410

048-003-00-6

cadmiumdiformat;

cadmiumformat

224-729-0

4464-23-7

Acute Tox. 3 *

Acute Tox. 3 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H351

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H301

H351

H373 ** H410

*

STOT RE 2; H373: C ≥ 0,25  %

048-004-00-1

cadmiumcyanid

208-829-1

542-83-6

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H351

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H351

H373 ** H410

EUH032

STOT RE 2; H373: C ≥ 0,1  %

EUH032:C ≥ 1 %

048-005-00-7

cadmiumhexafluorsilicat(2-);

cadmiumfluorsilicat

241-084-0

17010-21-8

Acute Tox. 3 *

Acute Tox. 3 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H351

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H301

H351

H373 ** H410

*

STOT RE 2; H373: C ≥ 0,1  %

048-006-00-2

cadmiumfluorid

232-222-0

7790-79-6

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H360FD

H330

H301

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H340

H360FD H330

H301

H372 ** H410

Carc. 1B; H350: C ≥ 0,01  %

- oral

STOT RE 1; H372: C ≥ 7 % STOT RE 2;

0,1  % ≤ C < 7 %

048-007-00-8

cadmiumiodid

232-223-6

7790-80-9

Acute Tox. 3 *

Acute Tox. 3 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H351

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H301

H351

H373 ** H410

*

STOT RE 2; H373: C ≥ 0,1  %

048-008-00-3

cadmiumchlorid

233-296-7

10108-64-2

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H360FD

H330

H301

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H340

H360FD H330

H301

H372 ** H410

Carc. 1B; H350: C ≥ 0,01  %

- oral

STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1  % ≤ C < 7 %

048-009-00-9

cadmiumsulfat

233-331-6

10124-36-4

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H360FD

H330

H301

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H340

H360FD H330

H301

H372 ** H410

Carc. 1B; H350: C ≥ 0,01  %

- oral

STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373:0,1  % ≤ C < 7 %

048-010-00-4

cadmiumsulfid

215-147-8

1306-23-6

Carc. 1B

Muta. 2

Repr. 2

STOT RE 1

Acute Tox. 4 *

Aquatic Chronic 4

H350

H341

H361fd

H372 **

H302

H413

GHS08

GHS07

Dgr

H350

H341

H361fd

H372 ** H302

H413

*

STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1  % ≤ C < 10 %

1

048-011-00-X

cadmium (ustabiliseret)

231-152-8

7440-43-9

Pyr. Sol. 1

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H250

H350

H341

H361fd

H330

H372 **

H400

H410

GHS02

GHS06

GHS08

GHS09

Dgr

H250

H350

H341

H361fd

H330

H372 ** H410

050-001-00-5

tintetrachlorid;

tinchlorid

231-588-9

7646-78-8

Skin Corr. 1B

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

STOT SE 3; H335:C ≥ 5 %

050-002-00-0

cyhexatin (ISO);

hydroxytricyclohexylstannan;

tri(cyclohexyl)tinhydroxid

236-049-1

13121-70-5

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

M = 1 000

050-003-00-6

fentinacetat (ISO);

triphenyltinacetat

212-984-0

900-95-8

Carc. 2

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H361d *** H330

H311

H301

H372 **

H335

H315

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H351

H361d *** H330

H311

H301

H372 **

H335

H315

H318

H410

M = 10

050-004-00-1

fentinhydroxid (ISO);

triphenyltinhydroxid

200-990-6

76-87-9

Carc. 2

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H361d *** H330

H311

H301

H372 **

H335

H315

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H351

H361d *** H330

H311

H301

H372 **

H335

H315

H318

H410

M = 10

050-005-00-7

trimethyltin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

*

A1

050-006-00-2

triethyltin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

*

A1

050-007-00-8

tripropyltin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

*

A1

050-009-00-9

fluortripentylstannan; [1]

hexapentyldistannoxan [2]

243-546-7 [1]

247-143-7 [2]

20153-49-5 [1]

25637-27-8 [2]

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

*

1

050-010-00-4

fluortrihexylstannan

243-547-2

20153-50-8

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

*

1

050-011-00-X

triphenyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

- M = 100

A1

050-012-00-5

tetracyclohexylstannan; [1]

chlortricyclohexylstannan; [2]

butyltricyclohexylstannan [3]

215-910-5 [1]

221-437-5 [2]

230-358-5 [3]

1449-55-4 [1]

3091-32-5 [2]

7067-44-9 [3]

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

*

A1

050-013-00-0

trioctylin-forbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 4

H319

H335

H315

H413

GHS07

Wng

H319

H335

H315

H413

Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %

A1

050-017-00-2

fenbutatin-oxid (ISO);

bis(tris(2-methyl-2-phenylpropyl)tin)-oxid

236-407-7

13356-08-6

Acute Tox. 2 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H330

H319

H315

H400

H410

GHS06

GHS09

Dgr

H330

H319

H315

H410

050-018-00-8

tin(II)methansulfonat

401-640-7

53408-94-9

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H314

H302

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H302

H317

H411

050-019-00-3

azocyclotin (ISO);

1-(tricyclohexylstannyl)-1H-1,2,4-triazol

255-209-1

41083-11-8

Acute Tox. 2 *

Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H301

H335

H315

H318

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H301

H335

H315

H318

H410

050-020-00-9

trioctylstannan

413-320-4

869-59-0

STOT RE 1

Skin Irrit. 2

Aquatic Chronic 4

H372 **

H315

H413

GHS08

GHS07

Dgr

H372 ** H315

H413

050-021-00-4

dichlordioctylstannan

222-583-2

3542-36-7

Acute Tox. 3 *

STOT RE 1

Aquatic Chronic 3

H331

H372 **

H412

GHS06

GHS08

Dgr

H331

H372 **

H412

050-022-00-X

dibutyltindichlorid;

(DBTC)

211-670-0

683-18-1

Muta. 2

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H341

H360FD

H330

H301

H312

H372 **

H314

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H341

H360FD H330

H301

H312

H372 **

H314

H410

Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01  % ≤ C < 5 %

Eye Dam.1; H318: 3 % ≤ C

< 5 %

Eye Irrit. 2; H319: 0,01  % ≤ C < 3 %

M = 10

050-023-00-5

blanding af: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannan;

bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxid; bis(1-phenyl-1,3-decandionyl)dioctylstannan;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decandionyl)dioctylstannan

422-920-5

—

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H400

H410

GHS08

GHS09

Wng

H373 **

H410

M = 10

050-024-00-0

blanding af: tri-p-tolyltinhydroxid;

hexa-p-tolyl-distannoxan

432-230-6

—

STOT RE 1

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H372 **

H302

H315

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H372 **

H302

H315

H318

H317

H410

050-025-00-6

trichlormethylstannan

213-608-8

993-16-8

Repr. 2

H361d

GHS08

Wng

H361d

050-026-00-1

2-ethylhexyl-10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]-thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat

260-828-5

57583-34-3

Repr. 2

H361d

GHS08

Wng

H361d

050-027-00-7

2-ethylhexyl-10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat

239-622-4

15571-58-1

Repr. 1B

H360D

GHS08

Dgr

H360D

050-028-00-2

2-ethylhexyl-10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoat

260-829-0

57583-35-4

Repr. 2

Acute Tox. 4

STOT RE 1

Skin Sens. 1A

H361d

H302

H372

(nervesystem, immunsystem)

H317

GHS08

GHS07

Dgr

H361d

H302

H372 (nervesystem, immunsystem)

H317

050-029-00-8

dimethyltindichlorid

212-039-2

753-73-1

Repr. 2

Acute Tox. 2

Acute Tox. 3

Acute Tox. 3

STOT RE 1

Skin Corr. 1B

H361d

H330

H301

H311

H372

(nervesystem, immunsystem)

H314

GHS08

GHS06

GHS05

Dgr

H361d

H330

H301

H311

H372 (nervesystem, immunsystem)

H314

EUH071

051-001-00-8

antimontrichlorid

233-047-2

10025-91-9

Skin Corr. 1B

Aquatic Chronic 2

H314

H411

GHS05

GHS09

Dgr

H314

H411

STOT SE 3; H335: C ≥ 5 %

051-002-00-3

antimonpentachlorid

231-601-8

7647-18-9

Skin Corr. 1B

Aquatic Chronic 2

H314

H411

GHS05

GHS09

Dgr

H314

H411

STOT SE 3; H335: C ≥ 5 %

051-003-00-9

antimonforbindelser, med undtagelse af antimontetraoxid (Sb2O4), antimonpentoxid (Sb2O5), antimontrisulfid (Sb2S3), antimonpentasulfid (Sb2S5) samt sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H332

H302

H411

GHS07

GHS09

Wng

H332

H302

H411

*

A1

051-004-00-4

antimontrifluorid

232-009-2

7783-56-4

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H331

H311

H301

H411

GHS06

GHS09

Dgr

H331

H311

H301

H411

051-005-00-X

antimontrioxid

215-175-0

1309-64-4

Carc. 2

H351

GHS08

Wng

H351

051-006-00-5

diphenyl(4-phenylthiophenyl)sulfoniumhexafluorantimonat

403-500-0

—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

051-007-00-0

bis(4-dodecylphenyl)iodonium hexafluorantimonat

404-420-9

71786-70-4

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

053-001-00-3

iod

231-442-4

7553-56-2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

H332

H312

H400

GHS07

GHS09

Wng

H332

H312

H400

053-002-00-9

hydrogeniodid

233-109-9

10034-85-2

Press. Gas

Skin Corr. 1A

H314

GHS04

GHS05

Dgr

H314

Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2  % ≤ C < 10 %

Skin Irrit. 2; H315: 0,02  % ≤ C < 0,2  %

Eye Irrit. 2; H319: 0,02  % ≤ C < 0,2  %

STOT RE 3; H335: C ≥ 0,02  %

U5

053-002-01-6

hydrogeniodidsyre ... %

—

—

Skin Corr. 1B

H314

GHS05

Dgr

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %

B

053-003-00-4

iodoxybenzen

—

696-33-3

Expl. ****

****

****

****

053-004-00-X

calciumiodoxybenzoat

—

—

Expl. ****

****

****

****

C

053-005-00-5

(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorphenyl)borat(1-)

422-960-3

178233-72-2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Wng

H312

H302

H373 ** H410

056-001-00-1

bariumperoxid

215-128-4

1304-29-6

Ox. Sol. 2

Acute Tox. 4 *

Acute Tox. 4 *

H272

H332

H302

GHS03

GHS07

Dgr

H272

H332

H302

056-002-00-7

bariumsalte, undtagen bariumsulfat, salte af 1-azo-2-hydroxynaphthalenylarylsulfonsyre, og salte nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

H332

H302

GHS07

Wng

H332

H302

*

A1

056-003-00-2

bariumcarbonat

208-167-3

513-77-9

Acute Tox. 4 *

H302

GHS07

Wng

H302

056-004-00-8

bariumchlorid

233-788-1

10361-37-2

Acute Tox. 3 *

Acute Tox. 4 *

H301

H332

GHS06

Dgr

H301

H332

064-001-00-8

gadolinium(III)sulfittrihydrat

456-900-2

51285-81-5

Aquatic Chronic 2

H411

GHS09

H411

072-001-00-4

hafnium-tetra-n-butoxid

411-740-2

22411-22-9

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

074-001-00-X

hexanatrium-dihydrogen-dodecawolframat

412-770-9

12141-67-2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

074-002-00-5

reaktionsprodukter af wolframhexachlorid med 2-methylpropan-2-ol, nonylphenol og pentan-2,4-dion

408-250-6

—

Flam. Liq. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H225

H332

H314

H317

H400

H410

GHS02

GHS05

GHS07

GHS09

Dgr

H225

H332

H314

H317

H410

076-001-00-5

osmiumtetraoxid;

osmiumsyre

244-058-7

20816-12-0

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1B

H330

H310

H300

H314

GHS06

GHS05

Dgr

H330

H310

H300

H314

078-001-00-0

tetrachlorplatinater, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H318

H334

H317

A

078-002-00-6

diammoniumtetrachlorplatinat

237-499-1

13820-41-2

Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H315

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H315

H318

H334

H317

078-003-00-1

dinatriumtetrachlorplatinat

233-051-4

10026-00-3

Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H315

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H315

H318

H334

H317

078-004-00-7

dikaliumtetrachlorplatinat

233-050-9

10025-99-7

Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H315

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H315

H318

H334

H317

078-005-00-2

hexachlorplatinater, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H318

H334

H317

A

078-006-00-8

dinatriumhexachlorplatinat

240-983-5

16923-58-3

Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H318

H334

H317

078-007-00-3

dikaliumhexachlorplatinat

240-979-3

16921-30-5

Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H318

H334

H317

078-008-00-9

diammoniumhexachlorplatinat

240-973-0

16919-58-7

Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H301

H318

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H318

H334

H317

078-009-00-4

hexachloroplatinsyre

241-010-7

16941-12-1

Acute Tox. 3 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

H301

H314

H334

H317

GHS06

GHS05

GHS08

Dgr

H301

H314

H334

H317

078-010-00-X

tetramminplatin(II)hydrogencarbonat

426-730-3

123439-82-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

078-011-00-5

hydroxydisulfitoplatin(II)syre

423-310-1

61420-92-6

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H373

H314

H334

H317

H412

GHS05

GHS08

GHS07

Dgr

H302

H373

H314

H334

H317

H412

078-012-00-0

platin(IV)nitrat/salpetersyreopløsning

432-400-1

—

Skin Corr. 1A

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

080-001-00-0

kviksølv

231-106-7

7439-97-6

Repr. 1B

Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H360D *** H330

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H360D *** H330

H372 **

H410

080-002-00-6

uorganiske kviksølvforbindelser, undtagen kviksølv (II) sulfid (cinnober) samt sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 ** H410

*

STOT RE 2; H373: C ≥ 0,1  %

A1

080-003-00-1

dikviksølvdichlorid

233-307-5

10112-91-1

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H335

H315

H410

080-004-00-7

organiske kviksølvforbindelser undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 ** H410

*

STOT RE 2; H373: C ≥ 0,1  %

A1

080-005-00-2

kviksølvdifulminat;

kviksølvfulminat;

fulminat af kviksølv

211-057-8

628-86-4

Unst. Expl.

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H200

H331

H311

H301

H373 **

H400

H410

GHS01

GHS06

GHS08

GHS09

Dgr

H200

H331

H311

H301

H373 ** H400

H410

080-005-01-X

kviksølvdifulmat;

kviksølvfulmat;

fulmat af kviksølv [≥ 20 % flegmatiseringsmiddel]

211-057-8

628-86-4

Expl. 1,1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H201

H331

H311

H301

H373 **

H400

H410

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H331

H311

H301

H373 ** H400

H410

080-006-00-8

dikviksølvdicyanidoxid;

kviksølvoxycyanid

215-629-8

1335-31-5

Expl. 1,1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H201

H331

H311

H301

H373 **

H400

H410

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H331

H311

H301

H373 **

H410

080-007-00-3

dimethylkviksølv; [1]

diethylkviksølv [2]

209-805-3 [1]

211-000-7 [2]

593-74-8 [1]

627-44-1 [2]

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 ** H410

*

STOT RE 2; H373: C ≥ 0,05  %

1

080-008-00-9

phenylkviksølvnitrat; [1]

phenylkviksølvhydroxid; [2]

blanding af (1) og (2) [3]

200-242-9 [1]

202-866-7 [2]

-[3]

55-68-5 [1]

100-57-2 [2]

8003-05-2 [3]

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H301

H372 **

H314

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H301

H372 ** H314

H410

080-009-00-4

2-methoxyethylkviksølvchlorid

204-659-7

123-88-6

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H301

H372 **

H314

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H301

H372 ** H314

H410

080-010-00-X

kviksølvdichlorid; kviksølvchlorid

231-299-8

7487-94-7

Muta. 2

Repr. 2

Acute Tox. 2 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H341

H361f *** H300

H372 **

H314

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H341

H361f *** H300

H372 **

H314

H410

080-011-00-5

phenylkviksølvacetat

200-532-5

62-38-4

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H301

H372 **

H314

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H301

H372 ** H314

H410

081-001-00-3

thallium

231-138-1

7440-28-0

Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 4

H330

H300

H373 **

H413

GHS06

GHS08

Dgr

H330

H300

H373 ** H413

081-002-00-9

thalliumforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2

H330

H300

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H330

H300

H373 ** H411

A

081-003-00-4

dithalliumsulfat;

thallium(I)sulfat

231-201-3

7446-18-6

Acute Tox. 2 *

STOT RE 1

Skin Irrit. 2

Aquatic Chronic 2

H300

H372 **

H315

H411

GHS06

GHS08

GHS09

Dgr

H300

H372 ** H315

H411

082-001-00-6

blyforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H332

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Dgr

H360Df

H332

H302

H373 ** H410

Repr.2 H361f C ≥ 2,5  %

*

STOT RE 2; H373: C ≥ 0,5  %

A1

082-002-00-1

blyalkyler

—

—

Repr. 1A

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H330

H310

H300

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H360Df

H330

H310

H300

H373 ** H410

Repr.1A; H360D: C ≥ 0,1  %

*

STOT RE 2; H373: C ≥ 0,05  %

A1

082-003-00-7

blydiazid;

blyazid

236-542-1

13424-46-9

Unst. Expl. Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H200

H360Df

H332

H302

H373 **

H400

H410

GHS01

GHS08

GHS07

GHS09

Dgr

H200

H360Df

H332

H302

H373 ** H410

1

082-003-01-4

blydiazid;

blyazid [≥ 20 % flegmatiseringsmiddel]

236-542-1

13424-46-9

Expl. 1,1

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H201

H360Df

H332

H302

H373 **

H400

H410

GHS01

GHS08

GHS07

GHS09

Dgr

H201

H360Df

H332

H302

H373 ** H410

1

082-004-00-2

blychromat

231-846-0

7758-97-6

Carc. 1B

Repr. 1A

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H350

H360Df H373 **

H400

H410

GHS08

GHS09

Dgr

H350

H360Df H373 **

H410

1

082-005-00-8

blydi(acetat)

206-104-4

301-04-2

Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H373 **

H400

H410

GHS08

GHS09

Dgr

H360Df

H373 ** H410

1

082-006-00-3

triblybis(orthophosphat)

231-205-5

7446-27-7

Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H373 **

H400

H410

GHS08

GHS09

Dgr

H360Df

H373 ** H410

1

082-007-00-9

blyacetat, basisk

215-630-3

1335-32-6

Carc. 2

Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H360Df

H373 **

H400

H410

GHS08

GHS09

Dgr

H351

H360Df

H373 ** H410

1

082-008-00-4

bly(II)methansulfonat

401-750-5

17570-76-2

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

H360Df

H332

H302

H373 **

H315

H318

GHS08

GHS05

GHS07

Dgr

H360Df

H332

H302

H373 ** H315

H318

1

082-009-00-X

blysulfochromatgul; C.I. Pigment Yellow 34;

[Denne forbindelse identificeres i Colour Index ved Colour Indeks Constitution Number C.I. 77603.]

215-693-7

1344-37-2

Carc. 1B

Repr. 1A

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H350

H360Df H373 **

H400

H410

GHS08

GHS09

Dgr

H350

H360Df H373 **

H410

1

082-010-00-5

blychromatmolybdatsulfatrød (C.I. Pigment Red 104;

[Denne forbindelse identificeres i Colour Index ved Colour Indeks Constitution-nummer, C.I. 77605.]

235-759-9

12656-85-8

Carc. 1B

Repr. 1A

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H350

H360Df H373 **

H400

H410

GHS08

GHS09

Dgr

H350

H360Df H373 **

H410

1

082-011-00-0

blyhydrogenarsenat

232-064-2

7784-40-9

Carc. 1A

Repr. 1A

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H360Df

H331

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H360Df

H331

H301

H373 ** H410

1

082-012-00-6

barium-bly-calcium-caesium-samarium-strontium-bromid-chlorid-fluorid-iodid, europium-doteret

431-780-4

199876-46-5

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H302

H373 **

H411

GHS08

GHS07

GHS09

Wng

H302

H373 **

H411

092-001-00-8

uran

231-170-6

7440-61-1

Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 4

H330

H300

H373 **

H413

GHS06

GHS08

Dgr

H330

H300

H373 ** H413

092-002-00-3

uranforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2

Aquatic Chronic 2

H330

H300

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H330

H300

H373 **

H411

A

601-001-00-4

methan

200-812-7

74-82-8

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

601-002-00-X

ethan

200-814-8

74-84-0

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

601-003-00-5

propan

200-827-9

74-98-6

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

601-004-00-0

butan; [1]

og isobutan [2]

203-448-7 [1]

200-857-2 [2]

106-97-8 [1]

75-28-5 [2]

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

C U

601-004-01-8

butan (indhold ≥ 0.1 % butadin (203-450-8)); [1]

isobutan (indhold ≥ 0.1 % butadin (203-450-8)) [2]

203-448-7 [1]

200-857-2 [2]

106-97-8 [1]

75-28-5 [2]

Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B

H220

H350

H340

GHS02

GHS04

GHS08

Dgr

H220

H350

H340

C S U

601-005-00-6

2,2-dimethylpropan;

neopentan

207-343-7

463-82-1

Flam. Gas 1

Press. Gas

Aquatic Chronic 2

H220

H411

GHS02

GHS04

GHS09

Dgr

H220

H411

U

601-006-00-1

pentan

203-692-4

109-66-0

Flam. Liq. 2

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2

H225

H304

H336

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H304

H336

H411

EUH066

C

601-007-00-7

hexan (indeholdende < 5 % n-hexan (203-777-6)); 2-methylpentan; [1]

3-methylpentan; [2]

2,2-dimethylbutan; [3]

2,3-dimethylbutan [4]

203-523-4 [1]

202-481-4 [2]

200-906-8 [3]

201-193-6 [4]

107-83-5 [1]

96-14-0 [2]

75-83-2 [3]

79-29-8 [4]

Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2

H225

H304

H315

H336

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H304

H315

H336

H411

C

601-008-00-2

heptan; n-heptan; [1]

2,4-dimethylpentan; [2]

2,2,3-trimethylbutan; [3]

3,3-dimethylpentan; [4]

2,3-dimethylpentan; [5]

3-methylhexan; [6]

2,2-dimethylpentan; [7]

2-methylhexan; [8]

3-ethylpentan; [9]

isoheptan; [10]

205-563-8 [1]

203-548-0 [2]

207-346-3 [3]

209-230-8 [4]

209-280-0 [5]

209-643-3 [6]

209-680-5 [7]

209-730-6 [8]

210-529-0 [9]

250-610-8 [10]

142-82-5 [1]

108-08-7 [2]

464-06-2 [3]

562-49-2 [4]

565-59-3 [5]

589-34-4 [6]

590-35-2 [7]

591-76-4 [8]

617-78-7 [9]

31394-54-4 [10]

Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H225

H304

H315

H336

H400

H410

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H304

H315

H336

H410

C

601-009-00-8

octan; n-octan; [1]

2,2,4-trimethylpentan; [2]

2,3,3-trimethylpentan; [3]

3,3-dimethylhexan; [4]

2,2,3-trimethylpentan; [5]

2,3,4-trimethylpentan; [6]

3,4-dimethylhexan; [7]

2,3-dimethylhexan; [8]

2,4-dimethylhexan; [9]

4-methylheptan; [10]

3-methylheptan; [11]

2,2-dimethylhexan; [12]

2,5-dimethylhexan; [13]

2-methylheptan; [14]

2,2,3,3-tetramethylbutan; [15]

3-ethyl-2-methylpentan; [16]

3-ethylhexan; [17]

3-ethyl-3-methylpentan; [18]

isooctan; [19]

203-892-1 [1]

208-759-1 [2]

209-207-2 [3]

209-243-9 [4]

209-266-4 [5]

209-292-6 [6]

209-504-7 [7]

209-547-1 [8]

209-649-6 [9]

209-650-1 [10]

209-660-6 [11]

209-689-4 [12]

209-745-8 [13]

209-747-9 [14]

209-855-6 [15]

210-187-2 [16]

210-621-0 [17]

213-923-0 [18]

247-861-0 [19]

111-65-9 [1]

540-84-1 [2]

560-21-4 [3]

563-16-6 [4]

564-02-3 [5]

565-75-3 [6]

583-48-2 [7]

584-94-1 [8]

589-43-5 [9]

589-53-7 [10]

589-81-1 [11]

590-73-8 [12]

592-13-2 [13]

592-27-8 [14]

594-82-1 [15]

609-26-7 [16]

619-99-8 [17]

1067-08-9 [18]

26635-64-3 [19]

Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H225

H304

H315

H336

H400

H410

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H304

H315

H336

H410

C

601-010-00-3

ethylen

200-815-3

74-85-1

Flam. Gas 1

Press. Gas

STOT SE 3

H220

H336

GHS02

GHS04

GHS07

Dgr

H220

H336

U

601-011-00-9

propen; propylen

204-062-1

115-07-1

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

601-012-00-4

but-1-en; [1]

buten, blanding af-1-og-2-isomerer; [2]

2-methylpropen; [3]

(Z)-but-2-en; [4]

(E)-but-2-en [5]

203-449-2 [1]

203-452-9 [2]

204-066-3 [3]

209-673-7 [4]

210-855-3 [5]

106-98-9 [1]

107-01-7 [2]

115-11-7 [3]

590-18-1 [4]

624-64-6 [5]

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

C U

601-013-00-X

1,3-butadien;

buta-1,3-dien

203-450-8

106-99-0

Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B

H220

H350

H340

GHS02

GHS04

GHS08

Dgr

H220

H350

H340

D U

601-014-00-5

isopren (stabiliseret) 2-methyl-1,3-butadien

201-143-3

78-79-5

Flam. Liq. 1

Carc. 1B Muta. 2

Aquatic Chronic 3

H224

H350

H341

H412

GHS02

GHS08

Dgr

H224

H350

H341

H412

D

601-016-00-6

cyclopropan

200-847-8

75-19-4

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

601-017-00-1

cyclohexan

203-806-2

110-82-7

Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H225

H304

H315

H336

H400

H410

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H304

H315

H336

H410

601-018-00-7

methylcyclohexan

203-624-3

108-87-2

Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2

H225

H304

H315

H336

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H304

H315

H336

H411

601-019-00-2

1,4-dimethylcyclohexan

209-663-2

589-90-2

Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2

H225

H304

H315

H336

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H304

H315

H336

H411

601-020-00-8

benzen

200-753-7

71-43-2

Flam. Liq. 2

Carc. 1a

Muta. 1B

STOT RE 1

Asp. Tox. 1

Eye Irrit. 2

Skin Irrit. 2

H225

H350

H340

H372 **

H304

H319

H315

GHS02

GHS08

GHS07

Dgr

H225

H350

H340

H372 ** H304

H319

H315

E

601-021-00-3

toluen

203-625-9

108-88-3

Flam. Liq. 2

Repr. 2

Asp. Tox. 1

STOT RE 2 *

Skin Irrit. 2

STOT SE 3

H225

H361d *** H304

H373 **

H315

H336

GHS02

GHS08

GHS07

Dgr

H225

H361d *** H304

H373 ** H315

H336

601-022-00-9

o-xylen; [1]

p-xylen; [2]

m-xylen; [3]

xylen [4]

202-422-2 [1]

203-396-5 [2]

203-576-3 [3]

215-535-7 [4]

95-47-6 [1]

106-42-3 [2]

108-38-3 [3]

1330-20-7 [4]

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

H226

H332

H312

H315

GHS02

GHS07

Wng

H226

H332

H312

H315

*

C

601-023-00-4

ethylbenzen

202-849-4

100-41-4

Flam. Liq. 2

Acute Tox. 4 *

STOT RE 2

Asp. Tox. 1

H225

H332

H373

(høreorganer)

H304

GHS02

GHS07

GHS08

Dgr

H225

H332

H373

(høreorganer)

H304

601-024-00-X

cumen; [1]

propylbenzen [2]

202-704-5 [1]

203-132-9 [2]

98-82-8 [1]

103-65-1 [2]

Flam. Liq. 3

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2

H226

H304

H335

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H304

H335

H411

C

601-025-00-5

mesitylen;

1,3,5-trimethylbenzen

203-604-4

108-67-8

Flam. Liq. 3

STOT SE 3

Aquatic Chronic 2

H226

H335

H411

GHS02

GHS07

GHS09

Wng

H226

H335

H411

STOT SE 3; H335: C ≥ 25 %

601-026-00-0

styren

202-851-5

100-42-5

Flam. Liq. 3

Repr. 2

Acute Tox. 4 *

STOT RE 1

Skin Irrit. 2

Eye Irrit. 2

H226

H361d

H332

H372

(høreorganer)

H315

H319

GHS02

GHS08

GHS07

Dgr

H226

H361d

H332

H372

(høreorganer)

H315

H319

*

D

601-027-00-6

2-phenylpropen;

α-methylstyren

202-705-0

98-83-9

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Aquatic Chronic 2

H226

H319

H335

H411

GHS02

GHS07

GHS09

Wng

H226

H319

H335

H411

STOT SE 3; H335: C ≥ 25 %

601-028-00-1

2-methylstyren;

2-vinyltoluen

210-256-7

611-15-4

Acute Tox. 4 *

Aquatic Chronic 2

H332

H411

GHS07

GHS09

Wng

H332

H411

601-029-00-7

dipenten; limonen; [1]

(R)-p-mentha-1,8-dien; d-limonen: [2]

(S)-p-mentha-1,8-dien; l-limonen; [3]

trans-1-methyl-4-(1-methylvinyl)cyclohexen; [4]

(±)-1-methyl-4-(1-methylvinyl)cyclohexen [5]

205-341-0 [1]

227-813-5 [2]

227-815-6 [3]

229-977-3 [4]

231-732-0 [5]

138-86-3 [1]

5989-27-5 [2]

5989-54-8 [3]

6876-12-6 [4]

7705-14-8 [5]

Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H315

H317

H400

H410

GHS02

GHS07

GHS09

Wng

H226

H315

H317

H410

C

601-030-00-2

cyclopentan

206-016-6

287-92-3

Flam. Liq. 2

Aquatic Chronic 3

H225

H412

GHS02

Dgr

H225

H412

601-031-00-8

2,4,4-trimethylpent-1-en

203-486-4

107-39-1

Flam. Liq. 2

Aquatic Chronic 2

H225

H411

GHS02

GHS09

Dgr

H225

H411

601-032-00-3

benzo[a]pyren;

benzo[def]chrysen

200-028-5

50-32-8

Carc. 1B

Muta. 1B

Repr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H340

H360FD

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H340

H360FD H317

H410

Carc. 1B; H350: C ≥ 0,01  %

601-033-00-9

benzo[a]anthracen

200-280-6

56-55-3

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

M = 100

601-034-00-4

benzo[e]acephenanthryleno

205-911-9

205-99-2

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

601-035-00-X

benzo[j]fluoranthen

205-910-3

205-82-3

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

601-036-00-5

benzo[k]fluoranthen

205-916-6

207-08-9

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

601-037-00-0

n-hexan

203-777-6

110-54-3

Flam. Liq. 2

Repr. 2

Asp. Tox. 1

STOT RE 2 *

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2

H225

H361f *** H304

H373 **

H315

H336

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H361f *** H304

H373 ** H315

H336

H411

STOT RE 2; H373: C ≥ 5 %

601-041-00-2

dibenzo[a, h]anthracen

200-181-8

53-70-3

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

Carc. 1B; H350: C ≥ 0,01  % M = 100

601-042-00-8

biphenyl;

diphenyl

202-163-5

92-52-4

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H319

H335

H315

H410

601-043-00-3

1,2,4-trimethylbenzen

202-436-9

95-63-6

Flam. Liq. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2

H226

H332

H319

H335

H315

H411

GHS02

GHS07

GHS09

Wng

H226

H332

H319

H335

H315

H411

601-044-00-9

3a,4,7,7a-tetrahydro-4,7-methanoinden

201-052-9

77-73-6

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2

H225

H332

H302

H319

H335

H315

H411

GHS02

GHS07

GHS09

Dgr

H225

H332

H302

H319

H335

H315

H411

601-045-00-4

1,2,3,4-tetrahydronaphtalen

204-340-2

119-64-2

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H319

H315

H411

GHS07

GHS09

Wng

H319

H315

H411

EUH019

601-046-00-X

7-methylocta-1,6-dien

404-210-7

42152-47-6

Flam. Liq. 3

Aquatic Acute 1

Aquatic Chronic 1

H226

H400

H410

GHS02

GHS09

Wng

H226

H410

601-047-00-5

m-mentha-1,3(8)-dien

404-150-1

17092-80-7

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

601-048-00-0

chrysen

205-923-4

218-01-9

Carc. 1B Muta. 2

Aquatic Acute 1

Aquatic Chronic 1

H350

H341

H400

H410

GHS08

GHS09

Dgr

H350

H341

H410

601-049-00-6

benzo[e]pyren

205-892-7

192-97-2

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

601-051-00-7

4-phenylbut-1-en

405-980-7

768-56-9

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

601-052-00-2

naphthalen

202-049-5

91-20-3

Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H400

H410

GHS07

GHS08

GHS09

Wng

H351

H302

H410

601-053-00-8

nonylphenol; [1]

4-nonylphenol, forgrenet [2]

246-672-0 [1]

284-325-5 [2]

25154-52-3 [1]

84852-15-3 [2]

Repr. 2

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H302

H314

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H361fd

H302

H314

H410

601-054-00-3

blanding af isomerer af: dibenzylbenzen; dibenzyl(methyl)benzen; dibenzyl(dimethyl)benzen; dibenzyl(trimethyl)benzen

405-570-8

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

601-055-00-9

blanding af isomerer af: mono-(2-tetradecyl)naphthalener og di-(2-tetradecyl)naphthalener og tri-(2-tetradecyl)naphthalener

410-190-0

132983-41-6

Eye Irrit. 2

Aquatic Chronic 4

H319

H413

GHS07

Wng

H319

H413

601-056-00-4

blanding af isomerer af: methyldiphenylmethan og dimethyldiphenylmethan

405-470-4

73807-39-3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

601-057-00-X

N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammoniumtosylat

421-130-8

156679-41-3

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H318

H317

H410

601-058-00-5

di-L-para-menthen

417-870-6

83648-84-4

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

601-059-00-0

methyl 2-benzyliden-3-oxobutyrat

420-940-9

15768-07-7

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H319

H315

H411

GHS07

GHS09

Wng

H319

H315

H411

601-060-00-6

1,2-bis[4-fluor-6-{4-sulfo-5-(2-(4-sulfonaphthalen-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalen-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethan;

x-natrium, y-kaliumsalte x = 7,755 y = 0,245

417-610-1

155522-09-1

Skin Sens. 1

H317

GHS07

Wng

H317

601-061-00-1

(ethyl-1,2-ethandiyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethandiyl)

418-960-8

—

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H317

H411

601-062-00-7

blanding af: forgrenet triacontan og forgrenet dotriacontan og forgrenet tetratriacontan og forgrenet hexatriacontan

417-030-9

151006-59-6

Aquatic Chronic 4

H413

—

H413

601-063-00-2

blanding af isomerer af forgrenet tetracosan

417-060-2

151006-61-0

Acute Tox. 4 *

Aquatic Chronic 4

H332

H413

GHS07

Wng

H332

H413

601-064-00-8

forgrenet hexatriacontan

417-070-7

151006-62-1

Aquatic Chronic 4

H413

—

H413

601-065-00-3

en blanding af: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxan-5,2'-norcaran) og (1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxan-5,2'-norcaran)

416-930-9

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

601-066-00-9

1-(4-(trans-4-heptylcyclohexyl)phenyl)ethan

426-820-2

78531-60-9

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

601-067-00-4

triethylarsenat

427-700-2

15606-95-8

Carc. 1A

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H331

H301

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H331

H301

H410

601-068-00-X

1,2-diacetoxybut-3-en

421-720-5

18085-02-4

Acute Tox. 4 *

H302

GHS07

Wng

H302

601-069-00-5

2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridiniumbromid

422-680-1

287933-44-2

Aquatic Chronic 3

H412

—

H412

601-070-00-0

en blanding af: forgrenet icosan og forgrenet docosan og forgrenet tetracosan

417-050-8

151006-58-5

Acute Tox. 4 *

Aquatic Chronic 4

H332

H413

GHS07

Wng

H332

H413

601-071-00-6

1-dimethoxymethyl-2-nitro-benzen

423-830-9

20627-73-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

601-072-00-1

en blanding af: 1-(4-isopropylphenyl)-1-phenylethan og 1-(3-isopropylphenyl)-1-phenylethan og 1-(2-isopropylphenyl)-1-phenylethan

430-690-2

52783-21-8

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

601-073-00-7

1-brom-3,5-difluorbenzen

416-710-2

461-96-1

Flam. Liq. 3

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H302

H373 ** H315

H317

H400

H410

GHS02

GHS08

GHS07

GHS09

Wng

H226

H302

H373 ** H315

H317

H410

601-074-00-2

en blanding af: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octan og 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octan og spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan] og spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]

422-040-1

—

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H319

H315

H411

GHS07

GHS09

Wng

H319

H315

H411

601-075-00-8

4,4'-bis(N-carbamoyl-4-methylbenzensulfonamid)diphenylmethan

418-770-5

151882-81-4

Carc. 2

H351

GHS08

Wng

H351

601-076-00-3

ethynylcyclopropan

425-430-1

6746-94-7

Flam. Liq. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H225

H315

H318

H412

GHS02

GHS05

Dgr

H225

H315

H318

H412

601-077-00-9

en blanding af: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octan og 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octan

426-510-7

196965-91-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

601-078-00-4

en blanding af: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptan og 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptan

427-040-5

—

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

601-079-00-X

en blanding af: trans-trans-cyclohexadeca-1,9-dien og cis-trans-cyclohexadeca-1,9-dien

429-620-3

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

601-080-00-5

blanding af: sec-butylphenyl(phenyl)methan, blandede isomerer og 1-(sec-butylphenyl(phenyl)-2-phenylethan, blandede isomerer og 1-(sec-butylphenyl-1-phenylethan, blandede isomerer

431-100-6

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

601-081-00-0

cyclohexadeca-1,9-dien

431-730-1

4277-06-9

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

601-082-00-6

blanding af: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan og exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan

434-420-4

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

601-083-00-1

5-endo-hexyl-bicyclo[2.2.1]hept-2-en

435-000-3

22094-83-3

Asp. Tox. 1

Skin Irrit. 2

Aquatic Chronic 4

H304

H315

H413

GHS08

GHS07

Dgr

H304

H315

H413

601-084-00-7

blanding af: 5-endo-butyl-bicyclo[2.2.1]hept-2-en og 5-exo-butyl-bicyclo[2.2.1]hept-2-en (80:20)

435-180-3

—

Asp. Tox. 1

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H304

H315

H400

H410

GHS08

GHS07

GHS09

Dgr

H304

H315

H410

601-085-00-2

isopentan;

2-methylbutan

201-142-8

78-78-4

Flam. Liq. 1

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2

H224

H304

H336

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H224

H304

H336

H411

EUH066

601-087-00-3

2,4,4-trimethylpenten

246-690-9

25167-70-8

Flam. Liq. 2

Asp. Tox. 1

STOT SE 3

H225

H304

H336

GHS02

GHS07

GHS08

Dgr

H225

H304

H336

D

601-088-00-9

4-vinylcyclohexen

202-848-9

100-40-3

Carc. 2

H351

GHS08

Wng

H351

601-089-00-4

muscalure; cis-tricos-9-en

248-505-7

27519-02-4

Skin Sens. 1B

H317

GHS07

Wng

H317

602-001-00-7

chlormethan;

methylchlorid

200-817-4

74-87-3

Flam. Gas 1

Press. Gas

Carc. 2

STOT RE 2 *

H220

H351

H373 **

GHS02

GHS04

GHS08

Dgr

H220

H351

H373 **

U

602-002-00-2

brommethan;

methylbromid

200-813-2

74-83-9

Press. Gas

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Ozone 1

H341

H331

H301

H373 **

H319

H335

H315

H400

H420

GHS04

GHS06

GHS08

GHS09

Dgr

H341

H331

H301

H373 ** H319

H335

H315

H400

H420

U

602-003-00-8

dibrommethan

200-824-2

74-95-3

Acute Tox. 4 *

Aquatic Chronic 3

H332

H412

GHS07

Wng

H332

H412

*

602-004-00-3

dichlormethan;

methylenchlorid

200-838-9

75-09-2

Carc. 2

H351

GHS08

Wng

H351

602-005-00-9

methyliodid;

iodmethan

200-819-5

74-88-4

Carc. 2

Acute Tox. 4 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

H351

H312

H331

H301

H335

H315

GHS06

GHS08

Dgr

H351

H312

H331

H301

H335

H315

602-006-00-4

chloroform;

trichlormethan

200-663-8

67-66-3

Carc. 2

Repr. 2

Acute Tox. 3

Acute Tox. 4

STOT RE 1

Eye Irrit. 2

Skin Irrit. 2

H351

H361d

H331

H302

H372

H319

H315

GHS06

GHS08

Dgr

H351

H361d

H331

H302

H372

H319

H315

602-007-00-X

bromoform;

tribrommethan

200-854-6

75-25-2

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H331

H302

H319

H315

H411

GHS06

GHS09

Dgr

H331

H302

H319

H315

H411

602-008-00-5

carbontetrachlorid;

tetrachlormethan

200-262-8

56-23-5

Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Aquatic

Chronic 3

Ozone 1

H351

H331

H311

H301

H372 **

H412

H420

GHS06

GHS08

Dgr

H351

H331

H311

H301

H372 ** H412

H420

*

STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,2  % ≤ C

< 1 %

602-009-00-0

chlorethan

200-830-5

75-00-3

Flam. Gas 1

Press. Gas

Carc. 2

Aquatic Chronic 3

H220

H351

H412

GHS02

GHS04

GHS08

Dgr

H220

H351

H412

U

602-010-00-6

1,2-dibromethan

203-444-5

106-93-4

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2

H350

H331

H311

H301

H319

H335

H315

H411

GHS06

GHS08

GHS09

Dgr

H350

H331

H311

H301

H319

H335

H315

H411

*

602-011-00-1

1,1-dichlorethan

200-863-5

75-34-3

Flam. Liq. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Chronic 3

H225

H302

H319

H335

H412

GHS02

GHS07

Dgr

H225

H302

H319

H335

H412

*

602-012-00-7

1,2-dichlorethan;

ethylendichlorid

203-458-1

107-06-2

Flam. Liq. 2

Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H225

H350

H302

H319

H335

H315

GHS02

GHS08

GHS07

Dgr

H225

H350

H302

H319

H335

H315

602-013-00-2

1,1,1-trichlorethan;

methylchloroform

200-756-3

71-55-6

Acute Tox. 4 *

Ozone 1

H332

H420

GHS07

Wng

H332

H420

F

602-014-00-8

1,1,2-trichlorethan

201-166-9

79-00-5

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H351

H332

H312

H302

GHS08

GHS07

Wng

H351

H332

H312

H302

EUH066

*

602-015-00-3

1,1,2,2-tetrachlorethan

201-197-8

79-34-5

Acute Tox. 2 *

Acute Tox. 1

Aquatic Chronic 2

H330

H310

H411

GHS06

GHS09

Dgr

H330

H310

H411

602-016-00-9

1,1,2,2-tetrabromethan

201-191-5

79-27-6

Acute Tox. 2 *

Eye Irrit. 2

Aquatic Chronic 3

H330

H319

H412

GHS06

Dgr

H330

H319

H412

602-017-00-4

pentachlorethan

200-925-1

76-01-7

Carc. 2

STOT RE 1

Aquatic Chronic 2

H351

H372 **

H411

GHS08

GHS09

Dgr

H351

H372 ** H411

STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2  % ≤ C < 1 %

602-018-00-X

1-chlorpropan; [1]

2-chlorpropan [2]

208-749-7 [1]

200-858-8 [2]

540-54-5 [1]

75-29-6 [2]

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H225

H332

H312

H302

GHS02

GHS07

Dgr

H225

H332

H312

H302

C

602-019-00-5

1-brompropan:

n-propylbromid

203-445-0

106-94-5

Flam. Liq. 2

Repr. 1B

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

STOT SE 3

H225

H360FD

H373 **

H319

H335

H315

H336

GHS02

GHS08

GHS07

Dgr

H225

H360FD H373 **

H319

H335

H315

H336

602-021-00-6

1,2-dibrom-3-chlorpropan

202-479-3

96-12-8

Carc. 1B

Muta. 1B

Repr. 1A

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3

H350

H340

H360f *** H301

H373 **

H412

GHS06

GHS08

Dgr

H350

H340

H360f *** H301

H373 ** H412

602-022-00-1

1-chlorpentan; [1]

2-chlorpentan; [2]

3-chlorpentan [3]

208-846-4 [1]

210-885-7 [2]

210-467-4 [3]

543-59-9 [1]

625-29-6 [2]

616-20-6 [3]

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H225

H332

H312

H302

GHS02

GHS07

Dgr

H225

H332

H312

H302

C

602-023-00-7

vinylchlorid;

chlorethylen

200-831-0

75-01-4

Press. Gas

Flam. Gas 1

Carc. 1A

H220

H350

GHS02

GHS08

Dgr

H220

H350

D U

602-024-00-2

bromethylen

209-800-6

593-60-2

Press. Gas

Flam. Gas 1

Carc. 1B

H220

H350

GHS02

GHS08

Dgr

H220

H350

U

602-025-00-8

1,1-dichlorethylen;

vinylidenchlorid

200-864-0

75-35-4

Flam. Liq. 1

Carc. 2

Acute Tox. 4 *

H224

H351

H332

GHS02

GHS08

GHS07

Dgr

H224

H351

H332

*

D

602-026-00-3

1,2-dichlorethylen; [1]

cis-dichlorethylen; [2]

trans-dichlorethylen [3]

208-750-2 [1]

205-859-7 [2]

205-860-2 [3]

540-59-0 [1]

156-59-2 [2]

156-60-5 [3]

Flam. Liq. 2

Acute Tox. 4 *

Aquatic Chronic 3

H225

H332

H412

GHS02

GHS07

Dgr

H225

H332

H412

*

C

602-027-00-9

trichlorethylen;

trichlorethen

201-167-4

79-01-6

Carc. 1B

Muta. 2

Eye Irrit. 2

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 3

H350

H341

H319

H315

H336

H412

GHS08

GHS07

Dgr

H350

H341

H319

H315

H336

H412

602-028-00-4

tetrachlorethylen

204-825-9

127-18-4

Carc. 2

Aquatic Chronic 2

H351

H411

GHS08

GHS09

Wng

H351

H411

602-029-00-X

3-chlorpropen;

allylchlorid

203-457-6

107-05-1

Flam. Liq. 2

Carc. 2

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H225

H351

H341

H332

H312

H302

H373 ** H319

H335

H315

H400

GHS02

GHS08

GHS07

GHS09

Dgr

H225

H351

H341

H332

H312

H302

H373 ** H319

H335

H315

H400

D

602-030-00-5

1,3-dichlorpropen; [1]

(Z)-1,3-dichlorpropen [2]

208-826-5 [1]

233-195-8 [2]

542-75-6 [1]

10061-01-5 [2]

Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Asp. Tox. 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H311

H301

H332

H304

H319

H335

H315

H317

H400

H410

GHS02

GHS06

GHS08

GHS09

Dgr

H226

H311

H301

H332

H304

H319

H335

H315

H317

H410

C D

602-031-00-0

1,1-dichlorpropen

209-253-3

563-58-6

Flam. Liq. 2

Acute Tox. 3 *

Aquatic Chronic 3

H225

H301

H412

GHS02

GHS06

Dgr

H225

H301

H412

602-032-00-6

3-chlor-2-methylpropen

209-251-2

563-47-3

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H225

H332

H302

H314

H317

H411

GHS02

GHS05

GHS07

GHS09

Dgr

H225

H332

H302

H314

H317

H411

602-034-00-7

1,2-dichlorbenzen;

ortho-dichlorbenzen

202-425-9

95-50-1

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H335

H315

H410

*

602-035-00-2

1,4-dichlorbenzen;

para-dichlorbenzen

203-400-5

106-46-7

Carc. 2

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H319

H400

H410

GHS08

GHS09

Wng

H351

H319

H410

602-036-00-8

chloropren (stabiliseret);

2-chlor-1,3-butadien (stabiliseret)

204-818-0

126-99-8

Flam. Liq. 2

Carc. 1B

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H225

H350

H332

H302

H373 **

H319

H335

H315

GHS02

GHS08

GHS07

Dgr

H225

H350

H332

H302

H373 ** H319

H335

H315

D

602-037-00-3

α-chlortoluen;

benzylchlorid

202-853-6

100-44-7

Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H350

H331

H302

H373 **

H335

H315

H318

GHS06

GHS08

GHS05

Dgr

H350

H331

H302

H373 ** H335

H315

H318

602-038-00-9

α, α,α-trichlortoluen;

trichlormethylbenzen

202-634-5

98-07-7

Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H350

H331

H302

H335

H315

H318

GHS06

GHS08

GHS05

Dgr

H350

H331

H302

H335

H315

H318

602-039-00-4

polychlorerede biphenyler;

PCB

215-648-1

1336-36-3

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H400

H410

GHS08

GHS09

Wng

H373 ** H410

STOT RE 2; H373: C ≥ 0.005 %

C

602-040-00-X

2-chlortoluen; [1]

3-chlortoluen; [2]

4-chlortoluen; [3]

chlortoluen [4]

202-424-3 [1]

203-580-5 [2]

203-397-0 [3]

246-698-2 [4]

95-49-8 [1]

108-41-8 [2]

106-43-4 [3]

25168-05-2 [4]

Acute Tox. 4 *

Aquatic Chronic 2

H332

H411

GHS07

GHS09

Wng

H332

H411

C

602-041-00-5

pentachlornaphthalen

215-320-8

1321-64-8

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H319

H315

H400

H410

GHS07

GHS09

Wng

H312

H302

H319

H315

H410

C

602-042-00-0

1,2,3,4,5,6-hexachlorcyclohexaner med undtagelse af sådanne angivet andetsteds i dette bilag

—

—

Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H301

H312

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H301

H312

H410

A C

602-043-00-6

lindan (ISO);

γ-HCH eller γ-BHC;

γ-1,2,3,4,5,6-hexachlorcyclohexan

200-401-2

58-89-9

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H301

H332

H312

H373 **

H362

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H332

H312

H373 ** H362

H410

M = 10

602-044-00-1

camphechlor (ISO);

toxaphen

232-283-3

8001-35-2

Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H301

H312

H335

H315

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H301

H312

H335

H315

H410

602-045-00-7

DDT (ikke anerkendt af ISO);

clofenotan (INN);

dicophan; 1,1,1-trichlor-2,2-bis(4-chlorphenyl)ethan;

dichlordiphenyltrichlorethan

200-024-3

50-29-3

Carc. 2

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H301

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H301

H372 ** H410

602-046-00-2

heptachlor (ISO);

1,4,5,6,7,8,8-heptachlor-3a,4,7,7a-tetrahydro-4,7-methanoinden

200-962-3

76-44-8

Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H311

H301

H373 ** H410

602-047-00-8

chlordan (ISO);

1,2,4,5,6,7,8,8-octachlor-3a,4,7,7a-tetrahydro-4,7-methanoindan

200-349-0

57-74-9

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H312

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H312

H302

H410

602-048-00-3

aldrin (ISO)

206-215-8

309-00-2

Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H311

H301

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H311

H301

H372 ** H410

602-049-00-9

dieldrin (ISO)

200-484-5

60-57-1

Carc. 2

Acute Tox. 1

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H310

H301

H372 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H310

H301

H372 ** H410

602-050-00-4

isodrin;

(1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachlor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalen

207-366-2

465-73-6

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

M = 100

602-051-00-X

endrin (ISO);

1,2,3,4,10,10-hexachlor-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalen

200-775-7

72-20-8

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H300

H311

H400

H410

GHS06

GHS09

Dgr

H300

H311

H410

602-052-00-5

endosulfan (ISO);

1,2,3,4,7,7-hexachlor-8,9,10-trinorborn-2-en-5,6-ylendimethylsulfit;

1,2,3,4,7,7-hexachlor-8,9,10-trinorborn-5-en-2,3-ylendimethylsulfit

204-079-4

115-29-7

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H312

H400

H410

GHS06

GHS09

Dgr

H330

H300

H312

H410

602-053-00-0

isobenzan (ISO);

1,3,4,5,6,7,8,8-octachlor- 1,3,3a,4,7,7a-hexahydro-4,7- methanoisobenzofuran

206-045-4

297-78-9

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

H310

H300

H400

GHS06

GHS09

Dgr

H310

H300

H400

602-054-00-6

3-iodpropen;

allyliodid

209-130-4

556-56-9

Flam. Liq. 2

Skin Corr. 1B

H225

H314

GHS02

GHS05

Dgr

H225

H314

602-055-00-1

bromethan;

200-825-8

74-96-4

Flam. Liq. 2

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

H225

H351

H332

H302

GHS02

GHS08

GHS07

Dgr

H225

H351

H332

H302

602-056-00-7

α, α,α-trifluortoluen;

trifluormethylbenzen

202-635-0

98-08-8

Flam. Liq. 2

Aquatic Chronic 2

H225

H411

GHS02

GHS09

Dgr

H225

H411

602-057-00-2

α-bromtoluen;

benzylbromid

202-847-3

100-39-0

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

602-058-00-8

α, α-dichlortoluen;

benzylidendichlorid;

benzalchlorid

202-709-2

98-87-3

Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H351

H331

H302

H335

H315

H318

GHS06

GHS08

GHS05

Dgr

H351

H331

H302

H335

H315

H318

602-059-00-3

1-chlorbutan;

butylchlorid

203-696-6

109-69-3

Flam. Liq. 2

H225

GHS02

Dgr

H225

602-060-00-9

brombenzen

203-623-8

108-86-1

Flam. Liq. 3

Skin Irrit. 2

Aquatic Chronic 2

H226

H315

H411

GHS02

GHS07

GHS09

Wng

H226

H315

H411

602-061-00-4

hexafluorpropen;

hexaflourpropylen

204-127-4

116-15-4

Press. Gas

Acute Tox. 4 *

STOT SE 3

H332

H335

GHS07

Wng

H332

H335

U

602-062-00-X

1,2,3-trichlorpropan

202-486-1

96-18-4

Carc. 1B

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H350

H360f *** H332

H312

H302

GHS08

GHS07

Dgr

H350

H360f *** H332

H312

H302

D

602-063-00-5

heptachlorepoxid;

2,3-epoxy-1,4,5,6,7,8,8-heptachlor-3a,4,7,7a-tetrahydro-4,7-methanoindan

213-831-0

1024-57-3

Carc. 2

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H301

H373 ** H410

602-064-00-0

1,3-dichlor-2-propanol

202-491-9

96-23-1

Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

H350

H301

H312

GHS06

GHS08

Dgr

H350

H301

H312

602-065-00-6

hexachlorbenzen

204-273-9

118-74-1

Carc. 1B

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H372 **

H400

H410

GHS08

GHS09

Dgr

H350

H372 ** H410

602-066-00-1

tetrachlor-p-benzoquinon

204-274-4

118-75-2

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

602-067-00-7

1,3-dichlorbenzen

208-792-1

541-73-1

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

602-068-00-2

ethylenbis(trichloracetat)

219-732-9

2514-53-6

Skin Irrit. 2

H315

GHS07

Wng

H315

602-069-00-8

dichloracetylen

—

7572-29-4

Unst. Expl. Carc. 2

STOT RE 2 *

H200

H351

H373 **

GHS01

GHS08

Wng

H200

H351

H373 **

602-070-00-3

3-chlor-4,5,α, α,α-pentafluortoluen

401-930-3

77227-99-7

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

H226

H332

H302

H400

GHS02

GHS07

GHS09

Wng

H226

H332

H302

H400

602-071-00-9

brombenzylbromtoluen, blanding af isomerer

402-210-1

99688-47-8

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 ** H317

H410

602-072-00-4

dichlor[(dichlorphenyl)methyl]methylbenzen, blanding af isomerer; (dichlorphenyl)(dichlortolyl)methan, blanding af isomerer (IUPAC)

278-404-3

76253-60-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

602-073-00-X

1,4-dichlorbut-2-en

212-121-8

764-41-0

Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H330

H311

H301

H314

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H350

H330

H311

H301

H314

H410

Carc. 1B; H350: C ≥ 0,01  % STOT SE 3; H335:C ≥ 5 %

602-074-00-5

pentachlorbenzen

210-172-0

608-93-5

Flam. Sol. 1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H228

H302

H400

H410

GHS02

GHS07

GHS09

Dgr

H228

H302

H410

T

602-075-00-0

4,4,5,5-tetrachlor-1,3-dioxolan-2-on

404-060-2

22432-68-4

Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B

H330

H302

H314

GHS06

GHS05

Dgr

H330

H302

H314

602-076-00-6

2,3,4-trichlorbut-1-en

219-397-9

2431-50-7

Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H331

H302

H319

H335

H315

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H331

H302

H319

H335

H315

H410

Carc. 2; H351: C

≥ 0,1  %

602-077-00-1

dodecachlorpentacyclo[5.2.1.02,6.03,9.05,8]decan;

mirex

219-196-6

2385-85-5

Carc. 2

Repr. 2

Lact.

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H361fd

H362

H312

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361fd

H362

H312

H302

H410

602-078-00-7

hexachlorcyclopentadien

201-029-3

77-47-4

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H330

H311

H302

H314

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H311

H302

H314

H410

602-079-00-2

2,3-dichlorpropen;

2,3-dichlorpropylen

201-153-8

78-88-6

Flam. Liq. 2

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H225

H341

H332

H312

H302

H335

H315

H318

H412

GHS02

GHS08

GHS05

GHS07

Dgr

H225

H341

H332

H312

H302

H335

H315

H318

H412

602-080-00-8

alkaner, C10-13-, chlor-; chlorerede paraffiner, C10-13

287-476-5

85535-84-8

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

EUH066

602-081-00-3

2-chlor-4,5-difluorbenzoesyre

405-380-5

—

Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H312

H302

H318

H317

GHS05

GHS07

Dgr

H312

H302

H318

H317

602-082-00-9

2,2,6,6-tetrakis(brommethyl)-4-oxaheptan-1,7-diol

408-020-5

109678-33-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

602-083-00-4

diphenylether, pentabromderivat;

pentabromdiphenylether

251-084-2

32534-81-9

STOT RE 2 *

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H362

H400

H410

GHS08

GHS09

Wng

H373 ** H362

H410

602-084-00-X

1,1-dichlor-1-fluorethan

404-080-1

1717-00-6

Aquatic

Chronic 3

Ozone 1

H412

H420

GHS07

Wng

H412

H420

602-085-00-5

2-brompropan

200-855-1

75-26-3

Flam. Liq. 2

Repr. 1a

STOT RE 2 *

H225

H360f *** H373 **

GHS02

GHS08

Dgr

H225

H360f *** H373 **

EUH066

602-086-00-0

trifluoriodmethan;

triflourmethyliodid

219-014-5

2314-97-8

Muta. 2

H341

GHS08

Wng

H341

602-087-00-6

1,2,4-trichlorbenzen

204-428-0

120-82-1

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H400

H410

GHS07

GHS09

Wng

H302

H315

H410

602-088-00-1

2,3-dibrompropan-1-ol;

2,3-dibrom-1-propanol

202-480-9

96-13-9

Carc. 1B Repr. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H350

H361f *** H311

H332

H302

H412

GHS08

GHS07

Dgr

H350

H361f *** H311

H332

H302

H412

602-089-00-7

4-brom-2-chlorfluorbenzen

405-580-2

60811-21-4

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H400

H410

GHS07

GHS09

Wng

H302

H315

H410

602-090-00-2

1-allyl-3-chlor-4-fluorbenzen

406-630-6

121626-73-1

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

602-091-00-8

1,3-dichlor-4-fluorbenzen

406-160-1

1435-48-9

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

H302

H373 **

H315

H411

GHS08

GHS07

Wng

H302

H373 ** H315

H411

602-092-00-3

1-brom-3,4,5-trifluorbenzen

418-480-9

138526-69-9

Flam. Liq. 3

Carc. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H226

H351

H315

H318

H411

GHS02

GHS08

GHS05

GHS09

Dgr

H226

H351

H315

H318

H411

602-093-00-9

α, α,α,4-tetrachlortoluen;

p-chlorbenzotrichlorid

226-009-1

5216-25-1

Carc. 1B Repr. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

H350

H361f *** H372 **

H312

H302

H335

H315

GHS08

GHS07

Dgr

H350

H361f *** H372 ** H312

H302

H335

H315

602-094-00-4

diphenylether, octabromderivat

251-087-9

32536-52-0

Repr. 1B

H360Df

GHS08

Dgr

H360Df

602-095-00-X

alkaner, C14-17-, chlor-;

chlorerede paraffiner, C14-17

287-477-0

85535-85-9

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H362

H400

H410

GHS09

Wng

H362

H410

EUH066

602-096-00-5

malachite green hydrochlorid; [1]

malachite green oxalat [2]

209-322-8 [1]

219-441-7 [2]

569-64-2 [1]

2437-29-8 [2]

Repr. 2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d *** H302

H318

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H361d *** H302

H318

H410

602-097-00-0

1-brom-9-(4,4,5,5,5-pentafluorpentylthio)nonan

422-850-5

148757-89-5

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

602-098-00-6

2-(3-bromphenoxy)tetrahydro-2H-pyran

429-030-6

57999-49-2

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

602-099-00-1

3-(4-fluorphenyl)-2-methylpropionylchlorid

426-370-7

—

Skin Corr. 1A

Acute Tox. 4 *

Aquatic Chronic 3

H314

H302

H412

GHS05

GHS07

Dgr

H314

H302

H412

EUH014

EUH029

602-100-00-5

en blanding af: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluorpentan;

(S,S)-1,1,1,2,2,3,4,5,5,5-decafluorpentan

420-640-8

—

Aquatic Chronic 3

H412

—

H412

602-101-00-0

2-chlor-4-fluor-5-nitrophenyl (isobutyl)carbonat

427-020-6

141772-37-4

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 **

H317

H410

602-102-00-6

1,1,1,3,3-pentafluorbutan

430-250-1

406-58-6

Flam. Liq. 2

H225

GHS02

Dgr

H225

602-103-00-1

1-(chlorphenylmethyl)-2-methylbenzen

431-450-1

41870-52-4

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

602-104-00-7

1,1,2,2,3,3,4-heptafluorcyclopentan

430-710-1

15290-77-4

Aquatic Chronic 3

H412

—

H412

602-105-00-2

natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butansulfinat

422-100-7

102061-82-5

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

602-106-00-8

2-brom-4,6-difluoranilin

429-430-0

444-14-4

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

602-107-00-3

3,3,4,4-tetrafluor-4-iod-1-buten

439-500-2

33831-83-3

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 2

H302

H315

H411

GHS07

GHS09

Wng

H302

H315

H411

602-108-00-9

(2,3,5,6-tetrafluorphenyl)methanol

443-840-7

4084-38-2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H302

H319

H317

GHS07

Wng

H302

H319

H317

602-109-00-4

hexabromcyclododecan [1]

1,2,5,6,9,10-hexabromcyclododecan [2]

247-148-4 [1]

221-695-9 [2]

25637-99-4 [1]

3194-55-6 [2]

Repr. 2

Lact.

H361

H362

GHS08

Wng

H361

H362

603-001-00-X

methanol

200-659-6

67-56-1

Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 1

H225

H331

H311

H301

H370**

GHS02

GHS06

GHS08

Dgr

H225

H331

H311

H301

H370**

*

STOT SE 1; H370: C ≥ 10 %

STOT SE 2; H371: 3 % ≤ C < 10 %

603-002-00-5

ethanol;

ethylalkohol

200-578-6

64-17-5

Flam. Liq. 2

H225

GHS02

Dgr

H225

603-003-00-0

propan-1-ol;

n-propanol

200-746-9

71-23-8

Flam. Liq. 2

Eye Dam. 1

STOT SE 3

H225

H318

H336

GHS02

GHS05

GHS07

Dgr

H225

H318

H336

603-004-00-6

butan-1-ol;

n-butanol

200-751-6

71-36-3

Flam. Liq. 3

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

STOT SE 3

H226

H302

H335

H315

H318

H336

GHS02

GHS05

GHS07

Dgr

H226

H302

H335

H315

H318

H336

603-005-00-1

2-methylpropan-2-ol;

tert-butylalkohol

200-889-7

75-65-0

Flam. Liq. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H225

H332

H319

H335

GHS02

GHS07

Dgr

H225

H332

H319

H335

603-006-00-7

pentanol-isomerer, undtagen sådanne nævnt andetsteds i dette bilag

250-378-8

Flam. Liq. 3

Acute Tox. 4 * STOT SE 3

H226

H332

H335

GHS02

GHS07

Wng

H226

H332

H335

EUH066

C

603-007-00-2

2-methyl-2-butanol;

tert-pentanolalkohol

200-908-9

75-85-4

Flam. Liq. 2

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

H225

H332

H335

H315

GHS02

GHS07

Dgr

H225

H332

H335

H315

603-008-00-8

4-methyl-2-pentanol;

methylamylalkohol

203-551-7

108-11-2

Flam. Liq. 3

STOT SE 3

H226

H335

GHS02

GHS07

Wng

H226

H335

STOT SE 3; H335: C ≥ 25 %

603-009-00-3

cyclohexanol

203-630-6

108-93-0

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

H332

H302

H335

H315

GHS07

Wng

H332

H302

H335

H315

603-010-00-9

2-methylcyclohexanol, blanding af isomerer; [1]

cis-2-methylcyclohexanol; [2]

trans-2-methylcyclohexanol [3]

209-512-0 [1]

231-187-9 [2]

231-186-3 [3]

583-59-5 [1]

7443-70-1 [2]

7443-52-9 [3]

Acute Tox. 4 *

H332

GHS07

Wng

H332

C

603-011-00-4

2-methoxyethanol;

methylglycol

203-713-7

109-86-4

Flam. Liq. 3

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H226

H360FD

H332

H312

H302

GHS02

GHS08

GHS07

Dgr

H226

H360FD H332

H312

H302

603-012-00-X

2-ethoxyethanol;

ethylglycol

203-804-1

110-80-5

Flam. Liq. 3

Repr. 1B

Acute Tox. 3

Acute Tox. 4

H226

H360FD

H331

H302

GHS02

GHS08

GHS06

Dgr

H226

H360FD H331

H302

603-013-00-5

2-isopropoxyethanol;

isopropylglycol

203-685-6

109-59-1

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

H332

H312

H319

GHS07

Wng

H332

H312

H319

603-014-00-0

2-butoxyethanol;

butylglycol

203-905-0

111-76-2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H332

H312

H302

H319

H315

GHS07

Wng

H332

H312

H302

H319

H315

603-015-00-6

allylalkohol

203-470-7

107-18-6

Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H225

H331

H311

H301

H319

H335

H315

H400

GHS02

GHS06

GHS09

Dgr

H225

H331

H311

H301

H319

H335

H315

H400

603-016-00-1

4-hydroxy-4-methyl-2-pentanon; diacetonalkohol

204-626-7

123-42-2

Eye Irrit. 2

H319

GHS07

Wng

H319

Eye Irrit. 2; H319: C ≥ 10 %

603-018-00-2

furfurylalkohol

202-626-1

98-00-0

Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

H351

H331

H312

H302

H373 **

H319

H335

GHS06

GHS08

Dgr

H351

H331

H312

H302

H373 **

H319

H335

603-019-00-8

dimethylether

204-065-8

115-10-6

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

603-020-00-3

methylethylether

—

540-67-0

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

U

603-021-00-9

methylvinylether

203-475-4

107-25-5

Flam. Gas 1

Press. Gas

H220

GHS02

GHS04

Dgr

H220

D U

603-022-00-4

diethylether;

ether

200-467-2

60-29-7

Flam. Liq. 1

Acute Tox. 4 *

STOT SE 3

H224

H302

H336

GHS02

GHS07

Dgr

H224

H302

H336

EUH019

EUH066

603-023-00-X

ethylenoxid;

oxiran

200-849-9

75-21-8

Press. Gas

Flam. Gas 1

Carc. 1B

Muta. 1B

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H220

H350

H340

H331

H319

H335

H315

GHS02

GHS04

GHS06

GHS08

Dgr

H220

H350

H340

H331

H319

H335

H315

U

603-024-00-5

1,4-dioxan

204-661-8

123-91-1

Flam. Liq. 2

Carc. 2

Eye Irrit. 2

STOT SE 3

H225

H351

H319

H335

GHS02

GHS08

GHS07

Dgr

H225

H351

H319

H335

EUH019

EUH066

D

603-025-00-0

tetrahydrofuran

203-726-8

109-99-9

Flam. Liq. 2

Carc. 2

Eye Irrit. 2

STOT SE 3

H225

H351

H319

H335

GHS02

GHS07

GHS08

Dgr

H225

H351

H319

H335

EUH019

STOT SE 3; H335: C ≥ 25 % Eye Irrit.2;

H319: C ≥ 25 %

603-026-00-6

1-chlor-2,3-epoxypropan; epichlorhydrin

203-439-8

106-89-8

Flam. Liq. 3

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

H226

H350

H331

H311

H301

H314

H317

GHS02

GHS06

GHS08

GHS05

Dgr

H226

H350

H331

H311

H301

H314

H317

*

603-027-00-1

ethandiol;

ethylenglycol

203-473-3

107-21-1

Acute Tox. 4 *

H302

GHS07

Wng

H302

603-028-00-7

2-chlorethanol;

ethylenchlorhydrin

203-459-7

107-07-3

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

H330

H310

H300

GHS06

Dgr

H330

H310

H300

603-029-00-2

bis(2-chlorethyl)ether

203-870-1

111-44-4

Carc. 2

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

H351

H330

H310

H300

GHS06

GHS08

Dgr

H351

H330

H310

H300

603-030-00-8

2-aminoethanol;

ethanolamin

205-483-3

141-43-5

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H332

H312

H302

H314

GHS05

GHS07

Dgr

H332

H312

H302

H314

STOT SE 3; H335: C ≥ 5 %

603-031-00-3

1,2-dimethoxyethan;

ethylenglycoldimethylether;

EDGME

203-794-9

110-71-4

Flam. Liq. 2

Repr. 1B

Acute Tox. 4 *

H225

H360FD

H332

GHS02

GHS08

GHS07

Dgr

H225

H360FD H332

EUH019

603-032-00-9

ethylendinitrat;

ethylenglycoldinitrat

211-063-0

628-96-6

Unst. Expl.

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2

H200

H330

H310

H300

H373 **

GHS01

GHS06

GHS08

Dgr

H200

H330

H310

H300

H373 **

603-033-00-4

oxydiethylendinitrat;

diethylenglycoldinitrat;

digoldinitrat

211-745-8

693-21-0

Unst. Expl

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 3

H200

H330

H310

H300

H373 **

H412

GHS01

GHS06

GHS08

Dgr

H200

H330

H310

H300

H373 **

H412

603-033-01-1

oxydiethylendinitrat;

diethylenglycoldinitrat;

digoldinitrat;

[>25 % flegmatiseringsmiddel]

211-745-8

693-21-0

Expl. 1,1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 3

H201

H330

H310

H300

H373 **

H412

GHS01

GHS06

GHS08

Dgr

H201

H330

H310

H300

H373 ** H412

603-034-00-X

glyceroltrinitrat; nitroglycerin

200-240-8

55-63-0

Unst. Expl.

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2

H200

H330

H310

H300

H373 ** H411

GHS01

GHS06

GHS08

GHS09

Dgr

H200

H330

H310

H300

H373 ** H411

603-034-01-7

glyceroltrinitrat; nitroglycerin; [>40 % flegmatiseringsmiddel]

200-240-8

55-63-0

Expl. 1,1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2

H201

H330

H310

H300

H373 ** H411

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H330

H310

H300

H373 ** H411

603-035-00-5

pentaerythritoltetranitrat; pentaerythrittetranitrat; PETN

201-084-3

78-11-5

Unst. Expl.

H200

GHS01

Dgr

H200

603-035-01-2

pentaerythritoltetranitrat; pentaerythrittetranitrat; PETN; [>20 % flegmatiseringsmiddel]

201-084-3

78-11-5

Expl. 1,1

H201

GHS01

Dgr

H201

T

603-036-00-0

mannitolhexanitrat; nitromannit

239-924-6

15825-70-4

Unst. Expl.

H200

GHS01

Dgr

H200

603-036-01-8

mannitolhexanitrat; nitromannit; [>40 % flegmatiseringsmiddel]

239-924-6

15825-70-4

Expl. 1,1

H201

GHS01

Dgr

H201

603-037-00-6

cellulosenitrat; nitrocellulose

—

—

Expl. 1,1

H201

GHS01

Dgr

H201

T

603-038-00-1

allylglycidylether; allyl 2,3-epoxypropylether; prop-2-en-1-yl 2,3-epoxypropylether

203-442-4

106-92-3

Flam. Liq. 3

Carc. 2

Muta. 2

Repr. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H226

H351

H341

H361f *** H332

H302

H335

H315

H318

H317

H412

GHS02

GHS08

GHS05

GHS07

Dgr

H226

H351

H341

H361f *** H332

H302

H335

H315

H318

H317

H412

603-039-00-7

1-butoxy-2,3-epoxypropan; butylglycidylether

219-376-4

2426-08-6

Flam. Liq. 3

Carc. 2

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Sens. 1

Aquatic Chronic 3

H226

H351

H341

H332

H302

H335

H317

H412

GHS02

GHS08

GHS07

Wng

H226

H351

H341

H332

H302

H335

H317

H412

603-040-00-2

natriummethanolat; natriummethoxid; [1] kaliummethanolat; kaliummethoxid; [2] lithiummethanolat; lithiummethoxid [3]

204-699-5 [1]

212-736-1 [2]

212-737-7 [3]

124-41-4 [1]

865-33-8 [2]

865-34-9 [3]

Self-heat 1

Skin Corr. 1B

H251

H314

GHS02

GHS05

Dgr

H251

H314

EUH014

T

603-041-00-8

kaliumethanolat; kaliumethoxid; [1] natriummethanolat; natriumethoxid [2]

213-029-0 [1]

205-487-5 [2]

917-58-8 [1]

141-52-6 [2]

Self-heat 1

Skin Corr. 1B

H251

H314

GHS02

GHS05

Dgr

H251

H314

EUH014

T

603-042-00-3

aluminiumtriisopropylat; aluminiumtriisopropoxid

209-090-8

555-31-7

Flam. Sol. 1

H228

GHS02

Dgr

H228

T

603-043-00-9

triarimol (ISO); 2,4-dichlorphenyl-α-phenyl-pyrimidin-5-yl-methanol

—

26766-27-8

Acute Tox. 4 *

H302

GHS07

Wng

H302

603-044-00-4

dicofol (ISO); 2,2,2-trichlor-1,1-bis(4-chlorphenyl)ethanol

204-082-0

115-32-2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H315

H317

H400

H410

GHS07

GHS09

Wng

H312

H302

H315

H317

H410

603-045-00-X

diisopropylether; [1] dipropylether [2]

203-560-6 [1]

203-869-6 [2]

108-20-3 [1]

111-43-3 [2]

Flam. Liq. 2

STOT SE 3

H225

H336

GHS02

GHS07

Dgr

H225

H336

EUH019

EUH066

C

603-046-00-5

bis(chlormethyl)ether; oxybis(chlormethan)

208-832-8

542-88-1

Flam. Liq. 2

Carc. 1A

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

H225

H350

H330

H311

H302

GHS02

GHS06

GHS08

Dgr

H225

H350

H330

H311

H302

Carc. 1A; H350: C ≥ 0,001  %

603-047-00-0

2-dimethylaminoethanol; N, N-dimethylethanolamin

203-542-8

108-01-0

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1B

H226

H332

H312

H302

H314

GHS02

GHS05

GHS07

Dgr

H226

H332

H312

H302

H314

STOT SE 3; H335: C ≥ 5 %

603-048-00-6

2-diethylaminoethanol; N, N-diethylethanolamin

202-845-2

100-37-8

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1B

H226

H332

H312

H302

H314

GHS02

GHS05

GHS07

GHS09

Dgr

H226

H332

H312

H302

H314

STOT SE 3; H335: C ≥ 5 %

603-049-00-1

chlorfenethol (ISO); 1,1-bis (4-chlorphenyl) ethanol

201-246-3

80-06-8

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

603-050-00-7

1-(2-butoxypropoxy)-2-propanol

246-011-6

24083-03-2

Acute Tox. 4 * Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

603-051-00-2

2-ethylbutanol

202-621-4

97-95-0

Acute Tox. 4 * Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

603-052-00-8

3-butoxy-2-propanol; propylenglycolmonobutylether

225-878-4

5131-66-8

Eye Irrit. 2

Skin Irrit. 2

H319

H315

GHS07

Wng

H319

H315

603-053-00-3

2-methyl-2,4-pentandiol

203-489-0

107-41-5

Eye Irrit. 2

Skin Irrit. 2

H319

H315

GHS07

Wng

H319

H315

603-054-00-9

di-n-butylether; dibutylether

205-575-3

142-96-1

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 3

H226

H319

H335

H315

H412

GHS02

GHS07

Wng

H226

H319

H335

H315

H412

STOT SE 3; H335: C ≥ 10 %

603-056-00-X

[(p-tolyloxy)methyl]oxiran; [1] [[(m-tolyloxy)methyl]oxiran; [2] 2,3-epoxypropyl-o-tolylether; [3][(tolyloxy)methyl]oxiran; cresylglycidylether [4]

218-574-8 [1]

218-575-3 [2]

218-645-3 [3]

247-711-4 [4]

2186-24-5 [1]

2186-25-6 [2]

2210-79-9 [3]

26447-14-3 [4]

Muta. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H341

H315

H317

H411

GHS08

GHS07

GHS09

Wng

H341

H315

H317

H411

C

603-057-00-5

benzylalkohol

202-859-9

100-51-6

Acute Tox. 4 * Acute Tox. 4 *

H332

H302

GHS07

Wng

H332

H302

603-058-00-0

oxetan

207-964-3

503-30-0

Flam. Liq. 2

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

H225

H332

H312

H302

GHS02

GHS07

Dgr

H225

H332

H312

H302

603-059-00-6

1-hexanol

203-852-3

111-27-3

Acute Tox. 4 *

H302

GHS07

Wng

H302

603-060-00-1

2,2'-bioxiran;1,2:3,4-diepoxybutan

215-979-1

1464-53-5

Carc. 1B Muta. 1B

Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

H350

H340

H330

H311

H301

H314

GHS06

GHS08

GHS05

Dgr

H350

H340

H330

H311

H301

H314

603-061-00-7

tetrahydro-2-furylmethanol; tetrahydrofurfurylalkohol

202-625-6

97-99-4

Repr. 1B Eye Irrit. 2

H360Df

H319

GHS08

GHS07

Dgr

H360Df

H319

603-062-00-2

2,5-bis(hydroxymethyl)oxolan

203-239-0

104-80-3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

STOT SE 3; H335: C ≥ 10 %

603-063-00-8

2,3-epoxypropan-1-ol; glycidol: oxiranmethanol

209-128-3

556-52-5

Carc. 1B Muta. 2

Repr. 1B

Acute Tox. 3 * Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H350

H341

H360f *** H331

H312

H302

H319

H335

H315

GHS06

GHS08

Dgr

H350

H341

H360f *** H331

H312

H302

H319

H335

H315

603-064-00-3

1-methoxy-2-propanol; monopropylenglycolmethylether

203-539-1

107-98-2

Flam. Liq. 3

STOT SE 3

H226

H336

GHS02

GHS07

Wng

H226

H336

603-065-00-9

resorcinoldiglycidylether; 1,3-bis(2,3-epoxypropoxy)benzen

202-987-5

101-90-6

Carc. 2

Muta. 2

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H351

H341

H312

H302

H319

H315

H317

H412

GHS08

GHS07

Wng

H351

H341

H312

H302

H319

H315

H317

H412

603-066-00-4

1,2-epoxy-4-epoxyethylcyclohexan; 4-vinylcyclohexendiepoxid

203-437-7

106-87-6

Carc. 2

Acute Tox. 3 * Acute Tox. 3 *

Acute Tox. 3 *

H351

H331

H311

H301

GHS06

GHS08

Dgr

H351

H331

H311

H301

*

603-067-00-X

phenylglycidylether; 2,3-epoxypropyl phenyl ether; 1,2-epoxy-3-phenoxypropan

204-557-2

122-60-1

Carc. 1B Muta. 2

Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H350

H341

H332

H335

H315

H317

H412

GHS08

GHS07

Dgr

H350

H341

H332

H335

H315

H317

H412

603-068-00-5

1-(2-ethylcyclohexanoxy)-2,3-epoxypropan; ethylcyclohexylglycidylether

—

130014-35-6

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

603-069-00-0

2,4,6-tris(dimethylamino-methyl)-phenol

202-013-9

90-72-2

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H302

H319

H315

GHS07

Wng

H302

H319

H315

603-070-00-6

2-amino-2-methylpropanol

204-709-8

124-68-5

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3

H319

H315

H412

GHS07

Wng

H319

H315

H412

603-071-00-1

2,2'-iminodiethanol; diethanolamin

203-868-0

111-42-2

Acute Tox. 4 * STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

H302

H373 ** H315

H318

GHS08

GHS05

GHS07

Dgr

H302

H373 ** H315

H318

603-072-00-7

1,4-bis(2,3 epoxypropoxy)butan; butandioldiglycidylether

219-371-7

2425-79-8

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H332

H312

H319

H315

H317

GHS07

Wng

H332

H312

H319

H315

H317

603-073-00-2

bisphenol-A-diglycidylether; 2,2-bis(p-(2,3-epoxipropoxi)phenyl]propan

216-823-5

1675-54-3

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 %

603-074-00-8

reaktionsprodukt: bisphenol-A-epichlorhydrin; epoxy harpiks (gennemsnitlig molekylevægt ≤ 700)

500-033-5

25068-38-6

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H319

H315

H317

H411

GHS07

GHS09

Wng

H319

H315

H317

H411

Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C ≥ 5 %

603-075-00-3

chlormethylmethylether; chlordimethylether

203-480-1

107-30-2

Flam. Liq. 2

Carc. 1A

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

H225

H350

H332

H312

H302

GHS02

GHS08

GHS07

Dgr

H225

H350

H332

H312

H302

603-076-00-9

but-2-yn-1,4-diol; 2-butyn-1,4-diol

203-788-6

110-65-6

Skin Corr. 1B

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 *

Skin Sens. 1

H314

H331

H301

H312

H373 ** H317

GHS06

GHS05

GHS08

Dgr

H314

H331

H301

H312

H373 ** H317

Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 25 % ≤ C < 50 %

Eye Irrit. 2; H319: 25 % ≤

C < 50 %

D

603-077-00-4

1-dimethylaminopropan-2-ol; dimepranol (INN)

203-556-4

108-16-7

Flam. Liq. 3

Acute Tox. 4 *

Skin Corr. 1B

H226

H302

H314

GHS02

GHS05

GHS07

Dgr

H226

H302

H314

603-078-00-X

prop-2-yn-1-ol; propargylalkohol

203-471-2

107-19-7

Flam. Liq. 3

Acute Tox. 3 * Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Chronic 2

H226

H331

H311

H301

H314

H411

GHS02

GHS06

GHS05

GHS09

Dgr

H226

H331

H311

H301

H314

H411

603-079-00-5

2,2'-methyliminodiethanol; N-methyldiethanolamin

203-312-7

105-59-9

Eye Irrit. 2

H319

GHS07

Wng

H319

603-080-00-0

2-methylaminoethanol; N-methylethanolamin; N-methyl-2-ethanolamin; N-methyl-2-aminoethanol; 2-(methylamino)ethanol

203-710-0

109-83-1

Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1B

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

STOT SE 3; H335: C ≥ 5 %

603-081-00-6

2,2'-thiodiethanol; thiodiglycol

203-874-3

111-48-8

Eye Irrit. 2

H319

GHS07

Wng

H319

603-082-00-1

1-aminopropan-2-ol; isopropanolamin

201-162-7

78-96-6

Skin Corr. 1B

H314

GHS05

Dgr

H314

603-083-00-7

1,1'-iminodipropan-2-ol; diisopropanolamin

203-820-9

110-97-4

Eye Irrit. 2

H319

GHS07

Wng

H319

603-084-00-2

styrenoxid; (epoxyethyl)benzen; phenyloxiran

202-476-7

96-09-3

Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2

H350

H312

H319

GHS08

GHS07

Dgr

H350

H312

H319

603-085-00-8

bronopol (INN); 2-brom-2-nitropropan-1,3-diol

200-143-0

52-51-7

Acute Tox. 4 * Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

H312

H302

H335

H315

H318

H400

GHS05

GHS07

GHS09

Dgr

H312

H302

H335

H315

H318

H400

M = 10

603-086-00-3

ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol

245-949-3

23947-60-6

Acute Tox. 4 *

H312

GHS07

Wng

H312

603-087-00-9

2-ethylhexan-1,3-diol; octylenglycol; ethoexadiol

202-377-9

94-96-2

Eye Dam. 1

H318

GHS05

Dgr

H318

603-088-00-4

2-(octylthio)ethanol; 2-hydroxyethyloctylsulfid

222-598-4

3547-33-9

Eye Dam. 1

H318

GHS05

Dgr

H318

603-089-00-X

7,7-dimethyl-3-oxa-6-azaoctan-1-ol

400-390-6

—

Skin Corr. 1A

Acute Tox. 4 *

H314

H302

GHS05

GHS07

Dgr

H314

H302

603-090-00-5

2-(2-bromethoxy)anisol

402-010-4

4463-59-6

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

603-091-00-0

exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol

402-470-6

87172-89-2

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

603-092-00-6

2-methyl-4-phenylpentanol

402-770-7

92585-24-5

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

603-093-00-1

cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptan

402-410-9

87818-31-3

Acute Tox. 4 *

Aquatic Chronic 2

H332

H411

GHS07

GHS09

Dgr

H332

H411

603-094-00-7

1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropan

241-536-7

17557-23-2

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

603-095-00-2

2-(propyloxy)ethanol; EGPE

220-548-6

2807-30-9

Acute Tox. 4 *

Eye Irrit. 2

H312

H319

GHS07

Wng

H312

H319

603-096-00-8

2-(2-butoxyethoxy)ethanol; diethylenglycolmonobutylether

203-961-6

112-34-5

Eye Irrit. 2

H319

GHS07

Wng

H319

603-097-00-3

1,1',1''-nitrilotripropan-2-ol; triisopropanolamin

204-528-4

122-20-3

Eye Irrit. 2

H319

GHS07

Wng

H319

603-098-00-9

2-phenoxyethanol

204-589-7

122-99-6

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

603-099-00-4

3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propan-1,2-diolhydrochlorid

403-440-5

93633-79-5

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

603-100-00-8

1,2-dimethoxypropan

404-630-0

7778-85-0

Flam. Liq. 2

H225

GHS02

Dgr

H225

EUH019

603-101-00-3

tetrahydro-2-isobutyl-4-methylpyran-4-ol, blanding af isomerer (cis og trans)

405-040-6

—

Eye Irrit. 2

H319

GHS07

Wng

H319

603-103-00-4

oxiran, mono[(C12-14-alkyloxy)methyl]derivater

271-846-8

68609-97-2

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

603-104-00-X

fenarimol (ISO); 2,4'-dichlor-α-(pyrimidin-5-yl)benzhydrylalkohol

262-095-7

60168-88-9

Repr. 2

Lact.

Aquatic Chronic 2

H361fd

H362

H411

GHS08

GHS09

Wng

H361fd

H362

H411

603-105-00-5

furan

203-727-3

110-00-9

Flam. Liq. 1

Carc. 1B Muta. 2

Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *

Skin Irrit. 2

Aquatic Chronic 3

H224

H350

H341

H332

H302

H373 ** H315

H412

GHS02

GHS08

GHS07

Dgr

H224

H350

H341

H332

H302

H373 ** H315

H412

EUH019

603-106-00-0

2-methoxypropanol

216-455-5

1589-47-5

Flam. Liq. 3

Repr. 1B

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H226

H360D *** H335

H315

H318

GHS02

GHS08

GHS05

GHS07

Dgr

H226

H360D *** H335

H315

H318

603-107-00-6

2-(2-methoxyethoxy)ethanol; diethylenglycolmonomethylether

203-906-6

111-77-3

Repr. 2

H361d ***

GHS08

Wng

H361d ***

603-108-00-1

2-methylpropan-1-ol; isobutanol

201-148-0

78-83-1

Flam. Liq. 3

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

STOT SE 3

H226

H335

H315

H318

H336

GHS02

GHS05

GHS07

Dgr

H226

H335

H315

H318

H336

603-109-00-7

en blanding af 1-ethoxy-1,1,2,3,3,3-hexafluor-2-(trifluormethyl)propan og 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorbutan

425-340-0

—

Aquatic Chronic 4

H413

—

H413

603-110-00-2

en blanding af cis-2-isobutyl-5-methyl-1,3-dioxan og trans-2-isobutyl-5-methyl-1,3-dioxan

426-130-1

166301-21-9

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

603-111-00-8

en blanding af 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexan og 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexan

426-530-6

—

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

603-112-00-3

cyclopentyl-2-phenylethyl-ether

428-340-9

—

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

603-113-00-9

6-glycidyloxynapht-1-yloxymethyloxiran

429-960-2

27610-48-6

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H341

H312

H315

H317

H412

GHS08

GHS07

Wng

H341

H312

H315

H317

H412

603-114-00-4

9-(2-propenyloxy)tricyclo[5.2.1.02,6]dec-3(eller-4-)-en

430-830-2

26912-64-1

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

603-115-00-X

en blanding af O, O',O''-(methylsilantriyl)tris(4-methyl-2-pentanonoxim) (3 stereoisomerer)

423-580-0

—

STOT RE 2 *

Aquatic Chronic 4

H373 ** H413

GHS08

Wng

H373 ** H413

603-116-00-5

(Z)-(2,4-difluorphenyl)piperidin-4-ylmethanonoxim monohydrochlorid

424-740-2

138271-16-6

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

603-117-00-0

propan-2-ol; isopropylalkohol; isopropanol

200-661-7

67-63-0

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

603-118-00-6

6-dimethylaminohexan-1-ol

404-680-3

1862-07-3

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3

H302

H314

H412

GHS05

GHS07

Dgr

H302

H314

H412

603-119-00-1

1,1'-(1,3-phenylendioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)

405-840-5

—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

603-120-00-7

2-methyl-5-phenylpentanol

405-890-8

25634-93-9

Eye Irrit. 2

Skin Irrit. 2

H319

H315

GHS07

Wng

H319

H315

603-121-00-2

4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinon

406-057-1

114565-66-1

Carc. 2

Skin Sens. 1

Aquatic Chronic 4

H351

H317

H413

GHS08

GHS07

Wng

H351

H317

H413

603-122-00-8

natrium-2-ethylhexanolat

406-150-7

38411-13-1

Flam. Sol. 1

Skin Corr. 1B

Aquatic Chronic 3

H228

H314

H412

GHS02

GHS05

Dgr

H228

H314

H412

T

603-123-00-3

4-methyl-8-methylentricyclo[3.3.1.13,7]decan-2-ol

406-330-5

122760-84-3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H315

H317

H411

GHS07

GHS09

Wng

H315

H317

H411

603-124-00-9

1,4-bis[2-(vinyloxy)ethoxy]benzen

406-900-3

84563-49-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

603-125-00-4

2-(2,4-dichlorphenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol

407-850-5

89544-40-1

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

603-126-00-X

2-((4-methyl-2-nitrophenyl)amino)ethanol

408-090-7

100418-33-5

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

603-127-00-5

butan-2-ol; [1](S)-butan-2-ol; [2] (R)-butan-2-ol; [3] (±)-butan-2-ol [4]

201-158-5 [1]

224-168-1 [2]

238-967-8 [3]

240-029-8 [4]

78-92-2 [1]

4221-99-2 [2]

14898-79-4 [3]

15892-23-6 [4]

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

STOT SE 3

H226

H319

H335

H336

GHS02

GHS07

Wng

H226

H319

H335

H336

C

603-128-00-0

2-(phenylmethoxy)naphthalen

405-490-3

613-62-7

Aquatic Chronic 4

H413

—

H413

603-129-00-6

1-tert-butoxypropan-2-ol

406-180-0

57018-52-7

Flam. Liq. 3

Eye Dam. 1

H226

H318

GHS02

GHS05

Dgr

H226

H318

603-130-00-1

blanding af isomerer af α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylen)

406-325-8

—

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

603-131-00-7

en blanding af 1-deoxy-1-[methyl-(1-oxododecyl)amino]-.sc.D.sc.-glucitol og 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-.sc.D.sc.-glucitol

407-290-1

—

Eye Dam. 1

H318

GHS05

Dgr

H318

603-132-00-2

2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decan

408-200-3

63187-91-7

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H315

H318

H412

GHS05

Dgr

H315

H318

H412

603-133-00-8

en blanding af 3-[(4-amino-2-chlor-5-nitrophenyl)amino]propan-1,2-diol og 3,3'-(2-chlor-5-nitro-1,4-phenylendiimino)bis(propan-1,2-diol)

408-240-1

—

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

603-134-00-3

blanding af substitueret dodecyl og/eller tetradecyl diphenylethere. Stoffet er fremstillet ved Friedel-Craft-reaktion. Katalysatoren bliver fjernet fra reaktionsprodukter. Diphenylether bliver substitueret med C1-C10 alkylgrupper. Alkylgrupperne bliver bundet tilfældigt til kulstofatomer mellem position 1 og 6. Lineær C12 og C14, 50/50 benyttes.

410-450-3

—

Aquatic Chronic 4

H413

—

H413

603-135-00-9

bis[[2,2',2''-nitrilotris-[ethanolato]]-(1-)N,O]-bis[2-(2-methoxyethoxy)ethoxy]titan

410-500-4

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

603-136-00-4

3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol

410-910-3

104226-19-9

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

603-137-00-X

blanding af 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-.sc.D.sc.-glucitol og 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-.sc.D.sc.-glucitol

411-130-6

—

Eye Dam. 1

H318

GHS05

Dgr

H318

603-138-00-5

3-(2,2-dimethyl-3-hydroxypropyl)toluen; (alt.): 2,2-dimethyl-3-(3-methylphenyl)propan-1-ol

403-140-4

103694-68-4

Aquatic Chronic 3

H412

—

H412

603-139-00-0

bis(2-methoxyethyl)ether

203-924-4

111-96-6

Flam. Liq. 3

Repr. 1B

H226

H360FD

GHS02

GHS08

Dgr

H226

H360FD

EUH019

603-140-00-6

2,2'-oxydiethanol; diethylenglycol

203-872-2

111-46-6

Acute Tox. 4 *

H302

GHS07

Wng

H302

603-141-00-1

blanding af dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]pentadecan og dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]heptadecan

413-780-6

—

Aquatic Chronic 3

H412

—

H412

603-142-00-7

2-(2-(2-hydroxyethoxy)-ethyl)-2-aza-bicyclo[2.2.1]heptan

407-360-1

116230-20-7

Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

H312

H302

H373 ** H315

H318

GHS06

GHS08

GHS05

Dgr

H312

H302

H373 ** H315

H318

603-143-00-2

R-2,3-epoxypropan-1-ol

404-660-4

57044-25-4

Self-react. C **** Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 3 * Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H242

H350

H341

H360f *** H331

H312

H302

H314

GHS02

GHS06

GHS08

GHS05

Dgr

H242

H350

H341

H360f *** H331

H312

H302

H314

603-144-00-8

en blanding af 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol og 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol

413-530-6

111850-00-1

Aquatic Chronic 2

H411

GHS09

H411

603-145-00-3

2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxy-propan

406-970-5

129228-11-1

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

603-146-00-9

2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol

406-080-7

83016-70-0

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3

H302

H314

H412

GHS05

GHS07

Dgr

H302

H314

H412

603-147-00-4

(-)-trans-4-(4'-fluorphenyl)-3-hydroxymethyl-N-methylpiperidin

406-030-4

105812-81-5

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

603-148-00-X

1,4-bis[(vinyloxy)methyl]cyclohexan

413-370-7

17351-75-6

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

603-149-00-5

blanding af diastereoisomerer af 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexan

407-640-3

63767-86-2

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H319

H315

H411

GHS07

GHS09

Wng

H319

H315

H411

603-150-00-0

(±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol

411-580-3

107898-54-4

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

603-151-00-6

(±)-2-(2,4-dichlorphenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol

413-570-4

—

Aquatic Chronic 3

H412

—

H412

603-152-00-1

2-(4-tert-butylphenyl)ethanol

410-020-5

5406-86-0

Repr. 2

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2

H361f *** H373 ** H318

H411

GHS08

GHS05

GHS09

Dgr

H361f *** H373 ** H318

H411

603-153-00-7

3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propan-1,2-diol

410-010-0

104333-00-8

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

603-154-00-2

1-[(2-tert-butyl)cyclohexyloxy]-2-butanol

412-300-2

139504-68-0

Aquatic Chronic 2

H411

GHS09

H411

603-156-00-3

2-(2,4-dichlorphenyl)-2-(2-propenyl)oxiran

411-210-0

89544-48-9

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

603-157-00-9

6,9-bis(hexadecyloxymethyl)-4,7-dioxanonan-1,2,9-triol

411-450-6

143747-72-2

Aquatic Chronic 4

H413

—

H413

603-158-00-4

blanding af 4 diastereoisomerer af 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-dien

412-460-3

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

603-159-00-X

2-cyclododecylpropan-1-ol

411-410-8

118562-73-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

603-160-00-5

1,2-diethoxypropan

412-180-1

10221-57-5

Flam. Liq. 2

H225

GHS02

Dgr

H225

EUH019

603-161-00-0

1,3-diethoxypropan

413-140-6

3459-83-4

Flam. Liq. 3

H226

GHS02

Wng

H226

603-162-00-6

α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-γ-(nonylphenoxy)poly[oxo(methyl-1,2-ethandiyl)]

413-420-8

144736-29-8

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H317

H411

603-163-00-1

2-phenyl-1,3-propandiol

411-810-2

1570-95-2

Eye Dam. 1

H318

GHS05

Dgr

H318

603-164-00-7

2-butyl-4-chlor-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazol

412-420-5

133909-99-6

Aquatic Chronic 4

H413

—

H413

603-165-00-2

en blanding af 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol

417-470-1

—

Muta. 2

Skin Sens. 1

H341

H317

GHS08

GHS07

Wng

H341

H317

603-166-00-8

(R)-1-chlor-2,3-epoxypropan

424-280-2

51594-55-9

Flam. Liq. 3

Carc. 1B

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

H226

H350

H331

H311

H301

H314

H317

GHS02

GHS06

GHS08

GHS05

Dgr

H226

H350

H331

H311

H301

H314

H317

603-167-00-3

3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol

407-920-5

6390-69-8

Aquatic Chronic 4

H413

GHS05

Dgr

H413

603-168-00-9

3-(2-ethylhexyloxy)propan-1,2-diol

408-080-2

70445-33-9

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

603-169-00-4

(±)-trans-4-(4-fluorphenyl)-3-hydroxymethyl-N-methylpiperidin

415-550-0

109887-53-8

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

603-170-00-X

en blanding af 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol og 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol og 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol

415-990-3

67739-11-1

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

603-171-00-5

5-tiazolilmetanol

414-780-9

38585-74-9

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

603-172-00-0

mono-2-[2-(4-dibenzo[b, f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol-trans-butendioat

415-180-1

773058-82-5

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

603-173-00-6

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octan

421-750-9

57280-22-5

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

603-174-00-1

4-cyclohexyl-2-methyl-2-butanol

420-630-3

83926-73-2

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

603-175-00-7

2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylenglycolmonohexylether; 3,6-dioxa-1-dodecanol; hexylcarbitol; 3,6-dioxadodecan-1-ol

203-988-3

112-59-4

Acute Tox. 4 *

Eye Dam. 1

H312

H318

GHS05

GHS07

Dgr

H312

H318

603-176-00-2

1,2-bis(2-methoxyethoxy)ethan; TEGDME; triethylenglycoldimethylether; triglym

203-977-3

112-49-2

Repr. 1B

H360Df

GHS08

Dgr

H360Df

EUH019

603-177-00-8

1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylenglycolmonoethylether; [1] propylenglycolmonoethylether; 2PG1EEA [2]

216-374-5 [1]

259-370-9 [2]

1569-02-4 [1]

54839-24-6 [2]

Flam. Liq. 3

STOT SE 3

H226

H336

GHS02

GHS07

Wng

H226

H336

603-178-00-3

2-hexyloxyethanol; ethylenglycolmonohexylether; n-hexylglycol

203-951-1

112-25-4

Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1B

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

603-179-00-9

ergocalciferol (ISO); Vitamin D2

200-014-9

50-14-6

Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1

H330

H311

H301

H372 **

GHS06

GHS08

Dgr

H330

H311

H301

H372 **

603-180-00-4

colecalciferol; Vitamin D3

200-673-2

67-97-0

Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1

H330

H311

H301

H372 **

GHS06

GHS08

Dgr

H330

H311

H301

H372 **

603-181-00-X

(tert-butyl)methylether; MTBE; 2-methoxy-2-methylpropan

216-653-1

04-04-1634

Flam. Liq. 2

Skin Irrit. 2

H225

H315

GHS02

GHS07

Dgr

H225

H315

603-182-00-5

en blanding af mættede, enkeltumættede og flerumættede langkædede, delvis forestrede alkoholer af vegetabilsk oprindelse (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) med O, O-diisobutyldithiophosphat og 2-ethylhexylamin og hydrogenperoxid

428-630-5

—

Skin Sens. 1

H317

GHS07

Wng

H317

603-183-00-0

2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylenglycolmonobutylether; butoxytriethylenglycol

205-592-6

143-22-6

Eye Dam. 1

H318

GHS05

Dgr

H318

Eye Dam.1; H318: C ≥ 30 % Eye Irrit. 2; H319: 20 % ≤ C < 30 %

603-184-00-6

2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propandiol

416-380-1

146925-83-9

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

603-185-00-1

2,4-dichlor-3-ethyl-6-nitrophenol

420-740-1

99817-36-4

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H301

H318

H317

H410

603-186-00-7

trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol

419-050-3

79944-37-9

Skin Sens. 1

H317

GHS07

Wng

H317

603-187-00-2

2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanoldichlorid

419-360-9

163661-77-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

603-188-00-8

en blanding af 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalen og 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalen

426-970-9

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

603-189-00-3

blanding af komplekser af titanium, 2,2'-oxydiethanol, ammoniumlactat, nitrilotris(2-propanol) og ethylenglycol

405-250-8

—

Aquatic Chronic 2

H411

GHS09

H411

603-190-00-9

8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decan

424-030-2

62406-73-9

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

603-191-00-4

2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol

419-740-4

137658-79-8

Aquatic Chronic 4

H413

—

H413

603-192-00-X

(E, E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol

423-240-1

125474-34-2

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

603-193-00-5

dinatrium-9,10-anthracendioxid

426-030-8

46492-07-3

Skin Corr. 1A

H314

GHS05

Dgr

H314

603-194-00-0

2-(2-aminoethylamino)ethanol; (AEEA)

203-867-5

111-41-1

Repr. 1B

Skin Corr. 1B

Skin Sens. 1

H360Df

H314

H317

GHS05

GHS08

GHS07

Dgr

H360Df

H314

H317

STOT SE 3; H335: C ≥ 5 %

603-195-00-6

2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol

430-810-3

154825-62-4

Aquatic Chronic 3

H412

—

H412

603-196-00-1

2-(7-ethyl-1H-indol-3-yl)ethanol

431-020-1

41340-36-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H302

H373 ** H411

GHS08

GHS07

GHS09

Wng

H302

H373 ** H411

603-199-00-8

etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorphenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetol

—

153233-91-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 100

603-200-00-1

1-pentanol; [1] 3-pentanol [2]

200-752-1 [1]

209-526-7 [2]

71-41-0 [1]

584-02-1 [2]

Flam. Liq. 3

Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

H226

H332

H335

H315

GHS02

GHS07

Wng

H226

H332

H335

H315

603-201-00-7

(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol

416-120-5

—

Skin Irrit. 2

Aquatic Chronic 4

H315

H413

GHS07

Wng

H315

H413

603-202-00-2

4,4,5,5,5-pentafluorpentan-1-ol

421-360-9

148043-73-6

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

603-203-00-8

(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecan

427-580-1

—

Skin Irrit. 2

H315

GHS07

Wng

H315

603-204-00-3

en blanding af 2,2'-(heptan-1,7-diyl)bis-1,3-dioxolan og 2,2'-(heptan-1,6-diyl)bis-1,3-dioxolan

428-110-8

—

Aquatic Chronic 3

H412

—

H412

603-205-00-9

(1S-cis)-4-(2-amino-6-chlor-9H-purin-9-yl)-2-cyclopenten-1-methanol hydrochlorid

426-200-1

172015-79-1

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H372 ** H302

H318

H317

H412

GHS05

GHS08

GHS07

Dgr

H372 ** H302

H318

H317

H412

603-206-00-4

2,2-dichlor-1,3-benzodioxol

426-850-6

2032-75-9

Flam. Liq. 3

Skin Corr. 1A

Acute Tox. 4 *

Skin Sens. 1

H226

H314

H302

H317

GHS02

GHS05

GHS07

Dgr

H226

H314

H302

H317

EUH014

603-207-00-X

2-isobutyl-2-isopropyl-1,3-dimethoxypropan

430-800-9

129228-21-3

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

603-208-00-5

1,2-diethoxyethan

211-076-1

629-14-1

Flam. Liq. 2

Repr. 1A Eye Irrit. 2

H225

H360Df

H319

GHS02

GHS08

GHS07

Dgr

H225

H360Df

H319

EUH019

603-209-00-0

spinosad (blanding af spinosyn A og spinosyn D i forholdet 95:5 til 50:50); blanding af 50-95 % (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacen-7,15-dion og 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacen-7,15-dion; [1]spinosyn A; [2]spinosyn D [3]

- [1]

- [2]

- [3]

- [1]

131929-60-7 [2]

131929-63-0 [3]

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

603-210-00-6

2,4-diethyl-1,5-pentandiol

429-310-8

57987-55-0

Eye Dam. 1

H318

GHS05

Dgr

H318

603-211-00-1

2,3-epoxypropyltrimethylammoniumchlorid ...%; glycidyltrimethylammoniumchlorid ...%

221-221-0

3033-77-0

Carc. 1B Muta. 2

Repr. 2

Acute Tox. 4 * Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H350

H341

H361f *** H312

H302

H373 ** H318

H317

H412

GHS05

GHS08

GHS07

Dgr

H350

H341

H361f *** H312

H302

H373 ** H318

H317

H412

B

603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolid; (HHCB)

214-946-9

1222-05-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

603-213-00-2

2-methoxy-2-methylbutan; tert-amylmethylether

213-611-4

994-05-8

Flam. Liq. 2

Acute Tox. 4 * STOT SE 3

H225

H302

H336

GHS02

GHS07

Dgr

H225

H302

H336

603-214-00-8

1,1-diisopropoxycyclohexan

413-740-8

1132-95-2

Skin Corr. 1B

H314

GHS05

Dgr

H314

603-215-00-3

1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octan-bis(tetrafluorborat)

418-330-2

162241-33-0

Expl. 1,1 ****

Acute Tox. 4 * STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H201

H302

H373 ** H318

H317

H400

H410

GHS01

GHS05

GHS08

GHS07

GHS09

Dgr

H201

H302

H373 ** H318

H317

H410

603-216-00-9

cis-1-amino-2,3-dihydro-1H-inden-2-ol

422-660-2

7480-35-5

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

603-217-00-4

2,4,6-tri-tert-butylphenyl-2-butyl-2-ethyl-1,3-propandiolphosphit

423-560-1

161717-32-4

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

603-220-00-0

1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol

432-890-5

72955-94-3

Aquatic Chronic 4

H413

—

H413

603-221-00-6

1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid; [indeholdende < 0,1 % 4-chloranilin (EF-nr. 203-401-0)]

433-580-2

214353-17-0

Acute Tox. 4 *

Skin Corr. 1B Aquatic Chronic 2

H302

H314

H411

GHS05

GHS07

GHS09

Dgr

H302

H314

H411

603-221-01-3

1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid; [indeholdende ≥ 0,1 % 4-chloranilin (EF-nr. 203-401-0)]

433-580-2

214353-17-0

Carc. 1B

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H350

H302

H314

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H350

H302

H314

H411

603-222-00-1

(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-oxo-1-oxacyclotetradecan

433-820-6

118058-74-5

Eye Irrit. 2

H319

GHS07

Wng

H319

603-223-00-7

2-cyclopentylidencyclopentanol; 1,1'-bi(cyclopentyliden)-2-ol

434-270-1

6261-30-9

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H315

H318

H412

GHS05

Dgr

H315

H318

H412

603-224-00-2

3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)-hexan

435-790-1

297730-93-9

Aquatic Chronic 4

H413

—

H413

603-225-00-8

erythromycin A9-oxim (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6,-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-dimethylamino-β-D-xylohexapyranosyl)oxy)oxacyclotetradecan-2-on-10-oxim (E)

437-070-0

13127-18-9

Aquatic Chronic 2

H411

GHS09

H411

603-226-00-3

4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzen-1,3-diol

444-500-0

1440-00-2

Aquatic Chronic 3

H412

—

H412

603-227-00-9

α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)]ether med 2,2-bis(hydroxymethyl)-1,3-propandiol (4:1); reaktionsprodukt af α-hydro-ω-((chlorcarbonyl)oxy)-poly(oxy(methyl-1,2-ethandiyl))ether med 2,2-bis(hydroxymethyl)-1,3-propandiol og kalium-1,1-dimethylethylperoxalat

445-060-2

203574-04-3

****

Aquatic Acute 1

Aquatic Chronic 1

**** H400

H410

**** GHS09

Wng

**** H410

603-228-00-4

(+/-)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluor-2-(2-oxiranyl)chroman

419-620-1

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

603-229-00-X

nnatrium-(Z)-3-chlor-3-(4-chlorphenyl)-1-hydroxy-2-propen-1-sulfonat

420-800-7

—

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

603-230-00-5

2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan

440-030-5

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 4

H315

H318

H413

GHS05

Dgr

H315

H318

H413

603-231-00-0

(S)-1,1-diphenyl-1,2-propandiol

443-220-6

—

Aquatic Chronic 3

H412

—

H412

603-232-00-6

3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecan

444-420-6

—

Aquatic Chronic 4

H413

—

H413

603-233-00-1

en blanding af 4-(1,3A,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol og 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol og 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol og 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol og (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol og (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

444-430-0

—

Aquatic Chronic 2

H411

GHS09

H411

603-234-00-7

(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-en

444-480-3

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

604-001-00-2

phenol; carbolsyre; monohydroxybenzen; phenylalkohol

203-632-7

108-95-2

Muta. 2

Acute Tox. 3 * Acute Tox. 3 *

Acute Tox. 3 * STOT RE 2 *

Skin Corr. 1B

H341

H331

H311

H301

H373 ** H314

GHS06

GHS08

GHS05

Dgr

H341

H331

H311

H301

H373 ** H314

*

Skin Corr. 1B; H314: C ≥ 3 %

Skin Irrit. 2; H315 1 % ≤ C < 3 %

Eye Irrit. 2; H319 1 % ≤ C < 3 %

604-002-00-8

pentachlorphenol

201-778-6

87-86-5

Carc. 2

Acute Tox. 2 * Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H330

H311

H301

H319

H335

H315

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H330

H311

H301

H319

H335

H315

H410

604-003-00-3

natriumpentachlorphenolat; [1] kaliumpentachlorphenolat [2]

205-025-2 [1]

231-911-3 [2]

131-52-2 [1]

7778-73-6 [2]

Carc. 2

Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H330

H311

H301

H319

H335

H315

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H330

H311

H301

H319

H335

H315

H410

604-004-00-9

m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4]

203-577-9 [1]

202-423-8 [2]

203-398-6 [3]

215-293-2 [4]

108-39-4 [1]

95-48-7 [2]

106-44-5 [3]

1319-77-3 [4]

Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

H311

H301

H314

GHS06

GHS05

Dgr

H311

H301

H314

*

C

604-005-00-4

1,4-dihydroxybenzen; hydroquinon; quinol

204-617-8

123-31-9

Carc. 2

Muta. 2

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H351

H341

H302

H318

H317

H400

GHS05

GHS08

GHS07

GHS09

Dgr

H351

H341

H302

H318

H317

H400

M = 10

604-006-00-X

3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(og 2,5)-xylenol [7]

202-439-5 [1]

202-461-5 [2]

203-321-6 [3]

208-395-3 [4]

209-400-1 [5]

215-089-3 [6]

276-245-4 [7]

95-65-8 [1]

95-87-4 [2]

105-67-9 [3]

526-75-0 [4]

576-26-1 [5]

1300-71-6 [6]

71975-58-1 [7]

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Chronic 2

H311

H301

H314

H411

GHS06

GHS05

GHS09

Dgr

H311

H301

H314

H411

C

604-007-00-5

2-naphthol

205-182-7

135-19-3

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

H332

H302

H400

GHS07

GHS09

Wng

H332

H302

H400

604-008-00-0

2-chlorphenol; [1] 4-chlorphenol; [2] 3-chlorphenol; [3] chlorphenol [4]

202-433-2 [1]

203-402-6 [2]

203-582-6 [3]

246-691-4 [4]

95-57-8 [1]

106-48-9 [2]

108-43-0 [3]

25167-80-0 [4]

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H332

H312

H302

H411

GHS07

GHS09

Wng

H332

H312

H302

H411

C

604-009-00-6

pyrogallol; 1,2,3-trihydroxybenzen

201-762-9

87-66-1

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H341

H332

H312

H302

H412

GHS08

GHS07

Wng

H341

H332

H312

H302

H412

*

604-010-00-1

resorcinol; 1,3-benzendiol

203-585-2

108-46-3

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

H302

H319

H315

H400

GHS07

GHS09

Wng

H302

H319

H315

H400

*

604-011-00-7

2,4-dichlorphenol

204-429-6

120-83-2

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H311

H302

H314

H411

GHS06

GHS05

GHS09

Dgr

H311

H302

H314

H411

604-012-00-2

4-chlor-o-cresol; 4-chlor-2-methylphenol

216-381-3

1570-64-5

Acute Tox. 3 *

Skin Corr. 1A Aquatic Acute 1

H331

H314

H400

GHS06

GHS05

GHS09

Dgr

H331

H314

H400

STOT SE 3; H335: C ≥ 1 %

604-013-00-8

2,3,4,6-tetrachlorphenol

200-402-8

58-90-2

Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H301

H319

H315

H400

H410

GHS06

GHS09

Dgr

H301

H319

H315

H410

*

Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2;

H315: C ≥ 5 %

604-014-00-3

chlorocresol; 4-chlor-m-cresol; 4-chlor-3-methylphenol

200-431-6

59-50-7

Acute Tox. 4 * Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H312

H302

H318

H317

H400

GHS05

GHS07

GHS09

Dgr

H312

H302

H318

H317

H400

*

604-015-00-9

2,2'-methylen-bis-(3,4,6-trichlorphenol); hexachlorophen

200-733-8

70-30-4

Acute Tox. 3 *

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H311

H301

H400

H410

GHS06

GHS09

Dgr

H311

H301

H410

*

604-016-00-4

dihydroxybenzen; pyrocatechol

204-427-5

120-80-9

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H312

H302

H319

H315

GHS07

Wng

H312

H302

H319

H315

604-017-00-X

2,4,5-trichlorphenol

202-467-8

95-95-4

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H315

H410

*

Eye Irrit. 2; H319: C ≥ 5 %

Skin Irrit.2; H315: C ≥ 5 %

604-018-00-5

2,4,6-trichlorphenol

201-795-9

88-06-2

Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H319

H315

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H319

H315

H410

604-019-00-0

dichlorophen (ISO)

202-567-1

97-23-4

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H400

H410

GHS07

GHS09

Wng

H302

H319

H410

604-020-00-6

2-phenylphenol (ISO); biphenyl-2-ol; 2-hydroxybiphenyl

201-993-5

90-43-7

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H319

H335

H315

H400

GHS07

GHS09

Wng

H319

H335

H315

H400

604-021-00-1

natrium-2-biphenylat; natriumbiphenyl-2-yloxid

205-055-6

132-27-4

Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

H302

H335

H315

H318

H400

GHS05

GHS07

GHS09

Wng

H302

H335

H315

H318

H400

604-022-00-7

2,2-dimethyl-1,3-benzodioxol-4-ol

400-900-7

22961-82-6

Eye Dam. 1

H318

GHS05

Dgr

H318

604-023-00-2

2,4-dichlor-3-ethylphenol

401-060-4

—

Skin Corr. 1B Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

604-024-00-8

4,4-isobutylethylidendiphenol

401-720-1

6807-17-6

Repr. 1B

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H360f *** H319

H400

H410

GHS08

GHS09

Dgr

H360f *** H319

H410

604-025-00-3

2,5-bis(1,1-dimethylbutyl)hydroquinon

400-220-0

—

Aquatic Chronic 2

H411

GHS09

H411

604-026-00-9

2,2-spirobi(6-hydroxy-4,4,7-trimethylchroman)

400-270-3

—

Aquatic Chronic 2

H411

GHS09

H411

604-027-00-4

2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinon

400-530-6

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

604-028-00-X

4-amino-3-fluorphenol

402-230-0

399-95-1

Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H350

H302

H317

H411

GHS08

GHS07

GHS09

Dgr

H350

H302

H317

H411

604-029-00-5

1-naphtol

201-969-4

90-15-3

Acute Tox. 4 * Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H312

H302

H335

H315

H318

GHS05

GHS07

Dgr

H312

H302

H335

H315

H318

604-031-00-6

guaiacol

201-964-7

90-05-1

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H302

H319

H315

GHS07

Wng

H302

H319

H315

604-032-00-1

thymol

201-944-8

89-83-8

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H302

H314

H411

GHS05

GHS07

GHS09

Dgr

H302

H314

H411

604-033-00-7

isobutylbut-3-enoat

401-170-2

24342-03-8

Flam. Liq. 3

H226

GHS02

Wng

H226

604-034-00-2

4,4'-thiodi-o-cresol

403-330-7

24197-34-0

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

604-035-00-8

4-nonylphenol, reaktionsprodukter med formaldehyd og dodecan-1-thiol

404-160-6

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

604-036-00-3

4,4'-oxybis(ethylenthio)diphenol

404-590-4

90884-29-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

604-037-00-9

3,5-xylenol, 3,5-dimethylphenol

203-606-5

108-68-9

Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

H311

H301

H314

GHS06

GHS05

Dgr

H311

H301

H314

604-038-00-4

4-chlor-3,5-dimethylphenol; [1] chlorxylenol [2]

201-793-8 [1]

215-316-6 [2]

88-04-0 [1]

1321-23-9 [2]

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H302

H319

H315

H317

GHS07

Wng

H302

H319

H315

H317

604-039-00-X

ethyl-2-[4-[(6-chlorbenzoxazol-2-yl)oxy]phenoxy]propionat; fenoxaprop-ethyl

266-362-9

66441-23-4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

604-040-00-5

fomesafen (ISO); 5-[2-chlor-4-(trifluormethyl)phenoxy]-N-(methylsulfonyl)-2-nitrobenzamid

276-439-9

72178-02-0

Acute Tox. 4 *

H302

GHS07

Wng

H302

604-041-00-0

acifluorfen (ISO); 5-[2-chlor-4-(trifluormethyl)phenoxy]-2-nitrobenzoesyre [1] natrium-5-[2-chlor-4-(trifluormethyl)phenoxy]-2- nitrobenzoat; acifluorfen-natrium [2]

256-634-5 [1]

263-560-7 [2]

50594-66-6 [1]

62476-59-9 [2]

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H315

H318

H410

604-042-00-6

4-nitrosophenol

203-251-6

104-91-6

Muta. 2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H341

H302

H318

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H341

H302

H318

H411

604-043-00-1

monobenzon; 4-hydroxyphenyl benzylether; hydroquinon monobenzylether

203-083-3

103-16-2

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

604-044-00-7

mequinol; 4-methoxyphenol; hydroquinon monomethylether

205-769-8

150-76-5

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H302

H319

H317

GHS07

Wng

H302

H319

H317

604-045-00-2

2,3,5-trimethylhydroquinon

211-838-3

700-13-0

Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H335

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H332

H335

H315

H318

H317

H410

604-046-00-8

4-(4-isopropoxyphenylsulfonyl)phenol

405-520-5

95235-30-6

Aquatic Chronic 2

H411

GHS09

H411

604-047-00-3

4-(4-tolyloxy)biphenyl

405-730-7

51601-57-1

STOT RE 2 *

Aquatic Chronic 4

H373 ** H413

GHS08

Wng

H373 ** H413

604-048-00-9

4,4',4''-(ethan-1,1,1-triyl)triphenol

405-800-7

27955-94-8

Aquatic Chronic 2

H411

GHS09

H411

604-049-00-4

4-4'-methylenbis(oxyethylenthio)diphenol

407-480-4

93589-69-6

Aquatic Chronic 2

H411

GHS09

H411

604-051-00-5

3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol

401-110-5

87113-78-8

Aquatic Chronic 3

H412

—

H412

604-052-00-0

2,2'-methylenbis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)

403-800-1

103597-45-1

Aquatic Chronic 4

H413

—

H413

604-053-00-6

2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol

410-760-9

157661-93-3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

604-054-00-1

en blanding af 2-methoxy-4-(tetrahydro-4-methylen-2H-pyran-2-yl)phenol og 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol

412-020-0

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

604-055-00-7

2,2'-((3,3',5,5'-tetramethyl(1,1'-biphenyl)-4,4'-diyl)bis(oxymethylen))bisoxiran

413-900-7

85954-11-6

Carc. 2

Skin Sens. 1

H351

H317

GHS08

GHS07

Wng

H351

H317

604-056-00-2

2-(2-hydroxy-3,5-dinitroanilin)ethanol

412-520-9

99610-72-7

Flam. Sol. 2

Repr. 2

Acute Tox. 4 *

H228

H361f *** H302

GHS02

GHS07

GHS08

Dgr

H228

H361f *** H302

604-058-00-3

1,2-bis(3-methylphenoxy)ethan

402-730-9

54914-85-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

604-059-00-9

2-n-hexadecylhydroquinon

406-400-5

—

STOT RE 2 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H373 ** H315

H317

H413

GHS08

GHS07

Wng

H373 ** H315

H317

H413

604-060-00-4

9,9-bis(4-hydroxyphenyl)fluoren

406-950-6

3236-71-3

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

604-061-00-X

en blanding af 2-chlor-5-sec-tetradecylhydroquinoner hvor sec-tetradecyl= 1-methyltridecyl; 1-ethyldodecyl;

1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl

407-740-7

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H315

H317

H412

GHS07

Wng

H315

H317

H412

604-062-00-5

2,4-dimethyl-6-(1-methyl-pentadecyl)-phenol

411-220-5

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

604-063-00-0

5,6-dihydroxy-indol

412-130-9

3131-52-0

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

604-064-00-6

2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol

411-380-6

147315-50-2

Aquatic Chronic 4

H413

—

H413

604-065-00-1

4,4',4''-(1-methylpropan-1-yl-3-yliden)tris(2-cyclohexyl-5-methylphenol)

407-460-5

111850-25-0

Aquatic Chronic 2

H411

GHS09

H411

604-066-00-7

blanding af phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-forbindelse) og methan, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-forbindelse); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol og 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol og 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol

414-550-8

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

604-067-00-2

en blanding af 2,2'-[[(2-hydroxyethyl)imino]bis(methylen)bis[4-dodecylphenol]; formaldehyd, oligomer med 4-dodecylphenol og 2-aminoethanol(n = 2); formaldehyd, oligomer med 4-dodecylphenol og 2-aminoethanol(n = 3, 4 og derover)

414-520-4

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

604-068-00-8

(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenolhydrochlorid

415-170-5

90274-24-1

Acute Tox. 4 * Acute Tox. 4 *

Skin Sens. 1

H332

H302

H317

GHS07

Wng

H332

H302

H317

604-069-00-3

2-(1-methylpropyl)-4-tert-butylphenol

421-740-4

51390-14-8

Skin Corr. 1B

Aquatic Chronic 2

H314

H411

GHS05

GHS09

Dgr

H314

H411

604-070-00-9

triclosan; 2,4,4'-trichlor-2'-hydroxydiphenylether; 5-chlor-2-(2,4-dichlorphenoxy)phenol

222-182-2

3380-34-5

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

M = 100

604-071-00-4

4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethyliden)diphenol

425-600-3

110726-28-8

Aquatic Chronic 4

H413

—

H413

604-072-00-X

1,2-bis(phenoxymethyl)benzen

428-620-0

10403-74-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

604-073-00-5

(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol

428-010-4

82413-20-5

Carc. 2

Repr. 1B Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H360f *** H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360f *** H317

H410

604-074-00-0

tetrabrombisphenol-A; 2,2',6,6'-tetrabrom-4,4'-isopropylidendiphenol

201-236-9

79-94-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol

205-426-2

140-66-9

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

M = 10

604-076-00-1

phenolphthalein

201-004-7

77-09-8

Carc. 1B Muta. 2

Repr. 2

H350

H341

H361f ***

GHS08

Dgr

H350

H341

H361f ***

Carc. 1B; H350: C ≥ 1 %

604-077-00-7

2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol

419-750-9

98809-58-6

Aquatic Chronic 4

H413

—

H413

604-079-00-8

4,4'-(1,3-phenylen-bis(1-methylethyliden))bis-phenol

428-970-4

13595-25-0

Repr. 2

Skin Sens. 1

Aquatic Chronic 2

H361f *** H317

H411

GHS08

GHS07

GHS09

Wng

H361f *** H317

H411

604-080-00-3

4-fluor-3-trifluormethylphenol

432-560-0

61721-07-1

Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1

Aquatic Chronic 2

H332

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H332

H314

H317

H411

604-081-00-9

1,1-bis(4-hydroxyphenyl)-1-phenylethan

433-130-5

1571-75-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

604-082-00-4

2-chlor-6-fluorphenol

433-890-8

2040-90-6

Muta. 1B Repr. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H340

H361f *** H302

H314

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H340

H361f *** H302

H314

H317

H411

604-083-00-X

4,4'-sulfonylbisphenol, polymer med ammoniumchlorid (NH4Cl), pentachlorphosphoran og phenol

439-270-3

260408-02-4

Aquatic Chronic 4

H413

—

H413

604-084-00-5

1-ethoxy-2,3-difluorbenzen

441-000-4

121219-07-6

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

604-087-00-1

en blanding af 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)monoester og 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol; 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)diester og 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol; ,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)triester og 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol

433-640-8

—

Pyr. Sol. 1

Aquatic Chronic 4

H250

H413

GHS02

Dgr

H250

H413

EUH044

604-089-00-2

2-methyl-5-tert-butylthiophenol

444-970-7

—

Flam. Liq. 3

Repr. 2

STOT RE 2 *

Asp. Tox. 1

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H226

H361d *** H373 ** H304

H319

H315

H317

H336

H400

H410

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H361d *** H373 ** H304

H319

H315

H317

H336

H410

604-090-00-8

4-tert-butylphenol

202-679-0

98-54-4

Repr. 2

Skin Irrit. 2

Eye Dam. 1

H361f

H315

H318

GHS08

GHS05

Dgr

H361f

H315

H318

604-091-00-3

etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzylether

407-980-2

80844-07-1

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H362

H400

H410

GHS09

Wng

H362

H410

M = 100

M = 1 000

605-001-00-5

formaldehyd ...%

200-001-8

50-00-0

Carc. 1B Muta. 2

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

H350

H341

H301

H311

H331

H314

H317

GHS08

GHS06

GHS05

Dgr

H350

H341

H301

H311

H331

H314

H317

*

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C

< 25 %

Eye Irrit. 2; H319: 5 % ≤ C

< 25 %

STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2  %

B, D

605-002-00-0

1,3,5-trioxan; trioxymethylen

203-812-5

110-88-3

Flam. Sol. 1

Repr. 2

STOT SE 3

H228

H361d *** H335

GHS02

GHS08

GHS07

Dgr

H228

H361d *** H335

T

605-003-00-6

acetaldehyd; ethanal

200-836-8

75-07-0

Flam. Liq. 1

Carc. 2

Eye Irrit. 2

STOT SE 3

H224

H351

H319

H335

GHS02

GHS08

GHS07

Dgr

H224

H351

H319

H335

605-004-00-1

2,4,6-trimethyl-1,3,5-trioxan; paraldehyd

204-639-8

123-63-7

Flam. Liq. 3

H226

GHS02

Wng

H226

605-005-00-7

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctan; metaldehyd

203-600-2

108-62-3

Flam. Sol. 2

Acute Tox. 4 *

H228

H302

GHS02

GHS07

Wng

H228

H302

605-006-00-2

butyraldehyd

204-646-6

123-72-8

Flam. Liq. 2

H225

GHS02

Dgr

H225

605-007-00-8

1,1-dimethoxyethan; dimethylacetal

208-589-8

534-15-6

Flam. Liq. 2

H225

GHS02

Dgr

H225

605-008-00-3

acrolein; prop-2-enal; acrylaldehyd

203-453-4

107-02-8

Flam. Liq. 2

Acute Tox. 1

Acute Tox. 2

Acute Tox. 3

Skin Corr. 1B Aquatic Acute 1

Aquatic Chronic 1

H225

H330

H300

H311

H314

H400

H410

GHS02

GHS06

GHS05

GHS09

Dgr

H225

H330

H300

H311

H314

H410

EUH071

Skin Corr. 1B; H314:C ≥ 0,1  %

M = 100

M = 1

D

605-009-00-9

crotonaldehyd; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyd [2]

224-030-0 [1]

204-647-1 [2]

4170-30-3 [1]

123-73-9 [2]

Flam. Liq. 2

Muta. 2

Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

H225

H341

H330

H311

H301

H373 ** H335

H315

H318

H400

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H225

H341

H330

H311

H301

H373 ** H335

H315

H318

H400

605-010-00-4

2-furaldehyd

202-627-7

98-01-1

Carc. 2

Acute Tox. 3 * Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H351

H331

H301

H312

H319

H335

H315

GHS06

GHS08

Dgr

H351

H331

H301

H312

H319

H335

H315

605-011-00-X

2-chlorbenzaldehyd; o-chlorbenzaldehyd

201-956-3

89-98-5

Skin Corr. 1B

H314

GHS05

Dgr

H314

605-012-00-5

benzaldehyd

202-860-4

100-52-7

Acute Tox. 4 *

H302

GHS07

Wng

H302

605-014-00-6

chloralhydrat: 2,2,2-trichlorethan-1,1-diol

206-117-5

302-17-0

Acute Tox. Eye Irrit. 2

Skin Irrit. 2

H301

H319

H315

GHS06

Dgr

H301

H319

H315

605-015-00-1

1,1-diethoxyethan; acetal

203-310-6

105-57-7

Flam. Liq. 2

Eye Irrit. 2

Skin Irrit. 2

H225

H319

H315

GHS02

GHS07

Dgr

H225

H319

H315

605-016-00-7

glyoxal ... %; ethandial ... %

203-474-9

107-22-2

Muta. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H341

H332

H319

H315

H317

GHS07

GHS08

Wng

H341

H332

H319

H315

H317

*

B

605-017-00-2

1,3-dioxolan

211-463-5

646-06-0

Flam. Liq. 2

H225

GHS02

Dgr

H225

605-018-00-8

propanal; propionaldehyd

204-623-0

123-38-6

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H225

H319

H335

H315

GHS02

GHS07

Dgr

H225

H319

H335

H315

605-019-00-3

citral

226-394-6

5392-40-5

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

605-020-00-9

safrole; 5-allyl-1,3-benzodioxol

202-345-4

94-59-7

Carc. 1B Muta. 2

Acute Tox. 4 *

H350

H341

H302

GHS08

GHS07

Dgr

H350

H341

H302

605-021-00-4

formaldehyd, reaktionsprodukter med butylphenol

294-145-9

91673-30-2

Skin Sens. 1

H317

GHS07

Wng

H317

605-024-00-0

2-brom-5-hydroxy-4-methoxybenzaldehyd

426-540-0

2973-59-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

605-025-00-6

chloracetaldehyd

203-472-8

107-20-0

Carc. 2

Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1

H351

H330

H311

H301

H314

H400

GHS06

GHS08

GHS05

GHS09

Dgr

H351

H330

H311

H301

H314

H400

STOT SE 3; H335: C ≥ 5 %

605-026-00-1

2,5,7,7-tetramethyloctanal

405-690-0

114119-97-0

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H315

H317

H411

GHS07

GHS09

Wng

H315

H317

H411

605-027-00-7

en blanding af 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-carboxaldehyd; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-carboxaldehyd

410-480-7

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

605-028-00-2

β-methyl-3-(1-methylethyl)-benzenpropanal

412-050-4

125109-85-5

Aquatic Chronic 2

H411

GHS09

H411

605-029-00-8

2-cyclohexyl propanal

412-270-0

2109-22-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

605-030-00-3

1-(p-methoxyphenyl)-acetaldehydoxim

411-510-1

3353-51-3

Skin Sens. 1

H317

GHS07

Wng

H317

605-031-00-9

en blanding af 2,2-dimethoxyethanal (denne komponent anses for at være anhydrid, hvad angår identitet, struktur og sammensætning. 2,2-dimethoxyethanal eksisterer dog i hydratform. 60 % anhydrid svarer til 70,4 % hydrat); vand (herunder frit vand og vand i 2,2-dimethoxyethanal-hydrat)

421-890-0

—

Skin Sens. 1

H317

GHS07

Wng

H317

605-032-00-4

3-[3-(4-fluorphenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal

425-370-4

93957-50-7

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

605-033-00-X

en blanding af 3,7,11-trimethyl-cis-6,10-dodecadienal og 3,7,11-trimethyl-trans-6,10-dodecadienal

425-910-9

32480-08-3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

605-034-00-5

en blanding af (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.02,6]decan-3-carbaldehyd; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decan-3-carbaldehyd og

(1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decan-4-carbaldehyd

429-860-9

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

605-035-00-0

(E)-3-(4-(4-fluorphenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal

426-330-9

177964-68-0

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H319

H317

H413

GHS07

Wng

H319

H317

H413

605-036-00-6

2-brommalonaldehyd

430-470-6

2065-75-0

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

605-037-00-1

trans-3-[2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd; 3-[(E)-2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd

421-800-1

120578-03-2

Aquatic Chronic 4

H413

—

H413

605-038-00-7

3-methyl-5-phenylpentan-1-al

433-900-0

55066-49-4

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H302

H315

H317

H411

GHS07

GHS09

Wng

H302

H315

H317

H411

605-039-00-2

3,4-dihydroxy-5-nitrobenzaldehyd

441-810-8

116313-85-0

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H302

H318

H317

GHS05

GHS07

Dgr

H302

H318

H317

606-001-00-8

acetone; propan-2-on; propanon

200-662-2

67-64-1

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

EUH066

606-002-00-3

butanon; ethylmethylketon

201-159-0

78-93-3

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

EUH066

606-003-00-9

3-heptanon; ethylbutylketon

203-388-1

106-35-4

Flam. Liq. 3

Acute Tox. 4 *

Eye Irrit. 2

H226

H332

H319

GHS02

GHS07

Wng

H226

H332

H319

606-004-00-4

4-methylpentan-2-on; methylisobutylketon

203-550-1

108-10-1

Flam. Liq. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H225

H332

H319

H335

GHS02

GHS07

Dgr

H225

H332

H319

H335

EUH066

606-005-00-X

2,6-dimethyl-4-heptanon; diisobutylketon

203-620-1

108-83-8

Flam. Liq. 3

STOT SE 3

H226

H335

GHS02

GHS07

Wng

H226

H335

STOT SE 3; H335: C ≥ 10 %

606-006-00-5

pentan-3-on; diethylketon

202-490-3

96-22-0

Flam. Liq. 2

STOT SE 3

STOT SE 3

H225

H335

H336

GHS02

GHS07

Dgr

H225

H335

H336

EUH066

606-007-00-0

3-methyl-2-butanon; ethylisopropylketon

209-264-3

563-80-4

Flam. Liq. 2

H225

GHS02

Dgr

H225

606-009-00-1

4-methyl-3-penten-2-on; mesityloxid

205-502-5

141-79-7

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 *

Acute Tox. 4 *

H226

H332

H312

H302

GHS02

GHS07

Wng

H226

H332

H312

H302

*

606-010-00-7

cyclohexanon

203-631-1

108-94-1

Flam. Liq. 3

Acute Tox. 4 *

H226

H332

GHS02

GHS07

Wng

H226

H332

606-011-00-2

2-methylcyclohexanon

209-513-6

583-60-8

Flam. Liq. 3

Acute Tox. 4 *

H226

H332

GHS02

GHS07

Wng

H226

H332

606-012-00-8

3,5,5-trimethylcyclohex-2-enon; isophoron

201-126-0

78-59-1

Carc. 2

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H351

H312

H302

H319

H335

GHS08

GHS07

Wng

H351

H312

H302

H319

H335

STOT SE 3; H335: C ≥ 10 %

606-013-00-3

p-benzoquinon; quinon

203-405-2

106-51-4

Acute Tox. 3 * Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

H331

H301

H319

H335

H315

H400

GHS06

GHS09

Dgr

H331

H301

H319

H335

H315

H400

M = 10

606-016-00-X

pindon (ISO), 2-pivaloylindan-1,3-dion

201-462-8

83-26-1

Acute Tox. 3 * STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H372 ** H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H372 ** H410

606-017-00-5

acetylketen; diketen

211-617-1

674-82-8

Flam. Liq. 3

Acute Tox. 4 *

H226

H332

GHS02

GHS07

Wng

H226

H332

D

606-018-00-0

dichlon (ISO); 2,3-dichlor-1,4-naphthoquinon

204-210-5

117-80-6

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H315

H410

606-019-00-6

chlordecon (ISO); perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one; decachlorpentacyclo[5,2,1,02,6,03,9,05,8]decan-4-on

205-601-3

143-50-0

Carc. 2

Acute Tox. 3 * Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H311

H301

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H311

H301

H410

606-020-00-1

5-methyl-3-heptanon

208-793-7

541-85-5

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

H226

H319

H335

GHS02

GHS07

Wng

H226

H319

H335

STOT SE 3; H335: C ≥ 10 %

606-022-00-2

1-phenyl-3-pyrazolidon

202-155-1

92-43-3

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

606-023-00-8

4-methoxy-4-methylpentan-2-on

203-512-4

107-70-0

Flam. Liq. 3

Acute Tox. 4 *

H226

H332

GHS02

GHS07

Wng

H226

H332

606-024-00-3

heptan-2-on; methylpentylketon

203-767-1

110-43-0

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 *

H226

H332

H302

GHS02

GHS07

Wng

H226

H332

H302

606-025-00-9

cyclopentanon

204-435-9

120-92-3

Flam. Liq. 3

Eye Irrit. 2

Skin Irrit. 2

H226

H319

H315

GHS02

GHS07

Wng

H226

H319

H315

606-026-00-4

5-methylhexan-2-on; isoamylmethylketon

203-737-8

110-12-3

Flam. Liq. 3

Acute Tox. 4 *

H226

H332

GHS02

GHS07

Wng

H226

H332

606-027-00-X

heptan-4-on; dipropylketon

204-608-9

123-19-3

Flam. Liq. 3

Acute Tox. 4 *

H226

H332

GHS02

GHS07

Wng

H226

H332

606-028-00-5

2,4-dimethylpentan-3-on; diisopropylketon

209-294-7

565-80-0

Flam. Liq. 2

Acute Tox. 4 *

H225

H332

GHS02

GHS07

Dgr

H225

H332

606-029-00-0

2,4-pentandion; acetylacetone

204-634-0

123-54-6

Flam. Liq. 3

Acute Tox. 4 *

H226

H302

GHS02

GHS07

Wng

H226

H302

606-030-00-6

hexan-2-on; methylbutylketon; butylmethylketon; methyl-n-butylketon

209-731-1

591-78-6

Flam. Liq. 3

Repr. 2

STOT RE 1

STOT SE 3

H226

H361f *** H372 ** H336

GHS02

GHS08

GHS07

Dgr

H226

H361f *** H372 ** H336

606-031-00-1

3-propanolid; 1,3-propiolacton

200-340-1

57-57-8

Carc. 1B

Acute Tox. 2 *

Eye Irrit. 2

Skin Irrit. 2

H350

H330

H319

H315

GHS06

GHS08

Dgr

H350

H330

H319

H315

606-032-00-7

hexachloracetone

204-129-5

116-16-5

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

606-033-00-2

2-(3,4-dichlorphenyl)-4-methyl-1,2,4-oxadiazolidindion; methazol

243-761-6

20354-26-1

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H312

H302

H319

H315

H411

GHS07

GHS09

Wng

H312

H302

H319

H315

H411

606-034-00-8

metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5-(4H)-on; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-on

244-209-7

21087-64-9

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 10

606-035-00-3

cloridazon (ISO); 5-amino-4-chlor-2-phenylpyridazin-3-on; pyrazon

216-920-2

1698-60-8

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

606-036-00-9

quinomethionat; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-on

219-455-3

2439-01-2

Repr. 2

Acute Tox. 4 * Acute Tox. 4 *

Acute Tox. 4 * STOT RE 2 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f *** H332

H312

H302

H373 ** H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f *** H332

H312

H302

H373 ** H319

H317

H410

606-037-00-4

triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanon

256-103-8

43121-43-3

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

606-038-00-X

diphacinon (ISO); 2-diphenylacetylindan-1,3-dion

201-434-5

82-66-6

Acute Tox. 2 * STOT RE 1

H300

H372 **

GHS06

GHS08

Dgr

H300

H372 **

606-039-00-5

5(eller 6)-tert-butyl-2'-chlor-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthen)-3-on

400-680-2

—

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H332

H400

H410

GHS07

GHS09

Wng

H332

H410

606-040-00-0

(N-benzyl-N-ethyl)amino-3-hydroxyacetophenonhydrochlorid

401-840-4

55845-90-4

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

606-042-00-1

acetophenon

202-708-7

98-86-2

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

606-043-00-7

2,4-di-tert-butylcyclohexanon

405-340-7

13019-04-0

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

606-044-00-2

2,4,6-trimethylbenzophenon

403-150-9

954-16-5

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H400

H410

GHS07

GHS09

Wng

H302

H319

H410

606-045-00-8

oxadiazon (ISO); 3-[2,4-dichlor-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxdiazol-2(3H)-on

243-215-7

19666-30-9

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-046-00-3

blanding af cis- og trans-cyclohexadec-8-en-1-on

401-700-2

3100-36-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-047-00-9

2-benzyl-2-dimethylamino-4-morpholinobutyrophenon

404-360-3

119313-12-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-048-00-4

2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-on

406-480-1

—

Aquatic Chronic 4

H413

—

H413

606-049-00-X

4-(trans-4-propylcyclohexyl)acetophenon

406-700-6

78531-61-0

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-050-00-5

6-anilin-1-benzoyl-4-(4-tert-pentylphenoxy)naphtho[1,2,3-de]chinolin-2,7-(3H)-dion

412-480-2

72453-58-8

Aquatic Chronic 2

H411

GHS09

H411

606-051-00-0

4-pentylcyclohexanon

406-670-4

61203-83-6

Aquatic Chronic 2

H411

GHS09

H411

606-052-00-6

4-(N, N-dibutylamino)-2-hydroxy-2'-carboxy-2-(4-dibutylamino-2-hydroxybenzoyl)benzoesyre

410-410-5

54574-82-2

Aquatic Chronic 3

H412

—

H412

606-053-00-1

flurtamon (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-on

—

96525-23-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-055-00-2

1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)-ethanon

411-180-9

92836-10-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H302

H373 ** H411

GHS08

GHS07

GHS09

Wng

H302

H373 ** H411

606-056-00-8

4-chlor-3',4'-dimethoxybenzophenon

404-610-1

116412-83-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-057-00-3

4-propylcyclohexanon

406-810-4

40649-36-3

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

606-058-00-9

4'-fluor-2,2-dimethoxyacetophenon

407-500-1

21983-80-2

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

606-059-00-4

2,4-difluor-α-(1H-1,2,4-triazol-1-yl)acetophenonhydrochlorid

412-390-3

86386-75-6

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H302

H318

H317

GHS05

GHS07

Dgr

H302

H318

H317

606-060-00-X

en blanding af trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalen-2-yl)-1,3-dioxolan; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalen-2-yl)-1,3-dioxolan

412-950-7

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-061-00-5

(3-chlorphenyl)-(4-methoxy-3-nitrophenyl)methanon

423-290-4

66938-41-8

Muta. 2

Aquatic Acute 1

Aquatic Chronic 1

H341

H400

H410

GHS08

GHS09

Wng

H341

H410

606-062-00-0

tetrahydrothiopyran-3-carboxaldehyd

407-330-8

61571-06-0

Repr. 1B

Eye Dam. 1

Aquatic Chronic 3

H360D *** H318

H412

GHS08

GHS05

Dgr

H360D *** H318

H412

606-063-00-6

(E)-3-(2-chlorphenyl)-2-(4-fluorphenyl)propenal

410-980-5

112704-51-5

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

606-064-00-1

pregn-5-en-3,20-dionbis(ethylenketal)

407-450-0

7093-55-2

Aquatic Chronic 4

H413

—

H413

606-065-00-7

1-(4-morpholinphenyl)butan-1-on

413-790-0

—

Aquatic Chronic 2

H411

GHS09

H411

606-066-00-2

(E)-5[(4-chlorphenyl)methylen]-2,2-dimethylcyclopentanon

410-440-9

164058-20-2

Aquatic Chronic 2

H411

GHS09

H411

606-067-00-8

en blanding af 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanon; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanon

414-870-8

96792-67-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-068-00-3

2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al

415-770-7

07-05-1638

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H373 ** H317

H412

GHS08

GHS07

Wng

H373 ** H317

H412

606-069-00-9

spiro[1,3-dioxolan-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methannaphthalen)]

415-460-1

154171-76-3

Aquatic Chronic 2

H411

GHS09

H411

606-070-00-4

butrozydim (ISO);5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-on

414-790-3

138164-12-2

Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H302

H315

H400

H410

GHS08

GHS07

GHS09

Wng

H361fd

H302

H315

H410

606-071-00-X

17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-dien-3-on

421-050-3

13258-43-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-072-00-5

3-acetyl-1-phenyl-pyrrolidin-2,4-dion

421-600-2

719-86-8

STOT RE 2 *

Aquatic Chronic 2

H373 ** H411

GHS08

GHS09

Wng

H373 ** H411

606-073-00-0

4,4'-bis(dimethylamino)benzophenon; Michlers keton

202-027-5

90-94-8

Carc. 1B Muta. 2

Eye Dam. 1

H350

H341

H318

GHS08

GHS05

Dgr

H350

H341

H318

606-074-00-6

en blanding af (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalen og (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalen

425-570-1

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-075-00-1

1-benzyl-5-ethoxyimidazolidin-2,4-dion

417-340-4

65855-02-9

Acute Tox. 4 *

H302

GHS07

Wng

H302

606-076-00-7

1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidindion

418-630-3

136465-99-1

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

606-077-00-2

(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanon

418-650-2

104872-06-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-078-00-8

1-octylazepin-2-on

420-040-6

59227-88-2

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H317

H411

606-079-00-3

2-n-butyl-benzo[d]isothiazol-3-on

420-590-7

4299-07-4

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

606-081-00-4

(3β, 5α, 6β)-3-(acetyloxy)-5-brom-6-hydroxy-androstan-17-on

419-790-7

4229-69-0

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

606-082-00-X

blanding af butan-2-on-oxim; syn-O, O'-di(butan-2-on-oxim)diethoxysilan

406-930-7

STOT RE 1

Skin Sens. 1

Aquatic Chronic 3

H372 ** H317

H412

GHS08

GHS07

Dgr

H372 ** H317

H412

606-083-00-5

2-chlor-5-sec-hexadexylhydroquinon

407-750-1

137193-60-3

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H319

H315

H317

H412

GHS07

Wng

H319

H315

H317

H412

606-084-00-0

1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propandion

414-540-3

484-33-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-085-00-6

(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-on

418-530-1

79200-56-9

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H302

H318

H317

GHS05

GHS07

Dgr

H302

H318

H317

606-086-00-1

1-(3,3-dimethylcyclohexyl)pent-4-en-1-one

422-330-8

56973-87-6

Aquatic Chronic 2

H411

GHS09

H411

606-087-00-7

6-ethyl-5-fluor-4(3H)-pyrimidon

422-460-5

137234-87-8

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

606-088-00-2

2,4,4,7-tetramethyl-6-octen-3-on

422-520-0

74338-72-0

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

606-089-00-8

en blanding af 1,4-diamino-2-chlor-3-phenoxyanthraquinon; 1,4-diamino-2,3-bis-phenoxyanthraquinon

423-220-2

12223-77-7

Aquatic Chronic 4

H413

—

H413

606-090-00-3

1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanon

430-920-1

73096-98-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

606-091-00-9

6-chlor-5-(2-chlorethyl)-1,3-dihydroindol-2-on

421-320-0

118289-55-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-092-00-4

en blanding af (E)-oxacyclohexadec-12-en-2-on; (E)-oxacyclohexadec-13-en-2-on; a) (Z)-oxacyclohexadec-(12)-en-2-on og b) (Z)-oxacyclohexadec-(13)-en-2-on

422-320-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-093-00-X

5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-on

414-470-3

95885-13-5

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

606-094-00-5

N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazol-4(1H),1'(3'H)-isobenzofuran]-3'-on

417-460-7

—

Aquatic Chronic 4

H413

—

H413

606-095-00-0

(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-on

421-830-3

49805-30-3

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

606-096-00-6

3-(6-O-(6-deoxy-α-L-mannopyranosyl-O-(α-D-glucopyranosyl)-(β-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-on

424-170-4

130603-71-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

606-097-00-1

2,2''-dihydroxy-4,4''-(2-hydroxy-propan-1,3-diyldioxy)dibenzophenon

424-210-0

23911-85-5

Aquatic Chronic 4

H413

—

H413

606-098-00-7

1-benzyl-5-(hexadecyloxy)-2,4-imidazolidindion

431-220-9

158574-65-3

Aquatic Chronic 4

H413

—

H413

606-099-00-2

5-methoxy-4'-(trifluormethyl)valerophenon

425-000-1

61718-80-7

Aquatic Chronic 2

H411

GHS09

H411

606-100-00-6

2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-on

425-150-8

94723-86-1

Repr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H360f *** H302

H317

H412

GHS08

GHS07

Dgr

H360f *** H302

H317

H412

606-101-00-1

en blanding af 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracendion; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracendion; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracendion; 1-[(2-ethylhexyl)amino]-5-[3-methoxypropyl)amino]-9,10-anthracendion: 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracendion og 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracendion

426-050-7

165038-51-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

606-102-00-7

4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenon

431-490-8

79876-59-8

Aquatic Chronic 2

H411

GHS09

H411

606-103-00-2

1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanon

426-460-6

—

Skin Sens. 1

H317

GHS07

Wng

H317

606-104-00-8

1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanon

426-830-7

78531-59-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-105-00-3

3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dion

431-500-0

226065-73-2

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-106-00-9

1-(4-(trans-4-butylcyclohexyl)phenyl)ethanon

427-320-7

83626-30-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-107-00-4

8-azaspiro[4.5]decan-7,9-dion

427-770-4

1075-89-4

Acute Tox. 3 *

Aquatic Chronic 2

H301

H411

GHS06

GHS09

Dgr

H301

H411

606-108-00-X

1,1,1,2,2,4,5,5,5-nonafluor-4-(trifluormethyl)-3-pentanon

436-710-6

756-13-8

Aquatic Chronic 3

H412

—

H412

606-109-00-5

2-(4-methyl-3-pentenyl)anthraquinon

428-320-1

71308-16-2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 4

H302

H317

H413

GHS07

Wng

H302

H317

H413

606-110-00-0

5-ethoxy-5H-furan-2-on

428-330-4

2833-30-9

Skin Corr. 1B

Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *

Skin Sens. 1

H314

H312

H302

H373 ** H317

GHS05

GHS08

GHS07

Dgr

H314

H312

H302

H373 ** H317

606-111-00-6

5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-on

428-410-9

67014-36-2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

606-112-00-1

(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-e, f][2]benzazepin-6-on

428-690-2

1668-86-6

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 3

H302

H319

H412

GHS07

Wng

H302

H319

H412

606-113-00-7

1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-on

429-040-0

272460-97-6

Eye Dam. 1

Aquatic Chronic 4

H318

H413

GHS05

Dgr

H318

H413

606-114-00-2

4,4',5,5',6,6',7,7'-octachlor-(2,2')biisoindolyl-1,1',3,3'-tetraon

429-150-9

67887-47-2

Aquatic Chronic 4

H413

—

H413

606-115-00-8

profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorphenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-on

—

139001-49-3

Carc. 2

Repr. 2

Skin Sens. 1

H351

H361d

H317

GHS08

GHS07

Wng

H351

H361d

H317

606-116-00-3

tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chlorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-on

—

149979-41-9

Carc. 2

Repr. 2

H351

H361fd

GHS08

Wng

H351

H361fd

606-117-00-9

2,6-bis(1,1-dimethylethyl)-4-(phenylenmethylen)cyclohexa-2,5-dien-1-on

429-460-4

7078-98-0

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-118-00-4

N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinondiimin

429-640-2

52870-46-9

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H400

H410

GHS07

GHS09

Wng

H319

H410

606-119-00-X

(E)-3-methyl-5-cyclopentadecen-1-on

429-900-5

—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

606-120-00-5

2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-on

430-170-5

114625-74-0

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

606-121-00-0

(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-spiro-1'-(cyclohex-2'-en-4'-on)

430-460-1

133636-82-5

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

606-122-00-6

3-(2-brompropionoyl)-4,4-dimethyl-1,3-oxazolan-2-on

430-820-8

114341-88-7

Acute Tox. 4 * STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H315

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H302

H373 ** H315

H318

H317

H410

606-123-00-1

4-hexadecyl-1-phenylpyrazolidin-3-on

430-840-7

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-124-00-7

1-cyclopropyl-3-(2-methylthio-4-trifluormethylphenyl)-1,3-propandion

421-080-7

161462-35-7

STOT RE 2 * Aquatic Acute 1

Aquatic Chronic 1

H373 ** H400

H410

GHS08

GHS09

Wng

H373 ** H410

606-125-00-2

1-benzylimidazolidin-2,4-dion

421-340-1

05-05-6777

Acute Tox. 4 *

H302

GHS07

Wng

H302

606-126-00-8

1,4-bis(2,3-dihydroxypropylamino)anthraquinon

421-470-7

99788-75-7

Aquatic Chronic 2

H411

GHS09

H411

606-128-00-9

2,2'-(1,3-phenylen)bis[5-chlor-1H-isoindol]-1,3(2H)-dion

422-650-8

148935-94-8

Aquatic Chronic 4

H413

—

H413

606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-on; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-on

423-090-7

156732-13-7

Aquatic Chronic 4

H413

—

H413

606-130-00-X

4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanon

423-860-2

56309-94-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

606-131-00-5

cyclisk 3-(1,2-ethandiylacetal)-estra-5(10),9(11)-dien-3,17-dion

427-230-8

5571-36-8

Repr. 1B

STOT RE 2 *

Aquatic Chronic 2

H360f *** H373 ** H411

GHS08

GHS09

Dgr

H360f *** H373 ** H411

606-132-00-0

(6β)-6,19-epoxyandrost-4-en-3,17-dion

433-490-3

6563-83-3

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

606-134-00-1

androsta-1,4,9(11)-trien-3,17-dion

433-560-3

15375-21-0

Repr. 2

H361f ***

GHS08

Wng

H361f ***

606-135-00-7

cyclohexadecanon

438-930-8

2550-52-9

Aquatic Chronic 4

H413

—

H413

606-136-00-2

(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosan-2,5,8,11,14,17,20,23-octaon

444-350-6

133413-70-4

Eye Irrit. 2

Aquatic Chronic 4

H319

H413

GHS07

Wng

H319

H413

606-137-00-8

trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinyliden]-3,3'-dion

444-750-0

211387-26-7

Aquatic Chronic 4

H413

—

H413

606-138-00-3

(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanon

444-800-1

141645-23-0

Flam. Liq. 3

Acute Tox. 4 * STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H302

H373 ** H315

H318

H317

H400

H410

GHS02

GHS05

GHS08

GHS07

GHS09

Dgr

H226

H302

H373 ** H315

H318

H317

H410

M = 10

606-139-00-9

(S)-4-(3,4-dichlorphenyl)-3,4-dihydro-2H-naphthalen-1-on

444-830-5

124379-29-9

Aquatic Chronic 4

H413

—

H413

606-140-00-4

2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-on

444-860-9

474510-57-1

STOT RE 2 * Aquatic Acute 1

Aquatic Chronic 1

H373 ** H400

H410

GHS08

GHS09

Wn

H373 ** H410

606-141-00-X

natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolat

418-410-7

—

Eye Irrit. 2

H319

GHS07

Wng

H319

606-142-00-5

en blanding af (1RS,2SR,7SR,8SR,E)-9- og 10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on; (1RS,2SR,7SR,8SR,Z)-10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on; (1RS,2SR,7SR,8SR,Z)-9-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on

434-290-9

—

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

606-143-00-0

abamectin (kombination af avermectin B1a og avermectin B1b) (ISO); [1] avermectin B1a (renhed ≥ 80 %); [2]

_ [1]

265-610-3 [2]

71751-41-2 [1]

65195-55-3 [2]

Repr. 2

Acute Tox. 2

Acute Tox. 1

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H300

H330

H372 (nervesystem) H400

H410

GHS06

GHS08

GHS09

Dgr

H361d

H300

H330

H372 (nervesystem) H410

STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5  %

≤ C < 5 %

M = 10 000

606-144-00-6

acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-ylacetat

—

57960-19-7

Skin Sens. 1

STOT SE 1

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H370 (lunge) (inhalation) H373 (blodsystem)

H400

H410

GHS07

GHS08

GHS09

Dgr

H317

H370 (lunge) (inhalation) H373 (blodsystem)

H410

M = 1 000

606-145-00-1

sulcotrion (ISO); 2-[2-chlor-4-(methylsulfonyl)benzoyl]cyclohexan-1,3-dion

99105-77-8

Repr. 2

STOT RE 2

Skin Sens. 1A Aquatic Acute 1

Aquatic Chronic 1

H373 (nyrer) H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361d H373 (nyrer) H317

H410

M = 1

M = 10

606-146-00-7

tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5- mesitylcyclohex-2-en-1-on

—

87820-88-0

Carc. 2

Acute Tox. 4

Aquatic Chronic 2

H351

H302

H411

GHS08

GHS07

GHS09

Wng

H351

H302

H411

606-147-00-2

cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3- yl)cyclohex-2-en-1-on

405-230-9

101205-02-1

Repr. 2

H361d

GHS08

Wng

H361d

607-001-00-0

myresyre ... %

200-579-1

64-18-6

Skin Corr. 1A

H314

GHS05

Dgr

H314

Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 %

Skin Irrit. 2; H315: 2 % ≤ C

< 10 %

Eye Irrit. 2; H319: 2 % ≤

< 10 %

B

607-002-00-6

eddikesyre ... %

200-580-7

64-19-7

Flam. Liq. 3

Skin Corr. 1A

H226

H314

GHS02

GHS05

Dgr

H226

H314

Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 25 % ≤ C < 90 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %

B

607-003-00-1

chloreddikesyre

201-178-4

79-11-8

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B Aquatic Acute 1

H331

H311

H301

H314

H400

GHS06

GHS05

GHS09

Dgr

H331

H311

H301

H314

H400

STOT SE 3; H335: C ≥ 5 %

607-004-00-7

TCA (ISO); trichloreddikesyre

200-927-2

76-03-9

Skin Corr. 1A Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

STOT SE 3; H335: C ≥ 1 %

607-005-00-2

TCA-Na (ISO); natriumtrichloracetat

211-479-2

650-51-1

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H335

H400

H410

GHS07

GHS09

Wng

H335

H410

607-006-00-8

oxalsyre

205-634-3

144-62-7

Acute Tox. 4 * Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

*

607-007-00-3

oxalsyrens salte undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 * Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

*

A

607-008-00-9

eddikesyreanhydrid

203-564-8

108-24-7

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1B

H226

H332

H302

H314

GHS02

GHS05

GHS07

Dgr

H226

H332

H302

H314

Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤ C

< 25 %

Eye Dam. 1; H318: 5 % ≤ C

< 25 %

Eye Irrit. 2; H319: 1 % ≤ C

< 5 %

STOT SE 3; H335: C ≥ 5 %

607-009-00-4

phthalsyreanhydrid

201-607-5

85-44-9

Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H302

H335

H315

H318

H334

H317

GHS08

GHS05

GHS07

Dgr

H302

H335

H315

H318

H334

H317

607-010-00-X

propionsyreanhydrid

204-638-2

123-62-6

Skin Corr. 1B

H314

GHS05

Dgr

H314

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C <25 %

Eye Irrit. 2; H319: 10 % ≤ C <25 %

607-011-00-5

acetylchlorid

200-865-6

75-36-5

Flam. Liq. 2

Skin Corr. 1B

H225

H314

GHS02

GHS05

Dgr

H225

H314

EUH014

607-012-00-0

benzoylchlorid

202-710-8

98-88-4

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H332

H312

H302

H314

H317

GHS05

GHS07

Dgr

H332

H312

H302

H314

H317

607-013-00-6

dimethylcarbonat

210-478-4

616-38-6

Flam. Liq. 2

H225

GHS02

Dgr

H225

607-014-00-1

methylformiat

203-481-7

107-31-3

Flam. Liq. 1

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H224

H332

H302

H319

H335

GHS02

GHS07

Dgr

H224

H332

H302

H319

H335

607-015-00-7

ethylformiat

203-721-0

109-94-4

Flam. Liq. 2

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H225

H332

H302

H319

H335

GHS02

GHS07

Dgr

H225

H332

H302

H319

H335

607-016-00-2

propylformiat; [1] isopropylformiat [2]

203-798-0 [1]

210-901-2 [2]

110-74-7 [1]

625-55-8 [2]

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

STOT SE 3

H225

H319

H335

H336

GHS02

GHS07

Dgr

H225

H319

H335

H336

C

607-017-00-8

butylformiat; [1] tert-butylformiat; [2] isobutylformiat [3]

209-772-5 [1]

212-105-0 [2]

208-818-1 [3]

592-84-7 [1]

762-75-4 [2]

542-55-2 [3]

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H335

GHS02

GHS07

Dgr

H225

H319

H335

C

607-018-00-3

isopentylformiat; [1] 2-methylbutylformiat [2]

203-769-2 [1]

252-343-2 [2]

110-45-2 [1]

35073-27-9 [2]

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H335

GHS02

GHS07

Dgr

H225

H319

H335

C

607-019-00-9

methylchlorformiat

201-187-3

79-22-1

Flam. Liq. 2

Acute Tox. 2 * Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H225

H330

H312

H302

H314

GHS02

GHS06

GHS05

Dgr

H225

H330

H312

H302

H314

607-020-00-4

ethylchlorformiat

208-778-5

541-41-3

Flam. Liq. 2

Acute Tox. 2 * Acute Tox. 4 *

Skin Corr. 1B

H225

H330

H302

H314

GHS02

GHS06

GHS05

Dgr

H225

H330

H302

H314

607-021-00-X

methylacetat

201-185-2

79-20-9

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

EUH066

607-022-00-5

ethylacetat

205-500-4

141-78-6

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

EUH066

607-023-00-0

vinylacetat

203-545-4

108-05-4

Flam. Liq. 2

Carc. 2

Acute Tox. 4

STOT SE 3

H225

H351

H332

H335

GHS02

GHS08

GHS07

Dgr

H225

H351

H332

H335

D

607-024-00-6

propylacetat; [1] isopropylacetat [2]

203-686-1 [1]

203-561-1 [2]

109-60-4 [1]

108-21-4 [2]

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

EUH066

C

607-025-00-1

n-butylacetat

204-658-1

123-86-4

Flam. Liq. 3

STOT SE 3

H226

H336

GHS02

GHS07

Wng

H226

H336

EUH066

607-026-00-7

sec-butylacetat; [1] isobutylacetat; [2] tert-butylacetat [3]

203-300-1 [1]

203-745-1 [2]

208-760-7 [3]

105-46-4 [1]

110-19-0 [2]

540-88-5 [3]

Flam. Liq. 2

H225

GHS02

Dgr

H225

EUH066

C

607-027-00-2

methylpropionat

209-060-4

554-12-1

Flam. Liq. 2

Acute Tox. 4 *

H225

H332

GHS02

GHS07

Dgr

H225

H332

607-028-00-8

ethylpropionat

203-291-4

105-37-3

Flam. Liq. 2

H225

GHS02

Dgr

H225

607-029-00-3

n-butylpropionat; [1] sec-butylpropionat; [2] iso-butylpropionat [3]

209-669-5 [1]

- [2]

208-746-0 [3]

590-01-2 [1]

591-34-4 [2]

540-42-1 [3]

Flam. Liq. 3

H226

GHS02

Wng

H226

C

607-030-00-9

propylpropionat

203-389-7

106-36-5

Flam. Liq. 3

Acute Tox. 4 *

H226

H332

GHS02

GHS07

Wng

H226

H332

607-031-00-4

butylbutyrat

203-656-8

109-21-7

Flam. Liq. 3

H226

GHS02

Wng

H226

C

607-032-00-X

ethylacrylat

205-438-8

140-88-5

Flam. Liq. 2

Acute Tox. 4 * Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H225

H332

H312

H302

H319

H335

H315

H317

GHS02

GHS07

Dgr

H225

H332

H312

H302

H319

H335

H315

H317

Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 %

D

607-033-00-5

n-butylmethacrylat

202-615-1

97-88-1

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H226

H319

H335

H315

H317

GHS02

GHS07

Wng

H226

H319

H335

H315

H317

D

607-034-00-0

methylacrylat; methylpropenoat

202-500-6

96-33-3

Flam. Liq. 2

Acute Tox. 4 * Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H225

H332

H312

H302

H319

H335

H315

H317

GHS02

GHS07

Dgr

H225

H332

H312

H302

H319

H335

H315

H317

D

607-035-00-6

methylmethacrylat; methyl 2-methylprop2enoat; methyl 2-methylpropenoat

201-297-1

80-62-6

Flam. Liq. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H225

H335

H315

H317

GHS02

GHS07

Dgr

H225

H335

H315

H317

D

607-036-00-1

2-methoxyethylacetat; methylglycolacetat

203-772-9

110-49-6

Repr. 1B

Acute Tox. 4 * Acute Tox. 4 *

Acute Tox. 4 *

H360FD H332

H312

H302

GHS08

GHS07

Dgr

H360FD H332

H312

H302

607-037-00-7

2-ethoxyethylacetat; ethylglycolacetat

203-839-2

111-15-9

Flam. Liq. 3

Repr. 1B

Acute Tox. 4 * Acute Tox. 4 *

Acute Tox. 4 *

H226

H360FD H332

H312

H302

GHS02

GHS08

GHS07

Dgr

H226

H360FD H332

H312

H302

607-038-00-2

2-butoxyethylacetat; butylglycolacetat

203-933-3

112-07-2

Acute Tox. 4 * Acute Tox. 4 *

H332

H312

GHS07

Wng

H332

H312

607-039-00-8

2,4-D (ISO); 2,4-dichlorphenoxyeddikesyre

202-361-1

94-75-7

Acute Tox. 4 * STOT SE 3

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H335

H318

H317

H412

GHS05

GHS07

Dgr

H302

H335

H318

H317

H412

607-040-00-3

salte af 2,4-D

—

—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

A

607-041-00-9

2,4,5-T; 2,4,5-trichlorphenoxyeddikesyre

202-273-3

93-76-5

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H335

H315

H410

607-042-00-4

salte og estere af 2,4,5-T; salte og estere af 2,4,5-trichlorphenoxyeddikesyre

—

—

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H335

H315

H410

A

607-043-00-X

dicamba (ISO); 2,5-dichlor-6-methoxybenzoesyre; 3,6-dichlor-2-methoxybenzoesyre

217-635-6

1918-00-9

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

607-044-00-5

3,6-dichlor-o-anissyre, forbindelse med dimethylamin (1:1); [1] kalium-3,6-dichlor-o-anisat [2]

218-951-7 [1]

233-002-7 [2]

2300-66-5 [1]

10007-85-9 [2]

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

607-045-00-0

dichlorprop (ISO); 2-(2,4-dichlorphenoxy) propionsyre

204-390-5

120-36-5

Acute Tox. 4 * Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

H312

H302

H315

H318

GHS05

GHS07

Dgr

H312

H302

H315

H318

607-046-00-6

salte af dichlorprop

—

—

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

H332

H312

H302

GHS07

Wng

H332

H312

H302

A

607-047-00-1

fenoprop (ISO); 2-(2,4,5-trichlorphenoxy)propionsyre

202-271-2

93-72-1

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H400

H410

GHS07

GHS09

Wng

H302

H315

H410

607-048-00-7

salte af fenoprop; salte af 2-(2,4,5-trichlorphenoxy)propionsyre

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

A

607-049-00-2

mecoprop (ISO); 2-(4-chlor-o-tolyloxy) propionsyre; (RS)-2-(4-chlor-o-tolyloxy) propionsyre; [1] 2-2-(4-chlor-2-methylphenoxy)propionsyre [2]

230-386-8 [1]

202-264-4 [2]

7085-19-0 [1]

708519-0 [2]

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H315

H318

H410

M = 100

607-050-00-8

salte af mechlorprop

—

—

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H315

H318

H410

A

607-051-00-3

MCPA (ISO); 4-chlor-o-tolyloxyeddikesyre

202-360-6

94-74-6

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H315

H318

H410

607-052-00-9

salte og estere af MCPA

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

A

607-053-00-4

MCPB (ISO); 4-(4-chlor-o-tolyloxy) smørsyre

202-365-3

94-81-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-054-00-X

salte og estere af MCPB

—

—

Acute Tox. 4 *

H302

GHS07

Wng

H302

A

607-055-00-5

endothalnatrium (ISO); dinatrium-7-oxabicyclo(2,2,1)heptan-2,3-dicarboxylat

204-959-8

129-67-9

Acute Tox. 3 * Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H301

H312

H319

H335

H315

GHS06

Dgr

H301

H312

H319

H335

H315

607-057-00-6

coumachlor (ISO); 3-(1-(4-chlorphenyl)-3-oxobutyl)-4-hydroxycumarin

201-378-1

81-82-3

STOT RE 2 *

Aquatic Chronic 3

H373 ** H412

GHS08

Wng

H373 ** H412

607-058-00-1

coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)-butyl]-coumarin

204-195-5

117-52-2

Acute Tox. 3 * STOT RE 1

Aquatic Chronic 3

H301

H372 ** H412

GHS06

GHS08

Dgr

H301

H372 ** H412

607-060-00-2

dicumarol; 4,4'-dihydroxy-3,3' methylenbis(2H-chromen-2-on)

200-632-9

66-76-2

STOT RE 1

Acute Tox. 4 *

Aquatic Chronic 2

H372 ** H302

H411

GHS08

GHS07

GHS09

Dgr

H372 ** H302

H411

607-061-00-8

acrylsyre; 2-propensyre

201-177-9

79-10-7

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1A Aquatic Acute 1

H226

H332

H312

H302

H314

H400

GHS02

GHS05

GHS07

GHS09

Dgr

H226

H332

H312

H302

H314

H400

STOT SE 3; H335: C ≥ 1 %

D

607-062-00-3

butylacrylat

205-480-7

141-32-2

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H226

H319

H335

H315

H317

GHS02

GHS07

Wng

H226

H319

H335

H315

H317

D

607-063-00-9

isosmørsyre

201-195-7

79-31-2

Acute Tox. 4 * Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

607-064-00-4

benzylchlorformiat

207-925-0

501-53-1

Skin Corr. 1B Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

STOT SE 3; H335: C ≥ 5 %

607-065-00-X

bromeddikesyre

201-175-8

79-08-3

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

H331

H311

H301

H314

H317

H400

GHS06

GHS05

GHS09

Dgr

H331

H311

H301

H314

H317

H400

607-066-00-5

dichloreddikesyre

201-207-0

79-43-6

Skin Corr. 1A Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

607-067-00-0

dichloracetylchlorid

201-199-9

79-36-7

Skin Corr. 1A Aquatic Acute 1

H314

H400

GHS05

GHS09

Dgr

H314

H400

607-068-00-6

iodeddikesyre

200-590-1

64-69-7

Acute Tox. 3 *

Skin Corr. 1A

H301

H314

GHS06

GHS05

Dgr

H301

H314

607-069-00-1

ethylbromacetat

203-290-9

105-36-2

Acute Tox. 2 * Acute Tox. 1

Acute Tox. 2 *

H330

H310

H300

GHS06

Dgr

H330

H310

H300

607-070-00-7

ethylchloracetat

203-294-0

105-39-5

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 * Aquatic Acute 1

H331

H311

H301

H400

GHS06

GHS09

Dgr

H331

H311

H301

H400

607-071-00-2

ethylmethacrylat

202-597-5

97-63-2

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H225

H319

H335

H315

H317

GHS02

GHS07

Dgr

H225

H319

H335

H315

H317

D

607-072-00-8

2-hydroxyethylacrylat

212-454-9

818-61-1

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

H311

H314

H317

H400

GHS06

GHS05

GHS09

Dgr

H311

H314

H317

H400

*

Skin Sens. 1; H317: C ≥ 0,2  %

D

607-073-00-3

4-CPA (ISO); 4-chlorphenoxyeddikesyre

204-581-3

122-88-3

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-074-00-9

chlorfenac; 2,3,6-trichlorphenyleddikesyre

201-599-3

85-34-7

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-075-00-4

chlorfenprop-methyl; methyl-2-chlor-3-(4-chlorphenyl)propionat

238-413-5

14437-17-3

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

607-076-00-X

dodin; dodecylguanidinacetat

219-459-5

2439-10-3

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H315

H400

H410

GHS07

GHS09

Wng

H302

H319

H315

H410

607-077-00-5

erbon; 2-(2,4,5-trichlorphenoxy)ethyl-2,2-dichlorpropionat

—

136-25-4

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-078-00-0

fluenetil (ISO); 2-fluorethylbiphenyl-4-ylacetat

—

4301-50-2

Acute Tox. 1

Acute Tox. 2 *

H310

H300

GHS06

Dgr

H310

H300

607-079-00-6

kelevan (ISO);ethyl 5-(perchlor-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoat; ethyl 5-(1,2,3,5,6,7,8,9,10,10- decachlor-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4- yl)-4-oxovalerat

—

4234-79-1

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Chronic 2

H311

H302

H411

GHS06

GHS09

Dgr

H311

H302

H411

607-080-00-1

chloracetylchlorid

201-171-6

79-04-9

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1

Skin Corr. 1A Aquatic Acute 1

H331

H311

H301

H372 ** H314

H400

GHS06

GHS08

GHS05

GHS09

Dgr

H331

H311

H301

H372 ** H314

H400

EUH014

EUH029

607-081-00-7

fluoreddikesyre

205-631-7

144-49-0

Acute Tox. 2 * Aquatic Acute 1

H300

H400

GHS06

GHS09

Dgr

H300

H400

607-082-00-2

monofluoracetater, opløselige

—

—

Acute Tox. 2 * Aquatic Acute 1

H300

H400

GHS06

GHS09

Dgr

H300

H400

A

607-083-00-8

2,4-DB (ISO); 4-(2,4-dichlorphenoxy)smørsyre

202-366-9

94-82-6

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-084-00-3

salte af 2,4-DB

—

—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

A

607-085-00-9

benzylbenzoat

204-402-9

120-51-4

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-086-00-4

diallylphthalat

205-016-3

131-17-9

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

607-088-00-5

methacrylsyre; 2-methylpropensyre

201-204-4

79-41-4

Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1A

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

STOT SE 3; H335: C ≥ 1 %

D

607-089-00-0

propionsyre ... %

201-176-3

79-09-4

Skin Corr. 1B

H314

GHS05

Dgr

H314

Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤

C < 25 %

STOT SE 3; H335: C ≥ 10 %

B

607-090-00-6

thioglycolsyre

200-677-4

68-11-1

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

H331

H311

H301

H314

GHS06

GHS05

Dgr

H331

H311

H301

H314

*

607-091-00-1

trifluoreddikesyre . . . %

200-929-3

76-05-1

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Chronic 3

H332

H314

H412

GHS05

GHS07

Dgr

H332

H314

H412

*

B

607-092-00-7

methyllactat; [1] methyl-(±)-lactat; [2] methyl-(R)-lactat; [3] methyl-(S)-(-)-lactat [4]

208-930-0 [1]

218-449-8 [2]

241-420-6 [3]

248-704-9 [4]

547-64-8 [1]

2155-30-8 [2]

17392-83-5 [3]

27871-49-4 [4]

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

H226

H319

H335

GHS02

GHS07

Wng

H226

H319

H335

C

607-093-00-2

propionylchlorid

201-170-0

79-03-8

Flam. Liq. 2

Skin Corr. 1B

H225

H314

GHS02

GHS05

Dgr

H225

H314

EUH014

B D

607-094-00-8

pereddikesyre . . . %

201-186-8

79-21-0

Flam. Liq. 3

Org. Perox. D **** Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A Aquatic Acute 1

H226

H242

H332

H312

H302

H314

H400

GHS02

GHS05

GHS07

GHS09

Dgr

H226

H242

H332

H312

H302

H314

H400

*

STOT SE 3; H335: C ≥ 1 %

B D

607-095-00-3

maleinsyre

203-742-5

110-16-7

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H302

H319

H335

H315

H317

GHS07

Wng

H302

H319

H335

H315

H317

Skin Sens. 1; H317: C ≥ 0,1  %

607-096-00-9

maleinsyreanhydrid

203-571-6

108-31-6

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

H302

H314

H334

H317

GHS08

GHS05

GHS07

Dgr

H302

H314

H334

H317

607-097-00-4

benzen-1,2,4-tricarboxylsyre-1,2-anhydrid; trimellitsyreanhydrid

209-008-0

552-30-7

STOT SE 3

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H335

H318

H334

H317

GHS08

GHS05

GHS07

Dgr

H335

H318

H334

H317

607-098-00-X

benzen-1,2:4,5-tetracarboxylsyredianhydrid; 1,2,4,5-benzentetracarboxylsyredianhydrid

201-898-9

89-32-7

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H318

H334

H317

GHS08

GHS05

Dgr

H318

H334

H317

607-099-00-5

1,2,3,6-tetrahydrophtalsyreanhydrid; [1] cis-1,2,3,6-tetrahydrophthalsyreanhydrid; [2] 3,4,5,6-tetrahydrophtalsyreanhydrid; [3] tetrahydrophthalsyreanhydrid [4]

201-605-4 [1]

213-308-7 [2]

219-374-3 [3]

247-570-9 [4]

85-43-8 [1]

935-79-5 [2]

2426-02-0 [3]

26266-63-7 [4]

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H334

H317

H412

GHS08

GHS05

Dgr

H318

H334

H317

H412

C

607-100-00-9

3,3',4,4'-benzophenontetracarboxylsyredianhydrid; 4,4'-carbonyldi(phtalsyreanhydrid)

219-348-1

2421-28-5

Eye Irrit. 2

STOT SE 3

H319

H335

GHS07

Wng

H319

H335

Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %

607-101-00-4

1,4,5,6,7,7-hexachlorbicyclo-[2,2,1]-hept-5-en-2,3-dicarboxylsyreanhydrid; chlorendinsyreanhydrid

204-077-3

115-27-5

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %

607-102-00-X

cyclohexan-1,2-dicarboxylsyreanhydrid; [1] cis-cyclohexan-1,2-dicarboxylsyreanhydrid; [2] trans-cyclohexan-1,2-dicarboxylsyreanhydrid [3]

201-604-9 [1]

236-086-3 [2]

238-009-9 [3]

85-42-7 [1]

13149-00-3 [2]

14166-21-3 [3]

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H318

H334

H317

GHS08

GHS05

Dgr

H318

H334

H317

C

607-103-00-5

ravsyreanhydrid

203-570-0

108-30-5

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H302

H319

H335

GHS07

Wng

H302

H319

H335

*

Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %

607-104-00-0

1,2,3,4-cyclopentantetracarboxylsyredianhydrid

227-964-7

6053-68-5

Eye Irrit. 2

STOT SE 3

H319

H335

GHS07

Wng

H319

H335

Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 %

607-105-00-6

8,9,10-trinorborn-5-en-2,3-dicarboxylsyreanhydrid; [1] 1,2,3,6-tetrahydro-3,6-methanophthalsyreanhydrid; [2](1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalsyreanhydrid [3]

204-957-7 [1]

212-557-9 [2]

220-384-5 [3]

129-64-6 [1]

826-62-0 [2]

2746-19-2 [3]

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H318

H334

H317

GHS08

GHS05

Dgr

H318

H334

H317

C

607-106-00-1

1-methyl-5-norbornen-2,3-dicarboxylsyreanhydrid; 8,9-dinorborn-5-en-2,3-dicarboxylsyreanhydrid

—

123748-85-6

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H302

H319

H335

H315

H334

GHS08

GHS07

Dgr

H302

H319

H335

H315

H334

STOT SE 3; H335: C ≥ 10 %

C

607-107-00-7

2-ethylhexylacrylat

203-080-7

103-11-7

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H335

H315

H317

GHS07

Wng

H335

H315

H317

D

607-108-00-2

2-hydroxy-1-methylethylacrylat; [1] 2-hydroxypropylacrylat; [2] acrylsyre, monoester med propan-1,2-diol [3]

220-852-9 [1]

213-663-8 [2]

247-118-0 [3]

2918-23-2 [1]

999-61-1 [2]

25584-83-2 [3]

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

H331

H311

H301

H314

H317

GHS06

GHS05

Dgr

H331

H311

H301

H314

H317

*

Skin Sens. 1; H317:C ≥ 0,2  %

C D

607-109-00-8

hexamethylendiacrylat; 1,6-hexandioldiacrylat

235-921-9

13048-33-4

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

D

607-110-00-3

pentaerythritoltriacrylat

222-540-8

3524-68-3

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

D

607-111-00-9

2,2-bis(acryloyloxymethyl)butylacrylat; trimethylolpropantriacrylat

239-701-3

15625-89-5

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

D

607-112-00-4

2,2-dimethylpropandiol-1,3-diacrylat; neopentylglycoldiacrylat

218-741-5

2223-82-7

Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H311

H319

H315

H317

GHS06

Dgr

H311

H319

H315

H317

*

D

607-113-00-X

isobutylmethacrylat

202-613-0

97-86-9

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H226

H319

H335

H315

H317

H400

GHS02

GHS07

GHS09

Wng

H226

H319

H335

H315

H317

H400

D

607-114-00-5

ethylendimethacrylat

202-617-2

97-90-5

STOT SE 3

Skin Sens. 1

H335

H317

GHS07

Wng

H335

H317

STOT SE 3; H335: C ≥ 10 %

D

607-115-00-0

isobutylacrylat

203-417-8

106-63-8

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

H226

H332

H312

H315

H317

GHS02

GHS07

Wng

H226

H332

H312

H315

H317

D

607-116-00-6

cyclohexylacrylat

221-319-3

3066-71-5

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2

H335

H315

H411

GHS07

GHS09

Wng

H335

H315

H411

STOT SE 3; H335: C ≥ 10 %

D

607-117-00-1

2,3-epoxypropylacrylat, glycidylacrylat

203-440-3

106-90-1

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

H331

H311

H301

H314

H317

GHS06

GHS05

Dgr

H331

H311

H301

H314

H317

*

Skin Sens. 1; H317:C ≥ 0,2  %

D

607-118-00-7

1-methyltrimethylendiacrylat; 1,3-butylenglycoldiacrylat

243-105-9

19485-03-1

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H312

H314

H317

GHS05

GHS07

Dgr

H312

H314

H317

D

607-119-00-2

tetramethylendiacrylat; 1,4-butylenglycoldiacrylat

213-979-6

1070-70-8

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H312

H314

H317

GHS05

GHS07

Dgr

H312

H314

H317

D

607-120-00-8

2,2'-oxydiethyldiacrylat; diethylenglycoldiacrylat

223-791-6

4074-88-8

Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H311

H319

H315

H317

GHS06

Dgr

H311

H319

H315

H317

*

Skin Sens. 1; H317:C ≥ 0,2  %

D

607-121-00-3

8,9,10-trinorborn-2-ylacrylat

—

10027-06-2

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

H312

H315

H317

GHS07

Wng

H312

H315

H317

D

607-122-00-9

pentaerythritoltetraacrylat

225-644-1

4986-89-4

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

D

607-124-00-X

2-hydroxyethylmethacrylat

212-782-2

868-77-9

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

D

607-125-00-5

2-hydroxypropylmethacrylat; [1] 3-hydroxypropylmethacrylat [2]

213-090-3 [1]

220-426-2 [2]

923-26-2 [1]

2761-09-3 [2]

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

C D

607-126-00-0

2,2'-(ethylendioxy)diethyldiacrylat; triethylenglycoldiacrylat

216-853-9

1680-21-3

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

D

607-127-00-6

2-diethylaminoethylmethacrylat

203-275-7

105-16-8

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H332

H319

H315

H317

GHS07

Wng

H332

H319

H315

H317

D

607-128-00-1

2-tert-butylaminoethylmethacrylat

223-228-4

3775-90-4

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

D

607-129-00-7

ethyllactat; ethyl DL-lactat; [1] ethyl (S)-2-hydroxypropionat; ethyl L-lactat; ethyl-(S)-lactat [2]

202-598-0 [1]

211-694-1 [2]

97-64-3 [1]

687-47-8 [2]

Flam. Liq. 3

STOT SE 3

Eye Dam. 1

H226

H335

H318

GHS02

GHS05

GHS07

Dgr

H226

H335

H318

C

607-130-00-2

pentylacetat; [1] isopentylacetat; [2] 1-methylbutylacetat; [3] 2-methylbutylacetat; [4] 2(eller 3)-methylbutyl acetat [5]

211-047-3 [1]

204-662-3 [2]

210-946-8 [3]

210-843-8 [4]

282-263-3 [5]

628-63-7 [1]

123-92-2 [2]

626-38-0 [3]

624-41-9 [4]

84145-37-9 [5]

Flam. Liq. 3

H226

GHS02

Wng

H226

EUH066

C

607-131-00-8

isopentylpropionat; [1] pentylpropionat; [2] 2-methylbutylpropionat [3]

203-322-1 [1]

210-852-7 [2]

219-449-0 [3]

105-68-0 [1]

624-54-4 [2]

2438-20-2 [3]

Flam. Liq. 3

H226

GHS02

Wng

H226

C

607-132-00-3

2-dimethylaminoethylmethacrylat

220-688-8

2867-47-2

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H312

H302

H319

H315

H317

GHS07

Wng

H312

H302

H319

H315

H317

D

607-133-00-9

monoalkyl eller monoaryl eller monoalkylaryl esters af acrylsyre undtagen sådanne nævnt andetsteds i dette bilag

—

—

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2

H319

H335

H315

H411

GHS07

GHS09

Wng

H319

H335

H315

H411

STOT SE 3; H335: C ≥ 10 %

A

607-134-00-4

monoalkyl eller monoaryl eller monoalkylaryl esters af methacrylater undtagen sådanne nævnt andetsteds i dette bilag

—

—

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

STOT SE 3; H335: C ≥ 10 %

A

607-135-00-X

smørsyre

203-532-3

107-92-6

Skin Corr. 1B

H314

GHS05

Dgr

H314

607-136-00-5

butyroylchlorid

205-498-5

141-75-3

Flam. Liq. 2

Skin Corr. 1B

H225

H314

GHS02

GHS05

Dgr

H225

H314

607-137-00-0

methylacetoacetat

203-299-8

105-45-3

Eye Irrit. 2

H319

GHS07

Wng

H319

607-138-00-6

butylchlorformiat; chlormyresyrebutylester

209-750-5

592-34-7

Flam. Liq. 3

Acute Tox. 3 *

Skin Corr. 1B

H226

H331

H314

GHS02

GHS06

GHS05

Dgr

H226

H331

H314

607-139-00-1

2-chlorpropionsyre

209-952-3

598-78-7

Acute Tox. 4 *

Skin Corr. 1A

H302

H314

GHS05

GHS07

Dgr

H302

H314

607-140-00-7

isobutyroylchlorid

201-194-1

79-30-1

Flam. Liq. 2

Skin Corr. 1A

H225

H314

GHS02

GHS05

Dgr

H225

H314

607-141-00-2

oxydiethylenbis(chloroformiat)

203-430-9

106-75-2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H302

H315

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H315

H318

H411

607-142-00-8

propylchlorformiat; chlormyresyrepropylester; n-propylchlorformiat

203-687-7

109-61-5

Flam. Liq. 2

Acute Tox. 3 *

Skin Corr. 1B

H225

H331

H314

GHS02

GHS06

GHS05

Dgr

H225

H331

H314

607-143-00-3

valerianesyre

203-677-2

109-52-4

Skin Corr. 1B

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

607-144-00-9

adipinsyre

204-673-3

124-04-9

Eye Irrit. 2

H319

GHS07

Wng

H319

607-145-00-4

methansulfonsyre

200-898-6

75-75-2

Skin Corr. 1B

H314

GHS05

Dgr

H314

607-146-00-X

fumarsyre

203-743-0

110-17-8

Eye Irrit. 2

H319

GHS07

Wng

H319

607-147-00-5

diethyloxalat; ethyloxalat

202-464-1

95-92-1

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

607-148-00-0

guanidinhydrochlorid; guanidiniumchlorid

200-002-3

50-01-1

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H302

H319

H315

GHS07

Wng

H302

H319

H315

607-149-00-6

urethan (INN); ethylcarbamat

200-123-1

51-79-6

Carc. 1B

H350

GHS08

Dgr

H350

607-150-00-1

endothal; 7-oxabicyclo(2,2,1)heptan-2,3-dicarboxylsyre

205-660-5

145-73-3

Acute Tox. 3 * Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H301

H312

H319

H335

H315

GHS06

Dgr

H301

H312

H319

H335

H315

607-151-00-7

propargit (ISO); 2-(4-tert-butylphenoxy) cyclohexylprop-2-ynylsulfit

219-006-1

2312-35-8

Carc. 2

Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H331

H315

H318

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H351

H331

H315

H318

H410

M = 10

607-152-00-2

2,3,6-TBA (ISO), 2,3,6-trichlorbenzoesyre

200-026-4

50-31-7

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-153-00-8

benazolin (ISO), 4-chlor-2-oxobenzothiazolin-3-yleddikesyre

223-297-0

3813-05-6

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3

H319

H315

H412

GHS07

Wng

H319

H315

H412

607-154-00-3

ethyl-N-benzoyl-N-(3,4-dichlorphenyl)-.sc.DL.sc.-alaninat; benzoylprop-ethyl (ISO)

244-845-5

22212-55-1

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

607-155-00-9

3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylsyre;

blasticidin-s

—

2079-00-7

Acute Tox. 2 *

H300

GHS06

Dgr

H300

607-156-00-4

chlorfenson (ISO); 4-chlorphenyl-4-chlorbenzensulfonat

201-270-4

80-33-1

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H400

H410

GHS07

GHS09

Wng

H302

H315

H410

607-158-00-5

natrium-salt af chloreddikesyre; natriumchloracetat

223-498-3

3926-62-3

Acute Tox. 3 *

Skin Irrit. 2

Aquatic Acute 1

H301

H315

H400

GHS06

GHS09

Dgr

H301

H315

H400

607-159-00-0

chlorobenzilat (ISO); ethyl 2,2-di(4-chlorphenyl)-2-hydroxyacetat; ethyl-4,4'-dichlorbenzilat

208-110-2

510-15-6

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

607-160-00-6

isobutyl-2-(4-(4-chlorphenoxy)phenoxy)propionat; clofop-isobutyl (ISO)

—

51337-71-4

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-161-00-1

salt af diethanolamin af 4-CPA

—

—

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-162-00-7

dalapon; 2,2-dichlorpropionsyre; [1] dalapon-natrium; natrium-2,2-dichlorpropionat [2]

200-923-0 [1]

204-828-5 [2]

75-99-0 [1]

127-20-8 [2]

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H315

H318

H412

GHS05

Dgr

H315

H318

H412

607-163-00-2

3-acetyl-6-methyl-2H-pyran-2,4(3H)-dion; dehydracetsyre

208-293-9

520-45-6

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-164-00-8

natrium-1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-yliden)ethanolat; natrium dehydracetat

224-580-1

4418-26-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-165-00-3

diclofop-methyl (ISO); methyl-2-(4-(2,4-dichlorphenoxy)phenoxy)propionat; methyl (RS)-2-[4-(2,4-dichlorphenoxy)phenoxy]propionat

257-141-8

51338-27-3

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

607-166-00-9

medinoterbacetat (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenylacetat

219-634-6

06-01-2487

Acute Tox. 3 * Acute Tox. 4 *

H301

H312

GHS06

Dgr

H301

H312

607-167-00-4

natrium-3-chloracrylat

—

4312-97-4

Acute Tox. 4 * Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

607-168-00-X

dipropyl-6,7-methylendioxy-1,2,3,4-tetrahydro-3-methylnaphthalen-1,2-dicarboxylat; propylisom

—

83-59-0

Acute Tox. 3 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H311

H302

H400

H410

GHS06

GHS09

Dgr

H311

H302

H410

607-169-00-5

natriumfluoracetat

200-548-2

62-74-8

Acute Tox. 2 * Acute Tox. 1

Acute Tox. 2 * Aquatic Acute 1

H330

H310

H300

H400

GHS06

GHS09

Dgr

H330

H310

H300

H400

607-170-00-0

bis(1,2,3-trithiacyclohexyldimethylammonium)oxalat; thiocyclamhydrogenoxalat

250-859-2

31895-22-4

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

607-173-00-7

dimethyl-(3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionat

400-460-6

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-174-00-2

blanding af tetradecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionat og dodecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionat

400-580-9

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-175-00-8

methyl-2-(2-nitrobenzyliden)acetoacetat

400-650-9

39562-27-1

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-176-00-3

blanding af α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylen) og α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylen)

400-830-7

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-177-00-9

tribenuron-methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoesyre-methylester; methyl-2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulfonyl)benzoat

401-190-1

101200-48-0

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 100

607-178-00-4

methyl-α-((4,6-dimethoxypyrimidin-2-yl)ureidosulfonyl)-o-toluat

401-340-6

83055-99-6

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-179-00-X

(benzothiazol-2-ylthio)ravsyre

401-450-4

95154-01-1

Skin Sens. 1

H317

GHS07

Wng

H317

607-180-00-5

kalium-2-hydroxycarbazol-1-carboxylat

401-630-2

96566-70-0

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Chronic 3

H302

H319

H335

H412

GHS07

Wng

H302

H319

H335

H412

607-181-00-0

3,5-dichlor-2,4-difluorbenzoylfluorid

401-800-6

101513-70-6

Acute Tox. 3 *

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H331

H314

H302

H317

H412

GHS06

GHS05

Dgr

H331

H314

H302

H317

H412

EUH029

607-182-00-6

methyl-3-sulfamoyl-2-thenoat

402-050-2

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-183-00-1

zink-2-hydroxy-5-C13-18-alkylbenzoat

402-280-3

—

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H319

H315

H411

GHS07

GHS09

Wng

H319

H315

H411

607-184-00-7

S-(3-trimethoxysilyl)propyl-19-isocyanoato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanthioat

402-290-8

85702-90-5

Flam. Liq. 3

Resp. Sens. 1

Skin Sens. 1

H226

H334

H317

GHS02

GHS08

Dgr

H226

H334

H317

607-185-00-2

ethyl-trans-3-dimethylaminoacrylat

402-650-4

1117-37-9

Skin Sens. 1

H317

GHS07

Wng

H317

607-186-00-8

quinclorac (ISO); 3,7-dichlorquinolin-8-carboxylsyre

402-780-1

84087-01-4

Skin Sens. 1

H317

GHS07

Wng

H317

607-187-00-3

bis(2,2,6,6-tetramethyl-4-piperidyl)succinat

402-940-0

62782-03-0

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

607-188-00-9

hydrogennatrium-N-carboxylatoethyl-N-octadec-9-enylmaleamat

402-970-4

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-189-00-4

trimethylendiamintetraeddikesyre

400-400-9

1939-36-2

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

607-190-00-X

methylacrylamidomethoxyacetat (der indeholder ≥ 0,1 % acrylamid)

401-890-7

77402-03-0

Carc. 1B Muta. 1B

Acute Tox. 4 *

Eye Irrit. 2

H350

H340

H302

H319

GHS08

GHS07

Dgr

H350

H340

H302

H319

607-191-00-5

isobutyl-3,4-epoxybutyrat

401-920-9

100181-71-3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

607-192-00-0

dinatrium-N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinat

402-360-8

92511-22-3

Eye Dam. 1

H318

GHS05

Dgr

H318

607-194-00-1

propylencarbonat

203-572-1

108-32-7

Eye Irrit. 2

H319

GHS07

Wng

H319

607-195-00-7

2-methoxy-1-methylethylacetat

203-603-9

108-65-6

Flam. Liq. 3

H226

GHS02

Wng

H226

607-196-00-2

heptansyre

203-838-7

111-14-8

Skin Corr. 1B

H314

GHS05

Dgr

H314

607-198-00-3

propyl-3,4,5-trihydroxybenzoat

204-498-2

121-79-9

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

607-199-00-9

octyl-3,4,5-trihydroxybenzoat

213-853-0

1034-01-1

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

607-200-00-2

dodecyl-3,4,5-trihydroxybenzoat

214-620-6

1166-52-5

Skin Sens. 1

H317

GHS07

Wng

H317

607-201-00-8

tiocarbonylchlorid

207-341-6

463-71-8

Acute Tox. 3 * Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H331

H302

H319

H335

H315

GHS06

Dgr

H331

H302

H319

H335

H315

607-203-00-9

2-ethylhexyl-[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetat

279-452-8

80387-97-9

Repr. 1B

Skin Sens. 1

Aquatic Chronic 3

H360D *** H317

H412

GHS08

GHS07

Dgr

H360D *** H317

H412

607-204-00-4

(chlorphenyl)(chlortolyl)methan, blanding af isomerer

400-140-6

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-205-00-X

methylchloracetat

202-501-1

96-34-4

Flam. Liq. 3

Acute Tox. 3 * Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H226

H331

H301

H335

H315

H318

GHS02

GHS06

GHS05

Dgr

H226

H331

H301

H335

H315

H318

607-206-00-5

isopropylchloracetat

203-301-7

105-48-6

Flam. Liq. 3

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H226

H301

H319

H335

H315

GHS02

GHS06

Dgr

H226

H301

H319

H335

H315

607-207-00-0

haloxyfop-etotyl (ISO); 2-ethoxyethyl-2-(4-(3-chlor-5-trifluormethyl-2-pyridyloxy)phenoxy)propionat; haloxyfop-(2-etoxyethyl)

402-560-5

87237-48-7

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

607-208-00-6

4,8,12-trimethyltrideca-3,7,11-triensyre, blanding af isomerer

403-000-2

91853-67-7

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

607-209-00-1

blanding af O, O'-diisopropyl-(trithio)dithioformiat og O, O'-diisopropyl-(tetrathio)dithioformiat og O, O'-diisopropyl-(pentathio)dithioformiat

403-030-6

—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

607-210-00-7

methylacrylamidoglycolat (der indeholder ≥ 0,1 % acrylamid)

403-230-3

77402-05-2

Carc. 1B Muta. 1B

Skin Corr. 1B

Skin Sens. 1

H350

H340

H314

H317

GHS08

GHS05

GHS07

Dgr

H350

H340

H314

H317

607-211-00-2

methyl-3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionat

403-270-1

6386-39-6

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-212-00-8

poly(oxypropylencarbonyl-co-oxy(ethylethylen)carbonyl), indholdende 27 % hydroxyvalerat

403-300-3

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-213-00-3

ethyl-3,3-bis(tert-pentylperoxy)butyrat

403-320-2

67567-23-1

Org. Perox. D **** Flam. Liq. 3

Aquatic Chronic 2

H242

H226

H411

GHS02

GHS09

Dgr

H242

H226

H411

607-214-00-9

N, N-hydrazinodieddikesyre

403-510-5

19247-05-3

Acute Tox. 3 * STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H301

H373 ** H317

H412

GHS06

GHS08

Dgr

H301

H373 ** H317

H412

607-215-00-4

3-(3-tert-butyl-4-hydroxyphenyl)propionsyre

403-920-4

107551-67-7

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

607-216-00-X

glutaminsyre, reaktionsprodukter med N-(C12-14-alkyl)propylendiamin

403-950-8

—

Acute Tox. 2 * Acute Tox. 4 *

Skin Corr. 1B Aquatic Acute 1

H330

H302

H314

H400

GHS06

GHS05

GHS09

Dgr

H330

H302

H314

H400

607-217-00-5

2-ethoxyethyl-2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetat

403-960-2

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-218-00-0

dichlorprop-P ISO; (+)-R-2-(2,4-dichlorphenoxy)propionsyre

403-980-1

15165-67-0

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H302

H315

H318

H317

GHS05

GHS07

Dgr

H302

H315

H318

H317

607-219-00-6

bis(2-ethylhexyl)dithiodiacetat

404-510-8

62268-47-7

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

607-221-00-7

6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalen-2-carboxylsyre

404-550-6

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-222-00-2

6-(2,3-dimethylmaleimido)hexylmethacrylat

404-870-6

63740-41-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-223-00-8

transfluthrin (ISO); 2,3,5,6-tetrafluorbenzyl-trans-2-(2,2-dichlorvinyl)-3,3-dimethylcyclopropancarboxylat

405-060-5

118712-89-3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

607-224-00-3

methyl-2-(3-nitrobenzyliden)acetoacetat

405-270-7

39562-17-9

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-225-00-9

3-azidosulfonylbenzoesyre

405-310-3

15980-11-7

Self-React. C **** STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H241

H373 ** H318

H317

GHS02

GHS08

GHS05

GHS07

Dgr

H241

H373 ** H318

H317

607-226-00-4

blanding af 2-methacryloyloxyethylhydrogencyclohexan-1,2-dicarboxylat og 2-acryloyloxyethylhydrogencyclohexan-1,2-dicarboxylat

405-360-6

—

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H315

H318

H317

H412

GHS05

GHS07

Dgr

H315

H318

H317

H412

607-227-00-X

kalium-2-amino-2-methylpropionatoctahydrat

405-560-3

120447-91-8

Acute Tox. 4 *

Skin Corr. 1A

H302

H314

GHS05

GHS07

Dgr

H302

H314

607-228-00-5

bis(2-methoxyethyl)phthalat

204-212-6

117-82-8

Repr. 1B

H360Df

GHS08

Dgr

H360Df

607-229-00-0

diethylcarbamoylchlorid

201-798-5

88-10-8

Carc. 2

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H351

H332

H302

H319

H335

H315

GHS08

GHS07

Wng

H351

H332

H302

H319

H335

H315

607-230-00-6

2-ethylhexansyre

205-743-6

149-57-5

Repr. 2

H361d ***

GHS08

Wng

H361d ***

607-231-00-1

clopyralid (ISO); 3,6-dichlorpyridin-2-carboxylsyre

216-935-4

1702-17-6

Eye Dam. 1

H318

GHS05

Dgr

H318

607-232-00-7

pyridat (ISO); O-(6-chlor-3-phenylpyridazin-4-yl)-S-octylthiocarbonat

259-686-7

55512-33-9

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

607-233-00-2

hexylacrylat

219-698-5

2499-95-8

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H319

H335

H315

H317

H411

GHS07

GHS09

Wng

H319

H335

H315

H317

H411

607-234-00-8

flurenol (ISO); 9-hydroxy-9H-fluoren-9-carboxylsyre

207-397-1

467-69-6

Aquatic Chronic 2

H411

GHS09

H411

607-235-00-3

mecrilat; methyl-2-cyanacrylat

205-275-2

137-05-3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

STOT SE 3; H335: C ≥ 10 %

607-236-00-9

ethyl-2-cyanacrylat

230-391-5

7085-85-0

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

STOT SE 3; H335: C ≥ 10 %

607-237-00-4

benzyl-2-chlor-4-(trifluormethyl)thiazol-5-carboxylat; flurazol

276-942-3

72850-64-7

Aquatic Chronic 2

H411

GHS09

H411

607-238-00-X

tau-fluvalinat; cyan(3-phenoxyphenyl)methyl-N-[2-chlor-4-(trifluoromethyl)phenyl-.sc.D.sc.-valinat

—

102851-06-9

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H400

H410

GHS07

GHS09

Wng

H302

H315

H410

607-239-00-5

fenpropathrin (ISO); α-cyan-3-phenoxybenzyl-2,2,3,3-tetramethylcyclopropancarboxylat

254-485-0

39515-41-8

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H330

H301

H312

H400

H410

GHS06

GHS09

Dgr

H330

H301

H312

H410

607-240-00-0

cis-1,2,3,6-tetrahydro-4-methylphthalsyreanhydrid; [1]1,2,3,6-tetrahydro-4-methylphthalsyreanhydrid; [2]1,2,3,6-tetrahydro-3-methylphthalsyreanhydrid; [3] tetrahydromethylphthalsyreanhydrid; [4] 1,2,3,6-tetrahydromethylphthalsyreanhydrid; [5] tetrahydro-4-methylphthalsyreanhydrid; [6]2,3,5,6-tetrahydro-2-methylphthalsyreanhydrid [7]

216-906-6 [1]

222-323-8 [2]

226-247-6 [3]

234-290-7 [4]

247-830-1 [5]

251-823-9 [6]

255-853-3 [7]

1694-82-2 [1]

3425-89-6 [2]

5333-84-6 [3]

11070-44-3 [4]

26590-20-5 [5]

34090-76-1 [6]

42498-58-8 [7]

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H318

H334

H317

GHS08

GHS05

Dgr

H318

H334

H317

C

607-241-00-6

hexahydro-4-methylphthalsyreanhydrid; [1] hexahydromethylphthalsyreanhydrid; [2] hexahydro-1-methylphthalsyreanhydrid; [3] hexahydro-3-methylphthalsyreanhydrid [4]

243-072-0 [1]

247-094-1 [2]

256-356-4 [3]

260-566-1 [4]

19438-60-9 [1]

25550-51-0 [2]

48122-14-1 [3]

57110-29-9 [4]

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H318

H334

H317

GHS08

GHS05

Dgr

H318

H334

H317

C

607-242-00-1

tetrachlorphthalsyreanhydrid

204-171-4

117-08-8

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H334

H317

H400

H410

GHS08

GHS05

GHS09

Dgr

H318

H334

H317

H410

607-243-00-7

natrium-3,6-dichlor-o-anisat; [1] 3,6-dichlor-o-anissyre, forbindelse med 2,2'-iminodiethanol (1:1); [2] 3,6-dichlor-o-anissyre, forbindelse med 2-aminoethanol (1:1) [3]

217-846-3 [1]

246-590-5 [2]

258-527-9 [3]

1982-69-0 [1]

25059-78-3 [2]

53404-28-7 [3]

Aquatic Chronic 3

H412

—

H412

607-244-00-2

isooctylacrylat

249-707-8

29590-42-9

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H319

H335

H315

H410

STOT SE 3; H335: C ≥ 10 %

607-245-00-8

tert-butylacrylat

216-768-7

1663-39-4

Flam. Liq. 2

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H225

H332

H312

H302

H335

H315

H317

H411

GHS02

GHS07

GHS09

Dgr

H225

H332

H312

H302

H335

H315

H317

H411

D

607-246-00-3

allylmethacrylat; 2-methylpropensyreprop-2-en-1-ylester

202-473-0

96-05-9

Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

H226

H331

H312

H302

H400

GHS02

GHS06

GHS09

Dgr

H226

H331

H312

H302

H400

607-247-00-9

dodecylmethacrylat

205-570-6

142-90-5

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H335

H315

H400

H410

GHS07

GHS09

Wng

H319

H335

H315

H410

STOT SE 3; H335: C ≥ 10 %

607-248-00-4

naptalam-natrium (ISO); natrium N-naphth-1-ylphthalamat

205-073-4

132-67-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-249-00-X

(1-methyl-1,2-ethandiyl)bis[oxy(methyl-2,1-ethandiyl)]diacrylat

256-032-2

42978-66-5

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H319

H335

H315

H317

H411

GHS07

GHS09

Wng

H319

H335

H315

H317

H411

STOT SE 3; H335: C ≥ 10 %

607-250-00-5

4H-3,1-benzoxazin-2,4(1H)-dion

204-255-0

118-48-9

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

607-251-00-0

2-methoxypropylacetat

274-724-2

70657-70-4

Flam. Liq. 3

Repr. 1B

STOT SE 3

H226

H360D *** H335

GHS02

GHS08

GHS07

Dgr

H226

H360D *** H335

607-252-00-6

lambda-cyhalothrin (ISO); en 1:1 blanding af (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chlor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropancarboxylat og

(R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chlor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropancarboxylat

415-130-7

91465-08-6

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H330

H301

H312

H400

H410

GHS06

GHS09

Dgr

H330

H301

H312

H410

M = 10 000

607-253-00-1

cyfluthrin (ISO); α-cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat

269-855-7

68359-37-5

Acute Tox. 2 *

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H300

H331

H400

H410

GHS06

GHS09

Dgr

H300

H331

H410

M = 1 000

607-254-00-7

a-cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat;

beta-cyfluthrin

269-855-7

68359-37-5

Acute Tox. 2 *

Acute Tox. 2 * Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H400

H410

GHS06

GHS09

Dgr

H330

H300

H410

607-255-00-2

fluroxypyr (ISO); 4-amino-3,5-dichlor-6-fluor-2-pyridyloxyeddikesyre

—

69377-81-7

Aquatic Chronic 3

H412

—

H412

607-256-00-8

azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4- yloxy]phenyl}-3-methoxyacrylat

—

131860-33-8

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H331

H400

H410

GHS06

GHS09

Dgr

H331

H410

607-257-00-3

isopropylpropionat

211-300-8

637-78-5

Flam. Liq. 2

H225

GHS02

Dgr

H225

607-258-00-9

dodecyl-3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorbenzoat

403-990-6

70950-45-7

Aquatic Chronic 4

H413

—

H413

607-259-00-4

methyl-2R,3S-(-)-3-(4-methoxyphenyl)oxirancarboxylat

404-130-2

105560-93-8

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-260-00-X

ethyl-2-(3-nitrobenzyliden)acetoacetat

404-490-0

39562-16-8

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-261-00-5

iso(C10-C14)alkyl-(3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetat

404-800-4

118832-72-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-262-00-0

7-chlor-1-cyclopropyl-6-fluor-1,4-dihydro-4-oxochinolin-3-carboxylsyre

405-050-0

86393-33-1

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

607-263-00-6

kalium/jern(III)-1,3-propandiamin-N, N,N',N'-tetraacetathemihydrat

405-680-6

—

Self-heat. 2 **** Aquatic Chronic 2

H252

H411

GHS02

GHS09

Wng

H252

H411

607-264-00-1

2-chlor-4-(methylsulfonyl)benzoesyre

406-520-8

53250-83-2

Eye Dam. 1

H318

GHS05

Dgr

H318

607-265-00-7

ethyl-2-chlor-2,2-diphenylacetat

406-580-5

52460-86-3

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

607-266-00-2

blanding af hydroxyaluminium-bis[2-hydroxy-3,5-di-tert-butylbenzoat]; 3,5-di-tert-butyl-salicylsyre

406-890-0

130296-87-6

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

607-267-00-8

tert-butyl-(5S,6R,7R)-3-brommethyl-5,8-dioxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-en-2-carboxylat

407-620-4

33610-13-8

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H334

H317

H412

GHS08

Dgr

H334

H317

H412

607-268-00-3

2-methylpropyl-(R)-2-hydroxypropanoat

407-770-0

61597-96-4

Eye Irrit. 2

H319

GHS07

Wng

H319

607-269-00-9

(R)-2-(4-hydroxyphenoxy)propansyre

407-960-3

94050-90-5

Eye Dam. 1

H318

GHS05

Dgr

H318

607-270-00-4

3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecan

410-730-5

90498-90-1

Acute Tox. 4 *

H312

GHS07

Wng

H312

607-271-00-X

2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropan

417-420-9

156324-82-2

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

607-272-00-5

fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichlor-6-fluor-2-pyridyloxy) acetat; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichlor-6-fluor-2-pyridyloxy) acetat [2]

279-752-9 [1]

- [2]

81406-37-3 [1]

154486-27-8 [2]

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-273-00-0

ammonium-7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoat

404-520-2

—

Aquatic Chronic 3

H412

—

H412

607-274-00-6

2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoat

405-350-1

54527-73-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-275-00-1

natrium-4-(benzoyloxy)benzensulfonat

405-450-5

66531-87-1

Skin Sens. 1

H317

GHS07

Wng

H317

607-276-00-7

bis[(1-methylimidazol)-(2-ethyl-hexanoat)], zinkcomplex

405-635-0

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

607-277-00-2

en blanding af 2-(hexylthio)ethylaminhydrochlorid; natriumpropionat

405-720-2

—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

607-278-00-8

blanding af isomerer af natriumphenethylnaphthalensulfonat og natrium(2-naphthylethyl)benzensulfonat

405-760-0

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-279-00-3

blanding af N-octadecylaminodiethylbis(hydrogenmaleat) og N-octadecylaminodiethylhydrogenmaleathydrogenphthalat

405-960-8

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-280-00-9

natrium-4-chlor-1-hydroxybutan-1-sulfonat

406-190-5

54322-20-2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H302

H319

H317

GHS07

Wng

H302

H319

H317

607-281-00-4

blanding af forgrenet og lineær C7-C9 alkyl-3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionater

407-000-3

127519-17-9

Aquatic Chronic 2

H411

GHS09

H411

607-282-00-X

2-acetoxymethyl-4-benzyloxybut-1-ylacetat

407-140-5

131266-10-9

Aquatic Chronic 3

H412

—

H412

607-283-00-5

(E)-ethyl-4-oxo-4-phenylcrotonat

408-040-4

15121-89-8

Acute Tox. 4 * Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H312

H302

H315

H318

H317

H410

607-284-00-0

en blanding af natrium-3,3’ (1,4-phenylenbis(carbonylimino-3,1-propandiylimino))bis(10-amino-6,13-dichlor)-4,11-triphenodioxazindisulfonat); lithium-3,3'-(1,4-phenylenbis(carbonylimino-3,1-propandiylimino))bis(10-amino-6,13-dichlor)-4,11-triphenodioxazindisulfonat)

410-040-4

136213-76-8

Aquatic Chronic 2

H411

GHS09

H411

607-285-00-6

en blanding af 7-(((3-aminophenyl)sulfonyl)amino)naphthalen-1,3-disulfonsyre; natrium-7-(((3-aminophenyl)sulfonyl)amino)naphthalen-1,3-disulfonat; kalium-7-(((3-aminophenyl)sulfonyl)amino)naphthalen-1,3-disulfonat

410-065-0

—

Skin Sens. 1

H317

GHS07

Wng

607-286-00-1

blanding af natrium/kalium-7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]naphthalen-1,3-disulfonat

410-070-8

141880-36-6

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-287-00-7

O'-methyl-O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalat

410-140-8

—

Aquatic Chronic 3

H412

—

H412

607-288-00-2

tetranatrium-(c-(3-(1-(3-(e-6-dichlor-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phtalocyanin-a, b,d-trisulfonat(6-))nikkel (II), hvor a er 1 eller 2 eller 3 eller 4, b er 8 eller 9 eller 10 eller 11, c er 15 eller 16 eller 17 eller 18, d er 22 eller 23 eller 24 eller 25, og hvor e og f er enten 2 og 4 eller 4 og 2

410-160-7

148732-74-5

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H319

H317

H412

GHS07

Wng

H319

H317

H412

607-289-00-8

3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propansyre

410-370-9

105488-33-3

Aquatic Chronic 4

H413

—

H413

607-290-00-3

blanding (forhold ukendt) af ammonium-1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethan-1-sulfonat og ammonium-2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethan-1-sulfonat

410-540-2

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

607-291-00-9

dodecyl-ω-(C5/C6-cycloalkyl)alkylcarboxylat

410-630-1

104051-92-5

Aquatic Chronic 4

H413

—

H413

607-292-00-4

en blanding af [1-(methoxymethyl)-2-(C12-alkoxy)ethoxy]eddikesyre og [1-(methoxymethyl)-2-(C14-alkoxy)ethoxy]eddikesyre

410-640-6

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

607-293-00-X

en blanding af N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenylether di-sulfonat;

N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenylether di-sulfonat

410-650-0

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

607-294-00-5

natrium-2-benzoyloxy-1-hydroxyethan-sulfonat

410-680-4

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-295-00-0

blanding af tetranatrium-phosphonethan-1,2-dicarboxylat; hexanatrium-phosphonbutan-1,2,3,4-tetracarboxylat

410-800-5

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-296-00-6

blanding af tetraestere af pentaerythriol med heptansyre og 2-ethylhexansyre

410-830-9

—

Aquatic Chronic 4

H413

—

H413

607-297-00-1

(E,E)-3,3'-(1,4-phenylendimethyliden)bis(2-oxobornan-10-sulfonsyre)

410-960-6

92761-26-7

Eye Dam. 1

H318

GHS05

Dgr

H318

607-298-00-7

2-(trimethylammonium)-ethoxycarboxybenzen-4-sulfonat

411-010-3

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-299-00-2

methyl-3-(acetylthio)-2-methylpropanat

411-040-7

97101-46-7

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

607-300-00-6

trinatrium-[2-(5-chlor-2,6-difluorpyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprat(II) hvor a =1,2,3 eller 4, b =8,9,10 eller 11, c=15,16,17 eller 18 og d =22,23,24 eller 25

411-430-7

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-301-00-1

blanding af dodecansyre; poly(1-7)lactatestere af dodecansyre

411-860-5

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-302-00-7

blanding af tetradecansyre og poly(1-7)lactatestere af tetradecansyre

411-910-6

—

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H315

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H411

607-303-00-2

1-cyclopropyl-6,7-difluor-1,4-dihydro-4-oxoquinolin-3-carboxylsyre

413-760-7

93107-30-3

Repr. 2

Aquatic Chronic 3

H361f *** H412

GHS08

Wng

H361f *** H412

607-304-00-8

fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluormethyl-2-pyridyloxy)phenoxy]propianat

274-125-6

69806-50-4

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D *** H400

H410

GHS08

GHS09

Dgr

H360D *** H410

607-305-00-3

fluazifop-butyl (ISO); butyl-2-[4-[[5-(trifluormethyl)-2-pyridyl]oxy]phenoxy]propionat

—

79241-46-6

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d *** H400

H410

GHS08

GHS09

Wng

H361d *** H410

607-306-00-9

chlozolinate (ISO); ethyl-(RS)-3-(3,5-dichlorphenyl)-5-methyl-2,4-dioxo-oxazolidin-5-carboxylat

282-714-4

84332-86-5

Carc. 2

Aquatic Chronic 2

H351

H411

GHS08

GHS09

Wng

H351

H411

607-307-00-4

vinclozolin (ISO); N-3,5-dichlorphenyl-5-methyl-5-vinyl-1,3-oxazolidin-2,4-dion

256-599-6

50471-44-8

Carc. 2

Repr. 1B

Skin Sens. 1

Aquatic Chronic 2

H351

H360FD H317

H411

GHS08

GHS07

GHS09

Dgr

H351

H360FD H317

H411

607-308-00-X

estere af 2,4-D

—

—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

A

607-309-00-5

carfentrazon-ethyl (ISO); ethyl (RS)-2-chlor-3-[2-chlor-4-fluor-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionat

—

128639-02-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-310-00-0

kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetat

—

143390-89-0

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

607-311-00-6

benazolin-ethyl; ethyl-4-chlor-2-oxo-2H-benzothiazol-3-acetat

246-591-0

25059-80-7

Aquatic Chronic 2

H411

GHS09

H411

607-312-00-1

methoxyeddikesyre

210-894-6

625-45-6

Repr. 1B

Acute Tox. 4 *

Skin Corr. 1B

H360FD H302

H314

GHS08

GHS05

GHS07

Dgr

H360FD H302

H314

STOT SE 3; H335: C ≥ 5 %

607-313-00-7

neodecanoylchlorid

254-875-0

40292-82-8

Acute Tox. 2 * Acute Tox. 4 *

Skin Corr. 1B

H330

H302

H314

GHS06

GHS06

Dgr

H330

H302

H314

STOT SE 3; H335: C ≥ 5 %

607-314-00-2

ethofumesat (ISO); (±)-(2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl)methansulfonat

247-525-3

26225-79-6

Aquatic Chronic 2

H411

GHS09

H411

607-315-00-8

glyphosat (ISO); N-(phosphonomethyl)glycin

213-997-4

1071-83-6

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

607-316-00-3

gliphosal-trimesium; glyphosat-trimethylsulfonium

—

81591-81-3

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-317-00-9

bis(2-ethylhexyl)phthalat; di-(2-ethylhexyl)phthalat; DEHP

204-211-0

117-81-7

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-318-00-4

dibutylphthalat; DBP

201-557-4

84-74-2

Repr. 1B

Aquatic Acute 1

H360Df

H400

GHS08

GHS09

Dgr

H360Df

H400

607-319-00-X

deltamethrin (ISO); (S)-α-cyan-3-phenoxybenzyl-(1R, 3R)-3-(2,2-dibromvinyl)-2,2-dimethylcyclopropancarboxylat

258-256-6

52918-63-5

Acute Tox. 3 *

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

M=1 000 000

607-320-00-5

bis[4-(ethenyloxy)butyl]-1,3-benzendicarboxylat

413-930-0

130066-57-8

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-321-00-0

(S)-methyl-2-chlorpropionat

412-470-8

73246-45-4

Flam. Liq. 3

STOT RE 2 *

Eye Irrit. 2

H226

H373 ** H319

GHS02

GHS08

Wng

H226

H373 ** H319

607-322-00-6

4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoesyre

413-120-7

107144-30-9

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-323-00-1

2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl-acrylat

413-850-6

123968-25-2

Aquatic Chronic 4

H413

—

H413

607-324-00-7

en blanding af N, N-di(hydrogeneret alkyl C14-C18) phthalamidsyre; dihydrogeneret alkyl (C14-C18)amin

413-800-3

—

Aquatic Chronic 4

H413

—

H413

607-325-00-2

(S)-2-chlorpropionsyre

411-150-5

29617-66-1

Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1A

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

607-326-00-8

blanding af isobutylhydrogen-2-(α-2,4,6-trimethylnon-2-enyl)succinat og

isobutylhydrogen-2-(ß-2,4,6-trimethylnon-2-enyl)succinat

410-720-0

141847-13-4

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

607-327-00-3

2-(2-iodethyl)-1,3-propandioldiacetat

411-780-0

127047-77-2

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-328-00-9

methyl-4-brommethyl-3-methoxybenzoat

410-310-1

70264-94-7

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

607-329-00-4

blanding af natrium-2-(C12-18-n-alkyl)amino-1,4-butandioat og natrium-2-octadecenyl-amino-1,4-butandioat

411-250-9

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-330-00-X

(S)-2,3-dihydro-1H-indol-2-carboxylsyre

410-860-2

79815-20-6

Repr. 2

STOT RE 2 *

Skin Sens. 1

H361f *** H373 ** H317

GHS08

GHS07

Wng

H361f *** H373 ** H317

607-331-00-5

blanding af bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decandioat og 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octan

406-750-9

—

Aquatic Chronic 4

H413

—

H413

607-332-00-0

cyclopentylchlorformiat

411-460-0

50715-28-1

Flam. Liq. 3

Acute Tox. 3 * Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H226

H331

H302

H373 ** H318

H317

GHS02

GHS06

GHS08

GHS05

Dgr

H226

H331

H302

H373 ** H318

H317

607-333-00-6

blanding af dodecyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninat og

tetradecyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninat

405-670-1

—

Acute Tox. 4 * STOT RE 2 *

Skin Corr. 1B Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H314

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H302

H373 ** H314

H410

607-334-00-1

ethyl-1-ethyl-6,7,8-trifluor-1,4-dihydro-4-oxoquinolin-3-carboxylat

405-880-3

100501-62-0

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-335-00-7

methyl-(R)-2-(4-(3-chlor-5-trifluormethyl-2-pyridyloxy)phenoxy)propionat

406-250-0

72619-32-0

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

607-336-00-2

4-methyl-8-methylentricyclo[3.3.1.13,7]dec-2-ylacetat

406-560-6

122760-85-4

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H315

H317

H411

GHS07

GHS09

Wng

H315

H317

H411

607-337-00-8

di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinat

406-052-4

125078-60-6

Flam. Liq. 3

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H226

H302

H315

H318

H411

GHS02

GHS05

GHS07

GHS09

Dgr

H226

H302

H315

H318

H411

607-338-00-3

2-methylpropyl-2-hydroxy-2-methylbut-3-enoat

406-235-9

72531-53-4

Eye Irrit. 2

Skin Irrit. 2

H319

H315

GHS07

Wng

H319

H315

607-339-00-9

2,3,4,5-tetrachlorbenzoylchlorid

406-760-3

42221-52-3

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H302

H314

H317

GHS05

GHS07

Dgr

H302

H314

H317

607-340-00-4

1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-ylacetat

406-990-4

—

Aquatic Chronic 2

H411

GHS09

H411

607-341-00-X

(9S)-9-amino-9-deoxyerythromycin

406-790-7

26116-56-3

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

607-342-00-5

4-chlorbutylveratrat

410-950-1

69788-75-6

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-343-00-0

4,7-methanooctahydro-1H-inden-diyldimethylbis(2-carboxybenzoat)

407-410-2

—

Aquatic Chronic 4

H413

—

H413

607-344-00-6

en blanding af 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoralkylsulfonamido)propionsyre og

N-[dimethyl-3-(C4-8-perfluoralkylsulfonamido)propylammonium-propionat og

3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoralkylsulfonamido)propionsyre-propionat

407-810-7

—

STOT RE 2 *

H373 **

GHS08

Wng

H373 **

607-345-00-1

kalium-2-(2,4-dichlorphenoxy)-(R)-propanat

413-580-9

113963-87-4

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H302

H315

H318

H317

GHS05

GHS07

Dgr

H302

H315

H318

H317

607-346-00-7

3-icosyl-4-henicosyliden-2-oxetanon

401-210-9

83708-14-9

Aquatic Chronic 4

H413

—

H413

607-347-00-2

natrium-(R)-2-(2,4-dichlorphenoxy)propionat

413-340-3

119299-10-4

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H302

H315

H318

H317

GHS05

GHS07

Dgr

H302

H315

H318

H317

607-348-00-8

magnesium-bis((R)-2-(2,4-dichlorphenoxy)propionat)

413-360-2

—

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H302

H315

H318

H317

GHS05

GHS07

Dgr

H302

H315

H318

H317

607-349-00-3

mono-(tetrapropylammonium)hydrogen-2,2'-dithiobisbenzoat

411-270-8

—

Aquatic Chronic 3

H412

H412

607-350-00-9

bis(4-(1,2-bis(ethoxycarbonyl)-ethylamino)-3-methyl-cyclohexyl)-methan

412-060-9

136210-32-7

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-351-00-4

methyl-O-(4-amino-3,5-dichlor-6-fluorpyridin-2-yloxy)acetat

407-550-4

69184-17-4

Aquatic Chronic 2

H411

GHS09

H411

607-352-00-X

4,4'-oxydiphtalsyreanhydrid

412-830-4

1823-59-2

Aquatic Chronic 3

H412

—

H412

607-353-00-5

blanding af ethyl-exo-tricyclo[5.2.1.02,6]decan-endo-2-carboxylat; ethyl-endo-tricyclo[5.2.1.02,6]decan-exo-2-carboxylat

407-520-0

80657-64-3

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-354-00-0

ethyl-2-cyclohexylpropionat

412-280-5

2511-00-4

Aquatic Chronic 2

H411

GHS09

H411

607-355-00-6

p-tolyl-4-chlorbenzoat

411-530-0

15024-10-9

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-356-00-1

ethyl-trans-2,2,6-trimethylcyclohexancarboxylat

412-540-8

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-357-00-7

en blanding af trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran og cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran

412-450-9

131766-73-9

Skin Sens. 1

H317

GHS07

Wng

H317

607-358-00-2

(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylat

412-670-5

54275-93-3

Resp. Sens. 1

H334

GHS08

Dgr

H334

607-359-00-8

(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylen-1-oxo-7-phenylacetamido-cepham-4-carboxylat

412-800-0

76109-32-5

Resp. Sens. 1

H334

GHS08

Dgr

H334

607-360-00-3

natrium-3-acetoacetylamino-4-methoxytolyl-6-sulfonat

411-680-7

133167-77-8

Skin Sens. 1

H317

GHS07

Wng

H317

607-361-00-9

methyl-(R)-2-(4-hydroxyphenoxy)-propionat

411-950-4

96562-58-2

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-362-00-4

en blanding af (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoat;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoat;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoat;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoat

413-500-2

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H315

H318

H411

GHS05

GHS09

Dgr

H315

H318

H411

607-363-00-X

methyl-3-methoxyacrylat

412-900-4

5788-17-0

Skin Sens. 1

H317

GHS07

Wng

H317

607-364-00-5

3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dion

413-330-9

134724-55-3

Aquatic Chronic 4

H413

H413

607-365-00-0

2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetylchloridhydrochlorid

410-620-7

119154-86-8

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H302

H314

H317

GHS05

GHS07

Dgr

H302

H314

H317

607-366-00-6

3,5-dimethylbenzoylchlorid

413-010-9

6613-44-1

Skin Corr. 1B

Skin Sens. 1

H314

H317

GHS05

GHS07

Dgr

H314

H317

607-367-00-1

kalium-bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N, O,O, N)-ferrat-(1-) monohydrat

411-640-9

153352-59-1

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-368-00-7

1-(N, N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazol

411-650-3

110895-43-7

Acute Tox. 3 *

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

607-369-00-2

en blanding af trans-(2R)-5-acetoxy-1,3-oxathiolan-2-carboxylsyre og cis-(2R)-5-acetoxy-1,3-oxathiolan-2-carboxylsyre

411-660-8

147027-04-1

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H302

H315

H318

H317

GHS05

GHS07

Dgr

H302

H315

H318

H317

607-370-00-8

2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol

412-210-3

41620-33-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-371-00-3

3-ethyl-5-methyl-4-(2-chlorphenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridindicarboxylat

413-410-3

88150-62-3

Aquatic Chronic 4

H413

—

H413

607-372-00-9

ethoxyleret-bisphenol A di-(norbornencarboxylat)

412-410-0

—

Aquatic Chronic 3

H412

—

H412

607-373-00-4

(±) tetrahydrofurfuryl-(R)-2-[4-(6-chlorchinoxalin-2-yloxy)-phenyloxy]propanoat

414-200-4

119738-06-6

Muta. 2

Repr. 1B

Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1

Aquatic Chronic 1

H341

H360Df

H302

H373 ** H400

H410

GHS08

GHS07

GHS09

Dgr

H341

H360Df

H302

H373 ** H410

607-374-00-X

5-amino-2,4,6-triiodo-1,3-benzendicarbonyldichlorid

417-220-1

37441-29-5

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-376-00-0

benzyl-2,4-dibrombutanoat

420-710-8

23085-60-1

Repr. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f *** H315

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f *** H315

H317

H410

607-377-00-6

trans-4-cyclohexyl-sc.L.sc.-prolinmonohydrochlorid

419-160-1

90657-55-9

Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H361f *** H302

H315

H318

H317

GHS08

GHS05

GHS07

Dgr

H361f *** H302

H315

H318

H317

607-378-00-1

ammonium-(Z)-α-methoxyimino-2-furylacetat

405-990-1

97148-39-5

Flam. Sol. 2

H228

GHS02

Dgr

H228

T

607-379-00-7

en blanding af 2-[N-(2-hydroxyethyl)stearamido]ethyl-stearat og

natrium-[bis[2-(stearoyloxy)ethyl]amino]methylsulfonat og natrium-[bis(2-hydroxyethyl)amino]methylsulfonat og N, N-bis(2-hydroxyethyl)stearamid

401-230-8

Aquatic Chronic 3

H412

—

H412

607-380-00-2

blanding af ammonium-1,2-bis(hexyloxycarbonyl)ethansulfonat;

ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethansulfonat;

ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethansulfonat

407-320-3

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H315

H318

H412

GHS05

Dgr

H315

H318

H412

607-381-00-8

blanding af triestere af 2,2-bis(hydroxymethyl)butanol med C7-alkansyre og 2-ethylhexansyre

413-710-4

—

Aquatic Chronic 4

H413

—

H413

607-382-00-3

2-((4-amino-2-nitrophenyl)amino)benzoesyre

411-260-3

117907-43-4

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-383-00-9

en blanding af 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoat og 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoat

415-430-8

86403-32-9

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H318

H317

H410

607-384-00-4

blanding af estere af C14-C15-forgrenede alkoholer med 3,5-di-t-butyl-4-hydroxyphenyl-propionsyre og

C15-forgrenet og ligekædet alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenpropanoat og

C13-forgrenet og ligekædet alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenpropanoat

413-750-2

171090-93-0

Aquatic Chronic 4

H413

—

H413

607-385-00-X

copolymer af vinyl-alkohol og vinyl-acetat delvis acetileret med 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium-methylsulfat

414-590-6

125229-74-5

Aquatic Chronic 2

H411

GHS09

H411

607-386-00-5

blanding af tetradecansyre (42.5-47,5 %) og poly(1-7)lactatestere af tetradecansyre (52,5-57,5 %)

412-580-6

174591-51-6

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

607-387-00-0

blanding af dodecansyre (35-40 %) og poly(1-7)lactatestere af dodecansyre (60-65 %)

412-590-0

58856-63-6

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

607-388-00-6

4-ethylamino-3-nitrobenzoesyre

412-090-2

2788-74-1

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

607-389-00-1

trinatrium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionat

414-130-4

119710-96-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-390-00-7

1,2,3,4-tetrahydro-6-nitro-quinoxalin

414-270-6

41959-35-7

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-391-00-2

dimethylcyclopropan-1,1-dicarboxylat

414-240-2

6914-71-2

Aquatic Chronic 3

H412

—

H412

607-392-00-8

2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoat

414-260-1

88938-37-8

Aquatic Chronic 4

H413

—

H413

607-393-00-3

3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsyre

415-750-8

106447-44-3

Skin Sens. 1

H317

GHS07

Wng

H317

607-394-00-9

5-methylpyrazin-2-carboxylsyre

413-260-9

5521-55-1

Eye Dam. 1

H318

GHS05

Dgr

H318

607-395-00-4

blanding af natrium-1-tridecyl-4-allyl-(2 eller 3)-sulfobutandioat og natrium-1-dodecyl-4allyl-(2 eller 3)-sulfobutandioat

410-230-7

—

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H317

H411

607-396-00-X

bis(1,2,2,6,6-pentamethyl-4-piperidinyl)-2-(4-methoxybenzyliden)malonat

414-840-4

147783-69-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-397-00-5

en blanding af Ca-salicylater (forgrenet C10-14- og C18-30-alkyleret) og Ca-phenater (forgrenet C10-14- og C18-30-alkyleret) og Ca-phenater, svovlbehandlede (forgrenet C10-14- og C18-30-alkyleret)

415-930-6

—

Repr. 2

Skin Sens. 1

H361f *** H317

GHS08

GHS07

Wng

H361f *** H317

607-398-00-0

ethyl-N-(5-chlor-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamat

414-820-5

125630-94-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-399-00-6

2,2-dimethyl-3-methyl-3-butenylpropanoat

415-610-6

104468-21-5

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

607-400-00-X

methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoat

414-400-1

32750-89-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-401-00-5

ethyl-3-hydroxy-5-oxo-3-cyclohexen-1-carboxylat

414-450-4

88805-65-6

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H315

H318

H317

GHS05

GHS07

Dgr

H315

H318

H317

607-402-00-0

methyl N-(phenyloxycarbonyl)-.sc.L.sc.-valinat

414-500-5

153441-77-1

Aquatic Chronic 3

H412

—

H412

607-403-00-6

blanding af bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammoniumsuccinat og

isopropylalkohol

414-810-0

—

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 ** H318

H400

H410

GHS08

GHS05

GHS09

Dgr

H373 ** H318

H410

607-404-00-1

en blanding af ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropansyre; di-((E)-3,7-dimethyl-2,6-octadienyl)butandioat; di-((Z)-3,7-dimethyl-2,6-octadienyl)butandioat;

(Z)-3,7-dimethyl-2,6-octadienylbutandioat; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropansyre

415-190-4

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-405-00-7

2-hexyldecyl-p-hydroxybenzoat

415-380-7

148348-12-3

Aquatic Chronic 2

H411

GHS09

H411

607-406-00-2

kalium-2,5-dichlorbenzoat

415-700-5

184637-62-5

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

607-407-00-8

ethyl-2-carboxy-3-(2-thienyl)propionat

415-680-8

143468-96-6

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H315

H318

H317

GHS05

GHS07

Dgr

H315

H318

H317

607-408-00-3

kalium-N-(4-fluorophenyl)glycinat

415-710-1

184637-63-6

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H373 ** H318

H317

H412

GHS08

GHS05

GHS07

Dgr

H373 ** H318

H317

H412

607-409-00-9

en blanding af (3R)-[1S-(1α, 2α, 6β ((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalen]-3,5-dihydroxyheptansyre og inert biomasse fra Aspergillus terreus

415-840-7

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-410-00-4

mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butandioat og/eller mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butandioat

415-880-5

779343-34-9

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

607-411-00-X

oxiranmethanol, 4-methylbenzen-sulfonat, (S)-

417-210-7

70987-78-9

Carc. 1B Muta. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H350

H341

H318

H317

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H350

H341

H318

H317

H411

607-412-00-5

ethyl-2-(1-cyanocyclohexyl)acetat

415-970-4

133481-10-4

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373 ** H412

GHS08

GHS07

Wng

H302

H373 ** H412

607-413-00-0

trans-4-phenyl-.sc.L.sc.-prolin

416-020-1

96314-26-0

Repr. 2

Skin Sens. 1

H361f *** H317

GHS08

GHS07

Wng

H361f *** H317

607-414-00-6

tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazin-2,4,6-triyltriimino)tribenzoat

402-070-1

88122-99-0

Aquatic Chronic 4

H413

—

H413

607-415-00-1

poly-(methylmethacrylat)-co-(butylmethacrylat)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzylcarbamat)-co-(maleinsyreanhydrid)

419-590-1

—

Flam. Sol. 1

Skin Sens. 1

H228

H317

GHS02

GHS07

Dgr

H228

H317

T

607-416-00-7

4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamid

420-730-7

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-417-00-2

3-chlorpropylchlorformiat

425-770-9

628-11-5

Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H331

H302

H373 ** H315

H318

H317

GHS06

GHS05

GHS08

Dgr

H331

H302

H373 ** H315

H318

H317

607-418-00-8

2-ethylhexyl-4-aminobenzoat

420-170-3

26218-04-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-419-00-3

(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-yliden)-1-methyl-ethyliden)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-eddikesyre

422-240-9

166596-68-5

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-420-00-9

2,2-bis(hydroxymethyl)butansyre

424-090-1

10097-02-6

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-421-00-4

cypermethrin cis/trans +/- 40/60; α-cyan-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat

257-842-9

52315-07-8

Acute Tox. 4 * Acute Tox. 4 * STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H335

H400

H410

GHS07

GHS09

Wng

H332

H302

H335

H410

607-422-00-X

α-cypermethrin (ISO); racemat bestående af (R)-α-cyan-3-phenoxybenzyl-(1S,3S)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat og (S)-α-cyan-3-phenoxybenzyl-(1R,3R)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat

257-842-9

67375-30-8

Acute Tox. 3 * STOT RE 2 * STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H301

H373 ** H335

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H373 ** H335

H410

M = 1 000

607-423-00-5

mechlorprop og mechlorprop-P, estere heraf

—

—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

A

607-424-00-0

trifloxystrobin (ISO); (E,E)-α-(methoxyimino)-2-[[[[1-[3-(trifluormethyl)phenyl]ethyliden]amino]oxy]methyl]phenyleddikesyremethylester

—

141517-21-7

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-425-00-6

metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-.sc.DL.sc.-alaninat

260-979-7

57837-19-1

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

607-426-00-1

1,2-benzendicarboxylsyredipentylester, forgrenet og ligekædet; [1] isopentyl-n-pentylphthalat; [2] dipentylphthalat; [3] diisopentylphthalat [4]

284-032-2 [1]

- [2]

205-017-9 [3]

210-088-4 [4]

84777-06-0 [1]

- [2]

131-18-0 [3]

605-50-5 [4]

Repr. 1B

Aquatic Acute 1

H360FD H400

GHS08

GHS09

Dgr

H360FD H400

607-427-00-7

bromoxynil-heptanoat (ISO); 2,6-dibrom-4-cyanphenylheptanoat

260-300-4

56634-95-8

Repr. 2

Acute Tox. 4 * Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d *** H332

H302

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361d *** H332

H302

H317

H410

607-428-00-2

tetranatrium-ethylendiamintetraacetat

200-573-9

64-02-8

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

607-429-00-8

edetinsyre; (EDTA)

200-449-4

60-00-4

Eye Irrit. 2

H319

GHS07

Wng

H319

607-430-00-3

BBP; benzylbutylphthalat

201-622-7

85-68-7

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H400

H410

GHS08

GHS09

Dgr

H360Df

H410

607-431-00-9

prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropancarboxylat

245-387-9

23031-36-9

Acute Tox. 3 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H400

H410

GHS06

GHS09

Dgr

H331

H302

H410

607-432-00-4

S-metolachlor; blanding af (S)-2-chlor-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamid (80-100 %); [1](R)-2-chlor-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamid (0-20 %) [2]

- [1]

- [2]

87392-12-9 [1]

178961-20-1 [2]

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-433-00-X

cypermethrin cis/trans +/- 80/20; (RS)-α-cyan-3-phenoxybenzyl(1RS;3RS; 1RS,3SR)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat

257-842-9

52315-07-8

Acute Tox. 4 * STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H335

H315

H317

H400

H410

GHS07

GHS09

Wng

H302

H335

H315

H317

H410

607-434-00-5

mecoprop-P [1] og salte heraf; (R)-2-(4-chlor-2-methylphenoxy)propionsyre

240-539-0

16484-77-8

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

607-435-00-0

2S-isopropyl-5R-methyl-1R-cyclohexyl-2,2-dihydroxyacetat

416-810-6

111969-64-3

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2

H373 ** H318

H411

GHS08

GHS05

GHS09

Dgr

H373 ** H318

H411

607-436-00-6

2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoat

417-350-9

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

607-437-00-1

3-(4-aminophenyl)-2-cyano-2-propensyre

417-480-6

252977-62-1

Skin Sens. 1

H317

GHS07

Wng

H317

607-438-00-7

methyl-2-[(aminosulfonyl)methyl]benzoat

419-010-5

112941-26-1

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

607-439-00-2

methyl tetrahydro-2-furancarboxylat

420-670-1

37443-42-8

Eye Dam. 1

H318

GHS05

Dgr

H318

607-440-00-8

methyl 2-aminosulfonyl-6-(trifluormethyl)pyridin-3-carboxylat

421-220-7

144740-59-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-441-00-3

3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionsyre

421-490-6

167684-63-1

Aquatic Chronic 4

H413

—

H413

607-442-00-9

benzyl-[hydroxy-(4-phenylbutyl)phosphinyl]acetat

416-050-5

87460-09-1

Eye Dam. 1

H318

GHS05

Dgr

H318

607-444-00-X

blanding af cis-1,4-dimethylcyclohexyldibenzoat og trans-1,4-dimethylcyclohexyldibenzoat

416-230-3

35541-81-2

Aquatic Chronic 4

H413

—

H413

607-445-00-5

jern (III) tris(4-methylbenzensulfonat)

420-960-8

77214-82-5

Eye Dam. 1

H318

GHS05

Dgr

H318

607-446-00-0

methyl-2-[4-(2-chlor-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionat

416-240-8

155522-12-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-447-00-6

natrium-4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzensulfonat

416-370-5

156738-27-1

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-448-00-1

2,3,5,6-tetrafluorbenzoesyre

416-800-1

652-18-6

Skin Irrit. 2

Eye Dam. 1

H315

H318

GHS05

Dgr

H315

H318

607-449-00-7

en blanding af 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazin-1,3,5-triyl)tris[methylen(3,5,5-trimethyl-3,1-cyclohexandiyl)iminocarbonyloxy-2,1-ethandiyl(ethyl)amino]]trisbenzendiazoniumtri[bis(2-methylpropyl)naphthalensulfonat] og 4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexandiyl)methylen]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazin-1,1',3,3'-tetrayl]tetrakis[methylen(3,5,5-trimethyl-3,1-cyclohexandiyl)iminocarbonyloxy-2,1-ethandiyl(ethyl)amino]]tetrakisbenzendiazoniumtetra[bis(2-methylpropyl)naphthalensulfonat]

417-080-1

—

Self-react. D

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H242

H317

H400

H410

GHS02

GHS07

GHS09

Dgr

H242

H317

H410

607-450-00-2

2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetat

419-040-9

89604-92-2

Aquatic Chronic 4

H413

—

H413

607-451-00-8

4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzensulfonsyre, natriumsalt

417-640-5

161935-19-9

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-453-00-9

4-benzyl-2,6-dihydroxy-4-azaheptylen bis(2,2-dimethyloctanoat)

418-100-1

172964-15-7

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-454-00-4

blanding af trans-2-(1-methylethyl)-1,3-dioxan-5-carboxylsyre og cis-2-(1-methylethyl)-1,3-dioxan-5-carboxylsyre

418-170-3

116193-72-7

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-455-00-X

1-amino-4-(3-[4-chlor-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinon-2-sulfonsyre, na/li-salt

419-520-8

172890-93-6

Skin Sens. 1

H317

GHS07

Wng

H317

607-456-00-5

3-amino-4-chlorbenzoesyre, hexadecylester

419-700-6

143269-74-3

Aquatic Chronic 2

H411

GHS09

H411

607-457-00-0

tetranatriumdihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazin-4,2-diyl-imino)]bis(2,2'-azonaphthalen-1',3,6-trisulfonat)

420-350-1

172277-97-3

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

607-458-00-6

en blanding af 2-ethyl-[2,6-dibrom-4-[1-[3,5-dibrom-4(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoat og 2,2'-diethyl-[4,4'-bis(2,6-dibromphenoxy)-1-methylethyliden] dipropenoat og 2,2'-[(1-methylethyliden)bis[[2,6-dibrom-4,1-phenylen)oxy]ethanol]]

420-850-1

—

Aquatic Chronic 2

H411

GHS09

H411

607-459-00-1

isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridyliden]hydrazino}benzoat

418-930-4

—

Aquatic Chronic 4

H413

—

H413

607-460-00-7

3-tridecyloxy-propyl-ammonium 9-octadecenoat

418-990-1

778577-53-0

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H373 ** H319

H315

H400

H410

GHS08

GHS07

GHS09

Wng

H373 ** H319

H315

H410

607-461-00-2

blanding af pentanatrium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethansulfonyl)-phenylamino]-1.3.5-triazin-2-ylamino}-benzen-1,4-disulfonat og

pentanatrium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethansulfonyl)-phenylamino]-1.3.5-triazin-2-ylamino}-benzen-1,4-disulfonat

421-160-1

—

Aquatic Chronic 3

H412

—

H412

607-462-00-8

en blanding af 1-hexylacetat og 2-methyl-1-pentylacetat og 3-methyl-1-pentylacetat og 4-methyl-1-pentylacetat og andre blandede ligekædede og forgrenede C6-alkylacetater

421-230-1

88230-35-7

Aquatic Chronic 2

H411

GHS09

H411

607-463-00-3

3-(phenothiazin-10-yl)propionsyre

421-260-5

362-03-8

Aquatic Chronic 2

H411

GHS09

H411

607-464-00-9

en blanding af blanding af 7-chlor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyre og

5-chlor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyre

421-280-4

Aquatic Chronic 3

H412

—

H412

607-465-00-4

tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalen-1,3-disulfonat

421-440-3

778583-04-3

Aquatic Chronic 3

H412

—

H412

607-466-00-X

blanding af phenyl 1-(1-[2-chlor-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazol-5-carboxylat og phenyl 2-(1-(2-chlor-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazol-5-carboxylat og phenyl 3-(1-(2-chlor-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazol-5-carboxylat

421-480-1

—

Aquatic Chronic 2

H411

GHS09

H411

607-467-00-5

1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate

419-430-9

56533-00-7

Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *

Skin Corr. 1B Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373 ** H314

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H312

H302

H373 ** H314

H410

607-468-00-0

en blanding af mononatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat og

dinatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat og

trinatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat og

tetranatrium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chlor-1,3,5-triazin-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridin-3-yl)azo)benzensulfonat

419-450-8

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-469-00-6

dinatrium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalensulfonat

419-460-2

120029-06-3

Aquatic Chronic 3

H412

—

H412

607-470-00-1

kalium natrium 6,13-dichlor-3,10-bis{2-[4-[3-(2-idrossisulfonylossiethansulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino-[2,3-b]phenoxazin-4,11-disulfonat

414-100-0

154336-20-6

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-471-00-7

1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexan

429-280-6

151900-44-6

Aquatic Chronic 4

H413

—

H413

607-473-00-8

pentaerythritol, dipentaerythritol, fedtsyrer, C6-10, blandede estere med adipinsyre, heptansyre og isostearinsyre

426-590-3

187412-41-5

Skin Sens. 1

H317

GHS07

Wng

H317

607-474-00-3

(4-(-4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo2-pyrazolin-1-yl)benzoesyre

410-430-4

117573-89-4

Aquatic Chronic 4

H413

—

H413

607-475-00-9

blanding (50/50) af tetranatrium-7-(4-[4-chlor-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat og tetranatrium-7-(4-[4-chlor-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat

412-940-2

148878-18-6

Skin Sens. 1

H317

GHS07

Wng

H317

607-476-00-4

N, N-bis(carbossimetil)-β-alanina di trisodio

414-070-9

129050-62-0

Skin Corr. 1B

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

607-477-00-X

(1α,5α,6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexan-methansulfonatsalt

426-740-8

—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

607-478-00-5

tetramethylammoniumhydrogenphthalat

416-900-5

79723-02-7

Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1

H301

H373 ** H400

GHS06

GHS08

GHS09

Dgr

H301

H373 ** H400

607-479-00-0

hexadecyl 4-chlor-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoat

418-550-9

168689-49-4

Aquatic Chronic 4

H413

—

H413

607-480-00-6

1,2-benzendicarboxylsyre, di-C7-11-forgrenede og ligekædede alkylestere

271-084-6

68515-42-4

Repr. 1B

H360Df

GHS08

Dgr

H360Df

607-481-00-1

blanding af trihexylcitrat; dihexyloctylcitrat, dioctylhexylcitrat og dihexyldecylcitrat

430-290-8

—

Aquatic Chronic 4

H413

—

H413

607-482-00-7

N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydrid

430-360-8

84793-24-8

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-483-00-2

1,2-benzendicarboxylsyre; di-C6-8-forgrenede og lineære alkylestere, C7-rige

276-158-1

71888-89-6

Repr. 1B

H360D ***

GHS08

Dgr

H360D ***

607-484-00-8

ethyl-2-{[3-acetylamino-4-(6-brom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionat

430-480-0

221452-67-1

Aquatic Chronic 4

H413

—

H413

607-485-00-3

(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorphenyl)-1-piperidincarboxylat

430-510-2

—

Aquatic Chronic 4

H413

—

H413

607-486-00-9

kaliumnatrium-5'-(6-chlor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalen-1,2',5,7'-disulfonat

402-110-8

110081-40-8

Aquatic Chronic 3

H412

—

H412

607-487-00-4

blanding af dinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienyliden)-4,5-dihydro-5-oxopyrazol-1-yl)benzensulfonatog trinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienyliden)-4,5-dihydro-5-oxopyrazol-1-yl)benzensulfonat

402-660-9

—

Repr. 1B

Aquatic Chronic 3

H360D *** H412

GHS08

Dgr

H360D *** H412

607-488-00-X

ethyl (2-acetylamino-5-fluor-4-isothiocyanatphenoxy)acetat

414-210-9

147379-38-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-489-00-5

en blanding af 2-ethylhexyllinolenat, linolat og olat og 2-ethylhexylepoxyolat og 2-ethylhexyldiepoxylinolat og

2-ethylhexyltriepoxylinolenat

414-890-7

71302-79-9

Skin Sens. 1

H317

GHS07

Wng

H317

607-490-00-0

N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methylglycinat

415-060-7

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-491-00-6

blanding af diester af 4,4'-methylenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonsyre (1:2) og

triester af 4,4'-methylenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] og 6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonsyre (1:3)

427-140-9

—

Carc. 2

H351

GHS08

Wng

H351

607-492-00-1

2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methylpropylpropanoat

415-490-5

141773-73-1

Aquatic Chronic 2

H411

GHS09

H411

607-493-00-7

methyl-(3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazol-6-carboxylat

415-670-3

78850-37-0

Eye Dam. 1

H318

GHS05

Dgr

H318

607-494-00-2

bis(2-ethylhexyl)octylphosphonat

417-170-0

52894-02-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-495-00-8

natrium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoat

417-550-6

168151-92-6

Skin Sens. 1

H317

GHS07

Wng

H317

607-496-00-3

2,2'-methylenbis(4,6-di-tert-butyl-phenyl)-2-ethylhexylphosphit

418-310-3

126050-54-2

Aquatic Chronic 4

H413

—

H413

607-497-00-9

ceriumoxidisostearat

419-760-3

—

Aquatic Chronic 4

H413

—

H413

607-498-00-4

(E)-3,7-dimethyl-2,6-octadienylhexadecanoat

421-370-3

3681-73-0

Skin Irrit. 2

Aquatic Chronic 4

H315

H413

GHS07

Wng

H315

H413

607-499-00-X

bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethandiyl-bis(2-hexadecenylsuccinat)

421-660-1

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

607-500-00-3

calcium 2,2,bis[(5-tetrapropylen-2-hydroxy)phenyl]ethanoat

421-670-4

—

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

607-501-00-9

blanding af triphenylthiophosphat og tertiære butylerede phenylderivater

421-820-9

192268-65-8

Aquatic Chronic 4

H413

—

H413

607-502-00-4

(N-benzyl-N, N,N-tributyl)ammonium 4-dodecylbenzensulfonat

422-200-0

178277-55-9

Skin Corr. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H314

H302

H411

GHS05

GHS07

GHS09

Dgr

H314

H302

H411

607-503-00-X

2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinan

422-210-5

68957-94-8

Skin Corr. 1B

H314

GHS05

Dgr

H314

607-504-00-5

diammonium-1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxy-phenylazo)-7-amino-3-naphthalensulfonat

422-670-7

—

Repr. 2

Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1

Aquatic Chronic 1

H361f

H301

H373 ** H400

H410

GHS06

GHS08

GHS09

Dgr

H361f

H301

H373 ** H410

607-505-00-0

pentanatrium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chlor-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat

422-930-1

Aquatic Chronic 3

H412

—

H412

607-506-00-6

blanding af strontium-(4-chlor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzensulfonat og

dinatrium-(4-chlor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzensulfonat

422-970-8

Aquatic Chronic 2

H411

GHS09

H411

607-507-00-1

kalium, natrium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzensulfonat

422-980-2

187026-95-5

Eye Dam. 1

H318

GHS05

Dgr

H318

607-508-00-7

dinatrium 3,3'-[iminobis[sulfonyl-4,1-phenylen-(5-hydroxy-3-methylpyrazol-1,4-diyl)azo-4,1-phenylensulfonylimino-(4-amino-6-hydroxypyrimidin-2,5-diyl)azo-4,1-phenylensulfonylimino(4-amino-6-hydroxypyrimidin-2,5-diyl)azo]bis(benzensulfonat)]

423-110-4

—

Eye Dam. 1

H318

GHS05

Dgr

H318

607-509-00-2

2-phenoxyethyl-4-aminobenzoat

430-880-5

88938-23-2

Aquatic Chronic 2

H411

GHS09

H411

607-510-00-8

(2S,5R)-6,6-dibrom-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-carboxylsyre-4,4-dioxid

427-200-4

76646-91-8

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H302

H315

H318

H317

GHS05

GHS07

Dgr

H302

H315

H318

H317

607-511-00-3

en blanding af 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxosmørsyre og

4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxosmørsyre

423-750-4

—

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

607-512-00-9

trinatrium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzensulfonat

423-970-0

182926-43-8

Aquatic Chronic 3

H412

—

H412

607-513-00-4

en blanding af trinatrium 4-benzoylamiino-6-(6-ethensulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hyroxynaphthalen-2,7-disulfonat og

5-(benzoylamino)-4-hyroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphtyl)azo)naphthalen-2,7-disulfonsyre natriumsalt og

5-(benzoylamino)-4-hyroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphtyl)azo)naphthalen-2,7-disulfonsyre

423-200-3

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-514-00-X

kalium-N-(1-methoxy-1-oxobut-2-en-3-yl)valinat

427-240-2

134841-35-3

Skin Sens. 1

H317

GHS07

Wng

H317

607-515-00-5

en blanding af dinatrium hexyldiphenyletherdisulfonat og dinatrium dihexyldiphenyletherdisulfonat

429-650-7

147732-60-3

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

607-516-00-0

N, N'-bis(trifluoracetyl)-S,S'-bis-.sc.L.sc.-homocystein

429-670-6

105996-54-1

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-517-00-6

(S)-α-(acetylthio)benzenpropansyre

430-300-0

76932-17-7

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H302

H318

H317

GHS05

GHS07

Dgr

H302

H318

H317

607-518-00-1

3-oxoandrost-4-en-17β-carboxylsyre

414-990-0

302-97-6

Repr. 2

Aquatic Chronic 4

H361f

H413

GHS08

Wng

H361f

H413

607-519-00-7

poly-[((4-((4-ethyl-ethylen)amino)phenyl)-(4-(ethyl-(2-oxyethylen)amino)phenyl)methinyl)cyclohexa-2,5-dienyliden)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetat]

427-280-0

176429-27-9

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H335

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H335

H315

H318

H410

607-520-00-2

blanding af natrium-4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphat og

dinatrium-4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphat

427-740-0

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-521-00-8

tetraethyl-N, N'-(methylendicyclohexan-4,1-diyl)bis-DL-aspartat

429-270-1

136210-30-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-522-00-3

natriumsalt af polymer af natrium-2-methyl-buta-1,3-dien-1-sulfonat med acrylsyre og 2-hydroxyethyl-2-methylacrylat

429-720-7

184246-86-4

Aquatic Chronic 3

H412

—

H412

607-523-00-9

blanding af mono- til tetra(lithium og/eller natrium)-3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6,13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og

mono- til tetra(lithium og/eller natrium)-3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6,13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og

mono- til penta(lithium og/eller natrium)-10,10'-diamino-6,6',13,13'-tetrachlor-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og

mono- til hepta(lithium og/eller natrium)-10-amino-6,6',13,13'-tetrachlor-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og

mono- til hepta(lithium og/eller natrium)-10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylendiiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat

430-200-7

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-524-00-4

tallolie-2-[(tetrahydro-2H-pyran-2-yl)thio]ethylestere

430-310-5

—

Aquatic Chronic 4

H413

H413

607-525-00-X

(Z)-2-methoxyimino-2-[2-(tritylamino)thiazol-4-yl]eddikesyre

431-520-1

64485-90-1

Flam. Sol. 1 **** Carc. 2

Aquatic Chronic 3

H228

H351

H412

GHS02

GHS08

Dgr

H228

H351

H412

607-526-00-5

cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propan

—

15263-53-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-527-00-0

en blanding af 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl) 12-(1''H,1''H,2''H,2''H-tridecafluoroctyl)dodecandioat og

1-(1'H,1'H,2'H,2'H-tridecafluoroctyl) 12-(1''H,1''H,2''H,2''H-heptdecafluordecyl)dodecandioat og

1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)12-(1''H,1''H,2''H,2''H-heneicosafluordodecyl)dodecandioat og

1-(1'H,1'H,2'H,2'H-tridecafluoroctyl) 12-(1''H,1''H,2''H,2''H-pentacosafluortetradecyl)dodecandioat og 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl) 12 (1''H,1''H,2''H,2''H-heptadecafluordecyl)dodecandioat og 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl) 12-(1''H,1''H,2''H,2''H-heneicosafluordodecyl)dodecandioat

423-180-6

—

STOT RE 2 *

H373 **

GHS08

Wng

H373 **

607-528-00-6

(S)-3-methyl-2-(2-oxotetrahydropyrimidin-1-yl)smørsyre

430-900-2

192725-50-1

Eye Dam. 1

H318

GHS05

Dgr

H318

607-529-00-1

benzyl-cis-4-ammonium-4'-toluensulfonato-1-cyclohexancarboxylat

426-070-6

67299-45-0

Aquatic Chronic 3

H412

—

H412

607-530-00-7

blanding af isomerer af C7-9-alkyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionat

406-040-9

125643-61-0

Aquatic Chronic 4

H413

—

H413

607-531-00-2

methyl-3-amino-4,6-dibrom-2-methyl-benzoat

425-190-6

119916-05-1

STOT RE 2 *

Aquatic Chronic 2

H373 ** H411

GHS08

GHS09

Wng

H373 ** H411

607-532-00-8

(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentancarboxylsyre, cyclohexylaminsalt

425-510-4

167944-94-7

Aquatic Chronic 3

H412

—

H412

607-533-00-3

pentanatrium-monohydrogen-6-chlor-3,10-bis[2-[4-chlor-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5,6][1,4]oxazino[2,3-b]phenoxazin-4,11-disulfonat

414-910-4

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-534-00-9

ethyl-2-(3-benzoylphenyl)propanoat

414-920-9

60658-04-0

Acute Tox. 3 * STOT RE 1

Skin Sens. 1

Aquatic Chronic 2

H301

H372 ** H317

H411

GHS06

GHS08

GHS09

Dgr

H301

H372 ** H317

H411

607-535-00-4

kalium-4-iod-2-sulfonato-benzoesyre

426-620-5

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-536-00-X

(2,6-xylyloxy)eddikesyre

430-910-7

13335-71-2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

607-537-00-5

isopropylammonium-2-(3-benzoylphenyl)propionat

417-970-1

—

Acute Tox. 3 * Acute Tox. 4 * STOT RE 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H372 ** H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H301

H312

H372 ** H318

H410

607-539-00-6

propyl-((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethylenamino)acetat

431-000-2

198705-81-6

Aquatic Chronic 4

H413

—

H413

607-540-00-1

1-(mercaptomethyl)cyclopropyleddikesyre

420-240-3

162515-68-6

Skin Corr. 1B

Acute Tox. 4 * Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H314

H312

H302

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H312

H302

H317

H411

607-541-00-7

[(1-methyl-1,2-ethandiyl)bis[nitrilobis(methylen)]]tetrakis(phosphonsyre)

421-940-1

28698-31-9

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

607-542-00-2

methyl-2-(4-butansulfonamido-phenoxy)tetradecanoat

422-110-1

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-543-00-8

poly-[((4-((4-(ethyl-ethylen)amino)phenyl)-(4-(ethyl-(2-oxyethylen)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienyliden)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetat]

427-480-8

176429-22-4

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H335

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H335

H315

H318

H410

607-544-00-3

ethyl-6,8-difluor-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinolin-3-carboxylat

427-490-2

158585-86-5

Aquatic Chronic 3

H412

—

H412

607-545-00-9

1,2-dimethyl-3-(1-methylethenyl)cyclopentylacetat

424-070-0

94346-09-5

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-546-00-4

blanding af methyl-{[5-acetylamino-4-(2-chlor-4-nitro-phenylazo)phenyl]methoxy-carbonylmethylamino}acetat og

methyl-{[5-acetylamino-4-(2-chlor-4-nitro-phenylazo)phenyl]ethoxy-carbonylmethylamino}acetat

424-290-7

188070-47-5

Skin Sens. 1

H317

GHS07

Wng

H317

607-547-00-X

18-methylnonadecyl-2,2-dimethylpropanoat

424-370-1

125496-22-2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

607-548-00-5

1-(2,4-dichlorphenyl)-2-(1H-imidazol-1-yl)ethanonmethansulfonat

431-010-7

154486-26-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

607-549-00-0

methyl-(E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoat

424-430-7

125778-19-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-550-00-6

2-amino-4-brom-5-chlorbenzoesyre

424-700-4

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-551-00-1

tetrabutylammonium-2-amino-6-iodpurinat

424-710-9

156126-48-6

Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H312

H302

H373 ** H315

H318

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H312

H302

H373 ** H315

H318

H317

H411

607-552-00-7

hexadecyl-3-amino-4-isopropoxybenzoat

424-830-1

—

Aquatic Chronic 4

H413

—

H413

607-553-00-2

7-amino-4-hydroxy-2-naphthalensulfonsyre, koblet med 5 (eller 8) -amino-8 (eller 5)-[[4-[[4-[[4-amino-6 (eller 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalensulfonsyre og 4-hydroxy-7-(phenylamino)-2-naphthalensulfonsyre, natriumsalt

424-850-0

—

Eye Dam. 1

H318

GHS05

Dgr

H318

607-554-00-8

2,4-diamino-5-[4-[(2-sulfoxylethyl)sulfonyl]phenylazo]benzensulfonsyre

424-870-1

27624-67-5

Expl. 1,1

Eye Dam. 1

Aquatic Chronic 3

H201

H318

H412

GHS01

GHS05

Dgr

H201

H318

H412

607-555-00-3

1,1,3,3-tetramethylbutylperoxypivalat

424-980-8

22288-41-1

Flam. Liq. 2

Org. Perox. D

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H225

H242

H315

H317

H411

GHS02

GHS07

GHS09

Dgr

H225

H242

H315

H317

H411

607-556-00-9

2-acetoxymethylen-4-acetylphenylacetat

425-160-2

24085-06-1

Acute Tox. 4 * STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09 Dgr

H302

H373 ** H318

H317

H410

607-557-00-4

salt af (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol og [R-[R*R*]]-2,3-dihydroxybutandisyre

425-210-3

169939-84-8

Skin Sens. 1

H317

GHS07

Wng

H317

607-558-00-X

2S-isopropyl-5R-methyl-1R-cyclohexyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]-oxathiolan-2-carboxylat

425-250-1

147027-10-9

Aquatic Chronic 2

H411

GHS09

H411

607-559-00-5

kokosolie, reaktionsprodukter med glycerolestere af 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenpropansyre

425-400-6

179986-09-5

Aquatic Chronic 4

H413

—

H413

607-560-00-0

(R,S)-2-butyloctandisyre

431-210-4

50905-10-7

Eye Dam. 1

H318

GHS05

Dgr

H318

607-561-00-6

natrium-4-hydroxy-3-(N'-(2-(2-hydroxyethylensulfonyl)ethylen)ureido)-5-nitro-benzensulfonat

425-460-3

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-562-00-1

en blanding af (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium-methansulfonat og

(2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium-methansulfonat

425-530-3

98769-75-6

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

607-563-00-7

5,7-dichlor-4-hydroxyquinolin-3-carboxylsyre

431-250-2

171850-30-9

Aquatic Chronic 2

H411

GHS09

H411

607-564-00-2

1,6-hexandiammonium-natrium-5-sulfato-1,3-benzendicarboxylat

425-730-0

51178-75-7

Skin Sens. 1

H317

GHS07

Wng

H317

607-565-00-8

3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat

425-820-1

88150-42-9

Acute Tox. 3 * STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H373 ** H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H301

H373 ** H318

H410

607-566-00-3

blanding af dodecylphenyl-dodecylhydroxybenzencarboxylat og

bis(dodecylphenyl)dodecyl-hydroxybenzendicarboxylat

426-140-6

—

Aquatic Chronic 4

H413

—

H413

607-567-00-9

kalium-3-iod-6-methylbenzensulfonat

426-300-5

—

Eye Dam. 1

H318

GHS05

Dgr

H318

607-568-00-4

kalium-2-chlor-3-(benzyloxy)propionat

426-350-8

138666-92-9

Acute Tox. 4 * STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H302

H373 ** H318

H317

GHS05

GHS08

GHS07

Dgr

H302

H373 ** H318

H317

607-569-00-X

blanding af natrium-2-amino-4-(2,6-difluorpyrimidin-4-ylamino)benzensulfonat og

natrium-2-amino-4-(4,6-difluorpyrimidin-4-ylamino)benzensulfonat

426-470-0

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-570-00-5

natrium-(6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carboxylat monohydrat

426-520-1

71420-85-4

Skin Sens. 1

H317

GHS07

Wng

H317

607-571-00-0

2-cyclopenten-1-eddikesyre, 3-hydroxy-2-pentyl-, methylesteracetat

431-400-7

57374-49-9

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-572-00-6

diethyl-thiophosphoryl-(Z)-(2-aminothiazol-4-yl)methoxyimino acetat

426-790-0

162208-27-7

Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373 ** H317

H400

H410

GHS08

GHS07

GHS09

Wng

H312

H302

H373 ** H317

H410

607-573-00-1

blanding af dinatrium-7-(2,4-difluorpyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalen-2-sulfonat og dinatrium-7-(4,6-difluorpyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalen-2-sulfonat

426-840-1

—

Eye Dam. 1

H318

GHS05

Dgr

H318

607-574-00-7

[1R-(1α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butandioat

426-890-4

77341-67-4

Eye Dam. 1

H318

GHS05

Dgr

H318

607-575-00-2

4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-yliden]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoesyre triethylaminsalt

426-900-7

—

STOT SE 3

Aquatic Chronic 3

H335

H412

GHS07

Wng

H335

H412

607-576-00-8

forgrenet octyl-3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoat

427-030-0

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-577-00-3

(2R*,3S*)-2-(2,4-difluorphenyl)-3-(5-fluor-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonat

427-100-0

—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

607-578-00-9

ethyl-4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazol-3-carboxylat

427-110-5

—

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 4

H302

H373 ** H413

GHS08

GHS07

Wng

H302

H373 ** H413

607-579-00-4

diethyl[(p-ethoxyanilino)methylen]malonat

431-430-0

103976-28-9

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-580-00-X

ethyl-7-chlor-1-(2,4-difluorphenyl)-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylat

422-360-1

100491-29-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-581-00-5

ethyl-2-ethoxy-4-carboxymethylbenzoat

427-630-2

99469-99-5

Eye Dam. 1

H318

GHS05

Dgr

H318

607-582-00-0

blanding af tetranatrium-7-(4-(4-fluor-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat og tetranatrium-7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat

427-650-1

—

Aquatic Chronic 3

H412

—

H412

607-583-00-6

4-amino-3-[[4-[[2-(sulfoxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalensulfonsyre

427-680-5

188907-52-0

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-584-00-1

trinatrium-3-[2-acetylamino-4-[4-chlor-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalen-1,5-disulfonat

427-710-7

215612-56-9

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-585-00-7

strontium-2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalen-1-sulfonat

427-930-3

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-586-00-2

dodecyl-3-amino-4-chlorbenzoat

428-020-9

6195-20-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-587-00-8

ethyl-cis-4-[4-[[2-(2,4-dichlorphenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-carboxylat

428-030-3

67914-69-6

Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 ** H410

607-588-00-3

en blanding af 2-ethylhexyl-2,3,4,5-tetrabrombenzoat og bis(2-ethylhexyl)-3,4,5,6-tetrabromphthalat

428-050-2

—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-589-00-9

tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butantetracarboxylat

428-070-1

91788-83-9

STOT RE 1

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H372 ** H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H372 ** H302

H410

607-590-00-4

hexadecyl-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoat

428-140-1

210706-50-6

Aquatic Chronic 4

H413

—

H413

607-591-00-X

blanding af trinatrium-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfoxyethansulfonyl)phenylazo)naphthalen-2,7-disulfonat og dinatrium-3-(4-ethensulfonylphenylazo)-5 (4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalen-2,7-disulfonat

428-400-4

—

Eye Dam. 1

H318

GHS05

Dgr

H318

607-592-00-5

di(C9-11-alkyl)cyclohexan-1,4-dicarboxylat

428-870-0

—

Aquatic Chronic 4

H413

—

H413

607-593-00-0

4-(2-methylacryloyloxy)phenyl-4-allyloxybenzoat

429-000-2

159235-16-2

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-594-00-6

ethyl-(1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-en-3-carboxylat

429-020-1

204254-96-6

STOT RE 2 *

Skin Sens. 1

H373 ** H317

GHS08

GHS07

Wng

H373 ** H317

607-595-00-1

N-amidino-N-methylglycin-2-oxopropionat

429-120-5

208535-04-0

Eye Dam. 1

H318

GHS05

Dgr

H318

607-596-00-7

ethyl-2-(4-phenoxyphenyl)lactat

429-220-9

132584-17-9

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-597-00-2

tetranatrium-4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilben-2,2'-disulfonat

429-230-3

—

Eye Dam. 1

H318

GHS05

Dgr

H318

607-598-00-8

trinatrium-3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluor-1,3,5-triazin-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalen-2,7-disulfonat

429-240-8

212652-59-0

Eye Dam. 1

H318

GHS05

Dgr

H318

607-599-00-3

1,1-dimethylpropyl-3,5,5-trimethylperoxyhexanoat

431-610-9

68860-54-8

Org. Perox. D

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H242

H317

H400

H410

GHS02

GHS07

GHS09

Dgr

H242

H317

H410

607-600-00-7

(1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl-propanoat

431-700-8

—

Aquatic Chronic 2

H411

GHS09

H411

607-601-00-2

1,4-dihydroxy-2,2,6,6-tetramethylpiperidinium-2-hydroxy-1,2,3-propantricarboxylat

429-370-5

220410-74-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-602-00-8

ethyl-(3-cyanmethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetat

429-680-0

122665-86-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-603-00-3

lithium-natrium-4,4',4''-(nitrilotris(ethan-2,1-diylimino(6-chlor-1,3,5-triazin-4,2-diyl)imino))-tris(5-hydroxy-6-(1-sulfonaphthalen-2-ylazo)-2,7-naphthalen)disulfonat

429-730-1

193562-37-7

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-604-00-9

guanidiniumbenzoat

429-820-0

26739-54-8

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-605-00-4

methyl-4-iod-2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl)benzoat

429-890-2

144550-06-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-606-00-X

(Z)-2-(2-tert-butoxycarbonylamino-4-thiazolyl)pent-2-ensyre

430-100-3

86978-24-7

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-607-00-5

en blanding af calcium-bis(C10-14 forgrenet alkyl-salicylat) og calcium-bis(C18-30-alkylsalicylat) og calcium-C10-14 forgrenet alkyl-salicylato-C18-30-alkylsalicylat og calcium-bis(C10-14 forgrenet alkyl-phenolat) og calcium-bis(C18-30-alkylphenolat) og calcium-C10-14 forgrenet alkyl-phenolato-C18-30-alkylphenolat og C10-14 forgrenet alkyl-phenol og C18-30-alkylphenol

430-180-1

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-608-00-0

pentakalium-2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-yliden]-3-(2-pyrrolidinon-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzen-1,4-disulfonat

430-210-1

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-609-00-6

ethyl-(3R)-4-cyan-3-hydroxybutanoat

430-220-6

141942-85-0

Eye Irrit. 2

H319

GHS07

Wng

H319

607-610-00-1

trinatrium-4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalen-2-sulfonat

430-280-3

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-611-00-7

methyl-3-amino-2,2,3-trimethylbutyrat

431-720-7

90886-53-6

Skin Corr. 1B

Acute Tox. 4 *

Aquatic Chronic 3

H314

H302

H412

GHS05

GHS07

Dgr

H314

H302

H412

607-612-00-2

blanding af 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluor-1-octansulfonsyre og ammonium-3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluor-1-octansulfonat

432-190-1

182176-52-9

Acute Tox. 4 * STOT RE 2 *

Eye Dam. 1

H302

H373 ** H318

GHS05

GHS08

GHS07

Dgr

H302

H373 ** H318

607-613-00-8

blanding af ravsyre; monoperoxyravsyre; diperoxyravsyre; monomethylester af ravsyre; monomethylester af peroxyravsyre; dimethylsuccinat; glutarsyre; monoperoxyglutarsyre; diperoxyglutarsyre; monomethylester af glutarsyre; monomethylester af peroxyglutarsyre; dimethylglutarat; adipinsyre; monoperoxyadipinsyre; diperoxyadipinsyre; monomethylester af adipinsyre; monomethylester af peroxyadipinsyre; dimethyladipat; hydrogenperoxid; methanol og vand

432-790-1

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

Skin Corr. 1B STOT SE 2

H332

H312

H302

H314

H371 (øjne)

GHS07

GHS05

GHS08

Dgr

H332

H312

H302

H314

H371 (øjne)

607-614-00-3

2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)ravsyre

426-480-5

63562-33-4

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-615-00-9

reaktionsprodukt af thioglycerol og mercaptoeddikesyre, som hovedsagelig består af 3-mercapto-1,2-bismercaptoacetoxypropan og oligomerer heraf

431-120-5

—

Acute Tox. 3 * Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H331

H302

H319

H317

GHS06

Dgr

H331

H302

H319

H317

607-616-00-4

2,4-dichlor-5-fluorbenzoylchlorid

428-390-1

86393-34-2

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H335

H315

H318

H317

H412

GHS05

GHS07

Dgr

H335

H315

H318

H317

H412

607-617-00-X

bis(2-ethylhexyl)-4,5-epoxycyclohexan-1,2-dicarboxylat

430-700-5

10138-36-0

Skin Sens. 1

H317

GHS07

Wng

H317

607-618-00-5

menadionnatriumbisulfit; 2-naphthalensulfonsyre, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, natriumsalt

204-987-0

130-37-0

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

607-619-00-0

menadionnicotinamidbisulfit; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalen-2-sulfonsyre, forbindelse med nicotin-3-amid (1:1)

277-543-7

73581-79-0

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

607-620-00-6

trinatriumnitrilotriacetat

225-768-6

5064-31-3

Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

H351

H302

H319

GHS08

GHS07

Wng

H351

H302

H319

Carc. 2; H351: C

≥ 5 %

607-621-00-1

milbemectin (ISO); [blanding af milbemycin A3 (CAS-nr. 51596-10-2) og milbemycin A4 (CAS-nr. 51596-11-3) (30:70)]

—

—

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H400

H410

GHS07

GHS09

Wng

H332

H302

H410

M = 100

607-622-00-7

2-ethylhexyl-2-ethylhexanoat

231-057-1

7425-14-1

Repr. 2

H361d ***

GHS08

Wng

H361d ***

607-624-00-8

perfluoroctansulfonsyre; heptadecafluoroctan-1-sulfonsyre; [1] kaliumperfluoroctansulfonat;

kaliumheptadecafluoroctan-1-sulfonat; [2] diethanolaminperfluoroctansulfonat; [3] ammoniumperfluoroctansulfonat; ammoniumheptadecafluoroctansulfonat; [4] lithiumperfluoroctansulfonat; lithiumheptadecafluoroctansulfonat [5]

217-179-8 [1]

220-527-1 [2]

274-460-8 [3]

249-415-0 [4]

249-644-6 [5]

1763-23-1 [1]

2795-39-3 [2]

70225-14-8 [3]

29081-56-9 [4]

29457-72-5 [5]

Carc. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 * Acute Tox. 4 *

Lact.

Aquatic Chronic 2

H351

H360D *** H372 **

H332

H302

H362

H411

GHS08

GHS07

GHS09

Dgr

H351

H360D *** H372 **

H332

H302

H362

H411

607-625-00-3

clodinafop-propargyl (ISO)

—

105512-06-9

Acute Tox. 4 * STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 ** H317

H410

Skin Sens. 1; H317: C ≥ 0,001  %

M = 1

607-626-00-9

ethyl-1-(2,4-dichlorphenyl)-5-(trichlormethyl)-1H-1,2,4-triazol-3-carboxylat

401-290-5

103112-35-2

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

607-627-00-4

[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzensulfonat

416-360-0

162221-28-5

Skin Sens. 1

H317

GHS07

Wng

H317

607-628-00-X

4-oxo-4-(p-tolyl)smørsyre, addukt med 4-ethylmorpholin

419-240-6

171054-89-0

Eye Dam. 1

H318

GHS05

Dgr

H318

607-629-00-5

[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]eddikesyre

419-270-1

123599-82-6

Eye Irrit. 2

H319

GHS07

Wng

H319

607-630-00-0

acrylsyre, 3-(trimethoxysilyl)propylester

419-560-6

4369-14-6

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H332

H314

H317

H412

GHS05

GHS07

Dgr

H332

H314

H317

H412

607-631-00-6

en blanding af 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl-oxo(phenyl)acetat og (2-(2-hydroxyethoxy)ethyl)-oxo(phenyl)acetat

442-300-8

—

Skin Sens. 1

H317

GHS07

Wng

H317

607-632-00-1

N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamid

420-210-1

111244-14-5

Aquatic Chronic 4

H413

—

H413

607-633-00-7

trinatrium-5-{[4-chlor-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalendisulfonat

440-480-2

341026-59-3

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-634-00-2

(S)-(-)-2-acetoxypropionylchlorid; (1S)-2-chlor-1-methyl-2-oxoethylacetat

420-610-4

36394-75-9

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H302

H314

H317

GHS05

GHS07

Dgr

H302

H314

H317

607-635-00-8

trinatrium-N-(3-propionato)-L-aspartat

422-090-4

172737-80-3

Eye Dam. 1

H318

GHS05

Dgr

H318

607-636-00-3

1-brom-2-methylpropylpropionat

422-900-6

158894-67-8

Flam. Liq. 3

Carc. 2

Skin Corr. 1B

Skin Sens. 1

H226

H351

H314

H317

GHS02

GHS05

GHS08

GHS07

Dgr

H226

H351

H314

H317

607-637-00-9

dinatrium-8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalen-2-sulfonat

423-730-5

250688-43-8

Eye Dam. 1

H318

GHS05

Dgr

H318

607-638-00-4

2-hydroxybenzoesyre-2-butyloctylester

431-090-3

190085-41-7

Aquatic Chronic 4

H413

—

H413

607-639-00-X

2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenylacetat

431-770-1

216698-07-6

Aquatic Chronic 4

H413

—

H413

607-641-00-0

2-(formylamino)-3-thiophencarboxylsyre; 2-formamido-3-thiophencarboxylsyre

431-930-9

43028-69-9

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

607-642-00-6

3,6,9-trithiaundecamethylen-1,11-dimethacrylat

432-210-7

141631-22-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

607-643-00-1

dimethyl (2S)-2-hydroxysuccinat

432-310-0

617-55-0

Flam. Liq. 3

Eye Dam. 1

Skin Sens. 1

H226

H318

H317

GHS02

GHS05

GHS07

Dgr

H226

H318

H317

607-644-00-7

methyl-2,2-dimethyl-6-methylencyclohexancarboxylat

432-350-9

81752-87-6

Skin Irrit. 2

H315

GHS07

Wng

H315

607-645-00-2

tetranatrium-2-(4-fluor-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalen-1,7-disulfonat

432-550-6

243858-01-7

Eye Dam. 1

H318

GHS05

Dgr

H318

607-646-00-8

D-erythro-hexansyre-2,4-dideoxy-3,5-O-(1-methylethyliden)-1,1-dimethylethylester; tert-butyl-2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetat

432-960-5

124655-09-0

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-647-00-3

5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolan

433-530-1

143446-73-5

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

H302

H317

H400

GHS07

GHS09

Wng

H302

H317

H400

607-649-00-4

[3-(chlorcarbonyl)-2-methylphenyl]acetat

433-690-0

167678-46-8

Skin Corr. 1A

Skin Sens. 1

H314

H317

GHS05

GHS07

Dgr

H314

H317

607-650-00-X

2-methyl-1,5-pentandiamin-1,3-benzendicarboxylat

433-910-5

145153-52-2

Skin Sens. 1

H317

GHS07

Wng

H317

607-651-00-5

natrium-2-(nonanoyloxy)benzensulfonat

434-360-9

91125-43-8

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-652-00-0

ethyl-N2-dodecanoyl-L-argininathydrochlorid

434-630-6

60372-77-2

Eye Dam. 1

Aquatic Acute 1

H318

H400

GHS05

GHS09

Dgr

H318

H400

607-653-00-6

tetrakis(bis(2-hydroxyethyl)methylammonium)-3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalen-2-sulfonat

434-840-8

225786-91-4

Aquatic Chronic 2

H411

GHS09

H411

607-654-00-1

(S)-3-hydroxy-γ-butyrolacton

434-990-4

7331-52-4

Skin Sens. 1

H317

GHS07

Wng

H317

607-655-00-7

ethyl-6,8-dichloroctanoat

435-080-1

1070-64-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-656-00-2

natriumsalt af 4-amino-3,6-bis[[5-[[4-chlor-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalendisulfonsyre

435-350-7

141250-43-3

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-657-00-8

pentanatrium-7-(4-(4-(3-(2-sulfatoethansulfonyl)phenylamino)-6-(4-(2-sulfatoethansulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat

436-920-8

172399-10-9

Eye Dam. 1

H318

GHS05

Dgr

H318

607-658-00-3

3,10-diamino-6,13-dichlor-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazindisulfonsyre, lithiumkaliumnatriumsalt

440-770-9

371921-63-0

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-659-00-9

pentanatrium-N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chlor-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropansyre

442-030-0

321912-47-4

Eye Dam. 1

H318

GHS05

Dgr

H318

607-660-00-4

2-{4-[4-[4-fluor-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalen-4,6,8-trisulfonat, trinatriumsalt

442-230-8

321679-52-1

Eye Dam. 1

H318

GHS05

Dgr

H318

607-661-00-X

1,1-dimethylethyl-4'-(brommethyl)biphenyl-2-carboxylat

442-850-9

114772-40-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-662-00-5

methyl-2-(acetylamino)-3-chlorpropionat

442-860-3

87333-22-0

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-663-00-0

bis(2-ethylhexyl)-naphthalen-2,6-dicarboxylat

442-980-6

127474-91-3

Aquatic Chronic 4

H413

—

H413

607-664-00-6

methyl-2-chlorsulfonyl-4-(methansulfonylaminomethyl)benzoat

443-120-2

393509-79-0

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

607-665-00-1

trans-methyl-2-ethyl-but-2-enoat

443-150-6

101226-85-1

Flam. Liq. 3

H226

GHS02

Wng

H226

607-666-00-7

(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentansyre

443-560-5

88784-33-2

Eye Irrit. 2

H319

GHS07

Wng

H319

607-667-00-2

chlor-1-ethylcyclohexylcarbonat

444-950-8

99464-83-2

Muta. 2

Skin Sens. 1

H341

H317

GHS08

GHS07

Wng

H341

H317

607-668-00-8

trans-2-isopropyl-5-carboxy-1,3-dioxan

445-770-2

42031-28-7

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-669-00-3

methyl-(9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoat

445-990-9

376588-17-9

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propylammoniumoxalat;

(5-amino-2-butylbenzofuran-3-yl)-[4-(3-dibutylaminopropoxy)phenyl]methanon, dioxalat

448-700-9

500791-70-8

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 ** H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H373 ** H318

H317

H410

M = 10

607-671-00-4

diethyl-1,4-cyclohexandicarboxylat

417-310-0

72903-27-6

Aquatic Chronic 2

H411

GHS09

H411

607-672-00-X

en blanding af 2-hydroxy-3-(methacryloyloxy)propyl-(2-benzoyl)benzoat; 1-hydroxymethyl-2-(methacryloyloxy)ethyl-(2-benzoyl)benzoat; x-hydroxy-y-(methacryloyloxy)propyl(eller -ethyl)-(2-benzoyl)benzoat

419-000-0

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-673-00-5

1-ethyl-5,6,7,8-tetrahydroquinoliniumtosylat

419-570-0

—

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

607-675-00-6

blanding af cis-9-octadecendisyre; cis-9-cis-12-octadecadiendisyre; hexadecandisyre;

octadecandisyre

422-260-8

—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

607-676-00-1

en blanding af 2-methylnonandisyre; 2,4-dimethyl-4-methoxycarbonylundecandisyre; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecandisyre; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecandisyre

423-670-1

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-677-00-7

2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinat

424-660-8

—

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H373 ** H318

H317

GHS05

GHS08

GHS07

Dgr

H373 ** H318

H317

607-678-00-2

blanding af ethyl-(2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat og ethyl-(2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat

427-090-8

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-679-00-8

en blanding af 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3 (methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammoniumdi(acetat); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat)

431-440-5

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

607-680-00-3

tert-butyl(6-{2-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetat

432-810-9

—

Aquatic Chronic 4

H413

—

H413

607-681-00-9

en blanding af 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecansyre; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecansyre;

dihexadecyl-9-nonyl-10-octylnonadecandioat; 1-octadecyl-19-hexadecyl-9-nonyl-10-octylnonadecandioat; dioctadecyl-9-nonyl-10-octylnonadecandioat

432-910-2

—

Aquatic Chronic 4

H413

—

H413

607-682-00-4

kompleks blanding af kinesisk gummiharpiks, efterfølgende behandlet med acrylsyre

434-230-1

144413-22-9

Aquatic Chronic 4

H413

—

H413

607-683-00-X

blanding af methyl-3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat; methyl-3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat (20:80)

435-450-0

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-684-00-5

alkener, C12-14, hydroformyleringsprodukter, destillationsrester, C-(hydrogensulfobutandioater), dinatriumsalte

435-660-2

243662-67-1

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

607-685-00-0

ammonium-2-cocoyloxyethansulfonat

441-050-7

—

Skin Irrit. 2

Eye Dam. 1

H315

H318

GHS05

Dgr

H315

H318

607-686-00-6

6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylen-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonyloxy)-6-methyl-2-phenylen]di(naphthalen-1-sulfonat)

441-550-5

—

Self-react. C **** Carc. 2

H242

H351

GHS02

GHS08

Dgr

H242

H351

607-687-00-1

en blanding af 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);

2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %)

442-800-6

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-688-00-7

(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchlorid

444-320-2

—

Acute Tox. 4 *

H302

GHS07

Wng

H302

607-689-00-2

blanding af methyl-1,4-dimethylcyclohexancarboxylat (»para-isomer« inkl. cis- og trans-isomerer); methyl-1,3-dimethylcyclohexancarboxylat (»meta-isomer« inkl. cis- og trans-isomerer)

444-920-4

—

Aquatic Chronic 3

H412

—

H412

607-690-00-8

dimethyl-[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N, N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoat

432-860-1

255387-46-3

Skin Sens. 1

H317

GHS07

Wng

H317

607-691-00-3

magnesiumsalte, fedtsyrer, C16-18- og C18-umættede, forgrenede og lineære

448-690-6

—

Aquatic Chronic 4

H413

—

H413

607-692-00-9

zinksalte, fedtsyrer, C16-18- og C18-umættede, forgrenede og lineære

446-470-4

—

Aquatic Chronic 4

H413

—

H413

607-693-00-4

hexyl-2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoat

443-860-6

302776-68-7

Aquatic Chronic 4

H413

—

H413

607-694-00-X

ethyl-5,5-diphenyl-2-isoxazolin-3-carboxylat

443-870-0

163520-33-0

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

607-696-00-0

pentylformat

211-340-6

638-49-3

Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

H226

H319

H335

GHS02

GHS07

Dgr

H226

H319

H335

C

607-697-00-6

tert-butylpropionat

—

20487-40-5

Flam. Liq. 2

H225

GHS02

Dgr

H225

C

607-698-00-1

4-tert-butylbenzoesyre

202-696-3

98-73-7

Repr. 1B

STOT RE 1

Acute Tox. 4

H360F H372

H302

GHS07

GHS08

Dgr

H360F H372

H302

607-699-00-7

bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chlor-3,3,3-trifluorprop-1-en-1-yl]-2,2-dimethylcyclopropancarboxylat

82657-04-3

Carc. 2

Acute Tox. 3

Acute Tox. 2

STOT RE 1

Skin Sens. 1B Aquatic Acute 1

Aquatic Chronic 1

H351

H331

H300

H372 (nervesystem)

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H331

H300

H372 (nervesystem)

H317

H410

M = 10 000

M = 100 000

607-700-00-0

indoxacarb (ISO); methyl (4aS)-7-chlor-2-{(methoxycarbonyl)[4-(trifluorme thoxy)phenyl]carbamoyl}-2,5- dihydroindeno[1,2-e][1,3,4]oxadiazin-4a(3H)-carboxylat [1]

blanding af (S)-indoxacarb og (R)-indoxacarb 75:25; methyl 7-chlor-2-{(methoxy-carbonyl)[4-(triflourmethoxy)phenyl]-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazin-4a(3H)-carboxylat

173584-44-6 [1]

144171-61-9 [2]

Acute Tox. 3

Acute Tox. 4

STOT RE 1

Skin Sens. 1B Aquatic Acute 1

Aquatic Chronic 1

H301

H332

H372 (blod, nervesystem, hjerte)

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H332

H372 (blod, nervesystem, hjerte)

H317

H410

M = 1

M = 1

607-702-00-1

dihexylphthalat

201-559-5

84-75-3

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-703-00-7

ammoniumpentadecafluoroctansyre

223-320-4

3825-26-1

Carc. 2

Repr. 1B Lact.

Acute Tox. 4

Acute Tox. 4

STOT RE 1

Eye Dam.1

H351

H360D H362

H332

H302

H372 (lever) H318

GHS08

GHS07

GHS05

Dgr

H351

H360D H362

H332

H302

H372 (lever) H318

607-704-00-2

perfluoroctansyre

206-397-9

335-67-1

Carc. 2

Repr. 1B Lact.

Acute Tox. 4

Acute Tox. 4

STOT RE 1

Eye Dam. 1

H351

H360D H362

H332

H302

H372 (lever) H318

GHS08

GHS07

GHS05

Dgr

H351

H360D H362

H332

H302

H372 (lever) H318

607-705-00-8

benzoesyre

200-618-2

65-85-0

STOT RE 1

Skin Irrit. 2

Eye Dam. 1

H372 (lunger) (indånding) H315

H318

GHS08

GHS05

Dgr

H372 (lunger) (indånding) H315

H318

607-706-00-3

methyl 2,5-dichlorbenzoat

220-815-7

2905-69-3

Acute Tox. 4

STOT SE 3

Aquatic Chronic 2

H302

H336

H411

GHS07

GHS09

Wng

H302

H336

H411

608-001-00-3

acetonitril; cyanmethan

200-835-2

75-05-8

Flam. Liq. 2

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

H225

H332

H312

H302

H319

GHS02

GHS07

Dgr

H225

H332

H312

H302

H319

608-002-00-9

trichloracetonitril

208-885-7

545-06-2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H331

H311

H301

H411

GHS06

GHS09

Dgr

H331

H311

H301

H411

608-003-00-4

acrylonitril

203-466-5

107-13-1

Flam. Liq. 2

Carc. 1B

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H225

H350

H331

H311

H301

H335

H315

H318

H317

H411

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H225

H350

H331

H311

H301

H335

H315

H318

H317

H411

*

D

608-004-00-X

2-hydroxy-2-methylpropionitril; 2-cyan-2-propanol; acetonecyanhydrin

200-909-4

75-86-5

Acute Tox. 2 * Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H400

H410

GHS06

GHS09

Dgr

H330

H310

H300

H410

608-005-00-5

n-butyronitril

203-700-6

109-74-0

Flam. Liq. 2

Acute Tox. 3 * Acute Tox. 3 *

Acute Tox. 3 *

H225

H331

H311

H301

GHS02

GHS06

Dgr

H225

H331

H311

H301

608-006-00-0

bromoxynil (ISO), 3,5-dibrom-4-hydroxybenzonitril; bromoxynil-phenol

216-882-7

1689-84-5

Repr. 2

Acute Tox. 2 * Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d *** H330

H301

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H361d *** H330

H301

H317

H410

M = 10

608-007-00-6

ioxynil (ISO); 4-hydroxy-3,5-diiodbenzonitril

216-881-1

1689-83-4

Repr. 2

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d *** H331

H301

H312

H373 ** H319

H400

H410

GHS06

GHS08

GHS09

Dgr

H361d *** H331

H301

H312

H373 ** H319

H410

M = 10

608-008-00-1

chloracetonitril

203-467-0

107-14-2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H331

H311

H301

H411

GHS06

GHS09

Dgr

H331

H311

H301

H411

608-009-00-7

malononitril

203-703-2

109-77-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

608-010-00-2

methacrylnitril; 2-methyl-2-propennitril

204-817-5

126-98-7

Flam. Liq. 2

Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *

Skin Sens. 1

H225

H331

H311

H301

H317

GHS02

GHS06

Dgr

H225

H331

H311

H301

H317

*

Skin Sens. 1; H317: C ≥ 0,2  %

D

608-011-00-8

oxalonitril; cyanogen

207-306-5

460-19-5

Press. Gas

Flam. Gas 1

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H220

H331

H400

H410

GHS02

GHS04

GHS06

GHS09

Dgr

H220

H331

H410

U

608-012-00-3

benzonitril

202-855-7

100-47-0

Acute Tox. 4 * Acute Tox. 4 *

H312

H302

GHS07

Wng

H312

H302

608-013-00-9

2-chlorbenzonitril

212-836-5

873-32-5

Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

H312

H302

H319

GHS07

Wng

H312

H302

H319

608-014-00-4

chlorothalonil (ISO); tetrachlorisophthalonitril

217-588-1

1897-45-6

Carc. 2

Acute Tox. 2 * STOT SE 3

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H330

H335

H318

H317

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H351

H330

H335

H318

H317

H410

M = 10

608-015-00-X

dichlobenil (ISO); 2,6-dichlorbenzonitril

214-787-5

1194-65-6

Acute Tox. 4 *

Aquatic Chronic 2

H312

H411

GHS07

GHS09

Wng

H312

H411

608-016-00-5

1,4-dicyano-2,3,5,6-tetra-chlor-benzen

401-550-8

1897-41-2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

608-017-00-0

bromoxynil-octanoat (ISO); 2,6-dibrom-4-cyanophenyloctanoat

216-885-3

1689-99-2

Repr. 2

Acute Tox. 3 * Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d *** H331

H302

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H361d *** H331

H302

H317

H410

M = 10

608-018-00-6

ioxynil-octanoat (ISO); 4-cyan-2,6-diiodophenyloctanoat

223-375-4

3861-47-0

Repr. 2

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d *** H301

H319

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H361d *** H301

H319

H317

H410

M = 10

608-019-00-1

2,2'-dimethyl-2,2'-azodipropiononitril; ADZN

201-132-3

78-67-1

Self-react. C

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Chronic 3

H242

H332

H302

H412

GHS02

GHS07

Dgr

H242

H332

H302

H412

T

608-020-00-7

diphenoxymethylencyanamid

427-300-8

79463-77-7

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

608-021-00-2

3-(2-(diaminomethylenamino)thiazol-4-ylmethylthio)propiononitril

403-710-2

76823-93-3

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

608-022-00-8

3,7-dimethyloctannitril

403-620-3

40188-41-8

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H315

H317

H411

GHS07

GHS09

Wng

H315

H317

H411

608-023-00-3

fenbuconazol (ISO); 4-(4-chlorphenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butannitril

406-140-2

114369-43-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

608-024-00-9

2-(4-(N-butyl-N-phenethylamino)phenyl)ethen-1,1,2-tricarbonitril

407-650-8

97460-76-9

Aquatic Chronic 4

H413

—

H413

608-025-00-4

2-nitro-4,5-bis(benzyloxy)phenylacetonitril

410-970-0

117568-27-1

Aquatic Chronic 4

H413

—

H413

608-026-00-X

3-cyano-3,5,5-trimethylcyclohexanon

411-490-4

04-11-7027

Acute Tox. 4 * STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H302

H373 ** H317

H412

GHS08

GHS07

Wng

H302

H373 ** H317

H412

608-027-00-5

en blanding af 3-(4-ethylphenyl)-2,2-dimethylpropannitril; 3-(2-ethylphenyl)-2,2-dimethylpropannitril;

3-(3-ethylphenyl)-2,2-dimethylpropannitril

412-660-0

—

Aquatic Chronic 2

H411

GHS09

H411

608-028-00-0

4-(2-cyano-3-phenylamino)-acryloyloxy-methyl-cyclohexyl-methyl-2-cyano-3-phenylamino)-acrylat

413-510-7

147374-67-2

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H373 ** H317

H411

GHS08

GHS09

Wng

H373 ** H317

H411

608-029-00-6

1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridincarbonitril

411-990-2

68612-94-2

Skin Sens. 1

H317

GHS07

Wng

H317

608-030-00-1

N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthiazol-5-yl-methylen)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamid

412-340-0

147741-93-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

608-031-00-7

2-benzyl-2-methyl-3-butenitril

407-870-4

97384-48-0

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

608-032-00-2

acetamiprid (ISO);

(E)-N1-[(6-chlor-3-pyridyl)methyl]-N2-cyan-N1-methylacetamidin

—

135410-20-7

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

608-033-00-8

N-butyl-3-(2-chlor-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-en-1,3-dicarboximid

407-970-8

75511-91-0

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

608-034-00-3

chlorfenapyr (ISO); 4-brom-2-(4-chlorphenyl)-1-ethoxymethyl-5-trifluormethylpyrrol-3-carbonitril

—

122453-73-0

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H400

H410

GHS06

GHS09

Dgr

H331

H302

H410

M = 100

608-035-00-9

(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorbenzen-aceto-nitril

419-290-9

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

608-036-00-4

3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitril

419-060-8

79026-02-1

Aquatic Chronic 4

H413

—

H413

608-037-00-X

en blanding af (E)-2,12-tridecadiennitril; (E)-3,12-tridecadiennitril; (Z)-3,12-tridecadiennitril

422-190-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

608-038-00-5

2,2,4-trimethyl-4-phenyl-butannitril

422-580-8

75490-39-0

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

608-039-00-0

2-phenylhexannitril

423-460-8

3508-98-3

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

608-040-00-6

4,4'-dithiobis(5-amino-1-(2,6-dichlor-4-(trifluormethyl)phenyl)-1H-pyrazol-3-carbonitril)

423-490-1

130755-46-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

608-041-00-1

4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)(1,1'-biphenyl)-2-carbonitril

423-500-4

138401-24-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

608-042-00-7

(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrilhydrobromid

421-810-4

194602-27-2

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

608-043-00-2

3-(cis-3-hexenyloxy)propannitril

415-220-6

142653-61-0

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H400

H410

GHS06

GHS09

Dgr

H331

H302

H410

608-044-00-8

2-cyclohexyliden-2-phenylacetonitril

423-740-1

10461-98-0

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

608-046-00-9

5-(4-chlor-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridin-3-carbonitril

425-310-7

77889-90-8

Aquatic Chronic 4

H413

—

H413

608-047-00-4

2-piperidin-1-yl-benzonitril

427-330-1

72752-52-4

Aquatic Chronic 2

H411

GHS09

H411

608-048-00-X

1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexancarbonitril

427-450-4

152630-47-2

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H302

H373 **

H317

H411

GHS08

GHS07

GHS09

Wng

H302

H373 ** H317

H411

608-049-00-5

2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyan-5-oxo-1,5-dihydropyrrol-2-yliden)propandinitril

429-180-2

157362-53-3

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

608-050-00-0

en blanding af 5-(2-cyan-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylamino-nicotinonitril og

5-(2-cyan-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylamino-nicotinonitril

429-760-5

—

Aquatic Chronic 4

H413

—

H413

608-051-00-6

(R)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril

430-760-2

219861-18-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

608-052-00-1

(S)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril

430-770-7

128173-52-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

608-053-00-7

(R,S)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril

430-780-1

103146-25-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

608-054-00-2

(R,S)-4-(4-dimethylamino-1-(4-fluorphenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril hemisulfat

430-790-6

—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

608-056-00-3

N-methyl-N-cyanmethylmorpholinium-methylsulfat

429-340-1

—

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

608-057-00-9

4-cyanmethyl-4-methylmorpholin-4-ium-hydrogensulfat

431-200-1

208538-34-5

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H302

H318

H317

GHS05

GHS07

Dgr

H302

H318

H317

608-058-00-4

esfenvalerat (ISO);

(S)-α-cyan-3-phenoxybenzyl-(S)-2-(4-chlorphenyl)-3-methylbutyrat

—

66230-04-4

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H317

H400

H410

GHS06

GHS09

Dgr

H331

H301

H317

H410

M = 10 000

608-059-00-X

5-amino-1-(2,6-dichlor-4-(trifluormethyl)phenyl)-1H-pyrazol-3-carbonitril

421-240-6

120068-79-3

Aquatic Chronic 2

H411

GHS09

H411

608-060-00-5

5-methyl-2-[(2-nitrophenyl)amino]-3-thiophencarbonitril

421-300-1

138564-59-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

608-062-00-6

2-fluor-4-hydroxybenzonitril

422-810-7

82380-18-5

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

608-063-00-1

(S)-α-hydroxy-3-phenoxy-benzenacetonitril

441-070-6

61826-76-4

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H301

H318

H317

H410

608-064-00-7

cyanmethyltrimethylammoniummethylsulfat

433-720-2

—

Aquatic Chronic 3

H412

—

H412

608-065-00-2

salte af bromoxynil undtagen sådanne nævnt andetsteds i dette bilag

—

—

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361D *** H330

H301

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H361D *** H330

H301

H317

H410

M = 10

A

608-066-00-8

salte af ioxynil undtagen sådanne nævnt andetsteds i dette bilag

—

—

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H361D *** H331

H301

H312

H373 **

H319

H400

H410

GHS06

GHS08

GHS09

Dgr

H361D *** H331

H301

H312

H373 **

H319

H410

M = 10

A

609-001-00-6

1-nitropropan

203-544-9

108-03-2

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H226

H332

H312

H302

GHS02

GHS07

Wng

H

226

H332

H312

H302

*

609-002-00-1

2-nitropropan

201-209-1

79-46-9

Flam. Liq. 3

Carc. 1B

Acute Tox. 4 *

Acute Tox. 4 *

H226

H350

H332

H302

GHS02

GHS08

GHS07

Dgr

H226

H350

H332

H302

609-003-00-7

nitrobenzen

202-716-0

98-95-3

Carc. 2. Repr. 1B

Acute Tox. 3

Acute Tox. 3

Acute Tox. 3

STOT RE 1

Aquatic Chronic 3

H351

H360F

H301

H331

H311

H372 (blod) H412

GHS06

GHS08

Dgr

H351

H360F

H301

H331

H311

H372 (blod) H412

609-004-00-2

dinitrobenzen; [1]

1,4-dinitrobenzen; [2]

1,3-dinitrobenzen; [3]

1,2-dinitrobenzen; [4]

246-673-6 [1]

202-833-7 [2]

202-776-8 [3]

208-431-8 [4]

25154-54-5 [1]

100-25-4 [2]

99-65-0 [3]

528-29-0 [4]

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 **

H410

609-005-00-8

1,3,5-trinitrobenzen

202-752-7

99-35-4

Expl. 1,1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H201

H330

H310

H300

H373 **

H400

H410

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H330

H310

H300

H373 **

H410

609-006-00-3

4-nitrotoluen

202-808-0

99-99-0

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H411

609-007-00-9

2,4-dinitrotoluen; [1]

dinitrotoluen [2]

204-450-0 [1]

246-836-1 [2]

121-14-2 [1]

25321-14-6 [2]

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H341

H361f ***

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H341

H361f ***

H331

H311

H301

H373 **

H410

609-008-00-4

2,4,6-trinitrotoluen; TNT

204-289-6

118-96-7

Expl. 1,1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H201

H331

H311

H301

H373 **

H411

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H331

H311

H301

H373 **

H411

609-009-00-X

2,4,6-trinitrophenol;

picrinsyre

201-865-9

88-89-1

Expl. 1,1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H201

H331

H311

H301

GHS01

GHS06

Dgr

H201

H331

H311

H301

609-010-00-5

picrinsyrens salte

—

—

Unst. Expl

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H201

H331

H311

H301

GHS01

GHS06

Dgr

H201

H331

H311

H301

T

609-011-00-0

2,4,6-trinitroanisol

—

606-35-9

Expl. 1,1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H201

H332

H312

H302

H411

GHS01

GHS07

GHS09

Wng

H201

H332

H312

H302

H411

609-012-00-6

2,4,6-trinitro-m-cresol

210-027-1

602-99-3

Expl. 1,1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H201

H332

H312

H302

GHS01

GHS07

Wng

H201

H332

H312

H302

609-013-00-1

2,4,6-trinitro-m-xylen

211-187-5

632-92-8

Expl. 1,1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

H201

H332

H312

H302

H373 **

GHS01

GHS08

GHS07

Wng

H201

H332

H312

H302

H373 **

609-015-00-2

4-nitrophenol;

p-nitrophenol

202-811-7

100-02-7

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

H332

H312

H302

H373 **

GHS08

GHS07

Wng

H332

H312

H302

H373 **

609-016-00-8

dinitrophenol, (blanding af isomerer); [1]

2,4(eller 2,6)-dinitrophenol [2]

247-096-2 [1]

275-732-9 [2]

25550-58-7 [1]

71629-74-8 [2]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H410

609-018-00-9

2,4,6-trinitroresorcinol

styphninsyre

201-436-6

82-71-3

Expl. 1,1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H201

H332

H312

H302

GHS01

GHS07

Dgr

H201

H332

H312

H302

609-019-00-4

bly-2,4,6-trinitro-m-phenylendioxid;

bly-2,4,6-trinitroresorcinoxid;

blystyphnat

239-290-0

15245-44-0

Unst. Expl

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H200

H360Df

H332

H302

H373 **

H400

H410

GHS01

GHS08

GHS07

GHS09

Dgr

H200

H360Df

H332

H302

H373 **

H410

1

609-019-01-1

bly-2,4,6-trinitro-m-phenylendioxid;

bly-2,4,6-trinitroresorcinoxid;

blystyphnat (≥ 20 % flegmatiseret)

239-290-0

15245-44-0

Expl. 1,1

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H201

H360Df

H332

H302

H373 **

H400

H410

GHS01

GHS08

GHS07

GHS09

Dgr

H201

H360Df

H332

H302

H373 **

H410

1

609-020-00-X

DNOC (ISO);

4,6-dinitro-o-cresol

208-601-1

534-52-1

Muta. 2

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H330

H310

H300

H315

H318

H317

H400

H410

GHS06

GHS08

GHS05

GHS07

GHS09

Dgr

H341

H330

H310

H300

H315

H318

H317

H410

EUH044

609-021-00-5

DNOC-Na;

natrium 4,6-dinitro-o-cresolat; [1]

DNOC-K; kalium 4,6-dinitro-o-cresolat [2]

219-007-7 [1]

- [2]

2312-76-7 [1]

5787-96-2 [2]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H410

609-022-00-0

DNOC-ammonium; ammonium 4,6-dinitro-o-tolyloxid

221-037-0

2980-64-5

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H300

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 **

H410

609-023-00-6

dinocap (ISO);

(RS)-2,6-dinitro-4-octylphenylcrotonater og (RS)-2,4-dinitro-6-octylphenylcrotonater, hvori »octyl« er en blanding

af 1-methylheptyl-, 1-ethylhexyl- og 1-propylpentylgrupper

254-408-0

39300-45-3

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360D ***

H332

H302

H373 **

H315

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H360D ***

H332

H302

H373 **

H315

H317

H410

M = 100

609-024-00-1

binapacryl (ISO);

2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonat

207-612-9

485-31-4

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H360D *** H312

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H360D *** H312

H302

H410

609-025-00-7

dinoseb(ISO);

6-sec-butyl-2,4-dinitrophenol

201-861-7

88-85-7

Repr. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H311

H301

H319

H400

H410

GHS06

GHS08

GHS09

Dgr

H360Df

H311

H301

H319

H410

EUH044

609-026-00-2

salte og estere af dinoseb, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Repr. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H311

H301

H319

H400

H410

GHS06

GHS08

GHS09

Dgr

H360Df

H311

H301

H319

H410

EUH044

A

609-027-00-8

dinocton

blanding af isomerer:

methyl 2-octyl-4,6-dinitrophenylcarbonat og methyl 4-octyl-2,6- dinitrophenylcarbonat

—

63919-26-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

609-028-00-3

dinex (ISO);

2-cyclohexyl-4,6-dinitrophenol

205-042-5

131-89-5

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

609-029-00-9

salte og estere af dinex

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

A

609-030-00-4

dinoterb (ISO);

2-tert-butyl-4,6-dinitrophenol

215-813-8

1420-07-1

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H360D *** H300

H311

H400

H410

GHS06

GHS08

GHS09

Dgr

H360D *** H300

H311

H410

EUH044

609-031-00-X

salte og estere af dinoterb

—

—

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H360D *** H300

H311

H400

H410

GHS06

GHS08

GHS09

Dgr

H360D *** H300

H311

H410

A

609-032-00-5

bromophenoxim (ISO);

3,5-dibrom-4-hydroxybenzaldehyd-O-(2,4-dinitrophenyl)-oxim

236-129-6

13181-17-4

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

609-033-00-0

dinosam (ISO);

2-(1-methyl-n-butyl)-4,6-dinitrophenol

—

4097-36-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

609-034-00-6

salte og estere af dinosam

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H410

A

609-035-00-1

nitroethan

201-188-9

79-24-3

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

H226

H332

H302

GHS02

GHS07

Wng

H226

H332

H302

*

609-036-00-7

nitromethan

200-876-6

75-52-5

Flam. Liq. 3

Acute Tox. 4 *

H226

H302

GHS02

GHS07

Wng

H226

H302

*

609-037-00-2

5-nitroacenaphthen

210-025-0

602-87-9

Carc. 1B

H350

GHS08

Dgr

H350

609-038-00-8

2-nitronaphthalen

209-474-5

581-89-5

Carc. 1B

Aquatic Chronic 2

H350

H411

GHS08

GHS09

Dgr

H350

H411

609-039-00-3

4-nitrobiphenyl

202-204-7

92-93-3

Carc. 1B

Aquatic Chronic 2

H350

H411

GHS08

GHS09

Dgr

H350

H411

609-040-00-9

nitrofen (ISO);

2,4-dichlorphenyl-4-nitrophenylether

217-406-0

1836-75-5

Carc. 1B

Repr. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H360D *** H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H360D *** H302

H410

609-041-00-4

2,4-dinitrophenol

200-087-7

51-28-5

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

H331

H311

H301

H373 **

H400

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H400

609-042-00-X

pendimethalin (ISO);

N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidin

254-938-2

40487-42-1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

609-043-00-5

quintozen (ISO);

pentachlornitrobenzen

201-435-0

82-68-8

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

609-044-00-0

tecnazen (ISO)

1,2,4,5-tetrachlor-3-nitrobenzen

204-178-2

117-18-0

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

609-045-00-6

en blanding af 4,6-dinitro-2-(3-octyl)phenylmethylcarbonat og 4,6-dinitro-2-(4-octyl)phenylmethylcarbonat og dinocton-6

—

8069-76-9

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

609-046-00-1

trifluralin (ISO) (indeholdende < 0,5 ppm NPDA);

α, α,α-trifluor-2,6-dinitro-N, N-dipropyl-p-toluidin (indeholdende < 0,5 ppm NPDA);

2,6-dinitro-N, N-dipropyl-4-trifluormethylanilin (indeholdende < 0,5 ppm NPDA);

N, N-dipropyl-2,6-dinitro-4-trifluormethylanilin (indeholdende < 0,5 ppm NPDA)

216-428-8

1582-09-8

Carc. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H317

H410

M = 10

609-047-00-7

2-nitroanisol

202-052-1

91-23-6

Carc. 1B

Acute Tox. 4 *

H350

H302

GHS08

GHS07

Dgr

H350

H302

609-048-00-2

natrium-3-nitrobenzensulfonat

204-857-3

127-68-4

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

609-049-00-8

2,6-dinitrotoluen

210-106-0

606-20-2

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3

H350

H341

H361f ***

H331

H311

H301

H373 **

H412

GHS06

GHS08

Dgr

H350

H341

H361f ***

H331

H311

H301

H373 **

H412

609-050-00-3

2,3-dinitrotoluen

210-013-5

602-01-7

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H341

H361f ***

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H341

H361f ***

H331

H311

H301

H373 **

H410

609-051-00-9

3,4-dinitrotoluen

210-222-1

610-39-9

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H350

H341

H361f ***

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H350

H341

H361f ***

H331

H311

H301

H373 **

H411

609-052-00-4

3,5-dinitrotoluen

210-566-2

618-85-9

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3

H350

H341

H361f ***

H331

H311

H301

H373 **

H412

GHS06

GHS08

Dgr

H350

H341

H361f ***

H331

H311

H301

H373 **

H412

609-053-00-X

hydrazin (trinitromethan)

414-850-9

—

Expl. 1,1 ****

Self-react. A

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

H201

H240

H350

H331

H301

H317

GHS01

GHS06

GHS08

Dgr

H201

H240

H350

H331

H301

H317

609-054-00-5

2,3-dinitrophenol; [1]

2,5-dinitrophenol; [2]

2,6-dinitrophenol; [3]

3,4-dinitrophenol; [4]

salte af dinitrophenol [5]

200-628-7 [1]

206-348-1 [2]

209-357-9 [3]

209-415-3 [4]-[5]

66-56-8 [1]

329-71-5 [2]

573-56-8 [3]

577-71-9 [4]-[5]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H411

609-055-00-0

2,5-dinitrotoluen

210-581-4

619-15-8

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H350

H341

H361f ***

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H350

H341

H361f ***

H331

H311

H301

H373 **

H411

609-056-00-6

2,2-dibrom-2-nitroethanol

412-380-9

69094-18-4

Expl. 1,1

Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H201

H351

H302

H373 **

H314

H317

H400

H410

GHS01

GHS08

GHS05

GHS07

GHS09

Dgr

H201

H351

H302

H373 **

H314

H317

H410

*

STOT SE 3; H335: C ≥ 1 %

T

609-057-00-1

3-chlor-2,4-difluornitrobenzen

411-980-8

3847-58-3

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H317

H410

609-058-00-7

2-nitro-2-phenylpropan-1,3-diol

410-360-4

5428-02-4

STOT RE 1;

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H372 ** H312

H302

H317

H411

GHS08

GHS07

GHS09

Dgr

H372 **

H312

H302

H317

H411

EUH070

609-059-00-2

2-chlor-6-(ethylamino)-4-nitrophenol

411-440-1

131657-78-8

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

609-060-00-8

4-[(3-hydroxypropyl)amino]-3-nitrophenol

406-305-9

92952-81-3

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

609-061-00-3

(E,Z)-4-chlorphenyl(cyclopropyl)keton-O-(4-nitrophenylmethyl)oxim

406-100-4

94097-88-8

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

609-062-00-9

2-brom-2-nitropropanol

407-030-7

24403-04-1

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H311

H302

H373 **

H314

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H311

H302

H373 **

H314

H317

H410

609-063-00-4

2-[(4-chlor-2-nitrophenyl)amino]ethanol

413-280-8

59320-13-7

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

609-064-00-X

mesotrion (ISO);

2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexandion

—

104206-82-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

609-065-00-5

2-nitrotoluen

201-853-3

88-72-2

Carc. 1B

Muta. 1B

Repr. 2

Acute Tox. 4 *

Aquatic Chronic 2

H350

H340

H361f *** H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H340

H361f *** H302

H411

609-066-00-0

lithium natrium 3-amino-10-{4-(10-amino-6,13-dichlor-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazin-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorbenzo[5,6][1,4]oxazino[2,3-b]phenoxazin-4,11-disulfonat

418-870-9

154212-58-5

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 2 **

H332

H312

H302

H371 **

GHS08

GHS07

Dgr

H332

H312

H302

H371 **

609-067-00-6

natrium- og kalium-4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazin

416-280-6

156769-97-0

Skin Sens. 1

H317

GHS07

Wng

H317

609-068-00-1

moskusxylen;

5-tert-butyl-2,4,6-trinitro-m-xyleno

201-329-4

81-15-2

Expl. 1,1

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H201

H351

H400

H410

GHS01

GHS08

GHS09

Wng

H201

H351

H410

T

609-069-00-7

moskusketon;

3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenon;

4'-tert-butyl-2',6'-dimethyl-3',

5'-dinitroacetophenon

201-328-9

81-14-1

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

609-070-00-2

1,4-dichlor-2-(1,1,2,3,3,3-hexafluorpropoxy)-5-nitrobenzen

415-580-4

130841-23-5

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

609-071-00-8

en blanding af 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazin og

2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol

423-520-3

156137-33-6

Skin Sens. 1

H317

GHS07

Wng

H317

609-072-00-3

4-mesyl-2-nitrotoluen

430-550-0

1671-49-4

Repr. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H361f ***

H302

H317

H412

GHS08

GHS07

Wng

H361f ***

H302

H317

H412

609-073-00-9

lithium-kalium-natrium-N, N''-bis(6-(7-(4-(4-chlor-1,3,5-triazin-2-yl)amino)-4-(2-ureidophenylazo))naphthalen-1,3,6-trisulfonato)-N'-(2-aminoethyl)piperazin

427-850-9

—

Skin Sens. 1

H317

GHS07

Wng

H317

610-001-00-3

trichlornitromethan;

chlorpicrin

200-930-9

76-06-2

Acute Tox. 2 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H330

H302

H319

H335

H315

GHS06

Dgr

H330

H302

H319

H335

H315

610-002-00-9

1,1-dichlor-1-nitroethan

209-854-0

594-72-9

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

610-003-00-4

chlordinitrobenzen

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H410

C

610-004-00-X

2-chlor-1,3,5-trinitrobenzen

201-864-3

88-88-0

Expl. 1,1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H201

H330

H310

H300

H400

H410

GHS01

GHS06

GHS09

Dgr

H201

H330

H310

H300

H410

610-005-00-5

1-chlor-4-nitrobenzen

202-809-6

100-00-5

Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H351

H341

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H351

H341

H331

H311

H301

H373 **

H411

610-006-00-0

chlornitroaniliner undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2

H330

H310

H300

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 **

H411

A C

610-007-00-6

1-chlor-1-nitropropan

209-990-0

600-25-9

Acute Tox. 4 *

Acute Tox. 4 *

H332

H302

GHS07

Wng

H332

H302

*

610-008-00-1

2,6-dichlor-4-nitroanisol

403-350-6

17742-69-7

Acute Tox. 3 *

Aquatic Chronic 2

H301

H411

GHS06

GHS09

Dgr

H301

H411

610-009-00-7

2-chlor-4-nitroanilin

204-502-2

121-87-9

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

610-010-00-2

2-(2-brom-2-nitroethenyl)furan

406-110-9

35950-52-8

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H314

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H302

H373 **

H314

H317

H410

611-001-00-6

azobenzen

203-102-5

103-33-3

Carc. 1B Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H341

H332

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H341

H332

H302

H373 **

H410

611-002-00-1

azoxybenzen

207-802-1

495-48-7

Acute Tox. 4 *

Acute Tox. 4 *

H332

H302

GHS07

Wng

H332

H302

611-003-00-7

fenaminosulf (ISO);

natrium-4-dimethylaminobenzendiazosulfonat

205-419-4

140-56-7

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Chronic 3

H301

H312

H412

GHS06

Dgr

H301

H312

H412

611-004-00-2

(methyl-ONN-azoxy)methylacetat;

(methylazoxymethyl)acetat

209-765-7

592-62-1

Carc. 1B

Repr. 1B

H350

H360D ***

GHS08

Dgr

H350

H360D ***

611-005-00-8

dinatrium-{5-[(4'-((2,6-dihydroxy-3-((2-hydroxy-5-sulfophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprat(2-);

CI Direct Brown 95

240-221-1

16071-86-6

Carc. 1B

H350

GHS08

Dgr

H350

611-006-00-3

4-o-tolylazo-o-toluidin;

4-amino-2',3-dimethylazobenzen;

fast garnet GBC base; AAT;

o-aminoazotoluen

202-591-2

97-56-3

Carc. 1B

Skin Sens. 1

H350

H317

GHS08

Dgr

H350

H317

611-007-00-9

tricyclazol (ISO);

5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazol

255-559-5

41814-78-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

611-008-00-4

4-aminoazobenzen;

4-phenylazoanilin

200-453-6

60-09-3

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

611-009-00-X

natrium-(1-(5-(4-(4-anilino-3-sulfophenylazo)-2-methyl-5-methylsulfonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulfonato-2-naphtholato)jern(II)

401-220-3

—

Acute Tox. 4 *

Aquatic Chronic 3

H332

H412

GHS07

Wng

H332

H412

611-010-00-5

2'-(2-cyan-4,6-dinitrophenylazo)-5'-(N, N-dipropylamino)propionanilid

403-010-7

106359-94-8

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

611-011-00-0

N, N,N',N'-tetramethyl-3,3'-(propylenbis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridin-3,1-diyl)))di(propylammonium)dilactat

403-340-1

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-012-00-6

blanding af 2-methylaminoethanol-6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazol-7-sulfonat og N, N-diethylpropan-1,3-diamin-6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazol-7-sulfonat og 2,2-iminodiethanol-6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazol-7-sulfonat

403-410-1

114565-65-0

Skin Sens. 1

H317

GHS07

Wng

H317

611-013-00-1

trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalen-3-sulfonat

403-650-7

117409-78-6

Expl. 1,3 ****

Aquatic Chronic 2

H203

H411

GHS01

GHS09

Dgr

H203

H411

611-014-00-7

(tetranatrium-1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium)hydroxid

404-250-5

115099-55-3

Skin Sens. 1

H317

GHS07

Wng

H317

611-015-00-2

tetranatrium-4-amino-5-hydroxy-6-(3-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat

404-320-5

116889-78-2

Skin Sens. 1

H317

GHS07

Wng

H317

611-016-00-8

blanding af; 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(eller2,6 eller3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridiniumdichlo og 1,1'-((dihydroxyphenylen)bis(azo-3,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridin-5,3-diyl)))dipyridiniumdichlorid, dihydrochlorid, blanding af isomerer

404-540-1

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-017-00-3

2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramid

404-910-2

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-018-00-9

tetraammonium-5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalat

405-130-5

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-019-00-4

tetralithium-6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalen-2,7-disulfonat

405-150-4

106028-58-4

Skin Sens. 1

H317

GHS07

Wng

H317

611-020-00-X

tetrakis(tetramethylammonium)-

6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalen-2,7-disulfonat

405-170-3

116340-05-7

Acute Tox. 3 *

Skin Sens. 1

Aquatic Chronic 3

H301

H317

H412

GHS06

Dgr

H301

H317

H412

611-021-00-5

2-(4-(4-cyan-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethylacetat

405-480-9

—

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Aquatic Chronic 4

H302

H373 ** H315

H413

GHS08

GHS07

Wng

H302

H373 **

H315

H413

611-022-00-0

4-dimethylaminobenzendiazonium-3-carboxy-4-hydroxybenzensulfonat

404-980-4

—

Self-react. C

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H242

H331

H301

H312

H373 **

H318

H317

H400

H410

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H242

H331

H301

H312

H373 **

H318

H317

H410

T

611-023-00-6

dinatrium-7-(4,6-dichlor-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalen-2-sulfonat

404-600-7

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-024-00-1

benzidinbaserede azofarvestoffer;

4,4'-diarylazobiphenyl farvestoffer, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Carc. 1B

H350

GHS08

Dgr

H350

A

611-025-00-7

dinatrium-4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphthalen-2,7-disulfonat;

C.I. Direct Black 38

217-710-3

1937-37-7

Carc. 1B Repr. 2

H350

H361D ***

GHS08

Dgr

H350

H361D ***

611-026-00-2

tetranatrium-3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalen-2,7-disulfonat];

C.I. Direct Blue 6

220-012-1

2602-46-2

Carc. 1B Repr. 2

H350

H361D ***

GHS08

Dgr

H350

H361D ***

611-027-00-8

dinatrium-3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalen-1-sulfonat); C.I. Direct Red 28

209-358-4

573-58-0

Carc. 1B Repr. 2

H350

H361D ***

GHS08

Dgr

H350

H361D ***

611-028-00-3

C, C'-azodi(formamid)

204-650-8

123-77-3

Resp. Sens. 1

H334

GHS08

Dgr

H334

G

611-029-00-9

o-dianisidin azobaserede farvestoffer;

4,4-diarylazo-3,3'dimethoxybiphenyl farvestoffer, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Carc. 1B

H350

GHS08

Dgr

H350

A

611-030-00-4

4,4'-bi-o-toluidin baserede azofarvestoffer, undtagen sådanne nævnt andetsteds i dette bilag;

4,4'-diarylazo-3,3'dimethylbiphenyl farvestoffer, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Carc. 1B

H350

GHS08

Dgr

H350

A

611-031-00-X

4,4'-(4-iminocyclohexa-2,5-dienylidenmethylen)dianilinhydrochlorid;

C.I. Basic Red 9

209-321-2

569-61-9

Carc. 1B

H350

GHS08

Dgr

H350

611-032-00-5

1,4,5,8-tetraaminoanthra-

quinon;

C.I. Disperse Blue 1

219-603-7

2475-45-8

Carc. 1B

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H350

H315

H318

H317

GHS08

GHS05

GHS07

Dgr

H350

H315

H318

H317

611-033-00-0

hexanatrium-[4,4''-azoxybis(2,2'-disulfonatostilben-4,4'-diylazo)]-bis[5'-sulfonatobenzen-2,2'-diolato-O(2),O(2),N(1)]-kobber(II)

400-020-3

82027-60-9

Aquatic Chronic 2

H411

GHS09

H411

611-034-00-6

N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamid

402-430-8

105076-77-5

Aquatic Chronic 4

H413

—

H413

611-035-00-1

tetralithium-6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalen-2,7-disulfonat

403-660-1

107246-80-0

Aquatic Chronic 2

H411

GHS09

H411

611-036-00-7

2-(4-(5,6(eller 6,7)-dichlor-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethylacetat

405-440-0

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-037-00-2

3(eller 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazoliummethylsulfat

406-055-0

124584-00-5

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

611-038-00-8

trinatrium-1-hydroxynaphthalen-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzen)-2',2'',4-trisulfonat

406-820-9

—

Eye Irrit. 2

H319

GHS07

Wng

H319

611-039-00-3

7-[((4,6-dichlor-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalen-2-sulfonsyre

407-050-6

117715-57-8

Skin Sens. 1

H317

GHS07

Wng

H317

611-040-00-9

3-(5-acetamido-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalensulfonsyre

407-670-7

115099-58-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

611-041-00-4

2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamid

407-680-1

98809-11-1

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

611-042-00-X

trinatrium-5-amino-3-[5-(2-bromacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalen-2,7-disulfonat

411-770-6

136213-71-3

Aquatic Chronic 3

H412

—

H412

611-043-00-5

blanding (2:1:1) af trinatrium-N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4(eller 6)-hydroxy-(eller 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalen-2,1'-azobenzen-1,2'-diolato-O(1),O(2'))-chromat;

trinatrium-N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonato

bis(naphthalen-2,1'-azobenzen-1,2'-diolato-O(1),O(2'))-chromat;

trinatrium-N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(eller 6)-hydroxy-(eller 4-amino-2-hydroxy)phenylazo]-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalen-2,1'-azobenzen-1,2'-diolato-O(1),O(2'))-chromat

402-850-1

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-044-00-0

en blanding af tert-alkyl(C12-C14)ammoniumbis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]chromat(1-); tert-alkyl(C12-C14)ammonium-bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]chromat(1-);

tert-alkyl(C12-C14)ammoniumbis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]chromat(1-);

tert-alkyl(C12-C14)ammonium-[[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]chromat(1-);

tert-alkyl(C12-C14)ammonium-[[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]chromat(1-);

C12-14-tert-alkylammonium

((1-(4(eller 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromat(1-)

403-720-7

117527-94-3

Aquatic Chronic 2

H411

GHS09

H411

611-045-00-6

2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophen

404-830-8

—

Aquatic Chronic 4

H413

—

H413

611-046-00-1

4,4'-diamino-2-methylazobenzen

407-590-2

43151-99-1

Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H373 **

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H373 **

H317

H410

611-047-00-7

en blanding af 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorbenzothiazol og 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorbenzothiazol

407-890-3

111381-11-4

Aquatic Chronic 4

H413

—

H413

611-048-00-2

en blanding (1:1) af 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorbenzothiazol og 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorbenzothiazol

407-900-6

111381-12-5

Aquatic Chronic 4

H413

—

H413

611-049-00-8

en blanding af 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)naphthalen-2-sulfonat, eddikesyre, malkesyre (2:1:1)

408-000-6

118658-98-3

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H373 **

H317

H412

GHS08

Wng

H373 **

H317

H412

611-050-00-3

en blanding af pentanatrium

-3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalen-2-sulfonat;

pentanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalen-2-sulfonat;

pentanatrium-6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat og

hexanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat

415-350-3

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-051-00-9

2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methylbenzothiazoliumchlorid

411-110-7

136213-74-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

611-052-00-4

mononatrium-aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonat], jernkomplex

400-720-9

—

Aquatic Chronic 3

H412

—

H412

611-053-00-X

2,2'-azobis[2-methylpropionamidin]dihydrochlorid

221-070-0

2997-92-4

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

611-055-00-0

C.I. Disperse Yellow 3;

N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamid

220-600-8

2832-40-8

Carc. 2

Skin Sens. 1

H351

H317

GHS08

GHS07

Wng

H351

H317

611-056-00-6

C.I. Solvent Yellow 14;

1-phenylazo-2-naphthol

212-668-2

842-07-9

Carc. 2

Muta. 2

Skin Sens. 1

Aquatic Chronic 4

H351

H341

H317

H413

GHS08

GHS07

Wng

H351

H341

H317

H413

611-057-00-1

6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridincarbonitril

400-340-3

85136-74-9

Carc. 1B

Aquatic Chronic 4

H350

H413

GHS08

Wng

H350

H413

611-058-00-7

(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium]-format

402-060-7

108225-03-2

Carc. 1B

Eye Dam. 1

Aquatic Chronic 2

H350

H318

H411

GHS08

GHS05

GHS09

Dgr

H350

H318

H411

611-059-00-2

octanatrium 2-(6-(4-chlor-6-(3-(N-methyl-N-(4-chlor-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalen-1,5-disulfonat

412-960-1

148878-21-1

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

611-060-00-8

blanding af natrium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophtalat;

ammonium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophtalat;

5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatnaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatnaphthalen-2-ylazo]-isophthalsyre

413-180-4

187285-15-0

Eye Dam. 1

H318

GHS05

Dgr

H318

611-061-00-3

dinatrium-5-[5-[4-(5-chlor-2,6-difluorpyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonat

412-530-3

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-062-00-9

octanatrium-2-(8-(4-chlor-6-(3-((4-chlor-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalen-1,5-disulfonat

413-550-5

—

Skin Irrit. 2

Eye Dam. 1

H315

H318

GHS05

Dgr

H315

H318

611-063-00-4

trinatrium-[4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O, O',O'',O''']kobber(II)

413-590-3

164058-22-4

Carc. 1B

H350

GHS08

Dgr

H350

611-064-00-X

4-(3,4-dichlorphenylazo)-2,6-di-sec-butyl-phenol

410-600-8

124719-26-2

STOT RE 2 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H315

H400

H410

GHS08

GHS07

GHS09

Wng

H373 **

H315

H410

611-065-00-5

4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol

410-610-2

111850-24-9

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H319

H315

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 **

H319

H315

H317

H410

611-066-00-0

tetranatrium-5-[4-chlor-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat

411-540-5

130201-57-9

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

611-067-00-6

en blanding af bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium)-7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalen-2-sulfonat og

bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium)-7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalen-2-sulfonat

406-910-8

—

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

611-068-00-1

tetranatrium-4-amino-3,6-bis(5-[4-chlor-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalen-2,7-disulfonat

400-690-7

85665-98-1

Aquatic Chronic 2

H411

GHS09

H411

611-069-00-7

N, N-di-[poly(oxyethylen)-co-poly(oxypropylen)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylanilin

413-380-1

—

Aquatic Chronic 2

H411

GHS09

H411

611-070-00-2

en blanding (1:1) af dinatrium-(6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chlor-2-oxidophenylazo)-2-naphtholato)chromat(1-) og

trinatriumbis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromat(1-)

405-665-4

—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

611-071-00-8

tris(tetramethylammonium)-5-hydroxy-1-(4-sulfonatophenyl)-4-(4-sulfonatophenylazo)pyrazol-3-carboxylat

406-073-9

131013-81-5

Acute Tox. 3 *

Aquatic Chronic 3

H301

H412

GHS06

Dgr

H301

H412

611-072-00-3

2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzendihydrochlorid

407-010-8

118208-02-9

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

611-073-00-9

dimethyl-3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionat

407-310-9

122630-55-1

Aquatic Chronic 4

H413

—

H413

611-074-00-4

blanding af natrium/kalium-(3-(4-(5-(5-chlor-2,6-difluorpyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)kobber(II) og

natrium/kalium-(3-(4-(5-(5-chlor-4,6-difluorpyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)kobber(II)

407-100-7

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-075-00-X

blanding (2:1) af tris(3,5,5-trimethylhexylammonium)-4-amino-3-(4-(4-(2-amino-4-hydroxyphenyl

azo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalen-2,7-disulfonat og

tris(3,5,5-trimethylhexylammonium)-2-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalen-2,7-disulfonat

406-000-0

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-076-00-5

3-(2,6-dichlor-4-nitrophenylazo)-1-methyl-2-phenylindol

406-280-4

117584-16-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

611-077-00-0

dilithiumdinatrium-(5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenbisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalen-2,7-disulfonato(8)))dicuprat(2-)

407-230-4

126637-70-5

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

611-078-00-6

(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dikobber(II)acetatlactat

407-240-9

159604-94-1

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-079-00-1

dinatrium-7-[4-chlor-6-(N-ethyl-o-toluidin)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalensulfonat

410-390-8

147703-64-8

Eye Dam. 1

H318

GHS05

Dgr

H318

611-080-00-7

natrium-3-(2-acetamid-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzensulfonat

410-150-2

147703-65-9

Skin Sens. 1

H317

GHS07

Wng

H317

611-081-00-2

tetranatrium-[7-(2,5-dihydroxy-КO2-7-sulfonato-6-[4-(2,5,6-trichlor-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-КO8-naphthalen-1,3,5-trisulfonato(6-)]cuprat(II)

411-470-5

141048-13-7

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

611-082-00-8

blanding af pentanatriumbis(1-(3(eller 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrat(1-) og pentanatrium-[(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrat(1-)

407-570-3

—

Aquatic Chronic 2

H411

GHS09

H411

611-083-00-3

en blanding (1:1) af 2-[N-ethyl-4-[(5,6-dichlorbenzothiazol-2-yl)azo]-m-toludin]ethyl-acetat og

2-[N-ethyl-4-[(6,7-dichlorbenzothiazol-2-yl)azo]-m-toludin]ethyl-acetat

411-560-4

—

STOT RE 1

Skin Sens. 1

Aquatic Chronic 2

H372 ** H317

H411

GHS08

GHS07

GHS09

Dgr

H372 ** H317

H411

611-085-00-4

en blanding af 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)-propylamino]-pyridin;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)-propylamino]-pyridin;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]-pyridin og

3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]-pyridin

411-880-4

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-086-00-X

monolithium-5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonat], jernkomplex,

monohydrat

411-360-7

—

Aquatic Chronic 3

H412

—

H412

611-087-00-5

en blanding af 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethylphenol og

3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)

411-710-9

—

Aquatic Chronic 4

H413

—

H413

611-088-00-0

blanding af trilithium-4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)-naphthalen-2,7-disulfonat og

trilithium-4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)-naphthalen-2,7-disulfonat

411-890-9

—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

611-089-00-6

2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium-methylsulfat

411-100-2

136213-73-5

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 ** H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 ** H317

H410

611-090-00-1

2,5-dibutoxy-4-(morpholin-4-yl)-benzendiazonium 4-methylbenzensulfonat

413-290-2

93672-52-7

Self-react. C

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H242

H302

H318

H317

H412

GHS02

GHS05

GHS07

Dgr

H242

H302

H318

H317

H412

T

611-091-00-7

natrium (1.0-1.95)/lithium (0.05-1)-5-((5-((5-chlor-6-fluor-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinmethylsulfonat

413-470-0

134595-59-8

Skin Sens. 1

H317

GHS07

Wng

H317

611-092-00-2

tert-(dodecyl/tetradecyl)-ammonium-bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzensulfonamidat)chromat

413-210-6

—

Aquatic Chronic 2

H411

GHS09

H411

611-093-00-8

natrium-2-(4-(4-fluor-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzen-1-sulfonat

410-770-3

146177-84-6

Skin Sens. 1

H317

GHS07

Wng

H317

611-094-00-3

en blanding (50:50) af 2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichlor-1,3-benzothiazol og

2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichlor-1,3-benzotriazol

411-600-0

143145-93-1

Aquatic Chronic 4

H413

—

H413

611-095-00-9

hexanatrium-1,1'-[(1-amino-8-hydroxy-3,6-disulfonato-2,7-naphthalendiyl)bis(azo(4-sulfonato-1,3-phenyl)imino[6-[(4-chlor-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxid

412-240-7

89797-03-5

Aquatic Chronic 2

H411

GHS09

H411

611-096-00-4

methyl-N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinat

413-040-2

149850-30-6

Skin Sens. 1

H317

GHS07

Wng

H317

611-097-00-X

blanding af jernkomplekser af 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)-benzen

og 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]-benzen (n=2,5,6)

414-150-3

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-098-00-5

tetrakis(tetramethylammonium)-3,3'-(6-(2-hydroxyethylamino)1,3,5-triazin-2,4-diyldiiminobis(2-methyl-4,1-phenylenazo))dinaphthalen-1,5-disulfonat

405-950-3

131013-83-7

Acute Tox. 3 * Aquatic Chronic 3

H301

H412

GHS06

Dgr

H301

H412

611-099-00-0

(methylenbis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridin-5,3-diyl)))-1,1'-dipyridiniumdichloriddihydrochlorid

401-500-5

118658-99-4

Carc. 1B

Aquatic Chronic 2

H350

H411

GHS08

GHS09

Dgr

H350

H411

611-100-00-4

kaliumnatrium-3,3'-(3(eller4)-methyl-1,2-phenylenbis(imino(6-chlor)-1,3,5-triazin-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalen-1,5-disulfonat

403-810-6

140876-13-7

Eye Dam. 1

H318

GHS05

Dgr

H318

611-101-00-X

2'-(4-chlor-3-cyan-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilid

405-200-5

104366-25-8

Skin Sens. 1

H317

GHS07

Wng

H317

611-102-00-5

reaktionsprodukt af C.I. Leuco Sulfur Black 1 og en blanding af dinatrium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid og dinatrium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzendiazoniumchlorid

424-500-7

—

Aquatic Chronic 3

H412

—

H412

611-103-00-0

trinatrium-(1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nikkel(II)

407-110-1

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

611-104-00-6

en blanding (1:1) af trinatrium-(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(eller 4 eller 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(eller 2 eller 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrat(1-);

trinatrium-bis(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrat(1-);

trinatrium-(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(eller 4 eller 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(eller 2 eller 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrat(1-); trinatrium-(2,4(eller 2,6 eller 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(eller

4 eller 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(eller 2 eller 6)-(3-sulfonatophenylazo)phenolato)ferrat(1-) og

dinatrium-3,3'-(2,4-dihydroxy-1,3(eller 1,5 eller 3,5)-phenylendiazo)dibenzensulfonat

406-870-1

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-105-00-1

natrium-4-(4-chlor-6-(N-ethylanilino)-,1,3,5-triazin-2-ylamino)-2-(1-(2-chlorphenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzensulfonat

407-800-2

136213-75-7

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-106-00-7

hexanatrium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenbis[imino(6-chlor-1,3,5-triazin-4,2-diyl)imino]]dinaphthalen-2-sulfonat

410-180-6

157627-99-1

Eye Dam. 1

H318

GHS05

Dgr

H318

611-107-00-2

kalium natrium 4-(4-chlor-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethansulfonyl)-phenylazo)-naphthalen-1,7-disulfonat

412-490-7

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-108-00-8

dinatrium-5-((4-((4-chlor-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalensulfonat

413-600-6

6527-62-4

Aquatic Chronic 3

H412

—

H412

611-109-00-3

reaktionsprodukter af kobber(II)sulfat og tetranatrium-2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazin (2:1)

407-710-3

—

Aquatic Chronic 2

H411

GHS09

H411

611-110-00-9

tetra-natrium/lithium-4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzen

408-210-8

124605-82-9

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-111-00-4

dinatrium 2-[[4-(2-chlor ethylsulfonyl)phenyl]-[(2- hydroxy-5-sulfo-3-[3-[2-(2-(sul fooxy)ethylsulfonyl)ethylazo]-4- sulfobenzoato(3-)cuprat(1-)

414-230-8

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-112-00-X

tetranatrium-4-hydroxy-5-[4-[3-(2-sulfatethansulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalen-2,7-disulfonat

413-070-6

—

Skin Sens. 1

H317

GHS07

Wng

H317

611-113-00-5

lithiumnatrium (2-(((5-((2,5-dichlorphenyl)azo)-2-hydroxyphenyl)methylen)amino)benzoato(2-))-(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-))-chromat(2-)

414-280-0

149626-00-6

Aquatic Chronic 2

H411

GHS09

H411

611-114-00-0

lithiumnatrium (4-((5-chlor-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))-(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzensulfonato(3-))-chromat(2-)

414-250-7

149564-66-9

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

611-115-00-6

trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalensulfonato(3-))chromat(3-)

414-290-5

149564-65-8

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

611-116-00-1

blanding af trinatrium 5-{4-chlor-6-[2-(2,6-dichlor-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat;

trinatrium 5-{4-chlor-6-[2-(2,6-dichlor-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat;

trinatrium 5-{4-chlor-6-[2-(4,6-dichlor-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat og

trinatrium 5-{4-chlor-6-[2-(4,6-dichlor-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalen-2,7-disulfonat

414-620-8

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-117-00-7

1,3-bis{6-fluor-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propan lithium-, natriumsalt

415-100-3

149850-29-3

Skin Sens. 1

H317

GHS07

Wng

H317

611-118-00-2

natrium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluor-1,3,5-triazin-2-ylamino]-propan, natriumsalt

413-990-8

Skin Sens. 1

H317

GHS07

Wng

H317

611-119-00-8

tetranatrium-4-[4-chlor-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalen-2,7-disulfonat

415-400-4

148878-22-2

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-120-00-3

5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chlor-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphtalen-2-ylazo)-naphthalen-2,7-disulfonsyre natriumsalt

418-340-7

157707-94-3

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-121-00-9

hovedkomponent 6 (isomer): asym. 1:2 Cr(III)-kompleks af A: 3-hydroxy-4-(2-hydroxy-naphthalen-1-ylazo)-naphthalen-1-sulfonsyre, natriumsalt og B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalen-2-ol;

hovedkomponent 8 (isomer):

asym. 1:2 Cr-kompleks af A:

3-hydroxy-4-(2-hydroxy-naphthalen-1-ylazo)-naphthalen-1-sulfonsyre, natriumsalt og B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalen-2-ol

417-280-9

30785-74-1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

611-122-00-4

hexanatrium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfonatoanilino]-6-chlor-1,3,5-triazin-2-ylamino}phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nikkel

417-250-5

151436-99-6

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-123-00-X

3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammoniumlactat

424-310-4

178452-66-9

Eye Dam. 1

H318

GHS05

Dgr

H318

611-124-00-5

en blanding af pentanatrium

5-amino-3-(5-{4-chlor-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibrompropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalen-2,7-disulfonat;

pentanatrium 5-amino-6-[5-(2-bromacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chlor-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat

tetranatrium 5-amino-3-[5-{4-chlor-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibrompropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalen-2,7-disulfonat

424-320-9

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-125-00-0

en blanding af dinatrium 4-((8-oxido-7-(2-oxido-4-ethenylsulfonyl-5-(methoxyphenyl)azo)-6-sulfonato)naphthalen-2-ylazo)-5-oxo-1-(4-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-3-carboxylsyre kobber (II) kompleks og

dinatrium 4-((8-oxido-7-(2-oxido-4-(2-hydroxyethylsulfonyl)-5-(methoxyphenyl)azo)-6-sulfonato)naphthalen-2-ylazo)-5-oxo-1-(4-sulfonatophenyl)-4,5-dihydro-1H-pyrazol-3-carboxylsyre kobber (II) kompleks

423-940-7

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-126-00-6

2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazin, dichlorid

424-120-1

174514-06-8

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

611-127-00-1

pentanatrium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethansulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethansulfonyl)phenylazo)naphthalen-2,7-disulfonat

423-790-2

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

G

611-128-00-7

N, N'-bis{6-chlor-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonsyre-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethan-1,2-diamin, natriumsalt

419-500-9

171599-85-2

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-129-00-2

en blanding af 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoesyre og

5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoesyre

418-230-9

163879-69-4

Expl. 1,3 ****

Repr. 2

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H203

H361f ***

H373 **

H317

H411

GHS01

GHS08

GHS07

GHS09

Dgr

H203

H361f ***

H373 **

H317

H411

611-130-00-8

tetraammonium-2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoat

418-520-5

183130-96-3

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

611-131-00-3

2-[2-hydroxy-3-(2-chlorphenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-on

420-580-2

151798-26-4

Repr. 1B

Aquatic Chronic 4

H360D *** H413

GHS08

Dgr

H360D *** H413

611-132-00-9

pentanatrium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalen-2-azobenzen-1,2'-diolato} chromat (III)

419-210-2

178452-71-6

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-133-00-4

procesprodukt-jernkompleks af azo-farvestoffer opnået ved kobling af en blanding af diazoteret 2-amino-1-hydroxybenzen-4-sulfanilid og 2-amino-1-hydroxybenzen-4-sulfonamid med resorcin, hvor den herved opnåede blanding efterfølgende underkastes en yderligere koblingsreaktion med en blanding af diazoteret 3-aminobenzen-1-sulfonsyre (metanilsyre) og 4'-amino-4-nitro-1,1'-diphenylamin-2-sulfonsyre og en metallisering med ferrichlorid, natriumsalt

419-260-5

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-134-00-X

trinatrium 2-{α[2-hydroxy-3-[4-chlor-6-[4-(2,3-dibrompropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenhydrazino}-4-sulfonatobenzoat, kobberkompleks

423-770-3

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-135-00-5

reaktionsprodukt af 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzensulfonsyre med 2,4,6-trifluorpyrimidin og delvis hydrolyse til det tilsvarende vinylsulfonylderivat, blandet kalium/natriumsalt

424-250-9

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-136-00-0

2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropylformat

424-260-3

—

Repr. 2

Eye Dam. 1

Aquatic Chronic 2

H361f ***

H318

H411

GHS05

GHS08

GHS09

Dgr

H361f ***

H318

H411

611-137-00-6

6-tert-butyl-7-chlor-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazol

419-870-1

159038-16-1

Aquatic Chronic 4

H413

—

H413

611-138-00-1

2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazol

415-910-7

152828-25-6

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

611-139-00-7

reaktionsprodukt af C.I. Leuco Sulfur Black 1 med (3-chlor-2-hydroxypropyl)trimethylammoniumchlorid

424-510-1

—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-140-00-2

azafenidin (ISO);

2-(2,4-dichlor-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro1,2,4-triazolo[4,3-a]pyridin3(2H)-on

—

68049-83-2

Repr. 1B

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360Df

H373 ** H400

H410

GHS08

GHS09

Dgr

H360Df

H373 **

H410

M = 1 000

611-141-00-8

5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenyl-azo)isophthalsyre, blandet mononatrium- og diammoniumsalt

414-410-6

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-142-00-3

procesprodukt-defineret polyazo-farvestof fremkommet ved kobling af 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzendiazonium med en blanding af 4-carboxybenzendiazonium og diphenylamin-3-sulfo-4,4'-bisdiazonium, og yderligere kobling af de herved opnåede forbindelser med en blanding af naphth-2-ol og 3-aminophenol, natriumsalte og

natriumchlorid

425-740-5

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-143-00-9

en blanding af trinatrium-2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzyliden]hydrazino-κ-N')-6-(2,6-difluorpyrimidin-4-ylamino)-4-sulfonatophenolatocuprat(II) og

trinatrium-2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzyliden]hydrazino-κ-N')-6-(4,6-difluorpyrimidin-2-ylamino)-4-sulfonatophenolatocuprat(II)

428-260-4

—

Eye Dam. 1

H318

GHS05

Dgr

H318

611-144-00-4

en blanding af 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2-sulfonsyre, Na/K-salt;

7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalen-2-sulfonsyre, Na/K-salt;

7-amino-8-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalen-2-sulfonsyre, Na/K-salt og

7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalen-2-sulfonsyre, Na/K-salt

429-070-4

214362-06-8

Eye Dam. 1

H318

GHS05

Dgr

H318

611-145-00-X

en blanding af tetranatrium-3-(1,5-disulfonatonaphthalen-2-ylazo)-4-hydroxy-7-{4-chlor-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}naphthalen-2-sulfonat og

3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chlor-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}naphthalen-2-sulfonsyre, natriumsalt

429-440-5

—

Eye Dam. 1

H318

GHS05

Dgr

H318

611-146-00-5

en blanding af

pentanatrium-3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalen-2-sulfonat;

pentanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalen-2-sulfonat;

pentanatrium-6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat og

hexanatrium-6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalen-2-sulfonat

430-070-1

—

Aquatic Chronic 2

H411

GHS09

H411

611-147-00-0

natrium-, kalium-, lithium-5-amino-3,6-bis(5-(4-chlor-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalen-2,7-disulfonat

430-090-0

205764-96-1

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-148-00-6

en blanding af 2-(3-(2,6-dichlor-4-nitrophenylazo)carbazol-9-yl)ethanol;

2-(2-(3-(2,6-dichlor-4-nitro-phenylazo)carbazol-9-yl)ethoxy)ethanol og

3-(2,6-dichlor-4-nitrophenylazo)carbazol

429-590-1

—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

611-149-00-1

2-(2-chloracetoxy)ethyl-3-((4-(2,5-dichlor-4-fluorsulfonylphenylazo)-3-methylphenyl)ethylamino)propionat

427-570-7

193486-83-8

Aquatic Chronic 2

H411

GHS09

H411

611-150-00-7

tetralithium-2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoat

440-460-3

—

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

611-151-00-2

chrysoidin;

4-(phenylazo)benzen-1,3-diamin

207-803-7

495-54-5

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H341

H302

H315

H400

H410

GHS08

GHS07

GHS09

Wng

H341

H302

H315

H410

611-152-00-8

chrysoidin monohydrochlorid;

4-phenylazophenylen-1,3-diamin monohydrochlorid; [1] chrysoidinmonoacetat;

4-(phenylazo)benzen-1,3-diaminmonoacetat; [2]

chrysoidinacetat

4-(phenylazo)benzen-1,3-diaminacetat; [3]

chrysoidin-p-dodecylbenzensulfonat; dodecylbenzensulfonsyre, forbindelse med 4-(phenylazo)benzen-1,3-diamin (1:1); [4]

chrysoidin dihydrochlorid;

4-(phenylazo)benzen-1,3-diamin dihydrochlorid; [5]

chrysoidinsulfat;

bis[4-(phenylazo)benzen-1,3-diamin]sulfat; [6]

208-545-8 [1]

278-290-5 [2]

279-116-0 [3]

264-409-8 [4]

281-549-5 [5]

282-432-1 [6]

532-82-1 [1]

75660-25-2 [2]

79234-33-6 [3]

63681-54-9 [4]

83968-67-6 [5]

84196-22-5 [6]

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H302

H315

H318

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H341

H302

H315

H318

H410

611-153-00-3

chrysoidin C10-14-alkylderivater;

benzensulfonsyre, mono-C10-14-alkylderivater, forbindelser

med 4-(phenylazo)-1,3-benzendiamin; [1]

chrysoidin, forbindelse med dibutylnaphtalensulfon

syre;

dibutylnaphthalensulfonsyre, forbindelse med 4-(phenylazo)benzen-1,3-diamin (1:1) [2]

286-946-7 [1]

304-236-8 [2]

85407-90-5 [1]

94247-67-3 [2]

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

H341

H302

H315

H318

GHS05

GHS08

GHS07

Dgr

H341

H302

H315

H318

611-154-00-9

trinatrium-5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalen-2,7-disulfonat

403-670-6

92408-46-3

Aquatic Chronic 3

H412

—

H412

611-155-00-4

4,4'-oxybis(benzensulfonylazid)

431-850-4

7456-68-0

Expl. 1.1 ****

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H201

H373 **

H400

H410

GHS01

GHS08

GHS09

Dgr

H201

H373 **

H410

611-156-00-X

triammonium-4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoat

432-270-4

221354-37-6

Repr. 2

STOT RE 2 *

Aquatic Chronic 2

H361f *** H373 **

H411

GHS08

GHS09

Wng

H361f *** H373 **

H411

611-157-00-5

benzensulfonsyre, 3,3'-(methylenbis((dihydroxyphenylen)azo))bis-, kaliumnatriumsalt

kaliumnatrium-3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzensulfonat

432-590-4

243869-48-9

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

611-158-00-0

reaktionsprodukt af 2,3,4,2',3',

4'-hexahydroxy-5,5'-diacetyl-diphenylmethan og 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonylchlorid og 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalensulfonylchlorid

421-520-8

—

****

Aquatic Chronic 4

**** H413

****

**** H413

611-159-00-6

dinatrium-4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalen-2,7-disulfonat

421-880-6

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-160-00-1

en blanding af 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalen-1''-sulfonato)ethan; 1,1,1-tris(phenyl-4'-(6''-diazo-5'',

6''-dihydro-5''-oxo-naphthalen-1''-sulfonato)ethan;

reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (2:1)

reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (1:2)

422-760-6

—

****

Aquatic Chronic 4

**** H413

****

**** H413

611-161-00-7

trinatrium-[1,2'-(2-(8-amino-3,5-disulfonatonaphthalen)azo)-(4'-nitrobenzen)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzen)diolato-O, O,N]chromat(III)

423-100-1

—

Eye Dam. 1

H318

GHS05

Dgr

H318

611-162-00-2

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolbis(methansulfonat)

429-600-4

—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

611-163-00-8

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolsulfat

429-610-9

—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

611-164-00-3

en blanding af 2,2'-dimethyl-2,2'-azobutannitril;

2-methylpentannitril-2-azo-2'-(2'-methylpropannitril);

2,2'-dimethyl-2,2'-azoheptannitril;

2-methylheptannitril-2-azo-2'-(2'-methylpropannitril) og

2-methylheptannitril-2-azo-2'-(2'-methylbutannitril)

429-710-2

—

Self-react. D

Acute Tox. 4 *

Aquatic Chronic 2

H242

H302

H411

GHS02

GHS07

GHS09

Dgr

H242

H302

H411

611-165-00-9

blanding af tetranatrium-4-amino-6-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat og

tetranatrium-4-amino-6-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat

431-830-5

—

Aquatic Chronic 3

H412

—

H412

611-166-00-4

en blanding af pentanatrium

4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat og

tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat og tetranatrium-4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat

432-100-9

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-167-00-X

natrium-bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato]cuprat(II)

435-240-9

—

Aquatic Chronic 3

H412

—

H412

611-168-00-5

en blanding af 3-[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chlor-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre og

3,5-bis[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre

435-440-6

—

Eye Dam. 1

H318

GHS05

Dgr

H318

611-169-00-0

natrium-5-(2-carboxyphenylazo)-6-hydroxynaphthalen-2-sulfonat

435-800-2

—

Aquatic Chronic 3

H412

—

H412

611-170-00-6

blanding af trinatrium-2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoat(5-)-κ-O)cuprat(II)

dinatrium-2-((1-(5-ethensulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoat-κ-O-(5-))cuprat(II)

435-880-9

—

Aquatic Chronic 3

H412

—

H412

611-171-00-1

blanding af trinatrium-3-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat og

trinatrium-3-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat

436-890-6

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-172-00-7

en blanding af triammonium-

6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalensulfonat og

diammonium-3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoat

438-310-7

—

Self-react. C ****

Repr. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H242

H361f ***

H302

H373 **

H412

GHS02

GHS08

GHS07

Dgr

H242

H361f ***

H302

H373 **

H412

611-173-00-2

en blanding af 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, trinatriumsalt og 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, dinatriumsalt

440-510-4

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-174-00-8

en blanding af 3-[5-(4-ethensulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt og

3-[5-(4-(2-chlorethansulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt

442-290-5

457624-86-1

Eye Dam. 1

H318

GHS05

Dgr

H318

611-175-00-3

blanding af trinatrium-5-{4-chlor-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat

trinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

dinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat og

tetranatrium-5-{4-chlor-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2,7-disulfonat

444-050-5

—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-176-00-9

2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol, ester med 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonat

444-250-2

—

Self-react. C **** Aquatic Chronic 2

H242

H411

GHS02

GHS09

Dgr

H242

H411

611-177-00-4

blanding af pentanatrium-bis[6-anilino-3,5'-disulfonatonaphthalen-2-azobenzen-1,2'-diolato]cobaltat(III);

tetranatrium-[6-anilino-3,5'-disulfonatonaphthalen-2-azobenzen-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato]cobaltat(III) og trinatrium-bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2'-diolato]cobaltat(III)

444-290-0

508202-43-5

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

611-178-00-X

en blanding af pentanatrium

-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat;

tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; tetranatrium-4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

trinatrium-4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[2-sulfonato-4-(2-hydro

xyethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat

445-280-9

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

611-179-00-5

en blanding af pentanatrium

-2-[[8-[[4-chlor-6-[[4-(2-sulfonatoethylsulfonyl)]phe

nyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat og

2-[[8-[[4-chlor-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat

450-010-8

—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-180-00-0

jern, komplekser med diazoteret

4-aminobenzensulfonamid, diazoteret 3-aminobenzensulfonsyre, diazoteret 3-amino-4-hydroxybenzensulfonamid, diazoteret 3-amino-4-hydroxy-N-phenylbenzensulfonamid, diazoteret 5-amino-2-(phenylamino)benzensulfonsyre og resorcinol, natriumsalte

417-850-7

—

Aquatic Chronic 2

H411

GHS09

H411

612-001-00-9

mono-methylamin; [1]

di-methylamin; [2]

tri-methylamin [3]

200-820-0 [1]

204-697-4 [2]

200-875-0 [3]

74-89-5 [1]

124-40-3 [2]

75-50-3 [3]

Flam. Gas 1

Press. Gas

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H220

H332

H335

H315

H318

GHS02

GHS04

GHS05

GHS07

Dgr

H220

H332

H335

H315

H318

*

Skin Irrit. 2;

H315: C ≥ 5 %

Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2;

H319: 0,5  % ≤

C < 5 %

STOT SE 3; H335: C ≥ 5 %

U5

612-001-01-6

mono-methylamin ... %; [1]

di-methylamin ... %; [2]

tri-methylamin ... % [3]

200-820-0 [1]

204-697-4 [2]

200-875-0 [3]

74-89-5 [1]

124-40-3 [2]

75-50-3 [3]

Flam. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H224

H332

H302

H314

GHS02

GHS05

GHS07

Dgr

H224

H332

H302

H314

*

STOT SE 3; H335: C ≥ 5 %

B

612-002-00-4

ethylamin

200-834-7

75-04-7

Flam. Gas 1

Press. Gas

Eye Irrit. 2

STOT SE 3

H220

H319

H335

GHS02

GHS04

GHS07

Dgr

H220

H319

H335

U

612-003-00-X

diethylamin

203-716-3

109-89-7

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H225

H332

H312

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H332

H312

H302

H314

STOT SE 3; H335: C ≥ 1 %

612-004-00-5

triethylamin

204-469-4

121-44-8

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H225

H332

H312

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H332

H312

H302

H314

STOT SE 3; H335: C ≥ 1 %

612-005-00-0

butylamin

203-699-2

109-73-9

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H225

H332

H312

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H332

H312

H302

H314

STOT SE 3; H335: C ≥ 1 %

612-006-00-6

ethylendiamin;

1,2-diaminoethan

203-468-6

107-15-3

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

H226

H312

H302

H314

H334

H317

GHS02

GHS08

GHS05

GHS07

Dgr

H226

H312

H302

H314

H334

H317

612-007-00-1

2-propanamin;

isopropylamin

200-860-9

75-31-0

Flam. Liq. 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H224

H319

H335

H315

GHS02

GHS07

Dgr

H224

H319

H335

H315

612-008-00-7

anilin

200-539-3

62-53-3

Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H351

H341

H331

H311

H301

H372 **

H318

H317

H400

GHS06

GHS08

GHS05

GHS09

Dgr

H351

H341

H331

H311

H301

H372 **

H318

H317

H400

*

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,2  % ≤ C < 1 %

612-009-00-2

salte af anilin

—

—

Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H351

H341

H331

H311

H301

H372 **

H318

H317

H400

GHS06

GHS08

GHS05

GHS09

Dgr

H351

H341

H331

H311

H301

H372 **

H318

H317

H400

*

STOT RE 1; H372: C ≥ 1 % STOT RE 2;

H373: 0,2  % ≤

C < 1 %

A

612-010-00-8

chloraniliner, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H410

C

612-011-00-3

4-nitrosoanilin

211-535-6

659-49-4

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H332

H312

H302

GHS07

Wng

H332

H312

H302

612-012-00-9

o-nitroanilin; [1] m-nitroanilin; [2] p-nitroanilin [3]

201-855-4 [1]

202-729-1 [2]

202-810-1 [3]

88-74-4 [1]

99-09-2 [2]

100-01-6 [3]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3

H331

H311

H301

H373 **

H412

GHS06

GHS08

Dgr

H331

H311

H301

H373 **

H412

C

612-013-00-4

3-aminobenzensulfonsyre;

metanilsyre

204-473-6

121-47-1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H332

H312

H302

GHS07

Wng

H332

H312

H302

612-014-00-X

sulfanilsyre;

4-aminobenzensulfonsyre

204-482-5

121-57-3

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H319

H315

H317

GHS07

Wng

H319

H315

H317

612-015-00-5

N-methylanilin

202-870-9

100-61-8

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H410

612-016-00-0

N, N-dimethylanilin

204-493-5

121-69-7

Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H351

H331

H311

H301

H411

GHS06

GHS08

GHS09

Dgr

H351

H331

H311

H301

H411

612-017-00-6

N-methyl-N-2,4,6-tetranitroanilin; tetryl

207-531-9

479-45-8

Expl. 1,1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2

H201

H331

H311

H301

H373 **

GHS01

GHS06

GHS08

Dgr

H201

H331

H311

H301

H373 **

612-018-00-1

bis(2,4,6-trinitrophenyl)amin;

hexyl

205-037-8

131-73-7

Expl. 1,1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2

Aquatic Chronic 2

H201

H330

H310

H300

H373 **

H411

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H330

H310

H300

H373 **

H411

612-019-00-7

dipicrylamin, ammoniumsalt

220-639-0

2844-92-0

Expl. 1,1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2

Aquatic Chronic 2

H201

H330

H310

H300

H373 **

H411

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H330

H310

H300

H373 **

H411

612-020-00-2

1-naphthylamin

205-138-7

134-32-7

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

612-022-00-3

2-naphthylamin

202-080-4

91-59-8

Carc. 1A

Acute Tox. 4 *

Aquatic Chronic 2

H350

H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H302

H411

Carc. 1A; H350: C ≥ 0,01  %

612-023-00-9

phenylhydrazin; [1]

phenylhydraziniumchlorid; [2]

phenylhydrazin-hydrochlorid; [3]

phenylhydraziniumsulfat (2:1) [4]

202-873-5 [1]

200-444-7 [2]

248-259-0 [3]

257-622-2 [4]

100-63-0 [1]

59-88-1 [2]

27140-08-5 [3]

52033-74-6 [4]

Carc. 1B

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H350

H341

H331

H311

H301

H372 **

H319

H315

H317

H400

GHS06

GHS08

GHS09

Dgr

H350

H341

H331

H311

H301

H372 **

H319

H315

H317

H400

612-024-00-4

m-toluidin;

3-aminotoluen

203-583-1

108-44-1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

H331

H311

H301

H373 **

H400

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H400

612-025-00-X

nitrotoluidiner, med undtagelse af sådanne specificeret andetsteds i dette bilag

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H411

C

612-026-00-5

diphenylamin

204-539-4

122-39-4

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H410

612-027-00-0

xylidiner, med undtagelse af sådanne specificeret andetsteds i dette bilag

dimethylaniliner, med undtagelse af sådanne specificeret andetsteds i dette bilag

—

—

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H411

C

612-028-00-6

p-phenylendiamin

203-404-7

106-50-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H319

H317

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H319

H317

H410

612-029-00-1

benzen-1,4-diamindihydrochlorid;

p-phenylendiamindihydrochlorid

210-834-9

624-18-0

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H319

H317

H400

H410

GHS06

GHS09

Dgr

H331

H311

H301

H319

H317

H410

612-030-00-7

2-methyl-p-phenylendiaminsulfat [1]

210-431-8 [1]

228-871-4 [2]

615-50-9 [1]

6369-59-1 [2]

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H301

H332

H312

H317

H411

GHS06

GHS09

Dgr

H301

H332

H312

H317

H411

612-031-00-2

N, N-dimethylbenzen-1,3-diamin; [1]

4-amino-N, N-dimethylanilin;

3-amino-N, N'-dimethylanilin

[2]

220-623-3 [1]

202-807-5 [2]

2836-04-6 [1]

99-98-9 [2]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H331

H311

H301

GHS06

Dgr

H331

H311

H301

C

612-032-00-8

N, N,N'-N'-tetramethyl-p-pheny

lendiamin

202-831-6

100-22-1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H332

H312

H302

GHS07

Wng

H332

H312

H302

612-033-00-3

2-aminofenol

202-431-1

95-55-6

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

H341

H332

H302

GHS08

GHS07

Wng

H341

H332

H302

612-034-00-9

2-amino-4,6-dinitrophenol;

picraminsyre

202-544-6

96-91-3

Expl. 1,1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H201

H332

H312

H302

H412

GHS01

GHS07

Dgr

H201

H332

H312

H302

H412

612-034-01-6

2-amino-4,6-dinitrophenol;

picraminsyre; [≥ 20 % vand]

202-544-6

96-91-3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H332

H312

H302

H412

GHS07

Wng

H332

H312

H302

H412

G

612-035-00-4

2-methoxyanilin;

ortho-anisidin

201-963-1

90-04-0

Carc. 1B Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

H350

H341

H331

H311

H301

GHS06

GHS08

Dgr

H350

H341

H331

H311

H301

612-036-00-X

3,3'-dimethoxybenzidin;

o-dianisidin

204-355-4

119-90-4

Carc. 1B

Acute Tox. 4 *

H350

H302

GHS08

GHS07

Dgr

H350

H302

612-037-00-5

salte af 3,3'-dimethoxyben

zidin; salte af o-dianisidin

—

—

Carc. 1B

Acute Tox. 4 *

H350

H302

GHS08

GHS07

Dgr

H350

H302

A

612-038-00-0

2-nitro-p-anisidin

4-methoxy-2-nitroanilin

202-547-2

96-96-8

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 3

H330

H310

H300

H373 **

H412

GHS06

GHS08

Dgr

H330

H310

H300

H373 **

H412

612-039-00-6

2-ethoxyanilin;

ortho-phenetidin

202-356-4

94-70-2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

H331

H311

H301

H373 **

GHS06

GHS08

Dgr

H331

H311

H301

H373 **

612-040-00-1

2,4-dinitroanilin

202-553-5

97-02-9

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2

H330

H310

H300

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 **

H411

612-041-00-7

4,4'-bis-o-toluidin

204-358-0

119-93-7

Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H350

H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H302

H411

612-042-00-2

benzidin

1,1'-biphenyl-4,4'-diamin;

4,4'-diaminobiphenyl;

biphenyl-4,4'-ylendiamin

202-199-1

92-87-5

Carc. 1A

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H410

Carc. 1A; H350: C ≥ 0,01  %

612-043-00-8

N, N'-dimethylbenzidin

—

2810-74-4

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H332

H312

H302

GHS07

Wng

H332

H312

H302

612-044-00-3

N, N'-diacetylbenzidin

210-338-2

613-35-4

Carc. 1B Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H350

H341

H332

H312

H302

GHS08

GHS07

Dgr

H350

H341

H332

H312

H302

612-046-00-4

allylamin

203-463-9

107-11-9

Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H225

H331

H311

H301

H411

GHS02

GHS06

GHS09

Dgr

H225

H331

H311

H301

H411

612-047-00-X

benzylamin

202-854-1

100-46-9

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

612-048-00-5

dipropylamin

205-565-9

142-84-7

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H225

H332

H312

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H332

H312

H302

H314

STOT SE 3; H335: C ≥ 1 %

612-049-00-0

dibutylamin; [1]

di-sec-butylamin [2]

203-921-8 [1]

210-937-9 [2]

111-92-2 [1]

626-23-3 [2]

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H226

H332

H312

H302

GHS02

GHS07

Wng

H226

H332

H312

H302

612-050-00-6

cyclohexylamin

203-629-0

108-91-8

Flam. Liq. 3

Repr. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H226

H361f ***

H312

H302

H314

GHS02

GHS05

GHS08

GHS07

Dgr

H226

H361f ***

H312

H302

H314

612-051-00-1

4,4'-diaminodiphenylmethan;

4,4'-methylendianilin

202-974-4

101-77-9

Carc. 1B

Muta. 2

STOT SE 1

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H350

H341

H370 **

H373 **

H317

H411

GHS08

GHS07

GHS09

Dgr

H350

H341

H370 **

H373 **

H317

H411

612-052-00-7

(S)-sec-butylamin

(S)-2-aminobutan; [1] (R)-sec-butylamin;

(R)-2-aminobutan; [2]

sec-butylamin;

2-aminobutan [3]

208-164-7 [1]

236-232-6 [2]

237-732-7 [3]

513-49-5 [1]

13250-12-9 [2]

13952-84-6 [3]

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1

H225

H332

H302

H314

H400

GHS02

GHS05

GHS07

GHS09

Dgr

H225

H332

H302

H314

H400

C

612-053-00-2

N-ethylanilin

203-135-5

103-69-5

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

H331

H311

H301

H373 **

GHS06

GHS08

Dgr

H331

H311

H301

H373 **

612-054-00-8

N, N-diethylanilin

202-088-8

91-66-7

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H411

*

612-055-00-3

N-methyl-o-toluidin; [1] N-methyl-m-toluidin; [2] N-methyl-p-toluidin [3]

210-260-9 [1]

211-795-0 [2]

210-769-6 [3]

611-21-2 [1]

696-44-6 [2]

623-08-5 [3]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3

H331

H311

H301

H373 **

H412

GHS06

GHS08

Dgr

H331

H311

H301

H373 **

H412

C

612-056-00-9

N, N-dimethyl-p-toluidin; [1] N, N-dimethyl-m-toluidin; [2] N, N-dimethyl-o-toluidin [3]

202-805-4 [1]

204-495-6 [2]

210-199-8 [3]

99-97-8 [1]

121-72-2 [2]

609-72-3 [3]

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3

H331

H311

H301

H373 **

H412

GHS06

GHS08

Dgr

H331

H311

H301

H373 **

H412

*

C

612-057-00-4

piperazin; [fast]

203-808-3

110-85-0

Repr. 2

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

H361fd

H314

H334

H317

GHS05

GHS08

Dgr

H361fd

H314

H334

H317

612-057-01-1

piperazin; [væske]

203-808-3

110-85-0

Repr. 2

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

H361fd

H314

H334

H317

GHS05

GHS08

Dgr

H361fd

H314

H334

H317

612-058-00-X

2,2'-iminodiethylamin;

diethylentriamin

203-865-4

111-40-0

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H312

H302

H314

H317

GHS05

GHS07

Dgr

H312

H302

H314

H317

612-059-00-5

3,6-diazaoctanethylendiamin;

triethylentetramin

203-950-6

112-24-3

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H312

H314

H317

H412

GHS05

GHS07

Dgr

H312

H314

H317

H412

612-060-00-0

3,6,9-triazaundecamethylendiamin; tetraethylen-pentamin

203-986-2

112-57-2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H312

H302

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H312

H302

H314

H317

H411

612-061-00-6

3-(dimethylamino)propylamin; N, N-dimethyl-1,3-diaminopropan

203-680-9

109-55-7

Flam. Liq. 3

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H226

H302

H314

H317

GHS02

GHS05

GHS07

Dgr

H226

H302

H314

H317

612-062-00-1

3-(diethylamino)propylamin);

N, N-diethyl-1,3-diaminopropan

203-236-4

104-78-9

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H226

H312

H302

H314

H317

GHS02

GHS05

GHS07

Dgr

H226

H312

H302

H314

H317

612-063-00-7

3,3'-iminodi(propylamin)

dipropylentriamin

200-261-2

56-18-8

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1

H330

H311

H302

H314

H317

GHS06

GHS05

Dgr

H330

H311

H302

H314

H317

612-064-00-2

3,6,9,12-tetraazatetradecan-k,4-diamin; pentaethylenhexamin

223-775-9

4067-16-7

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

612-065-00-8

polyethylenpolyaminer undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H312

H302

H314

H317

H410

612-066-00-3

dicyclohexylamin

202-980-7

101-83-7

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H410

612-067-00-9

3-aminomethyl-3,5,5-trimethylcyclohexylamin

220-666-8

2855-13-2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H312

H302

H314

H317

H412

GHS05

GHS07

Dgr

H312

H302

H314

H317

H412

612-068-00-4

3,3'-dichlorbenzidin

3,3'-dichlorbiphenyl-4,4'-ylendiamin

202-109-0

91-94-1

Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H312

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H312

H317

H410

612-069-00-X

salte af 3,3'-dichlorbenzidin;

salte af 3,3'-dichlorbiphenyl4,4'-ylendiamin

—

—

Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H312

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H312

H317

H410

A

612-070-00-5

salte af benzidin

208-519-6

208-520-1

244-236-4

252-984-8

531-85-1

531-86-2

21136-70-9

36341-27-2

Carc. 1A

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H410

A

612-071-00-0

salte af 2-nafthylamin

209-030-0

210-313-6

553-00-4

612-52-2

Carc. 1A

Acute Tox. 4 *

Aquatic Chronic 2

H350

H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H302

H411

A

612-072-00-6

biphenyl-4-ylamin;

xenylamin;

4-aminobiphenyl

202-177-1

92-67-1

Carc. 1A

Acute Tox. 4 *

H350

H302

GHS08

GHS07

Dgr

H350

H302

612-073-00-1

salte af biphenyl-4-ylamin;

salte af xenylamin;

salte af 4-aminobiphenyl

—

—

Carc. 1A

Acute Tox. 4 *

H350

H302

GHS08

GHS07

Dgr

H350

H302

A

612-074-00-7

benzyldimethylamin

203-149-1

103-83-3

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3

H226

H332

H312

H302

H314

H412

GHS02

GHS05

GHS07

Dgr

H226

H332

H312

H302

H314

H412

612-075-00-2

2-aminoethyldimethylamin

2-dimethylaminoethylamin

203-541-2

108-00-9

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H225

H312

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H312

H302

H314

612-076-00-8

ethyldimethylamin

209-940-8

598-56-1

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H225

H332

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H332

H302

H314

612-077-00-3

dimethylnitrosoamin;

N-nitrosodimethylamin

200-549-8

62-75-9

Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Chronic 2

H350

H330

H301

H372 **

H411

GHS06

GHS08

GHS09

Dgr

H350

H330

H301

H372 **

H411

Carc. 1B; H350: C ≥ 0,001  %

612-078-00-9

2,2'-dichlor-4,4'-methylendianilin

4,4'-methylenbis(2-chloranilin)

202-918-9

101-14-4

Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H410

612-079-00-4

salte af 2,2'-dichlor-4,4'-methylendianilin;

salte af 4,4'-methylenbis(2-chloranilin)

—

—

Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H410

A

612-080-00-X

4-amino-N, N-diethylanilin;

N, N-diethyl-4-aminoanilin

202-214-1

93-05-0

Acute Tox. 3 *

Skin Corr. 1B

H301

H314

GHS06

GHS05

Dgr

H301

H314

612-081-00-5

salte af 4,4'-bi-o-toluidin;

salte af 3,3′-dimethoxybenzidin;

salte af o-tolidin

210-322-5

265-294-7

277-985-0

612-82-8

64969-36-4

74753-18-7

Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H350

H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H302

H411

A

612-082-00-0

thiourea;

thiourinstof

200-543-5

62-56-6

Carc. 2

Repr. 2

Acute Tox. 4 *

Aquatic Chronic 2

H351

H361D *** H302

H411

GHS08

GHS07

GHS09

Wng

H351

H361D *** H302

H411

612-083-00-6

1-methyl-3-nitro-1-nitrosoguanidin

200-730-1

70-25-7

Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H350

H332

H319

H315

H411

GHS08

GHS07

GHS09

Dgr

H350

H332

H319

H315

H411

Carc. 1B; H350: C ≥ 0,01  %

612-084-00-1

dapson;

4,4'-diaminodiphenylsulfon

201-248-4

80-08-0

Acute Tox. 4 *

H302

GHS07

Wng

H302

612-085-00-7

4,4'-methylendi-o-toluidin

212-658-8

838-88-0

Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H302

H317

H410

612-086-00-2

amitraz (ISO)

N, N-bis(2,4-xylyliminomethyl)

methylamin

251-375-4

33089-61-1

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 ** H317

H410

M = 10

612-087-00-8

guazatin (ISO)

108173-90-6

Acute Tox. 2 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H312

H302

H335

H315

H318

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H312

H302

H335

H315

H318

H410

612-088-00-3

simazin (ISO)

6-chlor-N, N'-diethyl-1,3,5- triazin-2,4-diamin

204-535-2

122-34-9

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

612-089-00-9

1,5-naphthylendiamin

218-817-8

2243-62-1

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

612-090-00-4

2,2'-(nitrosoimino)bisethanol

214-237-4

1116-54-7

Carc. 1B

H350

GHS08

Dgr

H350

612-091-00-X

o-toluidin;

2-aminotoluen

202-429-0

95-53-4

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

H350

H331

H301

H319

H400

GHS06

GHS08

GHS09

Dgr

H350

H331

H301

H319

H400

612-092-00-5

N, N'-(2,2-dimethylpropyli

den)hexamethylendiamin

401-660-6

1000-78-8

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

612-093-00-0

3,5-dichlor-4-(1,1,2,2-tetrafluorethoxy)anilin

401-790-3

104147-32-2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

612-094-00-6

4-(2-chlor-4-trifluormethyl)phenoxy-2-fluoranilin hydrochlorid

402-190-4

113674-95-6

STOT RE 1

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H372 **

H302

H373 **

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H372 **

H302

H373 **

H318

H317

H410

612-095-00-1

benzyl-2-hydroxydodecyldi-

methylammoniumbenzoat

402-610-6

113694-52-3

Skin Corr. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H314

H302

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H302

H410

612-096-00-7

4,4'-carbonimidoylbis[N, N-dimethylanilin]

207-762-5

492-80-8

Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2

H351

H302

H319

H411

GHS08

GHS07

GHS09

Wng

H351

H302

H319

H411

612-097-00-2

salte af 4,4'-carbonimid-

oylbis[N, N-dimethylanilin]

—

—

Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2

H351

H302

H319

H411

GHS08

GHS07

GHS09

Wng

H351

H302

H319

H411

A

612-098-00-8

nitrosodipropylamin

210-698-0

621-64-7

Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H350

H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H302

H411

Carc. 1B; H350: C ≥ 0,001  %

612-099-00-3

4-methyl-m-phenylendiamin;

2,4-toluendiamin

202-453-1

95-80-7

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H350

H341

H361f ***

H301

H312

H373 **

H317

H411

GHS06

GHS08

GHS09

Dgr

H350

H341

H361f ***

H301

H312

H373 **

H317

H411

612-100-00-7

propylendiamin

201-155-9

78-90-0

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H226

H312

H302

H314

GHS02

GHS05

GHS07

Dgr

H226

H312

H302

H314

612-101-00-2

methenamin;

hexamethylentetramin

202-905-8

100-97-0

Flam. Sol. 2

Skin Sens. 1

H228

H317

GHS02

GHS07

Wng

H228

H317

612-102-00-8

N, N-bis(3-aminopro-

pyl)methylamin

203-336-8

105-83-9

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

H331

H311

H302

H314

GHS06

GHS05

Dgr

H331

H311

H302

H314

612-103-00-3

N, N,N',N'-tetramethylethylendiamin

203-744-6

110-18-9

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H225

H332

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H332

H302

H314

612-104-00-9

hexamethylendiamin

204-679-6

124-09-4

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Corr. 1B

H312

H302

H335

H314

GHS05

GHS07

Dgr

H312

H302

H335

H314

612-105-00-4

2-piperazin-1-ylethylamin

205-411-0

140-31-8

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H312

H302

H314

H317

H412

GHS05

GHS07

Dgr

H312

H302

H314

H317

H412

612-106-00-X

2,6-diethylanilin

209-445-7

579-66-8

Acute Tox. 4 *

H302

—

H302

612-107-00-5

1-phenylethylamin; [1]

.sc.DL.sc.-α-methylbenzylamin [2]

202-706-6 [1]

210-545-8 [2]

98-84-0 [1]

618-36-0 [2]

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

612-108-00-0

3-aminopropyltriethoxysilan

213-048-4

919-30-2

Acute Tox. 4 *

Skin Corr. 1B

H302

H314

GHS05

GHS07

Dgr

H302

H314

612-109-00-6

bis(2-dimethylaminoe-

thyl)(methyl)amin

221-201-1

3030-47-5

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

H311

H302

H314

GHS06

GHS05

Dgr

H311

H302

H314

612-110-00-1

2,2'-dimethyl-4,4'-methylenbis(cyclohexylamin)

229-962-1

6864-37-5

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Chronic 2

H331

H311

H302

H314

H411

GHS06

GHS05

GHS09

Dgr

H331

H311

H302

H314

H411

612-111-00-7

2-methyl-m-phenylendiamin;

2,6-toluendiamin

212-513-9

823-40-5

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H341

H312

H302

H317

H411

GHS08

GHS07

GHS09

Wng

H341

H312

H302

H317

H411

612-112-00-2

p-anisidin;

4-methoxyanilin

203-254-2

104-94-9

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

H330

H310

H300

H373 **

H400

GHS06

GHS08

GHS09

Dgr

H330

H310

H300

H373 **

H400

612-113-00-8

6-methyl-2,4-bis(methylthio)phenylen-1,3-diamin

403-240-8

106264-79-3

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

612-114-00-3

R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamidhydrogen-2,3-bis(benzoyloxy)succinat

404-390-7

—

Flam. Sol. 1

Skin Sens. 1

Aquatic Chronic 3

H228

H317

H412

GHS02

GHS07

Wng

H228

H317

H412

612-115-00-9

dimethyldioctadecylammoniumhydrogensulfat

404-050-8

123312-54-9

Eye Irrit. 2

Aquatic Chronic 4

H319

H413

GHS07

Wng

H319

H413

612-116-00-4

C8-18salkylbis(2-hydroxyethyl)ammoniumbis(2-ethylhexyl)phosphat

404-690-8

68132-19-4

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H314

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H331

H314

H317

H410

612-117-00-X

C12-14-tert-alkylamin, methylphosphonsyresalt

404-750-3

119415-07-5

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H302

H314

H411

GHS05

GHS07

GHS09

Dgr

H302

H314

H411

612-118-00-5

en blanding af (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium-4-toluensulfonat og

(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromid

405-080-4

—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

612-119-00-0

benzyldimethyloctadecylammonium-3-nitrobenzensulfonat

405-330-2

—

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

612-120-00-6

aclonifen (ISO);

2-chlor-6-nitro-3-phenoxyanilin

277-704-1

74070-46-5

Carc. 2

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H351

H317

H400

H410

GHS08

GHS07

GH09

Wng

H351

H317

H410

M = 100

M = 10

612-121-00-1

aminer, polyethylenpoly-; HEPA

268-626-9

68131-73-7

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H312

H302

H314

H317

H410

612-122-00-7

hydroxylamin ....%,

[> 55 % i vandig opløsning]

232-259-2

7803-49-8

Unst. Expl. Met. Corr. 1

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H200

H290

H351

H312

H302

H373 **

H335

H315

H318

H317

H400

GHS01

GHS05

GHS08

GHS07

GHS09

Dgr

H200

H290

H351

H312

H302

H373 **

H335

H315

H318

H317

H400

B

612-122-01-4

hydroxylamin ...% [≤ 55 % i vandig opløsning]

232-259-2

7803-49-8

Met. Corr. 1

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H290

H351

H312

H302

H373 **

H335

H315

H318

H317

H400

GHS05

GHS08

GHS07

GHS09

Dgr

H290

H351

H312

H302

H373 **

H335

H315

H318

H317

H400

B

612-123-00-2

hydroxylammoniumchlorid; hydroxylamin hydrochlorid;

[1] bis(hydroxylammonium)sulfat;

hydroxylamin sulfat (2:1) [2]

226-798-2 [1]

233-118-8 [2]

5470-11-1 [1]

10039-54-0 [2]

Met. Corr. 1

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H290

H351

H312

H302

H373 **

H319

H315

H317

H400

GHS05

GHS08

GHS07

GHS09

Wng

H290

H351

H312

H302

H373 **

H319

H315

H317

H400

612-124-00-8

N, N,N-trimethylaniliniumchlorid

205-319-0

138-24-9

Acute Tox. 3 *

Acute Tox. 3 *

H311

H301

GHS06

Dgr

H311

H301

612-125-00-3

2-methyl-p-phenylendiamin

2,5-toluendiamin

202-442-1

95-70-5

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H301

H332

H312

H317

H411

GHS06

GHS09

Dgr

H301

H332

H312

H317

H411

612-126-00-9

toluen-2,4-diammoniumsulfat;

4-methyl-m-phenylendiamin

sulfat

265-697-8

65321-67-7

Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H350

H301

H312

H319

H317

H411

GHS06

GHS08

GHS09

Dgr

H350

H301

H312

H319

H317

H411

612-127-00-4

3-aminophenol

209-711-2

591-27-5

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H332

H302

H411

GHS07

GHS09

Wng

H332

H302

H411

612-128-00-X

4-aminophenol

204-616-2

123-30-8

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H341

H332

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H341

H332

H302

H410

612-129-00-5

diisopropylamin

203-558-5

108-18-9

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H225

H332

H302

H314

GHS02

GHS05

GHS07

Dgr

H225

H332

H302

H314

STOT SE 3; H335: C ≥ 5 %

612-130-00-0

2,6-diamino-3,5-diethyltoluen;

4,6-diethyl-2-methylbenzen-1,3-diamin; [1]

2,4-diamino-3,5-diethyltoluen;

2,4-diethyl-6-methylbenzen-1,3-diamin; [2] diethylmethylbenzendiamin

[3]

218-255-3 [1]

218-256-9 [2]

270-877-4 [3]

04-01-2095 [1]

05-02-2095 [2]

68479-98-1 [3]

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373 **

H319

H400

H410

GHS08

GHS07

GHS09

Wng

H312

H302

H373 **

H319

H410

C

612-131-00-6

didecyldimethylammoniumchlorid

230-525-2

7173-51-5

Acute Tox. 4 *

Skin Corr. 1B

H302

H314

GHS05

GHS07

Dgr

H302

H314

612-132-00-1

N, N'-diphenyl-p-phenylendiamin

N, N'-diphenyl-1,4-benzendiamin

200-806-4

74-31-7

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

612-133-00-7

(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammoniumsulfat;

4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenyldiamin

sulfat

247-162-0

25646-77-9

Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H373 **

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H373 **

H317

H410

612-134-00-2

N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methansulfonamidsesquisulfat

4-(N-ethyl-N-2-metansulfonylaminoethyl)-2-methylphenylendiamin sesquisulfat monohydrat

247-161-5

25646-71-3

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

612-135-00-8

N-2-naphthylanilin;

N-phenyl-2-napthylamin

205-223-9

135-88-6

Carc. 2

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H351

H319

H315

H317

H411

GHS08

GHS07

GHS09

Wng

H351

H319

H315

H317

H411

612-136-00-3

N-isopropyl-N'-phenyl-p-phenylendiamin

202-969-7

101-72-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

Skin Sens. 1; H317:C ≥ 0,1  %

612-137-00-9

4-chloranilin

203-401-0

106-47-8

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H331

H311

H301

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H331

H311

H301

H317

H410

612-138-00-4

furalaxyl (ISO);

methyl-N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-.sc.DL.sc.-alaninat

260-875-1

57646-30-7

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

612-139-00-X

mefenacet (ISO);

2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamid

277-328-8

73250-68-7

Aquatic Chronic 2

H411

GHS09

H411

612-140-00-5

kvaternære ammoniumforbindelser, benzyl-C8-18-alkyldimethyl-, chlorider

264-151-6

63449-41-2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

H312

H302

H314

H400

GHS05

GHS07

GHS09

Dgr

H312

H302

H314

H400

612-141-00-0

4,4'-methylenbis(2-ethylanilin);

4,4'-methylenbis(2-ethylbenzenamin)

243-420-1

19900-65-3

Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H410

612-142-00-6

biphenyl-2-ylamin

201-990-9

90-41-5

Carc. 2

Acute Tox. 4 * Aquatic Chronic 3

H351

H302

H412

GHS08

GHS07

Wng

H351

H302

H412

612-143-00-1

N5,N5-diethyltoluen-2,5-diaminmonohydrochlorid

4-diethylamino-2-methylanilinmonohydrochlorid

218-130-3

2051-79-8

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H319

H317

H400

H410

GHS06

GHS09

Dgr

H301

H319

H317

H410

612-144-00-7

flumethralin (ISO)

N-(2-chlor-6-fluorbenzyl)-N-ethyl-α, α,α-trifluor-2,6-dinitro-p-toluidin

—

62924-70-3

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H317

H400

H410

GHS07

GHS09

Wng

H319

H315

H317

H410

612-145-00-2

o-phenylendiamin

202-430-6

95-54-5

Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H341

H301

H332

H312

H319

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H341

H301

H332

H312

H319

H317

H410

612-146-00-8

o-phenylendiamindihydrochlorid

210-418-7

615-28-1

Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H341

H301

H332

H312

H319

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H351

H341

H301

H332

H312

H319

H317

H410

612-147-00-3

m-phenylendiamin

203-584-7

108-45-2

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H331

H311

H301

H319

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H341

H331

H311

H301

H319

H317

H410

612-148-00-9

m-phenylendiamindihydrochlorid

208-790-0

541-69-5

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H331

H311

H301

H319

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H341

H331

H311

H301

H319

H317

H410

612-149-00-4

1,3-diphenylguanidin

203-002-1

102-06-7

Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2

H361f ***

H302

H319

H335

H315

H411

GHS08

GHS07

GHS09

Wng

H361f ***

H302

H319

H335

H315

H411

612-151-00-5

methyl-phenylendiamin;

diaminotoluen;

[teknisk produkt — blanding af 4-methyl-m-phenylendiamin (EF-nr. 202-453-1) og 2-methyl-m-phenylendiamin (EF-nr. 212-513-9)]

—

—

Carc. 1B Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H350

H341

H361f ***

H301

H312

H373 **

H319

H317

H411

GHS06

GHS08

GHS09

Dgr

H350

H341

H361f ***

H301

H312

H373 **

H319

H317

H411

612-152-00-0

N, N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamin

406-610-7

62478-82-4

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Aquatic Chronic 3

H226

H332

H302

H373 **

H314

H412

GHS02

GHS08

GHS05

GHS07

Dgr

H226

H332

H302

H373 **

H314

H412

612-153-00-6

4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzenmonohydrochlorid

407-020-2

132885-85-9

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

612-154-00-1

6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthen]

410-890-6

95235-29-3

Aquatic Chronic 4

H413

—

H413

612-155-00-7

2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthen

411-730-8

93071-94-4

Aquatic Chronic 4

H413

—

H413

612-156-00-2

blanding af trihexadecylmethylammoniumchlorid og dihexadecyldimethylammoniumchlorid

405-620-9

—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

612-157-00-8

(Z)-1-benzo[b]thien-2-ylethanonoximhydrochlorid

410-780-8

—

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H373 **

H318

H317

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H302

H373 **

H318

H317

H411

612-158-00-3

blanding af bis(5-dodecyl-2-hydroxybenzald-oximat)-kobber (II) C12-alkyl gruppen er forgrenet og

4-dodecylsalicylaldoxim

410-820-4

—

Aquatic Chronic 4

H413

—

H413

612-159-00-9

reaktionsprodukter af trimethylhexamethylendiamine (en blanding af 2,2,4-trimethyl-1,6-hexandiamin og 2,4,4-trimethyl-1,6-hexandiamin, EINECS listet), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxiran-derivater)

og p-toluen-sulfonsyre

410-880-1

—

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H410

612-160-00-4

p-toluidin;

4-aminotoluen; [1]

p-toluidiniumchlorid [2]

p-toluidinsulfat (1:1) [3]

203-403-1 [1]

208-740-8 [2]

208-741-3 [3]

106-49-0 [1]

540-23-8 [2]

540-25-0 [3]

Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H351

H331

H311

H301

H319

H317

H400

GHS06

GHS08

GHS09

Dgr

H351

H331

H311

H301

H319

H317

H400

612-161-00-X

2,6-xylidin;

2,6-dimethylanilin

201-758-7

87-62-7

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2

H351

H332

H312

H302

H335

H315

H411

GHS08

GHS07

GHS09

Wng

H351

H332

H312

H302

H335

H315

H411

612-162-00-5

dimethyldioctadecylammoniumchlorid

DODMAC

203-508-2

107-64-2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

612-163-00-0

metalaxyl-M (ISO)

mefenoxam

(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propion

syremethylester

—

70630-17-0

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

612-164-00-6

2-butyl-2-ethyl-1,5-diaminopentan

412-700-7

137605-95-9

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H312

H302

H373 **

H314

H317

H412

GHS08

GHS05

GHS07

Dgr

H312

H302

H373 **

H314

H317

H412

612-165-00-1

N, N'-diphenyl-N, N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamin

413-810-8

65181-78-4

Aquatic Chronic 2

H411

GHS09

H411

612-166-00-7

blanding af cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanmethylammonium-phosphat (1:1) og

trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanmethylammonium-phosphat (1:1)

411-830-1

114765-88-7

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

612-167-00-2

5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b, f]azepin hydrochlorid

410-490-1

—

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H373 **

H318

H317

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H302

H373 **

H318

H317

H411

612-168-00-8

3,5-dichlor-2,6-difluorpyridin-4-amin

220-630-1

2840-00-8

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Chronic 2

H312

H302

H411

GHS07

GHS09

Wng

H312

H302

H411

612-169-00-3

bis(N-methyl-N-phenylhydrazin)sulfat

423-170-1

618-26-8

Flam. Liq. 2

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H225

H372 **

H302

H318

H317

H400

H410

GHS02

GHS05

GHS08

GHS07

GHS09

Dgr

H225

H372 **

H302

H318

H317

H410

612-170-00-9

4-chlorphenylcyclopropylketon-O-(4-aminobenzyl)oxim

405-260-2

—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

612-171-00-4

N, N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethan

410-060-3

130728-76-6

Muta. 2

Skin Sens. 1

Aquatic Chronic 2

H341

H317

H411

GHS08

GHS09

Wng

H341

H317

H411

612-172-00-X

4,4'-methylenbis(N, N'-dimethyl-cyclohexanamin)

412-840-9

13474-64-1

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Aquatic Chronic 3

H302

H373 **

H314

H412

GHS08

GHS05

GHS07

Dgr

H302

H373 **

H314

H412

612-173-00-5

lithium-1-amino-4-(4-tert-butylanilino)-anthraquinon-2-sulfonat

411-140-0

125328-86-1

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

612-174-00-0

4,4-dimethoxybutylamin

407-690-6

19060-15-2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H302

H314

H317

H412

GHS05

GHS07

Dgr

H302

H314

H317

H412

612-175-00-6

2-(O-aminooxy)ethylamindihydrochlorid

412-310-7

37866-45-8

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

612-176-00-1

polymer af 1,3-dibrompropan og N, N-dietyl-N',N'-dimetyl-1,3-propandiamin

410-570-6

143747-73-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

612-177-00-7

2-naphthylamino-6-sulfo

methylamid

412-120-4

104295-55-8

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H373 **

H317

H411

GHS08

GHS09

Wng

H373 **

H317

H411

612-178-00-2

1,4,7,10-tetraazacyclododecan disulfat

412-080-8

112193-77-8

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

Aquatic Chronic 3

H302

H335

H318

H412

GHS05

GHS07

Dgr

H302

H335

H318

H412

612-179-00-8

1-(2-propenyl)pyridiniumchlorid

412-740-5

25965-81-5

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

612-180-00-3

3-aminobenzylamin

412-230-2

4403-70-7

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H302

H314

H411

GHS05

GHS07

GHS09

Dgr

H302

H314

H411

612-181-00-9

2-phenylthioanilin

413-030-8

1134-94-7

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

612-182-00-4

1-ethyl-1-methylmorpholiniumbromid

418-210-1

65756-41-4

Muta. 2

H341

GHS08

Wng

H341

612-183-00-X

1-ethyl-1-methylpyrrolidiniumbromid

418-200-5

69227-51-6

Muta. 2

H341

GHS08

Wng

H341

612-184-00-5

6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-on

403-830-5

89331-94-2

Aquatic Chronic 3

H412

—

H412

612-185-00-0

1-[3-[4-((heptadecafluornonyl)oxy)-benzamido]propyl]-N, N,N-trimethylammoniumiodid

407-400-8

59493-72-0

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

612-186-00-6

bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-yliden)dimethylammonium)sulfat

406-770-8

149057-64-7

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H318

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H373 **

H318

H317

H410

612-187-00-1

2,3,4-trifluoranilin

407-170-9

3862-73-5

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H312

H302

H373 **

H315

H318

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H312

H302

H373 **

H315

H318

H411

612-188-00-7

4,4'-(9H-fluoren-9-yliden)bis(2-chloranilin)

407-560-9

107934-68-9

Aquatic Chronic 2

H411

GHS09

H411

612-189-00-2

4-amino-2-(aminomethyl)phenoldihydrochlorid

412-510-4

135043-64-0

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

612-190-00-8

4,4'-methylenbis(2-isopropyl-6-methylanilin)

415-150-6

16298-38-7

STOT RE 2 *

Aquatic Chronic 2

H373 **

H411

GHS08

GHS09

Wng

H373 **

H411

612-191-00-3

polymer af allylaminhydrochlorid

415-050-2

71550-12-4

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

612-192-00-9

2-isopropyl-4-(N-methyl)aminomethylthiazol

414-800-6

154212-60-9

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H312

H302

H315

H318

H411

GHS05

GHS07

GHS09

Dgr

H312

H302

H315

H318

H411

612-193-00-4

3-methylaminomethylphenylamin

414-570-7

18759-96-1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H312

H302

H314

H317

H410

612-194-00-X

2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N, N,N-trimethyl-1-propanammoniumchlorid

414-670-0

141890-30-4

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

612-195-00-5

bis[tributyl(4-methylbenzyl)ammonium]-1,5-naphthalendisulfonat

415-210-1

160236-81-7

Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H332

H302

H318

H410

612-196-00-0

4-chlor-o-toluidin; [1]

4-chlor-o-toluidiniumchlorid [2]

202-441-6 [1]

221-627-8 [2]

95-69-2 [1]

3165-93-3 [2]

Carc. 1B

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1

H350

H341

H331

H311

H301

H400

H410

GHS06

GHS08

GHS09

Dgr

H350

H341

H331

H311

H301

H410

612-197-00-6

2,4,5-trimethylanilin [1]

2,4,5-trimethylaniliniumchlorid [2]

205-282-0 [1]-[2]

137-17-7 [1]

21436-97-5 [2]

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H350

H331

H311

H301

H411

GHS06

GHS08

GHS09

Dgr

H350

H331

H311

H301

H411

612-198-00-1

4,4'-thiodianilin salte heraf

205-370-9

139-65-1

Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2

H350

H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H302

H411

612-199-00-7

4,4'-oxydianilin, salte heraf

p-aminophenylether

202-977-0

101-80-4

Carc. 1B Muta.

1B Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2

H350

H340

H361f ***

H331

H311

H301

H411

GHS06

GHS08

GHS09

Dgr

H350

H340

H361f ***

H331

H311

H301

H411

612-200-00-0

2,4-diaminoanisol

4-methoxy-m-phenylendiamin [1]

2,4-diaminoanisolsulfat [2]

210-406-1 [1]

254-323-9 [2]

615-05-4 [1]

39156-41-7 [2]

Carc. 1B Muta. 2

Acute Tox. 4 *

Aquatic Chronic 2

H350

H341

H302

H411

GHS08

GHS07

GHS09

Dgr

H350

H341

H302

H411

612-201-00-6

N, N,N',N'-tetramethyl-4,4'-methylendianilin

202-959-2

101-61-1

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

612-202-00-1

3,4-dichloranilin

202-448-4

95-76-1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H331

H311

H301

H318

H317

H410

612-203-00-7

dimethyl (hydroxyethyl) (C8-10-alkyl) ammoniumchlorid, kæde < C8: < 3 %; kæde = C8: 40-70 %; kæde = C10: 30-60 %; kæde > C10: < 3 %

417-360-3

—

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

H312

H302

H315

GHS07

Wng

H312

H302

H315

612-204-00-2

C.I. Basic Violet 3;

4-[4,4'-bis(dimethylamino) benzhydryliden]cyclohexa-2,5-dien-1-yliden]dimethylammoniumchlorid

208-953-6

548-62-9

Carc. 2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H318

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H351

H302

H318

H410

612-205-00-8

C.I. Basic Violet 3 med ≥ 0,1 %

af Michlers keton (EF-nr.

202-027-5)

208-953-6

548-62-9

Carc. 1B

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H302

H318

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H350

H302

H318

H410

612-206-00-3

famoxadon (ISO)

3-anilin-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidin-2,4-dion

—

131807-57-3

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H400

H410

GHS08

GHS09

Wng

H373 **

H410

612-207-00-9

4-ethoxyanilin;

p-phenetidin

205-855-5

156-43-4

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H341

H332

H312

H302

H319

H317

GHS08

GHS07

Wng

H341

H332

H312

H302

H319

H317

612-208-00-4

N-methylbenzen-1,2-diammoniumhydrogenphosphat

424-460-0

—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

612-209-00-X

6-methoxy-m-toluidin;

p-cresidin

204-419-1

120-71-8

Carc. 1B

Acute Tox. 4 *

H350

H302

GHS08

GHS07

Dgr

H350

H302

612-210-00-5

5-nitro-o-toluidin; [1]

5-nitro-o-toluidinhydrochlorid [2]

202-765-8 [1]

256-960-8 [2]

99-55-8 [1]

51085-52-0 [2]

Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 3

H351

H331

H311

H301

H412

GHS06

GHS08

Dgr

H351

H331

H311

H301

H412

612-211-00-0

N-[(benzotriazol-1-yl)methyl)]-4-carboxybenzensulfonamid

416-470-9

170292-97-4

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

612-212-00-6

2,6-dichlor-4-trifluormethylanilin

416-430-0

24279-39-8

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H315

H317

H400

H410

GHS07

GHS09

Wng

H332

H302

H315

H317

H410

612-213-00-1

isobutyliden-(2-(2-isopropyl-4,4-dimethyloxazolidin-3-yl)-1,1-dimethylethyl)amin

419-850-2

148348-13-4

Skin Corr. 1B

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

612-214-00-7

4-(2,2-diphenylethenyl)-N, N-di-phenylbenzenamin

421-390-2

89114-90-9

Aquatic Chronic 4

H413

—

H413

612-215-00-2

3-chlor-2-(isopropylthio)anilin

421-700-6

179104-32-6

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

612-216-00-8

1-amino-1-cyanamino-2,2-dicya-

nethylen, natriumsalt

425-870-2

19450-38-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

612-217-00-3

1-methoxy-2-propylamin

422-550-4

37143-54-7

Flam. Liq. 2

Skin Corr. 1B

Acute Tox. 4 *

Aquatic Chronic 3

H225

H314

H302

H412

GHS02

GHS05

GHS07

Dgr

H225

H314

H302

H412

612-219-00-4

(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammoniumchlorid

402-200-7

—

Aquatic Chronic 3

H412

—

H412

612-220-00-X

N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amin

431-060-1

153719-38-1

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

612-221-00-5

2-amino-4-(trifluormethyl)benzenthiol hydrochlorid

429-560-8

4274-38-8

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

H314

H332

H312

H302

H373 **

H317

H400

GHS05

GHS08

GHS07

GHS09

Dgr

H314

H332

H312

H302

H373 **

H317

H400

612-222-00-0

cis-1-(3-(4-fluorphenoxy)propyl)-3-methoxy-4-piperidinamin

425-080-8

104860-26-6

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373 **

H318

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H312

H302

H373 **

H318

H410

612-223-00-6

N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amin

425-300-2

186450-73-7

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

612-224-00-1

N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazin-2,4,6-triamin

426-150-0

121246-28-4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

612-225-00-7

1,4,7,10-tetraazacyclododecan

425-450-9

294-90-6

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H314

H312

H302

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H312

H302

H410

612-226-00-2

3-(2'-phenoxyethoxy)propylamin

427-870-8

6903-18-0

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H302

H315

H318

H412

GHS05

GHS07

Dgr

H302

H315

H318

H412

612-227-00-8

benzyl-N-(2-(2-methoxyphenoxy)ethyl)amin hydrochlorid

428-290-8

120606-08-8

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

612-228-00-3

en blanding af N-(3-(trimethoxysilyl)propyl)ethylendiamin;

N-benzyl-N-(3-trimethoxysilyl)propyl)ethylendiamin; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylendiamin;

N, N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylendiamin; N, N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylendiamin og

N, N-bis-benzyl-N'-[3-(trimetho-

xysilyl)propyl]ethylendiamin

414-340-6

—

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H226

H332

H312

H302

H371

H318

H317

H412

GHS02

GHS05

GHS08

GHS07

Dgr

H226

H332

H312

H302

H371

H318

H317

H412

612-229-00-9

mepanipyrim

4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamin

—

110235-47-7

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

612-230-00-4

N, N-bis(cocoyl-2-oxypropyl)-N, N-dibutylammoniumbromid

431-530-4

—

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

612-231-00-X

3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N, N-dimethyl-1-propanaminiumchlorid

427-370-1

164288-56-6

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

612-232-00-5

en blanding af triisopropanolaminsalt af 1-amino-4-(3-propionamidoanilino)anthraquinon-2-sulfonsyre og

triisopropanolaminsalt af 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinon-2-sulfonsyre

430-410-9

186148-38-9

Aquatic Chronic 3

H412

—

H412

612-237-00-2

hydroxylammoniumhydrogensulfat;

hydroxylaminsulfat (1:1); [1]

hydroxylaminphosphat; [2]

hydroxylamindihydrogenphosphat; [3]

hydroxylamin-4-methylben

zensulfonat [4]

233-154-4 [1]

244-077-0 [2]

242-818-2 [3]

258-872-5 [4]

10046-00-1 [1]

20845-01-6 [2]

19098-16-9 [3]

53933-48-5 [4]

Expl. 1,1

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H201

H351

H312

H302

H373 **

H319

H315

H317

H400

GHS01

GHS08

GHS07

GHS09

Dgr

H201

H351

H312

H302

H373 **

H319

H315

H317

H400

T

612-238-00-8

(3-chlor-2-hydroxypropyl)

trimethylammoniumchlorid ...%

222-048-3

3327-22-8

Carc. 2

Aquatic Chronic 3

H351

H412

GHS08

Wng

H351

H412

B

612-239-00-3

biphenyl-3,3',4,4'-tetrayltetraamin;

diaminobenzidin

202-110-6

91-95-2

Carc. 1B Muta. 2

H350

H341

GHS08

Dgr

H350

H341

612-240-00-9

pyrimethanil (ISO);

N-(4,6-dimethylpyrimidin-2-yl)anilin

—

53112-28-0

Aquatic Chronic 2

H411

GHS09

H411

612-241-00-4

piperazinhydrochlorid; [1] piperazindihydrochlorid; [2] piperazinphosphat [3]

228-042-7 [1]

205-551-2 [2]

217-775-8 [3]

6094-40-2 [1]

142-64-3 [2]

1951-97-9 [3]

Repr. 2

Eye Irrit. 2

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H361fd

H319

H315

H334

H317

H412

GHS08

Dgr

H361fd

H319

H315

H334

H317

H412

612-242-00-X

cyprodinil (ISO);

4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amin

—

121552-61-2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 10

612-243-00-5

(1S-cis)-4-(3,4-dichlorphenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamin-2-hydroxy-2-phenylacetat

420-560-3

79617-97-3

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

M = 10

612-244-00-0

3-(piperazin-1-yl)-benzo[d]isothiazolhydrochlorid

421-310-6

87691-88-1

Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f ***

H302

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f ***

H302

H319

H317

H410

612-245-00-6

2-ethylphenylhydrazinhydrochlorid

421-460-2

19398-06-2

Carc. 2

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H372 **

H302

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H351

H372 **

H302

H318

H317

H410

M = 10

612-246-00-1

(2-chlorethyl)(3-hydroxypropyl)ammoniumchlorid

429-740-6

40722-80-3

Carc. 1B

Muta. 1B

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H350

H340

H373 **

H317

H412

GHS08

GHS07

Dgr

H350

H340

H373 **

H317

H412

612-247-00-7

N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzencarboximidamid

423-530-8

152828-23-4

STOT RE 1

Acute Tox. 4 *

Aquatic Chronic 3

H372 ** H302

H412

GHS08

GHS07

Dgr

H372 **

H302

H412

612-248-00-2

reaktionsprodukt af diphenylamin, phenothiazin og alkener, forgrenede (C8-10, C9-rige)

439-540-0

—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

612-249-00-8

4-[(3-chlorphenyl)(1H-imidazol-1-yl)methyl]-1,2-benzendiamindihydrochlorid

425-030-5

159939-85-2

Repr. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H361f ***

H302

H314

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H361f ***

H302

H314

H317

H411

612-250-00-3

chlor-N, N-dimethylformiminiumchlorid

425-970-6

3724-43-4

Repr. 1B

Acute Tox. 4 *

Skin Corr. 1A

H360D ***

H302

H314

GHS05

GHS08

GHS07

Dgr

H360D ***

H302

H314

EUH014

612-251-00-9

cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantanchlorid

426-020-3

51229-78-8

Flam. Sol. 2

Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H228

H361D ***

H302

H315

H317

H411

GHS02

GHS08

GHS07

GHS09

Wng

H228

H361D ***

H302

H315

H317

H411

612-252-00-4

imidacloprid (ISO);

1-(6-chlorpyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamin

428-040-8

138261-41-3

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on; [indeholdende < 0,5 % formamid (EF-nr. 200-842-0)]

429-400-7

199327-61-2

Aquatic Chronic 3

H412

—

H412

612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on; [indeholdende ≥ 0,5 % formamid (EF-nr. 200-842-0)]

429-400-7

199327-61-2

Repr. 1B

Aquatic Chronic 3

H360D ***

H412

GHS08

Dgr

H360D ***

H412

612-254-00-5

reaktionsprodukter af diisopropanolamin med formaldehyd (1:4)

432-440-8

220444-73-5

Carc. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H351

H302

H314

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H351

H302

H314

H317

H411

612-255-00-0

1-(3-methoxypropyl)-4-piperidinamin

431-950-8

179474-79-4

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3

H312

H302

H314

H412

GHS05

GHS07

Dgr

H312

H302

H314

H412

612-256-00-6

benzyl(S)-2-[(2'-cyanbiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrat

427-470-3

137864-22-3

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

612-257-00-1

tripropylammoniumdihydrogenphosphat

433-700-3

35687-90-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

612-259-00-2

N-ethyl-3-trimethoxysilyl-2-methyl-propanamin

437-720-3

227085-51-0

Eye Dam. 1

H318

GHS05

Dgr

H318

612-261-00-3

3,5-dichlor-2-fluor-4-(1,1,2,3,3,3-hexafluorpropoxy)anilin

441-190-9

121451-05-6

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M = 10

612-265-00-5

bis(2-hydroxyethyl)-(2-hydroxypropyl)ammoniumacetat

444-360-0

191617-13-7

Aquatic Chronic 3

H412

—

H412

612-266-00-0

3-chlor-4-(3-fluorbenzyloxy)anilin

445-590-4

202197-26-0

Muta. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H341

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Wng

H341

H302

H373 **

H410

612-267-00-6

bis(hydrogeneret C16-18-talgalkyl)hydroxylamin

418-370-0

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

612-269-00-7

en blanding af 1-[di(4-octylp-

henyl)aminomethyl]-5-methyl-1H-benzotriazol og

1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazol

en blanding af N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin og

N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin

420-720-2

—

Aquatic Chronic 4

H413

—

H413

612-270-00-2

(S)-azetidin-2-carboxylsyre

-4-cyanbenzylamidhydrochlorid

433-010-2

—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

612-271-00-8

blanding af ethyl-2-((4-(5,6-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat og

ethyl-2-((4-(6,7-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat

434-970-5

160987-57-5

Aquatic Chronic 4

H413

—

H413

612-272-00-3

ammonium-(η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butan-1,4-dioato(4-))jern(3+)monohydrat

435-210-5

—

Aquatic Chronic 2

H411

GHS09

H411

612-273-00-9

alkyl(rapsolie), bis(2-hydroxyethyl)ammoniumfluorid

435-650-8

—

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H410

612-274-00-4

(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanolacetat

445-750-3

—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

612-275-00-X

fedtsyrer, C18-umættede, dimerer, reaktionsprodukter med 1-piperazinethanamin og tallolie

447-880-6

206565-89-1

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

M = 10

612-276-00-5

1-amino-4-[(4-amino-2-sulfophenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracensulfonsyre, dinatriumsalt, reaktionsprodukter med 2-[[3-[(4,6-dichlor-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethylhydrogensulfat, natriumsalte

451-430-4

500717-36-2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

612-277-00-0

en blanding af 4-amino-3-(4-ethensulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalen-2,7-disulfonat kalium/natrium og

4-amino-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethansulfonyl)phenylazo)naphthalen-2,7-disulfonat kalium/natrium

451-440-9

586372-44-3

Eye Dam. 1

H318

GHS05

Dgr

H318

612-278-00-6

ethidiumbromid;

3,8-diamino-1-ethyl-6-phenylphenantridiniumbromid

214-984-6

1239-45-8

Muta. 2

Acute Tox. 2 *

Acute Tox. 4 *

H341

H330

H302

GHS06

GHS08

Dgr

H341

H330

H302

612-279-00-1

(R,S)-2-amino-3,3-dimethylbutanamid

447-860-7

144177-62-8

Repr. 2

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H361f *** H373 ** H319

H315

H317

GHS08

GHS07

Wng

H361f *** H373 **

H319

H315

H317

612-280-00-7

3-amino-9-ethylcarbazol;

9-ethylcarbazol-3-ylamin

205-057-7

132-32-1

Carc. 1B

H350

GHS08

Dgr

H350

612-281-00-2

leucomalakit grønt; N, N,N',N'-tetramethyl-4,4'- benzylidendianilin

204-961-9

129-73-7

Carc. 2

Muta. 2

H351

H341

GHS08

Wng

H351

H341

612-282-00-8

octadecylamin

204-695-3

124-30-1

Asp. Tox. 1

STOT RE 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H304

H373 (mavetarmkanal, lever, immun

system)

H315

H318

H400

H410

GHS05

GHS08

GHS09

Dgr

H304

H373 (mavetarmkanal, lever, immun

system)

H315

H318

H410

M = 10

M = 10

612-283-00-3

(Z)-octadec-9-enylamin

204-015-5

112-90-3

Acute Tox. 4

Asp Tox. 1

STOT SE 3

STOT RE 2

Skin Corr. 1B Aquatic Acute 1

Aquatic Chronic 1

H302

H304

H335

H373 (mavetarmkanal, lever, immunsystem)

H314

H400

H410

GHS05

GHS07

GHS08

GHS09

Dgr

H302

H304

H335

H373 (mavetarmkanal, lever, immunsystem)

H314

H410

M = 10

M = 10

612-284-00-9

aminer, hydrogeneret talg-alkyl

262-976-6

61788-45-2

Asp Tox. 1

STOT RE 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H304

H373 (mavetarmkanal, lever, immunsystem)

H315

H318

H400

H410

GHS08

GHS05

GHS09

Dgr

H304

H373 (mavetarmkanal, lever, immunsystem)

H315

H318

H410

M = 10

M = 10

612-285-00-4

aminer, kokosalkyl

262-977-1

61788-46-3

Acute Tox. 4

Asp. Tox. 1

STOT SE 3

STOT RE 2

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H302

H304

H335

H373 (mavetarmkanal, lever, immunsystem)

H314

H400

H410

GHS05

GHS07

GHS08

GHS09

Dgr

H302

H304

H335

H373 (mavetarmkanal, lever, immunsystem)

H314

H410

M = 10

M = 10

612-286-00-X

aminer, talg-alkyl

263-125-1

61790-33-8

Acute Tox. 4

Asp. Tox. 1

STOT RE 2

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H302

H304

H373 (mavetarmkanal, lever, immunsystem)

H314

H400

H410

GHS05

GHS07

GHS08

GHS09

Dgr

H302

H304

H373 (mavetarmkanal, lever, immunsystem)

H314

H410

M = 10

M = 10

612-287-00-5

fluazinam (ISO); 3-chlor-N-[3-chlor-2,6-dinitro-4-(trifluormethyl)phenyl]-5-(trifluormethyl)pyridin-2-amin

—

79622-59-6

Repr. 2

Acute Tox. 4

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H361d

H332

H318

H317

H400

H410

GHS08

GHS07

GHS05

GHS09

Dgr

H361d

H332

H318

H317

H410

M = 10

M = 10

613-001-00-1

ethyleneimin;

aziridin

205-793-9

151-56-4

Flam. Liq. 2

Carc. 1B

Muta. 1B

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Chronic 2

H225

H350

H340

H330

H310

H300

H314

H411

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H225

H350

H340

H330

H310

H300

H314

H411

D

613-002-00-7

pyridin

203-809-9

110-86-1

Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H225

H332

H312

H302

GHS02

GHS07

Dgr

H225

H332

H312

H302

*

613-003-00-2

1,2,3,4-tetranitrocarbazol

—

6202-15-9

Expl. 1.1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H201

H332

H312

H302

GHS01

GHS07

Dgr

H201

H332

H312

H302

613-004-00-8

crimidin (ISO);

2-chlor-6-methylpyrimidin-4- yldimethylamin

208-622-6

535-89-7

Acute Tox. 2 *

H300

GHS06

Dgr

H300

613-007-00-4

desmetryne (ISO);

6-isopropylamino-2-methylamino-4-methylthio-1,3,5- triazine

213-800-1

1014-69-3

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

613-008-00-X

dazomet (ISO);

tetrahydro-3,5-dimethyl-1,3,5- thiadiazine-2-thion

208-576-7

533-74-4

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H400

H410

GHS07

GHS09

Wng

H302

H319

H410

613-009-00-5

2,4,6-trichlor-1,3,5-triazin;

cyanurchlorid

203-614-9

108-77-0

Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H330

H302

H314

H317

GHS06

GHS05

Dgr

H330

H302

H314

H317

EUH014

STOT SE 3; H335: C ≥ 5 %

613-010-00-0

ametryn (ISO);

2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazin

212-634-7

834-12-8

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 100

613-011-00-6

amitrol (ISO);

1,2,4-triazol-3-ylamin

200-521-5

61-82-5

Repr. 2

STOT RE 2 *

Aquatic Chronic 2

H361d *** H373 **

H411

GHS08

GHS09

Wng

H361d *** H373 **

H411

613-012-00-1

bentazon (ISO);

3-isopropyl-2,1,3-benzothiadiazin-4-on-2,2-dioxid

246-585-8

25057-89-0

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H302

H319

H317

H412

GHS07

Wng

H302

H319

H317

H412

613-013-00-7

cyanazin (ISO);

2-(4-chlor-6-ethylamino-1,3,5-triazin-2-ylamino)-2-methylpropionitril

244-544-9

21725-46-2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-014-00-2

ethoxyquin (ISO);

6-ethoxy-1,2-dihydro-2,2,4-trimethylquinolin

202-075-7

91-53-2

Acute Tox. 4*

H302

GHS07

Wng

H302

613-015-00-8

fenazaflor (ISO);

phenyl 5,6-dichlor-2-trifluormethylbenzimidazol-1-carboxylat

238-134-9

14255-88-0

Acute Tox. 4*

Acute Tox. 4*

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

613-016-00-3

fuberidazol (ISO);

2-(2-furyl-)-1H-benzimidazol

223-404-0

3878-19-1

Carc. 2

Acute Tox. 4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H373 (heart)

H317

H400

H410

GHS07

GHS08

GHS09

Wng

H351

H302

H373 (heart)

H317

H410

M = 1

613-017-00-9

bis(8-hydroxyquinolinium)sulfat

205-137-1

134-31-6

Acute Tox. 4*

H302

GHS07

Wng

H302

613-018-00-4

morfamquat (ISO);

1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridyl

7411-47-4

Acute Tox. 4*

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 3

H302

H319

H335

H315

H412

GHS07

Wng

H302

H319

H335

H315

H412

613-019-00-X

thioquinox (ISO);

2-thio-1,3-dithiolo(4,5,b)quinoxalin

202-272-8

93-75-4

Acute Tox. 4 *

H302

GHS07

Wng

H302

613-020-00-5

tridemorph (ISO);

2,6-dimethyl-4-tridecylmorpholin

246-347-3

24602-86-6

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H360D *** H332

H302

H315

H400

H410

GHS08

GHS07

GHS09

Dgr

H360D *** H332

H302

H315

H410

613-021-00-0

dithianon (ISO);

5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazin-2,3-dicarbonitril

222-098-6

3347-22-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-022-00-6

pyrethriner indeholdende cineriner, med undtagelse af sådanne specificeret andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

A

613-023-00-1

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemat;

pyrethrin I

204-455-8

121-21-1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

613-024-00-7

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropancarboxylat;

pyrethrin II

204-462-6

121-29-9

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

613-025-00-2

cinerin I;

3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-

dimethyl-3-(2-methylprop-1- enyl)cyclopropanecarboxylate

246-948-0

25402-06-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-026-00-8

cinerin II;

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropancarboxylat

204-454-2

121-20-0

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-027-00-3

piperidin

203-813-0

110-89-4

Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

H225

H331

H311

H314

GHS02

GHS06

GHS05

Dgr

H225

H331

H311

H314

*

613-028-00-9

morpholin

203-815-1

110-91-8

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H226

H332

H312

H302

H314

GHS02

GHS05

GHS07

Dg

H226

H332

H312

H302

H314

613-029-00-4

dichlor-1,3,5-triazintrion;

dichlorisocyanursyre

220-487-5

2782-57-2

Ox. Sol. 2

Acute Tox. 4 * Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H272

H302

H319

H335

H400

H410

GHS03

GHS07

GHS09

Dgr

H272

H302

H319

H335

H410

EUH031

T

613-030-00-X

troclosen-kalium; [1]

troclosen-natrium [2]

218-828-8 [1]

220-767-7 [2]

2244-21-5 [1]

2893-78-9 [2]

Ox. Sol. 2

Acute Tox. 4 * Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H272

H302

H319

H335

H400

H410

GHS03

GHS07

GHS09

Dgr

H272

H302

H319

H335

H410

EUH031

*

STOT SE 3;

H335: C ≥ 10 % EUH031: C ≥10 %

G

613-030-01-7

troclosennatrium, dihydrat

220-767-7

51580-86-0

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H335

H400

H410

GHS07

GHS09

Wng

H302

H319

H335

H410

EUH031

613-031-00-5

symclosen; trichlorisocyanursyre; trichlor-1,3,5-triazinetrion

201-782-8

87-90-1

Ox. Sol. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H272

H302

H319

H335

H400

H410

GHS03

GHS07

GHS09

Dgr

H272

H302

H319

H335

H410

EUH031

613-032-00-0

methyl-2,3,5,6-tetrachlor-4-pyridylsulfon;

2,3,5,6-tetrachlor-4-(methylsulfonyl)pyridin

236-035-5

13108-52-6

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H312

H302

H319

H317

GHS07

Wng

H312

H302

H319

H317

613-033-00-6

2-methylaziridin;

propyleneimin

200-878-7

75-55-8

Flam. Liq. 2

Carc. 1B

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Eye Dam. 1

Aquatic Chronic 2

H225

H350

H330

H310

H300

H318

H411

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H225

H350

H330

H310

H300

H318

H411

Carc. 1B;

H350: C ≥ 0,01  %

613-034-00-1

1,2-dimethylimidazol

217-101-2

1739-84-0

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

H302

H315

H318

GHS05

GHS07

Dgr

H302

H315

H318

613-035-00-7

1-methylimidazol

210-484-7

616-47-7

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

613-036-00-2

2-methylpyridin;

2-picolin

203-643-7

109-06-8

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

H226

H332

H312

H302

H319

H335

GHS02

GHS07

Wng

H226

H332

H312

H302

H319

H335

613-037-00-8

4-methylpyridin;

4-picolin

203-626-4

108-89-4

Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H226

H311

H332

H302

H319

H335

H315

GHS02

GHS06

Dgr

H226

H311

H332

H302

H319

H335

H315

613-038-00-3

6-phenyl-1,3,5-triazin-2,4- diyldiamin;

6-phenyl-1,3,5-triazin-2,4-diamin;

benzoguanamin

202-095-6

91-76-9

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

613-039-00-9

ethylenthiourinstof;

imidazolidin-2-thion;

2-imidazolin-2-thiol

202-506-9

96-45-7

Repr. 1B

Acute Tox. 4 *

H360D *** H302

GHS08

GHS07

Dgr

H360D *** H302

613-040-00-4

azaconazol (ISO);

1-{[2-(2,4-dichlorphenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazol

262-102-3

60207-31-0

Acute Tox. 4 *

H302

GHS07

Wng

H302

613-041-00-X

morpholin-4-carbonylchlorid

239-213-0

15159-40-7

Carc. 2

Eye Irrit. 2

Skin Irrit. 2

H351

H319

H315

GHS08

Wng

H351

H319

H315

EUH014

613-043-00-0

imazalilsulfat (ISO) pulver;

1-[2-(allyloxy)ethyl-2-(2,4-dichlorphenyl)]-1H-imidazoliumhydrogensulfat; [1]

(±)-1-[2-(allyloxy)ethyl-2-(2,4-dichlorphenyl)]-1H-imidazoliumhydrogensulfat [2]

261-351-5 [1]

281-291-3 [2]

58594-72-2 [1]

83918-57-4 [2]

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

613-043-01-8

imazalilsulfat (ISO), vandig opløsning;

1-[2-(allyloxy)ethyl-2-(2,4- dichlorphenyl)]-1H-imidazoliumhydrogensulfat; [1]

(±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorphenyl)]-1H-imidazoliumhydrogensulfat [2]

261-351-5 [1]

281-291-3 [2]

58594-72-2 [1]

83918-57-4 [2]

Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Wng

H302

H314

H317

H410

Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 %

Eye Dam. 1; H318: 15 % ≤ C < 50 %

Eye Irrit. 2; H319: 5 % ≤ C < 15 %

613-044-00-6

captan (ISO);

1,2,3,6-tetrahydro-N-(trichlormethylthio)phthalimid

205-087-0

133-06-2

Carc. 2

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H351

H331

H318

H317

H400

GHS06

GHS05

GHS08

GHS09

Dgr

H351

H331

H318

H317

H400

M=10

613-045-00-1

folpet (ISO);

N-(trichlormethylthio)phthalimid

205-088-6

133-07-3

Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H351

H332

H319

H317

H400

GHS08

GHS07

GHS09

Wng

H351

H332

H319

H317

H400

M=10

613-046-00-7

captafol (ISO);

1,2,3,6-tetrahydro-N-(1,1,2,2- tetrachlorethylthio)phthalimid

219-363-3

2425-06-1

Carc. 1B Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H317

H400

H410

GHS08

GHS09

Dgr

H350

H317

H410

613-047-00-2

1-dimethylcarbamoyl-5-methylpyrazol-3-yldimethylcarbamat; dimetilan (ISO)

211-420-0

644-64-4

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H400

H410

GHS06

GHS09

Dgr

H301

H312

H410

613-048-00-8

carbendazim (ISO);

methylbenzimidazol-2-ylcarbamat

234-232-0

10605-21-7

Muta. 1B Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H340

H360FD H400

H410

GHS08

GHS09

Dgr

H340

H360FD H410

613-049-00-3

benomyl (ISO);

methyl-1-(butylcarbamoyl)benzimidazol-2-ylcarbamat

241-775-7

17804-35-2

Muta. 1B Repr. 1B STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H340

H360FD H335

H315

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H340

H360FD H335

H315

H317

H410

M = 10

613-050-00-9

carbadox (INN);

methyl 3-(quinoxalin-2-ylmethylen)carbazat-1,4-dioxid;

2-(methoxycarbonylhydrazonomethyl)quinoxalin-1,4-dioxid

229-879-0

6804-07-5

Flam. Sol. 1

Carc. 1B

Acute Tox. 4 *

H228

H350

H302

GHS02

GHS08

GHS07

Dgr

H228

H350

H302

T

613-051-00-4

molinat (ISO);

S-ethyl-1-perhydroazepincarbothioat;

S-ethyl-perhydroazepin-1-carbothioat

218-661-0

2212-67-1

Carc. 2

Repr. 2

Acute Tox. 4 * Acute Tox. 4 *

STOT RE 2 * Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H361f *** H332

H302

H373 ** H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361f *** H332

H302

H373 ** H317

H410

M = 100

613-052-00-X

trifenmorph (ISO);

4-tritylmorpholin

215-812-2

1420-06-0

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-053-00-5

anilazin (ISO);

2-chlor-N-(4,6-dichlor-1,3,5- triazin-2-yl)anilin

202-910-5

101-05-3

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

613-054-00-0

thiabendazol (ISO);

2-(thiazol-4-yl)benzimidazol

205-725-8

148-79-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-056-00-1

1,2-dimethyl-3,5-diphenylpyrazoliummethylsulfat; difenzoquatmethylsulfat

256-152-5

43222-48-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS09

Wng

H302

H410

613-058-00-2

permethrin (ISO);

m-phenoxybenzyl 3-(2,2-dichorovinyl)-2,2-dimethylcyclopropancarboxylat

258-067-9

52645-53-1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H317

H400

H410

GHS07

GHS09

Wng

H332

H302

H317

H410

M = 1 000

613-059-00-8

profluralin (ISO);

N-(cyclopropylmethyl)-α, α,α-trifluor-2,6-dinitro-N-propyl-p-toluidin

247-656-6

26399-36-0

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H400

H410

GHS07

GHS09

Wng

H319

H410

613-060-00-3

resmethrin (ISO);

5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemat

233-940-7

10453-86-8

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M=1000

613-061-00-9

6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl)pyrrol-2-carboxylat;

ryania

239-732-2

15662-33-6

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

613-062-00-4

sabadilla (ISO);

veratrin

—

8051-02-3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H319

H335

H315

GHS07

Wng

H319

H335

H315

613-063-00-X

secbumeton (ISO);

2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazin

247-554-1

26259-45-0

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H400

H410

GHS07

GHS09

Wng

H302

H319

H410

613-064-00-5

5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolan; sesamex

—

51-14-9

Acute Tox. 4 *

H302

GHS07

Wng

H302

613-065-00-0

simetryn (ISO);

2,4-bis(ethylamino)-6-methylthio-1,3,5-triazin

213-801-7

1014-70-6

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-066-00-6

terbumeton (ISO);

2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazin

251-637-8

33693-04-8

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-067-00-1

propazin (ISO);

2-chlor-4,6-bis(isopropylamino)-1,3,5-triazin

205-359-9

139-40-2

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

613-068-00-7

atrazin (ISO);

2-chlor-4-ethylamin-6-isopropylamin-1,3,5-triazin

217-617-8

1912-24-9

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 ** H317

H400

H410

GHS08

GHS09

Wng

H373 ** H317

H410

613-069-00-2

ε-caprolactam

203-313-2

105-60-2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

H332

H302

H319

H335

H315

GHS07

Wng

H332

H302

H319

H335

H315

613-070-00-8

propylenthiourinstof

—

2122-19-2

Repr. 2

Acute Tox. 4 *

Aquatic Chronic 3

H361d *** H302

H412

GHS08

GHS07

Wng

H361d *** H302

H412

613-071-00-3

2-fluor-5-trifluormethylpyridin

400-290-2

69045-82-5

Flam. Liq. 3

Skin Sens. 1

Aquatic Chronic 3

H226

H317

H412

GHS02

GHS07

Wng

H226

H317

H412

613-072-00-9

N, N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amin

401-280-0

91273-04-0

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H317

H411

613-073-00-4

N, N-dimethyl-2-(3-(4-chlorphenyl)-4,5-dihydropyrazol-1-ylphenylsulfonyl)ethylamin

401-410-6

10357-99-0

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H373 ** H317

H411

GHS08

GHS09

Wng

H373 ** H317

H411

613-074-00-X

3-(3-methylpent-3-yl)isoxazol-5-ylamin

401-460-9

82560-06-3

Acute Tox. 3 *

Acute Tox. 3 *

Eye Dam. 1

Aquatic Chronic 3

H331

H301

H318

H412

GHS06

GHS05

Dgr

H331

H301

H318

H412

613-075-00-5

1,3-dichlor-5-ethyl-5-methylimidazolidin-2,4-dion

401-570-7

89415-87-2

Ox. Sol. 1 ****

Acute Tox. 3 *

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

H271

H331

H314

H302

H317

H400

GHS03

GHS06

GHS05

GHS09

Dgr

H271

H331

H314

H302

H317

H400

613-076-00-0

3-chlor-5-trifluormethyl-2-pyridylamin

401-670-0

79456-26-1

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

613-077-00-6

blanding af 5-heptyl-1,2,4-triazol-3-ylamin og 5-nonyl-1,2,4-triazol-3-ylamin

401-940-8

—

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2

H302

H319

H411

GHS07

GHS09

Wng

H302

H319

H411

613-078-00-1

N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecan-1,10- diamin

401-990-0

106990-43-6

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

613-079-00-7

4-(1(eller 4 eller 5 eller 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridin, blanding af isomerer

402-520-7

—

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H315

H317

H400

H410

GHS07

GHS09

Wng

H312

H302

H315

H317

H410

613-080-00-2

3-(bis(2-ethylhexyl)aminomethyl)benzothiazol-2(3H)-thion

402-540-6

105254-85-1

Skin Corr. 1B Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

613-081-00-8

1-butyl-2-methylpyridiniumbromid

402-680-8

26576-84-1

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

613-082-00-3

2-methyl-1-pentylpyridiniumbromid

402-690-2

—

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H312

H302

H412

GHS07

Wng

H312

H302

H412

613-083-00-9

2-(4-(3-(4-chlorphenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammoniumformiat

402-120-2

—

Skin Corr. 1B STOT RE 2 * Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H373 ** H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H314

H373 ** H317

H410

613-084-00-4

2-(4-(3-(4-chlorphenyl)-4,5-dihydropyrazolyl)phenylsulfonyl)ethyldimethylammoniumhydrogenphosphonat

402-490-5

106359-93-7

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H400

H410

GHS07

GHS09

Wng

H319

H410

613-085-00-X

blanding af 1,1'-(methylenbis(4,1-phenylen))dipyrrol-2,5-dion og N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamid og 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrol-2,5-dion

401-970-1

—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

613-086-00-5

coffein

200-362-1

58-08-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

613-087-00-0

tetrahydrothiophen

203-728-9

110-01-0

Flam. Liq. 2

Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3

H225

H332

H312

H302

H319

H315

H412

GHS02

GHS07

Dgr

H225

H332

H312

H302

H319

H315

H412

613-088-00-6

1,2-benzisothiazol-3(2H)-on;

1,2-benzisothiazolin-3-on

220-120-9

2634-33-5

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H302

H315

H318

H317

H400

GHS05

GHS07

GHS09

Dgr

H302

H315

H318

H317

H400

Skin Sens. 1; H317: C ≥ 0,05  %

613-089-00-1

diquatdibromid; [1]

diquatdichlorid; [2]

6,7-dihydrodipyrido[1,2-α:2',1'- c]pyrazindiyliumdihydroxid [3]

201-579-4 [1]

223-714-6 [2]

301-467-6 [3]

85-00-7 [1]

4032-26-2 [2]

94021-76-8 [3]

Acute Tox. 2 * STOT RE 1

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H372 ** H302

H319

H335

H315

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H372 ** H302

H319

H335

H315

H317

H410

613-090-00-7

paraquat-dichlorid;

1,1-dimethyl-4,4'-bipyridiniumdichlorid; [1]

paraquat-dimethylsulfat;

1,1-dimethyl-4,4'-bipyridiniumdimethylsulfat [2]

217-615-7 [1]

218-196-3 [2]

1910-42-5 [1]

2074-50-2 [2]

Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H330

H311

H301

H372 ** H319

H335

H315

H400

H410

GHS06

GHS08

GHS09

Dgr

H330

H311

H301

H372 ** H319

H335

H315

H410

613-091-00-2

morfamquatdichlorid; [1]

morfamquatsulfat [2]

225-062-8 [1] [2]

4636-83-3 [1]

29873-36-7 [2]

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 3

H302

H319

H335

H315

H412

GHS07

Wng

H302

H319

H335

H315

H412

613-092-00-8

1,10-phenanthrolin

200-629-2

66-71-7

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

613-093-00-3

hexanatrium-6,13-dichlor-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacen-4,11-disulfonat

400-050-7

85153-92-0

Resp. Sens. 1

Skin Sens. 1

H334

H317

GHS08

Dgr

H334

H317

613-094-00-9

4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamin

401-360-5

5248-39-5

Acute Tox. 4 * STOT RE 2 *

H302

H373 **

GHS08

GHS07

Wng

H302

H373 **

613-095-00-4

natrium-3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzensulfonat

403-080-9

92484-48-5

Eye Dam. 1

H318

GHS05

Dgr

H318

613-096-00-X

2-amino-6-ethoxy-4-methylamino-1,3,5-triazin

403-580-7

62096-63-3

Acute Tox. 4 *

H302

GHS07

Wng

H302

613-097-00-5

7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylsyre

403-690-5

111298-82-9

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H334

H317

H412

GHS08

Dgr

H334

H317

H412

613-098-00-0

N-(n-octyl)-2-pyrrolidon

403-700-8

2687-94-7

Skin Corr. 1B Aquatic Chronic 2

H314

H411

GHS05

GHS09

Dgr

H314

H411

613-099-00-6

1-dodecyl-2-pyrrolidon

403-730-1

2687-96-9

Skin Corr. 1B Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

613-100-00-X

2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridin-7,14-dion

404-230-6

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

613-101-00-5

N-tert-pentyl-2-benzothiazolsulfenamid

404-380-2

110799-28-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-102-00-0

dimethomorph (ISO);

4-(3-(4-chlorphenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholin

404-200-2

110488-70-5

Aquatic Chronic 2

H411

GHS09

H411

613-103-00-6

natrium-5-n-butylbenzotriazol

404-450-2

118685-34-0

Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1

Aquatic Chronic 2

H302

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H314

H317

H411

613-104-00-1

5-tert-butyl-3-isoxazolylaminhydrochlorid

404-840-2

—

Acute Tox. 4 * STOT RE 2 * Eye Dam. 1

Aquatic Chronic 3

H302

H373 ** H318

H412

GHS08

GHS05

GHS07

Dgr

H302

H373 ** H318

H412

613-105-00-7

hexakis(tetramethylammonium)-4,4'-vinylenbis((3-sulfonato-4,1-phenylen)imino(6-morpholino-1,3,5-triazin-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalen-2,7-disulfonat)

405-160-9

124537-30-0

Acute Tox. 3 * Skin Sens. 1

Aquatic Chronic 3

H301

H317

H412

GHS06

Dgr

H301

H317

H412

613-106-00-2

tetrakalium-2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienyliden)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzen-1,4-disulfonat

405-240-3

—

Skin Sens. 1

H317

GHS07

Wng

H317

613-107-00-8

hexanatrium-2,2'-vinylenbis((3-sulfonato-4,1-phenylen)imino(6-(N-cyanethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazin-4,2-diyl)imino)dibenzen-1,4-disulfonat

405-280-1

76508-02-6

Eye Irrit. 2

H319

GHS07

Wng

H319

613-108-00-3

benzothiazol-2-thiol

205-736-8

149-30-4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

613-109-00-9

bis(piperidinothiocarbonyl)disulfid

202-328-1

94-37-1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

H319

H335

H315

H317

GHS07

Wng

H319

H335

H315

H317

613-110-00-4

dimepiperat (ISO);

S-(1-methyl-1-phenylethyl)piperidin-1-carbothioat

262-784-2

61432-55-1

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

613-111-00-X

1,2,4-triazol

206-022-9

288-88-0

Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

H361d *** H302

H319

GHS08

GHS07

Wng

H361d *** H302

H319

613-112-00-5

octhilinon (ISO);

2-octyl-2H-isothiazol-3-on

247-761-7

26530-20-1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H302

H314

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H331

H311

H302

H314

H317

H410

Skin Sens. 1; H317: C ≥ 0,05  %

613-113-00-0

2-(morpholinothio)benzothiazol

203-052-4

102-77-2

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H319

H315

H317

H411

GHS07

GHS09

Wng

H319

H315

H317

H411

613-114-00-6

2,2',2''-(hexahydro-1,3,5-triazin-1,3,5-triyl)triethanol;

1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazin

225-208-0

4719-04-4

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

Skin Sens. 1; H317: C ≥ 0,1  %

613-115-00-1

hymexazol (ISO);

3-hydroxy-5-methylisoxazol

233-000-6

10004-44-1

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

613-116-00-7

tolylfluanid (ISO);

dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid

indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm

211-986-9

731-27-1

Acute Tox. 2 * STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H330

H372** H319

H335

H315

H317

H400

GHS06

GHS08

GHS09

Dgr

H330

H372** H319

H335

H315

H317

H400

M=10

613-116-01-4

tolylfluanid (ISO);

dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid

indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm

211-986-9

731-27-1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H319

H335

H315

H317

H400

GHS07

GHS09

Wng

H319

H335

H315

H317

H400

M=10

613-117-00-2

diniconazol (ISO);

(E)-β-[(2,4-dichlorphenyl)methylen]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;

(E)-(RS)-1-(2,4-dichlorphenyl)-4,4-dimethyl-2-(1H-1,2,4- triazol-1-yl)pent-1-en-3-ol

—

76714-88-0

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-118-00-8

flubenzimin (ISO);

N-[3-phenyl-4,5-bis[(trifluormethyl)imino]thiazolidin-2-yliden]anilin

253-703-1

37893-02-0

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H400

H410

GHS07

GHS09

Wng

H319

H410

613-119-00-3

(benzothiazol-2-ylthio)methylthiocyanat;

TCMTB

244-445-0

21564-17-0

Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H319

H315

H317

H400

H410

GHS06

GHS09

Dgr

H330

H302

H319

H315

H317

H410

613-120-00-9

bioresmethrin (ISO);

(5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropancarboxylat

249-014-0

28434-01-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1000

613-122-00-X

diclobutrazol (ISO);

(R*, R*)-(±)-β-[(2,4-dichlorphenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorphenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol

—

75736-33-3

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

613-123-00-5

5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazol-3-thion;

etem

251-684-4

33813-20-6

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-124-00-0

fenpropimorph (ISO);

cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholin

266-719-9

67564-91-4

Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 2

H361d *** H302

H315

H411

GHS08

GHS07

GHS09

Wng

H361d *** H302

H315

H411

613-125-00-6

hexythiazox (ISO);

trans-5-(4-chlorphenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidincarboxamid

—

78587-05-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-126-00-1

imazapyr (ISO);

2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridincarboxylat

—

81334-34-1

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

613-127-00-7

1,1-dimethylpiperidiniumchlorid;

mepiquat-chlorid

246-147-6

24307-26-4

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

613-128-00-2

prochloraz (ISO);

N-propyl-N-[2-(2,4,6-trichlorphenoxy)ethyl]-1H-imidazol-1-carboxamid

266-994-5

67747-09-5

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-129-00-8

metamitron (ISO);

4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-on

255-349-3

41394-05-2

Acute Tox. 4 *

Aquatic Acute 1

H302

H400

GHS07

GHS09

Wng

H302

H400

613-131-00-9

pyroquilon (ISO);

1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-on

—

57369-32-1

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

613-132-00-4

hexazinon (ISO);

3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazin-2,4-dion

257-074-4

51235-04-2

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H400

H410

GHS07

GHS09

Wng

H302

H319

H410

613-134-00-5

myclobutanil (ISO);

2-(4-chlorphenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexannitril

—

88671-89-0

Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2

H361d *** H302

H319

H411

GHS08

GHS07

GHS09

Wng

H361d *** H302

H319

H411

613-135-00-0

di(benzothiazol-2-yl)disulfid

204-424-9

120-78-5

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

EUH031

613-136-00-6

N-cyclohexylbenzothiazol-2-sulfenamid

202-411-2

95-33-0

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

613-137-00-1

methabenzthiazuron (ISO);

1-(1,3-benzothiazol-2-yl)1,3-dimethylurinstof

242-505-0

18691-97-9

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-138-00-7

quinoxyfen (ISO);

5,7-dichlor-4-(4-fluorphenoxy)quinolin

—

124495-18-7

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

613-139-00-2

metsulfuron-methyl (ISO);

2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)benzoesyre

—

74223-64-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1000

613-140-00-8

cycloheximid (ISO);

4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidin-2,6-dion

200-636-0

66-81-9

Muta. 2

Repr. 1B

Acute Tox. 2 *

Aquatic Chronic 2

H341

H360D *** H300

H411

GHS06

GHS08

GHS09

Dgr

H341

H360D *** H300

H411

613-141-00-3

1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinon

401-470-3

93686-63-6

Aquatic Chronic 4

H413

—

H413

613-142-00-9

trans-N-methyl-2-styryl-[4'-aminomethin-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridiniumacetat

405-860-4

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

613-143-00-4

1-(3-phenylpropyl)-2-methylpyridiniumbromid

405-930-4

10551-42-5

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 3

H302

H319

H412

GHS07

Wng

H302

H319

H412

613-144-00-X

reaktionsprodukter af: poly(vinylacetat), delvist hydrolyseret, med (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethylsulfat

406-460-2

125139-08-4

Aquatic Chronic 3

H412

—

H412

613-145-00-5

(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium-4-methylbenzensulfonat

406-960-0

77497-97-3

Aquatic Chronic 2

H411

GHS09

H411

613-146-00-0

N-ethyl-N-methylpiperidiniumiodid

407-780-5

4186-71-4

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

613-147-00-6

4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholin

407-940-4

111681-72-2

Eye Dam. 1

H318

GHS05

Dgr

H318

613-148-00-1

tetranatrium-1,2-bis(4-fluor-6-[5-(1-amino-2-sulfonatoanthraquinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethan

411-240-4

143683-23-2

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-150-00-2

2,2'-[3,3'-(piperazin-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l, m,n][3,8]phenanthrolin-1,3,6-trion

406-295-6

—

Aquatic Chronic 4

H413

—

H413

613-151-00-8

1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymin

406-360-9

104218-44-2

Aquatic Chronic 4

H413

—

H413

613-152-00-3

phenyl-N-(4,6-dimethoxypyrimidin-2-yl)carbamat

406-600-2

89392-03-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

613-153-00-9

2,3,5-trichlorpyridin

407-270-2

16063-70-0

Aquatic Chronic 3

H412

—

H412

613-154-00-4

2-amino-4-chlor-6-methoxypyrimidin

410-050-9

5734-64-5

Acute Tox. 4 *

H302

GHS07

Wng

H302

613-155-00-X

5-chlor-2,3-difluorpyridin

410-090-7

89402-43-7

Flam. Liq. 3

Acute Tox. 4 *

Aquatic Chronic 3

H226

H302

H412

GHS02

GHS07

Wng

H226

H302

H412

613-156-00-5

2-butyl-4-chlor-5-formylimidazol

410-260-0

83857-96-9

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

613-157-00-0

2,4-diamino-5-methoxymethylpyrimidin

410-330-0

54236-98-5

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

H302

H373 ** H319

GHS08

GHS07

Wng

H302

H373 ** H319

613-158-00-6

2,3-dichlor-5-trifluormethylpyridin

410-340-5

69045-84-7

Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H332

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H332

H302

H318

H317

H411

613-159-00-1

fenazaquin (ISO);

4-[2-[4-(1,1-dimethylethyl)phenyl]ethoxy]quinazolin

410-580-0

120928-09-8

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H332

H400

H410

GHS06

GHS09

Dgr

H301

H332

H410

613-160-00-7

(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptandihydrobromid

411-000-9

125224-62-6

Skin Sens. 1

H317

GHS07

Wng

H317

613-161-00-2

2,4-diamino-6-hydroxymethylpteridin hydrobromid

430-620-0

76145-91-0

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H373** H317

H412

GHS08

GHS07

Wng

H373** H317

H412

613-162-00-8

(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-en-3-yl)methyl)pyridiniumiodid

423-260-0

100988-63-4

Muta. 2

Skin Sens. 1

Aquatic Chronic 2

H341

H317

H411

GHS08

GHS07

GHS09

Wng

H341

H317

H411

613-163-00-3

azimsulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urinstof

—

120162-55-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M=1000

613-164-00-9

flufenacet (ISO);

N-(4-fluorphenyl)-N-isopropyl-2-(5-trifluormethyl-[1,3,4]thiadiazol-2-yloxy)acetamid

—

142459-58-3

Acute Tox. 4 * STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373** H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373** H317

H410

M=100

613-165-00-4

flupyrsulfuron-methyl-natrium (ISO);

methyl-2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluormethyl]nicotinat, mononatriumsalt

—

144740-54-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M=100

613-167-00-5

en blanding af: 5-chlor-2-methyl-4-isothiazolin-3-on [EF nr. 247-500-7] og 2-methyl-2H-isothiazol-3-on [EF nr. 220-239-6] (3:1)

—

55965-84-9

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H314

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H331

H311

H301

H314

H317

H410

Skin Corr. 1B; H314: C ≥0,6  %

Skin Irrit. 2; H315: 0,06  % ≤ C < 0,6  %

Eye Irrit. 2; H319: 0,06  % ≤ C < 0,6  %

Skin Sens. 1; H317: C ≥ 0,0015  %

613-168-00-0

1-vinyl-2-pyrrolidon

201-800-4

88-12-0

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 * STOT RE 2 *

STOT SE 3

Eye Dam. 1

H351

H332

H312

H302

H373 ** H335

H318

GHS06

GHS05

GHS09

Dgr

H351

H332

H312

H302

H373 ** H335

H318

D

613-169-00-6

9-vinylcarbazol

216-055-0

1484-13-5

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H312

H302

H315

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H341

H312

H302

H315

H317

H410

M=100

613-170-00-1

2,2-ethylmethylthiazolidin

404-500-3

694-64-4

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

613-171-00-7

hexaconazol (ISO);

(RS)-2-(2,4-dichlorphenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol

413-050-7

79983-71-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

613-172-00-2

5-chlor-1,3-dihydro-2H-indol-2-on

412-200-9

17630-75-0

Repr. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H361f *** H302

H317

H412

GHS08

GHS07

Wng

H361f *** H302

H317

H412

613-173-00-8

fluquinconazol (ISO);

3-(2,4-dichlorphenyl)-6-fluor-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-on

411-960-9

136426-54-5

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H372 ** H312

H315

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H301

H372 ** H312

H315

H410

613-174-00-3

tetraconazol (ISO);

(+/-) 2-(2,4-dichlorphenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluorethylether

407-760-6

112281-77-3

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2

H332

H302

H411

GHS07

GHS09

Wng

H332

H302

H411

613-175-00-9

epoxiconazol (ISO); (2RS,3SR)-3-(2-chlorphenyl)-2-(4-fluorphenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxiran

406-850-2

133855-98-8

Carc. 2

Repr. 1B

Aquatic Chronic 2

H351

H360Df

H411

GHS08

GHS09

Dgr

H351

H360Df

H411

613-176-00-4

2-methyl-2-azabicyclo[2.2.1]heptan

404-810-9

4524-95-2

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

H226

H312

H302

H373 **

H314

GHS02

GHS08

GHS05

GHS07

Dgr

H226

H312

H302

H373 **

H314

613-177-00-X

8-amino-7-methylquinolin

412-760-4

5470-82-6

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H312

H302

H317

H411

GHS07

GHS09

Wng

H312

H302

H317

H411

613-178-00-5

4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidin

410-470-2

137796-06-6

Skin Corr. 1B

Skin Sens. 1

H314

H317

GHS05

GHS07

Dgr

H314

H317

STOT SE 3; H335: C ≥ 5 %

613-179-00-0

lithium-3-oxo-1,2-(2H)-benzisothiazol-2-id

411-690-1

111337-53-2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H302

H314

H317

H411

GHS05

GHS07

Dgr

H302

H314

H317

H411

613-180-00-6

N-(1,1-dimethylethyl)bis(2-benzothiazolsulfen)amid

407-430-1

3741-80-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-181-00-1

5,5-dimethyl-perhydro-pyrimidin-2-on-α-(4-trifluormethyltyryl)-α-(4-trifluormethyl)cinnamylidenhydrazon

405-090-9

67485-29-4

STOT RE 1

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H372 **

H302

H319

H400

H410

GHS08

GHS07

GHS09

Dgr

H372 **

H302

H319

H410

613-182-00-7

1-(1-naphthylmethyl)quinoliniumchlorid

406-220-7

65322-65-8

Carc. 2

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H351

H341

H302

H315

H318

H412

GHS08

GHS05

GHS07

Dgr

H351

H341

H302

H315

H318

H412

613-183-00-2

en blanding af 5-(N-methylperfluoroctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-on og

5-(N-methylperfluorheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-on

413-640-4

—

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H400

H410

GHS08

GHS09

Wng

H373 **

H410

613-184-00-8

nitrilotriethylenammoniopropan-2-ol-2-ethylhexanat

413-670-8

—

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

613-185-00-3

2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-on

407-630-9

82633-79-2

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H301

H318

H317

H410

613-186-00-9

(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-ylacetat

408-050-9

76855-69-1

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H319

H317

H411

GHS07

GHS09

Wng

H319

H317

H411

613-187-00-4

5-(2-amino-5-cyan-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilthiophen

410-530-8

—

Skin Sens. 1

H317

GHS07

Wng

H317

613-188-00-X

1-(3-(4-fluorphenoxy)propyl)-3-methoxy-4-piperidinon

411-500-7

116256-11-2

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

613-189-00-5

1,4,7,10-tetrachis(p-toluensolfonil)-1,4,7,10-tetraazaciclododecano

414-030-0

52667-88-6

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

613-190-00-0

dinatrium 1-amino-4-(2-(5-chlor-6-fluor-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracen-2-sulfonat

414-040-5

149530-93-8

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

613-191-00-6

3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidin

421-150-7

143860-04-2

Repr. 1B

Skin Corr. 1B Aquatic Acute 1

Aquatic Chronic 1

H360f *** H314

H400

H410

GHS08

GHS05

GHS09

Dgr

H360f *** H314

H410

613-192-00-1

3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexan

426-750-2

151860-15-0

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-193-00-7

pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecan-1,11-diyldisulfamoyl)di[phthalocyaninkobber(II)]heptalactat

414-930-3

—

Aquatic Chronic 2

H411

GHS09

H411

613-194-00-2

6,13-dichlor-3,10-bis{2-[4-fluor-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazin-4,11-disulfonsyre, lithium-, natriumsalt

418-000-8

163062-28-0

Eye Dam. 1

H318

GHS05

Dgr

H318

613-195-00-8

2,2-(1,4-phenylen)bis((4H-3,1-benzoxazin-4-on)

418-280-1

18600-59-4

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

613-196-00-3

5-[[4-chlor-6-[[2-[[4-fluor-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphthalen-2,7-disulfonsyre, natriumsalt

418-380-5

168113-78-8

Eye Dam. 1

H318

GHS05

Dgr

H318

613-197-00-9

en blanding af 2,4,6-tri(butylcarbamoyl)-1,3,5-triazin;

2,4,6-tri(methylcarbamoyl)-1,3,5-triazin;

[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazin og

[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazin

420-390-1

187547-46-2

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

613-198-00-4

2-amino-4-dimethylamino-6-trifluorethoxy-1,3,5-triazin

415-500-8

145963-84-4

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373 **

H412

GHS08

GHS07

Wng

H302

H373 **

H412

613-199-00-X

en blanding af 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazin-2,4,6-trion;

blanding af oligomerer af

3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazin-2,4,6-trion

421-550-1

—

Carc. 1B

Repr. 1B

Skin Sens. 1

Aquatic Chronic 3

H350

H360D *** H317

H412

GHS08

Dgr

H350

H360D *** H317

H412

613-200-00-3

reaktionsprodukt af kobber, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorsvovlsyre og 3-(2-sulfooxyethylsulfonyl)anilin, natriumsalte

420-980-7

—

Eye Dam. 1

H318

GHS05

Dgr

H318

613-201-00-9

(R)-5-brom-3-(1-methyl-2-pyrrolidinylmethyl)-1H-indol

422-390-5

143322-57-0

Repr. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f *** H372 **

H332

H302

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H361f *** H372 **

H332

H302

H317

H410

EUH070

613-202-00-4

pymetrozin (ISO);

(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethylenamino)-1,2,4-triazin-3(2H)-on

—

123312-89-0

Carc. 2

Aquatic Chronic 3

H351

H412

GHS08

Wng

H351

H412

613-203-00-X

pyraflufen-ethyl (ISO);

2-chlor-5-(4-chlor-5-difluormethoxy-1-methylpyrazol-3-yl)-4-fluorphenoxyeddikesyreethylester; [1] pyraflufen (ISO);

2-chlor-5-(4-chlor-5-difluormethoxy-1-methylpyrazol-3-yl)-4-fluorphenoxyeddikesyre [2]

- [1]

- [2]

129630-19-9 [1]

129630-17-7 [2]

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1 000

613-204-00-5

oxadiargyl (ISO);

3-[2,4-dichlor-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-on

254-637-6

39807-15-3

Repr. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H361D *** H373 **

H400

H410

GHS08

GHS09

Wng

H361D *** H373 **

H410

M = 1 000

613-205-00-0

propiconazol (ISO);

(+)-1-[2-(2,4-dichlorphenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol

262-104-4

60207-90-1

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

613-206-00-6

fenamidon (ISO);

(S)-5-methyl-2-methylthio-5-phenyl-3-phenyl-3,5-dihydroimidazol-4-on

—

161326-34-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-208-00-7

imazamox (ISO);

(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-(methoxymethyl)nicotinsyre

—

114311-32-9

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-209-00-2

cis-1-(3-chlorpropyl)-2,6-dimethyl-piperidinhydrochlorid

417-430-3

63645-17-0

Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H301

H373 **

H317

H411

GHS06

GHS08

GHS09

Dgr

H301

H373 **

H317

H411

613-210-00-8

2-(3-chlorpropyl)-2,5,5-trimethyl-1,3-dioxan

417-650-1

88128-57-8

STOT RE 2 *

Aquatic Chronic 3

H373 **

H412

GHS08

Wng

H373 **

H412

613-211-00-3

N-methyl-4-(p-formylstyryl)-pyridiniummethylsulfat

418-240-3

74401-04-0

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-212-00-9

4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinan-1,1-dioxid)

418-320-8

133467-41-1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-213-00-4

cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-.sc.L.sc.-prolin

416-040-0

120807-02-5

Aquatic Chronic 3

H412

—

H412

613-214-00-X

N, N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-chinolyliden)-1,3-dioxoindan-5-carboxamid

416-260-7

147613-95-4

Aquatic Chronic 4

H413

—

H413

613-215-00-5

2-chlormethyl-3,4-dimethoxypyridiniumchlorid

416-440-5

72830-09-2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H312

H302

H373 **

H315

H318

H317

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H312

H302

H373 **

H315

H318

H317

H411

613-216-00-0

6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazol

416-490-8

162208-01-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-217-00-6

4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidin

416-770-1

73754-27-5

Aquatic Chronic 4

H413

—

H413

613-218-00-1

6-hydroxyindol

417-020-4

2380-86-1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

613-219-00-7

7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazol

417-140-7

79185-77-6

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

613-220-00-2

trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol-, 7,7-dioxid

417-290-3

147086-81-5

Acute Tox. 4 *

H302

GHS07

Wng

H302

613-221-00-8

2-chlor-5-methyl-pyridin

418-050-0

18368-64-4

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 3

H312

H302

H315

H412

GHS07

Wng

H312

H302

H315

H412

613-222-00-3

4-(1-oxo-2-propenyl)-morpholin

418-140-1

04-12-5117

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H302

H373 **

H318

H317

GHS08

GHS05

GHS07

Dgr

H302

H373 **

H318

H317

613-223-00-9

N-isopropyl-3-(4-fluorphenyl)-1H-indol

418-790-4

93957-49-4

Aquatic Chronic 4

H413

—

H413

613-224-00-4

2,5-dimercaptomethyl-1,4-dithian

419-770-8

136122-15-1

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H317

H410

613-225-00-X

blanding af [2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl]-1,3,5-triazin og

2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazin

421-290-9

—

STOT RE 2 *

Aquatic Chronic 4

H373 **

H413

GHS08

Wng

H373 **

H413

613-226-00-5

1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl-pyridiniumdichlorid

420-950-3

163831-67-2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

613-227-00-0

(±)-[(R*,R*) og (R*,S*)]-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran

419-600-2

99199-90-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

613-228-00-6

(±)-(R*,S*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran

419-630-6

793669-26-8

Aquatic Chronic 2

H411

GHS09

H411

613-229-00-1

1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidin

411-930-5

106917-31-1

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

613-230-00-7

florasulam;

2',6',8-trifluor-5-methoxy-5-triazolo[1,5-c];

pyrimidin-2-sulfonanilid

—

145701-23-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-231-00-2

2,6-diamino-3-((pyridin-3-yl)azo)pyridin

421-430-9

28365-08-4

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H302

H373 **

H411

GHS08

GHS07

GHS09

Wng

H302

H373 **

H411

613-232-00-8

3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazin-4-oxid

431-030-6

163269-30-5

Acute Tox. 3 *

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H373 **

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H331

H373 **

H318

H410

613-233-00-3

4,4'-(oxy-(bismethylen))-bis-1,3-dioxolan

423-230-7

56552-15-9

Eye Dam. 1

H318

GHS05

Dgr

H318

613-234-00-9

imidazo[1,2-b]pyridazin hydrochlorid

431-510-5

18087-70-2

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

613-235-00-4

2,3-dihydro-2,2-dimethyl-1H-perimidin

424-060-6

6364-17-6

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 **

H317

H410

613-236-00-X

2-chlor-3-trifluormethylpyridin

424-520-6

65753-47-1

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Chronic 3

H311

H301

H372 **

H314

H412

GHS06

GHS05

GHS08

Dgr

H311

H301

H372 **

H314

H412

613-237-00-5

6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazin

424-950-4

133949-92-5

Aquatic Chronic 4

H413

—

H413

613-238-00-0

natrium-2-[[4-[(4,6-dichlor-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethylsulfat

430-890-1

81992-66-7

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

613-239-00-6

2-[3-(methylamino)propyl]-1H-benzimidazol

425-760-4

64137-52-6

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

613-241-00-7

3-(2H-tetrazol-5-yl)pyridin

426-810-8

3250-74-6

Eye Dam. 1

H318

GHS05

Dgr

H318

613-242-00-2

reaktionsprodukter af 3,10-bis((2-aminopropyl)amino)-6,13-dichlor-4,11-triphenodioxazindisulfonsyre med 2-amino-1,4-benzendisulfonsyre, 2-((4-aminophenyl)sulfonyl)ethylhydrogensulfat og 2,4,6-trifluor-1,3,5-triazin, natriumsalte

426-860-0

191877-09-5

Eye Dam. 1

H318

GHS05

Dgr

H318

613-243-00-8

4,4'-(1,6-hexamethylenbis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidin)

427-350-0

182235-14-9

Aquatic Chronic 2

H411

GHS09

H411

613-244-00-3

5,7-dichlor-4-hydroxyquinolin

427-420-0

21873-52-9

Aquatic Chronic 2

H411

GHS09

H411

613-245-00-9

2-fluor-6-trifluormethylpyridin

428-100-3

94239-04-0

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H226

H332

H302

H412

GHS02

GHS07

Wng

H226

H332

H302

H412

613-246-00-4

2-hydroxymethyl-3-methyl-4-(2,2,2-trifluorethoxy)pyridin

428-200-7

103577-66-8

Aquatic Chronic 3

H412

—

H412

613-247-00-X

3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindol

428-910-7

107786-36-7

Aquatic Chronic 4

H413

—

H413

613-248-00-5

3,4-dimethyl-1H-pyrazol

429-130-1

2820-37-3

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

613-249-00-0

1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfat

429-300-3

155601-30-2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

613-250-00-6

blanding af carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidin;

methyl-carbonato-N-ethyl-2-isopropyl-1,3-oxazolidin og

2-isopropyl-N-hydroxyethyl-1,3-oxazolidin

429-990-6

—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

613-251-00-1

(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indol

430-560-5

180637-89-2

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H302

H373 **

H318

H317

GHS05

GHS08

GHS07

Dgr

H302

H373 **

H318

H317

613-253-00-2

2,2-dialkyl-4-hydroxymethyl-1,3-dioxolan;

reaktionsprodukter med ethylenoxid, alkyl er C1-12 og tilsammen på C13, med en gennemsnitlig ethoxyleringsgrad på 3,5

430-580-4

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

EUH019

613-254-00-8

forchlorfenuron (ISO);

1-(2-chlor-4-pyridyl)-3-phenylurinstof

—

68157-60-8

Carc. 2

Aquatic Chronic 2

H351

H411

GHS08

GHS09

Wng

H351

H411

613-255-00-3

blanding af isomerer af natrium-[(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazin-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfophthalocyaninato)]kobber(II)

424-270-8

—

Eye Dam. 1

H318

GHS05

Dgr

H318

613-256-00-9

3'5'-anhydrothymidin

425-810-5

38313-48-3

Aquatic Chronic 3

H412

—

H412

613-257-00-4

2-phthalimidoethyl-N-[4-(2-cyan-4-nitrophenylazo)phenyl]-N-methyl-β-alaninat

426-400-9

170222-39-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

613-258-00-X

en blanding af 4-chlor-7-methylbenzotriazol natriumsalt;

4-chlor-5-methylbenzotriazol natriumsalt og

5-chlor-4-methylbenzotriazol natriumsalt

427-730-6

202420-04-0

Skin Corr. 1B

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

613-259-00-5

en blanding af [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemat og

[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemat

428-790-6

72963-72-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-260-00-0

(±)-4-(3-chlorphenyl)-6-[(4-chlorphenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin

430-730-9

—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

613-261-00-6

pyrazol-1-carboxamidin monohydrochlorid

429-520-1

4023-02-3

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H373 ** H318

H317

H412

GHS05

GHS08

GHS07

Dgr

H302

H373 **

H318

H317

H412

613-262-00-1

dinatrium-(E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethen

427-310-2

180850-95-7

Eye Dam. 1

H318

GHS05

Dgr

H318

613-263-00-7

mononatrium-3-cyan-5-fluor-6-hydroxy-pyridin-2-olat

429-570-2

—

Skin Sens. 1

H317

GHS07

Wng

H317

613-266-00-3

2-chlor-5-chlormethylthiazol

429-830-5

105827-91-6

Acute Tox. 3 *

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H311

H314

H302

H317

H411

GHS06

GHS05

GHS09

Dgr

H311

H314

H302

H317

H411

613-267-00-9

thiamethoxam (ISO)

3-(2-chlorthiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-yliden-N-nitroamin

428-650-4

153719-23-4

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 10

613-268-00-4

(4aS-cis-)-6-benzyl-octahydropyrrolo[3,4-b]pyridin

425-930-8

151213-39-7

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H314

H332

H302

H373 **

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H314

H332

H302

H373 **

H411

613-269-00-X

2-thiazolidinylidencyanamid

427-720-1

26364-65-8

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373 ** H412

GHS08

GHS07

Wng

H302

H373 **

H412

613-270-00-5

5-amino-N-(2,6-dichlor-3-methylphenyl)-1H-1,2,4-triazol-3-sulfonamid

428-150-6

113171-13-4

Aquatic Chronic 3

H412

—

H412

613-271-00-0

tritosulfuron (indeholdende ≤ 0,02 % AMTT);

1-[4-methoxy-6-(trifluormethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluormethyl)benzensul-fonyl]urinstof (indeholdende ≤ 0,02 % AMTT)

—

142469-14-5

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 10

613-272-00-6

pyraclostrobin; (ISO)

methyl-N-{2-[1-(4-chlorphenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamat

—

—

Acute Tox. 3 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H331

H315

H400

H410

GHS06

GHS09

Dgr

H331

H315

H410

M = 100

613-273-00-1

tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-yliden-N-nitroamin

427-600-9

192439-46-6

Aquatic Chronic 2

H411

GHS09

H411

613-274-00-7

2,6-dichlor-1-fluorpyridiniumtetrafluorborat

427-400-1

140623-89-8

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H302

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H302

H317

H410

613-275-00-2

3-(2-chlorethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-on monohydrochlorid

424-530-0

93076-03-0

Acute Tox. 3 *

STOT SE 2

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H301

H371 **

H373 **

H318

H317

H411

GHS06

GHS05

GHS08

GHS09

Dgr

H301

H371 **

H373 **

H318

H317

H411

613-276-00-8

1-(2-chlorphenyl)-1,2-dihydro-5H-tetrazol-5-on

426-110-2

98377-35-6

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-277-00-3

(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-on

427-070-9

—

Aquatic Chronic 4

H413

—

H413

613-278-00-9

(3-aminophenyl)pyridin-3-ylmethanon

428-230-0

79568-06-2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H400

H410

GHS08

GHS09

Wng

H373 **

H410

613-279-00-4

2-ethyl-2,3-dihydro-2-methyl-1H-perimidin

424-380-6

43057-68-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 **

H410

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-on;

dimethylpropylenurinstof

230-625-6

7226-23-5

Repr. 2

Acute Tox. 4 *

Eye Dam. 1

H361f ***

H302

H318

GHS05

GHS08

GHS07

Dgr

H361f ***

H302

H318

613-281-00-5

quinolin

202-051-6

91-22-5

Carc. 1B Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H350

H341

H312

H302

H319

H315

H411

GHS08

GHS07

GHS09

Dgr

H350

H341

H312

H302

H319

H315

H411

613-282-00-0

triticonazol (ISO);

(RS)-(E)-5-(4-chlorbenzyliden)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

—

131983-72-7

Aquatic Chronic 2

H411

GHS09

H411

613-283-00-6

ketoconazol;

1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorphenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanon

265-667-4

65277-42-1

Repr. 1B

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360F ***

H301

H373 **

H400

H410

GHS06

GHS08

GHS09

Dgr

H360f ***

H301

H373 **

H410

613-284-00-1

metconazol (ISO);

(1RS,5RS;1RS,5SR)-5-(4-chlorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

—

125116-23-6

Repr. 2

Acute Tox. 4 *

Aquatic Chronic 2

H361D ***

H302

H411

GHS08

GHS07

GHS09

Wng

H361D ***

H302

H411

613-285-00-7

1-hydroxybenzotriazol, vandfri; [1]

1-hydroxybenzotriazol, monohydrat [2]

219-989-7 [1]

219-989-7 [2]

2592-95-2 [1]

123333-53-9 [2]

Expl. 1,3

H203

GHS01

Dgr

H203

613-286-00-2

kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat;

[indeholdende < 0,5 % N, N-dimethylformamid (EF-nr.

200-679-5)]

418-260-2

183196-57-8

Skin Sens. 1

H317

GHS07

Wng

H317

613-286-01-X

kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat

[indeholdende ≥ 0,5 % N, N-dimethylformamid (EF-nr. 200-679-5)]

418-260-2

183196-57-8

Repr. 1B

Skin Sens. 1

H360D *** H317

GHS08

GHS07

Dgr

H360D *** H317

613-287-00-8

1-(3-iod-4-aminobenzyl)-1H-1,2,4-triazol

419-540-7

160194-26-3

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

613-288-00-3

1,3-bis(dimethylcarbamoyl)-imidazoliumchlorid

420-930-4

135756-61-5

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

613-289-00-9

3-(4-chlor-2-fluor-5-methylphenyl)-1-methyl-5-(trifluormethyl)-1H-pyrazol

432-020-4

142623-48-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-290-00-4

4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-onhydrochlorid

432-470-1

189012-93-9

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H318

H317

H410

613-291-00-X

2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-on

434-820-9

106461-41-0

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H400

H410

GHS08

GHS09

Wng

H373 **

H410

613-292-00-5

N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazin

435-010-8

26157-73-3

Muta. 2

Aquatic Chronic 3

H341

H412

GHS08

Wng

H341

H412

613-293-00-0

2-(4-tert-butylphenyl)-6-cyan-5-[bis(ethoxycarbonyl-

methyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazol-7-carboxylsyre-2,6-di-tert-butyl-4-methylcyclohexylester

448-050-6

444065-11-6

Aquatic Chronic 4

H413

—

H413

613-294-00-6

2-hexyldecansyre-[4-(6-tert-butyl-7-chlor-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester

448-260-8

379268-96-9

Aquatic Chronic 4

H413

—

H413

613-295-00-1

11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepinhydrochlorid

448-720-8

363138-44-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

613-296-00-7

pentakalium-2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-yliden]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzen-1,4-disulfonat

418-270-7

—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-297-00-2

5-(2-bromphenyl)-2-tert-butyl-2H-tetrazol

420-820-6

—

Flam. Liq. 3

Acute Tox. 4 *

Aquatic Chronic 2

H226

H302

H411

GHS02

GHS07

GHS09

Wng

H226

H302

H411

613-298-00-8

bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-on)ethylendilactat

421-560-6

—

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2

H373 **

H318

H411

GHS05

GHS08

GHS09

Dgr

H373 **

H318

H411

613-299-00-3

hovedkomponent 1 (isomer 1):

2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;

hovedkomponent 1 (isomer 2):

2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;

hovedkomponent 2: 2,3-bis-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;

hovedkomponent 3: 2,3-bis-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;

422-610-1

—

Eye Dam. 1

H318

GHS05

Dgr

H318

613-300-00-7

1-imidazol-1-yl-octadecan-2-ol

434-120-3

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

613-301-00-2

dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl}imidazol-4,5-dicarboxylat

443-910-7

—

Aquatic Chronic 4

H413

—

H413

613-302-00-8

dinatrium-2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridin-3-ylazo)-4-(4-fluor-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazin-2-ylamino)benzensulfonat

432-980-4

243858-60-8

Eye Dam. 1

H318

GHS05

Dgr

H318

613-303-00-3

2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridin

429-800-1

95737-68-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-304-00-9

5,6-dihydroxy-2,3-dihydro-1H-indoliumbromid

421-170-6

138937-28-7

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

613-305-00-4

2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazol

448-630-9

3147-77-1

Aquatic Chronic 4

H413

—

H413

613-306-00-X

(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethylcarbonat

433-520-5

82911-69-1

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

613-307-00-5

clothianidin (ISO);

3-[(2-chlor-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidin

—

210880-92-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 10

613-308-00-0

2-amino-5-methylthiazol

423-800-5

7305-71-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 **

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 **

H410

613-309-00-6

1-methyl-3-phenyl-1-piperazin

431-180-2

5271-27-2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H312

H302

H315

H318

H412

GHS05

GHS07

Dgr

H312

H302

H315

H318

H412

613-310-00-1

(-)(3S,4R)-4-(4-fluorphenyl)-3-(3,4-methylendioxy-phenoxymethyl)-N-benzylpiperidinhydrochlorid

432-360-3

105813-13-6

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

613-311-00-7

methyl-5-nitrophenyl-guanidin

435-500-1

152460-07-6

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H302

H319

H317

H412

GHS07

Wng

H302

H319

H317

H412

613-312-00-2

2-(4-methyl-2-phenyl-1-piperazinyl)benzenmethanolmonohydrochlorid

420-200-5

—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

613-313-00-8

2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindol-1,3(2H)-dion

442-780-9

173838-67-0

Aquatic Chronic 3

H412

—

H412

613-314-00-3

4-decyloxazolidin-2-on;

4-decyl-1,3-oxazolidin-2-on

443-770-7

7693-82-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

613-315-00-9

tetrakalium-4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-yliden]-3-(piperidinocarbonyl)penta-1,3-dienyliden]-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-3-carboxylat

430-390-1

—

Acute Tox. 4 *

Aquatic Chronic 3

H332

H412

GHS07

Wng

H332

H412

613-316-00-4

trimethylopropan-tri(3-aziridinylpropanoat);

(TAZ)

257-765-0

52234-82-9

Muta. 2

Eye Dam. 1

Skin Sens. 1

H341

H318

H317

GHS05

GHS08

GHS07

Dgr

H341

H318

H317

613-317-00-X

penconazol (ISO); 1-[2-(2,4- dichlorphenyl)pentyl]-1H1,2,4-triazol

266-275-6

66246-88-6

Repr. 2

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H361d

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H361d

H302

H410

M = 1

M = 1

614-002-00-X

salte af nicotin

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 2

H330

H310

H300

H411

GHS06

GHS09

Dgr

H330

H310

H300

H411

A

614-003-00-5

strychnin

200-319-7

57-24-9

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H310

H300

H400

H410

GHS06

GHS09

Dgr

H310

H300

H410

614-004-00-0

salte af strychnin

—

—

Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1

H330

H300

H400

H410

GHS06

GHS09

Dgr

H330

H300

H410

A

614-005-00-6

colchicin

200-598-5

64-86-8

Muta. 1B

Acute Tox. 2 *

H340

H300

GHS06

GHS08

Dgr

H340

H300

614-006-00-1

brucin;

2,3-dimethoxystrychnin

206-614-7

357-57-3

Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Chronic 3

H330

H300

H412

GHS06

Dgr

H330

H300

H412

614-007-00-7

brucinsulfat; [1]

brucinnitrat; [2]

strychnidin-10-on, 2,3-dimethoxy-, mono[(R)-1-methylheptyl-1,2-benzendicarboxylat]; [3]

strychnidin-10-on, 2,3-dimethoxy-, forbindelse med (S)-mono(1-methylheptyl)-1,2-benzendicarboxylat (1:1) [4]

225-432-9 [1]

227-317-9 [2]

269-439-5 [3]

269-710-8 [4]

4845-99-2 [1]

5786-97-0 [2]

68239-26-9 [3]

68310-42-9 [4]

Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Chronic 3

H330

H300

H412

GHS06

Dgr

H330

H300

H412

A

614-008-00-2

aconitin

206-121-7

302-27-2

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

614-009-00-8

salte af aconitin

—

—

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

A

614-010-00-3

atropin

200-104-8

51-55-8

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

614-011-00-9

salte af atropin

—

—

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

A

614-012-00-4

hyoscyamin

202-933-0

101-31-5

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

614-013-00-X

salte af hyoscyamin

—

—

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

A

614-014-00-5

scopolamin

200-090-3

51-34-3

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

H330

H310

H300

GHS06

Dgr

H330

H310

H300

614-015-00-0

salte af scopolamin

—

—

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

H330

H310

H300

GHS06

Dgr

H330

H310

H300

A

614-016-00-6

pilocarpin

202-128-4

92-13-7

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

614-017-00-1

salte af pilocarpin

—

—

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

A

614-018-00-7

papaverin

200-397-2

58-74-2

Acute Tox. 4 *

H302

GHS07

Wng

H302

614-019-00-2

salte af papaverin

—

—

Acute Tox. 4 *

H302

GHS07

Wng

H302

A

614-020-00-8

physostigmin

200-332-8

57-47-6

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

614-021-00-3

salte af physostigmin

—

—

Acute Tox. 2 *

Acute Tox. 2 *

H330

H300

GHS06

Dgr

H330

H300

A

614-022-00-9

digitoxin

200-760-5

71-63-6

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

H331

H301

H373 **

GHS06

GHS08

Dgr

H331

H301

H373 **

614-023-00-4

ephedrin

206-080-5

299-42-3

Acute Tox. 4 *

H302

GHS07

Wng

H302

614-024-00-X

salte af ephedrin

—

—

Acute Tox. 4 *

H302

GHS07

Wng

H302

A

614-025-00-5

G-strophantin

211-139-3

630-60-4

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

H331

H301

H373 **

GHS06

GHS08

Dgr

H331

H301

H373 **

614-026-00-0

K-strophantin

234-239-9

11005-63-3

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

H331

H301

H373 **

GHS06

GHS08

Dgr

H331

H301

H373 **

614-027-00-6

6β-acetoxy-3y(β-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolid

208-077-4

507-60-8

Acute Tox. 2 *

H300

GHS06

Dgr

H300

614-028-00-1

en blanding af 2-ethylhexyl-mono-D-glucopyranosid og

2-ethylhexyl-di-D-glucopyranosid

414-420-0

—

Eye Dam. 1

H318

GHS05

Dgr

H318

614-029-00-7

strukturisomerer af penta-O-allyl-β-.sc.D.sc.-fructofuranosyl-α-.sc.D.sc.-glucopyranosid;

strukturisomerer af hexa-O-allyl-β-.sc.D.sc.-fructofuranosyl-α-.sc.D.sc.-glucopyranosid og

strukturisomerer af hepta-O-allyl-β-.sc.D.sc.-fructofuranosyl-α-.sc.D.sc.-glucopyranosid

419-640-0

68784-14-5

Acute Tox. 4 *

H302

GHS07

Wng

H302

615-001-00-7

methylisocyanat

210-866-3

624-83-9

Flam. Liq. 2

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Resp. Sens. 1

Skin Sens. 1

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

H225

H361D *** H330

H311

H301

H334

H317

H335

H315

H318

GHS02

GHS06

GHS05

GHS08

Dgr

H225

H361D *** H330

H311

H301

H334

H317

H335

H315

H318

615-002-00-2

methylisothiocyanat

209-132-5

556-61-6

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H314

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H331

H301

H314

H317

H410

615-003-00-8

thiocyansyre

207-337-4

463-56-9

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H332

H312

H302

H412

GHS07

Wng

H332

H312

H302

H412

EUH032

615-004-00-3

salte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H332

H312

H302

H412

GHS07

Wng

H332

H312

H302

H412

EUH032

A

615-005-00-9

4,4'-methylendiphenyldiisocyanat; diphenylmethan-4,4'-diisocyanat; [1]

2,2'-methylendiphenyldiisocyanat; diphenylmethan-2,2'-diisocyanat; [2]

o-(p-isocyanatobenzyl)phenylisocyanat;

diphenylmethan-2,4'-diisocyanat; [3]

methylendiphenyldiisocyanat

[4]

202-966-0 [1]

219-799-4 [2]

227-534-9 [3]

247-714-0 [4]

101-68-8 [1]

2536-05-2 [2]

5873-54-1 [3]

26447-40-5 [4]

Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

H351

H332

H373 **

H319

H335

H315

H334

H317

GHS08

GHS07

Dgr

H351

H332

H373 **

H319

H335

H315

H334

H317

Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1  %

STOT SE 3; H335: C ≥ 5 %

C2

615-006-00-4

2-methyl-m-phenylendiisocyanat;

2,4-diisocyanatotoluen; [1]

4-methyl-m-phenylendiisocyanat;

2,6-diisocyanatotoluen; [2]

m-tolylidendiisocyanat;

diisocyanatoluen [3]

202-039-0 [1]

209-544-5 [2]

247-722-4 [3]

91-08-7 [1]

584-84-9 [2]

26471-62-5 [3]

Carc. 2

Acute Tox. 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H351

H330

H319

H335

H315

H334

H317

H412

GHS06

GHS08

Dgr

H351

H330

H319

H335

H315

H334

H317

H412

Resp. Sens. 1; H334: C ≥

0,1  %

C

615-007-00-X

1,5-naphthylendiisocyanat

221-641-4

3173-72-6

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Aquatic Chronic 3

H332

H319

H335

H315

H334

H412

GHS08

GHS07

Dgr

H332

H319

H335

H315

H334

H412

615-008-00-5

3-isocyanatomethyl-3,5,5-trimethylcyclohexylisocyanat; isophorondiisocyanat

223-861-6

4098-71-9

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 2

H331

H319

H335

H315

H334

H317

H411

GHS06

GHS08

GHS09

Dgr

H331

H319

H335

H315

H334

H317

H411

*

Resp. Sens. 1; H334: C ≥ 0,5  %

Skin Sens.1; H317: C ≥ 0,5  %

2

615-009-00-0

4,4'-methylendi(cyclohexylisocyanat); dicyclohexylmethan-4,4'-diisocyanat

225-863-2

5124-30-1

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

H331

H319

H335

H315

H334

H317

GHS06

GHS08

Dgr

H331

H319

H335

H315

H334

H317

*

Resp. Sens. 1; H334: C ≥ 0,5  %

Skin Sens. 1; H317: C ≥ 0,5  %

2

615-010-00-6

2,2,4-trimethylhexamethylen-1,6-diisocyanat; [1]

2,4,4-trimethylhexamethylen-1,6-diisocyanat [2]

241-001-8 [1]

239-714-4 [2]

16938-22-0 [1]

15646-96-5 [2]

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H331

H319

H335

H315

H334

GHS06

GHS08

Dgr

H331

H319

H335

H315

H334

*

Resp. Sens. 1; H334: C ≥ 0,5  %

Skin Sens. 1; H317: C ≥ 0,5  %

C2

615-011-00-1

hexamethylen-1,6-diisocyanat

212-485-8

822-06-0

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

H331

H319

H335

H315

H334

H317

GHS06

GHS08

Dgr

H331

H319

H335

H315

H334

H317

*

Resp. Sens. 1; H334: C ≥

0,5  %

Skin Sens. 1; H317: C ≥ 0,5  %

2

615-012-00-7

4-toluensulfonylisocyanat;

tosylisocyanat

223-810-8

4083-64-1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

EUH014

Eye Irrit.

H319: C ≥ 5 %

STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 %

615-014-00-8

tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrat

—

7276-58-6

Acute Tox. 4 *

H302

GHS07

Wng

H302

615-015-00-3

1,7,7-trimethylbicyclo(2,2,1)hept-2-ylthiocyanatoacetat;

isobornyl thiocyanoacetat

204-081-5

115-31-1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

615-016-00-9

kaliumcyanat

209-676-3

590-28-3

Acute Tox. 4 *

H302

GHS07

Wng

H302

615-017-00-4

calciumcyanamid

205-861-8

156-62-7

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H302

H335

H318

GHS05

GHS07

Dgr

H302

H335

H318

615-018-00-X

2-(2-butoxythoxy)ethylthio

cyanat

203-985-7

112-56-1

Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 3 *

H226

H311

H301

GHS02

GHS06

Dgr

H226

H311

H301

615-019-00-5

dicyclohexylcarbodiimid

208-704-1

538-75-0

Acute Tox. 3 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H311

H302

H318

H317

GHS06

GHS05

Dgr

H311

H302

H38

H317

615-020-00-0

methylendithiocyanat

228-652-3

6317-18-6

Acute Tox. 2 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

H330

H301

H314

H317

H400

GHS06

GHS05

GHS09

Dgr

H330

H301

H314

H317

H400

615-021-00-6

1,3,5-tris(oxiranylmethyl)-1,3,5-triazin-2,4,6(1H,3H,5H)-trion;

TGIC

219-514-3

2451-62-9

Muta. 1B

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H340

H331

H301

H373 **

H318

H317

H412

GHS06

GHS08

GHS05

Dgr

H340

H331

H301

H373 **

H318

H317

H412

615-022-00-1

methyl-3-isocyanatosulfonyl-2-thiophencarboxylat

410-550-7

79277-18-2

STOT RE 2 *

Resp. Sens. 1

Skin Sens. 1

H373 **

H334

H317

GHS08

Dgr

H373 **

H334

H317

EUH014

615-023-00-7

2-(isocyanatosulfonylmethyl)benzoesyre-methylester; (alt.):methyl 2-(isocyanatosulfo nylmethyl)benzoat

410-900-9

83056-32-0

Flam. Liq. 3

Muta. 2

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Resp. Sens. 1

H226

H341

H332

H373 **

H318

H334

GHS02

GHS08

GHS05

GHS07

Dgr

H226

H341

H332

H373 **

H318

H334

EUH014

615-024-00-2

2-phenylethylisocyanat

413-080-0

1943-82-4

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 2

H331

H302

H314

H334

H317

H411

GHS06

GHS08

GHS05

GHS09

Dgr

H331

H302

H314

H334

H317

H411

615-025-00-8

4,4'-ethylidendiphenyldicyanat

405-740-1

47073-92-7

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H373 **

H318

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H332

H302

H373 **

H318

H410

615-026-00-3

4,4'-methylenbis(2,6-dimethylphenylcyanat)

405-790-4

101657-77-6

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

615-028-00-4

ethyl-2-(isocyanatosulfonyl)benzoat

410-220-2

77375-79-2

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H302

H373 **

H318

H334

H317

GHS05

GHS08

GHS07

Dgr

H302

H373 **

H318

H334

H317

EUH014

615-029-00-X

2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptan

411-280-2

—

Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H330

H302

H314

H334

H317

H412

GHS06

GHS08

GHS05

Dgr

H330

H302

H314

H334

H317

H412

615-030-00-5

alkalisalte og jordalkalisalte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H332

H312

H302

H412

GHS07

Wng

H332

H312

H302

H412

A

615-031-00-0

thalliumthiocyanat

222-571-7

3535-84-0

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 4 *

STOT RE 2

Aquatic Chronic 2

H330

H300

H312

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H330

H300

H312

H373 **

H411

615-032-00-6

metalsalt af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag

—

—

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H312

H302

H400

H410

GHS07

GHS09

Wng

H332

H312

H302

H410

A

615-033-00-1

reaktionsprodukt af diphenylmethandiisocyanat, octylamin, oleylamin og cyclohexylamin (1:1.58:0.32:0.097)

430-980-9

—

Aquatic Chronic 4

H413

—

H413

615-034-00-7

reaktionsprodukt af diphenylmethandiisocyanat, octylamin,

4-ethoxyanilin og ethylendiamin (1:0.37:1.53:0.05)

430-750-8

—

Aquatic Chronic 4

H413

—

H413

615-035-00-2

reaktionsprodukt af diphenylmethandiisocyanat, octylamin og oleylamin (molforholdet

1:1.86:0.14)

430-930-6

122886-55-9

Aquatic Chronic 4

H413

—

H413

615-036-00-8

reaktionsprodukt af diphenylmethandiisocyanat, toluendiisocyanat (isomerblanding med:

65 % 2,4- og 35 % 2,6-diisocyanat), octylamin, oleylamin og 4-ethoxyanilin (molforholdet 4:1:7:1:2)

430-940-0

—

Aquatic Chronic 4

H413

—

H413

615-037-00-3

reaktionsprodukt af diphenylmethandiisocyanat, toluendiisocyanat (isomerblanding med: 65 % 2,4- og 35 % 2,6-diisocyanat), octylamin og oleylamin (molforholdet 4:1:9:1)

430-950-5

—

Aquatic Chronic 4

H413

—

H413

615-038-00-9

reaktionsprodukt af toluendiisocyanat (isomerblanding med: 65 % 2,4- og 35 % 2,6-diisocyanat) og anilin

(molforholdet 1:2)

430-960-1

—

Aquatic Chronic 4

H413

—

H413

615-039-00-4

reaktionsprodukt af diphenylmethandiisocyanat, toluendiisocyanat (isomerblanding med: 65 % 2,4- og 35 % 2,6-diisocyanat), octylamin, oleylamin og 4-ethoxyanilin (molforholdet 3.88:1:6.38:0.47:2.91)

430-970-4

—

Aquatic Chronic 4

H413

—

H413

615-044-00-1

4-chlorphenylisocyanat

203-176-9

104-12-1

Acute Tox. 2 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H335

H315

H318

H334

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H330

H302

H335

H315

H318

H334

H410

615-045-00-7

4,4'-methylen-bis(3-chlor-2,6-di-ethylphenylisocyanat)

420-530-1

—

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 4

H334

H317

H413

GHS08

Dgr

H334

H317

H413

616-001-00-X

N, N-dimethylformamid;

dimethylformamid

200-679-5

68-12-2

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

H360D *** H332

H312

H319

GHS08

GHS07

Dgr

H360D *** H332

H312

H319

616-002-00-5

2-fluoracetamid

211-363-1

640-19-7

Acute Tox. 2 *

Acute Tox. 3 *

H300

H311

GHS06

Dgr

H300

H311

616-003-00-0

acrylamid;

prop-2-enamid

201-173-7

79-06-1

Carc. 1B

Muta. 1B Repr. 2

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H350

H340

H361f *** H301

H372 **

H332

H312

H319

H315

H317

GHS06

GHS08

Dgr

H350

H340

H361f *** H301

H372 **

H332

H312

H319

H315

H317

D

616-004-00-6

allidochlor (ISO);

N, N-diallylchloracetamid

202-270-7

93-71-0

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H312

H302

H319

H315

H411

GHS07

GHS09

Wng

H312

H302

H319

H315

H411

616-005-00-1

chlorthiamid (ISO);

2,6-dichlor (thiobenzamid)

217-637-7

1918-13-4

Acute Tox. 4 *

H302

GHS07

Wng

H302

616-007-00-2

diphenamid (ISO);

N, N-dimethyl-2,2-diphenylacetamid

213-482-4

957-51-7

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-008-00-8

propachlor (ISO);

2-chlor-N-isopropylacetanilid

α-chlor-N-isopropylacetanilid

217-638-2

1918-16-7

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H319

H317

H400

H410

GHS07

GHS09

Wng

H302

H319

H317

H410

616-009-00-3

propanil (ISO);

3',4'-dichlorpropionanilid

211-914-6

709-98-8

Acute Tox. 4 *

Aquatic Acute 1

H302

H400

GHS07

GHS09

Wng

H302

H400

M = 10

616-010-00-9

tosylchloramidnatrium

204-854-7

127-65-1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

H302

H314

H334

GHS08

GHS05

GHS07

Dgr

H302

H314

H334

EUH031

616-012-00-X

N-(dichlorfluormethylthio)phthalimid;

N-(fluorodichloromethylthio)-phtalimid

211-952-3

719-96-0

Skin Irrit. 2

H315

GHS07

Wng

H315

616-013-00-5

butyraldehydoxim

203-792-8

110-69-0

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

H311

H302

H319

GHS06

Dgr

H311

H302

H319

616-014-00-0

2-butanonoxim;

ethylmethylketoxim;

ethylmethylketonoxim

202-496-6

96-29-7

Carc. 2

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H351

H312

H318

H317

GHS08

GHS05

GHS07

Dgr

H351

H312

H318

H317

616-015-00-6

alachlor (ISO);

2-chlor-2',6'-diethyl-N-(methoxymethyl)acetanilid

240-110-8

15972-60-8

Carc. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H317

H410

M = 10

616-016-00-1

1-(3,4-dichlorphenylimino)

thiosemicarbazid

—

5836-73-7

Acute Tox. 2 *

H300

GHS06

Dgr

H300

616-017-00-7

cartaphydrochlorid

239-309-2

15263-52-2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H400

H410

GHS07

GHS09

Wng

H312

H302

H410

616-018-00-2

N, N-diethyl-m-toluamid;

deet

205-149-7

134-62-3

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3

H302

H319

H315

H412

GHS07

Wng

H302

H319

H315

H412

616-019-00-8

perfluidon (ISO);

1,1,1-trifluor-N-(4-phenylsulfonyl-o-tolyl)methansulfonamid

253-718-3

37924-13-3

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

616-020-00-3

tebuthiuron (ISO);

1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurinstof

251-793-7

34014-18-1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

616-021-00-9

thiazfluron (ISO);

1,3-dimethyl-1-(5-trifluormethyl-1,3,4-thiadiazol-2-yl)urinstof

246-901-4

25366-23-8

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

616-022-00-4

acetamid

200-473-5

60-35-5

Carc. 2

H351

GHS08

Wng

H351

616-023-00-X

N-hexadecyl(eller octadecyl)-N-hexadecyl(eller octadecyl)benzamid

401-980-6

—

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

616-024-00-5

2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chlor-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilid

402-260-4

54942-74-4

Aquatic Chronic 4

H413

—

H413

616-025-00-0

valinamid

402-840-7

20108-78-5

Repr. 2

Eye Irrit. 2

Skin Sens. 1

H361f *** H319

H317

GHS08

Wng

H361f *** H319

H317

616-026-00-6

thioacetamid

200-541-4

62-55-5

Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3

H350

H302

H319

H315

H412

GHS08

GHS07

Dgr

H350

H302

H319

H315

H412

616-027-00-1

tris(-(2-hydroxyethoxy)ethyl)ammonium-3-acetoacetamido-4-methoxybenzensulfonat

403-760-5

—

Skin Sens. 1

H317

GHS07

Wng

H317

616-028-00-7

N-(4-(3-(4-cyanphenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamid

403-790-9

108673-51-4

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-029-00-2

N, N'-ethylenbis(vinylsulfonylacetamid)

404-790-1

66710-66-5

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

616-030-00-8

ethidimuron (ISO);

1-(5-ethylsulfonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurinstof

250-010-6

30043-49-3

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

616-031-00-3

dimethachlor (ISO):

2-chlor-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamid

256-625-6

50563-36-5

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

616-032-00-9

diflufenican (ISO);

N-(2,4-difluorphenyl)-2-[3-(trifluormethyl)phenoxy]-3-pyridincarboxamid

—

83164-33-4

Aquatic Chronic 3

H412

—

H412

616-033-00-4

cyprofuram (ISO);

N-(3-chlorphenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropancarboxamid

274-050-9

69581-33-5

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H400

H410

GHS06

GHS09

Dgr

H301

H312

H410

616-034-00-X

pyracarbolid (ISO);

3,4-dihydro-6-methyl-2H-pyran5-carboxanilid

246-419-4

24691-76-7

Aquatic Chronic 3

H412

—

H412

616-035-00-5

cymoxanil (ISO);

2-cyan-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamid

261-043-0

57966-95-7

Repr. 2

Acute Tox. 4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H302

H373 (blod, brissel)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361fd

H302

H373 (blod, brissel)

H317

H410

M = 1

M = 1

616-036-00-0

2-chloracetamid

201-174-2

79-07-2

Repr. 2

Acute Tox. 3 *

Skin Sens. 1

H361f *** H301

H317

GHS06

GHS08

Dgr

H361f *** H301

H317

Skin Sens. 1; H317: C ≥ 0,1  %

616-038-00-1

(4-aminophenyl)-N-methylmethylensulfonamidhydrochlorid

406-010-5

88918-84-7

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

616-039-00-7

3',5'-dichlor-4'-ethyl-2'-hydro

xypalmitanilid

406-200-8

117827-06-2

Skin Sens. 1

H317

GHS07

Wng

H317

616-040-00-2

kalium-N-(4-toluensulfonyl)-4-toluensulfonamid

406-650-5

97888-41-0

Eye Dam. 1

H318

GHS05

Dgr

H318

616-041-00-8

3',5'-dichlor-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxy-hexananilid

406-840-8

101664-25-9

Aquatic Chronic 4

H413

—

H413

616-042-00-3

N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazol[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamid

407-070-5

142859-67-4

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-043-00-9

isoxaben (ISO);

N-(3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl)-2,6-dimethoxybenzamid

407-190-8

82558-50-7

Aquatic Chronic 4

H413

—

H413

616-044-00-4

N-(3,5-dichlor-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)butanamid

402-510-2

—

Aquatic Chronic 2

H411

GHS09

H411

616-045-00-X

2'-(4-chlor-3-cyan-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilid

405-190-2

122371-93-1

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-046-00-5

N-(2-(6-chlor-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamid

406-390-2

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-047-00-0

en blanding af 2,2',2'',2'''-(ethylendinitrilotetrakis-N, N-di(C16)alkylacetamid og

2,2',2'',2'''-(ethylendinitrilotetrakis-N, N-di(C18)alkylacetamid

406-640-0

—

Skin Sens. 1

H317

GHS07

Wng

H317

616-048-00-6

3'-trifluormethylisobutyranilid

406-740-4

1939-27-1

STOT RE 2 *

Aquatic Chronic 2

H373 **

H411

GHS08

GHS09

Wng

H373 **

H411

616-049-00-1

2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichlor-4-ethyl-2-hydroxyphenyl)hexanamid

408-150-2

99141-89-6

Aquatic Chronic 4

H413

—

H413

616-050-00-7

lufenuron (ISO);

N-[2,5-dichlor-4-(1,1,2,3,3,3-hexafluorpropoxy)-phenyl-aminocarbonyl]-2,6-difluorbenzamid

410-690-9

103055-07-8

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

616-051-00-2

en blanding af 2,4 -bis(N'-(4-methylphenyl)ureido)toluen og

2,6 -bis(N'-(4-methylphenyl)ureido)toluen

411-070-0

—

Aquatic Chronic 4

H413

—

H413

616-052-00-8

formamid

200-842-0

75-12-7

Repr. 1B

H360D ***

GHS08

Dgr

H360D ***

616-053-00-3

N-methylacetamid

201-182-6

79-16-3

Repr. 1B

H360D ***

GHS08

Dgr

H360D ***

616-054-00-9

iprodion (ISO);

3-(3,5-dichlorphenyl)-2,4-dioxo-N-isopropylimidazolidin-1-carboxamid

253-178-9

36734-19-7

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

616-055-00-4

propyzamid (ISO);

3,5-dichlor-N-(1,1-dimethylprop-2-ynyl)benzamid

245-951-4

23950-58-5

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

616-056-00-X

N-methylformamid

204-624-6

123-39-7

Repr. 1B

Acute Tox. 4 *

H360D *** H312

GHS08

GHS07

Dgr

H360D *** H312

616-057-00-5

en blanding af N-[3-hydroxy-2-(2-methyl-acryloylamino-methoxy)-propoxymethyl]-2-methyl-acrylamid;

N-[2,3-bis-(2-methyl-acryloylamino-methoxy)propoxymethyl]-2-methylacrylamid; methacrylamid;

2-methyl-N-(2-methyl-acryloylamino-methoxy-methyl)-acrylamid og

N-(2,3-dihydroxy-propoxymethyl)-2-methyl-acrylamid

412-790-8

—

Carc. 1B

Muta. 2

STOT RE 2 *

H350

H341

H373 **

GHS08

Dgr

H350

H341

H373 **

616-058-00-0

1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzen

412-570-1

119462-56-5

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H318

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H373 **

H318

H317

H410

616-059-00-6

4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalencarboxamid

412-650-6

121487-83-0

Aquatic Chronic 4

H413

—

H413

616-060-00-1

kondensationsprodukt af 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexen-1,2-dicarboxylsyre med polyaminer (fortrinsvis amino-ethyl-piperazin og triethylentetramin)

413-770-1

—

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H317

H410

616-061-00-7

N, N'-1,6-hexandiylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamid

413-610-0

124172-53-8

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

616-062-00-2

N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenyl-acetamid

411-590-8

70693-57-1

Skin Corr. 1B

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

616-063-00-8

3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)yl) pyrrolidin-2,5-dion

411-920-0

106917-30-0

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H373 **

H314

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H331

H302

H373 **

H314

H410

616-064-00-3

N-tert-butyl-3-methylpicolinamid

406-720-5

32998-95-1

Aquatic Chronic 3

H412

—

H412

616-065-00-9

3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurinstof

411-970-3

79881-89-3

Acute Tox. 4 *

STOT RE 2 *

H302

H373 **

GHS08

GHS07

Wng

H302

H373 **

616-066-00-4

5,6,12,13-tetrachloranthra(2,1,9-def:6,5,10-d'e'f)diisoquinolin-1,3,8,10(2H,9H)-tetron

405-100-1

115662-06-1

Repr. 2

H361f ***

GHS08

Wng

H361f ***

616-067-00-X

dodecyl-3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorbenzoat

407-300-4

92683-20-0

Aquatic Chronic 4

H413

—

H413

616-068-00-5

kalium-4-(11-methacrylamidoundecanamido)benzensulfonat

406-500-9

174393-75-0

Skin Sens. 1

H317

GHS07

Wng

H317

616-069-00-0

1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamidchlorbenzoat

406-210-2

110560-22-0

Aquatic Chronic 4

H413

—

H413

616-070-00-6

en blanding af 3,3'-dicyclohexyl-1,1'-methylenbis(4,1-phenylen)diurinstof

3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urinstof

3,3'-dioctadecyl-1,1'-methylenbis(4,1-phenylen)diurinstof

406-530-2

—

Aquatic Chronic 4

H413

—

H413

616-071-00-1

blanding (1:2:1) af bis(N-cyclohexyl-N'-phenylenureido)methylen;

bis(N-octadecyl-N'-phenylenureido)methylen

bis(N-dicyclohexyl-N'-phenylenureido)methylen

406-550-1

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-072-00-7

1-(2-deoxy-5-O-trityl-β-.sc.D.sc.-threopentofuranosyl)thymin

407-120-6

55612-11-8

Aquatic Chronic 4

H413

—

H413

616-073-00-2

4'-ethoxy-2-benzimidazol-anilid

407-600-5

120187-29-3

Muta. 2

Aquatic Chronic 4

H341

H413

GHS08

Wng

H341

H413

616-074-00-8

N-butyl-2-(4-morpholinylcarbonyl)benzamid

407-730-2

104958-67-0

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H319

H317

H412

GHS07

Wng

H319

H317

H412

616-075-00-3

.sc.D.sc.,.sc.L.sc.-(N, N-diethyl-2-hydroxy-2-phenylacetamid)

408-120-9

65197-96-8

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

616-076-00-9

tebufenozid (ISO);

N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazid

412-850-3

112410-23-8

Aquatic Chronic 2

H411

GHS09

H411

616-077-00-4

en blanding af 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-yl-ethansulfonsyre;

kalium-2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def:

6,5,10-d'e'f']diisoquinolin-2-yl-ethansulfat

411-310-4

—

Eye Dam. 1

H318

GHS05

Dgr

H318

616-078-00-X

2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)-hexanamid

411-330-3

104541-33-5

Aquatic Chronic 4

H413

—

H413

616-079-00-5

1,6-hexandiyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamat

411-700-4

140921-24-0

Skin Sens. 1

H317

GHS07

Wng

H317

616-080-00-0

4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzensulfonamid)

411-850-0

119018-29-0

Aquatic Chronic 3

H412

—

H412

616-081-00-6

5-brom-8-naphtholactam

413-480-5

24856-00-6

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

616-082-00-1

N-(5-chlor-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)-benzamid

413-200-1

129604-78-0

Skin Sens. 1

H317

GHS07

Wng

H317

616-083-00-7

[2-[(4-nitrophenyl)amino]ethyl]urinstof

410-700-1

27080-42-8

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

616-084-00-2

2,4-bis[N'-(4-methylphenyl)ureido]-toluen

411-790-5

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-085-00-8

3-(2,4-dichlorphenyl)-6-fluorquinazolin-2,4(1H,3H)-dion

412-190-6

168900-02-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-086-00-3

2-acetylamino-6-chlor-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadien

412-250-1

102387-48-4

Aquatic Chronic 4

H413

—

H413

616-087-00-9

en blanding af 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoat og

7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoat

412-260-6

52658-19-2

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H319

H317

H411

GHS07

GHS09

Wng

H319

H317

H411

616-088-00-4

2-aminosulfonyl-N, N-dimethylnicotinamid

413-440-7

112006-75-4

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

616-089-00-X

5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin)-3- fluor-2-hydroxymethyltetrahydrofuran

415-360-8

41107-56-6

Muta. 2

H341

GHS08

Wng

H341

616-090-00-5

1-(1,4-benzodioxan-2-ylcarbonyl)piperazinhydrochlorid

415-660-9

70918-74-0

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2

H331

H311

H301

H373 **

H411

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H373 **

H411

616-091-00-0

1,3,5-tris-[(2S og 2R)-2,3-epoxypropyl]-1,3,5-triazin-2,4,6-(1H,3H,5H)-trion

423-400-0

59653-74-6

Muta. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H340

H331

H302

H373 **

H318

H317

GHS06

GHS08

GHS05

Dgr

H340

H331

H302

H373 **

H318

H317

616-092-00-6

polymerreaktionsprodukt af bicyclo[2.2.1]hepta-2,5-dien, ethen, 1,4-hexadien, 1-propen med N, N-di-2-propenylformamid

404-035-6

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-093-00-1

reaktionsprodukter af anilin-terephthalaldehyd-o-toluidinkondensat med maleinsyreanhydrid

406-620-1

129217-90-9

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-095-00-2

3,3'-dioctadecyl-1,1'-methylen

-bis(4,1-phenylen)diurinstof

406-690-3

43136-14-7

Aquatic Chronic 4

H413

—

H413

616-096-00-8

N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamid

408-110-4

110483-07-3

Aquatic Chronic 4

H413

—

H413

616-097-00-3

N, N'-1,4-phenylenbis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamid

411-840-6

83372-55-8

Aquatic Chronic 4

H413

—

H413

616-098-00-9

1-[4-chlor-3-((2,2,3,3,3-pentafluorpropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazol-3-carboxamid

411-750-7

119126-15-7

Aquatic Chronic 2

H411

GHS09

H411

616-099-00-4

2-[4-[(4-idrossifenil)solfonil]fenossi]-4,4-dimetil-N-[5-[(metilsolfonil)ammino]-2-[4-(1,1,3,3-tetrametilbutil)fenossi]fenil]-3-ossopentanammide

414-170-2

135937-20-1

Aquatic Chronic 4

H413

—

H413

616-100-00-8

1,3-dimetil-1,3-bis(trimetilsilil)urea

414-180-7

10218-17-4

Acute Tox. 4 *

Skin Irrit. 2

H302

H315

GHS07

Wng

H302

H315

616-101-00-3

(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isochinolincarboxamid

414-600-9

149182-72-9

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-102-00-9

blanding af α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylen-co-oxypropylen);

1,2-(eller 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylen-co-oxypropylen)]-3-(eller 2-)propanol og

1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylen-co-oxypropylen)]propan]

415-870-0

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-103-00-4

(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamid

415-030-3

120298-38-6

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

616-104-00-X

benalaxyl (ISO);

methyl-N-(2,6-dimethylphenyl)-N-(phenylacetyl)-.sc.DL.sc.-alaninat

275-728-7

71626-11-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-105-00-5

chlortoluron (ISO);

3-(3-chlor-p-tolyl)-1,1-dimethylurinstof

239-592-2

15545-48-9

Carc. 2

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H361D *** H400

H410

GHS08

GHS09

Wng

H351

H361D *** H410

616-106-00-0

phenmedipham (ISO);

methyl-3-(3-methylcarbaniloyloxy)carbanilat

237-199-0

13684-63-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-107-00-6

cinidon ethyl (ISO);

ethyl-(Z)-2-chlor-3-[2-chlor-5-(cyclohex-1-en-1,2-dicarboximido)phenyl]acrylat

—

142891-20-1

Carc. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H317

H410

616-108-00-1

iodsulfuron-methyl-natrium; natrium ({[5-iod-2-(methoxycarbonyl)phenyl]sulfonyl}}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanid

—

144550-36-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-109-00-7

sulfosulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2- yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea

—

141776-32-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-110-00-2

cyclanilid (ISO);

1-(2,4-dichloranilinocarbonyl)cyclopropancarboxylsyre

419-150-7

113136-77-9

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

616-111-00-8

fenhexamid (ISO);

N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid

422-530-5

126833-17-8

Aquatic Chronic 2

H411

GHS09

H411

616-112-00-3

oxasulfuron (ISO);

oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl]-carbamoylsulfamoyl]benzoat

—

144651-06-9

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373 **

H400

H410

GHS08

GHS09

Wng

H373 **

H410

616-113-00-9

desmedipham (ISO);

ethyl 3-phenylcarbamoyloxyphenylcarbamat

237-198-5

13684-56-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

616-114-00-4

dodecanamid, N, N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracen)-4,4'-diyl)bis-

418-010-2

136897-58-0

Aquatic Chronic 4

H413

—

H413

616-115-00-X

N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamid

416-150-9

136450-06-1

Aquatic Chronic 4

H413

—

H413

616-116-00-5

N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidat

416-790-9

143052-96-4

Aquatic Chronic 4

H413

—

H413

616-117-00-0

N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamid

416-860-9

777891-21-1

Repr. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f *** H317

H400

H410

GHS08

GHS09

Wng

H361f *** H317

H410

616-118-00-6

N-(2',6'-dimethylphenyl)-2-piperidincarboxamid hydrochlorid

417-950-0

65797-42-4

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-119-00-1

2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamid

418-060-5

118020-93-2

Aquatic Chronic 4

H413

—

H413

616-120-00-7

en blanding af N-(3-dimethylamino-4-methyl-phenyl)-benzamid;

N-(3-dimethylamino-2-methyl-phenyl)-benzamid og

N-(3-dimethylamino-3-methyl-phenyl)-benzamid

420-600-1

—

STOT RE 2 *

Aquatic Chronic 2

H373 **

H411

GHS08

GHS09

Wng

H373 **

H411

616-121-00-2

2,4-dihydroxy-N-(2-methoxyphenyl)benzamid

419-090-1

129205-19-2

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-122-00-8

methylneodecanamid

414-460-9

105726-67-8

Acute Tox. 4 *

H302

GHS07

Wng

H302

616-123-00-3

N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamid

414-740-0

96141-86-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-124-00-9

lithium-bis(trifluormethylsulfonyl)imid

415-300-0

90076-65-6

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Skin Corr. 1B

Aquatic Chronic 3

H311

H301

H373 **

H314

H412

GHS06

GHS05

GHS08

Dgr

H311

H301

H373 **

H314

H412

616-125-00-4

3-cyano-N-(1,1-dimethylethyl)androsta-3,5-dien-17-β-carboxamid

415-730-9

151338-11-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

410

616-126-00-X

1-methyl-4-nitro-3-propyl-1H-pyrazol-5-carboxamid

423-960-6

139756-01-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373 **

H412

GHS08

GHS07

Wng

H302

H373 **

H412

616-127-00-5

en blanding af N, N'-ethan-1,2-diylbis(decanamid);

12-hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamid og

N, N'-ethan-1,2-diylbis(12-hydroxyoctadecanamid)

430-050-2

—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-128-00-0

N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)acetamid

417-530-7

123590-00-1

Aquatic Chronic 4

H413

—

H413

616-129-00-6

N, N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamid

419-710-0

42774-15-2

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

616-130-00-1

N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamid

421-780-2

150919-56-5

Aquatic Chronic 4

H413

—

H413

616-131-00-7

1-aminocyclopentancarboxamid

422-950-9

17193-28-1

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

H372 **

H302

H318

GHS05

GHS08

GHS07

Dgr

H372 **

H302

H318

616-132-00-2

N-[4-(4-cyano-2-furfuryliden-2,5-dihydro-5-oxo-3-furyl)phenyl]butan-1-sulfonamid

423-250-6

130016-98-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-133-00-8

N-cyclohexyl-S,S-dioxo

-benzo[b]tiophen-2-carboxamid

423-990-1

149118-66-1

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

616-134-00-3

3,3'-bis(dioctyloxythiophosphinoylthio)-N, N'-oxybis(methylen)dipropionamid

401-820-5

793710-14-2

Aquatic Chronic 3

H412

—

H412

616-135-00-9

(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinolin-3-carboxamid

430-230-0

136522-17-3

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-136-00-4

reaktionsprodukt af kokosalkyldiethanolamider og kokosalkylmonoglycerider og molybdentrioxid (1,75-2,2: 0,75-1,0:0,1-1,1)

430-380-7

—

Aquatic Chronic 2

H411

GHS09

H411

616-137-00-X

4-dichloracetyl-1-oxa-4-azaspiro[4.5]decan

401-130-4

71526-07-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-138-00-5

benzoesyre, N-tert-butyl-N'-(4-chlorbenzoyl)hydrazid

431-600-4

112226-61-6

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-139-00-0

(3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolincarboxamid

420-380-5

136465-81-1

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

616-140-00-6

N, N''-(methylendi-4,1-phenylen)bis[N'-(4-methylphenyl)urinstof]

429-380-1

133336-92-2

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-141-00-1

zoxamid (ISO)

(RS)-3,5-dichlor-N-(3-chlor-1-ethyl-1-methyl-2-oxopropyl)-p-toluamid

—

156052-68-5

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 10

616-142-00-7

1,3-bis(vinylsulfonylacetamido)propan

428-350-3

93629-90-4

Muta. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H341

H318

H317

H412

GHS08

GHS05

GHS07

Dgr

H341

H318

H317

H412

616-143-00-2

N, N'-dihexadecyl-N, N'-bis(2-hydroxyethyl)propandiamid

422-560-9

149591-38-8

Repr. 2

Eye Irrit. 2

Aquatic Chronic 4

H361f *** H319

H413

GHS08

Wng

H361f *** H319

H413

616-144-00-8

3,4-dichlor-N-[5-chlor-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamid

431-130-1

—

Aquatic Chronic 4

H413

—

H413

616-145-00-3

pethoxamid (ISO);

2-chlor-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamid

—

106700-29-2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M = 100

616-146-00-9

N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentansyreamid

431-330-7

142776-95-2

Aquatic Chronic 4

H413

—

H413

616-147-00-4

1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazol-5-sulfonamid

424-160-1

139481-22-4

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-148-00-X

N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamid

424-550-1

84245-12-5

Carc. 1B

Muta. 1B

Repr. 1B

H350

H340

H360FD

GHS08

Dgr

H350

H340

H360FD

616-150-00-0

(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzensulfonamid hydrochlorid

425-260-6

—

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H373 **

H318

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H373 **

H318

H317

H411

616-151-00-6

N-(2-amino-4,6-dichlorpyrimidin-5-yl)formamid

425-650-6

171887-03-9

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

616-152-00-1

4-(4-fluorphenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamid

425-850-3

125971-96-2

Aquatic Chronic 4

H413

—

H413

616-153-00-7

4-methyl-3-oxo-N-phenyl-2-(phenylmethylen)pentanamid

425-860-8

125971-57-5

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-154-00-2

3,4-dichlor-N-[5-chlor-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamid

431-110-0

—

Aquatic Chronic 4

H413

—

H413

616-155-00-8

N, N,N',N'-tetracyclohexyl-1,3-benzendicarboxamid

431-040-0

104560-40-9

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-156-00-3

6-(2-chlor-6-cyan-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilid

430-500-8

204277-61-2

Aquatic Chronic 4

H413

—

H413

616-157-00-9

3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzensulfonamid hydrochlorid

427-780-9

114565-70-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

616-158-00-4

N-[4-cyan-3-trifluormethylphenyl]methacrylamid

427-880-2

90357-53-2

STOT RE 2 *

Aquatic Chronic 2

H373 **

H411

GHS08

GHS09

Wng

H373 **

H411

616-160-00-5

2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamid]

429-090-3

61551-69-7

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

616-161-00-0

2,4-dichlor-5-hydroxyacetanilid

429-110-0

67669-19-6

Aquatic Chronic 3

H412

—

H412

616-162-00-6

isostearinsyre monoisopropanolamid

431-540-9

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

616-163-00-1

4,4'-methylenbis[N-(4-chlorphenyl)-3-hydroxynaphthalen-2-carboxamid]

430-350-3

192463-88-0

Aquatic Chronic 4

H413

—

H413

616-164-00-7

dimoxystrobin (ISO);

(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid

—

149961-52-4

Carc. 2

Repr. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H361D ***

H332

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361D ***

H332

H410

M = 10

616-165-00-2

beflubutamid (ISO);

(RS)-N-benzyl-2-(α, α,α,4-tetrafluor-m-tolyoxy)butyramid

—

113614-08-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 100

616-166-00-8

cyazofamid (ISO);

4-chlor-2-cyan-N, N-dimethyl-5-p-tolylimidazol-1-sulfonamid

—

120116-88-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 10

616-167-00-3

N, N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamid

418-290-6

168612-06-4

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

616-168-00-9

1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium

418-440-0

136997-71-2

Skin Sens. 1

H317

GHS07

Wng

H317

616-169-00-4

4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chlor-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorphenyl)-2-pyrazolin-5-on

420-220-4

92771-56-7

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-170-00-X

(2R)-2-amino-2-phenylacetamid

420-370-0

6485-67-2

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

616-171-00-5

2-(p-chlorphenyl)glycinamid

420-830-0

102333-75-5

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

616-172-00-0

N-(2,2,6,6,-tetramethyl-1-oxylpiperidin-4-yl)acetamid;

(4-acetamido-2,2,6,6-tetra

-methyl-1-piperidinyl)oxidanyl

423-840-3

14691-89-5

Acute Tox. 4 *

H302

GHS07

Wng

H302

616-174-00-1

2-butyl-1,3-diazaspiro[4.4]non-1-en-4-onhydrochlorid

424-560-4

151257-01-1

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

616-175-00-7

2-(2-hexyldecyloxy)benzamid

431-230-3

202483-62-3

Aquatic Chronic 4

H413

—

H413

616-176-00-2

3-N, N-bis(methoxyethyl)aminoacetanilid

432-530-7

24294-01-7

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)-amino)-phenylthio)-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-ylamino)-4-chlorphenyl)tetradecanamid;

N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorphenyl]tetradecanamid

432-970-1

217324-98-6

Aquatic Chronic 4

H413

—

H413

616-178-00-3

N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyan-4,6-dinitrophenyl)azo)phenyl)acetamid

434-500-9

52583-35-4

Aquatic Chronic 4

H413

—

H413

616-179-00-9

2-chlor-N-(4-methylphenyl)acetamid

435-170-9

16634-82-5

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H318

H317

H410

616-180-00-4

N, N-(dimethylamino)thioacetamidhydrochlorid

435-470-1

27366-72-9

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D *** H400

H410

GHS08

GHS09

Dgr

H360D *** H410

616-181-00-X

4'-methyldodecan-1-sulfonanilid

435-490-9

17417-32-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-182-00-5

N'-(1,3-dimethylbutyliden)-3-hydroxy-2-naphthohydrazid

435-860-1

214417-91-1

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-183-00-0

N-dodecyl-4-methoxybenzamid

442-340-6

1854-15-5

Aquatic Chronic 4

H413

—

H413

616-184-00-6

3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamid

442-560-2

105043-55-8

Aquatic Chronic 4

H413

—

H413

616-186-00-7

N, N'-(2-chlor-1,4-phenylen)bis(3-oxobutanamid)

443-010-4

53641-10-4

Aquatic Chronic 3

H412

—

H412

616-188-00-8

2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentansyreamid

443-980-9

221215-20-9

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-189-00-3

N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-brom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamid

444-780-4

452962-97-9

Aquatic Chronic 4

H413

—

H413

616-190-00-9

N-decyl-4-nitrobenzamid

445-880-0

64026-19-3

Aquatic Chronic 4

H413

—

H413

616-191-00-4

2-ethyl-N-methyl-N-(3-methylphenyl)butanamid

446-190-2

406488-30-0

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H302

H319

H315

H317

H411

GHS07

GHS09

Wng

H302

H319

H315

H317

H411

616-192-00-X

2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilid

448-060-0

727678-39-9

Aquatic Chronic 4

H413

—

H413

616-193-00-5

N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamid

449-940-7

368450-39-9

Aquatic Chronic 4

H413

—

H413

616-194-00-0

2,2-diethoxy-N, N-dimethylacetamid

449-950-1

34640-92-1

Eye Irrit. 2

H319

GHS07

Wng

H319

616-196-00-1

dinatriumsalt af 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamid

419-990-4

—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

616-197-00-7

blanding af kalium-N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamidat og

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctan

sulfonamid

422-500-1

—

STOT RE 2 *

H373 **

GHS08

Wng

H373 **

616-198-00-2

1,3-bis[12-hydroxy-octadecamid-N-methylen]benzen

423-300-7

—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-200-00-1

blanding af N, N'-ethan-1,2-diylbis(hexanamid) og

12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamid og N, N'-ethan-1,2-diylbis(12-hydroxyoctadecanamid)

432-430-3

Aquatic Chronic 4

H413

H413

616-201-00-7

12-hydroxyoctadecansyre, reaktionsprodukter med 1,3-benzendimethanamin og hexamethylendiamin

432-840-2

220926-97-6

Acute Tox. 4 *

Aquatic Chronic 4

H332

H413

GHS07

Wng

H332

H413

616-202-00-2

en blanding af 2,2'-[(3,3'-dichlor[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamid;

2-[[3,3'-dichlor-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamid og

2-[[3,3'-dichlor-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamid

434-330-5

—

Carc. 2

Skin Sens. 1

Aquatic Chronic 4

H351

H317

H413

GHS08

GHS07

Wng

H351

H317

H413

616-203-00-8

en blanding af N-[5-[bis-(2-methoxy-ethyl)-amino]-2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)-phenyl]-acetamid og

N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]-acetamid

442-280-0

—

Aquatic Chronic 4

H413

—

H413

616-204-00-3

N, N''-(methylendi-4,1-phenylen)bis[N'-octylurinstof]

451-060-3

122886-55-9

Aquatic Chronic 4

H413

—

H413

616-205-00-9

metazachlor (ISO);

2-chlor-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamid

266-583-0

67129-08-2

Skin Sens. 1B

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H317

H351

H400

H410

GHS07

GHS08

GHS09

Wng

H317

H351

H410

M = 100

M = 100

616-206-00-4

flufenoxuron (ISO);

1-(4-(2-chlor-α, α,α-p-trifluortolyloxy)-2-fluorphenyl)-3- (2,6-difluorbenzolyl)urinstof

417-680-3

101463-69-8

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H362

H400

H410

GHS09

Wng

H362

H410

M = 10 000

M = 10 000

616-208-00-5

N-ethyl-2-pyrrolidon;

N-ethyl-2-pyrrolidon;

220-250-6

2687-91-4

Repr. 1B

H360D

GHS08

Dgr

H360D

616-209-00-0

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urinstof

407-380-0

120923-37-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 100

M = 100

616-210-00-6

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-4-chlor-3-ethyl-1-methyl-1H-pyrazol-5-carboxamid

119168-77-3

Acute Tox. 3

Acute Tox. 4

STOT RE 2

Skin Sens. 1B

Aquatic Acute 1

Aquatic Chronic 1

H301

H332

H373 (mavetarmkanal) (oral)

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H301

H332

H373 (mavetarmkanal) (oral)

H317

H410

M = 10

M = 10

616-211-00-1

proquinazid (ISO);

6-iod-2-propoxy-3-propylquinazolin-4(3H)-on

189278-12-4

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 1

M = 10

616-212-00-7

3-iod-2-propynyl-butylcarbamat;

3-iodprop-2-yn-1-yl-butylcarbamat

259-627-5

55406-53-6

Acute Tox. 3

Acute Tox. 4

STOT RE 1

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H302

H372 (strubehoved) H318

H317

H400

H410

GHS06

GHS08

GHS05

GHS09

Dgr

H331

H302

H372 (strubehoved) H318

H317

H410

M = 10

M = 1

617-001-00-2

di-tert-butylperoxid

203-733-6

110-05-4

Org. Perox. E

Flam. Liq. 2

Muta. 2

H242

H225

H341

GHS02

GHS08

Dgr

H242

H225

H341

617-002-00-8

α, α-dimethylbenzylhydroperoxid

cumenhydroperoxid

201-254-7

80-15-9

Org. Perox. E

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Aquatic Chronic 2

H242

H331

H312

H302

H373 **

H314

H411

GHS02

GHS06

GHS08

GHS05

GHS09

Dgr

H242

H331

H312

H302

H373 **

H314

H411

Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C

< 10 %

Eye Dam. 1; H318: 3 % ≤ C

< 10 %

Eye Irrit. 2; H319: 1 % ≤ C

< 3 %

STOT SE 3; H335: C < 10 %

617-003-00-3

dilauroylperoxid

203-326-3

105-74-8

Org. Perox. D

H242

GHS02

Dgr

H242

617-004-00-9

1,2,3,4-tetrahydro-1-naphthylhydroperoxid

212-230-0

771-29-9

Org. Perox. D

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H242

H302

H314

H400

H410

GHS02

GHS05

GHS07

GHS09

Dgr

H242

H302

H314

H410

STOT SE 3; H335: C ≥ 5 %

617-006-00-X

bis (α, α-dimethylbenzyl)

peroxid

201-279-3

80-43-3

Org. Perox. F

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H242

H319

H315

H411

GHS02

GHS07

GHS09

Wng

H242

H319

H315

H411

617-007-00-5

tert-butyl-α, α-dimethylbenzylperoxid

222-389-8

3457-61-2

Org. Perox. E

Skin Irrit. 2

Aquatic Chronic 2

H242

H315

H411

GHS02

GHS07

GHS09

Wng

H242

H315

H411

617-008-00-0

dibenzoylperoxid;

benzoylperoxid

202-327-6

94-36-0

Org. Perox. B

Eye Irrit. 2

Skin Sens. 1

H241

H319

H317

GHS01

GHS02

GHS07

Dgr

H241

H319

H317

617-010-00-1

1-hydroperoxycyclohexyl-1-hydroxycyclohexylperoxid; [1]

1,1'-dioxybiscyclohexan-1-ol; [2]

cyclohexylidenhydroperoxid; [3]

cyclohexanonperoxid [4]

201-091-1 [1]

219-306-2 [2]

220-279-4 [3]

235-527-7 [4]

78-18-2 [1]

2407-94-5 [2]

2699-11-8 [3]

12262-58-7 [4]

Org. Perox. A

Skin Corr. 1B

Acute Tox. 4 *

H240

H314

H302

GHS01

GHS05

GHS07

Dgr

H240

H314

H302

STOT SE 3; H335: C ≥ 5 %

C

617-010-01-9

1-hydroperoxycyclohexyl-1-hydroxycyclohexylperoxid; [1]

1,1'-dioxybiscyclohexan-1-ol; [2]

cyclohexylidenhydroperoxid;

[3] cyclohexanon, peroxid [4] [≤ 91 % opløsning]

201-091-1 [1]

219-306-2 [2]

220-279-4 [3]

235-527-7 [4]

78-18-2 [1]

2407-94-5 [2]

2699-11-8 [3]

12262-58-7 [4]

Org. Perox. C

Acute Tox. 4 *

Skin Corr. 1B

H242

H302

H314

GHS02

GHS05

GHS07

Dgr

H242

H302

H314

STOT SE 3; H335: C ≥ 5 %

C T

617-012-00-2

8-p-menthanylhydroperoxid;

p-menthanhydroperoxid

201-281-4

80-47-7

Org. Perox. D

Skin Corr. 1B

Acute Tox. 4 *

H242

H314

H332

GHS02

GHS05

GHS07

Dgr

H242

H314

H332

STOT SE 3; H335: C ≥ 5 %

617-013-00-8

O, O-tert-butyl-O-docosylmonoperoxyoxalat

404-300-6

116753-76-5

Org. Perox. C **** Aquatic Acute 1

Aquatic Chronic 1

H242

H400

H410

GHS02

GHS09

Dgr

H242

H410

617-014-00-3

6-(nonylamino)-6-oxo-peroxyhexansyre

406-680-9

104788-63-8

Org. Perox. C **** Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H242

H318

H317

H400

GHS02

GHS05

GHS07

GHS09

Dgr

H242

H318

H317

H400

617-015-00-9

bis(4-methylbenzoyl)peroxid

407-950-9

895-85-2

Org. Perox. B**** Aquatic Acute 1

Aquatic Chronic 1

H241

H400

H410

GHS01

GHS02

GHS09

Dgr

H241

H410

617-016-00-4

3-hydroxy-1,1-dimethylbutyl-2-ethyl-2-methylheptanperoxoat

413-910-1

—

Org. Perox. C **** Flam. Liq. 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H242

H226

H315

H400

H410

GHS02

GHS07

GHS09

Dgr

H242

H226

H315

H410

617-017-00-X

en blanding af 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzen og

2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzen

412-140-3

32144-25-5

Org. Perox. D

Aquatic Chronic 4

H242

H413

GHS02

Dgr

H242

H413

T

617-018-00-5

en blanding af 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxid,

63 vægtprocent og

1-methyl-1-(4-(1-methyl-

ethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxid, 31 vægtprocent

410-840-3

71566-50-2

Org. Perox. C ****

Aquatic Chronic 2

H242

H411

GHS02

GHS09

Dgr

H242

H411

T

617-019-00-0

6-(phthalimido)peroxyhexansyre

410-850-8

128275-31-0

Org. Perox. D

Eye Dam. 1

Aquatic Acute 1

H242

H318

H400

GHS02

GHS05

GHS09

Dgr

H242

H318

H400

T

617-020-00-6

1,3-di(prop-2,2-diyl)benzen bis(neodecanoylperoxid)

420-060-5

117663-11-3

Flam. Liq. 3

Org. Perox. D **** Aquatic Chronic 2

H226

H242

H411

GHS02

GHS09

Dgr

H226

H242

H411

617-021-00-1

methylethylketonperoxid trimer

429-320-2

—

Org. Perox. B****

Asp. Tox. 1

Skin Irrit. 2

Skin Sens. 1

H241

H304

H315

H317

GHS01

GHS02

GHS08

GHS07

Dgr

H241

H304

H315

H317

617-022-00-7

en blanding af 1,2-dimethylpropylidendihydroperoxid og dimethyl-1,2-benzendicarboxylat

442-480-8

—

Org. Perox. C

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H242

H302

H314

H317

H411

GHS02

GHS05

GHS07

GHS09

Dgr

H242

H302

H314

H317

H411

647-001-00-8

glucosidase, β-

232-589-7

9001-22-3

Resp. Sens. 1

H334

GHS08

Dgr

H334

647-002-00-3

cellulase

232-734-4

9012-54-8

Resp. Sens. 1

H334

GHS08

Dgr

H334

647-003-00-9

cellobiohydrolase, exo-

253-465-9

37329-65-0

Resp. Sens. 1

H334

GHS08

Dgr

H334

647-004-00-4

cellulaser undtagen sådanne nævnt andetsteds i dette bilag

—

—

Resp. Sens. 1

H334

GHS08

Dgr

H334

A

647-005-00-X

bromelain, saft

232-572-4

9001-00-7

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-006-00-5

ficin

232-599-1

9001-33-6

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-007-00-0

papain

232-627-2

9001-73-4

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-008-00-6

pepsin A

232-629-3

9001-75-6

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-009-00-1

rennin

232-645-0

9001-98-3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-010-00-7

trypsin

232-650-8

9002-07-7

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-011-00-2

chymotrypsin

232-671-2

9004-07-3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-012-00-8

subtilisin

232-752-2

9014-01-1

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

H335

H315

H318

H334

GHS08

GHS05

GHS07

Dgr

H335

H315

H318

H334

647-013-00-3

proteinase, mikrobiel neutral

232-966-6

9068-59-1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-014-00-9

proteaser undtagen sådanne nævnt andetsteds i dette bilag

—

—

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

H319

H335

H315

H334

GHS08

GHS07

Dgr

H319

H335

H315

H334

647-015-00-4

amylase, α-

232-565-6

9000-90-2

Resp. Sens. 1

H334

GHS08

Dgr

H334

647-016-00-X

amylaser undtagen sådanne nævnt andetsteds i dette bilag

—

—

Resp. Sens. 1

H334

GHS08

Dgr

H334

647-017-00-5

laccase

420-150-4

80498-15-3

Resp. Sens. 1

H334

GHS08

Dgr

H334

648-001-00-0

destillat (stenkulstjære), benzenfraktion;

letolie; [en sammensat blanding af carbonhydrider opnået ved destillationen af stenkulstjære. Den består af carbonhydrider, primært C4 til C10, med kogeinterval

omtrent fra 80 oC til

160 oC.]

283-482-7

84650-02-2

Carc. 1B

H350

GHS08

Dgr

H350

648-002-00-6

tjæreolier, brunkul; letolie;

[destillatet fra brunkulstjære, med kogeinterval omtrent fra 80 oC til 250 oC. Sammensat primært af aliphatiske og aromatiske carbonhydrider og monobasiske phenoler.]

302-674-4

94114-40-6

Carc. 1B

Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-003-00-1

benzenforløb (kul); redestilleret letolie, lavtkogende;

[destillat fra koksovns

letolie med et omtrentligt destillationsinterval under 100 oC. Sammensat primært af aliphatiske C4- til C6-carbonhydrider.]

266-023-5

65996-88-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-004-00-7

destillater (stenkulstjære), benzenfraktion, benzen-, toluen- og xylenrige;

redestilleret letolie, lavtkogende;

[en rest fra destillationen af rå benzen til fjernelse

af de første benzendestillationsprodukter.] Sammensat primært af benzen, toluen og xylen, med kogeinterval omtrent fra 75 oC til 200 oC.

309-984-9

101896-26-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-005-00-2

aromatiske carbonhydrider, C6-10-, C8-rige; redestilleret letolie,

lavtkogende

292-697-5

90989-41-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-006-00-8

solventnaphtha (kul), let; redestilleret letolie, lavtkogende

287-498-5

85536-17-0

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-007-00-3

solventnaphtha (kul), xylen-styrenfraktion; redestilleret letolie, mellemdestillat

287-502-5

85536-20-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-008-00-9

solventnaphtha (kul), coumaron-styrenholdig; redestilleret letolie,

mellemdestillat

287-500-4

85536-19-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-009-00-4

naphtha (kul), destillationsrester;

redestilleret letolie, højtkogende;

[resten tilbageblevet ved

destillation af genvundet naphta. Sammensat primært af naphthalen og kondensationsprodukter af inden og styren.]

292-636-2

90641-12-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-010-00-X

aromatiske carbonhydrider, C8; redestilleret letolie, højtkogende

292-694-9

90989-38-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-012-00-0

aromatiske carbonhydrider, C8-9, biprodukter fra carbonhydridharpikspolymerisation;

redestilleret letolie, højtkogende;

[en sammensat blanding af carbonhydrider opnået ved afdampning af solvent, under

vakuum, fra polymeriseret carbonhydridharpiks. Den består overvejende af aromatiske carbonhydrider,

overvejende C8 til og med C9, med kogeinterval omtrent fra 120 oC til

215 oC.]

295-281-1

91995-20-9

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-013-00-6

aromatiske carbonhydrider, C9-12-, benzendestillation;

redestilleret letolie, højtkogende

lavtkogende

295-551-9

92062-36-7

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-014-00-1

ekstraktionsrester (kul), alkalisk benzenfraktion, syreekstrakt;

syrefri letolie, lavtkogende;

[redestillatet fra destillatet,

befriet for tjæresyrer og tjærebaser, fra højtemperaturstjære fra bituminøse kul, med kogeinterval omtrent fra 90 oC til 160 oC. Det består overvejende af benzen, toluen og xylener.]

295-323-9

91995-61-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-015-00-7

ekstraktionsrester (stenkulstjære), benzolfraktion alkaliske, syreekstrakt;

syrefri letolie, lavtkogende

[en sammensat blanding af carbonhydrider opnået ved

redestillationen af destillatet af højtemperatursstenkulstjære (tjæresyre- og tjærebasefri). Den består overvejende af usubstituerede og substituerede monocycliske, aromatiske carbonhydrider med kogeinterval fra 85 oC til 195 oC.]

309-868-8

101316-63-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-016-00-2

ekstraktionsrester (kul), benzenfraktion, syre;

syrefri letolie, lavtkogende;

[et syreslamsbiprodukt fra svovlsyreraffineringen af rå højtemperaturskul. Sammensat primært af svovlsyre og organiske forbindelser.]

298-725-2

93821-38-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-017-00-8

ekstraktionsrester (kul), letolie alkaliske, destillationstopfraktioner;

syrefri letolie,

lavtkogende;

[den første fraktion fra destillation af aromatiske carbonhydrider, coumaron-, naphthalen- og indenrige præfraktioneringskolonnebundfraktioner eller vasket carbololie, kogt væsentligt under 145 oC.

Sammensat primært af C7 og C8 aliphatiske og aromatiske carbonhydrider.]

292-625-2

90641-02-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-018-00-3

ekstraktionsrester (kul), letolie-alkaliske, syreekstrakt, indenfraktion;

syrefri letolie, mellemdestillat

309-867-2

101316-62-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-019-00-9

ekstraktionsrester (kul), letolie alkaliske, indennaphthafraktion; syrefri letolie, højkogende;

[destillatet fra aromatiske carbonhydrider, coumaron-, naphthalen- og indenrige præfraktioneringskolonnebundfraktioner eller vasket

carbololie, med kogeinterval omtrent fra

155 oC til

180 oC. Sammensat primært af inden, indan og trimethylbenzener.]

292-626-8

90641-03-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-020-00-4

solventnaphtha (kul);

syrefri letolie, højtkogende;

destillatet fra enten højtemperatursstenkulstjære, koksovnsletolie eller alkalisk

ekstraktionsrest af stenkulstjæreolie, med et omtrentligt destillationsinterval fra 130 oC til 210 oC. Sammensat primært af inden og andre polycycliske ringsystemer indeholdende en enkelt aromatisk ring. Kan indeholde phenolforbindelser og aromatiske nitrogenbaser.]

266-013-0

65996-79-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-021-00-X

destillater (stenkulstjære), letolier, neutral fraktion; syrefri letolie, højtkogende

[et destillat fra den fraktionerede destillation af højtemperatursstenkulstjære. Sammensat primært af alkylsubstituerede, monocycliske, aromatiske carbonhydrider, med kogeinterval omtrent fra

135 oC til

210 oC. Kan også indeholde umættede carbonhydrider såsom inden og coumaron.]

309-971-8

101794-90-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-022-00-5

destillater (stenkulstjære), lette olier, syreekstrakter; syrefri letolie, højtkogende;

[denne olie er en sammensat blanding af aromatiske carbonhydrider, primært inden, naphthalen, coumaron, phenol og o-, m- og p-cresol, med kogeinterval fra 140 oC til 215 oC.]

292-609-5

90640-87-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-023-00-0

destillater (stenkulstjære), lette olier; karbololie;

[en sammensat blanding af carbonhydrider opnået ved destillation af stenkulstjære. Den består af aromater og andre carbonhydrider, phenolforbindelser og aromatiske nitrogenforbindelser og med destillationsinterval omtrent fra 150 oC

til 210 oC.]

283-483-2

84650-03-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-024-00-6

tjæreolier, stenkuls; letolie;

[destillat fra

højtemperatursstenkulstjære med et omtrentligt destillationsinterval fra 130 oC til 250 oC. Sammensat primært af naphthalen, alkylnaphthalener, phenolforbindelser og aromatiske nitrogenbaser.]

266-016-7

65996-82-9

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-026-00-7

ekstraktionsrester (kul), letolie alkaliske, syreekstrakt;

syrefri karbololie; [olien fremkommet ved syrevask

af alkalivasket carbololie for at fjerne mindre mængder af basiske forbindelser (tjærebaser).

Sammensat primært af inden,

indan og alkylbenzener.]

292-624-7

90641-01-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-027-00-2

ekstraktionsrester (kul), tjæreolie alkaliske;

syrefri karbololie [rest opnået fra stenkulstjæreolie ved en alkalisk vask, såsom

vandig natriumhydroxid, efter fjernelsen af råstenkulstjæresyrer. Sammensat primært af naphthalener og aromatiske

nitrogenbaser.]

266-021-4

65996-87-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-028-00-8

ekstraktionsolier (stenkul), letolier; syreekstrakt;

[det vandige ekstrakt fremstillet ved sur vask af alkalivasket carbololie. Sammensat

primært af syresalte af forskellige aromatiske nitrogenbaser, inklusive pyridin, quinolin og deres alkylderivater.]

292-622-6

90640-99-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-029-00-3

pyridin, alkylderivater; råtjærebaser;

[den sammensatte blanding af polyalkylerede pyridiner opnået

ved stenkulstjæredestillation eller som højtkogende destillater, omtrent højere end 150 oC, fra reaktion mellem ammoniak

og acetaldehyd, formaldehyd

eller paraformaldehyd.]

269-929-9

68391-11-7

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-030-00-9

tjærebaser, stenkuls-, picolinfraktion;

basedestillater;

[pyridinbaser, med kogeinterval omtrent fra 125 oC til 160 oC, opnået ved destillation af et neutraliseret syreekstrakt fra den baseholdige tjærefraktion, opnået ved destillationen af bituminøs stenkulstjære. Sammensat hovedsagelig af lutidiner og picoliner.]

295-548-2

92062-33-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-031-00-4

tjærebaser, stenkuls-, lutidinfraktion;

basedestillater

293-766-2

91082-52-9

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-032-00-X

ekstraktionsolier (kul), tjærebase, collidinfraktion;

basedestillater;

[ekstraktet fremstillet ved den sure ekstraktion af baser fra aromatiske olier fra rå kultjære, neutralisation og destillation af baserne. Sammensat primært af collidiner, anilin, toluidiner, lutidiner og xylidiner.]

273-077-3

68937-63-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-033-00-5

tjærebaser, stenkuls-, collidinfraktion;

basedestillater;

[destillationsfraktionen, med kogeinterval omtrent fra

181 oC til 186 oC,

fra råbaser, opnået fra den neutraliserede,

syreekstraherede, baseholdige tjærefraktion, opnået ved destillationen af bituminøs stenkulstjære. Den indeholder hovedsagelig anilin og collidiner.]

295-543-5

92062-28-7

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-034-00-0

tjærebaser, stenkuls-, anilinfraktion; basedestillater;

[destillationsfraktionen med kogeinterval omtrent fra

180 oC til 200 oC,

fra råbaser opnået ved at fjerne phenoler og

baser fra den carbolerede olie fra destillationen af stenkulstjære.

Den indeholder hovedsagelig anilin, collidiner, lutidiner og toluidiner.]

295-541-4

92062-27-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-035-00-6

tjærebaser, stenkuls-, toluidinfraktion;

basedestillater

293-767-8

91082-53-0

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-036-00-1

destillater (råolie), alken-alkyn-fabrikations-pyrolyseolie, blandet med højtemperatursstenkulstjære, indenfraktion;

redestillater;

[en sammensat blanding af carbonhydrider opnået som et redestillat fra den fraktionerede destillation af højtemperaturstjære fra bituminøse kul, og restolier, der er opnået fra den pyrolytiske fremstilling af alkener og alkyner ud fra råolieprodukter eller naturgas. Den består overvejende af inden og har kogeinterval omtrent fra 160 oC til 190 oC.]

295-292-1

91995-31-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-037-00-7

destillater (kul), stenkulstjære-restpyrolyseolier, naphthalenolier;

redestillater;

[redestillatet, opnået fra den fraktionerede destillation af højtemperaturstjære fra bituminøse kul og pyrolyserestolier, med kogeinterval omtrent fra 190 oC til 270 oC. Sammensat primært af substituerede, bicycliske aromater.]

295-295-8

91995-35-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-038-00-2

ekstraktionsrester (kul), stenkulstjære restpyrolyseolier, naphthalenolie, restdestillat; redestillater;

[redestillatet fra den fraktionerede destillation af phenol og basefri methylnaphthalenolie opnået fra højtemperaturstjære fra bituminøse kul og restpyrolyseolier, med kogeinterval omtrent fra 220 oC til 230 oC. Det består overvejende af usubstituerede og substituerede, bicycliske, aromatiske carbonhydrider.]

295-329-1

91995-66-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-039-00-8

ekstraktionsolier (stenkul), stenkulstjære rest-pyrolyseolier, naphthalenolier;

redestillater;

[en neutral olie opnået ved fjernelse af base og phenol fra olien opnået ved destillation af højtemperaturstjære og pyrolyserestolier, med kogeinterval omtrent fra 225 oC til 255 oC. Sammensat primært af substituerede bicykliske aromatiske carbonhydrider.]

310-170-0

122070-79-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-040-00-3

ekstraktionsolier (stenkul), stenkulstjære rest-pyrolyseolier, naphthalenolie, destillationsrester;

redestillater;

[rest fra destillationen af

methylnaphthalenolie (fra tjære fra bituminøse kul og pyrolyserestolier), der er befriet for phenol og baser, med et

kogeinterval fra 240 oC til

260 oC. Sammensat primært af substituerede bicykliske aromatiske og heterocycliske carbonhydrider.]

310-171-6

122070-80-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-041-00-9

absorptionsolier, bicycliske aromater og heterocyclisk carbonhydridfraktion;

redestilleret vaskeolie;

[en sammensat blanding af carbonhydrider opnået som et redestillat fra destillationen

af vaskeolie. Den består overvejende af 2-ringede aromatiske og heterocycliske carbonhydrider, med kogeinterval omtrent fra 260 oC til 290 oC.]

309-851-5

101316-45-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-042-00-4

destillater (stenkulstjære), øvre, fluorenrige;

redestilleret vaskeolie;

[en sammensat blanding af carbonhydrider opnået ved

krystallisationen af tjæreolie. Den består af aromatiske og polycycliske carbonhydrider, primært fluoren og noget acenaphthen.]

284-900-0

84989-11-7

Carc. 1B

H350

GHS08

Dgr

H350

M

648-043-00-X

creosotolie, acenaphthenfraktion, acenaphthenfri; redestilleret vaskeolie;

[den tiloversblevne olie efter fjernelse,

ved en krystallisationsproces, af acenaphthen fra acenaphthenolie fra stenkulstjære. Sammensat primært af naphthalen og alkylnaphthalener.]

292-606-9

90640-85-0

Carc. 1B

H350

GHS08

Dgr

H350

M

648-044-00-5

destillater (stenkulstjære), tunge olier; tung antracenolie; [destillater, fra fraktioneret destillation af stenkulstjære fra bituminøse kul, med kogeinterval omtrent fra 240 oC til 400 oC. Sammensat primært af tri- og polycycliske, carbonhydrider og heterocycliske forbindelser.]

292-607-4

90640-86-1

Carc. 1B

H350

GHS08

Dgr

H350

648-045-00-0

destillater (stenkulstjære), øvre; tung antracenolie;

[destillatet fra stenkulstjære

med et omtrentligt destillationsinterval fra 220 oC til 450 oC. Sammensat primært af aromatiske carbonhydrider,

bestående af tre- til firleddede kondenserede ringe og andre carbonhydrider.]

266-026-1

65996-91-0

Carc. 1B

H350

GHS08

Dgr

H350

M

648-046-00-6

anthracenolie, syreekstrakt; basefri antracenolie; [en sammensat blanding af carbonhydrider, fra den basebefriede fraktion opnået fra destillationen af stenkulstjære, med kogeinterval omtrent fra 325 oC til 365 oC. Den indeholder overvejende anthracen og phenanthren og deres alkylderivater]

295-274-3

91995-14-1

Carc. 1B

H350

GHS08

Dgr

H350

M

648-047-00-1

destillater (stenkulstjære); tung antracenolie;

[destillatet fra stenkulstjære med et omtrentligt destillationsinterval fra 100 oC til 450 oC. Sammensat primært af aromatiske carbonhydrider, bestående af to- til firleddede kondenserede ringe, phenolforbindelser og aromatiske nitrogenbaser.]

266-027-7

65996-92-1

Carc. 1B

H350

GHS08

Dgr

H350

M

648-048-00-7

destillater (stenkulstjære), beg-, tunge olier;

tung antracenolie;

[destillatet fra destillationen

af begen opnået fra bituminøs

højtemperaturstjære. Sammensat primært af tri- og polycycliske aromatiske carbonhydrider,

med kogeinterval omtrent fra 300 oC til 470 oC. Produktet kan også indeholde heteroatomer.]

295-312-9

91995-51-6

Carc. 1B

H350

GHS08

Dgr

H350

M

648-049-00-2

destillater (kultjære) beg; tung antracenolie;

[olien opnået ved kondensering af dampene fra varmebehandlingen af beg.

Sammensat primært af to- til firringede aromatiske forbindelser, med kogeinterval omtrent fra 200 oC til mere end 400 oC.]

309-855-7

101316-49-8

Carc. 1B

H350

GHS08

Dgr

H350

M

648-050-00-8

destillater (stenkulstjære), tunge olier, pyrenfraktion;

redestilleret tung antracenolie;

[redestillatet, opnået fra fraktioneret destillation af

begdestillat, med kogeinterval omtrent fra 350 oC til 400 oC. Består overvejende af tri- og polycycliske aromater og heterocycliske carbonhydrider.]

295-304-5

91995-42-5

Carc. 1B

H350

GHS08

Dgr

H350

M

648-051-00-3

destillater (stenkulstjære), beg-, pyrenfraktion;

redestilleret tung antracenolie;

[redestillatet, opnået fra fraktioneret destillation af

begdestillat, med kogeinterval omtrent fra 380 oC til 410 oC. Sammensat primært af tri- og polycycliske aromatiske carbonhydrider og heteocycliske forbindelser.]

295-313-4

91995-52-7

Carc. 1B

H350

GHS08

Dgr

H350

M

648-052-00-9

paraffinvokser (kul), brunkulhøjtemperaturstjære, carbonbehandlet;

syre- og basefri kultjære; [en sammensat blanding af carbonhydrider opnået ved behandlingen af brunkul-forkulningstjære med aktivt kul for at fjerne sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.] Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.]

308-296-6

97926-76-6

Carc. 1B

H350

GHS08

Dgr

H350

M

648-053-00-4

paraffinvokser (kul), brunkulhøjtemperaturstjære, lerbehandlet; syre- og basefri kultjære;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af brunkul-forkulningstjære med bentonit for at fjerne sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.]

308-297-1

97926-77-7

Carc. 1B

H350

GHS08

Dgr

H350

M

648-054-00-X

beg; tjærebeg

263-072-4

61789-60-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-055-00-5

beg, kultjære-, højtemperaturs-; tjærebeg; [resten fra destillationen af højtemperatursstenkulstjære. Et sort, fast stof med et blødgøringspunkt omtrent fra 30 oC til 180 oC. Består primært af en sammensat blanding af aromatiske carbonhydrider, bestående af tre- eller flerleddede kondenserede ringe.]

266-028-2

65996-93-2

Carc. 1B

H350

GHS08

Dgr

H350

648-056-00-0

beg, kultjære, højtemperatur, varmebehandlet; tjærebeg; [den varmebehandlede rest fra destillationen af

højtemperaturstenkulstjære. Et sort, fast stof med et blødgøringspunkt omtrent fra 80 oC til 180 oC. Sammensat primært af en kompleks blanding af tre- eller flerleddede, kondenserede, aromatiske carbonhydrider.]

310-162-7

121575-60-8

Carc. 1B

H350

GHS08

Dgr

H350

M

648-057-00-6

beg, kultjære-, højtemperaturs, sekundær;

redestilleret tjærebeg; [resten opnået under destillationen af højtkogende fraktioner fra højtemperaturstjære fra bituminøse kul og/eller begkoksolie, med et blødgøringspunkt fra 140 oC til 170 oC ifølge DIN 52025. Sammensat primært af tri-og polycycliske, aromatiske forbindelser, som også indeholder heteroatomer.]

302-650-3

94114-13-3

Carc. 1B

H350

GHS08

Dgr

H350

M

648-058-00-1

rester (stenkulstjære), begdestillations-; redestilleret tjærebeg;

[rest, fra den fraktionerede destillation af begdestillat,

med kogeinterval omtrent fra 400 oC til 470 oC. Sammensat primært af polycycliske, aromatiske carbonhydrider og heterocycliske forbindelser.]

295-507-9

92061-94-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-059-00-7

tjære, stenkuls-, højtemperatur, destillations- og oplageringsrester;

kultjæresediment;

[koks- og askeholdige, faste rester, der adskilles ved destillation og termisk behandling af højtemperaturstjære fra bituminøse kul i destillationsinstallationer og oplageringsbeholdere. Består overvejende af carbon, og indeholder små mængder af heteroforbindelser, så vel som askekomponenter.]

295-535-1

92062-20-9

Carc. 1B

H350

GHS08

Dgr

H350

M

648-060-00-2

tjære, stenkuls-, lagerrester; kultjæresediment;

[aflejringer, fjernet fra lagre af rå stenkulstjære. Består primært af stenkulstjære og kulholdigt, findelt stof.]

293-764-1

91082-50-7

Carc. 1B

H350

GHS08

Dgr

H350

M

648-061-00-8

tjære, stenkuls-, højtemperaturs-, rester, kultjæresediment;

[faste stoffer dannet under

forkoksningen af bituminøse kul for at fremstille rå højtemperaturstjære. Sammensat primært af koks- og kulpartikler, højt aromatiserede forbindelser og mineralske stoffer.]

309-726-5

100684-51-3

Carc. 1B

H350

GHS08

Dgr

H350

M

648-062-00-3

tjære, stenkuls-, højtemperatur, højt indhold af faste stoffer;

kultjæresediment;

[kondensationsproduktet opnået ved køling, omtrent til omgivende temperatur, af gassen udviklet ved højtemperaturstørdestillationen (højere end 700 oC) af kul. Består primært af en sammensat blanding af kondenserede aromatiske carbonhydrider med et højt faststof indhold af kul-og koks-lignende materialer.]

273-615-7

68990-61-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-063-00-9

affaldsstoffer, faste, kultjærebegsforkoksnings-;

kultjæresediment;

[det samlede affald dannet ved forkoksningen af bituminøs kultjærebeg. Der består overvejende af carbon.]

295-549-8

92062-34-5

Carc. 1B

H350

GHS08

Dgr

H350

M

648-064-00-4

ekstraktrester (kul), brunkul; syre- og basefri kultjære;

[resten fra toluenekstraktion af tørret brunkul.]

294-285-0

91697-23-3

Carc. 1B

H350

GHS08

Dgr

H350

M

648-065-00-X

paraffinvokser (kul), brunkulshøjtemperaturstjære;

syre -og basefri kultjære; [en sammensat blanding af carbonhydrider, opnået fra brunkulsforkulningstjære ved solventkrystallisation (solventafoliering), ved svedning eller en adduktionsproces. Den består overvejende af ligekædede og

forgrenede, mættede carbonhydrider, overvejende større end C12.]

295-454-1

92045-71-1

Carc. 1B

H350

GHS08

Dgr

H350

M

648-066-00-5

paraffinvokser (kul), brunkulshøjtemperaturstjære, hydrogenbehandlede;

syre -og basefri kultjære; [en sammensat blanding af carbonhydrider, opnået fra brunkulsforkulningstjære ved solventkrystallisation (solventafoliering), ved svedning eller en adduktionsproces, behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af ligekædede og forgrenede, mættede carbonhydrider, overvejende større end C12.]

295-455-7

92045-72-2

Carc. 1B

H350

GHS08

Dgr

H350

M

648-067-00-0

paraffinvokser (kul), brunkulhøjtemperaturstjære, kiselsyrebehandlet;

syre- og basefri kultjære;

[en sammensat blanding af carbonhydrider opnået ved

behandlingen af brunkul-forkulningstjære med kiselsyre for af fjerne sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større

end C12.]

308-298-7

97926-78-8

Carc. 1B

H350

GHS08

Dgr

H350

M

648-068-00-6

tjære, stenkuls-, lavtemperatur, destillationsrester;

kultjæreolie, mellemdestillat; [rester fra fraktioneret destillation af lavtemperatursstenkulstjære for at fjerne olier, der koger i området op til omtrent 300 oC. Sammensat primært af aromatiske forbindelser.]

309-887-1

101316-85-2

Carc. 1B

H350

GHS08

Dgr

H350

M

648-069-00-1

beg, kultjære-, lavtemperatur, tjærebeg;

[et sammensat sort, fast, eller halvfast stof opnået ved destillation af en lavtemperaturstenkulstjære. Det har et blødgøringspunkt mellem omtrent 40 oC og 180 oC. Sammensat primært af en kompleks blanding af carbonhydrider.]

292-651-4

90669-57-1

Carc. 1B

H350

GHS08

Dgr

H350

M

648-070-00-7

beg, kultjære, lavtemperatur, oxideret;

tjærebeg, oxideret;

[produktet opnået ved at luftgennemblæse lavtemperaturkultjærebeg ved forhøjet temperatur. Det har et blødgøringspunkt mellem omtrent 70 oC og

180 oC. Sammensat primært af en kompleks blanding af carbonhydrider.]

292-654-0

90669-59-3

Carc. 1B

H350

GHS08

Dgr

H350

M

648-071-00-2

beg, kultjære-, lavtemperatur, varmebehandlet;

tjærebeg, oxideret; tjærebeg, varmebehandlet;

[et sammensat sort, fast, stof opnået

ved varmebehandling af lavtemperaturkultjærebeg. Det har et blødgøringspunkt mellem omtrent 50 oC og 140 oC. Sammensat primært af en kompleks blanding af aromatiske forbindelser.]

292-653-5

90669-58-2

Carc. 1B

H350

GHS08

Dgr

H350

M

648-072-00-8

destillater (kul og råolie), kondenserede aromat-;

destillater;

[destillatet fra en blandning af stenkulstjære og aromatiske råoliestrømme med destillationsområde omtrent fra 220 oC til 450 oC. Sammensat primært af aromatiske carbonhydrider, bestående af 3- til 4-ledede kondenserede ringe.]

269-159-3

68188-48-7

Carc. 1B

H350

GHS08

Dgr

H350

M

648-073-00-3

aromatiske carbonhydrider, C20-28-, polycycliske, blandet kultjærebeg, polyethylen og polypropylen, pyrolyse-afledte; pyrolyseprodukter;

[en sammensat blanding af carbonhydrider opnået ved pyrolyse af blandet kultjærebeg, polyethylen og polypropylen. Sammensat primært af polycycliske, aromatiske carbonhydrider, overvejende C20 til og med C28, med et blødgøringspunkt fra 100 oC til 220 oC ifølge DIN 52025.]

309-956-6

101794-74-5

Carc. 1B

H350

GHS08

Dgr

H350

M

648-074-00-9

aromatiske carbonhydrider, C20-28-, polycycliske, blandet kultjærebeg og polyethylen, pyrolyseafledte;

pyrolyseprodukter;

[en sammensat blanding af carbonhydrider opnået ved

pyrolyse af blandet kultjærebeg og polyethylen. Sammensat primært af polycycliske, aromatiske carbonhydrider, overvejende C20 til og med C28, med et blødgøringspunkt fra 100 oC til 220 oC ifølge DIN 52025.]

309-957-1

101794-75-6

Carc. 1B

H350

GHS08

Dgr

H350

M

648-075-00-4

aromatiske carbonhydrider, C20-28-, polycycliske, blandet kultjærebeg og polystyren, pyrolyseafledte;

pyrolyseprodukter;

[en sammensat blanding af carbonhydrider opnået ved

pyrolyse af blandet kultjærebeg og polystyren. Sammensat primært af polycycliske, aromatiske carbonhydrider, overvejende C20 til og med C28, med et blødgøringspunkt fra 100 oC til

220 oC

ifølge DIN 52025.]

309-958-7

101794-76-7

Carc. 1B

H350

GHS08

Dgr

H350

M

648-076-00-X

beg, kultjære- og råolie-; tjærebeg;

[resten fra destillationen af en blanding af stenkulstjære og aromatiske råoliestrømme. Et fast stof med et blødgøringspunkt fra 40 oC til

180 oC. Sammensat primært af en kompleks blanding af aromatiske carbonhydrider, bestående af tre- eller flerleddede kondenserede ringe.]

269-109-0

68187-57-5

Carc. 1B

H350

GHS08

Dgr

H350

M

648-077-00-5

phenanthren, destillationsrester; redestilleret tung antracenolie;

[rest, fra destillationen af rå phenanthren, kogende i

området omtrent fra 340 oC til 420 oC. Den består overvejende af phenanthren, anthracen og carbazol.]

310-169-5

122070-78-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-078-00-0

destillater (stenkulstjære), øvre, fluorenfri; redestilleret vaskeolie;

[en sammensat blanding af carbonhydrider opnået ved

krystallisationen af tjæreolie. Den består af aromatiske, polycykliske carbonhydrider, primært diphenyl, dibenzofuran og acenaphthen.]

284-899-7

84989-10-6

Carc. 1B

H350

GHS08

Dgr

H350

M

648-079-00-6

anthracenolie; antracenolie;

[en sammensat blanding af polycycliske aromatiske carbonhydrider opnået fra stenkulstjære, med destillationsinterval omtrent fra 300 oC til 400 oC. Sammensat primært af phenanthren, anthracen og carbazol.]

292-602-7

90640-80-5

Carc. 1B

H350

GHS08

Dgr

H350

M

648-080-00-1

rester (stenkulstjære), creosotolie detillations-; redestilleret vaskeolie;

[resten, fra fraktioneret destillation af vaskeolie, med kogeinterval omtrent fra 270 oC til 330 oC. Den består overvejende af bicycliske aromatiske og heterocycliske carbonhydrider.]

295-506-3

92061-93-3

Carc. 1B

H350

GHS08

Dgr

H350

M

648-081-00-7

tjære, stenkuls-; stenkulstjære;

[biproduktet fra tørdestillation af kul. Næsten sort halvfast stof. En sammensat blanding af

aromatiske carbonhydrider, phenolforbindelser, nitrogenbaser og thiophen.]

232-361-7

8007-45-2

Carc. 1A

H350

GHS08

Dgr

H350

648-082-00-2

tjære, stenkuls-, højtemperaturs-; stenkulstjære; [kondensationsproduktet opnået ved at nedkøle, til omtrent omgivelsestemperatur, den gas, der udvikles ved tørdestillation af kul ved høj temperatur (højere end 700 oC). En sort, viskøs væske tungere end vand. Består primært af en sammensat blanding af kondenserede aromatiske carbonyhdrider. Kan indeholde mindre mængder phenolforbindelser og aromatiske nitrogenbaser.]

266-024-0

65996-89-6

Carc. 1A

H350

GHS08

Dgr

H350

648-083-00-8

tjære, stenkuls-, lavtemperatur; stenkulsolie;

[kondensationsproduktet opnået ved at nedkøle, til omtrent omgivelsestemperatur, den gas, der udvikles ved tørdestillation af kul ved lav temperatur (lavere end 700 oC). En sort, viskøs væske tungere end vand. Sammensat primært af kondenserede aromatiske carbonhydrider, phenolforbindelser, aromatiske nitrogenbaser og deres alkylderivater.]

266-025-6

65996-90-9

Carc. 1A

H350

GHS08

Dgr

H350

648-084-00-3

destillater (kul), koksovns-letolie, naphthalenfraktion; naftalinolie;

[den sammensatte blanding af carbonhydrider opnået ved præfraktionering (kontinuerlig

destillation) af koksovnsletolie. Den består overvejende af naphtalen, coumaron og inden og koger højere end

148 oC.]

285-076-5

85029-51-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-085-00-9

destillater (stenkulstjære), naph

thalenolier; naftalinolie;

[en sammensat blanding af carbonhydrider opnået ved

destillationen af stenskulstjære. Den består primært af aromater og andre carbonhydrider, phenolforbindelser og aromatiske nitrogenforbindelser med destillationsinterval omtrent fra 200 oC til 250 oC.]

283-484-8

84650-04-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-086-00-4

destillater (stenkulstjære), naphthalenolier, med lavt indhold af naphthalen; redestilleret naftalinolie; [en sammensat blanding af carbonhydrider opnået ved krystallisation af naphthalenolie. Sammensat primært af naphthalen, alkylnaphthalen og phenolforbindelser.]

284-898-1

84989-09-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-087-00-X

destillater (stenkulstjære), naphthalenolie-krystallisationsmoderlud; redestilleret naftalinolie;

[en sammensat blanding af organiske forbindelser, opnået som

et filtrat fra krystallisationen af naphthalenfraktionen fra stenkulstjære, med kogeinterval

omtrent fra 200 oC til

230 oC. Indeholder hovedsagelig naphthalen, thionaphthalen og alkylnaphthalener.]

295-310-8

91995-49-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-088-00-5

ekstraktionsrester (stenkul), naphtahalenolie, alkaliske; syrefri naftalinolie

;

[en sammensat blanding af carbonhydrider opnået fra den

alkaliske vask af naphthalenolie for at fjerne phenolforbindelser (tjæresyrer). Den består af naphthalen og alkylnaphthalener.]

310-166-9

121620-47-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-089-00-0

ekstraktionsrester (stenkul), naphthalenolie, alkaliske, med lavt indhold af naphthalen;

syrefri naftalinolie

;

[en sammensat blanding af carbonhydrider, der er blevet tilbage efter

fjernelsen af naphthalen fra alkalivasket naphthalenolie ved en krystalliseringsproces. Den er sammensat primært af

naphthalen og alkylnaphthalener.]

310-167-4

121620-48-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-090-00-6

destillater (stenkulstjære), naphthalenolier, naphthalenfrie, alkaliske ekstrakter;

syrefri naftalinolie

;

[Den tilbageblevne olie efter fjernelse af phenolforbindelser (tjæresyrer) fra drænet naphthalenolie ved en alkalisk vask. Sammensat primært af naphthalen og alkylnaphthalener.]

292-612-1

90640-90-7

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-091-00-1

ekstrationsrester (kul), naphthalenolie alkaliske, destillationstopfraktioner;

syrefri naftalinolie

;

[destillatet fra alkalivasket naphthalenolie med destillationsinterval omtrent fra 180 oC til 220 oC. Sammensat primært af naphthalen,

alkylbenzener, inden og indan.]

292-627-3

90641-04-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-092-00-7

destillater (stenkulstjære), naphthalenolier, methylnaphthalenfraktion;

methylnaftalin;

[et destillat fra den fraktionerede destillation af højtemperaturs-

stenkulstjære. Sammensat primært af substituerede, bicycliske, aromatiske carbonhydrider og aromatiske nitrogenbaser med kogeinterval omtrent fra 225 oC til 255 oC.]

309-985-4

101896-27-9

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-093-00-2

destillater (stenkulstjære), naphthalenolier, indol-methylnaphthalenfraktion; methylnaftalin;

[et destillat fra den fraktionerede destillation af højtemperaturs-

stenkulstjære. Sammensat primært af indol og methylnaphthalen, med kogeinterval omtrent fra 235 oC til 255 oC.]

309-972-3

101794-91-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-094-00-8

destillater (stenkulstjære), naphtalenolier, syreekstrakter; methylnaftalinolie;

[en sammensat blanding af carbonhydrider, opnået ved

at fjerne baser fra methylnaphthalenfraktionen opnået ved destillation af stenkulstjære, med kogeinterval omtrent fra 230 oC til 255 oC. Indeholder hovedsagelig 1(2)-methylnaphthalen, naphthalen, dimethylnaphthalen og biphenyl.]

295-309-2

91995-48-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-095-00-3

ekstraktionsrester (kul), naphthalenolie alkaliske, destillationsrester; methylnaftalinolie; [resten fra destillationen af alkalivasket naphthalenolie, med destillationsinterval omtrent fra 220 oC til 300 oC. Sammensat primært af naphthalen, alkylnaphthalener og aromatiske nitrogenbaser.]

292-628-9

90641-05-7

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-096-00-9

ekstraktionsolier (kul), sure, tjærebase-frie;

methylnaftalinolie;

[ekstraktionsolien, med kogeinterval omtrent fra 220 oC til 265 oC, fra alkaliske stenkultjære-ekstraktionsrester fremstillet ved en sur vask, såsom vandig svovlsyre, efter destillation for at fjerne tjærebaser. Sammensat primært af alkylnaphthalener.]

284-901-6

84989-12-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-097-00-4

destillater (stenkulstjære), benzolfraktion, destillationsrester;

vaskeolie;

[en sammensat blanding af carbonhydrider opnået ved

destillation af rå benzol (højtemperaturstenkulstjære). Den kan være en væske med et destillationsinterval omtrent fra 150 oC til 300 oC eller et halvfast eller fast stof med et smeltepunkt på op til 70 oC. Den er sammensat primært af naphthalen og alkylnaphthalener.]

310-165-3

121620-46-0

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-098-00-X

creosotolie, acenaphthenfraktion;

vaskeolie; [en sammensat blanding af carbonhydrider, fremstillet ved destillation af stenkulstjære, med kogeinterval omtrent fra 240 oC til 280 oC. Sammensat primært af acenaphthen, naphthalen og alkylnaphthalen.]

292-605-3

90640-84-9

Carc. 1B

H350

GHS08

Dgr

H350

M

648-099-00-5

creosotolie;

[En sammensat blanding af carbonhydrider opnået ved destillationen af stenkulstjære. Den

består primært af aromatiske carbonhydrider og kan indeholde betydelige mængder tjæresyrer og tjærebaser. Den destillerer i området omtrent fra 200 oC til 325 oC.]

263-047-8

61789-28-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-100-00-9

creosotolie, højtkogende destillat;

vaskeolie;

[Den højtkogende destillationsfraktion opnået fra højtemperaturforkulningen af bituminøse kul, som yderligere raffineres for at fjerne overskud af krystallinske salte. Den består primært af creosotolie, hvorfra nogle af de normale polycykliske aromatiske salte, som er komponenter af stenkulstjæredestillater, er fjernet. Den er krystalfri ved omtrent 5 oC.]

274-565-9

70321-79-8

Carc. 1B

H350

GHS08

Dgr

H350

M

648-101-00-4

creosot;

[destillatet af stenkulstjære fremstillet ved højtemperatursforkulning af bituminøs kul. Det består primært af aromatiske carbonhydrider, tjæresyrer og tjærebaser.]

232-287-5

8001-58-9

Carc. 1B

H350

GHS08

Dgr

H350

648-102-00-X

ekstraktionsrester (stenkul), creosotolie sure;

vaskeolieekstraktionsrest;

[en sammensat blanding af carbonhydrider fra den basebefriede fraktion fra destillationen af stenkulstjære, med kogeinterval omtrent fra 250 oC til 280 oC. Den består overvejende af biphenyl og isomere diphenylnaphthener.]

310-189-4

122384-77-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-103-00-5

Anthracenolie, anthracenpasta;

Antracenoliefraktion;

det anthracenrige faste stof, der fremkommer ved krystallisation og centrifugering af anthracenolie. Det er sammensat primært af anthracen, carbazol og phenanthren.]

292-603-2

90640-81-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-104-00-0

anthracenolie, med lavt indhold af anthracen; antracenoliefraktion;

[den tiloversblevne olie efter fjernelse, ved en krystallisationsproces, af et anthracenrigt fast stof (anthracenpasta) fra anthracenolie. Den er sammensat primært af bi, tri og tetracykliske aromatiske forbindelser.]

292-604-8

90640-82-7

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-105-00-6

rester (stenkulstjære), anthracenolie destillations-; antracenoliefraktion;

[resten fra fraktioneret destillation af rå anthracen, med kogeinterval omtrent fra 340 oC til 400 oC. Den består overvejende af tri- og polycycliske, aromatiske og heterocycliske carbonhydrider.]

295-505-8

92061-92-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-106-00-1

anthracenolie, anthracenpasta, anthracenfraktion; antracenoliefraktion;

[en sammensat blanding af

carbonhydrider fra destillationen af anthracen, opnået ved krystallisation af anthracenolie fra bituminøs højtemperaturstjære, med kogeinterval omtrent fra 330 oC til 350 oC. Den indeholder hovedsagelig anthracen,

carbazol og phenanthren.]

295-275-9

91995-15-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-107-00-7

anthracenolie, anthracenpasta, carbazolfraktion; antracenoliefraktion;

[en sammensat blanding af carbonhydrider fra destillationen af anthracen, opnået ved krystallisation af anthracenolie fra højtemperaturstjære fra bituminøse kul, med kogeinterval omtrent fra 350 oC til 360 oC. Den indeholder hovedsagelig anthracen, carbazol og phenanthren.]

295-276-4

91995-16-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-108-00-2

anthracenolie, anthracenpasta, lette destillationsfraktioner;

antracenoliefraktion;

[en sammensat blanding af carbonhydrider fra destillationen af anthracen, opnået ved krystallisation af anthracenolie fra bituminøs højtemperaturstjære, med kogeinterval omtrent fra 290 oC til 340 oC. Den indeholder hovedsagelig tricycliske aromater og deres dihydroderivater.]

295-278-5

91995-17-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-109-00-8

tjæreolier, stenkuls-, lavtemperaturs; kultjæreolie, højtkogende;

[et destillat fra lavtemperatursstenkulstjære. Sammensat primært af carbonhydrider, phenolforbindelser og aromatiske nitrogenbaser, med kogeinterval omtrent fra 160 oC til 340 oC.]

309-889-2

101316-87-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-110-00-3

ekstraktionsrester (stenkul), lavtemperaturstenkulstjære alkaliske;

[resten fra lavtemperaturstenkulstjæreolier efter en alkalisk vask, såsom vandig natriumhydroxid, for at fjerne råstenkulstjæresyrer. Sammensat primært af carbonhydrider og aromatiske nitrogenbaser.]

310-191-5

122384-78-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-111-00-9

phenoler, ammoniakludsekstrakt; alkaliske ekstrakter;

[blandingen af phenoler, ekstraheret ved brug af isobutylacetat, fra ammoniakluden, der er kondenseret fra gassen fra lavtemperaturstørdestillation (mindre end 700 oC) af kul. Den består overvejende af en blanding af mono og dihydroxyphenoler.]

284-881-9

84988-93-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-112-00-4

destillater (stenkulstjære), letolier, alkaliske ekstrakter;

alkaliske ekstrakter;

[det vandige ekstrakt fra carbololie fremstillet ved en alkalisk vask med f. eks. vandig natriumhydroxid. Sammensat primært af alkalimetalsalte af forskellige phenolforbindelser.]

292-610-0

90640-88-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-113-00-X

ekstrakter, stenkulstjæreolie, alkaliske; alkaliske ekstrakter;

[ekstrakt fra stenkulstjæreolie fremstillet ved en alkalisk vask med f.eks. vandig natriumhydroxid. Sammensat primært af alkalimetalsalte af forskellige phenolforbindelser.]

266-017-2

65996-83-0

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-114-00-5

destillater (stenkulstjære), naph

thalenolier, alkaliske ekstrakter; alkaliske ekstrakter;

[det vandige ekstrakt fra naph

thalenolie fremstillet ved en alkalisk vask med f. eks vandig natriumhydroxid. Sammensat primært af alkalimetalsalte af forskellige phenolforbindelser.]

292-611-6

90640-89-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-115-00-0

ekstraktionsrester (kul), tjæreolie, alkaliske, carbonaterede, kalkede;

råfenol; [produktet fra behandling af et alkalisk stenkulstjæreolieekstrakt med CO2 og CaO. Sammensat primært af CaCO3, Ca(OH)2, Na2CO3 og andre organiske og uorganiske urenheder.]

292-629-4

90641-06-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-116-00-6

tjæresyrer, stenkuls-, rå; råfenol;

[reaktionsprodukt opnået ved at neutralisere alkalisk ekstrakt fra stenkulstjæreolie med en sur opløsning, såsom vandig svovlsyre, eller gasformig carbondioxid, for at udvinde de frie syrer. Sammensat primært af tjæresyrer såsom phenol, cresoler og xylenoler.]

266-019-3

65996-85-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-117-00-1

tjæresyrer, brunkuls-, rå; råfenol;

[et forsuret alkalisk ekstrakt af brunkulstjæredestillat.

Sammensat primært af phenol og phenolhomologer.]

309-888-7

101316-86-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-118-00-7

tjæresyrer, brunkulsforgas

nings-;

råfenol;

[en sammensat blanding af organiske forbindelser fra brunkulsforgasning. Sammensat primært af C6-10-hydroxyaromatiske phenoler og deres homologer.]

295-536-7

92062-22-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-119-00-2

tjæresyrer, destillationsrester; fenoldestillater;

[en rest fra destillationen af råphenol fra kul. Den består overvejende af phenoler, C8 til og med C10, med blødgøringspunkt fra 60 oC til 80 oC.]

306-251-5

96690-55-0

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-120-00-8

tjæresyrer, methylphenolfraktion;

fenoldestillater;

[fraktionen af tjæresyre, rig på

3- og 4-methylphenol, genvundet ved destillation af rå tjæresyre fra lavtemperatursstenkuls

tjære.]

284-892-9

84989-04-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-121-00-3

tjæresyrer, polyalkylphenolfraktion;

fenoldestillater;

[fraktionen af tjæresyrer, genvundet ved destillation af rå tjæresyrer fra lavtemperatursstenkulstjære,

med kogeinterval omtrent fra 225 oC til

320 oC.] Sammensat primært af polyalkylphenoler.]

284-893-4

84989-05-9

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-122-00-9

tjæresyrer, xylenolfraktion; fenoldestillater;

[fraktionen af tjæresyrer, rig på

2,4- og 2,5-dimethylphenol, genvundet ved destillation af rå tjæresyrer fra lavtemperatursstenkuls

tjære.]

284-895-5

84989-06-0

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-123-00-4

tjæresyrer, ethylphenolfraktion; fenoldestillater;

[fraktionen af tjæresyrer, rig på

3- og 4-ethylphenol, genvundet ved destillation af rå tjæresyrer fra lavtemperatursstenkulstjære.]

284-891-3

84989-03-7

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-124-00-X

tjæresyrer, 3,5-xylenolfraktion; fenoldestillater;

[fraktionen af tjæresyrer, rig på

3,5-dimethylphenol, genvundet ved destillation af lavtemperatursstenkultjæresyrer.]

284-896-0

84989-07-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-125-00-5

tjæresyrer, rester, destillater, første fraktion;

fenoldestillater;

[resten fra destillationen i området fra 235 oC til 355 oC af let karbololie.]

270-713-1

68477-23-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-126-00-0

tjæresyrer, cresyliske, rester; fenoldestillater;

[resten fra rå stenkulstjæresyrer efter fjernelse af phenol, cresoler, xylenoler og alle højerekogende phenoler. Et sort fast stof med et smeltepunkt på omtrent 80 oC. Sammensat primært af polyalkylphenoler, harpiksgummier og uorganiske salte.]

271-418-0

68555-24-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-127-00-6

phenoler, C9-11; fenoldestillater

293-435-2

91079-47-9

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-128-00-1

tjæresyrer, cresyliske; fenoldestillater;

[en sammensat blanding af organiske forbindelser, opnået fra brunkul, med kogeinterval omtrent fra 200 oC til 230 oC. Den består hovedsagelig af phenoler og pyridinbaser.]

295-540-9

92062-26-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-129-00-7

tjæresyrer, brunkuls-, C2-alkylphenolfraktion

fenoldestillater;

[destillatet fra syrebehandlingen af alkalisk vasket brunkulstjæredestillat, med kogeinterval

omtrent fra 200 oC til

230 oC. Sammensat primært af m- og p-ethylphenol såvel som cresoler og xylenoler.]

302-662-9

94114-29-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-130-00-2

ekstraktionsolier (stenkul), naphtalenolier;

syreekstrakt;

[det vandige ekstrakt fremstillet ved en sur vask af alkali

vasket naphthalenolie. Sammensat primært af syresalte af forskellige aromatiske nitrogenbaser, inklusive

pyridin, quinolin og deres alkylderivater.]

292-623-1

90641-00-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-131-00-8

tjære, quinolinderivater; basedestillater

271-020-7

68513-87-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-132-00-3

tjærebaser, stenkuls-, quinolinderivatfraktion;

basedestillater

274-560-1

70321-67-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-133-00-9

tjærebaser, stenkuls-, destillationsrester; basedestillater;

[destillationsresten efter destillationen

af den neutraliserede, syreekstraherede, baseholdige tjærefraktion, opnået ved destillationen af stenkulstjærer. Den indeholder hovedsagelig anilin, collidiner, quinolinderivater og toluidiner.]

295-544-0

92062-29-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-134-00-4

carbonhydridolier, aromatiske, blandet med polyethylen og polypropylen, pyrolyserede, let oliefraktion;

varmebehandlede produkter [Olie opnået ved varmebehandling af en polyethylen/polypropylenblanding med kultjærebeg eller aromatiske olier. Den består overvejende af benzen og dens homologer, med kogeinterval omtrent fra 70 oC til 120 oC.]

309-745-9

100801-63-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-135-00-X

carbonhydridolier, aromatiske, blandet med polyethylen, pyrolyserede, let oliefraktion;

varmebehandlede produkter;

[olie opnået ved varmebehandling af polyethylen med kultjærebeg eller aromatiske olier. Den består overvejende af benzen og dens homologer, med kogeinterval omtrent fra 70 oC til 120 oC.]

309-748-5

100801-65-8

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-136-00-5

carbonhydridolier, aromatiske, blandet med polystyren, pyrolyserede, let oliefraktion;

varmebehandlede produkter;

[olie opnået ved varmebehandling af polystyren med kultjærebeg eller aromatiske olier. Den består overvejende af benzen og dens homologer, med kogeinterval omtrent fra 70 oC til 210 oC

.]

309-749-0

100801-66-9

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-137-00-0

ekstraktionsrester (kul), alkalisk tjæreolie, naphthalendestillationsrester; syrefri naftalinolie;

[resten opnået fra kemisk olie ekstraheret efter fjernelsen af naphthalen ved destillation, består primært af bi til tetracykliske kondenserede aromatiske carbonhydrider og aromatiske nitrogenbaser.]

277-567-8

73665-18-6

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-138-00-6

creosotolie, lavtkogende destillat;

vaskeolie;

[den lavtkogende destillationsfraktion opnået fra højtemperaturforkulningen af bituminøse kul, som yderligere raffineres for at fjerne overskud af krystallinske salte. Den består primært af creosotolie, hvorfra nogle af de normale polycykliske aromatiske salte, som er komponenter af stenkulstjæredestillat, er fjernet. Den er krystalfri ved omtrent 38 oC.]

274-566-4

70321-80-1

Carc. 1B

H350

GHS08

Dgr

H350

M

648-139-00-1

tjæresyrer, cresyliske, natriumsalte, kaustiske opløsninger; alkaliske ekstrakter

272-361-4

68815-21-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-140-00-7

ekstraktionsolier (kul), tjærebase-; syreekstrakt;

[ekstrakt fra alkalisk ekstraktionrest af stenkulstjæreolie fremstillet ved en sur vask med f.eks. vandig svovlsyre efter destillation for at fjerne naphthalen. Sammensat primært af syresalte af forskellige aromatiske nitrogenbaser, herunder pyridin, quinolin og deres alkylderivater.]

266-020-9

65996-86-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-141-00-2

tjærebaser, stenkuls-, rå; råtjærebaser

[reaktionsprodukt opnået

ved at neutralisere ekstraktionsolie fra stenkulstjærebase med en alkalisk opløsning, såsom vandig natriumhydroxid, for at udvinde de frie baser. Sammensat primært af organiske baser, såsom acridin, phenanthridin, pyridin, quinolin og deres alkylderivater.]

266-018-8

65996-84-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

JM

648-142-00-8

rester (kul), flydende solventekstraktions-;

[et kohæsivt pulver sammensat af kulmineralsk stof og

uopløst kul tilbageblevet efter ekstraktion af kul med et flydende solvent.]

302-681-2

94114-46-2

Carc. 1B

H350

GHS08

Dgr

H350

M

648-143-00-3

kulvæsker, flydende solventekstraktionsopløsning;

(produkt opnået ved filtrering af kulmineralsk stof og uopløst kul fra kulekstraktionsopløsning fremstillet ved at omsætte kul i et flydende solvent. En sort, viskøs og højkompleks væskeblanding sammensat primært af aromatiske og delvist hydrogenerede, aromatiske carbonhydrider, aromatiske nitrogenforbindelser, aromatiske svovlforbindelser, phenolske og andre aromatiske oxygenforbindelser og deres alkylderivater.]

302-682-8

94114-47-3

Carc. 1B

H350

GHS08

Dgr

H350

M

648-144-00-9

kulvæsker, flydende solventekstraktion;

[det substantielle solventfrie produkt opnået ved destillation af solventet fra filtreret kulekstraktionsopløsning fremstillet ved at omsætte kul i et flydende solvent. Et sort, halvfast stof, bestående primært af en sammensat blanding af ringkondenserede, aromatiske carbonhydrider, aromatiske nitrogenforbindelser, aromatiske svovlforbindelser, phenolforbindelser og andre aromatiske oxygenforbindelser og deres alkylderivater.]

302-683-3

94114-48-4

Carc. 1B

H350

GHS08

Dgr

H350

M

648-145-00-4

tjære, brunkuls-;

[en olie destilleret fra brunkulstjære. Sammensat primært af aliphatiske, naphthenske og bi- til tricycliske aromatiske carbonhybrider, deres alkylderivater, heteroaromater og en- og toringede phenoler, med kogeinterval omtrent fra 150 oC til 360 oC.]

309-885-0

101316-83-0

Carc. 1A

H350

GHS08

Dgr

H350

648-146-00-X

tjære, brunkuls-, lavtemperaturs-;

[en tjære, opnået ved lavtemperatursforkulning og lavtemperatursforgasning af brunkul. Sammensat primært af aliphatiske, naphtenske og cycliske aromatiske carbonhydrider, heteroaromatiske carbonhydrider og cycliske phenoler.]

309-886-6

101316-84-1

Carc. 1A

H350

GHS08

Dgr

H350

648-147-00-5

letolie (kul), koksovns-; rå benzol;

[den flygtige, organiske væske ekstraheret fra gassen fra tørdestillation af kul ved høj temperatur (højere end 700 oC). Sammensat primært af benzen, toluen og xylener. Kan indeholde andre mindre carbonhydridkomponenter.] Kan indeholde andre mindre carbonhydridkomponenter.]

266-012-5

65996-78-3

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-148-00-0

destillater (kul), flydende solventekstraktion, primære;

[det flydende produkt fra kondensation af dampe afgivet under omsætningen af kul i et flydende solvent, med kogeinterval omtrent fra 30 oC til 300 oC. Sammensat primært af delvist hydrogenerede polycykliske annelerede aromatiske carbonhydrider, aromatiske forbindelser indeholdende nitrogen, oxygen og svovl og deres alkylderivater, med carbonantal overvejende i området fra C4 til og med C14.]

302-688-0

94114-52-0

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-149-00-6

destillater (kul), solvent-ekstraktion, hydrokrakket;

[destillat fra hydrokrakning af kulekstrakt eller opløsning fremstillet ved flydende

solventekstraktions- eller superkritiske gasekstraktionsprocesser, med kogeinterval omtrent fra 30 oC til 300 oC. Sammensat primært af aromatiske, hydrogenerede aromatiske og naphthenske forbindelser, deres alkylderivater og alkaner med carbonantal overvejende C4 til og med C14. Nitrogen-, svovl- og oxygenholdige aromatiske og hydrogenerede aromatiske forbindelser er også til stede.]

302-689-6

94114-53-1

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-150-00-1

naphta (kul), solventekstraktion, hydrokrakket;

[fraktion af destillatet opnået ved hydrokrakning af kulekstrakt eller opløsning fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 30 oC til 180 oC. Sammensat primært af aromatiske, hydrogenerede aromatiske og naphtheniske forbindelser, deres alkylderivater og alkaner med carbonantal overvejende C4 til C9. Nitrogen-, svovl- og oxygenholdige aromatiske og hydrogenerede aromatiske forbindelser er også til stede.]

302-690-1

94114-54-2

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-151-00-7

benzin, kul solventekstraktion, hydrokrakket naphtha

[motorbrændstof fremstillet ved reformering af den raffinerede naphthafraktion fra produkterne fra hydrokrakning af kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 30 oC til 180 oC. Sammensat primært af aromatiske og naphthenske carbonhydrider, deres alkylderivater og alkylcarbonhydrider, C4 til og med C9.]

302-691-7

94114-55-3

Carc. 1B

H350

GHS08

Dgr

H350

648-152-00-2

destillater (kul), solventekstraktion, hydrokrakkede middeltunge;

[destillat opnået ved

hydrokrakning af kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 180 oC til 300 oC. Sammesat primært af bicycliske aromatiske, hydrogenerede aromatiske og naphtheniske forbindelser, deres alkylderivater og alkaner med carbonantal overvejende C9 til og med C14. Nitrogen-, svovl- og oxygenholdige forbindelser er også til stede.]

302-692-2

94114-56-4

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-153-00-8

destillater (kul), solventekstraktion hydrokrakkede hydrogenerede middeltunge;

[destillat fra hydrogeneringen af et hydrokrakket middeltungt destillat fra kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 180 oC til 280 oC. Sammensat primært af hydrogenerede, bicycliske carbonforbindelser og deres alkylderivater med carbonantal overvejende C9 til og med C14.]

302-693-8

94114-57-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

648-154-00-3

brændstoffer, jetfly-, kulsolventekstraktion, hydrokrakkede-hydrogenerede;

[jetmotorbrændstof fremstillet ved hydrogenering af den middeltunge destillationsfraktion fra produkterne fra hydrokrakning af kul-ekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med koge-interval omtrent fra 180 oC til 225 oC. Sammensat primært af hydrogenerede, bicycliske carbonhydrider og deres alkylderivater, overvejende C10 til og med C12.]

302-694-3

94114-58-6

Carc. 2

H351

GHS08

Wng

H350

648-155-00-9

brændstoffer, diesel- kul solventekstraktion, hydrokrakkede hydrogenerede; [dieselmotorbrændstof fremstillet ved hydrogenering af den middeltunge destillationsfraktion fra produkterne fra hydrokrakning af kulekstrakt eller opløsning, fremstillet ved flydende solventekstraktions- eller superkritisk gasekstraktionsprocesser, med kogeinterval omtrent fra 200 oC til 280 oC. Sammensat primært af hydrogenerede, bicycliske carbonhydrider og deres alkylderivater, overvejende C11 til og med C14.]

302-695-9

94114-59-7

Carc. 2

H351

GHS08

Wng

H350

648-156-00-4

letolie (kul), halvforkoksningsproces-; frisk olie; [den flygtige organiske væske kondenseret fra gassen udviklet ved lavtemperaturstørdestillation (lavere end 700 oC) af kul. Sammensat primært af C6-10-carbonhydrider.]

292-635-7

90641-11-5

Carc. 1B Muta. 1B

H350

H340

GHS08

Dgr

H350

H340

J

649-001-00-3

ekstrakter (råolie), let naphthendestillat solvent

265-102-1

64742-03-6

Carc. 1B

H350

GHS08

Dgr

H350

649-002-00-9

ekstrakter (råolie), tungt paraffindestillat solvent

265-103-7

64742-04-7

Carc. 1B

H350

GHS08

Dgr

H350

649-003-00-4

ekstrakter (råolie), let paraffindestillat solvent

265-104-2

64742-05-8

Carc. 1B

H350

GHS08

Dgr

H350

649-004-00-X

ekstrakter (råolie), tungt naphthendestillat solvent

265-111-0

64742-11-6

Carc. 1B

H350

GHS08

Dgr

H350

649-005-00-5

ekstrakter (råolie), let vakuumgasolie solvent

295-341-7

91995-78-7

Carc. 1B

H350

GHS08

Dgr

H350

649-006-00-0

carbonhydrider, C26-55, aromatrige

307-753-7

97722-04-8

Carc. 1B

H350

GHS08

Dgr

H350

649-007-00-6

fedtsyrer, tallolie, reaktionsprodukter med iminodiethanol og borsyre

400-160-5

—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

649-008-00-1

rester (råolie), atmosfærisk tårn;

fuelolie;

(en sammensat remanens fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-045-2

64741-45-3

Carc. 1B

H350

GHS08

Dgr

H350

649-009-00-7

gasolier (råolie), tunge vakuum;

fuelolie;

(en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C20 til og med C50, med kogeinterval omtrent fra 350 oC til 600 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-058-3

64741-57-7

Carc. 1B

H350

GHS08

Dgr

H350

649-010-00-2

destillater (råolie), tunge katalytisk krakkede;

fuelolie;

[en sammensat blanding af carbonhydrider fremstillet ved

destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C15 til og med C35, med kogeinterval omtrent fra 260 oC til 500 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-063-0

64741-61-3

Carc. 1B

H350

GHS08

Dgr

H350

649-011-00-8

klarede olier (råolie), katalytisk krakkede;

fuelolie;

[en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-064-6

64741-62-4

Carc. 1B

H350

GHS08

Dgr

H350

649-012-00-3

rester (råolie), hydro-

krakkede; fuelolie;

[en sammensat blanding af carbonhydrider fremstillet som

restfraktionen fra destillation af produkterne fra en hydrokrakningsproces. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC.]

265-076-1

64741-75-9

Carc. 1B

H350

GHS08

Dgr

H350

649-013-00-9

rester (råolie), termisk krakkede; fuelolie;

[en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-081-9

64741-80-6

Carc. 1B

H350

GHS08

Dgr

H350

649-014-00-4

destillater (råolie), tunge termisk krakkede;

fuelolie;

[en sammensat blanding af carbonhydrider fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C15 til og med C36, med kogeinterval omtrent fra 260 oC til 480 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-082-4

64741-81-7

Carc. 1B

H350

GHS08

Dgr

H350

649-015-00-X

gasolier (råolie), hydrogenbehandlede vakuum-; fuelolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C13 til og med C50, med kogeinterval omtrent fra 230 oC til 600 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-162-9

64742-59-2

Carc. 1B

H350

GHS08

Dgr

H350

649-016-00-5

rester (råolie), hydroafsvovlede atmosfærisk tårn; fuelolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle en remanens fra et atmosfærisk tårn med hydrogen i tilstedeværelse af en katalysator, under betingelser primært for at fjerne organiske svovlforbindelser. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-181-2

64742-78-5

Carc. 1B

H350

GHS08

Dgr

H350

649-017-00-0

gasolier (råolie), hydroafsvovlede

tunge vakuum-; fuelolie; [en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlningsproces. Den består af carbonhydrider, overvejende C20 til og med C50 med kogeinterval omtrent fra 350 oC til 600 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent eller mere aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-189-6

64742-86-5

Carc. 1B

H350

GHS08

Dgr

H350

649-018-00-6

rester (råolie), dampkrakkede;

fuelolie;

[en sammensat blanding af carbonhydrider opnået som restfraktionen fra destillation af produkterne fra en dampkrakningsproces (herunder dampkrakning for at fremstille ethylen). Den består overvejende af umættede carbonhydrider, overvejende større end C14, og koger omtrent over 260 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-193-8

64742-90-1

Carc. 1B

H350

GHS08

Dgr

H350

649-019-00-1

rester (råolie), atmosfæriske;

fuelolie;

[en sammensat remanens fra atmosfærisk destillation af råolie.

Den består af carbonhydrider, overvejende større end C11, og koger omtrent over 200 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

269-777-3

68333-22-2

Carc. 1B

H350

GHS08

Dgr

H350

649-020-00-7

klarede olier (råolie), hydroafsvovlede katalytisk krakkede;

fuelolie;

[En sammensat blanding af carbonhydrider opnået ved at behandle katalytisk krakkede, klarede olier med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består af carbonhydrider, overvejende større end C20, og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

269-782-0

68333-26-6

Carc. 1B

H350

GHS08

Dgr

H350

649-021-00-2

destillater (råolie), hydroafsvovlede intermediære katalytisk krakkede;

fuelolie;

[en sammensat blanding af carbonhydrider opnået ved

at behandle intermediære katalytisk krakkede destillater med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består af carbonhydrider, overvejende C11 til og med C30, med kogeinterval omtrent fra 205 oC til 450 oC. Den indeholder en forholdsvis stor del tricycliske, aromatiske carbonhydrider.]

269-783-6

68333-27-7

Carc. 1B

H350

GHS08

Dgr

H350

649-022-00-8

destillater (råolie), hydroafsvovlede tunge katalytisk krakkede;

fuelolie;

[en sammensat blanding af carbonhydrider opnået ved behandling af tunge katalytisk krakkede destillater med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består af carbonhydrider, overvejende C15 til og med C35, med kogeinterval omtrent fra 260 oC til 500 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

269-784-1

68333-28-8

Carc. 1B

H350

GHS08

Dgr

H350

649-023-00-3

brændselsolie, rester af straight-run gasolier, med højt indhold af svovl;

fuelolie;

270-674-0

68476-32-4

Carc. 1B

H350

HS08

Dgr

H350

649-024-00-9

brændselsolie, rest-; fuelolie;

[væskeproduktet fra forskellige raffinaderistrømme, sædvanligvis rester. Sammensætningen er kompleks og varierer med råoliekilden.]

270-675-6

68476-33-5

Carc. 1B

H350

GHS08

Dgr

H350

649-025-00-4

rester (råolie), katalytisk reformerfraktioneringskolonnerest, destillations-;

fuelolie;

(En sammensat remanens fra destillationen af katalytisk reformer- fraktioneringskolonnerest. Den koger omtrent over 399 oC.]

270-792-2

68478-13-7

Carc. 1B

H350

GHS08

Dgr

H350

649-026-00-X

rester (råolie), tung cokergasolie og vakuumgasolie;

fuelolie;

[en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillationen af tung coker-gasolie og vakuumgasolie. Den består overvejende af carbonhydrider, overvejende større end C13, og koger omtrent over 230 oC.]

270-796-4

68478-17-1

Carc. 1B

H350

GHS08

Dgr

H350

649-027-00-5

rester (råolie), tunge coker- og lette vakuum-;

fuelolie;

[en sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillationen af tung coker-gasolie og let vakuumgasolie. Den består overvejende af carbonhydrider, overvejende større end C13, og koger omtrent over 230 oC.]

270-983-0

68512-61-8

Carc. 1B

H350

GHS08

Dgr

H350

649-028-00-0

rester (råolie), lette vakuum-;

fuelolie; [en sammensat remanens fra vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende større end C13, og koger omtrent over 230 oC.]

270-984-6

68512-62-9

Carc. 1B

H350

GHS08

Dgr

H350

649-029-00-6

rester (råolie), dampkrakkede, lette;

fuelolie;

[en sammensat remanens fra destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af aromatiske og umættede carbonhydrider, større end C7, med kogeinterval omtrent fra 101 oC til 555 oC.]

271-013-9

68513-69-9

Carc. 1B

H350

GHS08

Dgr

H350

649-030-00-1

brændselsolie, nr. 6; fuelolie;

[en brændselsolie med en minimumsviskositet på 900cSt og en maximumsviskositet på 9000cSt ved 37,7 oC.]

271-384-7

68553-00-4

Carc. 1B

H350

GHS08

Dgr

H350

649-031-00-7

rester (råolie, topanlægs-, svovlfattige;

fuelolie;

[en sammensat, svovlfattig blanding af carbonhybrider fremstillet som restfraktionen fra topanlægsdestillation af råolie. Den udgør resten, efter at straight-run benzinfraktionen, petroleumfraktionen og gasoliefraktionen er blevet fjernet.]

271-763-7

68607-30-7

Carc. 1B

H350

GHS08

Dgr

H350

649-032-00-2

gasolier (råolie), tunge, atmosfæriske;

fuelolie;

(en sammensat, blanding af carbonhydrider opnået ved destillationen af råolie. Den består af carbonhydrider, overvejende C7 en C35, med kogeinterval omtrent fra 121 oC til 510 oC.]

272-184-2

68783-08-4

Carc. 1B

H350

GHS08

Dgr

H350

649-033-00-8

rester (råolie), coker skrubber, indeholder kondenserede aromater; fuelolie;

[en meget sammensat blanding af carbonhydrider fremstillet som restfraktionen fra destillationen af vakuumremanensen og produkterne fra en termisk krakningsproces. Den består overvejende af carbonhydrider, overvejende større end C20 og koger omtrent over 350 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

272-187-9

68783-13-1

Carc. 1B

H350

GHS08

Dgr

H350

649-034-00-3

destillater (råolie), råolierester vakuum-; fuelolie

[en sammensat blanding af carbonhydrider ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie.]

273-263-4

68955-27-1

Carc. 1B

H350

GHS08

Dgr

H350

649-035-00-9

rester (råolie), dampkrakket, harpiksholdige;

fuelolie;

[en sammensat remanens fra destillationen af dampkrakkede råolierester.]

273-272-3

68955-36-2

Carc. 1B

H350

GHS08

Dgr

H350

649-036-00-4

destillater (råolie), intermediær

vakuum;

fuelolie;

[en sammensat blanding af carbonhybrider fremstillet ved destillationen af remanensen af den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C14 og til og med C42 og koger omtrent i intervallet fra 250 oC til 545 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent eller mere af 4- til 6-leddede kondenserede aromatiske carbonhydrider.]

274-683-0

70592-76-6

Carc. 1B

H350

GHS08

Dgr

H350

649-037-00-X

destillater (råolie), lette vakuum-;

fuelolie;

[en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C11 til og med C35, med kogeinterval omtrent fra 250 oC til 545 oC.]

274-684-6

70592-77-7

Carc. 1B

H350

GHS08

Dgr

H350

649-038-00-5

destillater (råolie), vakuum-; fuelolie

[en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillationen af remanensen fra den atmosfæriske destillation af råolie. Den består af carbonhydrider, overvejende C15 til og med C50, med kogeinterval omtrent fra 270 oC til 600 oC. Denne strøm kan indeholde 5 vægtprocent, eller mere, aromatisk carbonhydrider bestående af 4- til 6-leddede kondenserede ringe.]

274-685-1

70592-78-8

Carc. 1B

H350

GHS08

Dgr

H350

649-039-00-0

gasolier (råolie), hydroafsvovlede tunge coker vakuum-; fuelolie;

[en sammensat blanding af carbonhydrider opnået ved hydroafsvovling af tunge coker-destillat råstoffer. Den består overvejende af carbonhydrider, overvejende C18 til C44, med kogeinterval omtrent fra 304 oC til 548 oC. Indeholder sandsynligvis 5 %, eller mere, aromatiske carbonhydrider bestående, af 4- til 6-leddede kondenserede ringe.]

285-555-9

85117-03-9

Carc. 1B

H350

GHS08

Dgr

H350

649-040-00-6

rester (råolie), dampkrakkede, destillater;

fuelolie;

[en sammensat blanding af carbonhydrider opnået under fremstillingen af raffineret råolietjære ved destillation af dampkrakket tjære. Den består overvejende af aromatiske og andre carbonhydrider organiske svovlforbindelser.]

292-657-7

90669-75-3

Carc. 1B

H350

GHS08

Dgr

H350

649-041-00-1

rester (råolie), vakuum-, lette;

fuelolie;

[en sammensat remanens fra vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består overvejende af carbonhydrider, overvejende større end C24, og koger omtrent over 390 oC.]

292-658-2

90669-76-4

Carc. 1B

H350

GHS08

Dgr

H350

649-042-00-7

brændselsolie, tung, højt svovlindhold; fuelolie;

[en sammensat blanding af

carbonhydrider opnået ved destillation af rå råolie. Den består overvejende af aliphatiske, aromatiske og cycloaliphatiske carbonhydrider, overvejende større end C25, der koger højere end omtrent over 400 oC.]

295-396-7

92045-14-2

Carc. 1B

H350

GHS08

Dgr

H350

649-043-00-2

rester (råolie), katalytisk kraknings-;

fuelolie;

[en sammensat blanding af carbonhydrider fremstillet som

restfraktionen fra destillationen af produkterne fra en katalytisk krakningsproces. Den består overvejende af carbonhydrider, overvejende større end C11, der koger

omtrent over 200 oC.]

295-511-0

92061-97-7

Carc. 1B

H350

GHS08

Dgr

H350

649-044-00-8

destillater (råolie), intermediære, katalytisk krakkede, termisk nedbrudte;

fuelolie;

[en sammensat blanding af carbonhydrider, fremstillet ved destillationen af produkter fra en katalytisk krakningsproces, som har været brugt som en varmeoverførselsvæske. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 220 oC til 450 oC. Denne strøm indeholder sandsynligvis organiske svovlforbindelser.]

295-990-6

92201-59-7

Carc. 1B

H350

GHS08

Dgr

H350

649-045-00-3

restolier (råolie); fuelolie;

[en sammensat blanding af carbonhydrider, svovlforbindelser og metalholdige organiske forbindelser opnået som resten fra raffinaderifraktionerings-krakningsprocesser. Den danner en færdig olie med viskositet over 2cSt. ved 100 oC.]

298-754-0

93821-66-0

Carc. 1B

H350

GHS08

Dgr

H350

649-046-00-9

rester, dampkrakkede, termisk behandlede;

fuelolie;

[en sammensat blanding af carbonhydrider opnået ved behandling og destillation af rå, dampkrakket naphtha. Den består overvejende af umættede carbonhydrider, der koger omtrent over 180 oC.]

308-733-0

98219-64-8

Carc. 1B

H350

GHS08

Dgr

H350

649-047-00-4

destillater (råolie), hydroafsvovlede full-range middeltunge; fuelolie;

[en sammensat blanding af carbonhydrider opnået ved

at behandle en rå råolie med hydrogen. Den består overvejende af carbonhydrider, overvejende C9 til og med C25, med kogeinterval omtrent fra 150 oC til 400 oC.]

309-863-0

101316-57-8

Carc. 1B

H350

GHS08

Dgr

H350

649-048-00-X

rester (råolie), katalytiske reformer-fraktionator-;

fuelolie;

[en sammensat blanding af carbonhydrider fremstillet som

restfraktionen fra destillation af produkterne fra en katalytisk reformeringsproces. Den består af overvejende aromatiske carbonhydrider, overvejende C10 til og med C25, med kogeinterval omtrent fra 160 oC til 400 oC. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

265-069-3

64741-67-9

Carc. 1B

H350

GHS08

Dgr

H350

649-049-00-5

råolie;

[en sammensat blanding af carbonhybrider. Den består overvejende af aliphatiske,

alicycliske og aromatiske carbonhybrider. Den kan også indeholde små mængder af nitrogen, oxygen- og svovlforbindelser. Denne kategori omfatter lette, middeltunge og tunge råolier, såvel som olier ekstraherede fra tjæresand. Carbonhydridholdige materialer, der kræver større kemiske forandringer for deres udvinding eller omdannelse til råolieraffinaderiføde såsom rå skiferolier, oprensede skiferolier og flydende kulbrændsel er ikke medtaget i denne beskrivelse.]

232-298-5

8002-05-9

Carc. 1B

H350

GHS08

Dgr

H350

649-050-00-0

destillater (råolie), lette paraffin-;

uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede, aliphatiske carbonhydrider normalt til stede i dette råoliedestillationsinterval.]

265-051-5

64741-50-0

Carc. 1A

H350

GHS08

Dgr

H350

649-051-00-6

destillater (råolie), tunge paraffin-;

uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede, aliphatiske carbonhydrider.]

265-052-0

64741-51-1

Carc. 1A

H350

GHS08

Dgr

H350

649-052-00-1

destillater (råolie), lette naphthen-;

uraffineret eller let raffineret

baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atomsfærisk destillation af råolie. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cST ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-053-6

64741-52-2

Carc. 1A

H350

GHS08

Dgr

H350

649-053-00-7

destillater (råolie), tunge naphthen-;

uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved vakuumdestillation af remanensen fra atmosfærisk destillation af råolie. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-054-1

64741-53-3

Carc. 1A

H350

GHS08

Dgr

H350

649-054-00-2

destillater (råolie), syrebehandlede tunge naphthen-; uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cST ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-117-3

64742-18-3

Carc. 1A

H350

GHS08

Dgr

H350

649-055-00-8

destillater (råolie), syrebehandlede tunge naphthen-; uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-118-9

64742-19-4

Carc. 1A

H350

GHS08

Dgr

H350

649-056-00-3

destillater (råolie), syrebehandlede tunge naphthen-; uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består overvejende af mættede carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC.]

265-119-4

64742-20-7

Carc. 1A

H350

GHS08

Dgr

H350

649-057-00-9

destillater (råolie), syrebehandlede lette paraffin-; uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består overvejende af mættede carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.]

265-121-5

64742-21-8

Carc. 1A

H350

GHS08

Dgr

H350

649-058-00-4

Destillater (råolie), kemisk neutraliserede tunge paraffin-;

uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider opnået ved en behandlingsproces til fjernelse af sure materialer. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del aliphatiske carbonhydrider.]

265-127-8

64742-27-4

Carc. 1A

H350

GHS08

Dgr

H350

649-059-00-X

destillater (råolie), kemisk neutraliserede lette paraffin-;

uraffineret eller let raffineret

baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet mindre end 19cSt ved 40 oC.]

265-128-3

64742-28-5

Carc. 1A

H350

GHS08

Dgr

H350

649-060-00-5

destillater (råolie) kemisk neutraliserede tunge naphthen-;

uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-135-1

64742-34-3

Carc. 1A

H350

GHS08

Dgr

H350

649-061-00-0

destillater (råolie), kemisk neutraliserede lette naphthen-;

uraffineret eller let raffineret baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C15 til og med C30 og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-136-7

64742-35-4

Carc. 1A

H350

GHS08

Dgr

H350

649-062-00-6

gasser (råolie), katalytisk krakket naphtha depropanizer-topfraktion, C3-rige syrefrie; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af katalytisk krakkede carbonhydrider og behandlet for at fjerne sure urenheder. Den består af carbonhydrider, C2 til og med C4, overvejende C3.]

270-755-0

68477-73-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-063-00-1

gasser (råolie), katalytiske krakker;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en katalytisk krakningsproces.] Den består overvejende af aliphatiske carbonhydrider, overvejende C1 til og med C6.

270-756-6

68477-74-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-064-00-7

gasser (råolie), katalytisk krakker, C1-5-rige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved

destillationen af produkter fra en katalytisk krakningsproces. Den består af aliphatiske carbonhydrider, C1 til og med C6, overvejende C1 til og med C5.]

270-757-1

68477-75-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-065-00-2

gasser (råolie), katalytisk polymeriseret; naphtha stabilizer-topfraktion, C2-4-rige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af katalytisk polymeriseret naphtha. Den består af aliphatiske carbonhydrider, C2 til og med C6, overvejende C2 til og med C4.]

270-758-7

68477-76-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-066-00-8

gasser (råolie), katalytisk krakker, C1-4-rige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk reformeringsproces. Den består af carbonhydrider, C1 til og med C6, overvejende C1 til og med C4.]

270-760-8

68477-79-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-067-00-3

gasser (råolie), C3-5 -olefin- og paraffin-alkyleringsføde-; kulbrintegasser;

[en sammensat blanding af olefin- og paraffin-carbonhydrider, C3 til og med C5, der anvendes som alkyleringsføde. De omgivende temperaturer er normalt højere end disse blandingers kritiske temperatur.]

270-765-5

68477-83-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-068-00-9

gasser (råolie), C4-rige; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en

katalytisk fraktioneringsproces. Den består af aliphatiske carbonhydrider, C3 til og med C5, overvejende C4.]

270-767-6

68477-85-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-069-00-4

gasser (råolie), deethanizer-topfraktioner;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af gas- og benzinfraktionerne fra den katalytiske krakningsproces. Den indeholder overvejende ethan og ethylen.]

270-768-1

68477-86-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-070-00-X

gasser (råolie), deisobutanizertårn-topfraktioner; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved den atmosfæriske destillation af en butan-butylenstrøm. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C4.]

270-769-7

68477-87-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-071-00-5

gasser (råolie), tørre depropanizer-, propenrige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra

gas- og benzinfranktionerne fra en katalytisk krakningsproces. Den består overvejende af propylen med noget ethan og propan.]

270-772-3

68477-90-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-072-00-0

gasser (råolie), depropanizer-topfraktioner;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved

destillation af produkterne fra gas- og benzinfraktionerne fra en katalytisk krakningsproces. Den består af aliphatiske carbonhydrider, overvejende C2 til og med C4.]

270-773-9

68477-91-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-073-00-6

gasser (råolie), gas-genvindingsanlæg depropanizer-topfraktioner; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af diverse carbonhydridstrømme. Den består overvejende af carbonhydrider, C1 til og med C4, overvejende propan.]

270-777-0

68477-94-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-074-00-1

gasser (råolie), Girbatol-enhed føde-;

kulbrintegasser;

(en sammensat blanding af carbonhydrider, der anvendes som føde i Girbatol-enheden for at fjerne hydrogensulfid. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C4.]

270-778-6

68477-95-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-075-00-7

gasser (råolie), isomeriseret naphtha-fraktioneringskolonne-, C4-rige, hydrogensulfidfri;

kulbrintegasser

270-782-8

68477-99-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-076-00-2

slutgas (råolie), katalytisk krakket klaret olie og termisk krakket vakuumrest fraktioneringsrefluxkammer;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af katalytisk krakket, klaret olie og termisk krakket vakuumrest. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.]

270-802-5

68478-21-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-077-00-8

slutgas (råolie), katalytisk krakket naphtha stabiliseringsabsorber-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved stabiliseringen af katalytisk krakket naphtha. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.]

270-803-0

68478-22-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-078-00-3

slutgas (råolie), katalytisk krakker, katalytisk reformer og hydroafsvovler, kombineret fraktioneringskolonne-; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af produkterne fra katalytiske kraknings-, katalytiske reformerings- og hydroafsvovlingsprocesser, behandlet for at fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.]

270-804-6

68478-24-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-079-00-9

slutgas (råolie), katalytisk reformeret naphtha fraktioneringsstabilizer-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af katalytisk reformeret naphtha. Den består overvejende af carbonhydrider, overvejende

C1 til og med C4.]

270-806-7

68478-26-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-080-00-4

slutgas (råolie), blandet saturatgasanlægsstrøm, C4-rig; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af straight-run naphtha, destillationsslutgas og katalytisk reformeret naphthastabilizerslutgas. Den består af carbonhydrider, C3 til og med C6, overvejende butan og isobutan.]

270-813-5

68478-32-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-081-00-X

slutgas (råolie), saturatgasanlæg genvindings-, C1-2-rig; kulbrintegasser

[en sammensat blanding af carbonhydrider opnået ved fraktionering af destillatslutgas, straight-run naphtha, katalytisk reformeret naphthastabilizerslutgas. Den består overvejende af carbonhydrider, C1 til og med C5, overvejende methan og ethan.]

270-814-0

68478-33-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-082-00-5

slutgas (råolie), vakuumrester, termisk krakker-; kulbrintegasser

[en sammensat blanding af carbonhydrider opnået ved termisk krakning af vakuumrester. Den består af carbonhydrider, overvejende C1 til og med C5.]

270-815-6

68478-34-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-083-00-0

carbonhydrider, C3-4-rige, råoliedestillat;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillation og kondensation af råolie. Den består af carbonhydrider, C3 til og med C5, overvejende C3 til og med C4.]

270-990-9

68512-91-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-084-00-6

gasser (råolie), full-range straight-run naphtha dehexanizer-aftræks-; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af full-range, straight-run naphtha. Den består af carbonhydrider, overvejende C2 til og med C6.]

271-000-8

68513-15-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-085-00-1

gasser (råolie), hydrokrakningsdepropanizer-aftræks-, carbonhydridrige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved

destillationen af produkterne fra en hydrokrakningsproces. Den består overvejende af carbonhydrider, overvejende C1 til og med C4. Den kan også indeholde små mængder hydrogen og hydrogensulfid.]

271-001-3

68513-16-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-086-00-7

gasser (råolie), let straight-run naphtha stabilizer-aftræks-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved stabiliseringen af let, straight-run naphtha. Den består af mættede, aliphatiske carbonhydrider, overvejende C2 til og med C6.]

271-002-9

68513-17-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-087-00-2

rester (råolie), alkyleringssplitter-, C4-rige

kulbrintegasser;

[en sammensat remanens fra destillationen af strømme fra forskellige

raffinaderiprocesser. Den består af carbonhydrider C4 til og med C5, overvejende butan, med kogeinterval omtrent fra -11,7 oC til 27,8 oC.]

271-010-2

68513-66-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-088-00-8

carbonhydrider, C1-4-; kulbrintegasser;

[en sammensat blanding af

carbonhydrider fremstillet ved termiske kraknings- og absorberprocesser samt ved destillation af råolie. Den består af carbonhydrider, overvejende C1 til og med C4, med kogeinterval omtrent fra - 164 oC til -0,5 oC.]

271-032-2

68514-31-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-089-00-3

carbonhydrider, C1-4-, sweetened; kulbrintegasser;

[ensammensat blanding af carbonhydrider opnået ved

at underkaste carbonhydrider en sweetening-proces for at omdanne mercaptaner eller for at fjerne sure urenheder. Den består af carbonhydrider, overvejende C1 til og med C4 med kogeinterval omtrent fra - 164 oC til -0,5 oC

.]

271-038-5

68514-36-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-090-00-9

carbonhydrider, C1-3-; kulbrintegasser;

[en sammensat blanding af carbonhydrider, overvejende C1 til og med C3, med kogeinterval omtrent fra - 164 oC til - 42 oC.]

271-259-7

68527-16-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-091-00-4

carbonhydrider, C1-4-, debutanizer-fraktion;

kulbrintegasser

271-261-8

68527-19-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-092-00-X

gasser (råolie), C1-5-, våde; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af råolie og/eller krakningen af tårn-gasolie. Den består af carbonhydrider, overvejende C1 til og med C5.]

271-624-0

68602-83-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-093-00-5

carbonhydrider, C2-4-; kulbrintegasser

271-734-9

68606-25-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-094-00-0

carbonhydrider, C3-; kulbrintegasser

271-735-4

68606-26-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-095-00-6

gasser (råolie), alkyleringsføde;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved

den katalytiske krakning af gasolie. Den består af carbonhydrider, overvejende C3 til og med C4.]

271-737-5

68606-27-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-096-00-1

gasser (råolie), depropanizer-bundfraktioner, fraktioneringsaftræks-; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af depropanizer-bundfraktioner. Den består overvejende af butan, isobutan og butadien.]

271-742-2

68606-34-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-097-00-7

gasser (råolie), raffinaderiblandings-;

kulbrintegasser;

[en sammensat blanding opnået fra forskellige raffinaderiprocesser.

Den består af hydrogen, hydrogensulfid og carbonhydrider, overvejende C1 til og med C5.]

272-183-7

68783-07-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-098-00-2

gasser (råolie), katalytisk krakkede;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en katalytisk krakningsproces.] Den består overvejende af carbonhydrider, overvejende C3 til og med C5.]

272-203-4

68783-64-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-099-00-8

gasser (råolie), C2-4-, sweetenede;

kulbrintegasser;

[en sammensat blanding af carbonhydrider, opnået ved

at underkaste et råoliedestillat en sweeteningsproces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af mættede og umættede carbonhydrider, overvejende C2 til og med C4, med kogeinterval omtrent fra - 51 oC til - 34 oC.]

272-205-5

68783-65-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-100-00-1

gasser (råolie), råoliefraktioneringsaftræks-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved fraktioneringen af råolie. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.]

272-871-7

68918-99-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-101-00-7

gasser (råolie), dehexanizer-aftræks-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved

fraktioneringen af kombinerede naphthastrømme. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.]

272-872-2

68919-00-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-102-00-2

gasser (råolie), let straight-run benzinfraktioneringsstabilizer-aftræks-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af let straight-run benzin. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.]

272-878-5

68919-05-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-103-00-8

gasser (råolie), naphthaunifiner-afsvovling, stripperaftræks-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved en naphtha unifiner-afsvovlingsproces og strippet fra naphthaproduktet. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C4.]

272-879-0

68919-06-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-104-00-3

gasser (råolie), straight-run naphtha katalytisk reformeringsaftræks-; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha og fraktionering af det totale udløb. Den består af methan, ethan og propan.]

272-882-7

68919-09-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-105-00-9

gasser (råolie), fluidiseret katalytisk krakker splitter-topfraktioner; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved fraktioneringen af chargen til

C3 -C4-splitteren. Den består overvejende af C3-carbonhydrider.]

272-893-7

68919-20-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-106-00-4

gasser (råolie), straight-run stabilizeraftræks-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af væsken fra det første tårn brugt ved destillationen af råolie. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C4.]

272-883-2

68919-10-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-107-00-X

gasser (råolie), katalytisk krakker naphtha debutanizer-; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af katalytisk krakket naphtha. Den består af carbonhydrider, overvejende C1 til og med C4.]

273-169-3

68952-76-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-108-00-5

slutgas (råolie), katalytisk krakket destillat- og naphthastabilizer-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af katalytisk krakket naphta og destillat. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.]

273-170-9

68952-77-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-109-00-0

slutgas (råolie), termisk krakket destillat, gasolie og naphtha absorber-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved separationen af termisk krakkede destillater, naphtha og gasolie. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.]

273-175-6

68952-81-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-110-00-6

slutgas (råolie), termisk krakket carbonhydrid fraktioneringsstabilizer, råolieforkoksnings-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabiliseringen af termisk krakkede carbonhydrider fra en råolieforkoksningsproces. Den består af carbonhydrider, overvejende C1 til og med C6.]

273-176-1

68952-82-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-111-00-1

gasser (råolie), lette, dampkrakkede, butadienkoncentrat; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en termisk krakningsproces. Den består af carbonhydrider, overvejende C4.]

273-265-5

68955-28-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-112-00-7

gasser (råolie), straight-run naphtha katalytisk reformer stabilizer topfraktions-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved naphtha og fraktioneringen af det totale udløb. Den består af mættede aliphatiske carbonhydrider, overvejende C2 til og med C4.]

273-270-2

68955-34-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-113-00-2

carbonhydrider, C4-; kulbrintegasser

289-339-5

87741-01-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-114-00-8

alkaner, C1-4-, C3-rige; kulbrintegasser

292-456-4

90622-55-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-115-00-3

gasser (råolie), dampkrakker, C3-rige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en dampkrakningsproces. Den består overvejende af propylen, sammen med noget propan, med kogeinterval omtrent fra - 70 oC til 0 oC.]

295-404-9

92045-22-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-116-00-9

carbonhydrider, C4-, dampkrakker-destillat;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af C4-carbonhydrider, overvejende 1-buten og 2-buten, og indeholder også butan og isobuten, med kogeinterval omtrent fra - 12 oC til 5 oC.]

295-405-4

92045-23-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-117-00-4

råoliegasser, fortættede, sweetenede, C4-fraktion; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved at underkaste en fortættet råoliegasblanding en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af mættede og umættede C4-carbonhydrider.]

295-463-0

92045-80-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K S U

649-118-00-X

carbonhydrider, C4-, 1,3-butadien- og isobutenfrie; kulbrintegasser

306-004-1

95465-89-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-119-00-5

raffinater (råolie), dampkrakket C4-fraktion, kobberammoniumacetatekstraktion, C3-5- og C3-5-umættede, butadienfrie; kulbrintegasser

307-769-4

97722-19-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-120-00-0

gasser (råolie), aminsystemføde-;

raffinaderigas;

[fødegassen til aminsystemet for fjernelse af hydrogensulfid. Den består af hydrogen. Carbonmonoxid, carbondioxid, hydrogensulfid og aliphatiske carbonhydrider, C1 til og med C5, kan også være til stede.]

270-746-1

68477-65-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-121-00-6

gasser (råolie), benzenenheds-hydroafsvovleraftræks-;

raffinaderigas;

[aftræksgasser fra benzenenheden. De består primært af hydrogen. Carbonmonoxid og carbonhydrider, overvejende C1 til og med C6, herunder benzen, kan også være til stede.]

270-747-7

68477-66-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-122-00-1

gasser (råolie), benzenenhed recirkulations-, hydrogenrige;

raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved at recirkulere gasserne fra benzenenheden. Den består primært af hydrogen med forskellige små mængder carbonmonoxid og carbonhydrider, C1 til og med C6.]

270-748-2

68477-67-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-123-00-7

gasser (råolie), blandingsolie-, hydrogen- og nitrogenrige;

raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved destillation af en blandingsolie. Den består primært af hydrogen og nitrogen med forskellige små mængder carbonmonoxid, carbondioxid og aliphatiske carbonhydrider, overvejende C1 til og med C5.]

270-749-8

68477-68-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-124-00-2

gasser (råolie), katalytisk reformeret naphtha-stripper-topfraktioner;

raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved stabiliseringen af katalytisk reformeret naphtha. Den består af hydrogen og mættede aliphatiske carbonhydrider, overvejende

C1 til og med C4.]

270-759-2

68477-77-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-125-00-8

gasser (råolie), C6-8-katalytisk reformer recirkulations-;

raffinaderigas;

[en sammensat blanding af carbonhydrider fremstillet ved

destillation af produkter fra katalytisk reformering af C6-C8-føde, og recirkuleret for at bevare hydrogen. De består primært af hydrogen. Den kan også indeholde varierende små mængder carbonmonoxid, carbondioxid, nitrogen og carbonhydrider, overvejende C1 til og med C6.]

270-761-3

68477-80-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-126-00-3

gasser (råolie), C6-8-katalytisk reformer-;

raffinaderigas;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra katalytisk reformering af C6-C8-føde. Den består af C1 til og med C5-carbonhydrider og hydrogen.]

270-762-9

68477-81-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-127-00-9

gasser (råolie), C6-8-katalytisk reformer recirkulations-, hydrogenrige; raffinaderigas

270-763-4

68477-82-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-128-00-4

gasser (råolie), C2-returstrøms-;

raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved

ekstraktionen af hydrogen fra en gasstrøm, som primært består af hydrogen med små mængder nitrogen, carbonmonoxid, methan, ethan og ethylen. Den består overvejende af carbonhydrider, såsom methan, ethan og ethylen, med små mængder hydrogen, nitrogen og carbonmonoxid.]

270-766-0

68477-84-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-129-00-X

gasser (råolie), tørre sure, gaskoncentreringsenhed aftræks-;

raffinaderigas;

[den sammensatte blanding af tørre gasser fra en gaskoncentreringsenhed. Den består af hydrogen, hydrogensulfid og carbonhydrider, overvejende C1 til og med C3.]

270-774-4

68477-92-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-130-00-5

gasser (råolie), gaskoncentrering reabsorberdestillations-;

raffinaderigas;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra blandede gasstrømme i en gaskoncentreringsreabsorber. Den består overvejende af hydrogen, carbonmonoxid, carbondioxid, nitrogen, hydrogensulfid og carbonhydrider, C1 til og med C3.]

270-776-5

68477-93-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-131-00-0

gasser (råolie), hydrogenabsorber- aftræks-;

raffinaderigas;

[en sammensat blanding opnået ved at absorbere

hydrogen fra en hydrogenrig strøm. Den består af hydrogen, carbonmonoxid, nitrogen og

methan med små mængder

C2-carbonhydrider.]

270-779-1

68477-96-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-132-00-6

gasser (råolie), hydrogenrige;

raffinaderigas;

[en sammensat blanding separeret som en gas fra carbonhydridgasser ved afkøling. Den består primært af hydrogen med forskellige små mængder carbonmonoxid, nitrogen, methan og C2-carbonhydrider.]

270-780-7

68477-97-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-133-00-1

gasser (råolie), hydrogenbehandler blandingsolierecirkulations-, hydrogen- og nitrogenrige;

raffinaderigas;

[en sammensat blanding opnået fra recirkuleret hydrogenbehandlet blandingsolie. Den består primært af hydrogen og nitrogen med forskellige små mængder carbonmonoxid, carbondioxid og carbonhydrider, overvejende C1 til og med C5.]

270-781-2

68477-98-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-134-00-7

gasser (råolie), recirkulations-, hydrogenrige;

raffinaderigas;

[en sammensat blanding opnået fra recirkulerede reaktorgasser. Den består primært af hydrogen med forskellige små mængder carbonmonoxid, carbondioxid, nitrogen, hydrogensulfid og mættede, aliphatiske carbonhydrider, C1 til og med C5.]

270-783-3

68478-00-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-135-00-2

gasser (råolie), reformer-make-up, hydrogenrige; raffinaderigas;

[en sammensat blanding

opnået fra reformerne. Den består primært af hydrogen med forskellige små mængder carbonmonoxid og aliphatiske carbonhydrider, overvejende C1 til og med C5.]

270-784-9

68478-01-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-136-00-8

gasser (råolie), reformeringshydrogenbehandler-;

raffinaderigas;

[en sammensat blanding opnået fra reformeringshydrogenbehandlingsprocessen. Den består primært af hydrogen, methan og ethan med forskellige små mængder hydrogensulfid og aliphatiske carbonhydrider, overvejende C3 til og med C5.]

270-785-4

68478-02-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-137-00-3

gasser (råolie), reformeringshydrogenbehandler-, hydrogen- og methanrige;

raffinaderigas;

[en sammensat blanding opnået fra reformerings

hydrogenbehandlingsprocessen. Den består primært af hydrogen og methan med forskellige små mængder carbonmonoxid, carbondioxid, nitrogen og mættede, aliphatiske carbonhydrider, overvejende

C2 til og med C5.]

270-787-5

68478-03-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-138-00-9

gasser (råolie), reformeringshydrogenbehandler make-up-, hydrogenrige;

raffinaderigas;

[en sammensat blanding opnået fra reformerings

hydrogenbehandlingsprocessen. Den består primært af hydrogen med forskellige små mængder carbonmonoxid og aliphatiske carbonhydrider, overvejende C1 til og med C5.]

270-788-0

68478-04-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-139-00-4

gasser (råolie), termisk krakning destillations-;

raffinaderigas;

[en sammensat blanding fremstillet ved destillation af produkterne fra en termisk krakningsproces. Den består af hydrogen, hydrogensulfid, carbonmonoxid, carbondioxid og carbonhydrider, overvejende C1 til og med C6.]

270-789-6

68478-05-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-140-00-X

slutgas (råolie), katalytisk krakker-refraktioneringsabsorber-; raffinaderigas;

[en sammensat blanding af

carbonhydrider opnået ved fraktionering af produkter fra en katalytisk krakningsproces. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C3.]

270-805-1

68478-25-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-141-00-5

slutgas (råolie), katalytisk reformeret naphtha-separator-; raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C6.]

270-807-2

68478-27-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-142-00-0

slutgas (råolie), katalytisk reformeret naphtha-stabilizer-; raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved stabiliseringen af katalytisk reformeret naphta. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C6.]

270-808-8

68478-28-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-143-00-6

slutgas (råolie), krakket destillat hydrogenbehandlerseparator-; raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved at behandle krakkede destillater med hydrogen i tilstedeværelse af en katalysator. Den består af hydrogen og mættede, aliphatiske carbonhydrider, overvejende C1 til og med C5.]

270-809-3

68478-29-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-144-00-1

slutgas (råolie), hydroafsvovlet straight-run-naphtha-separator-;

raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved

hydroafsvovling af straight-run naphtha. Den består af hydrogen og mættede, aliphatiske carbonhydrider, overvejende C1 til og med C6.]

270-810-9

68478-30-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-145-00-7

gasser (råolie), katalytisk reformeret straight-run naphtha stabilizer-topfraktioner;

raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha, efterfulgt af fraktionering af det totale udløb. Den består af hydrogen, methan, ethan og propan.]

270-999-8

68513-14-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-146-00-2

gasser (råolie), reformer-udløbs højtryksflashkammer aftræks-;

raffinaderigas;

[en sammensat blanding fremstillet ved højtryks-flashing af udløbet fra reformeringsreaktoren. Den består primært af hydrogen med forskellige små mængder methan, ethan og propan.]

271-003-4

68513-18-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-147-00-8

gasser (råolie), reformer-udløbs lavtryks-flashkammer aftræks-;

raffinaderigas;

[en sammensat blanding fremstillet ved lavtryks-flashing af udløbet fra reformeringsreaktoren. Den består primært af hydrogen med forskellige små mængder methan, ethan og propan.]

271-005-5

68513-19-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-148-00-3

gasser (råolie), olieraffinaderigas destillationsaftræks-;

raffinaderigas;

[en sammensat blanding separeret ved destillation af en gasstrøm indeholdende hydrogen, carbonmonoxid, carbondioxid og carbonhydrider, C1 til og med C6, eller opnået ved krakning af ethan og propan. Den består af carbonhydrider, overvejende C1 til og med C2, hydrogen, nitrogen og carbonmonoxid.]

271-258-1

68527-15-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-149-00-9

gasser (råolie), benzenenhed hydrogenbehandler depentanizer-topfraktioner; raffinaderigas;

[en sammensat blanding fremstillet ved at behandle føden fra benzenenheden med hydrogen i tilstedeværelse af en katalysator, efterfulgt af depentanisering. Den består primært af hydrogen, ethan og propan med forskellige små mængder nitrogen, carbonmonoxid, carbondioxid og carbonhydrider, overvejende C1 til og med C6. Den kan indeholde spormængder af benzen.]

271-623-5

68602-82-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-150-00-4

gasser (råolie), sekundære absorberaftræks-, fluidiseret katalytisk krakker-topfraktioner fraktionerings-; raffinaderigas;

[en sammensat blanding fremstillet ved fraktioneringen

af topfraktionsprodukterne fra den katalytiske krakningsproces i den fluidiserede katalytiske krakker. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C3.]

271-625-6

68602-84-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-151-00-X

råolieprodukter, raffinaderigasser;

rafinaderigas; [en sammensat blanding, som primært består af hydrogen

med forskellige små mængder methan, ethan og propan.]

271-750-6

68607-11-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-152-00-5

gasser (råolie), hydrokrakning lavtryks-separator-; raffinaderigas;

[en sammensat blanding opnået ved væske-damp-separationen af udløbet fra hydrokrakningsprocesreaktoren. Den består overvejende af hydrogen og mættede carbonhydrider, overvejende C1 til og med C3.]

272-182-1

68783-06-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-153-00-0

gasser (råolie), raffinaderi; raffinaderigas;

[en sammensat blanding opnået fra forskellige

råolieraffineringsoperationer. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C3.]

272-338-9

68814-67-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-154-00-6

gasser (råolie), platformer-produkter separatoraftræks-;

raffinaderigas;

[en sammensat blanding opnået fra den kemiske reformering af naphthener til aromater. Den består af hydrogen og mættede aliphatiske carbonhydrider, overvejende C2 til og med C4.]

272-343-6

68814-90-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-155-00-1

gasser (råolie), hydrogenbehandlet sur petroleum depentanizer stabilisatoraftræks-;

raffinaderigas;

[den sammensatte blanding opnået fra depentanizer-stabiliseringen af hydrogenbehandlet petroleum. Den består primært af hydrogen, methan, ethan og propan med forskellige små mængder af nitrogen, hydrogensulfid, carbonmonoxid og carbonhydrider, overvejende C4 til og med C5.]

272-775-5

68911-58-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-156-00-7

gasser (råolie), hydrogenbehandlet, sur petroleum-flashkammer-; raffinaderigas;

[en sammensat blanding opnået fra flashkammeret fra enheden, der behandler sur petroleum med hydrogen i tilstedeværelse af en katalysator. Den består primært af hydrogen og methan med forskellige små mængder af nitrogen, carbonmonoxid, og carbonhydrider, overvejende C2 til og med C5.]

272-776-0

68911-59-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-157-00-2

gasser (råolie), destillat unifiner afsvovlingsstripper aftræks-;

raffinaderigas;

[en sammensat blanding strippet fra væskeproduktet fra unifiner afsvovlingsprocessen. Den består af hydrogensulfid, methan, ethan og propan.]

272-873-8

68919-01-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-158-00-8

gasser (råolie), fluidiseret katalytisk krakker fraktioneringsaftræks-;

raffinaderigas;

[en sammensat blanding fremstillet ved fraktioneringen

af topfraktionsproduktet fra den fluidiserede katalytiske krakningsproces. Den består af hydrogen, hydrogensulfid, nitrogen og carbonhydrider, overvejende

C1 til og med C5.]

272-874-3

68919-02-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-159-00-3

gasser (råolie), fluidiseret katalytisk krakker skrubning, sekundære absorberaftræks-;

raffinaderigas;

[en sammensat blanding fremstillet ved at skrubbe topfraktionsgassen fra den fluidiserede, katalytiske krakker. Den består af hydrogen, nitrogen, methan, ethan og propan.]

272-875-9

68919-03-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-160-00-9

gasser (råolie), tungt destillat, hydrogenbehandlerafsvovler stripper aftræks-;

raffinaderigas;

[en sammensat blanding strippet fra væskeproduktet fra hydrogenbehandling-afsvovling af tungt destillat. Den består af hydrogen, hydrogensulfid og mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.]

272-876-4

68919-04-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-161-00-4

gasser (råolie), platformerstabilizer aftræks-, fraktionering af lette produkter;

raffinaderigas;

[en sammensat blanding opnået ved fraktioneringen af de lette produkter fra platinreaktorerne fra platformerenheden. Den består af hydrogen, methan, ethan og propan.]

272-880-6

68919-07-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-162-00-X

gasser (råolie), preflash-tårn aftræks-, rådestillation;

raffinaderigas;

[en sammensat blanding fremstillet fra det første tårn brugt ved destillationen af råolie. Den består af nitrogen og mættede aliphatiske carbonhydrider, overvejende C1 til og med C5.]

272-881-1

68919-08-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-163-00-5

gasser (råolie), tjærestripperaftræks-;

raffinaderigas;

[en sammensat blanding opnået ved fraktioneringen af reduceret råolie. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C4.]

272-884-8

68919-11-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-164-00-0

gasser (råolie), unifiner stripperaftræks-;

raffinaderigas;

[en blanding af hydrogen og methan opnået ved fraktioneringen af produkterne fra unifiner-enheden.]

272-885-3

68919-12-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-165-00-6

slutgas (råolie), katalytisk hydroafsvovlet naphthaseparator-;

raffinaderigas;

[en sammensat blanding af carbonhydrider opnået ved hydroafsvovlingen af naphtha. Den består af hydrogen, methan, ethan og propan.]

273-173-5

68952-79-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-166-00-1

slutgas (råolie), straight-run naphtha hydroafsvovler-; raffinaderigas;

[en sammensat blanding

opnået ved hydroafsvovlingen af straight-run naphtha. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C5.]

273-174-0

68952-80-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-167-00-7

gasser (råolie), sponge absorber aftræks-, fluidiseret katalytisk krakker og gasolieafsvovler topfraktionsfraktionering;

raffinaderigas;

[en sammensat blanding opnået ved fraktionering af produkterne fra den fluidiserede katalytiske krakker og gasolieafsvovler. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C4.]

273-269-7

68955-33-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-168-00-2

gasser (råolie), rådestillation og katalytisk krakning;

raffinaderigas;

[en sammensat blanding fremstillet ved rådestillations

og katalytiske krakningsprocesser. Den består af hydrogen, hydrogensulfid, nitrogen, carbonmonoxid og paraffin- og olefincarbonhydrider, overvejende C1 til og med C6.]

273-563-5

68989-88-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-169-00-8

gasser (råolie), gasolie diethanolaminskrubber- aftræks-; raffinaderigas;

[en sammensat blanding fremstillet ved afsvovling af gasolier med diethanolamin. Den består overvejende af hydrogensulfid, hydrogen og aliphatiske carbonhydrider, overvejende C1 til og med C5.]

295-397-2

92045-15-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-170-00-3

gasser (råolie), gasolie, hydroafsvovlingsudløbs-; raffinaderigas;

[en sammensat blanding opnået ved separation af væskefasen fra udløbet fra hydrogeneringsreaktionen. Den består overvejende af hydrogen, hydrogensulfid og aliphatiske carbonhydrider, overvejende C1 til og med C3.]

295-398-8

92045-16-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-171-00-9

gasser (råolie), gasoliehydroafsvovling-udblæsnings-; raffinaderigas;

[en sammensat blanding af gasser opnået fra reformeren og fra udblæsningerne fra hydrogeneringsreaktoren. Den består overvejende af hydrogen og aliphatiske carbonhydrider, overvejende C1 til og med C4.]

295-399-3

92045-17-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-172-00-4

gasser (råolie), hydrogenatorudløb-flashkammer- aftræks-;

raffinaderigas;

[en sammensat blanding af gasser opnået fra flashing af udløbene efter hydrogeneringsreaktionen. Den består overvejende af hydrogen og aliphatiske carbonhydrider, overvejende C1 til og med C6.]

295-400-7

92045-18-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-173-00-X

gasser (råolie), naphthadampkrakning højtryksrest-;

raffinaderigas;

[en sammensat blanding opnået som en blanding af

de ikke-kondenserbare dele af produktet fra en naphthadampkrakningsproces samt

restgasser opnået under bearbejdningen af efterfølgende produkter. Den består overvejende af hydrogen og paraffin og olefincarbonhydrider, overvejende C1 til og med C5, og kan også være iblandet naturgas.]

295-401-2

92045-19-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-174-00-5

gasser (råolie), restvisbreaking-aftræks-;

raffinaderigas;

[en sammensat blanding opnået fra viskositetsreduktion af rester i en ovn. Den består overvejende af hydrogensulfid og paraffin og olefincarbonhydrider, overvejende C1 til og med C5.]

295-402-8

92045-20-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-175-00-0

Foot's olie (råolie), syrebehandlet;

Foot's olie;

[en sammensat blanding af carbonhydrider opnået ved behandling af Foot's oil med svovlsyre. Den består overvejende af forgrenede carbonhydrider, overvejende C20 til og med C50.]

300-225-7

93924-31-3

Flam. Gas 1

Press. Gas

Carc. 1B

H220

H350

H340

GHS02

GHS04

GHS08

Dgr

H220

H350

H340

K U

649-176-00-6

Foot's oil (råolie), lerbehandlet;

solventekstraherede eller afvoksede tunge restolier;

[en sammensat blanding af carbonhydrider opnået ved behandling af Foot's oil med naturligt eller modificeret ler, enten i en kontakt- eller perkolationsproces for at fjerne spor af polære forbindelser og urenheder, som er til stede. Den består overvejende af forgrenede carbonhydrider, overvejende C20 til og med C50.]

300-226-2

93924-32-4

Flam. Gas 1

Press. Gas

Carc. 1B

H220

H350

H340

GHS02

GHS04

GHS08

Dgr

H220

H350

H340

K U

649-177-00-1

gasser (råolie), C3-4-; kulbrintegasser; [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra krakningen af råolie. Den består af carbonhydrider, C3

til og med C4, overvejende propan og propylen, med kogeinterval omtrent fra - 51 oC til - 1 oC.]

268-629-5

68131-75-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-178-00-7

slutgas (råolie), katalytisk krakket destillat- og katalytisk krakket naphtha fraktioneringsabsorber-; kulbrintegasser

[den sammensatte blanding af carbonhydrider fra destillationen af produkterne fra katalytisk krakkede destillater og katalytisk krakket naphtha. Den består overvejende af carbonhydrider, C1

til og med C4.]

269-617-2

68307-98-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-179-00-2

slutgas (råolie), katalytisk polymeriseret naphtha fraktionerings-stabilizer-; kulbrintegasser;

[en sammensat blanding af carbonhydrider fra fraktionerings-stabiliseringsprodukterne

fra polymerisering af naphtha. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.]

269-618-8

68307-99-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-180-00-8

slutgas (råolie), katalytisk reformeret naphtha fraktionerings-stabilizer-, hydrogensulfid-fri;

kulbrintegasser;

[en sammensat blanding af carbonhydrider, opnået ved fraktioneringsstabilisering af katalytisk reformeret naphtha, og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.]

269-619-3

68308-00-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-181-00-3

slutgas (råolie), krakket destillat hydrogenbehandler-stripper-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved at behandle termisk krakkede destillater med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede carbonhydrider, overvejende C1 til og med C6.]

269-620-9

68308-01-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-182-00-9

slutgas (råolie), straight-run destillat hydroafsvovler-, hydrogensulfidfri; kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved katalytisk hydroafsvovling af straight-run destillater og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C4.]

269-630-3

68308-10-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-183-00-4

slutgas (råolie), katalytisk gasoliekrakningsabsorber-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved destillation af produkter fra den katalytiske krakning af gasolie. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.]

269-623-5

68308-03-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-184-00-X

slutgas (råolie), gas-genudvindingsanlægs-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fra destillationen af produkter fra diverse carbonhydridstrømme. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.]

269-624-0

68308-04-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-185-00-5

slutgas (råolie), gas-genvindingsanlæg deethanizer-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fra destillationen af produkter fra diverse carbonhydridstrømme. Den består af carbonhydrider, overvejende C1 til og med C4.]

269-625-6

68308-05-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-186-00-0

slutgas (råolie), hydroafsvovlet destillat- og hydroafsvovlet naphtha fraktioneringskolonne-, syrefri;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af hydroafsvovlet naphtha og destillat carbonhydridstrømme og behandlet for at fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.]

269-626-1

68308-06-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-187-00-6

slutgas (råolie), hydroafsvovlet vakuumgasolie stripper-, hydrogensulfidfri;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved stripningsstabilisering af katalytisk hydroafsvovlet vakuumgasolie og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.]

269-627-7

68308-07-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-188-00-1

slutgas (råolie), let straight-run naphtha stabilizer-, hydrogensulfidfri;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringsstabilisering af straight-run naphtha og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C5.]

269-629-8

68308-09-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-189-00-7

slutgas (råolie), propan- og propylenalkyleringsføde forarbejdningsdeethanizer-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra reaktionen mellem propan og propylen. Den består af carbonhydrider, overvejende C1 til og med C4.]

269-631-9

68308-11-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-190-00-2

slutgas (råolie), vakuumgasolie hydroafsvovler-, hydrogensulfidfri;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved katalytisk hydroafsvovling af vakuumgasolie og fra hvilken hydrogensulfid er blevet fjernet ved aminbehandling. Den består overvejende af carbonhydrider, overvejende C1 til og med C6.]

269-632-4

68308-12-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-191-00-8

gasser (råolie), katalytisk krakker naphtha debutanizer-; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkter fra den katalytiske krakningsproces. Den består af carbonhydrider, overvejende C3 til og med C5, med kogeinterval omtrent fra - 48 oC til 32 oC.]

270-071-2

68409-99-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-193-00-9

alkaner, C1-2-; kulbrintegasser

270-651-5

68475-57-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-194-00-4

alkaner, C2-3-; kulbrintegasser

270-652-0

68475-58-1

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-195-00-X

alkaner, C3-4-;

kulbrintegasser

270-653-6

68475-59-2

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-196-00-5

alkaner, C4-5-; kulbrintegasser

270-654-1

68475-60-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-197-00-0

brændselsgasser; kulbrintegasser;

[en blanding af lette gasser. Den består overvejende af hydrogen og/eller lavmolekylære carbonhydrider.]

270-667-2

68476-26-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-198-00-6

brændselsgasser, råoliedestillater;

kulbrintegasser;

[en sammensat blanding af lette gasser fremstillet ved destillation af råolie og ved katalytisk reformering af naphtha. Den består af hydrogen og carbonhydrider, overvejende C1 til og med C4, med kogeinterval omtrent fra - 217 oC til - 12 oC.]

270-670-9

68476-29-9

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-199-00-1

carbonhydrider, C3-4-; kulbrintegasser

270-681-9

68476-40-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-200-00-5

carbonhydrider, C4-5-; kulbrintegasser

270-682-4

68476-42-6

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-201-00-0

carbonhydrider, C2-4-, C3-rige; kulbrintegasser

270-689-2

68476-49-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-202-00-6

råoliegasser, fortættede; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af råolie. Den består af carbonhydrider, overvejende C3 til og med C7, med kogeinterval omtrent fra 40 oC til 80 oC.]

270-704-2

68476-85-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K S U

649-203-00-1

råoliegasser, fortættede sweetenede;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved at underkaste en fortættet råoliegasblanding en sweetening-process for at omdanne mercaptaner eller for at fjerne sure urenheder. Den består af carbonhydrider, overvejende C3 til og med C7, med kogeinterval omtrent fra - 40 oC til 80 oC.]

270-705-8

68476-86-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K S U

649-204-00-7

gasser (råolie), C3-4-, isobutanrige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fra destillationen af mættede og umættede carbonhydrider, sædvanligvis C3 til og med C6, overvejende butan og

isobutan. Den består af mættede og umættede carbonhydrider, C3 til og med C4, overvejende isobutan.]

270-724-1

68477-33-8

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-205-00-2

gasser (råolie), C3-6-, piperylenrige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider fra destillationen af mættede og umættede, aliphatiske carbonhydrider, sædvanligvis C3 til og med C6. Den består af mættede og umættede carbonhydrider, C3 til og med C6, overvejende piperylener.]

270-726-2

68477-35-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-206-00-8

gasser (råolie), butansplitter- opfraktioner;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved destillationen af butanstrømmen. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C4.]

270-750-3

68477-69-0

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-207-00-3

gasser (råolie), C2-3-; kulbrintegasser;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkter fra en katalytisk fraktioneringsproces. Den indeholder overvejende ethan, ethylen, propan og propylen.]

270-751-9

68477-70-3

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-208-00-9

gasser (råolie), katalytisk krakket gasolie depropanizer-bundfraktioner, C4-rige syrefri;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af katalytisk krakket gasoliecarbonhydridstrøm

og behandlet for at fjerne hydrogensulfid og andre sure komponenter. Den består af C3 til og med C5-carbonhydrider, overvejende C4.]

270-752-4

68477-71-4

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-209-00-4

gasser (råolie), katalytisk krakket naphtha debutanizer-bundfraktioner, C3-5-rige;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået ved stabilisering af katalytisk krakket naphtha. Den består af aliphatiske carbonhydrider, overvejende C3 til og med C5.]

270-754-5

68477-72-5

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-210-00-X

slutgas (råolie), isomeriseret naphtha fraktioneringsstabilizer-;

kulbrintegasser;

[en sammensat blanding af carbonhydrider opnået fra produkter fra fraktioneringsstabiliseringen af isomeriseret naphtha Den består overvejende af carbonhydrider, overvejende C1 til og med C4.]

269-628-2

68308-08-7

Press. Gas

Flam. Gas 1

Carc. 1A Muta. 1B

H220

H350

H340

GHS04

GHS02

GHS08

Dgr

H220

H350

H340

K U

649-211-00-5

Foot's oil (råolie), carbonbehandlet;

solventekstraherede eller afvoksede tunge restolier

[en sammensat blanding af carbonhydrider opnået ved behandlingen af Foots oil med aktivt kul for at fjerne sporbestandele og urenheder. Den består overvejende af mættede ligekædede carbonhydrider, overvejende større end C12.]

308-126-0

97862-76-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-212-00-0

destillater (råolie), sweetenede, middeltunge;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået ved at underkaste et råoliedestillat en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består af carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 150 oC til 345 oC.]

265-088-7

64741-86-2

Carc. 1B

H350

GHS08

Dgr

H350

N

649-213-00-6

gasolier (råolie), solventraffinerede;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C11 til og med C25, med kogeinterval omtrent fra 205 oC til 400 oC.]

265-092-9

64741-90-8

Carc. 1B

H350

GHS08

Dgr

H350

N

649-214-00-1

destillater (råolie), solventraffinerede middeltunge;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 150 oC til 345 oC.]

265-093-4

64741-91-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-215-00-7

gasolier (råolie), syrebehandlede;

upecificeret gasolie;

[en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhybrider, overvejende C13 til og med C25, med kogeinterval omtrent fra 230 oC til 400 oC.]

265-112-6

64742-12-7

Carc. 1B

H350

GHS08

Dgr

H350

N

649-216-00-2

destillater (råolie), syrebehandlede, middeltunge;

upecificeret gasolie;

[en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C11 til og med C20, med kogeinterval omtrent fra 205 oC til 345 oC.]

265-113-1

64742-13-8

Carc. 1B

H350

GHS08

Dgr

H350

N

649-217-00-8

destillater (råolie), syrebehandlede, lette;

upecificeret gasolie;

[en sammensat blanding af carbonhybrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.]

265-114-7

64742-14-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-218-00-3

gasolier (råolie), kemisk neutraliserede;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C13 til og med C25, med kogeinterval omtrent fra 230 oC til 400 oC.]

265-129-9

64742-29-6

Carc. 1B

H350

GHS08

Dgr

H350

N

649-219-00-9

destillater (råolie), kemisk neutraliserede, middeltunge;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C11 til og med C20, med kogeinterval omtrent fra 205 oC til 345 oC.]

265-130-4

64742-30-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-220-00-4

destillater (råolie), lerbehandlede, middeltunge;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 150 oC til 345 oC.]

265-139-3

64742-38-7

Carc. 1B

H350

GHS08

Dgr

H350

N

649-221-00-X

destillater (råolie), hydrogen

behandlede middeltunge;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C11 til og med C25, med kogeinterval omtrent fra 205 oC til 400 oC.]

265-148-2

64742-46-7

Carc. 1B

H350

GHS08

Dgr

H350

N

649-222-00-5

gasolier (råolie), hydro

afsvovlede

upecificeret gasolie;

[en sammensat blandning af carbonhydrider opnået fra en rå råolie ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består overvejende af carbonhydrider, overvejende C13 til og med C25, med kogeinterval omtrent fra 230 oC til 400 oC]

265-182-8

64742-79-6

Carc. 1B

H350

GHS08

Dgr

H350

N

649-223-00-0

destillater (råolie), hydroafsvovlede, middeltunge;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået fra en rå råolie ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består af carbonhydrider, overvejende C11 til og med C25, med kogeinterval

omtrent fra 205 oC til 400 oC.]

265-183-3

64742-80-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-224-00-6

brændstoffer, diesel-;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af råolie. Den består af carbonhydrider, overvejende C9 til og med C20, med kogeinterval omtrent fra 163 oC til 357 oC.]

269-822-7

68334-30-5

Carc. 2

H351

GHS08

Wng

H351

N

649-225-00-1

brændselsolie, nr. 2;

upecificeret gasolie;

[en destillatolie med en minimumsviskositet på 2 cSt ved 37,7 oC til et maximum på 3.7 cSt ved 37,7 oC.]

270-671-4

68476-30-2

Carc. 2

H351

GHS08

Wng

H351

649-226-00-7

brændselsolie, nr. 4;

upecificeret gasolie;

[en destillatolie med en minimumsviskositet på 5.8 cSt ved 37,7 oC til et maximum på 26.4 cSt ved 37,7 oC.]

270-673-5

68476-31-3

Carc. 2

H351

GHS08

Wng

H351

649-227-00-2

brændstoffer, diesel-, nr. 2; uspecificeret gasolie;

[destillatolien med en minimumsviskositet på 2 cSt ved 37,7 oC til et maximum på 4.3 cSt ved 37,7 oC.]

270-676-1

68476-34-6

Carc. 2

H351

GHS08

Wng

H351

649-228-00-8

destillater (råolie), katalytisk reformer-fraktioneringskolonnerest, højtkogende;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider fra destillationen af en rest fra en katalytisk reformer fraktioneringskolonne. Den koger omtrent fra 343 oC til 399 oC.]

270-719-4

68477-29-2

Carc. 1B

H350

GHS08

Dgr

H350

N

649-229-00-3

destillater (råolie), katalytisk reformer-fraktioneringskolonnerest, intermediært kogende;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider fra destillationen af en rest fra en katalytisk reformer fraktioneringskolonne. Den koger omtrent fra 288 oC til 371 oC.]

270-721-5

68477-30-5

Carc. 1B

H350

GHS08

Dgr

H350

N

649-230-00-9

destillater (råolie), katalytisk reformer-fraktioneringskolonnerest, lavtkogende;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider fra destillationen af en rest fra en katalytisk reformer fraktioneringskolonne. Den koger omtrent under 288 oC.]

270-722-0

68477-31-6

Carc. 1B

H350

GHS08

Dgr

H350

N

649-231-00-4

destillater (råolie), højt raffinerede, middeltunge;

upecificeret gasolie;

(en sammensat blanding af carbonhydrider opnået ved at underkaste en råoliefraktion flere af følgende trin: filtrering, centrifugering, atmosfærisk destillation, vakuumdestillation, syrebehandling, neutralisering og lerbehandling. Den består overvejende af carbonhydrider, overvejende C10 til og med C20)

292-615-8

90640-93-0

Carc. 1B

H350

GHS08

Dgr

H350

N

649-232-00-X

destillater (råolie), katalytisk reformer-, tungt aromatisk koncentrat; uspecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået fra destillation af en katalytisk reformeret råoliefraktion. Den består overvejende af aromatiske carbonhydrider, overvejende C10 til og med C16, med kogeinterval omtrent fra 200 oC til

300 oC.]

295-294-2

91995-34-5

Carc. 1B

H350

GHS08

Dgr

H350

N

649-233-00-5

gasolier, paraffin-; uspecificeret gasolie;

[et destillat opnået ved redestillationen af en sammensat blanding af carbonhydrider, opnået ved destillationen af spildevandet fra kraftig, katalytisk hydrogenbehandling af paraffiner. Det har kogeinterval omtrent fra 190 oC til 330 oC.]

300-227-8

93924-33-5

Carc. 1B

H350

GHS08

Dgr

H350

N

649-234-00-0

naphtha (råolie), solvent-raffineret hydroafsvovlet tung;

uspecificeret gasolie

307-035-3

97488-96-5

Carc. 1B

H350

GHS08

Dgr

H350

N

649-235-00-6

carbonhydrider, C16-20-hydrogenbehandlet middeltungt destillat, lette destillater;

uspecificeret gasolie; [en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra behandlingen af et middeltungt destillat med hydrogen. Den består overvejende af carbonhydrider C16 til og med C20, med kogeinterval omtrent fra 290 oC til 350 oC. Den danner en færdig olie med en viskositet på 2 cSt ved 100 oC.]

307-659-6

97675-85-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-236-00-1

carbonhydrider, C12-20-, hydrogenbehandlet

paraffin, lette destillater;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra behandlingen af tunge paraffiner med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende fra C12 til og med C20,

med kogeinterval omtrent fra 230 oC til 350 oC. Den danner en færdig olie med en viskositet

på 2 cSt ved 100 oC.]

307-660-1

97675-86-0

Carc. 1B

H350

GHS08

Dgr

H350

N

649-237-00-7

carbonhydrider, C11-17-solvent-ekstraherede, lette, naphthenske;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået ved ekstraktionen af aromaterne fra et let naphthen destillat med en viskositet på 2,2 cSt.]

ved 40 oC. Den består overvejende af carbonhydrider, overvejende fra C11 til og med C17, med kogeinterval omtrent fra 200 oC til 300 o.]

307-757-9

97722-08-2

Carc. 1B

H350

GHS08

Dgr

H350

N

649-238-00-2

gasolier, hydrogenbehandlede; uspecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået ved redestillation af udløbene fra behandlingen af paraffiner med hydrogen, i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende fra C17 til og med C27, med kogeinterval omtrent fra 330 oC til 340 oC.]

308-128-1

97862-78-7

Carc. 1B

H350

GHS08

Dgr

H350

N

649-239-00-8

destillater (råolie), carbonbehandlet lette paraffin-;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået ved behandling af en råoliefraktion med aktivt kul, til fjernelse af spor af polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende C12 til og med C28.]

309-667-5

100683-97-4

Carc. 1B

H350

GHS08

Dgr

H350

N

649-240-00-3

destillater (råolie), intermediære paraffin-, carbonbehandlede;

upecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af råolie med aktivt kul, til fjernelse af spor af polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende C16 til og med C36.]

309-668-0

100683-98-5

Carc. 1B

H350

GHS08

Dgr

H350

N

649-241-00-9

destillater (råolie), intermediære paraffin-, lerbehandlede; uspecificeret gasolie;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af råolie med blegejord, til fjernelse af spor polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende C16 til og med C36.]

309-669-6

100683-99-6

Carc. 1B

H350

GHS08

Dgr

H350

N

649-242-00-4

alkaner, C12-26-forgrenede og ligekædede

292-454-3

90622-53-0

Carc. 1B

H350

GHS08

Dgr

H350

N

649-243-00-X

smørefedtstoffer; fedt;

[en sammensat blanding af carbonhydrider, overvejende C12 til og med C50, som kan indeholde organiske salte af alkalimetaller, jordalkalimetaller, og/eller aluminiumforbindelser.]

278-011-7

74869-21-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-244-00-5

slack wax (råolie), råparaffin;

[en sammensat blanding af carbonhydrider opnået fra en råoliefraktion ved solventkrystallisation (solventafvoksning), eller som en destillationsfraktion fra en meget voksagtig olie. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.]

265-165-5

64742-61-6

Carc. 1B

H350

GHS08

Dgr

H350

N

649-245-00-0

slack wax (råolie), syrebehandlet;

råparaffin;

[en sammensat blandning ekstraktcarbonhydrider opnået som et raffinat ved behandling af en råolie-slack wax i en svovlsyrebehandlingsproces. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.]

292-659-8

90669-77-5

Carc. 1B

H350

GHS08

Dgr

H350

N

649-246-00-6

slack wax (råolie), lerbehandlet;

råparaffin;

[en sammensat blanding af carbonhydrider opnået ved behandling af en råolie-slack wax-fraktion med neutralt eller modificeret ler i enten en kontakt- eller en perkoleringsproces. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.]

292-660-3

90669-78-6

Carc. 1B

H350

GHS08

Dgr

H350

N

649-247-00-1

slack wax (råolie), hydrogen

behandlet;

råparaffin;

[en sammensat blanding af carbonhydrider opnået ved at behandle slack wax med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C20.]

295-523-6

92062-09-4

Carc. 1B

H350

GHS08

Dgr

H350

N

649-248-00-7

slack wax (råolie), lavtsmeltende;

råparaffin;

[en sammensat blanding af carbonhydrider opnået fra en råoliefraktion ved solventafparaffinering. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.]

295-524-1

92062-10-7

Carc. 1B

H350

GHS08

Dgr

H350

N

649-249-00-2

slack wax (råolie), lavtsmeltende, hydrogenbehandlet;

råparaffin;

[en sammensat blanding af carbonhydrider opnået ved behandling af lavtsmeltende råolie-slack wax med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede, ligekædede og forgrenede carbonhydrider, overvejende større end C12.]

295-525-7

92062-11-8

Carc. 1B

H350

GHS08

Dgr

H350

N

649-250-00-8

slack wax (råolie), lavtsmeltende, carbonbehandlet;

råparaffin;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af lavtsmeltende slack wax med aktivt kul for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.]

308-155-9

97863-04-2

Carc. 1B

H350

GHS08

Dgr

H350

N

649-251-00-3

slack wax (råolie), lavtsmeltende, lerbehandlet;

råparaffin;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af lavtsmeltende råolie-slack wax med bentonit for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.]

308-156-4

97863-05-3

Carc. 1B

H350

GHS08

Dgr

H350

N

649-252-00-9

slack wax (råolie), lavtsmeltende, kiselsyrebehandlet; råparaffin; [en sammensat blanding af carbonhydrider opnået ved behandlingen af lavtsmeltende råolie-slack wax med kiselsyre for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede ligekædede og forgrenede carbonhydrider, overvejende større end C12.]

308-158-5

97863-06-4

Carc. 1B

H350

GHS08

Dgr

H350

N

649-253-00-4

slack wax (råolie), carbonbehandlet;

råparaffin;

[en sammensat blanding af carbonhydrider opnået ved behandling af råolie-slack wax med aktivt kul, for at fjerne spor af polære bestanddele og urenheder.]

309-723-9

100684-49-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-254-00-X

vaselin;

[en sammensat blanding af carbonhydrider udvundet som et halvfast stof fra afvoksning af paraffinrestolie. Den består overvejende af mættede krystallinske og flydende carbonhydrider, overvejende større end C25.]

232-373-2

08-03-8009

Carc. 1B

H350

GHS08

Dgr

H350

N

649-255-00-5

vaselin (råolie), oxideret;

vaselin;

[en sammensat blanding af organiske forbindelser, overvejende højmolekylære carboxylsyrer, opnået ved luftoxidation af vaselin.]

265-206-7

64743-01-7

Carc. 1B

H350

GHS08

Dgr

H350

N

649-256-00-0

vaselin (råolie), aluminiumoxidbehandlet;

vaselin;

[en sammensat blanding af carbonhydrider opnået når vaselin er behandlet med AL2O3 for at fjerne polære komponenter og urenheder. Den består overvejende af mættede, krystallinske og flydende carbonhydrider, overvejende større end C25.]

285-098-5

85029-74-9

Carc. 1B

H350

GHS08

Dgr

H350

N

649-257-00-6

vaselin (råolie), hydrogen

behandlet;

vaselin;

[en sammensat blanding af carbonhydrider opnået som et halvfast stof fra afvokset paraffinrestolie behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af mættede mikrokrystallinske og flydende carbonhydrider, overvejende større end C20.]

295-459-9

92045-77-7

Carc. 1B

H350

GHS08

Dgr

H350

N

649-258-00-1

vaselin (råolie) carbonbehandlet;

vaselin;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af råolievaselin med aktivt kul for at fjerne polære sporbestanddele og urenheder. Den består overvejende af mættede carbonhydrider, overvejende større end C20.]

308-149-6

97862-97-0

Carc. 1B

H350

GHS08

Dgr

H350

N

649-259-00-7

vaselin (råolie), kiselsyrebehandlede;

vaselin;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af råolievaselin med kiselsyre for at fjerne polære sporbestandele og urenheder. Den består overvejende af mættede carbonhydrider, overvejende større end C20.]

308-150-1

97862-98-1

Carc. 1B

H350

GHS08

Dgr

H350

N

649-260-00-2

vaselin (råolie), lerbehandlet;

vaselin; [en sammensat blanding af carbonhydrider opnået ved behandling af vaselin med blegejord, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af carbonhydrider, overvejende større end C25.]

309-706-6

100684-33-1

Carc. 1B

H350

GHS08

Dgr

H350

N

649-261-00-8

kondensat, naturgas-;

lavtkogende nafta;

[en sammensat blanding af carbonhydrider adskilt fra naturgas ved processer, såsom køling eller absorption. Den består overvejende af mættede aliphatiske carbonhydrider, overvejende C4 til og med C8, med kogeinterval omtrent fra - 20 oC til 120 oC.]

232-349-1

8006-61-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-262-00-3

naphtha;

lavtkogende nafta; [raffinerede, delvist raffinerede, eller uraffinerede råolieprodukter fremstillet ved destillation af naturgas. De består af carbonhydrider, overvejende C5 til og med C6, med kogeinterval omtrent fra 100 oC til 200 oC.]

232-443-2

8030-30-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-263-00-9

ligroin;

lavtkogende nafta;

[en sammensat blanding af carbonhydrider opnået ved fraktioneret destillation af råolie. Denne fraktion har kogeinterval omtrent fra 20 oC til 135 oC.]

232-453-7

8032-32-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-264-00-4

naphtha (råolie), tung straight-run; lavtkogende nafta; [en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC.]

265-041-0

64741-41-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-265-00-X

naphtha (råolie), full-range straight-run-;

lavtkogende nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 220 oC.]

265-042-6

64741-42-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-266-00-5

naphtha (råolie), let straight-run-;

lavtkogende nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består overvejende af aliphatiske carbonhydrider, overvejende C4 til og med C10, med kogeinterval omtrent fra - 20 oC til 180 oC.]

265-046-8

64741-46-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-267-00-0

solventnaphtha (råolie), let aliphatisk;

lavtkogende nafta;

[en sammensat blanding af carbonhydrider opnået ved destillation af råolie eller naturgaskondensat. Den består overvejende af mættede carbonhydrider, overvejende C5 til og med C10, med kogeinterval omtrent fra 35 oC til 160 oC.]

265-192-2

64742-89-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-268-00-6

destillater (råolie), straight-run, lette;

lavtkogende nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C2 til og med C7, med kogeinterval omtrent fra - 88 oC til 99 oC.]

270-077-5

68410-05-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-269-00-1

benzin, damp-genudvindings-; lavtkogende nafta;

[en sammensat blanding af carbonhydrider separeret fra gasserne fra dampgenvindingssystemer ved afkøling. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 196 oC.]

271-025-4

68514-15-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-270-00-7

benzin, straight-run topanlægs; lavtkogende nafta;

[en sammensat blanding af carbonhydrider fremstillet fra topanlægget ved destillation af råolie. Den har et kogeinterval omtrent fra 36,1 oC til 193,3 oC.]

271-727-0

68606-11-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-271-00-2

naphtha (råolie), ikke-sweetenet; [en sammensat blanding af carbonhydrider fremstillet ved destillation af naphthastrømme fra forskellige raffinaderiprocesser. Den består af carbonhydrider, overvejende C5 til og med C12, med kogeinterval omtrent fra 0 oC til 230 oC.]

272-186-3

68783-12-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-272-00-8

destillater (råolie), fraktionering af let straight-run benzin stabilizertopfraktioner; lavtkogende nafta;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af let straight-run benzin. Den består af mættede aliphatiske carbonhydrider, overvejende C3 til og med C6.]

272-931-2

68921-08-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-273-00-3

naphtha (råolie), tung straight-run-, aromatholdig;

lavtkogende nafta;

[en sammensat blanding af carbonhydrider opnået ved en destillationsproces af rå råolie. Den består overvejende af carbonhydrider,

overvejende C8 til og med C12, med kogeinterval omtrent fra 130 oC til 210 oC.]

309-945-6

101631-20-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-274-00-9

naphtha (råolie), full-range alkylat-;

lavtkogende modificeret

nafta;

[en sammensat blanding af carbonhydrider fremstillet ved

destillation af produkterne fra reaktionen mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 220 oC.]

265-066-7

64741-64-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-275-00-4

naphtha (råolie), tung alkylat-;

lavtkogende modificeret nafta; [en sammensat blanding af carbonhydrider fremstillet ved

destillation af produkterne fra reaktionen mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C9 til og med C12, med kogeinterval omtrent fra 150 oC til 220 oC.]

265-067-2

64741-65-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-276-00-X

naphtha (råolie), let alkylat-;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra reaktionen mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C7 til og med C10, med kogeinterval omtrent fra 90 oC til 160 oC.]

265-068-8

64741-66-8

Carc. 1B Muta. 1B Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-277-00-5

naphtha (råolie), isomeriserings-;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk isomerisering af ligekædede paraffincarbonhydrider, C4 til og med C6. Den består overvejende af mættede carbonhydrider, såsom isobutan, isopentan, 2,2-dimethylbutan, 2-methylpentan og 3-methylpentan.]

265-073-5

64741-70-4

Carc. 1B Muta. 1B Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-278-00-0

naphtha (råolie), solventraffineret let;

lavtkogende modificeret

nafta;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra en

solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 190 oC.]

265-086-6

64741-84-0

Carc. 1B Muta. 1B Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-279-00-6

naphtha (råolie), solventraffineret, tung;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider opnået som

raffinatet fra en solventekstraktionsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 230 oC.]

265-095-5

64741-92-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-280-00-1

raffinater (råolie), katalytisk reformer ethylenglycol-vand modstrømsekstrakter;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra UDEX-ekstraktionsprocessen af den katalytiske reformerstrøm. Den består af mættede carbonhydrider, overvejende C6 til og med C9.]

270-088-5

68410-71-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-281-00-7

raffinater (råolie), reformer-, Lurgi-enhedsseparerede;

lavtkogende modificeret nafta;

[den sammensatte blanding af carbonhydrider opnået som et raffinat fra en Lurgi-separationsenhed. Den består overvejende af ikke-aromatiske carbonhydrider med varierende små mængder aromatiske carbonhydrider, overvejende C6 til og med C8.]

270-349-3

68425-35-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-282-00-2

naphtha (råolie), full-range-alkylat-, butanholdig;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra reaktion mellem isobutan og monoolefiniske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C7 til og med C12, med nogle butaner, med kogeinterval omtrent fra 35 oC til 200 oC.]

271-267-0

68527-27-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-283-00-8

destillater (råolie), naphthadampkrakningsudvundne, solventraffinerede lette hydrogenbehandlede;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider opnået som raffinaterne fra en solventekstraktionsproces af et hydrogenbehandlet let destillat fra dampkrakket naphtha.]

295-315-5

91995-53-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-284-00-3

naphtha (råolie), C4-12 butanalkylat, isooctan-rig; lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider opnået ved alkylering af butaner. Den består overvejende af carbonhydrider, overvejende C4 til og med C12, rig på isooctan, med kogeinterval omtrent fra 35 oC til 210 oC.]

295-430-0

92045-49-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-285-00-9

carbonhydrider, hydrogenbehandlede, lette naphthadestillater, solventraffinerede;

lavtkogende modificeret nafta; [en sammensat blanding af carbonhydrider opnået fra destillationen af hydrogenbehandlet naphtha, efterfulgt af en solventekstraktions- og destillationsproces. Den består overvejende af mættede carbonhydrider, med kogeinterval omtrent fra 94 oC til 99 oC.]

295-436-3

92045-55-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-286-00-4

naphtha (råolie), isomerisation, C6-fraktion;

lavtkogende modificeret

nafta;

[en sammensat blanding af carbonhydrider opnået ved destillation af en benzin, der er blevet katalytisk isomeriseret. Den består overvejende af hexanisomerer med kogeinterval omtrent fra 60 oC til 66 oC.]

295-440-5

92045-58-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-287-00-X

carbonhydrider, C6-7 naphthakraknings-, solventraffinerede;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider opnået ved sorptionen af benzen fra en katalytisk, fuldt hydrogeneret,

benzen-rig carbonhydridfraktion, opnået ved destillation af præhydrogeneret, krakket naphtha. Den består overvejende af paraffin- og naphthencarbonhydrider, overvejende C6 til og med C7, med kogeinterval omtrent fra 70 oC til 100 oC.]

295-446-8

92045-64-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-288-00-5

carbonhydrider, C6-rige, hydrogenbehandlede lette naphthadistillater, solvent-raffinerede;

lavtkogende modificeret nafta;

[en sammensat blanding af carbonhydrider opnået ved destillation af hydrogenbehandlet naphtha

efterfulgt af solventekstraktion. Den består overvejende af mættede carbonhydrider, med kogeinterval omtrent fra 65 oC til 70 oC.]

309-871-4

101316-67-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-289-00-0

naphtha (råolie), tung, katalytisk krakket;

lavtkogende katalytisk krakket nafta:

[en sammensat blanding af

carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC. Den indeholder en forholdsvis stor del umættede carbonhydrider.]

265-055-7

64741-54-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-290-00-6

naphtha (råolie), let katalytisk krakket;

lavtkogende katalytisk krakket nafta:

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC. Den indeholder en forholdsvis stor del umættede carbonhydrider.]

265-056-2

64741-55-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-291-00-1

carbonhydrider, C3-11-, katalytisk krakkerdestillater;

lavtkogende katalytisk krakket nafta;

[en sammensat blanding af carbonhydrider fremstillet ved

destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C3 til og med C11, og koger omtrent op til 204 oC.]

270-686-6

68476-46-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-292-00-7

naphtha (råolie), katalytisk krakket let destilleret;

lavtkogende katalytisk krakket

nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C1 til og med C5.]

272-185-8

68783-09-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-293-00-2

destillater (råolie), naphthadampkrakningsudvundne, hydrogenbehandlede, lette, aromatiske;

lavtkogende katalytisk krakket nafta;

[en sammensat blanding af carbonhydrider opnået ved at behandle et let destillat fra dampkrakket naphtha. Den består overvejende af aromatiske carbonhydrider.]

295-311-3

91995-50-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-294-00-8

naphtha (råolie), tung katalytisk krakket sweetened; lavtkogende katalytisk krakket nafta;

[en sammensat blanding af carbonhydrider opnået ved at underkaste et katalytisk krakket råoliedestillat en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 60 oC til 200 oC.]

295-431-6

92045-50-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-295-00-3

naphtha (råolie), let katalytisk krakket sweetenet; lavtkogende katalytisk krakket nafta;

[en sammensat blanding af carbonhydrider, opnået ved at underkaste naphtha fra en katalytisk krakningsproces en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 35 oC til 210 oC.]

295-441-0

92045-59-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-296-00-9

carbonhydrider, C8-12 katalytisk kraknings-, kemisk neutraliserede;

lavtkogende katalytisk krakket nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af en fraktion fra den katalytiske krakningsproces, der er undergået en alkalisk vask. Den består overvejende af carbonhydrider, overvejende C8 til og med C12, med kogeinterval omtrent fra 130 oC til 210 oC.]

295-794-0

92128-94-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-297-00-4

carbonhydrider, C8-12- katalytisk krakkerdestillater;

lavtkogende katalytisk krakket

nafta;

[en sammensat blanding af carbonhydrider opnået ved destillation af produkter fra en katalytisk krakningsproces. Den består overvejende af carbonhydrider, overvejende C8 til og med C12, med kogeinterval omtrent fra 140 oC til 210 oC.]

309-974-4

101794-97-2

Carc. 1B

Muta. 1B A

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-298-00-X

carbonhydrider, C8-12 katalytisk kraknings-, kemisk neutraliserede, sweetenede;

lavtkogende katalytisk krakket nafta

309-987-5

101896-28-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-299-00-5

naphtha (råolie), let katalytisk reformeret;

lavtkogende katalytisk reformeret

nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk reformeringsproces. Den består af carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 190 oC. Den indeholder en forholdsvis stor del aromatiske og forgrenede carbonhydrider. Denne strøm kan indeholde 10 volumenprocent eller mere benzen.]

265-065-1

64741-63-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-300-00-9

naphtha (råolie), tung katalytisk reformeret;

lavtkogende katalytisk reformeret nafta; [en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk reformeringsproces. Den består af overvejende aromatiske carbonhydrider, overvejende C7 til og med C12,

med kogeinterval omtrent fra 90 oC til 230 oC.]

265-070-9

64741-68-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-301-00-4

destillater (råolie), katalytisk reformerede depentanizer-;

lavtkogende katalytisk reformeret nafta;

[en sammensat blanding af carbonhydrider fra destillationen af produkterne fra en katalytisk reformeringsproces. Den består overvejende af aliphatiske carbonhydrider, overvejende C3 til og med C6, med kogeinterval omtrent fra - 49 oC til 63 oC.]

270-660-4

68475-79-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-302-00-X

carbonhydrider, C2-6-, C6-8-

katalytisk reformer;

lavtkogende katalytisk reformeret nafta

270-687-1

68476-47-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-303-00-5

rester (råolie), C6-8-,

katalytisk reformer;

lavtkogende katalytisk reformeret nafta;

[en sammensat remanens fra den katalytiske reformering af C6-8-føde. Den består af carbonhydrider, overvejende C2 til og med C6.]

270-794-3

68478-15-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-304-00-0

naphtha (råolie), let katalytisk reformeret, aromatfri; lavtkogende katalytisk reformeret nafta;

[en sammensat blanding af carbonhydrider opnået ved

destillation af produkterne fra en katalytisk reformeringsproces. Den består overvejende af carbonhydrider,

overvejende C5 til og med C8, med kogeinterval omtrent fra 35 oC til 120 oC. Den indeholder en forholdsvis stor del forgrenede carbonhydrider, hvorfra de aromatiske komponenter er fjernet.]

270-993-5

68513-03-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-305-00-6

destillater (råolie), katalytisk reformeret straight-run naphtha topfraktioner;

lavtkogende katalytisk reformeret nafta;

[en sammensat blanding af carbonhydrider opnået ved den katalytiske reformering af straight-run naphtha, efterfulgt af fraktionering af det totale udløb. Den består af mættede, aliphatiske carbonhydrider, overvejende C2 til og med C6.]

271-008-1

68513-63-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-306-00-1

råolieprodukter, hydrofiner-powerformer reformater;

lavtkogende katalytisk reformeret nafta;

[den sammensatte blanding af carbonhydrider, opnået ved en hydrofiner-powerformer-proces, med kogeinterval omtrent fra 27 oC til 210 oC.]

271-058-4

68514-79-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-307-00-7

naphtha (råolie), full-range reformeret;

lavtkogende katalytisk reformeret nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en katalytisk reformeringsproces. Den består af carbonhydrider, overvejende C5 til og med C12, med kogeinterval omtrent fra 35 oC til 230 oC.]

272-895-8

68919-37-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-308-00-2

naphtha (råolie), katalytisk reformeret;

lavtkogende katalytisk reformeret nafta;

[en sammensat blanding af carbonhydrider fremstillet ved

destillationen af produkter fra en katalytisk reformeringsproces. Den består af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra 30 oC til 220 oC. Den indeholder en forholdsvis stor del aromatiske og forgrenede carbonhydrider. Denne strøm kan indeholde 10 volumenprocent, eller mere, benzen.]

273-271-8

68955-35-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-309-00-8

destillater (råolie), katalytiske reformerede hydrogenbehandlede lette, C8-12-aromatfraktion; lavtkogende katalytisk reformeret nafta;

[en sammensat blanding af alkylbenzener opnået ved katalytisk reformering af råolienaphta. Den består overvejende af alkylbenzener, overvejende C8 til og med C10, med kogeinterval omtrent fra 160 oC til 180 oC.]

285-509-8

85116-58-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-310-00-3

aromatiske carbonhydrider, C8-, katalytisk reformeringsudvundne;

lavtkogende katalytisk reformeret nafta

295-279-0

91995-18-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-311-00-9

aromatiske carbonhydrider, C7-12, C8-rige;

lavtkogende katalytisk reformeret

nafta;

[en sammensat blanding af carbonhydrider opnået ved separation fra den platformatholdige fraktion. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C12 (primært C8) og kan indeholde ikke-aromatiske carbonhydrider, begge med kogeinterval omtrent fra 130 oC til 200 oC.]

297-401-8

93571-75-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-312-00-4

benzin, C5-11-, højoktan stabiliseret reformeret;

lavtkogende katalytisk reformeret nafta;

[en sammensat højoktanblanding af carbonhydrider opnået ved katalytisk dehydrogenering af en overvejende naphthenisk naphtha. Den består overvejende af aromater og ikke-aromater, overvejende C5 til og med C11, med kogeinterval omtrent fra 45 oC til 185 oC.]

297-458-9

93572-29-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-313-00-X

carbonhydrider, C7-12-, C>9-aromatrige, reformering, tung fraktion; lavtkogende katalytisk reformeret nafta

[en sammensat blanding af carbonhydrider opnået ved separation fra den platformatholdige fraktion. Den består overvejende af ikke-aromatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval 120 oC til 210 oC, samt C9 og højere aromatiske carbonhydrider.]

297-465-7

93572-35-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-314-00-5

carbonhydrider, C5-11-, ikke-aromatrige, reformering, let fraktion;

lavtkogende katalytisk reformeret

nafta;

[en sammensat blanding af carbonhydrider opnået ved separation fra den platformatholdige fraktion. Den består overvejende af ikke-aromatiske carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 125 oC, samt benzen og toluen.]

297-466-2

93572-36-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-315-00-0

Foot's oil (råolie), kiselsyrebehandlet;

solventekstraherede eller afvoksede tunge restolier;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af Foots oil med kiselsyre for at fjerne sporbestandele og urenheder. Den består overvejende af mættede ligekædede carbonhydrider, overvejende større end C12.]

308-127-6

97862-77-6

Carc. 1B

H350

H304

GHS08

Dgr

H350

H304

L

649-316-00-6

naphtha (råolie), let termisk krakket;

lavtkogende termisk krakket nafta;

[en sammensat blanding af carbonhydrider fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C4 til og med C8, med kogeinterval omtrent fra - 10 oC til 130 oC.]

265-075-6

64741-74-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-317-00-1

naphtha (råolie), tung termisk krakket;

lavtkogende termisk krakket nafta;

[en sammensat blanding af carbonhydrider fra destillation af produkterne fra en termisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 220 oC.]

265-085-0

64741-83-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-318-00-7

destillater (råolie), tunge aromatiske;

lavtkogende termisk krakket nafta;

[den sammensatte blanding af carbonhydrider opnået ved destillationen af produkterne fra den termiske krakning af ethan og propan. Denne højerekogende fraktion består overvejende af aromatiske C5-7-carbonhydrider med nogle umættede aliphatiske carbonhydrider, overvejende C5. Denne strøm kan indeholde benzen.]

267-563-4

67891-79-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-319-00-2

destillater (råolie), lette aromatiske;

lavtkogende termisk krakket nafta; [den sammensatte blanding af carbonhydrider opnået ved destillationen af produkterne fra den termiske krakning af ethan og propan. Denne laverekogende fraktion består overvejende af aromatiske C5-7-carbonhydrider med nogle umættede aliphatiske

carbonhydrider, overvejende C5. Denne strøm kan indeholde benzen.]

267-565-5

67891-80-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

HS08

Dgr

H350

H340

H304

P

649-320-00-8

destillater (råolie), naphtha- og raffinatpyrolysatafledte, benzinblanding;

lavtkogende termisk krakket nafta; [den sammensatte blanding af carbonhydrider opnået ved pyrolysefraktionering ved 816 oC af naphtha og raffinat. Den består overvejende af C9-carbonhydrider og koger omtrent ved 204 oC.]

270-344-6

68425-29-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-321-00-3

aromatiske carbonhydrider, C6-8-, naphtha- og raffinatpyrolysatafledte; lavtkogende termisk krakket nafta; [en sammensat blanding af carbonhydrider opnået ved fraktioneringspyrolyse ved

816 oC af naphtha og raffinat. Den består overvejende af aromatiske carbonhydrider, overvejende C6 til og med C8, herunder benzen.]

270-658-3

68475-70-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-322-00-9

destillater (råolie), termisk krakket naphtha og gasolie; lavtkogende termisk krakket nafta;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af termisk krakket naphtha og/eller gasolie. Den består overvejende af olefincarbonhydrider, C5, med kogeinterval omtrent fra 33 oC til 60 oC.]

271-631-9

68603-00-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-323-00-4

destillater (råolie), termisk krakket naphtha og gasolie, C5-dimer-holdige;

lavtkogende termisk

krakket nafta; [en sammensat blanding af carbonhydrider fremstillet ved den ekstraktive destillation af termisk krakket naphtha og/eller gasolie. Den består overvejende af C5-carbonhydrider med nogle dimeriserede C5-olefiner, og har kogeinterval omtrent fra 33 oC til 184 oC.]

271-632-4

68603-01-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-324-00-X

destillater (råolie), termisk krakket naphtha og gasolie, ekstraktive;

lavtkogende termisk

krakket nafta;

[en sammensat blanding af carbonhydrider fremstillet ved den ekstraktive destillation af termisk krakket naphtha og/eller gasolie. Den består af paraffin og olefincarbonhydrider, overvejende isoamylener, såsom 2-methyl-1-buten og 2-methyl-2-buten, med kogeinterval omtrent fra 31 oC til 40 oC.]

271-634-5

68603-03-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-325-00-5

destillater (råolie), lette termisk krakkede, debutaniserede aromatiske;

lavtkogende termisk krakket nafta; [en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en termisk krakningsproces. Den består overvejende af aromatiske carbonhydrider, primært benzen.]

273-266-0

68955-29-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-326-00-0

naphtha (råolie), let termisk krakket sweetenet;

lavtkogende termisk

krakket nafta;

[en sammensat blanding af carbonhydrider opnået ved at underkaste et råoliedestillat fra højtemperaturtermisk krakning af tunge oliefraktioner en sweetening-proces for at omdanne mercaptaner. Den består overvejende af aromater, olefiner og mættede carbonhydrider med kogeinterval omtrent fra 20 oC til 100 oC.]

295-447-3

92045-65-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-327-00-6

naphtha (råolie), hydro-

genbehandlet tung;

lavtkogende hydrogeneret nafta; [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C6 til og med C13, med kogeinterval omtrent fra 65 oC til 230 oC.]

265-150-3

64742-48-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-328-00-1

naphtha (råolie), hydro-

genbehandlet let;

lavtkogende hydrogeneret nafta; [en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC.]

265-151-9

64742-49-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-329-00-7

naphtha (råolie), hydro-

afsvovlet let;

lavtkogende hydrogeneret nafta;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlingsproces. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC.]

265-178-6

64742-73-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-330-00-2

naphtha (råolie), hydro-

afsvovlet tung;

lavtkogende hydrogeneret nafta;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlningsproces. Den består af carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 230 oC.]

265-185-4

64742-82-1

Carc. 1B

Muta. 1B

STOT RE 1

Asp. Tox. 1

H350

H340

H372 (centralnervesystem)

H304

GHS08

Dgr

H350

H340

H372 (centralnervesystem)

H304

P

649-331-00-8

destillater (råolie), hydrogenbehandlede middeltunge, intermediært kogende;

lavtkogende hydrogeneret nafta; [en sammensat blanding af carbonhydrider opnået ved destillationen af produkter fra en hydrogenbehandlingsproces af middeltunge destillater. Den består af carbonhydrider, overvejende C5 til og med C10, med kogeinterval omtrent fra 127 oC til 188 oC.]

270-092-7

68410-96-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-332-00-3

destillater (råolie), let destillat hydrogenbehandlingsproces-, lavtkogende;

lavtkogende hydrogeneret nafta;

[en sammensat blanding af carbonhydrider opnået ved destillationen af produkter fra hydrogenbehandlingsprocessen af et let destillat. Den består af carbonhydrider, overvejende C6 til og med C9, med kogeinterval omtrent fra 3 oC til 194 oC.]

270-093-2

68410-97-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-333-00-9

destillater (råolie), hydrogenbehandlet tung naphtha, deisohexanizer-topfraktioner;

lavtkogende hydrogeneret

nafta;

[en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en hydrogenbehandlingsproces af tung naphtha. Den består af carbonhydrider, overvejende C3 til og med C6, med kogeinterval omtrent fra - 49 oC til 68 oC.]

270-094-8

68410-98-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-334-00-4

solventnaphtha (råolie), let aromatisk, hydrogenbehandlet;

lavtkogende hydrogeneret

nafta;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende C8 til og med C10, med kogeinterval omtrent fra 135 oC til 210 oC.]

270-988-8

68512-78-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-335-00-X

naphtha (råolie), hydroafsvovlet termisk krakket let; lavtkogende hydrogeneret nafta;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af et hydroafsvovlet termisk krakket destillat. Den består overvejende af

carbonhydrider, overvejende C5 til C11, med kogeinterval omtrent fra 23 oC til 195 oC.]

285-511-9

85116-60-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-336-00-5

naphtha (råolie), hydrogenbehandlet let, cycloalkanholdig; lavtkogende hydrogeneret nafta;

[en sammensat blanding af carbonhydrider opnået ved destillationen af en

råoliefraktion. Den består overvejende af alkaner og cycloalkaner med kogeinterval omtrent fra - 20 oC til 190 oC.]

285-512-4

85116-61-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-337-00-0

naphtha (råolie), tung dampkrakket, hydrogeneret; lavtkogende hydrogeneret nafta

295-432-1

92045-51-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-338-00-6

naphtha (råolie), hydroafsvovlet

full-range;

lavtkogende hydrogeneret naphtha;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk hydroafsvovlingsproces. Den består overvejende af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra 30 oC til 250 oC.]

295-433-7

92045-52-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-339-00-1

naphtha (råolie), hydrogenbehandlet

let dampkrakket;

lavtkogende hydrogeneret naphtha;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion, fremkommet ved en pyrolyseproces, med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af umættede carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 35 oC til 190 oC.]

295-438-4

92045-57-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-340-00-7

carbonhydrider, C4-12 naphtha-krakning, hydrogenbehandelede;

lavtkogende hydrogeneret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation

af produktet fra en naphtha-dampkrakningsproces og efterfølgende selektiv katalytisk hydrogenering af gummidannere. Den består af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra 30 oC til 230 oC.]

295-443-1

92045-61-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-341-00-2

solventnaphtha (råolie), hydrogenbehandlet let naphthen-; lavtkogende hydrogeneret naphtha;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af cycloparaffincarbonhydrider, overvejende C6 til og med C7, med kogeinterval omtrent fra 73 oC til 85 oC.]

295-529-9

92062-15-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-342-00-8

naphtha (råolie), let dampkrakket, hydrogeneret; lavtkogende hydrogeneret naphtha;

[en sammensat blanding af carbonhydrider fremstillet ved separation og efterfølgende hydrogenering af produkterne fra en dampkrakningsproces til fremstilling af ethylen. Den består overvejende af mættede og umættede paraffiner, cycliske paraffiner og cycliske aromatiske carbonhydrider, overvejende C4 til og med C10, med kogeinterval omtrent fra 50 oC til 200 oC. Andelen af benzencarbonhydrider kan være på til 30 vægtprocent, og strømmen kan også indeholde mindre mængder svovlforbindelser og oxygenerede forbindelser.]

296-942-7

93165-55-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-343-00-3

carbonhydrider, C6-11-, hydrogenbehandlede,

dearomatiserede;

lavtkogende hydrogeneret naphtha;

[en sammensat blanding af carbonhydrider opnået som solventer, der har været underkastet hydrogenbehandling for at omdanne aromater til naphthener ved katalytisk hydrogenering.]

297-852-0

93763-33-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-344-00-9

carbonhydrider, C9-12-, hydrogenbehandlede,

dearomatiserede;

lavtkogende hydrogeneret naphtha; [en sammensat blanding af carbonhydrider opnået som solventer, der har været underkastet hydrogenbehandling for at omdanne aromater til naphthener ved katalytisk hydrogenering.]

297-853-6

93763-34-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-345-00-4

mineralsk terpentin;

lavtkogende uspecificeret

naphtha;

[et farveløst, raffineret råoliedestillat, der er fri for harske eller frastødende lugte, med kogeinterval omtrent fra 148,8 oC til 204,2 oC.]

232-489-3

8052-41-3

Carc. 1B

Muta. 1B

STOT RE 1

Asp. Tox. 1

H350

H340

H372 (centralnervesystem)

H304

GHS08

Dgr

H350

H340

H372 (centralnervesystem)

H304

P

649-346-00-X

naturgaskondensater

(råolie);

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider adskilt som en væske fra naturgas i en overfladeseparator ved retrograd kondensation. Den består hovedsagelig af carbonhydrider, overvejende C2 til C20. Den er en væske ved atmosfærisk temperatur og tryk.]

265-047-3

64741-47-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-347-00-5

naturgas (råolie), rå væskeblanding; lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider adskilt som en væske fra naturgas i et gasgenanvendelsesanlæg ved sådanne processer som køling eller absorption. Den består hovedsagelig af mættede, aliphatiske carbonhydrider, C2 til og med C8.]

265-048-9

64741-48-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-348-00-0

naphtha (råolie), let hydrokrakket;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, overvejende C4 til og med C10, med kogeinterval omtrent fra - 20 oC til 180 oC.]

265-071-4

64741-69-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-349-00-6

naphtha (råolie), tung hydrokrakket;

lavtkogende uspecificeret nafta; [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC.]

265-079-8

64741-78-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-350-00-1

naphtha (råolie), sweetenet;

lavtkogende uspecificeret naphtha; [en sammensat blanding af carbonhydrider opnået ved at underkaste en råolienaphta en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra - 10 oC til 230 oC.]

265-089-2

64741-87-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-351-00-7

naphtha (råolie), syrebehandlet;

lavtkogende uspecificeret nafta; [en sammensat blanding af carbonhydrider opnået som et raffinat fra en svovlsyrebehandlingsproces. Den består af carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 230 oC.]

265-115-2

64742-15-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-352-00-2

naphtha (råolie), kemisk neutraliseret tung;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C6 til og med C12, med kogeinterval omtrent fra 65 oC til 230 oC.]

265-122-0

64742-22-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-353-00-8

nphtha (råolie), kemisk neutraliseret let;

lavtkogende uspecificeret naphtha; (en sammensat blanding af carbonhydrider fremstillet ved en behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC.]

265-123-6

64742-23-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-354-00-3

naphtha (råolie), katalytisk afvokset;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved

katalytisk afvoksning af en råoliefraktion. Den består overvejende af carbonhydrider, overvejende C5 til og med C12, med kogeinterval omtrent fra 35 oC til 230 oC.]

265-170-2

64742-66-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-355-00-9

naphtha (råolie), let dampkrakket;

lavtkogende uspecificeret naphtha; [en sammensat blanding af carbonhydrider fra destillation af produkterne fra en dampkrakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 190 oC. Denne strøm indeholder sædvanligvis 10 volumenprocent, eller mere, benzen.]

265-187-5

64742-83-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-356-00-4

solventnaphtha (råolie), let aromatisk;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af aromatiske strømme. Den består overvejende af aromatiske carbonhydrider, overvejende C8 til og med C10, med kogeinterval omtrent fra 135 oC til 210 oC.]

265-199-0

64742-95-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-357-00-X

aomatiske carbonhydrider, C6-10-, syrebehandlede, neutraliserede;

lavtkogende uspecificeret naphtha

268-618-5

68131-49-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-358-00-5

destillater (råolie), C3-5, 2-methyl-2-butenrige;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider fra destillationen af carbonhydrider, sædvanligvis C3 til og med C5, overvejende isopentan og 3-methyl-1-buten. Den består af mættede og umættede carbonhydrider, C3 til og med C5, overvejende 2-methyl-2-buten.]

270-725-7

68477-34-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-359-00-0

destillater (råolie), polymeriserede dampkrakkede råoliedestillater, C5-12-fraktion;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillationen af polymeriseret dampkrakket råoliedestillat. Den består overvejende af carbonhydrider, overvejende

C5 til og med C12.]

270-735-1

68477-50-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-360-00-6

destillater (råolie), dampkrakkede, C5-12-fraktion;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af organiske forbindelser opnået ved destillationen af produkter fra en dampkrakningsproces. Den

består af umættede carbonhydrider, overvejende C5 til og med C12.]

270-736-7

68477-53-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-361-00-1

destillater (råolie), dampkrakkede, C5-10-fraktion, blandet med let dampkrakket råolienaphtha-C5-fraktion; lavtkogende uspecificeret naphtha

270-738-8

68477-55-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-362-00-7

ekstrakter (råolie), koldsyre-, C4-6; lavtkogende uspecificeret

naphtha; [en sammensat blanding af organiske forbindelser, fremstillet ved koldsyre-enhedsekstraktion af mættede og umættede, aliphatiske carbonhydrider, sædvanligvis C3 til og med C6, overvejende pentaner og amylener. Den består overvejende af mættede og umættede carbonhydrider, C4 til og med C6, overvejende C5.]

270-741-4

68477-61-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-363-00-2

destillater (råolie), depentanizer-

topfraktioner;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk krakket gasstrøm. Den består af aliphatiske carbonhydrider, overvejende C4 til og med C6.]

270-771-8

68477-89-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-364-00-8

rester (råolie), butansplitter-bundfraktioner;

lavtkogende uspecificeret naphtha;

[en sammensat remanens fra destillationen af butanstrøm. Den består af aliphatiske carbonhydrider, overvejende C4 til og med C6.]

270-791-7

68478-12-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-365-00-3

restolier (råolie), deisobutanizertårn-;

lavtkogende uspecificeret naphtha;

[en sammensat remanens fra den atmosfæriske destillation af butan-butylenstrømmen. Den består af aliphatiske carbonhydrider, overvejende C4 til og med C6.]

270-795-9

68478-16-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-366-00-9

naphtha (råolie), full-range coker-;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en væske-coker. Den består overvejende af umættede carbonhydrider, overvejende C4 til og med C15, med kogeinterval omtrent fra 43 oC til 250 oC.]

270-991-4

68513-02-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-367-00-4

naphtha (råolie), dampkrakket middeltung aromatisk;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra - 130 oC til 220 oC.]

271-138-9

68516-20-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-368-00-X

naphtha (råolie), lerbehandlet full-range straight-run; lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider fremkomet ved behandling af full-range straight-run

naphtha med naturligt eller modificeret ler, sædvanligvis i en perkoleringsproces til fjernelse af spormængderne af polære forbindelser og urenheder. Den består af carbonhydrider, overvejende C4 til og med C11, med kogeinterval omtrent fra - 20 oC til 220 oC.]

271-262-3

68527-21-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-369-00-5

naphtha (råolie), lerbehandlet let straight-run;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider fremkommet ved behandling af let straight-run naphtha med naturligt eller modificeret ler, sædvanligvis i en perkoleringsproces til fjernelse af spormængderne af polære forbindelser og urenheder. Den består af carbonhydrider, overvejende C7 til og med C10, med kogeinterval omtrent fra 93 oC til 180 oC.]

271-263-9

68527-22-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-370-00-0

naphtha (råolie), let dampkrakket aromatisk;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af

carbonhydrider fremstillet ved destillation af produkterne fra en dampkrakningsproces. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C9, med kogeinterval omtrent fra 110 oC til 165 oC.]

271-264-4

68527-23-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-371-00-6

naphtha (råolie), let dampkrakket, afbenzeneret; lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkterne fra en dampkrakningsproces. Den består overvejende af carbonhydrider, overvejende C4 til og med C12, med kogeinterval omtrent fra 80 oC til 218 oC.]

271-266-5

68527-26-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-372-00-1

naphtha (råolie), aromatholdig;

lavtkogende uspecificeret

naphtha

271-635-0

68603-08-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-373-00-7

benzin, pyrolyse-, debutanizer-bundfraktioner;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af depropanizer-bundfraktioner. Den består af carbonhydrider, overvejende større end C5.]

271-726-5

68606-10-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-374-00-2

naphtha (råolie), let sweetenet;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider, opnået ved at underkaste et råoliedestillat en sweeteningsproces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af mættede og umættede carbonhydrider, overvejende C3 til og med C6, med kogeinterval omtrent fra - 20 oC til 100 oC.]

272-206-0

68783-66-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-375-00-8

naturgaskondensater;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider, som er separeret og/eller

kondenseret fra naturgas under transport, og som opsamles ved borehullet og/eller fra produktions, opsamlings-,

transmissions- og distributionspipelines i undergrunden, skrubbere etc. Den består overvejende af carbonhydrider, overvejende C2 til og med C8.]

272-896-3

68919-39-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-376-00-3

destillater (råolie), naphtaunifiner stripper-;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider fremstillet ved

stripning af produkterne fra naphthaunifineren. Den består af mættede, aliphatiske carbonhydrider, overvejende C2 til og med C6.]

272-932-8

68921-09-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-377-00-9

naphtha (råolie), katalytisk reformeret let, aromatfri fraktion;

lavtkogende uspecificeret naphtha;

285-510-3

[en sammensat blanding af carbonhydrider tilbageblevet efter fjernelse af aromatiske forbindelser fra katalytisk reformeret let naphta i en selektiv absorptionsproces. Den består overvejende af paraffiniske og cycliske forbindelser, overvejende C5 til C8, med kogeinterval omtrent fra 66 oC til 121 oC.]

85116-59-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-378-00-4

benzin;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider bestående primært af paraffiner,

cycloparaffiner, aromatiske og olefiniske carbonhydrider, overvejende større end C3, og med kogeinterval fra 30 oC til 260 oC.]

289-220-8

86290-81-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-379-00-X

aromatiske carbonhydrider, C7-8-, dealkyleringsprodukter, destillationsrester;

lavtkogende uspecificeret naphtha

292-698-0

90989-42-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-380-00-5

carbonhydrider, C4-6-, depentanizer lette, aromatisk hydrogenbehandling; lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået som det første gennemløb fra depentanizerkolonnen før hydrogenbehandling af de aromatiske charger. Den består overvejende af carbonhydrider, overvejende C4 til og med C6, overvejende pentaner og pentener, med kogeinterval omtrent fra 25 oC

til 40 oC.]

295-298-4

91995-38-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-381-00-0

destillater (råolie), varmeudblødt dampkrakket naphtha, C5-rige;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af varmeudblødt dampkrakket naphtha. Den består overvejende af carbonhydrider, C4 til og med C6, overvejende C5.]

295-302-4

91995-41-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-382-00-6

ekstrakter (råolie), katalytisk reformeret let naphtha solvent-; lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået som ekstraktet fra solventekstraktionen af en katalytisk reformeret råoliefraktion. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C8, med kogeinterval omtrent fra 100 oC til 200 oC.]

295-331-2

91995-68-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-383-00-1

naphtha (råolie), hydroafsvovlet let, dearomatiseret; lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af hydroafsvovlede og dearomatiserede lette råoliefraktioner. Den består overvejende af C7-paraffiner og cycloparaffiner med kogeinterval omtrent fra 90 oC

til 100 oC.]

295-434-2

92045-53-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-384-00-7

naphtha (råolie), let, C5-rig, sweetenet;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved at underkaste en råolienaphtha en sweetening-proces for

at omdanne mercaptaner eller fjerne sure urenheder. Den består af carbonhydrider, overvejende C4 til og med C5, overvejende C5, med kogeinterval omtrent fra - 10 oC til 35 oC.]

295-442-6

92045-60-8

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-385-00-2

carbonhydrider, C8-11-, naphtha-krakning, toluenfraktion;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation fra præhydrogeneret, krakket naphtha. Den består overvejende af carbonhydrider, overvejende C8 til og med C11, med kogeinterval omtrent fra 130 oC til 205 oC.]

295-444-7

92045-62-0

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-386-00-8

carbonhydrider, C4-11-, naphtha-krakning, aromatfrie;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af

carbonhydrider opnået fra præhydrogeneret, krakket naphtha efter destillativ separation af benzen- og toluenholdige carbonhydridfraktioner og en højerekogende fraktion. Den består overvejende af carbonhydrider, overvejende C4 til og med C11 med kogeinterval omtrent fra 30 oC til 205 oC.]

295-445-2

92045-63-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-387-00-3

naphtha (råolie), let varmeudblødt, dampkrakket;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider opnået ved fraktioneringen af dampkrakket]

naphtha efter genindvinding fra en varmeudblødningsproces. Den består overvejende af carbonhydrider, overvejende C4 til og med C6, med kogeinterval omtrent fra 0 oC til 80 oC.]

296-028-8

92201-97-3

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-388-00-9

destillater (råolie), C6-rige; Lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af råolieføde. Den består

af carbonhydrider, overvejende C5 til og med C7, rig på C6, med kogeinterval omtrent fra 60 oC til 70 oC.]

296-903-4

93165-19-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-389-00-4

benzin, pyrolyse-,

hydrogeneret;

lavtkogende uspecificeret naphtha;

[en destillationsfraktion fra hydrogeneringen af pyrolysebenzin med kogeinterval omtrent fra 20 oC til 200 oC.]

302-639-3

94114-03-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-390-00-X

destillater (råolie), dampkrakkede, C8-12-fraktion, polymeriserede, lette destillationsfraktioner;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af den polymeriserede C8 til og med C12-fraktion fra dampkrakkede råoliedestillater. Den består overvejende af aromatiske carbonhydrider, overvejende C8 til og med C12.]

305-750-5

95009-23-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-391-00-5

ekstrakter (råolie), tunge naphthasolvent-, lerbehandlede; lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved

behandlingen af tung naphthasolventråolieekstrakt med blegejord. Består overvejende af carbonhydrider, overvejende C6 til og med C10, med kogeinterval omtrent fra 80 oC til 180 oC.]

308-261-5

97926-43-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-392-00-0

naphtha (råolie), let dampkrakket, debenzeneret, termisk behandlet;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved behandling og destillation af debenzeneret, let dampkrakket råolienaphtha. Den består overvejende af carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 95 oC til 200 oC.]

308-713-1

98219-46-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-393-00-6

naphtha (råolie), let dampkrakket, termisk behandlet;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af

[en sammensat blanding af carbonhydrider opnået ved behandling og destillation af let dampkrakket råolienaphtha. Den består overvejende af carbonhydrider, overvejende C5 til og med C6,

med kogeinterval omtrent fra 35 oC til 80 oC.]

308-714-7

98219-47-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-394-00-1

destillater (råolie), C7-9 , C8-rige, hydroafsvovlede dearomatiserede;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af en let råoliefraktion, hydroafsvovlet og dearomatiseret. Den består overvejende af carbonhydrider,

C7 til og med C9, overvejende C8 paraffiner og cycloparaffiner, med kogeinterval omtrent fra 120 oC til 130 oC.]

309-862-5

101316-56-7

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-395-00-7

carbonhydrider, C6-8-, hydrogenerede sorption-dearomatiserede, toluenraffinering;

lavtkogende uspecificeret

naphtha;

[en sammensat blanding af carbonhydrider opnået under sorptionen af toluen fra en

carbonhydridfraktion fra krakket benzin, der er behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C6 til og med C8, med kogeinterval omtrent fra 80 oC til 135 oC.]

309-870-9

101316-66-9

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-396-00-2

naphtha (råolie), hydroafsvovlet full-range coker-;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af

carbonhydrider opnået ved fraktionering af hydroafsvovlet cokerdestillat. Den består overvejende af carbonhydrider, overvejende C5 til og med C11, med kogeinterval omtrent fra 23 oC til 196 oC.]

309-879-8

101316-76-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-397-00-8

naphtha (råolie), sweetenet let;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af

carbonhydrider opnået ved at underkaste en råolienaphtha en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C5 til og med C8, med kogeinterval omtrent fra 20 oC til 130 oC.]

309-976-5

101795-01-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-398-00-3

carbonhydrider, C3-6-, C5-rige, dampkrakket naphtha;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af dampkrakket naphtha. Den består overvejende af carbonhydrider, C3 til og med C6, overvejende C5.]

310-012-0

102110-14-5

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-399-00-9

carbonhydrider, C5-rige,

dicyclopentadienholdige;

lavtkogende uspecificeret nafta;

[en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en dampkrakningsproces. Den består overvejende af, C5 carbonhydrider og dicyclopentadien, med kogeinterval omtrent fra 30 oC til 170 oC.]

310-013-6

102110-15-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-400-00-2

rester (råolie), dampkrakkede lette, aromatiske;

lavtkogende uspecificeret naphtha;

[en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra dampkrakning eller lignende processer, efter fjernelse af de meget lette produkter, resulterende i en rest begyndende med C>5-carbonhydrider. Den består overvejende af aromatiske carbonhydrider,

større end C5, med kogepunkt over omtrent 40 oC.].

310-057-6

102110-55-4

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-401-00-8

carbonhydrider, C5-, C5-6-rige; lavtkogende uspecificeret naphtha

270-690-8

68476-50-6

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-402-00-3

carbonhydrider, C5-rige;

lavtkogende uspecificeret

naphtha

270-695-5

68476-55-1

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-403-00-9

aromatiske carbonhydrider, C8-10; lavtkogende uspecificeret naphtha

292-695-4

90989-39-2

Carc. 1B

Muta. 1B

Asp. Tox. 1

H350

H340

H304

GHS08

Dgr

H350

H340

H304

P

649-404-00-4

petroleum (råolie); straight-run, petroleum;

[en sammensat blanding af

carbonhydrider fremstillet ved destillation af råolie. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.]

232-366-4

8008-20-6

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-405-00-X

solventnaphtha (råolie), middeltung aliphatisk;

straight run petroleum;

[en sammensat blanding af carbonhydrider opnået ved destillation af råolie eller naturgaskondensat. Den består overvejende af mættede carbonhydrider, overvejende C9 til og med C12, med kogeinterval omtrent fra 140 oC til 220 oC.]

265-191-7

64742-88-7

STOT RE 1

Asp. Tox. 1

H372 (centralnervesystem)

H304

GHS08

Dgr

H372 (centralnervesystem)

H304

649-406-00-5

solventnaphtha (råolie),

tung aliphatisk;

straight run petroleum;

[en sammensat blanding af carbonhydrider opnået ved

destillation af råolie eller naturgaskondensat. Den består overvejende af mættede carbonhydrider, overvejende C11 til og med C16, med kogeinterval omtrent fra 190 oC til 290 oC.]

265-200-4

64742-96-7

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-407-00-0

petroleum (råolie); straight-run bred fraktion;

straight run petroleum;

[en sammensat blandning af carbonhydrider, opnået som en bred fraktion fra atmosfærisk destillation fra en carbonhydridbrændselsfraktion, med kogeinterval omtrent fra 70 oC til 220 oC.]

295-418-5

92045-37-9

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-408-00-6

destillater (råolie), dampkrakkede;

krakket petroleum;

[en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en dampkrakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C7 til og med C16, med kogeinterval omtrent fra 90 oC til 290 oC.]

265-194-3

64742-91-2

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-409-00-1

destillater (råolie), krakkede strippede dampkrakkede råoliedestillater, C8-10-fraktion;

krakket petroleum;

[en sammensat blanding af carbonhydrider, opnået ved

at destillere krakkede, strippede, dampkrakkede destillater. Den består af carbonhydrider, C8 til og med C10, med kogeinterval omtrent fra 129 oC til 194 oC.]

270-728-3

68477-39-4

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-410-00-7

destillater (råolie), krakkede strippede dampkrakkede råoliedestillater, C10-12-fraktion;

krakket petroleum;

[en sammensat blanding af carbonhydrider opnået ved at destillere krakkede, strippede, dampkrakkede destillater. Den består overvejende af aromatiske carbonhydrider, C10 til og med C12.]

270-729-9

68477-40-7

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-411-00-2

destillater (råolie), dampkrakkede, C8-12-fraktion;

krakket petroleum;

[en sammensat blanding af organiske forbindelser opnået ved destillationen af produkter fra en dampkrakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C8 til og med C12.]

270-737-2

68477-54-3

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-412-00-8

petroleum (råolie), hydroafsvovlet termisk krakket; krakket petroleum;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af hydroafsvovlet termisk krakket destillat. Den består overvejende af carbonhydrider, overvejende C8 til C16, med kogeinterval omtrent fra 120 oC til 283 oC.]

285-507-7

85116-55-8

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-413-00-3

aromatiske carbonhydrider, C≥10, dampkrakning, hydrogenbehandlede; krakket petroleum;

[en sammensat blanding af

carbonhydrider fremstillet ved destillation af produkterne fra en dampkrakningsproces og behandling med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende større end C10, med kogeinterval omtrent fra 150 oC til 320 oC.]

292-621-0

90640-98-5

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-414-00-9

naphtha (råolie), dampkrakket, hydrogenbehandlet, C9-10-aromatrig; krakket petroleum

[en sammensat blanding af carbonhydrider opnået ved destillation af produkterne fra en dampkrakningsproces, efterfulgt af behandling med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, C9 til og med C10, med kogeinterval omtrent fra 140 oC til 200 oC.]

292-637-8

90641-13-7

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-415-00-4

destillater (råolie), termisk krakkede, alkylaromat carbonhydrid-rige;

krakket petroleum;

[en sammensat blanding af carbonhydrider opnået ved destillation af termisk krakkede tunge tjærer. Den består overvejende af polyalkylerede aromatiske carbonhydrider, med kogeinterval omtrent fra 100 oC til 250 oC.]

309-866-7

101316-61-4

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-416-00-X

destillater (råolie), katalytisk krakket tung tjære, lette;

krakket petroleum;

[en sammensat blanding af carbonhydrider opnået ved destillation af katalytisk krakkede tunge tjærer. Den består overvejende af polyalkylerede aromatiske carbonhydrider, med kogeinterval omtrent fra 100 oC til 250 oC.]

309-938-8

101631-13-4

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-417-00-5

solventnaphtha (råolie), hydrokrakket tung aromatisk; krakket petroleum;

[en sammensat blanding af carbonhydrider opnået ved destillationen af hydrokrakket råoliedestillat. Den består overvejende af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 235 oC til 290 oC.]

309-881-9

101316-80-7

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-418-00-0

destillater (råolie), dampkrakket tung tjære, lette;

krakket petroleum;

[en sammensat blanding af carbonhydrider opnået ved destillation af dampkrakkede tunge tjærer. Den består overvejende af polyalkylerede aromatiske carbonhydrider, med kogeinterval omtrent fra 100 oC til 250 oC.]

309-940-9

101631-15-6

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-419-00-6

destillater (råolie), alkylat-; uspecificeret petroleum;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra reaktionen

mellem isobutan og monoolefinske carbonhydrider, sædvanligvis C3 til og med C5. Den består af overvejende forgrenede, mættede carbonhydrider, overvejende C11 til og med C17, med kogeinterval omtrent fra 205 oC til 320 oC.]

265-074-0

64741-73-7

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-420-00-1

ekstrakter (råolie), tung naphtha solvent-;

uspecifeceret petroleum

[en sammensat blanding af carbonhydrider opnået som ekstraktet fra en solventekstraktionsproces. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til og med C12, med kogeinterval omtrent fra 90 oC til 220 oC.]

265-099-7

64741-98-6

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-421-00-7

destillater (råolie), kemisk neutraliserede lette; uspecificeret petroleum;

[en sammensat blanding af carbonhydrider fremstillet ved en

behandlingsproces til fjernelse af sure materialer. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.]

265-132-5

64742-31-0

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-422-00-2

destillater (råolie), hydrogenbehandlede

lette;

uspecifeceret petroleum

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.]

265-149-8

64742-47-8

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-423-00-8

petroleum (råolie), hydroafsvovlet;

uspecificeret petroleum;

[en sammensat blanding af carbonhydrider opnået fra en rå råolie ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består af carbonhydrider, overvejende C9 til og med C16, med kogeinterval omtrent fra 150 oC til 290 oC.]

265-184-9

64742-81-0

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-424-00-3

solventnaphtha (råolie), let aromatisk;

uspecifeceret petroleum

[en sammensat blanding af carbonhydrider opnået ved destillation af aromatiske strømme. Den består overvejende af aromatiske carbonhydrider, overvejende C9 til og med C16,

med kogeinterval omtrent fra 165 oC til 290 oC

.]

265-198-5

64742-94-5

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-425-00-9

naphtha (råolie), tung coker-;

uspecificeret petroleum

[en sammensat blanding af carbonhydrider fra destillationen af produkterne fra en væske-coker. Den består overvejende af umættede carbonhydrider,

overvejende C6 til og med C15, med kongeinterval omtrent fra 157 oC til 288 oC.]

269-778-9

68333-23-3

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-426-00-4

naphtha (råolie), katalytisk reformeret hydroafsvovlet tung, aromatfraktion;

uspecificeret petroleum;

[en sammensat blanding af carbonhydrider fremstillet ved fraktionering af katalytisk reformeret, hydroafsvovlet naphtha. Den består overvejende af aromatiske carbonhydrider, overvejende C7 til C13, med kogeinterval omtrent fra 98 oC til 218 oC.]

285-508-2

85116-57-0

Asp. Tox. 1

H304

GHS08 Dgr

H304

649-427-00-X

petroleum (råolie), sweetenet;

uspecificeret petroleum;

[en sammensat blanding af carbonhydrider opnået ved at underkaste et råoliedestillat

en sweetening-proces for at omdanne mercaptaner eller fjerne sure urenheder. Den består overvejende af carbonhydrider, overvejende C9 til og med C16, med koge-interval omtrent fra 130 oC

til 290 oC.]

294-799-5

91770-15-9

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-428-00-5

petroleum (råolie), solventraffineret sweetenet;

uspecificeret petroleum;

[en sammensat blanding af carbonhydrider, opnået fra en rå råolie ved solventraffinering

og sweetening, med kogeinterval omtrent fra 150 oC til 260 oC.]

295-416-4

92045-36-8

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-429-00-0

carbonhydrider, C9-16-, hydrogenbehandlede,

afaromatiserede;

uspecificeret petroleum;

[en sammensat blanding af carbonhydrider opnået som solventer, der har været underkastet hydrogenbehandling for at omdanne aromater til naphthener ved katalytisk hydrogenering.]

297-854-1

93763-35-0

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-430-00-6

petroleum (råolie), solvent-raffineret hydroafsvovlet; uspecificeret petroleum

307-033-2

97488-94-3

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-431-00-1

destillater (råolie), hydroafsvovlede full-range middeltunge coker-;

uspecificeret petroleum;

[en sammensat blanding af carbonhydrider opnået ved fraktionering fra hydroafsvovlet coker-destillat. Den består overvejende af carbonhydrider,

overvejende C8 til og med C16, med kogeinterval omtrent fra 120 oC til 283 oC.]

309-864-6

101316-58-9

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-432-00-7

solventnaphtha (råolie), hydroafsvovlet tung aromatisk; uspecificeret petroleum;

[en sammensat blanding af carbonhydrider opnået ved den katalytiske hydroafsvovling af en råoliefraktion. Den består overvejende af carbonhydrider, overvejende C10 til og med C13, med kogeinterval omtrent fra 180 oC til 240 oC.]

309-882-4

101316-81-8

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-433-00-2

solventnaphtha (råolie), hydroafsvovlet middeltung; uspecificeret petroleum;

[en sammensat blanding af carbonhydrider opnået ved den katalytiske hydroafsvovling af en råoliefraktion. Den består overvejende af carbonhydrider,

overvejende C10 til og med C13, med kogeinterval omtrent fra 175 oC til 220 oC.]

309-884-5

101316-82-9

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-434-00-8

petroleum (råolie),

hydrogenbehandlet;

uspecificeret petroleum;

[en sammensat blanding af carbonhydrider opnået ved destillationen af råolie og efterfølgende hydrogenbehandling. Den består overvejende af alkaner, cycloalkaner og alkylbenzener, overvejende C12 til og med C16, med kogeinterval omtrent fra 230 oC til 270 oC.]

309-944-0

101631-19-0

Asp. Tox. 1

H304

GHS08

Dgr

H304

649-435-00-3

destillater (råolie), lette katalytisk krakkede;

krakket gasolie;

[en sammensat blanding af carbonhydrider fremstillet ved destillationen af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider,

overvejende C9 til og med C25, med kogeinterval omtrent fra 150 oC til 400 oC. Den indeholder en forholdsvis stor del bicycliske, aromatiske carbonhydrider.]

265-060-4

64741-59-9

Carc. 1B

H350

GHS08

Dgr

H350

649-436-00-9

destillater (råolie), intermediære katalytisk krakkede; krakket gasolie;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkter fra en katalytisk krakningsproces. Den består af carbonhydrider, overvejende C11 til og med C30, med kogeinterval omtrent fra 205 oC til 450 oC. Den indeholder en forholdsvis stor del tricycliske, aromatiske carbonhydrider.]

265-062-5

64741-60-2

Carc. 1B

H350

GHS08

Dgr

H350

649-437-00-4

destillater (råolie), lette hydrokrakkede;

krakket gasolie;

[en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, overvejende C10 til og med C18, med kogeinterval omtrent fra 160 oC til 320 oC.]

265-078-2

64741-77-1

Carc. 2

H351

GHS08

Wng

H351

649-438-00-X

destillater (råolie), lette termisk krakkede;

krakket gasolie;

[en sammensat blanding af carbonhydrider fra destillation af produkterne fra en temisk krakningsproces. Den består overvejende af umættede carbonhydrider, overvejende C10 til og med C22, med kogeinterval omtrent fra 160 oC til 370 oC.]

265-084-5

64741-82-8

Carc. 1B

H350

GHS08

Dgr

H350

649-439-00-5

destillater (råolie), hydroafsvovlede lette katalytisk krakkede;

krakket gasolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle lette, katalytisk krakkede destillater med hydrogen for at omdanne organisk svovl til hydrogensulfid, som fjernes. Den består overvejende af carbonhydrider, overvejende C9 til og med C25, med kogeinterval omtrent fra 150 oC

til 400 oC. Den indeholder en forholdsvis stor del bicycliske, aromatiske carbonhydrider.]

269-781-5

68333-25-5

Carc. 1B

H350

GHS08

Dgr

H350

649-440-00-0

destillater (råolie), let dampkrakket naphtha;

krakket gasolie;

[en sammensat blanding af carbonhydrider fra den multiple destillation af produkter fra en dampkrakningsproces. Den består af carbonhydrider, overvejende C10 til og med C18.]

270-662-5

68475-80-9

Carc. 1B

H350

GHS08

Dgr

H350

649-441-00-6

destillater (råolie), krakkede dampkrakkede råoliedestillater;

krakket gasolie;

[en sammensat blanding af carbonhydrider opnået ved at destillere et krakket dampkrakket destillat og/eller dets fraktioneringsprodukter. Den består af carbonhydrider, overvejende C10 til lavmolekylære polymerer.]

270-727-8

68477-38-3

Carc. 1B

H350

GHS08

Dgr

H350

649-442-00-1

gasolier (råolie), dampkrakkede;

krakket gasolie;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en dampkrakningsproces. Den består af carbonhydrider, overvejende større end C9, med kogeinterval omtrent fra 205 oC til 400 oC.]

271-260-2

68527-18-4

Carc. 1B

H350

GHS08

Dgr

H350

649-443-00-7

destillater (råolie), hydroafsvovlede termisk krakkede middeltunge;

krakket gasolie;

[en sammensat blanding af carbonhydrider opnået ved fraktionering fra hydroafsvovlet, termiske krakkede destillatråstoffer. Den består overvejende af carbonhydrider, overvejende C11 til C25, med kogeinterval omtrent fra 205 oC til 400 oC.]

285-505-6

85116-53-6

Carc. 1B

H350

GHS08

Dgr

H350

649-444-00-2

gasolier (råolie), termisk krakkende, hydrogenafsvovlede; krakket gasolie

295-411-7

92045-29-9

Carc. 1B

H350

GHS08

Dgr

H350

649-445-00-8

rester (råolie), hydrogeneret dampkrakket naphtha; krakket gasolie;

[en sammensat blanding af carbonhydrider opnået som en restfraktion fra destillation en af hydrogenbehandlet dampkrakket naphtha. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 200 oC til 350 oC.]

295-514-7

92062-00-5

Carc. 1B

H350

GHS08

Dgr

H350

649-446-00-3

rester (råolie), dampkrakkede naphthadestillations-

krakket gasolie;

[en sammensat blanding af carbonhydrider opnået som en kolonnebundfraktion fra separationen af udløb fra dampkrakning af naphtha ved høj temperatur. Den har kogeinterval omtrent fra 147 oC til 300 oC, og danner en færdig olie med en viskositet på 18cSt ved 50 oC.]

295-517-3

92062-04-9

Carc. 1B

H350

GHS08

Dgr

H350

649-447-00-9

destillater (råolie), lette katalytisk krakkede, termisk nedbrudte;

krakket gasolie;

[en sammensat blanding af carbonhydrider fremstillet ved destillation af produkterne fra en katalytisk krakningsproces, der har været brugt som en varmeoverførselsvæske. Den består overvejende af carbonhydrider med kogeinterval omtrent fra 190 oC til 340 oC. Denne strøm indeholder sandsynligvis organiske svovlforbindelser.]

295-991-1

92201-60-0

Carc. 1B

H350

GHS08

Dgr

H350

649-448-00-4

rester (råolie), dampkrakket varmeudblødt naphtha; krakket gasolie;

[en sammensat blanding af carbonhydrider, opnået som rest fra destillationen af dampkrakket varmeudblødt naphtha, med koge-interval omtrent fra 150 oC til 350 oC.]

297-905-8

93763-85-0

Carc. 1B

H350

GHS08

Dgr

H350

649-449-00-X

carbonhydrider, C16-20, solvent-afvokset hydrokrakket paraffindestillationsrest

krakket gasolie;

[en sammensat blanding af carbonhydrider opnået ved solventafvoksning af en destillationsrest fra et hydrokrakket paraffindestillat. Den består overvejende af carbonhydrider, overvejende fra C16 til og med C20, med kogeinterval omtrent fra 360 oC til 500 oC. Den danner en færdig olie med en viskositet på 4,5 cSt ved omtrent 100 oC.]

307-662-2

97675-88-2

Carc. 2

H351

GHS08

Wng

H351

649-450-00-5

gasolier (råolie), lette vakuum-, termisk-krakkede hydroafsvovlede;

krakket gasolie;

[en sammensat blanding af carbonhydrider opnået ved katalytisk hydroafsvovling af termisk-krakket let vakuumråolie. Den består overvejende af carbonhydrider, overvejende C14 til og med C20, med kogeinterval omtrent fra 270 oC til 370 oC.]

308-278-8

97926-59-5

Carc. 1B

H350

GHS08

Dgr

H350

649-451-00-0

destillater (råolie), hydroafsvovlede

middeltunge coker-; krakket gasolie;

[en sammensat blanding af carbonhydrider opnået ved fraktionering af hydroafsvovlede coker-destillat råstoffer. Den består overvejende af carbonhydrider, overvejende C12 til og med C21 med kogeinterval omtrent fra 200 oC til 360 oC.]

309-865-1

101316-59-0

Carc. 1B

H350

GHS08

Dgr

H350

649-452-00-6

destillater (råolie), tunge dampkrakkede;

krakket gasolie;

[en sammensat blanding af carbonhydrider opnået ved dampkrakkede tunge rester. Den består overvejende af polyalkylerede tunge aromatiske carbonhydrider, med kogeinterval omtrent fra 250 oC til 400 oC.]

309-939-3

101631-14-5

Carc. 1B

H350

GHS08

Dgr

H350

649-453-00-1

destillater (råolie), tunge hydrokrakkede;

uspecificeret baseolie

[en sammensat blanding af carbonhydrider fra destillation af produkterne fra en hydrokrakningsproces. Den består overvejende af mættede carbonhydrider, C15-C39, med kogeinterval omtrent fra 260 oC til 600 oC

.]

265-077-7

64741-76-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-454-00-7

destillater (råolie), solventraffinerede tunge paraffin-;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består overvejende af mættede carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC.]

265-090-8

64741-88-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-455-00-2

destillater (råolie), solventraffinerede lette paraffin-;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstaktionsproces. Den består overvejende af mættede carbonhydrider, overvejende C15 til og med C30 og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.]

265-091-3

64741-89-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-456-00-8

restolier (råolie), solventafasfalterede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som

den solventopløselige fraktion fra C3-C4-solventafasfaltering af en remanens. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.]

265-096-0

64741-95-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-457-00-3

destillater (råolie), solventraffinerede tunge naphthen-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cST ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-097-6

64741-96-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-458-00-9

destillater (råolie), solventraffinerede lette naphthen-;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som raffinatet fra en solventekstraktionsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-098-1

64741-97-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-459-00-4

restolier (råolie),

solventraffinerede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som den solventuopløselige fraktion fra solventraffinering af en remanens, ved at anvende et polært organisk solvent, såsom phenol eller furfural. Den består af carbonhydrider, overvejende C25, og koger omtrent over 400 oC.]

265-101-6

64742-01-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-460-00-X

destillater (råolie), lerbehandlede tunge paraffin-;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.]

265-137-2

64742-36-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-461-00-5

destillater (råolie), lerbehandlede lette paraffin-;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.]

265-138-8

64742-37-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-462-00-0

restolier (råolie), lerbehandlede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved

behandling af en restolie med naturligt eller modificeret ler, i enten en kontakt- eller prekoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.]

265-143-5

64742-41-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-463-00-6

destillater (råolie), lerbehandlede tunge naphthen-; uspecificeret baseolie; [en sammensat blanding af carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-146-1

64742-44-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-464-00-1

destillater (råolie), lerbehandlede lette naphthen-;

uspecificeret baseolie;

[en sammensat blanding a carbonhydrider fremkommet ved behandling af en råoliefraktion med naturligt eller modificeret ler, i enten en kontakt- eller perkoleringsproces, til fjernelse af spormængderne af polære forbindelser og tilstedeværende urenheder. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-147-7

64742-45-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-465-00-7

destillater (råolie),

hydrogenbehandlede tunge naphthen-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider, opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-155-0

64742-52-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-466-00-2

destillater (råolie),

hydrogenbehandlede lette naphten-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-156-6

64742-53-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-467-00-8

destillater (råolie),

hydrogenbehandlede tunge paraffin-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.]

265-157-1

64742-54-7

Carc. 1B

H350

GHS08

Dgr

H350

L

649-468-00-3

destillater (råolie),

hydrogenbehandlede lette paraffin-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af

carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder en forholdsvis stor del mættede carbonhydrider.]

265-158-7

64742-55-8

Carc. 1B

H350

GHS08

Dgr

H350

L

649-469-00-9

destillater (råolie), solventafvoksede lette paraffin-;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved

fjernelse af normalparaffiner fra en råoliefraktion ved solvenkrystallisation. Den består overvejende af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.]

265-159-2

64742-56-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-470-00-4

restolier (råolie), hydrogenbehandlede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle en råoliefraktion med hydrogen i tilstedeværelse af en katalysator. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.]

265-160-8

64742-57-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-471-00-X

restolier (råolie), solventafvoksede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved fjernelse af lange, forgrenede carbonhydrider fra en restolie ved solventkrystallisation. Den består af carbonhydrider, overvejende større end C25, og koger omtrent over 400 oC.]

265-166-0

64742-62-7

Carc. 1B

H350

GHS08

Dgr

H350

L

649-472-00-5

destillater (råolie), solventafvoksede tunge naphthen-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved fjernelse af normalparaffiner fra en råoliefraktion ved solventkrystallisation. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet ikke mindre end

19cSt ved

40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-167-6

64742-63-8

Carc. 1B

H350

GHS08

Dgr

H350

L

649-473-00-0

destillater (råolie), solventafvoksede tunge naphthen-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved fjernelse af normalparaffiner fra en råoliefraktion ved solventkrystallisation. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-168-1

64742-64-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-474-00-6

destillater (råolie), solventafvoksede tunge naphthen-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved fjernelse af normalparaffiner fra en råoliefraktion ved solventkrystallisation. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet ikke mindre end 19cSt ved 40 oC.]

265-169-7

64742-65-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-475-00-1

naphthenolier (råolie), katalytisk afvoksede tunge;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en

viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-172-3

64742-68-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-476-00-7

naphthenolier (råolie), katalytisk afvoksede lette;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-173-9

64742-69-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-477-00-2

paraffinolier (råolie), katalytisk afvoksede tunge;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og

danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC.]

265-174-4

64742-70-7

Carc. 1B

H350

GHS08

Dgr

H350

L

649-478-00-8

paraffinolier (råolie), katalytisk afvoksede lette;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved en katalytisk afvoksningsproces. Den består overvejende af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC.]

265-176-5

64742-71-8

Carc. 1B

H350

GHS08

Dgr

H350

L

649-479-00-3

naphthenolier (råolie), sammensatte afvoksede tunge;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at fjerne ligekædede

paraffincarbonhydrider som et fast stof ved behandling med et reagens, såsom urinstof. Den består af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på mindst 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

265-179-1

64742-75-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-480-00-9

naphthenolier (råolie), komplekse afvoksede lette;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved en

katalytisk afvoksningsproces. Den består af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder relativt få normalparaffiner.]

265-180-7

64742-76-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-481-00-4

smøreolier (råolie), C20-50, hydrogenbehandlede olie baseret, høj viskositet;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle let vakuumgasolie, tung vakuumgasolie og

solvent afasfalteret restolie med hydrogen, i tilstedeværelse af en katalysator, i en to trinsproces med afvoksning udført mellem de to trin. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på omtrent 112cSt ved 40 oC. Den indeholder en relativ stor mængde af mættede carbonhydrider.]

276-736-3

72623-85-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-482-00-X

smøreolier (råolie), C15-30, hydrogenbehandlede neutral olie baserede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider, opnået ved at behandle let vakuumgasolie, tung vakuumgasolie og solvent afasfalteret restolie med hydrogen, i tilstedeværelse af en katalysator, i en to trinsproces med afvoksning udført mellem de to trin. Den består overvejende af carbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på omtrent 15cSt ved 40 oC. Den indeholder en relativ stor mængde mættede carbonhydrider.]

276-737-9

72623-86-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-483-00-5

smøreolier (råolie), C20-50, hydrogenbehandlede neutral olie baserede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at behandle let vakuumgasolie, tung vakuumgasolie og solvent afasfalteret restolie med hydrogen, i tilstedeværelse af en katalysator, i en to trinsproces med afvoksning udført mellem de to trin. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på omtrent 32cSt ved 40 oC. Den indeholder en forholdsvis stor mængde mættede carbonhydrider.]

276-738-4

72623-87-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-484-00-0

smøreolier;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion og afvoksningsprocesser. Den består overvejende af mættede carbonhydrider, C15 til og med C50.]

278-012-2

74869-22-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-485-00-6

destillater (råolie), sammensatte afvoksede tunge paraffin-; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved afvoksning af et tungt paraffindestillat. Den består overvejende af carbonhydrider, overvejende C20 til og med C50, og danner en færdig olie med en viskositet på 19cSt eller mere ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

292-613-7

90640-91-8

Carc. 1B

H350

GHS08

Dgr

H350

L

649-486-00-1

destillater (råolie), sammensatte afvoksede lette patraffin-;

uspecificeret baseolie;

(en sammensat blanding af carbonhydrider opnået ved afvoksning af et let paraffindestillat. Det består overvejende af carbonhydrider, overvejende C12 til og med C30, og danner en færdig olie med en viskositet på mindre end 19cSt ved 40 oC. Den indeholder forholdsvis få normalparaffiner.]

292-614-2

90640-92-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-487-00-7

destillater (råolie), solventafvoksede tunge paraffin-, lerbehandlede; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved en afvoksning af et tungt paraffindestillat med neutral eller modificeret ler i enten en kontakt- eller perkoleringsproces. Den består overvejende af cartonhydrider, overvejende C20 til og med C50.]

292-616-3

90640-94-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-488-00-2

carbonhydrider, C20-50, solventafvoksede tunge paraffin-, hydrogenbehandlede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved at behandle et afvokset tungt paraffindestillat med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C20 til og med C50.]

292-617-9

90640-95-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-489-00-8

destillater (råolie), solventafvoksede lette paraffin-, lerbehandlede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider fremkommet ved behandling af et afvokset let paraffindestillat med naturligt eller modificeret ler i enten en kontakt- eller perkoleringsproces. Den består overvejende af carbonhydrider, overvejende C15 til og med C30.]

292-618-4

90640-96-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-490-00-3

destillater (råolie), solventafvoksede lette paraffin-, hydrogenbehandlede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider fremstillet ved

at behandle et afvokset let paraffindestillat med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C15 til og med C30.]

292-620-5

90640-97-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-491-00-9

restolier (olie), hydrogenbehandlede, solventafvoksede; uspecificeret baseolie;

292-656-1

90669-74-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-492-00-4

restolier (råolie) katalytisk afvoksede;

uspecificeret baseolie

294-843-3

91770-57-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-493-00-X

destillater (råolie), afvoksede tunge paraffin-, hydrogenbehandlede; uspecificeret baseolie;

[en sammensat blanding af

carbonhydrider opnået fra en intensiv hydrogenbehandling af afvokset destillat i tilstedeværelse af en katalysator. Den består overvejende af mættede carbonhydrider, overvejende C25 til og med C39, og danner en færdig olie med en viskositet på omtrent 44 cSt ved 50 oC.]

295-300-3

91995-39-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-494-00-5

destillater (råolie), afvoksede lette paraffin-, hydrogenbehandlede; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået fra en

intensiv hydrogenbehandling af afvoksede destillater i tilstedeværelse af en katalysator. Den

består overvejende af mættede carbonhydrider, overvejende C21 til og med C29, og danner en færdig olie med en viskositet på omtrent 13cSt ved 50 oC.]

295-301-9

91995-40-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-495-00-0

destillater (råolie), hydrokrakkede solventraffinerede, afvoksede;

uspecificeret baseolie; [en sammensat blanding af flydende carbonhydrider opnået ved rekrystallisation af afvoksede, hydrokrakkede, solventraffinerede råoliedestillater.]

295-306-6

91995-45-8

Carc. 1B

H350

GHS08

Dgr

H350

L

649-496-00-6

destillater (råolie), solventafvoksede lette naphthen-, hydrogenbehandlede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved at behandlede en råoliefraktion med hydrogen i tilstedeværelse af en katalysator og fjerne de aromatiske carbonhydrider ved solventekstraktion. Den består

overvejende af naphthencarbonhydrider, overvejende C15 til og med C30, og danner en færdig olie med en viskositet på mellem 13cSt og 15cSt ved 40 oC.]

295-316-0

91995-54-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-497-00-1

smøreolier (råolie), C17-35-, solvent-ekstraherede, afvoksede, hydrogenbehandlede;

uspecificeret baseolie

295-423-2

92045-42-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-498-00-7

smøreolier (råolie), hydrokrakkede ikke-aromatiske solvent-afparaffinerede;

uspecificeret baseolie

295-424-8

92045-43-7

Carc. 1B

H350

GHS08

Dgr

H350

L

649-499-00-2

restolier (råolie), hydrokrakkede syrebehandlede solventafvoksede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider, fremstillet ved

solventfjernelse af praffiner fra resten fra destillationen af syrebehandlede, hydrokrakkede tunge praffiner, og koger omtrent over 380 oC.]

295-499-7

92061-86-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-500-00-6

paraffinolier (råolier), solventraffinerede afvoksede tunge; uspecificeret baseolie;

[en sammensat blanding af

carbonhydrider opnået fra svovlholdig paraffinråolie. Den består overvejende af en solventraffineret, afparaffineret smøreolie med en viskositet på 65cSt ved 50 oC.]

295-810-6

92129-09-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-501-00-1

smøreolier (råolie), basisolier, paraffinske;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved raffinering af råolie. Den består

overvejende of aromater, naphthener og paraffiner, og danner en færdig olie med en viskositet på 23cSt ved 40 oC).]

297-474-6

93572-43-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-502-00-7

carbonhydrider, hydrokrakkede paraffiniske destillationsrester, solventafvoksede;

uspecificeret baseolie

297-857-8

93763-38-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-503-00-2

carbonhydrider, C20-50, restolie-hydrogenerings-vakuumdestillat-;

uspecificeret baseolie

300-257-1

93924-61-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-504-00-8

destillater (råolie), solvent-raffinerede hydrogenbehandlede tunge, hydrogenerede;

uspecificeret baseolie

305-588-5

94733-08-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-505-00-3

destillater (råolie), solventraffinerede hydrokrakkede lette; uspecificeret baseolie;

[en sammensat blanding af

carbonhydrider opnået ved solvent afaromatisering af resten fra hydrokrakket råolie. Den består overvejende af carbonhydrider, overvejende C18 til og med C27, med kogeinterval omtrent fra 370 oC til 450 oC.]

305-589-0

94733-09-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-506-00-9

smøreolier (råolie), C18-40, solventafvoksede hydrokrakkede destillatbaserede;

uspecificeret baseolie; [en sammensat blanding af carbonhydrider opnået ved solventafparaffinering af destillationsresten fra hydrorakket råolie. Den består overvejende af carbonhydrider, overvejende C18 til og med C40, med kogeinterval omtrent fra 370 oC til 550 oC.]

305-594-8

94733-15-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-507-00-4

smøreolier (råolie), C18-40, solventafvoksede hydrokrakkede raffinatbaserede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved solventafparaffinering af det hydrogenerede raffinat, opnået ved solventekstraktion af et hydrogenbehandlet råoliedestillat. Den består overvejende af carbonhydrider, overvejende C18 til og med C40, med kogeinterval omtrent fra 370 oC til 550 oC.]

305-595-3

94733-16-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-508-00-X

carbonhydrider, C13-30-, aromatrige, solvent-ekstraherede naphthenske destillater;

uspecificeret baseolie

305-971-7

95371-04-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-509-00-5

carbonhydrider, C16-32-, aromatrige, solvent-ekstraherede naphthenske destillater;

uspecificeret baseolie

305-972-2

95371-05-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-510-00-0

carbonhydrider, C37-68, afvoksede afasfalterede hydrogenbehandlede vakuumdestillationsrester;

uspecificeret baseolie

305-974-3

95371-07-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-511-00-6

carbonhydrider, C37-65-, hydrogenbehandlede afasfalterede vakuumdestillationsrester;

uspecificeret baseolie

305-975-9

95371-08-7

Carc. 1B

H350

GHS08

Dgr

H350

L

649-512-00-1

destillater (råolie), hydrokrakkede solventraffinerede, lette; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved solventbehandlingen af et destillat fra hydrokrakkede råoliedestillater. Den består overvejende af carbonhydrider, overvejende C18 til og med C27, med kogeinterval omtrent fra 370 oC til

450 oC.]

307-010-7

97488-73-8

Carc. 1B

H350

GHS08

Dgr

H350

L

649-513-00-7

destillater (råolie), solventraffinerede hydrogenerede tunge; uspecificeret baseolie; [en sammensat blanding af carbonhydrider opnået ved behandlingen af et hydrogeneret råoliedestillat med et solvent. Den består overvejende af carbonhydrider, overvejende C19 til og med C40, med kogeinterval omtrent fra 390 oC til 550 oC.]

307-011-2

97488-74-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-514-00-2

smøreolier (råolie), C18-27-, hydrokrakkede solvent-afvoksede;

uspecificeret baseolie

307-034-8

97488-95-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-515-00-8

carbonhydrider, C17-30-, hydrogenbehandlet solvent-afasfalteret atmosfærisk destillationsrest, lette destillater; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra behandlingen af en solvent-afasfalteret kort rest med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende fra C17 til og med C30, med kogeinterval omtrent fra 300 oC til 400 oC. Den danner en færdig olie med en viskositet på 4cSt ved omtrent 100 oC.]

307-661-7

97675-87-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-516-00-3

carbonhydrider, C17-40-, hydrogenbehandlet solvent-afasfalteret destillationsrest, lette vakuumdestillater; uspecificeret baseolie;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået som forløb fra vakuumdestillationen af udløb fra den katalytiske hydrogenbehandling af en solvent-afasfalteret kort rest, med en viskositet på 8cSt ved omtrent 100 oC. Den består overvejende af carbonhydrider, overvejende fra C17 til og med C40, med kogeinterval omtrent fra 300 oC til 500 oC.]

307-755-8

97722-06-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-517-00-9

carbonhydrider, C13-27-, solvent-ekstraherede, lette, naphthenske;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved ekstraktion af aromaterne fra et let naphthendestillat med en viskositet på 9,5cSt ved 40 oC. Den består overvejende af carbonhydrider, overvejende fra C13 til og med C27, med kogeinterval omtrent fra 240 oC til 400 oC]

307-758-4

97722-09-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-518-00-4

carbonhydrider, C14-29-, solvent-ekstraherede, lette, naphthenske;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider, opnået ved ekstraktion af aromaterne fra et let naphthendestillat, med en viskositet på 16cSt ved 40 oC. Den består overvejende af carbonhydrider, overvejende C14 til og med C29, med kogeinterval omtrent fra 250 oC til 425 oC.]

307-760-5

97722-10-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-519-00-X

carbonhydrider, C27-42-,

dearomatiserede;

uspecificeret baseolie

308-131-8

97862-81-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-520-00-5

carbonhydrider, C17-30-, hydrogenbehandlede destillater, lette destillationsfraktioner; uspecificeret baseolie

308-132-3

97862-82-3

Carc. 1B

H350

GHS08

Dgr

H350

L

649-521-00-0

carbonhydrider, C27-45-, naphthenske vakuumdistillations-;

uspecificeret baseolie

308-133-9

97862-83-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-522-00-6

carbonhydrider, C27-45-,

dearomatiserede;

uspecificeret baseolie

308-287-7

97926-68-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-523-00-1

carbonhydrider, C20-58-,

hydrogenbehandlede;

uspecificeret baseolie

308-289-8

97926-70-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-524-00-7

carbonhydrider, C27-42-,

naphthenske;

uspecificeret baseolie

308-290-3

97926-71-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-525-00-2

restolier (råolie), carbonbehandlede, solventafvoksede; uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved behandlingen af solventafvoksede råolierestolier med aktivt kul, for at fjerne spor af polære bestanddele og urenheder.]

309-710-8

100684-37-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-526-00-8

restolier (råolie), lerbehandlede solventafvoksede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider, opnået ved behandling af solventafvoksede råolierestolier med blegejord, for at fjerne spor af polære bestanddele og

urenheder.]

309-711-3

100684-38-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-527-00-3

smøreolier (råolie), C >25-, solventekstraherede, afasfalterede, afvoksede, hydrogenerede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion og hydrogenering af vakuumdestillationsrester. Den består overvejende af carbonhydrider,

overvejende større end C25, og danner en færdig olie med en viskositet i området 32cSt til 37cSt ved 100 oC.]

309-874-0

101316-69-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-528-00-9

smøreolier (råolie), C17-32-, solventekstraherede, afvoksede, hydrogenerede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion og hydrogenering af atmosfærisk destillationsrester. Den består overvejende af carbonhydrider, overvejende C17 til og med C32, og danner en færdig olie med en viskositet i området fra 17cSt til 23cSt ved 40 oC.]

309-875-6

101316-70-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-529-00-4

smøreolier (råolie), C20-35-, solventekstraherede, afvoksede, hydrogenerede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion of hydrogenering af atmosfærisk destillationsrester. Den består overvejende af carbonhydrider, overvejende C20 til og med C35, og danner en færdig olie med en viskositet i området fra 37cSt til 44cSt ved 40 oC.]

309-876-1

101316-71-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-530-00-X

smøreolier (råolie), C24-50-, solventekstraherede, afvoksede, hydrogenerede;

uspecificeret baseolie;

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion of hydrogenering af atmosfærisk destillationsrester. Den består overvejende af carbonhydrider, overvejende C24 til og med C, og danner en færdig olie med en viskositet i området fra 16cSt til 75cSt ved 40 oC.]

309-877-7

101316-72-7

Carc. 1B

H350

GHS08

Dgr

H350

L

649-531-00-5

ekstrakter (råolie), tungt naphthendestillat solvent-, aromatkoncentrat;

aromatisk ekstrakt af destillat (behandlet);

[et aromatkoncentrat fremstillet ved at sætte vand til solventekstrakter og ekstraktionssolvent af tungt naphthadestillat.]

272-175-3

68783-00-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-532-00-0

ekstrakter (råolie), solventraffineret tungt paraffindestillat solvent-;

aromatisk ekstrakt af destillat

(behandlet); [en sammensat blanding af carbonhydrider opnået som ekstraktet fra re-ekstraktionen af solventraffineret, tungt paraffindestillat. Den består af mættede og aromatiske carbonhydrider, overvejende C20 til og med C50.]

272-180-0

68783-04-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-533-00-6

ekstrakter (råolie), tunge paraffindestillater, solvent-afasfalterede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået som ekstraktet fra en solventekstraktion af tungt paraffindestillat.]

272-342-0

68814-89-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-534-00-1

ekstrakter (råolie), tungt naphthendestillat solvent-, hydrogenbehandlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået ved behandling af et tungt naphthendestillatsolventekstrakt med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende C20 til og med C50, og danner

en færdig olie på mindst 19cSt

ved 40 oC.]

292-631-5

90641-07-9

Carc. 1B

H350

GHS08

Dgr

H350

L

649-535-00-7

ekstrakter (råolie), tungt paraffindestillat solvent-, hydrogenbehandlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider fremstillet ved at behandle et tungt paraffindestillat-solventekstrakt med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C21 til og med C33, med kogeinterval omtrent fra 350 oC til 480 oC.]

292-632-0

90641-08-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-536-00-2

ekstrakter (råolie), let paraffindestillat solvent-, hydrogenbehandlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider fremstillet ved at behandle et let paraffindestillat-solventekstrakt med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af carbonhydrider, overvejende C17 til og med C26, med kogeinterval omtrent fra 280 oC til og med 400 oC.]

292-633-6

90641-09-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-537-00-8

ekstrakter (råolie), hydrogenbehandlet let paraffindestillat solvent-;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået som

ekstraktet fra solventekstraktion af et intermediært paraffintopsolventdestillat, der er behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider,

overvejende C16 til og med C36.]

295-335-4

91995-73-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-538-00-3

ekstrakter (råolie), let naphthendestillat solvent-, hydroafsvovlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået ved at behandle ekstraktet, opnået fra en solventekstraktionsproces, med hydrogen i tilstedeværelse af en katalysator under betingelser primært til fjernelse af svovlforbindelser. Den består overvejende af aromatiske carbonhydrider, overvejende C15 til og med C30. Denne strøm indeholder

sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider, bestående af 4- til 6-leddede kondenserede ringe.]

295-338-0

91995-75-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-539-00-9

ekstrakter (råolie), let paraffindestillat solvent-, syrebehandlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået som en fraktion fra destillationen af et ekstrakt fra solventekstraktionen af lette paraffintopfraktion-råoliedestillater, der er underkastet en svovlsyreraffinering. Den består overvejende af aromatiske carbonhydrider,

overvejende C16 til og med C32.]

295-339-6

91995-76-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-540-00-4

ekstrakter (råolie), let paraffindestillat solvent-, hydroafsvovlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion af et let paraffindestillat og behandlet med hydrogen for at omdanne

organisk svovl til hydrogensulfid, det fjernes. Den består overvejende af carbonhydrider, overvejende C15 til og med C40, og danner en færdig olie med viskositet på mere end 10cSt ved 40 oC.]

295-340-1

91995-77-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-541-00-X

ekstrakter (råolie), let vakuumgasolie solvent-, hydrogenbehandlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider, opnået ved solventekstraktion af let vakuumråoliegasolier og behandlet med hydrogen i tilstedeværelse af en katalysator. Den består overvejende af aromatiske carbonhydrider, overvejende C13 til og med C30.]

295-342-2

91995-79-8

Carc. 1B

H350

GHS08

Dgr

H350

L

649-542-00-5

ekstrakter (råolie), tungt paraffindestillat solvent-, lerbehandlede;

aromatisk ekstrakt af destillat (behandlet);

[en sammensat blanding af carbonhydrider opnået fra behandling af en råoliefraktion med naturligt eller modificeret ler i enten en kontakt- eller perkolationsproces for at fjerne spormængderne af polære forbindelser eller tilstedeværende urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C20 til og med C50. Denne strøm indeholder sandsynligvis 5 vægtprocent, eller mere, aromatiske carbonhydrider bestående af 4- til 6-leddede kondenserede ringe)

296-437-1

92704-08-0

Carc. 1B

H350

GHS08

Dgr

H350

L

649-543-00-0

ekstrakter (råolie), tungt naphthendestillat solvent-, hydroafsvovlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået ved et råolieråstof ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der

fjernes. Den består overvejende af carbonhydrider, overvejende C15 til og med C50, og danner en færdig olie med en viskositet større end 19cSt ved 40 oC.]

297-827-4

93763-10-1

Carc. 1B

H350

GHS08

Dgr

H350

L

649-544-00-6

ekstrakter (råolie), solventafvoksende tunge paraffindestillatsolvent-, hydroafsvovlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået fra et solventafvokset råolieråstof ved behandling med hydrogen for at omdanne organisk svovl til hydrogensulfid, der fjernes. Den består overvejende af carbonhydrider, overvejende C15 til og med C50, og danner en færdig olie med en viskositet større end 19cSt ved 40 oC.]

297-829-5

93763-11-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-545-00-1

ekstrakter (råolie), let paraffindestillat solvent-, carbonbehandlede;

aromatisk ekstrakt af destillat (behandlet);

[en sammensat blanding af carbonhydrider opnået som en fraktion fra destillation af et ekstrakt, genvundet ved solventekstraktion af let paraffin topråoliedestillat behandlet med aktivt kul, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C16 til og med C32.]

309-672-2

100684-02-4

Carc. 1B

H350

GHS08

Dgr

H350

L

649-546-00-7

ekstrakter (råolie), let paraffindestillat solvent-, lerbehandlede;

aromatisk ekstrakt af destillat (behandlet);

[en sammensat blanding af carbonhydrider opnået som en fraktion fra destillation af et ekstrakt genvundet ved solventekstraktion af let paraffin-topråoliedestillat, behandlet

med blegejord, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C16 til og med C32.]

309-673-8

100684-03-5

Carc. 1B

H350

GHS08

Dgr

H350

L

649-547-00-2

ekstrakter (råolie), let vakuum, gasoliesolvent, carbonbehandlede;

aromatisk ekstrakt af destillat

(behandlet);

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion af let vakuumråoliegasolie behandlet med aktivt kul, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C13 til

C30.]

309-674-3

100684-04-6

Carc. 1B

H350

GHS08

Dgr

H350

L

649-548-00-8

ekstrakter (råolie), let vakuumgasolie solvent-, lerbehandlede;

aromatisk ekstrakt af destillat (behandlet);

[en sammensat blanding af carbonhydrider opnået ved solventekstraktion af lette vakuumgasolier behandlede med blegejord, for at fjerne spor af polære bestanddele og urenheder. Den består overvejende af aromatiske carbonhydrider, overvejende C13 til og med C30.]

309-675-9

100684-05-7

Carc. 1B

H350

GHS08

Dgr

H350

L

649-549-00-3

foots olie (råolie), solventekstraherede eller afvoksede tunge restolier

[en sammensat blanding af carbonhydrider opnået som oliefraktionen fra en solventafolierings-eller vokssvedningsproces. Den består overvejende af forgrenede carbonhydrider, overvejende C20 til og med C50.]

265-171-8

64742-67-2

Carc. 1B

H350

GHS08

Dgr

H350

L

649-550-00-9

foot's oil (råolie), hydrogenbehandlet; solventekstraherede eller afvoksede tunge restolier

295-394-6

92045-12-0

Carc. 1B

H350

GHS08

Dgr

H350

L

650-002-00-6

terpentinolie

232-350-7

8006-64-2

Flam. Liq. 3

Acute Tox. 4 * Acute Tox. 4 *

Acute Tox. 4 *

Asp. Tox. 1

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H226

H332

H312

H302

H304

H319

H315

H317

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H332

H312

H302

H304

H319

H315

H317

H411

650-003-00-1

fenson (ISO);

4-chlorphenyl-benzensulfonat

201-274-6

80-38-6

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2

H302

H319

H411

GHS07

GHS09

Wng

H302

H319

H411

650-004-00-7

norbormid (ISO);

5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzyliden)bicyclo[2.2.1] hept-5-en-2,3-dicarboximid

213-589-6

991-42-4

Acute Tox. 4 *

H302

GHS07

Wng

H302

650-005-00-2

(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]cromen-6-on, rotenon

201-501-9

83-79-4

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H301

H319

H335

H315

H400

H410

GHS06

GHS09

Dgr

H301

H319

H335

H315

H410

650-006-00-8

benquinox (ISO);

p-benzoquinon-1-benzoylhy

drazon-4-oxim

207-807-9

495-73-8

Acute Tox. 3 * Acute Tox. 4 *

H301

H312

GHS06

Dgr

H301

H312

650-007-00-3

chlordimeform (ISO);

N2-(4-chlor-o-tolyl)-N1,N1-dimethylformamidin

228-200-5

6164-98-3

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H351

H312

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H312

H302

H410

650-008-00-9

drazoxolon (ISO);

4-(2-chlorphenylhydrazono)-3-methyl-5-isoxazolon

227-197-8

5707-69-7

Acute Tox. 3 * Aquatic Acute 1

Aquatic Chronic 1

H301

H400

H410

GHS06

GHS09

Dgr

H301

H410

650-009-00-4

chlordimeformhydrochlorid; N'-(4-chlor-o-tolyl)-N,N-dimethylformamidinmonohydrochlorid;

N2-(4-chlor-o-tolyl)-N1,N1-dimethylformamidin hydorchlorid

243-269-1

19750-95-9

Carc. 2

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H410

650-010-00-X

benzyl violet 4B;

α-[4-(4-dimethylamino-α-{4-[ethyl(3-natriosulfonatobenzyl)amino] phenyl}benzyliden)cyclohexa-2,5-dienyliden(ethyl)ammonio]toluen-3-sulfonat

216-901-9

1694-09-3

Carc. 2

H351

GHS08

Wng

H351

650-012-00-0

erionit

—

12510-42-8

Carc. 1A

H350

GHS08

Dgr

H350

650-013-00-6

asbest

—

—

—

—

—

—

—

12001-28-4

132207-32-0

12172-73-5

77536-66-4

77536-68-6

77536-67-5

12001-29-5

Carc. 1A

STOT RE 1

H350

H372 **

GHS08

Dgr

H350

H372 **

650-014-00-1

diethyl-2,4-dihydroxycyclodisiloxan-2,4-diylbis(trimethylen)diphosphonat, tetranatriumsalt, reaktionsprodukter med dinatriummetasilicat

401-770-4

—

Skin Corr. 1B

Acute Tox. 4 *

H314

H302

GHS05

GHS07

Dgr

H314

H302

650-015-00-7

terpentinfri harpiks

kolophonium

232-475-7

232-484-6

277-299-1

8050-09-7

8052-10-6

73138-82-6

Skin Sens. 1

H317

GHS07

Wng

H317

650-016-00-2

mineraluld, undtagen sådan nævnt andetsteds i dette bilag;

[syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+MgO+BaO) over 18 % (w/w)]

—

—

Carc. 2

H351

GHS08

Wng

H351

AQR

650-017-00-8

ildfaste keramiske fibre, specialfibre, undtagen sådanne nævnt andetsteds i dette bilag;

[syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+MgO+BaO) over 18 % (w/w)]

—

—

Carc. 1B

H350i

GHS08

Dgr

H350i

AR

650-018-00-3

reaktionsprodukt af acetophenon, formaldehyd, cyclohexylamin, methanol og eddikesyre

406-230-1

—

Flam. Liq. 3

Carc. 2

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H351

H314

H332

H317

H400

H410

GHS02

GHS08

GHS05

GHS07

GHS09

Dgr

H226

H351

H314

H332

H317

H410

650-031-00-4

bis(4-hydroxy-N-methylanilinium)sulfat

200-237-1

55-55-0

Acute Tox. 4 * STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373 ** H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373 ** H317

H410

650-041-00-9

triasulfuron (ISO);

1-[2-(2-chlorethoxy)phenylsulfonyl]

-3-(4-methoxy-6-methyl-

1,3,5-triazin-2-yl)urinstof

—

82097-50-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

650-042-00-4

reaktionsprodukt af polyethylen-polyamin-(C16-C18)-alkylamider og monothio-(C2)-alkyl phosphonater

417-450-2

—

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H319

H315

H317

H412

GHS07

Wng

H319

H315

H317

H412

650-043-00-X

reaktionsprodukt af 3,5-bis-tert-butylsalicylsyre og aluminiumsulfat

420-310-3

—

Acute Tox. 4 * Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

650-044-00-5

blanding af ligekædede og forgrenede C14-

15 alkoholer ethoxylerede, reaktionsprodukt med epichlorhydrin

420-480-9

158570-99-1

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

650-045-00-0

reaktionsprodukt af 1,2,3-propantricarboxylsyre, 2-hydroxy, diethylester, 1-propanol og zirconium tetra-n-propanolat

417-110-3

—

Flam. Liq. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2

H225

H315

H318

H411

GHS02

GHS05

GHS09

Dgr

H225

H315

H318

H411

650-046-00-6

di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamiddisulfonat, kobber(II)kompleks, derivater

416-180-2

12222-04-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H302

H373 ** H411

GHS08

GHS07

GHS09

Wng

H302

H373 ** H411

650-047-00-1

dibenzylphenylsulfonium hexafluorantimonat

417-760-8

134164-24-2

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H372 ** H302

H318

H317

H411

GHS08

GHS05

GHS07

GHS09

Dgr

H372 **

H302

H318

H317

H411

650-048-00-7

reaktionsprodukt af borax, hydrogenperoxid, eddikesyreanhydrid og eddikesyre

420-070-1

—

Org. Perox. D **** Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A Aquatic Acute 1

H242

H332

H312

H302

H314

H400

GHS02

GHS05

GHS07

GHS09

Dgr

H242

H332

H312

H302

H314

H400

650-049-00-2

2-alkoyloxyethyl hydrogenmaleat, hvor alkoyl (vægtmæssigt) udgør 70 til 85 % umættet octadecoyl, 0.5 til 10 % mættet octadecoyl, og 2 til 18 % mættet hexadecoyl

417-960-5

—

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

650-050-00-8

en blanding af 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamat og/eller 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamat;

1,3-butandiol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionat] isomerer;

1,3-butandiol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionat] isomerer

423-600-8

—

Aquatic Chronic 2

H411

GHS09

H411

650-055-00-5

sølvnatriumzirconiumhydrogenphosphat

422-570-3

155925-27-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

---